<SEC-DOCUMENT>0000721371-22-000058.txt : 20220811
<SEC-HEADER>0000721371-22-000058.hdr.sgml : 20220811
<ACCEPTANCE-DATETIME>20220811161706
ACCESSION NUMBER:		0000721371-22-000058
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		128
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220811
DATE AS OF CHANGE:		20220811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		221156122

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cah-20220630.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f,d:06b8b3ff48e94029843042d968c5bda7--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20220630" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cah-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN18xLTEtMS0xLTE0NzE1Nw_d4690fca-b7c9-453a-a0ea-e2c5060d7a38">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN18zLTEtMS0xLTE0NzE1Nw_cd3bb201-7982-474d-9dce-194f8a6a9540">2022</ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN180LTEtMS0xLTE0NzE1Nw_4164348a-46e0-4f0e-bacb-9809a10eadc9">FY</ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN181LTEtMS0xLTE0NzE1Nw_5df41b2f-2e44-42a3-a413-9cd844e81068">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891">http://fasb.org/us-gaap/2022#DeferredTaxAndOtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f">http://fasb.org/us-gaap/2022#DeferredTaxAndOtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffab656ed24e4a6ca73f74c927197d64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie2afea71cb9b47288a9896a84bf285d6_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id718ed1e33ce417a8b54b992f9f06368_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e1921e87f164ec2a076a8022000e553_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd42525ba6945e0a2388b3cfd583b55_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ab48f8f0ca84770b2cdd725d449c559_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a74100c06424e0c80abaeaaf61e0fae_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62cf4cc6eb9443bc92ba424345a43970_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idba5b8a7abac4a44b7b7aea83c67e7c3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16f1640dafb24aadbf40453cd1ad0423_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dee667c44cf4729bf5c5fff72aa3e3a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2a315588dc47fa848589f8d339e4f4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1647e6a3df7432b93b26a7bd668dfc9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib28ba902d1c94df4a3c67814f8c372a5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea5f56de7fee4d1dac477ee0cf61168f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d3316767394706be72a492bdcd2efd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0fb00ebcf504ae6b0af6dc851474deb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba299e1050549689ffb0f8eacbea9c0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934ea3588a144dd5b265a98b3005fb6d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie319b7f528d244d180aab748fdbce12d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e1f19c62f9f42bcb0e306e9ba872206_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73da689c634e4d5ba2674bf686bd3f86_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63aae49541134c39aa2c99f778658cc5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf660360901949d98a491a3d5fbb5d7d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id528f552d5104bcaa9fa12a73626119f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic85d2f2f06c94ebe83e8327bd00e68ce_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1711b8d7bfa14e438a604b5eb731fd63_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i242004258f7948c09176905c6439d71e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb7741eed65481097e07facd023b229_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9621b37a8dc4e7ea9c3508d6c8eb651_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie54dcff3023345b3b8dbceb05e183894_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2597c971f6604c2a9a6b84309d0885b9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77687ae7a5664be792bcbd38bb67e2b2_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8188d649f96f4d47aa2ede0789bc920c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4737f6e39b0e4dc09e8ec181488988cc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="organization"><xbrli:measure>cah:organization</xbrli:measure></xbrli:unit><xbrli:context id="ifb74843eaf0a48e78b9e853f892a30ba_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d51d1a743744443b9f40a909974d9c4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38cd3d843f544dd0ac41d8cae2504a85_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca12a2ea9cd462c9141a9d8057be00c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveWriteDownToNetRealizableValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4140159ea4a43739df00326c541235c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveExcessAndObsoleteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a45ec948a346c4a693ae4491ab887b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveExcessAndObsoleteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf515cb8fd624891a66b5f7e1ea44ba1_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7a6fadd3f148f883ebb6412075c8ac_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a58c6e8721a4d5c9f8d148d848b3c73_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42f20105ab0411cab507a7959ade5cb_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61d5020105b54ebdbda79ad2cdd2c486_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f4bb9b89da04d04968694a6fec77b68_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5978dceb66ad409fb3003c8699c5492a_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i887ae0d04a84497d824efb8ead276201_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c38ba87cbb64d34ac1bacba542abf6a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i033b0d1b48434099a70157ef43c38a49_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bf7f9f717bf419d972451fe5f3da912_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bf3f5eefca4129a06653b17bf04363_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee55f0b9ac1749cd8fad660d4398d09f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i937b0ef4a4ca4ea3bea8db2f1a6b54c7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e847a45be14fb698f7a64309bc2a65_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d6189c62c3b4fc08a6ec02502390bf5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb96066e3a547e9b5b6924d06661609_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9c6746ba5745d2bb4039a6f7b03117_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cah:segment</xbrli:measure></xbrli:unit><xbrli:context id="i2f8bd16b589e44678ce911885626954d_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce5118955de4439a550969fa0cc542c_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e703a9570f493582c8bc1a69a64a7d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a84380ffecb45f7abba964081bd5ef7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a1465dba6b406da9f48c90f84ff2fb_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546d299bf20c4b749073124f61b96f80_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1114e2457f3f4ea59b1038c632c920f6_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5735c211d1fd471db52d24b85e925378_D20210802-20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95da9ef4bd164992be47943c8af11f5a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4cc2b4bbaa0449790c4c94fb3395ed8_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28546e72017346d28b45df1b4a2b2885_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id264d3093a7a4580ad949f73349b6a5c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf2368a61474f8f89d5d38fec24f64f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied971d2805b0409083a7c40b38503d50_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0092967ac5424faf8778330ec9444ee4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75c1fef25e9e4f83a31d3467e3e59555_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd545e35312405cb520c9f72a124131_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002c719a8c5b420b8af67195661dda98_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25aa8308d1943b59cbe926e3c5d3649_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f92afd839604684abe9404d6d95434d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9fc6bbba81b4a1ca1be4f2ccbed4b27_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d77a4c2a834917a3f42f75ef217b73_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2570c791ecea44d9bc344bd115d28c3c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abfa91513984b189f3f0624a3d7175e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59345f7aaab84656a49d8caf50ebe1b9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbeba755f36e4c298fc6035248db673b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i111b02e3c4c4435d83e0af77b9189c58_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9bb8d1c3bce41a4917f5b1276888172_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e89ba2935f840fa91b39e91552d9dc6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80fae599ff554c3fa75995b90567c93a_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib41241d46b104c50b08e484eb87e196f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c528a8d9694aee94274e9b419173e7_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d56789271704cc391e10e73a9dc6d56_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7778605f8f09452483e387ca04e5f798_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iced246337ea748e18ce3b7196e968243_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ed9de2f40646068fda63624fe9021c_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aaeb4ce0c834fc793b1f0b25fa82f9b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101a75214a2841688c2ee6c7e7f23e10_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37112b83786b4ac1ba34031420b8575a_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice004f9102ba4d5fa58a7477de8fe13e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id882b2f82db24e5c857e6ba1a0e384af_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e77764f4c64f7abd7d4a5227eb6f41_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbf71c602bb40a5b964360fc429bff3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i885fe3ac6e1a4babbc66a8db94f82e38_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e90c5526e84b74be02b2b7a029bb5d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f78f224039402a88005fb30536dad1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b7d966b6b934db1a5c6c380f6d08006_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4a7953acf34ee99b0152b4348d298c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19940e136f3f4037ac958751189f0e42_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb2dda3fb1b24c6c9dd6058e3deb85a2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db02e14f91846b1b3f5268f07efaf25_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d82da09b63414d9e4d23de0552e992_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5be0282727a4d219c233e858971eab3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief95ead6d3304e5283a841e043450002_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ebb9851a4a6454d878d280244504203_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf9550d3a90c4fe7abe3b7f766ed70ad_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0809664ee714c24958018126d48a37c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1588ed89bc745b2a267d8c2daef772e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1ad8e9f740460c9717fa142af909bf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb9f3742e0b84411bd2e5b40340f02e2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4a7026d7514fa682d445bca65f8fce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621b77904b4340b2bcbbba0f4babdffd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15dc38ffa0654e75a949152dac07365f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a04d5f0835442bae0648463d282df4_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80b7f23b79f4c74a63a2aea8a160669_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c4addddd22425095e8747d5010555f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i880c502ad6a54517904d884280fcde32_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A32Notes2616NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3827a1282fa341608b2ab469d733c58a_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2624de343f9148a89e5e879c4c82b456_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25174483a8524ab68a643c722a044868_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotes2616NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fa51c2037854bb89d8846afa4ed5e99_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07524980d6a64ab0900fdee89c51519e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33da3620cedb405488c45ea93f45f9f7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia07846c1c0304317b72bad3a3eea1a34_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce95bfc57ac401db96d15c30dac19f1_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia624d146ecb046bebe9077aabecd86e5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbdef24d9ef64b91aa1ffa7ea2f55a2f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc70dd563e3469b9d8e95f7e3db1e7d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a684eeb749345e9b75d857b1e1719eb_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A24NotesDue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29917c8b4aab4eb2a08720812cda9e5f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2bf417d2ce4569b7095141c8585f43_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib802e2c8dcb949298f691230fa6a001e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41cb6234b1c242c1b3d5212ab191fccc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia602868425d84c939a48b46f4b7f99a3_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62274a161fe54af9b457ca7496c6d48e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58cef62c3cd5423a91e3afefd7967e2a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e0a63d6182434b947a044598b6b9be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e905accc4fc429dbe8fb2baa9d577ac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22cd37e98bb24d1eac47e3997f243e60_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b3c6bcb9476438a921794e67914851b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>cah:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="states"><xbrli:measure>cah:states</xbrli:measure></xbrli:unit><xbrli:unit id="numberofusterritories"><xbrli:measure>cah:numberOfUSTerritories</xbrli:measure></xbrli:unit><xbrli:context id="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df3ad6b3a5c472db6a4ef8acf2ccee2_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e04e176378443dbece7c929cced18b_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b99fd673554c27875a602f3ebd6229_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf6d168e90384511a71c377dfd7de3ce_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17df012ad7434bfbb9d2eb2b368409f0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7356694aafaa470bb4b7829c91e1f795_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fbfe1e2d6514850b46a3e54db3b64c8_I20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20857812252441139f2a9488cc8b4bba_I20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6e7b27e6d834a1c8986340dacdd8d75_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>cah:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i6832ede5864441bc8fc50fdb23a84d6d_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49994de05a53424c945a894b6a702b21_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3536e19ef529496ab3333df7b2c14579_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d64ff0f91940089c6a221af627861f_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d398a83243b4879a927f24535bca4ad_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7b1ad13d2d3426a96e738a22b1d3ab6_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:DOJInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a49e2802adb47ebb172f2416918baa4_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:GoodwillImpairmentAxis">cah:MedicalUnitGoodwillImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba6181b3f81427f9ba8073d79075732_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib692a8c8095746b7ac437f383074870f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9b4528179f4b06825682ef3bc16324_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib70a49e43657407780e301606b63b480_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie478c499b6e14ab2bbc046275533973f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf55d738e4c2417989763623ac863aba_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4049be5d431a45859642596069133d4c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf7f919960364e29acc09ea1ecf5403b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d73f184d2b949538033de20922de133_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf2679b91854d43ae797e4fa386a35a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i155edd13bdcd4fe6a997c9048e92a4cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f315442d4d144f597f8e7072738b52c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c79bf8fa09b4d96b7509598247edd5d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f334187da934dae8f50e09f680684be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e2109c867604d538c15c36e5773bfcd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2daf1b96e99540f9a365925bbd666b52_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702e037993f84f039a387fa5716c2c5f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b3e38adae184a0f962abd0822c6e227_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8252480092a4420d9a47a8420945e070_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0d0c9e1e2f467d97bbc64581905f40_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff344aae68f94110aca38462cc1fbfeb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f8e752754a4c0a8560dab2d9697e94_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06ff51c1469749a9be8eb3406df0e62c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic059bb286acc4a4f9c4085b5a0410159_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibccd2d0c1e544d42a1d4b65d126614e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d72cfa1fc7448e8a4d03ab71fc0b20_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a755a6106242698132be9ad227180a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8588473d4f2c40a7ac9bf6e97f477a07_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icddad5bf093244d1b4387d8a979d72cb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic69376b6c620458997976028c1214422_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cfc47e3aa3a4886af27a182bd671ec1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10d0b211539491aaf593b13a51c07c6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec28629ea39c43e4840b61f68f95c92c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d851e08ef540a6aceb7daa376a4bc2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i945df5b6d2454f3bb10a110ca1cfb83c_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8568be76a18940d69f23584500123552_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3961f5fc579946a7adb7919493a245f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e787599e79e498b900200587d8ebe7d_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6abd62fa79443881013d61bc42a3cd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec5a8f432dfb4a669e5b7ba55a35b302_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i773662d7d9b448b8b333e4a1b94246ba_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf50b11230f141ef80acceb9da69ce09_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i235c4dd623e14a40ae30c1c514b56b33_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20a6b75339f4305bd27c3566e131b42_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7bc307cde846ad8020785fb428b704_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6655370d79f845c5b210b9cbc38baa6a_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008e5300d1fe41a1815096bec1786b2e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec740da2e31443ca3a03df609402dba_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84712198fd34c77a01fe1cc4008c915_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d06eff618844ea9b294766cd40c0cbb_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d390067fa94438188ada7ef9dd06ef3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e636c0a4764fbda3673d5e4c24027e_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3689b6ecce894dcf9310fad3bfb4484c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1d6e92138f4a2bbfefa3aa6fa73311_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e36bc811b8e4e04b871a13fd2292653_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i012e1ceb9763423189450a46d2c76f14_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4b437cafd548ff9b69d8d997ae280d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfff6e07744441528f22c7027f392bc3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9ef85b7c88a4539972e810d6676bcd2_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50482f61b49343aea4800caf3921c613_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a7c5d5859848dd88abbc1a8fbb11c9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i421ac4ebd1c940d5be641a14b6a8565a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bee56b9093547aab3e10f4b7c9d0c93_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d114542faa4edc9d89c757065598f7_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a935fc8248a4a1890e47ba459c9f8bb_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269c8552647a4321a761031c80f05289_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cddbe3b6c7a4e719277441f86f08a81_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b8544764a8141e69a14460e4f902fb7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46bf92b1ae9412db7eb482248d3e631_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d0afbc7f24472f9a3373a8620e9bb0_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba25e5360ae47298c3f879441851557_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01d7cee22094964ba6e1b1c964e79d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:MaturityDateAxis">cah:September2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i49b160e1a7e845e9b7fce15173ef887a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:MaturityDateAxis">cah:June2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba1dd6808f54a86a81fd6308d260b0f_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d8c3f959e54f26b4608732cff6a528_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2f1b851c9794bb5a1866c1ef80be14e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2791b320bdf418283ef26f40f8960d2_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id83a99daa0324eaf9c0d86f62c609f16_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb30ce6147144d6cb2de94c1c28b34d8_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i458d92552dd24194973d1eecdc2b3c4e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a6cbd72cc74687b9d7255c26b5ee6f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a04898d27345438f4a7a3a130a15be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9f63f23b1554e848a59e032b744632e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cd2559051274accba49716a53ea4d55_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5cfbdd2a57c495092c1346adb91387e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie251c72e85d34942ab0769ac0f335908_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170f7cf26f08409dac798c226dec905e_D20190701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A500MillionShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A300MillionShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A200MillionShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic12e802652d64575be3f052d531ee71a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd6dc10bbdf4a9887f38ce5a9b7eebb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i017776f20a154be38946329695a6e3bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27066680d4f44a88bd6f0bde058453f4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0080970b8347daab96c670e8f07328_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i671a35d442834525849f31bba3176fbe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ae84c9f59a4cb4885c9e03cdef73cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if032321307a24934b26372b254b11bbe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14af28fc8088402b8cf9586da815c628_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1375be2585e496ba632f589f37aecdd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41b64a0ab009497cb6651f141753bb14_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ab01785f1e4a10a2f627369a131981_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe4938f791c47a7a2e7be341d8ae001_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26fa0488c0b0421a9bd978c6e75ec078_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib18eb292c9cd45549a3cce1a8564d34a_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf54a140331447bc971da869fab4170b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3a872d654474220917795caa5437ced_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d75341c0824694ace8cacae3c3cff4_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1190aafabb474bb7daeda0ceb4428e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c84b6027bc4bfc9c7fef1cc6232649_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5a57d0101144d68ed8cbf6f33a252b_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6012e2f082d64586a52d2f99291c081f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic772b6d04449407f823eef4bab315a1c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8120134644a4b72b67cf151f13a9267_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cfa5d379fec4924976b8c213fb2a55e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a97b6e528884b40b6ab715fd4b1afbf_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f0d63f2484f4781b52456c257c21f31_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cah:SterileSurgicalGownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedce1d5b11c3477faba70a05739a2a83_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if72f2f625f914e10845cc7ec67500cb9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ad6131da723466fbfb29da932695b7c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61201f0b4adc4f448c19177911dff7b9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0b4a7378184981b9c5ac2d3f486cba_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifddfe552f3a644c3aabf1bd148586afd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief926b64f91a4cdb97a0f010db30b234_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8396dd140b7c4e5088714d90bba871dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9470b5d20374655a7021f0f36d0030f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84a995d73354904960f0fc24a118169_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10081408aa87434ab81112bdd4bddd79_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaf9ed3e3c2146e69762157a21265754_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4540961b5e6b4808a8026bb9516ae3e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b498db236d3482f9f42a2a0a3f882f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0593a5c8012d425ebb9b526021b07458_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6f204ca12940be95285479dd9fd419_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fc8886bd8f4f4e8e6f8813d56985a8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a070ccd43d454bb5c9cb38b3cf6771_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38081f76db524efdac004049a6ebca1e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ba87bba31c44ccc98e13df2983e423b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d09281a7c14a70bbb09c9ca514ae47_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia467dc323b074fc7af8717e8d527a287_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vestingperiods"><xbrli:measure>cah:vestingPeriods</xbrli:measure></xbrli:unit><xbrli:context id="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b77b415b584f6ab312fd1c96fca6e3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43325093a8ee44ed8f85cdbf2059ce09_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad9e1e9c9c24a5a93fb7c80fa81eeeb_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e641c3a7b314110b555c0df32c0642c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056274b9166742cdaee278d9b684a643_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c301733ef2486eb8a91bd315f448fa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia953d01035744830b89e0d49aa3ef798_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b79de0e173c49a293e4e8121d68cf5d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a5929938d842bca82c533a67d3e5ad_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia768abc477b149ba8b237395ef925335_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic14268b63f5e4696bfec9d26f5249db2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7cd7c5e10e435f9a63d042307ff0a5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad140489fe934c8caf9ef36be5139d4f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica1d90385829420fac7b1024979b31c3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d67fb03b394de5bfd91a7161298584_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b7882d67e14e36b7002a6ff0299b96_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d69bac84194be3ae102ae751b16751_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b6099badb34def8ff80369a0b76e44_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i964db25469894c16b81360ef4522965e_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96021e36fcd47b580794c907494e1f0_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i06b8b3ff48e94029843042d968c5bda7_1"></div><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Washington,&#160;D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:100%">Form <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI2_272b9202-9a3e-4e8f-bd2c-ac3fd1fd4c37">10-K</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6YTRiZGFiOGI3NzJlNGMwNDg3NzY0MzFlMmViZGEwODAvdGFibGVyYW5nZTphNGJkYWI4Yjc3MmU0YzA0ODc3NjQzMWUyZWJkYTA4MF8wLTAtMS0xLTE0NzE1Nw_9ca55329-54f2-4d9c-9e10-47e9f4713a96">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV82NTk3MDY5NzY4ODk3_a43079dd-b4a7-42c2-ac3c-b0a60d7221af"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV82NTk3MDY5NzY4ODk3_6a898ad8-5ce8-4563-b71d-fa5e1618406f">June&#160;30</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MTNhNTU3OWI0YzA5NGJiYjliYjhlNGM0YjE5N2FlYWQvdGFibGVyYW5nZToxM2E1NTc5YjRjMDk0YmJiOWJiOGU0YzRiMTk3YWVhZF8wLTAtMS0xLTE0NzE1Nw_29cd4997-439b-458d-add3-395fa60a4440">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ________ to ________</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number:&#160;<ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI3_0db52025-d624-4dc4-9b78-16b18f3062be">1-11373</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIx_ece9da10-2ac4-4f03-8750-576d99497f87">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.544%"><tr><td style="width:1.0%"></td><td style="width:25.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8wLTAtMS0xLTE0NzE1Nw_abebeb72-6df4-4966-9d72-f968ee54d6cb">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8wLTYtMS0xLTE0NzE1Nw_e93cd6b8-110c-49fd-96f8-722a47b77d7b">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTAtMS0xLTE0NzE1Nw_90b3a3fd-17a8-4e07-a775-e770f63c438f">7000 Cardinal Place</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTItMS0xLTE0NzE1Nw_49c7ff7f-2d85-4fbc-9000-f83bc811ebe8">Dublin</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTQtMS0xLTE0NzE1Nw_e936c0ad-5b54-43f5-90f5-ec1a75f8b168">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTYtMS0xLTE0NzE1Nw_a0075288-72f0-4a3f-88bc-f697e3882c78">43017</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF82LTQtMS0xLTE0NzE1Nw_4a29d2b9-68e1-46eb-a728-b7b551c0b81b">(614)</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF82LTYtMS0xLTE0NzE1Nw_4ff9bc9d-636d-4b67-a05d-878442a4a744">757-5000</ix:nonNumeric></span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.370%"><tr><td style="width:1.0%"></td><td style="width:35.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTAtMS0xLTE0NzE1Nw_54a4340c-9e93-4919-a15d-ada4b31f6e8e">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTEtMS0xLTE0NzE1Nw_5f28e529-945a-4509-be82-774c878f7a89">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTItMS0xLTE0NzE1Nw_2175ebb8-e837-486f-ba09-250a83ce9105">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(g) of the Act: None</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIy_54d13830-6ecb-4eba-9fdc-1a60a64babdc">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI4_5dc0efaa-2754-429d-98d5-19f17b03787d">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIz_e41d3066-b218-4924-b28f-36e43a639f3e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI5_c7505e80-b571-466a-a01c-cc1e678dff6c">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.089%"><tr><td style="width:1.0%"></td><td style="width:18.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8wLTAtMS0xLTE0NzE1Nw_2ce96618-6599-4611-b078-112359a0e9bf">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8xLTQtMS0xLTE0NzE1Nw_1ed72823-4667-4f2a-9832-2d1db32c66e8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth&#160;company&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8yLTQtMS0xLTE0NzE1Nw_43f81462-d49e-4ea7-829f-9738a2873860">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.<br/>&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV81LTAtMS0xLTE0NzE1Nw_35a1daae-fb9f-4789-9220-ac25ce248629">&#254;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI0_da26b027-194c-4d93-9412-8fce01fd4ca3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates on December&#160;31, 2021, was the following: $<ix:nonFraction unitRef="usd" contextRef="iffab656ed24e4a6ca73f74c927197d64_I20211231" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8xODQw_15eb473c-2d29-44ff-9482-43c002acbde0">14,223,756,327</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of the registrant&#8217;s common shares, without par value, outstanding as of July&#160;31, 2022, was the following: <ix:nonFraction unitRef="shares" contextRef="ie2afea71cb9b47288a9896a84bf285d6_I20220731" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8xOTUw_c599c842-b233-4013-a1ca-350451bb8e1b">272,512,364</ix:nonFraction>.</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjMw_6e59be51-eb0c-4a24-9b0d-434658ece060" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents Incorporated by Reference: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its 2022 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div></ix:nonNumeric><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_7"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Fiscal 2022 Form 10-K                                                                                                                                   </span></div></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:91.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_10">Introduction</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_10">2</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_13">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_13">3</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_40">Explanation and Reconciliation of Non-GAAP Financial Measures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_40">23</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_49">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_49">28</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_52">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_52">30</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_55">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_55">39</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_58">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_58">46</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_61">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_61">47</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_64">Market for Registrant's Common Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_64">48</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_67">Reports</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_67">50</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_76">55</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_151">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_151">89</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_157">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_157">91</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_160">Form 10-K Cross Reference Index</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_160">95</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_163">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_163">96</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Introduction</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">References to Cardinal Health and Fiscal Years</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this report, "we," "our," "us," "Cardinal Health" and similar pronouns refer to Cardinal Health, Inc. and its majority-owned and consolidated subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30.&#160;References to fiscal 2023, 2022, 2021, 2020, 2019 and 2018 are to the fiscal years ended June&#160;30, 2023, 2022, 2021, 2020, 2019 and 2018, respectively. Except as otherwise specified, information in this report is provided as of June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, including in the "Fiscal 2022 Overview" section of Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), we use financial measures that are derived from consolidated financial data but are not presented in our financial statements that are prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These measures are considered &#8220;non-GAAP financial measures&#8221; under the Securities and Exchange Commission (&#8220;SEC&#8221;) rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this report.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MD&amp;A within this Form 10-K generally discusses fiscal 2022 and fiscal 2021 items and year-to-year comparisons between fiscal 2022 and fiscal 2021.&#160;Fiscal 2020 items and discussions of year-to-year comparisons between fiscal 2021 and fiscal 2020 that are not included in this Form 10-K can be found in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the "Fiscal 2021 Form 10-K").</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Information Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report (including information incorporated by reference) includes forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in MD&amp;A and Risk Factors, but there are others throughout this report, which may be identified by words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions, and include statements reflecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these risks and uncertainties are described in &#8220;Risk Factors&#8221; in this report and in Exhibit 99.1 to the Form 10-K included in this report. Forward-looking statements in this report speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports are available free of charge on our website (www.cardinalhealth.com), under the &#8220;Investor Relations &#8212; Financial Reporting &#8212; SEC Filings&#8221; caption, as soon as reasonably practicable after we electronically file them with, or furnish them to, the SEC. The SEC also maintains a website (www.sec.gov) where you can search for annual, quarterly and current reports, proxy and information statements, and other information regarding us and other public companies.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About Cardinal Health</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_16"></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">About Cardinal Health</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc., an Ohio corporation formed in 1979, is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.026%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Results</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Fiscal 2022 Overview</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for fiscal 2022 was $181.4 billion, a 12 percent increase from the prior year, primarily due to sales growth from pharmaceutical distribution and specialty pharmaceutical customers, which largely consisted of branded pharmaceutical sales to existing and net new customers.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP and Non-GAAP Operating Earnings/(Loss)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">324</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,050</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP operating earnings</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,990</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a GAAP operating loss of $596 million during fiscal 2022 due to $2.1 billion pre-tax non-cash goodwill impairment charges related to the Medical segment. See "Critical Accounting Policies and Sensitive Accounting Estimates" section of this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional detail. During fiscal 2021, we recognized pre-tax charges of $1.17 billion for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. See further description of opioid lawsuits in the Significant Developments in Fiscal 2022 and Trends section in this MD&amp;A and&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements." </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP operating earnings during fiscal 2022 decreased 12 percent primarily due to the decrease in Medical segment profit, largely resulting from net inflationary impacts (which primarily related to increased transportation and commodities costs, partially offset by certain price increases) and the adverse impact of global supply chain constraints.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP and Non-GAAP Diluted EPS </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">($ per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.27</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.87</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.93</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.31</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP diluted EPS </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.06</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.57&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Diluted earnings/(loss) per share attributable to Cardinal Health, Inc. ("diluted EPS" or "diluted loss per share").</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The reconciling items are presented within this table net of tax. See quantification of tax effect of each reconciling item in our GAAP to Non-GAAP Reconciliations in the section titled "Explanation and Reconciliation of Non-GAAP Financial Measures." </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">For fiscal 2022, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 279 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2022 non-GAAP diluted EPS is calculated using a weighted average of 280 million common shares, which includes potentially dilutive shares.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Impairments and (gain)/loss on disposals of assets, net includes pre-tax goodwill impairment charges of $2.1 billion related to the Medical segment recorded during fiscal 2022. The net tax benefit related to these charges was $150&#160;million.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Litigation (recoveries)/charges, net, includes a tax benefit recorded during fiscal 2021 related to a net operating loss carryback. Our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and adjusted our taxable income for fiscal 2015, 2016, 2017 and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act. The total benefit from the net operating loss carryback was $424 million; however, for purposes of Non-GAAP financial measures, we allocated $389 million of the benefit to litigation (recoveries)/charges, net, which is excluded from non-GAAP measures, based on the relative amount of the self-insurance pre-tax loss related to opioid litigation claims versus separate tax adjustments. The tax benefit allocated to the separate tax adjustments of $35 million is included in non-GAAP measures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, GAAP diluted EPS was adversely impacted by the goodwill impairment charges related to the Medical segment, which had a $(6.94) per share after-tax impact. See "Critical Accounting Policies and Sensitive Accounting Estimates" section of this MD&amp;A, and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional detail.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, GAAP diluted EPS was positively impacted by $1.44 per share due to a tax benefit from the net operating loss carryback primarily related to a self-insurance pre-tax loss, as further described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." The charges we recognized in fiscal 2021 for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications had a $(3.21) per share after-tax impact on GAAP diluted EPS. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, non-GAAP diluted EPS decreased 9 percent to $5.06 due to factors impacting non-GAAP operating earnings, partially offset by a lower share count as a result of share repurchases.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cash and Equivalents</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and equivalents balance was $4.7 billion at June&#160;30, 2022 compared to $3.4 billion at June&#160;30, 2021. The increase in cash during fiscal 2022 was due to net cash provided by operating activities of $3.1 billion. Net cash provided by operating activities includes a refund of $966&#160;million for the tax benefit from the net operating loss carryback related to a self-insurance pre-tax loss, and reflects the impact of $417&#160;million of payments related to the settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities, payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. Fiscal 2022 operating cash flow was also impacted by favorable timing of net working capital. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also received proceeds of $923 million, net of cash transferred, from the divestiture of the Cordis business, and we deployed $1.0 billion for share repurchases, $885 million for debt repayments, $559 million for dividends and $387 million for capital expenditures. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Significant Developments in Fiscal 2022 and Trends</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Opioid Lawsuits Developments</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">National Settlement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in fiscal year 2017, state attorneys general, counties and municipalities began filing lawsuits related to the distribution of prescription opioid pain medications against pharmaceutical wholesalers, including us, and other participants in the pharmaceutical supply chain. By fiscal year 2022, Cardinal Health was a defendant in approximately 2,775 lawsuits brought by state attorneys general and counties, municipalities and other political subdivisions. In July 2021, we and two other national distributors (collectively, the &#8220;Distributors&#8221;) announced a proposed settlement with a group of state attorneys general intended to resolve the vast majority of these lawsuits (the "National Settlement") as well as a proposed settlement agreement (the "Settlement Agreement") containing, among other things, a sign-on process to allow states and political subdivisions to participate in the National Settlement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Distributors announced that each company had determined that a sufficient number of states and political subdivisions had agreed to participate in the National Settlement to proceed to effectiveness of that settlement. The Settlement Agreement became effective on April 2, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties to the National Settlement include 46 out of 49 eligible states as well as the District of Columbia and all eligible territories. As of August 9, 2022, over 99 percent of eligible political subdivisions (as calculated by population under the Settlement Agreement) that had brought opioid-related suits against the companies have joined the settlement or otherwise had their claims addressed by state legislation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement includes a cash component, pursuant to which we will pay up to approximately $6.0 billion, the majority of which is expected to be paid over 18 years. The exact payment amount will depend on several factors, including the extent to which states take action to foreclose opioid lawsuits by political subdivisions (e.g., by passing laws barring or limiting opioid lawsuits by political subdivisions) and the extent to which additional political subdivisions in participating states file opioid lawsuits against us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement also includes injunctive relief terms related to distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating controlled substances monitoring programs; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the Distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which the Distributors will fund for ten years. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we made our first annual payment under the Settlement Agreement. Prior to the effective date of the Settlement Agreement, the Distributors had entered into separate settlement agreements with each of the states of Florida, New York, Ohio and Rhode Island. When the Settlement Agreement became effective, each of these states and their participating subdivisions became a part of the National Settlement; however, the New York, Ohio and Rhode Island agreements required us to make certain payments separately from those required by the Settlement Agreement. Accordingly, during fiscal 2022, we made payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. In total, we paid $417&#160;million in connection with these matters during fiscal 2022. We have $6.36&#160;billion accrued at June&#160;30, 2022, of which $532&#160;million is included in other accrued liabilities, and the remainder is included in deferred income taxes and other liabilities in our consolidated balance sheets. In July 2022, we made our second annual payment of $374&#160;million under the Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Settlements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Virginia subdivisions and Native American tribes are not a part of the National Settlement and we had separate negotiations with these groups. A bench trial before a federal judge in West Virginia in a case brought by Cabell County and City of Huntington against the Distributors concluded in July 2021. In July 2022, a judgment in favor of the Distributors was entered. In July 2022, the Distributors reached an agreement to settle the opioid-related claims of the majority of the remaining West Virginia subdivisions. Under this agreement, Cardinal Health agreed to pay eligible West Virginia subdivisions up to approximately $124 million over an eleven-year period. This agreement is subject to certain contingencies related to subdivision participation. In September 2021, we announced that the Distributors had reached an agreement with the Cherokee Nation in connection with ongoing negotiations toward a broader agreement with Native American tribes. In January 2022, the Distributors executed a term sheet with the Native American tribes. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Distributors reached an agreement with the Washington Attorney General, under which Cardinal Health will pay up to approximately $160 million to the State of Washington and its participating political subdivisions to resolve opioid-related claims. This amount is consistent with the amount that would have been allocated to Washington under the Settlement Agreement plus certain attorneys&#8217; fees and costs. The terms of this agreement are consistent with the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2022, the Distributors reached an agreement with the State of Oklahoma to resolve the opioid-related claims of the state and its political subdivisions. Under this agreement, Cardinal Health agreed to pay up to approximately $95 million to the State and its participating </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">subdivisions. This amount is consistent with the amount that would have been allocated to Oklahoma under the Settlement Agreement. The terms of this agreement are consistent with the terms of the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. If this agreement and the Washington agreement are finalized, Oklahoma and Washington would be subject to the Settlement Agreement and 48 of 49 eligible states would then be subject to the Settlement Agreement. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the lawsuits and claims brought by states and governmental entities, described above, we are involved in other opioid-related litigation and investigations, which are described further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note</a><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118"> 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221; </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Inflationary Impacts and Global Supply Chain Constraints</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical segment profit was significantly negatively affected by inflationary impacts, primarily related to transportation (including ocean and domestic freight), commodities, labor, and global supply chain constraints in fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect these inflationary impacts and global supply chain constraints to continue to adversely impact Medical segment profit in fiscal 2023 and beyond. In order to partially mitigate this impact, we have implemented initial phases of price increases and we intend to implement additional price increases. We are also evolving our commercial contracting processes to provide us with greater pricing flexibility and investing in additional supply chain capacity. These increased costs and global supply chain constraints are difficult to predict and may be greater than we expect or continue longer than our current expectations. In the event these costs decrease, the benefit to Medical segment profit will be delayed until the higher-cost inventory has moved through our supply chain. Our plans to increase prices and evolve our contracting strategies are subject to contingencies and uncertainties and it is possible that our results of operations will be adversely impacted to a greater extent than we currently anticipate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, inflationary impacts, primarily related to increased transportation and labor costs, also adversely impacted Pharmaceutical segment profit during fiscal 2022. We expect these inflationary costs to continue to adversely impact Pharmaceutical segment profit in fiscal 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PPE Demand and Pricing</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. Demand for PPE has fluctuated during fiscal 2022 and 2021, resulting in variability in sales volumes, inventory levels and costs to manufacture and source these products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PPE adversely impacted Medical segment profit on a year-over-year basis during fiscal 2022 primarily due to declines in volume and the prior-year positive impact of the timing of PPE cost mitigation efforts (primarily pricing). The demand and pricing for PPE is subject to risks and uncertainties, which may impact Medical segment profit and consolidated operating earnings in fiscal 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-over-year comparison was also impacted by an inventory reserve of $197 million, primarily related to certain categories of gloves, which adversely impacted Medical segment profit in fiscal 2021. See "Critical Accounting Policies and Sensitive Accounting Estimates" section of this MD&amp;A for additional detail.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Medical Goodwill</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the adverse impact on our financial results from, the risks and uncertainties related to inflationary impacts, global supply chain constraints and PPE demand and pricing, and increases in the risk-free interest rate, we performed goodwill impairment testing for the Medical reporting unit within the Medical segment during fiscal 2022. This testing resulted in cumulative pre-tax charges of $2.1 billion, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). See "Critical Accounting Policies and Sensitive Accounting Estimates" section of this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional detail.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes in key assumptions or a significant change in industry or economic trends during fiscal 2023 could result in additional goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Overview</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment Generics Program</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance of our Pharmaceutical segment generics program positively impacted the year-over-year comparison of Pharmaceutical segment profit in fiscal 2022, which includes improvement in volumes compared to the prior-year period. The Pharmaceutical segment generics program includes, among other things, the impact of generic pharmaceutical product launches, customer volumes, pricing changes and the Red Oak Sourcing, LLC venture ("Red Oak Sourcing") with CVS Health Corporation ("CVS Health"). The frequency, timing, magnitude and profit impact of generic pharmaceutical customer volumes, pricing changes, customer contract renewals, and branded and generic pharmaceutical manufacturer pricing changes all impact Pharmaceutical segment profit and are subject to risks and uncertainties. These risks and uncertainties may impact Pharmaceutical segment profit and consolidated operating earnings in fiscal 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cordis Divestiture</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $923 million, net of cash transferred, and we retained certain working capital accounts and certain liabilities. Cardinal Health will retain product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." In connection with the closing, we entered into a Transition Services Agreement ("TSA") with the buyer to provide support functions for a period of up to twenty-four months following the sale. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_100">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As anticipated, Medical segment revenue and Medical segment profit were adversely impacted by approximately $700 million and $70 million, respectively, in fiscal 2022 due to the divestiture of the Cordis business. The divestiture also resulted in a decrease in amortization of acquisition-related intangible assets during fiscal 2022. The divestiture of the Cordis business is subject to risks and uncertainties that may further adversely impact Medical segment profit. For example, the TSA period may be extended beyond our current expectations or could have unintended consequences, and the costs associated with the exit or disposal activities and stranded costs could be greater than anticipated.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><img src="cah-20220630_g1.jpg" alt="cah-20220630_g1.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/><img src="cah-20220630_g2.jpg" alt="cah-20220630_g2.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:72.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 Pharmaceutical segment revenue grew by $19.6 billion primarily due to sales growth from pharmaceutical distribution and specialty pharmaceutical customers, which largely consisted of branded pharmaceutical sales to existing and net new customers.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 Medical segment revenue decreased by $800&#160;million, primarily due to the impact of the divestiture of the Cordis business. Medical segment revenue was also adversely impacted by lower volumes within products and distribution, which was partially offset by sales growth in at-Home Solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold for fiscal 2022 increased $19.1 billion (12 percent) due to the factors affecting the changes in revenue and gross margin.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Gross Margin</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><img src="cah-20220630_g3.jpg" alt="cah-20220630_g3.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><img src="cah-20220630_g4.jpg" alt="cah-20220630_g4.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated Gross Margin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,545</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,778&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 consolidated gross margin decreased primarily due to the divestiture of the Cordis business and increased costs in the Medical segment due to net inflationary impacts and the adverse impact of global supply chain constraints, partially offset by the performance of our Pharmaceutical segment generics program and an improvement in volumes, primarily in generic and branded pharmaceuticals, compared to the prior-year period. The year-over-year comparison was also favorably impacted by the prior-year inventory reserve recorded in the Medical segment to reduce the carrying value of certain PPE, primarily certain categories of gloves, to net realizable value. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin rate declined 56 basis points during fiscal 2022 mainly due to changes in overall product mix, primarily driven by increased pharmaceutical distribution branded sales, which have a dilutive impact on our overall gross margin rate. The performance of Medical segment products and distribution, which reflects the divestiture of the Cordis business and increased costs due to net inflationary impacts and the adverse impact of global supply chain constraints, also had an adverse impact on gross margin rate. The year-over-year comparison was favorably impacted by the prior-year inventory reserve recorded in the Medical segment to reduce the carrying value of certain PPE, primarily certain categories of gloves, to net realizable value.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Distribution, Selling, General and Administrative ("SG&amp;A") Expenses</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SG&amp;A Expenses</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,557</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,533&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased slightly during fiscal 2022 largely due to inflationary impacts, primarily related to increased transportation and labor costs, increased costs related to investments in information technology infrastructure and higher costs to support sales growth, primarily offset by the impact of the divestiture of the Cordis business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-over-year comparison was also favorably impacted by the prior-year $41 million accrual for our estimated portion of the assessment on prescription opioid medications that were sold or distributed in New York state in calendar year 2017 and 2018 which was recognized during fiscal 2021. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information on the New York Opioid Stewardship Act.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Segment Profit</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_136">Note 13</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information on segment profit.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="cah-20220630_g5.jpg" alt="cah-20220630_g5.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/><img src="cah-20220630_g6.jpg" alt="cah-20220630_g6.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment Profit and Operating Earnings</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,770</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,986</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total consolidated operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021 </span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceutical Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 Pharmaceutical segment profit increased due to the performance of our generics program, partially offset by increased costs related to investments in information technology infrastructure and inflationary impacts, primarily related to increased transportation and labor costs. Pharmaceutical segment profit was also positively impacted by improvement in volumes, primarily in generic and branded pharmaceuticals, compared to the prior-year period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical segment profit includes opioid-related litigation defense and compliance costs, but does not include a one-time contingent attorneys' fee of $18 million recorded in fiscal 2022, which related to the finalization of the Settlement Agreement. Due to the unique nature and significance of the Settlement Agreement, and the one-time, contingent nature of the fee, this fee was included in litigation (recoveries)/charges, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 Pharmaceutical segment profit was positively impacted by a $16 million judgment for lost profits related to an ordinary course intellectual property rights claim. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 Medical segment profit decreased largely due to net inflationary impacts (which primarily related to increased transportation and commodities costs, partially offset by price increases), the adverse impact of global supply chain constraints and the divestiture of the Cordis business. The year-over-year comparison of Medical segment profit was also impacted favorably by the prior-year inventory reserve recorded to reduce the carrying value of certain PPE, primarily certain categories of gloves, to net realizable value, and unfavorably by the prior-year net positive impact of PPE sales.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Corporate during fiscal 2022 are due to the factors discussed in the Other Components of Consolidated Operating Earnings/(Loss) section that follows.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Components of Consolidated Operating Earnings/(Loss)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to revenue, gross margin, and SG&amp;A expenses discussed previously, consolidated operating earnings/(loss) were impacted by the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:74.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">324</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,050</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures, which includes facility exit costs related to decreasing our overall office space, and the divestiture of the Cordis business. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization and Other Acquisition-Related Costs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of acquisition-related intangible assets was $311 million and $428 million for fiscal 2022 and 2021, respectively. The decrease in amortization of acquisition-related intangible assets was primarily due to the divestiture of the Cordis business.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments and (Gain)/Loss on Disposal of Assets, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we recognized $2.1 billion of pre-tax non-cash goodwill impairment charges related to our Medical segment, as discussed further in the "Critical Accounting Policies and Sensitive Accounting Estimates" section of this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we recognized a $60 million pre-tax write-down of the assets held for sale from the divestiture of the Cordis business. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation (Recoveries)/Charges, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and 2021, we recognized estimated losses and legal defense costs associated with the IVC filter product liability claims of $87 million and $56 million, respectively. See&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we incurred a one-time contingent attorneys' fee of $18 million related to the finalization of the Settlement Agreement resulting in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. Due to the unique nature and significance of the Settlement Agreement, and the one-time, contingent nature of the fee, this fee was included in litigation (recoveries)/charges, net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and 2021, we recognized income of $18 million and $112 million, respectively, for recoveries in class action antitrust lawsuits in which we were a class member.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we recognized pre-tax charges of $1.17 billion associated with certain opioid matters. See Significant Developments in Fiscal 2022 and Trends section in this MD&amp;A and&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we recognized a $13 million charge in connection with a civil investigation by the United States Attorney&#8217;s Office for the District of Massachusetts related to discounts and rebates offered or provided to certain Specialty Solutions customers, as described further in&#160;</span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Components of Earnings/(Loss) Before Income Taxes</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items discussed above, earnings/(loss) before income taxes was impacted by the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, other (income)/expense, net was unfavorable compared to the prior-year period primarily due to a decrease in the value of our deferred compensation plan investments, which offsets fluctuations included within SG&amp;A expenses and is discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_124">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." The year-over-year comparison was also adversely impacted from net losses on investments in non-marketable equity securities recognized during fiscal 2022 compared to net gains recognized in fiscal 2021.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal 2022 interest expense decreased from fiscal 2021 primarily due to less debt outstanding.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss On Early Extinguishment of Debt</span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and 2021, we recognized losses of $10 million and $14&#160;million, respectively, in connection with the redemption and early debt repurchases as described further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_115">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the effective tax rates are primarily due to the impact of the goodwill impairment charges recognized in the Medical segment in fiscal 2022, the opioid litigation accrual recognized in fiscal 2021, as well as the impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate from continuing operations is as follows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:74.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Divestitures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4.9)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill Impairment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(49.5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(129.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense and fiscal 2021 is pretax income with tax benefit.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and 2021, the effective tax rate was (21.2) percent and (89.7) percent, respectively. Included in the effective tax rate for fiscal 2022 was $150 million of benefit related to the impairment of goodwill within the Medical segment. Included in the effective tax rate for fiscal 2021 was a $424 million benefit from the net operating loss carryback primarily related to a self-insurance pre-tax loss and net tax benefits related to the treatment of the tax impacts of the fiscal 2021 opioid litigation charges</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Goodwill Impairment Charge</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we recognized year-to-date cumulative pre-tax charges of $2.1 billion for goodwill impairment related to the Medical Unit. The net tax benefit related to these charges was $150 million for fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the CARES Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we received a U.S. federal income tax refund of $966 million in connection with this matter. We also increased our non-current deferred tax liability by approximately $700 million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effect of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net tax benefits associated with the opioid litigation charges were $228 million for fiscal 2021. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219 million. The fiscal 2021 net tax benefit and unrecognized tax benefits were primarily due to our assessment of the specific terms of the Settlement Agreement. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment and the actual amount of tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ongoing Audits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Tax laws are complex and subject to varying interpretations. New challenges related to future audits may adversely affect our effective tax rate or tax payments.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.230%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.539%;min-width:2.539%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.231%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations and cash requirements; tax payments; current and projected debt service requirements, dividends and share repurchases; and known opioid litigation settlement payments. If we decide to engage in one or more acquisitions, depending on the size and timing of such transactions, we may need to access capital markets for additional financing.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cash and Equivalents</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and equivalents balance was $4.7 billion at June&#160;30, 2022 compared to $3.4 billion at June&#160;30, 2021. Net cash provided by operating activities includes a refund of $966&#160;million for the tax benefit from the net operating loss carryback related to a self-insurance pre-tax loss, and reflects the impact of $417&#160;million of payments related to the settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities, payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. Fiscal 2022 operating cash flow was also impacted by favorable timing of net working capital and we expect some of this favorability to be offset in fiscal 2023. We also received proceeds of $923 million, net of cash transferred, from the divestiture of the Cordis business. We deployed $1.0 billion for share repurchases, $885 million for debt repayments, $559 million for dividends and $387 million for capital expenditures. At June&#160;30, 2022, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our cash and equivalents increased due to $2.4 billion of net cash provided by operating activities, offset by cash deployed of $573 million for dividends, $570 million for debt repayments, $400 million for capital expenditures and $200 million for share repurchases.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases, payments to vendors and tax payments in the regular course of business, as well as fluctuating working capital needs driven by customer and product mix.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash and equivalents balance at June&#160;30, 2022 included $588 million of cash and equivalents held by subsidiaries outside of the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we returned $160 million of cash held by foreign subsidiaries to the U.S.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, foreign earnings of approximately $833 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our consolidated financial statements in fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Financing Arrangements and Financial Instruments</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Credit Facilities and Commercial Paper</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity at June&#160;30, 2022 include a $2.0 billion commercial paper program, backed by a $2.0 billion revolving credit facility. We also have a $1.0 billion committed receivables sales facility. At June&#160;30, 2022, we had no amounts outstanding under our commercial paper program, revolving credit facility or our committed receivables sales facility. During fiscal 2022, under our commercial paper program and our committed receivables program, we had maximum combined total daily amounts outstanding of $1.2 billion&#160;and an average combined daily amount outstanding of $19 million.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, we amended our receivables sales facility to temporarily increase the maximum permitted delinquency ratio.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">than 3.75-to-1. As of June&#160;30, 2022, we were in compliance with this financial covenant. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liquidity and Capital Resources</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Obligations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had total long-term obligations, including the current portion and other short-term borrowings of $5.3 billion. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we redeemed all outstanding $572 million principal amount of 2.616% Notes due 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with this redemption, we recorded a $10&#160;million loss on early extinguishment of debt. We also repaid the full principal of the $282&#160;million Floating Rate Notes due 2022 as they became due.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principal amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. We also early repurchased $40 million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $2 million of the 2.616% Notes due 2022 with available cash. In connection with the early debt repurchases, we recorded a $1&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemption and repurchases were paid for with available cash and other short-term borrowings.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use interest rate swaps, foreign currency contracts and commodity contracts to manage our exposure to cash flow variability. We also use interest rate swaps to protect the value of our debt and use foreign currency forward contracts to protect the value of our existing and forecasted foreign currency assets and liabilities. See the "Quantitative and Qualitative Disclosures About Market Risk" section as well as </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_127">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for information regarding the use of financial instruments and derivatives as well as foreign currency, interest rate and commodity exposures.</span></div></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Capital Deployment</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opioid Litigation Settlement Agreement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $6.36&#160;billion accrued at June&#160;30, 2022 related to certain opioid litigation, as further described within the Significant Developments in Fiscal 2022 and Trends section in this MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements." We expect the majority of the payment amounts to be spread over 18 years. During fiscal 2022, we paid our first annual payment under the Settlement Agreement. We also made certain payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation Settlement. The effective date of the Settlement Agreement was April 2, 2022. In July 2022, we made our second annual payment of $374&#160;million under the Settlement Agreement. We expect to make subsequent annual payments under the Settlement Agreement every July for the term of the Settlement Agreement. The amounts of these future payments may differ from the payments that we have already made.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures during fiscal 2022 and 2021 were $387 million and $400 million, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect capital expenditures in fiscal 2023 to be around $500 million and to be primarily related to manufacturing and distribution infrastructure projects. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we paid quarterly dividends totaling $1.96 per share, an increase of 1 percent from fiscal 2021.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2022, our Board of Directors approved a quarterly dividend of $0.4957 per share, or $1.98 per share on an annualized basis, which was paid on July 15, 2022 to shareholders of record on July 1, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2022, our Board of Directors approved a quarterly dividend of $0.4957 per share, payable on October 15, 2022 to shareholders of record on October 3, 2022.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and 2021, we repurchased $1.0 billion and $200 million, respectively, of our common shares. We funded the repurchases with available cash. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_130">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional information. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021, we had $743 million authorized for share repurchases remaining on a program that expired on December 31, 2021. On November 4, 2021, our Board of Directors approved a $3.0 billion share repurchase program, which will expire on December 31, 2024. At June&#160;30, 2022, we had $2.7 billion remaining authorized for share repurchases under this program.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Contractual Obligations and Cash Requirements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, our contractual obligations and future cash requirements, including estimated payments due by period, were as follows: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:33.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 to 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026 to 2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">There-after</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt and short-term borrowings (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,241</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease obligations (2)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease obligations (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">539</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase obligations and other payments (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,578</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation settlement agreements (5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,322</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total contractual obligations and cash requirements (6)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,180</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,551</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,738</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,647</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,116</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents maturities of our long-term debt obligations and other short-term borrowings excluding finance lease obligations described below. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_115">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents minimum finance lease obligations included within current portion of long-term obligations and other short-term borrowings and long-term obligations, less current portion in our consolidated balance sheets and further described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_112">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents minimum operating lease obligations included within other accrued liabilities and deferred income taxes and other liabilities in our consolidated balance sheets and further described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_112">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">A purchase obligation is defined as an agreement to purchase goods or services that is legally enforceable and specifies all significant terms, including fixed or minimum quantities to be purchased; fixed, minimum or </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">variable price provisions; and approximate timing of the transaction. The purchase obligation amounts disclosed above represent estimates of the minimum for which we are obligated and the time period in which cash outflows will occur. Purchase orders and authorizations to purchase that involve no firm commitment from either party are excluded from the above table. In addition, contracts that can be unilaterally canceled with no termination fee or with proper notice are excluded from our total purchase obligations except for the amount of the termination fee or the minimum amount of goods that must be purchased during the requisite notice period. Purchase obligations and other payments also includes quarterly payments to CVS Health in connection with Red Oak Sourcing. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Represents future cash obligations under the Settlement Agreement, which became effective on April 2, 2022, as well as future cash obligations under the separate settlement agreements with the States of Oklahoma, Washington and West Virginia and the Cherokee Nation. We have $6.36&#160;billion accrued at June&#160;30, 2022, of which $532&#160;million is included in other accrued liabilities, and the remainder is included in deferred income taxes and other liabilities in our consolidated balance sheets. Excluded from the table is $41 million that remained in escrow at June 30, 2022, which is included in prepaid expenses and other assets in our consolidated balance sheets. The Settlement Agreement includes a cash component, pursuant to which we will pay up to approximately $6.0 billion, the majority of which is expected to be paid over 18 years. The exact payment amount will depend on several factors, including the extent to which states take action to foreclose opioid lawsuits by political subdivisions (e.g., by passing laws barring or limiting opioid lawsuits by political subdivisions, the conditions of the state agreements being satisfied, and the extent to which additional political subdivisions in participating states continue to litigate against us. See  </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Long-term liabilities, such as unrecognized tax benefits, deferred taxes and other tax liabilities, have been excluded from the above table due to the inherent uncertainty of the underlying tax positions or because of the inability to reasonably estimate the timing of any cash outflows. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for further discussion of income taxes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_34"></div></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Recent Financial Accounting Standards</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for a discussion of recent financial accounting standards.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Critical Accounting Policies and Sensitive Accounting Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies are those accounting policies that (i)&#160;can have a significant impact on our financial condition and results of operations and (ii)&#160;require the use of complex and subjective estimates based upon past experience and management&#8217;s judgment. Other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Because estimates are inherently uncertain, actual results may differ. In this section, we describe the significant policies applied in preparing our consolidated financial statements that management believes are the most dependent on estimates and assumptions. For further discussion of accounting policies for items within this section and of additional accounting policies, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts includes general and specific reserves. We determine our allowance for doubtful accounts by reviewing accounts receivable aging, historical write-off trends, payment history, pricing discrepancies, industry trends, customer financial strength, customer credit ratings or bankruptcies. We regularly evaluate how changes in economic conditions may affect credit risks. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Receivables and Allowance for Doubtful Accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 0.1 percent increase or decrease in the reserve as a percentage of trade receivables at June&#160;30, 2022, would result in an increase or decrease in bad debt expense of $11 million. We believe the reserve maintained and expenses recorded in fiscal 2022 are appropriate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, we are not aware of any analytical findings or customer issues that are likely to lead to a significant future </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase in the allowance for doubtful accounts as a percentage of revenue. The following table presents information regarding our allowance for doubtful accounts over the past three fiscal years:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.702%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.704%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for doubtful&#160;accounts at beginning of period</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">155</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reduction&#160;to allowance&#160;for&#160;customer deductions&#160;and write-offs </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(125)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">273</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance&#160;as a&#160;percentage of customer receivables</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allowance&#160;as a&#160;percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The sum of the components may not equal the total due to rounding.</span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFO Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (52 percent and 50 percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These are primarily merchandise inventories at the core pharmaceutical distribution facilities within our Pharmaceutical segment (&#8220;distribution facilities&#8221;). The LIFO impact on the consolidated statements of earnings/(loss) depends on pharmaceutical manufacturer price appreciation or deflation and our fiscal year-end inventory levels, which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end. Historically, prices for branded pharmaceuticals have generally tended to rise, resulting in an increase in cost of products sold, whereas prices for generic pharmaceuticals generally tend to decline, resulting in a decrease in cost of products sold. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further information on our policy for Inventories.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using LIFO, if there is a decrease in inventory levels that have experienced pharmaceutical price appreciation, the result generally will be a decrease in future cost of products sold as our older inventory is held at a lower cost. Conversely, if there is a decrease in inventory levels that have experienced a pharmaceutical price decline, the result generally will be an </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase in future cost of products sold as our older inventory is held at a higher cost. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within these distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation. At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $416 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$565 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIFO Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out ("FIFO") method, or net realizable value. We reserve for the lower of cost or net realizable value using the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain PPE </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. As selling prices and customer demand decreased compared to the peak of COVID-19, we recorded a reserve of $197&#160;million in fiscal 2021, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The remaining reserve at June 30, 2022 was $42 million, primarily due to sales of certain PPE during fiscal 2022. Our estimates for selling prices and demand are inherently uncertain and if our assumptions decline in the future, additional inventory reserves may be required.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excess and Obsolete Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $147 million and $185 million at June&#160;30, 2022 and 2021, respectively. If actual conditions are less favorable than our assumptions, additional inventory reserves may be required.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Goodwill and Other Indefinite-Lived Intangible Assets</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount, which may be performed utilizing either a qualitative or quantitative assessment. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for the annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. A reporting unit is defined as an operating segment or one level below an operating segment (also known as a component). </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (which are components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our determination of estimated fair value of our reporting units is based on a combination of the income-based and market-based approaches (using discount rates ranging from 10 to 12 percent). We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">internally-developed forecasts. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the market-based guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including actual operating results. The use of alternate estimates and assumptions, changes in the industry or peer groups, or changes in weightings assigned to the discounted cash flow method, guideline public company method or guideline transaction method could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment. If a reporting unit fails to achieve expected earnings or operating cash flow, or otherwise fails to meet current financial plans, or if there were changes to any other key assumptions used in the tests, the reporting unit could incur a goodwill impairment in a future period. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2022, 2021 and 2020 and, with the exception of the Medical Unit in fiscal 2022, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Unit Goodwill</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Medical Unit experienced adverse financial results related to inflationary impacts and the adverse impact of global supply chain constraints and lower volumes from PPE. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit at June&#160;30, 2022. This quantitative testing resulted in the carrying amount of the Medical Unit exceeding the fair value, resulting in a pre-tax impairment charge of $303 million and cumulative pre-tax impairment charges of $2.1 billion recognized during fiscal 2022, due to the impairment charges recognized during the third and second quarters of fiscal 2022 as described further below. This </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment charge was driven by an increase in the discount rate primarily due to an increase in the risk-free interest rate. Our determination of the estimated fair value of the Medical Unit was based on a combination of the income-based approach and the market-based approach. For this testing performed at June&#160;30, 2022, we used a discount rate of 10 percent and a terminal growth rate of 2 percent. Additionally, we assigned a weighting of 80 percent to the discounted cash flow method, 10 percent to the guideline public company method, and 10 percent to the guideline transaction method. The carrying value of the Medical Unit at June&#160;30, 2022 after recognizing the impairment charges was $7.0 billion, of which $1.9 billion was goodwill. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for further discussion.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third and second quarters of fiscal 2022, we performed interim goodwill impairment testing for the Medical Unit at March 31, 2022 and December 31, 2021, which resulted in pre-tax impairment charges of $474 million and $1.3 billion, respectively. Our determination of the estimated fair value of the Medical Unit was based on a combination of the income-based approach (using a terminal growth rate of 2 percent), and the market-based approach. For the income-based approach, we also used discount rates of 9.5 percent and 9 percent for the interim testing at March 31, 2022 and December 31, 2021, respectively. The increase in the discount rate was primarily due to an increase in the risk-free interest rate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we consider these assumptions to be reasonable and appropriate, they are complex and subjective, and additional adverse changes in one key assumption or a combination of key assumptions may significantly affect future estimates. These assumptions include, among other things, a failure to meet expected earnings or other financial plans, or unanticipated events and circumstances, such as changes in assumptions about the </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duration and magnitude of increased supply chain and commodities costs and our planned efforts to mitigate such impact, including price increases or surcharges; further disruptions in the supply chain; the impact of the Cordis divestiture; estimated demand and selling prices for PPE; an increase in the discount rate; a decrease in the terminal growth rate; increases in tax rates (including potential tax reform); or a significant change in industry or economic trends. Adverse changes in key assumptions may result in further decline in fair value below the carrying value in the future and therefore, an impairment of our Medical Unit goodwill in future periods, which could adversely affect our results of operations. For example, if we were to increase the discount rate by a hypothetical 0.5 percent or decrease the terminal growth rate by a hypothetical 1.75 percent, the fair value for the Medical Unit would have further decreased by approximately $330 million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks) involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of "Notes to Consolidated Financial Statements" for additional information regarding goodwill and other intangible assets.</span></div></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review contingencies and self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or outcomes can occur, assessing contingencies is highly subjective and requires judgments about future events.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of such contingencies include various lawsuits related to the distribution of prescription opioid pain medications and the IVC filter lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the Significant Developments in Fiscal 2022 and Trends section in this MD&amp;A, we recorded pre-tax charges of $1.17&#160;billion during fiscal 2021. In February 2022, we and two other national distributors announced that each company had determined that a sufficient </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of political subdivisions had agreed to participate in the previously disclosed Settlement Agreement to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure through a wholly-owned insurance subsidiary for employee healthcare, certain product liability matters, auto liability, property and workers' compensation and maintain insurance for losses exceeding certain limits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-insurance accruals include an estimate for expected settlements on pending claims, defense costs, administrative fees, </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims adjustment costs and an estimate for claims incurred but not reported. For certain types of exposures, we develop the estimate of expected ultimate costs to settle each claim based on specific information related to each claim if available. Other estimates are based on an assessment of outstanding claims, historical analysis and current payment trends. For claims incurred but not reported, the liabilities are calculated and derived in accordance with generally accepted actuarial practices or using an estimated lag period.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of loss may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review contingencies and self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. Our income tax expense, deferred income tax assets and liabilities, and unrecognized tax benefits reflect management&#8217;s assessment of estimated future taxes to be paid on items in the consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our tax position at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.247%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,584</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net deferred&#160;income&#160;tax assets</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net deferred income tax liability</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,994)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Total deferred income tax assets included $778 million and $805 million of loss and tax credit carryforwards at June&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The valuation allowance primarily relates to federal, state and international loss and credit carryforwards for which the ultimate realization of future benefits is uncertain.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly when it is more likely than not that at least a portion of the respective deferred tax assets will not be realized. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described previously. We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Goodwill Impairment Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we recognized cumulative pre-tax charges of $2.1&#160;billion for goodwill impairments related to the Medical Unit. The net tax benefit related to these charges was $150&#160;million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the CARES Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed for a U.S. federal income tax refund of $974&#160;million as a result of the net operating loss carryback under the CARES Act. In April 2022, we received a payment for $966 million, which was net of certain adjustments. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for additional detail. We also increased our non-current deferred tax liability by approximately $700 million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $1.17&#160;billion pre-tax charges for the opioid litigation during fiscal year 2021, respectively we recorded a tax benefit of $228&#160;million. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the U.S. Tax Cuts and Jobs Act ("Tax Act"); however, these estimates require significant judgment since the U.S. tax law </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.820%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Critical Accounting Policies and Sensitive Accounting Estimates</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governing deductibility was changed by the Tax Act. Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Tax laws are complex and subject to varying interpretations. During fiscal 2021, we resolved all open issues with respect to the Company&#8217;s activity within fiscal years 2008 through 2014 with the U.S. Internal Revenue Service ("IRS"). This resolution resulted in an adjustment to our provision for income taxes, including an impact to reserves for later years. New challenges related to future audits may adversely affect our effective tax rate or tax payments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assumptions and estimates around uncertain tax positions require significant judgment; the actual amount of tax benefit related to uncertain tax positions may differ from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding unrecognized tax benefits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our estimates for the valuation allowances against deferred tax assets and unrecognized tax benefits are appropriate based on current facts and circumstances. The amount we ultimately pay when matters are resolved may differ from the amounts accrued. Changes in our current estimates due to unanticipated market conditions, tax law changes or other factors could have a material effect on our ability to utilize deferred tax assets. For a further discussion on Provision for Income Taxes, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to the Consolidated Financial Statements.&#8221;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities includes estimates for uncertainties in the application of broad and complex changes to the U.S. tax code as per the Tax Act as enacted by the United States government on December 22, 2017. We have made reasonable estimates and recorded amounts based on management judgment and our current understanding of the Tax Act which is subject to further interpretation by the IRS. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report, including the "Fiscal 2022 Overview" section within MD&amp;A, contains financial measures that are not calculated in accordance with GAAP. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, engage in financial and operational planning, and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exclusions from Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">LIFO charges and credits</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges and credits from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results. We did not recognize any LIFO charges or credits during the periods presented. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Surgical gown recall costs or income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes inventory write-offs and certain remediation and supply disruption costs, net of related insurance recoveries, arising from the January 2020 recall of select Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for Presource Procedure Packs containing affected gowns. Income from surgical gown recall costs represents insurance recoveries of these certain costs. We have excluded these costs from our non-GAAP metrics to allow investors to better understand the underlying operating results of the business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">State opioid assessments related to prior fiscal years</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the portion of state assessments for prescription opioid medications that were sold or distributed in periods prior to the period in which the expense is incurred. This portion is excluded from non-GAAP financial measures because it is retrospectively applied to sales in prior fiscal years and inclusion would obscure analysis of the current fiscal year results of our underlying, ongoing business. Additionally, while states' laws may require us to make payments on an ongoing basis, the portion of the assessment related to sales in prior periods are contemplated to be one-time, nonrecurring items. Income from state opioid assessments related to prior fiscal years represents reversals of accruals when the underlying assessments were invalidated by a Court or reimbursed by manufacturers. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Restructuring and employee severance costs</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because they are not part of the ongoing operations of our underlying business. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Amortization and other acquisition-related costs</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which include transaction costs, integration costs, and changes in the fair value of contingent consideration obligations, are excluded because they are not part of the ongoing operations of our underlying business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies' financial results. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Impairments and gain or loss on disposal of assets</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Litigation recoveries or charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount. During fiscal 2022, we incurred a one-time contingent attorneys' fee of $18 million related to the finalization of the settlement agreement (the &#8220;Settlement Agreement&#8221;) resulting in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. Due to the unique nature and significance of the Settlement Agreement, and the one-time, contingent nature of the fee, this fee was included in litigation recoveries or charges, net. Additionally, during fiscal 2022 our Pharmaceutical segment profit was positively impacted by a $16 million judgment for lost profits. This judgment was the result of an ordinary course intellectual property rights claim and, therefore, is not adjusted in calculating the litigation recoveries or charges, net adjustment. During fiscal 2021, we incurred a tax benefit related to a carryback of a net operating loss. Some pre-tax amounts, which contributed to this loss, relate to litigation charges. As a result, we allocated substantially all of the tax benefit to litigation charges.  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Loss on early extinguishment of debt</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt extinguishment transactions. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">(Gain)/Loss on sale of equity interest in naviHealth</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was incurred in connection with the sale of our remaining equity interest in naviHealth in fiscal 2020. The equity interest was retained in connection with the initial sale of our majority interest in naviHealth during fiscal 2019. We exclude this significant gain because gains or losses on investments of this magnitude do not typically occur in the normal course of business and are similar in nature to a gain or loss from a divestiture of a majority interest, which we exclude from non-GAAP results. The gain on the initial sale of our majority interest in naviHealth in fiscal 2019 was also excluded from our non-GAAP measures. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt;text-decoration:underline">Transitional tax benefit, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the Tax Cuts and Jobs Act is excluded because it results from the one-time impact of a very significant change in the U.S. federal corporate tax rate and, due to the significant size of the benefit, obscures analysis of trends and financial performance. The transitional tax benefit includes the initial estimate and subsequent adjustments for the re-measurement of deferred tax assets and liabilities due to the reduction of the U.S. federal corporate income tax rate and the repatriation tax on undistributed foreign earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effect for each of the items listed above, other than the transitional tax benefit item, is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Definitions</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Growth rate calculation</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: growth rates in this report are determined by dividing the difference between current period results and prior period results by prior period results.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP operating earnings</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: operating earnings/(loss) excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, and (7) litigation (recoveries)/charges, net. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP earnings before income taxes</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: earnings/(loss) before income taxes excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP net earnings attributable to Cardinal Health, Inc.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: net earnings/(loss) attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP effective tax rate</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: provision for/(benefit from) income taxes adjusted for (1) LIFO charges/(credits), (2) surgical gown recall costs/(income), (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on early extinguishment of debt and (9) (gain)/loss on sale of equity interest in naviHealth, each net of tax, and (10) transitional tax benefit, net divided by (earnings before income taxes adjusted for the first nine items). </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP diluted earnings per share attributable to Cardinal Health, Inc.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">GAAP to Non-GAAP Reconciliations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.382%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per common share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Earnings/(Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Earnings/(Loss) Growth Rate</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(Benefit From) Income Taxes</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Growth Rate</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Tax Rate</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1,2</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Growth Rate</span></div></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(769)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(933)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.87&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">4,5</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on sale of equity interest in naviHealth investment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,990</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,824</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,419</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.06</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal Year 2021</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(89.7)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs/(income)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">6</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on sale of equity interest in naviHealth investment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal Year 2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.M.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Surgical gown recall costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State opioid assessment related to prior fiscal years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">6</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,741&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.84&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of equity interest in naviHealth investment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.68)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transitional tax benefit, net</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">7</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,384&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 %</span></div></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Attributable to Cardinal Health, Inc.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For fiscal 2022 and 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using weighted averages of 279 and 293 million common shares, respectively, which exclude potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Fiscal 2022 and 2020 non-GAAP diluted EPS are calculated using weighted averages of 280 and 295 million common shares, respectively, which included potentially dilutive shares</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3 &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairments and (gain)/loss on disposals of assets, net includes pre-tax goodwill impairment charges of $2.1 billion related to the Medical segment recorded during fiscal 2022. For fiscal 2022, the net tax benefit related to these charges is $150&#160;million and is included in the annual effective tax rate. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net includes a one-time contingent attorneys' fee of $18 million recorded during fiscal 2022 related to the finalization of the Settlement Agreement resulting in the settlement of the vast majority of opioid lawsuits filed by state and local governmental entities. Due to the unique nature and significance of the Settlement Agreement, and the one-time, contingent nature of the fee, this fee was included in litigation (recoveries)/charges, net.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">5&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net for fiscal 2022 does not include a $16 million judgement for lost profits related to an ordinary course intellectual property claim, which positively impacted Pharmaceutical segment profit.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">6&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net includes pre-tax charges of $1.17 billion and $5.63 billion recorded in fiscal 2021 and 2020, respectively, related to the opioid litigation. The net tax benefits associated with the opioid litigation charges were $228 million and $488 million for fiscal 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Litigation (recoveries)/charges, net, includes a tax benefit recorded during fiscal 2021 related to a net operating loss carryback. Our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and adjusted our taxable income for fiscal 2015, 2016, 2017 and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act. The total benefit from the net operating loss carryback was $424 million; however, for purposes of Non-GAAP financial measures, we allocated $389 million of the benefit to litigation (recoveries)/charges, net, which is excluded from non-GAAP measures, based on the relative amount of the self-insurance pre-tax loss related to opioid litigation claims versus separate tax adjustments. The tax benefit allocated to the separate tax adjustments of $35 million is included in non-GAAP measures.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">7&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Reflects the net transitional benefit from the remeasurement of our deferred tax assets and liabilities partially offset by the repatriation tax on cash and earnings of foreign subsidiaries.&#160;See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for more information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sum of the components and certain computations may reflect rounding adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to cash flow and earnings fluctuations as a result of certain market risks. These market risks primarily relate to foreign exchange, interest rate, and commodity price-related changes. We maintain a hedging program to manage volatility related to some of these market exposures which employs operational, economic, and derivative financial instruments in order to mitigate risk. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Note 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_127">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for further discussion regarding our use of derivative instruments.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Foreign Exchange Rate Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the nature of our global operations, we are exposed to cash flow and earnings fluctuations resulting from foreign exchange rate variation. These exposures are transactional and translational in nature. The following foreign currencies represent the principal drivers of our foreign exchange exposure: Canadian dollar, euro, Thai baht, Mexican peso, Chinese renminbi, Australian dollar, British pound, Japanese yen and Philippine peso.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply a Value-At-Risk ("VAR") methodology to our transactional and translational exposures. The VAR model is a risk estimation tool and is not intended to represent actual losses in fair value that could be incurred.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transactional Exposure</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactional exposure arises from the purchase and sale of goods and services in currencies other than our functional currency or the functional currency of our subsidiaries. At the end of each fiscal year, we perform sensitivity analyses on our </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasted transactional exposure for the upcoming fiscal year. These analyses include the estimated impact of our hedging program, which is designed to mitigate transactional exposure. Applying a VAR methodology to our transactional exposure and including the impact of our hedging program, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be $11 million, which is based on a one-year horizon and a 95 percent confidence level.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translational Exposure</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have exposure related to the translation of financial statements of our foreign operations into U.S.&#160;dollars, our functional currency. Applying a VAR methodology to our translational exposure, the potential maximum loss in earnings for the upcoming fiscal year is estimated to be $5 million, which is based on a one-year horizon and a 95 percent confidence level. </span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Interest Rate Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in interest rates primarily as a result of our borrowing and investing activities to maintain liquidity and fund operations. The nature and amount of our long-term and short-term debt can be expected to fluctuate as a result of business requirements, market conditions and other factors. Our policy is to manage exposures to interest rates using a mix of fixed and floating rate debt as deemed appropriate by management. We utilize interest rate swap instruments to mitigate our exposure to interest rate movements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk management program, we perform an annual sensitivity analysis on our forecasted exposure to interest rates for the upcoming fiscal year. This analysis assumes a hypothetical 50 basis point change in interest rates. At June&#160;30, 2022, the potential increase or decrease in annual interest expense under this analysis as a result of this hypothetical change would be $5 million.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to market risk from changes in interest rates related to our cash and cash equivalents, which includes marketable securities that are carried at fair value in the consolidated balance sheets. The fair value of our cash and cash equivalents is subject to change primarily as a result of changes in market interest rates and investment risk related to the issuers' credit worthiness. At June&#160;30, 2022, a hypothetical increase or decrease of 50 basis points in interest rates would result in a hypothetical $8 million change in the estimated fair value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:50.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Explanation and Reconciliation of Non-GAAP Financial Measures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Commodity Price Sensitivity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly exposed to market price changes for certain commodities, including oil-based resins, nitrile, cotton, diesel fuel and latex. We typically purchase raw materials at either market prices or prices tied to a commodity index and some finished goods at prices based in part on a commodity price index. During fiscal 2022, the prices of certain commodities experienced significant fluctuation due to inflationary impacts and the adverse impact of global supply chain constraints.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk management program, we perform sensitivity analysis on our forecasted direct commodity exposure for the upcoming fiscal year. Our forecasted direct commodity exposure at June&#160;30, 2022 increased approximately $51 million from June&#160;30, 2021. At June&#160;30, 2021, we had hedged a portion of these direct commodity exposures (see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_127">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Statements&#8221; for further discussion). There were no outstanding commodity contracts in our hedging program at June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forecasted direct commodity exposures for the upcoming fiscal year is $500 million. The potential gain/loss given a hypothetical 10 percent fluctuation in commodity prices, assuming pricing collectively shifts in the same direction and we are unable to change customer pricing in response to those shifts or otherwise offset, for the upcoming fiscal year is $50 million at June 30, 2022. The hypothetical offsetting impact of hedges in both periods was minimal. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Business</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a global integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, our Pharmaceutical segment:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Pharmaceutical Distribution division, distributes branded and generic pharmaceutical and over-the-counter healthcare and consumer products to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. This division:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">maintains prime vendor relationships that streamline the purchasing process resulting in greater efficiency and lower costs for our retail, hospital and other healthcare provider customers;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and chargeback administration;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">through the Outcomes service offering, connects pharmacists, payers and pharmaceutical companies and delivers health solutions for personalized medication therapy management, digital patient engagement and telepharmacy;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">provides pharmacy management services to hospitals and operates a limited number of pharmacies, including in community health centers; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">repackages generic pharmaceuticals and over-the-counter healthcare products;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Specialty Solutions division, distributes specialty pharmaceutical products to hospitals and other healthcare providers and provides consulting, patient support and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">through its Nuclear and Precision Health Solutions division, operates nuclear pharmacies and manufacturing facilities, which manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices. This division also contract manufactures a radiopharmaceutical treatment (Xofigo) and holds the North American rights to manufacture and distribute Lymphoseek, a radiopharmaceutical diagnostic imaging agent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_136">Note 13</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for Pharmaceutical segment revenue, profit and assets for fiscal 2022, 2021 and 2020.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharmaceutical Distribution</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical Distribution division&#8217;s gross margin includes margin from our generic pharmaceutical program, from distribution services agreements with branded pharmaceutical manufacturers and from over-the-counter healthcare and consumer products. It also includes manufacturer cash discounts. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin from our generic pharmaceutical program includes price discounts and rebates from manufacturers and may in limited instances include price appreciation. Our earnings on generic pharmaceuticals are generally highest during the period immediately following the initial launch of a product, because generic pharmaceutical selling prices are generally highest during that period and tend to decline over time. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Margin from distribution services agreements with branded pharmaceutical manufacturers is derived from compensation we receive for providing a range of distribution and related services to manufacturers. Our compensation typically is a percentage of the wholesale acquisition cost that is set by manufacturers. In addition, under a limited number of agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers, also serves as part of our compensation. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sourcing Venture with CVS Health Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health negotiates generic pharmaceutical supply contracts on behalf of both companies. In August 2021, we amended our agreement with CVS Health to extend the term of Red Oak Sourcing through June 2029.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specialty Pharmaceutical Products and Services</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to products and services offered by our Specialty Solutions division as &#8220;specialty pharmaceutical products and services.&#8221; The Specialty Solutions division distributes oncology, rheumatology, urology, nephrology and other pharmaceutical products ("specialty pharmaceutical products") and human-derived plasma products to hospitals, dialysis clinics, physician offices and other healthcare providers; provides consulting, patient support, logistics, group purchasing and other services to pharmaceutical manufacturers and healthcare providers primarily supporting the development, marketing and distribution of specialty pharmaceutical products; and provides specialty pharmacy services. Our use of the terminology "specialty pharmaceutical products and services" may not be comparable to the terminology used by other industry participants.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures and sources Cardinal Health branded general and specialty medical, surgical and laboratory products and devices. These products include exam and surgical gloves; needle, syringe and sharps disposal; compression; incontinence; nutritional delivery; wound care; single-use surgical drapes, gowns and apparel; fluid suction and collection systems; urology; operating room supply; and electrode product lines. Our Cardinal Health Brand products are sold directly or through third-party distributors in the United States, Canada, Europe, Asia and other markets. These products are generally higher-margin products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment also distributes a broad range of medical, surgical and laboratory products known as national brand products </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada and this segment also assembles and sells sterile and non-sterile procedure kits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through Cardinal Health at-Home Solutions, this segment also distributes medical products to patients' homes in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment, through its Wavemark division, also provides an automated technology platform for inventory management. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Acquisitions and Divestitures</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have acquired a number of businesses over the years that have enhanced our core strategic areas of Cardinal Health Brand medical products, generic pharmaceutical distribution and services, specialty pharmaceutical products and services, international and post-acute care. We expect to continue to pursue additional acquisitions in the future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for $6.1 billion in cash. We also completed several smaller acquisitions during the last five fiscal years.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lines</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">of&#160;Business</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisition</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(in billions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">07/17</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient Recovery Business of Medtronic, plc</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mansfield, MA</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency</span></td><td colspan="6" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past five fiscal years, we have also completed several divestitures. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, we completed the divestiture of the Cordis business to Hellman &amp; Freidman ("H&amp;F") for net proceeds of $923 million in cash. We have retained certain working capital accounts and product liability for lawsuits related to IVC filters in the U.S. and Canada, as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Consolidated Financial Statements. We acquired the Cordis business from Johnson &amp; Johnson for $1.9 billion in October 2015. This divestiture also included Access Closure, Inc., a manufacturer and distributor of extravascular closure devices, that we acquired for approximately $320 million in May 2014. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we completed the sale of our equity interest in naviHealth, Inc. to investor entities controlled by Clayton, Dubilier &amp; Rice, LLC for proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. In May 2020, we sold the remainder of our equity interest in naviHealth.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had acquired our equity interest in naviHealth through a series of transactions beginning in fiscal 2016, when we acquired a majority equity interest. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, we completed the sale of our pharmaceutical and medical products distribution business in China to Shanghai Pharmaceuticals Holding Co., Ltd. for proceeds of $861 million (after adjusting for third party indebtedness and preliminary transaction adjustments).</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Customers</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest customers, CVS Health and OptumRx, accounted for 25 percent and 16 percent of our fiscal 2022 revenue, respectively. In the aggregate, our five largest customers, including CVS Health and OptumRx, accounted for 49 percent of our fiscal 2022 revenue. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with group purchasing organizations (&#8220;GPOs&#8221;) that act as agents to negotiate vendor contracts on behalf of their members. Our two largest GPO relationships in terms of revenue are with Vizient, Inc. and Premier, Inc. Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for 19 percent of our revenue in fiscal 2022.</span></div></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on many different suppliers. Products obtained from our five largest suppliers accounted for an aggregate of 35 percent of our revenue during fiscal 2022, and our largest supplier&#8217;s products accounted for approximately 9 percent of revenue.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive environment in the distribution of pharmaceuticals and consumer healthcare products. We also operate in a highly competitive environment in the manufacturing and distribution of medical devices and surgical products. We compete on many levels, including price, service offerings, support services, customer service, breadth of product lines and product quality and efficacy.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Pharmaceutical segment, we compete with wholesale distributors with national reach, including McKesson Corporation and AmerisourceBergen Corporation, regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide specialty pharmaceutical services and nuclear pharmacies, among others. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Pharmaceutical segment has experienced competition from a number of organizations offering generic pharmaceuticals, including telemarketers. We also compete with manufacturers that distribute their products directly to customers.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Medical segment, we compete with many diversified healthcare companies and national medical product distributors, such as Medline Industries, Inc., Owens&#160;&amp; Minor, Inc. and Becton, Dickinson and Company, as well as regional medical product distributors and companies that are focused on specific product categories. We also compete with companies that distribute medical products to patients' homes and third-party logistics companies. </span></div></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employees </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, through our employees, improve the lives of people every day by solving complex healthcare problems. As of June 30, 2022, we had approximately 46,500 employees globally, approximately 16,300 of whom are based outside the United States. Approximately 98% of our workforce is full time employees. Approximately 28,700 of our employees worked in our distribution centers, manufacturing facilities and pharmacies, and 17,500 worked in other functions, including finance, information technology, human resources and sales.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 3,230 employees were primarily associated with the Cordis business and were transferred in the divestiture in August 2021. Most of these employees were based outside the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 11% of our workforce is covered by collective bargaining agreements or similar representation. The majority of these employees are based outside the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have engaged global professional services firms to perform certain business processes on our behalf, including within finance, information technology and human resources.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board Oversight</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors assesses and monitors our corporate culture and how it enables our business strategies. To inform the Board about human capital and cultural health, we have developed and annually share with the Board a culture scorecard. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Human Resources and Compensation Committee of the Board of Directors (the &#8220;HRCC&#8221;) is tasked with,</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among other things, overseeing and advising the Board about human capital management strategies and policies, including with respect to attracting, developing, retaining and motivating management and employees; workplace diversity, equity and inclusion initiatives and progress; employee relations; and workplace safety and culture. The HRCC is also responsible for overseeing the management succession process. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Culture &amp; Talent Focus</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Culture </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health&#8217;s culture is rooted in our values and behaviors and aligned to the company&#8217;s strategic framework. Providing a positive work environment supports our ability to attract, retain and develop </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our employees and enables business performance. We reinforce, monitor and assess our culture through a variety of programs and processes which include performance management, talent/succession planning, as well as employee engagement surveys and other listening strategies.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Talent Development and Learning</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cardinal Health&#8217;s talent development strategy is a segmented, multi-pronged approach to build capabilities, skills and competencies of leaders and employees throughout the enterprise ensuring employees capabilities connect to business needs and outcomes. This segmented approach includes broad based employee skill development and learning, manager development, differentiated diverse talent development and executive development. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have been refining our recruiting, development, succession and retention practices to promote equitable access and opportunity by expanding differentiated development programs and creating new offerings to bring an equity lens to our development practices. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have taken steps to increase available manufacturing and distribution talent for operational positions, including by decreasing the time needed to recruit and on-board new employees.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor our turnover data on a monthly and 12-month basis and benchmark against Bureau of Labor and Statistics and competitor data. Although turnover levels vary by site and region, we primarily look at the connection between key operational metrics and employee turnover. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation and Benefits </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our colleagues are essential to our success and we strive to offer comprehensive and competitive wages and benefits. The benefits we offer include annual bonuses and stock awards for eligible employees, 401(k) plans, health care and insurance benefits, paid time off, flexible work schedules, family leave, dependent care resources, employee assistance programs and many others. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal year 2022, we proactively invested in employee compensation to remain competitive in the labor market. These investments included increasing the U.S. minimum wage for hourly employees, broadly adjusting front-line wages in many locations and making targeted salary adjustments based on market dynamics.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Employee Feedback </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cardinal Health solicits feedback from employees through various mechanisms, including our biennial full employee engagement survey, which provides insight into the employee experience. The results of this survey are reviewed with the Board of Directors and at all levels throughout the organization. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Diversity, Equity &amp; Inclusion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At Cardinal Health, we are focused on building a diverse workforce and an inclusive workplace that values the unique perspectives and contributions of all of our employees. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our work is sponsored by our senior executives, led by our Diversity, Equity and Inclusion ("DE&amp;I") team, including our Chief Diversity Officer and HR organization, with input from our DE&amp;I Steering Council, African American and Black Racial Equity </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cabinet and our Employee Resource Groups ("ERGs"). All of our manager level and above employees are required to complete unconscious bias and racial equity training, which is included as a component of our annual incentive program. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our DE&amp;I Council is composed of senior leaders from across the organization and is charged with identifying and discussing barriers to DE&amp;I, challenging the status quo and empowering change. Our African American and Black Racial Equity Cabinet is made up of senior leaders who provide guidance to our senior executives in addressing racism, social injustice and other matters. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, our seven ERGs include groups focused on various racial and ethnic groups, members of the LGBTQ community, employees with disabilities, veterans and women and are designed to promote a culture of diversity, equity and inclusion. They are designed to foster an inclusive and engaged workforce and develop future leaders. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also monitor pay equity. We define pay equity as equal pay for people of all gender identities and ethnicities who are performing substantially similar work. We have a pay equity committee, which guides the ongoing analysis and benchmarking, in regular consultation with an independent third-party, to review and help inform our salary and compensation practices. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of the end of fiscal year 2022, 36% of our Board of Directors were women and 18% were ethnically diverse. 38% of our executive team (made up of the CEO, his direct reports and business presidents) were women and 12% were ethnically diverse. Approximately 50% of our total employee population were women and 49% of U.S. based employees were ethnically diverse. We have established long-range aspirational representation goals for specific under-represented groups in our manager-and-above level employee population. Progress toward those goals is evaluated as part of both our annual and long-term incentive programs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also regularly assess our progress in our DE&amp;I journey through a robust employee-listening strategy, which includes engagement surveys, focus groups and onboarding assessments. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Health &amp; Safety </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The health, safety and security of our employees is a priority for us. We employ systems designed to continually monitor our facilities and work environment to promote employee safety and identify and prevent or mitigate any potential risks. This includes procedures and equipment for security. We routinely assess facilities to closely monitor adherence to established security and safety standards. Our employees receive specialized training related to their role, work setting, and equipment used in their work environment. As our processes evolve, we update relevant safety training modules, which may include new employee training programs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For more information on our approach to human capital management, please refer to our annual Corporate Citizenship Report, which is available on our website. </span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Intellectual Property</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of trade secret, patent, copyright and trademark laws, nondisclosure and other contractual provisions, and technical measures to protect our products, services and intangible assets. We hold patents, and continue to pursue patent protection throughout the world, relating to the manufacture, operation and use of various medical and surgical products, to certain distribution and logistics systems, to the production and distribution of our nuclear pharmacy products and to other service offerings. We also operate under licenses for certain proprietary technologies, and in certain instances we license our technologies to third parties.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have taken all necessary steps to protect our proprietary rights, but no assurance can be given that we will be able to successfully enforce or protect our rights in the event that they are infringed upon by a third party. While all of these proprietary rights are important to our operations, we do not consider any particular patent, trademark, license, franchise or concession to be material to our overall business.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. Depending upon the specific business, we may be subject to regulation by government entities including:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">certain agencies within the U.S. Department of Health and Human Services, including the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">state health departments, insurance departments, Medicaid departments or other comparable state agencies; </span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">state boards of pharmacy and other controlled substance authorities;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Nuclear Regulatory Commission (the &#8220;NRC&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">the U.S. Federal Trade Commission (the "FTC");</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">U.S. Customs and Border Protection; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">agencies comparable to those listed above in markets outside the United States.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These regulatory agencies have a variety of civil, administrative and criminal sanctions at their disposal for failure to comply with applicable legal or regulatory requirements. They can suspend our ability to manufacture and distribute products, restrict our ability to import products, require us to initiate product recalls, seize products or impose criminal, civil and administrative sanctions.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Boards of Pharmacy, FDA, DEA and various other state authorities regulate the marketing, purchase, storage and distribution of pharmaceutical and medical products under various federal and state statutes including the federal Prescription Drug Marketing Act of 1987, Drug Quality and Security Act of 2013 (the &#8220;DQSA&#8221;), and Controlled Substances Act (the "CSA"). The CSA governs the sale, packaging, storage and distribution of controlled substances. Wholesale distributors of controlled substances must hold valid DEA registrations and state-level licenses, meet various security and operating standards including effective anti-diversion programs, and comply with the CSA. They must also comply with state requirements relating to controlled substances that differ from state to state. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Settlement Agreement, as described in the Significant Developments in Fiscal 2021 and Trends section in MD&amp;A and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Notes to Consolidated Financial Statements includes injunctive relief terms related to settling distributors' controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating our controlled substances monitoring program; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the settling distributors will engage a third-party </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">vendor to act as a clearinghouse for data aggregation and reporting and will fund the clearinghouse for ten years. See Note 7 of the "Notes to Consolidated Financial Statements" for more information about the Settlement Agreement and other opioid-related matters. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Manufacturing, Sourcing and Marketing</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our manufactured products in the United States, Canada, Europe, Asia, Latin America and other markets. The FDA and other governmental agencies in the United States, as well as foreign governmental agencies, administer requirements that cover the design, testing, safety, effectiveness, manufacturing (including good manufacturing practices), quality systems, labeling, promotion and advertising (including restrictions on promoting or advertising a product other than for the product's cleared or approved uses), distribution, importation and post-market surveillance for most of our manufactured products. We are also subject to these requirements when we source certain Medical segment products from third-party manufacturers. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We need specific approval or clearance from, and registrations with, regulatory authorities before we can market and sell some products in the United States and certain other countries, including countries in the European Union ("EU"). </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, authorization to commercially market a medical device is generally received in one of two ways. The first, known as pre-market notification or the 510(k) process, requires us to demonstrate that a medical device is substantially equivalent to a legally marketed medical device. The second more rigorous process, known as pre-market approval (&#8220;PMA&#8221;), requires us to independently demonstrate that a medical device is safe and effective. Many of our Medical segment branded products are cleared through the 510(k) process and certain products must be approved through the PMA process. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, we are required to obtain CE Mark Certification in order to market medical devices. In 2017, EU regulatory bodies finalized a new Medical Device Regulation ("MDR") became effective in May 2021. Under the MDR, medical devices marketed in the EU require significant pre-market and post-market requirements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It can be costly and time-consuming to obtain regulatory approvals, clearances and registrations of medical devices, and they might not be granted on a timely basis, if at all. Even after we obtain approval or clearance to market a product or obtain product registrations, the product and our manufacturing processes are subject to continued regulatory oversight, including periodic inspection of manufacturing facilities by FDA and other regulatory authorities both in the United States and internationally. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements or published standards. When we or a regulatory agency identify a quality or regulatory issue, we investigate and take appropriate corrective action, which may include recalling the </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product, correcting the product at the customer location, revising product labeling and notifying customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse regulatory action, depending on its magnitude, may limit our ability to effectively manufacture, source, market and sell our products, limit our ability to obtain future premarket approvals or result in a substantial modification to our business practices and operations. For additional information, please see our Risk Factor entitled</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to rigorous quality regulatory and licensing requirements."</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Privacy and Data Protection </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various and evolving privacy laws and regulations in many jurisdictions. Because we collect, handle and maintain patient-identifiable health information, we are subject to laws that require specified privacy and security measures and that regulate the use and disclosure of such information, including the U.S. Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as augmented by the Health Information Technology for Economic and Clinical Health Act as well as state laws, in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also collect, handle, and maintain other personal and financial information. Within the U.S., these activities are regulated by certain federal and state laws. California, Colorado, Utah and Virginia have recently enacted privacy laws that grant specified rights to consumers over the use of their personal information, including increased transparency. Other states are considering adopting similar or different comprehensive privacy laws and a comprehensive federal privacy bill has been proposed in the U.S. House of Representatives. Internationally, we are also subject to privacy and data protection laws that require significant compliance efforts, including the EU's General Data Protection Regulation (GDPR), Canada's Personal Information Protection and Electronic Documents Act, Japan's Act on the Protection of Personal Information, and China's Personal Information Protection Law, among many others. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nuclear Pharmacies and Related Businesses</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nuclear pharmacies and radiopharmaceutical manufacturing facilities (including for Xofigo) require licenses or permits and must abide by regulations issued by the NRC, applicable state boards of pharmacy and the radiologic health agency or department of health of each state in which we operate, including pharmacy sterile compounding standards and practices. In addition, our radiopharmaceutical manufacturing facilities also must comply with FDA regulations, including good manufacturing practices.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Tracing and Supply Chain Integrity</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title II of the DQSA, known as the Drug Supply Chain Security Act or "Track and Trace," establishes a phased-in national system for tracing pharmaceutical products through the pharmaceutical distribution supply chain to detect, prevent and rapidly respond to the introduction of drugs that may be counterfeit, diverted, stolen, adulterated, subject of a fraudulent transaction or otherwise unfit for distribution. The first phase of implementation began in 2015, and upon full implementation in 2023, we and other supply chain stakeholders will participate in an electronic, interoperable, </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescription drug tracing system. In addition, the FDA also has issued regulations requiring most medical device labeling to bear a unique device identifier. The MDR, described above, also introduces a new unique device identifier requirement.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Government Healthcare Programs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. federal healthcare fraud and abuse laws. These laws generally prohibit persons from soliciting, offering, receiving or paying any compensation in order to induce someone to order, recommend or purchase products or services that are in any way paid for by Medicare, Medicaid or other federally-funded healthcare programs. They also prohibit submitting any fraudulent claim for payment by the federal government. There are similar state healthcare fraud and abuse laws that apply to Medicaid and other state-funded healthcare programs. Violations of these laws may result in criminal or civil penalties, as well as breach of contract claims and qui tam actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program. These businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements. Other businesses within each segment manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs. For example, during fiscal year 2022, we agreed to pay approximately $13 million to the Department of Justice and our Specialty Pharmaceutical Distribution business in our Specialty Solutions division entered into a Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services in connection with an investigation into discounts and rebates offered or provided to certain Specialty Solutions customers. For more information on this matter, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal and state government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Environmental, Health and Safety Laws</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, we are subject to various federal, state and local environmental laws, including laws regulating the production or use of hazardous substances, as well as laws relating to safe working conditions and laboratory practices. Additionally, industry participants, including us, rely on ethylene oxide ("EtO") to sterilize certain medical products that we manufacture or distribute. Regulatory actions have been taken by certain environmental regulatory authorities to reduce EtO emissions during the sterilization and distribution process. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Antitrust Laws</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government, most U.S. states and many foreign countries have laws that prohibit certain types of conduct deemed to be anti-competitive. Violations of these laws can result in various sanctions, including criminal and civil penalties. Private plaintiffs also could bring civil lawsuits against us in the United States for alleged antitrust law violations, including claims for treble damages. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Laws Relating to Foreign Trade and Operations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and foreign laws require us to abide by standards relating to the import and export of finished goods, raw materials and supplies and the handling of information. We also must comply with various export control and trade embargo laws, which may require licenses or other authorizations for transactions within some countries or with some counterparties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, we are subject to U.S. and foreign laws concerning the conduct of our foreign operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and other foreign anti-bribery laws. Among other things, these laws generally prohibit companies and their intermediaries from offering, promising or making payments to officials of foreign governments for the purpose of obtaining or retaining business. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Other Information </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #ee2724;padding:0 1pt"></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our agreements with manufacturers sometimes require us to maintain inventory levels within specified ranges, our distribution businesses are generally not required by our customers to maintain particular inventory levels other than as needed to meet service level requirements. Certain customer contracts require us to maintain sufficient inventory to meet emergency demands, but we do not believe those requirements materially affect inventory levels.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return product for credit that can be added back to inventory and resold at full value, or that can be returned to vendors for credit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer market payment terms to our customers.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Risk Factors </span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks described below could materially and adversely affect our results of operations, financial condition, liquidity or cash flows. These are not the only risks we face. Our businesses also could be affected by risks we do not currently consider material to our operations or of which we are not presently aware.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Legal, Regulatory &amp; Compliance Risks</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes prescription opioid pain medications. The abuse of prescription opioid pain medication has become a public health crisis.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant number of states, counties, municipalities and other public plaintiffs, have filed lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors (including us), retail chains and others relating to the manufacturing, marketing or distribution of prescription opioid pain medications. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, an agreement settling the vast majority of opioid-related lawsuits filed against us by state and local governmental entities (the "Settlement Agreement") became effective. The Settlement Agreement includes a cash component, pursuant to which we will pay up to approximately $6.0 billion, the majority of which we expect to be paid over 18 years. The Settlement Agreement also includes injunctive relief terms relating to distributors' controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating controlled substances monitoring programs; (3) due diligence for new and existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which the distributors will fund for ten years. It is possible that the implementation and maintenance of the required changes to distributors' controlled substance anti-diversion programs may result in unforeseen costs or operational challenges which could have an adverse impact on our results of operations or performance. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the claims brought by states and other local governmental entities, we are also being sued by private plaintiffs, such as unions, other health and welfare funds, hospital systems, third party payors, other healthcare providers and individuals alleging personal injury for the same activities and could be named as a defendant in additional lawsuits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in legal proceedings with insurers related to the availability of insurance coverage for some matters described above, but the defense and resolution of current and future lawsuits and investigations are subject to uncertainty and could have a material adverse effect on our results of operations, financial condition, cash flows, liquidity, or our ability to pay dividends or repurchase our shares, beyond the amounts accrued and beyond what we may be able to recover from our insurers. In addition, they could have adverse reputational or operational effects on our business. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For example, several states have adopted or proposed taxes or other fees on the sale of opioids. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate them through operational changes or commercial arrangements where permitted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing unfavorable publicity regarding the abuse or misuse of prescription opioid pain medications and the role of wholesale distributors in the supply chain of such prescription medications, as well as the continued proliferation of the opioid lawsuits, investigations, regulations and legislative actions, and unfavorable publicity in relation to those lawsuits could continue to have a material adverse effect on our reputation or results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is subject to other rigorous quality, regulatory and licensing requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in greater detail in the "Business" section, products that we manufacture, source, distribute or market must comply with quality and regulatory requirements. Noncompliance or concerns over noncompliance, including noncompliance by third-party contract manufacturers, may result in suspension of our ability to distribute, import, manufacture or source products, as well as product bans, recalls, safety alerts or seizures, or criminal or civil sanctions, which, in turn, could result in product liability claims and lawsuits, including class actions. In addition, it can be costly and time-consuming to obtain regulatory approvals or product registrations to market a medical device or other product, and such approvals or registrations might not be granted on a timely basis, if at all. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as described in greater detail in the "Business" section, our business is highly regulated in the United States, at both the federal and state level, and in foreign countries. If we fail to comply with regulatory requirements, or if allegations are made that we fail to comply, our results of operations and financial condition could be adversely affected.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To lawfully operate our businesses, we are required to obtain and hold permits, product registrations, licenses and other regulatory approvals from, and to comply with operating and security standards of, numerous governmental bodies. For example, as a wholesale distributor of controlled substances, we must hold valid DEA registrations and state-level licenses, meet various security and operating standards, and comply with the CSA. Failure to maintain or renew necessary permits, product registrations, licenses or approvals, or to comply with required standards, could have an adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, handle and maintain patient-identifiable health information and other sensitive personal and financial information which are subject to federal, state and foreign laws that regulate the use and disclosure of such information. Regulations currently in place continue to evolve, and new laws in this area could further restrict our ability to collect, handle and maintain personal or patient information, or could require us to incur additional compliance costs, either of which could have an adverse impact on our results of operations. Violations of federal, state or foreign laws concerning privacy and data protection could subject us to civil or criminal penalties, breach of contract claims, costs for remediation and harm to our reputation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with laws relating to healthcare fraud and abuse. The requirements of these laws are complex and subject to varying interpretations. From time to time, regulatory authorities investigate our policies or practices, and may challenge them. We are periodically subject to federal or state government investigations or qui tam actions (false claims cases initiated by private parties purporting to act on behalf of federal or state governments), which could result in civil or criminal sanctions, including the loss of licenses or the ability to participate in Medicare, Medicaid and other federal and state healthcare programs or other remedial measures. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the United States Attorney&#8217;s Office for the District of Massachusetts and the Office of Inspector General of the Department of Health and Human Services conducted an investigation related to discounts and rebates offered or provided to certain Specialty Solutions customers as a result of qui tam actions. For more information on this investigation, see </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. In connection with this investigation, in January 2022, our Specialty Pharmaceutical Distribution business in the Specialty Solutions division entered into a Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services. It is possible that, as a result of the Corporate Integrity Agreement, we could incur greater costs or operational impacts than anticipated that may adversely impact our business. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some businesses within each of our segments are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program. In addition, some businesses manufacture pharmaceutical or medical products or repackage pharmaceuticals that are purchased or reimbursed through, or are </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otherwise governed by, federal or state healthcare programs. Failure to comply with applicable eligibility requirements, standards and regulations could result in civil or criminal sanctions, including the loss of our ability to participate in Medicare, Medicaid and other federal and state healthcare programs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private challenges to government healthcare policy may also have a significant impact on our business. For example, the federal 340B drug pricing program requires pharmaceutical manufacturers to offer discounts on certain drugs purchased by covered entities, and some of our Pharmaceutical segment customers are covered entities or contract pharmacies for covered entities. Over a dozen pharmaceutical manufacturers have unilaterally restricted sales under the 340B drug pricing program to contract pharmacies. These practices are the subject of ongoing litigation; however, if manufacturers continue this practice and if courts uphold this practice, our customers may be adversely impacted, which could adversely impact our business. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industry participants, including us, rely on ethylene oxide (&#8220;EtO&#8221;) to sterilize certain medical products that we manufacture or distribute. Regulatory actions have been taken by certain environmental regulatory authorities to reduce EtO emissions during the sterilization and distribution process. If such measures become more widespread, we could experience increased costs to comply with reduced emissions standards and it is possible that we and other industry participants may be unable to effectively sterilize medical products, possibly resulting in industry-wide supply shortages or a reduction in surgical or medical procedures. Such increased costs or industry-wide reductions in surgical and medical procedures would have a negative impact on our Medical segment profit. Additionally, we have been named as a defendant in several lawsuits alleging personal injury as a result of EtO emissions. As a result of a notice of violation we received from an environmental regulator in Georgia, we are making specified changes to a replenishment center in that state. It is possible that these or future regulatory actions or lawsuits could adversely impact our ability to procure products to distribute, resulting in increased costs or industry supply disruptions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our government contracts are subject to specific procurement requirements. Failure to comply with applicable rules or regulations or with contractual or other requirements may result in monetary damages and criminal or civil penalties as well as termination of our government contracts or our suspension or debarment from government contract work.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations (including transition services in connection with divestitures) are subject to the U.S. Foreign Corrupt Practices Act ("FCPA"), the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws. If we fail to comply, or are alleged to fail to comply, with any of these laws, we could be subject to investigations or suffer civil or criminal sanctions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to government import and export controls and regulations, including the requirement that we make a determination, based on the best information that we have available at the time, as to the country of origin of products that we </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">source or manufacture outside the United States. U.S. Customs and Border protection may challenge our determinations, which could result in products being detained, or the imposition of fines and penalties and may result in supply disruptions. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could be subject to adverse changes in the tax laws or </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">challenges to our tax positions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a large multinational corporation with operations in the United States and many foreign countries. As a result, we are subject to the tax laws of many jurisdictions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, proposals are made in the United States and other jurisdictions in which we operate that could adversely affect our tax positions, effective tax rate or tax payments. Specific initiatives that may impact us include possible increases in U.S. or foreign corporate income tax rates or other changes in tax law to raise revenue, the repeal of the LIFO (last-in, first-out) method of inventory accounting for income tax purposes, the establishment or increase in taxation at the U.S. state level on the basis of gross revenues, recommendations of the base erosion and profit shifting project undertaken by the Organization for Economic Cooperation and Development and the European Commission&#8217;s investigation into illegal state aid. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in connection with the accruals taken in connection with opioid-related lawsuits in fiscal years 2021 and 2020, we recorded net tax benefits of $228&#160;million and $488 million, respectively, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment and it is possible that they could be subject to challenges by the IRS. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. tax law governing deductibility was changed by the Tax Act and the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits, or tax law could change again. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" for more information regarding these matters. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, our provision for income taxes reflects a $424 million benefit from the tax benefits of a net operating loss carryback under the CARES Act. Also, as a result of this net operating loss carryback, we received a U.S. federal income tax refund of $966 million. In connection with this net operating loss carryback, certain industry participants, including us, received a letter from the U.S. House of Representatives&#8217; Committee on Oversight and Reform questioning, among other things, our plans to take tax deductions for opioid-related losses, including our use of the net operating loss carryback provisions under the CARES Act and deductibility under the Tax Act. We responded to the letter. It is possible that the IRS could challenge our tax position with respect to this self-insurance loss. If these initiatives are successful, our effective tax rate could be adversely impacted. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. Tax laws </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are complex and subject to varying interpretations. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. Proposed adjustments in ongoing audits may adversely affect our effective tax rate or tax payments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to the U.S. healthcare environment may not be favorable to us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over a number of years, the U.S. healthcare industry has undergone significant changes designed to increase access to medical care, improve safety and patient outcomes, contain costs and increase efficiencies. These changes include a general decline in Medicare and Medicaid reimbursement levels, efforts by healthcare insurance companies to limit or reduce payments to pharmacies and providers, the basis for payments beginning to transition from a fee-for-service model to value-based payments and risk-sharing models, and the industry shifting away from traditional healthcare venues like hospitals and into clinics, physician offices and patients&#8217; homes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the U.S. healthcare industry to continue to change significantly in the future. Possible changes include further reduction of or limitations on governmental funding at the state or federal level, efforts by healthcare insurance companies to further limit payments for products and services or changes in legislation or regulations governing prescription pharmaceutical pricing, healthcare services or mandated benefits. These possible changes, and the uncertainty surrounding these possible changes, may adversely affect us.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal proceedings could adversely impact our cash flows or results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of our business, which includes the distribution of controlled substances and other pharmaceutical products and the sourcing, marketing and manufacturing of medical products, we regularly become involved in disputes, litigation and regulatory matters. Litigation is inherently unpredictable and the unfavorable outcome of legal proceedings could adversely affect our results of operations or financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we are subject to a number of lawsuits and investigations related to the national health crisis involving the abuse of opioid pain medication as described above in the Risk Factor titled "The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business" and in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the "Notes to Consolidated Financial Statements."</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some of the products that we distribute or manufacture have been and may in the future be alleged to cause personal injury, subjecting us to product liability claims. For example, we are a defendant in product liability lawsuits that allege personal injuries associated with the use of Cordis OptEase and TrapEase IVC filter products and in lawsuits alleging impurities in the active pharmaceutical ingredients in certain pharmaceutical products. In addition, product liability insurance for these types of claims is becoming more limited and may not be available to us at </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts that we historically have obtained or that we would like to obtain. It is possible that a settlement of or judgment for a product liability claim may not be covered by insurance or exceed available insurance recoveries. If this happens, and if any such settlement or judgment is in excess of any prior accruals, our results of operations and financial condition could be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also operate in an industry characterized by extensive intellectual property litigation. Patent litigation can result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or force us to make royalty payments in order to continue selling the affected products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with legal proceedings, we occasionally enter into settlement agreements or become subject to consent decrees containing ongoing financial or operational obligations, including the injunctive relief provisions of the National Settlement Agreement and the Corporate Integrity Agreement mentioned above. Failure to comply with obligations under these agreements or decrees could lead to monetary or other penalties.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Business &amp; Operational Risks</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business and operations depend on the proper functioning of information systems, business processes, critical facilities and distribution networks.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our and third-party service providers' information systems for a wide variety of critical operations, including to obtain, rapidly process, analyze and manage data to:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">facilitate the purchase and distribution of inventory items from numerous distribution centers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">receive, process and ship orders on a timely basis;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">manage accurate billing and collections for thousands of customers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">process payments to suppliers;</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">facilitate manufacturing and assembly of medical products; and</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.13pt">generate financial information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also depends on the proper functioning of our and our suppliers' business processes, critical facilities, including our national logistics center, and our distribution networks. Our results of operations could be adversely affected if our or a service provider's business processes, information systems, critical facilities or distribution networks are disrupted (including disruption of access), are damaged or fail, whether due to physical disruptions, such as fire, natural disaster, pandemic (as they have been by the COVID-19 pandemic) or power outage, or due to cyber-security incidents, ransomware or other actions of third parties, including labor strikes or shortages, political unrest and terrorist attacks. Manufacturing disruptions also can occur due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product or component is manufactured at a single manufacturing facility with limited alternate facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our businesses perform business process improvements or infrastructure modernizations or use service </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providers for key systems and processes, such as receiving and processing customer orders, customer service and accounts payable. For example, during fiscal 2022, our Pharmaceutical segment implemented a replacement of certain finance and operating information systems and we have also transitioned certain finance processes to a third-party service provider. If any of these initiatives or similar initiatives are not successfully or efficiently implemented or maintained, they could adversely affect our business and our internal control over financial reporting.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively is increasingly dependent on access to and interpretation of data. Data quality impacts customer ordering, order fulfillment and higher order processing. If we fail to effectively implement and maintain data governance structures across our businesses or to effectively interpret and utilize such data, our operations could be impacted and we may be at a competitive disadvantage.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business and results of operations could be adversely affected if we experience a material cyber-attack or other systems breach.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business relies on the secure transmission, storage and hosting of patient-identifiable health information, financial information and other sensitive protected information relating to our customers, company, workforce and individuals with whom we and our customers conduct business. We have programs in place to detect, contain and respond to information security incidents. However, because the techniques used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently and may be difficult to detect for long periods of time, we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, hardware, software or applications developed internally or procured from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise information security.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized parties have gained access and will continue to attempt to gain access to our or a service provider's systems or facilities through fraud, trickery or other forms of deception. We have been the target of cyber attacks, including, in prior fiscal years, incidents where certain customer account information was accessed. Although we do not believe these incidents had a material impact on us, similar incidents or events in the future may negatively impact our business, reputation or financial results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any compromise of our or a service provider's information systems, including unauthorized access to or use or disclosure of sensitive information, could adversely impact our operations, results of operations or our ability to satisfy legal or regulatory requirements, including the EU general data protection regulation (GDPR) and those related to patient-identifiable health information and other sensitive personal and financial information as further described in the Risk Factor titled &#8220;Our business is subject to rigorous regulatory and licensing requirements,&#8221; above.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, insurance for losses arising from cyber-attacks or other breaches is becoming more costly and limited and may not be available to us at amounts that we historically have obtained or that we would like to obtain. It is possible that we could incur </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">losses that may not be covered by insurance or that would exceed available insurance recoveries. If this happens, our results of operations and financial condition could be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our goodwill may become further impaired, which could require us to record additional significant charges to earnings in accordance with generally accepted accounting principles.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP requires us to test our goodwill for impairment on an annual basis, or more frequently if indicators for potential impairment exist. As a result of adverse financial results in our Medical Unit resulting from inflationary impacts and global supply chain constraints, we performed interim goodwill impairment testing for the Medical Unit for the periods ended December 31, 2021 and March 31, 2022. As a result of both of these interim tests and the annual test conducted for the period ended June 30, 2022, we recorded an aggregate $2.1 billion impairment to goodwill related to our Medical Unit in fiscal year 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This testing involves estimates and significant judgments by management. We believe our assumptions and estimates are reasonable and appropriate; however additional adverse changes in key assumptions, including a failure to meet expected earnings or other financial plans, unanticipated events and circumstances such as changes in assumptions about the duration and magnitude of increased supply chain and commodities costs and our planned efforts to mitigate such impacts, further disruptions in the supply chain, the impact of the Cordis divestiture, estimated demand and selling prices for PPE, a further increase in the discount rate, a decrease in the terminal growth rate, increases in tax rates (including potential tax reform) or a significant change in industry or economic trends could affect the accuracy or validity of such estimates and may result in an additional goodwill impairment in our Medical Unit. It is also possible that we may record significant charges related to other reporting units. Any charge or charges could adversely affect our results of operations. See "Critical Accounting Policies and Sensitive Accounting Estimates" in MD&amp;A above for more information regarding goodwill impairment testing.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales and credit concentration is significant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health and OptumRx are large customers that generate a significant amount of our revenue. CVS Health accounted for 25 percent of our fiscal 2022 revenue and 24 percent of our gross trade receivable balance at June&#160;30, 2022 and OptumRx accounted for 16 percent of our fiscal 2022 revenue. If either of these customers terminates their agreements due to an alleged default by us, defaults in payment or significantly reduces their purchases from us, our results of operations and financial condition could be adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our results of operations could be adversely impacted if we fail to manage and complete divestitures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our portfolio of businesses to determine whether an asset or business may no longer help us meet our objectives or whether there may be a more advantaged owner for that business. For example, we completed the divestiture of the Cordis business in fiscal 2022, and in the past few years, we have also divested our pharmaceutical and medical products distribution </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business in China and our ownership interest in naviHealth, Inc. When we decide to sell assets or a business, we may encounter difficulty finding buyers or alternative exit strategies, which could delay the achievement of our strategic objectives. We could also incur higher costs or charges than planned or incur unexpected charges and could experience greater dis-synergies than expected, which could have a negative impact on our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to manage and complete acquisitions could impact our strategic objectives and financial condition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we look to acquire other businesses that expand or complement our existing businesses. Completion of acquisitions and the integration of acquired businesses involve a number of risks, including the following: we may overpay for a business or fail to realize the synergies and other benefits we expect from the acquisition; our management&#8217;s attention may be diverted to integration efforts; we may fail to retain key personnel of the acquired business; future developments may impair the value of our purchased goodwill or intangible assets; we may face difficulties or delays establishing, integrating or combining operations and systems, including manufacturing facilities; we may assume liabilities related to legal proceedings involving the acquired business; we may face challenges retaining the customers of the acquired business; or we may encounter unforeseen internal control, regulatory or compliance issues.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Industry &amp; Economic Risks</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could continue to suffer the adverse effects of competitive pressures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in greater detail in the "Business" section, we operate in markets that are highly competitive and dynamic. In addition, competitive pressures in our pharmaceutical and medical segments may be increased by new business models, new entrants, new regulations, changes in consumer demand or general competitive dynamics. Our businesses face continued pricing pressure from these factors, which adversely affects our margins. If we are unable to offset margin reductions caused by these pricing pressures through steps such as sourcing or cost control measures, additional service offerings and sales of higher margin products, our results of operations could continue to be adversely affected. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Pharmaceutical segment&#8217;s profit margin could be adversely affected by changes in industry or market dynamics that we are not able to accurately predict. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As has been the case for several years, the frequency, timing, magnitude and profit impact of generic pharmaceutical customer purchase volumes, pricing changes, customer contract renewals, generic pharmaceutical launches, and generic pharmaceutical manufacturer pricing changes remain uncertain as does their impact on Pharmaceutical segment profit and consolidated operating earnings. These factors have contributed to declines in some prior years and have more than offset the benefits from sourcing generic pharmaceuticals through our Red Oak Sourcing venture with CVS Health. If performance of our generic pharmaceutical program declines in future fiscal years and we are </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unable to offset the decline, our Pharmaceutical segment profit and consolidated operating earnings will be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to branded pharmaceutical products, compensation under our contractual arrangements with manufacturers for the purchase of branded pharmaceutical products is generally based on the wholesale acquisition cost set by the manufacturer. Sales prices of branded pharmaceutical products to our customers generally are a percentage discount from wholesale acquisition cost.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, almost all of our distribution services agreements with branded pharmaceutical manufacturers provide that we receive fees from the manufacturers to compensate us for services we provide them. However, under certain agreements, branded pharmaceutical price appreciation, which is determined by the manufacturers also serves as a part of our compensation. In recent years, manufacturers have increased prices less than in prior years. If manufacturers, in the aggregate, change their historical approach to setting and increasing wholesale acquisition cost, decide to reduce prices, not to increase prices or to implement only small increases and we are unable to negotiate alternative ways to be compensated by manufacturers or customers for the value of our services, our margins could be adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on direct and indirect suppliers to make their</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">products and raw materials available to us and are subject to fluctuations in costs, availability and regulatory risk associated with these products and raw materials.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing businesses use oil-based resins, pulp, cotton, latex and other commodities as raw materials in many products. Prices of oil and gas also affect our distribution and transportation costs. Prices of these commodities are volatile and can fluctuate significantly, causing our costs to produce and distribute our products to fluctuate. Beginning in the fourth quarter of fiscal year 2021, we have experienced higher supply chain costs, which had a negative impact on Medical segment profit in fiscal 2021 and 2022. Supply chain constraints have also had a negative impact on sales within our Medical segment. We expect these cost increases and supply chain constraints to continue to have a negative impact on segment profit, primarily in the Medical segment, in fiscal 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">W</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e do not expect to offset the full impact of</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> these cost increases in fiscal year 2023. We intend to offset some cost increases through cost reductions and through price increases or surcharges; however, due to competitive dynamics and contractual limitations, passing along cost increases is challenging. If we are not able to increase prices as planned, Medical segment profit could be negatively impacted to a greater extent than we currently anticipate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on others to manufacture some products that we market and distribute. Our operations are also dependent on various components, compounds, raw materials and energy supplied by others. We purchase many of these components, raw materials and energy, and source certain products from numerous suppliers in various countries. In some instances, for reasons of quality assurance, cost effectiveness, or availability, we procure </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain components and raw materials from a sole supplier. Our supplier relationships could be interrupted, become less favorable to us or be terminated and the supply of these components, compounds, raw materials or products could be interrupted or become insufficient.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These supply interruptions or other disruptions in manufacturing processes could be caused by events beyond our control, including natural disasters, supplier facility shutdowns, defective raw materials, the impact of epidemics or pandemics, such as COVID-19, and actions by U.S. or international governments, including import or export restrictions or tariffs. For example, the Uyghur Forced Labor Prevention Act, which went into effect in June 2022 prohibits the importation of any goods grown, produced, manufactured or mined in the Xinjiang Uyghur Autonomous Region of China unless importers can provide clear and convincing evidence that goods were not made using forced labor. If we determine that some of our imported source materials derive from this region, we could experience additional supply constraints and our performance could be negatively impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, due to the stringent regulatory requirements regarding the manufacture and sourcing of our products, we may not be able to quickly establish additional or replacement sources for certain components, materials or products. A sustained supply reduction or interruption, and an inability to develop alternative and additional sources for such supply, could result in lost sales, increased cost, damage to our reputation, and may have an adverse effect on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee attrition may have an adverse impact on our business, results of operations or internal controls.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract, retain and develop qualified and experienced employees, including key executives and other talent, is critical for us to meet our business objectives. We compete with many other businesses to attract and retain employees. Competition among potential employers has resulted in increases in salaries and wages, benefits and other employee-related costs. It is possible that we could experience loss of key personnel for a variety of causes. If we do not adequately plan for succession of key roles or if we are not successful in attracting or retaining new talent, our performance or internal control over financial reporting could be adversely impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation in the U.S. healthcare industry may negatively impact our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, U.S. healthcare industry participants, including distributors, manufacturers, suppliers, healthcare providers, insurers and pharmacy chains, have consolidated or formed strategic alliances. Consolidations create larger enterprises with greater negotiating power, and also could result in the possible loss of a customer where the combined enterprise selects one distributor from two incumbents. If this consolidation trend continues, it could adversely affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes or uncertainty in U.S. or international trade policies</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and exposure to economic, political and currency and other </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk Factors</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">risks could disrupt our global operations or negatively impact our financial results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our operations in various regions of the world outside of the United States, including Europe, Asia and Latin America. Global developments can affect our business in many ways. Our global operations are affected by local economic environments, including inflation, recession and competition. Additionally, divergent or unfamiliar regulatory systems and labor markets can increase the risks and burdens of operating in numerous countries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign operations expose us to a number of risks related to trade protection laws, tariffs, excise or other border taxes on goods sourced from certain countries or on the importation or exportation of products or raw materials. Changes or uncertainty in U.S. or international trade policies or tariffs could impact our global operations, as well as our customers and suppliers. We may be required to spend more money to source certain products or materials that we need or to manufacture certain of our products. This could adversely impact our business and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we conduct our business in U.S. dollars and various functional currencies of our foreign subsidiaries. Changes in foreign currency exchange rates could adversely affect our financial results, which are reported in U.S. dollars. We may not be able to hedge to protect us against these exposures, and any hedges may not successfully mitigate these exposures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical dynamics caused by political, economic, social or other conditions in foreign countries and regions may continue to impact our business and results of operations. Both of our segments have experienced increased costs, including for fuel, and it is possible that we could experience supply disruptions or shortages if tariffs or other protective measures are enacted. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">COVID-19 Risks</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have been and expect to continue to be negatively affected by the ongoing COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has significantly impacted our businesses in a variety of ways beginning in fiscal year 2020, including volume declines in our Pharmaceutical segment and supply chain constraints and unusual PPE supply and demand dynamics in our Medical segment. While volumes within the Pharmaceutical segment have largely rebounded, our Medical segment continues to experience the effects of inflation, supply chain constraints and PPE dynamics, which, due to the passage of time, intervening events and other market dynamics, we now consider to be independent from COVID-19 for purposes of our assessment of our financial condition. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the COVID-19 pandemic is ongoing and w</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e cannot estimate its continued length or severity or the related consequences on our business and operations, including whether and when normal economic and operating conditions will resume or the extent to which further disruption may impact our business, financial position, results of operations or cash flow. The COVID-19 pandemic has also heightened other risks, including risks associated with competitive pressures, supplier relationships, </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">international operations, regulatory and licensing, changes to the U.S. healthcare environment, cyber security, and access to capital markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Properties and Legal Proceedings</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Properties</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, at June&#160;30, 2022, the Pharmaceutical segment operated one national logistics center; a number of primary pharmaceutical and specialty distribution facilities as well as nuclear pharmacy and radiopharmaceutical manufacturing facilities. The Medical segment operated medical-surgical distribution, assembly, manufacturing and other operating facilities in the United States. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, our Medical segment also operated manufacturing facilities in Canada, Costa Rica, the Dominican Republic, Germany, Ireland, Japan, Malaysia, Malta, Mexico and Thailand.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are headquartered in an owned building located at 7000 Cardinal Place in Dublin, Ohio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider our operating properties to be in satisfactory condition and adequate to meet our present needs. However, we regularly evaluate operating properties and may make further additions and improvements or consolidate locations as we seek opportunities to expand or enhance the efficiency of our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Properties and Legal Proceedings</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the proceedings described below, the legal proceedings described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Melissa Cohen, a purported shareholder, filed an action on behalf of Cardinal Health, Inc. in the U.S. District Court for the Southern District of Ohio against certain current and former members of our Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor Cardinal Health's distribution of controlled substances and approving certain payments of executive compensation. In December 2019 and January 2020, similar complaints were filed in the U.S. District Court for the Southern District of Ohio by purported shareholders, Stanley M. Malone and Michael Splaine, respectively. In January, 2020, the court consolidated the derivative cases under the caption </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Cardinal Health, Inc. Derivative Litigation</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in March 2020, plaintiffs filed an amended complaint. The amended consolidated derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees. In February 2021, the court granted in part and denied in part defendants' motion to dismiss. The court dismissed the claim with respect to executive compensation but declined to dismiss the failure to monitor claim.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the parties reached an agreement in principle to settle this matter and in July 2022, the court granted preliminary approval of the settlement. Subject to final approval by the court, as part of this settlement, Cardinal's director and officer's liability insurance carriers, on behalf of the defendants, will pay Cardinal $124 million, less any attorneys' fees and expenses awarded by the court to plaintiffs' counsel. This settlement does not include any admission of liability. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market for Registrant's Common Equity</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are listed on the New York Stock Exchange under the symbol &#8220;CAH.&#8221; </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At July&#160;31, 2022 there were approximately 6,857 shareholders of record of our common shares.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to pay quarterly cash dividends in the future. The payment and amount of future dividends remain, however, within the discretion of our Board of Directors and will depend upon our future earnings, financial condition, capital requirements and other factors. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number<br/>of Shares<br/>Purchased&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid&#160;per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares<br/>Purchased<br/>as Part of Publicly Announced Programs&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar Value of<br/>Shares That May<br/>Yet be Purchased<br/>Under the Programs&#160;(3)<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">608,582&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.80&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">607,823&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 2022</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.93&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">609,051</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">65.79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">607,823</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,743</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Reflects 759, 216 and 253 common shares purchased in April, May and June 2022, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">On February 28, 2022, we entered into an accelerated share repurchase program ("ASR") to purchase common shares for an aggregate purchase price of $200&#160;million and received an initial delivery of 3.0&#160;million common shares using a reference price of $54.01. The program concluded on April 18, 2022 at a volume weighted average price per common share of $56.02 resulting in a final delivery of 0.6&#160;million common shares. See Note 10 of the "Notes to Consolidated Financial Statements" for additional information.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">On November 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that expired on December 31, 2021. On November 4, 2021, our Board of Directors approved a new $3.0 billion share repurchase program, which will expire on December 31, 2024. As of June 30, 2022, we have $2.7 billion authorized for share repurchases remaining under this program.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market for Registrant's Common Equity</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Five Year Performance Graph</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following line graph compares the cumulative total return of our common shares with the cumulative total return of the Standard &amp; Poor&#8217;s Composite&#8212;500 Stock Index (the "S&amp;P 500 Index") and the Standard &amp; Poor's Composite&#8212;500 Healthcare Index (the "S&amp;P 500 Healthcare Index"). The line graph assumes, in each case, an initial investment of $100 invested at the closing price on June 30, 2017, and is based on the market prices at the end of each fiscal year through and including June&#160;30, 2022, and reinvestment of dividends. The S&amp;P 500 Index and S&amp;P 500 Healthcare Index investments are weighted on the basis of market capitalization at the beginning of each period. </span></div><div style="margin-bottom:3pt;text-align:center"><img src="cah-20220630_g7.jpg" alt="cah-20220630_g7.jpg" style="height:463px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"/></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.630%"><tr><td style="width:1.0%"></td><td style="width:27.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2022</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.67&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.89&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.75&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.75&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">80.55</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">170.74</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S&amp;P 500 Healthcare Index</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.11&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121.02&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134.21&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171.68&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">177.47</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Management Reports</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of June&#160;30, 2022. Based on this evaluation, our principal executive officer and principal financial officer has concluded that our disclosure controls and procedures were effective as of June&#160;30, 2022 to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, controls deemed effective now may become inadequate in the future because of changes in conditions, or because compliance with policies or procedures has deteriorated or been circumvented.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of our internal control over financial reporting as of June&#160;30, 2022. In making this assessment, management used the criteria established in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). Based on management&#8217;s assessment and the COSO criteria, management believes that our internal control over financial reporting was effective as of June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Ernst&#160;&amp; Young LLP, has issued a report on our internal control over financial reporting. Ernst&#160;&amp; Young LLP&#8217;s report appears following this "Management Reports" section and expresses an unqualified opinion on the effectiveness of our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Pharmaceutical Segment Information Technology Initiative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Pharmaceutical segment implemented a replacement of certain finance and operating information systems. As a part of this project, we transitioned selected processes to new systems which affected our internal control over financial reporting during the fiscal year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cardinal Health, Inc. and subsidiaries&#8217; internal control over financial reporting as of June&#160;30, 2022, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Cardinal Health, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of June&#160;30, 2022, based on the COSO criteria.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of June&#160;30, 2022 and 2021, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity/(deficit) and cash flows for each of the three years in the period ended June&#160;30, 2022, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) and our report dated August&#160;11, 2022 expressed an unqualified opinion thereon.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying &#8220;Management&#8217;s Report on Internal Control Over Financial Reporting.&#8221; Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.358%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183MC9mcmFnOmQ4ZjczYzI1NDg4NDQ1MzQ5M2EzNjcyNTAyMDg0MWQwL3RhYmxlOmE4ZTU4MTIwOGZlZDQxOGY4NGFlZGI3ZWUwMTMwMGNlL3RhYmxlcmFuZ2U6YThlNTgxMjA4ZmVkNDE4Zjg0YWVkYjdlZTAxMzAwY2VfMC0wLTEtMS0xODIwOTMvdGV4dHJlZ2lvbjoyMWY2MDg2ZjE2ZGY0NTBmYmU5MTYwODA4M2NkNWM2Y18xOTI0MTQ1MzQ4NjEyMg_43294bb2-a126-4a48-8ff0-7a5d66224bdd">Ernst&#160;&amp; Young LLP</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183MC9mcmFnOmQ4ZjczYzI1NDg4NDQ1MzQ5M2EzNjcyNTAyMDg0MWQwL3RhYmxlOmE4ZTU4MTIwOGZlZDQxOGY4NGFlZGI3ZWUwMTMwMGNlL3RhYmxlcmFuZ2U6YThlNTgxMjA4ZmVkNDE4Zjg0YWVkYjdlZTAxMzAwY2VfMi0wLTEtMS0xODIwOTg_ba7b968a-e66a-4787-a9a1-9991e4be6755">Grandview Heights, Ohio</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 11, 2022</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Cardinal Health, Inc.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cardinal Health, Inc. and subsidiaries (the Company) as of June&#160;30, 2022 and 2021, the related consolidated statements of earnings/(loss), comprehensive income/(loss), shareholders' equity/(deficit) and cash flows for each of the three years in the period ended June&#160;30, 2022, and the related notes and the financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June&#160;30, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended June&#160;30, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June&#160;30, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated August&#160;11, 2022 expressed an unqualified opinion thereon.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Medical Unit Goodwill</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">At June 30, 2022, goodwill related to the Company&#8217;s Medical segment, including the Medical Unit was $3.2 billion. As discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Notes 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> to the consolidated financial statements, goodwill is tested for impairment at least annually at the reporting unit level, or when indicators of impairment exist. During fiscal 2022, the Company recognized goodwill impairment charges related to the Medical Unit of $2.1 billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Auditing management&#8217;s goodwill impairment test for the Medical Unit was challenging because there is significant judgement required in determining the fair value of the reporting unit. In particular, the fair value estimate was sensitive to significant judgmental assumptions including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company-specific risk premium, which are affected by expectations about future market or economic conditions.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit<br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:106%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment review process. For example, we tested controls over management&#8217;s review of significant judgmental assumptions, including the revenue growth rate, gross margin, distribution, selling, general and administrative expenses, and company-specific risk premium, among other assumptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">To test the estimated fair value of the Company&#8217;s Medical Unit, we performed audit procedures that included, among others, evaluating methodologies used, involving our valuation specialists in testing the significant assumptions described above and testing the underlying data used by the Company in its analysis for completeness and accuracy. We compared the significant assumptions used by management to current industry and economic trends, recent historical performance, changes to the reporting unit&#8217;s business model, customer base or product mix and other relevant factors. We assessed the historical accuracy of management&#8217;s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions. We evaluated the incorporation of the applicable assumptions into the model and tested the model&#8217;s computational accuracy. In addition, we inspected the</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> Company&#8217;s reconciliation of the fair value of all reporting units to the market capitalization of the Company and assessed the result. We have also assessed the adequacy of the Company&#8217;s disclosures included in </span><span style="color:#3051f2;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#3051f2;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Notes 1</a></span><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> and </span><span style="color:#3051f2;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#3051f2;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> in relation to this matter.</span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Liability Lawsuits</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">As described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_97">Notes 1</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, the Company is a defendant in various product liability claims in which individuals seek damages associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. The Company accrues for losses and defense costs related to product liability at the time a loss is probable and the amount of loss can be reasonably estimated. The methodology used by the Company to project future Cordis IVC claim costs is based largely on recent experience, including claim filing rates, indemnity severity by claim type, sales data, implant and injury to report lag patterns, and defense costs. The Company periodically reviews such estimates and records adjustments for changes in reserves in the period in which the change in estimate occurs. At June 30, 2022, the Company&#8217;s product liability reserve balance related to the Cordis IVC lawsuits totaled $512 million, net of estimated insurance recoveries. The Company believes there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, the Company has accrued the minimum amount in the range. The Company estimates the high end of the range to be approximately $1.05 billion net of estimated insurance recoveries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Auditing management&#8217;s accounting for and disclosure of loss contingencies related to the Cordis IVC product liability lawsuits was challenging due to the significant judgment required to develop the key assumptions utilized to calculate the estimated losses and the nature of information available given the early stages of these lawsuits and the limited claims and settlement history. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over management&#8217;s evaluation of the product liability litigation reserve. For example, we tested controls over management&#8217;s review of the loss calculation used to estimate the product liability reserve amount and the significant assumptions as described above used within the loss calculation. We also tested management&#8217;s controls over the completeness and accuracy of the data used in the loss calculation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">To test management&#8217;s assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable, we evaluated, for example, claims data of the Company, we evaluated the legal letters obtained from internal and external legal counsel, and we discussed the plaintiff's claims with internal and external legal counsel. Among other procedures we performed to test the measurement of the product liability litigation reserve, we evaluated the method of measuring the reserve for claims including analyses to determine the range of possible losses, tested the accuracy and completeness of the data, and evaluated new or contrary information affecting the estimate. In addition, we involved internal actuarial specialists to assist with our procedures related to the measurement of the product liability reserve. We have also assessed the adequacy of the Company&#8217;s disclosures included in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> in relation to these matters.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Tax Positions</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter </span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">As described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> to the consolidated financial statements, the Company&#8217;s unrecognized tax benefits related to its uncertain tax positions were approximately $943 million at June 30, 2022. Uncertain tax positions may arise as tax laws are subject to interpretation. The Company uses significant judgment in (1) determining if the tax position is more likely than not to be sustained upon examination, based on the technical merits of the position and (2) measuring the amount of tax benefit that qualifies for recognition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Auditing management's estimate of the amount of tax benefit related to the Company's uncertain tax positions that qualified for recognition was challenging because management's estimate required significant judgment in evaluating the technical merits of the positions, including interpretations of applicable tax laws and regulations.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reports</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s process to assess the technical merits of its uncertain tax positions, including the Company&#8217;s assessment as to whether a tax position is more likely than not to be sustained and management&#8217;s process to measure the benefit of its tax positions. <br/></span><span style="font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We involved our international tax, transfer pricing, and national tax professionals in assessing the technical merits of certain of the Company&#8217;s tax positions. Depending on the nature of the specific tax position and, where applicable, developments with the relevant tax authorities relating thereto, our procedures included obtaining and examining the Company&#8217;s analysis. For example, we evaluated the underlying facts upon which the tax positions are based, and, where applicable, obtained the Company&#8217;s correspondence with local tax authorities. We used our knowledge of international and local income tax laws, as well as historical settlement activity, where applicable, with local income tax authorities, to evaluate the Company&#8217;s accounting for its uncertain tax positions. We evaluated developments in the applicable tax jurisdictions to assess potential effects on the Company&#8217;s positions. We analyzed the Company&#8217;s assumptions and data used to evaluate the appropriateness of the Company&#8217;s measurement of tax benefits. We have also evaluated the Company&#8217;s income tax disclosures in relation to these matters.<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opioid Lawsuits</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">As discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> to the consolidated financial statements, the Company is a defendant in numerous lawsuits brought by certain state governments, Native American tribes, and other political subdivisions related to opioid matters. The Company accrues for losses related to legal matters at the time a loss is probable and the amount of loss can be reasonably estimated. In February 2022, the Company determined that </span><span style="color:#24282d;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">that a sufficient number of political subdivisions had agreed to participate in the Settlement Agreement. The Settlement Agreement became effective on April 2, 2022</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">. In addition, the Native American tribes and certain other subdivisions are not included within the Settlement Agreement and are negotiated separately. The Company has accrued $6.36 billion pretax under the cash component of the Settlement Agreement and for negotiations with Native American tribes and other subdivisions as of June 30, 2022. The Company is unable to reasonably estimate the liability associated with other plaintiffs that are not subject to the Settlement Agreement or other ongoing negotiations. Additionally, management is unable to estimate the range of possible loss associated with these matters.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">Auditing the Company&#8217;s accounting for, and disclosure of, loss contingencies related to the opioid lawsuits was challenging due to the significant judgment required to evaluate management&#8217;s assessment of the likelihood of a loss being incurred and management&#8217;s determination of whether a reasonable estimate of the range of loss can be made.</span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the identification and evaluation of this legal contingency. For example, we tested controls over management&#8217;s review of the assessment of the probability of occurrence of a loss and whether the loss was reasonably estimable and whether the assessment considered all relevant facts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%">To test the Company&#8217;s assessment of the probability of a loss and whether the loss was reasonably estimable, among other procedures, we read the Settlement Agreement, evaluated the legal letters obtained from internal and external legal counsel, met with internal counsel to discuss the status of the proceedings and negotiations of the Settlement Agreement and negotiations with other plaintiffs, and evaluated the reasonableness of management&#8217;s assessment regarding whether an unfavorable outcome is reasonably possible or probable and reasonably estimable. We also assessed the adequacy and the sufficiency of the Company&#8217;s disclosures included in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:107%"> in relation to these matters.</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.642%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183My9mcmFnOjNiMjAxMWViNDdkMzQ2MTJiNTU4YzQwNWI3MWFlN2FiL3RhYmxlOmM2MDIyYzU1MTI3MjRlODQ4YzRmZTU1ODQ0MGMwMjIyL3RhYmxlcmFuZ2U6YzYwMjJjNTUxMjcyNGU4NDhjNGZlNTU4NDQwYzAyMjJfMC0wLTEtMS0xODIxMDAvdGV4dHJlZ2lvbjo0NTBjZWIwNTU0Y2Q0ZDU0OTZhZDZlOTRkYTU5ZDE1OV8xOTI0MTQ1MzQ4NjEyMg_43294bb2-a126-4a48-8ff0-7a5d66224bdd">Ernst&#160;&amp; Young LLP</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company's auditor since 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183My9mcmFnOjNiMjAxMWViNDdkMzQ2MTJiNTU4YzQwNWI3MWFlN2FiL3RhYmxlOmM2MDIyYzU1MTI3MjRlODQ4YzRmZTU1ODQ0MGMwMjIyL3RhYmxlcmFuZ2U6YzYwMjJjNTUxMjcyNGU4NDhjNGZlNTU4NDQwYzAyMjJfMi0wLTEtMS0xODIxMDI_3834d1df-18c2-42eb-a96a-03135a9cbfa4">Grandview Heights, Ohio</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 11, 2022</span></td></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Financial Statements and Supplementary Data </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements and Schedule:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_79">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_79">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_82">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_82">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_85">Consolidated Balance Sheets at June&#160;30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_85">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_88">Consolidated Statements of Shareholders&#8217; Equity/(Deficit) for the Fiscal Years Ended June 30, 2022, 2021, and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_88">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_94">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_94">61</a></span></div></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Earnings/(Loss) </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.107%"><tr><td style="width:1.0%"></td><td style="width:62.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per common share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS0xLTEtMS0xNDcxNTc_7d77d764-03d0-42a4-989e-b3ad70862e02">181,364</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS0zLTEtMS0xNDcxNTc_0dbce59c-8b03-44ea-8614-9f085f16e681">162,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS01LTEtMS0xNDcxNTc_c4e13b54-b27a-420f-a0a6-96e1333d1ba3">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi0xLTEtMS0xNDcxNTc_aa07eb33-1b03-4118-b28c-e046ac90a49b">174,819</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi0zLTEtMS0xNDcxNTc_c9a3e5bb-400c-4dae-bb7f-0c14606a39ee">155,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi01LTEtMS0xNDcxNTc_f3d0da6b-4f69-4350-9d7e-b1900b18f918">146,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy0xLTEtMS0xNDcxNTc_9fccc018-d3ba-457b-a954-851085e69d15">6,545</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy0zLTEtMS0xNDcxNTc_8500a479-0c5b-4303-a2e2-01f7b81928a1">6,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy01LTEtMS0xNDcxNTc_b65ce289-50c2-4039-95d4-32712d2b76b8">6,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distribution, selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi0xLTEtMS0xNDcxNTc_31a7a468-78df-4d34-8c6d-ef2f32df8bcb">4,557</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi0zLTEtMS0xNDcxNTc_48d7de63-aa1d-48d6-a6ff-9ab4368072b2">4,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi01LTEtMS0xNDcxNTc_2afadcc1-19b1-4ef3-8a89-b56f93171b47">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and employee severance</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy0xLTEtMS0xNDcxNTc_a9520297-e45d-4f9d-b2e3-e6b2321c87b5">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy0zLTEtMS0xNDcxNTc_f056c967-5079-4e42-a451-9156b6770b75">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy01LTEtMS0xNDcxNTc_57bf3611-34e4-4412-9c15-490e8c9de103">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and other acquisition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC0xLTEtMS0xNDcxNTc_16af9825-7961-4acd-8fc6-340c1462cb80">324</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC0zLTEtMS0xNDcxNTc_9a63349a-fbf4-4ee7-be9f-1e634560039b">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:Amortizationandotheracquisitionrelatedcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC01LTEtMS0xNDcxNTc_16f9b5cb-5eb1-4941-aa52-4493bbafa5bd">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS0xLTEtMS0xNDcxNTc_f5c97154-8bf8-41b3-bb7c-37c474231a08">2,050</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS0zLTEtMS0xNDcxNTc_116959ff-410d-471e-8667-4cd7578db940">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS01LTEtMS0xNDcxNTc_1c37e577-6e9a-4b25-8270-ee2fb1650d6f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Litigation (recoveries)/charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtMS0xLTEtMTQ3MTU3_add129ed-0a9d-475a-8484-b344c33d5c33">109</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtMy0xLTEtMTQ3MTU3_bedb54b3-6b6c-4c38-a64a-a58d0a9fff49">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtNS0xLTEtMTQ3MTU3_5edf7519-8db1-49c5-a0f6-4ed41757c3af">5,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating earnings/(loss)</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtMS0xLTEtMTQ3MTU3_9b5cfcba-5c99-42a4-a1ba-89ee9830034a">596</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtMy0xLTEtMTQ3MTU3_7b1bb45b-a685-4ca7-b188-d3bdf9127dda">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtNS0xLTEtMTQ3MTU3_4291b38f-adc0-4431-997a-1d10f7491abc">4,098</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtMS0xLTEtMTQ3MTU3_3422b8c4-a677-4060-9cd2-c67f309dd244">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtMy0xLTEtMTQ3MTU3_c50afd7b-053e-42fb-a75e-6bdd2f77815e">47</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtNS0xLTEtMTQ3MTU3_c87f4979-b330-448b-9d2c-594353cfa188">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtMS0xLTEtMTQ3MTU3_3af37cf0-6343-49d2-9951-bdf13737611b">149</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtMy0xLTEtMTQ3MTU3_897b34de-13a6-46ce-954b-73a4f8f064f8">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtNS0xLTEtMTQ3MTU3_dc37b06c-7e50-4fb1-abc9-0b5c1ac6a0fd">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtMS0xLTEtMTQ3MTU3_4e6a7cfd-2edd-4e38-900f-b37abb6cb7ed">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtMy0xLTEtMTQ3MTU3_4ac328fe-50c1-4f64-9b95-980ff4f23f12">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtNS0xLTEtMTQ3MTU3_a6a58160-6ee6-4f9a-94e8-1e310ecc1ed5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtMS0xLTEtMTQ3MTU3_cb64ed2d-1166-423a-81e9-0193fa112d83">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtMy0xLTEtMTQ3MTU3_ca16772d-1ac9-494e-8262-2837fe60e466">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtNS0xLTEtMTQ3MTU3_011004d3-3feb-478b-924a-2034a631936e">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctMS0xLTEtMTQ3MTU3_48529eed-2b6d-48c9-a23e-dd147104a439">769</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctMy0xLTEtMTQ3MTU3_3f46c244-f597-455f-91be-70ca0059f0eb">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctNS0xLTEtMTQ3MTU3_5cba1a8c-86e3-4d3a-b777-205b15e939a4">3,772</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for/(benefit from) income taxes</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktMS0xLTEtMTQ3MTU3_4ae5814d-add5-4d61-8865-ad7265a5eeaa">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktMy0xLTEtMTQ3MTU3_43744f9e-9265-4e31-be76-361a8ba14b5f">289</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktNS0xLTEtMTQ3MTU3_fe76ea33-6153-43c1-9131-06ba09f73b69">79</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtMS0xLTEtMTQ3MTU3_e0fc800e-34fc-4739-a916-fb87cb4e0068">932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtMy0xLTEtMTQ3MTU3_799b4c27-de33-4eb0-80dc-a44a12be005d">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtNS0xLTEtMTQ3MTU3_c9580fa1-4794-41a9-8f3b-28f360c9d2ef">3,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItMS0xLTEtMTQ3MTU3_619b1082-6ab9-4ebd-9d88-c63f1e5af791">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtMS0xLTEtMTQ3MTU3_e63b649d-e9d2-4528-9156-0f8cb2f926e8">933</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtMy0xLTEtMTQ3MTU3_fc19b1ca-f65e-42c6-9857-a0e28dd3cd06">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtNS0xLTEtMTQ3MTU3_e6e10c9c-366e-43ce-abd7-b22dc7c346ec">3,696</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtMS0xLTEtMTQ3MTU3_5f4d9ba7-cf39-403c-b1bf-4d04e707f5d0">3.35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtMy0xLTEtMTQ3MTU3_5485c54f-a912-4dec-a3c6-12c7a1a362fe">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtNS0xLTEtMTQ3MTU3_3a2b97fc-d46b-4776-8522-4868256b3635">12.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctMS0xLTEtMTQ3MTU3_87a50ccb-b4a0-4507-b7e4-2410e24a727b">3.35</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctMy0xLTEtMTQ3MTU3_ea2f14c9-9803-47cd-98d2-076b028ca501">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctNS0xLTEtMTQ3MTU3_e656079e-537f-4fb3-9bc6-e5e8840fffac">12.61</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average number of common shares outstanding:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtMS0xLTEtMTQ3MTU3_f142d1eb-cd50-437d-9fbd-234b0fb3f535">279</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtMy0xLTEtMTQ3MTU3_fd9ffde4-f4c8-4ed0-a365-8f5c83f9640d">292</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtNS0xLTEtMTQ3MTU3_2fd165a7-c860-4986-b513-4063755da460">293</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtMS0xLTEtMTQ3MTU3_7c63e060-dcac-4a45-82b3-d52d0b13ead3">279</ix:nonFraction></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtMy0xLTEtMTQ3MTU3_8d1179ff-57da-423d-983b-8935f1d8c033">294</ix:nonFraction></span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtNS0xLTEtMTQ3MTU3_ebf0b7a2-43cd-4df2-9336-12f34fd82cb2">293</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income/(Loss)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS0xLTEtMS0xNDcxNTc_e0fc800e-34fc-4739-a916-fb87cb4e0068">932</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS0zLTEtMS0xNDcxNTc_799b4c27-de33-4eb0-80dc-a44a12be005d">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS01LTEtMS0xNDcxNTc_c9580fa1-4794-41a9-8f3b-28f360c9d2ef">3,693</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other comprehensive income/(loss):</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC0xLTEtMS0xNDcxNTc_5c5b8f83-a3e8-4d8f-abc4-c7a16500a8af">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC0zLTEtMS0xNDcxNTc_87eef964-82a0-48cc-ad03-e64692bc4046">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC01LTEtMS0xNDcxNTc_040bdb76-8aaa-4365-a949-d43bb48aaad9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gain/(loss) on derivative instruments, net of tax</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi0xLTEtMS0xNDcxNTc_4e91368b-adef-4cb4-8257-1f6a858c6fee">24</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi0zLTEtMS0xNDcxNTc_35d4de34-0798-45af-8eb5-73a786ce08ae">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi01LTEtMS0xNDcxNTc_880d9ba9-48eb-4e14-a7b4-118a07bd18cd">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy0xLTEtMS0xNDcxNTc_e43c7d53-0e5a-48fe-87ea-60a385617bfe">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy0zLTEtMS0xNDcxNTc_0b29494d-5099-4c1f-9499-eca81a36b87c">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy01LTEtMS0xNDcxNTc_044a0ac0-a6d7-473c-b706-6654990d8509">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income/(loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS0xLTEtMS0xNDcxNTc_8e6bd341-57c1-47a8-8d77-13312e2dc41b">1,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS0zLTEtMS0xNDcxNTc_8b99e982-0d3e-404c-b276-d7b89d72898c">682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS01LTEtMS0xNDcxNTc_0cf38a80-19d4-4742-b4d6-45eba4694f18">3,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtMS0xLTEtMTQ3MTU3_619b1082-6ab9-4ebd-9d88-c63f1e5af791">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total comprehensive income/(loss) attributable to Cardinal Health, Inc. </span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItMS0xLTEtMTQ3MTU3_8261652e-a0aa-4361-ae75-9b34378cefe5">1,013</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItMy0xLTEtMTQ3MTU3_fbc8a22c-9b87-42a2-85c3-9f0d6e8aacbd">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItNS0xLTEtMTQ3MTU3_092f4ada-2372-44e4-98af-cd7d405512c2">3,721</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNC0xLTEtMS0xNDcxNTc_2bc228ed-6742-4ecf-b98d-a0a1f8126481">4,717</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNC0zLTEtMS0xNDcxNTc_72c52634-9c14-4284-b269-6ff28e1008f4">3,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNS0xLTEtMS0xNDcxNTc_2e8f303b-4f50-4133-be21-10c306a56c42">10,561</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNS0zLTEtMS0xNDcxNTc_b0d06dff-4973-4751-a0c8-7ba9fc26874f">9,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNi0xLTEtMS0xNDcxNTc_898bd23e-b64e-4e26-b158-770f1c32a97f">15,636</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNi0zLTEtMS0xNDcxNTc_9f69061e-18cc-4883-bfee-f6173c0c30c1">14,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNy0xLTEtMS0xNDcxNTc_ee1cd574-c35c-4954-bdec-208c9e065b35">2,021</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNy0zLTEtMS0xNDcxNTc_5dd6c8a0-87dc-44cd-9d27-483a64709cdf">2,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOC0xLTEtMS0xNDcxNTc_44d85f4c-2c55-42db-aa88-efc8c0690da2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOC0zLTEtMS0xNDcxNTc_3f999de9-d743-4729-be8b-8acb3d898099">1,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOS0xLTEtMS0xNDcxNTc_c713f519-c8ee-4f09-9770-fddb2aeecedd">32,935</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOS0zLTEtMS0xNDcxNTc_f8a10b93-8b69-4015-9a13-7001c013c5ba">31,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTEtMS0xLTEtMTQ3MTU3_9f9c5d51-8f0a-476d-af16-47a42abc2a95">2,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTEtMy0xLTEtMTQ3MTU3_4e52a283-b0c1-4128-beca-f3ad3b23e315">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTItMS0xLTEtMTQ3MTU3_e209759b-db24-4240-b611-d3d60796c1f5">7,629</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTItMy0xLTEtMTQ3MTU3_1ca889ad-c61d-4517-bf0b-67ce010c2966">10,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTMtMS0xLTEtMTQ3MTU3_437148fb-3e45-4d5f-b356-e1a2e6fbfb40">953</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTMtMy0xLTEtMTQ3MTU3_1293b20d-39bd-44ea-91bb-9b2ef4184f71">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTQtMS0xLTEtMTQ3MTU3_baa7bca4-0c41-4d36-a55e-a509218ffbd4">43,878</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTQtMy0xLTEtMTQ3MTU3_b8ab21d4-536d-479a-b00f-b754c2813a77">44,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity/(Deficit)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTgtMS0xLTEtMTQ3MTU3_477f3466-2c2f-4606-85e3-3b340b78479a">27,128</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTgtMy0xLTEtMTQ3MTU3_5862d2ce-b5a3-4853-9944-05d8251c3fcf">23,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTktMS0xLTEtMTQ3MTU3_9de00f91-e393-4fe3-a525-6f7cbe36c1d4">580</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTktMy0xLTEtMTQ3MTU3_59c8dd51-bce7-4b72-9943-3f70449bab18">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjAtMS0xLTEtMTQ3MTU3_b6d69b89-ddb5-4bf2-96bb-a66cd33e13b4">2,842</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjAtMy0xLTEtMTQ3MTU3_f41fcbdc-5139-4c28-9372-e25781e8f757">2,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjEtMS0xLTEtMTQ3MTU3_6ad505d7-0fec-4827-b18c-16f7db1b231e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjEtMy0xLTEtMTQ3MTU3_a4b96005-cae7-435f-a4a8-f26754b0ca40">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjItMS0xLTEtMTQ3MTU3_e9f4dc4b-853c-4069-a3c2-fe1672fc5385">30,550</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjItMy0xLTEtMTQ3MTU3_304cb38b-a3aa-45ba-bebe-58802be7bd26">27,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjQtMS0xLTEtMTQ3MTU3_582b3df6-7c68-4054-af6d-52770a24406e">4,735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjQtMy0xLTEtMTQ3MTU3_2d447e03-a187-4fe8-b6b0-ae7133499c32">5,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjUtMS0xLTEtMTQ3MTU3_c913829c-736f-4257-9967-97574a71b788">9,299</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjUtMy0xLTEtMTQ3MTU3_75e51536-d1dd-4043-a82e-067c65dbbbde">9,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders&#8217; equity/(deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred shares, without par value:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMTU_9d91da76-9f53-490b-aac2-2e096d4fa4ff"><ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMTU_cfa97fa3-766e-4b75-a11b-e2e436cdf6cc">500</ix:nonFraction></ix:nonFraction> thousand</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> shares, Issued&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMzM_43905e17-d0e3-4b30-a36b-b02af0576d97"><ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMzM_fcd382f6-c2e4-43a1-86db-c9e8896cb084">none</ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMS0xLTEtMTQ3MTU3_87b8bba8-ecfe-41a6-a77b-627d5bb93c10">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMy0xLTEtMTQ3MTU3_d6f3775a-d74a-4fd3-b448-8bc5ccff8ef8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares, without par value:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMTU_6169d099-0cda-4000-9af2-fbd4e042e116"><ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMTU_b2fdcdf3-53b9-47d7-b4f7-094be46a7851">755</ix:nonFraction></ix:nonFraction> million shares, Issued&#8212; <ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMzQ_509d2dbc-ab46-4991-80ce-b3d627833835"><ix:nonFraction unitRef="shares" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMzQ_ac8fde34-cdd9-4c46-8940-f9797f5bf630">327</ix:nonFraction></ix:nonFraction> million shares at </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> and 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMS0xLTEtMTQ3MTU3_792bbbd2-a3df-4652-b6ec-b4a133cd7fdd">2,813</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMy0xLTEtMTQ3MTU3_5c753ef3-e390-456e-95c4-945c15eb5089">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings/(accumulated deficit)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzQtMS0xLTEtMTQ3MTU3_1c3921cd-ae06-41fa-80ba-3b1c6a0b4057">280</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzQtMy0xLTEtMTQ3MTU3_15d56397-3696-450e-9d1b-d245137ed405">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares in treasury, at cost: </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246MmNjOTc2NGI4MzVmNDI4MGJmZjBlMWQ0ZmExNDU0NzhfNDA_c96d9c1a-a1fa-4963-b10a-d428c933e5f1">54</ix:nonFraction> million </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">shares and <ix:nonFraction unitRef="shares" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246MmNjOTc2NGI4MzVmNDI4MGJmZjBlMWQ0ZmExNDU0NzhfNTQ_531a90ef-386b-457f-8f40-34bf68ec1c4f">36</ix:nonFraction> million shares at </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMS0xLTEtMTQ3MTU3_b98860e0-b233-4f48-802d-3664bf9e6377">3,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMy0xLTEtMTQ3MTU3_cb52a598-d1bb-435e-b395-a4fc3a658f02">2,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzYtMS0xLTEtMTQ3MTU3_b13ea251-2c89-4cff-91ee-5b2da79f7a95">114</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzYtMy0xLTEtMTQ3MTU3_1c437c77-d14b-46af-96de-b5cb6f7e4713">34</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Cardinal Health, Inc. shareholders' equity/(deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzctMS0xLTEtMTQ3MTU3_37b06dd4-203f-4a54-81b6-3b116d1b1abd">709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzctMy0xLTEtMTQ3MTU3_25d91214-ee81-4969-a348-91278d0a8325">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzgtMS0xLTEtMTQ3MTU3_ca2351e8-3334-4da4-9205-d539d2a695ba">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzgtMy0xLTEtMTQ3MTU3_08ed420e-e189-47b7-a62d-07d716982679">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity/(deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzktMS0xLTEtMTQ3MTU3_cde8dbaa-663f-40af-81eb-58edb6dfd06a">706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzktMy0xLTEtMTQ3MTU3_fda30820-b2f7-4ef1-9def-7d2e97095189">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity/(deficit)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNDAtMS0xLTEtMTQ3MTU3_bd8e7004-695b-400b-9ba9-cda19157967e">43,878</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNDAtMy0xLTEtMTQ3MTU3_7e6a01cf-3629-46db-8d57-055f7b707066">44,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders' Equity/(Deficit)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:25.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.073%"></td><td style="width:0.1%"></td></tr><tr style="height:51pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity/(Deficit)</span></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained<br/>Earnings/(Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xLTEtMS0xNDcxNTc_36ea8e35-5cc4-44d0-99c8-424f1cb7d4a6">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0zLTEtMS0xNDcxNTc_6533ebcf-6e3e-4ab6-aa68-ade25744f083">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e1921e87f164ec2a076a8022000e553_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi01LTEtMS0xNDcxNTc_00a092a4-da91-495c-9f13-d88bad194ea6">5,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iefd42525ba6945e0a2388b3cfd583b55_I20190630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi03LTEtMS0xNDcxNTc_59bd3ec2-0343-408c-ac0c-6b2e6e1fd87a">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefd42525ba6945e0a2388b3cfd583b55_I20190630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi05LTEtMS0xNDcxNTc_43613039-0b35-44aa-9bd2-7e92de56e126">1,790</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab48f8f0ca84770b2cdd725d449c559_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xMS0xLTEtMTQ3MTU3_05ef0103-ccf9-4a7e-88d9-4acc786f2252">79</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a74100c06424e0c80abaeaaf61e0fae_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xMy0xLTEtMTQ3MTU3_e84d29f6-7049-4849-a4bc-33bb441c7f20">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xNS0xLTEtMTQ3MTU3_c850a1fe-4b68-4713-bc3b-eed9fca18314">6,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy01LTEtMS0xNDcxNTc_aefd346f-afb9-4e1d-b907-d3bb1678176a">3,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy0xMy0xLTEtMTQ3MTU3_6c6240cf-c246-4ec4-b2f7-784fd7e232f5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy0xNS0xLTEtMTQ3MTU3_b6593f8d-8140-4bb4-8b20-7ddf425b7b6a">3,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idba5b8a7abac4a44b7b7aea83c67e7c3_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNC0xMS0xLTEtMTQ3MTU3_6d0cf0bb-d78b-4eb4-ba2f-b308268a234b">25</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNC0xNS0xLTEtMTQ3MTU3_1fefe622-15e4-4617-9f0c-edadfbf7d573">25</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0xLTEtMS0xNDcxNTc_dd0fdd68-0def-4f55-8af7-22663e10ca8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0zLTEtMS0xNDcxNTc_cf652744-904c-46ee-94c8-7d5abfb0e69a">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi03LTEtMS0xNDcxNTc_2a01ff37-a2a3-4945-b554-6e34eec8a5cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi05LTEtMS0xNDcxNTc_71bd8766-e10b-4bf9-950a-78886e7dcaf5">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0xNS0xLTEtMTQ3MTU3_304683d0-a82c-48b0-a892-ffe2bf0d47fc">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy03LTEtMS0xNDcxNTc_03f8edc8-8e07-408f-aada-2f78b65b1711">7</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy05LTEtMS0xNDcxNTc_3690b45c-124a-4a15-bf9a-80d428ba7cb6">350</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy0xNS0xLTEtMTQ3MTU3_0b845fd1-6e51-4063-a2ba-7b21b1450b76">350</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOC01LTEtMS0xNDcxNTc_9ad21aca-484b-48bc-a5e0-93ad7e4e1b69">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOC0xNS0xLTEtMTQ3MTU3_2f5b51a6-1a14-4f18-a542-79328a5e08b9">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0zLTEtMS0xNDcxNTc_b21f2f0e-3621-491d-8e1a-40e5bc7cb7b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS01LTEtMS0xNDcxNTc_a941a2af-d4ef-4fce-b8fe-245fba4e6492">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:StockholdersEquityOtherShares" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS03LTEtMS0xNDcxNTc_9eae2d2f-1c44-44a0-8c0c-465352115dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0xMy0xLTEtMTQ3MTU3_f40b4d49-9332-494f-91f1-e3d488fd5826">2</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0xNS0xLTEtMTQ3MTU3_64bbd09d-885d-4c58-8066-4c4bf0a84c8e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f1640dafb24aadbf40453cd1ad0423_I20200630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMS0xLTEtMTQ3MTU3_ced7f68a-35d3-4624-b68a-9667821b4ef3">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f1640dafb24aadbf40453cd1ad0423_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMy0xLTEtMTQ3MTU3_831febbb-a985-4cb6-8431-a13a760badf1">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dee667c44cf4729bf5c5fff72aa3e3a_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtNS0xLTEtMTQ3MTU3_789a3863-531f-41e7-8608-857affb27b95">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtNy0xLTEtMTQ3MTU3_4bb210bf-1b31-4ab5-95b6-2e2fc8a08aa3">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtOS0xLTEtMTQ3MTU3_c557980d-0cdd-4231-8243-b0a44155b48e">2,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a2a315588dc47fa848589f8d339e4f4_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTEtMS0xLTE0NzE1Nw_4d67a4c1-74a2-4c04-9efa-dcfe99b793f5">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1647e6a3df7432b93b26a7bd668dfc9_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTMtMS0xLTE0NzE1Nw_19b8653c-cad9-459a-8539-a9f235de3de1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTUtMS0xLTE0NzE1Nw_7d22df94-7d74-428e-b258-fb27a3221456">1,792</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItNS0xLTEtMTQ3MTU3_2622447e-6387-406c-be21-f3e7fef06dbd">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItMTMtMS0xLTE0NzE1Nw_7fc02ad4-7546-4de6-8e7d-307a0fc5b7c0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItMTUtMS0xLTE0NzE1Nw_c84a3a58-5352-4c92-bca3-5853df2c4386">612</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTMtMTEtMS0xLTE0NzE1Nw_5ddd1226-24b9-46f4-b11c-4cf83fa661e4">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTMtMTUtMS0xLTE0NzE1Nw_1323860c-84ec-4631-96c5-c04efb239c05">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMS0xLTEtMTQ3MTU3_e33b098e-2fc4-45cc-98f6-bea87c8a78b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMy0xLTEtMTQ3MTU3_37139832-db57-4359-b1e3-ac04c9558124">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtNy0xLTEtMTQ3MTU3_67c83bba-7517-4c9a-9241-6e9f9cb94d8b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtOS0xLTEtMTQ3MTU3_a08e1c5a-0aaa-4c60-89d4-529a8afcd02d">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMTUtMS0xLTE0NzE1Nw_46a79ad3-cc27-4626-a7cb-0cb34b208129">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtNy0xLTEtMTQ3MTU3_ab4d9c12-dd56-4958-aed5-abd1064ad574">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtOS0xLTEtMTQ3MTU3_b8a5af82-d960-4a44-a700-0c3ba9212aa5">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtMTUtMS0xLTE0NzE1Nw_952d83a6-ab4c-41c2-ac54-d6553947b9a1">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTctNS0xLTEtMTQ3MTU3_4cef6163-5b71-4745-af1e-58711e24e983">576</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTctMTUtMS0xLTE0NzE1Nw_789f10e8-e73d-4b39-bd81-0dc5db3ce0b5">576</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMy0xLTEtMTQ3MTU3_f0a15ea5-dc7a-4cee-8603-84f6f76df0b6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630" sign="-" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtNS0xLTEtMTQ3MTU3_6d8cd613-ebab-41eb-b33d-60723bad99a1"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:StockholdersEquityOtherShares" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtNy0xLTEtMTQ3MTU3_a8b2c881-a4d2-4a8e-b8ea-3b5731f1cb83">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMTMtMS0xLTE0NzE1Nw_ec9a692b-7433-4786-a6f5-96659a3bb3d9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMTUtMS0xLTE0NzE1Nw_ca4640bf-577d-4c84-8dcc-4156f4f57957">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib28ba902d1c94df4a3c67814f8c372a5_I20210630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMS0xLTEtMTQ3MTU3_f7204bf6-58c7-4284-b296-a4c573ceccdf">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28ba902d1c94df4a3c67814f8c372a5_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMy0xLTEtMTQ3MTU3_c0838320-f039-4d5e-9f63-b7e21f25800f">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea5f56de7fee4d1dac477ee0cf61168f_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtNS0xLTEtMTQ3MTU3_01995e32-8fb3-48e7-b704-0c3ca2444d0a">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtNy0xLTEtMTQ3MTU3_b0254f6e-c3d8-4f7b-9e08-24cc7ff22546">36</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtOS0xLTEtMTQ3MTU3_ac883d02-b951-445a-a6d9-1566af3f5676">2,186</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68d3316767394706be72a492bdcd2efd_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTEtMS0xLTE0NzE1Nw_26bfbb52-7295-4529-9454-c3810d98fdb1">34</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0fb00ebcf504ae6b0af6dc851474deb_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTMtMS0xLTE0NzE1Nw_f0f0cab8-9dfb-4b6f-90b9-b78a961be7d2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTUtMS0xLTE0NzE1Nw_d7f8a56c-aacd-4149-be5f-8c617d1a0a2b">1,794</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtNS0xLTEtMTQ3MTU3_e36fd618-6f5f-4ef0-8682-c62321d35dc5">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtMTMtMS0xLTE0NzE1Nw_4edc3dcc-af9f-474c-a03d-aa4a6ca56225">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtMTUtMS0xLTE0NzE1Nw_fed57d88-6164-4b32-abf9-9322eb219af3">932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjItMTEtMS0xLTE0NzE1Nw_d5b4530c-e36a-411a-a87e-46faf3c77dab">80</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjItMTUtMS0xLTE0NzE1Nw_4e0941bf-bc16-42a9-86e6-dad191ddd7ef">80</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock plans activity, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMS0xLTEtMTQ3MTU3_0c1955bd-d55e-4155-950a-57dc903db912">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMy0xLTEtMTQ3MTU3_a2db2ebc-51ba-402a-9ccf-f78608c54582">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtNy0xLTEtMTQ3MTU3_2799633e-9d99-493e-af4a-f9b99694b07a">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtOS0xLTEtMTQ3MTU3_8ebd8eb5-d1fc-485c-b8bb-be532a70f5e3">58</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMTUtMS0xLTE0NzE1Nw_8d6c2297-5a92-432b-a8d9-ea9e726e33da">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase program activity</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtNy0xLTEtMTQ3MTU3_4e87cb41-bbe7-4ec8-95d4-09cd5eebd5f0">20</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtOS0xLTEtMTQ3MTU3_8265796d-0a8d-4cc5-aaa5-4cc43edaecfb">1,000</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtMTUtMS0xLTE0NzE1Nw_8cf6c17b-6239-458f-bc43-dd501b7bf99c">1,000</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjYtNS0xLTEtMTQ3MTU3_bd2ace5c-7d10-4669-a712-fde23f3490d9">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjYtMTUtMS0xLTE0NzE1Nw_f59ccd6a-ff57-4ba2-a45e-4c411c53f531">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMy0xLTEtMTQ3MTU3_b8bea1fd-ccb3-4898-8f7a-1147410b824d"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctNS0xLTEtMTQ3MTU3_2ff556ec-4ad4-47a5-8e1a-7ab254ff0b3b"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"><ix:nonFraction unitRef="shares" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" xsi:nil="true" name="us-gaap:StockholdersEquityOtherShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctNy0xLTEtMTQ3MTU3_e2e9337d-f877-40aa-9d6d-1870e3e25a4a"></ix:nonFraction></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMTMtMS0xLTE0NzE1Nw_035d794d-fd86-48d7-bc41-b6bb57eac082">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMTUtMS0xLTE0NzE1Nw_9603a00a-cd2e-4970-b7cf-2883a3c042bc">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibba299e1050549689ffb0f8eacbea9c0_I20220630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMS0xLTEtMTQ3MTU3_0d7e4379-bd1a-4472-b2c9-b7e003c0167e">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba299e1050549689ffb0f8eacbea9c0_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMy0xLTEtMTQ3MTU3_8fc4b451-ed2f-4158-8033-bd19bbf7e133">2,813</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i934ea3588a144dd5b265a98b3005fb6d_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktNS0xLTEtMTQ3MTU3_6420b0a7-6cc0-4ec0-8d87-b23279a286de">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie319b7f528d244d180aab748fdbce12d_I20220630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktNy0xLTEtMTQ3MTU3_cfe3bbc5-b146-4515-bfd3-eef668a54de8">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie319b7f528d244d180aab748fdbce12d_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktOS0xLTEtMTQ3MTU3_4df98f83-7f58-43f5-adf8-b2f44ce6749b">3,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e1f19c62f9f42bcb0e306e9ba872206_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTEtMS0xLTE0NzE1Nw_b3625bfc-dc71-4d26-b308-99b4c7f3d4f9">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73da689c634e4d5ba2674bf686bd3f86_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTMtMS0xLTE0NzE1Nw_fedae516-20ac-4bcf-865b-06be04de97bf">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTUtMS0xLTE0NzE1Nw_c5be14a0-e536-4f33-b2aa-964f70711e81">706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi0xLTEtMS0xNDcxNTc_e0fc800e-34fc-4739-a916-fb87cb4e0068">932</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi0zLTEtMS0xNDcxNTc_799b4c27-de33-4eb0-80dc-a44a12be005d">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi01LTEtMS0xNDcxNTc_c9580fa1-4794-41a9-8f3b-28f360c9d2ef">3,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC0xLTEtMS0xNDcxNTc_0acf3eaf-b0cc-4894-9dd9-375440a11338">692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC0zLTEtMS0xNDcxNTc_7a12a4e4-6c04-4b6a-bb45-ab701757e81b">783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC01LTEtMS0xNDcxNTc_f4bc4321-2383-450b-bc7e-0847488a185d">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loss on sale of other investments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS0xLTEtMS0xNDcxNTc_731db939-0361-42ba-b347-cc3917213c2c">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS0zLTEtMS0xNDcxNTc_9831e684-32fa-4234-b65e-90a1ee0779ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS01LTEtMS0xNDcxNTc_f8cec5bd-60c0-4566-9137-428f55abeb98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain)/Loss on sale of equity interest in naviHealth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi0xLTEtMS0xNDcxNTc_3bcd1196-dae6-46f0-a8b5-39e6b9a9f6cf">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi0zLTEtMS0xNDcxNTc_f0c5d1f2-b28f-41be-8f23-6328d500d8f2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi01LTEtMS0xNDcxNTc_cd646cc0-be3b-4087-aeba-214c49b6a057">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and (gain)/loss on disposal of assets, net</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy0xLTEtMS0xNDcxNTc_aed193af-089f-4471-a665-d921bf1cffb5">2,050</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy0zLTEtMS0xNDcxNTc_36067d7c-87cb-4d70-86a5-b9fd69e9987a">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy01LTEtMS0xNDcxNTc_f91c0752-bc7a-47a6-85d1-f22e40b46ee7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC0xLTEtMS0xNDcxNTc_1bd9ac55-93d7-45c0-bb3e-906e7a04dd75">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC0zLTEtMS0xNDcxNTc_a876e174-c2e7-48c4-a5ef-bfcb6461382d">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC01LTEtMS0xNDcxNTc_db7daea8-6179-4a80-85fe-d6f9c0d7150d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS0xLTEtMS0xNDcxNTc_9ae7ce34-99b0-4e67-a29a-a44417f21565">81</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS0zLTEtMS0xNDcxNTc_8706fe6f-205f-401a-9d6c-b5e99553cbb1">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS01LTEtMS0xNDcxNTc_8de4841e-a03a-4303-841b-7e35a7df4cce">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for/(benefit from) deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtMS0xLTEtMTQ3MTU3_511c9ae9-8b0b-46d2-8a18-6f0e1296a598">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtMy0xLTEtMTQ3MTU3_35000819-e8a4-42cf-8366-c4d5d5e8f9cd">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtNS0xLTEtMTQ3MTU3_bc2072e5-6785-43e0-8f8d-a7460eb2a8cc">961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for bad debts</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtMS0xLTEtMTQ3MTU3_7265d74a-ef7d-4056-a11d-2c5e97bdd4b2">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtMy0xLTEtMTQ3MTU3_b20bdcf7-79dd-4895-8556-9afcf4a9b805">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtNS0xLTEtMTQ3MTU3_bdddb1d7-e26c-4288-a377-4b6c20b53d05">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Increase)/decrease in trade receivables</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtMS0xLTEtMTQ3MTU3_5d6e978c-c0b4-4185-a396-2420b9ce2cc2">1,526</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtMy0xLTEtMTQ3MTU3_7abe3638-ad7e-43bd-8447-1f78396b5c5a">904</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtNS0xLTEtMTQ3MTU3_e3ded83c-8c67-4d0b-abdb-d39fe5a13e43">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtMS0xLTEtMTQ3MTU3_a80e0351-bab5-4465-9c12-752564474d33">1,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtMy0xLTEtMTQ3MTU3_579a7c16-a4e5-45be-bf1e-af92deb81a17">1,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtNS0xLTEtMTQ3MTU3_2fc6559d-e0b2-4d83-9d16-8fd85c6196d8">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase/(decrease) in accounts payable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtMS0xLTEtMTQ3MTU3_cb0fe0df-be35-4170-866a-46a348378f04">3,428</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtMy0xLTEtMTQ3MTU3_3efe4718-6e01-4a70-bcea-f09d35d21609">2,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtNS0xLTEtMTQ3MTU3_f15fd74a-cbe9-47b4-8979-8497938b0c78">162</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities and operating items, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctMS0xLTEtMTQ3MTU3_1ea07090-3f81-469a-b8ba-08ad04e6d0de">293</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctMy0xLTEtMTQ3MTU3_5ae7fcb3-7874-4420-9296-e63856a7e2d2">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctNS0xLTEtMTQ3MTU3_cd2eba58-3287-437e-a149-4528daec99bf">6,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtMS0xLTEtMTQ3MTU3_ccdd7c73-53b4-4bce-887f-f348cee8e6a6">3,122</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtMy0xLTEtMTQ3MTU3_32b00452-67ac-4a10-a7d9-33c244db7045">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtNS0xLTEtMTQ3MTU3_6cee9cb3-5d55-4e7f-99ec-ab9b279e7553">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from divestitures, net of cash sold</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMS0xLTEtMTgxNTEz_85d5c1d7-8a26-4ec1-b3e9-5face4a8adae">923</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMy0xLTEtMTgxNTEz_a706ef18-e634-409a-a4e9-95a88ac30d8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtNS0xLTEtMTgxNTEz_39890a5f-eb86-4c25-8584-85188c7c286c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of subsidiaries, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMS0xLTEtMTQ3MTU3_395b367c-6266-43d1-84e5-7d81295c5d30">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMy0xLTEtMTQ3MTU3_115016af-af6c-4d78-b9f5-bab8ad5a78f1">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtNS0xLTEtMTQ3MTU3_cdf6f311-8907-4b3e-b1a2-4889ca99427d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to property and equipment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtMS0xLTEtMTQ3MTU3_cf96e40e-93d1-42d6-b5da-b32e444d66f4">387</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtMy0xLTEtMTQ3MTU3_d822904a-4c19-4c81-8feb-e03e066cb2b7">400</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtNS0xLTEtMTQ3MTU3_b0ff0723-134b-40aa-8106-50c6b7d4220b">375</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMS0xLTEtMTgyMTY0_b8b9f88f-0336-4181-be5b-73b01a628a48">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMy0xLTEtMTgyMTgx_b058c26a-5fd7-402d-b58b-feae1f6e9999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtNS0xLTEtMTgyMTg5_137c0291-f52f-4cc8-89a9-008f24ba837e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of other investments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItMS0xLTEtMTQ3MTU3_4eba6bb6-be66-4ef4-ae34-f250f03c6a44">78</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItMy0xLTEtMTQ3MTU3_26f21477-9ebc-4a76-986e-2bf94159d13d">22</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItNS0xLTEtMTQ3MTU3_efe56be4-12c3-40eb-9561-741c8032d081">20</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMS0xLTEtMTQ3MTU3_66ac4ef0-947c-4ed5-a7e4-191650dce6a1">29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMy0xLTEtMTQ3MTU3_88a8e4d2-d761-4f68-9bfd-649193f7456e">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtNS0xLTEtMTQ3MTU3_c5c335fe-b455-422f-b510-643770f7329e">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from net investment hedge terminations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtMS0xLTEtMTQ3MTU3_ae7413a1-4b0e-4706-80a8-326f07a291ac">71</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtMy0xLTEtMTQ3MTU3_a6cb7a0d-73e0-4ca4-b116-11fd1633ffb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtNS0xLTEtMTQ3MTU3_c3cf894f-b594-4ade-85e5-30bb607c1de3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by/(used in) investing activities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctMS0xLTEtMTQ3MTU3_51ea9b6a-8ea3-4449-9b14-09363de7be15">567</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctMy0xLTEtMTQ3MTU3_3474e45e-c66b-46b3-808f-0703d64fb3c6">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctNS0xLTEtMTQ3MTU3_b1e2a3db-39a2-42e4-ae85-f696d491c2e4">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change in short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtMS0xLTEtMTQ3MTU3_de670033-4c67-422b-b936-61c26d3e8eb6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtMy0xLTEtMTQ3MTU3_b1d97b18-b29b-4c93-b28b-d1aac5107075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtNS0xLTEtMTQ3MTU3_31f01a1d-6253-4110-8566-9715beafe21b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from interest rate swap terminations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItMS0xLTEtMTQ3MTU3_7a3eb3d7-810a-4a47-8fe4-c3905b7d0e3f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItMy0xLTEtMTQ3MTU3_cf63cb4c-8fef-485f-9978-e19313ccb991">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromHedgeFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItNS0xLTEtMTQ3MTU3_74deece4-6263-4dcf-a701-936deff2cf0f">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reduction of long-term obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtMS0xLTEtMTQ3MTU3_f40aa384-c391-4bd9-975f-2ee1f11648b8">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtMy0xLTEtMTQ3MTU3_9f92425d-409e-4bb7-a54a-e6cbfe34d44f">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtNS0xLTEtMTQ3MTU3_d1cae486-2383-4d3a-bfa7-1fe9299c0d69">1,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net tax proceeds/(withholding) from share-based compensation</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtMS0xLTEtMTQ3MTU3_92e24264-8ef6-4939-bf00-1f708db8b2f8">19</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtMy0xLTEtMTQ3MTU3_7aff6ea2-8a09-438f-b783-c8c285a69162">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtNS0xLTEtMTQ3MTU3_72135c22-0a88-4cc3-a304-fa3ac32a5885">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends on common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctMS0xLTEtMTQ3MTU3_2c8dfb9c-0ecf-474e-8db2-211b5e7dc307">559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctMy0xLTEtMTQ3MTU3_79be0d61-68f9-498a-b31f-8d06930c428c">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctNS0xLTEtMTQ3MTU3_9654f752-476e-450e-80bc-4b4b08f7ba83">569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtMS0xLTEtMTQ3MTU3_5fe92b43-451e-4c8d-b4ed-c3729fa9d72a">1,000</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtMy0xLTEtMTQ3MTU3_33649cd9-3bc1-438e-81ea-a4412533623d">200</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtNS0xLTEtMTQ3MTU3_b827bacd-8750-43bd-a895-2eb69f7d2edf">350</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktMS0xLTEtMTQ3MTU3_7d807045-66cf-4412-ac8a-3559ddacd528">2,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktMy0xLTEtMTQ3MTU3_ce3cdefe-e9ef-41b4-8fc4-5428615cedbd">1,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktNS0xLTEtMTQ3MTU3_567e3071-1143-4a8e-b387-3a3143533abe">2,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rates changes on cash and equivalents</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtMS0xLTEtMTQ3MTU3_01fce8f9-ec22-4729-8d86-6ecd01138c35">25</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtMy0xLTEtMTQ3MTU3_75a499c4-5604-4ee5-95be-8fc44458d3ea">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtNS0xLTEtMTQ3MTU3_79344c85-fc8c-4e03-bd10-fb7ef6808d5f">13</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash reclassified from/(to) assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:CashReclassifiedtoAssetsHeldforSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtMS0xLTEtMTQ3MTU3_dd211d78-ce30-464b-9cb1-586c4d29a887">109</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="cah:CashReclassifiedtoAssetsHeldforSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtMy0xLTEtMTQ3MTU3_ed0008e2-2235-4650-8540-d9b9c702a75e">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:CashReclassifiedtoAssetsHeldforSale" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtNS0xLTEtMTQ3MTU3_3dc2879d-c7db-4b18-8179-e47d796b70c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and equivalents</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItMS0xLTEtMTQ3MTU3_22312b29-ee34-40ed-b091-f26ad32c001a">1,310</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItMy0xLTEtMTQ3MTU3_8bd97b8a-61d2-4ba6-b29a-708f99e0bc8f">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItNS0xLTEtMTQ3MTU3_d590e962-6564-49de-8b42-c2e77466ed6e">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtMS0xLTEtMTQ3MTU3_7cc49403-05b3-43c4-a246-cde41af44c54">3,407</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtMy0xLTEtMTQ3MTU3_3af94fe9-bfa0-4d1f-90ba-6442d0a69d48">2,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtNS0xLTEtMTQ3MTU3_d053073f-4c18-4fd6-8c03-279cf4eb2c48">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and equivalents at end of period</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtMS0xLTEtMTQ3MTU3_4103bc0f-e93d-4082-8dca-d1d68046fbf6">4,717</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtMy0xLTEtMTQ3MTU3_63d86d53-f926-47c5-9e31-b140c916e67e">3,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtNS0xLTEtMTQ3MTU3_62e87a40-5698-496d-b48f-6e0bd9567270">2,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental Information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash payments for interest</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtMS0xLTEtMTQ3MTU3_9df41cda-09d1-465b-bfbc-0431f6246636">153</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtMy0xLTEtMTQ3MTU3_e9170332-b861-4990-b9cc-b83b05d14dcf">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtNS0xLTEtMTQ3MTU3_91e38fc6-284b-4847-9b39-13f2268b7de8">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash payments/(refunds) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctMS0xLTEtMTQ3MTU3_05dca837-2057-4a5b-bdd5-5cf7c62e0d8b">766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctMy0xLTEtMTQ3MTU3_95c6c4d2-c071-43d5-9533-b957999f0b4c">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctNS0xLTEtMTQ3MTU3_74f49850-9c7b-4fff-90a1-2609304449c3">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements </span></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_97"></div><div style="width:100.000%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg5MDE_538981e8-776f-44b2-bea5-2b282203d3b7" continuedAt="ib48c286c5f5c45b8ac5d60537abe0a4d" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">1. Basis of Presentation and Summary of Significant Accounting Policies </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we,&#8221; &#8220;our,&#8221; "us," and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries, unless the context otherwise requires.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on June&#160;30. References to fiscal 2022, 2021 and 2020 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2022, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDE_7bf5c8c7-d880-400f-a80a-f0496f2a656c" continuedAt="ic7beb6f2185b4749ba0ff3ba1ce0486d" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic7beb6f2185b4749ba0ff3ba1ce0486d">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively. Certain prior year amounts have been reclassified to conform to the current year presentation.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4Mjc_5cb22037-ed71-49e3-97eb-237995fd2f20" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, vendor reserves, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts may differ from these estimated amounts.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTA_344b3ce2-56b5-4834-9369-d71517c5dc3d" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDg_05f69d97-752a-4778-868d-e8294ba37214" continuedAt="i235e55b252464c2cbdc93866345a6fe0" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i63aae49541134c39aa2c99f778658cc5_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjU0OA_100e5a6b-faae-44df-9f8d-7904ec1758b9">273</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjU1NQ_095b0882-9a8c-48a0-99b7-5a8a966ceba2">243</ix:nonFraction> million at June&#160;30, 2022 and 2021, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i235e55b252464c2cbdc93866345a6fe0"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from <ix:nonNumeric contextRef="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630" name="cah:ReceivableFinancingAgreementTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzM4Nw_d29372e4-cc59-4b7b-b261-713088b1cbee">1</ix:nonNumeric> year&#160;to <ix:nonNumeric contextRef="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630" name="cah:ReceivableFinancingAgreementTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzM5Mw_cc8eeab5-f355-495d-b018-6b2311b55146">5</ix:nonNumeric> years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY1OQ_84415bb3-f1d0-4d56-84db-928760db494f">63</ix:nonFraction> million (current portion $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY3OQ_c7fc187c-0015-4cda-aa25-642a07bc6e74">12</ix:nonFraction> million) and $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY4Nw_3744e6b5-7e14-4e02-a808-3c7f2d6dae9c">63</ix:nonFraction> million (current portion $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzcwNw_d333db62-0e56-4f6a-8229-76787d83e498">7</ix:nonFraction> million) at June&#160;30, 2022 and 2021, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $<ix:nonFraction unitRef="usd" contextRef="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzkzMA_f2de80a3-a842-4fb5-8742-920e3dcd4d49">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzkzNw_321e1f92-fe5c-4d45-a061-a4d01ff70bc0">12</ix:nonFraction> million at June&#160;30, 2022 and 2021, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MDc_5cd4f9da-3cde-42e2-b573-db718d055b17" continuedAt="i4a1f1c31871f4b199e96686defcdc91d" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4a1f1c31871f4b199e96686defcdc91d">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3MzU_04b64d3f-457e-47d0-9a28-f17c89145a9e" continuedAt="i406a3255e87644e0afaf9af900e00278" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS Health") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div></ix:nonNumeric></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="ib48c286c5f5c45b8ac5d60537abe0a4d" continuedAt="idbc013c9b297410681411ace02eeed46"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i406a3255e87644e0afaf9af900e00278" continuedAt="iddebb15a28344ee998bb916aa5b0b47c"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTE_1b9369ee-f56f-4b7f-a66c-0a49b6871231" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:35.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS Health</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic85d2f2f06c94ebe83e8327bd00e68ce_D20210701-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi0xLTEtMS0xNDcxNTc_c72b471b-5cd2-444c-ab27-0e6725bd8409">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1711b8d7bfa14e438a604b5eb731fd63_D20200701-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi0zLTEtMS0xNDcxNTc_1ddc5b9c-7ae4-4e5e-8e25-6858252b58b2">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i242004258f7948c09176905c6439d71e_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi01LTEtMS0xNDcxNTc_1f659a2e-2f18-4031-beca-ee91d4ee4c4b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebb7741eed65481097e07facd023b229_I20220630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi03LTEtMS0xNDcxNTc_d55d4898-3fb4-4ea8-8622-c480c7a531a7">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9621b37a8dc4e7ea9c3508d6c8eb651_I20210630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi05LTEtMS0xNDcxNTc_64d82a85-b849-40b3-b50d-0140272b4cc1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie54dcff3023345b3b8dbceb05e183894_D20210701-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy0xLTEtMS0xNDcxNTc_e1d607dd-1068-4e26-95ef-8f4003916f84">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2597c971f6604c2a9a6b84309d0885b9_D20200701-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy0zLTEtMS0xNDcxNTc_3637dc91-8da1-46e0-94bd-c74d94738af7">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77687ae7a5664be792bcbd38bb67e2b2_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy01LTEtMS0xNDcxNTc_1662cfee-9e4f-4860-a951-e5fc780cb3c3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8188d649f96f4d47aa2ede0789bc920c_I20220630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy03LTEtMS0xNDcxNTc_13eac0b3-6b88-4e39-9d01-a2a32a51910c">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4737f6e39b0e4dc09e8ec181488988cc_I20210630" decimals="2" name="cah:GrossTradeReceivablesMajorCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy05LTEtMS0xNDcxNTc_1ab92b13-5101-44dd-89c5-6a2dd1d037d4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iddebb15a28344ee998bb916aa5b0b47c">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our <ix:nonFraction unitRef="organization" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjExOA_03cefdb2-8b0f-45ec-bdab-7929370996a2">two</ix:nonFraction> largest GPO member relationships in terms of revenue. Sales to members of these <ix:nonFraction unitRef="organization" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="cah:ConcentrationRiskLargestGroupPurchasingOrganizations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjIwMQ_03cefdb2-8b0f-45ec-bdab-7929370996a2">two</ix:nonFraction> GPOs collectively accounted for <ix:nonFraction unitRef="number" contextRef="ifb74843eaf0a48e78b9e853f892a30ba_D20210701-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjIzNg_9ec76502-7d27-4747-8e5f-538343a68929">19</ix:nonFraction> percent, <ix:nonFraction unitRef="number" contextRef="i5d51d1a743744443b9f40a909974d9c4_D20200701-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjI0MA_669cff5c-2882-44f9-b28b-055b1d299a89">19</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i38cd3d843f544dd0ac41d8cae2504a85_D20190701-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjI0Nw_1f148b68-232d-41c5-84ab-54f692fe5fbd">21</ix:nonFraction> percent of revenue for fiscal 2022, 2021 and 2020, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</ix:continuation>.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NDQ_9878b297-0fd8-4ae8-8f42-1ba3a94469f6" continuedAt="i82b2b7afe8424a1186b488106bb4c779" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (<ix:nonFraction unitRef="number" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="2" name="us-gaap:PercentageOfLIFOInventory" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjUxMg_b77491be-a59f-4f4e-930e-91c793ecdccb">52</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="2" name="us-gaap:PercentageOfLIFOInventory" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjUxOQ_6c9ed684-fe23-409f-9545-c164ba3ee9c3">50</ix:nonFraction> percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNzQyNA_89ee0d2e-420a-4edd-9da2-d0417ccd6f23">416</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNzQzMQ_f2eee512-86ca-498d-b59c-4ee47ac4914f">565</ix:nonFraction> million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain personal protective equipment as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i82b2b7afe8424a1186b488106bb4c779"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand decreased compared to the peak of COVID-19, during fiscal 2021 we recorded a reserve of $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfODYwNg_bb4e4428-0af6-449c-b5fe-2a4846071669">197</ix:nonFraction>&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i5ca12a2ea9cd462c9141a9d8057be00c_I20220630" decimals="-6" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjU5NzA2OTgxOTgxMw_d24dad87-94ef-4c57-840b-3b6f92d34d3d">42</ix:nonFraction>&#160;million at June 30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $<ix:nonFraction unitRef="usd" contextRef="id4140159ea4a43739df00326c541235c_I20220630" decimals="-6" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfOTA5NQ_c74c7509-0416-4f8b-8e4c-2fbb67739c0a">147</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i99a45ec948a346c4a693ae4491ab887b_I20210630" decimals="-6" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfOTEwMg_b302b596-dcdf-430d-830f-6900516dc589">185</ix:nonFraction> million at June&#160;30, 2022 and 2021, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:CashDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NTI_ad0da08e-133a-453e-856d-1450dd67d1db" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NDY_60e14338-180f-44b4-9a2d-a86ebae47396" continuedAt="i59b72a938bec46fdb2dae96f36be4bd2" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize project costs relating to computer software developed or obtained for internal use when the activities related to the project reach the application stage. Costs that are associated with the preliminary stage activities, training, maintenance, and all other post-implementation stage activities are expensed as they are incurred.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;<ix:nonNumeric contextRef="iaf515cb8fd624891a66b5f7e1ea44ba1_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwNjQ_e949613b-3c18-4a73-a337-dce52166b2bd">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ifd7a6fadd3f148f883ebb6412075c8ac_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwNzA_a283d2c4-266c-4155-b4ce-bb9baaa438cc">39</ix:nonNumeric> years; machinery and equipment&#8212;<ix:nonNumeric contextRef="i0a58c6e8721a4d5c9f8d148d848b3c73_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwOTg_95498f0e-c786-495a-bb03-4a1965950974">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ib42f20105ab0411cab507a7959ade5cb_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxMDQ_b9b906f8-6ab7-4188-a041-4e57f6766865">20</ix:nonNumeric> years; capitalized software held for internal use&#8212;<ix:nonNumeric contextRef="i61d5020105b54ebdbda79ad2cdd2c486_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NjAwNQ_fe5bed20-cee1-439f-a2cb-ffc1a922bc1a">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i2f4bb9b89da04d04968694a6fec77b68_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NjAxMA_f86fda25-0500-4e1e-aa75-a20c1debc467">7</ix:nonNumeric> years; and furniture and fixtures&#8212;<ix:nonNumeric contextRef="i5978dceb66ad409fb3003c8699c5492a_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxMzU_537fd904-7f57-47e2-b5ce-9f21d6041f6c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i887ae0d04a84497d824efb8ead276201_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxNDE_114d177a-fd1e-4d30-9da8-5caff8b5b1ab">7</ix:nonNumeric> years. We recorded depreciation and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxOTg_09dc214f-d559-4694-8f2d-6b90ed2761c9">412</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAyMDI_789bf71e-0695-4989-8c6f-b08deee6aa88">377</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAyMDk_1ac340d5-e2c0-4991-850d-0e5b15f50163">405</ix:nonFraction> million for fiscal 2022, 2021 and 2020, respectively.</span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="idbc013c9b297410681411ace02eeed46" continuedAt="i36429e3bc09f42f3a74c1b5c9b81cd86"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i59b72a938bec46fdb2dae96f36be4bd2"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4ODg_aeaa5bab-0f3d-4995-ba93-2b7d8784af20" escape="true"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c38ba87cbb64d34ac1bacba542abf6a_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMS0xLTEtMS0xNDcxNTc_5ebfb90e-1a0a-4362-bc96-af96bf609fdf">1,724</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033b0d1b48434099a70157ef43c38a49_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMS0zLTEtMS0xNDcxNTc_683ac023-cda7-4758-a5ff-4393bf75f0e5">1,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf7f9f717bf419d972451fe5f3da912_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMi0xLTEtMS0xNDcxNTc_5487e56e-1140-4d2b-a7aa-c541fa01385b">2,114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bf3f5eefca4129a06653b17bf04363_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMi0zLTEtMS0xNDcxNTc_9d34616e-6861-4274-b628-fcaaa45f8b12">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized software held for internal use</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee55f0b9ac1749cd8fad660d4398d09f_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0xLTEtMS0xNzcyMjU_7396164e-cd20-4882-acaa-c7e201f2c0bb">1,562</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i937b0ef4a4ca4ea3bea8db2f1a6b54c7_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0zLTEtMS0xNzcyMzI_ceed25a4-17e6-4955-9076-319d4b568ece">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e847a45be14fb698f7a64309bc2a65_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0xLTEtMS0xNDcxNTc_ed446cd6-9514-4d74-812a-7e1fde487d3b">125</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6189c62c3b4fc08a6ec02502390bf5_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0zLTEtMS0xNDcxNTc_bc7c5682-c353-4212-980c-6719b523a407">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb96066e3a547e9b5b6924d06661609_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0xLTEtMS0xODEwMzM_471ad126-21b3-4fc0-8bbc-9c59f5bfea10">358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9c6746ba5745d2bb4039a6f7b03117_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0zLTEtMS0xODEwNDA_054ba74e-8949-48f9-ae5a-50d92260f656">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNC0xLTEtMS0xNDcxNTc_c60907fc-1b67-4899-830e-b6d056fe9993">5,883</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNC0zLTEtMS0xNDcxNTc_24cfb292-cc12-4d73-ab0f-24bb7f277645">5,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0xLTEtMS0xNDcxNTc_32706df2-6c6b-49e9-9152-e6b9960ca112">3,522</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0zLTEtMS0xNDcxNTc_d9c0255e-2bbe-419b-afec-ea3adf408a4c">3,228</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNi0xLTEtMS0xNDcxNTc_9f9c5d51-8f0a-476d-af16-47a42abc2a95">2,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNi0zLTEtMS0xNDcxNTc_4e52a283-b0c1-4128-beca-f3ad3b23e315">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was <ix:nonFraction unitRef="number" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="2" name="us-gaap:LongtermDebtWeightedAverageInterestRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTA1NTI_9f80eda2-d172-42e1-b477-b7ca1671c08d">4</ix:nonFraction> percent at June&#160;30, 2022. The amount of capitalized interest was immaterial for all periods presented.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDk_2ba23c5f-e4c3-47dd-b1ea-54a041841fd3" continuedAt="ia3359d9115734135a37df0a6149fc38c" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTE4MTE_5e64b6dc-eba0-4a58-b5d9-13dcb65de422"><ix:nonFraction unitRef="segment" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTE4MTE_765cef87-0218-4706-871c-886e2c395149">two</ix:nonFraction></ix:nonFraction> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="ia3359d9115734135a37df0a6149fc38c" continuedAt="ie6a80a3be8ac444da7811b1a6f157409"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from <ix:nonFraction unitRef="number" contextRef="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630" decimals="3" name="cah:DiscountRatefairvalueinputs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTM1NTU_f2804057-730d-432d-a92e-8ff8c9a327ec">10</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630" decimals="3" name="cah:DiscountRatefairvalueinputs" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTM1NjE_d91a8988-0044-461b-a56f-a2f8aa06897a">12</ix:nonFraction> percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2022, 2021 and 2020 and with the exception of our Medical Unit in fiscal 2022, concluded that there were <ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTQ1NjU_c008bc39-a9dc-428e-b3fd-4f29bee02e4c"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTQ1NjU_c79764f4-745e-4e2b-a494-0f74596fcff6">no</ix:nonFraction></ix:nonFraction> impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. As discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements," during fiscal 2022, we recognized goodwill impairment charges related to our Medical Unit of $<ix:nonFraction unitRef="usd" contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjU5NzA2OTgxOTgyOA_45ba1b67-4027-473a-b19d-a383f27d9d7a">2.1</ix:nonFraction>&#160;billion, respectively, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings. There were tax benefits related to these goodwill impairment charges. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated </span></div></ix:continuation></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i36429e3bc09f42f3a74c1b5c9b81cd86" continuedAt="i63ac1232fb7d4da18516f1ff2a68729d"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie6a80a3be8ac444da7811b1a6f157409">methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</ix:continuation></span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:AssetsHeldforSalePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTQ_ddf22f2f-6622-47c6-8f79-ae3d115ce6c8" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we signed a definitive agreement with Hellman &amp; Friedman to sell the Cordis business. Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $<ix:nonFraction unitRef="usd" contextRef="idce5118955de4439a550969fa0cc542c_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTY5NDY_aeec2005-8505-460c-8c2c-9d52998ddb06">923</ix:nonFraction> million net of cash transferred, and we retained certain working capital accounts and certain liabilities. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_100">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information. Cardinal Health retained product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTE_5fd2d286-cd6a-4caa-84a4-972b6ef9fdb6" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4ODcwMA_f7893a6a-17ff-4923-9665-1959d4906a8d" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2022, 2021, and 2020 was not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms from less than <ix:nonNumeric contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NTc0MA_f84b2d23-e8ba-4fd3-b6f7-4d5882ca6b82">1</ix:nonNumeric> year up to approximately <ix:nonNumeric contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NTc2Ng_52c04bf0-667d-458e-bd96-a99a511a2647">20</ix:nonNumeric> years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_112">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding leases.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:CostofSalesVendorReservesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODU_803ee605-bee0-4933-91c1-4e64281a1b44" continuedAt="i0c3986db7e83457586241e1b473eeba8" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically update our reserve estimates to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i63ac1232fb7d4da18516f1ff2a68729d" continuedAt="i68343c7b14594751911bf5205900ce04"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0c3986db7e83457586241e1b473eeba8">the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues. Vendor reserves were $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:VendorReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTk0MjE_84c2e177-54df-45e8-b280-4dd95a2a7dcf">105</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="cah:VendorReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzI5ODUzNDkyMjI3Nw_3af308c2-539b-413b-acb5-4d83be0ad30a">77</ix:nonFraction> million at June&#160;30, 2022 and 2021 respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</ix:continuation></span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTM_3f772ffd-2a56-4249-8477-b7a4feca0a24" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NjM_cb26c444-a8a1-4238-a346-2615b88599f4" continuedAt="i8bccd7884c624854bc60689c49c7ffbe" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTIwOTQ2Mjc5NTUyNjQ_a222c96c-009b-42fc-abc1-1161d3c2568a">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTIwOTQ2Mjc5NTUyNzI_add96698-bb05-402d-a363-7d8b0449b70a">5.63</ix:nonFraction> billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively, which were retained at Corporate. In February 2022, we and two other national distributors announced that each company had determined that a sufficient number of political subdivisions had agreed to participate in the previously disclosed settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i8bccd7884c624854bc60689c49c7ffbe"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODc_a6732632-f4e7-4c78-a5c8-53cd1acfe58b" continuedAt="i07082f963cc745958c0cd036d9bc39f6" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i07082f963cc745958c0cd036d9bc39f6">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2022.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NTc_f1b57541-c283-4dc8-bd57-0ff1576d3119" continuedAt="i5e8c4fa37c8f49ed8e5af06f2fc0de95" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i68343c7b14594751911bf5205900ce04" continuedAt="i84faa7e9143e4abea9b5afc682d24afa"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i5e8c4fa37c8f49ed8e5af06f2fc0de95"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_121">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDY_b1b1035e-a6af-42c7-b63f-302fd668ad16" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTk_18b7c422-1390-4d39-aab6-9fe99c48e73c" continuedAt="i5264d6b8dfb94340947111dcc536c36b" escape="true">Noncontrolling Interests</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5264d6b8dfb94340947111dcc536c36b">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MDQ_4f47d46b-22c6-4440-abde-48907b1c6491" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_139">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:DividendsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NTI_2ae458b4-9d88-460f-932a-528d6f1a109e" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MTQ_58e74017-b754-4127-8d18-da1d4426887c">1.96</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MTg_3d659ab0-ce79-4558-b97c-b7334dbeb6bb">1.94</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MjU_b506d121-ea2a-4375-8d25-51f77657cafe">1.92</ix:nonFraction> in fiscal 2022, 2021 and 2020, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NjU_3aeb56c8-2f30-4bcb-89c0-a0ff7c524415" continuedAt="i6e56323f38ee4d479c1281f9b6b6469b" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6e56323f38ee4d479c1281f9b6b6469b" continuedAt="i6716c931b3394f99b212267af0f65997">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6716c931b3394f99b212267af0f65997">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:SalesreturnsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTQ_bd9fe41f-4658-4935-85ff-19b753066ca2" continuedAt="i63e4f05bab164d8d95c852b3c463e0f3" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2022 and 2021, the accrual for estimated sales returns and allowances was $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAxMDU_fdaa4f1f-6c15-46e7-be20-d2364accd657">617</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="cah:RevenueRecognitionReserveforSalesReturnsandAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAxMTI_f5696bba-884a-4027-b0ae-f05c13eb618f">689</ix:nonFraction> million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-8" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNjY_a18b7577-ea2d-4cad-b6d1-00eac2035958">2.4</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-8" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNzA_d176d1c3-77d0-41d6-a16c-15fa2fffa7db">2.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-8" name="us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNzc_f5c11f63-f234-4cd8-bc2e-8b42733fb6da">2.3</ix:nonFraction> billion, for fiscal 2022, 2021 and 2020, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2022, 2021 and 2020. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect </span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i84faa7e9143e4abea9b5afc682d24afa" continuedAt="i7fc7da92839f44339bd271f02e4161ae"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i63e4f05bab164d8d95c852b3c463e0f3">or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:ShippingandHandlingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTU_1dac3697-bf52-411d-98f7-3ef5c6a7f922" continuedAt="i889f676a9d484b1982aaee4f428fc810" escape="true">Shipping and Handling</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i889f676a9d484b1982aaee4f428fc810">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $<ix:nonFraction unitRef="usd" contextRef="i16a1465dba6b406da9f48c90f84ff2fb_D20210701-20220630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3NjM_452e8e5f-c0f9-4d22-b5b8-bfdd8783a039">748</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i546d299bf20c4b749073124f61b96f80_D20200701-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3Njc_ae778e78-282f-4de6-a54b-e001550f9ad9">634</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1114e2457f3f4ea59b1038c632c920f6_D20190701-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3NzQ_1f4f73c8-1818-4197-a5a0-aacd90981106">620</ix:nonFraction> million, for fiscal 2022, 2021 and 2020, respectively.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTE_b8831882-a046-4e13-a575-4e75b6ec9464" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_103">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODg_07b17ad5-4864-44c1-a29b-ddd744a3f746" continuedAt="ic467a69b0f23456fb3f4a43f6a0a7227" escape="true">Amortization and Other Acquisition-Related Costs</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="ic467a69b0f23456fb3f4a43f6a0a7227" continuedAt="i64a9e5d868c04843965ed4ec9391e945"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span></ix:continuation><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64a9e5d868c04843965ed4ec9391e945"> for additional information regarding amortization of acquisition-related intangible assets.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTI_b584b9e1-a519-4339-b54f-b004c76dc99c" continuedAt="i768af0b5789047618602c69758de271f" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="i768af0b5789047618602c69758de271f"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2022 and 2021 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_130">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></ix:continuation></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MzQ_d5a88531-4bbc-4b7b-ba63-760d7932b03f" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_127">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3Njc_cb967f29-c1c1-434c-8d5a-59413d477190" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_124">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i7fc7da92839f44339bd271f02e4161ae"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTc_683ff95e-5a10-462e-8d0f-af8b8ec9ba3b" escape="true"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting standards adopted in fiscal 2022 that had a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the adoption impacts of recently issued accounting standards by the FASB on our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2021 Form 10-K. There were no accounting standards issued in fiscal 2022 that will have a material impact on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_100"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4NTg_8260b209-7b81-420e-9e98-0b3e6753734a" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">2. Divestitures and Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5735c211d1fd471db52d24b85e925378_D20210802-20210802" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzQwOQ_d9f1c18c-5768-4925-a09f-f8b38d49e3b8">923</ix:nonFraction> million, net of cash transferred, and we retained certain working capital accounts and certain liabilities. Cardinal Health retained product liability associated with lawsuits and claims related to IVC filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Cordis business operated within our Medical segment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. We determined that the sale of the Cordis business did not meet the criteria to be classified as discontinued operations. In connection with the divestiture, we recognized a $<ix:nonFraction unitRef="usd" contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630" decimals="-6" name="cah:WriteDownOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzY1OTcwNjk3NzQ5OTk_7bad20bc-0a3e-49e9-8cfc-17a58b49a584">60</ix:nonFraction>&#160;million pre-tax loss in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss) in fiscal 2021.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">naviHealth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia4cc2b4bbaa0449790c4c94fb3395ed8_D20180801-20180831" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzIwODk_be02e403-a9f4-458c-a862-5a07f4f37194">737</ix:nonFraction> million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i28546e72017346d28b45df1b4a2b2885_D20190701-20200630" decimals="-6" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzI5NjU_5cb2d145-1828-4c3a-bd9a-4f94c483fcbe">579</ix:nonFraction>&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not complete any acquisitions during fiscal 2020. While we completed small acquisitions during fiscal 2022 and 2021, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4MTQ_395b367c-6266-43d1-84e5-7d81295c5d30">22</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4MjE_e47fac4b-fb0c-421f-93ea-34b4fe3f1f37">3</ix:nonFraction> million for fiscal 2022 and 2021, respectively.</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div id="i06b8b3ff48e94029843042d968c5bda7_103"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExODc_0f6a2d23-872b-44cf-8019-2e5259f9db62" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">3. Restructuring and Employee Severance </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExNzU_e0b91c3e-1342-47b9-b6b7-cef978e4b409" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:57.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtMS0xLTEtMTQ3MTU3_4b5c1a70-4cca-433a-8439-183f1701a383">35</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtMy0xLTEtMTQ3MTU3_f6e43588-cc35-4e0f-a5d2-e16f2c04f699">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtNS0xLTEtMTQ3MTU3_cb071aa3-1b7b-4a6c-a65c-37f3b4da6cb8">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItMS0xLTEtMTQ3MTU3_73928f81-6c75-47d4-bc8e-a8c97aececd7">66</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItMy0xLTEtMTQ3MTU3_3ecfc601-7381-4670-b780-cac12184693a">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:FacilityExitAndOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItNS0xLTEtMTQ3MTU3_f9661e65-5a64-4fc7-98ce-2bad796770bd">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtMS0xLTEtMTQ3MTU3_325c4f34-56ad-46f2-845f-c129a3c82284">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtMy0xLTEtMTQ3MTU3_111d1f84-89b7-4dd5-8b0f-73c6a09f6258">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtNS0xLTEtMTQ3MTU3_9a5908ca-e532-4381-b4df-e4d30b490847">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of accelerated depreciation, lease costs associated with vacant facilities, professional, project management and other service fees to support divestitures, vendor transition fees, project consulting fees, and certain other divestiture-related costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022 and 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures, which includes facility exit costs related to decreasing our overall office space, and the divestiture of the Cordis business. In fiscal 2020, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExNjM_4cd41e73-612f-4385-a974-a90eb0571f4d" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:42.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id264d3093a7a4580ad949f73349b6a5c_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtMS0xLTEtMTQ3MTU3_809f4a73-8a00-431d-bdc3-6e394e13811e">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2368a61474f8f89d5d38fec24f64f_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtMy0xLTEtMTQ3MTU3_2042746a-1dee-4f52-a75d-b5370ce46a03">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtNS0xLTEtMTQ3MTU3_0e876cfc-ca5f-4007-94c6-f82aee6bb021">96</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItMS0xLTEtMTQ3MTU3_b305d0d3-bf2b-455a-8676-807d482f9134">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied971d2805b0409083a7c40b38503d50_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItMy0xLTEtMTQ3MTU3_42de5b92-5962-4589-84f7-e861aa5f9010">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItNS0xLTEtMTQ3MTU3_29e8c7c9-fe3c-4c80-8007-dee599231ef1">75</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtMS0xLTEtMTQ3MTU3_a843d81f-9c70-4723-9dd3-560a0846b4bc">64</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied971d2805b0409083a7c40b38503d50_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtMy0xLTEtMTQ3MTU3_211bdfec-b65d-4e51-a244-b23cb4ab4e1f">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtNS0xLTEtMTQ3MTU3_7ea732c0-0f37-4d6e-8262-8aae4be9ae00">92</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0092967ac5424faf8778330ec9444ee4_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtMS0xLTEtMTQ3MTU3_1989b474-3660-494a-9b47-03625fdd031b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c1fef25e9e4f83a31d3467e3e59555_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtMy0xLTEtMTQ3MTU3_c9dbc1a5-c3b9-4bb5-b312-d9b6e7321cc2">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtNS0xLTEtMTQ3MTU3_97bc1d3f-dea2-4dd7-9404-66aa5cfe147c">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtMS0xLTEtMTQ3MTU3_9c552f79-352f-4148-96a7-23589d609465">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtMy0xLTEtMTQ3MTU3_c22d8ab5-c0f4-4677-9d3e-8dd33ad906e9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtNS0xLTEtMTQ3MTU3_677d97e6-333a-4f58-94ec-59a2879b8a9e">59</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtMS0xLTEtMTQ3MTU3_8bdf7b8a-f04e-4fcd-8552-692e14f96821">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtMy0xLTEtMTQ3MTU3_f0fe8514-86bd-461e-94ee-c69aeac1a9f8">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtNS0xLTEtMTQ3MTU3_ad861415-47d0-4cd1-9df1-501e4008dcd6">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd545e35312405cb520c9f72a124131_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctMS0xLTEtMTQ3MTU3_207287bc-8d16-47cc-b852-5119a312c41d">56</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002c719a8c5b420b8af67195661dda98_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctMy0xLTEtMTQ3MTU3_16a194b7-b92b-4726-8ce7-e10f2269300e">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctNS0xLTEtMTQ3MTU3_73bde5cd-c386-483c-9fb6-627ec807b50f">66</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_106"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzEwMjE_bb3c53da-d79d-4f43-973a-f1c0e4f60625" continuedAt="i7fc6b97ba8524cc593d32545b86fe8de" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">4. Goodwill and Other Intangible Assets </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk5MQ_4b737215-e43f-40d9-b3d8-431eba12eb98" continuedAt="i4b551a4374464511affab95d0e6d5704" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25aa8308d1943b59cbe926e3c5d3649_I20200630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtMS0xLTEtMTQ3MTU3_f9fcc405-021b-476c-90cc-c50ae158fec2">2,657</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f92afd839604684abe9404d6d95434d_I20200630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtMy0xLTEtMTQ3MTU3_fe922605-7c95-4723-b020-aba003009201">5,700</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtNS0xLTEtMTQ3MTU3_02fed061-3a1c-4989-95d6-7f9dcab71479">8,357</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItMS0xLTEtMTQ3MTU3_6f510d56-0d8d-4733-8c1e-e23990dd2635">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItMy0xLTEtMTQ3MTU3_f9388e91-fe7f-480e-b26d-b0afeb176e4f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItNS0xLTEtMTQ3MTU3_833b942f-aa76-4e90-85df-5b7cb1eb59fc">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtMS0xLTEtMTQ3MTU3_4e50cc08-3844-4687-8b46-5cf8ca203885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtMy0xLTEtMTQ3MTU3_a04cbc9c-fa93-466d-af87-112c80bfae86">18</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtNS0xLTEtMTQ3MTU3_1f65ea76-8a57-41f5-acb5-7eb084a06171">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fc6bbba81b4a1ca1be4f2ccbed4b27_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtMS0xLTEtMTQ3MTU3_152e13fe-7095-4ce5-a555-440da2cd44d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtMy0xLTEtMTQ3MTU3_2792ad04-717c-4bfb-a0f0-83186c7d52c6">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtNS0xLTEtMTQ3MTU3_10489cf9-796d-4dde-a476-302c536ceffb">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2570c791ecea44d9bc344bd115d28c3c_I20210630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctMS0xLTEtMTQ3MTU3_01152ede-aa30-4a7f-be28-20e071f97df5">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctMy0xLTEtMTQ3MTU3_b7cf6251-a262-4c4b-bada-7229c909f4ae">5,330</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctNS0xLTEtMTQ3MTU3_f5e6a82e-f2dc-4d70-b41d-c4603d695735">7,989</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtMS0xLTEtMTQ3MTU3_e1175a5d-6517-4b43-87d1-00ba7e0e0bff">14</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtMy0xLTEtMTQ3MTU3_dede11a7-2e7f-4c7a-a88b-ea9ad9619379">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtNS0xLTEtMTQ3MTU3_939ab85a-c58c-42c3-ab25-e3fede70cffe">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktMS0xLTEtMTQ3MTU3_e1ceb4b5-0aa0-4075-b3fe-9610b659a1a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktMy0xLTEtMTQ3MTU3_d6ab9224-0453-4809-8292-0bf2341b248f">64</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktNS0xLTEtMTQ3MTU3_fe03d9d0-5b54-431c-beab-7eef733fb87a">64</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTEtMS0xLTE0NzE1Nw_c068a20b-4193-4c28-bd44-0da8c3ae9882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTMtMS0xLTE0NzE1Nw_bec1018c-e7d5-48b9-a41f-720d008be733">2,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTUtMS0xLTE0NzE1Nw_381a36da-90e8-4261-a3a2-4a33e261a75c">2,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1abfa91513984b189f3f0624a3d7175e_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTEtMS0xLTE0NzE1Nw_e324b4f9-9371-4e59-ba2c-d1e220a83a8f">2,673</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59345f7aaab84656a49d8caf50ebe1b9_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTMtMS0xLTE0NzE1Nw_eae2ff1b-3440-46dc-880b-8fcec7b4ad87">3,182</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTUtMS0xLTE0NzE1Nw_2e09aba2-2330-4fef-8761-4b8cdec16143">5,855</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Pharmaceutical segment accumulated goodwill impairment loss was $<ix:nonFraction unitRef="usd" contextRef="i2570c791ecea44d9bc344bd115d28c3c_I20210630" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzIwOQ_69e97f42-534e-4aa3-81ce-febc27235533"><ix:nonFraction unitRef="usd" contextRef="i1abfa91513984b189f3f0624a3d7175e_I20220630" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzIwOQ_ca50729c-4589-401d-b2af-b5978449df57">829</ix:nonFraction></ix:nonFraction> million.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4b551a4374464511affab95d0e6d5704">(2)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Medical segment accumulated goodwill impairment loss was $<ix:nonFraction unitRef="usd" contextRef="i59345f7aaab84656a49d8caf50ebe1b9_I20220630" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzI5Mg_6c5f8100-1ed0-4a0e-8917-d524e3604741">3.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIzMjY_a5a04856-ca85-4182-8379-04a4dbd6d840">1.4</ix:nonFraction> billion, respectively.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Medical Unit experienced adverse financial results related to inflationary impacts and the adverse impact of global supply chain constraints and lower volumes from PPE. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit at June&#160;30, 2022. This quantitative testing resulted in the carrying amount of the Medical Unit exceeding the fair value, resulting in a pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3NzQzODE_9d541597-a71a-41de-9e16-87df6fad5b00">303</ix:nonFraction> million and cumulative pre-tax impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA0OTU_45ba1b67-4027-473a-b19d-a383f27d9d7a">2.1</ix:nonFraction>&#160;billion recognized during fiscal 2022, due to the impairment charges recognized during the third and second quarters of fiscal 2022 as described further below. This impairment charge was driven by an increase in the discount rate primarily due to an increase in the risk-free interest rate. Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach and the market-based approach. For this testing performed at June&#160;30, 2022, we used a discount rate of <ix:nonFraction unitRef="number" contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630" decimals="3" name="cah:DiscountRatefairvalueinputs" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MzE_ef74a9bf-19b2-49f3-ae0e-fe7fb2826cc0">10</ix:nonFraction> percent and a terminal growth rate of <ix:nonFraction unitRef="number" contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_38e93912-92ee-4fa7-86a6-7feb120e3a92"><ix:nonFraction unitRef="number" contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_41c41006-7af3-4ddf-9077-1fe5667a490c"><ix:nonFraction unitRef="number" contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_d7eb36c4-122c-4b76-9b55-ec60127a3422">2</ix:nonFraction></ix:nonFraction></ix:nonFraction> percent. The goodwill balance of the Medical Unit, after recognizing the impairment, was $<ix:nonFraction unitRef="usd" contextRef="ifbeba755f36e4c298fc6035248db673b_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3Nzg0ODk_ab717f91-f422-492f-8755-fefcb703b291">1.9</ix:nonFraction> billion at June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third and second quarters of fiscal 2022, we performed interim goodwill impairment testing for the Medical Unit at March 31, 2022 and December 31, 2021, which resulted in pre-tax impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIxMDI_296b1589-54da-4219-8428-736e6e91ae7e">1.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIxMTY_f27c6e1d-c46e-48e0-bc19-f9f659211a00">474</ix:nonFraction>&#160;million, which were recognized during the second and third quarters of fiscal 2022, respectively, and are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(using a terminal growth rate of <ix:nonFraction unitRef="number" contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_38e93912-92ee-4fa7-86a6-7feb120e3a92"><ix:nonFraction unitRef="number" contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_41c41006-7af3-4ddf-9077-1fe5667a490c"><ix:nonFraction unitRef="number" contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630" decimals="3" name="cah:TerminalGrowthRateFairValueInput" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_d7eb36c4-122c-4b76-9b55-ec60127a3422">2</ix:nonFraction></ix:nonFraction></ix:nonFraction> percent), and the market-based approach. For the income-based approach, we also used discount rates of <ix:nonFraction unitRef="number" contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231" decimals="3" name="cah:DiscountRatefairvalueinputs" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MTc_de36e96f-440e-4875-b9b6-05db3a4d6bdc">9</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331" decimals="3" name="cah:DiscountRatefairvalueinputs" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MTI_5ebb4422-ae67-47fa-a329-978ac1bc9ba0">9.5</ix:nonFraction> percent for the interim testing during the second and third quarters of fiscal 2022, respectively. The increase in the discount rate was primarily due to an increase in the risk-free interest rate. Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture of the Cordis business, during fiscal 2021 we allocated and reclassified $<ix:nonFraction unitRef="usd" contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIzNDc_2792ad04-717c-4bfb-a0f0-83186c7d52c6">388</ix:nonFraction> million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzEwMDc_b7484b52-d6f6-48ec-b098-f3ea7fe47d88" continuedAt="ic26b6b5b51b641af80b9b4b01d1eb9a5" escape="true"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk4OQ_dafabb82-c0bd-4e9f-880e-631c8d30d85f" continuedAt="i527c82f0ba03454e9307db175cad8497" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.653%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111b02e3c4c4435d83e0af77b9189c58_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzMtMS0xLTEtMTQ3MTU3_36d15f6f-2cb9-4ecc-a7f9-1174c763556a">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111b02e3c4c4435d83e0af77b9189c58_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzMtNS0xLTEtMTQ3MTU3_731829a4-64e0-4a30-b127-b3bd36c57127">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzQtMS0xLTEtMTQ3MTU3_103dabb9-926e-476e-8b6e-1bbcf6c9ef69">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzQtNS0xLTEtMTQ3MTU3_eaa0f40a-b475-44ad-b54b-aa92d181225c">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtMS0xLTEtMTQ3MTU3_6d618b92-115c-4720-9e57-046de288366e">3,272</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtMy0xLTEtMTQ3MTU3_dcc4e400-fd54-48be-b978-c12f8c34c030">2,165</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtNS0xLTEtMTQ3MTU3_2eab534b-8b2d-4d49-ba06-0b22d80dfe19">1,107</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if9bb8d1c3bce41a4917f5b1276888172_D20210701-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtNy0xLTEtMTQ3MTU3_4a0d166f-9b43-4fc0-902d-269f3570bb73">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctMS0xLTEtMTQ3MTU3_a6551cbf-8f1e-43bc-8edd-802e61338521">552</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctMy0xLTEtMTQ3MTU3_4ecb0d2c-c253-4d2f-b059-fe0146cd41ae">360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctNS0xLTEtMTQ3MTU3_bf094705-b6de-49f4-b311-5dd4e779b9a9">192</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i80fae599ff554c3fa75995b90567c93a_D20210701-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctNy0xLTEtMTQ3MTU3_a689c396-fd7d-4289-9b29-f7531423bbb7">8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtMS0xLTEtMTQ3MTU3_3c5bbb33-74b0-4507-8454-913ea7b0c2d9">1,038</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtMy0xLTEtMTQ3MTU3_73ed8443-498a-42d9-86c4-98a5c0b9c16f">574</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtNS0xLTEtMTQ3MTU3_3892642d-abc4-4e3b-82b7-c7062b48ed44">464</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie7c528a8d9694aee94274e9b419173e7_D20210701-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtNy0xLTEtMTQ3MTU3_543ca5bb-0e54-4e3e-b50a-8cc8bf690a12">9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktMS0xLTEtMTQ3MTU3_e4f6c73b-c1bd-47b5-a4d2-aae0f774695c">4,862</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktMy0xLTEtMTQ3MTU3_ddfb4bd4-c59d-406a-b837-57d9e6c53828">3,099</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktNS0xLTEtMTQ3MTU3_1837dc20-0914-4a85-8e53-a816a922ba49">1,763</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktNy0xLTEtMTQ3MTU3_b07b667f-e069-4e87-a4fd-05f53b3eade6">9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTEtMS0xLTE0NzE1Nw_7f29cde0-f101-4d0d-a014-1570aeab3cf5">4,873</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTMtMS0xLTE0NzE1Nw_0f6f955d-7702-41c0-8dec-fdd10bf74790">3,099</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTUtMS0xLTE0NzE1Nw_5902ae49-bded-4f10-bc91-3c4c0e99d684">1,774</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><ix:continuation id="i7fc6b97ba8524cc593d32545b86fe8de" continuedAt="if5b6c0b1d6d146a5b50a6bda41571871"><ix:continuation id="ic26b6b5b51b641af80b9b4b01d1eb9a5"><ix:continuation id="i527c82f0ba03454e9307db175cad8497"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:42.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d56789271704cc391e10e73a9dc6d56_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzMtMS0xLTEtMTQ3MTU3_b8299432-7d7b-4068-9eaa-3b58711ed228">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d56789271704cc391e10e73a9dc6d56_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzMtNS0xLTEtMTQ3MTU3_43fa2953-6d63-4402-b55e-7cb3a344f228">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzQtMS0xLTEtMTQ3MTU3_d63ef1f1-a79f-4d33-8c1c-a4a2ce17b29d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzQtNS0xLTEtMTQ3MTU3_5705415c-b6d0-4f76-927c-450364609325">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtMS0xLTEtMTQ3MTU3_b3a1dea6-7a53-4589-9c82-80544d196e2d">3,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtMy0xLTEtMTQ3MTU3_8dec28e7-4cca-4ad4-be9b-95f03f05afeb">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtNS0xLTEtMTQ3MTU3_47b620c6-3a4c-42d1-b9f6-026f628b3e00">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778605f8f09452483e387ca04e5f798_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctMS0xLTEtMTQ3MTU3_be699c56-7c05-41ff-8c01-0ec7b21c048c">551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778605f8f09452483e387ca04e5f798_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctMy0xLTEtMTQ3MTU3_df304fac-12cc-4237-a26b-0df5e12b88b6">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778605f8f09452483e387ca04e5f798_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctNS0xLTEtMTQ3MTU3_33dcd87f-dfd6-4872-9c90-50b9d112227f">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced246337ea748e18ce3b7196e968243_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtMS0xLTEtMTQ3MTU3_881d0dd5-060b-4344-ace6-ca379cab1b24">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced246337ea748e18ce3b7196e968243_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtMy0xLTEtMTQ3MTU3_fad6b989-6699-4e6b-99e3-e41fe4a894fa">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced246337ea748e18ce3b7196e968243_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtNS0xLTEtMTQ3MTU3_2837ef56-b1af-4ec1-becc-594c9b68562e">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktMS0xLTEtMTQ3MTU3_54296a86-0441-44ae-be58-48218b9fabc8">4,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktMy0xLTEtMTQ3MTU3_0209f32d-3746-4b97-a1d7-b88a07902742">2,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktNS0xLTEtMTQ3MTU3_8ec54155-0349-49d4-a382-fe0ae9cf3190">2,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTEtMS0xLTE0NzE1Nw_cdd8b582-86fa-42aa-8eab-d04a7e174bc5">4,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTMtMS0xLTE0NzE1Nw_ab6f5f30-be8f-4166-8ff6-bdf6017240a1">2,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTUtMS0xLTE0NzE1Nw_89cfc6e3-0f3d-4df8-92bd-a07cd1fa5765">2,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></ix:continuation></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if5b6c0b1d6d146a5b50a6bda41571871">Total amortization of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgxNg_0e0358e3-63b2-413d-9cc1-40a515b6755a">311</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgyMA_5afbabdc-1863-423c-b1d7-43f1e4bd1ec6">428</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgyNw_df3a3dbe-7e02-48a3-bfaf-054e1adb8d9d">512</ix:nonFraction> million for fiscal 2022, 2021 and 2020, respectively. The estimated annual amortization for intangible assets for fiscal 2023 through 2027 is as follows: $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk2Ng_2e0fdb8e-995a-4212-a935-eee7123abd5d">283</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3MA_7c3dd462-ce86-40fe-8ab3-71b93921cac7">260</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3NA_1e74d544-4081-4b5b-aa83-f3e9662885b4">235</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3OA_37c45e38-2499-4394-bf1f-fc34729b5f9c">208</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk4NQ_2a92a00c-9e71-4c52-9954-2fcaf61547ec">175</ix:nonFraction> million.</ix:continuation> </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_112"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:LeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2NzY_dda544f5-c9e9-4397-a597-32c542d32fee" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">5. Leases </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzc_18f83345-c049-4e49-b23c-4039734417e2" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:27.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMS0xLTEtMTQ3MTU3_586bfbcc-e14a-40e8-8e44-8f7bf8763855">117</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMi0xLTEtMTQ3MTU3_c70b74e1-1487-42ed-8a0c-c693f6244026">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMy0xLTEtMTgxNDcw_a55e8531-575b-4204-91ff-b10fed8b679d">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMS0xLTEtMTQ3MTU3_b5c15bf9-4498-495c-ae21-dfaaf78b6871">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMi0xLTEtMTQ3MTU3_25283d5d-4c95-42fb-b9cf-ed166a058bfa">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMy0xLTEtMTgxNDc4_30a22a2c-df72-41f5-bf54-f4ee888a0c77">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMS0xLTEtMTQ3MTU3_d2fce808-47b9-4d27-99f4-4d926291eb4e">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMi0xLTEtMTQ3MTU3_00586cbe-51ee-49cf-8806-28e54a660d90">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMy0xLTEtMTgxNDg2_f2fd5fc4-b13b-4a2b-b5e3-fd42d07a3d81">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTEtMS0xLTE0NzE1Nw_bd9905a6-4964-4a75-9bde-414fdd1edd7e">153</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTItMS0xLTE0NzE1Nw_660326c8-db68-45ab-8af5-3b3a104ba181">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTMtMS0xLTE5NzU3Mg_35298ffc-43e6-4e54-9c72-944a774888fa">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost primarily includes payments for property taxes, maintenance and insurance. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:LeasesSupplementalBalanceSheetInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzg_77250d45-73bf-4401-8827-2e3eeeef48c9" continuedAt="i21db703bd08045829a1112c3ee5785ab" escape="true">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i21db703bd08045829a1112c3ee5785ab"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe">Operating lease right-of-use assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMS0xLTEtMTQ3MTU3_4f9ffd17-0d91-4f64-a637-34cc9dd1f706">457</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMi0xLTEtMTQ3MTU3_1cee382d-2e08-4d15-9278-713394035407">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711">Current portion of operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMS0xLTEtMTQ3MTU3_a1305f09-b38a-4d25-9a8e-569567f857fd">102</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMi0xLTEtMTQ3MTU3_5b2d71f0-aed3-4391-8fdd-dace2ee516e3">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f">Long-term operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMS0xLTEtMTQ3MTU3_18a24a65-9744-4e86-9389-44c447118571">388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMi0xLTEtMTQ3MTU3_8dcdd0b8-580d-4a64-a533-0d207aec91d2">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzYtMS0xLTEtMTQ3MTU3_b7a5cb1e-bc77-4921-8c1e-08c5fbd8f6f3">490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzYtMi0xLTEtMTQ3MTU3_0e3d6b8e-f55c-4011-a5fd-e7aa77a23608">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f">Finance lease right-of-use assets</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMS0xLTEtMTQ3MTU3_a4c5b199-65c9-4027-b3b2-95ec89bd3c33">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMi0xLTEtMTQ3MTU3_a1fbf283-7b7b-4282-b11e-24aae79877ea">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c">Current portion of finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTEtMS0xLTE0NzE1Nw_82f0943a-5108-408d-8411-4576761438f3">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTItMS0xLTE0NzE1Nw_5302449f-338a-41cf-b45c-52baea355fab">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTEtMS0xLTE0NzE1Nw_59f3e017-1a80-41c7-8798-d6dafb39b2e7">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTItMS0xLTE0NzE1Nw_92497bb8-1342-45d5-8fe0-b2676f63c877">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEzLTEtMS0xLTE0NzE1Nw_fa3c5015-76bb-4025-83a1-c0236f4536b9">72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEzLTItMS0xLTE0NzE1Nw_95e09638-bca7-40b8-bac2-d9b3a0a25ba9">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE2LTEtMS0xLTE0NzE1Nw_72363d27-b820-47e6-8af3-313fcd405703">6.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE2LTItMS0xLTE0NzE1Nw_7f76a777-f34d-4be0-99c2-81ac80f8906b">6.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE3LTEtMS0xLTE0NzE1Nw_721d8eaa-0eae-4a2b-b773-871e4d3959b6">4.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE3LTItMS0xLTE0NzE1Nw_43f846b7-f871-4968-a11c-0b915632c947">4.2</ix:nonNumeric> years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIwLTEtMS0xLTE0NzE1Nw_c1d03c19-8be6-4f6a-89d5-cd44152995a3">3.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIwLTItMS0xLTE0NzE1Nw_0084f280-f282-4f46-9b30-3aaf1db5f0da">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIxLTEtMS0xLTE0NzE1Nw_93d1219a-c633-49c4-a0f3-0c9699c4a8e2">1.8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIxLTItMS0xLTE0NzE1Nw_13d5f0ee-c748-4226-9f13-a57a705ad03c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheets. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheets. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:LeasePaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzk_99cad79a-97b6-437d-ba55-df1f39e48f8b" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMS0xLTEtMTQ3MTU3_c6a9eb73-b380-44f7-b783-0d5a6a0bc53f">123</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMi0xLTEtMTQ3MTU3_93c4f0fa-b3c5-4558-862c-92447313d3ac">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMy0xLTEtMTgyNzc1_1811eb55-37a2-4205-8631-0fd97b4df2d8">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMS0xLTEtMTQ3MTU3_0ea84457-8e39-426f-9e4e-5e0d31c1c81c">21</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMi0xLTEtMTQ3MTU3_99a1bf7e-1311-455d-9404-7dd93ee91967">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMy0xLTEtMTgyNzgz_8802fe04-5722-4d08-8fa8-27261b24e146">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMS0xLTEtMTQ3MTU3_9a7ff814-decc-4cea-b177-34deda45e953">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMi0xLTEtMTQ3MTU3_f0dde28a-3b14-4436-9cfa-62d904e06de7">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMy0xLTEtMTgyNzkx_b666057a-4725-4cc6-85e9-d87b866adca9">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMS0xLTEtMTQ3MTU3_0153c507-204d-44c8-a737-74a15bcc1ae4">28</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMi0xLTEtMTQ3MTU3_0d75b192-4c33-4eb1-a20a-471e48c7c11c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMy0xLTEtMTgyNzkx_26c7c15d-2d00-4382-9352-cb0c3d9afde7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed9de2f40646068fda63624fe9021c_D20210701-20220630" decimals="-6" name="cah:Impactofadoptionofnewaccountingstandard" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMS0xLTEtMTgyODAz_249aa1d4-166d-4f94-9835-94177d08acc9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aaeb4ce0c834fc793b1f0b25fa82f9b_D20200701-20210630" decimals="-6" name="cah:Impactofadoptionofnewaccountingstandard" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMi0xLTEtMTgyODAz_73553e23-3f02-4db3-bcbc-260d22e52766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101a75214a2841688c2ee6c7e7f23e10_D20190701-20190701" decimals="-6" name="cah:Impactofadoptionofnewaccountingstandard" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMy0xLTEtMTgyODAz_9609bbc3-924d-465c-b13d-5bb9093de4da">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Includes the effect of $<ix:nonFraction unitRef="usd" contextRef="i37112b83786b4ac1ba34031420b8575a_D20190701-20190701" decimals="-6" name="cah:ReclassificationofdeferredrentinaccordancewithASC842" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzU0OTc1NTgxNDczMzc_729ff462-8963-4d78-a9e4-fdf016035fcb">22</ix:nonFraction>&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2ODA_90ccb4b1-0dcb-49a2-81de-b10cd9d5a18a" escape="true"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2ODA_c1746bb7-f000-410b-b8fa-73f88da4487b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:50.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItMS0xLTEtMTQ3MTU3_a143006b-fdfd-40c1-8fba-68245cdc7f49">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItMy0xLTEtMTQ3MTU3_9ccff6e6-abb9-4183-a39a-e9131d41c662">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItNS0xLTEtMTQ3MTU3_2846f22e-2014-4fc0-8f07-7644979f9a14">138</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtMS0xLTEtMTQ3MTU3_94186ecc-127f-41bf-8c9c-9d462385365b">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtMy0xLTEtMTQ3MTU3_bc0413ff-7443-4e37-8f24-f0b94903d9c3">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtNS0xLTEtMTQ3MTU3_b25fc4c7-0069-4ab7-b60b-44641136f382">117</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtMS0xLTEtMTQ3MTU3_700df52a-af63-4d27-a53a-4aff81af735a">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtMy0xLTEtMTQ3MTU3_6b93bad7-2c2c-49d8-8895-ac1aca247972">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtNS0xLTEtMTQ3MTU3_f4115a19-cd85-4a92-9bac-1fc2edeb336b">102</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtMS0xLTEtMTQ3MTU3_51d9f738-2ec5-497a-906e-78f2aad28a01">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtMy0xLTEtMTQ3MTU3_8094bf41-6faa-4810-a7e7-27777c3fbbb5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtNS0xLTEtMTQ3MTU3_773b7eb1-eab4-41ea-9030-fdb7c0a2d292">78</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtMS0xLTEtMTQ3MTU3_a43178c2-8be4-4ba6-811d-14e88b60f005">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtMy0xLTEtMTQ3MTU3_645d0997-6da3-4906-9ad8-c42691e92ce6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtNS0xLTEtMTQ3MTU3_596cd0c1-3a42-4ff6-a443-39dd4f4c42bc">59</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctMS0xLTEtMTQ3MTU3_dc8b0edb-334c-469e-a9ff-068672979dfc">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctMy0xLTEtMTQ3MTU3_95af9db9-6a03-4c65-8f5c-dd071dc2a071">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctNS0xLTEtMTQ3MTU3_6f044e2b-d14b-4cc7-8578-a2c0ce4e9abd">120</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtMS0xLTEtMTQ3MTU3_0261401d-9c94-43e4-b9d3-92647785c320">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtMy0xLTEtMTQ3MTU3_2bdf8c30-331d-42fe-a396-e277a8a9f967">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:TotalLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtNS0xLTEtMTQ3MTU3_a0a69caa-0eef-4bc5-b7fd-9c57692a571e">614</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="cah:OperatingLeaseImputedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTEtMS0xLTE0NzE1Nw_df5dea03-f7a5-46d3-ba1a-e50476c58039">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="cah:FinanceLeaseImputedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTMtMS0xLTE0NzE1Nw_774208f6-3e29-4885-b493-21666f50c74a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:TotalLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTUtMS0xLTE0NzE1Nw_087cdf27-832d-44f2-ac45-8eae813288af">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTEtMS0xLTE0NzE1Nw_03ef4059-e170-4319-b9f8-1f524720dcae">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTMtMS0xLTE0NzE1Nw_08225a69-36fc-4649-8ef5-70cdb703307b">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:TotalLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTUtMS0xLTE0NzE1Nw_838b7a2e-7401-466a-bde9-c40a627d3dd4">562</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_115"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU1NTc_3d93ebea-c5a2-46dd-bc34-bac5d6a6ea47" continuedAt="i85ad21d11868474691d8de97dd053a57" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">6. Long-Term Obligations and Other Short-Term Borrowings </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU1NjA_82cf2899-792e-46ff-b013-d99a34156f25" continuedAt="ied7bdbb8158e4f5ab6cdc8b022f5f71d" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:57.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.026%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice004f9102ba4d5fa58a7477de8fe13e_I20220630" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzMtMS0xLTEtMTQ3MTU3_081eff37-44b3-43fd-9167-70305f506499">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id882b2f82db24e5c857e6ba1a0e384af_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzMtMy0xLTEtMTQ3MTU3_984624fd-7a9e-4e61-9fbe-699d52ad16f6">572</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e77764f4c64f7abd7d4a5227eb6f41_I20220630" decimals="-6" name="us-gaap:NotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzUtMS0xLTEtMTQ3MTU3_757a0b4d-e911-41af-babf-cf2515fbe55c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbf71c602bb40a5b964360fc429bff3_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzUtMy0xLTEtMTQ3MTU3_f4a491c4-c940-44c2-92bc-87cb6aa1eaca">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i885fe3ac6e1a4babbc66a8db94f82e38_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzYtMS0xLTEtMTQ3MTU3_b2a2a8c4-0d06-47a9-90cb-38e81561e781">556</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e90c5526e84b74be02b2b7a029bb5d_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzYtMy0xLTEtMTQ3MTU3_fe0dc609-05dc-461c-a351-f38b9f77f4a7">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f78f224039402a88005fb30536dad1_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzctMS0xLTEtMTQ3MTU3_211a78cb-762a-4e45-b9d9-f61cbec55cd0">779</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b7d966b6b934db1a5c6c380f6d08006_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzctMy0xLTEtMTQ3MTU3_4361cad0-3bb9-4630-b318-c3e8b2406993">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4a7953acf34ee99b0152b4348d298c_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzgtMS0xLTEtMTQ3MTU3_2a62c87d-aeeb-4573-8f62-917800f489b1">407</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19940e136f3f4037ac958751189f0e42_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzgtMy0xLTEtMTQ3MTU3_506805e7-f1a5-47b1-8934-16f74b008476">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2dda3fb1b24c6c9dd6058e3deb85a2_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzktMS0xLTEtMTQ3MTU3_26ca8b6e-38b0-4ca0-a59d-015ae2c8be72">518</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db02e14f91846b1b3f5268f07efaf25_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzktMy0xLTEtMTQ3MTU3_4b93d848-ceb8-4cf6-b749-741bc85721db">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d82da09b63414d9e4d23de0552e992_I20220630" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEwLTEtMS0xLTE0NzE1Nw_c478e8b9-b6c6-4014-9cdb-0288dc73217a">1,193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5be0282727a4d219c233e858971eab3_I20210630" decimals="-6" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEwLTMtMS0xLTE0NzE1Nw_9b514a5f-2d91-4463-819c-6d68b4a46df8">1,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief95ead6d3304e5283a841e043450002_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzExLTEtMS0xLTE0NzE1Nw_7c5409ef-673a-4870-97d6-ecb46a1745a0">321</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebb9851a4a6454d878d280244504203_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzExLTMtMS0xLTE0NzE1Nw_5baa982d-99b1-406d-8d7d-e9c2699dce34">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9550d3a90c4fe7abe3b7f766ed70ad_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEyLTEtMS0xLTE0NzE1Nw_e5878acb-bdae-4bb7-b175-4c3a7687abda">342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0809664ee714c24958018126d48a37c_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEyLTMtMS0xLTE0NzE1Nw_b13e4c08-593b-4e27-975d-b6c9360213d6">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1588ed89bc745b2a267d8c2daef772e_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEzLTEtMS0xLTE0NzE1Nw_b399e870-85e4-4432-9eba-60051ec8109b">441</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida1ad8e9f740460c9717fa142af909bf_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEzLTMtMS0xLTE0NzE1Nw_163a04c0-1a28-4a8a-b606-aee3700b1a70">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9f3742e0b84411bd2e5b40340f02e2_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE0LTEtMS0xLTE0NzE1Nw_eb3ffe1d-569d-40a1-92c2-6e32c37a43f7">560</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4a7026d7514fa682d445bca65f8fce_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE0LTMtMS0xLTE0NzE1Nw_dd8546ef-4122-4413-82a7-cec34103e95f">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621b77904b4340b2bcbbba0f4babdffd_I20220630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE1LTEtMS0xLTE0NzE1Nw_31061e4f-37cc-4a81-8c37-e963a1be15aa">124</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15dc38ffa0654e75a949152dac07365f_I20210630" decimals="-6" name="us-gaap:NotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE1LTMtMS0xLTE0NzE1Nw_0be284f6-7c32-4fcd-8793-a0af293123e9">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE2LTEtMS0xLTE0NzE1Nw_2ef69ecd-1e22-4749-853c-6f0995a53399">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OtherBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE2LTMtMS0xLTE0NzE1Nw_c4583914-c847-4991-bc0b-a39520981409">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE3LTEtMS0xLTE0NzE1Nw_cffe9551-f239-4765-a8bd-f4820e450c09">5,315</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE3LTMtMS0xLTE0NzE1Nw_5e4ae259-7808-4ccd-83fc-c50cca48e82a">6,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE4LTEtMS0xLTE0NzE1Nw_9de00f91-e393-4fe3-a525-6f7cbe36c1d4">580</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE4LTMtMS0xLTE0NzE1Nw_59c8dd51-bce7-4b72-9943-3f70449bab18">871</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE5LTEtMS0xLTE0NzE1Nw_582b3df6-7c68-4054-af6d-52770a24406e">4,735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE5LTMtMS0xLTE0NzE1Nw_5aebd993-8c1d-466b-a928-52d808468721">5,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ied7bdbb8158e4f5ab6cdc8b022f5f71d">(1)      Maturities are presented on a calendar year basis.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of existing long-term obligations and other short-term borrowings for fiscal 2023 through 2027 and thereafter are as follows: $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMwMg_ffd26063-36c7-4367-abf7-349118cc34aa">580</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMwNg_00b6d8f7-773a-44c3-8b1c-9a2f9ddbb206">1.2</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxMA_d4e9b8c8-8250-47aa-9aad-405a6f33b377">532</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxNA_db481658-0189-4b06-9143-2ad8514265b0">131</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxOA_b765e458-1fb4-41e7-970c-be41314b5e9b">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMyNQ_e529e34e-ec63-40a4-8c4c-40a72c4cf7e6">1.7</ix:nonFraction> billion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The 7.0% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-8" name="us-gaap:AccountsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzk3Mw_54d2c61b-217a-48cc-95b1-08480115ffd7">27.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:AccountsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzk4MA_0c2fe1eb-2b12-40df-9089-6e83a4750aef">23.7</ix:nonFraction> billion at June&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we redeemed all outstanding $<ix:nonFraction unitRef="usd" contextRef="ia6a04d5f0835442bae0648463d282df4_D20210701-20220630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDg5Mjg_d114659d-76ac-4245-a280-229a63739906">572</ix:nonFraction> million principal amount of 2.616% Notes due 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with this redemption, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDg5NzQ_439d80de-8e68-40db-a87f-5c2102cd19e2">10</ix:nonFraction>&#160;million loss on early extinguishment of debt. We also repaid the full principal of the $<ix:nonFraction unitRef="usd" contextRef="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNTA2MzE_91c1026a-9870-458a-8f4d-8cb1c10473f2">282</ix:nonFraction>&#160;million Floating Rate Notes due 2022 as they became due. The early redemption and repayment were funded with available cash.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $<ix:nonFraction unitRef="usd" contextRef="ic80b7f23b79f4c74a63a2aea8a160669_D20200701-20210630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDU3Mzk_989a5a0a-1194-4c19-b935-705540fd226f">238</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if2c4addddd22425095e8747d5010555f_D20210401-20210630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDU3NDc_9a22ebb2-69f6-48da-b31c-d46c25340531">262</ix:nonFraction>&#160;million aggregate principal amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i880c502ad6a54517904d884280fcde32_D20200701-20210630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYwMDY_e1f76b63-b384-4768-8306-f4a935882512">13</ix:nonFraction>&#160;million loss on early extinguishment of debt. We also early repurchased $<ix:nonFraction unitRef="usd" contextRef="i3827a1282fa341608b2ab469d733c58a_D20200701-20210630" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYyOTk_77728f38-1b96-4400-9bbc-c5b22b8b800f">40</ix:nonFraction> million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i2624de343f9148a89e5e879c4c82b456_D20200701-20210630" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYzMDU_836cbab4-5736-4607-98a5-1ae13fa5d72c">2</ix:nonFraction> million of the 2.616% Notes due 2022. In connection with the early debt repurchases, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i25174483a8524ab68a643c722a044868_D20200701-20210630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYyMTE_e7d17a0d-f198-404a-94ec-0aa5cba676cf">1</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we redeemed $<ix:nonFraction unitRef="usd" contextRef="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE2MTg_2355840b-9246-4704-acf5-e0162f1fa73e">500</ix:nonFraction> million aggregate principal amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $<ix:nonFraction unitRef="usd" contextRef="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE4Nzc_580da2e6-8d01-4e2f-9b7a-9b22b9f3540d">7</ix:nonFraction> million loss on early extinguishment of debt. We also early repurchased&#160;$<ix:nonFraction unitRef="usd" contextRef="i7fa51c2037854bb89d8846afa4ed5e99_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE5NDQ_345578a4-d9da-494d-90f9-c06a64c88516">247</ix:nonFraction>&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$<ix:nonFraction unitRef="usd" contextRef="i07524980d6a64ab0900fdee89c51519e_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE5Nzc_3992d599-10af-4f2a-bb10-67462c93e6b5">11</ix:nonFraction>&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$<ix:nonFraction unitRef="usd" contextRef="i33da3620cedb405488c45ea93f45f9f7_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwMDg_ac2537a2-047a-49da-8600-259c3694c284">20</ix:nonFraction>&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $<ix:nonFraction unitRef="usd" contextRef="ia07846c1c0304317b72bad3a3eea1a34_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwNDg_c461067a-1390-44af-b704-d020d2911f0e">104</ix:nonFraction>&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$<ix:nonFraction unitRef="usd" contextRef="i5ce95bfc57ac401db96d15c30dac19f1_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwODA_d4ce0d38-89d7-4d3a-b072-7efb1ade7f50">6</ix:nonFraction>&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$<ix:nonFraction unitRef="usd" contextRef="ia624d146ecb046bebe9077aabecd86e5_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIxMTE_18ccc180-6729-4890-a21a-ab634e16b87a">5</ix:nonFraction>&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$<ix:nonFraction unitRef="usd" contextRef="icbdef24d9ef64b91aa1ffa7ea2f55a2f_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIxNDY_e1ce0a11-2680-420c-85b7-171771a0ab13">35</ix:nonFraction>&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$<ix:nonFraction unitRef="usd" contextRef="i6dc70dd563e3469b9d8e95f7e3db1e7d_D20190701-20200630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIyNDI_9816ff0f-4c42-432b-bdd2-ae40deb4c9cc">9</ix:nonFraction> million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $<ix:nonFraction unitRef="usd" contextRef="i3a684eeb749345e9b75d857b1e1719eb_D20190701-20200630" decimals="-6" name="cah:NotesPayableRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIzMjQ_7d795ab3-39d7-447a-9c49-416520092fff">450</ix:nonFraction>&#160;million 2.4% Notes due 2019 as they became due. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemptions and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poor's Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at <ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="cah:OfferAsPercentageOfPrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM1MTM_be785158-d63e-4a5d-8b9d-8a8209fdfdd3">101</ix:nonFraction>% of the principal amount plus accrued and unpaid interest.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Financing Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$<ix:nonFraction unitRef="usd" contextRef="i29917c8b4aab4eb2a08720812cda9e5f_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3MDE_a55554d1-484e-4f9a-9de2-87a4cc3045d1">2.0</ix:nonFraction> billion&#160;commercial paper program backed by a $<ix:nonFraction unitRef="usd" contextRef="i3c2bf417d2ce4569b7095141c8585f43_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3NDE_cfbcde25-25f9-4dbe-9409-01707b373f3e">2.0</ix:nonFraction> billion&#160;revolving credit facility. We also have a&#160;$<ix:nonFraction unitRef="usd" contextRef="ib802e2c8dcb949298f691230fa6a001e_I20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3ODY_eac47226-3ebd-4573-9bfd-60a87c1b2a69">1.0</ix:nonFraction> billion&#160;committed receivables sales facility.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, we amended our receivables sales facility to temporarily increase the maximum permitted delinquency ratio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more </span></div></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i85ad21d11868474691d8de97dd053a57"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">than 3.75-to-1. As of June&#160;30, 2022, we were in compliance with this financial covenant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, we had <ix:nonFraction unitRef="usd" contextRef="i41cb6234b1c242c1b3d5212ab191fccc_I20220630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ2Nzk_2aa18ae0-4c4f-4b06-b2fa-ffbfdc76727c"><ix:nonFraction unitRef="usd" contextRef="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ2Nzk_2e363821-c375-487f-b9bb-66a5005adc9f">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ4MDk_2ce247e9-49ea-470a-b257-9cdd9ac86b66"><ix:nonFraction unitRef="usd" contextRef="i41cb6234b1c242c1b3d5212ab191fccc_I20220630" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ4MDk_9f2a6ac8-05e4-4117-9805-5604a9de4bf6">1</ix:nonFraction></ix:nonFraction> million at both June&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we had a daily maximum amount outstanding under our commercial paper and committed receivables programs of $<ix:nonFraction unitRef="usd" contextRef="ia602868425d84c939a48b46f4b7f99a3_D20210701-20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ5MjY_b2e988dc-e877-4fab-8a07-8220128f90a4">1.2</ix:nonFraction> billion and an average daily amount outstanding of $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:LineOfCreditFacilityAverageOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDk1MjE_f13a8a89-ffd6-4210-a617-adb43df8d6d0">19</ix:nonFraction> million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i62274a161fe54af9b457ca7496c6d48e_I20220630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ5OTc_138272b1-b84a-4862-9fe1-e2932bffbbf7">no</ix:nonFraction> amounts outstanding as of June&#160;30, 2022 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i58cef62c3cd5423a91e3afefd7967e2a_I20210630" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUxNjM_8e58788b-3b1c-4001-a0d0-16fa5abb2cfb"><ix:nonFraction unitRef="usd" contextRef="i67e0a63d6182434b947a044598b6b9be_I20220630" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUxNjM_ee17e444-c223-4e9d-a709-739295697d73">31</ix:nonFraction></ix:nonFraction> million at both June&#160;30, 2022 and 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i6e905accc4fc429dbe8fb2baa9d577ac_I20210630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUyMDk_3cdb2df2-b6a3-4979-96d5-37fdbe2c83bb"><ix:nonFraction unitRef="usd" contextRef="i29917c8b4aab4eb2a08720812cda9e5f_I20220630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUyMDk_bc9c05c2-7641-4e28-a4f1-96c223852c95">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the commercial paper program as of June&#160;30, 2022 and 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OtherBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0Mjk_2ef69ecd-1e22-4749-853c-6f0995a53399">74</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:OtherBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0MzY_c4583914-c847-4991-bc0b-a39520981409">67</ix:nonFraction> million balance of other obligations at June&#160;30, 2022 and 2021, respectively, consisted of finance leases and short-term borrowings.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE5MjQxNDUzNTQwNTM5_8db7e30c-d18b-4640-b98d-d590b989d373" continuedAt="ic2ca1cc5904b4d69ace88a2af9c65153" escape="true"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">7. Commitments, Contingent Liabilities and Litigation </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commitments</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture with CVS Health Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations and Cash Requirements section of MD&amp;A. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New York Opioid Stewardship Act</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $<ix:nonFraction unitRef="usd" contextRef="i22cd37e98bb24d1eac47e3997f243e60_I20220630" decimals="-6" name="cah:AggregateAnnualAssessment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzgzNQ_02b04daa-5c3b-46bf-af73-f94c73204a0b">100</ix:nonFraction>&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $<ix:nonFraction unitRef="usd" contextRef="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630" decimals="-6" name="cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExMzI_c4562e87-a92b-42ba-a4cd-a5b353783df7">41</ix:nonFraction>&#160;million for calendar years 2017 and 2018 during the fiscal year ended June 30, 2021 based on the probable estimated payment amount. In the second quarter of fiscal year 2022, we paid the State of New York approximately $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExMDc_76acc6c4-9e78-48e6-a330-10577ed16f60">20</ix:nonFraction>&#160;million, our portion of the assessment for calendar year 2017. As a result, as of June&#160;30, 2022, we had an accrual of $<ix:nonFraction unitRef="usd" contextRef="i22cd37e98bb24d1eac47e3997f243e60_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExNzU_76f429d8-8caa-4e1b-9302-a49c698aabb8">20</ix:nonFraction>&#160;million, which reflects our best estimate of the portion of the assessment that we may owe for sales during calendar year 2018.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, temporary interruptions in product sales, restrictions on importation, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss); however, losses and recoveries of lost profits from disputes that occur in the ordinary course of business are included within segment profit. For example, in the second quarter of fiscal year 2022, our Pharmaceutical segment profit was positively impacted by a $<ix:nonFraction unitRef="usd" contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630" decimals="-6" name="cah:JudgmentForLostProfits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjE2MDU_5a6ee2d1-bfbd-4b01-9236-09fafbf43203">16</ix:nonFraction>&#160;million judgment for lost profits related to an ordinary course intellectual property rights claim.</span></div><div style="text-align:justify"><span><br/></span></div></div></ix:nonNumeric></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="ic2ca1cc5904b4d69ace88a2af9c65153" continuedAt="i59432ebd2f884b5da888ee2235ac63a0"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opioid Lawsuits and Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">States &amp; Political Subdivisions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">National Settlement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in fiscal year 2017, state attorneys general, counties and municipalities began filing lawsuits related to the distribution of prescription opioid pain medications against pharmaceutical wholesalers, including us, and other participants in the pharmaceutical supply chain. These lawsuits sought equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. The lawsuits filed by states and political subdivisions were filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and were transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By fiscal year 2022, Cardinal Health was a defendant in approximately <ix:nonFraction unitRef="lawsuit" contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630" decimals="0" name="cah:LossContingencyLawsuitsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4NjY_08ff9261-269f-420e-8b8d-79353f074de9">2,775</ix:nonFraction> lawsuits brought by these plaintiffs. In July 2021, we and two other national distributors (collectively, the "Distributors") announced a proposed settlement with a group of state attorneys general intended to resolve the vast majority of these lawsuits (the "National Settlement") as well as a proposed settlement agreement (the "Settlement Agreement") containing, among other things, a sign-on process to allow states and political subdivisions to participate in the National Settlement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Distributors each determined that a sufficient number of states and political subdivisions had agreed to participate in the National Settlement to proceed with the Settlement Agreement. The Settlement Agreement became effective on April 2, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Distributors, parties to the Settlement Agreement include <ix:nonFraction unitRef="states" contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630" decimals="0" name="cah:SettlingStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjMwMTM_8acfb336-9e07-47d4-9433-770b17812b6f">46</ix:nonFraction> states, the District of Columbia and <ix:nonFraction unitRef="numberofusterritories" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="0" name="cah:SettlingUSTerritories" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjMwMTc_80f369fe-1c96-46b1-b4b1-03984053b507">5</ix:nonFraction> U.S. territories. As of August 9, 2022, over 99 percent of political subdivisions (by population as calculated under the Settlement Agreement) that had brought opioid-related suits against us as calculated under the Settlement Agreement had chosen to join the Settlement Agreement or have had their claims addressed by state legislation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this Settlement Agreement, we will pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEwMjIy_5470db0b-563b-4eb6-8f55-8c9fff263782">6.0</ix:nonFraction>&#160;billion, the majority of which is expected to be paid over 18 years. The exact payment amount will depend on several factors, including the extent to which states take action to foreclose opioid lawsuits by political subdivisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by passing laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which additional political subdivisions in participating states file additional opioid lawsuits against us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement also includes injunctive relief terms related to distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating controlled substances monitoring programs; (3) due diligence for new and </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the Distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which distributors will fund for ten years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The participating states and the distributors are cooperating to obtain consent judgments embodying the terms of the Settlement Agreement in each participating state and the participating states and subdivisions are dismissing their lawsuits. As a result, as of August 9, 2022, approximately <ix:nonFraction unitRef="lawsuit" contextRef="i5df3ad6b3a5c472db6a4ef8acf2ccee2_D20220809-20220809" decimals="0" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMzY_bcc82f15-68d2-4308-9e22-7efe6d01ce09">2,300</ix:nonFraction> lawsuits against us have been dismissed. We expect additional lawsuits to be dismissed over the coming months.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the effective date of the Settlement Agreement, Distributors had entered into separate settlement agreements with each of the states of Florida, New York, Ohio and Rhode Island. When the Settlement Agreement became effective, each of these states and their participating subdivisions became a part of the National Settlement; however, the New York, Ohio and Rhode Island agreements required us to make certain payments separately from those required by the Settlement Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended June&#160;30, 2022, we made our first annual payment under the Settlement Agreement. We also made certain payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. In total, during fiscal year ended June&#160;30, 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="i57e04e176378443dbece7c929cced18b_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MDQ2OTQ_03ed7322-9ce0-4981-944e-3f892252de02">417</ix:nonFraction>&#160;million in connection with these matters. In July 2022, we made our second annual payment of $<ix:nonFraction unitRef="usd" contextRef="i22b99fd673554c27875a602f3ebd6229_D20220701-20220731" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEyMDk0NjI3OTU2NzI5_81e46ea9-c14a-4d2a-ad00-9a3416f15efc">374</ix:nonFraction>&#160;million under the Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Settlements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Virginia subdivisions and Native American tribes were not a part of the National Settlement and we had separate negotiations with these groups. A bench trial before a federal judge in West Virginia in a case brought by Cabell County and City of Huntington against the Distributors concluded in July 2021. In July 2022, a judgment in favor of the Distributors was entered. In July 2022, the Distributors reached an agreement to settle the opioid-related claims of the majority of the remaining West Virginia subdivisions. Under this agreement, we have agreed to pay eligible West Virginia subdivisions up to approximately $<ix:nonFraction unitRef="usd" contextRef="iaf6d168e90384511a71c377dfd7de3ce_I20220731" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMTc_b1f3f8f7-5fc9-4a48-ab5c-bc898988ed3f">124</ix:nonFraction>&#160;million over an eleven-year period. This agreement is subject to certain contingencies related to subdivision participation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Distributors reached an agreement with the State of Oklahoma to resolve the opioid-related claims of the state and its political subdivisions. Under this agreement, Cardinal Health agreed to pay approximately $<ix:nonFraction unitRef="usd" contextRef="i17df012ad7434bfbb9d2eb2b368409f0_I20220630" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4NzM_ba6fda75-84ed-4a91-b9b0-bc2fdb48edc4">95</ix:nonFraction>&#160;million to the State and its participating subdivisions. This amount is consistent with the amount that would have been allocated to Oklahoma under the Settlement Agreement. The terms of this agreement are consistent with the terms of the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i59432ebd2f884b5da888ee2235ac63a0" continuedAt="i20aa21f61a6042d1bae2132ea17bdb22"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Distributors reached an agreement with the Washington Attorney General, under which Cardinal Health will pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="i7356694aafaa470bb4b7829c91e1f795_I20220630" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjgwOTg_f8b7b3d2-f9ac-435b-affa-263efa112320">160</ix:nonFraction>&#160;million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with the amount that would have been allocated to Washington under the Settlement Agreement plus certain attorneys' fees and costs. The terms of this agreement in principle are substantially consistent with the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. If this agreement and the Washington agreement are finalized, Oklahoma and Washington would become subject to the Settlement Agreement and 48 of <ix:nonFraction unitRef="states" contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630" decimals="0" name="cah:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4OTA_1eba0df1-2ad9-40e8-aa5f-d1987bf40e25">49</ix:nonFraction> eligible states would then be subject to the Settlement Agreement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021 we announced that the Distributors had reached an agreement with the Cherokee Nation in connection with ongoing negotiations toward a broader agreement with Native American tribes. In January 2022, the Distributors entered into a term sheet with the Native American tribes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement and separate state settlements have not resolved all opioid lawsuits and claims brought by states and political subdivisions. As of August 9, 2022, we are still defendants in approximately <ix:nonFraction unitRef="lawsuit" contextRef="i6fbfe1e2d6514850b46a3e54db3b64c8_I20220809" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMzE_b6aa1655-1d52-4013-8b98-65b743b7a58e">475</ix:nonFraction> lawsuits brought by counties, municipalities and other political subdivisions; however, we expect this number to decline as additional cases are dismissed as a result of the Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In total, we have recorded total pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzExNTQ1_a222c96c-009b-42fc-abc1-1161d3c2568a">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTA3ODI_ed620e9e-5d00-4817-a3e0-4854b7e46584">5.63</ix:nonFraction>&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $<ix:nonFraction unitRef="usd" contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzExNjUy_dcd7b07f-ec9d-4d7f-8311-0d92ac4f1db2">6.36</ix:nonFraction>&#160;billion accrued at June&#160;30, 2022, of which $<ix:nonFraction unitRef="usd" contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630" decimals="-6" name="us-gaap:LitigationReserveCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTA3NzA_d860c02f-a936-42ce-b115-01ec622fee5f">532</ix:nonFraction>&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and none of these agreements is an admission of liability or wrongdoing.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with these investigations. We are unable to predict the outcome of any of these investigations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Plaintiffs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately 440 lawsuits as of August 9, 2022. Of these, <ix:nonFraction unitRef="lawsuit" contextRef="i20857812252441139f2a9488cc8b4bba_I20220809" decimals="0" name="cah:LossContingencyLawsuitsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEzNzk1_bcaee0b6-7c3b-4433-99e8-8b701e0c0931">151</ix:nonFraction> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A trial in a case involving <ix:nonFraction unitRef="plaintiff" contextRef="if6e7b27e6d834a1c8986340dacdd8d75_D20220701-20220731" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNzM4NzY_eefcf79a-bc8b-431e-8861-cd0a18475b48">21</ix:nonFraction> plaintiffs began in state court in Georgia in July 2022. A mistrial was declared shortly thereafter due to rising COVID-19 cases and a new trial date has not been set. We are vigorously defending ourselves in all of these matters; however, trials are inherently unpredictable and it is possible that an unfavorable outcome in these matters, individually or in the aggregate, could have a negative impact on our financial results.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in ongoing legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#8220;National Union&#8221;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis IVC Filter Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Lawsuits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August 9, 2022, we are named as a defendant in <ix:nonFraction unitRef="lawsuit" contextRef="i6832ede5864441bc8fc50fdb23a84d6d_D20220809-20220809" decimals="0" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1NTky_ad900197-bb61-4166-a3ad-65b6ec47d0a0">470</ix:nonFraction> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately <ix:nonFraction unitRef="plaintiff" contextRef="i49994de05a53424c945a894b6a702b21_D20220809-20220809" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1NzE1_8423e72a-5a29-43a1-8d0a-78d590678e31">5,967</ix:nonFraction> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase IVC filter products. Another <ix:nonFraction unitRef="lawsuit" contextRef="i3536e19ef529496ab3333df7b2c14579_D20220809-20220809" decimals="0" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1ODY2_f330cd76-fd04-4dc4-9825-2f611e236c17">18</ix:nonFraction> lawsuits involving similar claims by approximately <ix:nonFraction unitRef="plaintiff" contextRef="i34d64ff0f91940089c6a221af627861f_D20220809-20220809" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1OTIw_c8de768f-2ae4-4754-a34a-91f8be8faa1a">20</ix:nonFraction> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately <ix:nonFraction unitRef="lawsuit" contextRef="i0d398a83243b4879a927f24535bca4ad_D20210701-20210731" decimals="0" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4OTM_dfffea85-eac3-4665-a56a-8cd0fe7bae77">1,300</ix:nonFraction> claims. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with plaintiffs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had a total of $<ix:nonFraction unitRef="usd" contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE2MzQ4_7487ca0e-74d0-4904-a132-50f59917d9f0">512</ix:nonFraction>&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, related to the IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $<ix:nonFraction unitRef="usd" contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE2ODMy_8fd75594-226d-4cb3-b306-afe0d76aee87">1.05</ix:nonFraction>&#160;billion, net of estimated </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i20aa21f61a6042d1bae2132ea17bdb22" continuedAt="if8b5351f1c2545678e610e7e04096407"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Mexico Attorney General Action</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Attorney General for the State of New Mexico filed an action against certain IVC filter manufacturers, including us, alleging claims under New Mexico's Unfair Practices Act, Medicaid Fraud Act and Fraud Against Taxpayers Act. The allegations made are similar to those made in the product liability lawsuits, described above. We intend to vigorously defend ourselves against these claims.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Securities Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In September 2021, the court denied our motion to dismiss. We are vigorously defending ourselves against these claims.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Solutions DOJ Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the United States Attorney&#8217;s Office for the District of Massachusetts (the "USAO") commenced an investigation of Cardinal Health regarding possible violations of the U.S. healthcare fraud and abuse laws. In January 2022, without admitting liability, we settled this matter with the DOJ for approximately $<ix:nonFraction unitRef="usd" contextRef="ib7b1ad13d2d3426a96e738a22b1d3ab6_D20200701-20210630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE5MzA5_69850f97-70d3-4ad4-83ba-f04483679797">13</ix:nonFraction> million, which was recorded as expense within litigation charges/(recoveries) net in our consolidated statements of earnings/(loss) during the fiscal year ended June 30, 2021. </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="if8b5351f1c2545678e610e7e04096407"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Civil Litigation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. The court granted our motion to dismiss, and the indirect purchasers filed an amended complaint. We intend to vigorously defend ourselves. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation Proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:IncomefromSettlementsofClassActionLawsuits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzQ4_d21fbb46-25b3-4d7c-b2e6-876a5ebb41a6">18</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:IncomefromSettlementsofClassActionLawsuits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzUy_59d68807-0855-48b8-994a-0e99ee446053">112</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:IncomefromSettlementsofClassActionLawsuits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzU5_ef3bd930-cc79-4852-bb3c-07e9eb9d2fff">16</ix:nonFraction> million during fiscal 2022, 2021, and 2020, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_121"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkwOTM_83bba078-6171-410e-8065-82dd076a03f6" continuedAt="i6270fd311dcc429a8c35274b88d95cb2" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">8. Income Taxes </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTc_b67820b5-e2a6-4bd6-a3ae-1dbce64f09ab" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtMS0xLTEtMTQ3MTU3_42647347-6dc6-4909-875b-db0e91355c32">1,000</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtMy0xLTEtMTQ3MTU3_1495839f-24cc-4dda-ad32-178a17c7f3c2">47</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtNS0xLTEtMTQ3MTU3_d79d40d2-5812-4a0e-9805-122f98bd3073">4,056</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItMS0xLTEtMTQ3MTU3_98e11cbc-8943-4fc3-9a93-b6bf414b98f6">231</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItMy0xLTEtMTQ3MTU3_e340e62b-1eaa-4dd9-9517-e8c3e44644d9">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItNS0xLTEtMTQ3MTU3_92ab3eaf-2480-487a-a48c-6b11b018c002">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtMS0xLTEtMTQ3MTU3_28362f86-2296-4a45-a084-18ba08b3024b">769</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtMy0xLTEtMTQ3MTU3_4323cb1a-f89a-45de-9b46-7cebfd174e09">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtNS0xLTEtMTQ3MTU3_64f6b524-dfb9-4118-9ff0-de755f273270">3,772</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i6270fd311dcc429a8c35274b88d95cb2" continuedAt="i317fc42daf3641e3a6ffdc32b665a2c3"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTI_feccb40d-f107-4931-851b-0369e9fb95a7" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItMS0xLTEtMTQ3MTU3_e375b5bb-e68e-4525-a90d-fe5e47d70d41">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItMy0xLTEtMTQ3MTU3_b0c5a442-4132-4ecf-9e6f-0debe24695b1">989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItNS0xLTEtMTQ3MTU3_faa4b849-8aa8-4452-8076-5fc1177f948c">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtMS0xLTEtMTQ3MTU3_871b6d2f-ab25-4aea-8541-0e4845503428">29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtMy0xLTEtMTQ3MTU3_8d55b8e1-1a51-48a6-9420-69d6d6098af0">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtNS0xLTEtMTQ3MTU3_a262f609-42d8-46ce-aeac-bf8c396105b5">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtMS0xLTEtMTQ3MTU3_1884a07a-f6d1-4ccc-a88e-ddafa30a1a78">93</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtMy0xLTEtMTQ3MTU3_a93ab989-a49b-4993-90e6-cbc6691bc71e">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtNS0xLTEtMTQ3MTU3_9f2c9825-8634-4db9-b4f2-dd45dbb840b2">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtMS0xLTEtMTQ3MTU3_a8dede5f-b1fb-4ed6-92f7-4197e22fa3fb">156</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtMy0xLTEtMTQ3MTU3_ebb1accf-6268-4709-a863-3a0aa753d6b3">785</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtNS0xLTEtMTQ3MTU3_a2c75a8a-2f62-48b5-9824-9245c8eee984">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtMS0xLTEtMTQ3MTU3_bc92ed19-a262-4bd1-85eb-932d04a79afb">30</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtMy0xLTEtMTQ3MTU3_84f83cb5-5c4c-4102-a4b9-dc86d0e0a5fd">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtNS0xLTEtMTQ3MTU3_7d3ca6d6-ed01-47a3-a1bf-e109cc076345">822</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktMS0xLTEtMTQ3MTU3_88781fc1-2a74-4a6a-b851-cc72c4bb9661">22</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktMy0xLTEtMTQ3MTU3_a7eef617-fdee-4802-9bb3-4ac6f857790d">28</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktNS0xLTEtMTQ3MTU3_81acaa7b-6d1c-4c24-9a8d-5488dd327334">127</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTEtMS0xLTE0NzE1Nw_cfd5b629-38e2-49ee-b74d-4a2540f0d6d3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTMtMS0xLTE0NzE1Nw_053d4cf6-ee7f-4812-8267-591c2be56f66">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTUtMS0xLTE0NzE1Nw_44290378-2034-4718-9233-3f3256845c92">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTEtMS0xLTE0NzE1Nw_51caa9db-06f1-4721-86d8-2e2973731559">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTMtMS0xLTE0NzE1Nw_96a65b81-6a1e-4640-9696-e9458eb62140">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTUtMS0xLTE0NzE1Nw_1808985d-c3eb-49c8-b04e-cc9b630dce18">961</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTEtMS0xLTE0NzE1Nw_ac52959c-08f4-41f3-946b-373494aa95c4">163</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTMtMS0xLTE0NzE1Nw_d54f6180-db24-40e0-af0d-a54f52f1a433">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTUtMS0xLTE0NzE1Nw_4d55aff2-a0d7-489e-a223-d2debc5c501d">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Goodwill Impairment Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we recognized cumulative pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODM5MDc_45ba1b67-4027-473a-b19d-a383f27d9d7a">2.1</ix:nonFraction>&#160;billion for goodwill impairments related to the Medical Unit. The net tax benefit related to these charges was $<ix:nonFraction unitRef="usd" contextRef="i3a49e2802adb47ebb172f2416918baa4_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTAwNzM_4f65ed65-cf6a-47b9-8262-66c236345cc1">150</ix:nonFraction>&#160;million.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-Tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $<ix:nonFraction unitRef="usd" contextRef="i1ba6181b3f81427f9ba8073d79075732_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTEzMTk_f20bd410-4dae-49a3-a65b-a5902a8595c6">424</ix:nonFraction> million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we filed for a refund of $<ix:nonFraction unitRef="usd" contextRef="ib692a8c8095746b7ac437f383074870f_I20210630" decimals="-6" name="us-gaap:IncomeTaxReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzE0MDk_2c4bc038-f3b7-4df3-8849-fd0ad0acbf9a">974</ix:nonFraction>&#160;million and in April 2022, we received a payment for $<ix:nonFraction unitRef="usd" contextRef="idd9b4528179f4b06825682ef3bc16324_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromIncomeTaxRefunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTE0OTg_8acece84-79b8-4e91-a90d-51024b0e8ae6">966</ix:nonFraction>&#160;million, which was net of certain adjustments. See Note 7 of the "Notes to Consolidated Financial Statements" for additional detail. We also increased our non-current deferred tax liability by approximately $<ix:nonFraction unitRef="usd" contextRef="ib692a8c8095746b7ac437f383074870f_I20210630" decimals="-6" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzE3MjU2_8a2c43cc-738f-4112-8bbb-3184354cf8d3">700</ix:nonFraction>&#160;million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $<ix:nonFraction unitRef="usd" contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzIxMDU_8f096e93-c07f-4276-8d6d-827a00a32852">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyOTA_ed620e9e-5d00-4817-a3e0-4854b7e46584">5.63</ix:nonFraction>&#160;billion pre-tax charges for the opioid litigation recorded during fiscal 2021 and 2020, the net tax benefits were approximately $<ix:nonFraction unitRef="usd" contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzIyMTI_c607fa27-67af-426d-92cb-c2df5e50b0ea">228</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyNTk_52b2933d-2ef2-4618-9b90-1cf21b51eec9">488</ix:nonFraction> million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="ib70a49e43657407780e301606b63b480_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzI0ODQ_0ad9bf2a-edc7-4ea4-b5d8-9947c42cbb22">219</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie478c499b6e14ab2bbc046275533973f_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyNzA_287e80bb-1a1e-4009-ae85-777139c92311">469</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the U.S. Tax Cuts and Jobs Act ("Tax Act"); however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxMTA_f98025b9-e823-4f14-bffd-ae755972a66f" continuedAt="i46568764b70f49f8a794781fa84336d1" escape="true"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.482%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtMS0xLTEtMTQ3MTU3_2e58dde4-6f04-4346-b8df-ee9e5a01c347">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtMy0xLTEtMTQ3MTU3_2a6aaf4c-e580-4bbd-9137-9bd4adc1ba4f">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtNS0xLTEtMTQ3MTU3_4072cb93-6c74-4394-b51a-b052739a2e02">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItMS0xLTEtMTQ3MTU3_576c85e0-79f5-4dab-ba22-699e17c5b106">2.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItMy0xLTEtMTQ3MTU3_68cfdf0d-9f0e-4c6d-8cfd-fd55b6deb812">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItNS0xLTEtMTQ3MTU3_24524e56-7be3-49b3-9030-c85956179788">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtMS0xLTEtMTQ3MTU3_1fca69fc-8de1-40fc-b049-93cc5b967169">3.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtMy0xLTEtMTQ3MTU3_7873a204-2c19-4297-ba9a-d2b1270141be">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtNS0xLTEtMTQ3MTU3_2c357cae-64b4-431f-be14-f04cb007cda9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtMS0xLTEtMTQ3MTU3_1cf1cfbe-55cb-4562-9751-0a80aa19e8ce">1.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtMy0xLTEtMTQ3MTU3_7b55695c-8ad7-42ea-ad30-654e10a0c060">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtNS0xLTEtMTQ3MTU3_e68a397b-55b3-44bf-8b1d-2383ea41b88d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Divestitures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtMS0xLTEtMTQ3MTU3_48d35ad7-98f2-421b-80b5-cdb3925ab34e">4.9</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtMy0xLTEtMTQ3MTU3_7bdcfba1-c088-4646-992a-bc3394150915">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtNS0xLTEtMTQ3MTU3_5149a009-1cdc-462f-a62e-97a9fcae0685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtMS0xLTEtMTQ3MTU3_a8957c46-7374-4e70-92f0-b7fdbdd9f6bd">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtMy0xLTEtMTQ3MTU3_0a9e4f7a-8eaa-4388-8fa4-b64ae436ae03">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtNS0xLTEtMTQ3MTU3_f01f216c-d5af-4bf8-896d-8f54a1e544b6">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctMS0xLTEtMTQ3MTU3_d3456d71-af3f-49b1-aae3-0c126e91f992">3.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctMy0xLTEtMTQ3MTU3_e0707784-57b1-42a9-af31-ddfd2aa41592">1.4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctNS0xLTEtMTQ3MTU3_b4352b6c-6477-4e57-ac2e-863e649aec46">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtMS0xLTEtMTQ3MTU3_ceaab9ec-3d2d-443d-befd-8e92c1bfbb2b">3.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtMy0xLTEtMTQ3MTU3_fad78a35-f410-4be2-902e-b9beb9028d2b">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtNS0xLTEtMTQ3MTU3_d3f9de96-dc1a-403d-923d-c4fe35129e45">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTEtMS0xLTE0NzE1Nw_3665fd66-5d9f-4d50-b442-8f7fccbe1624">0.6</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTMtMS0xLTE0NzE1Nw_5662556d-71ab-4164-aa78-abc5b86d241c">13.6</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTUtMS0xLTE0NzE1Nw_3c575f86-463f-4e98-9a69-388fc82083b1">0.4</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTEtMS0xLTE0NzE1Nw_ab46617b-76f8-46f9-a24c-2ec622ce0865">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTMtMS0xLTE0NzE1Nw_934783d1-8c4c-42d3-a553-40ab40339f39">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxReconciliationOpioidLitigation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTUtMS0xLTE0NzE1Nw_9d4c391e-cd15-4f57-836e-ba5c0e013160">23.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill Impairment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTEtMS0xLTE5NzcyNg_e6f2efbe-71cc-40f7-ae60-5c6490a4f430">49.5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTMtMS0xLTE5NzcyOA_b841b6c8-3c22-4e78-b1db-63df062f7cba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTUtMS0xLTE5NzczMA_06128b6e-cce1-41a0-b342-239d7ce38b73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTEtMS0xLTE0NzE1Nw_b375d062-149e-4144-b95d-df3ca4d1cd85">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTMtMS0xLTE0NzE1Nw_5a7db7a8-9a31-4c0f-b577-214ce54a1478">129.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTUtMS0xLTE0NzE1Nw_87ba0b85-13da-4a56-9088-7c5b18b7041a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTEtMS0xLTE0NzE1Nw_4f26ac32-2e8a-4aa9-a371-e8996cff27e5">0.8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTMtMS0xLTE0NzE1Nw_b3c0a88c-bc64-4cd7-9b32-bfdfd248f809">1.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTUtMS0xLTE0NzE1Nw_6e00bddc-7eec-4580-8c6e-408347e6367d">0.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTEtMS0xLTE0NzE1Nw_1783fb13-5d98-48a5-9eae-f0b97ec09d6d">21.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTMtMS0xLTE0NzE1Nw_b504a7df-d4b1-40a7-9857-674e0922f848">89.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTUtMS0xLTE0NzE1Nw_1b7b93b0-8c7d-493c-ae21-59760c3c6bc2">2.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense, fiscal 2021 is pretax income with tax benefit, and fiscal 2020 is pretax loss with tax benefit.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i46568764b70f49f8a794781fa84336d1">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit rate was (<ix:nonFraction unitRef="number" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM3NDU_8d20b820-b23c-4b7d-9905-7568cdbac31d">21.2</ix:nonFraction>)% and (<ix:nonFraction unitRef="number" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM3NTI_b504a7df-d4b1-40a7-9857-674e0922f848">89.7</ix:nonFraction>)% in fiscal 2022 and fiscal 2021 compared to an income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM4MjQ_1b7b93b0-8c7d-493c-ae21-59760c3c6bc2">2.1</ix:nonFraction>% in fiscal 2020. Fluctuations in the effective tax rates are primarily due to the impact of goodwill impairment in fiscal 2022, impact of opioid litigation in fiscal 2021 and 2020, as well as the </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i317fc42daf3641e3a6ffdc32b665a2c3" continuedAt="i85c34ab5f8194a05b130fee15620a42a"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzQzMTM_0af09547-bdbe-41a9-a1cf-2a5fcd651799">21</ix:nonFraction> million during fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, foreign earnings of approximately $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzQzNzg_bace3bd9-ee8d-4c3c-a6ce-5fde1dfbc5f0">833</ix:nonFraction> million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our consolidated financial statements in fiscal 2022. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTk_981e26fa-d061-47a3-b89c-20bf48717da4" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzItMS0xLTEtMTQ3MTU3_1382bb0a-dafb-4df4-9548-c956bf4dba5f">41</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzItMy0xLTEtMTQ3MTU3_736c7fe7-d90c-4a84-bc01-be50c6d59078">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzMtMS0xLTEtMTQ3MTU3_73771a53-9c17-4d2e-9c0e-84b13ac0b58e">675</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzMtMy0xLTEtMTQ3MTU3_ac0e167d-17e9-4aa2-b8b3-49d4cdfcfd40">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzQtMS0xLTEtMTQ3MTU3_f15b70c7-bcce-42e3-802c-90d5e450e47c">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzQtMy0xLTEtMTQ3MTU3_6f5f035e-be21-4fad-96ad-af52bcdb4dfe">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzUtMS0xLTEtMTQ3MTU3_f6f63e4c-9db8-493d-83e2-f7b044164072">778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzUtMy0xLTEtMTQ3MTU3_95e83830-2584-4e12-8ba5-e767af919b92">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzYtMS0xLTEtMTQ3MTU3_b6959f19-a613-4c14-a653-70f81e08ca2c">33</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="cah:DeferredTaxAssetsRelatedtouncertaintaxpositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzYtMy0xLTEtMTQ3MTU3_1a2f612f-e59c-4f06-b738-4196afe346a2">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzctMS0xLTEtMTQ3MTU3_3549d35b-66f1-4d44-bbc5-4da68aa79b3e">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzctMy0xLTEtMTQ3MTU3_d4b56a55-a5d5-4c69-b58f-0c5d24215a0f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzgtMS0xLTEtMTQ3MTU3_cb3260f6-666c-49e1-ad4e-19b28d14b753">1,584</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzgtMy0xLTEtMTQ3MTU3_8a6cdf33-6c4f-4fdf-83f9-5b0a9fea0a10">1,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzktMS0xLTEtMTQ3MTU3_ea27a41b-035c-4f6a-a30e-f2d325f79dea">468</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzktMy0xLTEtMTQ3MTU3_9072d248-2816-47bc-a0d1-0fb6f9df7bc2">515</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEwLTEtMS0xLTE0NzE1Nw_fa914b96-b62c-4027-aa5c-e3f1da287103">1,116</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEwLTMtMS0xLTE0NzE1Nw_7ac30a29-1acb-48cf-b3d4-4e93d18e3b2a">1,293</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEzLTEtMS0xLTE0NzE1Nw_392fd549-59e4-443b-b6fd-5ec0eac7dae3">1,164</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEzLTMtMS0xLTE0NzE1Nw_db62f17f-98ce-455f-9850-fdd8a331fd03">1,119</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE0LTEtMS0xLTE0NzE1Nw_7fee9e79-9fae-48a7-9ca9-6dc0c7ab8090">288</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE0LTMtMS0xLTE0NzE1Nw_e389f4ac-135a-47df-aba7-8a5387916cc8">375</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE1LTEtMS0xLTE0NzE1Nw_83749c12-aa4e-4711-b333-30a5d008ce5d">683</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE1LTMtMS0xLTE0NzE1Nw_40ac1732-7a89-4244-945a-ac2cf95a1ba2">733</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE2LTEtMS0xLTE0NzE1Nw_8c53d0c0-2943-49fe-98e6-471b549df7b3">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE2LTMtMS0xLTE0NzE1Nw_146e75e1-324f-4b5d-b2e5-46ee2a3f2539">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE3LTEtMS0xLTE0NzE1Nw_6e8c3efe-c04a-4c86-a635-677bf332fe5f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE3LTMtMS0xLTE0NzE1Nw_72866a11-9160-4d91-a28f-909661eea7b9">23</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE4LTEtMS0xLTE0NzE1Nw_903df654-06ad-4ff8-8f43-481b04269bfa">3,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE4LTMtMS0xLTE0NzE1Nw_9bd7e5a7-685f-4e7d-8bfa-bdb90cad68f0">3,225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE5LTEtMS0xLTE0NzE1Nw_68adc421-c1be-4905-8674-5621271bfeca">1,994</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE5LTMtMS0xLTE0NzE1Nw_1262f747-99a2-433b-b000-885e65dc5dea">1,932</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTQ_6f041e0f-1892-467c-bc82-82fd89a778a8" continuedAt="i3e0c4111f897478a8a55f6b02474ce67" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzEtMS0xLTEtMTQ3MTU3_53c52ae0-a054-4a78-b0ad-135fba1ca759">36</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzEtMy0xLTEtMTQ3MTU3_6388f132-e319-4c80-ac34-64dd9b23f117">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzItMS0xLTEtMTQ3MTU3_122538e9-fa5d-4e70-a9ab-71702e4a46a9">2,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzItMy0xLTEtMTQ3MTU3_9ecc0c5c-b6ad-4f79-8f5f-2ec6c27d179a">1,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzMtMS0xLTEtMTQ3MTU3_39ee76ef-8d2e-4313-a78a-b42b2c7e1b80">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzMtMy0xLTEtMTQ3MTU3_db32f8a5-73c6-4f26-9e59-fb7c40a397c9">3</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzQtMS0xLTEtMTQ3MTU3_f2479498-0e59-4857-b12a-2e1e4db0aa1a">1,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzQtMy0xLTEtMTQ3MTU3_68099b2b-2e34-42df-b3da-5a9f58c29bf7">1,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i3e0c4111f897478a8a55f6b02474ce67"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 we had gross federal, state and international loss and credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="iaf55d738e4c2417989763623ac863aba_I20220630" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MDM_ba088f93-cff1-484a-b1f1-0d4b966f5785">275</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4049be5d431a45859642596069133d4c_I20220630" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MDc_6d72d6c0-a233-46cc-be5e-848a51b7655a">3.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="idf7f919960364e29acc09ea1ecf5403b_I20220630" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MTQ_4e6b8229-1668-4320-81e7-77863a32c17a">2.2</ix:nonFraction> billion, respectively, the tax effect of which is an aggregate deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1OTQ_fe1f6918-3409-4fa0-9af7-b212388b4c54">778</ix:nonFraction> million. Substantially all of these carryforwards are available for at least three years. Approximately $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU2OTM_a0544b23-bf66-42a9-b783-1d45d5c318a6">449</ix:nonFraction> million of the valuation allowance at June&#160;30, 2022 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwNzY_29fecf06-0832-4f3f-ba65-7a088d776307">943</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwODA_29c10ccb-c67a-4f44-8380-1297aad14a98">932</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwODc_076b192b-6bfa-499b-94e7-0644822c7894">998</ix:nonFraction> million of unrecognized tax benefits at June&#160;30, 2022, 2021 and 2020, respectively. The June&#160;30, 2022, 2021 and 2020 balances include $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxODY_8c0f044c-4fb7-4c02-9e51-5aa28eff38e2">858</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxOTA_56ea1d18-fa5f-48f9-804b-590e2167d457">849</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxOTc_982b335e-20a6-41fc-b7eb-6794f96c3e01">753</ix:nonFraction> million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxMDY_6851a3a8-3964-4f57-b0dc-18a03c970fc9" continuedAt="i8302857d478342a1b6791097eb7b2655" escape="true">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i8302857d478342a1b6791097eb7b2655"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtMS0xLTEtMTQ3MTU3_4ca68944-453d-4758-a507-069a26da0fd3">932</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtMy0xLTEtMTQ3MTU3_32d28539-6fb2-4fe5-8841-0bfdf74a9dad">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtNS0xLTEtMTQ3MTU3_7c22e367-9b90-4538-8fba-59526d51c069">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItMS0xLTEtMTQ3MTU3_7f1f1a76-4e2c-42eb-a60b-05b4f30a616d">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItMy0xLTEtMTQ3MTU3_73387f20-7480-45ff-aef2-1311a4f80811">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItNS0xLTEtMTQ3MTU3_c89fb16c-fa93-46a8-857a-1242fa62ca3a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtMS0xLTEtMTQ3MTU3_5e7a4d90-d36e-4072-84ea-0c45aea2e9fe">39</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtMy0xLTEtMTQ3MTU3_00ac3ff8-3125-4980-a2e0-681e25221549">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtNS0xLTEtMTQ3MTU3_8821f164-6dea-4aae-aa09-771bd2b0f0e5">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtMS0xLTEtMTQ3MTU3_a173556a-ba1b-47f0-aa46-4e21bb162e0c">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtMy0xLTEtMTQ3MTU3_6b210485-b0e1-4af1-af23-77fdde1264e5">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtNS0xLTEtMTQ3MTU3_474f1977-65de-4d85-a575-1ba92cbf11c5">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtMS0xLTEtMTQ3MTU3_86fbd332-b540-40e2-977f-76e24f133c96">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtMy0xLTEtMTQ3MTU3_5bdd1fd3-d4a7-4e28-9d06-1b1c2cbbbc68">271</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtNS0xLTEtMTQ3MTU3_1cfd2554-5ece-46c9-9f75-708466553969">6</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtMS0xLTEtMTQ3MTU3_190c4f75-b957-40de-b019-2ece6dd02349">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtMy0xLTEtMTQ3MTU3_39081b2e-27f5-4ad9-a5c1-e06f25e13407">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtNS0xLTEtMTQ3MTU3_a19dd9f9-baef-4819-be53-b3d7c7768e9c">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctMS0xLTEtMTQ3MTU3_29fecf06-0832-4f3f-ba65-7a088d776307">943</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctMy0xLTEtMTQ3MTU3_29c10ccb-c67a-4f44-8380-1297aad14a98">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctNS0xLTEtMTQ3MTU3_076b192b-6bfa-499b-94e7-0644822c7894">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between <ix:nonFraction unitRef="usd" contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzczMDg_166f774a-7da4-4e8d-b1f9-203e8505254f">zero</ix:nonFraction> and a net decrease of up to $<ix:nonFraction unitRef="usd" contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzczMTQ_aca0d641-7591-4695-83e9-f729a169b75b">75</ix:nonFraction> million, exclusive of penalties and interest.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2022, 2021 and 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc0OTY_2e49b456-0f3b-498c-8f68-36dbcb9baae4">48</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc1MDA_2c08bc30-c56e-48d0-85a3-400d8d4f7b7f">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc1MDc_4bed1c6a-99c5-4cf1-9fd4-9309885d123e">146</ix:nonFraction> million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i85c34ab5f8194a05b130fee15620a42a"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2022 and 2021. During fiscal 2020, we recognized $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc5MDM_667b25a3-f504-4ba7-af7d-0cc9a114133e">16</ix:nonFraction> million of expense for interest and penalties in income tax expense, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Tax Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly based on available information. This information may support either an increase or a decrease in the required valuation allowance. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described above. We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $<ix:nonFraction unitRef="usd" contextRef="i9d73f184d2b949538033de20922de133_I20220630" decimals="-6" name="cah:IndemnificationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg2MTI_c7c9cfbd-f499-455f-bcb9-dd1907841849">75</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3cf2679b91854d43ae797e4fa386a35a_I20210630" decimals="-6" name="cah:IndemnificationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg2MTk_788dd3d5-fefd-4ac5-9954-32587d5ce48b">72</ix:nonFraction> million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $<ix:nonFraction unitRef="usd" contextRef="i155edd13bdcd4fe6a997c9048e92a4cb_I20220630" decimals="-6" name="cah:IndemnificationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg5ODM_e0a9ab51-fdb8-4de6-95a1-240570f46671">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4f315442d4d144f597f8e7072738b52c_I20210630" decimals="-6" name="cah:IndemnificationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg5OTA_e269efc0-ed3c-4867-aa39-329bfa924dbf">12</ix:nonFraction> million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_124"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2NjI_539253e5-72b2-405a-98ad-70a5243fa003" continuedAt="ib54be79966eb4f6ebca748146866da4c" escape="true"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2Nzg_157716a3-d1ea-4dd4-8005-2eab27c425a4" continuedAt="ifc39e79ced7147208d64919acae02139" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2OTI_8f9c51e9-763f-4707-8fba-ca91486f75d9" continuedAt="i2dfdd4501f5d4368a2013df83d807797" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtMS0xLTEtMTQ3MTU3_671a4774-93c4-45e9-bd8e-22891e3d41ed">2,425</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f334187da934dae8f50e09f680684be_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtMy0xLTEtMTQ3MTU3_4988a149-bd95-45c3-846f-35037b150772">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtNS0xLTEtMTQ3MTU3_908ee27f-faa5-46e1-ac73-9276018e5958">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtNy0xLTEtMTQ3MTU3_0049dd9b-6196-4c22-a1e1-de0cc5302eb8">2,425</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtMS0xLTEtMTQ3MTU3_4de6e142-9edb-459c-82e0-78c335be78df">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f334187da934dae8f50e09f680684be_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtMy0xLTEtMTQ3MTU3_14e83da4-5b23-41a8-987a-8a9b25555cdf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtNS0xLTEtMTQ3MTU3_9767b630-7b84-4471-b6da-191402490392">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtNy0xLTEtMTQ3MTU3_bc13f6b1-18b1-4df2-ad8a-bb04e4ab595b">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtMS0xLTEtMTQ3MTU3_703a166c-864a-4d65-b30d-5c46d9bded31">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f334187da934dae8f50e09f680684be_I20220630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtMy0xLTEtMTQ3MTU3_ed78e079-151a-409f-9ffb-bbd21b5710e2">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtNS0xLTEtMTQ3MTU3_860c8da3-bebe-4502-b45c-7c8912fa6a65">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtNy0xLTEtMTQ3MTU3_5bed8762-9090-4de9-8c2d-b80fcac24acd">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="ib54be79966eb4f6ebca748146866da4c"><ix:continuation id="ifc39e79ced7147208d64919acae02139" continuedAt="if9e069b91aff4ba89fd7f947f87875d6"><ix:continuation id="i2dfdd4501f5d4368a2013df83d807797" continuedAt="i1378ffdb3a174ffcbd0abb99c7889994"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtMS0xLTEtMTQ3MTU3_52e09c25-eea0-4902-bd8a-8f1a1c93cb07">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtMy0xLTEtMTQ3MTU3_ae00def7-75e4-4cbe-8ce4-db2a110864d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtNS0xLTEtMTQ3MTU3_47e1930a-43be-455f-a9c0-60b403fd2a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtNy0xLTEtMTQ3MTU3_ba92d581-0051-44f5-8911-615d2d41ded3">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtMS0xLTEtMTQ3MTU3_9b8df0eb-26b7-42e6-a2cd-26c2f66046b7">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtMy0xLTEtMTQ3MTU3_038a1482-9f70-4260-b9fe-9bc438f85c37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtNS0xLTEtMTQ3MTU3_edf876d0-3305-4fc2-9ccb-9e6dd2ac730d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtNy0xLTEtMTQ3MTU3_4c22c6a3-8cd7-4dd6-91ea-400d6e3bd4bf">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtMS0xLTEtMTQ3MTU3_18a64580-cc13-4c98-9816-cd743734dc8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtMy0xLTEtMTQ3MTU3_eab1e37e-a542-45b1-ace4-ced19538c5f8">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtNS0xLTEtMTQ3MTU3_04567cb1-94ab-4f6a-a328-ce9695fdac26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtNy0xLTEtMTQ3MTU3_88b44442-47b3-4bd0-8a5c-6e430c7ca8a4">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="if9e069b91aff4ba89fd7f947f87875d6" continuedAt="id3578d017f1940cba06c070258b0ccf6"><ix:continuation id="i1378ffdb3a174ffcbd0abb99c7889994" continuedAt="iccbaa168c4a4499780dba50db562b1df">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"><ix:continuation id="id3578d017f1940cba06c070258b0ccf6"><ix:continuation id="iccbaa168c4a4499780dba50db562b1df">The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets and (Liabilities) Measured on a Nonrecurring Basis</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities held for sale of $<ix:nonFraction unitRef="usd" contextRef="i8252480092a4420d9a47a8420945e070_I20210630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzY1OTcwNjk3Nzg1NTY_328deaab-97fa-45a4-b2a6-bd9e22ea6411">1.1</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i8252480092a4420d9a47a8420945e070_I20210630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzY1OTcwNjk3Nzg1NjY_ad6adcec-8925-483a-ab3c-f1370dba64a6">96</ix:nonFraction> million, respectively, at June&#160;30, 2021 were primarily related to the divestiture of the Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_100">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the divestiture of Cordis business.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_127"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzMw_6e5b814f-77f2-40f9-98e7-85f33f549967" continuedAt="i26aefc5a16a240d2863058030f06583b" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">10. Financial Instruments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into </span></div></ix:nonNumeric></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="i26aefc5a16a240d2863058030f06583b" continuedAt="ie8e13f299e38497d8f483d90b9f8cefd"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Currency Exchange Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzgw_9fa35ae3-3db3-4f61-9f7c-6b3d9306d12e" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:69.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e0d0c9e1e2f467d97bbc64581905f40_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzItMS0xLTEtMTQ3MTU3_726df017-f0cb-4457-a79a-1576bac18571">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff344aae68f94110aca38462cc1fbfeb_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzItMy0xLTEtMTQ3MTU3_75ff64c3-a0b4-4fe7-a407-890940ccdadd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f8e752754a4c0a8560dab2d9697e94_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzMtMS0xLTEtMTQ3MTU3_f63ea49a-69ae-4110-a996-8bb01dd66749">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ff51c1469749a9be8eb3406df0e62c_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzMtMy0xLTEtMTQ3MTU3_f2bc452f-6e71-4a5a-9448-6c3ff5011fb7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic059bb286acc4a4f9c4085b5a0410159_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzQtMS0xLTEtMTQ3MTU3_c501324e-7a81-4009-a965-2b89e27e6bfd">29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd2d0c1e544d42a1d4b65d126614e6_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzQtMy0xLTEtMTQ3MTU3_f79c02b5-342d-44b9-be3f-e2094a8dc032">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d72cfa1fc7448e8a4d03ab71fc0b20_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzUtMS0xLTEtMTQ3MTU3_45da23ad-ca2e-4b51-a501-12a5277d8f55">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a755a6106242698132be9ad227180a_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzUtMy0xLTEtMTQ3MTU3_29c9ab9a-95ac-482d-a7fe-b2843745f762">5</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzktMS0xLTEtMTQ3MTU3_e6abaad1-1f45-4442-8530-0c1b175dcded">61</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzktMy0xLTEtMTQ3MTU3_014565c8-208d-4779-a40d-c5508629a56a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8588473d4f2c40a7ac9bf6e97f477a07_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzEzLTEtMS0xLTE0NzE1Nw_155ef93b-6ba5-4c3d-b309-3b2b24bc38b3">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddad5bf093244d1b4387d8a979d72cb_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzEzLTMtMS0xLTE0NzE1Nw_84cf0007-f90b-4a2e-b622-ccdff28a2879">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69376b6c620458997976028c1214422_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE1LTEtMS0xLTE0NzE1Nw_3c06836e-0c9e-485e-b437-c1bcdf9e71ed">43</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cfc47e3aa3a4886af27a182bd671ec1_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE1LTMtMS0xLTE0NzE1Nw_f6505c22-f387-4b8a-b055-6efa5cbf8881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE3LTEtMS0xLTE0NzE1Nw_3e6b4342-9588-4ca8-87d6-37a0a4ff182e">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE3LTMtMS0xLTE0NzE1Nw_90d75b25-0ce0-4e5f-bfc7-44162cde0f7b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2022, 2021 and 2020 there was <ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_915df962-7812-45d2-95f7-b2dbfd333656"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_e0a05a6d-85f9-4110-a24c-854295fca80c"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_edbcff67-8073-4b13-865d-81e831c5e3ad">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> gain or loss recorded to interest expense as changes in the market value of our </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we entered into pay-floating interest rate swaps with total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="id10d0b211539491aaf593b13a51c07c6_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4MTI_de9d6be0-37d0-45b4-9968-8dd0fc74061f">600</ix:nonFraction> million. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $<ix:nonFraction unitRef="usd" contextRef="iec28629ea39c43e4840b61f68f95c92c_I20210630" decimals="-6" name="cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NDQ_c2b56258-7240-475a-985c-94da7c8ab3fa">550</ix:nonFraction>&#160;million. In connection with the unwind of these contracts, we received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie6d851e08ef540a6aceb7daa376a4bc2_I20210630" decimals="-6" name="us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NTg_7856d43e-f130-460a-9470-d5dd689bf702">18</ix:nonFraction>&#160;million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="iec28629ea39c43e4840b61f68f95c92c_I20210630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NzE_a0ee9269-bcc4-43c0-a757-73f71e7f1225">200</ix:nonFraction>&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630" decimals="-6" name="us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzQ3OTI_04a2b4ca-4893-4986-a09f-da184057b59a">112</ix:nonFraction> million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June 30, 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the debt repayment as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_115">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, two pay-floating interest rate swaps with notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630" decimals="-6" name="cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzUxMjI_1eedac9d-ec2a-403c-8d2a-780e7995f036">200</ix:nonFraction> million matured in the second quarter of fiscal 2020.</span></div><ix:nonNumeric contextRef="i945df5b6d2454f3bb10a110ca1cfb83c_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzU0_1ba9dddb-b2a8-40b9-8e56-67dc796f624a" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8568be76a18940d69f23584500123552_I20220630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo2OWMyNDBlNjhmN2M0ZTYyOGI2ZDNiMDc2NmE2ZGJiZS90YWJsZXJhbmdlOjY5YzI0MGU2OGY3YzRlNjI4YjZkM2IwNzY2YTZkYmJlXzItMS0xLTEtMTQ3MTU3_e58dc1a7-452c-4c4c-808c-4cf196c23486">800</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2027</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 2029</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0YjY5ODZlNTFhYTk0YTFlOTkwY2M2OGJkZWIwMGE2Mi90YWJsZXJhbmdlOjRiNjk4NmU1MWFhOTRhMWU5OTBjYzY4YmRlYjAwYTYyXzItMS0xLTEtMTQ3MTU3_1c29ebc3-4020-4d21-ad88-4ebbc3e554f6">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQw_cf6d955e-958d-4cf7-bfde-c223e4d6ab13" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e787599e79e498b900200587d8ebe7d_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtMS0xLTEtMTQ3MTU3_5a53839b-0e0c-4515-894d-552799aca10b">44</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa6abd62fa79443881013d61bc42a3cd_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtMy0xLTEtMTQ3MTU3_445913c5-048c-4fc4-b65c-00b8d5588291">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec5a8f432dfb4a669e5b7ba55a35b302_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtNS0xLTEtMTQ3MTU3_42566fd3-2b51-4d5f-a88d-1d610c63912b">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i773662d7d9b448b8b333e4a1b94246ba_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItMS0xLTEtMTQ3MTU3_4bd9f0b9-61da-432d-8d5b-fc08f3cf3b63">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf50b11230f141ef80acceb9da69ce09_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItMy0xLTEtMTQ3MTU3_c55eee73-5727-48a8-a669-886c66db6ac5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i235c4dd623e14a40ae30c1c514b56b33_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItNS0xLTEtMTQ3MTU3_1c842ad3-3332-48fc-8e10-a339e77c0e17">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into </span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><ix:continuation id="ie8e13f299e38497d8f483d90b9f8cefd" continuedAt="i0edd8249da0f44e18964a2fc38d41451"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="ie20a6b75339f4305bd27c3566e131b42_I20210630" decimals="-6" name="cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzY0MzE_0b67c904-98b2-4795-a82e-052bfbcb97e5"><ix:nonFraction unitRef="usd" contextRef="i2a7bc307cde846ad8020785fb428b704_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzY0MzE_eecd2c6c-0366-40c2-bf77-2f4e015a9d93">200</ix:nonFraction></ix:nonFraction>&#160;million to hedge probable, but not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2022 and 2021, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, Euro, Chinese renminbi, Thai baht, Philippine peso, Japanese yen, Australian dollar and British pound.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><ix:nonNumeric contextRef="i6655370d79f845c5b210b9cbc38baa6a_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzU2_6d1bd0d9-ff1b-4f73-a742-5dcdcf56834c" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo3Y2UwNWEzMzlmZWM0OWEyOTRiZWZmZGM1NjhiNDdlZi90YWJsZXJhbmdlOjdjZTA1YTMzOWZlYzQ5YTI5NGJlZmZkYzU2OGI0N2VmXzMtMS0xLTEtMTQ3MTU3_77c959fe-daf1-4902-86a9-fc66d51b62db">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec740da2e31443ca3a03df609402dba_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTphN2E4N2JmZDM4ZmQ0MGQyODZlYTlhMzIyZTJiZGU4Ni90YWJsZXJhbmdlOmE3YTg3YmZkMzhmZDQwZDI4NmVhOWEzMjJlMmJkZTg2XzMtMS0xLTEtMTQ3MTU3_6c840f1b-cb14-488c-851d-44001e0f602a">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQx_957fd3d1-2178-40fa-a2f0-b24c0547e340" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84712198fd34c77a01fe1cc4008c915_D20210701-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtMS0xLTEtMTQ3MTU3_da782b5b-d535-4dbe-8fbb-9fb208da6dfe">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d06eff618844ea9b294766cd40c0cbb_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtMy0xLTEtMTQ3MTU3_1dfcd06d-ebba-49a1-874e-c2d571946e17">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d390067fa94438188ada7ef9dd06ef3_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtNS0xLTEtMTQ3MTU3_6dd1eff2-5c91-40b5-b055-224dcfcb4756">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e636c0a4764fbda3673d5e4c24027e_D20210701-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItMS0xLTEtMTQ3MTU3_3acb9f70-bdc8-4b27-bc2a-9b388d6e8c8e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3689b6ecce894dcf9310fad3bfb4484c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItMy0xLTEtMTQ3MTU3_c6714ef5-63a7-4387-9ad5-4b8e2bc493db">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad1d6e92138f4a2bbfefa3aa6fa73311_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItNS0xLTEtMTQ3MTU3_0f69f275-f36f-4d52-81f4-96681641e05b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e36bc811b8e4e04b871a13fd2292653_D20210701-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtMS0xLTEtMTQ3MTU3_2403a700-a85c-435c-a5cf-a56d7c296bcc">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012e1ceb9763423189450a46d2c76f14_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtMy0xLTEtMTQ3MTU3_5d19700d-aa0f-4349-9173-9dfa45ef2bed">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4b437cafd548ff9b69d8d997ae280d_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtNS0xLTEtMTQ3MTU3_487f3723-3fd5-4210-bc41-3e3ec6ac8847">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ5_9ef47731-d1b0-4ec0-9e7a-5da564e76786" continuedAt="i5ea5436924a84d7cb80292556efcb3d6" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:46.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtMS0xLTEtMTQ3MTU3_6064ba09-1982-4af6-9303-c4bf1a0bfb22">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfff6e07744441528f22c7027f392bc3_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtMy0xLTEtMTQ3MTU3_0d243abd-f1aa-40a4-8813-c7523dbab5cf">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ef85b7c88a4539972e810d6676bcd2_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtNS0xLTEtMTQ3MTU3_a52a5641-0a89-401a-934e-ee21b88f15ff">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50482f61b49343aea4800caf3921c613_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItMS0xLTEtMTQ3MTU3_84838c81-74c7-43bc-9ccc-f224e671201a">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25a7c5d5859848dd88abbc1a8fbb11c9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItMy0xLTEtMTQ3MTU3_fc89a775-fe24-4345-99af-8d4d970bd71a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i421ac4ebd1c940d5be641a14b6a8565a_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItNS0xLTEtMTQ3MTU3_7122c460-6950-4c22-b9ad-24c7ecd1745b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bee56b9093547aab3e10f4b7c9d0c93_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtMS0xLTEtMTQ3MTU3_ff136f6d-2b34-4fba-9543-c4dc1d0306ac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d114542faa4edc9d89c757065598f7_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtMy0xLTEtMTQ3MTU3_8ee7eef5-ca0c-4ec0-8440-a81f827b60e7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a935fc8248a4a1890e47ba459c9f8bb_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtNS0xLTEtMTQ3MTU3_c9e7e37c-403d-4ab6-a20a-58fb992de5cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269c8552647a4321a761031c80f05289_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtMS0xLTEtMTQ3MTU3_25d9a734-1429-4264-9844-7a900959e9e5">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cddbe3b6c7a4e719277441f86f08a81_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtMy0xLTEtMTQ3MTU3_68061dcc-c600-449d-b7d5-fa23c68bbc30">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8544764a8141e69a14460e4f902fb7_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtNS0xLTEtMTQ3MTU3_ae000b0d-cda1-47bf-8cae-0da63710c340">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46bf92b1ae9412db7eb482248d3e631_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtMS0xLTEtMTQ3MTU3_a0914d12-0b25-4b66-9ad8-4128d5058e0d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66d0afbc7f24472f9a3373a8620e9bb0_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtMy0xLTEtMTQ3MTU3_7c261f1e-e205-4740-9513-cd7357a02095">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba25e5360ae47298c3f879441851557_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtNS0xLTEtMTQ3MTU3_48979008-8e83-4be2-9859-7707bead9b9e">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i5ea5436924a84d7cb80292556efcb3d6"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div></ix:continuation><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we entered into a &#165;<ix:nonFraction unitRef="jpy" contextRef="ie01d7cee22094964ba6e1b1c964e79d9_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1Mjk_6db8f9ae-6838-45e8-bd0c-e77c4f08bee3">24</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="ie01d7cee22094964ba6e1b1c964e79d9_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1MTE_0328b7f7-20c2-4a97-bfa1-613c19e987ba">200</ix:nonFraction>&#160;million) cross-currency swap maturing in September 2025 and a &#165;<ix:nonFraction unitRef="jpy" contextRef="i49b160e1a7e845e9b7fce15173ef887a_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1NDc_c9b8a1b9-031e-4e8b-9c26-a2f0374b9e18">24</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i49b160e1a7e845e9b7fce15173ef887a_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1NjU_73836b12-8bbc-4077-962a-a110306ac044">200</ix:nonFraction>&#160;million) cross-currency swap maturing in June 2027.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we terminated the &#165;<ix:nonFraction unitRef="jpy" contextRef="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzg0NjM_ff948a95-d35b-4ab5-9f8d-6cc9ca04ecf2">64</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzg0Njc_6ed0db1b-e288-4714-8f3d-217a188b7648">600</ix:nonFraction> million) cross-currency swap entered into in August 2019 and received a net settlement of $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI4NzY_27e65111-c4ab-4a76-8593-ca34e8bcfde7">71</ix:nonFraction>&#160;million in cash recorded in proceeds from net investment hedge terminations in our consolidated statements of cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $<ix:nonFraction unitRef="usd" contextRef="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzkyNzM_2b0895c4-024e-48c1-9374-ef0cb8e53147">86</ix:nonFraction> million gain and a $<ix:nonFraction unitRef="usd" contextRef="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzkyODc_77ce379e-eace-454c-ac91-5171a033436d">7</ix:nonFraction> million loss during fiscal 2022 and 2021, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $<ix:nonFraction unitRef="usd" contextRef="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzk1Mjg_ca9bfab3-6993-43c3-88b1-4f1e25eac03c">21</ix:nonFraction> million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630" decimals="-6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzk1MzU_0aa20dc2-fa42-4518-a35f-b04116e57f94">19</ix:nonFraction> million during fiscal 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Economic (Non-Designated) Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currencies managed through foreign currency contracts are the Canadian dollar, Euro, Chinese renminbi, Indian rupee and Thai baht.</span></div></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i0edd8249da0f44e18964a2fc38d41451"><ix:nonNumeric contextRef="ibba1dd6808f54a86a81fd6308d260b0f_D20210701-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ1_43da7a0a-5fca-47b5-93df-ffc1416b3164" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d8c3f959e54f26b4608732cff6a528_I20220630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo1NWQ0MjU4OWQzZWI0ZWFkOTQ1OGFkNjZhNjZkYTY1Yi90YWJsZXJhbmdlOjU1ZDQyNTg5ZDNlYjRlYWQ5NDU4YWQ2NmE2NmRhNjViXzItMS0xLTEtMTQ3MTU3_2a58f0b9-8eb1-41d0-8e09-fcc48992ebee">265</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2022</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f1b851c9794bb5a1866c1ef80be14e_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToyZmJmNjE0ZmM5NzE0MDQ3ODMxZWM1NTg5YmM2N2JmNS90YWJsZXJhbmdlOjJmYmY2MTRmYzk3MTQwNDc4MzFlYzU1ODliYzY3YmY1XzItMS0xLTEtMTQ3MTU3_a199d81f-43c4-4b6d-96ba-60ecebfddea1">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzEx_fab98b43-2e5a-4d49-b4b6-d831a52762ce" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"></td><td style="width:46.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.359%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2791b320bdf418283ef26f40f8960d2_D20210701-20220630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtMS0xLTEtMTQ3MTU3_2fcfeb38-7f3a-469d-b1ea-20af9a5743b7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id83a99daa0324eaf9c0d86f62c609f16_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtMy0xLTEtMTQ3MTU3_ac1653d5-78e9-40b2-8f31-67ece829a797">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb30ce6147144d6cb2de94c1c28b34d8_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtNS0xLTEtMTQ3MTU3_ef83cbe7-919e-4130-bd5f-882ad889a890">11</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2022 and 2021 approximate fair value due to their short-term maturities.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzIz_186b6a8d-f925-4f6e-bf4e-236d8efd693f" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i458d92552dd24194973d1eecdc2b3c4e_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzEtMS0xLTEtMTQ3MTU3_42ac0e1e-a619-4ffc-a69a-984da44008b6">5,049</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a6cbd72cc74687b9d7255c26b5ee6f_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzEtMy0xLTEtMTQ3MTU3_da94ba0e-4767-439d-a795-f9d99f93e37a">6,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzItMS0xLTEtMTQ3MTU3_d75e4c41-0552-4456-ba4b-a70f00b1685b">5,315</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzItMy0xLTEtMTQ3MTU3_e7a3be46-dd91-49f7-b1b6-70b84f3ab3d9">6,236</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ4_b0ed23c1-904a-4761-9787-90a95d2a415e" escape="true"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:31.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8568be76a18940d69f23584500123552_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItMS0xLTEtMTQ3MTU3_8812fc12-0916-474d-9262-286d7172d365">800</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8568be76a18940d69f23584500123552_I20220630" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItMy0xLTEtMTQ3MTU3_336f0bc0-cf68-4542-a24f-010caeaa4127">43</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItNS0xLTEtMTQ3MTU3_5bd08e5f-ee12-468c-8d77-1bd543668ee3">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItNy0xLTEtMTQ3MTU3_14cfc763-8896-404a-92e8-c50696aeedf1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtMS0xLTEtMTQ3MTU3_ca5e02ac-7932-470e-b94a-d1a0ab4aadeb">592</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtMy0xLTEtMTQ3MTU3_54e06528-0e09-4a59-b0f0-740a9eab0b96">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec740da2e31443ca3a03df609402dba_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtNS0xLTEtMTQ3MTU3_ee85194d-af50-4752-9a6b-ed8ae9282e74">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec740da2e31443ca3a03df609402dba_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtNy0xLTEtMTQ3MTU3_48fadfaf-2c4b-4b02-b489-ac2f6fc82c46">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a04898d27345438f4a7a3a130a15be_I20220630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtMS0xLTEtMTQ3MTU3_5e9d12b9-65c2-4bf6-a1ae-bfa79e31f86e">633</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a04898d27345438f4a7a3a130a15be_I20220630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtMy0xLTEtMTQ3MTU3_9a853164-9ed5-42e4-ad4c-541beb6ef4ac">54</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f63f23b1554e848a59e032b744632e_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtNS0xLTEtMTQ3MTU3_6b8b817b-8a3e-478e-87df-56b66d4db9f1">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f63f23b1554e848a59e032b744632e_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtNy0xLTEtMTQ3MTU3_f0c93a49-0050-45a2-813a-7b552109a7c6">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_130"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzIwNzM_f7cb6269-f69a-4336-a8fe-6ddcb1e0bf9b" continuedAt="if6165462a4fc4fc990028432d41fd8dc" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">11. Shareholders' Equity/(Deficit) </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, authorized capital shares consisted of the following: <ix:nonFraction unitRef="shares" contextRef="i1cd2559051274accba49716a53ea4d55_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzc3_bdff0f35-5629-48db-bb9c-9a7b857f9e9d">750</ix:nonFraction> million Class A common shares, without par value; <ix:nonFraction unitRef="shares" contextRef="ib5cfbdd2a57c495092c1346adb91387e_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzEyMg_483f8a2d-a73f-43c4-a245-beb225e2131f">5</ix:nonFraction> million Class B common shares, without par value; and <ix:nonFraction unitRef="shares" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3MQ_d97a7314-b992-4855-80d4-1a25547b8847">500</ix:nonFraction> thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of </span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="if6165462a4fc4fc990028432d41fd8dc" continuedAt="i58b97eba09fa4143a0258b3295159eb8"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to <ix:nonFraction unitRef="number" contextRef="ie251c72e85d34942ab0769ac0f335908_D20210701-20220630" decimals="INF" name="cah:CommonStockVotingRightsVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzU3Ng_6cc4eea6-6a29-4dd9-8faa-cdf4a206df84">one</ix:nonFraction> vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased $<ix:nonFraction unitRef="usd" contextRef="i170f7cf26f08409dac798c226dec905e_D20190701-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzkwNw_e01ede48-6d32-498f-b98f-7f1657f40703">1.6</ix:nonFraction> billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, as described below. We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we repurchased <ix:nonFraction unitRef="shares" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3Njg3NTc_3db649d6-2078-4c0b-8451-c47669245808">19.5</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzEyNzg_fc084c8c-2a45-429b-bc37-a9c43c21d6ac">1.0</ix:nonFraction> billion. We repurchased <ix:nonFraction unitRef="shares" contextRef="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwMjI_00bde260-b837-44e8-a664-32568cdb5c3f">9.8</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwMjg_20b10832-8dcf-465b-8cf0-5b4ebd858649">6.1</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwNDc_14547a7f-b112-42c9-a8ec-ae57150ebd46">3.6</ix:nonFraction>&#160;million common shares under multiple accelerated share repurchase ("ASR") programs with average paid per common share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzNjc_f5bca8cd-9633-4969-9577-ac0a9609315d">51.10</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzNzY_5f870085-e2b8-43aa-934c-b7b22ecdebf9">49.39</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzODg_f7e67541-7209-485a-af5b-967e448b3302">56.02</ix:nonFraction>, respectively. These repurchases began on August 18, 2021 and concluded on April 18, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we repurchased <ix:nonFraction unitRef="shares" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE0OTA_9eef6293-7639-4c26-a3e1-d888cfa00a97">3.7</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE1MzU_12cf96c2-6ad2-4518-a333-c6368ffc0208">200</ix:nonFraction> million. The average price paid per common share was $<ix:nonFraction unitRef="usdPerShare" contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE1ODM_e09bf3dc-447e-4a6c-ae6f-84f16631c565">54.40</ix:nonFraction>. These repurchases were made under an ASR program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we repurchased <ix:nonFraction unitRef="shares" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3MTQ_72321de9-10c3-475d-92d5-934aae44cc51">7.3</ix:nonFraction> million common shares having an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3NTk_315b6e24-091d-4e46-9302-6667a6e28fad">350</ix:nonFraction> million. The average price paid per common share was $<ix:nonFraction unitRef="usdPerShare" contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE4MDc_e0cd0e0c-73cf-42d4-951d-621d05687929">48.00</ix:nonFraction>. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i58b97eba09fa4143a0258b3295159eb8"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzIwODQ_011b3fe2-9aed-42ab-adb2-c558896aef8a" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.875%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic12e802652d64575be3f052d531ee71a_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtMS0xLTEtMTQ3MTU3_1e8532ad-4900-44cc-abad-9e8db545ebf8">92</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd6dc10bbdf4a9887f38ce5a9b7eebb_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtMy0xLTEtMTQ3MTU3_1be00ec5-88a9-402b-be38-1bbdbc2f3ab2">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a2a315588dc47fa848589f8d339e4f4_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtNS0xLTEtMTQ3MTU3_1556a40c-27a2-44ba-b88b-c76ca0218921">104</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItMS0xLTEtMTQ3MTU3_76088ad7-aaf9-4801-b32a-661f0d9bde71">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItMy0xLTEtMTQ3MTU3_350b050a-bcf1-4d86-93bd-931909d0d769">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItNS0xLTEtMTQ3MTU3_a24311d6-37a8-4417-a157-4de771d3242d">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtMS0xLTEtMTQ3MTU3_bdd47eec-9103-40bc-8b27-44cbb89dd25c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtMy0xLTEtMTQ3MTU3_b6200625-3e7d-4379-955a-6a5819b72dbe">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtNS0xLTEtMTQ3MTU3_f0f2f706-0fa3-403d-bad1-57ce6e45c5b1">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YzdkYTZhYmY0MDhjNDg5MWE4MTg2ZGE4YWMzY2RkODdfNjU5NzA2OTc2Njc4MQ_a842777d-9a44-4ae8-915f-4abac5bbe07f">4</ix:nonFraction>&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMS0xLTEtMTQ3MTU3_112d2a3a-374d-4050-9870-415c1cfd91e5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMy0xLTEtMTQ3MTU3_13e80da0-7495-49ba-bb4e-9cbd8d2b02a0">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtNS0xLTEtMTQ3MTU3_b1748ffe-7819-48cb-80aa-77461f35f181">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i017776f20a154be38946329695a6e3bc_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtMS0xLTEtMTQ3MTU3_1bb250e3-9292-4257-ad6f-a4dae0826891">46</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27066680d4f44a88bd6f0bde058453f4_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtMy0xLTEtMTQ3MTU3_972d864e-0188-4fdb-9680-7e0ea7644ab1">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68d3316767394706be72a492bdcd2efd_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtNS0xLTEtMTQ3MTU3_6f1a89fa-bc9e-4bd2-b408-0b7aaa3e3042">34</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtMS0xLTEtMTQ3MTU3_e633172b-caa8-4c14-8ee2-9552d5bd5d09">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtMy0xLTEtMTQ3MTU3_ded37b79-c4fd-40c3-ba0b-0aeebcecbda0">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtNS0xLTEtMTQ3MTU3_dfc98fc1-fcdd-4884-8247-24e844fb5ea9">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctMS0xLTEtMTQ3MTU3_c22eb153-2282-4502-893e-a218a1b03ae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctMy0xLTEtMTQ3MTU3_27ef4869-b320-4cf0-a1a9-80576da39c8c">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctNS0xLTEtMTQ3MTU3_15d47745-2130-4a8d-b170-4ae90486918f">8</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246N2NjMmNiOTI1NDc3NDFhNTg1ZDI3Y2Y0OGMyNDg1MmRfNjU5NzA2OTc2Njc4NQ_9338f577-0f61-46d9-ba33-1f96c45b5045">24</ix:nonFraction>&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMS0xLTEtMTQ3MTU3_6a1b8780-d169-4b3b-b5ac-a7f51fee3a3e">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMy0xLTEtMTQ3MTU3_a8227995-b8b8-4238-a8e8-d6f9608d560e">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtNS0xLTEtMTQ3MTU3_94f47a64-1e3f-40e0-b383-c0459fcfab26">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671a35d442834525849f31bba3176fbe_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktMS0xLTEtMTQ3MTU3_b7ec08b6-e73f-421b-89b2-e718081f401d">102</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6ae84c9f59a4cb4885c9e03cdef73cb_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktMy0xLTEtMTQ3MTU3_028ddd9b-9e9c-4bb7-a3c3-90b7f43b7459">12</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if032321307a24934b26372b254b11bbe_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktNS0xLTEtMTQ3MTU3_6d659973-1440-42e4-b94d-99bca938e97f">114</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i06b8b3ff48e94029843042d968c5bda7_133"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzY0NA_c6f1de78-faa0-4f5e-ab0a-92d4bc960d21" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzY0Ng_7220cf7d-34ea-4b7c-adb1-c99d3f38c3ed" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtMS0xLTEtMTQ3MTU3_0a3506a5-aef1-49b6-9f90-a783bf639c7f">932</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtMy0xLTEtMTQ3MTU3_4a9252bc-c4c4-42c7-afc2-c735ce009590">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtNS0xLTEtMTQ3MTU3_14545488-f088-4d0d-8099-f92f413604c5">3,693</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItMS0xLTEtMTQ3MTU3_1a60259d-5bbd-45bd-9271-1af40f8bb836">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtMS0xLTEtMTQ3MTU3_88f83389-eac7-4223-a120-31a04745346b">933</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtMy0xLTEtMTQ3MTU3_fc19b1ca-f65e-42c6-9857-a0e28dd3cd06">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtNS0xLTEtMTQ3MTU3_e6e10c9c-366e-43ce-abd7-b22dc7c346ec">3,696</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtMS0xLTEtMTQ3MTU3_e065f466-e66b-44ae-a2b4-90fe0adecaf8">279</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtMy0xLTEtMTQ3MTU3_fd9ffde4-f4c8-4ed0-a365-8f5c83f9640d">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtNS0xLTEtMTQ3MTU3_2fd165a7-c860-4986-b513-4063755da460">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtMS0xLTEtMTQ3MTU3_473cb17e-85da-4c9f-9991-f5e8e5cfc352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtMy0xLTEtMTQ3MTU3_0d359041-80f2-4a26-b267-77831aa58a41">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtNS0xLTEtMTQ3MTU3_cda98c6b-c9b8-43fe-8e90-e9e93763cebc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktMS0xLTEtMTQ3MTU3_3b7f7501-f867-4a40-affd-8101f196e1f3">279</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktMy0xLTEtMTQ3MTU3_8d1179ff-57da-423d-983b-8935f1d8c033">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktNS0xLTEtMTQ3MTU3_ebf0b7a2-43cd-4df2-9336-12f34fd82cb2">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTEtMS0xLTE0NzE1Nw_4878608f-107f-49d2-b7fc-486bdb1b3ff9">3.35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTMtMS0xLTE0NzE1Nw_641e4783-5e07-426b-96b5-f2fbcf718b27">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTUtMS0xLTE0NzE1Nw_64275d2e-016b-4553-bba2-f77a5b9e33de">12.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTEtMS0xLTE0NzE1Nw_ed6a9511-f032-4829-9de4-12d88d050887">3.35</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTMtMS0xLTE0NzE1Nw_ea2f14c9-9803-47cd-98d2-076b028ca501">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTUtMS0xLTE0NzE1Nw_f8c3d038-327b-4e56-9e5f-5dc56fbdd29e">12.61</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020 were <ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzI5MQ_58714914-2bb5-47be-9aed-fa49e165e0ad">5</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzI5NQ_a26678fd-dca7-43e9-94ba-13462d84dae4">3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzE2NDkyNjc0NDIzNDg_f1a57583-b226-4621-a177-664453e6b115">6</ix:nonFraction> million, respectively. During fiscal 2022 and 2020, there were <ix:nonFraction unitRef="shares" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-3" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzU0OTc1NTgxMzk2MDE_1701c182-cb34-4381-9176-c281e6023f71">1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-3" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzU0OTc1NTgxMzk2MTY_efc2b0da-d879-4e65-98ef-f745c05f7bdf">2</ix:nonFraction> million potentially dilutive employee stock options, restricted share units and performance share units, respectively, not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal years.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div id="i06b8b3ff48e94029843042d968c5bda7_136"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzQ_e784333a-c5c6-4659-80c5-c5c6c0052faa" continuedAt="i465c3389480d400fb80880c501ac694b" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">13. Segment Information </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are principally managed on a products and services basis and are comprised of <ix:nonFraction unitRef="segment" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzEwMg_5e64b6dc-eba0-4a58-b5d9-13dcb65de422"><ix:nonFraction unitRef="segment" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzEwMg_765cef87-0218-4706-871c-886e2c395149">two</ix:nonFraction></ix:nonFraction> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzNDA_3164e035-9965-427a-82b7-80906bf920a5" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtMS0xLTEtMTQ3MTU3_802d0497-81e8-429a-bde9-18af3c649845">165,491</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtMy0xLTEtMTQ3MTU3_2af607b4-d231-438e-80ab-616003345e5b">145,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtNS0xLTEtMTQ3MTU3_c9aa5c6d-bfc1-41c4-bb43-05533397f080">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItMS0xLTEtMTQ3MTU3_40cbfe6c-2db2-4813-99a5-bc556dd54934">15,887</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItMy0xLTEtMTQ3MTU3_7193016e-1541-481b-8847-d80f4b69d1a0">16,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItNS0xLTEtMTQ3MTU3_a3d69dee-48a1-4d8a-821d-b8e7c8a12a40">15,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtMS0xLTEtMTQ3MTU3_a3578fb7-eb42-4844-87e0-35b8e2790670">181,378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtMy0xLTEtMTQ3MTU3_f7cbf0fb-26b9-4edb-9443-ec606957d2ec">162,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtNS0xLTEtMTQ3MTU3_d08b0776-060e-471a-9b79-bcf117002a2e">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtMS0xLTEtMTQ3MTU3_e60a7f95-4204-472e-be0f-11eb9f63c48d">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtMy0xLTEtMTQ3MTU3_05276cc6-fe8d-4b30-9202-565728fe6f28">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtNS0xLTEtMTQ3MTU3_1a589bf2-dcb0-4183-9e9c-76844fdd0fee">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtMS0xLTEtMTQ3MTU3_f21fcc0b-1d4e-411c-8ab3-e2a2f7378835">181,364</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtMy0xLTEtMTQ3MTU3_5b3906b0-f6ad-482b-85a7-9f8dd9da3375">162,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtNS0xLTEtMTQ3MTU3_0b16bbc0-7481-40f3-a231-34dd0069a388">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><ix:continuation id="i465c3389480d400fb80880c501ac694b" continuedAt="i44188a30b8be4f43b0fedf5ca6323428"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMjk_f4817a91-c140-48c6-a8d4-46c765b3ac3c" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMDg_2177b1e3-8af4-4550-a244-9c65176266f6" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14af28fc8088402b8cf9586da815c628_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtMS0xLTEtMTQ3MTU3_596f32f7-7375-4884-b333-9243fa2945b4">164,580</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1375be2585e496ba632f589f37aecdd_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtMy0xLTEtMTQ3MTU3_2e75dcdf-112d-4870-8845-51974dc1eec8">144,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b64a0ab009497cb6651f141753bb14_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtNS0xLTEtMTQ3MTU3_0540a852-daf3-4db8-adc5-9d9248caa142">136,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ab01785f1e4a10a2f627369a131981_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItMS0xLTEtMTQ3MTU3_942d2826-d1eb-499a-83da-e859846fa5da">911</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe4938f791c47a7a2e7be341d8ae001_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItMy0xLTEtMTQ3MTU3_f1a04dbb-3f38-4cca-af12-32eb5687aba3">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fa0488c0b0421a9bd978c6e75ec078_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItNS0xLTEtMTQ3MTU3_a4ac78de-7f70-4c7c-9e36-e7b2af2e5946">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtMS0xLTEtMTQ3MTU3_802d0497-81e8-429a-bde9-18af3c649845">165,491</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtMy0xLTEtMTQ3MTU3_2af607b4-d231-438e-80ab-616003345e5b">145,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtNS0xLTEtMTQ3MTU3_c9aa5c6d-bfc1-41c4-bb43-05533397f080">137,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18eb292c9cd45549a3cce1a8564d34a_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtMS0xLTEtMTQ3MTU3_d1581670-6627-4eb1-9455-134a4027b3a3">13,462</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf54a140331447bc971da869fab4170b_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtMy0xLTEtMTQ3MTU3_7c39c619-24e3-4f3a-bc34-a6e9fb4de5b2">14,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a872d654474220917795caa5437ced_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtNS0xLTEtMTQ3MTU3_4887eb46-e71c-4b27-bffe-499fb6b53bd5">13,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d75341c0824694ace8cacae3c3cff4_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtMS0xLTEtMTQ3MTU3_acb60276-615d-4d16-8d3f-459154139908">2,425</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1190aafabb474bb7daeda0ceb4428e_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtMy0xLTEtMTQ3MTU3_02ec3b41-6b21-4a03-99c7-6a5897da68bd">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c84b6027bc4bfc9c7fef1cc6232649_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtNS0xLTEtMTQ3MTU3_ca201509-309b-4c3c-934c-2750aeefd319">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtMS0xLTEtMTQ3MTU3_40cbfe6c-2db2-4813-99a5-bc556dd54934">15,887</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtMy0xLTEtMTQ3MTU3_7193016e-1541-481b-8847-d80f4b69d1a0">16,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtNS0xLTEtMTQ3MTU3_a3d69dee-48a1-4d8a-821d-b8e7c8a12a40">15,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctMS0xLTEtMTQ3MTU3_a3578fb7-eb42-4844-87e0-35b8e2790670">181,378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctMy0xLTEtMTQ3MTU3_f7cbf0fb-26b9-4edb-9443-ec606957d2ec">162,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctNS0xLTEtMTQ3MTU3_d08b0776-060e-471a-9b79-bcf117002a2e">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtMS0xLTEtMTQ3MTU3_e60a7f95-4204-472e-be0f-11eb9f63c48d">14</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtMy0xLTEtMTQ3MTU3_05276cc6-fe8d-4b30-9202-565728fe6f28">16</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtNS0xLTEtMTQ3MTU3_1a589bf2-dcb0-4183-9e9c-76844fdd0fee">17</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktMS0xLTEtMTQ3MTU3_f21fcc0b-1d4e-411c-8ab3-e2a2f7378835">181,364</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktMy0xLTEtMTQ3MTU3_5b3906b0-f6ad-482b-85a7-9f8dd9da3375">162,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktNS0xLTEtMTQ3MTU3_0b16bbc0-7481-40f3-a231-34dd0069a388">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzA_029f5c7f-1f82-4e0e-8dd9-0901a015aa1d" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5a57d0101144d68ed8cbf6f33a252b_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtMS0xLTEtMTQ3MTU3_91a8c0eb-2d7f-49e3-ba81-016af9276183">176,855</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6012e2f082d64586a52d2f99291c081f_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtMy0xLTEtMTQ3MTU3_a4d46fad-5a4f-42ae-845c-606bc780f07e">157,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic772b6d04449407f823eef4bab315a1c_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtNS0xLTEtMTQ3MTU3_2eaa89d6-2d9c-474c-bb71-102ec808a414">148,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8120134644a4b72b67cf151f13a9267_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItMS0xLTEtMTQ3MTU3_19eba950-e209-42a7-a8b7-3c60a47a4dc6">4,523</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfa5d379fec4924976b8c213fb2a55e_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItMy0xLTEtMTQ3MTU3_1e3a814b-4a8f-4dca-99e5-74b510558b14">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a97b6e528884b40b6ab715fd4b1afbf_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItNS0xLTEtMTQ3MTU3_dad34951-a7d8-4083-bd90-289ce0565e6d">4,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtMS0xLTEtMTQ3MTU3_4c9bef9e-0ff9-4bc8-8223-eb2892d6ec77">181,378</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtMy0xLTEtMTQ3MTU3_b50d0e28-de9b-4ce4-b2e2-843386d08900">162,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtNS0xLTEtMTQ3MTU3_8492704f-5491-47dc-a02e-770a42434670">152,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtMS0xLTEtMTQ3MTU3_a7ef9957-f737-4816-8839-c2545c2e63b9">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtMy0xLTEtMTQ3MTU3_616a73a0-3464-44e2-9a95-84b5a979a155">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtNS0xLTEtMTQ3MTU3_f9cf3ef4-82af-40fc-acfe-cbae18bd2b47">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtMS0xLTEtMTQ3MTU3_e3a97ac1-f755-436d-a4e9-437b5b85191d">181,364</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtMy0xLTEtMTQ3MTU3_fa1c2bbc-9ac5-4b31-8f83-310579128152">162,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtNS0xLTEtMTQ3MTU3_755935bb-6f43-4cda-8301-9cbd26bb85dc">152,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate the following items to our segments: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">last-in first-out, or ("LIFO"), inventory charges/(credits);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i4f0d63f2484f4781b52456c257c21f31_D20190701-20200630" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ4ODI_8010f5e6-b16c-4273-b5d1-5f14430745b4">85</ix:nonFraction>&#160;million during fiscal 2020;</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630" decimals="-6" name="cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MDY_c4562e87-a92b-42ba-a4cd-a5b353783df7">41</ix:nonFraction>&#160;million during fiscal 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">restructuring and employee severance;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">amortization and other acquisition-related costs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">impairments and (gain)/loss on disposal of assets; in connection with goodwill impairment testing for the Medical Unit as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_106">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5Mzk_45ba1b67-4027-473a-b19d-a383f27d9d7a">2.1</ix:nonFraction>&#160;billion during fiscal 2022; in connection with the divestiture of the Cordis business, we recognized a $<ix:nonFraction unitRef="usd" contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630" decimals="-6" name="cah:WriteDownOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5NjA_7bad20bc-0a3e-49e9-8cfc-17a58b49a584">60</ix:nonFraction>&#160;million pre-tax write-down of the net assets held for sale</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_118">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzQ1ODM_a222c96c-009b-42fc-abc1-1161d3c2568a">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU0OTc1NTgxNDY4MzQ_add96698-bb05-402d-a363-7d8b0449b70a">5.63</ix:nonFraction> billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other (income)/expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">interest expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">loss on early extinguishment of debt;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_100">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a $<ix:nonFraction unitRef="usd" contextRef="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630" decimals="-6" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MDk_31a942fc-450e-4c5e-bb74-131c99b443e0">579</ix:nonFraction>&#160;million pre-tax gain ($<ix:nonFraction unitRef="usd" contextRef="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630" decimals="-6" name="cah:GainonDivestitureAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MjM_0a0ecbe9-bd17-4ff2-8183-11c024ca84d9">493</ix:nonFraction>&#160;million after tax) during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">provision for/(benefit from) income taxes </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="cah:ProjectCostsOnInvestmentAndOtherSpending" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3MjQ_09d2547a-ba54-47ad-991c-f5e45ed0b455">50</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="cah:ProjectCostsOnInvestmentAndOtherSpending" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3Mjg_e7f300f0-f5f9-435c-b5a2-ec35a1696a1a">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="cah:ProjectCostsOnInvestmentAndOtherSpending" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3MzU_f3c05a71-4d20-40ac-9a29-b51a4c959783">69</ix:nonFraction> million for fiscal 2022, 2021 and 2020, respectively. </span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzNDI_4ac12fe3-5b7e-415e-ad26-a86cc56fd264" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:51.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtMS0xLTEtMTQ3MTU3_3d740c4b-f275-4967-8544-bab7f12b8042">1,770</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtMy0xLTEtMTQ3MTU3_8e33472c-c048-4666-a705-1b2a55bcc258">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtNS0xLTEtMTQ3MTU3_02357bf8-1ff8-4514-98d9-76a76a297b25">1,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItMS0xLTEtMTQ3MTU3_f1bb65d1-ced6-472a-9c1b-8cfa573df6aa">216</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItMy0xLTEtMTQ3MTU3_b60d226b-267a-4407-b0fa-0156e9a53d37">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItNS0xLTEtMTQ3MTU3_f9c2e494-9028-4bcc-bb29-6af061ce46d7">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtMS0xLTEtMTQ3MTU3_68544d04-c691-4d92-8631-f8b2dd3eeedf">1,986</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtMy0xLTEtMTQ3MTU3_a83dc327-4220-4e9f-8a06-4e8efef8b84e">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtNS0xLTEtMTQ3MTU3_847b1f0c-8771-4fb4-b0fa-41f6b6f9654a">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtMS0xLTEtMTQ3MTU3_17be8ffa-b904-4729-a0c8-a4d0794a3e24">2,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtMy0xLTEtMTQ3MTU3_01dadb19-2c9b-4cd6-9441-faf6b7386591">1,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtNS0xLTEtMTQ3MTU3_9e82aa57-2304-4c8d-a2ac-1ab2e8350da4">6,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtMS0xLTEtMTQ3MTU3_33349ef3-6b63-41f3-907a-bd783f74705f">596</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtMy0xLTEtMTQ3MTU3_a07d0d59-d8f7-4848-b226-cb891e9cd684">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtNS0xLTEtMTQ3MTU3_d1550003-c8e1-4ad8-b1ac-004e4c8d9d2f">4,098</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="i44188a30b8be4f43b0fedf5ca6323428"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMjA_c6b7cc63-4984-4052-ba02-5d3f626cccf3" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:47.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtMS0xLTEtMTQ3MTU3_f4999d69-0581-46c9-a14e-85f19884aff8">193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtMy0xLTEtMTQ3MTU3_e5fede83-38db-4c44-98d4-4c2891723cce">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtNS0xLTEtMTQ3MTU3_4111bdac-6bd1-4d34-b413-27df27bd9a57">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItMS0xLTEtMTQ3MTU3_a8ff5339-9dce-4346-ac26-d05e2c107e29">216</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItMy0xLTEtMTQ3MTU3_29aef5c9-6bbd-47d9-b305-0092ddeae768">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItNS0xLTEtMTQ3MTU3_cca26091-db40-4db1-a0d7-0483b3051ebd">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtMS0xLTEtMTQ3MTU3_107e492e-8da5-4d45-80af-490a2f748716">283</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtMy0xLTEtMTQ3MTU3_262408cc-831f-4a7c-9976-48d64b6ad979">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtNS0xLTEtMTQ3MTU3_00e2555e-1770-4e27-9097-4f7b3a613a39">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtMS0xLTEtMTQ3MTU3_296ffaa9-bb38-4fc7-9fdf-b7bab24f03f5">692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtMy0xLTEtMTQ3MTU3_273e7863-cf7c-4472-97b2-33dfa42703a8">783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtNS0xLTEtMTQ3MTU3_97bc9ed8-62a1-4904-864c-b5393e48d223">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:47.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtMS0xLTEtMTQ3MTU3_0b40e75b-e0f1-4df8-85bd-c111123b5c32">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtMy0xLTEtMTQ3MTU3_b30afddb-74eb-4436-8df8-fdf5a0a8e53e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtNS0xLTEtMTQ3MTU3_121ecb22-9e67-4287-b1a0-48978f3ca2d5">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItMS0xLTEtMTQ3MTU3_732ffab1-940c-4e58-8e5a-8e668cf3b536">140</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItMy0xLTEtMTQ3MTU3_1672bb2a-51b6-405c-ae19-ce99648581ef">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItNS0xLTEtMTQ3MTU3_a337a1a6-06e2-4c60-8fec-b5d1f197f3a5">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtMS0xLTEtMTQ3MTU3_23c2d8be-001a-4032-a123-0b220b172687">168</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtMy0xLTEtMTQ3MTU3_61f34419-6579-48e9-b589-63be9a8f2bac">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtNS0xLTEtMTQ3MTU3_95833bbe-8ea2-4e37-b05f-9b80b6dabb60">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtMS0xLTEtMTQ3MTU3_f12a77d0-0ead-42ef-9210-460f247c4aab">387</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtMy0xLTEtMTQ3MTU3_af940f12-1cf5-493a-b5bf-7b7eab0997ba">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtNS0xLTEtMTQ3MTU3_d46cf2fc-fccd-4902-af9e-2477b6cfedc9">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzM_3f7f88ad-8328-47e0-8a58-ec707e9a1f31" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:46.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedce1d5b11c3477faba70a05739a2a83_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtMS0xLTEtMTQ3MTU3_bf6fb6e8-e754-43df-be98-9e84eaeab145">26,409</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if72f2f625f914e10845cc7ec67500cb9_I20210630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtMy0xLTEtMTQ3MTU3_24a640aa-6e9a-4483-b8c0-98fe3a674193">23,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad6131da723466fbfb29da932695b7c_I20200630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtNS0xLTEtMTQ3MTU3_9a3d8ba8-64ac-4887-80b1-53b4d031fe0f">22,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61201f0b4adc4f448c19177911dff7b9_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItMS0xLTEtMTQ3MTU3_976c8bb0-c679-4730-b068-bc1eefdd5ec8">11,632</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0b4a7378184981b9c5ac2d3f486cba_I20210630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItMy0xLTEtMTQ3MTU3_9d0e15f9-ade3-43e2-96a6-375ca094a7d1">15,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifddfe552f3a644c3aabf1bd148586afd_I20200630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItNS0xLTEtMTQ3MTU3_1b727132-9254-439e-9969-50e9faf72eb5">14,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief926b64f91a4cdb97a0f010db30b234_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtMS0xLTEtMTQ3MTU3_6eaaba25-c295-4473-b6da-39d29d44e221">5,837</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8396dd140b7c4e5088714d90bba871dd_I20210630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtMy0xLTEtMTQ3MTU3_e186f8d3-3e6b-4eb4-acd6-a04251bf60c4">5,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9470b5d20374655a7021f0f36d0030f_I20200630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtNS0xLTEtMTQ3MTU3_f3a873d8-8d89-486b-97ba-e51339a8edaa">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtMS0xLTEtMTQ3MTU3_58685e24-236f-4d3b-b20e-839be72caf88">43,878</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtMy0xLTEtMTQ3MTU3_d8420e24-ab7e-497a-8825-03299fb68d83">44,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtNS0xLTEtMTQ3MTU3_00a7a8b8-368b-44ea-966b-88358094112d">40,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $<ix:nonFraction unitRef="usd" contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYxMTQ_08b01a59-7cf1-4856-91e8-b15176d779a6">1.1</ix:nonFraction> billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYyOTc_a0ce00a3-b9e0-40d6-8e20-f212ecf42f3a" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:46.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84a995d73354904960f0fc24a118169_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtMS0xLTEtMTQ3MTU3_12b4e6a6-8edb-48da-aa93-883a2bd34da5">1,976</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10081408aa87434ab81112bdd4bddd79_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtMy0xLTEtMTQ3MTU3_69c283d4-3c43-4535-a0ca-25a96841c09b">1,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf9ed3e3c2146e69762157a21265754_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtNS0xLTEtMTQ3MTU3_2538bb70-b1eb-438a-9340-614075a6e701">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4540961b5e6b4808a8026bb9516ae3e9_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItMS0xLTEtMTQ3MTU3_d900a4fc-d0e0-4070-aa11-04cf17dd5fad">385</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b498db236d3482f9f42a2a0a3f882f5_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItMy0xLTEtMTQ3MTU3_66ffd8c3-9bb1-418e-b369-c7497f5d31b1">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0593a5c8012d425ebb9b526021b07458_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItNS0xLTEtMTQ3MTU3_8a50b2da-658d-4d69-a8a7-f431981ab2e2">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtMS0xLTEtMTQ3MTU3_3145d0a2-08f9-47d8-a069-128a27f263d9">2,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtMy0xLTEtMTQ3MTU3_ba19bdcc-6a6c-4da7-bdbc-b4e7ca9f9c2a">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtNS0xLTEtMTQ3MTU3_83315ab1-7bd7-4b48-88d4-87ee9c84a487">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i06b8b3ff48e94029843042d968c5bda7_139"></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNTA_9c16f1cf-4e33-4fe6-b3b2-dbad08f1307c" continuedAt="i08d635d739ea4433ad1edce4e513de34" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">14. Share-Based Compensation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i7f6f204ca12940be95285479dd9fd419_I20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzE0Nw_65bfcdc9-7121-454b-830d-c34174ad9fb3">24</ix:nonFraction> million shares remain available for future grants under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan ("2021 LTIP"). Under the 2021 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only <ix:nonFraction unitRef="shares" contextRef="i73fc8886bd8f4f4e8e6f8813d56985a8_I20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQ3NA_7a467323-e251-41c7-b209-9154c7a5dc56">10</ix:nonFraction> million shares could be issued under awards other than stock options while <ix:nonFraction unitRef="shares" contextRef="i93a070ccd43d454bb5c9cb38b3cf6771_I20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzU0NA_dac23c1b-f0b0-4a4c-9146-658701fd1deb">24</ix:nonFraction> million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were <ix:nonFraction unitRef="shares" contextRef="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_799065df-b3df-423f-9f02-a128ba91c504"><ix:nonFraction unitRef="shares" contextRef="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_a46e897c-51e7-404d-a88c-d53438d20737"><ix:nonFraction unitRef="shares" contextRef="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_f11e1cfb-d270-45d9-8f9e-f380471d8f8b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> stock options granted to employees during fiscal 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwMjg_d9556d7e-58a5-4931-a1b4-b73482178c62" continuedAt="i11b9743fd15b4654a34c40d5c98eb90d" escape="true">The following table provides total share-based compensation expense by type of award:</ix:nonNumeric></span></div></ix:nonNumeric></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"><ix:continuation id="i08d635d739ea4433ad1edce4e513de34" continuedAt="ifd51b43e12df4a6284d36a96a7157dde"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i11b9743fd15b4654a34c40d5c98eb90d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:58.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtMS0xLTEtMTQ3MTU3_174b6071-ec7b-4a93-ac38-ce3808ad392b">69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtMy0xLTEtMTQ3MTU3_aca71e04-f67d-4dda-b193-cb14d75badff">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtNS0xLTEtMTQ3MTU3_80a5d375-b1d8-418d-86ef-2ad71118598b">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMS0xLTEtMTgxNTM2_f59f082e-bfac-4770-ad10-d40584d36243">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMy0xLTEtMTgxNTM2_430ad74b-b3c3-4ccf-8286-9bfd288b2991">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItNS0xLTEtMTgxNTM2_14322383-2105-4999-8c48-16547a7b1230">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMS0xLTEtMTQ3MTU3_a5d9faad-4738-4bad-8dfd-1abd2d9a70f2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMy0xLTEtMTQ3MTU3_a7e6f1af-608a-4b2e-b6b3-dc1797d4033b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItNS0xLTEtMTQ3MTU3_56275f11-da54-473f-8a10-f344fd4b8d07">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtMS0xLTEtMTQ3MTU3_df386620-b6f8-4113-bb41-636d09c817be">81</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtMy0xLTEtMTQ3MTU3_8135c3c1-7d46-41d4-85e7-89a2f13c514c">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtNS0xLTEtMTQ3MTU3_a9746c13-32f5-4a7a-8304-d73b9bd6dd5d">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total tax benefit related to share-based compensation was $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg4Mg_97d1d3ee-c8a4-4acf-a0bc-9fcf8ba2f1d2">12</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg4Ng_f8c52f48-af9b-441c-809d-93274766cd70">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg5Mw_1b52f609-4fa5-4149-9a18-b84d55f0cdad">16</ix:nonFraction> million for fiscal 2022, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share units granted under the Plans generally vest in equal annual installments over <ix:nonNumeric contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEwNTU_4cb90cd3-a26d-4a7a-a5cb-b65f7df3edbf">three years</ix:nonNumeric>. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNzE_51b52274-0e31-4a09-8a92-12135da4e144" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:51.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzEtMS0xLTEtMTQ3MTU3_17a59c09-d5fd-440f-b915-985d248cf8bb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzEtMy0xLTEtMTQ3MTU3_7bc585e5-01dc-4a2d-a68d-e2264b706ee4">45.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzItMS0xLTEtMTQ3MTU3_29f918da-403f-417e-beda-eba1cef76681">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzItMy0xLTEtMTQ3MTU3_846d1029-91f4-4c36-9c34-a960a7a6c6f0">53.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzMtMS0xLTEtMTQ3MTU3_a2c11046-abea-4d8b-96b5-ada7c4845342">1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzMtMy0xLTEtMTQ3MTU3_d1d9d9d5-1bcb-4edb-b9ea-07c4b6cb6061">49.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzQtMS0xLTEtMTQ3MTU3_4547c4f2-0add-4afd-9dae-69778e5d4d77">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzQtMy0xLTEtMTQ3MTU3_4e6c7bb0-1fc1-4b97-90df-b3b338230b24">48.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzUtMS0xLTEtMTQ3MTU3_66e28f46-69ed-44f4-9cbb-56ddb7af2208">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzUtMy0xLTEtMTQ3MTU3_c118f47e-13f0-4e63-a8ad-1b930eb15f94">49.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzYtMS0xLTEtMTQ3MTU3_b95a4cbe-2e06-4b04-b088-a347c782612b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzYtMy0xLTEtMTQ3MTU3_fb9282ec-3a5d-437c-8491-f3db336b41c4">51.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzctMS0xLTEtMTQ3MTU3_5c25bb20-c461-444d-a607-c2978a3b3092">2</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzctMy0xLTEtMTQ3MTU3_a9ecef00-8c95-4e11-8738-044bb8a1d168">49.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzgtMS0xLTEtMTQ3MTU3_8c91c47a-8061-4d33-a3d5-9964c144f97d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzgtMy0xLTEtMTQ3MTU3_fd10d617-711b-44e6-acb2-4e6bdea7429d">50.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzktMS0xLTEtMTQ3MTU3_b791839b-a404-440b-a45a-7e948b8c3f9f">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzktMy0xLTEtMTQ3MTU3_15b6bd81-629e-4323-ab47-b8f87db5ccd1">46.03</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwODk_bd6b3337-6154-4d23-bbcc-ecf3b6005f5e" escape="true"><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:53.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtMS0xLTEtMTQ3MTU3_65038797-0b64-4011-bdcd-7ccff006e023">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtMy0xLTEtMTQ3MTU3_e0cc533f-3555-46bd-a339-dba061f22c42">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtNS0xLTEtMTQ3MTU3_615cee8e-cd6d-421a-b76a-ba86ee1aba8c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItMS0xLTEtMTQ3MTU3_c04a6d94-eeee-4a68-8a41-61c0f4f7c51d">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItMy0xLTEtMTQ3MTU3_befda654-20d8-4997-afdd-3aeedc99e6b7">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItNS0xLTEtMTQ3MTU3_017b3b08-2f1e-409a-b562-dac1fac71658">2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtMS0xLTEtMTQ3MTU3_ad84d0d3-0413-43ce-ac08-e4c3b70e44bd">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtMy0xLTEtMTQ3MTU3_13160a97-4161-4f64-98f0-97924b365b0d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtNS0xLTEtMTQ3MTU3_679d67ca-677a-4498-bb61-693d1cd558d4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" xsi:nil="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwMjE_cfaa8186-fff6-49af-9b19-370c1e818bcf" escape="true"></ix:nonNumeric>Performance Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units generally vest over a <ix:nonFraction unitRef="vestingperiods" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="INF" name="cah:VestingPeriodinyearsforShares" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzMwNDk_03b2d9b3-3fa9-434a-826e-dc06997c357c">three</ix:nonFraction>-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from <ix:nonFraction unitRef="number" contextRef="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzMyMTI_22cc094e-303f-4943-a0e2-c4cd44697a87">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i61b77b415b584f6ab312fd1c96fca6e3_D20190701-20200630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDg0MDY_06a0cb84-0c1e-4af3-9295-002a4b1a6511"><ix:nonFraction unitRef="number" contextRef="i43325093a8ee44ed8f85cdbf2059ce09_D20200701-20210630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDg0MDY_b4798d46-7a77-4efd-9c6d-98bebd52f5e5">240</ix:nonFraction></ix:nonFraction> percent of the target award amount for fiscal 2020 and 2021 grants and <ix:nonFraction unitRef="number" contextRef="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDgwNzk_22cc094e-303f-4943-a0e2-c4cd44697a87">zero</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i1ad9e1e9c9c24a5a93fb7c80fa81eeeb_D20210701-20220630" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDgyNzY_f58a9927-1bf7-4fb5-ba71-bdb898ee1079">234</ix:nonFraction> percent for the fiscal 2022 grant. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:24.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Financial Statements</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.214%"><ix:continuation id="ifd51b43e12df4a6284d36a96a7157dde"><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNDg_32f73e9f-9ddc-4908-aa64-05e54ff7b51f" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:49.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzEtMS0xLTEtMTQ3MTU3_5d07ce3c-ae5b-4039-b116-a03c9268c690">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzEtMy0xLTEtMTQ3MTU3_780c2a17-48fa-4b8a-9095-4e5335850da3">54.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzItMS0xLTEtMTQ3MTU3_95c703a0-e40d-4413-8b54-7b48e8645f50">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzItMy0xLTEtMTQ3MTU3_033ea652-577d-4a74-a8aa-759a8ea11bd7">55.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzMtMS0xLTEtMTQ3MTU3_ec0ad549-de4a-475b-847f-111713b587d6">0.1</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzMtMy0xLTEtMTQ3MTU3_fbbade5a-cfed-4397-a240-e0b304c926c8">42.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzQtMS0xLTEtMTQ3MTU3_214522f1-94b1-4cb8-945b-bee5fd042a9d">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzQtMy0xLTEtMTQ3MTU3_2bcba604-86fc-4c80-a8bc-00edf1ba19e3">53.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzUtMS0xLTEtMTQ3MTU3_caa5022c-387e-4333-957c-a238b0302ec3">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzUtMy0xLTEtMTQ3MTU3_1801cf14-be7f-4e24-8108-f58dfd85eec4">54.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzYtMS0xLTEtMTQ3MTU3_18927200-5ab6-486d-8730-5035e07a501f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzYtMy0xLTEtMTQ3MTU3_975f691e-6b09-4100-bd76-32af4f5d0597">51.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzctMS0xLTEtMTQ3MTU3_33316acc-d76f-4da6-99d8-3ccfc793e92d">0.3</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzctMy0xLTEtMTQ3MTU3_44a4a8c0-3923-4e89-9c55-6abee7181b18">52.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzgtMS0xLTEtMTQ3MTU3_bdf39b7a-a3e1-47ab-82be-9e9d63c91be9">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzgtMy0xLTEtMTQ3MTU3_ad968f50-8bce-4d74-8d6b-683ace7582b0">52.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i056274b9166742cdaee278d9b684a643_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzktMS0xLTEtMTQ3MTU3_4203e866-3e86-41c9-8125-8ce2eda5be0a">1.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i056274b9166742cdaee278d9b684a643_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzktMy0xLTEtMTQ3MTU3_d26ca77b-dd0c-48e7-8aa9-7a0355e35ec8">54.32</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="cah:AdditionalPerformanceShareUnitsDataTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNTc_37214633-7d40-44b5-82df-a67211ddf0cb" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:58.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.283%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056274b9166742cdaee278d9b684a643_I20220630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtMS0xLTEtMTQ3MTU3_c545b16d-b096-43cc-bed0-5edaee3a8fa2">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtMy0xLTEtMTQ3MTU3_a8da6a90-a279-473f-9081-b7a47b69b9a2">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtNS0xLTEtMTQ3MTU3_273664f5-5a89-4c38-8f93-d87cb89169f6">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItMS0xLTEtMTQ3MTU3_fae84110-3fae-4895-99e5-3202996b0e4e">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItMy0xLTEtMTQ3MTU3_e45d09d3-d93a-4412-ad10-219b0ee9a412">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItNS0xLTEtMTQ3MTU3_6d479277-be16-4eb0-835a-7e75740e9836">2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtMS0xLTEtMTQ3MTU3_f07931ee-5e63-4623-9d80-095b843d7cc9">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtMy0xLTEtMTQ3MTU3_93fb41f9-ba83-41bd-9a71-2da496602944">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtNS0xLTEtMTQ3MTU3_463d7366-8547-47fe-974f-fd187d2cfc8d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee Retirement Savings Plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986 and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was $<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzODI_a8d8d4aa-2b46-4801-a4aa-90c50d22178b">60</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzODg_ea87b048-126b-4ff4-b00e-d692aaa8e2e9">55</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzOTY_fb0e5cf8-b351-45c6-9376-18fe6cc24ae2">66</ix:nonFraction> million for fiscal 2022, 2021 and 2020, respectively.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.215%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:24.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Schedule II</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation and Qualifying Accounts</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzYzNg_f29a323b-7bff-450c-9707-3bc695238357" continuedAt="iabee3afac5a6471a899db2ac3dc8b966" escape="true"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Cardinal Health, Inc. and Subsidiaries</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Schedule&#160;II - Valuation and Qualifying Accounts</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to Costs<br/>and Expenses (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other Accounts&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions&#160;(3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItMS0xLTEtMTQ3MTU3_095b0882-9a8c-48a0-99b7-5a8a966ceba2">243</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItMy0xLTEtMTQ3MTU3_6f2c07f9-9df1-4719-a65d-c07501117769">154</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItNS0xLTEtMTQ3MTU3_9791b89d-9ecc-49e6-8fcb-649865a5e09b">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItNy0xLTEtMTQ3MTU3_b2cbd840-c533-4144-b78b-30f755b639a9">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63aae49541134c39aa2c99f778658cc5_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItOS0xLTEtMTQ3MTU3_100e5a6b-faae-44df-9f8d-7904ec1758b9">273</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtMS0xLTEtMTQ3MTU3_767817c6-dc92-496b-a6b5-25adc90ecac1">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtMy0xLTEtMTQ3MTU3_009c1d5e-4721-460a-a85e-6dd2b5178f58">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtNS0xLTEtMTQ3MTU3_b68ea4e4-5d32-42ff-ad80-b34a1f509e6c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtNy0xLTEtMTQ3MTU3_59067f45-5240-4225-a4bc-ee30cba621b5">5</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtOS0xLTEtMTQ3MTU3_120243f6-03da-43c2-8554-dbe3d2c5d702">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c301733ef2486eb8a91bd315f448fa_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtMS0xLTEtMTQ3MTU3_1ee231df-cd6e-475d-9580-66a1c1c565f7">689</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtMy0xLTEtMTQ3MTU3_1e57442b-c774-4bac-b447-676dc8a16850">2,359</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtNS0xLTEtMTQ3MTU3_242f77e3-f518-4d71-a690-56bf09068354">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtNy0xLTEtMTQ3MTU3_a54b8ba7-b36c-4701-af58-13720c1bc170">2,431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia953d01035744830b89e0d49aa3ef798_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtOS0xLTEtMTQ3MTU3_30d2605d-04bd-4154-a8b3-e0d3274040c7">617</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtMS0xLTEtMTQ3MTU3_ac4a1201-e3ac-4e13-8d61-2af63b585124">944</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtMy0xLTEtMTQ3MTU3_4112809d-a394-49af-bb9e-82fc47435808">2,514</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtNS0xLTEtMTQ3MTU3_a528193f-579a-4615-902e-5f124d91aef3">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtNy0xLTEtMTQ3MTU3_e0b05856-5ba3-4fc8-ab07-217e9504c139">2,561</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtOS0xLTEtMTQ3MTU3_64b2fa3c-bab3-42f7-bfb3-2f4f71860ebd">898</ix:nonFraction></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b79de0e173c49a293e4e8121d68cf5d_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktMS0xLTEtMTQ3MTU3_6e4dd675-79a0-4b5c-a56d-6ad188ad6778">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktMy0xLTEtMTQ3MTU3_44f9a675-5243-4557-b2ee-faeecf4d02da">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktNS0xLTEtMTQ3MTU3_9c6c073d-8fab-4cc0-9ee8-f8ebec03200d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktNy0xLTEtMTQ3MTU3_10d2a5c8-04a5-4bdf-b969-b1041a04b4c6">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktOS0xLTEtMTQ3MTU3_095b0882-9a8c-48a0-99b7-5a8a966ceba2">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5929938d842bca82c533a67d3e5ad_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTEtMS0xLTE0NzE1Nw_61606fec-2a6e-4f2c-bb5c-3f547bc3a991">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTMtMS0xLTE0NzE1Nw_7d7b3030-b605-4b31-9140-dec22a2e0a02">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTUtMS0xLTE0NzE1Nw_f6286dd8-c1ad-414c-a222-532d83961a96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTctMS0xLTE0NzE1Nw_67c19b77-6793-4a78-8ef6-4512c49cd418">20</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTktMS0xLTE0NzE1Nw_767817c6-dc92-496b-a6b5-25adc90ecac1">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia768abc477b149ba8b237395ef925335_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTEtMS0xLTE0NzE1Nw_fc8401ab-10f9-4d51-bf54-ec30c8c00a08">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTMtMS0xLTE0NzE1Nw_b2be865b-d662-439e-9976-8ae081a3a484">2,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTUtMS0xLTE0NzE1Nw_a0d25d5e-60a3-49a9-89cf-34316964a75a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTctMS0xLTE0NzE1Nw_08ead8e3-2e74-48eb-abcc-dd91df0bc66a">2,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c301733ef2486eb8a91bd315f448fa_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTktMS0xLTE0NzE1Nw_1ee231df-cd6e-475d-9580-66a1c1c565f7">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTEtMS0xLTE0NzE1Nw_6b66b394-4967-4430-810c-90931814b5c6">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTMtMS0xLTE0NzE1Nw_9e6e998b-f1f1-4c14-a487-af4a43075c96">2,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTUtMS0xLTE0NzE1Nw_09c42e9a-7bab-4dcf-9887-6a9770750853">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTctMS0xLTE0NzE1Nw_a8451c2d-ff00-401d-801e-c081359e2bd6">2,488</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTktMS0xLTE0NzE1Nw_c116ddf8-06ec-45b5-9237-390aef83333a">944</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14268b63f5e4696bfec9d26f5249db2_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTEtMS0xLTE0NzE1Nw_c13d5aec-2698-4e30-b03a-cebcb9d003c2">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTMtMS0xLTE0NzE1Nw_fb7cc82f-115d-48ec-83db-c3d3bf41f5a4">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTUtMS0xLTE0NzE1Nw_878a21e3-9d0e-412a-91fc-eb586787160d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTctMS0xLTE0NzE1Nw_821e7bcc-602c-4106-aab9-addec033b6dd">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b79de0e173c49a293e4e8121d68cf5d_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTktMS0xLTE0NzE1Nw_f9d9b7df-1e93-4a31-ab0c-6f3e25b3289d">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7cd7c5e10e435f9a63d042307ff0a5_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTEtMS0xLTE0NzE1Nw_3f8b2e1e-25ee-4e1f-b3d4-6cad12c4dca9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTMtMS0xLTE0NzE1Nw_69b678ab-3b52-42be-a279-e76763f37631">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTUtMS0xLTE0NzE1Nw_2cae6325-63d7-40c0-98fe-d936c346f080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTctMS0xLTE0NzE1Nw_19967e39-3132-4706-b380-5a6b27149dfe">2</ix:nonFraction>)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5929938d842bca82c533a67d3e5ad_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTktMS0xLTE0NzE1Nw_388d0858-da65-475f-ac7e-a96f1c00e37e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad140489fe934c8caf9ef36be5139d4f_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTEtMS0xLTE0NzE1Nw_5bd85225-3eee-4522-ae0b-986738d6b854">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTMtMS0xLTE0NzE1Nw_fba3ea5a-89e7-4afc-9245-19f0d11b971b">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTUtMS0xLTE0NzE1Nw_1e858453-7739-4f61-9fe8-18774a392e9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTctMS0xLTE0NzE1Nw_ce4fe697-a731-4e2e-a9b9-422fc52cf2d4">2,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia768abc477b149ba8b237395ef925335_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTktMS0xLTE0NzE1Nw_8c714c05-1457-4ff8-a27b-ae62e5c4a92c">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTEtMS0xLTE0NzE1Nw_e73b049d-9386-42ab-8aa3-d9c7db7bbdd9">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTMtMS0xLTE0NzE1Nw_1def2278-8403-46f3-8f2e-b022a5abacf7">2,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTUtMS0xLTE0NzE1Nw_4ec7b145-db28-4af3-a7c9-e87c07cff5ff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTctMS0xLTE0NzE1Nw_04df4150-a1b0-4e2d-ae54-75241660e162">2,366</ix:nonFraction>)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTktMS0xLTE0NzE1Nw_d5420105-7466-4988-b784-fa57ceef5b00">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Fiscal 2022, 2021 and 2020 include $<ix:nonFraction unitRef="usd" contextRef="ie6d67fb03b394de5bfd91a7161298584_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEyNA_2ccb743a-b1f8-4856-ae4b-65ed04649084">87</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i79b7882d67e14e36b7002a6ff0299b96_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEyOA_f9469bce-d836-4c62-aa33-a89da48c0416">70</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i71d69bac84194be3ae102ae751b16751_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEzNQ_f3687535-2a39-481d-bf59-b84d8825fb2e">49</ix:nonFraction> million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Recoveries of amounts provided for or written off in prior years was $<ix:nonFraction unitRef="usd" contextRef="i82b6099badb34def8ff80369a0b76e44_D20200701-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_7067e515-2cf1-416f-9a19-be4aa03aa159"><ix:nonFraction unitRef="usd" contextRef="i964db25469894c16b81360ef4522965e_D20210701-20220630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_8f7646d1-3966-4398-80bb-056e5d1d01b5"><ix:nonFraction unitRef="usd" contextRef="if96021e36fcd47b580794c907494e1f0_D20190701-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_b4d0b4ae-db5c-4828-827e-0a3cb54fea68">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million in each fiscal year 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Write-off of uncollectible accounts or actual sales returns.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="iabee3afac5a6471a899db2ac3dc8b966">The sum of the components may not equal the total due to rounding.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_151"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, Executive Officers, and Corporate Governance</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Information About Our Executive Officers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a list of our executive officers:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Position</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael C. Kaufmann</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jason M. Hollar</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Victor L. Crawford</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer, Pharmaceutical segment</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stephen M. Mason</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Executive Officer, Medical segment</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michele A. M. Holcomb</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Vice President, Strategy and Corporate Development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ola M. Snow</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Human Resources Officer</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jessica L. Mayer</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Legal and Compliance Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brian S. Rice</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer and Customer Support Services </span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business experience summaries provided below for our executive officers describe positions held during the last five years (unless otherwise indicated).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Kaufmann has served as Chief Executive Officer since January 2018. From November 2014 through December 2017, Mr. Kaufmann served as Chief Financial Officer. On August 11, 2022, we announced that Mr. Kaufmann will depart from the Company effective September 1, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hollar has served as Chief Financial Officer since May 2020. Prior to that, Mr. Hollar served as the Executive Vice President and Chief Financial Officer of Tenneco Inc. ("Tenneco") from July 2018. From June 2017 to June 2018, Mr. Hollar was Senior Vice President Finance at Tenneco. Prior to that, Mr. Hollar served as Chief Financial Officer of Sears Holding Corporation ("Sears") from October 2016 to April 2017. Sears filed for Chapter 11 bankruptcy in October 2018. On August 11, 2022, we announced that our Board of Directors has elected Mr. Hollar as Chief Executive Officer, effective September 1, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Crawford has served as Chief Executive Officer, Pharmaceutical segment since November 2018. From September 2012 until November 2018, Mr. Crawford served as the Chief Operating Officer, Healthcare, Education, Business Dining for Aramark Corporation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Mason has served as Chief Executive Officer, Medical segment since August 2019. From September 2016 through August 2019, he served as President of Cardinal Health at-Home Solutions within our Medical segment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Holcomb has served as Executive Vice President, Strategy and Corporate Development since January 2017. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Snow has served as Chief Human Resources Officer since October 2018. From January 2016 through September 2018, Ms. Snow served as our Senior Vice President, Human Resources, Total Rewards, Talent Acquisition and Corporate Business Partner. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Mayer has served as Chief Legal and Compliance Officer since March 2019. Ms. Mayer served as Executive Vice President, Deputy General Counsel and Secretary from September 2017 through March 2019 and was Senior Vice President, Deputy General Counsel from December 2015 through September 2017.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Rice has served as Executive Vice President, Chief Information Officer and Customer Support Services since February 2019. From 2009 until the beginning of 2019, Mr. Rice served as Senior Vice President, Chief Information Officer &amp; Global and Business Services for Kellogg Company. Mr. Rice has informed the Company of his intention to resign from his role at Cardinal Health effective August 26, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Directors and Corporate Governance</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that apply to all of our directors, officers and employees. The </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outline our corporate values and standards of integrity and behavior and are designed to protect and promote our reputation. The full text of the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is posted on our website at www.cardinalhealth.com under &#8220;About Us &#8212; Ethics and Compliance.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any waiver of the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for directors or executive officers must be approved by the Risk Oversight Committee. As required under SEC and New York Stock Exchange rules, we will disclose future amendments to our </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and waivers from the </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standards of Business Conduct</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for our principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions, and our other executive officers and directors on our website within four business days following the date of the amendment or waiver.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors, Executive Officers, and Corporate Governance</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information called for by Item&#160;10 of Form 10-K is incorporated by reference to our Definitive Proxy Statement (which will be filed with the SEC pursuant to Regulation 14A under the Exchange Act) relating to our 2022 Annual Meeting of Shareholders (our &#8220;2022 Proxy Statement&#8221;) under the captions &#8220;Corporate Governance&#8221; and &#8220;Share Ownership Information.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information called for by Item 12 of Form 10-K is incorporated by reference to our 2022 Proxy Statement under the caption "Share Ownership Information."</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_157"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Exhibits, Financial Statement Schedules</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) The following financial statements are included in the "Financial Statements" section of this report:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements and Schedule:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_76">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:6.75pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_70">Report</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_70">s</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_70"> of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (PCAOB ID: <ix:nonNumeric contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNTcvZnJhZzo1NDhiOGI3MzhmMjI0YzRlYjEyYTBhYmY4YjcxYzc1Mi90YWJsZTo2MjkxNTRkZGU2Yzk0YjNjYjhjYzIxNzhlYmNjNmYzZS90YWJsZXJhbmdlOjYyOTE1NGRkZTZjOTRiM2NiOGNjMjE3OGViY2M2ZjNlXzMtMC0xLTEtMTk4NTM1L3RleHRyZWdpb246MWI0MDMxODI2ZDNhNDM4ZDljZTdmYmYyZGY5ZDU3YmFfMTkyNDE0NTM0ODY1MjY_f43d67cb-082e-4916-afb7-8ce529d089e9">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_70">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_70">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_79">Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_79">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_82">Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_82">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_85">Consolidated Balance Sheets at June&#160;30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_85">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_88">Consolidated Statements of Shareholders&#8217; Equity/(Deficit) for the Fiscal Years Ended June 30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_88">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">Consolidated Statements of Cash Flows for the Fiscal Years Ended June&#160;30, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_91">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_94">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_94">61</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) The following Supplemental Schedule is included in this report:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_148">Schedule II - Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_148">88</a></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules not listed above have been omitted as not applicable or because the required information is included in the Consolidated Financial Statements or in the Notes thereto.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517127390/d380332dex21.htm">Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.1 to Cardinal Health's Current Report on Form 8-K filed on April 18, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit222.htm">Amendment No. 1, dated as of July 28, 2017, to Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.2.2 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm">Quarterly</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm"> Report on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm">10-Q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm"> filed on November </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm">9, 2021,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm"> File No. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/restatedcodeofregulationsn.htm">1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015201504123/l89994aex4-01.txt">Specimen Certificate for Common Shares of Cardinal Health, Inc. (incorporated by reference to Exhibit 4.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2001, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015208004364/l31811aexv4w1.htm">Indenture, dated as of June 2, 2008, between Cardinal Health, Inc. and The Bank of New York Trust Company, N.A. (incorporated by reference to Exhibit 4.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 2, 2008, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512241732/d351025dex42.htm">Form of 3.200% Notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on May 21, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex42.htm">Form of 3.200% Notes due 2023 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312513071020/d490312dex43.htm">Form of 4.600% Notes due 2043 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on February 22, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex42formof2024note.htm">Form of 3.500% Notes due 2024 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000270/ex43formof2044note.htm">Form of 4.500% Notes due 2044 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 19, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex42.htm">Form of 3.750% Notes due 2025 (incorporated by reference to Exhibit 4.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312515232063/d941651dex43.htm">Form of 4.900% Notes due 2045 (incorporated by reference to Exhibit 4.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 23, 2015, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex42.htm">Form of 2.616% notes due 2022 (incorporated by reference to Exhibit 4.2 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex43.htm">Form of Floating rate notes due 2022 (incorporated by reference to Exhibit 4.3 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex44.htm">Form of 3.079% notes due 2024 (incorporated by reference to Exhibit 4.4 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex45.htm">Form of 3.410% notes due 2027 (incorporated by reference to Exhibit 4.5 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312517200734/d412167dex46.htm">Form of 4.368% notes due 2047 (incorporated by reference to Exhibit 4.6 to Cardinal Health's Current Report on Form 8-K filed on June 12, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015205007585/l15839aexv4w07.txt">Agreement to furnish to the Securities and Exchange Commission upon request a copy of instruments defining the rights of holders of certain long-term debt of Cardinal Health, Inc. and consolidated subsidiaries (incorporated by reference to Exhibit 4.07 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2005, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000090/a19q4_10-kx63019xexhibit44.htm">Description of Securities (incorporated by reference to Exhibit 4.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit101-2021ltip.htm">Cardinal Health, Inc. 2021 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373)* </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit102-formof2021ltipr.htm">Form of Restricted Share Units Agreement under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit103-formof2021ltipp.htm">Form of Performance Share Units Agreement under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373)* </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit104-formof2021ltipn.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373)* </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit105-formof2021ltipd.htm">Form of Directors&#8217; Restricted Share Units Agreement under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.5 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373) </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000120/exhibit106-mip.htm">Cardinal Health, Inc. Management Incentive Plan (incorporated by reference to Exhibit 10.6 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 9, 2021, File No. 1-11373)* </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex101.htm">Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1012.htm">First Amendment to Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312511296273/d241126dex102.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K/A filed on November 4, 2011, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit1013nqso.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.3 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000154/a13q4_10kx063013xex1019.htm">Form of Amendment to Stock Option and Restricted Share Units Agreements under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan, the Cardinal Health, Inc. 2005 Long-Term Incentive Plan and the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.1.9 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2013, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000353/exhibit101-amendedcardinal.htm">Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on November 7, 2016, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1022.htm">First Amendment to Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.2 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit102.htm">Second Amendment to the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 3019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1023.htm">Form of Nonqualified Stock Option Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.3 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1024.htm">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit103.htm">Form of Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporate by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1025.htm">Form of Performance Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan  (incorporated by reference to Exhibit 10.2.5 to Cardinal Health's Annual Report on Form 10-K  for the fiscal year end June 30, 2017, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137121000116/performanceshareunitsagree.htm">Form of Performance Share Units Agreement under the Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000010/a19q2_10qx123118xexhibit104.htm">Form of Directors Restricted Share Units Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex101.htm">Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1011.htm">First Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1012.htm">Second Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/a14q4_10kx063014xexhibit1024.htm">Third Amendment to Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2014)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex10111.htm">Form of Nonqualified Stock Option Agreement under the Cardinal Health, Inc. 2005 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1.11 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508020700/dex104.htm">Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2007, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509229321/dex1021.htm">First Amendment to Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.2.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2009, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312512042612/d263502dex105.htm">Second Amendment to the Cardinal Health, Inc. 2007 Nonemployee Directors Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended December 31, 2011, File No. 1-11373)*</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit1.htm">Cardinal Health Deferred Compensation Plan, Amended and Restated effective January 1, 2020 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137122000032/a22q3_10qx033122xexhibit102.htm">First Amendment to the Cardinal Health Deferred Compensation Plan, as amended and restated on January 1, 2020 (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000088/exhibit101-seniorexecutive.htm">Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on September 26, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit101.htm">First Amendment to the Cardinal Health, Inc. Senior Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000095015206006573/l21691aexv10w09.htm">Cardinal Health, Inc. Policy Regarding Shareholder Approval of Severance Agreements (incorporated by reference to Exhibit 10.09 to Cardinal Health&#8217;s Current Report on Form 8-K filed on August&#160;7, 2006, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312510198300/dex1015.htm">Confidentiality and Business Protection Agreement, effective as of February 15, 2010, between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.15 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2010, File&#160;No.&#160;1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000038/a18q3_10qx033118xexhibit102.htm">Aircraft Time Sharing Agreement, effective as of February 8, 2018, by and between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137122000013/a22q2_10qx123121xexhibit107.htm">Aircraft Time Sharing Agreement, effective as of January 1, 2022, by and between Cardinal Health, Inc. and Michael C. Kaufmann (incorporated by reference to Exhibit 10.7 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2021, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10131.htm">Confidentiality and Business Protection Agreement, effective as of November 1, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.1 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000090/exhibit10132.htm">Letter Agreement, dated October 30, 2018, between Cardinal Health, Inc. and Victor L. Crawford (incorporated by reference to Exhibit 10.13.2 to Cardinal Health's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, File No. 1-11373) *</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit101cfoofferlett.htm">Letter Agreement, dated March 9, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit102cfocbpagreem.htm">Confidentiality and Business Protection Agreement, effective as of April 27, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000095015204007635/l09353bexv10w38.txt">Form of Indemnification Agreement between Cardinal Health, Inc. and certain individual directors (incorporated by reference to Exhibit 10.38 to Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June 30, 2004, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1001.htm">Issuing and Paying Agency Agreement, dated August 9, 2006, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1001.htm">First Amendment to Issuing and Paying Agency Agreement, dated February 28, 2007, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.01 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit102.htm">Second Amendment to Issuing and Paying Agency Agreement, effective as of December 1, 2016, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit102.htm">Third Amendment to Issuing and Paying Agency Agreement, dated September 15, 2017, between Cardinal Health, Inc. and The Bank of New York (incorporated by reference to Exhibit 10.2 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1002.htm">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and J.P.&#160;Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1002.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and J.P. Morgan Securities Inc. (incorporated by reference to Exhibit 10.02 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit104.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and J.P. Morgan Securities LLC (formerly known as J.P. Morgan Securities Inc.) (incorporated by reference to Exhibit 10.4 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit106.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and J.P. Morgan Securities LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.6 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1003.htm">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit 10.03 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1003.htm">First Amendment to Commercial Paper Dealer Agreement, dated February&#160;28, 2007, between Cardinal Health, Inc. and Banc of America Securities LLC (incorporated by reference to Exhibit&#160;10.03 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March&#160;6, 2007, File&#160;No.&#160;1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit105.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, f/k/a Banc of America Securities LLC (incorporated by reference to Exhibit 10.5 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit103.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.3 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1004.htm">Commercial Paper Dealer Agreement, dated August 9, 2006, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.04 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2006, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1004.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Wachovia Capital Markets, LLC (incorporated by reference to Exhibit&#160;10.04 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File&#160;No.&#160;1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit106.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Wells Fargo Securities, LLC, as successor in interest to Wachovia Capital Markets, LLC (incorporated by reference to Exhibit 10.6 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit105.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Wells Fargo Securities, LLC, effective as of December 1, 2016 (incorporated by reference to Exhibit 10.5 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312506184453/dex1005.htm">Commercial Paper Dealer Agreement, dated August&#160;9, 2006, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2006, File No. 1-11373)</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibits</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312507046940/dex1005.htm">First Amendment to Commercial Paper Dealer Agreement, dated February 28, 2007, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.05 to Cardinal Health&#8217;s Current Report on Form 8-K filed on March 6, 2007, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit107.htm">Second Amendment to Commercial Paper Dealer Agreement, effective as of December 31, 2012, between Cardinal Health, Inc. and Goldman, Sachs &amp; Co. (incorporated by reference to Exhibit 10.7 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit104.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and Goldman Sachs &amp; Co., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509083079/dex102.htm">Form of Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on April 21, 2009, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000022/a13q2_10qx123112xexhibit108.htm">Form of First Amendment to Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc. (incorporated by reference to Exhibit 10.8 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.12.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000015/a17q2_10qx123116xexhibit107.htm">Commercial Paper Dealer Agreement between Cardinal Health, Inc. and SunTrust Robinson Humphrey, Inc., effective as of December 1, 2016 (incorporated by reference to Exhibit 10.7 to Cardinal Health's Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000042/ex101secondamendedandresta.htm">Second Amended and Restated Five-Year Credit Agreement, dated as of June 27, 2019, among JPMorgan Chase Bank, N.A. as Administrative Agent, Joint Lead Arranger and Joint Book Manager, Bank of America, N.A. as Syndication Agent, MUFG Bank, Ltd. as Syndication Agent, Joint Lead Arranger and Joint Book Manager, Barclays Bank PLC, Deutsche Bank AG New York Branch, Goldman Sachs Bank USA, HSBC Bank USA, N.A. and Wells Fargo Bank, N.A., as Documentation Agents, and BOFA Securities, Inc., as Joint Lead Arranger and Joint Book Manager (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on June 28, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000179/a14q1_10qx093013xexhibit101.htm">Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, among Cardinal Health Funding, LLC, as Seller, Griffin Capital, LLC, as Servicer, the Conduits party thereto, the Financial Institutions Party thereto, the Managing Agents party thereto, and LC Banks party thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Agent (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000235/a15q1_10qx093014xexhibit103.htm">First Amendment and Joinder, dated as of November 3, 2014, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1043.htm">Second Amendment, dated as of November 14, 2016, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.4.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000110/a83117_8kxex101.htm">Third Amendment, dated as of August 30, 2017, to the Fourth Amended and Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on August 31, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex101_4thamendmentjoindert.htm">Fourth Amendment and Joinder, dated September 30, 2019, to the Fourth Amended and Restated Receivables Purchase Agreement (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on October 2, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.14.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx063022xex10146.htm">Fifth Amendment, dated as of May 13, 2022, to the Fourth Amended and Restated Receivables Purchase Agreement</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx093017xexhibit1051.htm">Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016, executed by Cardinal Health, Inc. in favor of Cardinal Health Funding, LLC (incorporated by reference to Exhibit 10.5.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000145/a18q1_10qx93017xexhibit1052.htm">Amendment No. 1 to Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016 (incorporated by reference to Exhibit 10.5.2 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, File No. 1-11373</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137118000100/a19q1_10qx93018xexhibit104.htm">Amendment No. 2 to Seventh Amended and Restated Performance Guaranty, dated as of November 6, 2018 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report on Form 10-Q for the Quarter ended September 30, 2018, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.15.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex102_3rdamendmentto7tharp.htm">Amendment No. 3 to Seventh Amended and Restated Performance Guaranty (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed October 2, 2019, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.16.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000119312509187778/dex103.htm">Tax Matters Agreement, dated as of August 31, 2009, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Current Report on Form 8-K filed on September 4, 2009, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.16.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/721371/000072137112000069/a10-kexhibit102021stamendt.htm">First Amendment to Tax Matters Agreement, dated as of May 28, 2012, by and between Cardinal Health, Inc. and CareFusion Corporation (incorporated by reference to Exhibit 10.20.2 to Cardinal Health&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2012, File No. 1-11373)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx63022xexhibit211.htm">List of Subsidiaries of Cardinal Health, Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx63022xexhibit231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx063022xexhibit311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx063022xexhibit312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx063022xexhibit321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a22q4_10kx063022xexhibit991.htm">Statement Regarding Forward-Looking Information</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_160"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.115%"><tr><td style="width:1.0%"></td><td style="width:27.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form 10-K Cross Reference Index</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Form 10-K Cross Reference Index</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page(s)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part 1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_52">Business</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_52">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_55">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_55">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1B</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unresolved Staff Comments </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_58">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_58">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_61">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_61">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_64">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_64">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_13">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_49">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_49">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_76">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_67">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9B</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_151">Directors, Executive Officers and Corporate Governance </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_151">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(b)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(c)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(d)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_157">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_157">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_163">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i06b8b3ff48e94029843042d968c5bda7_163">96</a></span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:3.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not applicable</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 11 of Form 10-K is incorporated by reference to our 2022 Proxy Statement under the captions &#8220;Corporate Governance&#8221; and &#8220;Executive Compensation.&#8221;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 12 of Form 10-K is incorporated by reference to our 2022 Proxy Statement under the captions "Executive Compensation" and "Share Ownership Information."</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 13 of Form 10-K is incorporated by reference to our 2022 Proxy Statement under the caption "Corporate Governance."</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The information called for by Item 14 of Form 10-K is incorporated by reference to our 2022 Proxy Statement under the caption &#8220;Audit Committee Matters.&#8221;</span></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">|</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div id="i06b8b3ff48e94029843042d968c5bda7_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.262%"><tr><td style="width:1.0%"></td><td style="width:24.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#e41f35;border-bottom:1pt solid #e41f35;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signatures</span></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #e41f35;padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:3pt"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on August&#160;11, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:54.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michael C. Kaufmann</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer </span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed below by the following persons on behalf of the registrant and in the capacities indicated on August&#160;11, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:298.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director (principal executive officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Michael C. Kaufmann</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JASON M. HOLLAR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer (principal financial officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jason M. Hollar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;PATRICIA M. ENGLISH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer (principal accounting officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patricia M. English</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;CARRIE S. COX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrie S. Cox</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/   BRUCE L. DOWNEY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bruce L. Downey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;SHERI H. EDISON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sheri H. Edison</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;DAVID C. EVANS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">David C. Evans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;PATRICIA A. HEMINGWAY HALL<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director<br/></span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patricia A. Hemingway Hall</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;AKHIL JOHRI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Akhil Johri</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;GREGORY B. KENNY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gregory B. Kenny</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;NANCY KILLEFER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nancy Killefer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DEAN A. SCARBOROUGH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dean A. Scarborough</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/  JOHN H. WEILAND</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">John H. Weiland</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"><span style="font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:32.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health </span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">| </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022 Form 10-K</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14.6
<SEQUENCE>2
<FILENAME>a22q4_10kx063022xex10146.htm
<DESCRIPTION>EX-10.14.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i600e0a84f31c48d98e7b1bde252e7c04_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 10.14.6</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">FIFTH AMENDMENT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">TO THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This FIFTH AMENDMENT TO THE FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), dated as of May 13, 2022, is entered into by and among the following parties&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)     CARDINAL HEALTH FUNDING, LLC, a Nevada limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Seller</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)   GRIFFIN CAPITAL, LLC, a Nevada limited liability company (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Griffin</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and, together with the Seller, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Seller Parties</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and each, a &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Seller Party</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)   WELLS FARGO BANK, N.A. (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">WF</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) as a Financial Institution and as the Managing Agent for WF&#8217;s Purchaser Group&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)     LIBERTY STREET FUNDING LLC (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Liberty Street</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as a Conduit&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(v)    THE BANK OF NOVA SCOTIA (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">BNS</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as the Related Financial Institution for Liberty Street and as the Managing Agent for Liberty Street&#8217;s Purchaser Group&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(vi)     ATLANTIC ASSET SECURITIZATION LLC (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Atlantic</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as a Conduit&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(vii)   CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK NEW YORK BRANCH (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Credit Agricole&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), as the Related Financial Institution for Atlantic and as the Managing Agent for Atlantic&#8217;s Purchaser Group&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(viii)   U.S. BANK NATIONAL ASSOCIATION (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">U.S. Bank&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), as the Related Financial Institution for U.S. Bank and as the Managing Agent for U.S. Bank&#8217;s Purchaser Group&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ix)    PNC BANK, NATIONAL ASSOCIATION (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">PNC</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as a Financial Institution, as the Managing Agent for PNC&#8217;s Purchaser Group and as an LC Bank&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(x)      VICTORY RECEIVABLES CORPORATION (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Victory</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), as a Conduit&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(xi)     MUFG BANK, LTD. (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">MUFG</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) (f&#47;k&#47;a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as the Related Financial Institution for Victory, as Managing Agent for Victory&#8217;s Purchaser Group and as the Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">PRELIMINARY STATEMENTS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the parties hereto are parties to that certain Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Receivables Purchase Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WHEREAS, the parties hereto desire to amend the Receivables Purchase Agreement as set forth herein. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the premises herein contained and for other good and valuable consideration, the receipt and adequacy of which the parties hereto hereby acknowledge, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 1.     </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Capitalized terms used herein and not otherwise defined herein shall have the respective meanings assigned thereto in the Receivables Purchase Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 2.  </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Amendments to the Receivables Purchase Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Receivables Purchase Agreement is hereby amended as follows&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">         </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Receivables Purchase Agreement is hereby amended by restating </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">clause (f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> thereof in its entirety as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">       (f)        As at the end of any calendar month occurring (x) from April 30, 2022 through September 30, 2022, the Delinquency Ratio shall exceed 10.50% and (y) at any other time, the Delinquency Ratio shall exceed 5.75%.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 3.    </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. On the date hereof, each Seller Party hereby represents and warrants (as to itself) to the Purchasers, the Managing Agents and the Agent as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">          (A)     after giving effect to this Amendment and each of the Related Agreements, no event or condition has occurred and is continuing which constitutes an Amortization Event or Potential Amortization Event&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">        (B)     after giving effect to this Amendment and each of the Related Agreements, the representations and warranties of such Person set forth in the Receivables Purchase Agreement and each other Transaction Document are true and correct as of the date hereof, as though made on and as of such date (except to the extent such representations and warranties relate solely to an earlier date and then as of such earlier date)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">             (C)    this Amendment and each of the Related Agreements to which such Person is a party, constitutes the valid and binding obligation of such Person, enforceable against such Person in accordance with its terms.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 4.   </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conditions to Effectiveness of this Amendment</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Amendment shall become effective as of the date hereof upon receipt by the Agent of counterparts of this Amendment, duly executed by each of the parties hereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 5.      </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">          (A)   </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Effect of Amendment&#59; Ratification</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as specifically set forth herein, the Receivables Purchase Agreement (as amended hereby) is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect.  After this Amendment becomes effective, all references in the Receivables Purchase Agreement (or in any other Transaction Document) to &#8220;the Receivables Purchase Agreement&#8221;, &#8220;this Agreement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, or words of similar effect, in each case referring to the Receivables Purchase Agreement, shall be deemed to be references to the Receivables Purchase Agreement as amended hereby.  This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Receivables Purchase Agreement other than as specifically set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">          (B)     </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Costs, Fees and Expenses</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Seller agrees to reimburse each of the parties hereto (other than Griffin) on demand for all reasonable costs, fees and expenses incurred by such parties (including, without limitation, their reasonable agreed fees and expenses of counsel) incurred in connection with the preparation, execution and delivery of this Amendment and each of the Related Agreements.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">         (C)      </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Counterparts&#59; Delivery</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.  Delivery of an executed counterpart of a signature page to this Amendment by facsimile or other electronic means shall be effective as delivery of a manually executed counterpart of this Amendment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">        (D)      </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Any provision contained in this Amendment which is held to be inoperative, unenforceable or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable or invalid without affecting the remaining provisions of this Amendment in that jurisdiction or the operation, enforceability or validity of such provision in any other jurisdiction.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">        (E)      </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Receivables Purchase Agreement or any provision hereof or thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">         (F)      </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF ILLINOIS.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">     (G)   </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">WAIVER OF TRIAL BY JURY</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  EACH PARTY HERETO HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ANY DOCUMENT EXECUTED BY ANY SELLER PARTY PURSUANT TO THIS AMENDMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Signature Pages Follow</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be executed as of the date first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CARDINAL HEALTH FUNDING, LLC, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Seller</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">                                                                              &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">GRIFFIN CAPITAL, LLC, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Servicer</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">                                                                             </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">WELLS FARGO BANK, N.A.,</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Financial Institution and as Managing Agent</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for WF&#8217;s Purchaser Group</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________ </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ATLANTIC ASSET SECURITIZATION LLC, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Conduit</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                           </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                            </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CREDIT AGRICOLE CORPORATE AND</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">INVESTMENT BANK NEW YORK BRANCH, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Related Financial Institution for Atlantic and as</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Managing Agent for Atlantic&#8217;s Purchaser Group</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                            </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                           </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PNC BANK, NATIONAL ASSOCIATION, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Financial Institution and as Managing Agent</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for PNC&#8217;s Purchaser Group</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                            </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PNC BANK, NATIONAL ASSOCIATION, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as an LC Bank</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________                                                                            </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">VICTORY RECEIVABLES CORPORATION, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Conduit</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;_____________________________________  </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">MUFG BANK, LTD., </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Related Financial Institution for Victory</font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">_______________________________________ </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;   </font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">MUFG BANK, LTD., </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Managing Agent for Victory&#8217;s Purchaser Group</font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">_______________________________________ </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;   </font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">MUFG BANK, LTD., </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Agent </font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">_______________________________________ </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58; </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LIBERTY STREET FUNDING LLC, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Conduit </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________ </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THE BANK OF NOVA SCOTIA, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as Related Financial Institution for Liberty Street</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and as Managing Agent for Liberty Street&#8217;s</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Purchaser Group</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________ </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div><div><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">U.S BANK NATIONAL ASSOCIATION, </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a Financial Institution and as Managing Agent</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for U.S. Bank&#8217;s Purchaser Group</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58; ______________________________________ </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>a22q4_10kx63022xexhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2e6ab1e939e54e239c78624febc0a000_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Subsidiaries of the Registrant</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Listed below are majority-owned subsidiaries of Cardinal Health, Inc. as of June 30, 2022.  Subsidiaries excluded from the list below would not, considered in the aggregate as a single subsidiary, constitute a &#8220;significant subsidiary&#8221; of Cardinal Health, Inc. as that term is defined in Rule 1-02(w) of SEC Regulation S-X.</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A+ Secure Packaging, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aero-Med, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Connecticut</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allegiance Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Blue Robin, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 2, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 3, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 5, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 6, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 7, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 100, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indiana</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 104 LP</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 105, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 107, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 108, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 110, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 112, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 113, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 114, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 115, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 116, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 118, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 119, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 121, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 122, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 123, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 124, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 126, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 127, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kansas</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 132, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 200, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 201, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 222 (Thailand) Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 247, Inc. </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 249, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health 414, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Australia 503 Pty. Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Austria 504 GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Belgium 505 BVBA</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Canada Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Canada Holdings Cooperative U.A.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Chile Limitada</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Colombia S.A.S.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health do Brasil Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health D.R. 203 II Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Denmark ApS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Finland Oy</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Foundation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health France 506 SAS</font></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr></table></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Funding, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Germany 507 GmbH</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Germany Manufacturing GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health International India Private Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health International Philippines, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health IPS, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland 419 Designated Activity Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland 508 Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Ireland Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Italy 509 Srl</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Japan G.K.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health K.K.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Korea Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Malaysia 211 Sdn. Bhd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Malta 212 Limited</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Managed Care Services, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Mexico 514 S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Middle East FZ-LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Netherlands 502 B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Pharmaceutical Contracting, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Pharmacy Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 120, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 218, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health P.R. 220, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Singapore 225 Pte. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Spain 511 S.L.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Sweden 512 A.B.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Switzerland 515 GmbH</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Technologies, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Technologies Switzerland GmbH</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health U.K. 432 Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health Medical Equipment Consulting (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cirpro de Delicias S.A. de C.V.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertors de Mexico S.A. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis Corporation</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis (Shanghai) Medical Devices Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cornerstone Rheumatology, L.P.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covidien Manufacturing Solutions, S.A.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EPIC Insurance Company</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vermont</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Especialidades Medicas Kenmex S.A. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GetOutcomes, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Griffin Capital, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Innovative Therapies, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Instant Diagnostic Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alabama</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kendall-Gammatron Limited</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr></table></div><div><font><br></font></div></div></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:237.75pt"><tr><td style="width:1.0pt"></td><td style="width:169.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary Name</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State&#47;Jurisdiction<br>of Incorporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR Australia Pty. Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">KPR U.S., LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leader Drugstores, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ludlow Technical Products Canada, Ltd.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marin Apothecaries</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">California</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicine Shoppe International, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mediquip Sdn. Bhd.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mirixa Corporation</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MosaicGPO, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">mscripts, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">One Cloverleaf, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outcomes Incorporated</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinnacle Intellectual Property Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pinnacle Intellectual Property Services-International, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quiroproductos de Cuauhtemoc S. de R.L. de C.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RainTree GPO, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Renal Purchasing Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RGH Enterprises, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rxealtime, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sonexus Health, LLC</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TelePharm, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Iowa</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Harvard Drug Group, L.L.C.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Traverse GPO, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">WaveMark, Inc.</font></td><td colspan="3" style="background-color:#acacac;padding:0 1pt"></td><td colspan="3" style="background-color:#acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a22q4_10kx63022xexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8edb897eb2a445edb1dc6a7eb1bbf2de_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58; </font></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Registration Statement on Form S-3 No.&#160;333-233377 of Cardinal Health, Inc., </font></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Registration Statements on Form S-4 No.&#160;333-62938 and No.&#160;333-74761 of Cardinal Health, Inc., and </font></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Registration Statements on Form S-8&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.361%"><tr><td style="width:1.0%"></td><td style="width:9.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">S-8 Registration Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Description</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33-42357</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Distribution, Inc. Profit Sharing and Retirement Savings Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-90423</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. Incentive Deferred Compensation Plan, As Amended</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-38192</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. Outside Directors Equity Incentive Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-38198</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. Profit Sharing and Retirement Savings Plan, As Amended</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-56010</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. Profit Sharing, Retirement and Savings Plan for Employees of Puerto Rico</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-129725</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2005 Long-Term Incentive Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-149107</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan, as amended and restated effective January 1, 2005</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan (as amended and restated January 1, 2006)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan For Employees of Puerto Rico (as amended and restated January 1, 2005)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Syncor International Corporation Employees&#8217; Savings and Stock Ownership Plan, as amended and restated effective January 1, 1997</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-155156</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2005 Long-Term Incentive Plan, (As Amended and Restated as of November 5, 2008)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-163128</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2005 Long-Term Incentive Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2007 Nonemployee Directors Equity Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-164736</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan, as amended and restated effective January 1, 2009 (as amended)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan, as amended and restated January 1, 2006 (as amended)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-177728</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2011 Long-Term Incentive Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-183471</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-206339</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-206340</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2011 Long-Term Incentive Plan</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.361%"><tr><td style="width:1.0%"></td><td style="width:9.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-214412</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-219892</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-233380</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health Deferred Compensation Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-260921</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc. 2021 Long-Term Incentive Plan</font></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated August 11, 2022, with respect to the consolidated financial statements and schedule of Cardinal Health, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Cardinal Health, Inc. and subsidiaries, included in this Annual Report (Form 10-K) of Cardinal Health, Inc. and subsidiaries for the year ended June&#160;30, 2022.</font></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst&#160;&#38; Young LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandview Heights, Ohio</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 11, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>a22q4_10kx063022xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i66a2952a3f22491e8991772e7f2c19af_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.1</font></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael C. Kaufmann, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">I have reviewed this Form 10-K of Cardinal Health, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.46pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;11, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:147.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:319.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; MICHAEL C. KAUFMANN</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael C. Kaufmann</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>a22q4_10kx063022xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia7b77bd8b0ce46b5aae4a73647f8bfb9_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.2</font></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jason M. Hollar, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">I have reviewed this Form 10-K of Cardinal Health, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.46pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.16pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;11, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:136.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:372.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> JASON M. HOLLAR</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Hollar</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>a22q4_10kx063022xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i95bd135f131f4a1993f9f37fda5f684f_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 32.1</font></td></tr></table></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;) and Jason M. Hollar, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26pt">the Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022 containing the financial statements of the Company (the &#8220;Annual Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26pt">the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; August&#160;11, 2022 </font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; MICHAEL C. KAUFMANN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael C. Kaufmann</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JASON M. HOLLAR</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Hollar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>a22q4_10kx063022xexhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i824c2facaaa04cdc9e240694e0538835_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Statement Regarding Forward-Looking Information </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including this Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022 (the &#8220;2022 Form 10-K&#8221;), and our quarterly reports on Form 10-Q, and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, including materials posted on our website, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">competitive pressures in the markets in which we operate, including pricing pressures&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to the pricing of and demand for generic pharmaceuticals&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">significantly increased costs for commodities and other materials used in the Medical segment manufacturing, including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities and the possibility that we may not successfully offset or mitigate these increases&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches or other components of our pharmaceutical generics program&#59;  </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in manufacturer approaches to pricing branded pharmaceutical products and risks related to our compensation under contractual arrangements with manufacturers being set as a percentage of the wholesale acquisition cost of branded pharmaceuticals and where a part of our compensation is based on branded pharmaceutical price appreciation, changes in the magnitude of such price appreciation&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in the timing or frequency of the introduction of branded pharmaceuticals&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">continuing risks associated with the resolution and defense of the lawsuits and investigations in which we have been or will be named relating to the distribution of prescription opioid pain medication, including the investigations by the Department of Justice which we believe concern our anti-diversion program, our anti-diversion policies and procedures and our distribution of certain controlled substances&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the national settlement agreement to resolve the vast majority of opioid-related claims brought by states and other governmental entities, including the risk that the implementation and maintenance of the required changes to distributors' controlled substance anti-diversion programs may result in unforeseen costs or operational challenges and the risk that if we fail to or are alleged to have failed to comply with the terms of the settlement agreement, we could incur monetary or other penalties or result in additional lawsuits being filed against us&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">potential damage to our reputation, adverse operational impacts or other effects that may result from the national opioid epidemic, the allegations that have been made about our role in such epidemic and the ongoing unfavorable publicity surrounding the lawsuits and investigations against us&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the tax benefit from our self-insurance loss claims, including risks associated with the letter certain industry participants, including us, received from the U.S. House of Representatives' Committee on Oversight and Reform questioning, among other things, our plans to take tax deductions for opioid-related losses, including the net operating loss carryback provisions under the CARES Act and deductibility under the Tax Act&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with our Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services, including the risk that failure to comply with the requirements set forth therein could result in monetary or other penalties&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the possibility of additional adverse impacts to our financial results from enacted and proposed state taxes or other assessments on the sale or distribution of opioid medications&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our high sales concentration with certain key customers, including CVS Health Corporation and OptumRx&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">costs or claims resulting from quality issues, whether related to the manufacture of some of our sterile surgical gowns or pre-filled syringes, or other potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from recalls, remediation efforts, and related product liability claims and lawsuits, including class action lawsuits&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of company or customer information, disruption of access and ancillary risks associated with our ability to effectively manage any issues arising from any such compromise or disruption&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties related to our Medical segment's Cardinal Health Brand products, including our ability to manage cost, infrastructure and to retain margin or improve its performance&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the realignment of our Medical segment's supply chain and other businesses, including our ability to achieve the expected benefits from such realignment&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties with respect to our cost-savings initiatives or IT infrastructure activities, including the ability to achieve the expected benefits from such initiatives, the risk that we could incur unexpected charges, and the risk that we may fail to retain key personnel&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining or maintaining requisite regulatory consents, whether our own or third parties', or approvals associated with those activities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">manufacturing disruptions, whether due to regulatory action, including regulatory action to reduce Ethylene Oxide emissions, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with industry reliance on ethylene oxide (&#34;EtO&#34;) to sterilize certain medical products that we manufacture or distribute, including the possibility that regulatory actions to reduce EtO emissions could become more widespread, which may result in increased costs or supply shortages&#59; and risks that the lawsuits against us alleging personal injury resulting from EtO exposure could become more widespread&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the possibility that we could be subject to adverse changes in the tax laws or challenges to our tax positions, including the possibility that the corporate tax rate in the U.S. could be increased&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from possible violations of healthcare fraud and abuse laws&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from pharmaceutical manufacturers' restriction of sales under the 340B drug pricing program to contract pharmacies, which may adversely impact our customers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">material reductions in purchases, pricing changes, non-renewal, early termination, or delinquencies or defaults under contracts with key customers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">unfavorable changes to the terms or with our ability to meet contractual obligations of key customer or supplier relationships, or changes in customer mix&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks arising from changes in U.S. or foreign tax laws and unfavorable challenges to our tax positions and payments to settle these challenges, which may adversely affect our effective tax rate or tax payments&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties due to possible government healthcare reform, including proposals related to Medicare drug rebate arrangements, possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act, proposals related to prescription drug pricing transparency and the possible adoption of Medicare-For-All&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties arising as a result of the Supreme Court decision on Dobbs vs. Jackson, including uncertainties associated with states' proposed and adopted laws which may impact our ability to distribute or store certain pharmaceutical products and the risk that we could incur unforeseen costs to comply with these new laws in various jurisdictions&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in hospital buying groups or hospital buying practices&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">continuing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks to our business and information and controls systems in the event that business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the risk that we may not effectively implement and maintain data governance structures across businesses to allow us to access and interpret our data, which could put us at a competitive disadvantage relative to our peers&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, patent infringement claims, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions, government investigations, shareholder lawsuits or other legal proceedings&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the possibility that our business performance or internal control over financial reporting may be adversely impacted if we are not successful at attracting, retaining and developing talent&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the importation of products or source materials used in products that we manufacture or distribute, including risks associated with our country-of-origin determinations and the possibility that we could experience supply disruptions as a result of the Uyghur Forced Labor Prevention Act&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to maintain adequate intellectual property protections&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with the divestiture of the Cordis business, including the risk that the costs associated with exit or disposal activities could ultimately be greater than we currently expect or that we could incur greater stranded costs than expected&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to manage and complete divestitures or other strategic business combination transactions, including our ability to find buyers or other strategic exit opportunities and risks associated with the possibility that we could experience greater dis-synergies than anticipated or otherwise fail to achieve our strategic objectives&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties with respect to U.S. or international trade policies, tariffs, excise or border taxes and their impact on our ability to source products or materials that we need to conduct our business&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">our ability to introduce and market new products and our ability to keep pace with advances in technology&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">significant charges to earnings if goodwill or intangible assets become impaired&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">uncertainties relating to general political, business, industry, regulatory and market conditions&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">certain risks arising from the ongoing COVID-19 pandemic&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other factors described in the &#8220;Risk Factors&#8221; section of the 2022 Form 10-K.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cah-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.cardinal.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEarnings" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings">
        <link:definition>100010003 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>100020004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets">
        <link:definition>100030005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>100050007 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100060008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails">
        <link:definition>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails">
        <link:definition>240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails">
        <link:definition>240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails">
        <link:definition>240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails">
        <link:definition>240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails">
        <link:definition>240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails">
        <link:definition>240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails">
        <link:definition>240114008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails">
        <link:definition>240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails">
        <link:definition>240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails">
        <link:definition>240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails">
        <link:definition>240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails">
        <link:definition>240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails" roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails">
        <link:definition>240174014 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitions" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitions">
        <link:definition>210181002 - Disclosure - Divestitures and Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitionsTables" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsTables">
        <link:definition>230193002 - Disclosure - Divestitures and Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresandAcquisitionsNarrativeDetails" roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails">
        <link:definition>240204015 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeverance">
        <link:definition>210211003 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables">
        <link:definition>230223003 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails">
        <link:definition>240234016 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails">
        <link:definition>240244017 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>210251004 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>230263004 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
        <link:definition>240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails">
        <link:definition>240284019 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>240294020 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cardinal.com/role/Leases">
        <link:definition>210301005 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cardinal.com/role/LeasesTables">
        <link:definition>230313005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.cardinal.com/role/LeasesDetails">
        <link:definition>240324021 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails">
        <link:definition>240334022 - Disclosure - Leases Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240344023 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>240354024 - Disclosure - Leases Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureLeasePaymentsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails">
        <link:definition>240364025 - Disclosure - Leases Schedule of Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings">
        <link:definition>210371006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsTables" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables">
        <link:definition>230383006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails">
        <link:definition>240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails">
        <link:definition>240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails">
        <link:definition>240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails">
        <link:definition>240424029 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesandLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation">
        <link:definition>210431007 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesandLitigationDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails">
        <link:definition>240444030 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>210451008 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cardinal.com/role/IncomeTaxesTables">
        <link:definition>230463007 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails">
        <link:definition>240474031 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails">
        <link:definition>240484032 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>240494033 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240504034 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails">
        <link:definition>240524036 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails">
        <link:definition>240534037 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Guarantees" roleURI="http://www.cardinal.com/role/Guarantees">
        <link:definition>210541009 - Disclosure - Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>210551010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>230563008 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>240574038 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details">
        <link:definition>240584039 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsDetails">
        <link:definition>240594040 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>210601011 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>230613009 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails">
        <link:definition>240624041 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>240634042 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails">
        <link:definition>240644043 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails">
        <link:definition>240654044 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails">
        <link:definition>240664045 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>240684047 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails">
        <link:definition>240694048 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails">
        <link:definition>240704049 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails">
        <link:definition>240714050 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails">
        <link:definition>240724051 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>210731012 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>230743010 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>240754052 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240764053 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc">
        <link:definition>210771013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables">
        <link:definition>230783011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails">
        <link:definition>240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails">
        <link:definition>240804055 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>210811014 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>230823012 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>240834056 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenuebyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails">
        <link:definition>240844057 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails">
        <link:definition>240854058 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails">
        <link:definition>240864059 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsbyReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails">
        <link:definition>240874060 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails">
        <link:definition>240884061 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>210891015 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>230903013 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240914062 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails">
        <link:definition>240924063 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails">
        <link:definition>240934064 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails">
        <link:definition>240944065 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails">
        <link:definition>240954066 - Disclosure - Share-Based Compensation Schedule of Remaining Stock Option Plan Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails">
        <link:definition>240964067 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails">
        <link:definition>240974068 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails">
        <link:definition>240984069 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails">
        <link:definition>240994070 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationsandQualifyingAccounts" roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts">
        <link:definition>211001016 - Disclosure - Schedule II - Valuations and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationsandQualifyingAccountsDetails" roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails">
        <link:definition>241014071 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cah_MedicalUnitGoodwillImpairmentMember" abstract="true" name="MedicalUnitGoodwillImpairmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TerminalGrowthRateFairValueInput" abstract="false" name="TerminalGrowthRateFairValueInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_CardinalHealthAtHomeSolutionsMember" abstract="true" name="CardinalHealthAtHomeSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CashDiscountsPolicyTextBlock" abstract="false" name="CashDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" abstract="true" name="ShareRepurchaseProgramAggregatePurchasePriceAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_VendorReserves" abstract="false" name="VendorReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_InventoryReserveWriteDownToNetRealizableValueMember" abstract="true" name="InventoryReserveWriteDownToNetRealizableValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NaviHealthMember" abstract="true" name="NaviHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackDomain" abstract="true" name="NetOperatingLossCarrybackDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_InventoryReserveTableTable" abstract="true" name="InventoryReserveTableTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_GrossTradeReceivablesMajorCustomerPercentage" abstract="false" name="GrossTradeReceivablesMajorCustomerPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_ClassActionLawsuitsMember" abstract="true" name="ClassActionLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" abstract="true" name="ShareRepurchaseProgramAggregatePurchasePriceDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_JudgmentForLostProfits" abstract="false" name="JudgmentForLostProfits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GoodwillImpairmentDomain" abstract="true" name="GoodwillImpairmentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" abstract="false" name="EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_FinanceLeaseImputedInterest" abstract="false" name="FinanceLeaseImputedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Amortizationandotheracquisitionrelatedcosts" abstract="false" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" abstract="false" name="EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" abstract="false" name="LeasesSupplementalBalanceSheetInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" abstract="false" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" abstract="false" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LeasePaymentsTableTextBlock" abstract="false" name="LeasePaymentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_GownRecallDomain" abstract="true" name="GownRecallDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" abstract="false" name="Sharesthatwouldbeantidilutiveasaresultofnetloss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" abstract="false" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LawsuitTypeDomain" abstract="true" name="LawsuitTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A7.0Debenturesduefiscal2027Member" abstract="true" name="A7.0Debenturesduefiscal2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_InventoryReserveTableLineItems" abstract="true" name="InventoryReserveTableLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_CashReclassifiedtoAssetsHeldforSale" abstract="false" name="CashReclassifiedtoAssetsHeldforSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallMemberDomain" abstract="true" name="SterileSurgicalGownRecallMemberDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" abstract="false" name="DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" abstract="false" name="EstimatedLiabilityForNewYorkOpioidStewardshipAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_NuclearPrecisionHealthServicesMember" abstract="true" name="NuclearPrecisionHealthServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LossContingencyNumberOfEligibleStates" abstract="false" name="LossContingencyNumberOfEligibleStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_Impactofadoptionofnewaccountingstandard" abstract="false" name="Impactofadoptionofnewaccountingstandard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_AssetsHeldforSalePolicyPolicyTextBlock" abstract="false" name="AssetsHeldforSalePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_CarryingAmountofLongTermandotherShortTermBorrowings" abstract="false" name="CarryingAmountofLongTermandotherShortTermBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GoodwillImpairmentAxis" abstract="true" name="GoodwillImpairmentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_ConcentrationRiskLargestGroupPurchasingOrganizations" abstract="false" name="ConcentrationRiskLargestGroupPurchasingOrganizations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_PrivatePartiesMember" abstract="true" name="PrivatePartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CordisDivestitureMember" abstract="true" name="CordisDivestitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" abstract="false" name="EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_ASC842Member" abstract="true" name="ASC842Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CommonStockVotingRightsVotes" abstract="false" name="CommonStockVotingRightsVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cah_MedicalUnitMember" abstract="true" name="MedicalUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_September2025Member" abstract="true" name="September2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_AdditionalPerformanceShareUnitsDataTableTextBlock" abstract="false" name="AdditionalPerformanceShareUnitsDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_PlaintiffTypeDomain" abstract="true" name="PlaintiffTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_InventoryReserveExcessAndObsoleteMember" abstract="true" name="InventoryReserveExcessAndObsoleteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_IncomefromSettlementsofClassActionLawsuits" abstract="false" name="IncomefromSettlementsofClassActionLawsuits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallDomain" abstract="true" name="SterileSurgicalGownRecallDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NotesPayableRepurchased" abstract="false" name="NotesPayableRepurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_SettlingUSTerritories" abstract="false" name="SettlingUSTerritories" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_AlamedaCountyMember" abstract="true" name="AlamedaCountyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FloatingRateNotesdue2022Member" abstract="true" name="FloatingRateNotesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A2021LTIPMember" abstract="true" name="A2021LTIPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ReclassificationofdeferredrentinaccordancewithASC842" abstract="false" name="ReclassificationofdeferredrentinaccordancewithASC842" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A3.41Notesdue2027Member" abstract="true" name="A3.41Notesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_MaturityDateAxis" abstract="true" name="MaturityDateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFour" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A200MillionShareRepurchaseProgramMember" abstract="true" name="A200MillionShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LitigationTypeAxis" abstract="true" name="LitigationTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" abstract="false" name="DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_GoodsandservicessoldLineItems" abstract="true" name="GoodsandservicessoldLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_ReceivableFinancingAgreementTerm" abstract="false" name="ReceivableFinancingAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cah_A4.625Notesdue2021Member" abstract="true" name="A4.625Notesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A300MillionShareRepurchaseProgramMember" abstract="true" name="A300MillionShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GainonDivestitureAfterTax" abstract="false" name="GainonDivestitureAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_DOJInvestigationMember" abstract="true" name="DOJInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GoodwillAndIntangibleAssetsLineItems" abstract="true" name="GoodwillAndIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackAxis" abstract="true" name="NetOperatingLossCarrybackAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" abstract="false" name="EffectiveIncomeTaxRateReconciliationWithholdingTaxes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_A4.5Notesdue2044Member" abstract="true" name="A4.5Notesdue2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" abstract="false" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A3.2Notesdue2023Member" abstract="true" name="A3.2Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" abstract="false" name="OtherAccruedLiabilitiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_CordisDivestitureAxis" abstract="true" name="CordisDivestitureAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_OfferAsPercentageOfPrincipalAmount" abstract="false" name="OfferAsPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_AwardsOtherThanStockOptionsMember" abstract="true" name="AwardsOtherThanStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NaviHealthAxis" abstract="true" name="NaviHealthAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_IPRDTrademarksandOtherMember" abstract="true" name="IPRDTrademarksandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LeasesTextBlock" abstract="false" name="LeasesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_A3.079Notesdue2024Member" abstract="true" name="A3.079Notesdue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TaxMatterDomain" abstract="true" name="TaxMatterDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OpioidLitigationDomain" abstract="true" name="OpioidLitigationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_SterileSurgicalGownRecallAxis" abstract="true" name="SterileSurgicalGownRecallAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_OperatingLeaseMember" abstract="true" name="OperatingLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LesseeLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_CordisDivestitureDomain" abstract="true" name="CordisDivestitureDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A24NotesDue2019Member" abstract="true" name="A24NotesDue2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" abstract="false" name="DeferredTaxAssetsRelatedtouncertaintaxpositions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_AggregateAnnualAssessment" abstract="false" name="AggregateAnnualAssessment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ProductLiabilityLawsuitsMember" abstract="true" name="ProductLiabilityLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" abstract="false" name="DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_OperatingLeaseImputedInterest" abstract="false" name="OperatingLeaseImputedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" abstract="false" name="ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_PharmaceuticalDistributionandSpecialtyMember" abstract="true" name="PharmaceuticalDistributionandSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_June2027Member" abstract="true" name="June2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CostofSalesVendorReservesPolicyPolicyTextBlock" abstract="false" name="CostofSalesVendorReservesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_FacilityExitAndOtherCosts" abstract="false" name="FacilityExitAndOtherCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_FixedRateDebtMember" abstract="true" name="FixedRateDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" abstract="false" name="EffectiveTaxRateImpactFromCertainForeignJurisdictions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_LawsuitTypeAxis" abstract="true" name="LawsuitTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_NewYorkOpioidStewardshipActMember" abstract="true" name="NewYorkOpioidStewardshipActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CommittedReceivablesSalesFacilityProgramMember" abstract="true" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DividendsPolicyPolicyTextBlock" abstract="false" name="DividendsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_PharmaceuticalMember" abstract="true" name="PharmaceuticalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A4.6Notesdue2043Member" abstract="true" name="A4.6Notesdue2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NetOperatingLossCarrybackMember" abstract="true" name="NetOperatingLossCarrybackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GownRecallAxis" abstract="true" name="GownRecallAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_WriteDownOfAssetsHeldForSale" abstract="false" name="WriteDownOfAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_GoodsandservicessoldTable" abstract="true" name="GoodsandservicessoldTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_FloatingRateNotes2616NotesMember" abstract="true" name="FloatingRateNotes2616NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LitigationTypeDomain" abstract="true" name="LitigationTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearThree" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ShortTermCreditFacilitiesMember" abstract="true" name="ShortTermCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_GoodwillAndIntangibleAssetsTable" abstract="true" name="GoodwillAndIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cah_RevenueRecognitionReserveforSalesReturnsandAllowances" abstract="false" name="RevenueRecognitionReserveforSalesReturnsandAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_OptumRxMember" abstract="true" name="OptumRxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TotalLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A500MillionShareRepurchaseProgramMember" abstract="true" name="A500MillionShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_MaturityDateDomain" abstract="true" name="MaturityDateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearOne" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_A3.2Notesdue2022Member" abstract="true" name="A3.2Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" abstract="false" name="AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_A3.5Notesdue2025Member" abstract="true" name="A3.5Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TotalLeaseLiabilityPaymentsDue" abstract="false" name="TotalLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" abstract="false" name="AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_TaxMatterAxis" abstract="true" name="TaxMatterAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_CareFusionMember" abstract="true" name="CareFusionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_TotalOpioidLitigationMember" abstract="true" name="TotalOpioidLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_CVSCaremarkCorporationMember" abstract="true" name="CVSCaremarkCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LossContingencyLawsuitsNumber" abstract="false" name="LossContingencyLawsuitsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_MedicaldistributionandproductsMember" abstract="true" name="MedicaldistributionandproductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_DiscountRatefairvalueinputs" abstract="false" name="DiscountRatefairvalueinputs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_OpioidLitigationAxis" abstract="true" name="OpioidLitigationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_IndemnificationReceivable" abstract="false" name="IndemnificationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_SettlingStates" abstract="false" name="SettlingStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_GroupPurchasingOrganizationsMember" abstract="true" name="GroupPurchasingOrganizationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_OtherJurisdictionsMember" abstract="true" name="OtherJurisdictionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PriorYearRecoveriesMember" abstract="true" name="PriorYearRecoveriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_NaviHealthDomain" abstract="true" name="NaviHealthDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFive" abstract="false" name="LesseeLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_ShippingandHandlingCostsPolicyTextBlock" abstract="false" name="ShippingandHandlingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_OpioidLawsuitsMember" abstract="true" name="OpioidLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A4.368Notesdue2047Member" abstract="true" name="A4.368Notesdue2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_VestingPeriodinyearsforShares" abstract="false" name="VestingPeriodinyearsforShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_TotalLeaseLiability" abstract="false" name="TotalLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cah_SalesreturnsPolicyTextBlock" abstract="false" name="SalesreturnsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_TrademarksAndPatentsMember" abstract="true" name="TrademarksAndPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" abstract="false" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cah_MedicalMemberMember" abstract="true" name="MedicalMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PatientRecoveryBusinessMember" abstract="true" name="PatientRecoveryBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_EffectiveIncomeTaxReconciliationOpioidLitigation" abstract="false" name="EffectiveIncomeTaxReconciliationOpioidLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cah_A4.9Notesdue2045Member" abstract="true" name="A4.9Notesdue2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PlaintiffTypeAxis" abstract="true" name="PlaintiffTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cah_A3.75Notesdue2026Member" abstract="true" name="A3.75Notesdue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_PricingDisputesMember" abstract="true" name="PricingDisputesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A32Notes2616NotesMember" abstract="true" name="A32Notes2616NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A2.616Notesdue2022Member" abstract="true" name="A2.616Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" abstract="true" name="A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>cah-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f6b5e545-b5b4-43cb-aefd-cbc0ddadda4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_us-gaap_GrossProfit_f6b5e545-b5b4-43cb-aefd-cbc0ddadda4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f634265-b482-4dc7-b60f-cab925774bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f634265-b482-4dc7-b60f-cab925774bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3b3a501a-9a66-4e5c-bc45-e0909b36c9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_us-gaap_RestructuringCharges_3b3a501a-9a66-4e5c-bc45-e0909b36c9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_b0e0dbc7-4597-411a-b63b-351757fa1e19" xlink:href="cah-20220630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_b0e0dbc7-4597-411a-b63b-351757fa1e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_88dbfacd-3173-4db0-ac1f-d281518b6aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_88dbfacd-3173-4db0-ac1f-d281518b6aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6b74d61b-db8f-45f2-8a49-dfe0e0270b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63ec13f8-f91b-4e6b-9092-323a5e50b6a2" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6b74d61b-db8f-45f2-8a49-dfe0e0270b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4a7ce0f2-70bd-41bd-8139-d6fbf8acdd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_50656e5d-5e1a-4c92-b0cb-397b66323fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4a7ce0f2-70bd-41bd-8139-d6fbf8acdd81" xlink:to="loc_us-gaap_ProfitLoss_50656e5d-5e1a-4c92-b0cb-397b66323fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_11d5f7bb-168e-45f5-8170-16ea3f6720f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4a7ce0f2-70bd-41bd-8139-d6fbf8acdd81" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_11d5f7bb-168e-45f5-8170-16ea3f6720f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_937afd48-d930-409d-8135-36295e79513d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:to="loc_us-gaap_OperatingIncomeLoss_937afd48-d930-409d-8135-36295e79513d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7010f009-be40-44ed-a476-ea8733a1045d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7010f009-be40-44ed-a476-ea8733a1045d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ea2fb78c-a278-4790-8d30-11da3fb4439a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:to="loc_us-gaap_InterestExpense_ea2fb78c-a278-4790-8d30-11da3fb4439a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f2ce67c1-5f91-401c-aaec-89eb403fee22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f2ce67c1-5f91-401c-aaec-89eb403fee22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_98aea37f-b36c-4c70-92ed-26c398e231f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1633c857-01e2-4d44-8916-1f31a92efcc7" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_98aea37f-b36c-4c70-92ed-26c398e231f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_41bd30af-dc6a-43b1-8cc3-cdff030233df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd3a9192-b9fd-4605-9b5c-ffb98f88c884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_41bd30af-dc6a-43b1-8cc3-cdff030233df" xlink:to="loc_us-gaap_Revenues_dd3a9192-b9fd-4605-9b5c-ffb98f88c884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c2db36c4-b921-4618-aa25-840ceb8833ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_41bd30af-dc6a-43b1-8cc3-cdff030233df" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c2db36c4-b921-4618-aa25-840ceb8833ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_894a217c-848c-4e18-b1dc-1bab28d58ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09c2574d-2c2e-4956-a94e-71e1850de71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_894a217c-848c-4e18-b1dc-1bab28d58ca6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09c2574d-2c2e-4956-a94e-71e1850de71f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_51115e64-8e7e-499b-995b-93c900d15def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_894a217c-848c-4e18-b1dc-1bab28d58ca6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_51115e64-8e7e-499b-995b-93c900d15def" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd31e5d3-b43d-4c78-ad79-b764a8422375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_82e9666f-9294-46e2-8df0-ae4ac3c4eaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd31e5d3-b43d-4c78-ad79-b764a8422375" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_82e9666f-9294-46e2-8df0-ae4ac3c4eaf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1cc1c5f5-ca3d-4ec1-bf61-c69b666de5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd31e5d3-b43d-4c78-ad79-b764a8422375" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1cc1c5f5-ca3d-4ec1-bf61-c69b666de5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_212d9472-f4c7-4f50-8f28-d059cfe6ffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_09066ea8-6173-4206-ba0e-5525c438399c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_212d9472-f4c7-4f50-8f28-d059cfe6ffeb" xlink:to="loc_us-gaap_ProfitLoss_09066ea8-6173-4206-ba0e-5525c438399c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_728ada87-59a0-44d5-8b36-b04dac45688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_212d9472-f4c7-4f50-8f28-d059cfe6ffeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_728ada87-59a0-44d5-8b36-b04dac45688b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_16c7b680-ba41-4384-945d-8515c50de6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_81209f34-5d2c-4b46-8787-72aad08cee44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_16c7b680-ba41-4384-945d-8515c50de6dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_81209f34-5d2c-4b46-8787-72aad08cee44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5539209f-6813-4e64-a3a7-4c1d8d4ae54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_16c7b680-ba41-4384-945d-8515c50de6dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5539209f-6813-4e64-a3a7-4c1d8d4ae54d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b2194f3b-78f2-43e9-83d6-bdb2eeadd4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b2194f3b-78f2-43e9-83d6-bdb2eeadd4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_260284ce-454f-47b7-9a43-8d90807f404b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:to="loc_us-gaap_ReceivablesNetCurrent_260284ce-454f-47b7-9a43-8d90807f404b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_81fe3b99-7b51-4db7-8add-880fe91876b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:to="loc_us-gaap_InventoryNet_81fe3b99-7b51-4db7-8add-880fe91876b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a49704d4-7d75-45d8-996e-bff84bfd959d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:to="loc_us-gaap_OtherAssetsCurrent_a49704d4-7d75-45d8-996e-bff84bfd959d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_720c75d8-1438-4ef8-85e4-5f6c8a280fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_adf0bacf-b90d-4c93-b506-deb5d5f80190" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_720c75d8-1438-4ef8-85e4-5f6c8a280fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9e0a17a2-eec3-4244-998c-5a2a47f162df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d659847e-672a-4a73-9bb3-2d6ffa5a7c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9e0a17a2-eec3-4244-998c-5a2a47f162df" xlink:to="loc_us-gaap_AccountsPayableCurrent_d659847e-672a-4a73-9bb3-2d6ffa5a7c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3d70dd49-b4e3-4a7a-9c16-631307bbf920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9e0a17a2-eec3-4244-998c-5a2a47f162df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3d70dd49-b4e3-4a7a-9c16-631307bbf920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13466935-6539-45bd-8577-2b9eef0b681b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9e0a17a2-eec3-4244-998c-5a2a47f162df" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13466935-6539-45bd-8577-2b9eef0b681b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0056308-ec7a-4ba9-b3bb-f6e07cecc6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9e0a17a2-eec3-4244-998c-5a2a47f162df" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c0056308-ec7a-4ba9-b3bb-f6e07cecc6f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ba9ea8-b58c-4baa-bb5e-99ebd661675e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8f158eab-1d69-4d73-a9dc-45f69f0d4424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ba9ea8-b58c-4baa-bb5e-99ebd661675e" xlink:to="loc_us-gaap_LiabilitiesCurrent_8f158eab-1d69-4d73-a9dc-45f69f0d4424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_19209b82-6a4f-4d0d-bb9f-6674af7be568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ba9ea8-b58c-4baa-bb5e-99ebd661675e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_19209b82-6a4f-4d0d-bb9f-6674af7be568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_33c813eb-267c-4a71-a898-6276416ce011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ba9ea8-b58c-4baa-bb5e-99ebd661675e" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_33c813eb-267c-4a71-a898-6276416ce011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d8daebf3-3843-436b-8694-27097a652c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ba9ea8-b58c-4baa-bb5e-99ebd661675e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d8daebf3-3843-436b-8694-27097a652c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_313099e4-1d65-494d-8f2c-668a4ab38e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_94613a9d-960d-4d74-bad5-2edf36de0c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_313099e4-1d65-494d-8f2c-668a4ab38e26" xlink:to="loc_us-gaap_StockholdersEquity_94613a9d-960d-4d74-bad5-2edf36de0c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_bd338e54-ddf9-4e00-86db-1f170276b77e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_313099e4-1d65-494d-8f2c-668a4ab38e26" xlink:to="loc_us-gaap_MinorityInterest_bd338e54-ddf9-4e00-86db-1f170276b77e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a7552e9d-3c41-43cb-a2a4-8f33a5589922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_23910bf4-93fa-4bad-9b0b-f002e6645aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a7552e9d-3c41-43cb-a2a4-8f33a5589922" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_23910bf4-93fa-4bad-9b0b-f002e6645aaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_647eafa9-fda5-4754-af5a-ce7b92e55759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a7552e9d-3c41-43cb-a2a4-8f33a5589922" xlink:to="loc_us-gaap_AssetsCurrent_647eafa9-fda5-4754-af5a-ce7b92e55759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2835328c-8039-44c7-9e65-d1c0ad72566a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a7552e9d-3c41-43cb-a2a4-8f33a5589922" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2835328c-8039-44c7-9e65-d1c0ad72566a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b280e635-93c3-4044-8093-8175a14544fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a7552e9d-3c41-43cb-a2a4-8f33a5589922" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b280e635-93c3-4044-8093-8175a14544fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f8467bb9-1955-4bdc-abad-34074d44c717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:to="loc_us-gaap_PreferredStockValue_f8467bb9-1955-4bdc-abad-34074d44c717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_249ff983-6a52-4133-8325-66d04410b145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:to="loc_us-gaap_CommonStockValue_249ff983-6a52-4133-8325-66d04410b145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb0b208a-ee76-42fb-b0c8-6cadbddbdda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb0b208a-ee76-42fb-b0c8-6cadbddbdda0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b0a967bd-1351-43b6-a298-fd10b1d08abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:to="loc_us-gaap_TreasuryStockValue_b0a967bd-1351-43b6-a298-fd10b1d08abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_73dd33d7-0132-4000-b3e9-2ee098d5809f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d027e9a-2b4f-4d71-91f6-0f9fac1b6c4f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_73dd33d7-0132-4000-b3e9-2ee098d5809f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a5734a5e-8190-47c8-bafe-9a0001a65c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a5734a5e-8190-47c8-bafe-9a0001a65c41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1189c84e-af35-4eed-bd49-b4a255a932c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1189c84e-af35-4eed-bd49-b4a255a932c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_04700676-14d6-46a7-8424-ec52da11fadc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_04700676-14d6-46a7-8424-ec52da11fadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_bb995bb9-ca93-4d81-9475-c170cb26fc9b" xlink:href="cah-20220630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_bb995bb9-ca93-4d81-9475-c170cb26fc9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_e3e011f8-e630-48b3-aa80-3638b4aeb147" xlink:href="cah-20220630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_e3e011f8-e630-48b3-aa80-3638b4aeb147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e520ef0a-7d0f-40e5-9bc9-ebb2d2555006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_e520ef0a-7d0f-40e5-9bc9-ebb2d2555006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_f9b75c0f-cbaa-4cc8-81a2-4676a04c7edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_442b4206-6393-4b26-b33f-b7b7174488f2" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_f9b75c0f-cbaa-4cc8-81a2-4676a04c7edb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_219738ba-15ac-457c-9bc7-8cf5f54b7279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_ProfitLoss_219738ba-15ac-457c-9bc7-8cf5f54b7279" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_24afc940-74f5-4c68-85ec-df22a6fad7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_24afc940-74f5-4c68-85ec-df22a6fad7c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_a2740cbd-c84a-4801-8982-45536474db32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_a2740cbd-c84a-4801-8982-45536474db32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_0deaa414-060c-4bbb-a434-4382bb436ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_0deaa414-060c-4bbb-a434-4382bb436ad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_7df57726-f684-4438-9025-2075c4a58146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_7df57726-f684-4438-9025-2075c4a58146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_140153b8-3162-4d8c-98dd-f67dcc2badd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_140153b8-3162-4d8c-98dd-f67dcc2badd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c78872d9-6d63-4b4c-9d97-11f990fe5987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_ShareBasedCompensation_c78872d9-6d63-4b4c-9d97-11f990fe5987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10a025ca-20a8-468c-ae21-9a1d12bbfc88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10a025ca-20a8-468c-ae21-9a1d12bbfc88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_26d4539e-d7af-4cab-a136-7fd9bad36e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_26d4539e-d7af-4cab-a136-7fd9bad36e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_326992ca-2136-4ca8-b156-3f89d0bfce23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_326992ca-2136-4ca8-b156-3f89d0bfce23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a93c53ba-611d-4243-9950-ad6fa3c64ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a93c53ba-611d-4243-9950-ad6fa3c64ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_da42c03a-df01-42de-b59f-fc2a429a163e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_da42c03a-df01-42de-b59f-fc2a429a163e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_721d5932-826b-40ed-8bd6-3b1b3a4c3eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fd38bf22-9217-4192-82d1-88dd568d83dc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_721d5932-826b-40ed-8bd6-3b1b3a4c3eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_66bdadc2-12f5-41a1-babe-c5dfb9bd3028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_66bdadc2-12f5-41a1-babe-c5dfb9bd3028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_7cfef097-0398-43cd-8092-0722abd223ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_7cfef097-0398-43cd-8092-0722abd223ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f97c2d93-fe5f-4202-ab67-ba78833b3eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f97c2d93-fe5f-4202-ab67-ba78833b3eca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_c722c585-afaf-48dc-ba32-b02c9390ca67" xlink:href="cah-20220630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_c722c585-afaf-48dc-ba32-b02c9390ca67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b1341089-eed6-4858-9f48-aff674e728b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b1341089-eed6-4858-9f48-aff674e728b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e2a8a75-5690-4ad3-8415-cb5bffb3a435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf9f30f9-d4ee-4b88-89a5-12c4bf98e2d8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e2a8a75-5690-4ad3-8415-cb5bffb3a435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b55f3db9-1e09-426c-b465-13aca7466c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b55f3db9-1e09-426c-b465-13aca7466c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e1b129d-f6bd-405f-bd0b-46d6ff375c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e1b129d-f6bd-405f-bd0b-46d6ff375c69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26202275-d027-4464-8418-15b98e6763dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26202275-d027-4464-8418-15b98e6763dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_6b7f03ca-7961-4218-8026-d0b8803e05a6" xlink:href="cah-20220630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_6b7f03ca-7961-4218-8026-d0b8803e05a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c2ce071-4add-4c78-a112-b068b8bb60de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a67bb62-d465-4503-b39f-97728242fd6d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c2ce071-4add-4c78-a112-b068b8bb60de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c4ddce2a-e175-45ee-9859-e7f768afea9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2390c43e-4863-4c83-8d3e-012fac67db6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_c4ddce2a-e175-45ee-9859-e7f768afea9a" xlink:to="loc_us-gaap_SeveranceCosts1_2390c43e-4863-4c83-8d3e-012fac67db6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts_01581d2b-6f66-4936-8287-81df8f7cbbc7" xlink:href="cah-20220630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_c4ddce2a-e175-45ee-9859-e7f768afea9a" xlink:to="loc_cah_FacilityExitAndOtherCosts_01581d2b-6f66-4936-8287-81df8f7cbbc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesScheduleofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ccf5cbc5-023f-4ce7-80dc-0cb5db39951b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a9f0f4fa-199c-4b9b-8d75-2f98fe4cf6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ccf5cbc5-023f-4ce7-80dc-0cb5db39951b" xlink:to="loc_us-gaap_OperatingLeaseCost_a9f0f4fa-199c-4b9b-8d75-2f98fe4cf6e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_522547b3-f5da-4029-93ad-9d75a6c0cae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ccf5cbc5-023f-4ce7-80dc-0cb5db39951b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_522547b3-f5da-4029-93ad-9d75a6c0cae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_6167533d-f5da-418c-bcc1-17c4d0a9feed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ccf5cbc5-023f-4ce7-80dc-0cb5db39951b" xlink:to="loc_us-gaap_VariableLeaseCost_6167533d-f5da-418c-bcc1-17c4d0a9feed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_499b7304-a314-4d6a-ad34-6726b3a59ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0ac82b42-3b2a-4a65-8d1b-1c142c00a57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_499b7304-a314-4d6a-ad34-6726b3a59ce8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0ac82b42-3b2a-4a65-8d1b-1c142c00a57e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6e6d2b13-5ce4-4bd1-841b-d18f04b0bed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_499b7304-a314-4d6a-ad34-6726b3a59ce8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6e6d2b13-5ce4-4bd1-841b-d18f04b0bed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7fd3881a-345d-4849-ba3c-113023939c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_126cf6aa-b450-4b78-a757-03e36f530ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_7fd3881a-345d-4849-ba3c-113023939c9b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_126cf6aa-b450-4b78-a757-03e36f530ac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8837e28-099a-4309-a907-d7c81a2ca4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_7fd3881a-345d-4849-ba3c-113023939c9b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b8837e28-099a-4309-a907-d7c81a2ca4e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_491d30ab-8d10-43c8-901c-6c5356df6360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_21a9cc12-66e0-4594-958a-324547870c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_491d30ab-8d10-43c8-901c-6c5356df6360" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_21a9cc12-66e0-4594-958a-324547870c69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fe604707-a508-4a75-9a74-39cbe86900d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_491d30ab-8d10-43c8-901c-6c5356df6360" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fe604707-a508-4a75-9a74-39cbe86900d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ac7e25-4972-48b8-8eb4-af4f19c4b65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e0832e44-7eae-4865-bade-0d94e5a1cb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ac7e25-4972-48b8-8eb4-af4f19c4b65d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e0832e44-7eae-4865-bade-0d94e5a1cb67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_98cdddc8-fc2f-4907-a160-455d348f9cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ac7e25-4972-48b8-8eb4-af4f19c4b65d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_98cdddc8-fc2f-4907-a160-455d348f9cb4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1869d7ca-4454-45ca-8a61-6a9768480405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1398d928-e14a-434d-bd39-9809b5a86c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1869d7ca-4454-45ca-8a61-6a9768480405" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1398d928-e14a-434d-bd39-9809b5a86c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_07a721c1-38de-4e6a-b2b0-0232cb322a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1869d7ca-4454-45ca-8a61-6a9768480405" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_07a721c1-38de-4e6a-b2b0-0232cb322a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_408a16bd-d4f8-443b-a96c-c0896996542b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1869d7ca-4454-45ca-8a61-6a9768480405" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_408a16bd-d4f8-443b-a96c-c0896996542b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbbfb7bb-002a-4503-9ecc-3f0c95984b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc6ea10d-d218-4486-9ff0-aacf269c52fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_dbbfb7bb-002a-4503-9ecc-3f0c95984b8e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cc6ea10d-d218-4486-9ff0-aacf269c52fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_378a2a6a-c982-4463-a7c9-7979ec72bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_dbbfb7bb-002a-4503-9ecc-3f0c95984b8e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_378a2a6a-c982-4463-a7c9-7979ec72bea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f5e50a87-55f2-406e-84d6-2a5f358cc6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c503ed89-7c4b-4d7c-86c6-6b95512d5ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f5e50a87-55f2-406e-84d6-2a5f358cc6c9" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c503ed89-7c4b-4d7c-86c6-6b95512d5ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7f8b8b4a-458c-468f-ab32-17853b951f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f5e50a87-55f2-406e-84d6-2a5f358cc6c9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7f8b8b4a-458c-468f-ab32-17853b951f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_abb9a89c-2f9e-4ee4-9f07-2333b794c105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f5e50a87-55f2-406e-84d6-2a5f358cc6c9" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_abb9a89c-2f9e-4ee4-9f07-2333b794c105" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_27c080d6-db13-4bd6-8c36-a3f313a51ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_27c080d6-db13-4bd6-8c36-a3f313a51ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_e96f7efd-dea2-431f-b648-024415afb830" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_e96f7efd-dea2-431f-b648-024415afb830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7b6509d2-f537-4d64-bd86-e125c98e4968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7b6509d2-f537-4d64-bd86-e125c98e4968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d2b0edfe-bbb0-402a-8e8c-12554396e8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d2b0edfe-bbb0-402a-8e8c-12554396e8e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_80ffb15e-c915-4199-8c0e-534cbdf8e0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_80ffb15e-c915-4199-8c0e-534cbdf8e0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_fc922a82-6895-4a4f-952b-0534eae4357c" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_fc922a82-6895-4a4f-952b-0534eae4357c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ad27f3b7-e36a-48ff-9397-f786fd59126a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ad27f3b7-e36a-48ff-9397-f786fd59126a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_4a7ae054-a1f5-488a-810a-a9048ad226a1" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_4a7ae054-a1f5-488a-810a-a9048ad226a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_9540e48c-3d2f-4b15-84c1-78404971abd2" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_9540e48c-3d2f-4b15-84c1-78404971abd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_5c47f70e-f483-4c4e-b88c-9d98bf1fabf7" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_5c47f70e-f483-4c4e-b88c-9d98bf1fabf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_01b78b93-7762-4a45-a830-f6454fdc9040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_01b78b93-7762-4a45-a830-f6454fdc9040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_b8f7b5d5-6347-472a-b482-e0c232f9a841" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_b8f7b5d5-6347-472a-b482-e0c232f9a841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_e08d819c-80d4-41f3-a6ae-d62622609c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d016e4f-9282-481b-95af-a010e61e00df" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_e08d819c-80d4-41f3-a6ae-d62622609c7b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a4f9cdfa-ea47-4d89-bd13-1968e0e4aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a4f9cdfa-ea47-4d89-bd13-1968e0e4aa35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9b42ccca-cdcc-4670-9e8d-39ee3aa50756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9b42ccca-cdcc-4670-9e8d-39ee3aa50756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_07213cf9-f5c0-4097-8ce7-620688723dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_07213cf9-f5c0-4097-8ce7-620688723dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_4213bd01-9fae-4d17-adbb-1f7b8ea1e4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_4213bd01-9fae-4d17-adbb-1f7b8ea1e4fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_922ecd6d-bca4-456b-89ee-e13c2579d3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d45999f7-1410-4554-86a0-a595b277b4bd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_922ecd6d-bca4-456b-89ee-e13c2579d3cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_dcdf3553-9376-4cfa-aff8-d97fe13626f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_dcdf3553-9376-4cfa-aff8-d97fe13626f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0beaffc0-9b6d-49f5-b4ef-22fa156a4873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0beaffc0-9b6d-49f5-b4ef-22fa156a4873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_a3492be9-2b56-4c78-b3c7-ef54d464510f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_a3492be9-2b56-4c78-b3c7-ef54d464510f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a011ee84-b826-4251-8b37-98ae853ba2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a011ee84-b826-4251-8b37-98ae853ba2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_184e0e7a-9033-4d74-a256-02948a35736d" xlink:href="cah-20220630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_184e0e7a-9033-4d74-a256-02948a35736d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_6b4d8a8a-89f6-4225-be85-42208133ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f2bd414b-3d8c-4382-b7af-1cf5fc69d24d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_6b4d8a8a-89f6-4225-be85-42208133ec12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_537797a0-2208-40b3-b301-d95933ce47df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e9334b73-3273-4173-8a2b-b670427a1696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_537797a0-2208-40b3-b301-d95933ce47df" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_e9334b73-3273-4173-8a2b-b670427a1696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_90dc950d-6b71-429b-a481-bc36fb29d271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_537797a0-2208-40b3-b301-d95933ce47df" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_90dc950d-6b71-429b-a481-bc36fb29d271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_40f24521-bae5-4786-8df5-ce00bc29db41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e47192ee-4d5e-40df-a259-0c3158697669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_40f24521-bae5-4786-8df5-ce00bc29db41" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e47192ee-4d5e-40df-a259-0c3158697669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_984507a7-61c1-4ee7-96eb-f52d856c2b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_40f24521-bae5-4786-8df5-ce00bc29db41" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_984507a7-61c1-4ee7-96eb-f52d856c2b2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_5462b571-3e57-44e3-8fd2-dce9e7492c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_8a904b96-138b-4588-9321-4a13fe0adc3a" xlink:href="cah-20220630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5462b571-3e57-44e3-8fd2-dce9e7492c29" xlink:to="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_8a904b96-138b-4588-9321-4a13fe0adc3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_25ffb74c-cec6-4334-a656-2efc7baa2b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5462b571-3e57-44e3-8fd2-dce9e7492c29" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_25ffb74c-cec6-4334-a656-2efc7baa2b8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_808e5010-231a-4dff-a7db-428d0a2942ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5462b571-3e57-44e3-8fd2-dce9e7492c29" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_808e5010-231a-4dff-a7db-428d0a2942ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_310df79d-d50b-4f3a-8615-40d338f1f718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fae24bde-0e37-4795-83e8-728c28496a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_310df79d-d50b-4f3a-8615-40d338f1f718" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fae24bde-0e37-4795-83e8-728c28496a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2b8bb76f-870f-44a0-92e9-414283e3b6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_310df79d-d50b-4f3a-8615-40d338f1f718" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2b8bb76f-870f-44a0-92e9-414283e3b6f2" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>cah-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="ie3d7bc0dd43f463aa11a4e30645901dc_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0df4a2ed-28ed-4e2d-96d4-8b6f78d3e534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:to="loc_us-gaap_NetIncomeLoss_0df4a2ed-28ed-4e2d-96d4-8b6f78d3e534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9b482ea5-24fb-40fb-a2d4-ad73d9785483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_CommonStockSharesIssued_9b482ea5-24fb-40fb-a2d4-ad73d9785483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec985448-bcc1-4a84-bbcb-327b28074d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec985448-bcc1-4a84-bbcb-327b28074d06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b3299522-2373-47c5-b1f4-21ef2f3ba479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockShares_b3299522-2373-47c5-b1f4-21ef2f3ba479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3e4ec7c6-39f4-42df-a070-dc040b3fc784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockValue_3e4ec7c6-39f4-42df-a070-dc040b3fc784" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a30ada2-2bea-45e3-bf27-c64d90a4b542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_ProfitLoss_9a30ada2-2bea-45e3-bf27-c64d90a4b542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_f06dc759-7675-40e1-900c-0b6871630f8f" xlink:href="cah-20220630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_f06dc759-7675-40e1-900c-0b6871630f8f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e144c5a0-d30e-4e49-b773-a72635b9560f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e144c5a0-d30e-4e49-b773-a72635b9560f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_742b09f4-8b50-4b60-ab1e-890d3233ac14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_742b09f4-8b50-4b60-ab1e-890d3233ac14" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c422b6f-2bac-4079-aa93-11afb13573b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c422b6f-2bac-4079-aa93-11afb13573b8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_151856ec-ff23-4ede-b99c-be944f4544d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_151856ec-ff23-4ede-b99c-be944f4544d2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_765327b9-58f9-4564-a086-4d6eb5fb84a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_765327b9-58f9-4564-a086-4d6eb5fb84a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_a0299a7e-f270-4904-a954-5c463c96c026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_Dividends_a0299a7e-f270-4904-a954-5c463c96c026" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares_b32de6c3-5779-46d8-8933-47d3c6f8c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityOtherShares_b32de6c3-5779-46d8-8933-47d3c6f8c4f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_4b864f51-92d6-4ed6-8aaa-082c8077d1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityOther_4b864f51-92d6-4ed6-8aaa-082c8077d1e5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_646de46a-2a02-4309-9a9e-ae632648164c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_30cbd952-13dd-45b1-82ad-514c13269b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1271ec1a-a21d-4c09-aa08-cd31f360486e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_fa78eb5e-f65e-4b02-9c58-dc14340a5d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:to="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1375affc-80e4-48c5-a620-6a335bbf43f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:to="loc_us-gaap_EquityComponentDomain_1375affc-80e4-48c5-a620-6a335bbf43f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:to="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5e7ed1bb-6b1a-4bbf-8914-bfc442bcccdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_CommonStockMember_5e7ed1bb-6b1a-4bbf-8914-bfc442bcccdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fac61971-c56a-48b6-9617-1b2ec142fba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_RetainedEarningsMember_fac61971-c56a-48b6-9617-1b2ec142fba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9d3ce755-53c1-4547-8ee4-4df0a3b054b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_TreasuryStockMember_9d3ce755-53c1-4547-8ee4-4df0a3b054b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5916db49-4885-4cb4-8058-a37bb441efe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5916db49-4885-4cb4-8058-a37bb441efe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_35ffe387-edd1-4b05-8cb6-5962edb6b313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_NoncontrollingInterestMember_35ffe387-edd1-4b05-8cb6-5962edb6b313" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended" id="i9deb8fbad99041a48b95f5f5803c57ea_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_05ba2030-a602-4b85-9002-8135f27e4111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_05ba2030-a602-4b85-9002-8135f27e4111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_5de8d0cf-b72c-48db-bc47-935bda58ca56" xlink:href="cah-20220630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_5de8d0cf-b72c-48db-bc47-935bda58ca56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_871daa11-ebc3-41fd-bd55-f5b042acf799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_NotesReceivableNet_871daa11-ebc3-41fd-bd55-f5b042acf799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b41c37f-4da6-4ccc-bf56-23cc8043088b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b41c37f-4da6-4ccc-bf56-23cc8043088b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_6cf20671-1392-4d70-a714-fb5d1bc7dcd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_6cf20671-1392-4d70-a714-fb5d1bc7dcd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_9b3d934f-b1b4-4bfd-ba7f-c1a1b869f2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_9b3d934f-b1b4-4bfd-ba7f-c1a1b869f2bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8e70f4db-3884-4ef1-9105-c0cbb124aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8e70f4db-3884-4ef1-9105-c0cbb124aa41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:to="loc_srt_RangeMember_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:to="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_03d65b73-9c4c-4415-addf-d6e026f35344" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:to="loc_srt_MinimumMember_03d65b73-9c4c-4415-addf-d6e026f35344" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26da792a-f31e-4081-95a4-a51c13843cb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:to="loc_srt_MaximumMember_26da792a-f31e-4081-95a4-a51c13843cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_721b52b6-ddfb-474c-8a59-0902b9ca10c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:to="loc_us-gaap_ReceivableTypeDomain_721b52b6-ddfb-474c-8a59-0902b9ca10c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_fecce7ce-9472-462c-8d8c-5a2cebb9d17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:to="loc_us-gaap_ReceivableTypeDomain_fecce7ce-9472-462c-8d8c-5a2cebb9d17e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="extended" id="id98d232f62554a019bc2682367561505_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f56dbd30-b2e7-4f4e-a64a-0f44bc9ff96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f56dbd30-b2e7-4f4e-a64a-0f44bc9ff96b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_49f73320-e546-40ee-937f-b41707901019" xlink:href="cah-20220630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_49f73320-e546-40ee-937f-b41707901019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cb5e7763-5d99-4fe6-8db0-ea851a6969a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:to="loc_us-gaap_SegmentDomain_cb5e7763-5d99-4fe6-8db0-ea851a6969a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:to="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_d11acaed-3be4-4491-ba4e-c5f5219acd3b" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:to="loc_cah_PharmaceuticalMember_d11acaed-3be4-4491-ba4e-c5f5219acd3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_57877813-a177-4dfa-8cf7-953c632f5dcc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:to="loc_srt_NameOfMajorCustomerDomain_57877813-a177-4dfa-8cf7-953c632f5dcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:to="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember_eb75fc11-55d7-4c8d-a3f0-63abb7b4cccf" xlink:href="cah-20220630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:to="loc_cah_CVSCaremarkCorporationMember_eb75fc11-55d7-4c8d-a3f0-63abb7b4cccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember_bba7ea80-02ff-49fb-8329-bca498811ee4" xlink:href="cah-20220630.xsd#cah_OptumRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:to="loc_cah_OptumRxMember_bba7ea80-02ff-49fb-8329-bca498811ee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9790b5bc-9c06-47d1-a8ce-16eb018b12af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9790b5bc-9c06-47d1-a8ce-16eb018b12af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_015ff090-f8bc-44aa-9390-bb2e2dc3f93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:to="loc_us-gaap_SalesRevenueNetMember_015ff090-f8bc-44aa-9390-bb2e2dc3f93d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4268c808-ce57-420d-b392-b3c139e560ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4268c808-ce57-420d-b392-b3c139e560ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_06e79536-7c8f-47ef-b30f-1014e15001f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_06e79536-7c8f-47ef-b30f-1014e15001f1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended" id="iffc0b6ea7bd34f61aadded287e43c3fb_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_3211fe56-2482-4bf6-89f5-b41767aeeea8" xlink:href="cah-20220630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_3211fe56-2482-4bf6-89f5-b41767aeeea8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_428e8da0-859c-49ec-995c-09a1aaa8a046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_428e8da0-859c-49ec-995c-09a1aaa8a046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:to="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b62f69e-fe9a-4cc5-95ab-6d6780f51993_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b62f69e-fe9a-4cc5-95ab-6d6780f51993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:to="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_df7d3fb7-dcad-4c0e-950f-55ad2041e08e" xlink:href="cah-20220630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_df7d3fb7-dcad-4c0e-950f-55ad2041e08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cab47b30-3ac5-4caa-90c2-a78602ccbfa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cab47b30-3ac5-4caa-90c2-a78602ccbfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_47da65fe-e09b-4b75-9200-203f3017c971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:to="loc_us-gaap_SalesRevenueNetMember_47da65fe-e09b-4b75-9200-203f3017c971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_718e35af-25ee-42c9-b395-96572e35a6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_718e35af-25ee-42c9-b395-96572e35a6a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended" id="i13021564a9d64fb79bb03ba90bf545c0_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_3de7b3f8-3181-40e0-bb38-506caa200489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:to="loc_us-gaap_InventoryValuationReserves_3de7b3f8-3181-40e0-bb38-506caa200489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:to="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_68ac8288-d881-4629-980f-651b99e114f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_68ac8288-d881-4629-980f-651b99e114f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveExcessAndObsoleteMember_b6bc3838-2043-450b-9e3b-8a79f7500a57" xlink:href="cah-20220630.xsd#cah_InventoryReserveExcessAndObsoleteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:to="loc_cah_InventoryReserveExcessAndObsoleteMember_b6bc3838-2043-450b-9e3b-8a79f7500a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember_e97707c2-2a9e-4e64-8da4-4a72779d1148" xlink:href="cah-20220630.xsd#cah_InventoryReserveWriteDownToNetRealizableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:to="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember_e97707c2-2a9e-4e64-8da4-4a72779d1148" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="extended" id="iedb1e3454faf4e7f95557c4cc6e08461_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_56d1d23b-21ac-4b4f-a874-477dbd2b542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_56d1d23b-21ac-4b4f-a874-477dbd2b542f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_74a2bc47-5600-431d-81cb-6ab56131ce16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:to="loc_us-gaap_Depreciation_74a2bc47-5600-431d-81cb-6ab56131ce16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_8cc3798e-60bb-4243-b609-7f2c9d638012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_8cc3798e-60bb-4243-b609-7f2c9d638012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_57190807-1539-48a9-8fba-5ce3bfa57c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_57190807-1539-48a9-8fba-5ce3bfa57c96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6c379eee-9275-4b9c-a03b-3d7c79e45106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6c379eee-9275-4b9c-a03b-3d7c79e45106" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:to="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17172006-d5ea-4806-8d7b-35c9177f67fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:to="loc_srt_RangeMember_17172006-d5ea-4806-8d7b-35c9177f67fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:to="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7638a230-b97b-4683-9eea-42f4b8d50327" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:to="loc_srt_MinimumMember_7638a230-b97b-4683-9eea-42f4b8d50327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9a3c209b-6caf-42fe-a03d-ad32658286ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:to="loc_srt_MaximumMember_9a3c209b-6caf-42fe-a03d-ad32658286ab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="extended" id="ia42c46de3f4d4658abdcfb17cb09b1a2_BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ad30e352-ecff-49a1-bc03-9a89be1bb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ad30e352-ecff-49a1-bc03-9a89be1bb1fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_02081f60-6401-4118-afbf-e0d0c0f7cdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_02081f60-6401-4118-afbf-e0d0c0f7cdce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0f883ee3-a895-4490-9ec6-ad2edfb1ce31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0f883ee3-a895-4490-9ec6-ad2edfb1ce31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9c12f6ba-2d16-4a06-bb48-4973798d8357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9c12f6ba-2d16-4a06-bb48-4973798d8357" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:to="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4fd8faa6-b17e-403e-8634-1173d7a9274f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:to="loc_srt_RangeMember_4fd8faa6-b17e-403e-8634-1173d7a9274f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:to="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b03b9f5-f526-4245-bfa4-7d4871c3a9bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:to="loc_srt_MaximumMember_8b03b9f5-f526-4245-bfa4-7d4871c3a9bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5793928a-fe8c-481c-853f-06f65cb6a48f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:to="loc_srt_MinimumMember_5793928a-fe8c-481c-853f-06f65cb6a48f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e082e63-e5e3-4338-b1a6-a7768f561777_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e082e63-e5e3-4338-b1a6-a7768f561777_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a601e58a-b027-473a-8262-a6a6693e4750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a601e58a-b027-473a-8262-a6a6693e4750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_869a6ec2-11a6-485b-9cf8-54d232b33d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_869a6ec2-11a6-485b-9cf8-54d232b33d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0c8b1c22-e281-4a9a-9a13-dec17df82128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0c8b1c22-e281-4a9a-9a13-dec17df82128" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c613238c-7eed-4234-be96-65569fccaf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c613238c-7eed-4234-be96-65569fccaf1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e7ce6ac8-3487-4ce4-8322-d161c73cbd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_ConstructionInProgressMember_e7ce6ac8-3487-4ce4-8322-d161c73cbd40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e51f844-e139-4481-8797-20455d8a6927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e51f844-e139-4481-8797-20455d8a6927" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="if07335e9f1c84a2193eabf656b32f097_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_d18221dd-3539-4456-8c42-decb40febdeb" xlink:href="cah-20220630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_cah_DiscountRatefairvalueinputs_d18221dd-3539-4456-8c42-decb40febdeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5007de88-a234-45a8-a5d9-20e8a99ea57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5007de88-a234-45a8-a5d9-20e8a99ea57b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5305afaa-3fec-4535-b9d3-35ec57b11db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5305afaa-3fec-4535-b9d3-35ec57b11db7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:to="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:to="loc_srt_RangeMember_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:to="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_751a521d-8abb-4d91-84af-84c331996cd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:to="loc_srt_MinimumMember_751a521d-8abb-4d91-84af-84c331996cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3e528bf0-7d94-4753-b7f8-79c27e85a96c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:to="loc_srt_MaximumMember_3e528bf0-7d94-4753-b7f8-79c27e85a96c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:to="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_d2f5c406-16ed-480e-b32d-0204e9b23806_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:to="loc_us-gaap_ReportingUnitDomain_d2f5c406-16ed-480e-b32d-0204e9b23806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:to="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_fa8567db-b496-498c-a5cf-621c8b13663d" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:to="loc_cah_MedicalUnitMember_fa8567db-b496-498c-a5cf-621c8b13663d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="extended" id="if212e7cd1330442e9fed789150bd55ee_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2b42ea6-615b-411a-a162-39c491e9ceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2b42ea6-615b-411a-a162-39c491e9ceb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:to="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:to="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_12bc9266-df4d-4484-867f-78646cfbf9b7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:to="loc_srt_ProductsAndServicesDomain_12bc9266-df4d-4484-867f-78646cfbf9b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:to="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_fe7e04a2-8455-4200-8a45-2401687ab1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:to="loc_us-gaap_ShippingAndHandlingMember_fe7e04a2-8455-4200-8a45-2401687ab1da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended" id="iff9851f843124ac5a4f0873e7a902dee_BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_43bba95a-4130-4466-bf44-73b6d349baf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_43bba95a-4130-4466-bf44-73b6d349baf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:to="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:to="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_93f64a75-8b7b-4836-8398-ba156cf9ac2f_default" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:to="loc_cah_OpioidLitigationDomain_93f64a75-8b7b-4836-8398-ba156cf9ac2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:to="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_6e34ffcf-f0f2-4fc1-9e10-ce0114ec85ab" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:to="loc_cah_TotalOpioidLitigationMember_6e34ffcf-f0f2-4fc1-9e10-ce0114ec85ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#DivestituresandAcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="extended" id="i63d91287e40b4904aae4d896edcea8f1_DivestituresandAcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fea7265-2baf-4da7-9c40-48ee5e14c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fea7265-2baf-4da7-9c40-48ee5e14c056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02156597-32c8-4e03-a098-69ea46332e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02156597-32c8-4e03-a098-69ea46332e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5b71c392-b1f5-40af-b9bc-5b5666ddbdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5b71c392-b1f5-40af-b9bc-5b5666ddbdb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_dd0bc3d4-5af4-4339-bd3d-fe1ae84ebbe8" xlink:href="cah-20220630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_dd0bc3d4-5af4-4339-bd3d-fe1ae84ebbe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18fe29cc-5c94-4bb7-a620-9c5225d28807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18fe29cc-5c94-4bb7-a620-9c5225d28807" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6783ae82-c9e7-48fb-9841-ed2dde649a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6783ae82-c9e7-48fb-9841-ed2dde649a10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_e8caaf11-eecd-4511-af10-f9663f7bb0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_e8caaf11-eecd-4511-af10-f9663f7bb0e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_90fb743f-e48b-4512-bcca-e12c101bdb20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_90fb743f-e48b-4512-bcca-e12c101bdb20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_219b9564-a76b-4560-953b-6eee44cb188d" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:to="loc_cah_NaviHealthMember_219b9564-a76b-4560-953b-6eee44cb188d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_faa72e04-9159-41aa-873f-5afbdd0ec608_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_faa72e04-9159-41aa-873f-5afbdd0ec608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_79133114-0339-4c68-bab7-4e790436e9a6" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:to="loc_cah_PatientRecoveryBusinessMember_79133114-0339-4c68-bab7-4e790436e9a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b21d31c-fdd4-4c17-ae4b-405297240b64_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:to="loc_srt_RangeMember_3b21d31c-fdd4-4c17-ae4b-405297240b64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9572e856-037d-4b45-a0a5-be636755ce58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:to="loc_srt_RangeMember_9572e856-037d-4b45-a0a5-be636755ce58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dee1b32-fa62-47a3-a422-6c6008219414_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dee1b32-fa62-47a3-a422-6c6008219414_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_3f54f295-8615-4a66-9e40-f5cd70c9c980" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:to="loc_cah_PatientRecoveryBusinessMember_3f54f295-8615-4a66-9e40-f5cd70c9c980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_284bb19f-eb53-4ecf-b3f0-84a64197e066_default" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:to="loc_cah_CordisDivestitureDomain_284bb19f-eb53-4ecf-b3f0-84a64197e066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:to="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_f457a287-7826-49d3-97f2-7b853c64e860" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:to="loc_cah_CordisDivestitureMember_f457a287-7826-49d3-97f2-7b853c64e860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:href="cah-20220630.xsd#cah_NaviHealthAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_e3f75888-4322-4ef5-8c7a-549d9926aae4_default" xlink:href="cah-20220630.xsd#cah_NaviHealthDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:to="loc_cah_NaviHealthDomain_e3f75888-4322-4ef5-8c7a-549d9926aae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:href="cah-20220630.xsd#cah_NaviHealthDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:to="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_6902fdd3-1af8-4005-8408-0844d0dd0310" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:to="loc_cah_NaviHealthMember_6902fdd3-1af8-4005-8408-0844d0dd0310" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c1c58df6-2a1a-434b-979b-42f31c44b078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c1c58df6-2a1a-434b-979b-42f31c44b078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_29d5880e-f3b0-4148-a2cf-f6d47627d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:to="loc_us-gaap_SubsequentEventMember_29d5880e-f3b0-4148-a2cf-f6d47627d75c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="extended" id="ieb3e1c3c2e9746f3bd392c89411f0013_RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:to="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f94bfbda-e6ca-46a6-9146-432d99738996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_RestructuringReserve_f94bfbda-e6ca-46a6-9146-432d99738996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0577420c-6ca5-43cc-aa47-82b05e943c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_RestructuringCosts_0577420c-6ca5-43cc-aa47-82b05e943c8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4712fdb1-d017-4419-b812-56a04993bd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_PaymentsForRestructuring_4712fdb1-d017-4419-b812-56a04993bd20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b207d61f-da40-4d90-bbc1-3ccc1f04ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bc4e6054-5a8c-4936-8469-67d270799ca1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bc4e6054-5a8c-4936-8469-67d270799ca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c453c119-78e2-44ec-9e0f-584ac4ee6431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c453c119-78e2-44ec-9e0f-584ac4ee6431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_142092a3-560e-45bb-8d22-c5496433bc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:to="loc_us-gaap_FacilityClosingMember_142092a3-560e-45bb-8d22-c5496433bc47" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended" id="i46678a4745214c7882bbed8a3882ccc6_GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:to="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_abcc0bc1-7450-4094-af40-c6fb7c7ac2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_Goodwill_abcc0bc1-7450-4094-af40-c6fb7c7ac2e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_25c3502f-628f-41a3-b8fb-f8a9aac87f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_25c3502f-628f-41a3-b8fb-f8a9aac87f66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c1e554c9-8cae-4475-a9ec-014e22bcd18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c1e554c9-8cae-4475-a9ec-014e22bcd18c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_c9e66f3d-3136-4b94-a974-5dfcc0642589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_c9e66f3d-3136-4b94-a974-5dfcc0642589" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_794aab9d-49ad-4973-b784-164921b2406c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_794aab9d-49ad-4973-b784-164921b2406c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8b980e2-ed6a-4f9f-bfe9-db11cfdff355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aeea14bb-efac-4090-8916-ec6de71f2074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aeea14bb-efac-4090-8916-ec6de71f2074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1b00053-0f9a-4e41-b6c7-b95be71306e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:to="loc_us-gaap_SegmentDomain_f1b00053-0f9a-4e41-b6c7-b95be71306e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:to="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_7e0c58bb-d688-4f0b-a973-ce71c88b3d1d" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:to="loc_cah_MedicalMemberMember_7e0c58bb-d688-4f0b-a973-ce71c88b3d1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_11f93b1f-7370-4ed3-9615-c5341139ed9e" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:to="loc_cah_PharmaceuticalMember_11f93b1f-7370-4ed3-9615-c5341139ed9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:to="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_2176b240-7f1d-4a3b-9ceb-ab772dd32263_default" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:to="loc_cah_CordisDivestitureDomain_2176b240-7f1d-4a3b-9ceb-ab772dd32263_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:to="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_daf10f3b-f5a6-4b2b-a6ec-3a43b8887f67" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:to="loc_cah_CordisDivestitureMember_daf10f3b-f5a6-4b2b-a6ec-3a43b8887f67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i70e955b443a040ce8691f484bcd35953_GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37958349-0d73-47f5-bc3f-936b050ccaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37958349-0d73-47f5-bc3f-936b050ccaa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4d700c75-e334-4b8e-b3a2-e22412e95b51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4d700c75-e334-4b8e-b3a2-e22412e95b51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember_05e70f8a-caf0-4f64-8b78-6e8f6959599b" xlink:href="cah-20220630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:to="loc_cah_IPRDTrademarksandOtherMember_05e70f8a-caf0-4f64-8b78-6e8f6959599b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d61dfc4e-cc64-4148-b1a7-fb70a02c1953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d61dfc4e-cc64-4148-b1a7-fb70a02c1953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_44362de1-c008-4763-aad5-9cd8203444b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_44362de1-c008-4763-aad5-9cd8203444b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_187a8371-4010-42e8-a1b3-0e8f74adf957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_187a8371-4010-42e8-a1b3-0e8f74adf957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d29ec060-b1a0-47b0-b90d-c921ba964428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d29ec060-b1a0-47b0-b90d-c921ba964428" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_c81b13f8-8fd5-458f-9d3c-b4ea82744eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_c81b13f8-8fd5-458f-9d3c-b4ea82744eb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6943b5a-061f-45a3-a15a-cb7fd8de04e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6943b5a-061f-45a3-a15a-cb7fd8de04e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2967d00f-42ea-46a2-a1c9-77378b6b7b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2967d00f-42ea-46a2-a1c9-77378b6b7b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember_d74754f4-2e84-41ff-8038-8ea644e4bc16" xlink:href="cah-20220630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_cah_TrademarksAndPatentsMember_d74754f4-2e84-41ff-8038-8ea644e4bc16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ed5af643-26b0-4451-b37a-c37b5395c740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ed5af643-26b0-4451-b37a-c37b5395c740" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i3b26201f7e8b4f5182b5d273f63715eb_GoodwillandOtherIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_e1d3b114-6283-4a76-92a4-c1cae0e10b9d" xlink:href="cah-20220630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_cah_DiscountRatefairvalueinputs_e1d3b114-6283-4a76-92a4-c1cae0e10b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc1fb658-501e-4ef2-a9b1-e108b3a10cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_Goodwill_cc1fb658-501e-4ef2-a9b1-e108b3a10cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d8b4540-82b9-4aff-9b5a-32a5a37ea09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d8b4540-82b9-4aff-9b5a-32a5a37ea09b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c0ee6849-35ec-4ec4-9338-4076ed527bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c0ee6849-35ec-4ec4-9338-4076ed527bff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_712fc2f7-0606-494e-99d9-263810b19c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_712fc2f7-0606-494e-99d9-263810b19c04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_00445a48-5df7-47de-8d18-2a60493d8c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_00445a48-5df7-47de-8d18-2a60493d8c43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b1e7784e-7e82-49fc-a837-26398b8722e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b1e7784e-7e82-49fc-a837-26398b8722e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_921c6b0f-541e-4ddb-8bc6-433db800cfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_921c6b0f-541e-4ddb-8bc6-433db800cfb4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5fa4dd5a-fb9c-4f03-a013-d3280428d113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5fa4dd5a-fb9c-4f03-a013-d3280428d113" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b47a1373-974a-4b88-bbb7-fe23d7e2e658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b47a1373-974a-4b88-bbb7-fe23d7e2e658" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TerminalGrowthRateFairValueInput_73408293-c123-41fb-8260-a3f18347110e" xlink:href="cah-20220630.xsd#cah_TerminalGrowthRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_cah_TerminalGrowthRateFairValueInput_73408293-c123-41fb-8260-a3f18347110e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_39b2b69e-9e24-4440-b212-73d9f4903867_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_39b2b69e-9e24-4440-b212-73d9f4903867_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_5a8d9c3b-8ec6-4e30-8890-3fdcf5db787a" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:to="loc_cah_NaviHealthMember_5a8d9c3b-8ec6-4e30-8890-3fdcf5db787a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_41b12b8d-eb58-4446-8709-8786a75b2510_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:to="loc_us-gaap_SegmentDomain_41b12b8d-eb58-4446-8709-8786a75b2510_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:to="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_87da93a1-3ac5-4c88-89cc-59a0d961afeb" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:to="loc_cah_MedicalMemberMember_87da93a1-3ac5-4c88-89cc-59a0d961afeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_cadfd387-5c11-4db5-a959-edbe335c0b10" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:to="loc_cah_PharmaceuticalMember_cadfd387-5c11-4db5-a959-edbe335c0b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_dafdb9a4-0657-452c-a462-5b8423a1991c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:to="loc_us-gaap_ReportingUnitDomain_dafdb9a4-0657-452c-a462-5b8423a1991c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:to="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_9e8c6a78-1300-4d10-8204-e2600db131d5" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:to="loc_cah_MedicalUnitMember_9e8c6a78-1300-4d10-8204-e2600db131d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended" id="i88926f1dc05349f68bf52f6ad49a10c3_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_89e3fff9-891f-438c-a1bd-0227ab19044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_89e3fff9-891f-438c-a1bd-0227ab19044b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_8ab2bb67-d31c-4b96-bfad-80f31858420c" xlink:href="cah-20220630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_8ab2bb67-d31c-4b96-bfad-80f31858420c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_416a96dd-c649-405e-8b10-a02f2d27027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_416a96dd-c649-405e-8b10-a02f2d27027b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5f8f2417-a8ba-41e6-85b0-6a6d508235c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5f8f2417-a8ba-41e6-85b0-6a6d508235c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f86c9169-df6e-4141-88e7-2af17a0a5f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f86c9169-df6e-4141-88e7-2af17a0a5f54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf5c80d7-97ec-40a4-8d1a-ce5cf2d4b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf5c80d7-97ec-40a4-8d1a-ce5cf2d4b090" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:to="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:to="loc_srt_RangeMember_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:to="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f72161bc-0cc6-4b81-bda1-1cc2c1cd347a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:to="loc_srt_MinimumMember_f72161bc-0cc6-4b81-bda1-1cc2c1cd347a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bf808d7-35fa-4a7a-93c2-5386c3b9ad49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:to="loc_srt_MaximumMember_6bf808d7-35fa-4a7a-93c2-5386c3b9ad49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" id="ib0cfeb40b2534bcc9a002ee700a40646_LeasesSupplementalCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_310eb597-f5cf-4181-bcea-6b2e73c0c8ec" xlink:href="cah-20220630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_310eb597-f5cf-4181-bcea-6b2e73c0c8ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_fade2189-ec71-4f01-a66b-93a5614a69be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_OperatingLeasePayments_fade2189-ec71-4f01-a66b-93a5614a69be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_e2e4eb58-6097-49d6-bdd5-c90f2fa7e1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_e2e4eb58-6097-49d6-bdd5-c90f2fa7e1e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_208b3543-1074-418c-bcbe-f0179c9350ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_208b3543-1074-418c-bcbe-f0179c9350ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_46e286f1-162e-4048-9fc8-06619c06988c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_46e286f1-162e-4048-9fc8-06619c06988c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_6c57262e-e91b-40a4-b16d-e8848ffdcd26" xlink:href="cah-20220630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_6c57262e-e91b-40a4-b16d-e8848ffdcd26" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cf6238f7-de46-4404-a607-77c83cb2fe8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cf6238f7-de46-4404-a607-77c83cb2fe8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member_8494fa5b-fccd-42da-a9b7-db353f9f47fb" xlink:href="cah-20220630.xsd#cah_ASC842Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:to="loc_cah_ASC842Member_8494fa5b-fccd-42da-a9b7-db353f9f47fb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesScheduleofFutureLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="extended" id="i4c3cbe180fbc47369624550bda5abd8b_LeasesScheduleofFutureLeasePaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7e21ceb5-be6a-4cd1-9ad2-2536325ba74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7e21ceb5-be6a-4cd1-9ad2-2536325ba74d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f3aac4ed-c0a3-4500-9d60-d4eff4aeefdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f3aac4ed-c0a3-4500-9d60-d4eff4aeefdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_1aa53fd1-02dd-4746-9186-13fc81a6799f" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_1aa53fd1-02dd-4746-9186-13fc81a6799f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57e2a5e8-c7b3-4a68-a027-aee6cd454ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57e2a5e8-c7b3-4a68-a027-aee6cd454ca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_90d0baae-c933-4ca3-96a8-3ca5ef7aed4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_90d0baae-c933-4ca3-96a8-3ca5ef7aed4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_5c500189-3e7b-4c66-b3b1-31f5853d2a9f" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_5c500189-3e7b-4c66-b3b1-31f5853d2a9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_db9c54ab-ac59-4b8c-a6f3-0ee54e2aacd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_db9c54ab-ac59-4b8c-a6f3-0ee54e2aacd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_44600d80-771d-442a-8391-4b109cc71d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_44600d80-771d-442a-8391-4b109cc71d33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_997a1fb9-0649-4c73-88fe-0d3db051e84a" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_997a1fb9-0649-4c73-88fe-0d3db051e84a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f74fda8-a679-401e-b619-c9f2d4e842f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f74fda8-a679-401e-b619-c9f2d4e842f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_09db63dd-b2a0-4b89-a391-028f23f791ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_09db63dd-b2a0-4b89-a391-028f23f791ae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_cefdae24-d10a-4485-8a50-c978881d3b46" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_cefdae24-d10a-4485-8a50-c978881d3b46" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6ea5cd9-6e03-4955-b008-60cfe98da671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6ea5cd9-6e03-4955-b008-60cfe98da671" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24983ff2-5ab7-442d-8b9f-2eab0883f045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24983ff2-5ab7-442d-8b9f-2eab0883f045" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_18af446a-2d5d-46bc-970c-e72c4398219b" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_18af446a-2d5d-46bc-970c-e72c4398219b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fbc0a714-6a9c-45bb-8783-b3f15a64e786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fbc0a714-6a9c-45bb-8783-b3f15a64e786" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_691f20be-9e92-4a20-8d6f-2f7f5324649a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_691f20be-9e92-4a20-8d6f-2f7f5324649a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_0102668a-3366-44d1-a2b8-8f36e11a0115" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_0102668a-3366-44d1-a2b8-8f36e11a0115" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_00076ad0-b840-443d-8119-52629a191711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_00076ad0-b840-443d-8119-52629a191711" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d4bb9f6-7d09-40e9-baae-be58a1ba22d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d4bb9f6-7d09-40e9-baae-be58a1ba22d1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_409dd38e-d88f-4ddc-a8ca-64ab55cee16d" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_409dd38e-d88f-4ddc-a8ca-64ab55cee16d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest_a41e09fd-bbb0-4b00-bf0d-8b2d5a1e5557" xlink:href="cah-20220630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_OperatingLeaseImputedInterest_a41e09fd-bbb0-4b00-bf0d-8b2d5a1e5557" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest_8827e631-0181-41d5-9b56-bf8b2f0bbbe8" xlink:href="cah-20220630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_FinanceLeaseImputedInterest_8827e631-0181-41d5-9b56-bf8b2f0bbbe8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_c658b339-99e6-4d3a-a3f2-55fb5195c206" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_c658b339-99e6-4d3a-a3f2-55fb5195c206" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e43bd090-0e45-4016-8a3d-47c510375cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_OperatingLeaseLiability_e43bd090-0e45-4016-8a3d-47c510375cee" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fcf3f180-78a9-4d09-aae3-15dab67a05db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiability_fcf3f180-78a9-4d09-aae3-15dab67a05db" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability_1f2ebbe6-3228-471b-bfd4-12a7886fa77f" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiability_1f2ebbe6-3228-471b-bfd4-12a7886fa77f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember_8510b394-65b0-4b28-a570-ff59a03ee391" xlink:href="cah-20220630.xsd#cah_OperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:to="loc_cah_OperatingLeaseMember_8510b394-65b0-4b28-a570-ff59a03ee391" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember_fd1da9ba-80b1-419e-b731-0a0c51c55c73" xlink:href="cah-20220630.xsd#cah_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:to="loc_cah_FinanceLeaseMember_fd1da9ba-80b1-419e-b731-0a0c51c55c73" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended" id="i1ed86c76398b474caa53d20203f5e0ff_LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4ddcb95-d1ef-458d-b6cf-8f7bf687a1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4ddcb95-d1ef-458d-b6cf-8f7bf687a1dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_53774334-2200-4360-8d93-385da687386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_NotesPayable_53774334-2200-4360-8d93-385da687386b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_eba0c144-9376-4104-b54d-c1e8c9a434f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_OtherBorrowings_eba0c144-9376-4104-b54d-c1e8c9a434f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c9e12e71-5ce5-4dc5-8a63-4731c62b9000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c9e12e71-5ce5-4dc5-8a63-4731c62b9000" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19bcaab3-b479-4bd9-81ae-201d1f7e04af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19bcaab3-b479-4bd9-81ae-201d1f7e04af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5c4e2da2-f63d-4b03-9095-f9cbe0721c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5c4e2da2-f63d-4b03-9095-f9cbe0721c76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:to="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_29f942d3-bd70-4265-8dd0-b3e01e1c0b98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_29f942d3-bd70-4265-8dd0-b3e01e1c0b98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_68ea7d7b-d829-4501-845a-1efe3b0e9769" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A24NotesDue2019Member_68ea7d7b-d829-4501-845a-1efe3b0e9769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_be5995ea-2422-4ab6-a0c8-23c6f0d172a1" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.625Notesdue2021Member_be5995ea-2422-4ab6-a0c8-23c6f0d172a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_78db32e8-3bfe-4c6c-93e5-fe63ea044be1" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A2.616Notesdue2022Member_78db32e8-3bfe-4c6c-93e5-fe63ea044be1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_c9da4ecf-883a-4aca-bba4-0af6b653ceec" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.2Notesdue2022Member_c9da4ecf-883a-4aca-bba4-0af6b653ceec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_19fafea9-edcd-48ce-94c3-b33066a382dd" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_FloatingRateNotesdue2022Member_19fafea9-edcd-48ce-94c3-b33066a382dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_1c4411ae-9277-4b05-9a0e-dc9b30ba1686" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.2Notesdue2023Member_1c4411ae-9277-4b05-9a0e-dc9b30ba1686" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_955eeff9-7047-482e-9a37-6ad30edbed0d" xlink:href="cah-20220630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.079Notesdue2024Member_955eeff9-7047-482e-9a37-6ad30edbed0d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_6c89e28b-883c-43c3-bab8-8f7be4244ab1" xlink:href="cah-20220630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.5Notesdue2025Member_6c89e28b-883c-43c3-bab8-8f7be4244ab1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_4504bd1e-7dec-464a-843a-f359414cc5fc" xlink:href="cah-20220630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.75Notesdue2026Member_4504bd1e-7dec-464a-843a-f359414cc5fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_f34b5aa0-915d-4bcc-9a1c-89b90964e80d" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.41Notesdue2027Member_f34b5aa0-915d-4bcc-9a1c-89b90964e80d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_83481cd2-9c5f-4cf6-bbd3-9132ff0b6f29" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.6Notesdue2043Member_83481cd2-9c5f-4cf6-bbd3-9132ff0b6f29" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_c8e9330c-a074-495e-b86f-08ee3725d654" xlink:href="cah-20220630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.5Notesdue2044Member_c8e9330c-a074-495e-b86f-08ee3725d654" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_65839359-50d4-4534-a5e9-05394b2d98c6" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.9Notesdue2045Member_65839359-50d4-4534-a5e9-05394b2d98c6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_765e1fd8-bd7b-4434-87f3-19f98e248e8c" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.368Notesdue2047Member_765e1fd8-bd7b-4434-87f3-19f98e248e8c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_b935e77c-ba2d-47dd-863d-b6a16b2f14e4" xlink:href="cah-20220630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_b935e77c-ba2d-47dd-863d-b6a16b2f14e4" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended" id="ib2232cdd532a43648d34399f3429562f_LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6cceecdf-7894-4487-9b99-465932534777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCredit_6cceecdf-7894-4487-9b99-465932534777" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b5004446-5ca9-4578-9f39-363d8c5de543" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_dei_DocumentFiscalYearFocus_b5004446-5ca9-4578-9f39-363d8c5de543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ce2cfd1d-082b-4aa7-a269-28dad0a5773c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_AccountsPayableCurrent_ce2cfd1d-082b-4aa7-a269-28dad0a5773c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_95145b87-8a49-4225-a079-e38c27202dc2" xlink:href="cah-20220630.xsd#cah_NotesPayableRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_cah_NotesPayableRepurchased_95145b87-8a49-4225-a079-e38c27202dc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_5e1bf588-55de-4318-aae6-777f50759686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_5e1bf588-55de-4318-aae6-777f50759686" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c85f3f6-e2b7-49d2-84ec-f37509a804d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c85f3f6-e2b7-49d2-84ec-f37509a804d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_14fb5501-f237-482b-803c-714d53e0e175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_OtherBorrowings_14fb5501-f237-482b-803c-714d53e0e175" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecd776ea-b54f-42a6-9b3e-0fbca06824e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecd776ea-b54f-42a6-9b3e-0fbca06824e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_0d29dbbd-b6e3-46e7-a1e3-f70b20b453a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_0d29dbbd-b6e3-46e7-a1e3-f70b20b453a1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c79e82-7133-4c96-8831-80158b75ed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c79e82-7133-4c96-8831-80158b75ed8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c45510b3-0a28-404f-9057-bbb5b05ad341_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c45510b3-0a28-404f-9057-bbb5b05ad341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_eca837c5-413a-4d0d-b9e0-2dbe363e3f5a" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A2.616Notesdue2022Member_eca837c5-413a-4d0d-b9e0-2dbe363e3f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_4c8e9d78-4d7e-497c-a068-a3d065f2c52b" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.2Notesdue2023Member_4c8e9d78-4d7e-497c-a068-a3d065f2c52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_be4017e3-f627-4908-b636-16a1d06f205d" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_FloatingRateNotesdue2022Member_be4017e3-f627-4908-b636-16a1d06f205d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_a8d9f691-2908-453a-bc18-e55dabcb8933" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.41Notesdue2027Member_a8d9f691-2908-453a-bc18-e55dabcb8933" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_63c9b989-4c08-45c0-9499-4e18fa46057a" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.6Notesdue2043Member_63c9b989-4c08-45c0-9499-4e18fa46057a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_3a9cc52a-6a2c-4a2d-a36a-678acc920a78" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.9Notesdue2045Member_3a9cc52a-6a2c-4a2d-a36a-678acc920a78" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_a0796eba-8e52-4863-878b-b0e253eee4b6" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.368Notesdue2047Member_a0796eba-8e52-4863-878b-b0e253eee4b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_e9b65b36-6f80-4039-9823-08ca2e610a15" xlink:href="cah-20220630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_e9b65b36-6f80-4039-9823-08ca2e610a15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_2919252c-d2d6-4c04-aedb-6b3513df0fc2" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.625Notesdue2021Member_2919252c-d2d6-4c04-aedb-6b3513df0fc2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_91b91357-9c70-4b1a-ad3f-b9e024112130" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.2Notesdue2022Member_91b91357-9c70-4b1a-ad3f-b9e024112130" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember_e6db5bbf-d352-4333-93a6-fe51949c6991" xlink:href="cah-20220630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_FloatingRateNotes2616NotesMember_e6db5bbf-d352-4333-93a6-fe51949c6991" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember_fe9a05e7-a065-4b6b-aa3e-e2fdefd2bcb1" xlink:href="cah-20220630.xsd#cah_A32Notes2616NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A32Notes2616NotesMember_fe9a05e7-a065-4b6b-aa3e-e2fdefd2bcb1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_3b403553-2920-4e71-b863-a50e0b1b6f72" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A24NotesDue2019Member_3b403553-2920-4e71-b863-a50e0b1b6f72" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_da9be430-d138-4646-80e6-da1e6ba679df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_da9be430-d138-4646-80e6-da1e6ba679df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7336277b-515f-4a0d-8eda-04ee8449b087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7336277b-515f-4a0d-8eda-04ee8449b087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_05a5bacd-60fc-42a0-84ec-544217d2e475_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:to="loc_us-gaap_CreditFacilityDomain_05a5bacd-60fc-42a0-84ec-544217d2e475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:to="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b3dc0c97-8d33-43e4-b856-0975e40d7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_LetterOfCreditMember_b3dc0c97-8d33-43e4-b856-0975e40d7c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_8343d44d-6d45-462e-887e-ad980f01bca7" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_8343d44d-6d45-462e-887e-ad980f01bca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9ed1b9c2-fc38-4740-94fc-2615c710bda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9ed1b9c2-fc38-4740-94fc-2615c710bda9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_25e35c70-1680-48b9-adf1-a93ea1b52637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_CommercialPaperMember_25e35c70-1680-48b9-adf1-a93ea1b52637" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_228fc80e-7ce1-4df9-9990-806c45bd2b2c" xlink:href="cah-20220630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_228fc80e-7ce1-4df9-9990-806c45bd2b2c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended" id="i9fda2b08340b4ebbbce7352a7c1ecb27_LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7d6ebee7-41a9-40f6-a48a-500001bed576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_AccountsPayableCurrent_7d6ebee7-41a9-40f6-a48a-500001bed576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3aef816a-6254-4ae8-8764-53f6032e44a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3aef816a-6254-4ae8-8764-53f6032e44a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_4f0976cb-c3f5-41ba-ab42-6b366cd80865" xlink:href="cah-20220630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_4f0976cb-c3f5-41ba-ab42-6b366cd80865" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5df2576-e159-444b-869b-72f8e77c9871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_LineOfCredit_b5df2576-e159-444b-869b-72f8e77c9871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5f61c5ac-5a3f-4ac1-a5b4-799119effffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5f61c5ac-5a3f-4ac1-a5b4-799119effffc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_afbf9f7d-e096-4bf2-95ca-0a691cf5c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_afbf9f7d-e096-4bf2-95ca-0a691cf5c7cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_fccdb0c8-0183-4879-be32-c0a2fe9ce1e8" xlink:href="cah-20220630.xsd#cah_NotesPayableRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_cah_NotesPayableRepurchased_fccdb0c8-0183-4879-be32-c0a2fe9ce1e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b4ae923e-8138-4e9b-84fd-8ff30c7597c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:to="loc_us-gaap_CreditFacilityDomain_b4ae923e-8138-4e9b-84fd-8ff30c7597c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a97d16c5-6aa7-445d-bbe3-a8d368fef188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:to="loc_us-gaap_CreditFacilityDomain_a97d16c5-6aa7-445d-bbe3-a8d368fef188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_ca2c0005-3396-4575-afb0-71f687683212" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A2.616Notesdue2022Member_ca2c0005-3396-4575-afb0-71f687683212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_398e2b11-3108-4378-a2b0-2363e8ddf978" xlink:href="cah-20220630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.079Notesdue2024Member_398e2b11-3108-4378-a2b0-2363e8ddf978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_2101b88e-3aac-4201-bd8b-16d9f84c8fc2" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.41Notesdue2027Member_2101b88e-3aac-4201-bd8b-16d9f84c8fc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_28427701-f10a-41fa-a3cd-aba46736c135" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.368Notesdue2047Member_28427701-f10a-41fa-a3cd-aba46736c135" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_1ce792d9-4a0c-4366-9b4b-95aead1c5c8d" xlink:href="cah-20220630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_1ce792d9-4a0c-4366-9b4b-95aead1c5c8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_0e1cf721-e5d5-4a73-8b8a-6b2ad7888a4d" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_FloatingRateNotesdue2022Member_0e1cf721-e5d5-4a73-8b8a-6b2ad7888a4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_40f2675a-119c-4467-9f93-9a08a59f70f9" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A24NotesDue2019Member_40f2675a-119c-4467-9f93-9a08a59f70f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_b7e90ff3-86f2-47c5-b857-c72326d1f8f1" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.2Notesdue2022Member_b7e90ff3-86f2-47c5-b857-c72326d1f8f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_2601f1af-9800-41c0-98a6-e4f4b7890f8e" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.2Notesdue2023Member_2601f1af-9800-41c0-98a6-e4f4b7890f8e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_cff33b3d-4163-44ed-8c2e-7670e0e0b6de" xlink:href="cah-20220630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.5Notesdue2025Member_cff33b3d-4163-44ed-8c2e-7670e0e0b6de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_b4de5871-e21f-4c26-86fc-54d700d329b7" xlink:href="cah-20220630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.75Notesdue2026Member_b4de5871-e21f-4c26-86fc-54d700d329b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_19b44eef-44e3-4d01-b77d-bf3291d1cda6" xlink:href="cah-20220630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.5Notesdue2044Member_19b44eef-44e3-4d01-b77d-bf3291d1cda6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_aad22b01-c842-41af-bfdd-65ae5a74ac50" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.6Notesdue2043Member_aad22b01-c842-41af-bfdd-65ae5a74ac50" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_25c4b1df-8a2f-4aa8-8945-4cae7c47ce3d" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.625Notesdue2021Member_25c4b1df-8a2f-4aa8-8945-4cae7c47ce3d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_983f6ae5-b23b-4823-a3cd-800ba20450f8" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.9Notesdue2045Member_983f6ae5-b23b-4823-a3cd-800ba20450f8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_302ce194-bf11-4bb1-9442-5bc669ed6095" xlink:href="cah-20220630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_302ce194-bf11-4bb1-9442-5bc669ed6095" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1dbd498e-0652-4fc4-864b-ebed4120a595_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:to="loc_dei_EntityDomain_1dbd498e-0652-4fc4-864b-ebed4120a595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_006a63bd-ff8e-4871-b110-fd90426671a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:to="loc_dei_EntityDomain_006a63bd-ff8e-4871-b110-fd90426671a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended" id="ie6cb83ca4a2f4ca9989c2e67b5746227_LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61f4e177-dda5-4cdd-83b9-0a13317659cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61f4e177-dda5-4cdd-83b9-0a13317659cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9b10c5fe-2bd6-4bd1-a072-fedff00c41ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCredit_9b10c5fe-2bd6-4bd1-a072-fedff00c41ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_4e8dbe75-da1b-4224-8f3a-cb0b75a4084d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_OtherBorrowings_4e8dbe75-da1b-4224-8f3a-cb0b75a4084d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_b223abff-e876-4465-9a59-ca967972f659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_OtherShortTermBorrowings_b223abff-e876-4465-9a59-ca967972f659" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_cb3dc345-a47d-4f41-8f34-ac94e3797ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_cb3dc345-a47d-4f41-8f34-ac94e3797ca3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5ecf7ebe-717d-41b9-8db8-481caeed1d80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:to="loc_us-gaap_CreditFacilityDomain_5ecf7ebe-717d-41b9-8db8-481caeed1d80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:to="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7803417e-db0b-4758-a60d-b425878732f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7803417e-db0b-4758-a60d-b425878732f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_75d94cf5-e0b9-4256-a65c-5b43f893b338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_LetterOfCreditMember_75d94cf5-e0b9-4256-a65c-5b43f893b338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_a62d05ba-933c-4ffa-b217-b069396c9be8" xlink:href="cah-20220630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_a62d05ba-933c-4ffa-b217-b069396c9be8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b7606946-f401-4501-aeb9-dd33369335f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_CommercialPaperMember_b7606946-f401-4501-aeb9-dd33369335f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_2fce0bb1-3a31-4338-bd25-ef61653dab5a" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_2fce0bb1-3a31-4338-bd25-ef61653dab5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d620181-e545-413c-9547-0408e2a4c754_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d620181-e545-413c-9547-0408e2a4c754_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ff7253bb-2c1f-41d3-b279-b4d25d6b18c1" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ff7253bb-2c1f-41d3-b279-b4d25d6b18c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94554626-2d60-437f-98b1-2e9b43af6ff4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:to="loc_srt_RangeMember_94554626-2d60-437f-98b1-2e9b43af6ff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85d538d0-3a26-4880-ac2e-87c963c317d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:to="loc_srt_RangeMember_85d538d0-3a26-4880-ac2e-87c963c317d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#CommitmentsContingentLiabilitiesandLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="extended" id="i1b931e3a5e504205959b7e398109b8b9_CommitmentsContingentLiabilitiesandLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_dc22012e-5ad9-47b6-8a8d-f67b11777493" xlink:href="cah-20220630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_dc22012e-5ad9-47b6-8a8d-f67b11777493" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_09fc59b1-830c-4ee0-9177-e71207bd3a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_09fc59b1-830c-4ee0-9177-e71207bd3a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_JudgmentForLostProfits_d46967b5-63df-4448-afd0-a67dd4b2dbd5" xlink:href="cah-20220630.xsd#cah_JudgmentForLostProfits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_JudgmentForLostProfits_d46967b5-63df-4448-afd0-a67dd4b2dbd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingStates_2e2c0533-4dd5-4626-892b-fa02bf785f91" xlink:href="cah-20220630.xsd#cah_SettlingStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_SettlingStates_2e2c0533-4dd5-4626-892b-fa02bf785f91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingUSTerritories_d02accdf-205a-443f-9ae7-9a7460dd5674" xlink:href="cah-20220630.xsd#cah_SettlingUSTerritories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_SettlingUSTerritories_d02accdf-205a-443f-9ae7-9a7460dd5674" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_8452126c-6d5f-4668-80c6-6d8f61efc6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_8452126c-6d5f-4668-80c6-6d8f61efc6e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyNumberOfEligibleStates_ed15c59f-52b7-480f-b6f3-9eea4b3eecf8" xlink:href="cah-20220630.xsd#cah_LossContingencyNumberOfEligibleStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_LossContingencyNumberOfEligibleStates_ed15c59f-52b7-480f-b6f3-9eea4b3eecf8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_48f03e80-031b-46af-b6bd-86e7bf3b59ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_48f03e80-031b-46af-b6bd-86e7bf3b59ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_221a0ffd-e124-4c67-ab77-cb70fe3f8125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationReserve_221a0ffd-e124-4c67-ab77-cb70fe3f8125" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_984dbce9-9712-4b13-96d8-a9ae6d3ba729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_InventoryRecallExpense_984dbce9-9712-4b13-96d8-a9ae6d3ba729" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_203ed359-132c-4b00-8a7c-12c805f2182b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationReserveCurrent_203ed359-132c-4b00-8a7c-12c805f2182b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_85711d33-6e54-41c5-bfa2-2321d5c81205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_85711d33-6e54-41c5-bfa2-2321d5c81205" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_5f910ecb-2b97-496c-9025-d861a43e50aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationSettlementExpense_5f910ecb-2b97-496c-9025-d861a43e50aa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_90bf0e7f-27af-4100-bd7b-3199821f9d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_90bf0e7f-27af-4100-bd7b-3199821f9d5e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1b3b818-c2bd-4b66-bf9a-3ec67a72033a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1b3b818-c2bd-4b66-bf9a-3ec67a72033a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_8169f5a3-dd8a-4ac1-ac8a-4caae2f5cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_8169f5a3-dd8a-4ac1-ac8a-4caae2f5cae6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_00bbf88b-2328-4087-bfe9-8c70d9cf3777" xlink:href="cah-20220630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_00bbf88b-2328-4087-bfe9-8c70d9cf3777" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c57fa1c5-ba0b-44f6-af76-e231821f96ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c57fa1c5-ba0b-44f6-af76-e231821f96ba" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2336844b-7c22-4388-bb0c-f0ad68c28e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2336844b-7c22-4388-bb0c-f0ad68c28e48" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fa68e1a8-a792-4a0b-a108-de71ea467c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fa68e1a8-a792-4a0b-a108-de71ea467c29" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber_58f618a4-d24c-42d0-a6a9-b21a0031c592" xlink:href="cah-20220630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_LossContingencyLawsuitsNumber_58f618a4-d24c-42d0-a6a9-b21a0031c592" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment_fdbed198-3d70-49b6-bd7e-2b4a306b19c2" xlink:href="cah-20220630.xsd#cah_AggregateAnnualAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_AggregateAnnualAssessment_fdbed198-3d70-49b6-bd7e-2b4a306b19c2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_443d172d-24fe-4062-8a4c-b90df3618daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_443d172d-24fe-4062-8a4c-b90df3618daf" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:href="cah-20220630.xsd#cah_LawsuitTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_8291620b-28a0-4789-9815-97a68ad11275_default" xlink:href="cah-20220630.xsd#cah_LawsuitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:to="loc_cah_LawsuitTypeDomain_8291620b-28a0-4789-9815-97a68ad11275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:href="cah-20220630.xsd#cah_LawsuitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:to="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_5f3a4208-309c-4109-bbc5-fa57418bd754" xlink:href="cah-20220630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:to="loc_cah_ClassActionLawsuitsMember_5f3a4208-309c-4109-bbc5-fa57418bd754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_fe9b4da0-a800-4f51-9b19-45ed5edf210b_default" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:to="loc_cah_PlaintiffTypeDomain_fe9b4da0-a800-4f51-9b19-45ed5edf210b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:to="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember_43831bbd-7284-4ad8-b1ac-25038fbbfd2f" xlink:href="cah-20220630.xsd#cah_PrivatePartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:to="loc_cah_PrivatePartiesMember_43831bbd-7284-4ad8-b1ac-25038fbbfd2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_2fef1472-be3d-4e4e-b087-f583e6a3db61_default" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:to="loc_cah_OpioidLitigationDomain_2fef1472-be3d-4e4e-b087-f583e6a3db61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:to="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_f4d02261-dc7f-4a2a-953a-0f57f6d48ea7" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:to="loc_cah_TotalOpioidLitigationMember_f4d02261-dc7f-4a2a-953a-0f57f6d48ea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:href="cah-20220630.xsd#cah_GownRecallAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_8f09db65-531c-4b6d-98be-37dffe3df8da_default" xlink:href="cah-20220630.xsd#cah_GownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:to="loc_cah_GownRecallDomain_8f09db65-531c-4b6d-98be-37dffe3df8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_4d134d71-00ea-4c55-b505-afa6c1d54736" xlink:href="cah-20220630.xsd#cah_GownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:to="loc_cah_GownRecallDomain_4d134d71-00ea-4c55-b505-afa6c1d54736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_a1779ff5-69ac-4bef-ab6a-37cbb2160b0c" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_a1779ff5-69ac-4bef-ab6a-37cbb2160b0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64fad793-8163-4804-8b3e-c94671eb6d97_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:to="loc_srt_RangeMember_64fad793-8163-4804-8b3e-c94671eb6d97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:to="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0bf50061-37cb-4839-898e-73f9fc47dff9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:to="loc_srt_MinimumMember_0bf50061-37cb-4839-898e-73f9fc47dff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b844cf0-de60-4e31-a46d-c5064a5ece2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:to="loc_srt_MaximumMember_5b844cf0-de60-4e31-a46d-c5064a5ece2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_719f1a99-12de-4dbb-b41e-b68feecc8c0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_719f1a99-12de-4dbb-b41e-b68feecc8c0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_837da4ba-b31f-40fc-969d-e87373f68647" xlink:href="cah-20220630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_837da4ba-b31f-40fc-969d-e87373f68647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:href="cah-20220630.xsd#cah_LitigationTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_c2f33ab8-284c-49c6-9e2f-477423a08121_default" xlink:href="cah-20220630.xsd#cah_LitigationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:to="loc_cah_LitigationTypeDomain_c2f33ab8-284c-49c6-9e2f-477423a08121_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:href="cah-20220630.xsd#cah_LitigationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:to="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_29bdaabd-f549-47ae-a347-b091b0b00667" xlink:href="cah-20220630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:to="loc_cah_ClassActionLawsuitsMember_29bdaabd-f549-47ae-a347-b091b0b00667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f80876b8-6578-4a25-906e-29dccc5361d8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:to="loc_srt_SegmentGeographicalDomain_f80876b8-6578-4a25-906e-29dccc5361d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:to="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember_b5c3db33-22d1-444d-a83e-bd1d99b85b38" xlink:href="cah-20220630.xsd#cah_AlamedaCountyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_cah_AlamedaCountyMember_b5c3db33-22d1-444d-a83e-bd1d99b85b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_69b267ff-2dde-4327-a59a-95c22f84ba71" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_WA_69b267ff-2dde-4327-a59a-95c22f84ba71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_bd825ffc-2269-4bea-acd5-b8a2976d842d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_WV_bd825ffc-2269-4bea-acd5-b8a2976d842d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_a552915b-16b2-4d88-8219-fa362de859e7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_OK_a552915b-16b2-4d88-8219-fa362de859e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_7b30e024-0e4e-48ad-a27b-e24622298ffa" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_GA_7b30e024-0e4e-48ad-a27b-e24622298ffa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember_436070e7-b69a-410c-a67c-22351d28fcbe" xlink:href="cah-20220630.xsd#cah_OtherJurisdictionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_cah_OtherJurisdictionsMember_436070e7-b69a-410c-a67c-22351d28fcbe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_497ce518-1cd8-4532-84ce-86d0bd78593d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_497ce518-1cd8-4532-84ce-86d0bd78593d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_723db101-6518-4fcf-8305-745a5fd0494d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_723db101-6518-4fcf-8305-745a5fd0494d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_71dd3379-d2a2-4472-9fe5-a88745976735_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:to="loc_srt_LitigationCaseTypeDomain_71dd3379-d2a2-4472-9fe5-a88745976735_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:to="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember_40412bae-2197-474b-aae6-9eb5db9f37a2" xlink:href="cah-20220630.xsd#cah_OpioidLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_OpioidLawsuitsMember_40412bae-2197-474b-aae6-9eb5db9f37a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_861c82d8-997a-442a-a0f3-d22e4204195a" xlink:href="cah-20220630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_861c82d8-997a-442a-a0f3-d22e4204195a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_0e663bb9-2e99-4b60-a120-5600106dd1d2" xlink:href="cah-20220630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_0e663bb9-2e99-4b60-a120-5600106dd1d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember_e0c66bd8-b79d-4847-abcc-be1e2d2aecf7" xlink:href="cah-20220630.xsd#cah_DOJInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_DOJInvestigationMember_e0c66bd8-b79d-4847-abcc-be1e2d2aecf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_84f8de92-0a66-4047-a61f-97eb4f5ec896_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_84f8de92-0a66-4047-a61f-97eb4f5ec896_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_94fda416-ddeb-4293-9094-f626bd3d7dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:to="loc_us-gaap_SubsequentEventMember_94fda416-ddeb-4293-9094-f626bd3d7dd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2da773e-669d-427b-937b-a55be3ef5749_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2da773e-669d-427b-937b-a55be3ef5749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_99f8d21b-1186-46d4-bb18-502ee9ef308c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_99f8d21b-1186-46d4-bb18-502ee9ef308c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4aded7d-bc3e-4773-a335-cb83ded62c93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:to="loc_us-gaap_SegmentDomain_a4aded7d-bc3e-4773-a335-cb83ded62c93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:to="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_9b17c40d-f6f4-4a9e-961d-83f23bf86e70" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:to="loc_cah_PharmaceuticalMember_9b17c40d-f6f4-4a9e-961d-83f23bf86e70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ia340d25465d14ce892ea9ea356c81936_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_287f38f7-9bd7-4e41-9b12-27145ba0cd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_287f38f7-9bd7-4e41-9b12-27145ba0cd0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ecc70f71-279e-40e1-977e-9069ebb94ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_LitigationReserve_ecc70f71-279e-40e1-977e-9069ebb94ff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c2d6a4bf-1eff-48b1-9ab3-00307df16994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c2d6a4bf-1eff-48b1-9ab3-00307df16994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3c5b82bb-86ea-487b-a329-38240635a859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3c5b82bb-86ea-487b-a329-38240635a859" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_0143495d-b616-4dc9-afca-88379fb9b81e" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_0143495d-b616-4dc9-afca-88379fb9b81e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_2005de40-69d2-4af9-b477-f28126fe92a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_2005de40-69d2-4af9-b477-f28126fe92a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9c7b2625-ff14-4755-b9a0-0dcac6ed61a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9c7b2625-ff14-4755-b9a0-0dcac6ed61a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5a79ce3c-56d7-45bb-a2b6-4ad6edd3309b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5a79ce3c-56d7-45bb-a2b6-4ad6edd3309b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_e1941ce0-4e23-4516-88b8-3c121657baee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_e1941ce0-4e23-4516-88b8-3c121657baee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_016a1936-2984-4d85-a5ed-a1d04c2afc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_016a1936-2984-4d85-a5ed-a1d04c2afc1f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_943b5282-f91c-4256-aeb3-f993f3a95aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_943b5282-f91c-4256-aeb3-f993f3a95aae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6705d53b-b9ef-4963-b9d1-e0d8bacea263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6705d53b-b9ef-4963-b9d1-e0d8bacea263" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0a2ed055-c674-4b82-99a8-f15a7f0243f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0a2ed055-c674-4b82-99a8-f15a7f0243f7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_89120d03-7872-422c-ba80-c44917ab6526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_89120d03-7872-422c-ba80-c44917ab6526" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_b488101a-ed04-4dcb-9446-adca77bb912c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_b488101a-ed04-4dcb-9446-adca77bb912c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_90946640-b10e-4c29-a787-0b8539e8234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_90946640-b10e-4c29-a787-0b8539e8234d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b6e41ffa-a0db-4317-b433-1386bde869b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b6e41ffa-a0db-4317-b433-1386bde869b8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6b83ce28-7853-412b-8c8e-e103175e6d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6b83ce28-7853-412b-8c8e-e103175e6d3c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_aba039e6-8047-49d0-8ef9-85bdccdab990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_aba039e6-8047-49d0-8ef9-85bdccdab990" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable_00fbfd71-fb15-4341-91ee-6fa4d55698cb" xlink:href="cah-20220630.xsd#cah_IndemnificationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_cah_IndemnificationReceivable_00fbfd71-fb15-4341-91ee-6fa4d55698cb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_0ddd71d7-651b-4a1c-a8e7-ef595ae8767f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_IncomeTaxReceivable_0ddd71d7-651b-4a1c-a8e7-ef595ae8767f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d9de6bc5-cc0c-46f5-85e2-2da7df11fbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d9de6bc5-cc0c-46f5-85e2-2da7df11fbc0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_b553cecd-5ed9-4dd4-b429-4d6592d320ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_LitigationSettlementExpense_b553cecd-5ed9-4dd4-b429-4d6592d320ea" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_790325d2-f731-4e6e-ab5a-1816f83727ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_790325d2-f731-4e6e-ab5a-1816f83727ff" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentDomain_08acdfcf-00d5-4ae1-a079-ac7adb67d742_default" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:to="loc_cah_GoodwillImpairmentDomain_08acdfcf-00d5-4ae1-a079-ac7adb67d742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:to="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitGoodwillImpairmentMember_30bbcb69-367c-48d2-8793-a730ebea5bb8" xlink:href="cah-20220630.xsd#cah_MedicalUnitGoodwillImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:to="loc_cah_MedicalUnitGoodwillImpairmentMember_30bbcb69-367c-48d2-8793-a730ebea5bb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_0f5f9ace-d7b2-46bb-8363-dceb89f4621e_default" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:to="loc_cah_OpioidLitigationDomain_0f5f9ace-d7b2-46bb-8363-dceb89f4621e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:to="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_fff59c31-085d-440c-88d5-c8946262db94" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:to="loc_cah_TotalOpioidLitigationMember_fff59c31-085d-440c-88d5-c8946262db94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:href="cah-20220630.xsd#cah_TaxMatterAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_52d6a1df-7609-496e-adb7-c9eb710337d6_default" xlink:href="cah-20220630.xsd#cah_TaxMatterDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:to="loc_cah_TaxMatterDomain_52d6a1df-7609-496e-adb7-c9eb710337d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:href="cah-20220630.xsd#cah_TaxMatterDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:to="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_6cb015cb-0cab-41cc-ac68-1021db59f85d" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:to="loc_cah_PatientRecoveryBusinessMember_6cb015cb-0cab-41cc-ac68-1021db59f85d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember_5ba1fc08-d87c-45ee-ae36-53abc8f98aea" xlink:href="cah-20220630.xsd#cah_CareFusionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:to="loc_cah_CareFusionMember_5ba1fc08-d87c-45ee-ae36-53abc8f98aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_0ca89663-3ea1-4de6-99a0-3523c68963ce" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:to="loc_cah_PatientRecoveryBusinessMember_0ca89663-3ea1-4de6-99a0-3523c68963ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_789b895f-eabf-4dd5-ad1e-829afb57e1bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_789b895f-eabf-4dd5-ad1e-829afb57e1bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2d94977b-4abf-45fd-a725-1788e4a92e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2d94977b-4abf-45fd-a725-1788e4a92e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_792d2c11-9c5e-4563-9866-4d424f24d043_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_792d2c11-9c5e-4563-9866-4d424f24d043_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_5bc831f4-846b-495f-84a1-1c3249c3785e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_5bc831f4-846b-495f-84a1-1c3249c3785e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0ee0e505-813e-4436-843a-855b8b46324d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0ee0e505-813e-4436-843a-855b8b46324d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2694daa3-ffff-4998-8421-1e76f8c4fe31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_ForeignCountryMember_2694daa3-ffff-4998-8421-1e76f8c4fe31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_209ce798-3f86-4920-ba9e-5c78813c8571_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:to="loc_srt_RangeMember_209ce798-3f86-4920-ba9e-5c78813c8571_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:to="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_be006231-cd35-4d64-bce7-aba319547c79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:to="loc_srt_MinimumMember_be006231-cd35-4d64-bce7-aba319547c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ddc9bdc-b0a5-4238-8a6d-e5feece4b5d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:to="loc_srt_MaximumMember_4ddc9bdc-b0a5-4238-8a6d-e5feece4b5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_80c6e64b-8d3f-4b95-91b4-720518a374eb_default" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_80c6e64b-8d3f-4b95-91b4-720518a374eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember_9cef4162-8fc6-49fc-a550-f6d52c87082b" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:to="loc_cah_NetOperatingLossCarrybackMember_9cef4162-8fc6-49fc-a550-f6d52c87082b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2ade14d3-c932-46e7-b123-6cf99a18b2b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:to="loc_us-gaap_ReportingUnitDomain_2ade14d3-c932-46e7-b123-6cf99a18b2b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:to="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_d6fd9c52-0273-419a-8842-16382db42a77" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:to="loc_cah_MedicalUnitMember_d6fd9c52-0273-419a-8842-16382db42a77" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended" id="iae102c6ef5dc4ab2b3ad21cb0fb31bf4_IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_214d4bbf-7bb3-4acd-94cc-e93529c10610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_214d4bbf-7bb3-4acd-94cc-e93529c10610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8334a05-f379-406b-8f70-a2a60b09d072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8334a05-f379-406b-8f70-a2a60b09d072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2cff4511-99f7-4a3a-846c-cb42d87763be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2cff4511-99f7-4a3a-846c-cb42d87763be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_83644660-a946-440a-bce3-232c6b8c198c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_83644660-a946-440a-bce3-232c6b8c198c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3548d228-9eeb-4722-ac9e-d248ed905671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3548d228-9eeb-4722-ac9e-d248ed905671" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31250049-9539-48fd-b34d-2bb4c711f593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31250049-9539-48fd-b34d-2bb4c711f593" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bcd1b7a-4038-4459-aa75-75a3e1f1153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bcd1b7a-4038-4459-aa75-75a3e1f1153a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bc2134-1f6e-4e1c-9f8b-d2e60e1c2919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bc2134-1f6e-4e1c-9f8b-d2e60e1c2919" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbfdcdde-fb6d-4ca5-8adb-5adc2247e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dbfdcdde-fb6d-4ca5-8adb-5adc2247e9f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_82f09435-5b0b-44c4-939e-bbb395438cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_82f09435-5b0b-44c4-939e-bbb395438cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ea6c60f0-a3d0-4e9c-985c-e96e48c4712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ea6c60f0-a3d0-4e9c-985c-e96e48c4712e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_273219ff-7571-4d73-9b9e-5f46d9de0326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_273219ff-7571-4d73-9b9e-5f46d9de0326" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5787d0f3-0d35-408f-bed7-be1f11f35103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5787d0f3-0d35-408f-bed7-be1f11f35103" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e84b86d0-5175-400b-9f1e-e95b44a0e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e84b86d0-5175-400b-9f1e-e95b44a0e3f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a84f01b9-d01d-4ff4-b8f9-1bd04d9061ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a84f01b9-d01d-4ff4-b8f9-1bd04d9061ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d12da6d6-b4e8-48c6-94f7-ca74e34377f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_03f513c2-05cf-4df0-8989-b62447377d20" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:to="loc_cah_PatientRecoveryBusinessMember_03f513c2-05cf-4df0-8989-b62447377d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_21b1ca0f-6ef2-4944-8599-2605c4cd10c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_21b1ca0f-6ef2-4944-8599-2605c4cd10c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b9541aa5-24cc-40ef-93e6-33563d61b11d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:to="loc_us-gaap_TaxPeriodDomain_b9541aa5-24cc-40ef-93e6-33563d61b11d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_76b46bc7-25f9-4ed0-b190-881922119ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:to="loc_us-gaap_TaxPeriodDomain_76b46bc7-25f9-4ed0-b190-881922119ed7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="idc4ed51fe13b4993bc8e1cdddc758798_FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9228b4ad-0a16-448e-98c3-3cac7ab582a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9228b4ad-0a16-448e-98c3-3cac7ab582a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_b02ed29c-f836-4e5f-90b9-7bc730994ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_b02ed29c-f836-4e5f-90b9-7bc730994ea6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_63779451-9918-44a9-8983-44118aeda525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_63779451-9918-44a9-8983-44118aeda525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88c96d01-2b95-49dc-8b4e-d87288c6c774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88c96d01-2b95-49dc-8b4e-d87288c6c774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0f81bba6-21f6-42b6-9f9b-8e5f31c003b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e4bc5c7e-7d87-4efc-b229-eec35ff6f121_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e4bc5c7e-7d87-4efc-b229-eec35ff6f121_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_876f805b-b763-4ab2-bc96-ebcd1f40b4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_876f805b-b763-4ab2-bc96-ebcd1f40b4f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5ccd29f9-25cc-46ed-921d-f8b011067a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5ccd29f9-25cc-46ed-921d-f8b011067a2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f274d03-08e7-40cc-9af2-dc38bf0af8f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f274d03-08e7-40cc-9af2-dc38bf0af8f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_366dbd00-a939-4bb9-bd11-a49546dde922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_366dbd00-a939-4bb9-bd11-a49546dde922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_62bc9efb-2069-41a1-828b-0103c13a1a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_62bc9efb-2069-41a1-828b-0103c13a1a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5c7379e4-8f4a-4439-b1c0-204de34e9d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5c7379e4-8f4a-4439-b1c0-204de34e9d89" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended" id="i01ef36a489224002bf9d0bc43f11b397_FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c51ba2a4-64fe-4c5c-bc70-943b9b5e48fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c51ba2a4-64fe-4c5c-bc70-943b9b5e48fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e188a5e1-6a87-45d0-8243-d941b16b4c9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e188a5e1-6a87-45d0-8243-d941b16b4c9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9650a1be-41bd-4aec-b4e9-01dd26fab53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9650a1be-41bd-4aec-b4e9-01dd26fab53a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fcf65c9d-a701-4d58-82ed-bc30c3035301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fcf65c9d-a701-4d58-82ed-bc30c3035301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e2413473-605e-4b7a-a768-44323db2d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e2413473-605e-4b7a-a768-44323db2d5ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c436726d-ecfb-4396-bf7f-939feb59aa93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c436726d-ecfb-4396-bf7f-939feb59aa93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_df6d410a-785c-4e4b-a609-c13f5cf1d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_df6d410a-785c-4e4b-a609-c13f5cf1d3d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9a81715b-cf7a-4b03-9afa-ae37bb5c9912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9a81715b-cf7a-4b03-9afa-ae37bb5c9912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5ac576be-7c3b-48fc-b740-4878c755d954_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5ac576be-7c3b-48fc-b740-4878c755d954_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db105c44-337d-49bb-91a0-dc9d07c89c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db105c44-337d-49bb-91a0-dc9d07c89c0a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i20256d4c88e14db79c6f26e79577c907_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8b9b29cc-7d8a-44fa-b8bb-4dcaf9bc300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8b9b29cc-7d8a-44fa-b8bb-4dcaf9bc300c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_da296674-4ae9-4c9d-b1bd-0ea53af52d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_da296674-4ae9-4c9d-b1bd-0ea53af52d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a1eddf7f-38bf-4205-84bc-ef2e46153ad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a1eddf7f-38bf-4205-84bc-ef2e46153ad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9b151bb9-6348-4d68-bd7d-37d751417f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9b151bb9-6348-4d68-bd7d-37d751417f7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" id="ib28813c40b8148aaa52dc6441855b2aa_FinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_b5e4052d-ca5c-493b-b87b-daf320568355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_b5e4052d-ca5c-493b-b87b-daf320568355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:to="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7a0fa883-51b4-4e4a-b490-b76ee8489482_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7a0fa883-51b4-4e4a-b490-b76ee8489482_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2417fb47-0d88-4d5a-9a4a-f75516acb27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:to="loc_us-gaap_FairValueHedgingMember_2417fb47-0d88-4d5a-9a4a-f75516acb27d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_93698227-ecdf-4432-8f13-52ca710b2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:to="loc_us-gaap_CashFlowHedgingMember_93698227-ecdf-4432-8f13-52ca710b2fc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:to="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a5cec002-4cb0-4f8a-bee0-e26938d675fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:to="loc_us-gaap_HedgingDesignationDomain_a5cec002-4cb0-4f8a-bee0-e26938d675fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:to="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5b7c14e3-c66b-43fc-b67a-bb5ba6abb439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:to="loc_us-gaap_NondesignatedMember_5b7c14e3-c66b-43fc-b67a-bb5ba6abb439" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i47cef4fca764450aa6b9f7b301dedab5_FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0ec06fcf-0ad2-4946-9afd-4ad414ec41b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0ec06fcf-0ad2-4946-9afd-4ad414ec41b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f97fe547-d408-4aa3-a1bc-66cfa8ba14b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f97fe547-d408-4aa3-a1bc-66cfa8ba14b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_abd09c98-a061-414a-9287-cec8510fc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_abd09c98-a061-414a-9287-cec8510fc5f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c63dd68f-164c-4a73-a445-f25f32270084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c63dd68f-164c-4a73-a445-f25f32270084" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_529d5026-0eeb-48d8-ace7-79e77d49c0a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_529d5026-0eeb-48d8-ace7-79e77d49c0a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fe095133-c84a-497c-a517-a221845454ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:to="loc_us-gaap_CashFlowHedgingMember_fe095133-c84a-497c-a517-a221845454ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d62601e6-31ff-4b6a-90d6-3577065fe119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:to="loc_us-gaap_FairValueHedgingMember_d62601e6-31ff-4b6a-90d6-3577065fe119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8fb2d38a-08fa-4963-8e9d-765a30db0ddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8fb2d38a-08fa-4963-8e9d-765a30db0ddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e9da2771-fda2-4298-b0a9-79f58770c827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e9da2771-fda2-4298-b0a9-79f58770c827" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f01ec2be-e315-4374-b129-c21258474a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_InterestRateSwapMember_f01ec2be-e315-4374-b129-c21258474a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_4e4a2662-3756-401a-a1e9-0350862dcbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_4e4a2662-3756-401a-a1e9-0350862dcbcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6ec638c2-fa24-409d-ad04-469e270b7560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_CommodityContractMember_6ec638c2-fa24-409d-ad04-469e270b7560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18961325-b148-4efa-bf9b-15de3622bef3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18961325-b148-4efa-bf9b-15de3622bef3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_83b413df-87d7-44ef-ba5e-66f37b541ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_OtherAssetsMember_83b413df-87d7-44ef-ba5e-66f37b541ff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_221e5bd0-97f7-4859-af1d-0c58bda04c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_221e5bd0-97f7-4859-af1d-0c58bda04c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_a75f6e4c-03fc-4d1c-a7b5-c6b28b6ad2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_a75f6e4c-03fc-4d1c-a7b5-c6b28b6ad2c5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="ia5503dfe555049fc8d42e4129d6e3485_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ce5d4411-2fb1-4123-8372-a0ffc75f648e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ce5d4411-2fb1-4123-8372-a0ffc75f648e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_5cc98334-562c-4430-81a9-362d665187aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_5cc98334-562c-4430-81a9-362d665187aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_84839013-38e5-4b5d-945a-574f624ff1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_84839013-38e5-4b5d-945a-574f624ff1fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_da935939-3550-472b-a48f-e553b4d2d5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_da935939-3550-472b-a48f-e553b4d2d5b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_91509e90-8977-4fbb-bb47-4c3922e4338d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_91509e90-8977-4fbb-bb47-4c3922e4338d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_4bf447d2-3e9a-4d9f-9b54-673b2daa6f20" xlink:href="cah-20220630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_4bf447d2-3e9a-4d9f-9b54-673b2daa6f20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_48ee963e-a1e3-4a03-9049-ed40c4d75117" xlink:href="cah-20220630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_VestingPeriodinyearsforShares_48ee963e-a1e3-4a03-9049-ed40c4d75117" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_39bbb53f-6fbd-4fe8-87fa-ecff476bdbc1" xlink:href="cah-20220630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_39bbb53f-6fbd-4fe8-87fa-ecff476bdbc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_55b91632-5b9a-4f09-a0f5-c846362b03b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_55b91632-5b9a-4f09-a0f5-c846362b03b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f48e82bf-8bee-4c6c-8481-96525f7f296a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f48e82bf-8bee-4c6c-8481-96525f7f296a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_730c4bef-0448-45f8-9d8a-c24174af2f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_730c4bef-0448-45f8-9d8a-c24174af2f42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9900da78-c0a2-4859-9b6a-c0049e42e304_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9900da78-c0a2-4859-9b6a-c0049e42e304_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:to="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3e5fe38c-8a69-4f1c-83fd-090bb56b1a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_FairValueHedgingMember_3e5fe38c-8a69-4f1c-83fd-090bb56b1a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a12f9306-7caf-4d1a-b5ac-d5428f405521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_CashFlowHedgingMember_a12f9306-7caf-4d1a-b5ac-d5428f405521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_04aa80cc-26e5-4e0d-80a4-dfd7408e745a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_04aa80cc-26e5-4e0d-80a4-dfd7408e745a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_96eaae76-f4dc-4834-aa5c-981da9dc5c06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_96eaae76-f4dc-4834-aa5c-981da9dc5c06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ccfec77b-c9c4-403e-a143-46ef95c23e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_InterestRateSwapMember_ccfec77b-c9c4-403e-a143-46ef95c23e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_417a893c-f6d5-4d58-bcee-f6c957fcc09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_CurrencySwapMember_417a893c-f6d5-4d58-bcee-f6c957fcc09d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6ec2ffdc-39d0-4f64-9ab8-136f9375d60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6ec2ffdc-39d0-4f64-9ab8-136f9375d60e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0c9cdfce-6275-4f08-8432-b8d6b110f8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_CashFlowHedgingMember_0c9cdfce-6275-4f08-8432-b8d6b110f8af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:href="cah-20220630.xsd#cah_MaturityDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateDomain_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b_default" xlink:href="cah-20220630.xsd#cah_MaturityDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:to="loc_cah_MaturityDateDomain_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:href="cah-20220630.xsd#cah_MaturityDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:to="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_September2025Member_529e947f-fcba-4edb-9a1d-11cb7d1b90b7" xlink:href="cah-20220630.xsd#cah_September2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:to="loc_cah_September2025Member_529e947f-fcba-4edb-9a1d-11cb7d1b90b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_June2027Member_ba867339-6f63-444a-a22c-453f04604f80" xlink:href="cah-20220630.xsd#cah_June2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:to="loc_cah_June2027Member_ba867339-6f63-444a-a22c-453f04604f80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_42f46ef1-076b-461d-8482-b617b92b04f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_42f46ef1-076b-461d-8482-b617b92b04f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13181fe5-81fc-4f5d-ab97-a544e3e2dbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13181fe5-81fc-4f5d-ab97-a544e3e2dbdf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended" id="id4cbd7e4b10b4afe99e840764893e2b2_FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_234aee46-8005-418a-9d2e-464ce9815c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_234aee46-8005-418a-9d2e-464ce9815c4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_ccb99db2-593f-45a7-87c8-015c817424dc" xlink:href="cah-20220630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_ccb99db2-593f-45a7-87c8-015c817424dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_52ab2ec9-833f-48dd-876f-e12a4b98629f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_52ab2ec9-833f-48dd-876f-e12a4b98629f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5631d7cb-9b1f-4932-97a8-47e630357cea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:to="loc_us-gaap_HedgingDesignationDomain_5631d7cb-9b1f-4932-97a8-47e630357cea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:to="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d84361d3-812c-4ea7-b066-f2c0bbe77f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d84361d3-812c-4ea7-b066-f2c0bbe77f44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_35417bd6-18e0-4c73-aca8-0bd3ffb1355d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_35417bd6-18e0-4c73-aca8-0bd3ffb1355d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9b3c645a-ae11-40d7-96f4-6124c42613ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:to="loc_us-gaap_FairValueHedgingMember_9b3c645a-ae11-40d7-96f4-6124c42613ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_811a86a7-c500-4238-a9ce-c76f7c61d11d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_811a86a7-c500-4238-a9ce-c76f7c61d11d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_caee7673-04f4-49c3-9404-0f1302c24b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:to="loc_us-gaap_InterestRateSwapMember_caee7673-04f4-49c3-9404-0f1302c24b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_923f162d-7b7a-448d-b23c-ca051a63d345_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:to="loc_srt_RangeMember_923f162d-7b7a-448d-b23c-ca051a63d345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:to="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_50bf3fd6-c9bd-4a25-b910-73dbb6ad2b79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:to="loc_srt_MinimumMember_50bf3fd6-c9bd-4a25-b910-73dbb6ad2b79" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="extended" id="ibb34c74850ad4f4a97e711aad8e99f9a_FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_be4f9c9d-0025-420f-b837-a1ead29d0d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_be4f9c9d-0025-420f-b837-a1ead29d0d61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:to="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_72e7a2c4-d849-49bf-9779-882c75a5e66f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_72e7a2c4-d849-49bf-9779-882c75a5e66f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_40cb6285-4bd0-4adb-9965-6453a7ea3441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:to="loc_us-gaap_FairValueHedgingMember_40cb6285-4bd0-4adb-9965-6453a7ea3441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0e8b642-2763-481a-be7a-d327ccec8999_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0e8b642-2763-481a-be7a-d327ccec8999_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c822584f-cff7-4b75-8cfa-cfbd80cb6e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:to="loc_us-gaap_InterestRateSwapMember_c822584f-cff7-4b75-8cfa-cfbd80cb6e2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember_bae5c6e6-1e83-4199-b925-145523e3c459" xlink:href="cah-20220630.xsd#cah_FixedRateDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:to="loc_cah_FixedRateDebtMember_bae5c6e6-1e83-4199-b925-145523e3c459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dea47152-fa66-4491-9ff2-8148f2bc77c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dea47152-fa66-4491-9ff2-8148f2bc77c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_db3eb1c5-cd5b-4836-a402-b4741c43d630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:to="loc_us-gaap_InterestExpenseMember_db3eb1c5-cd5b-4836-a402-b4741c43d630" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended" id="i9e564d6311194b43922e3042e10fae6a_FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_195f8ba1-7d20-409c-8061-716a9584c9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_195f8ba1-7d20-409c-8061-716a9584c9ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_43ece46a-74c4-48ff-86c4-5468c52b60bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_43ece46a-74c4-48ff-86c4-5468c52b60bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:to="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_34b3f219-0102-40a1-857c-49f399701194_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:to="loc_us-gaap_HedgingDesignationDomain_34b3f219-0102-40a1-857c-49f399701194_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:to="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9d8e8802-33b7-4f20-9155-e88cb9f9a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9d8e8802-33b7-4f20-9155-e88cb9f9a3c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1ec670cb-dacd-4759-a36a-b1ce1a8068ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1ec670cb-dacd-4759-a36a-b1ce1a8068ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b652fe39-649d-4cbc-866d-7fa0ecf9331e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:to="loc_us-gaap_FairValueHedgingMember_b652fe39-649d-4cbc-866d-7fa0ecf9331e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_216e225e-fa46-4271-b494-9b419f345a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:to="loc_us-gaap_CashFlowHedgingMember_216e225e-fa46-4271-b494-9b419f345a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_38b5ab6c-c969-48b0-a498-90b49745cbb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_38b5ab6c-c969-48b0-a498-90b49745cbb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce4b6f38-5070-461f-8322-33b939394b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_InterestRateSwapMember_ce4b6f38-5070-461f-8322-33b939394b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_86b22beb-9503-48e3-8d12-dc78cab7af77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_86b22beb-9503-48e3-8d12-dc78cab7af77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_fa0e16c2-9bac-4ec8-9ad5-5da09542b165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_CommodityContractMember_fa0e16c2-9bac-4ec8-9ad5-5da09542b165" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_07398ab9-ecc6-4f2b-81ac-bbc41ba6566e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_07398ab9-ecc6-4f2b-81ac-bbc41ba6566e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_33150581-19ea-407c-ac7a-d0cf3112924b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_ForwardContractsMember_33150581-19ea-407c-ac7a-d0cf3112924b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed66de27-1ab3-47c6-8f96-997bd96f22f5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:to="loc_srt_RangeMember_ed66de27-1ab3-47c6-8f96-997bd96f22f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:to="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4dcd7899-314c-40f8-afd3-f6ab9d81621d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:to="loc_srt_MinimumMember_4dcd7899-314c-40f8-afd3-f6ab9d81621d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5dea59e9-854d-4b73-a0ca-e1d62a5fe418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:to="loc_srt_MaximumMember_5dea59e9-854d-4b73-a0ca-e1d62a5fe418" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended" id="i1915bc3041004465934b3f10581b80e5_FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a997aa97-09f7-4049-8ab7-11a45bd21dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a997aa97-09f7-4049-8ab7-11a45bd21dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:to="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4b8e844a-4c16-426b-a0f5-7b218ef626f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4b8e844a-4c16-426b-a0f5-7b218ef626f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f1f29e98-3c82-4208-a423-9677c388dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:to="loc_us-gaap_CashFlowHedgingMember_f1f29e98-3c82-4208-a423-9677c388dfb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_aa3f2bcb-5438-4150-98b9-dfadb19da8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_ForwardContractsMember_aa3f2bcb-5438-4150-98b9-dfadb19da8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_33d04d59-41ae-4d84-b781-f61e30d3022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_InterestRateSwapMember_33d04d59-41ae-4d84-b781-f61e30d3022b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6520d2de-296c-41f9-97b7-f82d63964d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_CommodityContractMember_6520d2de-296c-41f9-97b7-f82d63964d1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a0341b79-189a-41de-806b-3579f018f9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a0341b79-189a-41de-806b-3579f018f9c1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended" id="i70ebcb718a434d33be4ded752ede47a2_FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bf3a72fa-661b-499b-ae11-5e931108cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bf3a72fa-661b-499b-ae11-5e931108cb5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:to="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_16d152fc-7efc-47b8-9a7f-490bd39b1afd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_16d152fc-7efc-47b8-9a7f-490bd39b1afd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_af3c1dbd-0db6-46fe-9044-0a2b14a249fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:to="loc_us-gaap_CashFlowHedgingMember_af3c1dbd-0db6-46fe-9044-0a2b14a249fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1549b966-f0df-4eaa-be8e-d417e1b3e963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1549b966-f0df-4eaa-be8e-d417e1b3e963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_ff6c2bf1-05ac-44a4-b9e9-dff4343a5a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_ForwardContractsMember_ff6c2bf1-05ac-44a4-b9e9-dff4343a5a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_9ee6bc75-a01d-4fbf-a43b-0bdc3bdf8823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_CommodityContractMember_9ee6bc75-a01d-4fbf-a43b-0bdc3bdf8823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_25f198f8-b974-4486-9394-727159c3c45a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_25f198f8-b974-4486-9394-727159c3c45a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_96fc920f-ccb5-4f42-bfb8-6852921db54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_SalesMember_96fc920f-ccb5-4f42-bfb8-6852921db54d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_df0b8278-72d6-45ff-aa5d-35a35aa9d176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_CostOfSalesMember_df0b8278-72d6-45ff-aa5d-35a35aa9d176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1080b68d-88b1-4432-a02a-7dd9dc543bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1080b68d-88b1-4432-a02a-7dd9dc543bb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_86914416-94ae-43fa-99ab-99ce4776a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_InterestExpenseMember_86914416-94ae-43fa-99ab-99ce4776a8c4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended" id="i9c900479a0254d038ae65754259bd8eb_FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9686e7b1-c176-4444-8fa1-ec9143b00db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9686e7b1-c176-4444-8fa1-ec9143b00db7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:to="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b201a587-6604-4fc0-a3fa-0bbfddb6b94f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:to="loc_srt_RangeMember_b201a587-6604-4fc0-a3fa-0bbfddb6b94f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:to="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_477e093f-8a09-4b45-9eac-7d5372060a79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:to="loc_srt_MinimumMember_477e093f-8a09-4b45-9eac-7d5372060a79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d0860af-e74d-46ba-a2a0-e6635812c782" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:to="loc_srt_MaximumMember_0d0860af-e74d-46ba-a2a0-e6635812c782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5012f20-5fa2-4ac6-920e-1aa531e1f167_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5012f20-5fa2-4ac6-920e-1aa531e1f167_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_462e508b-f0ab-492d-8a2c-0f9e2ecafd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_462e508b-f0ab-492d-8a2c-0f9e2ecafd9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b3f71207-2b49-4c49-8b35-d41c405ec1c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_b3f71207-2b49-4c49-8b35-d41c405ec1c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c6a8d05c-f63e-4436-8fb4-d0c8ff5faea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:to="loc_us-gaap_NondesignatedMember_c6a8d05c-f63e-4436-8fb4-d0c8ff5faea3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="extended" id="i99b3fe64ef1b4bd0b513dcd5d8acf9d4_FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7d301caa-9183-41bc-a219-0100f3934f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7d301caa-9183-41bc-a219-0100f3934f78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:to="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_318cf411-33fb-41d9-97e4-d2330486e3aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_318cf411-33fb-41d9-97e4-d2330486e3aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_22ca5ecd-1177-499a-ae77-e0852073bd59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:to="loc_us-gaap_NondesignatedMember_22ca5ecd-1177-499a-ae77-e0852073bd59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a00b061f-97fe-407e-a08c-f0a5f8728afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a00b061f-97fe-407e-a08c-f0a5f8728afb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c3eaabed-7d54-44f4-ab0b-48239b4300fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c3eaabed-7d54-44f4-ab0b-48239b4300fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_cd4bd280-50f1-4bb0-9a05-3f0df122abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_cd4bd280-50f1-4bb0-9a05-3f0df122abe0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="extended" id="ice430e41ac58439498e6db1283a48178_FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f6497a13-8237-4ca1-afc9-1a2d25c73204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f6497a13-8237-4ca1-afc9-1a2d25c73204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_1cf9b19e-894a-46af-8632-3d4361f268bb" xlink:href="cah-20220630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_1cf9b19e-894a-46af-8632-3d4361f268bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_267566ef-00ee-4932-b5cb-2ad1c4ee97a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_267566ef-00ee-4932-b5cb-2ad1c4ee97a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6c953633-fed5-4ff7-a81e-eb03e6793872_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6c953633-fed5-4ff7-a81e-eb03e6793872_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_73a92efd-49f8-40b3-ad56-1498c33d2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:to="loc_us-gaap_InterestRateSwapMember_73a92efd-49f8-40b3-ad56-1498c33d2af1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_74d5dd13-b68b-44de-ac6d-27fdef55a84a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:to="loc_us-gaap_HedgingDesignationDomain_74d5dd13-b68b-44de-ac6d-27fdef55a84a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:to="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77c33b54-35f4-4e84-9968-01e7eb2d556f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77c33b54-35f4-4e84-9968-01e7eb2d556f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a57e3dd3-eb34-40a3-a4d4-1b08e8529827_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a57e3dd3-eb34-40a3-a4d4-1b08e8529827_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:to="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_6aff23b3-4071-4df3-a02d-d46736237903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:to="loc_us-gaap_FairValueHedgingMember_6aff23b3-4071-4df3-a02d-d46736237903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_996c6a8c-ac8b-4789-810f-8c02d89ca686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_996c6a8c-ac8b-4789-810f-8c02d89ca686" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended" id="i77bdc4c10ae7458a8345c69fe2c46089_FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_abbae813-dcb4-4ca5-9f2c-3221f9ca65b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_abbae813-dcb4-4ca5-9f2c-3221f9ca65b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9fdfb611-3049-4221-989a-e41046dfc085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9fdfb611-3049-4221-989a-e41046dfc085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:to="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b1937fc3-0e7b-49e9-91c1-bb8537f0af63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b1937fc3-0e7b-49e9-91c1-bb8537f0af63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:to="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_da6d2e62-dcca-41be-856d-a82deb7bb870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:to="loc_us-gaap_FairValueHedgingMember_da6d2e62-dcca-41be-856d-a82deb7bb870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_adb4e5e7-1fae-4923-8a9c-ba73d9c92709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:to="loc_us-gaap_CashFlowHedgingMember_adb4e5e7-1fae-4923-8a9c-ba73d9c92709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_578829cc-c55b-4c18-8cc0-c9a1aa821946_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_578829cc-c55b-4c18-8cc0-c9a1aa821946_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9de1d147-cfc5-45db-8ff5-4660131b7cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_InterestRateSwapMember_9de1d147-cfc5-45db-8ff5-4660131b7cae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f760296b-3724-4628-b6e0-97b778bd05e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f760296b-3724-4628-b6e0-97b778bd05e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_c41e95f6-d0cb-4aaf-a9d5-024db6ddb942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_ForwardContractsMember_c41e95f6-d0cb-4aaf-a9d5-024db6ddb942" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6da36939-b30a-4148-b566-ccbe4bf08694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_CurrencySwapMember_6da36939-b30a-4148-b566-ccbe4bf08694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_c506bb4e-af11-4140-aa62-0da9f5c27694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_CommodityContractMember_c506bb4e-af11-4140-aa62-0da9f5c27694" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="i909ea94336c64295a14d1f7dfee908a1_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_df5c5624-7985-48fe-9b92-4f80e418211d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_df5c5624-7985-48fe-9b92-4f80e418211d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9ed84a44-47cc-48cf-a710-5ace61274740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9ed84a44-47cc-48cf-a710-5ace61274740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e133d99-1392-4755-9070-8f39dad3acf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e133d99-1392-4755-9070-8f39dad3acf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f27cfc52-bc92-4aa4-8b91-1e4bc9f4e79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f27cfc52-bc92-4aa4-8b91-1e4bc9f4e79b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_028e98bd-f88e-48f4-a2a2-4a1c4f45224b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_028e98bd-f88e-48f4-a2a2-4a1c4f45224b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_575d0579-8953-43b4-baaf-bc5abcb89203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_575d0579-8953-43b4-baaf-bc5abcb89203" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes_16d7cc99-86f8-45a3-a9d3-c2be4481c6a5" xlink:href="cah-20220630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_cah_CommonStockVotingRightsVotes_16d7cc99-86f8-45a3-a9d3-c2be4481c6a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:to="loc_us-gaap_EquityComponentDomain_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:to="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_06120ff7-780e-4bb5-8274-d455c6da46c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:to="loc_us-gaap_TreasuryStockMember_06120ff7-780e-4bb5-8274-d455c6da46c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f108cdbd-3d71-4e3b-b81c-5dcdc242c626_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:to="loc_us-gaap_ClassOfStockDomain_f108cdbd-3d71-4e3b-b81c-5dcdc242c626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:to="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f545f8e6-812a-44f7-80cd-a9da8b377077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:to="loc_us-gaap_CommonClassAMember_f545f8e6-812a-44f7-80cd-a9da8b377077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_1c949706-fe07-4a19-8f50-3338575c6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:to="loc_us-gaap_CommonClassBMember_1c949706-fe07-4a19-8f50-3338575c6174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3_default" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:to="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:to="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A200MillionShareRepurchaseProgramMember_57cb80ef-6f9e-4e74-a5c2-05c904dcbeca" xlink:href="cah-20220630.xsd#cah_A200MillionShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A200MillionShareRepurchaseProgramMember_57cb80ef-6f9e-4e74-a5c2-05c904dcbeca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A300MillionShareRepurchaseProgramMember_c733f5fb-cbf8-4abd-8290-c85809d4939d" xlink:href="cah-20220630.xsd#cah_A300MillionShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A300MillionShareRepurchaseProgramMember_c733f5fb-cbf8-4abd-8290-c85809d4939d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A500MillionShareRepurchaseProgramMember_ae53c7fc-4517-42b8-b37f-9ee6d7ab7476" xlink:href="cah-20220630.xsd#cah_A500MillionShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A500MillionShareRepurchaseProgramMember_ae53c7fc-4517-42b8-b37f-9ee6d7ab7476" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="ic5791ce36881416f92dd88b1607b5588_ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d11d4204-6455-4fe9-a746-7925f37bc0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d11d4204-6455-4fe9-a746-7925f37bc0bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7c7f3693-bc14-472f-8a88-5d8038c37d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7c7f3693-bc14-472f-8a88-5d8038c37d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d52875a1-a517-4801-aa37-c0a3e970f8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d52875a1-a517-4801-aa37-c0a3e970f8c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_51e150da-0130-436e-924c-18eeb819c755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_51e150da-0130-436e-924c-18eeb819c755" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_487be81c-4ae4-4a74-a7bc-ea9e3769038d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_95017242-31a6-4b30-bcf1-fa0c1cd8556f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_95017242-31a6-4b30-bcf1-fa0c1cd8556f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b1ecf71c-3328-49f4-8fff-a90d9100d280_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:to="loc_us-gaap_EquityComponentDomain_b1ecf71c-3328-49f4-8fff-a90d9100d280_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:to="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eee094c2-5444-4098-b795-2d4ef4c51546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eee094c2-5444-4098-b795-2d4ef4c51546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_7052dd9f-e891-4f17-b3dd-cddaf763a247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_7052dd9f-e891-4f17-b3dd-cddaf763a247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_42fb0df4-17b7-4108-a3e9-8c2bb7dddfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_42fb0df4-17b7-4108-a3e9-8c2bb7dddfef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4365c7cb-e1e8-48a2-855a-040f5a1abc75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4365c7cb-e1e8-48a2-855a-040f5a1abc75" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i9691bb49706b420d90c7e22c318f152a_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_df01f4fa-8f98-4b2d-94ab-2091591b122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_NumberOfReportableSegments_df01f4fa-8f98-4b2d-94ab-2091591b122f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_c08f3b04-449c-403b-bf14-8c26303291f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_InventoryRecallExpense_c08f3b04-449c-403b-bf14-8c26303291f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_5f585907-3fb8-40b6-8fd2-ef85a6801f5a" xlink:href="cah-20220630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_5f585907-3fb8-40b6-8fd2-ef85a6801f5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c88774c2-03f4-4fdb-806a-3d271d2841aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_LitigationSettlementExpense_c88774c2-03f4-4fdb-806a-3d271d2841aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_3f76d12d-1aac-4937-9006-a8756ee6b205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_3f76d12d-1aac-4937-9006-a8756ee6b205" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax_d71b92c4-36a9-4b91-a65a-e7055960ed25" xlink:href="cah-20220630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_GainonDivestitureAfterTax_d71b92c4-36a9-4b91-a65a-e7055960ed25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_63678e6a-e8df-4954-8f81-04e56c31d49e" xlink:href="cah-20220630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_63678e6a-e8df-4954-8f81-04e56c31d49e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_6571474f-5e0a-44b9-a908-c0ff6e6d06d1" xlink:href="cah-20220630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_6571474f-5e0a-44b9-a908-c0ff6e6d06d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7_default" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:to="loc_cah_OpioidLitigationDomain_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:to="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_0d14ed51-da65-4650-8785-ebd51a51da73" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:to="loc_cah_TotalOpioidLitigationMember_0d14ed51-da65-4650-8785-ebd51a51da73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38252144-859e-46bb-860b-5f4b81e3a783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38252144-859e-46bb-860b-5f4b81e3a783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_02696824-302e-4e63-ab84-867cf0b5dab7" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:to="loc_cah_NaviHealthMember_02696824-302e-4e63-ab84-867cf0b5dab7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b004669b-9e28-40b5-9fd3-5d4d42205e09_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:to="loc_srt_LitigationCaseTypeDomain_b004669b-9e28-40b5-9fd3-5d4d42205e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:to="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_62c32e62-bc9b-47af-8bd4-4fdef783fb35" xlink:href="cah-20220630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_62c32e62-bc9b-47af-8bd4-4fdef783fb35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_e18881f5-a532-455f-8e29-1164fbc3469f_default" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_e18881f5-a532-455f-8e29-1164fbc3469f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_4ad21d9d-89c7-46d1-aa0a-8c09472fc3af" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_4ad21d9d-89c7-46d1-aa0a-8c09472fc3af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_c1116320-c54a-4322-9912-f2c4e9db98ee_default" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:to="loc_cah_CordisDivestitureDomain_c1116320-c54a-4322-9912-f2c4e9db98ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:to="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_b07ae8ae-4894-4b79-b783-656928b2d5e6" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:to="loc_cah_CordisDivestitureMember_b07ae8ae-4894-4b79-b783-656928b2d5e6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationRevenuebyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="extended" id="i2a11f4ec89b443f5b5fa004550c1a2b4_SegmentInformationRevenuebyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2795f2f4-e3cb-453a-87a9-dd0fe9cb4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:to="loc_us-gaap_Revenues_2795f2f4-e3cb-453a-87a9-dd0fe9cb4fc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ffd34cc0-7653-41db-b313-80025eafdaa8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:to="loc_srt_ConsolidationItemsDomain_ffd34cc0-7653-41db-b313-80025eafdaa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:to="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_df63e0c2-682d-4d37-8895-5a85a9293c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:to="loc_us-gaap_OperatingSegmentsMember_df63e0c2-682d-4d37-8895-5a85a9293c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5ab8909d-08de-4642-9eb0-b1d5838a2cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5ab8909d-08de-4642-9eb0-b1d5838a2cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc05f749-6ddd-4d00-b8ea-ed4fe079e205_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:to="loc_us-gaap_SegmentDomain_bc05f749-6ddd-4d00-b8ea-ed4fe079e205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:to="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_40c567c0-3a72-4b4c-a79e-0e3bc91d4972" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:to="loc_cah_PharmaceuticalMember_40c567c0-3a72-4b4c-a79e-0e3bc91d4972" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_1b7346f4-b9f5-4d4b-a48b-e2441ee8cd3a" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:to="loc_cah_MedicalMemberMember_1b7346f4-b9f5-4d4b-a48b-e2441ee8cd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_367d796b-90b7-4ca9-b782-c21164752082_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:to="loc_us-gaap_SubsegmentsDomain_367d796b-90b7-4ca9-b782-c21164752082_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:to="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_8544fd7c-a4d9-43ed-8168-c43573954a38" xlink:href="cah-20220630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_8544fd7c-a4d9-43ed-8168-c43573954a38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_f0a8c19a-15e5-4aac-add8-c883ec242a61" xlink:href="cah-20220630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_f0a8c19a-15e5-4aac-add8-c883ec242a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember_ca5e205a-0031-4fcf-9c9c-d770b56bc757" xlink:href="cah-20220630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_MedicaldistributionandproductsMember_ca5e205a-0031-4fcf-9c9c-d770b56bc757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_2165ceff-b102-43b8-a524-da3552cdeb80" xlink:href="cah-20220630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_2165ceff-b102-43b8-a524-da3552cdeb80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ade4baa0-f749-4d29-ac5b-c76869ff7560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ade4baa0-f749-4d29-ac5b-c76869ff7560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2b3f3300-f91d-43e1-b3f2-6643dbe4a679_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:to="loc_srt_SegmentGeographicalDomain_2b3f3300-f91d-43e1-b3f2-6643dbe4a679_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:to="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_1c33849e-4433-452c-be85-045fee98e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:to="loc_us-gaap_NonUsMember_1c33849e-4433-452c-be85-045fee98e34a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_94d3d83d-0caf-42f8-aa72-7b1e8e2819cc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:to="loc_country_US_94d3d83d-0caf-42f8-aa72-7b1e8e2819cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationSegmentProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="extended" id="i3df676bc9a0a4ada86fb7c25af550dc3_SegmentInformationSegmentProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_200ce2e7-8d0d-4c20-95f5-b70034420c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:to="loc_us-gaap_OperatingIncomeLoss_200ce2e7-8d0d-4c20-95f5-b70034420c02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:to="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a41922bf-bbf1-4bed-bee4-07412fc8b9a0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:to="loc_srt_ConsolidationItemsDomain_a41922bf-bbf1-4bed-bee4-07412fc8b9a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:to="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4b4ad532-003e-47b9-8e3f-51bc3ad74cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:to="loc_us-gaap_OperatingSegmentsMember_4b4ad532-003e-47b9-8e3f-51bc3ad74cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b1641276-a566-45a4-9c68-0055af190ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b1641276-a566-45a4-9c68-0055af190ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dd078379-852b-44f7-ac83-ffd8974455c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:to="loc_us-gaap_SegmentDomain_dd078379-852b-44f7-ac83-ffd8974455c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:to="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_28a95a35-b467-42c5-a330-f350a2ac7a98" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:to="loc_cah_PharmaceuticalMember_28a95a35-b467-42c5-a330-f350a2ac7a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ad96ed29-6009-4d67-be95-e85c4bb290ec" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:to="loc_cah_MedicalMemberMember_ad96ed29-6009-4d67-be95-e85c4bb290ec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="extended" id="id9a8cfc1766e445e9a736e03c88e9806_SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f7cb2333-e9a7-4fdc-aaf0-296fb311b78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f7cb2333-e9a7-4fdc-aaf0-296fb311b78f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_28b4bbd1-17ed-49c8-94e3-272a99a95fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_28b4bbd1-17ed-49c8-94e3-272a99a95fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:to="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_01d85c57-f7c4-475e-8b0a-a32adc1f8428_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:to="loc_srt_ConsolidationItemsDomain_01d85c57-f7c4-475e-8b0a-a32adc1f8428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:to="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_360b7f82-772f-4a17-bdef-1b5d82c4248c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:to="loc_us-gaap_OperatingSegmentsMember_360b7f82-772f-4a17-bdef-1b5d82c4248c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9b6857b1-1123-4569-a47a-2616e441feac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9b6857b1-1123-4569-a47a-2616e441feac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1f896ba5-309b-45fa-b64e-c5a5d7ce238a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:to="loc_us-gaap_SegmentDomain_1f896ba5-309b-45fa-b64e-c5a5d7ce238a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:to="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_c4c12bec-8f02-4e7f-bc84-33aac30df568" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:to="loc_cah_PharmaceuticalMember_c4c12bec-8f02-4e7f-bc84-33aac30df568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_b1a69d7c-226a-4c04-a342-b99a9abd728d" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:to="loc_cah_MedicalMemberMember_b1a69d7c-226a-4c04-a342-b99a9abd728d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationAssetsbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="extended" id="i1f90e66682b34b64a03ea397259bf52e_SegmentInformationAssetsbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e9d34090-070a-42b6-acbe-2c596acde2af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:to="loc_us-gaap_Assets_e9d34090-070a-42b6-acbe-2c596acde2af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_51704d50-e4bd-4aa8-b1f1-9bb8fc7885c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_51704d50-e4bd-4aa8-b1f1-9bb8fc7885c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:to="loc_srt_ConsolidationItemsDomain_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:to="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c17e7497-4bf3-4b97-b69e-ef07e94c5e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:to="loc_us-gaap_OperatingSegmentsMember_c17e7497-4bf3-4b97-b69e-ef07e94c5e25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f1aaa8a2-9356-4c7c-8c2d-32b7bd9c0630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f1aaa8a2-9356-4c7c-8c2d-32b7bd9c0630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0642aaf8-9068-46a1-8045-ec414fd14229_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:to="loc_us-gaap_SegmentDomain_0642aaf8-9068-46a1-8045-ec414fd14229_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:to="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_2eb25c9e-f245-48e5-a883-147eda3aff57" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:to="loc_cah_PharmaceuticalMember_2eb25c9e-f245-48e5-a883-147eda3aff57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_4ecb2266-9ecb-451d-96ed-f949db760d1f" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:to="loc_cah_MedicalMemberMember_4ecb2266-9ecb-451d-96ed-f949db760d1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_ea6b6bb0-d82a-4f30-96af-07445ce66417_default" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:to="loc_cah_CordisDivestitureDomain_ea6b6bb0-d82a-4f30-96af-07445ce66417_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:to="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_718e21bc-a6e4-4fd2-971e-17d62592be44" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:to="loc_cah_CordisDivestitureMember_718e21bc-a6e4-4fd2-971e-17d62592be44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="extended" id="ia6d7b37f2017405ca9ace676bd0b2875_SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e8947097-adfb-4a3d-918e-5bbcc1b21582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e8947097-adfb-4a3d-918e-5bbcc1b21582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:to="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b31896e0-1751-41e2-8c04-eb5a9f40655c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:to="loc_srt_SegmentGeographicalDomain_b31896e0-1751-41e2-8c04-eb5a9f40655c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:to="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_57e6475a-4f51-46ac-b2a1-98cf73c451be" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:to="loc_country_US_57e6475a-4f51-46ac-b2a1-98cf73c451be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_78f5e02d-2703-40c3-81a5-6cc3bcd876ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:to="loc_us-gaap_NonUsMember_78f5e02d-2703-40c3-81a5-6cc3bcd876ad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i5f9d29c0bebf4eb7a94dfd8622faf949_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0713ea36-9203-418c-b590-26721310b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0713ea36-9203-418c-b590-26721310b2f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4ec5fcc2-e1d4-4c36-b677-ca512cb10297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4ec5fcc2-e1d4-4c36-b677-ca512cb10297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a912e0c-75f1-40cb-b109-a86279f8baa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a912e0c-75f1-40cb-b109-a86279f8baa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d6f5a7ee-8d96-467b-b487-5f471dde5658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d6f5a7ee-8d96-467b-b487-5f471dde5658" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f7173ae0-191a-4251-991b-4c9b821d40c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f7173ae0-191a-4251-991b-4c9b821d40c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93785c24-5f88-4080-bbac-6dfd484b172c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93785c24-5f88-4080-bbac-6dfd484b172c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e43745b7-9697-43bd-9885-403ca2172ac0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:to="loc_us-gaap_PlanNameDomain_e43745b7-9697-43bd-9885-403ca2172ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:to="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2021LTIPMember_fbaa9569-5546-4ef9-be3f-72070c0050a3" xlink:href="cah-20220630.xsd#cah_A2021LTIPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:to="loc_cah_A2021LTIPMember_fbaa9569-5546-4ef9-be3f-72070c0050a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_7b5701e2-271d-4d31-8676-59b654cfd903" xlink:href="cah-20220630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_7b5701e2-271d-4d31-8676-59b654cfd903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_197cb7ab-2146-46e9-bb4d-c570206dcfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_us-gaap_PerformanceSharesMember_197cb7ab-2146-46e9-bb4d-c570206dcfff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1fbd5e5f-17d6-4b9b-b32a-613d7f4f12ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1fbd5e5f-17d6-4b9b-b32a-613d7f4f12ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19484ceb-21f4-4426-bf12-3a9c33e20e1b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:to="loc_srt_RangeMember_19484ceb-21f4-4426-bf12-3a9c33e20e1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:to="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30deffd1-5f90-4540-b83c-76c814cef4ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:to="loc_srt_MaximumMember_30deffd1-5f90-4540-b83c-76c814cef4ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="extended" id="i3d4ef615b5d04122a8bc818f3cbfa6c5_ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e65cb1ab-66f5-4604-96d7-c8bf830ebed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e65cb1ab-66f5-4604-96d7-c8bf830ebed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f3f05497-20f1-4fb0-85cc-d8d935657217_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f3f05497-20f1-4fb0-85cc-d8d935657217_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b05d59f2-5a73-4ed7-9ba7-14d51f8f9bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b05d59f2-5a73-4ed7-9ba7-14d51f8f9bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_49789bbe-b84f-4940-aee7-6df4ac9e66fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_EmployeeStockOptionMember_49789bbe-b84f-4940-aee7-6df4ac9e66fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_433565e2-acdf-4284-a90b-5eb4067ca979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_PerformanceSharesMember_433565e2-acdf-4284-a90b-5eb4067ca979" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3a94315a-8b32-4e40-8b12-df4f46745f00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:to="loc_us-gaap_PlanNameDomain_3a94315a-8b32-4e40-8b12-df4f46745f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b966ce3e-8ea5-46f7-809d-5fd1d5d21fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:to="loc_us-gaap_PlanNameDomain_b966ce3e-8ea5-46f7-809d-5fd1d5d21fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:to="loc_srt_RangeMember_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:to="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6967a246-5a66-4f58-a4c7-58f1c1ae5af7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:to="loc_srt_MinimumMember_6967a246-5a66-4f58-a4c7-58f1c1ae5af7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_960af7d7-cc63-4d36-b4e8-c1336b558a03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:to="loc_srt_MaximumMember_960af7d7-cc63-4d36-b4e8-c1336b558a03" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="extended" id="i22f0beae49e846289e883d6abea21bf8_ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b177970c-b86c-44b7-9ce6-bb57e188e424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b177970c-b86c-44b7-9ce6-bb57e188e424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:to="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a3cef3b7-ce60-4ceb-950f-f9037c74cada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a3cef3b7-ce60-4ceb-950f-f9037c74cada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9de78bc7-1af6-4c93-9c73-97afec0d2b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9de78bc7-1af6-4c93-9c73-97afec0d2b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:to="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1dd2af12-218e-47f6-9271-f506933bd314_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:to="loc_srt_RangeMember_1dd2af12-218e-47f6-9271-f506933bd314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:to="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2264036-be0d-498f-9384-82ee6a5bb303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:to="loc_srt_MaximumMember_e2264036-be0d-498f-9384-82ee6a5bb303" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="extended" id="i7869935c436d46358f085aaf216d4da9_ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c91634a0-a271-4684-8b98-5bba7576d91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c91634a0-a271-4684-8b98-5bba7576d91a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:to="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c217f602-dac4-4365-8ba2-2eba45ad8c54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c217f602-dac4-4365-8ba2-2eba45ad8c54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_76dbe643-b692-46c8-8008-3a154ee1b0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_76dbe643-b692-46c8-8008-3a154ee1b0da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="extended" id="id16537d3c8524b399433e5be837c55b5_ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5b9ae0b-8288-4d74-bd71-61d7c71da633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5b9ae0b-8288-4d74-bd71-61d7c71da633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0049b8ad-4f20-4dc4-863c-6dc678ad17f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0049b8ad-4f20-4dc4-863c-6dc678ad17f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_07b83531-6013-427f-a143-cecd18c0b81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_07b83531-6013-427f-a143-cecd18c0b81d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_761c80e5-6c82-499c-8055-be1d6b4a3d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_761c80e5-6c82-499c-8055-be1d6b4a3d00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4805be85-f415-4f46-a245-8485daaea2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4346b1d-aa1e-41b3-9056-b0b38c2f3b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4346b1d-aa1e-41b3-9056-b0b38c2f3b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f73c55d-4602-41c0-a40f-ff97f081cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f73c55d-4602-41c0-a40f-ff97f081cb94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c80c993e-f77e-4277-a339-0577d4a9c81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c80c993e-f77e-4277-a339-0577d4a9c81e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e838dd4a-da3b-4291-9877-3583065ad5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e838dd4a-da3b-4291-9877-3583065ad5c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5b41fca6-0d23-44e4-b86d-b3f83194e582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:to="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a31fbdd1-2d3a-4788-b756-fd8cc24594a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a31fbdd1-2d3a-4788-b756-fd8cc24594a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f7b51a41-cded-4fe1-971d-2a4c322c9919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f7b51a41-cded-4fe1-971d-2a4c322c9919" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="extended" id="ic2a6ebd4ccee43719b382d776cb4dc1c_ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46d03217-9b0d-4fbc-8700-890e87c602a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46d03217-9b0d-4fbc-8700-890e87c602a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5a7b9ffe-8e15-44b9-9e37-2d856b577f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5a7b9ffe-8e15-44b9-9e37-2d856b577f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4387ab99-c792-4746-9cbc-fdb76807253b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4387ab99-c792-4746-9cbc-fdb76807253b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_00ef7d10-2d7d-4cc6-988b-f484768feb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_00ef7d10-2d7d-4cc6-988b-f484768feb9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:to="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eaa37abf-2c87-43eb-9324-9befb9d17be0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eaa37abf-2c87-43eb-9324-9befb9d17be0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9c079208-d7b5-4541-bed4-6f7328261804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9c079208-d7b5-4541-bed4-6f7328261804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3d8aa253-25e1-4415-8c79-3c0ad902307f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:to="loc_us-gaap_PerformanceSharesMember_3d8aa253-25e1-4415-8c79-3c0ad902307f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="extended" id="if2a83499c6ad497f8d3564d733923fe3_ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e796b2db-dfdc-4c63-9237-19c0bf3f614d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e796b2db-dfdc-4c63-9237-19c0bf3f614d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40fac0d2-8818-4c30-9425-5e2d19adf50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40fac0d2-8818-4c30-9425-5e2d19adf50a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0116ab58-d953-4262-925c-a248b5bb0d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0116ab58-d953-4262-925c-a248b5bb0d64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02fd71b8-4081-4171-af75-8c2cbc215c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02fd71b8-4081-4171-af75-8c2cbc215c96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ebc995ba-0b91-4556-bb78-4f950ada47ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a8c6475-18f2-4859-a894-7c6ef4d090e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a8c6475-18f2-4859-a894-7c6ef4d090e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb739f57-ee74-4018-b864-7a0be9a4703e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb739f57-ee74-4018-b864-7a0be9a4703e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_eff761a9-de82-44af-99be-4fa16e5c3f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_eff761a9-de82-44af-99be-4fa16e5c3f91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9b4e2cb3-dcb0-4fd6-9da2-e907c34d0a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9b4e2cb3-dcb0-4fd6-9da2-e907c34d0a76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5bb7b806-e368-46ae-be20-75c721c82c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7c293e98-838d-4e31-8a41-0a284e6b436e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7c293e98-838d-4e31-8a41-0a284e6b436e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:to="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_59b89b69-6eb8-449b-8a35-892403de7712_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_59b89b69-6eb8-449b-8a35-892403de7712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5fd19e62-9c90-4afe-bed3-1a6a7a081130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:to="loc_us-gaap_PerformanceSharesMember_5fd19e62-9c90-4afe-bed3-1a6a7a081130" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="extended" id="i2d1177d998d7469b982d448725dd0c67_ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ac786261-1487-4432-928e-f82d76cbd491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ac786261-1487-4432-928e-f82d76cbd491" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_68444d5f-66a4-4cb5-ac0d-304eb3b9b5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_68444d5f-66a4-4cb5-ac0d-304eb3b9b5b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_68f1176c-eb04-4de4-b74d-3e1735a2bf00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_68f1176c-eb04-4de4-b74d-3e1735a2bf00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_6fcb0f1a-dd38-4e8b-85f6-9aa02fb14a85" xlink:href="cah-20220630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_cah_VestingPeriodinyearsforShares_6fcb0f1a-dd38-4e8b-85f6-9aa02fb14a85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ae07c64f-0254-4753-9692-86d17d357c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ae07c64f-0254-4753-9692-86d17d357c1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:to="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04adc076-b7aa-469f-8a72-0639d71bd53e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04adc076-b7aa-469f-8a72-0639d71bd53e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d32a1ac7-1ff6-4283-80c0-8a630a8899b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:to="loc_us-gaap_PerformanceSharesMember_d32a1ac7-1ff6-4283-80c0-8a630a8899b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:to="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dde70197-4b7b-4e49-a85a-4b5fbbe46470_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:to="loc_srt_RangeMember_dde70197-4b7b-4e49-a85a-4b5fbbe46470_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:to="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f9566ea9-2814-48a6-a8ae-053907692eea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:to="loc_srt_MinimumMember_f9566ea9-2814-48a6-a8ae-053907692eea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ScheduleIIValuationsandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="extended" id="i93cdd88d4770460ca331484867333e8d_ScheduleIIValuationsandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ba016df6-4c46-4e08-96b2-243bd34e8970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_ba016df6-4c46-4e08-96b2-243bd34e8970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_be345dde-4b9d-4ca8-99b4-406d9807826c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_be345dde-4b9d-4ca8-99b4-406d9807826c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec441f56-fceb-4a10-bcf8-5cc8b3913828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec441f56-fceb-4a10-bcf8-5cc8b3913828" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a7ac865b-7a57-4f60-bdf8-dc98815db029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a7ac865b-7a57-4f60-bdf8-dc98815db029" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_946ded70-5499-4586-a3f0-8d840c58026a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_946ded70-5499-4586-a3f0-8d840c58026a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6b5b27ce-5cd9-48bd-8f85-d79eda53ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6b5b27ce-5cd9-48bd-8f85-d79eda53ed9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_a527471b-e9dd-4b3c-bd5e-5f4a548917f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:to="loc_us-gaap_ReceivableTypeDomain_a527471b-e9dd-4b3c-bd5e-5f4a548917f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_b8153fd7-b5cd-42fc-b9d2-1c1d97eaf53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:to="loc_us-gaap_ReceivableTypeDomain_b8153fd7-b5cd-42fc-b9d2-1c1d97eaf53d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_39e1b07d-67a2-40da-a2bc-513e56fdb12b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_39e1b07d-67a2-40da-a2bc-513e56fdb12b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember_a4a3d5b6-90b0-4939-9b97-51c2f0ccf139" xlink:href="cah-20220630.xsd#cah_PricingDisputesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_cah_PricingDisputesMember_a4a3d5b6-90b0-4939-9b97-51c2f0ccf139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_c2f7861e-d9b3-4249-8097-20a93b189d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_c2f7861e-d9b3-4249-8097-20a93b189d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember_1fa592b4-b183-43af-bb82-7b5346eff495" xlink:href="cah-20220630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_cah_PriorYearRecoveriesMember_1fa592b4-b183-43af-bb82-7b5346eff495" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_382d69d5-ebba-4770-83be-24cba8e6bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_382d69d5-ebba-4770-83be-24cba8e6bb43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_6a335b2f-82df-462f-9a79-88181b637708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_6a335b2f-82df-462f-9a79-88181b637708" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>cah-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_99207ca9-aaf0-414a-99e2-8a9cf3b1e070_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_dffde515-222d-419b-b5ae-df53ee0da5f8_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_193675a5-537d-4caa-abe1-4be63b987c10_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.9Notesdue2045Member_9468a385-d72e-4dee-aac8-abf55a0c9d2a_terseLabel_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_label_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045 [Member]</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_documentation_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.9Notesdue2045Member" xlink:to="lab_cah_A4.9Notesdue2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_0276a239-0daf-48e3-b448-5b4a5fc70fe0_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_1253b35c-78a7-49a5-955d-17e16124439d_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cec7f4f9-57c3-4456-8518-b3b12c10333c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_14aba29d-735a-4c59-b485-194469df0073_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackDomain_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackDomain" xlink:to="lab_cah_NetOperatingLossCarrybackDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_a992bcad-6409-412e-bcdf-a91094c88860_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_37032837-bb5f-4169-a75f-81838f65ddea_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_3dcee5f9-c499-47c2-ab0b-3dbe21a23b73_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_InventoryReserveExcessAndObsoleteMember_2dcaf823-940f-41fa-9f1f-9ef8716bec09_terseLabel_en-US" xlink:label="lab_cah_InventoryReserveExcessAndObsoleteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Excess and Obsolete [Member]</link:label>
    <link:label id="lab_cah_InventoryReserveExcessAndObsoleteMember_label_en-US" xlink:label="lab_cah_InventoryReserveExcessAndObsoleteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Excess and Obsolete [Member]</link:label>
    <link:label id="lab_cah_InventoryReserveExcessAndObsoleteMember_documentation_en-US" xlink:label="lab_cah_InventoryReserveExcessAndObsoleteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Excess and Obsolete</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveExcessAndObsoleteMember" xlink:href="cah-20220630.xsd#cah_InventoryReserveExcessAndObsoleteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InventoryReserveExcessAndObsoleteMember" xlink:to="lab_cah_InventoryReserveExcessAndObsoleteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ee4f7e0-5128-488b-98d4-3b556de13a7a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8faef2b6-b29a-4bc1-af7a-c85617c45c97_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ee7dabc4-5680-4230-b037-693164cbf2e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_fbf98cb7-64a0-4be8-9b51-12322b26bc36_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_dc20c198-1ba1-4812-b1c3-382c0443e994_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_812265db-9422-43d6-9da4-45bb5cb3ad0e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5e611567-0af4-4311-983a-67217245711f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_6c47f65c-d72c-4a87-88cf-6d38278a8d2e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_33591807-ec90-4f53-86c4-f58dd2420f28_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_2c47cf9a-13dc-4881-98c8-ffd74db4c40b_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsTable_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable" xlink:to="lab_cah_GoodwillAndIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_c6b0dc65-3db5-4fdc-9749-ef53a5165e8b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_f4eecd59-a4bd-48f7-ba17-c238a4c21fa1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_938ba19d-9d78-485c-a3e5-dc12414543fb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_721da981-398a-43ac-af38-e376df681144_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_0c741cef-5732-4359-b31e-4aa2bf3b6511_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ClassActionLawsuitsMember_d570515b-c039-4cfe-b93e-200b0985373a_terseLabel_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_label_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_documentation_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember" xlink:href="cah-20220630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ClassActionLawsuitsMember" xlink:to="lab_cah_ClassActionLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d99ee275-0bd9-404f-9c01-9d1460dfb067_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_0afdc9ae-d1c2-42b6-8cb1-bc67eba7269d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_73b4e1c7-7822-49f0-87bb-210cc00cd851_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_722ecc3c-2f44-4388-af46-f7e6e258a2a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_2a54075c-a7e9-4099-8b28-ccc927e9a20c_terseLabel_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares and Restricted Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_label_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:href="cah-20220630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:to="lab_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_63ba2789-89bd-49d9-9ee0-37c0ba988774_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate, Currency and Commodity Risk</link:label>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_label_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:to="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5020bd5f-d5da-4e8f-a84e-8a735f4709fd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ccf67401-6644-4840-9fa4-e7a943bd02ff_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f05f0c7a-f7f5-4664-b2d4-d2a6237ecb15_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_dad95d8e-b794-47f4-9412-5e5a3806a75b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance notes and related accrued interest, net, current</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_aaa59887-d93e-40f7-bac1-8fc369e84498_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_b391e869-0c5d-4563-91a9-c6002b92742d_terseLabel_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_label_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:label id="lab_cah_WriteDownOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_cah_WriteDownOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of assets held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale" xlink:href="cah-20220630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_WriteDownOfAssetsHeldForSale" xlink:to="lab_cah_WriteDownOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a2ad1ce9-fb86-42a5-a1d4-1321a5a2a263_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8ed1aff5-3a7e-4b33-974d-0f98defc6d3f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_f5c0027a-248e-4ad1-9a15-21784760e8dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_f287e95e-4ce9-4533-af10-c13440d288b4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_c9fae81e-b232-4f7b-9dda-45a8e1f1af94_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_June2027Member_1c0da499-2e38-401a-9e65-3e598981c91b_terseLabel_en-US" xlink:label="lab_cah_June2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2027 [Member]</link:label>
    <link:label id="lab_cah_June2027Member_label_en-US" xlink:label="lab_cah_June2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2027 [Member]</link:label>
    <link:label id="lab_cah_June2027Member_documentation_en-US" xlink:label="lab_cah_June2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_June2027Member" xlink:href="cah-20220630.xsd#cah_June2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_June2027Member" xlink:to="lab_cah_June2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7f8c5afb-d1f3-4e68-8eec-db866d9c9d5a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_d445d490-b844-4232-82eb-5cc7ff97a780_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_75531be7-6247-4314-bc51-ddc397ac76b0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_de570ad9-dd7b-4bde-b7f5-73b56fb3fff7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_adfa4ce9-32c3-4ddd-bfb5-4ace3a4a37a9_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:to="lab_cah_EffectiveIncomeTaxReconciliationOpioidLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8d575444-5ad1-4513-9a23-2487cb9a2723_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_81a2502a-1869-4888-8427-b0bd60509498_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_1f126d94-437e-44b1-b706-5f8401966b7e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2ea6d5df-43fd-46a7-a485-8df61eab4edf_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_cc039e31-caa8-4711-9c44-99f1ebeb68ac_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_9de1e306-3527-4616-866e-07d39c5c3655_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a263687c-4217-4138-b1a7-cb4973efbaed_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_6aa9f6cb-2e23-4263-b7c1-59b6a80e6ec8_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project costs on investment and other spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:href="cah-20220630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c9ec2d2f-0640-4cca-80ba-a896a7796280_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_5426feb6-dfc9-431a-866e-1940adb93975_terseLabel_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_label_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_cah_CommonStockVotingRightsVotes_documentation_en-US" xlink:label="lab_cah_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes" xlink:href="cah-20220630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommonStockVotingRightsVotes" xlink:to="lab_cah_CommonStockVotingRightsVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6fc44e55-8f8c-4f56-b182-9744a3877ee9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_f544b92a-06f6-45b6-bebc-2eb725e97e41_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a741fad4-1588-4d26-8b93-f7517d05fc33_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements with tax authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IndemnificationReceivable_a215b11e-4616-4bf8-a943-fe0a24012751_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_label_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable" xlink:href="cah-20220630.xsd#cah_IndemnificationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable" xlink:to="lab_cah_IndemnificationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A24NotesDue2019Member_e4b7e7b1-8553-4a7d-a963-9e94d4012d90_terseLabel_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019</link:label>
    <link:label id="lab_cah_A24NotesDue2019Member_label_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A24NotesDue2019Member_documentation_en-US" xlink:label="lab_cah_A24NotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.4% Notes due 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A24NotesDue2019Member" xlink:to="lab_cah_A24NotesDue2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1c78c859-d8b7-4536-aff2-7a8a62ece5ac_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_989b2600-4f58-4d4e-8b55-03953121dd2a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_1eda47e4-bdbe-46a3-802a-f4adb59f56d1_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a263d962-7814-4372-9dff-93883bb9d157_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures, net of cash sold</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_e52127fd-a3c6-40e0-aa8b-97c4d1efdeb4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_8c1cd77b-6752-4c1a-b80c-d2e8e68f9f33_terseLabel_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_label_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cah_GoodwillAndIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems" xlink:to="lab_cah_GoodwillAndIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_InventoryReserveTableLineItems_aa5c63eb-b3c4-4d93-b50e-b433aed36fed_terseLabel_en-US" xlink:label="lab_cah_InventoryReserveTableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table [Line Items]</link:label>
    <link:label id="lab_cah_InventoryReserveTableLineItems_label_en-US" xlink:label="lab_cah_InventoryReserveTableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table [Line Items]</link:label>
    <link:label id="lab_cah_InventoryReserveTableLineItems_documentation_en-US" xlink:label="lab_cah_InventoryReserveTableLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableLineItems" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InventoryReserveTableLineItems" xlink:to="lab_cah_InventoryReserveTableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_10b46325-2b77-4ec6-9499-1c33e11a6944_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loss on sale of other investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0b5d51d2-d7d3-4ff9-940a-4c8134cb9945_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48ee27f8-aa76-40aa-870e-7c0b777cafd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5db8889a-c64f-4311-971e-db06ac54ae6e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8aa3ff7a-3fa6-4b2e-b788-bad133075bfd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c565b9a4-228a-455c-867a-633dbe64cc3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_88246055-9293-46e3-9ef2-38d150128434_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_44275741-2efd-420b-a9be-7559fe1317ab_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ed27ad81-3348-4947-9c27-175a1b4d0c70_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_df5dfd3c-8d7d-406d-a966-d7205f02d4c9_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c1650b89-b4ba-47d3-92c6-13e53408eca1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_88456033-7e62-4983-9263-84e9472eeb7c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c75d96c2-b520-43d3-864d-c0155cf5db6e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.368Notesdue2047Member_f1b19b22-25ff-4178-95ca-51f740d9559d_terseLabel_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due fiscal 2047</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_label_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_documentation_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.368% Notes due 2047</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.368Notesdue2047Member" xlink:to="lab_cah_A4.368Notesdue2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_d608dfcd-a322-4aa0-a3f1-87b3ac94cabb_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7ff8cee6-80ad-40e7-8b0e-86246e5d3c16_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d60dd0d5-9491-4164-b79a-0c8601138f16_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AuditInformationAbstract_label_en-US" xlink:label="lab_cah_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_cah_AuditInformationAbstract_documentation_en-US" xlink:label="lab_cah_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AuditInformationAbstract" xlink:href="cah-20220630.xsd#cah_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AuditInformationAbstract" xlink:to="lab_cah_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_dffcfe5b-1c0a-4b0b-928d-2984c776c4b3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e70f2635-91bc-4c62-a14c-90c43865a13c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_52d0be8d-7d11-4cab-8be0-a5fa6975e768_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2.616Notesdue2022Member_e1d4776d-2f14-472e-9c7e-152b18a57c1d_terseLabel_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_label_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_documentation_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notesdue2022Member" xlink:to="lab_cah_A2.616Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiability_ded0b5aa-1861-4801-aa4c-43936167a3b3_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_label_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiability" xlink:to="lab_cah_TotalLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_ac73f871-b55e-4476-b646-90c4ff456e06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_1b6cbb25-23c8-4d03-9cf8-916e2fabcaba_terseLabel_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_label_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_documentation_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs" xlink:href="cah-20220630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DiscountRatefairvalueinputs" xlink:to="lab_cah_DiscountRatefairvalueinputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_96f265b6-841b-46a0-9f96-c88e92930d6c_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6b14158f-8a3b-4026-a86d-a413365c11e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_c3d7c365-bc80-4a99-9157-5f4df7f8ad2f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Average Outstanding Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_1a7a09fa-1bb8-4ac4-93ff-c3d32d446816_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts" xlink:href="cah-20220630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts" xlink:to="lab_cah_FacilityExitAndOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_746dcfd3-44eb-4852-98dd-db551af444f2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ba598010-b0ca-4ebc-8a43-694524200948_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_319e3340-196d-47d3-b181-dbf560fe49f1_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding Taxes (2)</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdb529c9-ff1e-41e3-985d-cb5bb51263f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_785d8c60-9fe2-415e-b860-e6b3da145835_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_c09a0caf-2fce-4a1f-92b9-add708ded0b8_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Member]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackMember_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackMember" xlink:to="lab_cah_NetOperatingLossCarrybackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_964e64bc-57db-405f-b683-eaaa32e2860e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ASC842Member_c1be36ee-12fc-4d1e-ad17-78abf25f10ef_terseLabel_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_cah_ASC842Member_label_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842 [Member]</link:label>
    <link:label id="lab_cah_ASC842Member_documentation_en-US" xlink:label="lab_cah_ASC842Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member" xlink:href="cah-20220630.xsd#cah_ASC842Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ASC842Member" xlink:to="lab_cah_ASC842Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ba1a8c4b-6c25-42f1-9db2-6a901d0a7a4c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity/(deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_43346e40-bf6a-4eee-9b79-cf95a7e7b4a1_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_75ad7c27-c01f-4e86-ac4b-b5db5ee285b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments and Other</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_794b12ad-fd72-41ea-85f7-f21b055cdb0f_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts" xlink:href="cah-20220630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_67ec1c15-8c57-4a1f-af4e-80725f5d9a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_e5413e0b-77fb-46f6-ba26-da8fd2e09ac2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillImpairmentAxis_60168583-3378-44da-be90-b48c9a8f1222_terseLabel_en-US" xlink:label="lab_cah_GoodwillImpairmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment [Axis]</link:label>
    <link:label id="lab_cah_GoodwillImpairmentAxis_label_en-US" xlink:label="lab_cah_GoodwillImpairmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment [Axis]</link:label>
    <link:label id="lab_cah_GoodwillImpairmentAxis_documentation_en-US" xlink:label="lab_cah_GoodwillImpairmentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentAxis" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillImpairmentAxis" xlink:to="lab_cah_GoodwillImpairmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_67fc61a6-adbb-46bd-84c0-362207600249_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_cdcf6abb-5611-49d6-b164-8e2a26d05907_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4d2ff0e8-2898-4d23-9d1e-098273b34742_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_51879589-60fe-4f32-b88e-7d104094a6a6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_aa458fee-f12b-44b9-ba6d-4ed7de771533_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_91d833ed-651b-4814-a4fe-7bea489e667c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Valuation Allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_371b7afd-9e76-4d64-8bd3-a1d20b8e15d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cd37ad49-b4cc-432f-906b-609ae8672bdb_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4209b562-247a-4908-9cb2-d28ea83c82af_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_da7ade26-5129-49b9-8e5d-71045c3f8cdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_16375849-e4e3-40b4-a708-4dd751b8f2bf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_99f215f1-3fc7-418e-a716-3f9ad657b4c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7c54a640-b423-49dc-baca-bb7b44b4efe1_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_bb08c668-0a74-4a17-b731-91c1e849c815_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_038e93bf-9c66-4168-8f5f-3be9d1e0d76f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_6719fca5-ce96-4579-91c2-7ebbf51182e4_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_7fe112b0-030f-4490-a6db-505c9e6687ff_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_5e38a998-b0a7-4fd6-87dc-1c916bf6165d_terseLabel_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales, Vendor Reserves, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:to="lab_cah_CostofSalesVendorReservesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f8a08a7-b228-4f3d-b1c1-6e292a6441d1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity/(deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b546d0d2-1525-4970-ab90-c08d744bc347_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_404c0a38-80b9-4e84-9cd4-e423d0a709d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f6a0ff83-cc55-48b4-bfad-1ed438846420_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TerminalGrowthRateFairValueInput_6d34df17-6eee-4609-b8e6-daecd7a79355_terseLabel_en-US" xlink:label="lab_cah_TerminalGrowthRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminal Growth Rate, Fair Value Input</link:label>
    <link:label id="lab_cah_TerminalGrowthRateFairValueInput_label_en-US" xlink:label="lab_cah_TerminalGrowthRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminal Growth Rate, Fair Value Input</link:label>
    <link:label id="lab_cah_TerminalGrowthRateFairValueInput_documentation_en-US" xlink:label="lab_cah_TerminalGrowthRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminal Growth Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TerminalGrowthRateFairValueInput" xlink:href="cah-20220630.xsd#cah_TerminalGrowthRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TerminalGrowthRateFairValueInput" xlink:to="lab_cah_TerminalGrowthRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_68a9d509-d030-4f11-bee6-b4fd07fe9210_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_cf1274c3-51dd-4a9a-a7b6-3156fb594540_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_443a636a-5a6f-4920-8fae-38a619919ec0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_e64f6c22-fca4-4246-9633-ce9beedbf8e9_terseLabel_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_label_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Related to uncertain tax positions</link:label>
    <link:label id="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_documentation_en-US" xlink:label="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets related to uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:href="cah-20220630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:to="lab_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1b07b1d0-fc8a-47c5-b54c-6635a2ca6ed2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37327465-805f-4c7b-b1ec-0c0e2952dd3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d5d0688f-6ecc-43e4-9078-cb96bd9b173f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_5a80675b-a70c-4c79-9c80-08110f4964d3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance on operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_91e6222f-caa7-4df4-81ea-5ba26cee7306_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c3f9b58e-165f-4663-92a0-5445eb1ea7d6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_c161dc7b-fa9f-4aab-9a81-d3a939cfea2d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_537b68cb-993d-464a-9332-386f52a388c1_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Credit Facilities</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember" xlink:href="cah-20220630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember" xlink:to="lab_cah_ShortTermCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bf5b4c27-e8fa-471b-b354-c819d8dbe34a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_3323ff3a-a687-49fe-9abf-7c2824f38a03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f9a38a32-b31a-4174-9974-c9a9dce3a939_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1db97d39-f230-478f-8992-5479fcf903d6_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_13c49e03-0374-44c7-a1ce-205d7e514fcc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_InventoryReserveTableTable_6b4664f1-157e-41e0-87d4-8faf4690efa9_terseLabel_en-US" xlink:label="lab_cah_InventoryReserveTableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table [Table]</link:label>
    <link:label id="lab_cah_InventoryReserveTableTable_label_en-US" xlink:label="lab_cah_InventoryReserveTableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table [Table]</link:label>
    <link:label id="lab_cah_InventoryReserveTableTable_documentation_en-US" xlink:label="lab_cah_InventoryReserveTableTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableTable" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InventoryReserveTableTable" xlink:to="lab_cah_InventoryReserveTableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_04b22de8-5d71-431c-b1bf-b5039e0511fa_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b14c740-51ad-4393-966e-0bb54dbad98b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d59f2eaf-ca27-4b5d-971b-987998ebb292_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2bf43aad-181b-404e-9c69-83ab5c32ece0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_75b61d1b-905e-4fac-ba14-403f08faaa27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e48ca127-aa68-4104-b47d-a862428fdc93_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_526b3341-317a-47c4-9ff4-95d02956dd37_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_acbe3d57-651a-4dd7-8c98-2472f44b756f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, major customer, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_064f2999-41a8-4d2b-8e9f-02a7858d3eb4_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_54c1f07c-060e-4be5-be3f-d8f1d9f8cc7b_terseLabel_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Data Related to Performance Share Units Activity</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_label_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_documentation_en-US" xlink:label="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Performance Share Units Data [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:href="cah-20220630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:to="lab_cah_AdditionalPerformanceShareUnitsDataTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0a3473df-c07b-4466-b5df-5706f47aa1a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9f877a1f-7a0d-4209-86d6-7ce83c7e5992_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_42fd7ba7-24c4-4bb5-8f5f-aee87917c26c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.6Notesdue2043Member_94e2407d-418a-4444-98f3-bb80455a6549_terseLabel_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_label_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043 [Member]</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_documentation_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.6Notesdue2043Member" xlink:to="lab_cah_A4.6Notesdue2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_18439489-a84d-49ff-a500-1119e248ed73_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4e11f75d-aea3-4e4e-af82-4e7ea9d752c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested during the year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_315645d6-7506-4d43-a4b1-1d99d9650e77_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_699bfc69-6025-4e04-b90e-4de9770ff611_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_fc7583bb-f312-46a7-a588-b8d77f834646_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_49051455-81c4-43be-81e4-4fcec72f8835_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7e87ed26-cfc1-4a4c-9915-d1e200a49048_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_edb675e7-3c44-48f1-820a-20086b32e18f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_label_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:to="lab_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NotesPayableRepurchased_b82911bb-9cfb-45b1-9c00-237f0723f558_terseLabel_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_label_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_documentation_en-US" xlink:label="lab_cah_NotesPayableRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount of Notes Payable Repurchased during the year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased" xlink:href="cah-20220630.xsd#cah_NotesPayableRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NotesPayableRepurchased" xlink:to="lab_cah_NotesPayableRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_bd252b8e-fb06-41c4-b8ea-1c78ff6dbd5a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_ff9677e3-b050-46c4-b526-e208628dc184_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and patents</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember" xlink:href="cah-20220630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember" xlink:to="lab_cah_IPRDTrademarksandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4d4aec96-f746-494e-b511-14c4a8b0202f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3cce7162-cd95-457f-97ab-d636376068dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6d878a06-95bf-4f61-912f-23f0214a775c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_GA_f80f6807-8ee5-4f79-83c0-5a97bc61b795_terseLabel_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:label id="lab_stpr_GA_label_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_GA" xlink:to="lab_stpr_GA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2da31a81-afe7-4b80-ae1b-85e87c624737_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6cf085e2-60d5-412a-ba83-71869cb7c75e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_66ef9c4d-0b75-4191-a354-6ec208779177_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fed57c7e-89d4-43f3-98eb-494f43786875_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_db16f5c4-9780-4326-8fd5-8077ca730966_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f83f8381-1257-4613-ad6d-6b7b948a33cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_c03afab2-f49f-42ce-a50d-a0b8cef3936e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_58a7ffb1-b740-4374-a3b9-821c774346c1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_028aafb1-710d-46a7-b4f7-70e3057e1218_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_c27d3f53-24fe-48db-98af-a4d93c7d2849_terseLabel_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_label_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:label id="lab_cah_IncomefromSettlementsofClassActionLawsuits_documentation_en-US" xlink:label="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Settlements of Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits" xlink:href="cah-20220630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IncomefromSettlementsofClassActionLawsuits" xlink:to="lab_cah_IncomefromSettlementsofClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_efa9a166-68dc-406e-8fd3-e7d9cb935f88_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_a1547620-2f79-47b1-b6c3-8312c823208c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.5Notesdue2044Member_c4ef17c2-2ea8-4ee5-be7b-7c7c65bcd888_terseLabel_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_label_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044 [Member]</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_documentation_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member" xlink:href="cah-20220630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.5Notesdue2044Member" xlink:to="lab_cah_A4.5Notesdue2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_42307848-3e25-4723-9b92-d722ab4b38c8_terseLabel_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_label_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LeasesSupplementalBalanceSheetInformation [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_documentation_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:href="cah-20220630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:to="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_1b8e98e8-d349-41d2-9104-6e5982f4cf06_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TaxMatterDomain_8a1ed8c3-2762-4f29-8ff2-a74f7cc985ed_terseLabel_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_label_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_documentation_en-US" xlink:label="lab_cah_TaxMatterDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Tax Matter [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain" xlink:href="cah-20220630.xsd#cah_TaxMatterDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterDomain" xlink:to="lab_cah_TaxMatterDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0c83afb5-0f78-4c67-b212-f8e6491b1bb1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_38989b8f-0251-49c9-9423-93548ee76b6d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_31f3118f-552d-4135-8ff7-397d7f63f5c3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_3c5e7a31-cc94-4f4e-a210-3126c7327a6f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from net investment hedge terminations</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_be3bcc21-1990-4725-bd2c-3e32af161f4d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4f8c8b2e-7ca8-49c9-b5d6-703b4775dced_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings/(accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ef2f2ae8-f744-4332-9cb3-3fdc282a6908_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings decrease</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c3bfce09-bdb1-4189-bed6-398973fc0959_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicalUnitGoodwillImpairmentMember_168b3342-4a7c-4468-b98d-e5d2e6e637df_terseLabel_en-US" xlink:label="lab_cah_MedicalUnitGoodwillImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit Goodwill Impairment [Member]</link:label>
    <link:label id="lab_cah_MedicalUnitGoodwillImpairmentMember_label_en-US" xlink:label="lab_cah_MedicalUnitGoodwillImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit Goodwill Impairment [Member]</link:label>
    <link:label id="lab_cah_MedicalUnitGoodwillImpairmentMember_documentation_en-US" xlink:label="lab_cah_MedicalUnitGoodwillImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit Goodwill Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitGoodwillImpairmentMember" xlink:href="cah-20220630.xsd#cah_MedicalUnitGoodwillImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalUnitGoodwillImpairmentMember" xlink:to="lab_cah_MedicalUnitGoodwillImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SettlingStates_e2999471-3067-40cf-ac2b-5d9c24e9b6d8_terseLabel_en-US" xlink:label="lab_cah_SettlingStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State</link:label>
    <link:label id="lab_cah_SettlingStates_label_en-US" xlink:label="lab_cah_SettlingStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling States</link:label>
    <link:label id="lab_cah_SettlingStates_documentation_en-US" xlink:label="lab_cah_SettlingStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingStates" xlink:href="cah-20220630.xsd#cah_SettlingStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SettlingStates" xlink:to="lab_cah_SettlingStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7d051bab-5ba8-4c42-a2c8-7f8bd6f1ec75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_d0487452-e228-4f0d-b47d-bc10397782ef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable basis difference</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5eaa8fd0-0ddb-4d86-aa24-f98574bec5c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GownRecallAxis_1f330116-f44e-48cd-b3fa-95c1d1d86481_terseLabel_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_label_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_documentation_en-US" xlink:label="lab_cah_GownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis" xlink:href="cah-20220630.xsd#cah_GownRecallAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallAxis" xlink:to="lab_cah_GownRecallAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5b6050d6-786e-4529-a994-4fd98e70cbc4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_857d8fab-be9f-441e-8941-50a4208b7007_terseLabel_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_cah_CashDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashDiscountsPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_CashDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashDiscountsPolicyTextBlock" xlink:to="lab_cah_CashDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_dde8d158-1268-4fb9-a9a2-08c4d871a859_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_8d6f0c5c-1622-492c-8923-9337eb8c9243_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_081d900a-8fec-45f0-a2ff-3ed14ba1d13d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d03e34af-4b5a-46d4-bc9b-fe416cb9f320_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_dab90da8-1648-46e0-96f4-28453ea97130_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_8b05329e-b5fb-4773-846a-37fddfb2e0cc_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_e3f8925a-42ce-4aa8-970a-eb427504ca74_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_23beed6d-c770-4ba6-af1a-174d219e7bd6_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_label_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Line Items]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldLineItems_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for goods and services sold [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldLineItems" xlink:to="lab_cah_GoodsandservicessoldLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_29593dfe-c387-4e4c-b052-854e4bc3f3ec_terseLabel_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_label_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_documentation_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:href="cah-20220630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:to="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_864ddd41-1d59-4ab1-817f-aa0e8e433919_terseLabel_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Service Agreement and Other Vendor Fees</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_label_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Service Agreement And Other Vendor Fees [Policy Text Block]</link:label>
    <link:label id="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:to="lab_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LawsuitTypeDomain_fb4558f3-8097-4a75-b2c4-92967de8da77_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_label_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_documentation_en-US" xlink:label="lab_cah_LawsuitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Lawsuit Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain" xlink:href="cah-20220630.xsd#cah_LawsuitTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeDomain" xlink:to="lab_cah_LawsuitTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLitigationDomain_52aff9fe-c494-43a6-9fab-e173d55a0ac9_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_label_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_documentation_en-US" xlink:label="lab_cah_OpioidLitigationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationDomain" xlink:to="lab_cah_OpioidLitigationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b28db374-aae5-4d6b-9ac4-d30586ce9328_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_ba0f5355-1748-44e8-b897-e6b4829c8789_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;Value Gain/(Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b977dd84-8d53-46b9-9bfa-9a8d8ff509d1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CareFusionMember_acdd0ffa-6432-4aef-a0b9-33b7942e70a2_terseLabel_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_label_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_documentation_en-US" xlink:label="lab_cah_CareFusionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember" xlink:href="cah-20220630.xsd#cah_CareFusionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CareFusionMember" xlink:to="lab_cah_CareFusionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LitigationTypeDomain_59c1eb12-2f75-41cd-bf48-00646a79e194_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_label_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_documentation_en-US" xlink:label="lab_cah_LitigationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Litigation Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain" xlink:href="cah-20220630.xsd#cah_LitigationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeDomain" xlink:to="lab_cah_LitigationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_509108dc-ebfd-46f1-bd26-cc7bc5f83b66_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_28847195-a94a-44bf-99f5-46cf09716010_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_69f82acb-339d-478a-8199-bc2ec0f234cf_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_6c25eb25-320b-4ae5-a800-2542efaed5c9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_030c2b6d-5cf5-4457-bc84-7f18cc241905_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_415ae123-f056-4940-8c6d-1bca7577a49c_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ddf8f14c-3748-4086-b441-8ece54765e96_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_10cfb6dd-41b5-42cd-a256-ca9c88221c83_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_3f25888b-24b1-4ebc-a9dd-59b60bac1441_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_75b90940-8da7-45d3-a762-a3631519f4fb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3784533e-c04a-4de5-ab2c-fcec57aa1a39_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a9a09665-86c0-43f9-bf6c-afdb00d0c051_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ad1beacb-e32f-4088-a37c-e4a838ea45e0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_06255ba2-961c-458a-a720-58b1e7caa62b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ec8302a4-773f-464b-ace2-38f80fad9335_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_6bd7cd1b-9816-48a4-a5cf-12adbb94ac0a_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_cc398032-f7c3-4477-8df3-a45772f34b92_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_520d4829-c49c-41ea-891c-1e6f228f2004_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_cbced16f-2f47-487d-b0c3-d0117b0f46db_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FixedRateDebtMember_6dfb8d07-36f4-4a03-a51a-0260dc77c00d_terseLabel_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-Rate Debt</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_label_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:label id="lab_cah_FixedRateDebtMember_documentation_en-US" xlink:label="lab_cah_FixedRateDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember" xlink:href="cah-20220630.xsd#cah_FixedRateDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FixedRateDebtMember" xlink:to="lab_cah_FixedRateDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a226b5d9-2f17-41e7-a8b8-79c9cd6fa7f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LitigationTypeAxis_d84ff99c-8f32-44f8-bfc4-20484d1c0ef8_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_label_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:label id="lab_cah_LitigationTypeAxis_documentation_en-US" xlink:label="lab_cah_LitigationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis" xlink:href="cah-20220630.xsd#cah_LitigationTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeAxis" xlink:to="lab_cah_LitigationTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_83d25121-62f6-4aa0-a984-9bf95640c835_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_6f2d558d-8f11-4cb7-ac93-e763dbbbe9e1_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember" xlink:to="lab_cah_PatientRecoveryBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicalUnitMember_a5ac5c8f-52cf-4959-8bb1-870367545f70_terseLabel_en-US" xlink:label="lab_cah_MedicalUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit</link:label>
    <link:label id="lab_cah_MedicalUnitMember_label_en-US" xlink:label="lab_cah_MedicalUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit [Member]</link:label>
    <link:label id="lab_cah_MedicalUnitMember_documentation_en-US" xlink:label="lab_cah_MedicalUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalUnitMember" xlink:to="lab_cah_MedicalUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_c4b3fcd7-0fae-4dc3-911e-a2473589e2c2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5b2c945a-6ec6-447e-a30b-6679b3d154ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212; 327 million shares at June 30, 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_c4a65f70-b660-4fdb-b91c-f898006c88cc_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_label_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:label id="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Impact From Certain Foreign Jurisdictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:to="lab_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1df4a774-38cb-4ac2-8f65-8c8dee4c1534_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a0d95a71-f849-4be3-abf6-dd93fd1a9b10_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d7816d82-9788-4f50-bd8c-ac93eb3383cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_VendorReserves_2f90d4e5-bf5d-4dcb-8c9f-6074ab0aa283_terseLabel_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor reserves</link:label>
    <link:label id="lab_cah_VendorReserves_label_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Reserves</link:label>
    <link:label id="lab_cah_VendorReserves_documentation_en-US" xlink:label="lab_cah_VendorReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VendorReserves" xlink:href="cah-20220630.xsd#cah_VendorReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VendorReserves" xlink:to="lab_cah_VendorReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_bb81dbde-1db3-4f02-a3cc-8ecdf9f627b8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_119c8784-c507-4e2e-8d1b-0dde9c46ee32_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5f4da7cd-e13e-4d96-ad89-0f19265b685f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_d4a8d035-3a87-46b4-a076-eaf5c11b8cba_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Gain/(Loss) Derivative Instrument</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_label_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_documentation_en-US" xlink:label="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:href="cah-20220630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:to="lab_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ccc6eb8-29a3-47e9-9173-6f67158037e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35f2f924-40b8-4e6a-9169-bf367bd109a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f0f6925a-8319-4807-b851-a38017594846_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_cc9d1968-44b5-4a5e-bc0c-9e3f955b6c32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7b71ee4f-cb5c-4171-9a77-88754a4de151_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A32Notes2616NotesMember_8d93e759-b463-4465-a8b2-7456bd55207f_terseLabel_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes</link:label>
    <link:label id="lab_cah_A32Notes2616NotesMember_label_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes [Member]</link:label>
    <link:label id="lab_cah_A32Notes2616NotesMember_documentation_en-US" xlink:label="lab_cah_A32Notes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% notes, 2.616% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember" xlink:href="cah-20220630.xsd#cah_A32Notes2616NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A32Notes2616NotesMember" xlink:to="lab_cah_A32Notes2616NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_57234932-0cde-420d-8197-d8520132a239_terseLabel_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_label_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_documentation_en-US" xlink:label="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:href="cah-20220630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:to="lab_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fd520c20-32ab-4a5d-9ee8-81d4597bbba2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_86c438d1-067a-48c0-9c4c-7beaba70c5b2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_3c2116a6-8436-4f37-ab95-1e8d29e71dc5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_11d646ea-1ada-40b5-8910-8b767b41dbf8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_da11641d-0d7d-4bf8-9b74-fc1b13b91ce5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_d8de715f-b8d5-489e-81a2-4d0cec7db63c_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8fce2c1-e047-47c6-b2eb-34f89a23e9d2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income/(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_b91aa05f-79f6-4260-af0d-83ac45e9243f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_a0fd3f58-dae4-4d12-9ae6-7c9b2c40ef3b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_dca5b553-2ba3-4ede-9e4a-c0fe46c628d7_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_3c0075f7-8a99-4d52-9f8f-d17dea62093d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Divestitures</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cee4912-8e33-4676-8733-9fc36798cb7f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b045d6f7-1407-4e42-8ba5-4603beac3926_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_721d62e7-f032-4abc-9b86-02c0678468ef_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_cf230440-235b-441b-9868-560abe0afcd7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a1699f13-22d6-476e-864a-1ef4aa105af4_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_5c72884b-8da5-4094-b826-cf41799f0c99_terseLabel_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="cah-20220630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_c348b48b-fd13-4509-a5bd-b6fd9033a565_terseLabel_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program aggregate purchase price [Axis]</link:label>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_label_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program aggregate purchase price [Axis]</link:label>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_documentation_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program aggregate purchase price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:to="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_bf2f5480-be67-4287-a56e-01a7520b8f30_terseLabel_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_label_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:label id="lab_cah_SalesreturnsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_SalesreturnsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">sales returns [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SalesreturnsPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_SalesreturnsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SalesreturnsPolicyTextBlock" xlink:to="lab_cah_SalesreturnsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_70a7862d-f45e-400f-9920-52aa8d5f1e4b_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityContractMember_17c5c2f1-f992-4d2d-a6cf-39311dbe8c51_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contracts</link:label>
    <link:label id="lab_us-gaap_CommodityContractMember_label_en-US" xlink:label="lab_us-gaap_CommodityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityContractMember" xlink:to="lab_us-gaap_CommodityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_cf06decb-a930-451a-b9f5-fc6cb796cae7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_cd6ed71e-60e1-4fd4-a338-6f1081a40fa4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_7b2a765c-9d66-4175-9bd1-adccea7a06c0_terseLabel_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:to="lab_cah_AssetsHeldforSalePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_0b75a27d-2faa-4c14-b65f-a9c7e57d7ac1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_11e8026d-1fb1-421f-8f27-c8250a989153_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LawsuitTypeAxis_5572b766-2fe8-4423-89cd-57cb7f874f12_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_label_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_documentation_en-US" xlink:label="lab_cah_LawsuitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis" xlink:href="cah-20220630.xsd#cah_LawsuitTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeAxis" xlink:to="lab_cah_LawsuitTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_21d87a96-8ef8-4152-9286-6af1ae5d9f74_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_e60a421e-2ac2-4718-80bd-93bb5df03a8a_terseLabel_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash reclassified from/(to) assets held for sale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_label_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:label id="lab_cah_CashReclassifiedtoAssetsHeldforSale_documentation_en-US" xlink:label="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CashReclassifiedtoAssetsHeldforSale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale" xlink:href="cah-20220630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashReclassifiedtoAssetsHeldforSale" xlink:to="lab_cah_CashReclassifiedtoAssetsHeldforSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ad02935e-04d0-4e9b-af25-343be1057b54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_223ae320-9e44-41e4-ae15-c030686c8180_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9e1f36e7-895d-4196-b3f4-b64c651c96f5_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_89459679-f7f4-4f88-9083-21e698636ec0_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares in treasury, at cost: 54 million shares and 36 million shares at June 30, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_68600b2d-8a51-439f-912c-16d8eb18968b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_7dec62c2-0c3e-4cde-993c-6633527659d1_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury, balance at end of period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_44ec6e64-abd8-43dc-a0d2-24598165f642_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1369c2a7-fbac-48cf-b567-df4279d27b69_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7a15e90c-3e8e-4ae7-a98d-ec09b4f18c7e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6b2fcdb7-c0a4-410f-8f14-0503bc4b3f19_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_fd48dcda-d8cb-4072-b59a-f64e4ec5503b_terseLabel_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_label_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:label id="lab_cah_GroupPurchasingOrganizationsMember_documentation_en-US" xlink:label="lab_cah_GroupPurchasingOrganizationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Purchasing Organizations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember" xlink:href="cah-20220630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GroupPurchasingOrganizationsMember" xlink:to="lab_cah_GroupPurchasingOrganizationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0f48c638-e58a-4cb5-aa4f-8168b114aad6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_363d7ca4-573f-46b5-ad33-f3d836c42344_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_fb2678bd-5d86-4b91-ae92-4dda6c3527ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_d0f863c0-6d4d-47c7-b899-7e29a2f2b523_terseLabel_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_label_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_documentation_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard" xlink:href="cah-20220630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Impactofadoptionofnewaccountingstandard" xlink:to="lab_cah_Impactofadoptionofnewaccountingstandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_627b463d-869d-47cd-a16e-e4c8b3e46e32_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_de0b4ecf-0fde-44dd-9d0e-9fdd8943f293_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ea427ad3-3d7d-44ab-82a9-32ae94f3422f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2e05078e-6f5c-4e6b-9f3f-2307c5ec3eba_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ca40d850-ac10-4566-8038-806ff6a3f771_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_eebe2dde-84f5-40be-8c87-358f3c043f71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_3eb771a7-bc74-448e-a8cf-7b9721191817_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureAxis_efc6817b-f601-4cbf-8364-7ce434ae5d2c_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Axis]</link:label>
    <link:label id="lab_cah_CordisDivestitureAxis_label_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Axis]</link:label>
    <link:label id="lab_cah_CordisDivestitureAxis_documentation_en-US" xlink:label="lab_cah_CordisDivestitureAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureAxis" xlink:to="lab_cah_CordisDivestitureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_cbf2a4c3-4c1c-4233-85e1-c75c37b31648_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_365d0ad4-71c6-4046-b1b6-88b533c130a7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8c63abee-f237-4c2c-9892-933db048e400_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_b1f818d8-f622-4a1c-b304-eb174698b00b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherBorrowings_bfe155b4-f586-4b27-9506-86dcadb7225d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other obligations</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_e1eed20b-1f48-494f-a4a6-4d70801d4b0e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherBorrowings" xlink:to="lab_us-gaap_OtherBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_206bd4ef-85ba-40ed-adc2-a20e986e8951_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_6f4d5b5e-ee22-42b4-95ad-275c3dfec2a8_terseLabel_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_label_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act [Member]</link:label>
    <link:label id="lab_cah_NewYorkOpioidStewardshipActMember_documentation_en-US" xlink:label="lab_cah_NewYorkOpioidStewardshipActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Stewardship Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember" xlink:href="cah-20220630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NewYorkOpioidStewardshipActMember" xlink:to="lab_cah_NewYorkOpioidStewardshipActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2faac8c5-660d-42b7-8c22-d33a67fac6fd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0906387d-1e2c-4808-aa32-03b40c0a6602_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_a47aba19-e462-48c3-807d-46583537950f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_58c6e84c-65a0-4966-b47a-e9ea3aa4e70a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8905ecc4-a65a-4d7f-9302-71efb3f60dbb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity/(Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c38a02d8-1769-45cf-bae0-2d208abc8682_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_61463cee-3690-42a3-bffd-07d2213c9a3d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_bea4fbac-ad4d-4351-8ac8-de630f85c388_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4f76521b-f003-4842-9d0b-ed9b55f4ba45_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_f5e5f1d6-dbfe-4748-a6c0-4f069d89e9e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b9f569d-bb09-4a41-902a-ced347483535_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc3c7b7c-7ad5-4038-9095-ebfa94a3707d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_a78aabe5-fb3a-446b-9948-798f1a9a9ffc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_d73e962b-9281-4dbd-960f-cd8813773908_terseLabel_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable financing agreement term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_label_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:label id="lab_cah_ReceivableFinancingAgreementTerm_documentation_en-US" xlink:label="lab_cah_ReceivableFinancingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Financing Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm" xlink:href="cah-20220630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReceivableFinancingAgreementTerm" xlink:to="lab_cah_ReceivableFinancingAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_7e09a2a1-f161-4f69-9970-1649791fcc36_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_78b8a2c4-17df-4db6-b3fb-c2c9ac7da782_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_d0e8631d-d048-4296-a8cd-9a3253e1c177_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e8d85e9f-b2bc-4c4b-9060-969a0d9a3e97_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_92f29a83-7a85-49f3-9426-91164d126f61_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_fd164c11-75f0-4029-8800-2af8a9b92290_negatedTerseLabel_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_label_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:label id="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_documentation_en-US" xlink:label="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:href="cah-20220630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:to="lab_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_c0a03bf7-a07b-4bb1-a229-c6d6266f3dec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_0940440a-4312-4d8a-bf16-4b7512d32416_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_cb7b41d3-1c35-411f-af73-aa17cbee1059_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4b483f15-3031-4f02-86c0-7a3df053b00d_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_aa5aff1f-bd6c-41d8-ba58-8442958bad67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_678fd8d9-094f-4d58-b8c0-c3cd3a5cbb10_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PlaintiffTypeAxis_7c90c540-b5e5-4cf3-bb9a-22283ebf06d8_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_label_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeAxis" xlink:to="lab_cah_PlaintiffTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_6528ded5-792e-4503-b3ec-dc640242a201_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_19081087-4cdc-4a18-8917-04a71f377d62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_9a5a1543-5990-46f3-a1d5-56cb32a3abe5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_dd3cf5e6-73de-4b0f-b9cc-9c73025deafa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GainonDivestitureAfterTax_aa7ecace-2b6b-4bca-b5f6-d654bf6df505_terseLabel_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_label_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:label id="lab_cah_GainonDivestitureAfterTax_documentation_en-US" xlink:label="lab_cah_GainonDivestitureAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Divestiture After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax" xlink:href="cah-20220630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GainonDivestitureAfterTax" xlink:to="lab_cah_GainonDivestitureAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_4d803628-8d27-4f56-8160-584776547f25_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a1f82fc2-d63b-45a7-8720-c549a7ceb341_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4a9801c8-b0e9-4ac4-b1c3-2d0bdd8ede0a_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_760aed9b-9296-44af-b296-5e17ba7dd63e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_361400d1-89a3-4a05-8d62-224999eb431e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_a3b745f4-c51b-4531-b2ca-5406e3e55b5c_terseLabel_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_label_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:label id="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_documentation_en-US" xlink:label="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:href="cah-20220630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:to="lab_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_910486e4-3fb4-4932-a6be-1e68000c3437_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_182b0828-f183-4db9-8c03-ccadc30d1254_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TaxMatterAxis_cc94c4be-0faf-46ed-876d-ca56644ddc6f_terseLabel_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_label_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_documentation_en-US" xlink:label="lab_cah_TaxMatterAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis" xlink:href="cah-20220630.xsd#cah_TaxMatterAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterAxis" xlink:to="lab_cah_TaxMatterAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLawsuitsMember_f5d04d97-8434-4efa-850c-e04036b46c91_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember" xlink:href="cah-20220630.xsd#cah_OpioidLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember" xlink:to="lab_cah_OpioidLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OK_22f3a651-b688-4606-9b88-ecfbeb9c0df3_terseLabel_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:label id="lab_stpr_OK_label_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OK" xlink:to="lab_stpr_OK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fbe7f500-3744-423e-94bd-ccb394cd52bb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8c62ccae-f7fa-4974-91ff-17b285acd481_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_b76fe98d-42dc-45d6-86b1-52152d61afe8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PrivatePartiesMember_589fb913-a3a2-4ac9-a61e-70d270c14700_terseLabel_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_label_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_documentation_en-US" xlink:label="lab_cah_PrivatePartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember" xlink:href="cah-20220630.xsd#cah_PrivatePartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrivatePartiesMember" xlink:to="lab_cah_PrivatePartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A4.625Notesdue2021Member_442e9b92-2312-4167-b9f5-7282092c3f75_terseLabel_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2020</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_label_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2021 [Member]</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_documentation_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Notes due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.625Notesdue2021Member" xlink:to="lab_cah_A4.625Notesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_71acd8c0-cd10-4c77-b53f-f5f2a3b7c42f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_b952e344-6699-4ef7-99af-10a9fb70ba30_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e677fff9-7d25-4610-b6b8-4841b6c22f46_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_3eeab19a-dd22-49ca-87bb-da1ea1a72ec6_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_0395eda6-ea4f-4d17-8108-85fd447d2a9d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_9525de12-347d-44ad-9229-3dc1a2303dd8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_d499c77d-51cf-4924-9e02-23313409f794_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_5e53a1ff-c12e-45c5-88c9-c260fddb9425_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5bae858b-c23e-481f-ae39-079b33d65e9f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_1737bb7c-9837-43b0-99cf-be14ac71b6e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Outstanding Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_a5709ffa-3de2-477d-bb95-21b9735b3cb7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_9f10e851-bb3f-4991-9c23-941187b8a02d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_b20e31e2-7ff9-44db-b7ee-e9ec2e28557b_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Taxes on International Income (2)(3)</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_label_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, US Taxes on International Income</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, US Taxes on International Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:to="lab_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d2b095f5-9da3-48a2-820f-3186cbdff87e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AggregateAnnualAssessment_4cbccf14-1421-4991-96f4-8d7647804949_terseLabel_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:label id="lab_cah_AggregateAnnualAssessment_label_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:label id="lab_cah_AggregateAnnualAssessment_documentation_en-US" xlink:label="lab_cah_AggregateAnnualAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Annual Assessment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment" xlink:href="cah-20220630.xsd#cah_AggregateAnnualAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AggregateAnnualAssessment" xlink:to="lab_cah_AggregateAnnualAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_b9bfee66-5f69-42dc-9329-e3b23f008fa9_terseLabel_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_label_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:label id="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_documentation_en-US" xlink:label="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:href="cah-20220630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:to="lab_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_4f9df528-9e06-4b48-a9db-2479cd18f958_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthDomain_172d4940-fb27-43d4-8acf-c9d6591573a5_terseLabel_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:label id="lab_cah_NaviHealthDomain_label_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:label id="lab_cah_NaviHealthDomain_documentation_en-US" xlink:label="lab_cah_NaviHealthDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain" xlink:href="cah-20220630.xsd#cah_NaviHealthDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthDomain" xlink:to="lab_cah_NaviHealthDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1e90ccb9-3039-401f-b49e-baced5d5957c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_740e5506-857d-4a2e-b7db-bfb008bbd4e3_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:href="cah-20220630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f5ce4e81-aa8e-4b6f-b15a-67b0d8476687_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_b933326f-7deb-4583-ae22-55bae97aea81_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_cc94a6fc-61b7-4079-944f-6c4e4e7a2e58_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_146a87b3-d201-4107-8e0e-47d0a4660505_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_0297961d-4318-4f98-a0f2-e5bf0daf3cd3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_51156e1c-d931-4b05-9b2c-8f9ea356a85f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_0f362a4b-8337-4c53-a403-7c36df820371_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_label_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_documentation_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest" xlink:href="cah-20220630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseImputedInterest" xlink:to="lab_cah_FinanceLeaseImputedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5a1409c5-8e31-415c-8073-09522364846e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8fbb65d3-8564-4646-b29c-b7b4fa4d5996_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_db6d0c38-dc94-4ab6-afee-f989b0770c59_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net by Geographic Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_6e08374f-47a6-4727-8536-84bff24634a1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_02bd8032-9744-471a-828e-ce35f1d465eb_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WA_d324475f-d988-440d-b7bb-133ab099e82f_terseLabel_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WASHINGTON</link:label>
    <link:label id="lab_stpr_WA_label_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WASHINGTON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WA" xlink:to="lab_stpr_WA" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_71fd7c4d-9bab-4f8c-ab75-36e6572a9a02_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_9012f310-ba5b-49ab-84f7-53ae8d81fa55_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d01a63ba-b59c-49a7-a808-d19e580a398e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_5427598d-d63d-400e-bda2-d030a716a2bd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bb2e232b-e9d5-4c2d-b01f-9ac7f27d2136_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_7aed40e1-483e-4c48-be8a-93578ceb2e3a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e62a41bd-6722-4d2e-a32d-84de3cda1e1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e20f20f8-bec5-4128-84ba-78a67ca1f7f9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ceaf8468-b999-49a6-a8a8-374482c6a499_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6562054-1a9b-4917-8d98-fa59a0495d41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_355c4ce2-d42b-4c0f-8052-4df485ee6098_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.2Notesdue2023Member_8c49fd39-81fc-4540-a3aa-2d1b267ec32d_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_label_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2023Member" xlink:to="lab_cah_A3.2Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_5de9d5be-a19a-49b9-aca6-41ba44cf9372_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_081abb59-86a3-4660-a550-f6f97af654a2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_46cc217a-3f24-432d-bba2-022b67ee6c03_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4dd1de6c-8239-47c5-9637-c0cc769f2264_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_07f5763c-01d6-4e9f-8a62-6975dc915f10_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_42adc579-321e-4ca8-b901-3a8ba8602f95_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings - 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_94531210-6a6f-4225-b949-8e57537277a7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_24b78bec-7bbf-4d5f-81f3-175f7df248a5_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e51a71ec-9813-4fef-8734-82dc6f835d51_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d3b31e9-f018-4de8-b817-89c84e7dfed9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.2Notesdue2022Member_fabedd57-75f3-44df-8d69-19a828c9cbe0_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_label_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2022Member" xlink:to="lab_cah_A3.2Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ad75c6bb-d4c0-4547-9bc3-03041a37c7d1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6a359349-37f0-4e0e-9a3f-188350d56b70_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca84e001-7d42-4957-9ef3-a56c984fb846_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_baf4e674-3067-4d84-9283-2ee0b0ae2b97_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_74283860-5aff-45b9-9b4f-1168a2f14796_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (2)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c4643d66-2dbc-42eb-9c90-a2bac0af9624_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_d95f2718-5e41-499e-93f8-b3d681b089a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aae6f98c-a610-480c-a435-1803c4d8f490_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0e7b7e94-935b-44ea-872b-18f3cf2d2153_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_4cc0b70b-e74e-4402-a80b-9365a1a84dfd_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5c2aa05f-710d-475c-8813-703b5071693d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b92832b0-20d3-401b-a501-3be70da51b9a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_46422e3b-3c12-4662-9234-847baa63726f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_be4ca02b-e712-401e-bf60-753ffc0ce3ae_terseLabel_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_label_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_documentation_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:href="cah-20220630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:to="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_56da65ca-2011-41b9-9380-82c1dd3fd61d_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f89722cc-4737-40a6-bcd5-b0de20728f3a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_50196f29-eaad-4597-bda7-b4993ae92876_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PharmaceuticalMember_e7eccde2-3177-4fcc-a8a0-eee9cb9a7671_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_label_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember" xlink:to="lab_cah_PharmaceuticalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_29934979-c3ff-40a8-8566-45713eed0b98_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_a3cd960f-3372-4b49-a21a-c93c4c8a8a22_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_354fbe7a-c751-4f07-8b88-a930616d428f_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_81eaf9d2-73bc-4a8c-8439-5bd4981f588e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_355613e5-f8c1-4337-b3b3-2d0e13926e91_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7cc079c4-0014-4b6f-8cee-ae16d15b5735_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2db429b5-8aee-48f1-bb81-bf131513b728_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7558dcce-2d3b-4508-bfb0-3a6a95600808_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-related</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_0c7c136d-224a-4c56-bf9c-02df59df37b4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_f7473b31-45e1-4f0f-9d0a-8500f606a57f_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_3d14fe68-02d3-4341-9549-3c69f6a9cac2_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4e955dd4-ed31-4222-98ad-e6b1e850bd70_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_0452e714-0d00-4715-886b-acb871fd6608_terseLabel_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_label_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_documentation_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares" xlink:href="cah-20220630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VestingPeriodinyearsforShares" xlink:to="lab_cah_VestingPeriodinyearsforShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_2fc765ba-f2c8-42c4-8ae4-7bb73a1741c5_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember" xlink:href="cah-20220630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember" xlink:to="lab_cah_ProductLiabilityLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c044422c-31da-4ed4-8238-347697bbb10b_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_82bdb089-47a8-4238-9d40-c3ef8e1bceb6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodsandservicessoldTable_97c48f7f-2c89-45ab-b699-17c0bd2b68d1_terseLabel_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_label_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:label id="lab_cah_GoodsandservicessoldTable_documentation_en-US" xlink:label="lab_cah_GoodsandservicessoldTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">goods and services sold [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodsandservicessoldTable" xlink:to="lab_cah_GoodsandservicessoldTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f71305f-a403-4e53-b036-dc6852bb976b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_32f3eb2c-7a1e-44b5-937e-5962bc72a568_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_8bfc590f-5409-4215-bc14-a0b9e94d1042_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureDomain_930433d2-fa25-401b-bd18-491c0d7f792b_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:label id="lab_cah_CordisDivestitureDomain_label_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:label id="lab_cah_CordisDivestitureDomain_documentation_en-US" xlink:label="lab_cah_CordisDivestitureDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureDomain" xlink:to="lab_cah_CordisDivestitureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_3317579f-4b41-4e84-a48e-a697d7ca2e82_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_e573418a-39bb-4da6-8f88-86b5b1e613f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program activity</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_f02d39a8-9e46-40cc-b632-cf094442a764_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_93444f05-55c6-416d-9e5f-2239a553fbd3_terseLabel_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_label_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_documentation_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember" xlink:href="cah-20220630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NuclearPrecisionHealthServicesMember" xlink:to="lab_cah_NuclearPrecisionHealthServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_295a7ab0-3b89-48b9-8088-c972a06c63cf_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_75b2a1d1-e521-4d84-aca9-8f67209113f3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MaturityDateAxis_e3ae5e29-83ff-4b1a-8765-b881165b1a28_terseLabel_en-US" xlink:label="lab_cah_MaturityDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date [Axis]</link:label>
    <link:label id="lab_cah_MaturityDateAxis_label_en-US" xlink:label="lab_cah_MaturityDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date [Axis]</link:label>
    <link:label id="lab_cah_MaturityDateAxis_documentation_en-US" xlink:label="lab_cah_MaturityDateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateAxis" xlink:href="cah-20220630.xsd#cah_MaturityDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaturityDateAxis" xlink:to="lab_cah_MaturityDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_8495c5f0-fffa-422f-9c18-35e8ce88c529_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_624c9cde-1e20-4cf2-a214-2d2d0c75f0d5_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes</link:label>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_label_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotes2616NotesMember_documentation_en-US" xlink:label="lab_cah_FloatingRateNotes2616NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes, 2.616% Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember" xlink:href="cah-20220630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotes2616NotesMember" xlink:to="lab_cah_FloatingRateNotes2616NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_2b105c41-ef2e-474d-8776-b26f54385686_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WV_9e51d7cf-1fc1-45ae-8734-10e0596db5bb_terseLabel_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:label id="lab_stpr_WV_label_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WV" xlink:to="lab_stpr_WV" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e7e159ae-bfc6-4f27-b1ea-85920d5b96ce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_5faab8a8-178c-470a-8d15-4c2338036e2a_terseLabel_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_label_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:label id="lab_cah_AwardsOtherThanStockOptionsMember_documentation_en-US" xlink:label="lab_cah_AwardsOtherThanStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Other than Stock Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember" xlink:href="cah-20220630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AwardsOtherThanStockOptionsMember" xlink:to="lab_cah_AwardsOtherThanStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_5eb66f1e-3325-40dd-8a89-47a56a56c294_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_bc5c97f2-7fae-4b4d-b720-5ac9aa17389c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_afb0eca6-531a-4c9c-8227-bb912c3d1b8c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_2855a9ad-60fc-42dd-b5d3-06d0ce02f22f_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallAxis" xlink:to="lab_cah_SterileSurgicalGownRecallAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_6d50914a-8cb8-4787-8b5a-a13dba00986e_terseLabel_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_label_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:label id="lab_cah_CVSCaremarkCorporationMember_documentation_en-US" xlink:label="lab_cah_CVSCaremarkCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Caremark Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember" xlink:href="cah-20220630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSCaremarkCorporationMember" xlink:to="lab_cah_CVSCaremarkCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d1e62e87-77e2-49a4-b39c-08a642830022_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_55a0ace3-c214-4c69-9644-c1cc0185f68c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GownRecallDomain_4d35128b-d246-4d96-a768-2932e75e57fb_terseLabel_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_label_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_documentation_en-US" xlink:label="lab_cah_GownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gown Recall [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain" xlink:href="cah-20220630.xsd#cah_GownRecallDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallDomain" xlink:to="lab_cah_GownRecallDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_a3e35787-b141-44de-ad15-122b7c83b6d3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_3466bbf5-93f8-4055-841e-75c218045a9f_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Receivables Sales Facility Program</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_8d092953-c541-44f9-882f-6252ba5a803a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_85b65621-2300-4a01-9577-712cd83ea84e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4c61aea1-3dcc-4349-8c10-d522c56d7bdd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_645d5b55-7f53-44f7-a929-2d1d06bb8e4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.079Notesdue2024Member_a1dcb728-3223-4c2b-84ec-96eb6b0789ec_terseLabel_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due fiscal 2024</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_label_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_documentation_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.079% Notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member" xlink:href="cah-20220630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.079Notesdue2024Member" xlink:to="lab_cah_A3.079Notesdue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_September2025Member_53012a24-dc80-47d8-9ca5-634cb9d3103d_terseLabel_en-US" xlink:label="lab_cah_September2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2025 [Member]</link:label>
    <link:label id="lab_cah_September2025Member_label_en-US" xlink:label="lab_cah_September2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2025 [Member]</link:label>
    <link:label id="lab_cah_September2025Member_documentation_en-US" xlink:label="lab_cah_September2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_September2025Member" xlink:href="cah-20220630.xsd#cah_September2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_September2025Member" xlink:to="lab_cah_September2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DOJInvestigationMember_a390689b-6f7d-447c-982c-4eb13cb4274c_terseLabel_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation</link:label>
    <link:label id="lab_cah_DOJInvestigationMember_label_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation [Member]</link:label>
    <link:label id="lab_cah_DOJInvestigationMember_documentation_en-US" xlink:label="lab_cah_DOJInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ Investigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember" xlink:href="cah-20220630.xsd#cah_DOJInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DOJInvestigationMember" xlink:to="lab_cah_DOJInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_88698f7d-dd9f-4a0a-a828-3e5ace39ad69_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dde2cf25-b263-4bc8-b179-1212060114b9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_314ee770-897a-42c9-8051-c2aaa62d0a8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_e41aac9d-2ffb-4da1-bb02-9032e104254f_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tax proceeds/(withholding) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:href="cah-20220630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_63380338-b969-43df-ac02-ef9bf1723644_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible/nontaxable items (2)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PlaintiffTypeDomain_ccd39475-05ef-4941-84a6-c3d8281cc84c_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_label_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Plaintiff Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeDomain" xlink:to="lab_cah_PlaintiffTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e4109de0-563e-4bb8-918f-889295a9eab0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_f3973409-ecea-43e4-a177-8def9168df66_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_8dc2356d-76c5-450f-8283-ecdb77a59e95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_7e23d4a8-db43-47da-a62b-14220dd7f3a4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_4fa03428-01c7-4285-8947-c7fc0e8efefd_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_8a8c0df7-573f-45dc-b957-d825d75060bf_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_label_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_documentation_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest" xlink:href="cah-20220630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseImputedInterest" xlink:to="lab_cah_OperatingLeaseImputedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SettlingUSTerritories_9eb0680e-28e8-4097-a9dc-2eed858d6efa_terseLabel_en-US" xlink:label="lab_cah_SettlingUSTerritories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling U.S Territories</link:label>
    <link:label id="lab_cah_SettlingUSTerritories_label_en-US" xlink:label="lab_cah_SettlingUSTerritories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling U.S Territories</link:label>
    <link:label id="lab_cah_SettlingUSTerritories_documentation_en-US" xlink:label="lab_cah_SettlingUSTerritories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling U.S Territories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingUSTerritories" xlink:href="cah-20220630.xsd#cah_SettlingUSTerritories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SettlingUSTerritories" xlink:to="lab_cah_SettlingUSTerritories" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_7fc4c05d-2eae-4a5d-8f4f-5a9f0046f6b1_terseLabel_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offer as percentage of principal amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offer As Percentage Of Principal Amount</link:label>
    <link:label id="lab_cah_OfferAsPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount" xlink:href="cah-20220630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OfferAsPercentageOfPrincipalAmount" xlink:to="lab_cah_OfferAsPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aebecac9-1297-4e03-ad15-f98fc3a5985b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e49c6278-1c11-40e5-83f8-c0c1c7794c66_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_63362b6b-19f9-4ed8-a617-a97721defea2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_ed9044e4-1825-4dd8-98b7-a08c61d8f0a2_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_19e6d3f1-4c17-4269-984a-4d209e3e4c1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7f5c3961-93c9-44e9-b726-f6d1e08bde02_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_d6a3739e-1589-43d4-adda-2f9b58453327_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_c4a706c4-d3fb-4458-8777-f367e2786cd7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_21c98d33-315f-4acc-81a6-1ad78019f23d_terseLabel_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0%&#160;Debentures due 2026</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_label_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0% Debentures due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_documentation_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.0% Debentures due fiscal 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member" xlink:href="cah-20220630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A7.0Debenturesduefiscal2027Member" xlink:to="lab_cah_A7.0Debenturesduefiscal2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_b2aa0146-cd03-4a12-a277-ccdf580e3eba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cfeebdc7-fa2d-42ad-bca2-b8eb51c83d29_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_074c1868-601c-4c4a-a730-7b3e1a79ca04_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cf49daca-ea25-43fd-8a00-a30d3247a79f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_27a888ad-dc68-4dd5-ad46-d9d84ee613ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f7794c32-ec8a-48ee-a3e2-bbbb1226b8f6_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CordisDivestitureMember_28c47726-bec5-427b-a0bf-61f937d7d855_terseLabel_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:label id="lab_cah_CordisDivestitureMember_label_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture [Member]</link:label>
    <link:label id="lab_cah_CordisDivestitureMember_documentation_en-US" xlink:label="lab_cah_CordisDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cordis Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CordisDivestitureMember" xlink:to="lab_cah_CordisDivestitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_37f3de99-23fd-4c2c-9cfb-418bb94f5332_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_656a3efb-ad78-4c0d-8801-7687bb42fef4_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:href="cah-20220630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_fa3eaed3-e763-4409-8512-57d5e7484611_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7bd034b9-60b9-4c47-8a7d-8a157c3cb3ee_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_30da6218-6ca2-4aae-9537-66e3bf3059be_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_380d7028-8eed-4cf6-8354-22eebf3c63c1_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_88e26138-a653-4ade-b354-df0a7df29740_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_dd99c699-ae7b-41e4-8c66-ccfd8deaa58d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_b7437d69-6685-42a6-a074-b2b58e7d5f14_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_75a2e3c6-1f4f-4a0c-8f9d-e5cafeb2934d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_bb1b6ecc-f1c8-4e2c-961e-4b11bb989849_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_4e3689c6-6f21-4a09-ac43-e059f74863d6_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e081853a-7c48-417f-9dcd-832cc5d97a70_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_1c1aaaf4-3e35-4773-94c2-5ccf45ac64a6_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain)/Loss on sale of equity interest in naviHealth</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_68cfa342-7c48-49b7-9413-9faa69eeaa72_terseLabel_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent&#160;of&#160;Gross Trade&#160;Receivables</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_label_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:label id="lab_cah_GrossTradeReceivablesMajorCustomerPercentage_documentation_en-US" xlink:label="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Trade Receivables, Major Customer Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:href="cah-20220630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:to="lab_cah_GrossTradeReceivablesMajorCustomerPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_c759f2e6-1f82-4920-b2a1-efdd5fa048c5_terseLabel_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_label_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeSolutionsMember_documentation_en-US" xlink:label="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health At Home Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember" xlink:href="cah-20220630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CardinalHealthAtHomeSolutionsMember" xlink:to="lab_cah_CardinalHealthAtHomeSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_92bb85d0-99b9-47ff-b3b5-a409595d8bf8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4c7a1f81-8527-4bc1-a286-6af7f9593cb3_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_4d8dc676-4221-4fcd-b9cf-373c19c3ddda_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8dae78e2-e93f-41ba-8485-3aacd19c5027_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_e3b1df61-3363-4fb8-b94c-8e77e69fb2ed_terseLabel_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:to="lab_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_fa2e0d9c-dcf2-4f76-80bf-059db1e2148d_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_763903af-ab01-4f01-99e2-68c1de738c57_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_c20d40d1-f228-4955-b1f0-3d25129c71c3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fc40786f-05d3-47e1-84dd-5e3827439839_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f2b3be8b-0073-4f5e-8780-be9189b44b10_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e891d62a-d863-4b59-8bd2-964fbaa4fac2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_2efee832-1e06-426b-9a9a-cc9b518ed088_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_76fc2129-a8cc-4808-9b4f-1ab9fec25a42_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_9b1b918f-40dc-4c8a-b435-cc10ac077099_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5ba7698c-dca1-4866-aa36-4cba21d00102_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_af05f250-547d-4d6f-a028-9aa918484d4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_1190eb40-6ec7-4477-a63d-392c650145a3_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_55fccc42-3ffd-4707-8600-83f71f5393b8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5f339a09-126f-4787-8552-d50d3d5e15ea_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f692bb00-6cc8-4ff7-8231-268308935091_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_a7bdb004-d317-47d7-97ed-31aabc760c1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c0cf44b7-15a1-4db5-857a-7ad0675e1ea2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_9207fc2e-923c-4ae0-9e81-caa8dfa00889_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_097475e0-667b-47f6-8a89-8f98dd02cd36_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_dd1ba99e-808f-4bef-8ada-a32d85fa0209_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted Lease Liability Payments Due for both operating and financing leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityPaymentsDue" xlink:to="lab_cah_TotalLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_b0f7e229-0eba-4441-afb3-2d042cff380e_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_63053b70-5ebb-4d30-b335-cbbdaa9906e0_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, building and improvements</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_1cfc16cf-393a-4fb8-b880-a7699f25436b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_5bd2db7b-2819-4aff-99ab-8d215198c879_terseLabel_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Resolutions with IRS and other related matters (2)</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_label_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</link:label>
    <link:label id="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_documentation_en-US" xlink:label="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:to="lab_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_7a98cd5c-4cc9-49ab-be8b-81986b1031fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_c28b1e34-682c-4b02-b337-4823c2873f6b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5d7a0564-7ea6-4acb-b19e-eada49ee39a9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2b37f40b-9c6b-4527-a230-eb796d3d09fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a4af3cc1-90e3-438c-a67e-6c977bce035b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OptumRxMember_c73e0f02-7fb8-4c15-86f1-6cc2b3754584_terseLabel_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_label_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:label id="lab_cah_OptumRxMember_documentation_en-US" xlink:label="lab_cah_OptumRxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember" xlink:href="cah-20220630.xsd#cah_OptumRxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OptumRxMember" xlink:to="lab_cah_OptumRxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_1b24db76-c88c-4bd5-b36b-e10b0e8535d8_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_86265664-884d-45f2-bc4d-cd9a19820940_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.5Notesdue2025Member_612b9cce-0255-4c1a-88a1-4bdb7ec5a255_terseLabel_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due fiscal 2025</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_label_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due 2025 [Member]</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_documentation_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member" xlink:href="cah-20220630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.5Notesdue2025Member" xlink:to="lab_cah_A3.5Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5550a08-fc36-4aa5-83a3-a68bd6e96884_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e822f58a-cdad-450b-a253-8c55163cfc43_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e57d460-0bf2-45d0-91f8-0f1c9b91697c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_4a2eb026-27f2-4d87-9d8f-fbd98c1c0b13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_efc5dfc4-f394-4556-99f7-ea73e90d6efd_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_298724a0-7907-45f4-9847-b961f4d547d1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_e37ca82a-0cfc-4d45-8b0c-d242867a704b_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, matured notional amounts</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:href="cah-20220630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_b835a73d-98e4-4828-8406-31c270c7de1a_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_730588d1-3721-4d8f-adc1-1c631d56d52d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_6b52578f-564e-4a14-a74d-f5389baf4b4a_terseLabel_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_label_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:label id="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_documentation_en-US" xlink:label="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Liability for New York Opioid Stewardship Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:href="cah-20220630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:to="lab_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_JudgmentForLostProfits_a7e4780a-c123-41d2-a37d-e10ce2e4bf95_terseLabel_en-US" xlink:label="lab_cah_JudgmentForLostProfits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment for lost profits</link:label>
    <link:label id="lab_cah_JudgmentForLostProfits_label_en-US" xlink:label="lab_cah_JudgmentForLostProfits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment for lost profits</link:label>
    <link:label id="lab_cah_JudgmentForLostProfits_documentation_en-US" xlink:label="lab_cah_JudgmentForLostProfits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgment for lost profits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_JudgmentForLostProfits" xlink:href="cah-20220630.xsd#cah_JudgmentForLostProfits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_JudgmentForLostProfits" xlink:to="lab_cah_JudgmentForLostProfits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_78a323bd-aae6-43e3-bf27-4eba512c2111_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f950db66-a4c0-4290-bd17-b47ccab1de47_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_70c81be5-478f-4167-bc0a-be14d0b811a6_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8483d838-921c-466e-bc6b-5e37c0a9e4b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain/(loss) on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2cb6684d-045d-47be-ab38-ce02bc40c4cb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_01d20c6c-b102-4f7f-b404-410700137f98_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_7e90d1e7-7ebb-47f8-8a39-e09374e81349_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of inventories held at LIFO, percentage</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TrademarksAndPatentsMember_07b933c1-eeaa-494e-805a-1abc2d4db78a_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, trade names and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember" xlink:href="cah-20220630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember" xlink:to="lab_cah_TrademarksAndPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_506dec07-059e-4340-a0f1-eab3c920907a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_5ba643d6-4d9f-4023-aca8-3ae292fcb52f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_5172772b-c233-4610-ad82-1f935d812ccc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1687bcad-7725-4afa-8068-bf74b1af0cfb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_14983c4c-12b6-4350-9451-588e636aa35a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_2a9cab77-6ee4-42dc-8323-ae660a036e18_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_687d1e52-66d8-4165-826e-d61cb55100cc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_e86e1077-87ea-45be-908e-06a0a186ea6f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_70a8b070-7436-4591-bb32-5cb104f30698_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_14420b36-e870-4043-90eb-790278aace07_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity/(deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_750b8636-d521-4774-8c09-dc5174081257_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_31a840b1-8c02-4277-9259-87a4f7efe451_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85ad0518-a913-47b0-bfa9-a378dcf013d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_08cb4b13-9eff-4b8d-8c6b-751e9e4ebf6d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_18f8cea6-09e9-4afe-bad2-4d6b93878831_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets on tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_4a73727a-f184-4f7a-bf55-dc50bb3920e6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_cdabcbaa-d589-4323-9a52-428b452fb8ea_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance notes and related accrued interest, net, total</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_90896067-c49a-44b1-a114-4fd090479e2b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_71035a0a-e072-41ef-b64c-ea9b3d9ecd7a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6bd79e3b-979e-4bcf-af7d-3ce7d21a2a7d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b36295be-76a7-4035-9bcd-e0db8df1ff5c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3845dd18-4258-4b03-a775-553912c74ee1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings/(Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_44c8d8a0-fb06-4d33-ac34-f7c8e26f36ba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_71e7a332-b7b7-4fcf-a8a8-3f292324489c_terseLabel_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_DividendsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_DividendsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_DividendsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DividendsPolicyPolicyTextBlock" xlink:to="lab_cah_DividendsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_ab848e4e-3ba5-459d-90bd-c217eaf072cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_8348aa29-83c4-4389-b18d-231d27647f4a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_07ce00db-4b42-4bec-9f8b-5033d739257b_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_93997446-8376-4065-afd3-77e62280c82a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_0f5e4448-d4e5-4bdc-8cdf-ab19300d67c0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_9ca98dba-e344-4c79-ac0e-f48ffe970c77_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8511c274-826a-403f-9ea0-8e29cdb03e46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_af98979c-d4f4-45a5-97c7-51a843366d4a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ca544350-4329-4636-aac5-95570a18dfdb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21dc1074-9952-4457-830d-a4935c42d89b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_77b04af2-076f-4d32-af42-58d7fe35b9fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-Based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_1cbb6b00-e0fb-4a54-9a85-7488c7a66cff_terseLabel_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_label_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_documentation_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember" xlink:href="cah-20220630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicaldistributionandproductsMember" xlink:to="lab_cah_MedicaldistributionandproductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_d6d82401-ee1a-4ef9-9d18-fd25d20049a5_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_ffab27c6-cc2f-4154-b733-fafd8c44b1ec_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e5694ffb-8d15-4807-8663-096c874e954c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_b6d46a3f-3f26-418f-a076-6cfbecb9cd8e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expense on employee retirement savings plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_dfbb9c92-1a89-4381-9eb8-f5443c181ee7_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_54f721ea-aa0a-4b99-9bc3-fbf08b5c8adc_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_860ea293-3043-45bb-b226-ce23ffb96003_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d1112ab0-dbbd-42cb-92a7-ba9b3708c219_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_8961a28a-5da2-4c1e-b792-b8ba985f4fda_terseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b754d5bc-bd1b-4bcc-ad97-c7a40c0413f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_6d540ab0-d381-4d0d-a6e7-8186cb540a36_terseLabel_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest group purchasing organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_label_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:label id="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_documentation_en-US" xlink:label="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Largest Group Purchasing Organizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:href="cah-20220630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:to="lab_cah_ConcentrationRiskLargestGroupPurchasingOrganizations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_0a886923-d2eb-4b0b-b6e2-68bcd3d3c5a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_01d0510c-001e-4b94-8c19-0f7bea918227_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_8bcb6ef0-e493-43dc-aa4b-b4e443e386fa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_562aec6c-bfee-4f14-8a8a-eb4047fe21f9_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due fiscal 2022</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_label_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_documentation_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotesdue2022Member" xlink:to="lab_cah_FloatingRateNotesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c69e1d1a-55f9-402e-a63a-427ef4b5b6ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_60c2ef0b-9bd0-43a0-be2d-ac1848181213_terseLabel_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program Aggregate Purchase Price [Domain]</link:label>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_label_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program Aggregate Purchase Price [Domain]</link:label>
    <link:label id="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_documentation_en-US" xlink:label="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program Aggregate Purchase Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:to="lab_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_da70ab48-62f0-47e3-932e-d699b5f05d78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30f10504-8e72-411c-b554-6f380d195e45_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_693c951e-7930-4cda-81e1-7e16a4ce3297_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A300MillionShareRepurchaseProgramMember_c5652511-d179-45d7-8fd9-80918faed7d1_terseLabel_en-US" xlink:label="lab_cah_A300MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A300MillionShareRepurchaseProgramMember_label_en-US" xlink:label="lab_cah_A300MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A300MillionShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_cah_A300MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million share repurchase program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A300MillionShareRepurchaseProgramMember" xlink:href="cah-20220630.xsd#cah_A300MillionShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A300MillionShareRepurchaseProgramMember" xlink:to="lab_cah_A300MillionShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2908c2a9-8c67-4c16-8a5c-76faea271b90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_e34d19ca-9825-4888-ae30-e799e8af79e2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LossContingencyNumberOfEligibleStates_2e9bb3d4-0f57-4b8a-a1a0-c84ec7fd8700_terseLabel_en-US" xlink:label="lab_cah_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_cah_LossContingencyNumberOfEligibleStates_label_en-US" xlink:label="lab_cah_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_cah_LossContingencyNumberOfEligibleStates_documentation_en-US" xlink:label="lab_cah_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyNumberOfEligibleStates" xlink:href="cah-20220630.xsd#cah_LossContingencyNumberOfEligibleStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyNumberOfEligibleStates" xlink:to="lab_cah_LossContingencyNumberOfEligibleStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6f981c39-190f-4703-833e-7fef3d8323fd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_95c72ce3-b5d1-4905-8f32-ce2372793124_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OtherJurisdictionsMember_51f4fffc-c192-42e7-a6a6-eee3182871d8_terseLabel_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_label_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_documentation_en-US" xlink:label="lab_cah_OtherJurisdictionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember" xlink:href="cah-20220630.xsd#cah_OtherJurisdictionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherJurisdictionsMember" xlink:to="lab_cah_OtherJurisdictionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_993d3aeb-b51e-4cfe-8a6b-c63fe2077b3e_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fadfe7d2-b4d1-4760-a33f-739760baee03_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_6f0320d3-8cf5-488c-bf1a-dcea1746d912_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_231c619c-2a87-4f64-9292-bdb9d0a7fd4a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_0b4411b3-9001-4b6c-a713-6836ac3cb288_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_30fcdb56-1dc3-48fc-bd97-ad24f7ca297d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a82b2050-18d4-44ca-b226-efdfef72cd2d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8a4ea7dd-2c8a-40f5-93a8-1e2d376c9902_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A500MillionShareRepurchaseProgramMember_6f489e20-98d3-4ad7-a086-0129895f7570_terseLabel_en-US" xlink:label="lab_cah_A500MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A500MillionShareRepurchaseProgramMember_label_en-US" xlink:label="lab_cah_A500MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A500MillionShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_cah_A500MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500 million share repurchase program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A500MillionShareRepurchaseProgramMember" xlink:href="cah-20220630.xsd#cah_A500MillionShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A500MillionShareRepurchaseProgramMember" xlink:to="lab_cah_A500MillionShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_f26b7afe-fced-466c-8260-0cf56f6b3398_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1349d66c-3abb-4ecd-b5ad-a73ab189f2b2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5a828f09-290c-48cd-9737-32ace6c58f37_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_GoodwillImpairmentDomain_3012b1b2-43e3-4c45-9a05-93cf1f888040_terseLabel_en-US" xlink:label="lab_cah_GoodwillImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment [Domain]</link:label>
    <link:label id="lab_cah_GoodwillImpairmentDomain_label_en-US" xlink:label="lab_cah_GoodwillImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment [Domain]</link:label>
    <link:label id="lab_cah_GoodwillImpairmentDomain_documentation_en-US" xlink:label="lab_cah_GoodwillImpairmentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentDomain" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GoodwillImpairmentDomain" xlink:to="lab_cah_GoodwillImpairmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_de30f392-81ee-4c7b-8706-707abe1fe73d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_96ff62db-8d79-441c-858f-59463ce11e1e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_01a27f06-0b50-4adf-9ace-89eeee039f31_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_605e8ce3-0202-4e41-86d0-65ce6661bb6e_terseLabel_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_label_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_documentation_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:href="cah-20220630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:to="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_760edc4e-4f0e-4499-a024-4a32ea7c916c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_760c636f-5dc6-400a-8353-3d486bee0c19_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_cdc02159-8553-466e-ad60-0d0f3ed3e4a0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6f6d2393-710a-4e73-871a-413382c0e8cb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_12ae7266-88ca-4e25-98c8-4b25863a36f4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_72e904f2-03d0-4bef-9d49-559c6979665a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e46cce99-f08b-4d47-b787-eddcb860425e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_b65b5ba7-af62-4656-94f0-be76571ccabc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e2305b4a-e335-42e7-83cc-99c240f4326f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2b52dfad-9464-4dd2-b375-125e9beed50b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5949a72c-b64c-4752-8f07-a423f7d49d3e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fd2f008f-8789-455d-b73c-2e25535a6fde_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_d4089024-da88-4f45-a29b-4efe19051b4e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) per common share attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_6f2f35a9-4d7f-4e00-874c-062ba358509d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1ed63175-fd90-438e-9d34-84a8e063e247_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80478b2f-a1ec-4e35-840e-8a1874d7bef7_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_5aa79d7c-00a5-4293-a8d1-581f7c6294a4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_5d0794ae-a5df-4dae-9153-ffff45ac2070_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_f9f00004-fa0a-48e8-a66a-8d1cadffd453_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_b3fe710e-f012-47b8-bae2-2473c58485f8_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_e2012bf3-f3e6-43ec-97ed-2f8fbe67f23e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_ae415776-87b6-4791-b7cd-54e023017046_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_38fe35bd-a34a-470a-a424-1dc43e1372a2_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_label_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_documentation_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:href="cah-20220630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:to="lab_cah_PharmaceuticalDistributionandSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_79e8d4d4-a3fc-41be-988b-08d79e680d0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_a0ec3321-032c-4be5-b676-da2c363fa8e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from interest rate swap terminations</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MaturityDateDomain_c79939b2-e4e6-4c67-a14f-bb31c6d8a17c_terseLabel_en-US" xlink:label="lab_cah_MaturityDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date [Domain]</link:label>
    <link:label id="lab_cah_MaturityDateDomain_label_en-US" xlink:label="lab_cah_MaturityDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date [Domain]</link:label>
    <link:label id="lab_cah_MaturityDateDomain_documentation_en-US" xlink:label="lab_cah_MaturityDateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateDomain" xlink:href="cah-20220630.xsd#cah_MaturityDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaturityDateDomain" xlink:to="lab_cah_MaturityDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_163aa815-3e94-45b7-abdf-0c247e1d3579_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_823fa2a8-2d8c-46ff-9f60-7f42fc0fce5f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e24d8392-b93d-4ba6-9df8-d7f14a96b444_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_0efddec4-1f66-4b41-a4a4-6f531f8b2060_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_50c38b00-f010-4344-80ec-98110d162364_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c452f9ec-c5e1-464d-a55e-2da34d9e2645_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7289dbfb-9bad-4be7-92b1-69857d0fdebb_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0c99bdff-0ac0-4f43-9373-1c5d1ff28316_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_87d9f558-3073-4181-9495-3d9ca02295f8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_759fed16-1de4-478f-9b1b-bf11ad05e1cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_188ba102-0759-4e1c-b35f-d8dacff8201e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d724ad54-5d17-4be3-8b47-f7c2ea460100_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_aac6d783-4bbb-47ad-b82d-e6353cc05f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A2021LTIPMember_aeea67c9-4184-4b78-a29a-4e5140274d34_terseLabel_en-US" xlink:label="lab_cah_A2021LTIPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 LTIP [Member]</link:label>
    <link:label id="lab_cah_A2021LTIPMember_label_en-US" xlink:label="lab_cah_A2021LTIPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 LTIP [Member]</link:label>
    <link:label id="lab_cah_A2021LTIPMember_documentation_en-US" xlink:label="lab_cah_A2021LTIPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 LTIP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2021LTIPMember" xlink:href="cah-20220630.xsd#cah_A2021LTIPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2021LTIPMember" xlink:to="lab_cah_A2021LTIPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_ba7a7f92-d13c-44d5-a9cf-e7b630a5ef21_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_d5efda74-4e2e-4749-9842-30ba5be57d15_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0ca4aee1-1a3a-4832-b1ee-3a46fdfc265d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_9693b116-178b-4d25-b629-990da375e91a_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_cf9e336c-59b6-4035-b196-2b5a894b564f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_c9535339-5264-4039-bd09-9ab6c9e12616_terseLabel_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Supplemental Cash Flow Information</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_label_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_documentation_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Lease Payments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasePaymentsTableTextBlock" xlink:href="cah-20220630.xsd#cah_LeasePaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasePaymentsTableTextBlock" xlink:to="lab_cah_LeasePaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_130f8f86-1d63-4935-a9c6-1ccd05a7f28c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_137ceddb-df07-43c3-9375-ac54a2a9ac63_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_FinanceLeaseMember_b049432c-ba7a-4bbe-a035-87bae427c838_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_label_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_documentation_en-US" xlink:label="lab_cah_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember" xlink:href="cah-20220630.xsd#cah_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseMember" xlink:to="lab_cah_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_37a2639e-69f6-443d-a726-b4e6155e50b8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_9436e202-4261-4e4e-962d-20ebc68ba8a8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0f30bcb2-5c1f-4d11-b983-5a89edea4f8c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_b8b725e4-78ba-496a-893a-3d196a3c3ab6_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cfcaed7a-45ee-40f8-9cd9-68cf399124dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e6401f8a-912a-45d0-9f66-91812e731db8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_bf2bea97-e2d6-4526-a82e-f31a1299af77_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_fed3683c-21cd-404c-b68b-692e1ce63610_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ede62136-7b65-4ef8-b7db-d5968dd4b97d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_fcfbc653-dab1-4eed-97c8-0d17483cf4e0_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_07627427-baf0-4cc3-818e-4f48e43ec415_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision at Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_caf78b08-4636-4561-ab52-85b6a5b6eb82_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_TotalOpioidLitigationMember_d718c9cd-59e4-4d51-90e5-0a9626fffb5b_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationMember" xlink:to="lab_cah_TotalOpioidLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_7e5702de-fff8-427a-ba16-045405268676_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c24f43f1-a88e-4697-a428-0ba06bcaaaba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_5cee3849-25b6-422d-9b11-1cd227396d06_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Sales Returns, Reserve for Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:to="lab_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_c5f921a6-d1bf-4aae-ab13-214c0e5088b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_0821f255-360a-41d8-8a9c-c497cf7a33fe_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c2e88031-c30c-48ec-89ef-66a8740e4eb0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_1d39486a-1a3d-4080-ae16-475a496369e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1ef84fdd-c897-4a67-8a6e-9ff111c3cd1d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LeasesTextBlock_190c8a3a-deef-4273-b002-51efb3fcc109_terseLabel_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cah_LeasesTextBlock_label_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:label id="lab_cah_LeasesTextBlock_documentation_en-US" xlink:label="lab_cah_LeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesTextBlock" xlink:href="cah-20220630.xsd#cah_LeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesTextBlock" xlink:to="lab_cah_LeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5ed1b088-9563-4648-a6e7-ae477ed58280_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_031029f2-7e00-46d1-8c7c-693fc42c5ed2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_576ed745-1488-4b36-89e5-f7cce1db5fef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_d7da8ee3-3d4d-4706-abf9-09dee41a44cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_9993563f-f824-488c-9cb1-c76194553b07_terseLabel_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_label_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:label id="lab_cah_ShippingandHandlingCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ShippingandHandlingCosts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:to="lab_cah_ShippingandHandlingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_e4da8842-9674-4f4a-aad3-fbd594828326_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_47afdbc5-3545-4fcd-bd2c-0a55182f905c_negatedLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_81565fa7-10be-49c8-8ebd-ce6d5dbd016f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f84a8b59-773d-447c-9353-2ec7184937e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5deedece-9b8c-4c09-9623-1289df4309be_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_698eb182-9748-459e-90c1-7d0d47264928_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a06e7cc0-5277-481a-9bd2-ef9dc67e8d64_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_52a6dcf5-fc01-4252-ac63-7bb6f092a6db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_905184d0-edc2-4c8f-b475-20cf44530efe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_779957c3-8977-41d6-abe0-1ad44026915e_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallDomain" xlink:to="lab_cah_SterileSurgicalGownRecallDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_550c18e9-77b7-44dc-ae42-a296a3a266a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6e112dc2-05ed-49d3-b839-c752494aabd3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_147866db-0e39-474f-8f9b-8bbed6db1564_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash payments/(refunds) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_cbfa0f46-9fa4-48e7-bad7-c979a1d8e2f0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7184a368-8647-4989-bff2-3e6fecf50d89_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_7c9ab1c7-080f-40e5-aac3-72007a0912f3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_9c5bfe84-e424-4c32-a68d-ffeb75524898_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9f0a86ed-dd42-4db1-ab51-294d3720e7a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_16b6755d-1ce9-43d7-b92e-c1ceeae37a39_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_55ce22ba-9c1c-4acc-a405-e56c672af68d_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_6e3077bd-fb8f-49b2-9b9b-05438ea646a9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthAxis_e39453e1-d59f-41ed-bfe4-e4b9fa516d96_terseLabel_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Axis]</link:label>
    <link:label id="lab_cah_NaviHealthAxis_label_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Axis]</link:label>
    <link:label id="lab_cah_NaviHealthAxis_documentation_en-US" xlink:label="lab_cah_NaviHealthAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis" xlink:href="cah-20220630.xsd#cah_NaviHealthAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthAxis" xlink:to="lab_cah_NaviHealthAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_938a9ede-b8ad-40c6-b01e-fd28520ad555_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_b1273d0b-f775-4189-90ff-bd799a1bbf6d_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallMemberDomain" xlink:to="lab_cah_SterileSurgicalGownRecallMemberDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_134fe535-80c7-4906-a649-3b84593040bc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_51844c72-3026-43f2-ba5e-b4147636e52c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_63211b27-746c-41a9-b7d2-51770216ceca_terseLabel_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Axis]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_label_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback [Axis]</link:label>
    <link:label id="lab_cah_NetOperatingLossCarrybackAxis_documentation_en-US" xlink:label="lab_cah_NetOperatingLossCarrybackAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NetOperatingLossCarrybackAxis" xlink:to="lab_cah_NetOperatingLossCarrybackAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_50d6df13-555d-4a53-b5d5-b0053ebb85a7_terseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments" xlink:to="lab_us-gaap_GainOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2ae4abd1-cbb7-4fd5-8cc2-20765d4afcbc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_8dc315f6-7d3e-4b54-ac2a-c94d5d98d17f_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b28f8fab-ca10-4080-8af0-08c33721a073_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5b2427a7-3500-439f-90e6-e1d8d5438127_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0f090793-a9e2-4ef6-b176-b98733ae93d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_6350a66a-ed19-4f45-a92c-da6cd04c6586_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7e92cadc-113e-4328-8d3e-26a708520971_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b136a4aa-ebcf-4365-b202-1c26a9692a9e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_111ee432-15c1-40a9-ae4e-5f7bddb3fbfb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_d6d441ad-28cd-4032-880d-c11bdda0219b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_c8bcd4ee-c0c5-4623-9cc5-fc414f2c3da6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Lease Payments for Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_559e5a36-45fe-41f1-9df0-718c0362d135_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_394784a5-c7f6-40bc-98f0-d54bf8eb249f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_c3c5e40c-d89f-4261-96a9-b28ff1aad47e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_NaviHealthMember_be735364-451d-4298-bad8-3d402eda08de_terseLabel_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_label_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_documentation_en-US" xlink:label="lab_cah_NaviHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember" xlink:to="lab_cah_NaviHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_589dd0f5-3235-4a4c-a8be-12a4a05c7a8b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_95ca9721-4de2-40a0-bd24-7c1505bda46a_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_908ed35b-9d9d-42fc-be25-3e274e310c6b_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3cfbff1d-b0cd-43c3-9aad-a79256a86997_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f98284d5-a98c-4598-a549-1b84d1b07d6a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of existing long-term obligations and other short-term borrowings-2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_a192209c-9aa2-4a1a-a15b-eeaf628484ff_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_0ab627f1-7587-4f97-8e0a-b5a1c38d2718_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_16942eca-d558-4e11-b305-59efabe9bfe8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_79b02afe-1e66-4d1e-a492-ebcc61b2c3d8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_99ba1802-60d0-41ff-b6ca-58c54e467f4e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_f6ff7517-aca3-4ce6-af26-791c0743b86f_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_e9626717-a7fd-4b6d-9884-3069fa80dc8f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PricingDisputesMember_3e1ada40-5162-427c-8e5e-7377a36aa9a8_terseLabel_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_label_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Disputes [Member]</link:label>
    <link:label id="lab_cah_PricingDisputesMember_documentation_en-US" xlink:label="lab_cah_PricingDisputesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin in the consolidated statements of earnings.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember" xlink:href="cah-20220630.xsd#cah_PricingDisputesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PricingDisputesMember" xlink:to="lab_cah_PricingDisputesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_8faa38e1-ac10-410b-af50-8eaec5b5d5bb_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year One</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Liability Payments Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_87c7d30d-a4f8-4c47-a28f-a2cd02266486_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b6beca39-9033-43c8-ba28-a981262c0788_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_420e1108-6e91-4b8a-ae3c-a9744f675352_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_ddd4d688-6711-45d5-ba55-7f73b97c01fb_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_3dcfd7ad-ebac-46e1-a8f2-ce4b3700c79f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:to="lab_us-gaap_AllowanceForLossesOnFinanceReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_678733d9-e628-4b44-b0c5-b08f7156f5fc_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8e5d59a7-d24f-40d9-9c50-c99b4a1a893c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_b46bb323-4cdd-403b-aef6-5528d00844da_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_30f6d54b-ace6-455a-81bf-fabd0e09dceb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_49e69a8d-38af-434b-ba1a-fd16ddc09043_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a8e646b6-c3a2-4c5e-81d4-9cf40b21f8a8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_868474c8-e6f7-4615-a855-c7cdc3c03d18_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f259cd29-c051-4bb9-b95e-29df58ce08ec_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.41Notesdue2027Member_64e29cbd-b17b-4810-98e6-015316ee81f9_terseLabel_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due fiscal 2027</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_label_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_documentation_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.41% Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.41Notesdue2027Member" xlink:to="lab_cah_A3.41Notesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e3563b4b-23ef-49ff-b801-de78e0fefd0e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity/(deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_12ca4bab-9272-456a-b79d-9b08128dbd96_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OperatingLeaseMember_cfc06225-243d-46ae-82ac-e12c917d4eed_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_label_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_documentation_en-US" xlink:label="lab_cah_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember" xlink:href="cah-20220630.xsd#cah_OperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseMember" xlink:to="lab_cah_OperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOtherShares_636170a2-4aa0-4165-bfde-794e180de199_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOtherShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other Shares</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOtherShares_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOtherShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOtherShares" xlink:to="lab_us-gaap_StockholdersEquityOtherShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_ce3ebfcc-6a82-442a-8732-82a573ab05cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_4a787905-0d42-496c-b278-86d165c52fc1_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_6fda760c-84bd-4094-b0c0-58a7ef4139ba_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_bb45654a-4d84-4e70-8c44-22c3a4770bcb_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f4e36af4-1ef9-4531-9b38-fedfaac33953_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_67885d21-2a70-427c-b6be-e69bece9d0a8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b9cadbcf-a5d2-4080-ae4c-d2afafdc6638_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4e7e6a71-7a87-4058-a93d-54a21bb21add_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_2e318851-d7b1-4f21-85f9-6acf47ff78e4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acfc27cc-ca5e-4a20-85c6-56c370e90234_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AlamedaCountyMember_efa2ab5e-3c77-4cf8-b5a1-be92a389ff98_terseLabel_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_label_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_documentation_en-US" xlink:label="lab_cah_AlamedaCountyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember" xlink:href="cah-20220630.xsd#cah_AlamedaCountyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AlamedaCountyMember" xlink:to="lab_cah_AlamedaCountyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_274145cd-ba6e-46dc-916c-4c7f23b02952_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ef6d7464-4e73-40b9-b0c7-22f89f56cbba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_577af4c6-6fc6-490f-b9ac-fc02f71a1acd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_eba848d2-e173-4f06-b26d-c72b001cd144_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of foreign operations</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_465da716-db78-4261-b9bc-41467df607ad_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d03ae499-1868-4b3d-9d8c-0c499c66bddf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_7b86b4bd-9a53-4ab9-b073-86008ed7499d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_af2e2622-153c-423f-a8a2-ab6ceaa29426_terseLabel_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Carryback Claims</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_label_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</link:label>
    <link:label id="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_documentation_en-US" xlink:label="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Loss Carryback Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:to="lab_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d2cb2c2b-a41d-4e3c-b7ed-7c7a9a639f8c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ced49a22-9928-417f-afae-83eb58106fb1_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8796d831-b829-4030-b1c9-950e746a1958_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_24dc1e69-1b59-46a1-8afc-1b2a330b2510_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_22d05bee-5ee6-4529-83ae-66868fe3f594_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_OpioidLitigationAxis_05b540c7-e2ff-40b5-9c19-cc6042b9056f_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_label_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_documentation_en-US" xlink:label="lab_cah_OpioidLitigationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationAxis" xlink:to="lab_cah_OpioidLitigationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_7ba0fd7a-b2a5-459d-ba50-20824cdb2d1f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f0d63d3b-395a-4140-8c60-3f60bf1ea6e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Lease Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_89a120d8-863d-461d-a857-1aa628308b78_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_ffc7c43c-4228-499f-98d8-cdb021bea061_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b74424a5-2bd6-469d-ae8e-247ab6531504_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_1c581306-7a6b-464b-9a4d-3f1e3d49cc18_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_1771fa2f-92bd-4e46-86af-088ce2f421bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_MedicalMemberMember_bc111dc8-2093-491c-a8ef-9a5220725b18_terseLabel_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMemberMember_label_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Member [Member]</link:label>
    <link:label id="lab_cah_MedicalMemberMember_documentation_en-US" xlink:label="lab_cah_MedicalMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMemberMember" xlink:to="lab_cah_MedicalMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember_8d2d710e-108a-4437-a6b4-c6974a6e6a9d_terseLabel_en-US" xlink:label="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve Write-down to Net Realizable Value [Member]</link:label>
    <link:label id="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember_label_en-US" xlink:label="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve - Write-down to Net Realizable Value [Member]</link:label>
    <link:label id="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember_documentation_en-US" xlink:label="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Reserve - Write-down to Net Realizable Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:href="cah-20220630.xsd#cah_InventoryReserveWriteDownToNetRealizableValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:to="lab_cah_InventoryReserveWriteDownToNetRealizableValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a40c97d2-fc40-4081-bae8-3beddc952c89_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A200MillionShareRepurchaseProgramMember_8de46a90-a42e-4093-8b1f-4a7f689c1ea2_terseLabel_en-US" xlink:label="lab_cah_A200MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A200MillionShareRepurchaseProgramMember_label_en-US" xlink:label="lab_cah_A200MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million share repurchase program [Member]</link:label>
    <link:label id="lab_cah_A200MillionShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_cah_A200MillionShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million share repurchase program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A200MillionShareRepurchaseProgramMember" xlink:href="cah-20220630.xsd#cah_A200MillionShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A200MillionShareRepurchaseProgramMember" xlink:to="lab_cah_A200MillionShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_29b1efc8-63d6-4de3-9f34-f0d9641020e6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_a7fed658-786c-4ee8-8ba3-75bb4d2a5f83_terseLabel_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for estimated sales returns and allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_label_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:label id="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_documentation_en-US" xlink:label="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Reserve for Sales Returns and Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:href="cah-20220630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:to="lab_cah_RevenueRecognitionReserveforSalesReturnsandAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_4e40413f-b1a8-4050-80e5-6608ed9be989_terseLabel_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_label_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_documentation_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber" xlink:href="cah-20220630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyLawsuitsNumber" xlink:to="lab_cah_LossContingencyLawsuitsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_A3.75Notesdue2026Member_9eb001b1-c854-4838-8071-0c6b7dd7dd06_terseLabel_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2025</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_label_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2026 [Member]</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_documentation_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member" xlink:href="cah-20220630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.75Notesdue2026Member" xlink:to="lab_cah_A3.75Notesdue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_7217b8e6-4186-470f-8626-e469f0bfe126_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_5b99f9ea-21d7-4b0a-8fc1-c372b0a30052_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories valued at LIFO amount higher than average cost value</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_08546f70-c98c-4111-8ce5-25a60a0ed330_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_57fd22ed-098b-44c6-815d-7992726998df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_540f7acb-978f-4169-ac40-b67bdc91b94f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_b33b954d-3452-44ff-b255-b20937179b66_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_PriorYearRecoveriesMember_02953889-56f3-4085-ac2e-0e9bd85f04cb_terseLabel_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_label_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:label id="lab_cah_PriorYearRecoveriesMember_documentation_en-US" xlink:label="lab_cah_PriorYearRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Recoveries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember" xlink:href="cah-20220630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PriorYearRecoveriesMember" xlink:to="lab_cah_PriorYearRecoveriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_a62a43b7-a359-48aa-b9e5-1d988d73ddd8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7ece51d2-7645-48ab-be4a-adfb6b6ee5f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_582b4b5c-d1cf-483b-b1eb-36ee8cb42b18_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ac4edc94-8af8-4532-b224-48262bec561b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options, restricted share units, and performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_d7a22bf0-c2be-4438-9730-1d43769d0116_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_40a57449-0f03-4422-b21b-2ecaa4cbace2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_127b9d82-3c32-4c57-8273-8deaabb566ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_f1734320-72ea-43aa-8bbe-2b4daa2a4e79_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_26475118-5ccb-44cc-9f1a-aaa53386c5c9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization of intangible assets - 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1416dfb2-5027-415e-85ed-fa514bce2af3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_743f453d-e570-4cce-a893-0a38059bea6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f605d848-5918-4ea1-afb4-f6284e064f33_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_46e57a8a-99f6-4910-9005-6271a8b10fdc_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_b2e12ebb-0728-46f5-baf3-f1fb78223646_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_c8270c6f-8a32-442c-aff0-5d8929781a8e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_374dd919-fc11-447b-bfe5-b92129bf5874_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_3f3726f2-b875-42aa-95b9-fc98b36273bd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_09b7a9ee-c737-44a0-9ccd-1c99622eca95_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_14d73c05-b51d-46dc-9f4c-aa84e67286c3_terseLabel_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and Other Acquisition-Related Costs</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and Other Acquisition Related Costs Policy [Policy Text Block]</link:label>
    <link:label id="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:href="cah-20220630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:to="lab_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_ef4df332-d5ec-4598-88cf-775b32c2302c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_00f13465-f932-4ea8-9144-d604373dcb74_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_2bb3a8a9-8554-451a-af66-828150f074b0_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_053a04b2-7e90-4c03-9348-255d83087756_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRecallExpense_ff66eb35-3a47-4e0e-8d7a-3e7de1d0bb46_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense" xlink:to="lab_us-gaap_InventoryRecallExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_878bcf86-39d0-473c-b254-6587fe4967ae_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_080bc26f-c852-43c6-be2e-d780a17bf120_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>cah-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f50a7428-f354-4b07-91fc-6ccf634720d1,g:c498d509-ad5a-46ae-88d6-bf804ed9c36f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:type="simple" xlink:href="cah-20220630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5550c0af-04bc-4b57-9a1c-26782573a5c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentType_5550c0af-04bc-4b57-9a1c-26782573a5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0a70bdaf-354c-4180-be6c-5bdb6bd528d6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentAnnualReport_0a70bdaf-354c-4180-be6c-5bdb6bd528d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cb7df48e-9a59-4123-a2a6-dc246aa704fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentTransitionReport_cb7df48e-9a59-4123-a2a6-dc246aa704fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_585ff8bd-afd9-42d3-95b7-82da4a931f1d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityFileNumber_585ff8bd-afd9-42d3-95b7-82da4a931f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3bbc538a-89a4-4c6a-bc72-38371acd3659" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityRegistrantName_3bbc538a-89a4-4c6a-bc72-38371acd3659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c73d1380-7df1-4514-ad09-c17786fd1adc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c73d1380-7df1-4514-ad09-c17786fd1adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_953b3d7a-9437-44a0-8edc-9cddb60063ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityTaxIdentificationNumber_953b3d7a-9437-44a0-8edc-9cddb60063ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_42e4220b-c39f-494e-99e1-2b5587e8fee9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityAddressAddressLine1_42e4220b-c39f-494e-99e1-2b5587e8fee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dfe9ced2-dfb4-421f-9e31-c60a89119ad4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityAddressCityOrTown_dfe9ced2-dfb4-421f-9e31-c60a89119ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c3cb9083-ad05-42fb-9184-e5d2221a04c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityAddressStateOrProvince_c3cb9083-ad05-42fb-9184-e5d2221a04c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dfdcf2b3-e267-4b31-9574-123bf089e1c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityAddressPostalZipCode_dfdcf2b3-e267-4b31-9574-123bf089e1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_17e15197-43d5-4355-b832-9d2eb8be2634" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_CityAreaCode_17e15197-43d5-4355-b832-9d2eb8be2634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ee95324c-9ab3-4aa5-b81e-8455e4e9d00c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_LocalPhoneNumber_ee95324c-9ab3-4aa5-b81e-8455e4e9d00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9c9e0da5-1691-4695-aa1e-64cb788d4925" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_Security12bTitle_9c9e0da5-1691-4695-aa1e-64cb788d4925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2ef7131c-19f5-4943-a527-6aa00b896c2f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_TradingSymbol_2ef7131c-19f5-4943-a527-6aa00b896c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_579e83d7-02b1-4a3f-a708-0eef473a6390" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_SecurityExchangeName_579e83d7-02b1-4a3f-a708-0eef473a6390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_c64b6871-61da-4320-a3fa-d226bd4fbb4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_c64b6871-61da-4320-a3fa-d226bd4fbb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3d4fbb2e-e6ed-4529-bb23-64c438ba993c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityVoluntaryFilers_3d4fbb2e-e6ed-4529-bb23-64c438ba993c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8f442784-d1c9-4d59-92e3-d11bdb02d6de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityCurrentReportingStatus_8f442784-d1c9-4d59-92e3-d11bdb02d6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9c2261a5-fbd5-428c-bb08-580241c90fd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityInteractiveDataCurrent_9c2261a5-fbd5-428c-bb08-580241c90fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d243589d-5273-43af-a00c-24813538409b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityFilerCategory_d243589d-5273-43af-a00c-24813538409b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8d453d7c-ba13-459b-b148-1c0c127879cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntitySmallBusiness_8d453d7c-ba13-459b-b148-1c0c127879cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_82d8cd7f-2f07-4511-ac90-5541c6ca86e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityEmergingGrowthCompany_82d8cd7f-2f07-4511-ac90-5541c6ca86e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_087cdfc2-6445-47c5-b134-a8de1eef4eeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_IcfrAuditorAttestationFlag_087cdfc2-6445-47c5-b134-a8de1eef4eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cf364fff-7ced-414d-aa32-df060678e233" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityShellCompany_cf364fff-7ced-414d-aa32-df060678e233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_0ac5196c-f815-41e0-a10a-1eeda01bb7fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityPublicFloat_0ac5196c-f815-41e0-a10a-1eeda01bb7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d5ba9f29-937b-4507-be2c-8af6e88774a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d5ba9f29-937b-4507-be2c-8af6e88774a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b5c7c09f-af24-4d58-bdaf-ebe69b6ea0bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_AmendmentFlag_b5c7c09f-af24-4d58-bdaf-ebe69b6ea0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9c773c32-66b7-4e35-8d08-ce9f2b48e63a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentFiscalYearFocus_9c773c32-66b7-4e35-8d08-ce9f2b48e63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_55f61494-7943-44f1-8352-93fe4f493532" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentFiscalPeriodFocus_55f61494-7943-44f1-8352-93fe4f493532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_545f580c-78ae-48c4-be30-dec02a8f03c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_EntityCentralIndexKey_545f580c-78ae-48c4-be30-dec02a8f03c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bb1d1dc5-ff42-4616-9829-9cc5a10009b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_CurrentFiscalYearEndDate_bb1d1dc5-ff42-4616-9829-9cc5a10009b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_59db3a23-9374-4a83-9ee7-255389866618" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_59db3a23-9374-4a83-9ee7-255389866618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_071b8c2a-6fc8-4b0d-8af2-0f160ca72ca8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4d5a99c-b48d-4766-80f6-031187ac2221" xlink:to="loc_dei_DocumentPeriodEndDate_071b8c2a-6fc8-4b0d-8af2-0f160ca72ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/AuditInformation" xlink:type="simple" xlink:href="cah-20220630.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cah_AuditInformationAbstract_2ef84a72-79c8-4db8-8a36-5006cc31ac93" xlink:href="cah-20220630.xsd#cah_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_022a9340-de0c-48f8-ad90-0f3de6619e91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_AuditInformationAbstract_2ef84a72-79c8-4db8-8a36-5006cc31ac93" xlink:to="loc_dei_AuditorName_022a9340-de0c-48f8-ad90-0f3de6619e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c6678f7b-4177-4b52-976c-d932efaf98da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_AuditInformationAbstract_2ef84a72-79c8-4db8-8a36-5006cc31ac93" xlink:to="loc_dei_AuditorLocation_c6678f7b-4177-4b52-976c-d932efaf98da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_69b5ff62-cd66-42b0-8b75-f3c4219cf069" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_AuditInformationAbstract_2ef84a72-79c8-4db8-8a36-5006cc31ac93" xlink:to="loc_dei_AuditorFirmId_69b5ff62-cd66-42b0-8b75-f3c4219cf069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6cae4df8-f474-45d2-bc3f-d574a75a9fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_Revenues_6cae4df8-f474-45d2-bc3f-d574a75a9fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bf38eece-c420-4ec8-bbc7-a5e361eff16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bf38eece-c420-4ec8-bbc7-a5e361eff16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fa3a393f-7db1-4797-8b34-76f51ffa4a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_GrossProfit_fa3a393f-7db1-4797-8b34-76f51ffa4a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_79a4db14-6000-4762-aefb-e9af56428219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_79a4db14-6000-4762-aefb-e9af56428219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ae9557e2-a161-4ef2-a993-6088e8c58d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:to="loc_us-gaap_RestructuringCharges_ae9557e2-a161-4ef2-a993-6088e8c58d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_9f4144c0-75c3-449e-b22b-e2293b481c81" xlink:href="cah-20220630.xsd#cah_Amortizationandotheracquisitionrelatedcosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_9f4144c0-75c3-449e-b22b-e2293b481c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9bb80831-e3ea-4c82-bdc4-5e113aa4e5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9bb80831-e3ea-4c82-bdc4-5e113aa4e5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_3e3be319-98f4-437b-938d-ecafa02b118c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f815abbd-de49-42b9-b567-ac2c5392346a" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_3e3be319-98f4-437b-938d-ecafa02b118c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d7db63a9-361f-45f6-998d-6ad08de96e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_OperatingIncomeLoss_d7db63a9-361f-45f6-998d-6ad08de96e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f3e6a78c-c011-40ff-8eab-5dab4d749013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f3e6a78c-c011-40ff-8eab-5dab4d749013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_17497b1e-aeca-4fd2-a9d7-3bde86d75302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_InterestExpense_17497b1e-aeca-4fd2-a9d7-3bde86d75302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_448cecda-e8ab-436e-a317-f0a167ea6039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_448cecda-e8ab-436e-a317-f0a167ea6039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_2a4fd5ee-6b8b-4eb8-87c4-82953221c5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_2a4fd5ee-6b8b-4eb8-87c4-82953221c5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_217986a6-8f91-4e24-8788-1463d27953df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_217986a6-8f91-4e24-8788-1463d27953df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2634d8c9-9c62-4822-887a-69287819204a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2634d8c9-9c62-4822-887a-69287819204a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_900275f2-5eba-4ee9-83e8-6a02cfd8c220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_ProfitLoss_900275f2-5eba-4ee9-83e8-6a02cfd8c220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2b62b0f1-4eee-4efe-bf36-0a5756672979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2b62b0f1-4eee-4efe-bf36-0a5756672979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c57571a5-f6db-49aa-a204-2af8e83d0911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_NetIncomeLoss_c57571a5-f6db-49aa-a204-2af8e83d0911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_a643a858-3f07-482a-9c53-78ca3669731e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_a643a858-3f07-482a-9c53-78ca3669731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_acde7442-7925-46ca-88ac-87bb21efc2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_a643a858-3f07-482a-9c53-78ca3669731e" xlink:to="loc_us-gaap_EarningsPerShareBasic_acde7442-7925-46ca-88ac-87bb21efc2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_13e153b1-bb59-446d-9d0c-86ca8c58247d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_a643a858-3f07-482a-9c53-78ca3669731e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_13e153b1-bb59-446d-9d0c-86ca8c58247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b8bf624d-64fa-489d-8508-b1752512369d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c4e20477-0e5f-4a09-878d-1716a277e902" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b8bf624d-64fa-489d-8508-b1752512369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3dd26e3a-2522-470a-822b-14739284ecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b8bf624d-64fa-489d-8508-b1752512369d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3dd26e3a-2522-470a-822b-14739284ecc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f5d1332e-cc84-4540-a976-9b50ea71a42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b8bf624d-64fa-489d-8508-b1752512369d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f5d1332e-cc84-4540-a976-9b50ea71a42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_60b82db4-fec8-4c0a-8ce7-085cb5393755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:to="loc_us-gaap_ProfitLoss_60b82db4-fec8-4c0a-8ce7-085cb5393755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_20a05929-bbb5-4979-809c-c19ab2545f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_20a05929-bbb5-4979-809c-c19ab2545f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b5a17296-f1f3-474d-a46d-16072b4447ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_20a05929-bbb5-4979-809c-c19ab2545f6d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b5a17296-f1f3-474d-a46d-16072b4447ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_79258668-641b-447f-9405-bb844b0933d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_20a05929-bbb5-4979-809c-c19ab2545f6d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_79258668-641b-447f-9405-bb844b0933d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9447d362-6a30-4a4e-aa0f-d43083c48f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_20a05929-bbb5-4979-809c-c19ab2545f6d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9447d362-6a30-4a4e-aa0f-d43083c48f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ba98edea-1249-46fb-bc35-7a613c8c72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ba98edea-1249-46fb-bc35-7a613c8c72e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_64152860-f511-429e-99f5-8f5d3b2cdb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_64152860-f511-429e-99f5-8f5d3b2cdb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_29557e99-507d-40dc-8d73-e000a55c974b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f5a31ece-759f-476c-b990-d36c4be0cd76" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_29557e99-507d-40dc-8d73-e000a55c974b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2395d250-ea03-4a4b-bec5-ca367b2df3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2395d250-ea03-4a4b-bec5-ca367b2df3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f5873ecf-0a92-4425-8346-ca958bac742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f5873ecf-0a92-4425-8346-ca958bac742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d7472e5d-9511-4f48-b0b0-31489e58e9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_InventoryNet_d7472e5d-9511-4f48-b0b0-31489e58e9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6e1bdaf9-6c6b-4c65-88c3-9ba6aa5af738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_OtherAssetsCurrent_6e1bdaf9-6c6b-4c65-88c3-9ba6aa5af738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_52800b34-a9ac-4f1c-ab0b-e386b1713056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_52800b34-a9ac-4f1c-ab0b-e386b1713056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f59b2950-952e-42bb-a67a-84dd403f1b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c1bde4b3-a76f-4921-a833-233b5f8451d8" xlink:to="loc_us-gaap_AssetsCurrent_f59b2950-952e-42bb-a67a-84dd403f1b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_66d0ba98-8525-45d7-b0dd-cf77277d340e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_66d0ba98-8525-45d7-b0dd-cf77277d340e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c6a568f9-dace-42c4-9ca1-23c1d50ec3db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c6a568f9-dace-42c4-9ca1-23c1d50ec3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_83e7c9ed-c264-4db3-bd27-11d1572c3c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_83e7c9ed-c264-4db3-bd27-11d1572c3c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_622f62ed-4c87-40ce-aa2c-e8e044500861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_958d8b92-b4b1-4f95-b714-425e8ea3d9e0" xlink:to="loc_us-gaap_Assets_622f62ed-4c87-40ce-aa2c-e8e044500861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_81116b5d-d262-4f96-a98f-38d3f206a45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:to="loc_us-gaap_AccountsPayableCurrent_81116b5d-d262-4f96-a98f-38d3f206a45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_caa633da-4d40-4c54-b533-407d0028be1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_caa633da-4d40-4c54-b533-407d0028be1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b2ab9f08-c691-4101-8d20-f88badc6154c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b2ab9f08-c691-4101-8d20-f88badc6154c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e8d74937-8314-47d4-bc94-a67e0e63ea13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e8d74937-8314-47d4-bc94-a67e0e63ea13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4dede12b-2250-4e82-af26-17d448eb3c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85642c8d-035c-47f2-b579-891b23caab5f" xlink:to="loc_us-gaap_LiabilitiesCurrent_4dede12b-2250-4e82-af26-17d448eb3c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e0706ee2-678d-47fc-b4e4-e391446f4102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e0706ee2-678d-47fc-b4e4-e391446f4102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_31e83f6e-ab62-45ca-9f81-3cade6f65e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_31e83f6e-ab62-45ca-9f81-3cade6f65e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:to="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_de3b2429-8afa-4dca-83b7-2f7946f4b7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_de3b2429-8afa-4dca-83b7-2f7946f4b7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a346d58f-6e2d-4f31-8f8c-4353fdbed36b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_de3b2429-8afa-4dca-83b7-2f7946f4b7bf" xlink:to="loc_us-gaap_PreferredStockValue_a346d58f-6e2d-4f31-8f8c-4353fdbed36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a04d37eb-607a-4420-8758-a4c4bc9cf064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a04d37eb-607a-4420-8758-a4c4bc9cf064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_31b95b15-6085-40ca-a488-1224e7ffca55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a04d37eb-607a-4420-8758-a4c4bc9cf064" xlink:to="loc_us-gaap_CommonStockValue_31b95b15-6085-40ca-a488-1224e7ffca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_72786328-6a82-481d-816a-f2aa29192454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_72786328-6a82-481d-816a-f2aa29192454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_2421921d-1daf-4c0b-8c0b-22a1b55c1234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_TreasuryStockShares_2421921d-1daf-4c0b-8c0b-22a1b55c1234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_1bca138e-c8b8-4af4-b707-c5e3fa3bff8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_TreasuryStockValue_1bca138e-c8b8-4af4-b707-c5e3fa3bff8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fa5a4dd6-f0a9-4521-b276-5809227c63cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fa5a4dd6-f0a9-4521-b276-5809227c63cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56333bd4-adab-4871-8e1c-c45975b95cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_StockholdersEquity_56333bd4-adab-4871-8e1c-c45975b95cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3a7495f2-ebc4-417f-a4b6-0fe836c020d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_MinorityInterest_3a7495f2-ebc4-417f-a4b6-0fe836c020d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cb1775f-9fb1-4a35-9ef4-fedd2ca45429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_49bcac0d-97ed-4680-832e-eab5644b9458" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cb1775f-9fb1-4a35-9ef4-fedd2ca45429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ebc491a-b492-4008-a803-d11b5ab97e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e6cd807-2641-4dac-8b6e-a491f23923df" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ebc491a-b492-4008-a803-d11b5ab97e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_65ecb5f2-067e-4762-a523-d88e0eea4e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_65ecb5f2-067e-4762-a523-d88e0eea4e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4d764bb0-7e09-4995-958e-45ae5833b1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4d764bb0-7e09-4995-958e-45ae5833b1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ec248bb5-07c9-40bd-98f3-29f763c50230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ec248bb5-07c9-40bd-98f3-29f763c50230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_606dd7f8-4457-4839-aae2-369e0eabba74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d04b51af-8a04-41b5-b724-f608ef692025" xlink:to="loc_us-gaap_CommonStockSharesIssued_606dd7f8-4457-4839-aae2-369e0eabba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a99d2046-4526-4fb9-bb69-263a45ccc470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2e8b1200-38a4-44f2-823c-d29a98244db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2e8b1200-38a4-44f2-823c-d29a98244db0" xlink:to="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1375affc-80e4-48c5-a620-6a335bbf43f5" xlink:to="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5e7ed1bb-6b1a-4bbf-8914-bfc442bcccdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_CommonStockMember_5e7ed1bb-6b1a-4bbf-8914-bfc442bcccdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_fac61971-c56a-48b6-9617-1b2ec142fba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_RetainedEarningsMember_fac61971-c56a-48b6-9617-1b2ec142fba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_9d3ce755-53c1-4547-8ee4-4df0a3b054b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_TreasuryStockMember_9d3ce755-53c1-4547-8ee4-4df0a3b054b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5916db49-4885-4cb4-8058-a37bb441efe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5916db49-4885-4cb4-8058-a37bb441efe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_35ffe387-edd1-4b05-8cb6-5962edb6b313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fb1baae8-8562-4628-a0b3-87fa6e9a2656" xlink:to="loc_us-gaap_NoncontrollingInterestMember_35ffe387-edd1-4b05-8cb6-5962edb6b313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_62144633-242a-48b5-8fb8-b354873df71e" xlink:to="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0df4a2ed-28ed-4e2d-96d4-8b6f78d3e534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:to="loc_us-gaap_NetIncomeLoss_0df4a2ed-28ed-4e2d-96d4-8b6f78d3e534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e114ad14-ad06-4f4e-b5de-9503253cedf1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9b482ea5-24fb-40fb-a2d4-ad73d9785483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_CommonStockSharesIssued_9b482ea5-24fb-40fb-a2d4-ad73d9785483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec985448-bcc1-4a84-bbcb-327b28074d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec985448-bcc1-4a84-bbcb-327b28074d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b3299522-2373-47c5-b1f4-21ef2f3ba479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockShares_b3299522-2373-47c5-b1f4-21ef2f3ba479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3e4ec7c6-39f4-42df-a070-dc040b3fc784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockValue_3e4ec7c6-39f4-42df-a070-dc040b3fc784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a30ada2-2bea-45e3-bf27-c64d90a4b542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_ProfitLoss_9a30ada2-2bea-45e3-bf27-c64d90a4b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_f06dc759-7675-40e1-900c-0b6871630f8f" xlink:href="cah-20220630.xsd#cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_f06dc759-7675-40e1-900c-0b6871630f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e144c5a0-d30e-4e49-b773-a72635b9560f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e144c5a0-d30e-4e49-b773-a72635b9560f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_742b09f4-8b50-4b60-ab1e-890d3233ac14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_742b09f4-8b50-4b60-ab1e-890d3233ac14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c422b6f-2bac-4079-aa93-11afb13573b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c422b6f-2bac-4079-aa93-11afb13573b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_151856ec-ff23-4ede-b99c-be944f4544d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_151856ec-ff23-4ede-b99c-be944f4544d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_765327b9-58f9-4564-a086-4d6eb5fb84a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_765327b9-58f9-4564-a086-4d6eb5fb84a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_a0299a7e-f270-4904-a954-5c463c96c026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_Dividends_a0299a7e-f270-4904-a954-5c463c96c026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOtherShares_b32de6c3-5779-46d8-8933-47d3c6f8c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOtherShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityOtherShares_b32de6c3-5779-46d8-8933-47d3c6f8c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_4b864f51-92d6-4ed6-8aaa-082c8077d1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityOther_4b864f51-92d6-4ed6-8aaa-082c8077d1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_646de46a-2a02-4309-9a9e-ae632648164c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_CommonStockSharesIssued_646de46a-2a02-4309-9a9e-ae632648164c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_30cbd952-13dd-45b1-82ad-514c13269b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_30cbd952-13dd-45b1-82ad-514c13269b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1271ec1a-a21d-4c09-aa08-cd31f360486e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockShares_1271ec1a-a21d-4c09-aa08-cd31f360486e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_fa78eb5e-f65e-4b02-9c58-dc14340a5d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efe8abf3-080d-4f1a-a5d0-2d03c6430910" xlink:to="loc_us-gaap_TreasuryStockValue_fa78eb5e-f65e-4b02-9c58-dc14340a5d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cah-20220630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c1b8554-9ebc-499b-be62-695c176d0aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c1b8554-9ebc-499b-be62-695c176d0aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad6ee026-dc03-4f30-98e7-d4f949c8a740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c1b8554-9ebc-499b-be62-695c176d0aef" xlink:to="loc_us-gaap_ProfitLoss_ad6ee026-dc03-4f30-98e7-d4f949c8a740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c1b8554-9ebc-499b-be62-695c176d0aef" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_af4d8344-50f4-4a9d-90da-feb3339691f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_af4d8344-50f4-4a9d-90da-feb3339691f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherInvestments_98bc380e-ad87-45a1-89eb-6d008490a83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherInvestments_98bc380e-ad87-45a1-89eb-6d008490a83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_e5ee09a4-bc57-45e3-a3fb-06ca7f0c8a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_e5ee09a4-bc57-45e3-a3fb-06ca7f0c8a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_aba73113-b575-4f09-a145-6cea30538e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_aba73113-b575-4f09-a145-6cea30538e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cee7f682-ec75-4135-8968-e594d5f0ea18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cee7f682-ec75-4135-8968-e594d5f0ea18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e35dccb1-fcd7-4b69-8140-7fc7b4954048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_ShareBasedCompensation_e35dccb1-fcd7-4b69-8140-7fc7b4954048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c652b78d-4c67-4a9d-ac7a-f1f9fd6d365e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c652b78d-4c67-4a9d-ac7a-f1f9fd6d365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_add6295e-7c0d-4893-bc0d-977742d99b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_add6295e-7c0d-4893-bc0d-977742d99b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f0bfc1ff-1818-4f66-b37d-690659806205" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3815c54b-d882-46cd-8d82-0d660fbedb86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_3815c54b-d882-46cd-8d82-0d660fbedb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c9230461-eed5-42e4-a7d0-0a4e1d4ab110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c9230461-eed5-42e4-a7d0-0a4e1d4ab110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_be9c0617-ef66-415e-a1ab-3de69fe11df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_be9c0617-ef66-415e-a1ab-3de69fe11df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3dbff8a7-17f3-4567-a480-2b4868494ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_683c52e2-bbc5-4e76-bd3b-a338d8f15d5b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3dbff8a7-17f3-4567-a480-2b4868494ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90f6bc67-9469-4649-9eff-4aa1732ff634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7c1b8554-9ebc-499b-be62-695c176d0aef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90f6bc67-9469-4649-9eff-4aa1732ff634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a926302c-4e5d-4f4b-bd2a-e6911e2196c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a926302c-4e5d-4f4b-bd2a-e6911e2196c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b4933601-7ad0-4de0-b78c-1bbdbcd72bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b4933601-7ad0-4de0-b78c-1bbdbcd72bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77195020-23d9-4ac4-af70-cf500e766d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77195020-23d9-4ac4-af70-cf500e766d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1e7bd361-c25f-4be3-8be9-8c6bd7a6de44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1e7bd361-c25f-4be3-8be9-8c6bd7a6de44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_35a4a8d9-d8c1-4a81-a1ac-8d0667f504ba" xlink:href="cah-20220630.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_35a4a8d9-d8c1-4a81-a1ac-8d0667f504ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_9ab02b4d-fc0f-4d33-88f4-45752c34a91c" xlink:href="cah-20220630.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_9ab02b4d-fc0f-4d33-88f4-45752c34a91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_5dc22033-e3c2-402e-bfc8-4c5092fa34dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_5dc22033-e3c2-402e-bfc8-4c5092fa34dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d66ffc2f-271e-45b9-abc0-9076c03b3bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a79a6c06-01d9-46cb-b8f6-f70045a4acaf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d66ffc2f-271e-45b9-abc0-9076c03b3bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_18e8bb10-7ef5-4ccb-8503-121a0f1d15a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_18e8bb10-7ef5-4ccb-8503-121a0f1d15a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_7cdcb915-02ed-4d4b-8b4f-78edec5ee18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_7cdcb915-02ed-4d4b-8b4f-78edec5ee18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ae143f2e-b2e9-448f-836e-bba7dbf609c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ae143f2e-b2e9-448f-836e-bba7dbf609c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_54aec014-7d6f-42f3-b5be-9d682f39bb73" xlink:href="cah-20220630.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_54aec014-7d6f-42f3-b5be-9d682f39bb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_7b338602-181d-4088-b124-0b3ff301da61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_7b338602-181d-4088-b124-0b3ff301da61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19a69489-300f-4ea6-9171-f77e2a43858f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_19a69489-300f-4ea6-9171-f77e2a43858f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cee4e760-85cb-4c06-b5da-45ca3b65b342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cee4e760-85cb-4c06-b5da-45ca3b65b342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1846510f-c318-45f4-9846-f547a463e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2608b8d2-36fe-41bc-be6c-87948ad690d8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1846510f-c318-45f4-9846-f547a463e5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashReclassifiedtoAssetsHeldforSale_5fefb08b-f084-4946-9ae3-0f80b580579b" xlink:href="cah-20220630.xsd#cah_CashReclassifiedtoAssetsHeldforSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_cah_CashReclassifiedtoAssetsHeldforSale_5fefb08b-f084-4946-9ae3-0f80b580579b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4cbd247f-3697-462b-83be-db08c5ffe1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4cbd247f-3697-462b-83be-db08c5ffe1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaa74565-5ef4-43c2-ad40-979c89872253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaa74565-5ef4-43c2-ad40-979c89872253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c48b5e5-af02-46a7-8766-91865e421a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c48b5e5-af02-46a7-8766-91865e421a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7318d3fa-55c1-4ec0-9c2d-a6bcebb9e258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4bd4f39a-de39-467e-aad0-d91d6ddc5904" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7318d3fa-55c1-4ec0-9c2d-a6bcebb9e258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fa201215-aa14-4337-8f76-c8b5aa43af97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7318d3fa-55c1-4ec0-9c2d-a6bcebb9e258" xlink:to="loc_us-gaap_InterestPaidNet_fa201215-aa14-4337-8f76-c8b5aa43af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_90a7ed0d-abde-47fa-bcb6-41e4296e0cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7318d3fa-55c1-4ec0-9c2d-a6bcebb9e258" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_90a7ed0d-abde-47fa-bcb6-41e4296e0cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22882e3f-3f4d-4bf5-87d6-e264164ccbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f27483e6-7347-419f-bbdc-724ba16381ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22882e3f-3f4d-4bf5-87d6-e264164ccbac" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f27483e6-7347-419f-bbdc-724ba16381ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_81e7996a-0ab9-4a42-94f1-3ceedee9f169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_81e7996a-0ab9-4a42-94f1-3ceedee9f169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_95471a9f-1fdd-4507-b98e-952f794d3529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_UseOfEstimates_95471a9f-1fdd-4507-b98e-952f794d3529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_04e67dae-3944-4eac-9734-88e9b74bbad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_04e67dae-3944-4eac-9734-88e9b74bbad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_9f234ec9-af49-45db-83f4-3a11d247e160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_9f234ec9-af49-45db-83f4-3a11d247e160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_41d461d3-1803-4c30-a059-a50d995ecdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_41d461d3-1803-4c30-a059-a50d995ecdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_97ed097f-3229-45a5-9e69-04ccbe80d74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_97ed097f-3229-45a5-9e69-04ccbe80d74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_ff9081f4-add6-4ed4-914b-530f1ac03d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_ff9081f4-add6-4ed4-914b-530f1ac03d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CashDiscountsPolicyTextBlock_48150bb7-58b8-45a9-b7f8-faf56b0c89c4" xlink:href="cah-20220630.xsd#cah_CashDiscountsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_CashDiscountsPolicyTextBlock_48150bb7-58b8-45a9-b7f8-faf56b0c89c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0553dde2-604c-4010-a9f7-007c8c3ac292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0553dde2-604c-4010-a9f7-007c8c3ac292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cd7b1a85-06f3-40c6-b156-628569360a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cd7b1a85-06f3-40c6-b156-628569360a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_ca2517c9-4695-41d7-a910-bc906d7604f9" xlink:href="cah-20220630.xsd#cah_AssetsHeldforSalePolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_AssetsHeldforSalePolicyPolicyTextBlock_ca2517c9-4695-41d7-a910-bc906d7604f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_f3307eac-cb6d-4f4c-9cd0-b8022838a442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_f3307eac-cb6d-4f4c-9cd0-b8022838a442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_dbf5a2de-d5f3-4444-b9c2-24106952adc4" xlink:href="cah-20220630.xsd#cah_CostofSalesVendorReservesPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_CostofSalesVendorReservesPolicyPolicyTextBlock_dbf5a2de-d5f3-4444-b9c2-24106952adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_8a2bbcab-a514-4710-af59-9a9f93ef620b" xlink:href="cah-20220630.xsd#cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock_8a2bbcab-a514-4710-af59-9a9f93ef620b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5378d778-81b4-45a9-b1bc-224e6bfeb098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5378d778-81b4-45a9-b1bc-224e6bfeb098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_70a87347-9231-42d6-ab88-b802060ac46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_70a87347-9231-42d6-ab88-b802060ac46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_42cd7241-4c37-43d7-a4f7-b650fa28a1a7" xlink:href="cah-20220630.xsd#cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock_42cd7241-4c37-43d7-a4f7-b650fa28a1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_0d801e05-0422-4564-98d1-aec74b5279b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_0d801e05-0422-4564-98d1-aec74b5279b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_05dd316b-0cdb-4b7e-acb4-d14bb36a9964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_05dd316b-0cdb-4b7e-acb4-d14bb36a9964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DividendsPolicyPolicyTextBlock_e99839d4-e0b2-4cde-95d6-d7753facaff0" xlink:href="cah-20220630.xsd#cah_DividendsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_DividendsPolicyPolicyTextBlock_e99839d4-e0b2-4cde-95d6-d7753facaff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_82d0def2-e1de-4c54-9d92-d48362ea3c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_82d0def2-e1de-4c54-9d92-d48362ea3c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SalesreturnsPolicyTextBlock_1c8cf7f5-6771-4c10-b8b9-0308d7c936de" xlink:href="cah-20220630.xsd#cah_SalesreturnsPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_SalesreturnsPolicyTextBlock_1c8cf7f5-6771-4c10-b8b9-0308d7c936de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShippingandHandlingCostsPolicyTextBlock_48038990-ffb7-417a-90f0-303fd25d8b7e" xlink:href="cah-20220630.xsd#cah_ShippingandHandlingCostsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_ShippingandHandlingCostsPolicyTextBlock_48038990-ffb7-417a-90f0-303fd25d8b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_5caf03f7-4286-4534-9e4f-2c0c369bb356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_5caf03f7-4286-4534-9e4f-2c0c369bb356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_93c1856e-1a29-497a-bbfb-9dfcfca93788" xlink:href="cah-20220630.xsd#cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock_93c1856e-1a29-497a-bbfb-9dfcfca93788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ab9c9e17-eedb-4ebd-aae4-3648f4bc784d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ab9c9e17-eedb-4ebd-aae4-3648f4bc784d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_6329fed5-5370-4897-93be-da1a5502b049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_6329fed5-5370-4897-93be-da1a5502b049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_78bf3b41-7329-4643-873f-f8fa5fbc62fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_78bf3b41-7329-4643-873f-f8fa5fbc62fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1323ed8c-2a2d-46c9-a08f-3223ccb5b930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1323ed8c-2a2d-46c9-a08f-3223ccb5b930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_2456ba3f-b7af-4ed1-911b-eec7576601ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_2456ba3f-b7af-4ed1-911b-eec7576601ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_2915395f-6628-47e4-adb3-2f02290161cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88acc58d-c588-4957-952a-21f608201bff" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_2915395f-6628-47e4-adb3-2f02290161cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8ccb0d46-0476-4b8f-94cf-8a5cb0ee8d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_43481e48-b40c-483a-b302-671843a6d23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8ccb0d46-0476-4b8f-94cf-8a5cb0ee8d65" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_43481e48-b40c-483a-b302-671843a6d23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ef0a6c9a-e3d2-45ba-99a2-056a1c789bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8ccb0d46-0476-4b8f-94cf-8a5cb0ee8d65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ef0a6c9a-e3d2-45ba-99a2-056a1c789bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bfb54f49-8216-4a82-8ac7-ce681efaee83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bfb54f49-8216-4a82-8ac7-ce681efaee83" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6cf20671-1392-4d70-a714-fb5d1bc7dcd3" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_9b3d934f-b1b4-4bfd-ba7f-c1a1b869f2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_9b3d934f-b1b4-4bfd-ba7f-c1a1b869f2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8e70f4db-3884-4ef1-9105-c0cbb124aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_0de84746-2c67-4a71-b266-115127f43de9" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_8e70f4db-3884-4ef1-9105-c0cbb124aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_00e61cdb-5002-4fc8-91c6-f11ea06ad1a4" xlink:to="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_03d65b73-9c4c-4415-addf-d6e026f35344" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:to="loc_srt_MinimumMember_03d65b73-9c4c-4415-addf-d6e026f35344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_26da792a-f31e-4081-95a4-a51c13843cb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_00a7f41d-d63a-4eef-8749-87b950785e01" xlink:to="loc_srt_MaximumMember_26da792a-f31e-4081-95a4-a51c13843cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_fecce7ce-9472-462c-8d8c-5a2cebb9d17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_721b52b6-ddfb-474c-8a59-0902b9ca10c0" xlink:to="loc_us-gaap_ReceivableTypeDomain_fecce7ce-9472-462c-8d8c-5a2cebb9d17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56d30182-a7df-41ed-a47f-1e2b04c9f57f" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_05ba2030-a602-4b85-9002-8135f27e4111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_05ba2030-a602-4b85-9002-8135f27e4111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReceivableFinancingAgreementTerm_5de8d0cf-b72c-48db-bc47-935bda58ca56" xlink:href="cah-20220630.xsd#cah_ReceivableFinancingAgreementTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_cah_ReceivableFinancingAgreementTerm_5de8d0cf-b72c-48db-bc47-935bda58ca56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_871daa11-ebc3-41fd-bd55-f5b042acf799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_NotesReceivableNet_871daa11-ebc3-41fd-bd55-f5b042acf799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b41c37f-4da6-4ccc-bf56-23cc8043088b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_e60abdbd-b0b3-4e17-a5d8-c4282362a916" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_9b41c37f-4da6-4ccc-bf56-23cc8043088b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bdbc8e05-3570-4ebe-8078-ff11033fc759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bdbc8e05-3570-4ebe-8078-ff11033fc759" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb5e7763-5d99-4fe6-8db0-ea851a6969a5" xlink:to="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_d11acaed-3be4-4491-ba4e-c5f5219acd3b" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c698c642-141c-40db-8b01-b1367fb77bc9" xlink:to="loc_cah_PharmaceuticalMember_d11acaed-3be4-4491-ba4e-c5f5219acd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_57877813-a177-4dfa-8cf7-953c632f5dcc" xlink:to="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CVSCaremarkCorporationMember_eb75fc11-55d7-4c8d-a3f0-63abb7b4cccf" xlink:href="cah-20220630.xsd#cah_CVSCaremarkCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:to="loc_cah_CVSCaremarkCorporationMember_eb75fc11-55d7-4c8d-a3f0-63abb7b4cccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OptumRxMember_bba7ea80-02ff-49fb-8329-bca498811ee4" xlink:href="cah-20220630.xsd#cah_OptumRxMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bd7804eb-ca75-4cc9-a496-7ba1583058c8" xlink:to="loc_cah_OptumRxMember_bba7ea80-02ff-49fb-8329-bca498811ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9790b5bc-9c06-47d1-a8ce-16eb018b12af" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_015ff090-f8bc-44aa-9390-bb2e2dc3f93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ce419a14-5726-43b3-be1b-6d1616dd2af4" xlink:to="loc_us-gaap_SalesRevenueNetMember_015ff090-f8bc-44aa-9390-bb2e2dc3f93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4268c808-ce57-420d-b392-b3c139e560ab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_06e79536-7c8f-47ef-b30f-1014e15001f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4fe3d624-7881-451d-894b-46423f6b513d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_06e79536-7c8f-47ef-b30f-1014e15001f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_9dfdd1a1-414d-403b-9ca1-1ff42202bd4d" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f56dbd30-b2e7-4f4e-a64a-0f44bc9ff96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f56dbd30-b2e7-4f4e-a64a-0f44bc9ff96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_49f73320-e546-40ee-937f-b41707901019" xlink:href="cah-20220630.xsd#cah_GrossTradeReceivablesMajorCustomerPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_d2d67993-6021-4ad4-b015-1c01c142a8b7" xlink:to="loc_cah_GrossTradeReceivablesMajorCustomerPercentage_49f73320-e546-40ee-937f-b41707901019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_819909f9-142b-4a70-b066-216239c337ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_819909f9-142b-4a70-b066-216239c337ae" xlink:to="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8b62f69e-fe9a-4cc5-95ab-6d6780f51993" xlink:to="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GroupPurchasingOrganizationsMember_df7d3fb7-dcad-4c0e-950f-55ad2041e08e" xlink:href="cah-20220630.xsd#cah_GroupPurchasingOrganizationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26a401f0-1815-47aa-bcd7-52891b3c9f3c" xlink:to="loc_cah_GroupPurchasingOrganizationsMember_df7d3fb7-dcad-4c0e-950f-55ad2041e08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_cab47b30-3ac5-4caa-90c2-a78602ccbfa3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_47da65fe-e09b-4b75-9200-203f3017c971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c83f3fd5-32ac-47a4-911e-2acbe8493bfe" xlink:to="loc_us-gaap_SalesRevenueNetMember_47da65fe-e09b-4b75-9200-203f3017c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_fdab52af-8d0e-4cab-90b7-b3cdd76d8a77" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_718e35af-25ee-42c9-b395-96572e35a6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_da5ef3df-ab67-4cf4-98f3-7c1cacfbf530" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_718e35af-25ee-42c9-b395-96572e35a6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_785f79fc-d23c-46f1-89cb-996d51c6cc11" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_3211fe56-2482-4bf6-89f5-b41767aeeea8" xlink:href="cah-20220630.xsd#cah_ConcentrationRiskLargestGroupPurchasingOrganizations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:to="loc_cah_ConcentrationRiskLargestGroupPurchasingOrganizations_3211fe56-2482-4bf6-89f5-b41767aeeea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_428e8da0-859c-49ec-995c-09a1aaa8a046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_91558793-b3e3-4b82-ac68-34d391c57351" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_428e8da0-859c-49ec-995c-09a1aaa8a046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b0515226-85bf-4fe0-9c62-eeefece07afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_639de7ca-eab1-4065-97cd-81bd2fe390f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0515226-85bf-4fe0-9c62-eeefece07afc" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_639de7ca-eab1-4065-97cd-81bd2fe390f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_d59d92b6-c61f-42ce-893c-ccdcd6b3b3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0515226-85bf-4fe0-9c62-eeefece07afc" xlink:to="loc_us-gaap_InventoryLIFOReserve_d59d92b6-c61f-42ce-893c-ccdcd6b3b3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_1aa47282-7359-404c-85cf-39de94ce5f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0515226-85bf-4fe0-9c62-eeefece07afc" xlink:to="loc_us-gaap_InventoryWriteDown_1aa47282-7359-404c-85cf-39de94ce5f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0515226-85bf-4fe0-9c62-eeefece07afc" xlink:to="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_68ac8288-d881-4629-980f-651b99e114f1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveExcessAndObsoleteMember_b6bc3838-2043-450b-9e3b-8a79f7500a57" xlink:href="cah-20220630.xsd#cah_InventoryReserveExcessAndObsoleteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:to="loc_cah_InventoryReserveExcessAndObsoleteMember_b6bc3838-2043-450b-9e3b-8a79f7500a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember_e97707c2-2a9e-4e64-8da4-4a72779d1148" xlink:href="cah-20220630.xsd#cah_InventoryReserveWriteDownToNetRealizableValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_dfb1f54b-abc5-4d55-9217-d3cefb85cd65" xlink:to="loc_cah_InventoryReserveWriteDownToNetRealizableValueMember_e97707c2-2a9e-4e64-8da4-4a72779d1148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:href="cah-20220630.xsd#cah_InventoryReserveTableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_InventoryReserveTableTable_f840dc5f-72c2-4362-aa6f-bf010a718b9e" xlink:to="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_3de7b3f8-3181-40e0-bb38-506caa200489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_InventoryReserveTableLineItems_d6390aa0-5150-4b6f-8307-f628a1197d7f" xlink:to="loc_us-gaap_InventoryValuationReserves_3de7b3f8-3181-40e0-bb38-506caa200489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2dfc5a4d-7c20-42b1-ae53-8a6c5d03b1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2dfc5a4d-7c20-42b1-ae53-8a6c5d03b1d5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b9ed0ac-3ea8-4b5c-a43a-7b97dd0e7ecb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_8cc3798e-60bb-4243-b609-7f2c9d638012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_8cc3798e-60bb-4243-b609-7f2c9d638012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_57190807-1539-48a9-8fba-5ce3bfa57c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_57190807-1539-48a9-8fba-5ce3bfa57c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6c379eee-9275-4b9c-a03b-3d7c79e45106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598f8d13-6736-4a96-af15-1ca1f96ad2a7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6c379eee-9275-4b9c-a03b-3d7c79e45106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:to="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17172006-d5ea-4806-8d7b-35c9177f67fb" xlink:to="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7638a230-b97b-4683-9eea-42f4b8d50327" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:to="loc_srt_MinimumMember_7638a230-b97b-4683-9eea-42f4b8d50327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9a3c209b-6caf-42fe-a03d-ad32658286ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76830f35-5789-49b9-9d24-f8423840d770" xlink:to="loc_srt_MaximumMember_9a3c209b-6caf-42fe-a03d-ad32658286ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a66838ec-520f-4eff-91ac-05cc5435bc13" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_56d1d23b-21ac-4b4f-a874-477dbd2b542f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_56d1d23b-21ac-4b4f-a874-477dbd2b542f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_74a2bc47-5600-431d-81cb-6ab56131ce16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1734867e-7b65-4393-99d5-022048d4d8ee" xlink:to="loc_us-gaap_Depreciation_74a2bc47-5600-431d-81cb-6ab56131ce16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5c117c42-8353-4f07-ac23-d7ea6972bd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2dfc5a4d-7c20-42b1-ae53-8a6c5d03b1d5" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5c117c42-8353-4f07-ac23-d7ea6972bd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f7eca1a0-8f5e-48d5-a1de-021ae028e666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f7eca1a0-8f5e-48d5-a1de-021ae028e666" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:to="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4fd8faa6-b17e-403e-8634-1173d7a9274f" xlink:to="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b03b9f5-f526-4245-bfa4-7d4871c3a9bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:to="loc_srt_MaximumMember_8b03b9f5-f526-4245-bfa4-7d4871c3a9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5793928a-fe8c-481c-853f-06f65cb6a48f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fff198ed-05c0-45d9-a1bc-221cf16d9d56" xlink:to="loc_srt_MinimumMember_5793928a-fe8c-481c-853f-06f65cb6a48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e082e63-e5e3-4338-b1a6-a7768f561777" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_a601e58a-b027-473a-8262-a6a6693e4750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_a601e58a-b027-473a-8262-a6a6693e4750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_869a6ec2-11a6-485b-9cf8-54d232b33d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_869a6ec2-11a6-485b-9cf8-54d232b33d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0c8b1c22-e281-4a9a-9a13-dec17df82128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0c8b1c22-e281-4a9a-9a13-dec17df82128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c613238c-7eed-4234-be96-65569fccaf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c613238c-7eed-4234-be96-65569fccaf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e7ce6ac8-3487-4ce4-8322-d161c73cbd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_ConstructionInProgressMember_e7ce6ac8-3487-4ce4-8322-d161c73cbd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e51f844-e139-4481-8797-20455d8a6927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc7d71ea-682c-4042-a8f8-f620bf52f175" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e51f844-e139-4481-8797-20455d8a6927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e211f289-4a57-473b-83e8-7296156dce82" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ad30e352-ecff-49a1-bc03-9a89be1bb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ad30e352-ecff-49a1-bc03-9a89be1bb1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_02081f60-6401-4118-afbf-e0d0c0f7cdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_02081f60-6401-4118-afbf-e0d0c0f7cdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0f883ee3-a895-4490-9ec6-ad2edfb1ce31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0f883ee3-a895-4490-9ec6-ad2edfb1ce31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9c12f6ba-2d16-4a06-bb48-4973798d8357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6ea5d258-b22c-4560-911c-31558b8d84e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9c12f6ba-2d16-4a06-bb48-4973798d8357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a60bb31f-b219-465a-9531-334c1ceb6899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a60bb31f-b219-465a-9531-334c1ceb6899" xlink:to="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:to="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_89ecc0fa-dd2a-460d-b6d6-f8ce8c006d85" xlink:to="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_751a521d-8abb-4d91-84af-84c331996cd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:to="loc_srt_MinimumMember_751a521d-8abb-4d91-84af-84c331996cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3e528bf0-7d94-4753-b7f8-79c27e85a96c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db5e37c0-d694-4a12-91b3-a93da6022c90" xlink:to="loc_srt_MaximumMember_3e528bf0-7d94-4753-b7f8-79c27e85a96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:to="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_d2f5c406-16ed-480e-b32d-0204e9b23806" xlink:to="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_fa8567db-b496-498c-a5cf-621c8b13663d" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_557d8f8f-6aa7-4abe-b51e-11e4c438a8d1" xlink:to="loc_cah_MedicalUnitMember_fa8567db-b496-498c-a5cf-621c8b13663d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:href="cah-20220630.xsd#cah_GoodwillAndIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsTable_c35d4419-4aad-4f30-bdbd-31b5b22dea8c" xlink:to="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_d18221dd-3539-4456-8c42-decb40febdeb" xlink:href="cah-20220630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_cah_DiscountRatefairvalueinputs_d18221dd-3539-4456-8c42-decb40febdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5007de88-a234-45a8-a5d9-20e8a99ea57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5007de88-a234-45a8-a5d9-20e8a99ea57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5305afaa-3fec-4535-b9d3-35ec57b11db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillAndIntangibleAssetsLineItems_07865ccd-d927-4604-862f-3db1f2826def" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5305afaa-3fec-4535-b9d3-35ec57b11db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a3cdbc7f-25de-4581-b417-71f00af047c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VendorReserves_a789f020-4320-4e72-a211-b83e4056638b" xlink:href="cah-20220630.xsd#cah_VendorReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a3cdbc7f-25de-4581-b417-71f00af047c3" xlink:to="loc_cah_VendorReserves_a789f020-4320-4e72-a211-b83e4056638b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cd1c41dd-56cc-4707-bff4-6fcb432c530d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd1c41dd-56cc-4707-bff4-6fcb432c530d" xlink:to="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:to="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_12bc9266-df4d-4484-867f-78646cfbf9b7" xlink:to="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_fe7e04a2-8455-4200-8a45-2401687ab1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_754eaf11-0d03-4cb1-9b1e-e34ff85812de" xlink:to="loc_us-gaap_ShippingAndHandlingMember_fe7e04a2-8455-4200-8a45-2401687ab1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:href="cah-20220630.xsd#cah_GoodsandservicessoldLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldTable_d21a7121-5457-4a87-9443-e823b18778d9" xlink:to="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2b42ea6-615b-411a-a162-39c491e9ceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodsandservicessoldLineItems_63f467b8-cd2d-4af0-85fb-b1171b7aceaa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c2b42ea6-615b-411a-a162-39c491e9ceb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_914c15ae-611a-4eef-b8dc-38dc8c5d4f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_689ef19c-c079-4f27-afd7-651aaa22de43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_914c15ae-611a-4eef-b8dc-38dc8c5d4f4e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_689ef19c-c079-4f27-afd7-651aaa22de43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_869616c0-6f86-4b48-90a3-8e078c7e3b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_42623783-0a30-4efa-8e0b-c4006d1fc768" xlink:href="cah-20220630.xsd#cah_RevenueRecognitionReserveforSalesReturnsandAllowances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_869616c0-6f86-4b48-90a3-8e078c7e3b1e" xlink:to="loc_cah_RevenueRecognitionReserveforSalesReturnsandAllowances_42623783-0a30-4efa-8e0b-c4006d1fc768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_0dc2fe06-3aa5-4fff-b628-2a752b638a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_869616c0-6f86-4b48-90a3-8e078c7e3b1e" xlink:to="loc_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns_0dc2fe06-3aa5-4fff-b628-2a752b638a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8510134f-c6cb-4f04-b134-2552d34f49f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8510134f-c6cb-4f04-b134-2552d34f49f2" xlink:to="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:to="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_93f64a75-8b7b-4836-8398-ba156cf9ac2f" xlink:to="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_6e34ffcf-f0f2-4fc1-9e10-ce0114ec85ab" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_9ee12ec2-ea74-48f7-be65-0e1984cd1045" xlink:to="loc_cah_TotalOpioidLitigationMember_6e34ffcf-f0f2-4fc1-9e10-ce0114ec85ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c74e8c8b-a47f-4671-891b-a3520bae593b" xlink:to="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_43bba95a-4130-4466-bf44-73b6d349baf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_307bfebb-ce9d-460b-858c-feeebfb691b9" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_43bba95a-4130-4466-bf44-73b6d349baf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0e1fb892-388c-405e-a6ea-d480b9bb1e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ad7e2a0b-602b-4086-bd79-c8f4716fac24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0e1fb892-388c-405e-a6ea-d480b9bb1e00" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ad7e2a0b-602b-4086-bd79-c8f4716fac24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitions" xlink:type="simple" xlink:href="cah-20220630.xsd#DivestituresandAcquisitions"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7f8d8922-1699-4177-b523-71e84d101a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4c47c828-f3a2-4f19-b67b-f37021c25412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7f8d8922-1699-4177-b523-71e84d101a76" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4c47c828-f3a2-4f19-b67b-f37021c25412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#DivestituresandAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_87a7c27a-697f-410d-95fd-ff5e44666a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#DivestituresandAcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_93cf6b39-f297-4372-9d96-6f3c90c48e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_93cf6b39-f297-4372-9d96-6f3c90c48e67" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_90fb743f-e48b-4512-bcca-e12c101bdb20" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_219b9564-a76b-4560-953b-6eee44cb188d" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0ddb21ed-549d-48f0-b555-2b667676fa7b" xlink:to="loc_cah_NaviHealthMember_219b9564-a76b-4560-953b-6eee44cb188d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_faa72e04-9159-41aa-873f-5afbdd0ec608" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_79133114-0339-4c68-bab7-4e790436e9a6" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbca36cf-936a-4e12-86a9-1b8b350420c1" xlink:to="loc_cah_PatientRecoveryBusinessMember_79133114-0339-4c68-bab7-4e790436e9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9572e856-037d-4b45-a0a5-be636755ce58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3b21d31c-fdd4-4c17-ae4b-405297240b64" xlink:to="loc_srt_RangeMember_9572e856-037d-4b45-a0a5-be636755ce58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6dee1b32-fa62-47a3-a422-6c6008219414" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_3f54f295-8615-4a66-9e40-f5cd70c9c980" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75ccdee2-e4d6-4e82-b1a7-ae73601391e4" xlink:to="loc_cah_PatientRecoveryBusinessMember_3f54f295-8615-4a66-9e40-f5cd70c9c980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_284bb19f-eb53-4ecf-b3f0-84a64197e066" xlink:to="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_f457a287-7826-49d3-97f2-7b853c64e860" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_811a9baf-b9c5-428f-aeea-b70c66d2d941" xlink:to="loc_cah_CordisDivestitureMember_f457a287-7826-49d3-97f2-7b853c64e860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:href="cah-20220630.xsd#cah_NaviHealthAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:href="cah-20220630.xsd#cah_NaviHealthDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NaviHealthAxis_e3f75888-4322-4ef5-8c7a-549d9926aae4" xlink:to="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_6902fdd3-1af8-4005-8408-0844d0dd0310" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NaviHealthDomain_ccc36654-5c8c-4115-a51c-6441c0a65c3b" xlink:to="loc_cah_NaviHealthMember_6902fdd3-1af8-4005-8408-0844d0dd0310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1c58df6-2a1a-434b-979b-42f31c44b078" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_29d5880e-f3b0-4148-a2cf-f6d47627d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_92db96b6-d220-4cc6-8656-56feb8c006ea" xlink:to="loc_us-gaap_SubsequentEventMember_29d5880e-f3b0-4148-a2cf-f6d47627d75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bec492ba-68ff-4bc4-8947-e46857e4b0f2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fea7265-2baf-4da7-9c40-48ee5e14c056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fea7265-2baf-4da7-9c40-48ee5e14c056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02156597-32c8-4e03-a098-69ea46332e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02156597-32c8-4e03-a098-69ea46332e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5b71c392-b1f5-40af-b9bc-5b5666ddbdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5b71c392-b1f5-40af-b9bc-5b5666ddbdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_dd0bc3d4-5af4-4339-bd3d-fe1ae84ebbe8" xlink:href="cah-20220630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_dd0bc3d4-5af4-4339-bd3d-fe1ae84ebbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18fe29cc-5c94-4bb7-a620-9c5225d28807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_18fe29cc-5c94-4bb7-a620-9c5225d28807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6783ae82-c9e7-48fb-9841-ed2dde649a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6783ae82-c9e7-48fb-9841-ed2dde649a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_e8caaf11-eecd-4511-af10-f9663f7bb0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7ff4c610-aa8c-4e40-8bae-0f27f3a6f673" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_e8caaf11-eecd-4511-af10-f9663f7bb0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeverance" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeverance"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_709d2961-39a7-45bb-964b-df8cc96e59da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02b4dc2b-c8cb-4e2d-84d0-642b2035243d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_709d2961-39a7-45bb-964b-df8cc96e59da" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02b4dc2b-c8cb-4e2d-84d0-642b2035243d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeveranceTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_66412d43-c8af-4104-8796-cd0aef1d2558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_24072015-1b9b-4a51-9b77-0d1c4e28a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_66412d43-c8af-4104-8796-cd0aef1d2558" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_24072015-1b9b-4a51-9b77-0d1c4e28a5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e2b1687b-31bc-4a7c-9de1-1817e8b5b5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_66412d43-c8af-4104-8796-cd0aef1d2558" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e2b1687b-31bc-4a7c-9de1-1817e8b5b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_340ae608-fd2f-45ea-a95f-1dfae446a5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_d06a0b0f-20f8-409e-a595-8e4500a462db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_340ae608-fd2f-45ea-a95f-1dfae446a5d0" xlink:to="loc_us-gaap_SeveranceCosts1_d06a0b0f-20f8-409e-a595-8e4500a462db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FacilityExitAndOtherCosts_2628d292-cf9a-47f8-a32d-b0bd90d69af4" xlink:href="cah-20220630.xsd#cah_FacilityExitAndOtherCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_340ae608-fd2f-45ea-a95f-1dfae446a5d0" xlink:to="loc_cah_FacilityExitAndOtherCosts_2628d292-cf9a-47f8-a32d-b0bd90d69af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8ee6fe63-b3f1-4093-8975-03bcd9d12159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_340ae608-fd2f-45ea-a95f-1dfae446a5d0" xlink:to="loc_us-gaap_RestructuringCharges_8ee6fe63-b3f1-4093-8975-03bcd9d12159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_0b7cca90-5f89-4bd5-ac4b-ddcc1a6f99c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_0b7cca90-5f89-4bd5-ac4b-ddcc1a6f99c5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bc4e6054-5a8c-4936-8469-67d270799ca1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c453c119-78e2-44ec-9e0f-584ac4ee6431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c453c119-78e2-44ec-9e0f-584ac4ee6431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_142092a3-560e-45bb-8d22-c5496433bc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c410b08-f498-401d-8278-02f49aa2d915" xlink:to="loc_us-gaap_FacilityClosingMember_142092a3-560e-45bb-8d22-c5496433bc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_227f378a-0525-4a03-9ab9-395add31bb89" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a2b987a9-a344-4110-b005-353966ae2f02" xlink:to="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f94bfbda-e6ca-46a6-9146-432d99738996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_RestructuringReserve_f94bfbda-e6ca-46a6-9146-432d99738996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0577420c-6ca5-43cc-aa47-82b05e943c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_RestructuringCosts_0577420c-6ca5-43cc-aa47-82b05e943c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4712fdb1-d017-4419-b812-56a04993bd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_PaymentsForRestructuring_4712fdb1-d017-4419-b812-56a04993bd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b207d61f-da40-4d90-bbc1-3ccc1f04ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_b41d2e1a-2d92-4437-b153-008693c09448" xlink:to="loc_us-gaap_RestructuringReserve_b207d61f-da40-4d90-bbc1-3ccc1f04ac17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77eb432c-357c-42ae-8516-ed5eb174c46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_97e307b0-2f2d-45d4-8f27-7ab1a09b34b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77eb432c-357c-42ae-8516-ed5eb174c46a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_97e307b0-2f2d-45d4-8f27-7ab1a09b34b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0097e997-c3d2-467f-af5c-8055859cce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9572c064-a7a5-42ae-bdca-a3f6598dc2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0097e997-c3d2-467f-af5c-8055859cce6b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9572c064-a7a5-42ae-bdca-a3f6598dc2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_10a37d6b-8331-46da-aacd-d9b2415d55a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0097e997-c3d2-467f-af5c-8055859cce6b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_10a37d6b-8331-46da-aacd-d9b2415d55a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_39b02652-6b9e-43c8-a8b5-e86be69dd528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0097e997-c3d2-467f-af5c-8055859cce6b" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_39b02652-6b9e-43c8-a8b5-e86be69dd528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46a33386-573d-4bb1-80e5-62e2a4b91452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46a33386-573d-4bb1-80e5-62e2a4b91452" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f1b00053-0f9a-4e41-b6c7-b95be71306e2" xlink:to="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_7e0c58bb-d688-4f0b-a973-ce71c88b3d1d" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:to="loc_cah_MedicalMemberMember_7e0c58bb-d688-4f0b-a973-ce71c88b3d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_11f93b1f-7370-4ed3-9615-c5341139ed9e" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b3a7b21e-44c8-42e2-9ae1-4a1ec367ed79" xlink:to="loc_cah_PharmaceuticalMember_11f93b1f-7370-4ed3-9615-c5341139ed9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:to="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_2176b240-7f1d-4a3b-9ceb-ab772dd32263" xlink:to="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_daf10f3b-f5a6-4b2b-a6ec-3a43b8887f67" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_e6bf980c-7c07-4646-9556-4311ff317d73" xlink:to="loc_cah_CordisDivestitureMember_daf10f3b-f5a6-4b2b-a6ec-3a43b8887f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c0404a74-070c-4ae8-b561-a18037e1b34d" xlink:to="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:to="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_abcc0bc1-7450-4094-af40-c6fb7c7ac2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_Goodwill_abcc0bc1-7450-4094-af40-c6fb7c7ac2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_25c3502f-628f-41a3-b8fb-f8a9aac87f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_25c3502f-628f-41a3-b8fb-f8a9aac87f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c1e554c9-8cae-4475-a9ec-014e22bcd18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c1e554c9-8cae-4475-a9ec-014e22bcd18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_c9e66f3d-3136-4b94-a974-5dfcc0642589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_c9e66f3d-3136-4b94-a974-5dfcc0642589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_794aab9d-49ad-4973-b784-164921b2406c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_794aab9d-49ad-4973-b784-164921b2406c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8b980e2-ed6a-4f9f-bfe9-db11cfdff355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b0de3637-60a5-409c-ab3f-746cd32780e2" xlink:to="loc_us-gaap_Goodwill_b8b980e2-ed6a-4f9f-bfe9-db11cfdff355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aeea14bb-efac-4090-8916-ec6de71f2074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3957ee1e-cbc5-40bf-950c-dabe91f89d6e" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aeea14bb-efac-4090-8916-ec6de71f2074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cb9d6d9-b2a1-4fd2-8045-713d1f7d1e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cb9d6d9-b2a1-4fd2-8045-713d1f7d1e99" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4d700c75-e334-4b8e-b3a2-e22412e95b51" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IPRDTrademarksandOtherMember_05e70f8a-caf0-4f64-8b78-6e8f6959599b" xlink:href="cah-20220630.xsd#cah_IPRDTrademarksandOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_03e09a39-38b8-429d-a4f9-2e84e9e1a115" xlink:to="loc_cah_IPRDTrademarksandOtherMember_05e70f8a-caf0-4f64-8b78-6e8f6959599b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_891c05dc-6825-4ca7-b8c0-9cb028cb52ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37958349-0d73-47f5-bc3f-936b050ccaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_275671c0-baeb-4e46-81c0-b3ece0fdaca1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_37958349-0d73-47f5-bc3f-936b050ccaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cb9d6d9-b2a1-4fd2-8045-713d1f7d1e99" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b6943b5a-061f-45a3-a15a-cb7fd8de04e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2967d00f-42ea-46a2-a1c9-77378b6b7b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2967d00f-42ea-46a2-a1c9-77378b6b7b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TrademarksAndPatentsMember_d74754f4-2e84-41ff-8038-8ea644e4bc16" xlink:href="cah-20220630.xsd#cah_TrademarksAndPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_cah_TrademarksAndPatentsMember_d74754f4-2e84-41ff-8038-8ea644e4bc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ed5af643-26b0-4451-b37a-c37b5395c740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42cae976-6a8a-4b12-9f85-879d3b01eb47" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ed5af643-26b0-4451-b37a-c37b5395c740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_df46d87b-26d4-477a-9ae0-4c2efc3bc825" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d61dfc4e-cc64-4148-b1a7-fb70a02c1953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d61dfc4e-cc64-4148-b1a7-fb70a02c1953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_44362de1-c008-4763-aad5-9cd8203444b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_44362de1-c008-4763-aad5-9cd8203444b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_187a8371-4010-42e8-a1b3-0e8f74adf957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_187a8371-4010-42e8-a1b3-0e8f74adf957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d29ec060-b1a0-47b0-b90d-c921ba964428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d29ec060-b1a0-47b0-b90d-c921ba964428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_c81b13f8-8fd5-458f-9d3c-b4ea82744eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_760bc8d2-d1e1-4968-af10-c7a942e83938" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_c81b13f8-8fd5-458f-9d3c-b4ea82744eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e5ff2ef0-b971-4a6a-95fa-db46b363d2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cb9d6d9-b2a1-4fd2-8045-713d1f7d1e99" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e5ff2ef0-b971-4a6a-95fa-db46b363d2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ebc67acc-fd70-4116-bf03-cbc686a9de54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cb9d6d9-b2a1-4fd2-8045-713d1f7d1e99" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ebc67acc-fd70-4116-bf03-cbc686a9de54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c5ba0b86-63f5-4087-832d-45034d36b103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c5ba0b86-63f5-4087-832d-45034d36b103" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_39b2b69e-9e24-4440-b212-73d9f4903867" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_5a8d9c3b-8ec6-4e30-8890-3fdcf5db787a" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fced85c1-336a-4e38-9606-bee2920e1aea" xlink:to="loc_cah_NaviHealthMember_5a8d9c3b-8ec6-4e30-8890-3fdcf5db787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41b12b8d-eb58-4446-8709-8786a75b2510" xlink:to="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_87da93a1-3ac5-4c88-89cc-59a0d961afeb" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:to="loc_cah_MedicalMemberMember_87da93a1-3ac5-4c88-89cc-59a0d961afeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_cadfd387-5c11-4db5-a959-edbe335c0b10" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_876fe1c3-4263-4852-89f8-d78aa1659beb" xlink:to="loc_cah_PharmaceuticalMember_cadfd387-5c11-4db5-a959-edbe335c0b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_dafdb9a4-0657-452c-a462-5b8423a1991c" xlink:to="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_9e8c6a78-1300-4d10-8204-e2600db131d5" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_773281bf-fde4-42a4-81ae-46d89bbcc019" xlink:to="loc_cah_MedicalUnitMember_9e8c6a78-1300-4d10-8204-e2600db131d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9f9981f3-004c-44dc-8fc3-82312405a3ce" xlink:to="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DiscountRatefairvalueinputs_e1d3b114-6283-4a76-92a4-c1cae0e10b9d" xlink:href="cah-20220630.xsd#cah_DiscountRatefairvalueinputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_cah_DiscountRatefairvalueinputs_e1d3b114-6283-4a76-92a4-c1cae0e10b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc1fb658-501e-4ef2-a9b1-e108b3a10cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_Goodwill_cc1fb658-501e-4ef2-a9b1-e108b3a10cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0d8b4540-82b9-4aff-9b5a-32a5a37ea09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0d8b4540-82b9-4aff-9b5a-32a5a37ea09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c0ee6849-35ec-4ec4-9338-4076ed527bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c0ee6849-35ec-4ec4-9338-4076ed527bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_712fc2f7-0606-494e-99d9-263810b19c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_712fc2f7-0606-494e-99d9-263810b19c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_00445a48-5df7-47de-8d18-2a60493d8c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_00445a48-5df7-47de-8d18-2a60493d8c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b1e7784e-7e82-49fc-a837-26398b8722e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b1e7784e-7e82-49fc-a837-26398b8722e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_921c6b0f-541e-4ddb-8bc6-433db800cfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_921c6b0f-541e-4ddb-8bc6-433db800cfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5fa4dd5a-fb9c-4f03-a013-d3280428d113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5fa4dd5a-fb9c-4f03-a013-d3280428d113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b47a1373-974a-4b88-bbb7-fe23d7e2e658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b47a1373-974a-4b88-bbb7-fe23d7e2e658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TerminalGrowthRateFairValueInput_73408293-c123-41fb-8260-a3f18347110e" xlink:href="cah-20220630.xsd#cah_TerminalGrowthRateFairValueInput"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_1a22e611-0824-4458-a55b-21f811b50aa5" xlink:to="loc_cah_TerminalGrowthRateFairValueInput_73408293-c123-41fb-8260-a3f18347110e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:type="simple" xlink:href="cah-20220630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d11cd55b-b437-4827-abb8-1e911cc9e899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesTextBlock_c458b498-ee8b-4752-b73c-ff84b442b360" xlink:href="cah-20220630.xsd#cah_LeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d11cd55b-b437-4827-abb8-1e911cc9e899" xlink:to="loc_cah_LeasesTextBlock_c458b498-ee8b-4752-b73c-ff84b442b360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_712879c3-0b9a-4983-aebf-112f73929519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_712879c3-0b9a-4983-aebf-112f73929519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_8d3c88eb-baa9-41c6-aff1-bdcb146a3b6b" xlink:href="cah-20220630.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:to="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_8d3c88eb-baa9-41c6-aff1-bdcb146a3b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LeasePaymentsTableTextBlock_7a85547a-f47b-4900-addc-97c699d0ff5a" xlink:href="cah-20220630.xsd#cah_LeasePaymentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:to="loc_cah_LeasePaymentsTableTextBlock_7a85547a-f47b-4900-addc-97c699d0ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e5dbf16d-8a2f-433f-bacc-40d2cc796d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e5dbf16d-8a2f-433f-bacc-40d2cc796d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_93e71e5b-ecb6-424f-b969-2aa3053de7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fc4d99ad-2770-4b02-9f09-9c882bf08772" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_93e71e5b-ecb6-424f-b969-2aa3053de7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5cd71acf-0d59-4f1e-bde2-e51afe7c6031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cd71acf-0d59-4f1e-bde2-e51afe7c6031" xlink:to="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:to="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b3b2c50b-cb1b-4151-b7ba-9073ad6a4ca4" xlink:to="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f72161bc-0cc6-4b81-bda1-1cc2c1cd347a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:to="loc_srt_MinimumMember_f72161bc-0cc6-4b81-bda1-1cc2c1cd347a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bf808d7-35fa-4a7a-93c2-5386c3b9ad49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_411a3e04-97f1-4bb4-8dcc-202b5ba1b37f" xlink:to="loc_srt_MaximumMember_6bf808d7-35fa-4a7a-93c2-5386c3b9ad49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cf81535d-4872-42ce-80e9-5b4d0934576a" xlink:to="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_89e3fff9-891f-438c-a1bd-0227ab19044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_89e3fff9-891f-438c-a1bd-0227ab19044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_8ab2bb67-d31c-4b96-bfad-80f31858420c" xlink:href="cah-20220630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_8ab2bb67-d31c-4b96-bfad-80f31858420c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_416a96dd-c649-405e-8b10-a02f2d27027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_416a96dd-c649-405e-8b10-a02f2d27027b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5f8f2417-a8ba-41e6-85b0-6a6d508235c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5f8f2417-a8ba-41e6-85b0-6a6d508235c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f86c9169-df6e-4141-88e7-2af17a0a5f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f86c9169-df6e-4141-88e7-2af17a0a5f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf5c80d7-97ec-40a4-8d1a-ce5cf2d4b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4988294-0649-4320-b87b-08290648102e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf5c80d7-97ec-40a4-8d1a-ce5cf2d4b090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesScheduleofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_923eefdc-ef28-4439-8e9f-fc74a4304db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dd550342-723f-47e9-91bd-59fd95e8bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_923eefdc-ef28-4439-8e9f-fc74a4304db0" xlink:to="loc_us-gaap_OperatingLeaseCost_dd550342-723f-47e9-91bd-59fd95e8bea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f84a607a-6d06-48a2-a901-9da2fe548c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_923eefdc-ef28-4439-8e9f-fc74a4304db0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f84a607a-6d06-48a2-a901-9da2fe548c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_63042129-ae2b-4c6b-9402-1ec665643dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_923eefdc-ef28-4439-8e9f-fc74a4304db0" xlink:to="loc_us-gaap_VariableLeaseCost_63042129-ae2b-4c6b-9402-1ec665643dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c2777f81-7cee-4cf9-9526-dcc388513472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_923eefdc-ef28-4439-8e9f-fc74a4304db0" xlink:to="loc_us-gaap_LeaseCost_c2777f81-7cee-4cf9-9526-dcc388513472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5a81813-6db3-4551-89d4-060a398a5560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5a81813-6db3-4551-89d4-060a398a5560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_700a4dde-8155-4abd-bfcb-7ce0bf86db04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_700a4dde-8155-4abd-bfcb-7ce0bf86db04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6655576b-be1a-45ba-a1f2-07fed7397026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6655576b-be1a-45ba-a1f2-07fed7397026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_af7fae85-ccf9-4741-888c-0062300b7e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseLiability_af7fae85-ccf9-4741-888c-0062300b7e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7c2e2ae2-44b7-4753-865d-f63faaffde1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseLiability_7c2e2ae2-44b7-4753-865d-f63faaffde1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e61eab33-3e20-4039-b4e9-7c301795138b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e61eab33-3e20-4039-b4e9-7c301795138b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e88b887b-f074-475f-89ad-7669338693ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e88b887b-f074-475f-89ad-7669338693ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6b1ec31b-f502-43d4-bc2b-2185a649f56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6b1ec31b-f502-43d4-bc2b-2185a649f56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d13af29b-0301-41df-8da1-ee9e6474d751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d13af29b-0301-41df-8da1-ee9e6474d751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b5e529f2-96c5-4674-8005-f4f45ba66040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b5e529f2-96c5-4674-8005-f4f45ba66040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2b93c2f1-f36a-4ab4-802a-8dd120870edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2b93c2f1-f36a-4ab4-802a-8dd120870edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2998b2d5-31d1-4ca9-8a1c-afbbb82aa905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2998b2d5-31d1-4ca9-8a1c-afbbb82aa905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_442cc078-9366-4909-9df9-031a424fc0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_442cc078-9366-4909-9df9-031a424fc0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9cf8a1ef-1d7e-47ae-8107-48c2d674bc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9cf8a1ef-1d7e-47ae-8107-48c2d674bc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_df6543cf-0a9b-4b14-b4f3-6c235d54ddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_df6543cf-0a9b-4b14-b4f3-6c235d54ddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2acd0e00-8789-4dea-b92b-ba53ee86fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2acd0e00-8789-4dea-b92b-ba53ee86fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_01543152-c91f-4760-8a45-93d623bbcda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_01543152-c91f-4760-8a45-93d623bbcda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d61d31f8-5aa2-47a1-86a6-b957666a492b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cda3cbad-4318-4a4a-955b-d2adefc69bf2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d61d31f8-5aa2-47a1-86a6-b957666a492b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_42eebd57-ae1c-405d-be8e-d37129b86261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42eebd57-ae1c-405d-be8e-d37129b86261" xlink:to="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cf6238f7-de46-4404-a607-77c83cb2fe8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ASC842Member_8494fa5b-fccd-42da-a9b7-db353f9f47fb" xlink:href="cah-20220630.xsd#cah_ASC842Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6fd15429-1fd6-4590-8998-f938984a37a5" xlink:to="loc_cah_ASC842Member_8494fa5b-fccd-42da-a9b7-db353f9f47fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_98319817-275d-4f0f-b843-d7e742e7ab74" xlink:to="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_310eb597-f5cf-4181-bcea-6b2e73c0c8ec" xlink:href="cah-20220630.xsd#cah_Impactofadoptionofnewaccountingstandard"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_310eb597-f5cf-4181-bcea-6b2e73c0c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_fade2189-ec71-4f01-a66b-93a5614a69be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_OperatingLeasePayments_fade2189-ec71-4f01-a66b-93a5614a69be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_e2e4eb58-6097-49d6-bdd5-c90f2fa7e1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_e2e4eb58-6097-49d6-bdd5-c90f2fa7e1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_208b3543-1074-418c-bcbe-f0179c9350ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_208b3543-1074-418c-bcbe-f0179c9350ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_46e286f1-162e-4048-9fc8-06619c06988c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_46e286f1-162e-4048-9fc8-06619c06988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_6c57262e-e91b-40a4-b16d-e8848ffdcd26" xlink:href="cah-20220630.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_35644576-254e-4515-9f6a-c60150748274" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_6c57262e-e91b-40a4-b16d-e8848ffdcd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LeasesScheduleofFutureLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4fc67420-d41a-4870-8cf5-7aa727397365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fc67420-d41a-4870-8cf5-7aa727397365" xlink:to="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d6d03c43-aff0-447d-9fd3-ac5d1e536e6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseMember_8510b394-65b0-4b28-a570-ff59a03ee391" xlink:href="cah-20220630.xsd#cah_OperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:to="loc_cah_OperatingLeaseMember_8510b394-65b0-4b28-a570-ff59a03ee391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseMember_fd1da9ba-80b1-419e-b731-0a0c51c55c73" xlink:href="cah-20220630.xsd#cah_FinanceLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5da41d74-a24e-473d-923e-1ee801f23e48" xlink:to="loc_cah_FinanceLeaseMember_fd1da9ba-80b1-419e-b731-0a0c51c55c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_31297461-35e3-4993-b3ce-60841aedc7ce" xlink:to="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7e21ceb5-be6a-4cd1-9ad2-2536325ba74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7e21ceb5-be6a-4cd1-9ad2-2536325ba74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f3aac4ed-c0a3-4500-9d60-d4eff4aeefdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f3aac4ed-c0a3-4500-9d60-d4eff4aeefdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_1aa53fd1-02dd-4746-9186-13fc81a6799f" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearOne_1aa53fd1-02dd-4746-9186-13fc81a6799f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57e2a5e8-c7b3-4a68-a027-aee6cd454ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57e2a5e8-c7b3-4a68-a027-aee6cd454ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_90d0baae-c933-4ca3-96a8-3ca5ef7aed4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_90d0baae-c933-4ca3-96a8-3ca5ef7aed4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_5c500189-3e7b-4c66-b3b1-31f5853d2a9f" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_5c500189-3e7b-4c66-b3b1-31f5853d2a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_db9c54ab-ac59-4b8c-a6f3-0ee54e2aacd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_db9c54ab-ac59-4b8c-a6f3-0ee54e2aacd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_44600d80-771d-442a-8391-4b109cc71d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_44600d80-771d-442a-8391-4b109cc71d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_997a1fb9-0649-4c73-88fe-0d3db051e84a" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_997a1fb9-0649-4c73-88fe-0d3db051e84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f74fda8-a679-401e-b619-c9f2d4e842f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f74fda8-a679-401e-b619-c9f2d4e842f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_09db63dd-b2a0-4b89-a391-028f23f791ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_09db63dd-b2a0-4b89-a391-028f23f791ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_cefdae24-d10a-4485-8a50-c978881d3b46" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_cefdae24-d10a-4485-8a50-c978881d3b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6ea5cd9-6e03-4955-b008-60cfe98da671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b6ea5cd9-6e03-4955-b008-60cfe98da671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24983ff2-5ab7-442d-8b9f-2eab0883f045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24983ff2-5ab7-442d-8b9f-2eab0883f045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_18af446a-2d5d-46bc-970c-e72c4398219b" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_18af446a-2d5d-46bc-970c-e72c4398219b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fbc0a714-6a9c-45bb-8783-b3f15a64e786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fbc0a714-6a9c-45bb-8783-b3f15a64e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_691f20be-9e92-4a20-8d6f-2f7f5324649a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_691f20be-9e92-4a20-8d6f-2f7f5324649a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_0102668a-3366-44d1-a2b8-8f36e11a0115" xlink:href="cah-20220630.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_0102668a-3366-44d1-a2b8-8f36e11a0115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_00076ad0-b840-443d-8119-52629a191711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_00076ad0-b840-443d-8119-52629a191711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d4bb9f6-7d09-40e9-baae-be58a1ba22d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d4bb9f6-7d09-40e9-baae-be58a1ba22d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_409dd38e-d88f-4ddc-a8ca-64ab55cee16d" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_409dd38e-d88f-4ddc-a8ca-64ab55cee16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OperatingLeaseImputedInterest_a41e09fd-bbb0-4b00-bf0d-8b2d5a1e5557" xlink:href="cah-20220630.xsd#cah_OperatingLeaseImputedInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_OperatingLeaseImputedInterest_a41e09fd-bbb0-4b00-bf0d-8b2d5a1e5557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FinanceLeaseImputedInterest_8827e631-0181-41d5-9b56-bf8b2f0bbbe8" xlink:href="cah-20220630.xsd#cah_FinanceLeaseImputedInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_FinanceLeaseImputedInterest_8827e631-0181-41d5-9b56-bf8b2f0bbbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_c658b339-99e6-4d3a-a3f2-55fb5195c206" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_c658b339-99e6-4d3a-a3f2-55fb5195c206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e43bd090-0e45-4016-8a3d-47c510375cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_OperatingLeaseLiability_e43bd090-0e45-4016-8a3d-47c510375cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fcf3f180-78a9-4d09-aae3-15dab67a05db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_us-gaap_FinanceLeaseLiability_fcf3f180-78a9-4d09-aae3-15dab67a05db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalLeaseLiability_1f2ebbe6-3228-471b-bfd4-12a7886fa77f" xlink:href="cah-20220630.xsd#cah_TotalLeaseLiability"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2653cf51-89e2-41ec-a212-2241444a18ce" xlink:to="loc_cah_TotalLeaseLiability_1f2ebbe6-3228-471b-bfd4-12a7886fa77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowings"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8cc23ec5-1e58-4ae1-9f08-7e7fe8ac7df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6b1a9474-b1a6-4739-a4c6-8b8b0df0a324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8cc23ec5-1e58-4ae1-9f08-7e7fe8ac7df6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6b1a9474-b1a6-4739-a4c6-8b8b0df0a324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7d2e3536-7c98-411b-b613-52c59de90f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_054a0e8f-8f54-4532-ae7d-c46655e49996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7d2e3536-7c98-411b-b613-52c59de90f45" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_054a0e8f-8f54-4532-ae7d-c46655e49996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49519993-802f-4a7a-9986-8a1a9523a22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49519993-802f-4a7a-9986-8a1a9523a22e" xlink:to="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:to="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_29f942d3-bd70-4265-8dd0-b3e01e1c0b98" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_68ea7d7b-d829-4501-845a-1efe3b0e9769" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A24NotesDue2019Member_68ea7d7b-d829-4501-845a-1efe3b0e9769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_be5995ea-2422-4ab6-a0c8-23c6f0d172a1" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.625Notesdue2021Member_be5995ea-2422-4ab6-a0c8-23c6f0d172a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_78db32e8-3bfe-4c6c-93e5-fe63ea044be1" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A2.616Notesdue2022Member_78db32e8-3bfe-4c6c-93e5-fe63ea044be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_c9da4ecf-883a-4aca-bba4-0af6b653ceec" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.2Notesdue2022Member_c9da4ecf-883a-4aca-bba4-0af6b653ceec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_19fafea9-edcd-48ce-94c3-b33066a382dd" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_FloatingRateNotesdue2022Member_19fafea9-edcd-48ce-94c3-b33066a382dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_1c4411ae-9277-4b05-9a0e-dc9b30ba1686" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.2Notesdue2023Member_1c4411ae-9277-4b05-9a0e-dc9b30ba1686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_955eeff9-7047-482e-9a37-6ad30edbed0d" xlink:href="cah-20220630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.079Notesdue2024Member_955eeff9-7047-482e-9a37-6ad30edbed0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_6c89e28b-883c-43c3-bab8-8f7be4244ab1" xlink:href="cah-20220630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.5Notesdue2025Member_6c89e28b-883c-43c3-bab8-8f7be4244ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_4504bd1e-7dec-464a-843a-f359414cc5fc" xlink:href="cah-20220630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.75Notesdue2026Member_4504bd1e-7dec-464a-843a-f359414cc5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_f34b5aa0-915d-4bcc-9a1c-89b90964e80d" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A3.41Notesdue2027Member_f34b5aa0-915d-4bcc-9a1c-89b90964e80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_83481cd2-9c5f-4cf6-bbd3-9132ff0b6f29" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.6Notesdue2043Member_83481cd2-9c5f-4cf6-bbd3-9132ff0b6f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_c8e9330c-a074-495e-b86f-08ee3725d654" xlink:href="cah-20220630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.5Notesdue2044Member_c8e9330c-a074-495e-b86f-08ee3725d654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_65839359-50d4-4534-a5e9-05394b2d98c6" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.9Notesdue2045Member_65839359-50d4-4534-a5e9-05394b2d98c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_765e1fd8-bd7b-4434-87f3-19f98e248e8c" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A4.368Notesdue2047Member_765e1fd8-bd7b-4434-87f3-19f98e248e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_b935e77c-ba2d-47dd-863d-b6a16b2f14e4" xlink:href="cah-20220630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5afffa5b-d3f8-472d-a87b-12dd65783252" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_b935e77c-ba2d-47dd-863d-b6a16b2f14e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3017cb3e-8969-4634-9ab6-d8b9f47b6f20" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4ddcb95-d1ef-458d-b6cf-8f7bf687a1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4ddcb95-d1ef-458d-b6cf-8f7bf687a1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_53774334-2200-4360-8d93-385da687386b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_NotesPayable_53774334-2200-4360-8d93-385da687386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_eba0c144-9376-4104-b54d-c1e8c9a434f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_OtherBorrowings_eba0c144-9376-4104-b54d-c1e8c9a434f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c9e12e71-5ce5-4dc5-8a63-4731c62b9000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c9e12e71-5ce5-4dc5-8a63-4731c62b9000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19bcaab3-b479-4bd9-81ae-201d1f7e04af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19bcaab3-b479-4bd9-81ae-201d1f7e04af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5c4e2da2-f63d-4b03-9095-f9cbe0721c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fa569eea-ba39-4ce4-916a-546a1e54f8b8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5c4e2da2-f63d-4b03-9095-f9cbe0721c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c79e82-7133-4c96-8831-80158b75ed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7a900c0a-0ea5-46a9-90f9-d5bc0c2ee04e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c79e82-7133-4c96-8831-80158b75ed8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c45510b3-0a28-404f-9057-bbb5b05ad341" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_eca837c5-413a-4d0d-b9e0-2dbe363e3f5a" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A2.616Notesdue2022Member_eca837c5-413a-4d0d-b9e0-2dbe363e3f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_4c8e9d78-4d7e-497c-a068-a3d065f2c52b" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.2Notesdue2023Member_4c8e9d78-4d7e-497c-a068-a3d065f2c52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_be4017e3-f627-4908-b636-16a1d06f205d" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_FloatingRateNotesdue2022Member_be4017e3-f627-4908-b636-16a1d06f205d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_a8d9f691-2908-453a-bc18-e55dabcb8933" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.41Notesdue2027Member_a8d9f691-2908-453a-bc18-e55dabcb8933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_63c9b989-4c08-45c0-9499-4e18fa46057a" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.6Notesdue2043Member_63c9b989-4c08-45c0-9499-4e18fa46057a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_3a9cc52a-6a2c-4a2d-a36a-678acc920a78" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.9Notesdue2045Member_3a9cc52a-6a2c-4a2d-a36a-678acc920a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_a0796eba-8e52-4863-878b-b0e253eee4b6" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.368Notesdue2047Member_a0796eba-8e52-4863-878b-b0e253eee4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_e9b65b36-6f80-4039-9823-08ca2e610a15" xlink:href="cah-20220630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_e9b65b36-6f80-4039-9823-08ca2e610a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_2919252c-d2d6-4c04-aedb-6b3513df0fc2" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A4.625Notesdue2021Member_2919252c-d2d6-4c04-aedb-6b3513df0fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_91b91357-9c70-4b1a-ad3f-b9e024112130" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A3.2Notesdue2022Member_91b91357-9c70-4b1a-ad3f-b9e024112130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotes2616NotesMember_e6db5bbf-d352-4333-93a6-fe51949c6991" xlink:href="cah-20220630.xsd#cah_FloatingRateNotes2616NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_FloatingRateNotes2616NotesMember_e6db5bbf-d352-4333-93a6-fe51949c6991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A32Notes2616NotesMember_fe9a05e7-a065-4b6b-aa3e-e2fdefd2bcb1" xlink:href="cah-20220630.xsd#cah_A32Notes2616NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A32Notes2616NotesMember_fe9a05e7-a065-4b6b-aa3e-e2fdefd2bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_3b403553-2920-4e71-b863-a50e0b1b6f72" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14e34a52-45f5-4c1b-8888-9324e1c0daee" xlink:to="loc_cah_A24NotesDue2019Member_3b403553-2920-4e71-b863-a50e0b1b6f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7336277b-515f-4a0d-8eda-04ee8449b087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_da9be430-d138-4646-80e6-da1e6ba679df" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7336277b-515f-4a0d-8eda-04ee8449b087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_05a5bacd-60fc-42a0-84ec-544217d2e475" xlink:to="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b3dc0c97-8d33-43e4-b856-0975e40d7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_LetterOfCreditMember_b3dc0c97-8d33-43e4-b856-0975e40d7c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_8343d44d-6d45-462e-887e-ad980f01bca7" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_8343d44d-6d45-462e-887e-ad980f01bca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9ed1b9c2-fc38-4740-94fc-2615c710bda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9ed1b9c2-fc38-4740-94fc-2615c710bda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_25e35c70-1680-48b9-adf1-a93ea1b52637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_us-gaap_CommercialPaperMember_25e35c70-1680-48b9-adf1-a93ea1b52637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_228fc80e-7ce1-4df9-9990-806c45bd2b2c" xlink:href="cah-20220630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_782154c2-d815-470e-934f-aa4b8699d07c" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_228fc80e-7ce1-4df9-9990-806c45bd2b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_655b7c62-1994-4e22-925e-b92bff763a61" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6cceecdf-7894-4487-9b99-465932534777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCredit_6cceecdf-7894-4487-9b99-465932534777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b5004446-5ca9-4578-9f39-363d8c5de543" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_dei_DocumentFiscalYearFocus_b5004446-5ca9-4578-9f39-363d8c5de543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ce2cfd1d-082b-4aa7-a269-28dad0a5773c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_AccountsPayableCurrent_ce2cfd1d-082b-4aa7-a269-28dad0a5773c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_95145b87-8a49-4225-a079-e38c27202dc2" xlink:href="cah-20220630.xsd#cah_NotesPayableRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_cah_NotesPayableRepurchased_95145b87-8a49-4225-a079-e38c27202dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_5e1bf588-55de-4318-aae6-777f50759686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_5e1bf588-55de-4318-aae6-777f50759686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c85f3f6-e2b7-49d2-84ec-f37509a804d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c85f3f6-e2b7-49d2-84ec-f37509a804d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_14fb5501-f237-482b-803c-714d53e0e175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_OtherBorrowings_14fb5501-f237-482b-803c-714d53e0e175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecd776ea-b54f-42a6-9b3e-0fbca06824e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecd776ea-b54f-42a6-9b3e-0fbca06824e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_0d29dbbd-b6e3-46e7-a1e3-f70b20b453a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e1c4f955-1f5e-49ca-aefc-80e1597c6418" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_0d29dbbd-b6e3-46e7-a1e3-f70b20b453a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57b5bbdb-ec1a-45b4-b1b3-657f756dcbef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57b5bbdb-ec1a-45b4-b1b3-657f756dcbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_11628822-fc73-4238-b04b-2db57f0fada7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_11628822-fc73-4238-b04b-2db57f0fada7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_da509b2f-8c8d-4c98-a784-73072f546dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_da509b2f-8c8d-4c98-a784-73072f546dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7846dfa2-17d3-4124-acce-9cebfb041c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7846dfa2-17d3-4124-acce-9cebfb041c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c9b390b4-c806-4ccb-87bd-c60eea04b1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c9b390b4-c806-4ccb-87bd-c60eea04b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6a9b7825-f983-4e3e-9cc6-eb506da390af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d34c5251-b1ac-4916-850d-bd07f7049f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6a9b7825-f983-4e3e-9cc6-eb506da390af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ff697308-8946-4f2d-aa41-7b7ef78576ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ff697308-8946-4f2d-aa41-7b7ef78576ec" xlink:to="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a97d16c5-6aa7-445d-bbe3-a8d368fef188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b4ae923e-8138-4e9b-84fd-8ff30c7597c3" xlink:to="loc_us-gaap_CreditFacilityDomain_a97d16c5-6aa7-445d-bbe3-a8d368fef188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b74c5b8-7ec6-4c70-9f0d-99a1a7a62cc3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notesdue2022Member_ca2c0005-3396-4575-afb0-71f687683212" xlink:href="cah-20220630.xsd#cah_A2.616Notesdue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A2.616Notesdue2022Member_ca2c0005-3396-4575-afb0-71f687683212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.079Notesdue2024Member_398e2b11-3108-4378-a2b0-2363e8ddf978" xlink:href="cah-20220630.xsd#cah_A3.079Notesdue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.079Notesdue2024Member_398e2b11-3108-4378-a2b0-2363e8ddf978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.41Notesdue2027Member_2101b88e-3aac-4201-bd8b-16d9f84c8fc2" xlink:href="cah-20220630.xsd#cah_A3.41Notesdue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.41Notesdue2027Member_2101b88e-3aac-4201-bd8b-16d9f84c8fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.368Notesdue2047Member_28427701-f10a-41fa-a3cd-aba46736c135" xlink:href="cah-20220630.xsd#cah_A4.368Notesdue2047Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.368Notesdue2047Member_28427701-f10a-41fa-a3cd-aba46736c135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_1ce792d9-4a0c-4366-9b4b-95aead1c5c8d" xlink:href="cah-20220630.xsd#cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember_1ce792d9-4a0c-4366-9b4b-95aead1c5c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FloatingRateNotesdue2022Member_0e1cf721-e5d5-4a73-8b8a-6b2ad7888a4d" xlink:href="cah-20220630.xsd#cah_FloatingRateNotesdue2022Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_FloatingRateNotesdue2022Member_0e1cf721-e5d5-4a73-8b8a-6b2ad7888a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A24NotesDue2019Member_40f2675a-119c-4467-9f93-9a08a59f70f9" xlink:href="cah-20220630.xsd#cah_A24NotesDue2019Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A24NotesDue2019Member_40f2675a-119c-4467-9f93-9a08a59f70f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2022Member_b7e90ff3-86f2-47c5-b857-c72326d1f8f1" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2022Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.2Notesdue2022Member_b7e90ff3-86f2-47c5-b857-c72326d1f8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.2Notesdue2023Member_2601f1af-9800-41c0-98a6-e4f4b7890f8e" xlink:href="cah-20220630.xsd#cah_A3.2Notesdue2023Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.2Notesdue2023Member_2601f1af-9800-41c0-98a6-e4f4b7890f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.5Notesdue2025Member_cff33b3d-4163-44ed-8c2e-7670e0e0b6de" xlink:href="cah-20220630.xsd#cah_A3.5Notesdue2025Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.5Notesdue2025Member_cff33b3d-4163-44ed-8c2e-7670e0e0b6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A3.75Notesdue2026Member_b4de5871-e21f-4c26-86fc-54d700d329b7" xlink:href="cah-20220630.xsd#cah_A3.75Notesdue2026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A3.75Notesdue2026Member_b4de5871-e21f-4c26-86fc-54d700d329b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.5Notesdue2044Member_19b44eef-44e3-4d01-b77d-bf3291d1cda6" xlink:href="cah-20220630.xsd#cah_A4.5Notesdue2044Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.5Notesdue2044Member_19b44eef-44e3-4d01-b77d-bf3291d1cda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.6Notesdue2043Member_aad22b01-c842-41af-bfdd-65ae5a74ac50" xlink:href="cah-20220630.xsd#cah_A4.6Notesdue2043Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.6Notesdue2043Member_aad22b01-c842-41af-bfdd-65ae5a74ac50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.625Notesdue2021Member_25c4b1df-8a2f-4aa8-8945-4cae7c47ce3d" xlink:href="cah-20220630.xsd#cah_A4.625Notesdue2021Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.625Notesdue2021Member_25c4b1df-8a2f-4aa8-8945-4cae7c47ce3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A4.9Notesdue2045Member_983f6ae5-b23b-4823-a3cd-800ba20450f8" xlink:href="cah-20220630.xsd#cah_A4.9Notesdue2045Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A4.9Notesdue2045Member_983f6ae5-b23b-4823-a3cd-800ba20450f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_302ce194-bf11-4bb1-9442-5bc669ed6095" xlink:href="cah-20220630.xsd#cah_A7.0Debenturesduefiscal2027Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c49fdf5-c594-4dc7-8754-4fc73a0fae09" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_302ce194-bf11-4bb1-9442-5bc669ed6095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_006a63bd-ff8e-4871-b110-fd90426671a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1dbd498e-0652-4fc4-864b-ebed4120a595" xlink:to="loc_dei_EntityDomain_006a63bd-ff8e-4871-b110-fd90426671a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8f2d137-05de-40b0-b67c-545188669d39" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7d6ebee7-41a9-40f6-a48a-500001bed576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_AccountsPayableCurrent_7d6ebee7-41a9-40f6-a48a-500001bed576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3aef816a-6254-4ae8-8764-53f6032e44a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3aef816a-6254-4ae8-8764-53f6032e44a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OfferAsPercentageOfPrincipalAmount_4f0976cb-c3f5-41ba-ab42-6b366cd80865" xlink:href="cah-20220630.xsd#cah_OfferAsPercentageOfPrincipalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_cah_OfferAsPercentageOfPrincipalAmount_4f0976cb-c3f5-41ba-ab42-6b366cd80865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5df2576-e159-444b-869b-72f8e77c9871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_LineOfCredit_b5df2576-e159-444b-869b-72f8e77c9871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5f61c5ac-5a3f-4ac1-a5b4-799119effffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5f61c5ac-5a3f-4ac1-a5b4-799119effffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_afbf9f7d-e096-4bf2-95ca-0a691cf5c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_afbf9f7d-e096-4bf2-95ca-0a691cf5c7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NotesPayableRepurchased_fccdb0c8-0183-4879-be32-c0a2fe9ce1e8" xlink:href="cah-20220630.xsd#cah_NotesPayableRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc21914e-8a30-4dd7-ae9b-f897454ac224" xlink:to="loc_cah_NotesPayableRepurchased_fccdb0c8-0183-4879-be32-c0a2fe9ce1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c2fd8eee-6389-491d-ad85-d5e1607a6e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c2fd8eee-6389-491d-ad85-d5e1607a6e05" xlink:to="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5ecf7ebe-717d-41b9-8db8-481caeed1d80" xlink:to="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7803417e-db0b-4758-a60d-b425878732f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7803417e-db0b-4758-a60d-b425878732f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_75d94cf5-e0b9-4256-a65c-5b43f893b338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_LetterOfCreditMember_75d94cf5-e0b9-4256-a65c-5b43f893b338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_a62d05ba-933c-4ffa-b217-b069396c9be8" xlink:href="cah-20220630.xsd#cah_ShortTermCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_a62d05ba-933c-4ffa-b217-b069396c9be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b7606946-f401-4501-aeb9-dd33369335f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_us-gaap_CommercialPaperMember_b7606946-f401-4501-aeb9-dd33369335f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_2fce0bb1-3a31-4338-bd25-ef61653dab5a" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f2b13694-233e-4f59-b5b5-d6b26d05b9fe" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_2fce0bb1-3a31-4338-bd25-ef61653dab5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d620181-e545-413c-9547-0408e2a4c754" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ff7253bb-2c1f-41d3-b279-b4d25d6b18c1" xlink:href="cah-20220630.xsd#cah_CommittedReceivablesSalesFacilityProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23d27003-6633-4fe0-b51a-5da913cb4197" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ff7253bb-2c1f-41d3-b279-b4d25d6b18c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85d538d0-3a26-4880-ac2e-87c963c317d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_94554626-2d60-437f-98b1-2e9b43af6ff4" xlink:to="loc_srt_RangeMember_85d538d0-3a26-4880-ac2e-87c963c317d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_246af3e0-dd90-49ea-b90a-6bfee5875193" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61f4e177-dda5-4cdd-83b9-0a13317659cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61f4e177-dda5-4cdd-83b9-0a13317659cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9b10c5fe-2bd6-4bd1-a072-fedff00c41ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCredit_9b10c5fe-2bd6-4bd1-a072-fedff00c41ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherBorrowings_4e8dbe75-da1b-4224-8f3a-cb0b75a4084d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_OtherBorrowings_4e8dbe75-da1b-4224-8f3a-cb0b75a4084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_b223abff-e876-4465-9a59-ca967972f659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_OtherShortTermBorrowings_b223abff-e876-4465-9a59-ca967972f659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_cb3dc345-a47d-4f41-8f34-ac94e3797ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7e41bc7d-64d8-4e72-b65d-987a02bcb929" xlink:to="loc_us-gaap_LineOfCreditFacilityAverageOutstandingAmount_cb3dc345-a47d-4f41-8f34-ac94e3797ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation" xlink:type="simple" xlink:href="cah-20220630.xsd#CommitmentsContingentLiabilitiesandLitigation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40e3d3b9-7ef6-451b-89e3-47f3d9a047df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f57c9fc0-a696-446d-b378-9600356e4c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40e3d3b9-7ef6-451b-89e3-47f3d9a047df" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f57c9fc0-a696-446d-b378-9600356e4c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#CommitmentsContingentLiabilitiesandLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b1747b9a-1aa6-41e9-9a22-81f79a33eebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b1747b9a-1aa6-41e9-9a22-81f79a33eebb" xlink:to="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:href="cah-20220630.xsd#cah_LawsuitTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:href="cah-20220630.xsd#cah_LawsuitTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeAxis_8291620b-28a0-4789-9815-97a68ad11275" xlink:to="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_5f3a4208-309c-4109-bbc5-fa57418bd754" xlink:href="cah-20220630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeDomain_57b60f47-c835-44c1-b3e7-b0866108965c" xlink:to="loc_cah_ClassActionLawsuitsMember_5f3a4208-309c-4109-bbc5-fa57418bd754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:href="cah-20220630.xsd#cah_PlaintiffTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeAxis_fe9b4da0-a800-4f51-9b19-45ed5edf210b" xlink:to="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PrivatePartiesMember_43831bbd-7284-4ad8-b1ac-25038fbbfd2f" xlink:href="cah-20220630.xsd#cah_PrivatePartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeDomain_4efde676-57c9-4a45-8fed-b20140aa7069" xlink:to="loc_cah_PrivatePartiesMember_43831bbd-7284-4ad8-b1ac-25038fbbfd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_2fef1472-be3d-4e4e-b087-f583e6a3db61" xlink:to="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_f4d02261-dc7f-4a2a-953a-0f57f6d48ea7" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_90d0cc3d-72fe-4c07-a94f-17d11d5c42af" xlink:to="loc_cah_TotalOpioidLitigationMember_f4d02261-dc7f-4a2a-953a-0f57f6d48ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:href="cah-20220630.xsd#cah_GownRecallAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GownRecallDomain_4d134d71-00ea-4c55-b505-afa6c1d54736" xlink:href="cah-20220630.xsd#cah_GownRecallDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:to="loc_cah_GownRecallDomain_4d134d71-00ea-4c55-b505-afa6c1d54736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_a1779ff5-69ac-4bef-ab6a-37cbb2160b0c" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_8f09db65-531c-4b6d-98be-37dffe3df8da" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_a1779ff5-69ac-4bef-ab6a-37cbb2160b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_64fad793-8163-4804-8b3e-c94671eb6d97" xlink:to="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0bf50061-37cb-4839-898e-73f9fc47dff9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:to="loc_srt_MinimumMember_0bf50061-37cb-4839-898e-73f9fc47dff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b844cf0-de60-4e31-a46d-c5064a5ece2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8479e935-b6b2-4c82-9042-001a5167790b" xlink:to="loc_srt_MaximumMember_5b844cf0-de60-4e31-a46d-c5064a5ece2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_719f1a99-12de-4dbb-b41e-b68feecc8c0c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_837da4ba-b31f-40fc-969d-e87373f68647" xlink:href="cah-20220630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_68fbd9c5-8bd9-46e8-9bc0-271cade625c1" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_837da4ba-b31f-40fc-969d-e87373f68647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:href="cah-20220630.xsd#cah_LitigationTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:href="cah-20220630.xsd#cah_LitigationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeAxis_c2f33ab8-284c-49c6-9e2f-477423a08121" xlink:to="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ClassActionLawsuitsMember_29bdaabd-f549-47ae-a347-b091b0b00667" xlink:href="cah-20220630.xsd#cah_ClassActionLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeDomain_d928554d-62ac-4aa4-a936-917736b11116" xlink:to="loc_cah_ClassActionLawsuitsMember_29bdaabd-f549-47ae-a347-b091b0b00667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f80876b8-6578-4a25-906e-29dccc5361d8" xlink:to="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AlamedaCountyMember_b5c3db33-22d1-444d-a83e-bd1d99b85b38" xlink:href="cah-20220630.xsd#cah_AlamedaCountyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_cah_AlamedaCountyMember_b5c3db33-22d1-444d-a83e-bd1d99b85b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_69b267ff-2dde-4327-a59a-95c22f84ba71" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_WA_69b267ff-2dde-4327-a59a-95c22f84ba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_bd825ffc-2269-4bea-acd5-b8a2976d842d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_WV_bd825ffc-2269-4bea-acd5-b8a2976d842d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_a552915b-16b2-4d88-8219-fa362de859e7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_OK_a552915b-16b2-4d88-8219-fa362de859e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_7b30e024-0e4e-48ad-a27b-e24622298ffa" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_GA"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_stpr_GA_7b30e024-0e4e-48ad-a27b-e24622298ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OtherJurisdictionsMember_436070e7-b69a-410c-a67c-22351d28fcbe" xlink:href="cah-20220630.xsd#cah_OtherJurisdictionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f65b7807-c340-4cd1-bbe8-4ba00fb9a19f" xlink:to="loc_cah_OtherJurisdictionsMember_436070e7-b69a-410c-a67c-22351d28fcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_723db101-6518-4fcf-8305-745a5fd0494d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_497ce518-1cd8-4532-84ce-86d0bd78593d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_723db101-6518-4fcf-8305-745a5fd0494d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_71dd3379-d2a2-4472-9fe5-a88745976735" xlink:to="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLawsuitsMember_40412bae-2197-474b-aae6-9eb5db9f37a2" xlink:href="cah-20220630.xsd#cah_OpioidLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_OpioidLawsuitsMember_40412bae-2197-474b-aae6-9eb5db9f37a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_861c82d8-997a-442a-a0f3-d22e4204195a" xlink:href="cah-20220630.xsd#cah_ProductLiabilityLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_861c82d8-997a-442a-a0f3-d22e4204195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_0e663bb9-2e99-4b60-a120-5600106dd1d2" xlink:href="cah-20220630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_0e663bb9-2e99-4b60-a120-5600106dd1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DOJInvestigationMember_e0c66bd8-b79d-4847-abcc-be1e2d2aecf7" xlink:href="cah-20220630.xsd#cah_DOJInvestigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1bbd0279-61a1-4d4a-9d8a-c81b86dc0026" xlink:to="loc_cah_DOJInvestigationMember_e0c66bd8-b79d-4847-abcc-be1e2d2aecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84f8de92-0a66-4047-a61f-97eb4f5ec896" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_94fda416-ddeb-4293-9094-f626bd3d7dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1bff5be4-a232-4dc6-958f-9a54dc41eafd" xlink:to="loc_us-gaap_SubsequentEventMember_94fda416-ddeb-4293-9094-f626bd3d7dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f2da773e-669d-427b-937b-a55be3ef5749" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_99f8d21b-1186-46d4-bb18-502ee9ef308c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_015b1bc7-aea2-4bb4-a876-d66babcac63e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_99f8d21b-1186-46d4-bb18-502ee9ef308c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4aded7d-bc3e-4773-a335-cb83ded62c93" xlink:to="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_9b17c40d-f6f4-4a9e-961d-83f23bf86e70" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5adccbbf-1e24-478c-9d86-26f61bb4dd0c" xlink:to="loc_cah_PharmaceuticalMember_9b17c40d-f6f4-4a9e-961d-83f23bf86e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c633bad1-cb21-4916-ab40-c3b45a75bbb2" xlink:to="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_dc22012e-5ad9-47b6-8a8d-f67b11777493" xlink:href="cah-20220630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_dc22012e-5ad9-47b6-8a8d-f67b11777493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_09fc59b1-830c-4ee0-9177-e71207bd3a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_09fc59b1-830c-4ee0-9177-e71207bd3a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_JudgmentForLostProfits_d46967b5-63df-4448-afd0-a67dd4b2dbd5" xlink:href="cah-20220630.xsd#cah_JudgmentForLostProfits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_JudgmentForLostProfits_d46967b5-63df-4448-afd0-a67dd4b2dbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingStates_2e2c0533-4dd5-4626-892b-fa02bf785f91" xlink:href="cah-20220630.xsd#cah_SettlingStates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_SettlingStates_2e2c0533-4dd5-4626-892b-fa02bf785f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SettlingUSTerritories_d02accdf-205a-443f-9ae7-9a7460dd5674" xlink:href="cah-20220630.xsd#cah_SettlingUSTerritories"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_SettlingUSTerritories_d02accdf-205a-443f-9ae7-9a7460dd5674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_8452126c-6d5f-4668-80c6-6d8f61efc6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_8452126c-6d5f-4668-80c6-6d8f61efc6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyNumberOfEligibleStates_ed15c59f-52b7-480f-b6f3-9eea4b3eecf8" xlink:href="cah-20220630.xsd#cah_LossContingencyNumberOfEligibleStates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_LossContingencyNumberOfEligibleStates_ed15c59f-52b7-480f-b6f3-9eea4b3eecf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_48f03e80-031b-46af-b6bd-86e7bf3b59ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_48f03e80-031b-46af-b6bd-86e7bf3b59ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_221a0ffd-e124-4c67-ab77-cb70fe3f8125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationReserve_221a0ffd-e124-4c67-ab77-cb70fe3f8125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_984dbce9-9712-4b13-96d8-a9ae6d3ba729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_InventoryRecallExpense_984dbce9-9712-4b13-96d8-a9ae6d3ba729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_203ed359-132c-4b00-8a7c-12c805f2182b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationReserveCurrent_203ed359-132c-4b00-8a7c-12c805f2182b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_85711d33-6e54-41c5-bfa2-2321d5c81205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_85711d33-6e54-41c5-bfa2-2321d5c81205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_5f910ecb-2b97-496c-9025-d861a43e50aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LitigationSettlementExpense_5f910ecb-2b97-496c-9025-d861a43e50aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_90bf0e7f-27af-4100-bd7b-3199821f9d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_90bf0e7f-27af-4100-bd7b-3199821f9d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1b3b818-c2bd-4b66-bf9a-3ec67a72033a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d1b3b818-c2bd-4b66-bf9a-3ec67a72033a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_8169f5a3-dd8a-4ac1-ac8a-4caae2f5cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_8169f5a3-dd8a-4ac1-ac8a-4caae2f5cae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IncomefromSettlementsofClassActionLawsuits_00bbf88b-2328-4087-bfe9-8c70d9cf3777" xlink:href="cah-20220630.xsd#cah_IncomefromSettlementsofClassActionLawsuits"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_IncomefromSettlementsofClassActionLawsuits_00bbf88b-2328-4087-bfe9-8c70d9cf3777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c57fa1c5-ba0b-44f6-af76-e231821f96ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c57fa1c5-ba0b-44f6-af76-e231821f96ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2336844b-7c22-4388-bb0c-f0ad68c28e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2336844b-7c22-4388-bb0c-f0ad68c28e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fa68e1a8-a792-4a0b-a108-de71ea467c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fa68e1a8-a792-4a0b-a108-de71ea467c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_LossContingencyLawsuitsNumber_58f618a4-d24c-42d0-a6a9-b21a0031c592" xlink:href="cah-20220630.xsd#cah_LossContingencyLawsuitsNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_LossContingencyLawsuitsNumber_58f618a4-d24c-42d0-a6a9-b21a0031c592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AggregateAnnualAssessment_fdbed198-3d70-49b6-bd7e-2b4a306b19c2" xlink:href="cah-20220630.xsd#cah_AggregateAnnualAssessment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_cah_AggregateAnnualAssessment_fdbed198-3d70-49b6-bd7e-2b4a306b19c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_443d172d-24fe-4062-8a4c-b90df3618daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_fa95cfe2-2919-477f-a865-fd9737cf027b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_443d172d-24fe-4062-8a4c-b90df3618daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_11ccdfe2-3b3f-4207-924f-12102526cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_84a72e90-6def-4163-bf10-fde4c62bd1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_11ccdfe2-3b3f-4207-924f-12102526cbe9" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_84a72e90-6def-4163-bf10-fde4c62bd1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1e6ae073-1cfa-4967-a064-d770ee8ca93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1e6ae073-1cfa-4967-a064-d770ee8ca93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_9e0cd739-05eb-447b-8dd5-be46b559b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_9e0cd739-05eb-447b-8dd5-be46b559b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1bf1bf24-0233-4f32-afcc-6f3972992533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1bf1bf24-0233-4f32-afcc-6f3972992533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1d30d3e7-ae2a-4233-b1d9-26c34a4cb9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1d30d3e7-ae2a-4233-b1d9-26c34a4cb9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_6956e5d8-6fff-408e-a60d-f602f202753a" xlink:href="cah-20220630.xsd#cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock_6956e5d8-6fff-408e-a60d-f602f202753a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_96644ae3-aeab-47b3-bfae-5922028523a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be115e3-99bd-4951-8bcd-6f47a22319c0" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_96644ae3-aeab-47b3-bfae-5922028523a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8d977dfb-6e56-4f69-8047-e1ab147d5bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_959891db-8945-428c-9073-9ddb70fbd6c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8d977dfb-6e56-4f69-8047-e1ab147d5bd0" xlink:to="loc_dei_DocumentFiscalYearFocus_959891db-8945-428c-9073-9ddb70fbd6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7d302160-1904-4fa3-a657-cdb3e6c85f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8d977dfb-6e56-4f69-8047-e1ab147d5bd0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7d302160-1904-4fa3-a657-cdb3e6c85f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8f981e44-73a6-46a3-8002-e2285c45b493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8d977dfb-6e56-4f69-8047-e1ab147d5bd0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8f981e44-73a6-46a3-8002-e2285c45b493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f4825c1a-d757-4d40-a24f-325872b39e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8d977dfb-6e56-4f69-8047-e1ab147d5bd0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f4825c1a-d757-4d40-a24f-325872b39e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_51c9f65c-4f3e-4fb3-8078-30d8a1cb788d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51c9f65c-4f3e-4fb3-8078-30d8a1cb788d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_79e54e1b-06e0-46e6-8062-50a792419b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_79e54e1b-06e0-46e6-8062-50a792419b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_434bb664-8084-41d5-b418-e6ddd8abd6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_434bb664-8084-41d5-b418-e6ddd8abd6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2ac1359d-4fef-497e-91ea-3e20966dfae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2ac1359d-4fef-497e-91ea-3e20966dfae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_63786f16-1c6a-41f7-b564-53023759e768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8ae5bef3-89e0-40b2-aaf0-8bc23dfeacbc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_63786f16-1c6a-41f7-b564-53023759e768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51c9f65c-4f3e-4fb3-8078-30d8a1cb788d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fffdcdc-29f7-4394-8a6a-188a0f359b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fffdcdc-29f7-4394-8a6a-188a0f359b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6332edf6-2b43-4729-b86a-3979bc2292ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6332edf6-2b43-4729-b86a-3979bc2292ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0a02e8aa-884b-4c72-8161-903d93a026aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0a02e8aa-884b-4c72-8161-903d93a026aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4ba1eee1-09de-4925-84d4-fe89eeee8a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cc02f5b0-4ae3-45b9-b7b7-44a82a16a98f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4ba1eee1-09de-4925-84d4-fe89eeee8a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5e890dbf-d9a2-47cf-8242-e6a74f5fb537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_51c9f65c-4f3e-4fb3-8078-30d8a1cb788d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5e890dbf-d9a2-47cf-8242-e6a74f5fb537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_903a6be3-5098-4cd4-ba96-dc7f2a452c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_903a6be3-5098-4cd4-ba96-dc7f2a452c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f028332d-c1fd-4632-90fa-ab6df933df97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f028332d-c1fd-4632-90fa-ab6df933df97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_8f4f8abe-1c9e-4e0f-9e46-6a43ad58e632" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations_8f4f8abe-1c9e-4e0f-9e46-6a43ad58e632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_eee8d8c6-0292-4a06-93c6-dc05fd30da0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_eee8d8c6-0292-4a06-93c6-dc05fd30da0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_e428476e-167f-4c0b-beea-a1b55f605ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_e428476e-167f-4c0b-beea-a1b55f605ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_0da73d15-c303-40bb-a927-bc2cb43b745f" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes_0da73d15-c303-40bb-a927-bc2cb43b745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e09522a2-b4c7-4f04-8179-a5371e36767a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e09522a2-b4c7-4f04-8179-a5371e36767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_eb483277-bde1-4865-9d4c-5cc85d5e4e36" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome_eb483277-bde1-4865-9d4c-5cc85d5e4e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_6822369b-9717-4d87-a07d-0d27f8251ba3" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters_6822369b-9717-4d87-a07d-0d27f8251ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_13513214-79fd-4073-9f12-60cf8ea9dcfb" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxReconciliationOpioidLitigation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveIncomeTaxReconciliationOpioidLitigation_13513214-79fd-4073-9f12-60cf8ea9dcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_68bf9bb5-881b-44ab-b9d3-4e812f605cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_68bf9bb5-881b-44ab-b9d3-4e812f605cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_928da134-5589-48a0-8395-7a1c51ba4e52" xlink:href="cah-20220630.xsd#cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims_928da134-5589-48a0-8395-7a1c51ba4e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_87fc4682-67d2-4299-a6bc-4fa9f24a3506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_87fc4682-67d2-4299-a6bc-4fa9f24a3506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9e877cbf-24f0-45c6-8afa-3289151723a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad89ea59-10f1-425d-a3dc-50b3026f4f41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9e877cbf-24f0-45c6-8afa-3289151723a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f60693ee-30ee-4b5c-af90-df78afd74b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f60693ee-30ee-4b5c-af90-df78afd74b44" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:href="cah-20220630.xsd#cah_GoodwillImpairmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillImpairmentAxis_08acdfcf-00d5-4ae1-a079-ac7adb67d742" xlink:to="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitGoodwillImpairmentMember_30bbcb69-367c-48d2-8793-a730ebea5bb8" xlink:href="cah-20220630.xsd#cah_MedicalUnitGoodwillImpairmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GoodwillImpairmentDomain_b367d729-891a-4398-9a6a-2ab519956407" xlink:to="loc_cah_MedicalUnitGoodwillImpairmentMember_30bbcb69-367c-48d2-8793-a730ebea5bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_0f5f9ace-d7b2-46bb-8363-dceb89f4621e" xlink:to="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_fff59c31-085d-440c-88d5-c8946262db94" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_fac77085-14d3-4623-b30d-6d7ce3c0692a" xlink:to="loc_cah_TotalOpioidLitigationMember_fff59c31-085d-440c-88d5-c8946262db94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:href="cah-20220630.xsd#cah_TaxMatterAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:href="cah-20220630.xsd#cah_TaxMatterDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterAxis_52d6a1df-7609-496e-adb7-c9eb710337d6" xlink:to="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_6cb015cb-0cab-41cc-ac68-1021db59f85d" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:to="loc_cah_PatientRecoveryBusinessMember_6cb015cb-0cab-41cc-ac68-1021db59f85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CareFusionMember_5ba1fc08-d87c-45ee-ae36-53abc8f98aea" xlink:href="cah-20220630.xsd#cah_CareFusionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_0dced34b-a403-4fab-b8d7-e980d5446f69" xlink:to="loc_cah_CareFusionMember_5ba1fc08-d87c-45ee-ae36-53abc8f98aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b424ebd4-9ac3-42ee-a3bd-a820d6ceadd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_0ca89663-3ea1-4de6-99a0-3523c68963ce" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f330b8b-fd8c-47c1-a6c3-a201cc952024" xlink:to="loc_cah_PatientRecoveryBusinessMember_0ca89663-3ea1-4de6-99a0-3523c68963ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2d94977b-4abf-45fd-a725-1788e4a92e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_789b895f-eabf-4dd5-ad1e-829afb57e1bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2d94977b-4abf-45fd-a725-1788e4a92e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_792d2c11-9c5e-4563-9866-4d424f24d043" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_5bc831f4-846b-495f-84a1-1c3249c3785e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_5bc831f4-846b-495f-84a1-1c3249c3785e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0ee0e505-813e-4436-843a-855b8b46324d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0ee0e505-813e-4436-843a-855b8b46324d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_2694daa3-ffff-4998-8421-1e76f8c4fe31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_459fdc89-7222-468c-8cb5-ff8c3a6ae1e2" xlink:to="loc_us-gaap_ForeignCountryMember_2694daa3-ffff-4998-8421-1e76f8c4fe31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_209ce798-3f86-4920-ba9e-5c78813c8571" xlink:to="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_be006231-cd35-4d64-bce7-aba319547c79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:to="loc_srt_MinimumMember_be006231-cd35-4d64-bce7-aba319547c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ddc9bdc-b0a5-4238-8a6d-e5feece4b5d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3df4139-c62f-4a07-af53-05078fec36f6" xlink:to="loc_srt_MaximumMember_4ddc9bdc-b0a5-4238-8a6d-e5feece4b5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NetOperatingLossCarrybackAxis_80c6e64b-8d3f-4b95-91b4-720518a374eb" xlink:to="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NetOperatingLossCarrybackMember_9cef4162-8fc6-49fc-a550-f6d52c87082b" xlink:href="cah-20220630.xsd#cah_NetOperatingLossCarrybackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NetOperatingLossCarrybackDomain_96c8df87-0b57-4981-8ee6-79cae1e5ef76" xlink:to="loc_cah_NetOperatingLossCarrybackMember_9cef4162-8fc6-49fc-a550-f6d52c87082b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_2ade14d3-c932-46e7-b123-6cf99a18b2b5" xlink:to="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalUnitMember_d6fd9c52-0273-419a-8842-16382db42a77" xlink:href="cah-20220630.xsd#cah_MedicalUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_e606bb80-6b10-4118-a75e-25e8d8344a4b" xlink:to="loc_cah_MedicalUnitMember_d6fd9c52-0273-419a-8842-16382db42a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_ce23c9a8-3434-47fb-88e2-9d620f5608ed" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_287f38f7-9bd7-4e41-9b12-27145ba0cd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_287f38f7-9bd7-4e41-9b12-27145ba0cd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_ecc70f71-279e-40e1-977e-9069ebb94ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_LitigationReserve_ecc70f71-279e-40e1-977e-9069ebb94ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c2d6a4bf-1eff-48b1-9ab3-00307df16994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c2d6a4bf-1eff-48b1-9ab3-00307df16994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3c5b82bb-86ea-487b-a329-38240635a859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_3c5b82bb-86ea-487b-a329-38240635a859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_0143495d-b616-4dc9-afca-88379fb9b81e" xlink:href="cah-20220630.xsd#cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions_0143495d-b616-4dc9-afca-88379fb9b81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_2005de40-69d2-4af9-b477-f28126fe92a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_2005de40-69d2-4af9-b477-f28126fe92a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9c7b2625-ff14-4755-b9a0-0dcac6ed61a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9c7b2625-ff14-4755-b9a0-0dcac6ed61a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5a79ce3c-56d7-45bb-a2b6-4ad6edd3309b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5a79ce3c-56d7-45bb-a2b6-4ad6edd3309b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_e1941ce0-4e23-4516-88b8-3c121657baee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_e1941ce0-4e23-4516-88b8-3c121657baee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_016a1936-2984-4d85-a5ed-a1d04c2afc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_016a1936-2984-4d85-a5ed-a1d04c2afc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_943b5282-f91c-4256-aeb3-f993f3a95aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_943b5282-f91c-4256-aeb3-f993f3a95aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6705d53b-b9ef-4963-b9d1-e0d8bacea263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_6705d53b-b9ef-4963-b9d1-e0d8bacea263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0a2ed055-c674-4b82-99a8-f15a7f0243f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0a2ed055-c674-4b82-99a8-f15a7f0243f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_89120d03-7872-422c-ba80-c44917ab6526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_89120d03-7872-422c-ba80-c44917ab6526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_b488101a-ed04-4dcb-9446-adca77bb912c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_b488101a-ed04-4dcb-9446-adca77bb912c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_90946640-b10e-4c29-a787-0b8539e8234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_90946640-b10e-4c29-a787-0b8539e8234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b6e41ffa-a0db-4317-b433-1386bde869b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b6e41ffa-a0db-4317-b433-1386bde869b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6b83ce28-7853-412b-8c8e-e103175e6d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6b83ce28-7853-412b-8c8e-e103175e6d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_aba039e6-8047-49d0-8ef9-85bdccdab990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_aba039e6-8047-49d0-8ef9-85bdccdab990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_IndemnificationReceivable_00fbfd71-fb15-4341-91ee-6fa4d55698cb" xlink:href="cah-20220630.xsd#cah_IndemnificationReceivable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_cah_IndemnificationReceivable_00fbfd71-fb15-4341-91ee-6fa4d55698cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_0ddd71d7-651b-4a1c-a8e7-ef595ae8767f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_IncomeTaxReceivable_0ddd71d7-651b-4a1c-a8e7-ef595ae8767f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d9de6bc5-cc0c-46f5-85e2-2da7df11fbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_d9de6bc5-cc0c-46f5-85e2-2da7df11fbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_b553cecd-5ed9-4dd4-b429-4d6592d320ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_LitigationSettlementExpense_b553cecd-5ed9-4dd4-b429-4d6592d320ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_790325d2-f731-4e6e-ab5a-1816f83727ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_a5309b01-9c04-4c46-9944-d1c058bab2e6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_790325d2-f731-4e6e-ab5a-1816f83727ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_90915d94-c188-425a-98b5-cc1825bdc84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_90915d94-c188-425a-98b5-cc1825bdc84b" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_8a96490e-203f-48e1-b7dd-85833c62c3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_8a96490e-203f-48e1-b7dd-85833c62c3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5733edb0-80f0-4768-874b-fab8954ce99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5733edb0-80f0-4768-874b-fab8954ce99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7eabab3d-2fa7-4377-964f-ea343777efb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7eabab3d-2fa7-4377-964f-ea343777efb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_efa089c8-6791-4134-b775-467a32e590f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_efa089c8-6791-4134-b775-467a32e590f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_2e6a712d-c172-41c4-b172-50d6fae1f1db" xlink:href="cah-20220630.xsd#cah_DeferredTaxAssetsRelatedtouncertaintaxpositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions_2e6a712d-c172-41c4-b172-50d6fae1f1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_c919c22c-15c2-46d5-a893-b8652626f18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_c919c22c-15c2-46d5-a893-b8652626f18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_294f05e7-7338-4481-a058-05939a4a088e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_294f05e7-7338-4481-a058-05939a4a088e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dab21235-b1e2-40f2-a4e6-8373c8fad4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dab21235-b1e2-40f2-a4e6-8373c8fad4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f8e146d9-babe-4093-ae15-094fbd9b688e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5178ffa0-9993-47f4-a1f2-c2c21dd92647" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f8e146d9-babe-4093-ae15-094fbd9b688e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_90915d94-c188-425a-98b5-cc1825bdc84b" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_452bcdfe-318f-4bc9-91c1-bbd3defc9425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_452bcdfe-318f-4bc9-91c1-bbd3defc9425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1034b685-28ba-4c8d-bd2b-a180a994959e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1034b685-28ba-4c8d-bd2b-a180a994959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_87509dde-a734-437b-950f-aa12c833c796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_87509dde-a734-437b-950f-aa12c833c796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_4436a8e0-3245-4f12-a254-4ff1e8a7576d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_4436a8e0-3245-4f12-a254-4ff1e8a7576d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_59b15e6d-3ead-4bf5-9c65-216e1d82f0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_59b15e6d-3ead-4bf5-9c65-216e1d82f0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b946dbcb-a12e-4d00-9797-150ad0f5c0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_da37e9ac-89a5-4b78-a8f7-b61682132864" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b946dbcb-a12e-4d00-9797-150ad0f5c0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_81b12d78-3024-4b30-a111-74870f927eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_90915d94-c188-425a-98b5-cc1825bdc84b" xlink:to="loc_us-gaap_DeferredTaxLiabilities_81b12d78-3024-4b30-a111-74870f927eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0c014f7a-8983-4509-a0d7-2c5332bde5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_299b094f-5156-4626-b61d-c372967a3659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c014f7a-8983-4509-a0d7-2c5332bde5c8" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_299b094f-5156-4626-b61d-c372967a3659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_1ed56020-2545-4e0f-88a7-fc4e72d60ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c014f7a-8983-4509-a0d7-2c5332bde5c8" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_1ed56020-2545-4e0f-88a7-fc4e72d60ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_7e858473-eee5-42fb-8b4c-48cd02ca98ff" xlink:href="cah-20220630.xsd#cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c014f7a-8983-4509-a0d7-2c5332bde5c8" xlink:to="loc_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent_7e858473-eee5-42fb-8b4c-48cd02ca98ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_62202d34-2163-4454-b93a-b7f3487c5709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0c014f7a-8983-4509-a0d7-2c5332bde5c8" xlink:to="loc_us-gaap_DeferredTaxLiabilities_62202d34-2163-4454-b93a-b7f3487c5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f5cc760b-d7e1-4722-95d4-71d2ad27af39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f5cc760b-d7e1-4722-95d4-71d2ad27af39" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acf1e4a3-fa7c-4e7c-b767-f6cf6fc0ef27" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PatientRecoveryBusinessMember_03f513c2-05cf-4df0-8989-b62447377d20" xlink:href="cah-20220630.xsd#cah_PatientRecoveryBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a42b1b8-4207-44ea-afec-b42c1874e597" xlink:to="loc_cah_PatientRecoveryBusinessMember_03f513c2-05cf-4df0-8989-b62447377d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_21b1ca0f-6ef2-4944-8599-2605c4cd10c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a4448a55-a8e9-440b-8a1a-105ab3ce4fc4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_21b1ca0f-6ef2-4944-8599-2605c4cd10c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_76b46bc7-25f9-4ed0-b190-881922119ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_b9541aa5-24cc-40ef-93e6-33563d61b11d" xlink:to="loc_us-gaap_TaxPeriodDomain_76b46bc7-25f9-4ed0-b190-881922119ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_4f070424-4327-46d6-a6da-e2d20274a751" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_214d4bbf-7bb3-4acd-94cc-e93529c10610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_214d4bbf-7bb3-4acd-94cc-e93529c10610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8334a05-f379-406b-8f70-a2a60b09d072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8334a05-f379-406b-8f70-a2a60b09d072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2cff4511-99f7-4a3a-846c-cb42d87763be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_2cff4511-99f7-4a3a-846c-cb42d87763be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_83644660-a946-440a-bce3-232c6b8c198c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_83644660-a946-440a-bce3-232c6b8c198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3548d228-9eeb-4722-ac9e-d248ed905671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3548d228-9eeb-4722-ac9e-d248ed905671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31250049-9539-48fd-b34d-2bb4c711f593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31250049-9539-48fd-b34d-2bb4c711f593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bcd1b7a-4038-4459-aa75-75a3e1f1153a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1bcd1b7a-4038-4459-aa75-75a3e1f1153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bc2134-1f6e-4e1c-9f8b-d2e60e1c2919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bc2134-1f6e-4e1c-9f8b-d2e60e1c2919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbfdcdde-fb6d-4ca5-8adb-5adc2247e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dbfdcdde-fb6d-4ca5-8adb-5adc2247e9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_122e7187-9fdb-46a1-bc91-7911610e1c3f" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_82f09435-5b0b-44c4-939e-bbb395438cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_82f09435-5b0b-44c4-939e-bbb395438cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ea6c60f0-a3d0-4e9c-985c-e96e48c4712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ea6c60f0-a3d0-4e9c-985c-e96e48c4712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_273219ff-7571-4d73-9b9e-5f46d9de0326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_273219ff-7571-4d73-9b9e-5f46d9de0326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5787d0f3-0d35-408f-bed7-be1f11f35103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5787d0f3-0d35-408f-bed7-be1f11f35103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e84b86d0-5175-400b-9f1e-e95b44a0e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e84b86d0-5175-400b-9f1e-e95b44a0e3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a84f01b9-d01d-4ff4-b8f9-1bd04d9061ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a84f01b9-d01d-4ff4-b8f9-1bd04d9061ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d12da6d6-b4e8-48c6-94f7-ca74e34377f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f5df021d-3701-412d-bf91-0f32e6a004d3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d12da6d6-b4e8-48c6-94f7-ca74e34377f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/Guarantees" xlink:type="simple" xlink:href="cah-20220630.xsd#Guarantees"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Guarantees" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_78990612-7dab-4f39-bf2c-2dcfdbf2a52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_53116873-fe59-4382-889b-e7634eec9212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_78990612-7dab-4f39-bf2c-2dcfdbf2a52a" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_53116873-fe59-4382-889b-e7634eec9212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b375ca11-79f2-4480-888d-e7823b7fa71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_78990612-7dab-4f39-bf2c-2dcfdbf2a52a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b375ca11-79f2-4480-888d-e7823b7fa71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bcce91ee-ea56-4625-b14c-1cfeb7db08dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f15bb597-c7d6-42d2-a2ae-43b3ace982d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bcce91ee-ea56-4625-b14c-1cfeb7db08dc" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f15bb597-c7d6-42d2-a2ae-43b3ace982d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_71ccdb27-9bd5-4d50-a0bf-62f98b6bfb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_71ccdb27-9bd5-4d50-a0bf-62f98b6bfb46" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e4bc5c7e-7d87-4efc-b229-eec35ff6f121" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_876f805b-b763-4ab2-bc96-ebcd1f40b4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_876f805b-b763-4ab2-bc96-ebcd1f40b4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5ccd29f9-25cc-46ed-921d-f8b011067a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c3f8f204-edc7-4f9e-9450-414311aeedc4" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5ccd29f9-25cc-46ed-921d-f8b011067a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f274d03-08e7-40cc-9af2-dc38bf0af8f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_366dbd00-a939-4bb9-bd11-a49546dde922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_366dbd00-a939-4bb9-bd11-a49546dde922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_62bc9efb-2069-41a1-828b-0103c13a1a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_62bc9efb-2069-41a1-828b-0103c13a1a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5c7379e4-8f4a-4439-b1c0-204de34e9d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f73630b-3cfc-4c12-8d20-95d2e8c8bc03" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5c7379e4-8f4a-4439-b1c0-204de34e9d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_76a79ced-b69d-47e8-96ae-461aef312cc3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9228b4ad-0a16-448e-98c3-3cac7ab582a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9228b4ad-0a16-448e-98c3-3cac7ab582a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_b02ed29c-f836-4e5f-90b9-7bc730994ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_b02ed29c-f836-4e5f-90b9-7bc730994ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_63779451-9918-44a9-8983-44118aeda525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_50f68500-ae01-485b-8c62-4a88e66d3504" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_63779451-9918-44a9-8983-44118aeda525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88c96d01-2b95-49dc-8b4e-d87288c6c774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a602ece-a8d9-41dd-b04d-c2cb9b639087" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88c96d01-2b95-49dc-8b4e-d87288c6c774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0f81bba6-21f6-42b6-9f9b-8e5f31c003b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_88c96d01-2b95-49dc-8b4e-d87288c6c774" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0f81bba6-21f6-42b6-9f9b-8e5f31c003b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_42ada148-e4e7-4cea-8f6f-b322c53c1796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_42ada148-e4e7-4cea-8f6f-b322c53c1796" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e188a5e1-6a87-45d0-8243-d941b16b4c9f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9650a1be-41bd-4aec-b4e9-01dd26fab53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9650a1be-41bd-4aec-b4e9-01dd26fab53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fcf65c9d-a701-4d58-82ed-bc30c3035301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fcf65c9d-a701-4d58-82ed-bc30c3035301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e2413473-605e-4b7a-a768-44323db2d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_198fe6b3-c27b-4d7c-bc83-1d2bca0bd13b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e2413473-605e-4b7a-a768-44323db2d5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c436726d-ecfb-4396-bf7f-939feb59aa93" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_df6d410a-785c-4e4b-a609-c13f5cf1d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_df6d410a-785c-4e4b-a609-c13f5cf1d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9a81715b-cf7a-4b03-9afa-ae37bb5c9912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f6d9ebaf-b4e6-4364-af81-fc320aef6278" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9a81715b-cf7a-4b03-9afa-ae37bb5c9912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db105c44-337d-49bb-91a0-dc9d07c89c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5ac576be-7c3b-48fc-b740-4878c755d954" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db105c44-337d-49bb-91a0-dc9d07c89c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bbcb2115-c57c-4344-8f36-21beb90587db" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c51ba2a4-64fe-4c5c-bc70-943b9b5e48fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_18dc8c67-c53b-4e02-bfff-7cf249d46845" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_c51ba2a4-64fe-4c5c-bc70-943b9b5e48fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_65f00c67-f5e9-4d9f-962a-85de13e533be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_65f00c67-f5e9-4d9f-962a-85de13e533be" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a1eddf7f-38bf-4205-84bc-ef2e46153ad7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9b151bb9-6348-4d68-bd7d-37d751417f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3ea1936b-8a98-45b4-a4f2-19f22bf0a5c9" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_9b151bb9-6348-4d68-bd7d-37d751417f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3911cf68-f7b4-4c89-a224-ef2297401334" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8b9b29cc-7d8a-44fa-b8bb-4dcaf9bc300c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8b9b29cc-7d8a-44fa-b8bb-4dcaf9bc300c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_da296674-4ae9-4c9d-b1bd-0ea53af52d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c34f88ed-12a8-49fa-a771-7d1364b00a73" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_da296674-4ae9-4c9d-b1bd-0ea53af52d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb218ca0-6503-4fc6-bd07-4844cab59c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_f3552648-9002-4809-a8d7-c7f0ae7e83ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb218ca0-6503-4fc6-bd07-4844cab59c18" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_f3552648-9002-4809-a8d7-c7f0ae7e83ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_28af13ac-b4bc-4584-90f7-09eddf4aaa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_28af13ac-b4bc-4584-90f7-09eddf4aaa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7a0fa883-51b4-4e4a-b490-b76ee8489482" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_2417fb47-0d88-4d5a-9a4a-f75516acb27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:to="loc_us-gaap_FairValueHedgingMember_2417fb47-0d88-4d5a-9a4a-f75516acb27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_93698227-ecdf-4432-8f13-52ca710b2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bec7c63f-1fdf-46d6-8efd-8817caeb07da" xlink:to="loc_us-gaap_CashFlowHedgingMember_93698227-ecdf-4432-8f13-52ca710b2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:to="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5cec002-4cb0-4f8a-bee0-e26938d675fa" xlink:to="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5b7c14e3-c66b-43fc-b67a-bb5ba6abb439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b598f727-8065-4ac8-9763-cea72b28d651" xlink:to="loc_us-gaap_NondesignatedMember_5b7c14e3-c66b-43fc-b67a-bb5ba6abb439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0b2b08f9-9852-409e-8a76-52753c636693" xlink:to="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_b5e4052d-ca5c-493b-b87b-daf320568355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_91b071b4-2de5-4240-894c-93080617a5fa" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_b5e4052d-ca5c-493b-b87b-daf320568355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_8ee3c0dd-df8c-4c4f-b8b5-236bb523c8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_8ee3c0dd-df8c-4c4f-b8b5-236bb523c8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f1d5e32d-f3e1-47c8-9a84-299a17abfe0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f1d5e32d-f3e1-47c8-9a84-299a17abfe0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2c5841f0-1ce9-433a-b3c4-88c51783544b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2c5841f0-1ce9-433a-b3c4-88c51783544b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_3e0eccf8-8bb7-4b3a-9322-462d43204082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_3e0eccf8-8bb7-4b3a-9322-462d43204082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_5c4a0b2c-a765-46d6-ba4b-0d2684bf349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_5c4a0b2c-a765-46d6-ba4b-0d2684bf349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_d86d0ee9-f25a-4399-907c-c661dd2dd316" xlink:href="cah-20220630.xsd#cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d6195ab1-f310-44d7-b208-dba1104ee141" xlink:to="loc_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock_d86d0ee9-f25a-4399-907c-c661dd2dd316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65e146e2-f7b3-4386-af35-897fe683cf68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_65e146e2-f7b3-4386-af35-897fe683cf68" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_9c7c19ae-431e-4bb7-9463-83b8f81ec3f0" xlink:to="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c63dd68f-164c-4a73-a445-f25f32270084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a2825caf-7027-475c-9ace-65ed12d0cba3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c63dd68f-164c-4a73-a445-f25f32270084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_529d5026-0eeb-48d8-ace7-79e77d49c0a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fe095133-c84a-497c-a517-a221845454ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:to="loc_us-gaap_CashFlowHedgingMember_fe095133-c84a-497c-a517-a221845454ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d62601e6-31ff-4b6a-90d6-3577065fe119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6aa820a1-94ee-42c3-8303-12b79532cf36" xlink:to="loc_us-gaap_FairValueHedgingMember_d62601e6-31ff-4b6a-90d6-3577065fe119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8fb2d38a-08fa-4963-8e9d-765a30db0ddd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e9da2771-fda2-4298-b0a9-79f58770c827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e9da2771-fda2-4298-b0a9-79f58770c827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f01ec2be-e315-4374-b129-c21258474a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_InterestRateSwapMember_f01ec2be-e315-4374-b129-c21258474a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_4e4a2662-3756-401a-a1e9-0350862dcbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_4e4a2662-3756-401a-a1e9-0350862dcbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6ec638c2-fa24-409d-ad04-469e270b7560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_18a484c8-5249-472a-81a7-9d7e2d54c166" xlink:to="loc_us-gaap_CommodityContractMember_6ec638c2-fa24-409d-ad04-469e270b7560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_18961325-b148-4efa-bf9b-15de3622bef3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_83b413df-87d7-44ef-ba5e-66f37b541ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_OtherAssetsMember_83b413df-87d7-44ef-ba5e-66f37b541ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_221e5bd0-97f7-4859-af1d-0c58bda04c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_221e5bd0-97f7-4859-af1d-0c58bda04c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_a75f6e4c-03fc-4d1c-a7b5-c6b28b6ad2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0841a6fc-087c-45d6-abf6-d01625c8377e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_a75f6e4c-03fc-4d1c-a7b5-c6b28b6ad2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e1644083-522e-449a-8fb9-2f0271bbb6ba" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0ec06fcf-0ad2-4946-9afd-4ad414ec41b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0ec06fcf-0ad2-4946-9afd-4ad414ec41b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f97fe547-d408-4aa3-a1bc-66cfa8ba14b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_f97fe547-d408-4aa3-a1bc-66cfa8ba14b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_abd09c98-a061-414a-9287-cec8510fc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_e28f6689-2b8e-4512-a6de-8123c74fab8b" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_abd09c98-a061-414a-9287-cec8510fc5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2dc581e-6c9c-480c-be1e-5d96bcd9af82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2dc581e-6c9c-480c-be1e-5d96bcd9af82" xlink:to="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a0c8508c-9aa6-4562-9dee-d69cd62f5bfa" xlink:to="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_730c4bef-0448-45f8-9d8a-c24174af2f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8bf95752-d503-4642-b817-680fe0f418dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_730c4bef-0448-45f8-9d8a-c24174af2f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_9900da78-c0a2-4859-9b6a-c0049e42e304" xlink:to="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3e5fe38c-8a69-4f1c-83fd-090bb56b1a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_FairValueHedgingMember_3e5fe38c-8a69-4f1c-83fd-090bb56b1a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a12f9306-7caf-4d1a-b5ac-d5428f405521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_CashFlowHedgingMember_a12f9306-7caf-4d1a-b5ac-d5428f405521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_04aa80cc-26e5-4e0d-80a4-dfd7408e745a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_de80d0c2-c803-46be-bd67-fe734137cd1f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_04aa80cc-26e5-4e0d-80a4-dfd7408e745a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_96eaae76-f4dc-4834-aa5c-981da9dc5c06" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ccfec77b-c9c4-403e-a143-46ef95c23e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_InterestRateSwapMember_ccfec77b-c9c4-403e-a143-46ef95c23e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_417a893c-f6d5-4d58-bcee-f6c957fcc09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_CurrencySwapMember_417a893c-f6d5-4d58-bcee-f6c957fcc09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6ec2ffdc-39d0-4f64-9ab8-136f9375d60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6ec2ffdc-39d0-4f64-9ab8-136f9375d60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0c9cdfce-6275-4f08-8432-b8d6b110f8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3b2618e0-fdc0-476d-b5cb-461735f719a2" xlink:to="loc_us-gaap_CashFlowHedgingMember_0c9cdfce-6275-4f08-8432-b8d6b110f8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:href="cah-20220630.xsd#cah_MaturityDateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:href="cah-20220630.xsd#cah_MaturityDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MaturityDateAxis_52ab8a11-1e45-4de0-aa9f-835b4cb25e4b" xlink:to="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_September2025Member_529e947f-fcba-4edb-9a1d-11cb7d1b90b7" xlink:href="cah-20220630.xsd#cah_September2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:to="loc_cah_September2025Member_529e947f-fcba-4edb-9a1d-11cb7d1b90b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_June2027Member_ba867339-6f63-444a-a22c-453f04604f80" xlink:href="cah-20220630.xsd#cah_June2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MaturityDateDomain_6484f272-30d0-444f-b9e7-4081184fa788" xlink:to="loc_cah_June2027Member_ba867339-6f63-444a-a22c-453f04604f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_13181fe5-81fc-4f5d-ab97-a544e3e2dbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_42f46ef1-076b-461d-8482-b617b92b04f3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_13181fe5-81fc-4f5d-ab97-a544e3e2dbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2e12d0e-d69d-4d26-8f31-0334d79df3ef" xlink:to="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ce5d4411-2fb1-4123-8372-a0ffc75f648e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_ce5d4411-2fb1-4123-8372-a0ffc75f648e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_5cc98334-562c-4430-81a9-362d665187aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_5cc98334-562c-4430-81a9-362d665187aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_84839013-38e5-4b5d-945a-574f624ff1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_84839013-38e5-4b5d-945a-574f624ff1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_da935939-3550-472b-a48f-e553b4d2d5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_da935939-3550-472b-a48f-e553b4d2d5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_91509e90-8977-4fbb-bb47-4c3922e4338d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_91509e90-8977-4fbb-bb47-4c3922e4338d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_4bf447d2-3e9a-4d9f-9b54-673b2daa6f20" xlink:href="cah-20220630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_4bf447d2-3e9a-4d9f-9b54-673b2daa6f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_48ee963e-a1e3-4a03-9049-ed40c4d75117" xlink:href="cah-20220630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_VestingPeriodinyearsforShares_48ee963e-a1e3-4a03-9049-ed40c4d75117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_39bbb53f-6fbd-4fe8-87fa-ecff476bdbc1" xlink:href="cah-20220630.xsd#cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount_39bbb53f-6fbd-4fe8-87fa-ecff476bdbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_55b91632-5b9a-4f09-a0f5-c846362b03b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_55b91632-5b9a-4f09-a0f5-c846362b03b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f48e82bf-8bee-4c6c-8481-96525f7f296a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b695da60-ebe3-427f-8408-8280ca336544" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_f48e82bf-8bee-4c6c-8481-96525f7f296a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_751ddecc-0778-4092-a319-885d9721cca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_751ddecc-0778-4092-a319-885d9721cca2" xlink:to="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5631d7cb-9b1f-4932-97a8-47e630357cea" xlink:to="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d84361d3-812c-4ea7-b066-f2c0bbe77f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c20cf2c-1084-40eb-93cd-500f85749050" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d84361d3-812c-4ea7-b066-f2c0bbe77f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_35417bd6-18e0-4c73-aca8-0bd3ffb1355d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9b3c645a-ae11-40d7-96f4-6124c42613ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6c55ba00-9bc9-4637-abad-b68bf0f27711" xlink:to="loc_us-gaap_FairValueHedgingMember_9b3c645a-ae11-40d7-96f4-6124c42613ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_811a86a7-c500-4238-a9ce-c76f7c61d11d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_caee7673-04f4-49c3-9404-0f1302c24b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_de463368-6854-44a3-ac96-03559c776fee" xlink:to="loc_us-gaap_InterestRateSwapMember_caee7673-04f4-49c3-9404-0f1302c24b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_923f162d-7b7a-448d-b23c-ca051a63d345" xlink:to="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_50bf3fd6-c9bd-4a25-b910-73dbb6ad2b79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7af10de9-22d1-4502-b948-eb7acf99bd90" xlink:to="loc_srt_MinimumMember_50bf3fd6-c9bd-4a25-b910-73dbb6ad2b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_89823815-f03a-40b7-a87c-2acb44d9d805" xlink:to="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_234aee46-8005-418a-9d2e-464ce9815c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge_234aee46-8005-418a-9d2e-464ce9815c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_ccb99db2-593f-45a7-87c8-015c817424dc" xlink:href="cah-20220630.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_ccb99db2-593f-45a7-87c8-015c817424dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_52ab2ec9-833f-48dd-876f-e12a4b98629f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f033cabb-f8cd-429c-9447-f8ae9f0e07b1" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_52ab2ec9-833f-48dd-876f-e12a4b98629f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ee72e1c0-fa2c-4f39-9e24-fbc64c17e90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ee72e1c0-fa2c-4f39-9e24-fbc64c17e90e" xlink:to="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_72e7a2c4-d849-49bf-9779-882c75a5e66f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_40cb6285-4bd0-4adb-9965-6453a7ea3441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_332830d4-1660-4c19-b1e9-e35ed6bb7049" xlink:to="loc_us-gaap_FairValueHedgingMember_40cb6285-4bd0-4adb-9965-6453a7ea3441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e8b642-2763-481a-be7a-d327ccec8999" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c822584f-cff7-4b75-8cfa-cfbd80cb6e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:to="loc_us-gaap_InterestRateSwapMember_c822584f-cff7-4b75-8cfa-cfbd80cb6e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_FixedRateDebtMember_bae5c6e6-1e83-4199-b925-145523e3c459" xlink:href="cah-20220630.xsd#cah_FixedRateDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72a6b751-f0bf-4220-ae5d-c0dc6db50e94" xlink:to="loc_cah_FixedRateDebtMember_bae5c6e6-1e83-4199-b925-145523e3c459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dea47152-fa66-4491-9ff2-8148f2bc77c3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_db3eb1c5-cd5b-4836-a402-b4741c43d630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ab7f6cf4-1240-4d0f-898f-160329687b69" xlink:to="loc_us-gaap_InterestExpenseMember_db3eb1c5-cd5b-4836-a402-b4741c43d630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_12f42886-36c2-48ac-b778-77aef2311787" xlink:to="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_be4f9c9d-0025-420f-b837-a1ead29d0d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b29e3f44-d95c-40c4-8e7f-63c3bf0d54cd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_be4f9c9d-0025-420f-b837-a1ead29d0d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_622bbe5a-4772-4b00-a8e9-6156862357da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_622bbe5a-4772-4b00-a8e9-6156862357da" xlink:to="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_34b3f219-0102-40a1-857c-49f399701194" xlink:to="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9d8e8802-33b7-4f20-9155-e88cb9f9a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_faa563f1-ad1f-4538-9f6f-c270d6d34fc5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9d8e8802-33b7-4f20-9155-e88cb9f9a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1ec670cb-dacd-4759-a36a-b1ce1a8068ec" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b652fe39-649d-4cbc-866d-7fa0ecf9331e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:to="loc_us-gaap_FairValueHedgingMember_b652fe39-649d-4cbc-866d-7fa0ecf9331e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_216e225e-fa46-4271-b494-9b419f345a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c2617565-dcdc-408e-a859-020e80ab2f6f" xlink:to="loc_us-gaap_CashFlowHedgingMember_216e225e-fa46-4271-b494-9b419f345a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38b5ab6c-c969-48b0-a498-90b49745cbb7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce4b6f38-5070-461f-8322-33b939394b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_InterestRateSwapMember_ce4b6f38-5070-461f-8322-33b939394b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_86b22beb-9503-48e3-8d12-dc78cab7af77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_86b22beb-9503-48e3-8d12-dc78cab7af77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_fa0e16c2-9bac-4ec8-9ad5-5da09542b165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_CommodityContractMember_fa0e16c2-9bac-4ec8-9ad5-5da09542b165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_07398ab9-ecc6-4f2b-81ac-bbc41ba6566e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_07398ab9-ecc6-4f2b-81ac-bbc41ba6566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_33150581-19ea-407c-ac7a-d0cf3112924b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0266587-e90a-4b28-814b-8224f12fce2d" xlink:to="loc_us-gaap_ForwardContractsMember_33150581-19ea-407c-ac7a-d0cf3112924b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ed66de27-1ab3-47c6-8f96-997bd96f22f5" xlink:to="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4dcd7899-314c-40f8-afd3-f6ab9d81621d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:to="loc_srt_MinimumMember_4dcd7899-314c-40f8-afd3-f6ab9d81621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5dea59e9-854d-4b73-a0ca-e1d62a5fe418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55fca929-8560-41c5-9bda-0475d44ba168" xlink:to="loc_srt_MaximumMember_5dea59e9-854d-4b73-a0ca-e1d62a5fe418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f0e88f8-debd-4a28-9d8f-31f36c2870da" xlink:to="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_195f8ba1-7d20-409c-8061-716a9584c9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_195f8ba1-7d20-409c-8061-716a9584c9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_43ece46a-74c4-48ff-86c4-5468c52b60bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ef08b37e-950b-45a2-83e9-60886a35610c" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_43ece46a-74c4-48ff-86c4-5468c52b60bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_41c53709-6eb9-495a-9f04-54cd35529a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_41c53709-6eb9-495a-9f04-54cd35529a51" xlink:to="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b8e844a-4c16-426b-a0f5-7b218ef626f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f1f29e98-3c82-4208-a423-9677c388dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e0e76b76-0c00-4035-b623-76fba25fc7f7" xlink:to="loc_us-gaap_CashFlowHedgingMember_f1f29e98-3c82-4208-a423-9677c388dfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_36ce2c00-5f89-43e0-87b3-a51d6e2ab0c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_aa3f2bcb-5438-4150-98b9-dfadb19da8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_ForwardContractsMember_aa3f2bcb-5438-4150-98b9-dfadb19da8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_33d04d59-41ae-4d84-b781-f61e30d3022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_InterestRateSwapMember_33d04d59-41ae-4d84-b781-f61e30d3022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_6520d2de-296c-41f9-97b7-f82d63964d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_CommodityContractMember_6520d2de-296c-41f9-97b7-f82d63964d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a0341b79-189a-41de-806b-3579f018f9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e712d7c-a18d-423b-9ec1-435b75e007c7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a0341b79-189a-41de-806b-3579f018f9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_743b6788-5640-48cd-8450-0923710dd6d9" xlink:to="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a997aa97-09f7-4049-8ab7-11a45bd21dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92467f8d-8c79-41da-98da-641265d8c9ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a997aa97-09f7-4049-8ab7-11a45bd21dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_18a48208-1874-4911-b396-a7246f524804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_18a48208-1874-4911-b396-a7246f524804" xlink:to="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_16d152fc-7efc-47b8-9a7f-490bd39b1afd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_af3c1dbd-0db6-46fe-9044-0a2b14a249fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b7478efa-371b-41d6-9d1c-52b56cf6dd91" xlink:to="loc_us-gaap_CashFlowHedgingMember_af3c1dbd-0db6-46fe-9044-0a2b14a249fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_88e9dba3-b4cf-4a06-9d06-dd980e53f4bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1549b966-f0df-4eaa-be8e-d417e1b3e963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1549b966-f0df-4eaa-be8e-d417e1b3e963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_ff6c2bf1-05ac-44a4-b9e9-dff4343a5a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_ForwardContractsMember_ff6c2bf1-05ac-44a4-b9e9-dff4343a5a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_9ee6bc75-a01d-4fbf-a43b-0bdc3bdf8823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac8f2a02-4936-448d-aaf9-9037d23c632a" xlink:to="loc_us-gaap_CommodityContractMember_9ee6bc75-a01d-4fbf-a43b-0bdc3bdf8823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25f198f8-b974-4486-9394-727159c3c45a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_96fc920f-ccb5-4f42-bfb8-6852921db54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_SalesMember_96fc920f-ccb5-4f42-bfb8-6852921db54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_df0b8278-72d6-45ff-aa5d-35a35aa9d176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_CostOfSalesMember_df0b8278-72d6-45ff-aa5d-35a35aa9d176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1080b68d-88b1-4432-a02a-7dd9dc543bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1080b68d-88b1-4432-a02a-7dd9dc543bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_86914416-94ae-43fa-99ab-99ce4776a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad1e3224-50fa-49e9-bb95-a9f81cc39ea1" xlink:to="loc_us-gaap_InterestExpenseMember_86914416-94ae-43fa-99ab-99ce4776a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ec742a6-2ce2-470c-9315-16261feece5f" xlink:to="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bf3a72fa-661b-499b-ae11-5e931108cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bac0cd0-18a7-437a-b7d6-927b76be3d0e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bf3a72fa-661b-499b-ae11-5e931108cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1fd54b8d-7df8-49a7-ade0-ce979d33e58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1fd54b8d-7df8-49a7-ade0-ce979d33e58a" xlink:to="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b201a587-6604-4fc0-a3fa-0bbfddb6b94f" xlink:to="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_477e093f-8a09-4b45-9eac-7d5372060a79" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:to="loc_srt_MinimumMember_477e093f-8a09-4b45-9eac-7d5372060a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d0860af-e74d-46ba-a2a0-e6635812c782" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b3920046-affd-4f34-933c-bf5156de079e" xlink:to="loc_srt_MaximumMember_0d0860af-e74d-46ba-a2a0-e6635812c782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5012f20-5fa2-4ac6-920e-1aa531e1f167" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_462e508b-f0ab-492d-8a2c-0f9e2ecafd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9bd99c82-b29a-4ae0-b780-55092d5dc5f4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_462e508b-f0ab-492d-8a2c-0f9e2ecafd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f71207-2b49-4c49-8b35-d41c405ec1c0" xlink:to="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c6a8d05c-f63e-4436-8fb4-d0c8ff5faea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a1de528e-a5fd-4b97-8153-b0ff9254623f" xlink:to="loc_us-gaap_NondesignatedMember_c6a8d05c-f63e-4436-8fb4-d0c8ff5faea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cc15a40a-0190-484c-9dad-16ccc1605205" xlink:to="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9686e7b1-c176-4444-8fa1-ec9143b00db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_06892799-6d17-45d3-95d3-301ecbcbd372" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9686e7b1-c176-4444-8fa1-ec9143b00db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86704943-d208-49d4-a6bf-9155e3e7e1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86704943-d208-49d4-a6bf-9155e3e7e1ed" xlink:to="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_318cf411-33fb-41d9-97e4-d2330486e3aa" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_22ca5ecd-1177-499a-ae77-e0852073bd59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6b60ea0b-9fc3-4e4c-a61e-f86471ff5641" xlink:to="loc_us-gaap_NondesignatedMember_22ca5ecd-1177-499a-ae77-e0852073bd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5c97fc6-6e7a-4ea5-aefd-4d0ef174949a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a00b061f-97fe-407e-a08c-f0a5f8728afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7e122565-8796-4dc9-9533-ca1c96eec3da" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a00b061f-97fe-407e-a08c-f0a5f8728afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c3eaabed-7d54-44f4-ab0b-48239b4300fd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_cd4bd280-50f1-4bb0-9a05-3f0df122abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d47d2658-4243-4389-a0d8-a98767b37ef9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_cd4bd280-50f1-4bb0-9a05-3f0df122abe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_72f01ef0-ec90-4c72-8bb4-503b46e95cec" xlink:to="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7d301caa-9183-41bc-a219-0100f3934f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bce5fb2b-68e9-46af-8ae3-3b3b8b5466a0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7d301caa-9183-41bc-a219-0100f3934f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_725ca9a0-c1ae-4553-af19-778542496887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_725ca9a0-c1ae-4553-af19-778542496887" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6c953633-fed5-4ff7-a81e-eb03e6793872" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_73a92efd-49f8-40b3-ad56-1498c33d2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_659e965a-3c91-41c8-9fbb-2dd3d4a6a769" xlink:to="loc_us-gaap_InterestRateSwapMember_73a92efd-49f8-40b3-ad56-1498c33d2af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_74d5dd13-b68b-44de-ac6d-27fdef55a84a" xlink:to="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77c33b54-35f4-4e84-9968-01e7eb2d556f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_02554310-a3bc-47f7-a2d8-68b04be9bd00" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_77c33b54-35f4-4e84-9968-01e7eb2d556f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a57e3dd3-eb34-40a3-a4d4-1b08e8529827" xlink:to="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_6aff23b3-4071-4df3-a02d-d46736237903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_95cbed93-bf6b-4688-86c9-19870548fc79" xlink:to="loc_us-gaap_FairValueHedgingMember_6aff23b3-4071-4df3-a02d-d46736237903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fe0131b8-cf8c-4cd3-8f89-150c07e0b40e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_996c6a8c-ac8b-4789-810f-8c02d89ca686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_793fffdc-4720-46a9-850c-7a84a00d1cc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_996c6a8c-ac8b-4789-810f-8c02d89ca686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fce40c0f-0fc3-408d-a204-9fcadc55331b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f6497a13-8237-4ca1-afc9-1a2d25c73204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f6497a13-8237-4ca1-afc9-1a2d25c73204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_1cf9b19e-894a-46af-8632-3d4361f268bb" xlink:href="cah-20220630.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_1cf9b19e-894a-46af-8632-3d4361f268bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_267566ef-00ee-4932-b5cb-2ad1c4ee97a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_93dc3c43-62ff-4ce9-8e8f-b42bb4251b48" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_267566ef-00ee-4932-b5cb-2ad1c4ee97a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_50067898-a8c7-44a2-8bf9-b7e8a98aa6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_50067898-a8c7-44a2-8bf9-b7e8a98aa6d6" xlink:to="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b1937fc3-0e7b-49e9-91c1-bb8537f0af63" xlink:to="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_da6d2e62-dcca-41be-856d-a82deb7bb870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:to="loc_us-gaap_FairValueHedgingMember_da6d2e62-dcca-41be-856d-a82deb7bb870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_adb4e5e7-1fae-4923-8a9c-ba73d9c92709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_583de2da-acf9-4e12-9c56-97b1936dd74e" xlink:to="loc_us-gaap_CashFlowHedgingMember_adb4e5e7-1fae-4923-8a9c-ba73d9c92709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_578829cc-c55b-4c18-8cc0-c9a1aa821946" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9de1d147-cfc5-45db-8ff5-4660131b7cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_InterestRateSwapMember_9de1d147-cfc5-45db-8ff5-4660131b7cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f760296b-3724-4628-b6e0-97b778bd05e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f760296b-3724-4628-b6e0-97b778bd05e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_c41e95f6-d0cb-4aaf-a9d5-024db6ddb942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_ForwardContractsMember_c41e95f6-d0cb-4aaf-a9d5-024db6ddb942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_6da36939-b30a-4148-b566-ccbe4bf08694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_CurrencySwapMember_6da36939-b30a-4148-b566-ccbe4bf08694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityContractMember_c506bb4e-af11-4140-aa62-0da9f5c27694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e877f87f-e336-4fbc-b994-685822cba63c" xlink:to="loc_us-gaap_CommodityContractMember_c506bb4e-af11-4140-aa62-0da9f5c27694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_99a845f0-d5eb-4c78-9477-9a337eb95819" xlink:to="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_abbae813-dcb4-4ca5-9f2c-3221f9ca65b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:to="loc_us-gaap_DerivativeNotionalAmount_abbae813-dcb4-4ca5-9f2c-3221f9ca65b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9fdfb611-3049-4221-989a-e41046dfc085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a495e705-a25c-4075-824c-56b47db217a1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9fdfb611-3049-4221-989a-e41046dfc085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c6ff699d-499c-4540-adf7-82b8f8969aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d5040e87-f0be-40b7-9223-3931c428d037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c6ff699d-499c-4540-adf7-82b8f8969aa4" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d5040e87-f0be-40b7-9223-3931c428d037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ecd9690b-b2ca-483c-afd7-6ec146332fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_45b784af-7445-4e8a-a95d-aa330978234e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ecd9690b-b2ca-483c-afd7-6ec146332fc2" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_45b784af-7445-4e8a-a95d-aa330978234e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dc49d6b4-eeb6-4991-ae65-a32ed06911d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dc49d6b4-eeb6-4991-ae65-a32ed06911d5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_71d6e3bc-e8fe-4142-a6d2-4ff94b3b57ff" xlink:to="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_06120ff7-780e-4bb5-8274-d455c6da46c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34910da8-40d2-4d51-9bc0-c529fb4c7b29" xlink:to="loc_us-gaap_TreasuryStockMember_06120ff7-780e-4bb5-8274-d455c6da46c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f108cdbd-3d71-4e3b-b81c-5dcdc242c626" xlink:to="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f545f8e6-812a-44f7-80cd-a9da8b377077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:to="loc_us-gaap_CommonClassAMember_f545f8e6-812a-44f7-80cd-a9da8b377077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_1c949706-fe07-4a19-8f50-3338575c6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6afc82f0-49b8-4e57-9f88-11cf0114a0b4" xlink:to="loc_us-gaap_CommonClassBMember_1c949706-fe07-4a19-8f50-3338575c6174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:href="cah-20220630.xsd#cah_ShareRepurchaseProgramAggregatePurchasePriceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis_e7bc260d-ff47-4da4-a8bd-61b4edc38fb3" xlink:to="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A200MillionShareRepurchaseProgramMember_57cb80ef-6f9e-4e74-a5c2-05c904dcbeca" xlink:href="cah-20220630.xsd#cah_A200MillionShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A200MillionShareRepurchaseProgramMember_57cb80ef-6f9e-4e74-a5c2-05c904dcbeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A300MillionShareRepurchaseProgramMember_c733f5fb-cbf8-4abd-8290-c85809d4939d" xlink:href="cah-20220630.xsd#cah_A300MillionShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A300MillionShareRepurchaseProgramMember_c733f5fb-cbf8-4abd-8290-c85809d4939d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A500MillionShareRepurchaseProgramMember_ae53c7fc-4517-42b8-b37f-9ee6d7ab7476" xlink:href="cah-20220630.xsd#cah_A500MillionShareRepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShareRepurchaseProgramAggregatePurchasePriceDomain_c055a46a-d31a-404a-a3f0-ceefea087150" xlink:to="loc_cah_A500MillionShareRepurchaseProgramMember_ae53c7fc-4517-42b8-b37f-9ee6d7ab7476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9d2cdd3f-3042-43ac-b6c0-86f37ee44738" xlink:to="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_df5c5624-7985-48fe-9b92-4f80e418211d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_df5c5624-7985-48fe-9b92-4f80e418211d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9ed84a44-47cc-48cf-a710-5ace61274740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9ed84a44-47cc-48cf-a710-5ace61274740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e133d99-1392-4755-9070-8f39dad3acf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6e133d99-1392-4755-9070-8f39dad3acf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f27cfc52-bc92-4aa4-8b91-1e4bc9f4e79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f27cfc52-bc92-4aa4-8b91-1e4bc9f4e79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_028e98bd-f88e-48f4-a2a2-4a1c4f45224b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_028e98bd-f88e-48f4-a2a2-4a1c4f45224b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_575d0579-8953-43b4-baaf-bc5abcb89203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_575d0579-8953-43b4-baaf-bc5abcb89203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CommonStockVotingRightsVotes_16d7cc99-86f8-45a3-a9d3-c2be4481c6a5" xlink:href="cah-20220630.xsd#cah_CommonStockVotingRightsVotes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_e589cfe0-4dbd-4076-a778-2a31ab149e35" xlink:to="loc_cah_CommonStockVotingRightsVotes_16d7cc99-86f8-45a3-a9d3-c2be4481c6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_959babd5-7d8c-4d13-89ec-9521841a3990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_959babd5-7d8c-4d13-89ec-9521841a3990" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1ecf71c-3328-49f4-8fff-a90d9100d280" xlink:to="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eee094c2-5444-4098-b795-2d4ef4c51546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eee094c2-5444-4098-b795-2d4ef4c51546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_7052dd9f-e891-4f17-b3dd-cddaf763a247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_7052dd9f-e891-4f17-b3dd-cddaf763a247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_42fb0df4-17b7-4108-a3e9-8c2bb7dddfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_42fb0df4-17b7-4108-a3e9-8c2bb7dddfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4365c7cb-e1e8-48a2-855a-040f5a1abc75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6661a924-7ac8-475d-adba-ff19cc809253" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4365c7cb-e1e8-48a2-855a-040f5a1abc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_581bcd46-07b9-4bf7-bfae-29841e66c0b2" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_68f20601-780f-4184-ae5e-f13e4c4ba08e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d11d4204-6455-4fe9-a746-7925f37bc0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d11d4204-6455-4fe9-a746-7925f37bc0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7c7f3693-bc14-472f-8a88-5d8038c37d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7c7f3693-bc14-472f-8a88-5d8038c37d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d52875a1-a517-4801-aa37-c0a3e970f8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_d52875a1-a517-4801-aa37-c0a3e970f8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_51e150da-0130-436e-924c-18eeb819c755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_51e150da-0130-436e-924c-18eeb819c755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_487be81c-4ae4-4a74-a7bc-ea9e3769038d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_487be81c-4ae4-4a74-a7bc-ea9e3769038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_95017242-31a6-4b30-bcf1-fa0c1cd8556f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_8adc0a2a-0a93-4d80-a67c-e66b96815752" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_95017242-31a6-4b30-bcf1-fa0c1cd8556f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc" xlink:type="simple" xlink:href="cah-20220630.xsd#EarningsPerShareAttributabletoCardinalHealthInc"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_325765f2-ed0a-4328-9249-632fa35fc55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8dae087e-aa7b-4d9b-ad4b-0ab4791a8d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_325765f2-ed0a-4328-9249-632fa35fc55b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8dae087e-aa7b-4d9b-ad4b-0ab4791a8d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables" xlink:type="simple" xlink:href="cah-20220630.xsd#EarningsPerShareAttributabletoCardinalHealthIncTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f68e4589-d12d-4ac3-b177-c30f339eabc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_978511aa-3428-47a0-8383-dda0b6e9918a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f68e4589-d12d-4ac3-b177-c30f339eabc4" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_978511aa-3428-47a0-8383-dda0b6e9918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_53692e5a-601f-4f4e-8f75-e54dce878343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_ProfitLoss_53692e5a-601f-4f4e-8f75-e54dce878343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ad373ab-7879-4915-9028-8c876a893d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ad373ab-7879-4915-9028-8c876a893d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_484c396a-ef3f-4e28-aa7f-16f1daf70b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_NetIncomeLoss_484c396a-ef3f-4e28-aa7f-16f1daf70b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b865b237-e546-4dca-960c-f9638ff5315f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b865b237-e546-4dca-960c-f9638ff5315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_89de457e-0e8d-48d2-867b-f329b008e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_89de457e-0e8d-48d2-867b-f329b008e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_202974be-248f-440c-bb95-fd62efdda211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_89de457e-0e8d-48d2-867b-f329b008e20b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_202974be-248f-440c-bb95-fd62efdda211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_34f55433-a9cb-4dd6-9d82-6c63d714a35c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_34f55433-a9cb-4dd6-9d82-6c63d714a35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_bdba774c-05d5-45b6-9200-eb57c66dc04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_bdba774c-05d5-45b6-9200-eb57c66dc04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_f346fc15-4d43-4696-8865-a16f64d6857c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_f346fc15-4d43-4696-8865-a16f64d6857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c5869a0a-90ee-47fd-b34a-184091d3b2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_EarningsPerShareBasic_c5869a0a-90ee-47fd-b34a-184091d3b2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_99e0c7a9-d2ff-4595-b895-40847578d697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_551bb3c7-74ac-439a-a0d8-0a11d0cd756c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_99e0c7a9-d2ff-4595-b895-40847578d697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8824fd7-ea6f-498c-8b0d-20a8ec302edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2c1d8c00-4229-4019-85d7-445e14c464fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8824fd7-ea6f-498c-8b0d-20a8ec302edc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2c1d8c00-4229-4019-85d7-445e14c464fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_9eaf5a12-3ca7-4741-aa73-fcc106d4fcac" xlink:href="cah-20220630.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8824fd7-ea6f-498c-8b0d-20a8ec302edc" xlink:to="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_9eaf5a12-3ca7-4741-aa73-fcc106d4fcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_59a3b10f-dbfc-435d-9b3f-99ff70d72af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b96cc767-da59-454b-baeb-271bfbed4091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_59a3b10f-dbfc-435d-9b3f-99ff70d72af7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b96cc767-da59-454b-baeb-271bfbed4091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_19556309-97fd-4392-be66-08f51acfc6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_19556309-97fd-4392-be66-08f51acfc6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_df3d99db-7518-4b51-8591-d5d4977fcecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_df3d99db-7518-4b51-8591-d5d4977fcecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b4525c95-e66e-41f9-866f-df4c041ff7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b4525c95-e66e-41f9-866f-df4c041ff7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_af5d3f5c-b3f5-4571-92c5-b65009e571f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_af5d3f5c-b3f5-4571-92c5-b65009e571f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_773778d4-01fd-4319-8ba4-61c4fec507c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_773778d4-01fd-4319-8ba4-61c4fec507c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_5d7d0350-9953-42bd-9719-bd0edc7d8368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_5d7d0350-9953-42bd-9719-bd0edc7d8368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_1e28aad1-590f-4275-a36a-5b90ea74985c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_1e28aad1-590f-4275-a36a-5b90ea74985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_a724d4e6-dd88-4585-a09f-15640e9e8465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7bfbac7-168b-4944-b2c1-a21071fa6a89" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_a724d4e6-dd88-4585-a09f-15640e9e8465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3e750418-4a28-49f3-be61-aeee7f584759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3e750418-4a28-49f3-be61-aeee7f584759" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:href="cah-20220630.xsd#cah_OpioidLitigationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:href="cah-20220630.xsd#cah_OpioidLitigationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_d0fc9dc4-5fab-4bad-b5f8-82e80ac611a7" xlink:to="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_TotalOpioidLitigationMember_0d14ed51-da65-4650-8785-ebd51a51da73" xlink:href="cah-20220630.xsd#cah_TotalOpioidLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_ccf3e0a6-15c6-40d8-9996-5337eb82aca0" xlink:to="loc_cah_TotalOpioidLitigationMember_0d14ed51-da65-4650-8785-ebd51a51da73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_38252144-859e-46bb-860b-5f4b81e3a783" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NaviHealthMember_02696824-302e-4e63-ab84-867cf0b5dab7" xlink:href="cah-20220630.xsd#cah_NaviHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e54bb79-8adf-4fff-9a9c-079cf0524451" xlink:to="loc_cah_NaviHealthMember_02696824-302e-4e63-ab84-867cf0b5dab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b004669b-9e28-40b5-9fd3-5d4d42205e09" xlink:to="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NewYorkOpioidStewardshipActMember_62c32e62-bc9b-47af-8bd4-4fdef783fb35" xlink:href="cah-20220630.xsd#cah_NewYorkOpioidStewardshipActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_bf8f8da3-711e-4295-a39b-8cc8f12ded6e" xlink:to="loc_cah_NewYorkOpioidStewardshipActMember_62c32e62-bc9b-47af-8bd4-4fdef783fb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_e18881f5-a532-455f-8e29-1164fbc3469f" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_4ad21d9d-89c7-46d1-aa0a-8c09472fc3af" xlink:href="cah-20220630.xsd#cah_SterileSurgicalGownRecallMemberDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_609d568a-931e-46d3-b7a9-3c1d599c86cb" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_4ad21d9d-89c7-46d1-aa0a-8c09472fc3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_c1116320-c54a-4322-9912-f2c4e9db98ee" xlink:to="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_b07ae8ae-4894-4b79-b783-656928b2d5e6" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_66f82c77-853b-47bb-b3c5-ebb58946178b" xlink:to="loc_cah_CordisDivestitureMember_b07ae8ae-4894-4b79-b783-656928b2d5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d392ac5b-ac4d-4d53-bcf1-4014570458fa" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_df01f4fa-8f98-4b2d-94ab-2091591b122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_NumberOfReportableSegments_df01f4fa-8f98-4b2d-94ab-2091591b122f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_c08f3b04-449c-403b-bf14-8c26303291f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_InventoryRecallExpense_c08f3b04-449c-403b-bf14-8c26303291f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_5f585907-3fb8-40b6-8fd2-ef85a6801f5a" xlink:href="cah-20220630.xsd#cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct_5f585907-3fb8-40b6-8fd2-ef85a6801f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c88774c2-03f4-4fdb-806a-3d271d2841aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_LitigationSettlementExpense_c88774c2-03f4-4fdb-806a-3d271d2841aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_3f76d12d-1aac-4937-9006-a8756ee6b205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_3f76d12d-1aac-4937-9006-a8756ee6b205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_GainonDivestitureAfterTax_d71b92c4-36a9-4b91-a65a-e7055960ed25" xlink:href="cah-20220630.xsd#cah_GainonDivestitureAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_GainonDivestitureAfterTax_d71b92c4-36a9-4b91-a65a-e7055960ed25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_63678e6a-e8df-4954-8f81-04e56c31d49e" xlink:href="cah-20220630.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_63678e6a-e8df-4954-8f81-04e56c31d49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_WriteDownOfAssetsHeldForSale_6571474f-5e0a-44b9-a908-c0ff6e6d06d1" xlink:href="cah-20220630.xsd#cah_WriteDownOfAssetsHeldForSale"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33bfcf91-a78d-4985-abf8-2773c20e5f59" xlink:to="loc_cah_WriteDownOfAssetsHeldForSale_6571474f-5e0a-44b9-a908-c0ff6e6d06d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationRevenuebyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_32f81812-90bd-459d-a22a-8bd82aa966d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_32f81812-90bd-459d-a22a-8bd82aa966d5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ffd34cc0-7653-41db-b313-80025eafdaa8" xlink:to="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_df63e0c2-682d-4d37-8895-5a85a9293c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:to="loc_us-gaap_OperatingSegmentsMember_df63e0c2-682d-4d37-8895-5a85a9293c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5ab8909d-08de-4642-9eb0-b1d5838a2cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_548a11cc-5519-49ba-9faa-0720f1d6a9d3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5ab8909d-08de-4642-9eb0-b1d5838a2cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bc05f749-6ddd-4d00-b8ea-ed4fe079e205" xlink:to="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_40c567c0-3a72-4b4c-a79e-0e3bc91d4972" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:to="loc_cah_PharmaceuticalMember_40c567c0-3a72-4b4c-a79e-0e3bc91d4972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_1b7346f4-b9f5-4d4b-a48b-e2441ee8cd3a" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_981c8254-5077-4765-9a6c-ef00000cca98" xlink:to="loc_cah_MedicalMemberMember_1b7346f4-b9f5-4d4b-a48b-e2441ee8cd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_367d796b-90b7-4ca9-b782-c21164752082" xlink:to="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_8544fd7c-a4d9-43ed-8168-c43573954a38" xlink:href="cah-20220630.xsd#cah_PharmaceuticalDistributionandSpecialtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_8544fd7c-a4d9-43ed-8168-c43573954a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_f0a8c19a-15e5-4aac-add8-c883ec242a61" xlink:href="cah-20220630.xsd#cah_NuclearPrecisionHealthServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_f0a8c19a-15e5-4aac-add8-c883ec242a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicaldistributionandproductsMember_ca5e205a-0031-4fcf-9c9c-d770b56bc757" xlink:href="cah-20220630.xsd#cah_MedicaldistributionandproductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_MedicaldistributionandproductsMember_ca5e205a-0031-4fcf-9c9c-d770b56bc757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CardinalHealthAtHomeSolutionsMember_2165ceff-b102-43b8-a524-da3552cdeb80" xlink:href="cah-20220630.xsd#cah_CardinalHealthAtHomeSolutionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_09fc9307-bbc5-4aaa-9762-bcdd1b8bd7de" xlink:to="loc_cah_CardinalHealthAtHomeSolutionsMember_2165ceff-b102-43b8-a524-da3552cdeb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ade4baa0-f749-4d29-ac5b-c76869ff7560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_2ef3fe5c-1dd5-4410-be51-647cb3f1a2d5" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ade4baa0-f749-4d29-ac5b-c76869ff7560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2b3f3300-f91d-43e1-b3f2-6643dbe4a679" xlink:to="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_1c33849e-4433-452c-be85-045fee98e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:to="loc_us-gaap_NonUsMember_1c33849e-4433-452c-be85-045fee98e34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_94d3d83d-0caf-42f8-aa72-7b1e8e2819cc" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53038e18-0ff5-447b-8931-fb5b2a4dd083" xlink:to="loc_country_US_94d3d83d-0caf-42f8-aa72-7b1e8e2819cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aab07387-cc26-4072-a320-a12b6dc8b913" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2795f2f4-e3cb-453a-87a9-dd0fe9cb4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5aec546b-e479-4188-a239-411005cff2d9" xlink:to="loc_us-gaap_Revenues_2795f2f4-e3cb-453a-87a9-dd0fe9cb4fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationSegmentProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_56f27bcc-15a8-4110-8fe3-f2307d5ccca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_56f27bcc-15a8-4110-8fe3-f2307d5ccca9" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:to="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a41922bf-bbf1-4bed-bee4-07412fc8b9a0" xlink:to="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4b4ad532-003e-47b9-8e3f-51bc3ad74cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:to="loc_us-gaap_OperatingSegmentsMember_4b4ad532-003e-47b9-8e3f-51bc3ad74cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b1641276-a566-45a4-9c68-0055af190ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7d23fda4-4a3f-471e-9749-959ce78222d7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b1641276-a566-45a4-9c68-0055af190ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dd078379-852b-44f7-ac83-ffd8974455c5" xlink:to="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_28a95a35-b467-42c5-a330-f350a2ac7a98" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:to="loc_cah_PharmaceuticalMember_28a95a35-b467-42c5-a330-f350a2ac7a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_ad96ed29-6009-4d67-be95-e85c4bb290ec" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efc138a4-ce63-4450-89f6-305bff977a5a" xlink:to="loc_cah_MedicalMemberMember_ad96ed29-6009-4d67-be95-e85c4bb290ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_4b78795d-2dda-408d-9697-4016389a98b7" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_200ce2e7-8d0d-4c20-95f5-b70034420c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_b7705f9f-7635-44b2-b033-ea87e16f86b3" xlink:to="loc_us-gaap_OperatingIncomeLoss_200ce2e7-8d0d-4c20-95f5-b70034420c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3c9edca6-39c8-4476-b6c7-58209ad46ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3c9edca6-39c8-4476-b6c7-58209ad46ee7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:to="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_01d85c57-f7c4-475e-8b0a-a32adc1f8428" xlink:to="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_360b7f82-772f-4a17-bdef-1b5d82c4248c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:to="loc_us-gaap_OperatingSegmentsMember_360b7f82-772f-4a17-bdef-1b5d82c4248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9b6857b1-1123-4569-a47a-2616e441feac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d9e66478-d24c-4787-9123-be636094c245" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9b6857b1-1123-4569-a47a-2616e441feac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f896ba5-309b-45fa-b64e-c5a5d7ce238a" xlink:to="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_c4c12bec-8f02-4e7f-bc84-33aac30df568" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:to="loc_cah_PharmaceuticalMember_c4c12bec-8f02-4e7f-bc84-33aac30df568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_b1a69d7c-226a-4c04-a342-b99a9abd728d" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_db0279f9-6d79-4a02-b16e-2bcc95605605" xlink:to="loc_cah_MedicalMemberMember_b1a69d7c-226a-4c04-a342-b99a9abd728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8ed57038-7c15-433c-9edd-d9df11539943" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f7cb2333-e9a7-4fdc-aaf0-296fb311b78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f7cb2333-e9a7-4fdc-aaf0-296fb311b78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_28b4bbd1-17ed-49c8-94e3-272a99a95fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c5a3b58d-6198-4bca-a795-1e5b3f1fb04d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_28b4bbd1-17ed-49c8-94e3-272a99a95fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationAssetsbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c82d878b-aea6-4e1b-9a58-8a95fa86cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c82d878b-aea6-4e1b-9a58-8a95fa86cd36" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8d5cc21e-0d12-4ea5-b0f9-9a9e91d7c17b" xlink:to="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c17e7497-4bf3-4b97-b69e-ef07e94c5e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:to="loc_us-gaap_OperatingSegmentsMember_c17e7497-4bf3-4b97-b69e-ef07e94c5e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f1aaa8a2-9356-4c7c-8c2d-32b7bd9c0630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c42f067b-ecfc-47f9-8524-65bbc2e7bb5b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f1aaa8a2-9356-4c7c-8c2d-32b7bd9c0630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0642aaf8-9068-46a1-8045-ec414fd14229" xlink:to="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PharmaceuticalMember_2eb25c9e-f245-48e5-a883-147eda3aff57" xlink:href="cah-20220630.xsd#cah_PharmaceuticalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:to="loc_cah_PharmaceuticalMember_2eb25c9e-f245-48e5-a883-147eda3aff57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_MedicalMemberMember_4ecb2266-9ecb-451d-96ed-f949db760d1f" xlink:href="cah-20220630.xsd#cah_MedicalMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f78cc35b-9b6d-4861-9d11-c1b27a9978e3" xlink:to="loc_cah_MedicalMemberMember_4ecb2266-9ecb-451d-96ed-f949db760d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:href="cah-20220630.xsd#cah_CordisDivestitureAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:href="cah-20220630.xsd#cah_CordisDivestitureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureAxis_ea6b6bb0-d82a-4f30-96af-07445ce66417" xlink:to="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_CordisDivestitureMember_718e21bc-a6e4-4fd2-971e-17d62592be44" xlink:href="cah-20220630.xsd#cah_CordisDivestitureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_CordisDivestitureDomain_3e0e5262-088f-44db-95ab-838432d78959" xlink:to="loc_cah_CordisDivestitureMember_718e21bc-a6e4-4fd2-971e-17d62592be44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2a73af55-0233-4db0-a71b-7cf2d20ee2ce" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e9d34090-070a-42b6-acbe-2c596acde2af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:to="loc_us-gaap_Assets_e9d34090-070a-42b6-acbe-2c596acde2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_51704d50-e4bd-4aa8-b1f1-9bb8fc7885c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f667077e-b2ac-405c-b14c-758e98878537" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_51704d50-e4bd-4aa8-b1f1-9bb8fc7885c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_12e996c1-7b16-492d-bccb-b68269b60fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_12e996c1-7b16-492d-bccb-b68269b60fe8" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:to="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b31896e0-1751-41e2-8c04-eb5a9f40655c" xlink:to="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_57e6475a-4f51-46ac-b2a1-98cf73c451be" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:to="loc_country_US_57e6475a-4f51-46ac-b2a1-98cf73c451be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_78f5e02d-2703-40c3-81a5-6cc3bcd876ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d1f87cae-d382-4601-b2fe-687de2821aa5" xlink:to="loc_us-gaap_NonUsMember_78f5e02d-2703-40c3-81a5-6cc3bcd876ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_db1b5994-cb6d-4bf6-ba66-409175e849ee" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e8947097-adfb-4a3d-918e-5bbcc1b21582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_56b9db5e-c16e-4197-be31-53bf6522d23a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e8947097-adfb-4a3d-918e-5bbcc1b21582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_555f23aa-7eb6-4e32-a288-381e965c57ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_712ee8a4-635c-4e76-9114-7c927f70b265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_555f23aa-7eb6-4e32-a288-381e965c57ea" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_712ee8a4-635c-4e76-9114-7c927f70b265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2ddd67e1-0a1c-4d6b-8aee-d2daeb0d7c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2ddd67e1-0a1c-4d6b-8aee-d2daeb0d7c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3f6ee777-a3ac-467a-9fc8-afbe8a56c82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3f6ee777-a3ac-467a-9fc8-afbe8a56c82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f097e2a7-96d7-40c6-b266-a9c958228e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f097e2a7-96d7-40c6-b266-a9c958228e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_e58fdea3-1237-4ce7-9481-538a94e90644" xlink:href="cah-20220630.xsd#cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock_e58fdea3-1237-4ce7-9481-538a94e90644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_e1208c67-f42d-4961-93c4-7f2dd5ed32b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_e1208c67-f42d-4961-93c4-7f2dd5ed32b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_7db1782f-d789-4773-a975-9a75ca71a1fc" xlink:href="cah-20220630.xsd#cah_AdditionalPerformanceShareUnitsDataTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_45c43e84-f594-4865-b2ea-92981752f49c" xlink:to="loc_cah_AdditionalPerformanceShareUnitsDataTableTextBlock_7db1782f-d789-4773-a975-9a75ca71a1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_729062dd-6785-4b78-86da-b205fd9b94bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_729062dd-6785-4b78-86da-b205fd9b94bd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e43745b7-9697-43bd-9885-403ca2172ac0" xlink:to="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_A2021LTIPMember_fbaa9569-5546-4ef9-be3f-72070c0050a3" xlink:href="cah-20220630.xsd#cah_A2021LTIPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_23a60d2c-6303-4807-9515-169b0bd806a3" xlink:to="loc_cah_A2021LTIPMember_fbaa9569-5546-4ef9-be3f-72070c0050a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_61cf503e-1dc1-4eab-a8d5-eb47ddb8184c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_AwardsOtherThanStockOptionsMember_7b5701e2-271d-4d31-8676-59b654cfd903" xlink:href="cah-20220630.xsd#cah_AwardsOtherThanStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_cah_AwardsOtherThanStockOptionsMember_7b5701e2-271d-4d31-8676-59b654cfd903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_197cb7ab-2146-46e9-bb4d-c570206dcfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_us-gaap_PerformanceSharesMember_197cb7ab-2146-46e9-bb4d-c570206dcfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1fbd5e5f-17d6-4b9b-b32a-613d7f4f12ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c56725-5c56-4726-a0d6-ea2ca985beb9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1fbd5e5f-17d6-4b9b-b32a-613d7f4f12ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_19484ceb-21f4-4426-bf12-3a9c33e20e1b" xlink:to="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30deffd1-5f90-4540-b83c-76c814cef4ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_963f09b8-f45f-4c73-b7b4-b7b71f8e4000" xlink:to="loc_srt_MaximumMember_30deffd1-5f90-4540-b83c-76c814cef4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_54a632cb-2eff-4415-b21f-be14270a4d72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0713ea36-9203-418c-b590-26721310b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0713ea36-9203-418c-b590-26721310b2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4ec5fcc2-e1d4-4c36-b677-ca512cb10297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4ec5fcc2-e1d4-4c36-b677-ca512cb10297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a912e0c-75f1-40cb-b109-a86279f8baa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a912e0c-75f1-40cb-b109-a86279f8baa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d6f5a7ee-8d96-467b-b487-5f471dde5658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d6f5a7ee-8d96-467b-b487-5f471dde5658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f7173ae0-191a-4251-991b-4c9b821d40c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f7173ae0-191a-4251-991b-4c9b821d40c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93785c24-5f88-4080-bbac-6dfd484b172c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50cc05a1-00df-4dda-8c6d-e18216c222be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_93785c24-5f88-4080-bbac-6dfd484b172c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5893437d-9b0e-46cc-89fa-874d1bc50713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5893437d-9b0e-46cc-89fa-874d1bc50713" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f3f05497-20f1-4fb0-85cc-d8d935657217" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b05d59f2-5a73-4ed7-9ba7-14d51f8f9bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b05d59f2-5a73-4ed7-9ba7-14d51f8f9bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_49789bbe-b84f-4940-aee7-6df4ac9e66fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_EmployeeStockOptionMember_49789bbe-b84f-4940-aee7-6df4ac9e66fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_433565e2-acdf-4284-a90b-5eb4067ca979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dc4beb4-8173-4a5a-b76e-478271d5f175" xlink:to="loc_us-gaap_PerformanceSharesMember_433565e2-acdf-4284-a90b-5eb4067ca979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b966ce3e-8ea5-46f7-809d-5fd1d5d21fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3a94315a-8b32-4e40-8b12-df4f46745f00" xlink:to="loc_us-gaap_PlanNameDomain_b966ce3e-8ea5-46f7-809d-5fd1d5d21fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e7c12ffd-71b9-45a2-89ed-e53a87ed37f8" xlink:to="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6967a246-5a66-4f58-a4c7-58f1c1ae5af7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:to="loc_srt_MinimumMember_6967a246-5a66-4f58-a4c7-58f1c1ae5af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_960af7d7-cc63-4d36-b4e8-c1336b558a03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2fca991-d442-4ec5-9d7d-a53aced09637" xlink:to="loc_srt_MaximumMember_960af7d7-cc63-4d36-b4e8-c1336b558a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9627397b-5f45-430c-a694-2b623461d312" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e65cb1ab-66f5-4604-96d7-c8bf830ebed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04b88134-845c-4338-b9ba-38bd0a550c7d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e65cb1ab-66f5-4604-96d7-c8bf830ebed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllStockOptionTransactionsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_969a8445-4ef1-4deb-a76d-98d896db34ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50b07b91-cf63-443e-bf94-d88c7022a779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50b07b91-cf63-443e-bf94-d88c7022a779" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:to="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a3cef3b7-ce60-4ceb-950f-f9037c74cada" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9de78bc7-1af6-4c93-9c73-97afec0d2b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5cfa4cd-3c4c-4895-b5d6-c37355cbb35c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9de78bc7-1af6-4c93-9c73-97afec0d2b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:to="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1dd2af12-218e-47f6-9271-f506933bd314" xlink:to="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2264036-be0d-498f-9384-82ee6a5bb303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_efc55e21-2947-41d7-985c-098c6a327420" xlink:to="loc_srt_MaximumMember_e2264036-be0d-498f-9384-82ee6a5bb303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53ef2a1a-1cfa-474f-bf9a-c86420dcc35a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b177970c-b86c-44b7-9ce6-bb57e188e424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d18e59ff-6428-4961-b6b9-fb04acba2956" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b177970c-b86c-44b7-9ce6-bb57e188e424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_259888f6-fa2b-4e49-9378-79c346c5b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_259888f6-fa2b-4e49-9378-79c346c5b6b4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:to="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c217f602-dac4-4365-8ba2-2eba45ad8c54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_76dbe643-b692-46c8-8008-3a154ee1b0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_057a82c7-e8c7-4b83-bc2b-e1172b2ef56c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_76dbe643-b692-46c8-8008-3a154ee1b0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e3698ec1-8a33-49a2-84b2-5c31a0efff80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c91634a0-a271-4684-8b98-5bba7576d91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16fb770a-3bb1-42dd-8179-8bdf2b5dbccb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c91634a0-a271-4684-8b98-5bba7576d91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1087f94a-a7d1-490a-87ca-36c096337fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1087f94a-a7d1-490a-87ca-36c096337fb9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:to="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a31fbdd1-2d3a-4788-b756-fd8cc24594a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f7b51a41-cded-4fe1-971d-2a4c322c9919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8d3c867-4ce6-4045-a510-73e0ca7cdde0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f7b51a41-cded-4fe1-971d-2a4c322c9919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc39b247-24cf-42d6-87a5-b64ad2f7f004" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5b9ae0b-8288-4d74-bd71-61d7c71da633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5b9ae0b-8288-4d74-bd71-61d7c71da633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0049b8ad-4f20-4dc4-863c-6dc678ad17f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0049b8ad-4f20-4dc4-863c-6dc678ad17f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_07b83531-6013-427f-a143-cecd18c0b81d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_07b83531-6013-427f-a143-cecd18c0b81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_761c80e5-6c82-499c-8055-be1d6b4a3d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_761c80e5-6c82-499c-8055-be1d6b4a3d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4805be85-f415-4f46-a245-8485daaea2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_82d13aff-4eab-4e15-8a6e-26cb9da3c767" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4805be85-f415-4f46-a245-8485daaea2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82c8c514-b280-47af-877a-04b427cec1ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4346b1d-aa1e-41b3-9056-b0b38c2f3b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4346b1d-aa1e-41b3-9056-b0b38c2f3b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f73c55d-4602-41c0-a40f-ff97f081cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6f73c55d-4602-41c0-a40f-ff97f081cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c80c993e-f77e-4277-a339-0577d4a9c81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c80c993e-f77e-4277-a339-0577d4a9c81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e838dd4a-da3b-4291-9877-3583065ad5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e838dd4a-da3b-4291-9877-3583065ad5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5b41fca6-0d23-44e4-b86d-b3f83194e582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b701a511-b1f9-4cf0-bb2e-03f78b62fb3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5b41fca6-0d23-44e4-b86d-b3f83194e582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7fc2a481-0e6a-45a1-b32f-8fe56ff393b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7fc2a481-0e6a-45a1-b32f-8fe56ff393b7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:to="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eaa37abf-2c87-43eb-9324-9befb9d17be0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9c079208-d7b5-4541-bed4-6f7328261804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9c079208-d7b5-4541-bed4-6f7328261804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3d8aa253-25e1-4415-8c79-3c0ad902307f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ed22c5d-9b66-4fa1-ada2-0d3273079b0c" xlink:to="loc_us-gaap_PerformanceSharesMember_3d8aa253-25e1-4415-8c79-3c0ad902307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_961be1e1-d5fc-4923-b820-b095b81a0537" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46d03217-9b0d-4fbc-8700-890e87c602a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_46d03217-9b0d-4fbc-8700-890e87c602a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5a7b9ffe-8e15-44b9-9e37-2d856b577f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5a7b9ffe-8e15-44b9-9e37-2d856b577f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4387ab99-c792-4746-9cbc-fdb76807253b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4387ab99-c792-4746-9cbc-fdb76807253b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_00ef7d10-2d7d-4cc6-988b-f484768feb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09111d71-5c3e-49a6-950e-e631362e52dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_00ef7d10-2d7d-4cc6-988b-f484768feb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e0c2672-91d0-4767-90ce-a02162838108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e0c2672-91d0-4767-90ce-a02162838108" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:to="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_59b89b69-6eb8-449b-8a35-892403de7712" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5fd19e62-9c90-4afe-bed3-1a6a7a081130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e9c0075-d5af-4836-aab2-999e7e21bc68" xlink:to="loc_us-gaap_PerformanceSharesMember_5fd19e62-9c90-4afe-bed3-1a6a7a081130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac389bb-8b8a-4fda-887e-aea2609e16ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e796b2db-dfdc-4c63-9237-19c0bf3f614d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e796b2db-dfdc-4c63-9237-19c0bf3f614d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40fac0d2-8818-4c30-9425-5e2d19adf50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40fac0d2-8818-4c30-9425-5e2d19adf50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0116ab58-d953-4262-925c-a248b5bb0d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0116ab58-d953-4262-925c-a248b5bb0d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02fd71b8-4081-4171-af75-8c2cbc215c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02fd71b8-4081-4171-af75-8c2cbc215c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ebc995ba-0b91-4556-bb78-4f950ada47ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8ef6dfee-01b5-4506-8132-b8d84b5f6c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ebc995ba-0b91-4556-bb78-4f950ada47ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ca50e37-b55e-43c7-b0fe-7c9d73aa444a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a8c6475-18f2-4859-a894-7c6ef4d090e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a8c6475-18f2-4859-a894-7c6ef4d090e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb739f57-ee74-4018-b864-7a0be9a4703e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cb739f57-ee74-4018-b864-7a0be9a4703e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_eff761a9-de82-44af-99be-4fa16e5c3f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_eff761a9-de82-44af-99be-4fa16e5c3f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9b4e2cb3-dcb0-4fd6-9da2-e907c34d0a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9b4e2cb3-dcb0-4fd6-9da2-e907c34d0a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5bb7b806-e368-46ae-be20-75c721c82c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5bb7b806-e368-46ae-be20-75c721c82c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7c293e98-838d-4e31-8a41-0a284e6b436e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a78c7f0a-9f87-48f3-8907-d32fc13168e7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7c293e98-838d-4e31-8a41-0a284e6b436e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9e39d1b-f592-4612-8d69-a444c2e1faa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9e39d1b-f592-4612-8d69-a444c2e1faa0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:to="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_04adc076-b7aa-469f-8a72-0639d71bd53e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d32a1ac7-1ff6-4283-80c0-8a630a8899b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8bbb1781-e0ee-407b-9920-69ac087405ff" xlink:to="loc_us-gaap_PerformanceSharesMember_d32a1ac7-1ff6-4283-80c0-8a630a8899b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:to="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dde70197-4b7b-4e49-a85a-4b5fbbe46470" xlink:to="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f9566ea9-2814-48a6-a8ae-053907692eea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fd5b4703-7ba5-499c-8a1f-48a2d177e0d1" xlink:to="loc_srt_MinimumMember_f9566ea9-2814-48a6-a8ae-053907692eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b4bdd5e0-5a86-4915-84ba-ef3f21e6f316" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ac786261-1487-4432-928e-f82d76cbd491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ac786261-1487-4432-928e-f82d76cbd491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_68444d5f-66a4-4cb5-ac0d-304eb3b9b5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_68444d5f-66a4-4cb5-ac0d-304eb3b9b5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_68f1176c-eb04-4de4-b74d-3e1735a2bf00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_68f1176c-eb04-4de4-b74d-3e1735a2bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_VestingPeriodinyearsforShares_6fcb0f1a-dd38-4e8b-85f6-9aa02fb14a85" xlink:href="cah-20220630.xsd#cah_VestingPeriodinyearsforShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_cah_VestingPeriodinyearsforShares_6fcb0f1a-dd38-4e8b-85f6-9aa02fb14a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ae07c64f-0254-4753-9692-86d17d357c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17b05150-fca5-4bef-b0f9-693e8f45c3f7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ae07c64f-0254-4753-9692-86d17d357c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts" xlink:type="simple" xlink:href="cah-20220630.xsd#ScheduleIIValuationsandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_b3399514-5b38-4ec7-9719-a2e43ec289e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_62dc2132-538e-467f-bd2d-a15cb8908e2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_b3399514-5b38-4ec7-9719-a2e43ec289e3" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_62dc2132-538e-467f-bd2d-a15cb8908e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="simple" xlink:href="cah-20220630.xsd#ScheduleIIValuationsandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_9ce8e0ea-bd8c-4e1d-91dc-e072694223a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_9ce8e0ea-bd8c-4e1d-91dc-e072694223a9" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_b8153fd7-b5cd-42fc-b9d2-1c1d97eaf53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a527471b-e9dd-4b3c-bd5e-5f4a548917f5" xlink:to="loc_us-gaap_ReceivableTypeDomain_b8153fd7-b5cd-42fc-b9d2-1c1d97eaf53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_39e1b07d-67a2-40da-a2bc-513e56fdb12b" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PricingDisputesMember_a4a3d5b6-90b0-4939-9b97-51c2f0ccf139" xlink:href="cah-20220630.xsd#cah_PricingDisputesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_cah_PricingDisputesMember_a4a3d5b6-90b0-4939-9b97-51c2f0ccf139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_c2f7861e-d9b3-4249-8097-20a93b189d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_c2f7861e-d9b3-4249-8097-20a93b189d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cah_PriorYearRecoveriesMember_1fa592b4-b183-43af-bb82-7b5346eff495" xlink:href="cah-20220630.xsd#cah_PriorYearRecoveriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_cah_PriorYearRecoveriesMember_1fa592b4-b183-43af-bb82-7b5346eff495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_382d69d5-ebba-4770-83be-24cba8e6bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLossesOnFinanceReceivablesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_AllowanceForLossesOnFinanceReceivablesMember_382d69d5-ebba-4770-83be-24cba8e6bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_6a335b2f-82df-462f-9a79-88181b637708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7c7c8604-4338-4dc3-8483-826de8fe8bd0" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_6a335b2f-82df-462f-9a79-88181b637708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_c25e1ba0-e177-4059-b13c-d178506eba07" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_ba016df6-4c46-4e08-96b2-243bd34e8970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_ba016df6-4c46-4e08-96b2-243bd34e8970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_be345dde-4b9d-4ca8-99b4-406d9807826c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_be345dde-4b9d-4ca8-99b4-406d9807826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec441f56-fceb-4a10-bcf8-5cc8b3913828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_ec441f56-fceb-4a10-bcf8-5cc8b3913828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a7ac865b-7a57-4f60-bdf8-dc98815db029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a7ac865b-7a57-4f60-bdf8-dc98815db029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_946ded70-5499-4586-a3f0-8d840c58026a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_946ded70-5499-4586-a3f0-8d840c58026a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6b5b27ce-5cd9-48bd-8f85-d79eda53ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_5fdcdac3-dddf-4c0f-961a-71f919497dd1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6b5b27ce-5cd9-48bd-8f85-d79eda53ed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cah-20220630_g1.jpg
<TEXT>
begin 644 cah-20220630_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"W7B[3O"]S8Z5X6T1M:NK6WL)[R&5KJ]402(3.4AME5B< (202%*L_X-=_\
M@E)^RS_P4!\2_'*W_;*\)WGC/PW\-9[/3O"WAN?6[NVM(+W43=+=7P6WE0B;
MRM/MT#9P0<D$QH5 /Z-/V??VD/@/^U;\,;/XS?LX?%C1/&?A>_=X[?6=!O5G
MB\Q.'B;',<BY&Z-P&7(R!FO$OBI_P6P_X)0_!3XFWOP>^)G[=W@'3O$6FW9M
M=2L%U-IQ9SAMK12RPJ\<3JV0RLP*$$, 0:_+?_@T0T;4T\$?ML?LPO\ $_5=
M T+1=3TNWL-=LKN.*?2);B+6[2;4(FD4QQS*EG ^]E*@PJ2"!BOE3X[>%/\
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M$O1]'L)[N[N_ &LPVMK;1&22:1K&951%4$LQ)  '))Q7YN?\&>OP:^,'P/\
M^"<GC[PM\:?A3XE\(:G<_&R_NK?3O%&A7&GSRP'2-)02K'.BLR%D=0P&,HPS
MD&OUBHH _GL_X(E_L._M@>)/V$/^"AWP+B^$/BSP?XI^(FCPV/@Q/$VBW&EC
M5Y&AUD&&)[A$#+('6)F!VJ)P6(!KR7]@7]I/]MGX<_\ !,7XF_\ !&;X%_\
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MYTN/5YG'B1?*AEN$165_.CC9U)"B=2>",^/_ /!//]I']MKX2_\ !-OXH_\
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M72CH,6JQ^,?#)5-)V^5Y"WS/_:2P!#L"8$@C^0*$&V@#*\._\%2OVGOVJ/\
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M*Z67_!;'X2?\%-_VQ_%WA?QA-):R:E\2M3T?5(((-"N6LK^RATRSM_E:6*&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /GG_@I__P $XO@[_P %3?V3-4_96^,>KWVDQ37\&J:!X@TV-7GTC4H
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MO]K3Q!)]MTSX,:-)X(\((QW1V3)<C3Q)$>P=;+47]S=N:]0_9>_;/^$GC/\
MX.1/B_\ LDZ3^PW\-]#\4:#X:NKB]^,FFVI&OZLBVVFL8IWVX*D3(IYZ0I7B
MO_!I>LEK^UQ^WC8ZWQJZ?$K2A>"3[Y(O_$0;_P ?SGZBLG]A_P#Y7*/VA/\
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M_:6U3X2/')HL&A>(!KLEB1Y?FK-I<=UN(X)^WYS_ +8/>L+_ (-9_P#D3_\
M@H/];+_T7XCH Y7_ ((/_P#*LU^W+_UY^+?_ %%;>O0_^"87QJ\(_L[?\&E/
MCKXR^//@7X:^)>DZ)XOO7O/ _B^(OIVJ"36[&)5F4 Y"-(L@X^]&M>>?\$'_
M /E6:_;E_P"O/Q;_ .HK;TO[-G_*E5\7/^QIF_\ 4CTR@#]'OV7O^"IO[-G[
M,_\ P09\&?\ !13QU\%M$^'7A--$N3H_PU\"1!(#>-J=U!#862-CYI9%+L3P
MH:1S\JDU\*V7_!U]_P %-_#.B:9^UG\5?^"4,=I^SUK&K+;V7B.UM=5B9XV<
MH!'JLH^RS/E6"GR45V1E!!R1\^?\%%[+Q;-_P:=_L;WNFF8Z+!\1+P:JL>=H
MF9]=\AF^@$P!Z9;W%?KO^W]XF_9KE_X-NO&.LV-WI!\!77[-EM%X0VLGV?SG
MTZ%-*2/MO%U]E"@<AU'<4 7O^"BO_!:GP_\ LU_\$I/#G_!4+]E+PKIGCS1?
M%FH:4FC66MW$ELODW9D619?*RR31/&T;ID[71U)XKX;^.G_!U!_P4-T?X3^'
M_P!K_P"!G_!,$/\  H"RL]=\?^*[;4%M]2U%E5+I+.:)E2W@%SYMO'+(LP9D
M&[:Y,2_+OB2Q\9V?_!FMH,OBE9A97'QY:7PZ)<X^Q?;KA6VY_A^TK<_CFOT#
M_;-\.Z-I_P#P9S:/IMI81) W[.O@.[,:H /.>;2)V?'J96+9]3F@#WC]KO\
MX+Z? _\ 9M_X)+^"/^"G_ASX=7NN-\38;.U\%>#)[Y87.J31S/+!<3JK;([?
M[-<AW53N,2JN/,!'R'<?\'&O_!73]DCQQX&\7?\ !3C_ ()56?A/X7^/=5AM
M-/U7PS!>1ZA"L@W<+)<7"R7"QYD%JZ022!& VX)'*^"/V3/V5/VT?^#5O]G[
MX4?M+?M>>#/@QJ6GW^J:SX#\5>-]:M[6UEU"#5M5B:V9)9$::-X9W5A%ET)C
M<*VW8W@_CKXP?\'*/_!O-IWA_P 9_'CQ_:?$?X.66LP:9I\NM:]#XAT>Y8QO
MY=O#--MU*P!A201D") .,,!MH ^_O^#N#X;R>*?^"9WA3]K7X>ZB]KK_ ,)/
MB7H^OZ'KMKQ+;P71-OE"1E<SR64F?6%:_1?]D/X[V?[4/[*GPV_:0L8HXD\=
M^!=*UYH(^D+W5I',\7U1G92.Q6OAK_@O_P#&3PQ^T#_P;;>.OC[IVG2V6G>.
M_!?@O7],LKI@985O=8T>YBC8CJRB0 X]#7N/_!!:VU2U_P"".?[/,6L!O./P
MYM73?U\IF=HOP\LICVH ^N:*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#\;O^"=WAF3]A+_@Z*_:7_9IUR/['H_QY\*2>./"#L-JW]P]PM\Z
MH/1'FU=..GV8]NGU+\"_^",>I_!K_@M#\1/^"M4O[0\&HV_CO1)[!/ B^%VB
M>R,D%E%O-Y]I828^R$X\E?\ 68SQS[E^T/\ \$Z?@'^TA^U=\)/VT_$^H^(=
M&^('P:NKE_#6J^'+Z& 7UM.-LME>B2&0S6Y4RKM4HP$\N&&\U[U0!\)?\$Y?
M^",>I_L%?\%!?V@?VX[O]H>#Q1%\<-:U*_B\-1^%VLVT<7>K2Z@$,YN9!/M$
MGEYV)G&[ SBCX+?\$8M3^$G_  6G\?\ _!7"3]H>"_M_&^BS6"> U\+-&]F7
MM;.#>;S[2PDQ]D+8\E?OXSQD_=M% !7XA^!?^#0#QU\&/!.K>*?@5_P4U\2>
M$/BW)K4TND>.?"FC7>DQG2YXU6;3;A(+\RD%U#B5)%^\RO'("I3]O** /A7_
M ((G?\$//AC_ ,$@_!GB76KKXD3>/OB5XW>/_A*/&5Q8?9D2WC9G2TMHF>1E
M3>S.[LY:5@I(4*JKA?\ !*G_ ((;:K_P35T;]HC2;[]I:W\8_P#"]O)\J2+P
MDUA_8OEKJ2\@W4OVC/\ : _YY_ZK_:X_0>B@#\X_V"/^""&K?L4?\$P_CM_P
M3LNOVHK;Q'-\9X=72+Q;'X.:T72?MNE1Z>";8W<AGV&/S/\ 6)NSMXZT?#/_
M (((:M\/?^"(_B__ () /^U%;7=SXIU5[Q?'X\',B6V[4K6]V_8_M9+\6^S/
MG#[^<<8/Z.44 ?&OPJ_X(U_!FV_X)#Z+_P $DOVD/$[>-M TW1I[2;Q-I^G_
M -G7"W#7TUY!>6R,\WD2Q/*NW+.&V$,"KLA_//0O^#.7XO7FJ:?\&_B3_P %
M4_$VI_ _2M9-_:>"[/1KB.098EO*@DO)+2VG(9@;@1OR2WE\[:_=:B@#XK_X
M*+?\$;/A_P#MB?\ !-'0O^":?P)\<6GPM\->&;W2GT.Z&AMJ2V]O9!P(VC\^
M)G=]Y9I6<L6+,VXL36W\</\ @E[?_&+_ ((W67_!**/XTPZ?<6GPQ\/>$CXY
M;P^94=M,%GFY^R>>I D^R'Y/-^7S/O-CGZYHH _.WQ!_P;S?!?XJ?\$?/ G_
M  2O^-_Q:N=2U#X=3W5[X6^)FCZ*MK/97\MY=SB46KRR!HBETT4D)DPX4,&1
M@C)\QZ+_ ,&JG[6/Q>NO"GPJ_;N_X*]^,_B)\'O!=]%+I7@:""]R\42^6D<?
MVJ[EBLR(BT8<)*40E4P#D?M=10!^2_\ P=<ZQ;>#?^":OPT_8)^!OAZ-=7^*
M7Q,T+PMX1\+6(QOL[-=T<4:^BSC3X@/^FBU^F/[-'P6TC]F_]G/P%^SUH$JR
M67@7P9IF@6LJK@2)9VL=N'_X%Y>?7FO//CI_P3J^ G[1O[8_PL_;7^+&H^(=
M1\0?!RWNQX(\/&^A&C07-Q]^]D@,)D>X!$15A*%4V\1VY7)]ZH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2'^3UYG7IG[/W_'MJG_72'^3T >B4444 %%%% !1110 4444 %%%% !1110
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M;\/[3]H+0_&WP=U33=$@@CETZV:Z:+1H7M[=4FF:*YBA</F4/:EB'$H)^O\
M_@WU_95^+_[,O[&&NZU\;_A^W@_6OB5\1-0\6P^#7A,3:)9SQ6\4%N\1&8GQ
M 6V'#*C(K!64@ 'S-_P1N_9R^&G[(W_!=K]HO]G#X/VEU#X<\)_#*QM-.%_<
MF:>3/]D222R.0,N\CNYP H+$*J@ #R#X>?'_ /;<T3_@NM^U/KG[$G[-FB?$
MKXG7,]UIEM+XJU 066CZ/93V\,C,3-!N9_(LXD42ISV(Z?6G[#WPX^(>B?\
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MP4X^$/AKPW\0)]";6O!^K>$R1;7\*H96A/[Z59 8EE=9%9<?9Y$==W->\_\
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M1CU>2-(EBC2*,")9D(ARB3>8%)%?UEW7_'M)_P!<S_*OD;_A1_PT_P"%Z?\
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MVKVB@ HHHH **** "BBB@ HHHH **** &77_ ![2?]<S_*OG*OHVZ_X]I/\
MKF?Y5\Y4 %%%% !1110 4444 %>F?L_?\>VJ?]=(?Y/7F=>F?L_?\>VJ?]=(
M?Y/0!Z)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >(?%3_D?]1_ZZ)_Z+6N>KH?BI_R/^H_]=$_]%K7
M/4 %%%% !1110 4444 =1\'?^1_M/^N<O_HMJ]HKQ?X._P#(_P!I_P!<Y?\
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M?_':^O** /D/_A+OC9_T:;X[_P"_5M_\=H_X2[XV?]&F^._^_5M_\=KZ\HH
M^0_^$N^-G_1IOCO_ +]6W_QVC_A+OC9_T:;X[_[]6W_QVOKRB@#Y6\'?%+XV
M>$]?AUS_ (9 \=W'E*P\K%LF=RD=?,/KZ5VO_#6'QL_Z,?\ '?\ X%6W_P 5
M7NE% 'A?_#6'QL_Z,?\ '?\ X%6W_P 51_PUA\;/^C'_ !W_ .!5M_\ %5[I
M10!X7_PUA\;/^C'_ !W_ .!5M_\ %4?\-8?&S_HQ_P =_P#@5;?_ !5>Z44
M>%_\-8?&S_HQ_P =_P#@5;?_ !5'_#6'QL_Z,?\ '?\ X%6W_P 57NE% 'A?
M_#6'QL_Z,?\ '?\ X%6W_P 51_PUA\;/^C'_ !W_ .!5M_\ %5[I10!X7_PU
MA\;/^C'_ !W_ .!5M_\ %4?\-8?&S_HQ_P =_P#@5;?_ !5>Z44 >$R_M6_&
MR2)H_P#AB#QV-RD9^U6W_P 57G/_  EWQL_Z--\=_P#?JV_^.U]>44 ?(?\
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MD)#1BOWPKYA_9H_X)B>!/V:?V_OC5^W[H?Q/U?4]8^-,%I'JGA^[LXDMM-$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cah-20220630_g2.jpg
<TEXT>
begin 644 cah-20220630_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ):ZI%)8266SS/M*W"L8S%L^;S-VW;SG%?-GAO\ X+E?\$BO%WQ$A^%?A_\
MX*!?#F?6+B\%K;JVL^7;33$[0J73J+=LD@ B0AB>":^<?#/_  1Z\&?L6?\
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MJ:DL-W>VN9@9D5NJ9MY_FS@>4WI7(_ 3_@J7_P $[/VHOB3JOPA_9_\ VQ?
MOBKQ'HUM-<WNF:9K2EC!%_K9HF;"7$: 99XBZJ.20.:_'+_@Y ^!6E?M/?\
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MV/V63\&O"4VO7FD_#;P/>QW$=_<3J]C)?ZA+'<HDH20M:I&61 5B^4'YG?\
M7'_@O#_P3:_X*=_'SXU^ /VV/^"5_P"T'J^B>,O!^E1:7K7@FW\92:3#JD4%
MW)=VTRAG6VG.^>9)8K@A'CV#+ %3\QZ/_P $L_\ @O/_ ,%9OVT?A)\4O^"Q
MNA>$O GPZ^$FLKJ46C:1J6F2O?+YT$TT,$6GW%QF2X-M!&\DTBB.-24!/RL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/.Q@BM/$\D<9/"L_AF ,1]0B_P#?(K]-?^"(7_!/_P#:3_8=_P""2M]^R/\
MM!>'=.L/&L][XAECL[#5HKJ$K=@B'][&2O.>?3O7C7_!#O\ X(P?M*?LS?\
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MY^-D=U#X.\9A8?[*_M" A382DR"59G:2W1<(5+740R,DCZ,H **** "BBB@
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M:RUNXDME\F[,BR++Y662:)XVC=,G:Z.I/%?#?QT_X.H/^"ANC_"?P_\ M?\
MP,_X)@A_@4!96>N^/_%=MJ"V^I:BRJETEG-$RI;P"Y\VWCED68,R#=M<F)?E
MWQ)8^,[/_@S6T&7Q2LPLKCX\M+X=$N<?8OMUPK;<_P /VE;G\<U^@?[9OAW1
MM/\ ^#.;1]-M+")(&_9U\!W9C5 !YSS:1.SX]3*Q;/J<T >\?M=_\%]/@?\
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M]V/!'AXWT(T:"YN/OWLD!A,CW (B*L)0JFWB.W*Y/O5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !17G=Y\>_LEW+:_\(IN\J1DW?;L9P<9^Y4?_  T'_P!2C_Y/_P#V
MN@#TBBO-_P#AH/\ ZE'_ ,G_ /[71_PT'_U*/_D__P#:Z /2**\W_P"&@_\
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M0 4444 8GQ(_Y$;4_P#KV/\ ,5X57NOQ(_Y$;4_^O8_S%>%4 %%%% !1110
M4444 %>@? '_ )"VH?\ 7LG_ *%7G]>@? '_ )"VH?\ 7LG_ *%0!ZA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?/&L?\ (6NO^OE__0C5:K.L?\A:Z_Z^7_\ 0C5:@ HHHH ****
M"BBB@#<^&_\ R/.F?]?(_D:]TKPOX;_\CSIG_7R/Y&O=* "BBB@ HHHH ***
M* "BBB@ HHHH Q/B1_R(VI_]>Q_F*\*KW7XD?\B-J?\ U['^8KPJ@ HHHH *
M*** "BBB@ KT#X _\A;4/^O9/_0J\_KT#X _\A;4/^O9/_0J /4**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR8[$);Q*?]T4 ?L?\-_^1YTS_KY'\C7NE>%_#?\ Y'G3/^OD?R->Z4 %%%%
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M@K^Q]=#[1X1^$/A^?XL>-;0G,5SJ(E-GI$3CIOBE+3[3G<DA^M 'U!^R-?\
M[1&K?LT^#-8_:QM-,MOB+>Z)'<^*[31X#';VUS(2_DA<G#(C(C8)&]6P2,&O
MH;X _P#(6U#_ *]D_P#0J\_KT#X _P#(6U#_ *]D_P#0J /4**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#Y/_:'T;XF>(OA?XVT'X+>+4T#QC>:)J,/A36Y;>*9+#4FBD%M,R2HZ.JR
ME&*LK @$8K^>'XF_M1_\%!?VEO&/B/\ 9#_:+_8W\6>+OCGK?PA;X>3_ &C1
M5C9V_P"$D748]7DC2)8HTBC B69"(<HDWF!217](^L?\A:Z_Z^7_ /0C7%?\
M*/\ AI_PO3_AI+^P7_X3'_A$O^$:_M3[9+M_LS[5]J\GRMWEY\[YM^W?VSCB
M@#C?V>?@EK?[/7["7@[]GO6+U;_4_!_PMLM#O)[?++/<6^GK"YCXR5+J=HZX
MP*^-_P#@VH^&?Q=\ _\ !+CQ%X0USPWJ?A'Q)<>/]9?2U\1:-+"\#O96:Q3M
M#*JET#C/3#;2*_2:B@#\-_C;_P %3/\ @I)XO_98^)?_  3"_:F_8J\:^(?C
MOXNNKK0-+UO0_#BQZ?/IUPZHTB1P1@2!4WB.6/=&ZNCLXVG=]A_#SXB?'S_@
MDA\!?V/OV&M"_9SN_'TWC"\71/'^NZ;-.T/A:6:]LWN)BT,,BO&KZC<;6=HU
M*VV<X)V_H+10!^5G_!2#_@H+\:OV4OV[=5\*_M8?\$XM"^+_ ,-H]%CN_@7K
MNF>!EN[J+5&CB)62ZN!,J.)EE1UB"2*HBD",&&?7/^#>O]C;XS?LN_LD>(/B
M+^T?X=GT?QS\6?&4_B;4](O(C'<65LR*L$<\9YCE9O.E*'YE$RJP#*P'WO10
M!N?#?_D>=,_Z^1_(U[I7A?PW_P"1YTS_ *^1_(U[I0 4444 %%%% !1110 4
M444 %%%% &)\2/\ D1M3_P"O8_S%?GU_P4[_ &._B-^U[\#] /P)\7V&A?$G
MX;^.M-\:_#O4=6#?8VU.R+[8+C8"WE2)(ZG /S;200"*_07XD?\ (C:G_P!>
MQ_F*\*H _*C]DC]G?]N[]N'XY6MY^T[X#\(^ ?AU\+?VE-2\>>(=.T?73J%[
MK/BNV"B"UB*C;':0.Y<LQRX? R>5^W?^"GO[.OQ$_:T_8+^)/[.GPF%B?$7B
MK18[72AJ=UY,'F+<PR'>X!VC:C<X/.*]XCBBBW>5$J[F+-M7&2>I/O3J /G[
M]M/]BJX_;!_8CF_9K/BP>'O$EI9Z;>^&?$<2>8-+UFP:.6WGQU*>9'L; SL=
ML<XKP";]GK_@J-^W/\1OAAX*_;T^'7PZ\#_#WX7^,;+Q3XBNO"/B)[^?QOJE
MB";18HBH^R6AE)>1)#N(P!T&/T HH \Q\.S?M8']K+Q#!XFM?"P^#8\*6Q\-
M36Q?^USK'F+YXFR=OD[-VW SG%>;_LU?LI_%+X?_ /!0[]HO]K7XDC3GTOXB
M0>%].\!_9;PR306-A8O'<K(NT>7OG97 R<XSQ7TM10 5Z!\ ?^0MJ'_7LG_H
M5>?UZ!\ ?^0MJ'_7LG_H5 'J%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\\:Q_R%KK_KY?_P!"-5JL
MZQ_R%KK_ *^7_P#0C5:@ HHHH **** "BBB@#<^&_P#R/.F?]?(_D:]TKPOX
M;_\ (\Z9_P!?(_D:]TH **** "BBB@ HHHH **** "BBB@#$^)'_ "(VI_\
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MWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\
MH;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E
M<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE%
M'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44 >%_\
M.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T
M-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\ T-OCO_PL
MKG_&C_AWO\$_^AM\=_\ A97/^->Z44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_
MX=[_  3_ .AM\=_^%E<_XU[I10!X7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_
M *&WQW_X65S_ (U[I10!X7_P[W^"?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A
M97/^->Z44 >%_P##O?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I1
M0!X7_P .]_@G_P!#;X[_ /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?
M_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_
M]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\
M+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :
M/^'>_P $_P#H;?'?_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*Y_QKL_@S^S7X
M"^!FIWNK>$-9\0W4E_ L4RZUKDMVJJ&R"H<_*<]Q7H-% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?(?C3_@O9_P2!^'
M?C'5OA_XT_;I\)Z?K.A:G/I^K6$UM>E[:YAD:.6)L0$95U93@D<5]>5^)'_!
M*O\ :X_X(Y? _1?C]X-_;R\9_"&P\;/^U+XVN8(/'/AZWNKTV#74:Q,'D@<^
M7O67 SC(;CF@#](?!/\ P6'_ .":'Q%\&Z5\1?!O[7/AR]T#6O&\'@_3M9$%
MU':R:Y-&LL5BTCPA8Y&1@P+E5P&.?E;'T?J>IZ;HFFW&LZS?PVEG:0/-=75S
M*$CAC12S.S'A5 !))X %?(7Q:_9,_8"_X*N?\$S?%GPE_9<C\$Q^!OB%;W$W
MAGQ5X*T6*UMK;6[25HX+]1%&A9X;F (_ 9D5X\X8U\'M_P %#?VEO^"B/[%W
M@+_@BZE]?:)^TSXJ\77_ ,-_VA;[EI_#OA[1A&-6UIVZ-]LM6BC0G"3237*(
M<A30!^I5I_P48_8@NOV6E_;8E_:2\.6GPIEFDBMO&^IS/:6=S(DK0E(3.J-,
MQE1T"HK%F1@H)!J?]D7_ (*"?L7_ +>6CZEK7[(G[17AWQS'HSHNKV^ESNES
M9;\[&EMYE26-6VL%=D"L58 G!QYA\5O^"1_P-^)GC/\ 9ITM+VTM?A7^S:+V
M32_A+=Z$MW8:[<M8I:V%Q<2-( )+1E:92T<AD>1]V-Q)\.U71_AM>?\ !ROX
M+T_]E;PUI]AJ?A3X":N?V@[OP_:I# ]O=2P_V1:WGE@*UT)0DP5OWAB\L_=0
M8 /I+XX_\%?O^"9/[-GQH_X9Z^.7[:?@?PYXQ25(KO1[W468V+N 56ZE16BM
M#@AL3,A ()X(-?1EA?V.JV,.J:7>Q7-M<Q++;W$$@>.6-@"KJPX92"""."#7
MPAH/[ '[%/\ P3,_X)A_%>W_ &RKSP[\1+/48/$/B3XO?$/Q%X9@MKSQ1<WL
M\\J!E>29A,!+#;PJLA)E"L@5Y,5W?_!!CPS\7O!__!'WX!:!\<TO$\01>!D<
M17^1-%823S2:?&P;E=MD]LNT\J% XQ0!]<T444 %%%% !1110 4444 %%%%
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M)'$_M6?\%)/V&/V'M-T;4OVL/VE/#W@=O$,/G:-8:NTOVVZBXS(MK&C3A 2
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M_P#!-G]GSQQ'\2O@E^Q=X"\,:_%9W-I%JVD:*L4ZP7$+PS1A@> \3NA]0QH
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M#C2O"N@_;[B]_LK1[810_:)Y#)-+M'\3N2Q/<FO'OBM_P2$_X)C?'+XBZO\
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cah-20220630_g3.jpg
<TEXT>
begin 644 cah-20220630_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#P_XV\-W$S0IJ_AS4DN8EE4 M$^TYCD4,N8W 8;AD#(K^9']HSXA_!7]@/\
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M^];<T@C89_=FP )[RU^OG_!%'XM>'/!?_!$;X*_&'XW?$BTTS2].^'IO-?\
M$_B?5EBAMXEN)MTL]Q,P"@#'S,?2OPL_;+US3?VX?B3_ ,%/_P!OW2[U-5T+
MPQ8^&O"GAO4HSNAEA?Q;HUI:SQ'T>UT5R/\ 9F.>M?H58_L__LL_M%?\&L7P
M.\*_MF?MAZG\%O .FZ+9:EJ/B'3DCE%_/'/=B"SDMRC27BEW$JP0XD9X$8?<
M- 'W]\&?^"T?_!*W]H/XG67P:^$/[<O@35O$VIW0MM,TLZBUNU[.3A8H'G1$
MF=CPJ(Q9C]T&O5/C-^V-^RW^SO\ $+PC\)_CC\=O#GA;Q)X\O5M/!NC:SJ A
MGU>=IHX1' I^^3)-$GU<>M?RG?\ !6?XC?\ !&'5/A9X#L/^"1G[//Q"T+5_
M"&MI;>(/BOJL=W!9:RHMV9%!GN'?[69(Q,&\J @!\ C 3[E_X.S=#\2_&WX^
M_L5>&[76I++6/%VCSVT>HPY5X+FZNM+42KM((*O)N&".E '[9_LX?\%!_P!B
M;]KW6?%'A_\ 9F_::\)>-+OP8V/$T6B:F)/L2EF42DG >(E& E0M&<<-7)>
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M3+"+2KW7Y;#PG>2_V,CWNC2E;S;&?LK*JON63:5V-G&TX_=.B@#Y'_X+B_L
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MJ$D* .F\9?\ *[OX3_[$R3_U#+VM#]CK_@D)_P %>_VV_P#@J;X2_P""B/\
MP6O&B:)8_"B6UG\)>&M*U/3YQ?7%I*T]FD$5A++'!;I<L;F1Y7\UV54VX;='
M[QXC_P""6_[7NI?\'.&@?\%/;7PII)^$FG^&WL[G53KL(NA*?#=S8 "VSYA'
MVB1%SCH<]!0!\[_\$Z?^5PK]IK_L3-5_GHM'_!M[_P IR/V]O^QSUK_U)KRO
MHC]CS_@EO^U[\'/^#B/XV?\ !1;QSX4TF#X7^-_#=_9^']2@UV&2YEEE.F;
MUNIWH/\ 1I>2.,#U%'_!&G_@EO\ M>_L8?\ !4']JW]J/X[^%-)L?"'Q8\2:
MG>>#+NQUV&YEN(IM;N;N,R1(2T1,,B'#="<=10!^=O\ P0A^(OC7X2_\$IO^
M"D'Q$^'5Y-:ZWI?AM9-.O+=BLEJ[66K)YZ$=&C#%P>Q0&OLW_@T__8@_9*\8
M?\$F+SXC^.O@KX5\5:U\1?%&KV?B^YU[1H+QY+2!Q;Q6),JMMA"*9-@P"T[-
MW&.G_P"#?W_@C9^T9^QO\(/VEO@M^WE\/M(BT+XS36UG#8Z;KT-X+W3GM]0@
MND<Q$^7E+I1SS\Q]*^6/!/\ P2G_ .#EO_@DSJ_C?]FW_@EOXZTCQA\)O&&J
M2W6G:V^JZ+#-IS2*(A=-!J;QO:W?E*BN8!+&WEJPR57: 8O_  05$_P0^-7_
M  4A_8[^'6HW%Q\//#GAOQ)_8Z/,9(XVL+G4K&W<,2?FDMV^9NKB%<YVBO8?
M^#,K]F;X&^-OV"?C!\4_''PNT/6M6\1?$BX\+:I<ZKIL=P9M)ATNQF^R'S <
M1,][,60</\N[.U<?2G_!(_\ X(@>,_\ @G+_ ,$_/B[X)\=>)[#Q/\;/C1X>
MOAXHU"UNF:U@D-G<1VEBD\H#2!9+B5Y)F"[GF;@JBL=S_@VE_P""=7[4'_!,
MW]A_Q?\  W]K#PUINE^(=8^*UYKMC;Z7K$5[&UE)IFFVZL7B) ;S+:4;3S@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %%%% !1110!]$:/_P @FU_Z]D_]!%6*KZ/_ ,@FU_Z]D_\
M015B@ HHHH **** /GC6/^0M=?\ 7R__ *$:K59UC_D+77_7R_\ Z$:K4 %%
M%% !1110 4444 %%%% !7T1H_P#R";7_ *]D_P#017SO7T1H_P#R";7_ *]D
M_P#010!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *^>-8_Y"UU_U\O_ .A&OH>OGC6/^0M=?]?+_P#H1H K4444 %%8O_"QO ?_
M  L7_A4?_"7:?_PD_P#8O]K_ -@_:5^U?8/.\G[3Y?7R_-^3=TW<5M4 %%%%
M !1110 4444 ?1&C_P#()M?^O9/_ $$58JOH_P#R";7_ *]D_P#015B@ HHH
MH **** /GC6/^0M=?]?+_P#H1JM5G6/^0M=?]?+_ /H1JM0 445\GK_P6M_X
M)X/^U]_PQTOQ^T<ZQ]F\O_A(/M0_LK^T_M'D_P!E_:?N?:/XLY\O^#?O^2@#
MZPHKEOC-\;_A#^SM\/;[XK_'+XC:1X5\.:<%^V:OK5XL,*,QPJ G[SL>%1<L
MQX )KG/V9/VR?V7OVR_#-[XO_9A^->B>,;'3;A8-2.ES,);1V!*B6&15DCW!
M6*EE ;:<$X- 'IE%4O$?B/P_X/T"]\5^+-=L]+TO3;22ZU'4M0N5A@M8(U+/
M+)(Y"HBJ"2Q(  )->,?L]_\ !3+]@K]JOXAS_"?]GW]J+POXF\20)(XT>TN'
MCFG2,9=H!*J_: H!8F+<  3TYH ]THHHH *^B-'_ .03:_\ 7LG_ *"*^=Z^
MB-'_ .03:_\ 7LG_ *"* +%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7SQK'_(6NO\ KY?_ -"-?0]?/&L?\A:Z_P"OE_\ T(T
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MUO7]"OSYD<\=U%<01J\44W)EBC^78<],<T ?EK_P2R_86N?VBO$WPK^*5O\
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MA,T ?6/_  7<^$_Q8^-'_!*[XJ^"O@WODU5-/M-0NK2.<1-=6-I>07-U&&)
M_P!3$[;<_/LV<[L'\KOV>=3_ &*/VI?VQOV)/!O_  2_^$EQX7\=>!KFTU3X
MRZL;+[$9;6T^QR7:S2,_^FRLL=Z-XSN%PJY(;:GUS_P62_;=\"_M[?\ !$KQ
MS\:/V(/%VJZQX6LO'>GZ1XRNAI5Q9R"VCD@EE1DE57,?F3V19L;2"0> U?,?
M[7GQ%_X)_>.?$'[$>D_\$K[/PW#\4;/Q9I"RCP;IP@O[2#-J#%J;1JK/-YVX
MMYQ9L"X8G:Y+ '[WT444 %?1&C_\@FU_Z]D_]!%?.]?1&C_\@FU_Z]D_]!%
M%BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYXUC
M_D+77_7R_P#Z$:^AZ^>-8_Y"UU_U\O\ ^A&@"M537M"T;Q3H5[X9\1Z9#>Z?
MJ-I):W]E<QAX[B&12CQNIX*LI(([@U;HH _("P_X-?/@]8_MRSZ*/&'CS_A0
MEQX9&KS6":U GF:D-0!&B.X/G-;B)1+YGE[\ #S=XWU]S_\ !0;_ ()7?LX?
M\%"?@3H'P7\:1W?A:;P6ZOX$\0>&D2.?0ML:1^5&A&UH&2.,-'Q_JD(*E%(^
MF** /D#_ ()P_P#!'CX/?\$]]7\5?$M_BCXD^(GQ%\9V7V+6_'7BIP;@6F5)
M@B7<Q569(V<N[LQB3D!0*B_9O_X(L?LS? C]@KQI_P $\O$OB/7/&7@OQQKL
M^JZE=:KY,-W;SR16J(\+1*%1HGM(I48@_..01Q7V)10!^<_[)G_!N7\#/V=O
MCSX5^,_Q,_:2\<_$ZS^'MSY_P[\*>)BBV.BR*X>-MH9@^QPLBK&(DWJK%3C%
M?HQ110 4444 ?1&C_P#()M?^O9/_ $$58JOH_P#R";7_ *]D_P#015B@ HHH
MH **** /GC6/^0M=?]?+_P#H1JM5G6/^0M=?]?+_ /H1JM0 5\H6_P#P1Z_8
M]M?V]#^VS!\&_!J@^&_*_P"$9_X1=#$->^V_:/[;!+^6)]GR<19W?O-VZOJ^
MB@#DOC;\"/@W^TC\.[SX3?'CX;:1XK\.7Y5KG2=:M%FB+J<K(N>4=3RKJ0RG
MH16'^S?^Q[^S%^R%X-N_ '[-7P4T/PAI>H2B748=+MCYEXX!4--*Y:28@$@;
MV. 2!C->DT4 >>_"3]DW]FGX#_"_4_@G\(?@?X;T'PAK4\\VK^&K/3$^Q7KS
M1)#*98F!63?'&B,"""J@$5QGP!_X)E_L$?LM_$>?XN_ +]EGPKX:\2S*ZKK%
MI:L\MLK@AQ!YK,+8,"5(B"94D=#BO=:* "BBB@ KZ(T?_D$VO_7LG_H(KYWK
MZ(T?_D$VO_7LG_H(H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?/&L?\ (6NO^OE__0C7T/7SQK'_ "%KK_KY?_T(T 5J***
M"BBB@ HHHH **** "BBB@#Z(T?\ Y!-K_P!>R?\ H(JQ5?1_^03:_P#7LG_H
M(JQ0 4444 %%%% 'SQK'_(6NO^OE_P#T(U6JSK'_ "%KK_KY?_T(U6H ****
M "BBB@ HHHH **** "OHC1_^03:_]>R?^@BOG>OHC1_^03:_]>R?^@B@"Q11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\\:Q_P A
M:Z_Z^7_]"-?0]?/&L?\ (6NO^OE__0C0!6HHHH **** "BBB@ HHHH ****
M/HC1_P#D$VO_ %[)_P"@BK%5]'_Y!-K_ ->R?^@BK% !1110 4444 ?/&L?\
MA:Z_Z^7_ /0C5:K.L?\ (6NO^OE__0C5:@ HHHH **** "BBB@ HHHH *^B-
M'_Y!-K_U[)_Z"*^=Z^B-'_Y!-K_U[)_Z"* +%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >6W_ .VQ^REI=]/IFH?'+0XKBVF:*>)Y6RCJ
M2&4_+U!!%1?\-S_LC_\ 1>M!_P"_S_\ Q-=Y+\-/AQ/*T\_P_P!$=W8L[OI4
M)+$]23MY--_X5=\,_P#HG>A?^"B'_P")H X7_AN?]D?_ *+UH/\ W^?_ .)K
MQG4OVD/@+<:C<3Q?%O02CS.RG^T$Y!)([U]0?\*N^&?_ $3O0O\ P40__$T?
M\*N^&?\ T3O0O_!1#_\ $T ?+/\ PT5\"?\ HK.@_P#@Q3_&C_AHKX$_]%9T
M'_P8I_C7U-_PJ[X9_P#1.]"_\%$/_P 31_PJ[X9_]$[T+_P40_\ Q- 'RS_P
MT5\"?^BLZ#_X,4_QH_X:*^!/_16=!_\ !BG^-?4W_"KOAG_T3O0O_!1#_P#$
MT?\ "KOAG_T3O0O_  40_P#Q- 'RS_PT5\"?^BLZ#_X,4_QH_P"&BO@3_P!%
M9T'_ ,&*?XU]3?\ "KOAG_T3O0O_  40_P#Q-'_"KOAG_P!$[T+_ ,%$/_Q-
M 'RS_P -%? G_HK.@_\ @Q3_ !H_X:*^!/\ T5G0?_!BG^-?4W_"KOAG_P!$
M[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !- 'RS_ ,-%? G_ **SH/\ X,4_
MQH_X:*^!/_16=!_\&*?XU]3?\*N^&?\ T3O0O_!1#_\ $T?\*N^&?_1.]"_\
M%$/_ ,30!Y]IO[</[)=OIUO!+\>-!#I"JL/.;@@ '^&I_P#AN?\ 9'_Z+UH/
M_?Y__B:[K_A5WPS_ .B=Z%_X*(?_ (FC_A5WPS_Z)WH7_@HA_P#B: .%_P"&
MY_V1_P#HO6@_]_G_ /B:/^&Y_P!D?_HO6@_]_G_^)KNO^%7?#/\ Z)WH7_@H
MA_\ B:/^%7?#/_HG>A?^"B'_ .)H X7_ (;G_9'_ .B]:#_W^?\ ^)H_X;G_
M &1_^B]:#_W^?_XFNZ_X5=\,_P#HG>A?^"B'_P")H_X5=\,_^B=Z%_X*(?\
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MEI'CO_@BGXN\%V]IX<U&_LM1U7XLZ3/%>7EO;/+!8@01LR/<2*L*O@JK."W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cah-20220630_g4.jpg
<TEXT>
begin 644 cah-20220630_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#P_XV\-W$S0IJ_AS4DN8EE4 M$^TYCD4,N8W 8;AD#(K^9']HSXA_!7]@/\
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M^];<T@C89_=FP )[RU^OG_!%'XM>'/!?_!$;X*_&'XW?$BTTS2].^'IO-?\
M$_B?5EBAMXEN)MTL]Q,P"@#'S,?2OPL_;+US3?VX?B3_ ,%/_P!OW2[U-5T+
MPQ8^&O"GAO4HSNAEA?Q;HUI:SQ'T>UT5R/\ 9F.>M?H58_L__LL_M%?\&L7P
M.\*_MF?MAZG\%O .FZ+9:EJ/B'3DCE%_/'/=B"SDMRC27BEW$JP0XD9X$8?<
M- 'W]\&?^"T?_!*W]H/XG67P:^$/[<O@35O$VIW0MM,TLZBUNU[.3A8H'G1$
MF=CPJ(Q9C]T&O5/C-^V-^RW^SO\ $+PC\)_CC\=O#GA;Q)X\O5M/!NC:SJ A
MGU>=IHX1' I^^3)-$GU<>M?RG?\ !6?XC?\ !&'5/A9X#L/^"1G[//Q"T+5_
M"&MI;>(/BOJL=W!9:RHMV9%!GN'?[69(Q,&\J @!\ C 3[E_X.S=#\2_&WX^
M_L5>&[76I++6/%VCSVT>HPY5X+FZNM+42KM((*O)N&".E '[9_LX?\%!_P!B
M;]KW6?%'A_\ 9F_::\)>-+OP8V/$T6B:F)/L2EF42DG >(E& E0M&<<-7)>
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M3+"+2KW7Y;#PG>2_V,CWNC2E;S;&?LK*JON63:5V-G&TX_=.B@#Y'_X+B_L
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M%7[,C_\ !)SX<OX1C^$B:H8=.^)VG^,;"WELK$W7V@Q13^<NH16YERY46IF
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MB+P[96]CBULY[N0N\=[)(N8X'V_NSEBH.,D@ _0VBBB@ HHHH ***^6O$_\
MP5U_9A\)?\%.=!_X).ZGX;\9-\2_$6FF^L=1ATJV.CK&-/N+_#SFY$H;RK:0
M8$)^8J,X)( /J6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *9=75O96TEY>3I%##&7EDD;"HH&22>P
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M="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%EC_ +,\.Z5,+R[@4\1_;;V:7[.N.JK$_4X9< U]T?\ !3__ ((8?#?]N/\
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MZ4(-"O[U[:*Y^UZI:63;I$5BNU;DN, Y*@=Z_(BT_P"#Q?\ ;=N/""_$A/\
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MKG]'Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDOCK^R!I7B7QIXCT:[GUK6+_ %_4\74D>I7,2$P)="$82)%P$ ('.<G/Z?\
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MA!O&I:? S?>BFB!O(MH"'RYW&3,,@'S=\(/#GPI_X.)_VH/C)^U+_P %&/\
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M^9M(T^PN--E(51\WE07/GOC^&!SVP0#\H?B+^QIX"_8<_8:\'_\ !5_]F?\
MX++:+JO[2\']D:_XN\'Z1\0-/N+]A?R0[[58TN'N;F:!ID%RDRR)*B3[D55(
M/U=_P<I?MF>)_P!I?_@D3^Q_^UYX7U"?1+_QOJ*:MJ=KIEU)''%>'3 ;B$%6
MRT:3K(HR>0HKYGB_:F_X-I_"?["7P[\2>&O^":]S\0_C]<V^F:;XR^']QXL\
M2Z;&;M(U2\O%O8YY("DKJ6B2)7?,RAHT ('T1_P="_#CPS\)_P#@D)^R5X%\
M'_ -_A9I]MK$DT7PXEUJ;49/#;SZ<9Y+%[F;YYGC>5U9F_B! X H \M_X+._
M\$H_VG/V%?V;/ '_  6&\7?MY^-_$_QTUOQ;IQ\9WSR&V&E7=Y;37,?]G31M
MOABMWB\@1\(RL"JQ*OEGVS_@Z/\ V@?B%\5_^"3?['7Q^E\0W>G:OXZLK+7-
M6?3+AK</-=Z%;W+C"$?+OD.!T%?2G_!W)Q_P17T8#_HHGA[_ -);JOD[_@X3
M^&_BWQ#_ ,&\'[$'Q*T?2)KC2_#?A+PG!K,\,986HNO#$*Q.^/NH7BV;CQN=
M%ZL 0#Z\_P"#N3Q!KOA[_@CQHFI:!K=W8W!^)N@J;BSN6B<J;2]R-RD'!P/R
MKYR_X+0?\% /CA\&_P#@DS^Q5^Q1\#OBO)X0UGXY_"_PZ/%OC!]6:S>UTR+3
M--B,<EUD&&*:6ZW2R @^7;.K':[ ^1_\' /_  7'_9<_X*7_ /!-CP1\"/V4
MM+\4:MJNGZWI/B7XD75YX?FM[;PRL5M-:K:32N LDKW-T@5XRT9$9^8E@*T?
M^"^/[->NW?\ P37_ & ?VXKGX<3>*O!/@3X6^'-'^(FEQR2(IM;C3M+GMTD>
M,AXHIO)N8#*"-KRQ $,ZT >9_%OP7\*/^#=WXZ_!K]K/_@G3_P %2]%^,FDZ
MMKBZ?\8O!NA^+-/NA?0J$>8O;64\@-O+'YX0R@O!*D;"1V8;?O?_ (/+O#L5
MQ_P3Y^$_[0GA2]\O5_"GQELCI.IP'YH8;G3KV0NC=OWMK;,/]T>E?%_COXN?
M\&VOQ$^-?PC^!?\ P3G_ ."1E_\ &[Q#\1;U;36M&O/'?B?0)M$GE:-8H=\D
MLRS.F97E9 842+=YI&2OVK_P>5:QI7A;_@EW\.?A#H%J?M&K?&+3(--L(RSN
M;>VTO400N<LQ#- O<G?0!^KOP1^((^+7P8\(_%58EC'B;POI^K!%Z+]HMHYL
M#_ONNGKC_P!GKP!=?"?X!>!_A9?8\[PUX/TS2IL'(W6]K'"?U2NPH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \8'_!.7]@!?B^/V@%_8G^%0\;"\^UCQ2/ 5A]M^T[MWVCS
M?*W>=GGS?O\ ^U7I_C[X>^ ?BMX0OOA[\4? ^C^)= U.,1ZEH>OZ9%>6=V@8
M.%EAF5DD 958!@>5![5L44 8OP[^&WP[^$/@VR^'7PG\ Z+X7\/Z:KKIVA>'
M=*ALK.U#NTCB."%51-SN[':!EF)/)-,^)7PN^&?QF\&W?PZ^,'PZT+Q7X>OS
M&;[0O$ND0WUE<&.19$,D$ZLC[717&0<,H(Y K=HH R/ 7P^\!?"KPA8_#[X7
M^"-(\-Z!ID9CTW1- TV*SL[1"Q8K%#"JI&"S,<*!R2>]<OJ7[*'[+6L_%U/V
M@=7_ &:O %UX]CGBGC\;W/@VQ?5TECC$<<@O&B,P94544[\A5 & ,5W]% 'E
M?[0'[#/[&/[5NJV>O?M+_LJ?#[QYJ&G1B.QU#Q7X2M+ZX@C!W>6LLL9<)DDE
M,[3GD5Z!X)\#^"OAKX4L/ ?PY\'Z7X?T/2[<0:9HNB:?':6EG$.D<4,2JD:C
M^ZH K4HH X[Q-^SM^S]XT^*&E?&_QC\"_!VK>--"A2'1/%^I^&+2?5-/C1G9
M4@NWC,L2AI)" K  R,1]XY[!E5U*.H((P01P12T4 >+^$?\ @G'_ ,$_O 'Q
M97X[^!_V)_A5H_C*.Y-S#XFTWP%80WD,Y.3,DB1 QRDY)D7#')R>:[CXP_L\
M_ ']H?3+/1/C_P# WP?XYLM.G:?3[3QCX9M=3BMI2NTR1I<QN$8KP2 #CBNP
MHH YCXH_!+X,_''PBGP_^-7PC\,>,-!CN(YX]$\4Z!;ZA9K*@(200SHR!E#,
M <9 )QUI^K_!SX1^(/A:?@=KOPM\.7O@HZ5'IG_"(76B02:7]AC54CM?LK(8
MO)5555CV[5"@ # KI** /'_"?_!/C]@[P-\,[[X,>$OV,/A98^$=4OH[W4_#
M4/@+3_L-[<QY\N::$PE)9$R=K,"5SP17HTOPV^'4_P /E^$LW@'17\*KI2Z8
MOAEM*A.GBQ6,1K:BWV^7Y(0!!'MVA0!C'%;5% 'DOP)_8(_8A_9?\57?CG]G
M+]D;X<>!M:OHVCN=7\*^#;.QN6C;K&)8HU98S@?("%]J_/K_ (*D?"#Q=_P4
M?_X+K_LR_L=VGA6_G^'OP2TZ;XC?$C56LW^Q-*UQ"\-B[D;7=C:6D>T'(2_<
M_P +8_5^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIU 'T1H__()M?^O9/_015BJ^C_\ ()M?^O9/_015B@ HHHH **** /GC6/\
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M$5O<"YLKB:WCE**,DV"1Q+_K&:4LR*L9(_;*B@#Y0\*_M1_$C]J7]L3XY?\
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MC_\ ()M?^O9/_017SO7T1H__ "";7_KV3_T$4 6**** "BBB@ HHHH ****
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MU_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \30!PO\ PW/^R/\
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MK0?^_P __P 31_PW/^R/_P!%ZT'_ +_/_P#$UW7_  J[X9_]$[T+_P %$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cah-20220630_g5.jpg
<TEXT>
begin 644 cah-20220630_g5.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
MX &0 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUK0/ &DV]^L/AS7CJ$=A&)VU"\U#$\YDQN+LL\B%B<[,+T % 'ZX_P#!0_\
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MI/>ZY<::-$TWPE.U_!Y C,ES+%(4$<&90JN6S(5D"*WEMCY]_P"#.#]E_P"
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M\%E<-%<!&BMXY@)I8YH[:07%O$-T<[Q'HS5];_MZ_P#!P7_P33_X)T?&V/\
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M\"_%#XN:[XP^,?@N^O+_ .)6H:S9NH U+5M1ELA%)@1L@@C"B.,!8E14"J
M/TIK\XO^#4WPGX3TO_@BM\+O%>E^&M.M]5U2[\0+JNI6]G&EQ=B+7M16,2R
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M]@S_ ()0?\$+/$7[->M?LR^+/B/\(+*XMT\;0Z3J,*:XTUS<IG76G9 GGQ7
MMV!"JB!8UQY:%:_#_P#:A^ __!)GQ_\ LT?"CX(_\$S?CQ\3OBS\<?B/\0M'
MM[;0?&]A,L_A#29+>[232E6.WCMO-:\N;?>T32JWV<NI1.9/ZY=4TO3-;TVX
MT;6M.@N[.[@>&[M+J%9(IHV!5D=6!#*02"",$'%>:_"K]A[]BOX$^,W^(_P0
M_9 ^%W@WQ#(KK)KWA7X?Z;IUZP<$,#/;PHY!R<\\Y- 'EGB7_@E?\+O$W_!4
MWPM_P55N/B7KT7BCPIX'?PS:>&$B@-A- T5W%YKL5\S?B[<\'&4'O3_V;O\
M@EK\,?V:O^"@OQA_X*&>'/B7KVH^(/C'9Q6^L:#?10BSL!&T)!A*J')/DC[Q
M/4U]0T4 ?%7[*O\ P0S_ &6_V;_V>OCA^S!XE\2ZWX[\(_'G7[G5/%EEKZPQ
M-;M,I&V!H54H4;;(DGWE=%8'(%?/OP%_X-4/V?\ X9_%WP9XB^,?[9_Q6^*7
MP\^&NKG4OA_\)_%EZITK39O-$H5U#%&C+JK.D,4 E*C?E2R']5Z* /EZ\_X)
M:_#&\_X*IVO_  5;?XEZ\/%-KX)/AI/# B@_L]H#$\?FEMOF;\.3]['%)\&O
M^"6GPP^#'_!4#XH?\%1]&^)>O7GB?XI>%(="U3PU<Q0"PLXHTTY!)$RJ)"Q&
MFQ_>)'[QO:OJ*B@#X#_X)M_\$#OAE_P3(_:^\7_M)?!?]IWQM?>&O$MO?Q6?
MPRU!$73K W4T,I<LK?OGC$*QHY17V<$MW]I_X*H_\$T_AQ_P59_9CA_9?^*7
MQ$UOPQID/B>TUL:EH$4+SF6".9%CQ,K+M(F8GC/ KZ3HH R? /A&T^'_ ($T
M7P'874D\&B:3;6$,\P >1(8EC#-CC)"@G%?.G[8'_!+7X8_MB_MD_ W]L[Q?
M\2]>TG6?@5JLE]H>D:;%"UMJ3M/#,5G+J7 S"!\A'!-?4-% 'SG_ ,%-O^"8
M/[-?_!5;]G]?@/\ M$VFH6K:???VAX9\3:'*D=_HMX%*>9$SJRLC*2KQ."KC
M!X94=?G7_@G5_P &YOP(_8C_ &D[7]L#XO?M'>.?C=\0]$LFL_"&K^.I1Y.A
MPE&C5HXV>1WE6)V1&:38@=BL:MAE_1:B@#Y>^$__  2U^&/PE_X*G_$S_@JO
MI7Q+UZZ\4_$[P9!X<U+PQ<10C3[.&*+2XQ+$P7S"Y&E1$[B1^]?VQ@_LJ?\
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M$D%W&C:;(8I$;(=&V ,I!# D$$$T ?HY_P $^O\ @O'_ ,$[/^"E_P 8=7^
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MU/XEZ];>*?AQX*G\-Z=X8@B@.GW<,L6J1F61BOF!P-4E/RL!^Z3WS[1^T_\
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MKV>=]G\W]YY.[9O^;&>: .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#[71_PT'_U*/\ Y/\ _P!KH ](HKS?_AH/_J4?_)__ .UT?\-!_P#4H_\
MD_\ _:Z /2**\W_X:#_ZE'_R?_\ M='_  T'_P!2C_Y/_P#VN@#TBBO-_P#A
MH/\ ZE'_ ,G_ /[71_PT'_U*/_D__P#:Z /2**\W_P"&@_\ J4?_ "?_ /M=
M>B6=Q]KM(KK9M\V-7VYSC(SB@"2BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KYXUC_D+77_7R_\ Z$:^AZ^>-8_Y"UU_U\O_ .A&
M@"M1110 4444 %%%% !1110 4444 ?1&C_\ ()M?^O9/_015BJ^C_P#()M?^
MO9/_ $$58H **** "BBB@#YXUC_D+77_ %\O_P"A&JU6=8_Y"UU_U\O_ .A&
MJU !1110 4444 %%%% !1110 5]$:/\ \@FU_P"O9/\ T$5\[U]$:/\ \@FU
M_P"O9/\ T$4 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OGC6/^0M=?]?+_P#H1KZ'KYXUC_D+77_7R_\ Z$: *U%%% !1110
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M)_Z"* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV-O#5WX3_9B^".A>#K/4)5EU$Z7;DS7C*"$,TTA:67:"VT.Q"[CC&37IE%%
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M+_\ H1H K4444 %%%% !1110 4444 %%%% 'T1H__()M?^O9/_015BJ^C_\
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M1110 4444 %%%% !7YI_\%K/A/\ $GXX_P#!2C]A;X6_"+X^ZQ\+_$6J:O\
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M &@_CO\ M#:]_P %;?VV_!TWA3Q=XN\,+X<^$OPNN&S)X&\)&87 6[]=1NY
MDLW ,0 C^7)BC[;_ (*D_P#!,9_^"F?AKX?^&Y?VG/%/PW7X?>+U\3:?-X9L
M8)VN-2B0+:SL)N T&9&0X.#*3V%<E\ _^"6/[5?P>\3:OKOC3_@L+\;_ !Y;
M:EX4U/2;?2_$JVQ@LKBZMVBBOT"]9H&82)GC<HS0!YO^T[XS\1?\%L_CQJG_
M  3X^ LD\'[.?@#Q- G[1GQ-@8K'XFOK29)QX3TMQ]_]XB&[G4X0 *",J)_T
M:M;6UL;6.QLK:.&&&,)##$@544# 4 <  < 5^9/P3_X-Y?CS^S=\-[#X/_ ;
M_@M3\>?"?AC3&E:PT/0[2R@MX6ED:61@J_Q-([,2>26)-?I5X3T:]\.^%M-\
M/ZEKMQJEQ8Z?#;SZG>8\V[=$"M,^.-SD%C[DT :%%%% !1110 4444 %%%%
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M( 1_+DQ1L_;>LK+3O^"R'[!MEI]I%!"@^*.R*&,*JY\/6Y. .!R373_L<_\
M!-O]I?\ 9D^-EO\ %3XH?\%6/C'\6])@T^XMW\&^-?L_V&5Y% 68[.=R'E?>
MO6OC-^Q]X;^,W[6?P6_:RU/QC?66H_!;_A(_[+TB"!&AU+^U[".SD\UC\R>6
ML89=O4G!H ]AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cah-20220630_g6.jpg
<TEXT>
begin 644 cah-20220630_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$VIO^"@7C7_@H;^W9X@_9X_9(^#/Q6U[4/BCJ&D_$ ?&'6VMY]-L'U'5$%G
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M_@CGXR\7ZW_P7Z_;S\.:SXJU*[T_3M4MAI]A=7TDD-L/M;C]VC$JGX 5\O\
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MAQIU_HGBO0=+T&7_ $KQ3)%<V^9@@\RZC1WM]F28E.7 W#=6%_P<8_ CX2_
MWX+?L'Q?"GP!I.A-X9^)&EZ3I$VF6$<+PVOE6DGE[E )!DB5SGJV6ZDFNO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0A-V 6;  .*^GZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O*_P!N
M/]I?2?V-OV/?B5^U+K$$<Z>!?!M_JUM:RG"W5S'"WV> GMYDQCC_ .!UZI7P
M#_P=#W6L6G_!#3XW/HY<%QX>2Y:/J(6\0Z:'_ @X/L30!\9>%_@;\+?!O_!L
M?8_%;]L[]J+Q9\-]0^-GQ C^(_CWXD^&M"EU+4KG4=2OR]L3%%)&["6VCM@Q
MW8!+'&#7Z%^-/^"J7[!7[ '@?X)?!_\ :%^.M[IZ^-/AS!>^%_$>J:+.(;NP
ML[&)GNKEQN\AV3:VPDL6;:-S$9^'?^"V-IIMC_P:B?">ST;9]DB\$?#9;8H,
M QBSM-I'X8KSS_@I?\./!GQ;_P""@G_!*[X>?$/P_:ZMHFI>&-'74M+OH1)!
M=QHVFR&*1&R'1M@#*00P)!!!- 'Z.?\ !/K_ (+Q_P#!.S_@I?\ &'5_@/\
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M:Z597VN:6- GD-U]KBMIK>"T91BYF9+N)MBGY5$C,56-F'7?L&_\%=_V&_\
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M8_\ !NS\-?V1OB_X[UWPI-X5:W\,>)GTJ",WVFWF@73016[I,I"DP1V[$$9
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M?C9XE\$0I%\/(/&T@%GH C!$+K&7D:1XLDQ#<L<;'>(]P1E_2VB@#Y>^&/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!\\:Q_P A:Z_Z^7_]"-5JLZQ_R%KK
M_KY?_P!"-5J "BBB@ HHHH **** "BBB@ KZ(T?_ )!-K_U[)_Z"*^=Z^B-'
M_P"03:_]>R?^@B@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\\
M:Q_R%KK_ *^7_P#0C5:K.L?\A:Z_Z^7_ /0C5:@ HHHH **** "BBB@ HHHH
M *^B-'_Y!-K_ ->R?^@BOG>OHC1_^03:_P#7LG_H(H L4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?/&L?\ (6NO^OE__0C5:K.L?\A:Z_Z^7_\
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MC_\ ()M?^O9/_010!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_D_;K**X\K?NV;T#;<X&<9QG J[6+\-_^2=Z!_V!;7_T2M;5 !1110 4444
M?/&L?\A:Z_Z^7_\ 0C5:K.L?\A:Z_P"OE_\ T(U6H ;)%%+M\V)6VL&7<N<'
MU'O3J** "BBB@ HHHH **** "OHC1_\ D$VO_7LG_H(KYWKZ(T?_ )!-K_U[
M)_Z"* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQE^)'_)1-?\
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M **** "BBB@ KZ(T?_D$VO\ U[)_Z"*^=Z^B-'_Y!-K_ ->R?^@B@"Q1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B6J?M2_&6PU.YL+;]
MBWQO=1P3O''<Q7-MMF4,0'&6Z$#(^M0?\-8?&S_HQ_QW_P"!5M_\57NE% 'A
M?_#6'QL_Z,?\=_\ @5;?_%5\9>)/V//C9XA\17^O_P#"HO'</VZ]EN/*_P"$
M=MFV;W+;<_;!G&<9P*_4&B@#\L?^&)/C9_T2KQW_ .$W;?\ R;1_PQ)\;/\
MHE7CO_PF[;_Y-K]3J* /RQ_X8D^-G_1*O'?_ (3=M_\ )M'_  Q)\;/^B5>.
M_P#PF[;_ .3:_4ZB@#\L?^&)/C9_T2KQW_X3=M_\FT?\,2?&S_HE7CO_ ,)N
MV_\ DVOU.HH _+'_ (8D^-G_ $2KQW_X3=M_\FT?\,2?&S_HE7CO_P )NV_^
M3:_4ZB@#\L?^&)/C9_T2KQW_ .$W;?\ R;1_PQ)\;/\ HE7CO_PF[;_Y-K]3
MJ* /G[PW^TS\;/#WAVPT#_AB?QW-]ALHK?S?/MEW[$"[L;CC.,XR:N_\-8?&
MS_HQ_P =_P#@5;?_ !5>Z44 >%_\-8?&S_HQ_P =_P#@5;?_ !5'_#6'QL_Z
M,?\ '?\ X%6W_P 57NE% 'A?_#6'QL_Z,?\ '?\ X%6W_P 51_PUA\;/^C'_
M !W_ .!5M_\ %5[I10!\CWGC7XV7=W+=?\,E>.U\V1GV^7;'&3G'^MJ/_A+O
MC9_T:;X[_P"_5M_\=KZ\HH ^0_\ A+OC9_T:;X[_ ._5M_\ ':/^$N^-G_1I
MOCO_ +]6W_QVOKRB@#Y#_P"$N^-G_1IOCO\ []6W_P =H_X2[XV?]&F^._\
MOU;?_':^O** /D/_ (2[XV?]&F^._P#OU;?_ !VC_A+OC9_T:;X[_P"_5M_\
M=KZ\HH ^0_\ A+OC9_T:;X[_ ._5M_\ ':/^$N^-G_1IOCO_ +]6W_QVOKRB
M@#Y#_P"$N^-G_1IOCO\ []6W_P =KT.S_:H^-EI:16O_  Q%X[;RHU3=]IMA
MG QG[U>\T4 >%_\ #6'QL_Z,?\=_^!5M_P#%4?\ #6'QL_Z,?\=_^!5M_P#%
M5[I10!!I=W/?Z9;7US8R6LDT"226TI&Z)BH)0X[@G!^E3T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%?"W_  5A^./[<VA_M:?L
MP?LA?L0_M#Z1\-+_ .,VH>+X=:\0ZQX-MM:CC72]*BOXOW,^",[94^5EYD!.
M=N* /NFBOBSX/?LI_P#!:GP[K^I7/QI_X*N^$?$FFW'AS4;;3K72O@=86$MK
MJ4ELZ6=V9-[ATAG*2-$5(D52O&<U6_8 _P""IZ>*_P!@?QY\6OV[[ZU\-?$?
M]G6YU/0_C[8Q1)'Y5]IX8B[@B&T,EW$$>(( CR.Z1Y"B@#[<HK\WO"G[7O\
MP5IU+]ACX=_$"/P=I\GQA_:6^* C\$Z?J7A9GTCX4^%;M)+B"?4/LZ*]P\-I
M$K9G8,TUTB-GRV1^Q^ G[2O[<W[)G[<T?[#W[>WQI\/_ !BTSQ?\+]3\9^ _
M'WA7P(NAZE'-ILL2WNFW&GP2RQNICE5X9$;<S*5.2V$ /O"BORH\8?M:_P#!
M;3P+^QI=?\%@O&GQ \ :)X-TZ+_A(=0_9<U7X?/!>6_AD7.TI)K,DHN$U/[,
M?,V&$1A^-O\ RRK]1O"/B?2_&WA33/&>B&0V6KZ=!>V9E3:QBEC61,CL=K#(
MH T:*** "BBB@ HHHH **** "BBB@ HKX6_X*P_'']N;0_VM/V8/V0OV(?VA
M](^&E_\ &;4/%\.M>(=8\&VVM1QKI>E17\7[F?!&=LJ?*R\R G.W%:WP>_93
M_P""U/AW7]2N?C3_ ,%7?"/B33;CPYJ-MIUKI7P.L+"6UU*2V=+.[,F]PZ0S
ME)&B*D2*I7C.: /M.BOB/]@#_@J>GBO]@?QY\6OV[[ZU\-?$?]G6YU/0_C[8
MQ1)'Y5]IX8B[@B&T,EW$$>(( CR.Z1Y"BO.O"G[7O_!6G4OV&/AW\0(_!VGR
M?&']I;XH"/P3I^I>%F?2/A3X5NTDN()]0^SHKW#PVD2MF=@S372(V?+9' /T
MAHKX;_9B^/7[=W[./_!0?3/^"??[=7QR\+_%RR\?_#R^\5?#[XB:!X+3P_>V
M]Q83PQWFGW=E%-+%Y>R=)(YE;)*LISNPG(6W_!8_QA\=?^"OOPC_ &.?V;_!
MFJ1_"&^U/QAI'C#X@:OH30V_B;6M)TN:6:PTUIE#F*SG$7FSI@22.$!V+ND
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
510 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cah-20220630_g7.jpg
<TEXT>
begin 644 cah-20220630_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUGQ1XITCQG-/J6N^%]'T];X6?]IQOYCPWD]Y;*TJ.&:)2%;!(/2?L(^!X?V
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MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM
M/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_
M +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L
M[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT
M*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_
M .?&'_OT*FHH R/!4CR:3(9'+8NY0,G.!NZ5KUC^!_\ D$2_]?LW_H5;% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X+^US_R
M7#X&?]CW+_Z(KWJO!?VN?^2X? S_ +'N7_T10![U1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]E_R.
M][_UY1?S-;%8]E_R.][_ ->47\S6Q0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_P CO>_]>47\S6Q6
M/9?\CO>_]>47\S0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% &/X'_ .01+_U^S?\ H5;%8_@?_D$2
M_P#7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %8_@?_ )!$O_7[-_Z%6Q6/X'_Y!$O_ %^S?^A4
M ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A5L4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@O[7/\
MR7#X&?\ 8]R_^B*]ZKP7]KG_ )+A\#/^Q[E_]$4 >]4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?
M\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5CV7_([WO_7E%_,U
ML5CV7_([WO\ UY1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 8_@?_ )!$O_7[-_Z%6Q6/X'_Y
M!$O_ %^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !6/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_
M *%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &/X'_P"01+_U^S?^A5L5C^!_^01+_P!?LW_H5;%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X+^US
M_P EP^!G_8]R_P#HBO>J\%_:Y_Y+A\#/^Q[E_P#1% 'O5%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C
MV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->4
M7\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_
M@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !6/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_
M]?LW_H5 &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\
MH5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MX+^US_R7#X&?]CW+_P"B*]ZKP7]KG_DN'P,_['N7_P!$4 >]4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,UL4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_\
M7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_\ 7[-_Z%6Q
M6/X'_P"01+_U^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6/X'_ .01+_U^S?\ H5;%8_@?_D$2
M_P#7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_]?LW
M_H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5X+^US_R7#X&?]CW+_Z(KWJO!?VN?^2X? S_ +'N7_T10![U1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S6Q0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_P CO>_]
M>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% &/X'_ .01+_U^S?\ H5;%
M8_@?_D$2_P#7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %8_@?_ )!$O_7[-_Z%6Q6/X'_Y!$O_
M %^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?
M^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7@O[7/\ R7#X&?\ 8]R_^B*]ZKP7]KG_ )+A\#/^Q[E_]$4 >]4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5CV7_([W
MO_7E%_,UL5CV7_([WO\ UY1?S- &Q1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_ )!$O_7[-_Z%
M6Q6/X'_Y!$O_ %^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6/X'_Y!$O\ U^S?^A5L5C^!_P#D
M$2_]?LW_ *%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% &/X'_P"01+_U^S?^A5L5C^!_^01+_P!?
MLW_H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5X+^US_P EP^!G_8]R_P#HBO>J\%_:Y_Y+A\#/^Q[E_P#1% 'O5%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R
M.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_ -?L
MW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_Y!$O_ %^S?^A5L5C^
M!_\ D$2_]?LW_H5 &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_P#7[-_Z%6Q6/X'_ .01
M+_U^S?\ H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5X+^US_R7#X&?]CW+_P"B*]ZKP7]KG_DN'P,_['N7_P!$4 >]4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,UL4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9
M?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_\
M7[-_Z%6Q6/X'_P"01+_U^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_ .01+_U^S?\ H5;%
M8_@?_D$2_P#7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &/X'_Y!$O_ %^S?^A5L5C^!_\
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M_93_ &I_"OC37-!C:74M)TRY=+@0JP1IXTE5#/"&*@RQ;T!=?F^89 /=ZQ_
M_P#R")?^OV;_ -"K)^,GQX^$'[/NAZ7XD^,WCVQ\/V>M^)-/\/Z/+>EB;S4[
MV=8+6UC506=Y)& P!@ ,S$*K,-;P/_R")?\ K]F_]"H V**\(_:B_P""G7[
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MM["]\36;7UEX.M]-MI9M>NS"&0W3VKPM#%&Q19'="V/NGT3]@[]H[]K7PO\
MM;_$+_@G#^W;X^\/>-O&/A?PEIWC3P-\1O#OAT:./$WAZ[GEM)3<6*R2);3V
M]W"8SY;E6613U4LWP)_P2AAGTOQU_P $U_$>I*4TS7K3X]'0=XPJ&XU*2[A
MS_STMD9UQU4&OM]HVU+_ (.18[K3CN32?V)I(M4=.0CW/BZ-K=&]"5MYV /.
M ?6@#[@HHHH *\%_:Y_Y+A\#/^Q[E_\ 1%=5\5O"G[6>K^+GO/@_\5_"^D:*
M8$"66K:$]Q,) /G8N".">@KPWXR>&?VG](^.WP</Q?\ B=X;U=)/&A&FC2M%
M:W,+B/+E\D[@5X [&@#["HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\
M: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E
M_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W
M9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7
MC?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[
M%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH
M V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_
M (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E
M_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-
M_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7
MC?\ Z#=E_P" Q_QH ++_ )'>]_Z\HOYFMBN4M;7Q2?%-U''JEL+@6T9DD,!V
ME<G  K3^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q
M_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_
MX#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q
M_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_
MX#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q
M_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_
MX#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q
M_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_
MX#'_ !H^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q
M_P : -BL>R_Y'>]_Z\HOYFC[%XW_ .@W9?\ @,?\:S+6U\4GQ3=1QZI;"X%M
M&9)# =I7)P * .KHK'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?
M_H-V7_@,?\:/L7C?_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X
M#'_&@#8HK'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,
M?\:/L7C?_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8H
MK'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?
M_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,
M?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^@W9?^ Q_
MQH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: #P/_
M ,@B7_K]F_\ 0JV*Y3PK:^*9-.D:PU2VC3[3("LD!)W;N36G]B\;_P#0;LO_
M  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_
M -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;
M_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%
M%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !
MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
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M47\S0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%6
MQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445^9O_!07_@H+^U[\#_VO?%WPN^%WQ<_LO0M+^P?8;'^P-/G\KS-
M/MIG^>:!G;+R.>6.,X&  *]_ASAS'<3XV6%PLHQE&+E[S:5DTNBEK[RZ'!F.
M8T,LH*K53:;MI;LWU:['Z95C^!_^01+_ -?LW_H5?C__ ,/7?V^_^B]?^6MI
M7_R+4-C_ ,%3?V\--A,%E\==B,Y<C_A&-+/).2>;:OM/^(1\2?\ /VC_ .!3
M_P#E9XO^MN6_R3^Y?_)'[/45^9O_  3Z_P""@O[7OQP_:]\(_"[XH_%S^U-"
MU3[?]NL?[ T^#S?+T^YF3YX8%=</&AX89Q@Y!(K],J^+XCX<QW#&-CA<5*,I
M2BI>ZVU9MKJHZ^Z^A[679C0S.@ZM)-).VMNR?1ON%%%%> =X4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+
M_P!?LW_H5;%8_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>"_M<_\EP^!G_8]R_^B*]ZKP7]KG_DN'P,
M_P"Q[E_]$4 >]4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% &/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,
MUL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !6/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,T ;%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A5L4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?C/\ \%7?
M^3^_'O\ W"__ $U6=?LQ7XS_ /!5W_D_OQ[_ -PO_P!-5G7ZGX1_\E)5_P"O
M,O\ TNF?+<6_\BV'^-?E(^=Z***_HD_/#Z(_X)1?\G]^ O\ N*?^FJ\K]F*_
M$3_@G[JGQ.T7]KKPEJOP<\+Z?K7B.'[>VGZ5JE[]GAN1]@N?-4R?P'RO,*D\
M;@N>,U^ER?\ !0B/X=N+3]JK]G'QQ\.64XFU=M/.JZ2I[XN[4'/X(>*_!_%#
M*<=F&?TIX:*FU2BN5-<_QSVA?F:\TGKH?=\,8NAA\!)5';WGK9VVCUV7S9]&
MT5R'PO\ C_\ !+XU6HN_A3\4]#UWY-S0:?J"/-&/]N+.]/\ @2BNOK\@K4*V
M'J.G5BXR71II_<SZ^$X5(\T'=>04445D4%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,UL4 %%%% !1110
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MP4445X9W!6/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%%
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M_P"1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTY_PS;^TSI_]NZAY/ASQ3MTG7=[X2+>W[BX/8>7(1D]D>3UK]FZ_G;K]F_\
M@F/^TY_PTE^S-I_]NZAYWB/PMMTG7=[Y>78O[BX/<^9&!D]W23TKT?!CB3^)
MDM:7>=/_ -OC_P"W)?XF:Y!B]\/+U7ZK]?O/HFBBBOZ /I@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KP7]KG_DN'P,_['N7_P!$5[U7
M@O[7/_)</@9_V/<O_HB@#WJBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=
M[W_KRB_F:V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K'LO\ D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BB
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0JV* "BBB@
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M@ HHHH *Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@
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M1DN2H[-12:NHVW[:'YQCLAS:MC:M2%.Z<I-:QV;?F?G?7T1_P2B_Y/[\!?\
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M'LO^1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ)\,?$5U>P:?XCL=0TN^GTV[:WN8X;B-XG:*5?FCD"N2KCE3@CI7Y&?MW?\
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M['N7_P!$4 >]4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,U
ML4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+^$].LKI9)I+Y-4TRXOHBBDE3;+:3K-D8B*8;'%?JA7@GPJ_X)<_\$]?@?\
MM$WW[6/PE_9'\&:#\0]1DGEF\2V&F[9(I)@1-)#&28K=Y SAGB1&8.P)(8Y
M/1/AW\5OA=J/C+4O@WI_Q)T"?Q?IL!U+4?"D.L0-J5K922E([F2V#>:D+,"J
MR,H4D$ DU\D_L"Q#]H7_ (*V?M<_M<:N/M$'@6\T3X/^"I7.396]C:KJ&JQ
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MK+QK^R=^SU_P3D^)OQHU#X>V&DS^+-8\%7]G';V$FHV[7%O"XG8'<8E+?YY
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MT+"Z+1[2J;#U4?,<]J^PJ\%_:Y_Y+A\#/^Q[E_\ 1% 'L7_"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q
M10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q
M10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q
M10!REKKFHKXINKI?#=RSO;1JT 9=R@$\FM/_ (275_\ H4+W_OI:++_D=[W_
M *\HOYFMB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:V** ,?_A)=7_Z
M%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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MA-\+(_B'X"^)?AWPFNA37-@NH+I]W97MC'+)''(DTD31M&V&0MDECM0 ^O\
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M?LX:&^C?"?X-2V,EP,W^J2N)KV^;.2TT[DN^3DXSM!)P!7JM%=F"R/"X6O\
M6:LG5K?SSLVNZBDE&"\H)7ZW>I=/#PA+GE[TN[_3HOD8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM;%%>R=!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q
M10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M6Q10!C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+6Q10!C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2UF>%=<U&UTZ2.'PW<S@W
M,C%T9< ENGX5U=8_@?\ Y!$O_7[-_P"A4 '_  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\
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M7\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PG[
M35E9R?L^^/-1DM(FN(O FL1Q3F,%T1[1RRANH!*(2.AV+GH*^<?^"3/Q@^%G
MP+_X(J_L\_$7XR_$+2/"^@P?"_0+:;5]<OTMK=)IUCAAC+N0-SRNB*.I9@!R
M:^L?B%X/MOB%X!USP#>7CV\.N:/<Z?+<1*"T2S1-&6 /!(#9_"O#-+_X)G_
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M_P %/?VZ=#CT;XM_%71[;2?#_@.&7S(_A_X2AD,UMHY? \RYDD87%RV /-P
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M_P#0JV*Q_ __ "")?^OV;_T*MB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#@FZN.8[90?O$Y9>I4#FN5MOV4/CM^TY<Q^(?VX/B*+?1"XDM_A7X,NG@T]
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M110 4444 %%%% !1110!C^!_^01+_P!?LW_H5;%8_@?_ )!$O_7[-_Z%6Q0
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M43YA_P""N/[4WP<_::_X5]-\'M7O]0M='_M;[1>W.CW%K%+YWV/;Y9G1"_\
MJFS@<97UKXR8X%?9?_!7#QK^TAXV_P"%?7_Q[^"FE^"(5_M;^P["T\1)J,[Y
M^Q^=YSQ@(,8BV[>N6ST%?&3$D\FO5X[\9J'"?A"L/EF$Q%*KB54I4:E1**5Y
M2YY)R]G4;C%MIJE:,W%-KK\1F5.=;-IRF[[7T<>BZ.[7S8*<&G99NG IE/4Y
M%?FGT7>)*^?SJ<$X_'5*6'2E6ITZ;Y'4V]I3=5?O(Q2]]1I.$I7J-RM=/BQ<
M5']XEJ?NO\ OV3/@E^SC;S7/@'PTT^LWF3JGB?6)C=:G?L3EFDG?GD\E5VKG
MG&:]*HHKZ["8/"X"@J.'@H06R2LOZ[OJ?J\*<*<>6"L@HHHKI+"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_ _\ R")?
M^OV;_P!"K8K'\#_\@B7_ *_9O_0J -BBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q_ _P#R")?^OV;_
M -"K8K'\#_\ ((E_Z_9O_0JV* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KP7]KG_DN'P,_P"Q[E_]$5[U7@O[7/\ R7#X&?\
M8]R_^B* />J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO?\ KRB_F:V*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+:\F9OMBPRGR99BJ,-Q,84-D 'Z5T444 %%%% !1110 4444 %%%% !1110
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M/_R")?\ K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#'\#_ /((E_Z_9O\ T*MBL?P/_P @
MB7_K]F_]"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O!?VN?^2X? S_ +'N7_T17O5>"_M<_P#)</@9_P!CW+_Z(H ]ZHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KYG_8._9<^*_P"S]\?/VF?B%\1;.QBTWXI?&-?$?A-K2]$KR6(TNSMLRJ!^
M[?S()/E/;![U],44 ?,_[:?[+GQ7^./[7/[+WQD\!VEC)HGPH^(.KZOXNDNK
MT1R1VUQHUS:1F)"/WK>;*@('09/:M?XY_P#!*?\ X)Q_M,_$_4?C3\?_ -C7
MP)XM\5ZLL*ZGK^M:,LUS<B&%(8@[GKMCC1![*!7T#10!^=G_  3'_P""?/QV
M_P""9?\ P3B\0^!O@/\ !+X>6W[15WHVH7%R+V=GTW6KY=4OY-,6\GA>-GCC
MM)XT^5E*C*YXKT/]J'X8_P#!33PC\9_A=^W1^S#I.B^-O$.E_#M_#'Q:^ ^H
M^.)M'T?53.T5S]MTV>0306]U#=*Z>;*C,\!";CC!^N++_D=[W_KRB_F:V* /
MSE\,_P#!)CX[_M@?"3]J+QW_ ,% M0T#PM\0_P!IW1=,TBR\.>$;QM0LO NG
MZ3&QTI#.P3[9.MR5N)V7",4 0J#@.M?V>_\ @K7^V[X^^"_PG_;[^$GPY\%^
M!O@QX\TSQCXN\9^%?&K:G/\ $35=*#-8"UL_(C.GV[7!6:99B6.T!<?=/Z,4
M4 %%%% !1110 445E^*/''@OP1:?;_&GB_2](@QGSM4U".W3'UD8"JA"=27+
M%7?D)M15V:E%>)^,?^"C/[%?@F4VU_\ 'W2+^?.U(-!2743(W8*;9'7]<5@_
M\/!+CQ7^[^#'[(_Q8\4[O]5?2>&Q863^G[^9N/Q6O7I\/9W4CSNA*,>\ER+[
MY67XG)+,,%%V]HF^RU?W*[/HJBOG7_A:'_!2CQWQX2_9D\">"8W^Y+XT\7OJ
M# >I2Q4$'V[4?\*"_;[\<#=\0/VV--\/0/\ ZW3_  1X*A_\=N+AO,7\JO\
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M'#%&NV.*) JJ/0 <"I***]I))61T!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '-?&CPOJWCCX.^+/!6@HC7VL>&;^RLEE?:IEEMWC0$]A
MN8<]J^3/"7_!/C]I&Y_X(@^$/V!M(^,$_P -_BQX=^'&D6-AXI\/:O*(]/UB
MP>&=$::##26TCP^3+@'=%*_RMT/VQ10!^>4?P%_X*D?\%!_CW\%[C]O?X">
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M$/QO\7^*--6PO1.K:?J.I27%LS$ ;7,;#<O\)XKZ8HH **** "BBB@ HHHH
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M_HB@#WJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR/AO)N&Z4Z674^2,W=KFG)7VO[TG;Y6OI?9'7A\)0PD6J2LGYM_F%%%%>X=
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!C^!_^01+_P!?LW_H5;%8_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_@?\
MY!$O_7[-_P"A5L5C^!_^01+_ -?LW_H5 &Q1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_\
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M:YY?^!3YI?B5'"8:+ORION]7][*VDZ-I&@V*:7H6E6UE;1C$=O:0+'&OT50
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M110 4444 8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A5L4 %%%% !1110
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M5.WP#^SQ\8O$^[_5OHG@"5D;WS(Z8'O1_P -@_M/:\<> ?\ @G?XTN=WW/\
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M/=2DMO?;!81Q(#_P+&*Z_P"'O_!.KQ[X2V/I7QG^%?AB1/NW&E_"^'5YX_\
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M)X1\3> /AGH?@CQCXT_X2+4M)TZ.TN=<-D;=KWRQM61HS))ABH7<=QRV3QG
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MB704\6W=Z^J1")[6-4DSP2"<B@#IJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
MOJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC
M_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\
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MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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MY+R;/U>?"5'-HNKP[6^L=71:Y,1'_N'=JJEWHRF[:RA#8^G_ .SM/_Y\8?\
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M/VA-#\2?M;1_MJ_$?3?%'CO1_CBK>*-5TN)QI]N_]AV$K6]FD@W);0JPBC&
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M_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\
MSXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344
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M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
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M_/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\
M?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:
M?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4
MU% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\
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M[XSTB^OOA/JK3Z+J=OXC@M8M]W;+>::@%M=I ?,:W+,0F=S E _WQ0 4444
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MN/;]33^NXM;X:?R<'^<T'^K?#]3^'G5!?XZ>*C_Z3AYK\3Z=HKYB_P"%8_\
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M=Z;_ /)-GI9GUA1117VI_,P4444 %%%% !1110 4444 %%%% !1110 4444
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M^WA^Q@/L_P =?!K_ !L\ V_ \:^#;)8=?L(1_%=V&=MP !RT9X +.Y/%>Z_
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M]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6L<A/H$+[B?8"HJ5:5)7G))>;L=6$P.-Q]3V>&I2J2[1BY/[DF=[17S?K_\
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MNKZO.@^TZI<XPTTK#\E0?*B\#N3X'#605\TKJM.\:47OU?DOU9^M>-/BUE?
MV5RRZ@HU<;5CI!ZJFGM.?YPCNVKZ)7//O#__  27_8,T:\_M;5O@N^OWYQYE
M_P")?$%]>O)_O+),4/\ WS7JG@K]ES]FKX<;&\!?L_\ @O2'C^[-I_AFUBDS
MZEU3<3[DYKNZ*_5Z67X&@[TZ45Z12_0_@7'\6<4YI'EQF.K5%VE4G)?<W9+R
M$5510B* H&  . *6BBNL^?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_M;29_&O6?"/PU^'/@"'[/X#\ :)HD>,;-(TJ&V&/3$:BBV;SZPA_P"!3_\
MD YO#W#?9Q5?YTJ'Z8G\SY[_ .'GWAWQ,-GP<_9'^-OC'?\ ZF\T_P "/!9G
MW::9UVCZK2_\--_\%%_&IV_#[_@G?;:' W^KU'QK\1;1/^^K>%?,'YU]/44?
M5,;/X\0U_AC%?FI/\0_UAX:P_P#NV44WYUJM:H__ "G.C%_.+7D?,'_"+_\
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MHH *Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0J -BBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q
M_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KP7]KG_DN'P,_['N7_ -$5[U7@
MO[7/_)</@9_V/<O_ *(H ]ZHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6'_!.KX_,HX8W'A"*(Y]@9CGZT?\/$?B1_TCF^.W_A-0_P#QVOIVBCZKC_\
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M%%% &/X'_P"01+_U^S?^A5L5C^!_^01+_P!?LW_H5;% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_^
M01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A4 ;%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_\ D$2_
M]?LW_H5;%8_@?_D$2_\ 7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>"_M<_\ )</@9_V/<O\ Z(KWJO!?VN?^2X?
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MT=T;%%%%=)XP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A5L4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX3^&OA_PQXZU33P##H\,NHSS16".(XS=7 032A$S$_S9#8_;^OCG]G3XQ_\
M!,KQQJW[55BGP?\ #G@6^\+^/=2T[]H6'QQ8V<$FM1I A_M:YS))YFG7$3,T
M+2;0P$AV*S-D \E_:R^'?A#6Y?V/O^"2'P&^-WBG_A5'Q5FUS6?%'BG2/&<T
M^I:[X7T?3UOA9_VG&_F/#>3WELK2HX9HE(5L$@])^PCX'A_8#_X*E>/O^":/
MPS\6>(+WX4^(_@U8_$[X?>'_ !'K]SJ;>%IX]3?2]1LK:>ZDDF,$C-;3['=M
MK,V#EF)^-?\ @G4VH? /0O\ @FK^T#\5+JYT;P'>:M\4_"6A:GXAD9!8V>M2
MRW'AR*5Y#\OGQ6FV+)Y5X@.!Q]O?#[4M*^,G_!P_XV\;>!-1AU+3?A+^RS9^
M$/%=U:R!TLM:U3Q =0CM'(X$@M;,.5ZCS.0* /NBBBB@ KP7]KG_ )+A\#/^
MQ[E_]$5U7Q6_9*^&OQB\7/XT\4:_XHM[MX$A,>D^(YK:':@P#L0XSZGO7@O[
M07['OPR\%?$_X7>'M(\2>+'@\1^*9;*_:[\2SRND?D,V8RQ_=MG^(<T ?95%
M>"_\.ZO@?_T-WCO_ ,*^>C_AW5\#_P#H;O'?_A7ST >]45X+_P .ZO@?_P!#
M=X[_ /"OGH_X=U? _P#Z&[QW_P"%?/0![U17@O\ P[J^!_\ T-WCO_PKYZ/^
M'=7P/_Z&[QW_ .%?/0![U17@O_#NKX'_ /0W>.__  KYZ/\ AW5\#_\ H;O'
M?_A7ST >]45X+_P[J^!__0W>._\ PKYZ/^'=7P/_ .AN\=_^%?/0![U17@O_
M  [J^!__ $-WCO\ \*^>C_AW5\#_ /H;O'?_ (5\] 'O5%>"_P##NKX'_P#0
MW>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO@?\ ]#=X[_\ "OGH_P"'
M=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U? _\ Z&[QW_X5
M\] 'O5%>"_\ #NKX'_\ 0W>._P#PKYZ/^'=7P/\ ^AN\=_\ A7ST >]45X+_
M ,.ZO@?_ -#=X[_\*^>C_AW5\#_^AN\=_P#A7ST >]45X+_P[J^!_P#T-WCO
M_P *^>C_ (=U? __ *&[QW_X5\] 'O5>9?M4?L:?LM_MN_#V/X5_M7_!#0O'
M&A070N;2TUFW)>UG *^;#*A62!]I*EHV4D$@G!Q7)?\ #NKX'_\ 0W>._P#P
MKYZ/^'=7P/\ ^AN\=_\ A7ST >C? #]G7X&?LK?"[3_@K^SI\+-&\'>%=+W&
MRT70[,0PJ['+R-CF21CRSL2S'DDU;?X)?"B7XV1?M'R>!K$^.8?"TGAN+Q*4
M/VE=)>Y2Z>T!SCRS/&DF,9W*.:\N_P"'=7P/_P"AN\=_^%?/1_P[J^!__0W>
M._\ PKYZ .S^'7P%^#OPU^-'CSX@>!?A[IVFZSX^:UO/&6H6\9WZM/%'Y,<D
MV202L?RC@<5Q'P%_X)8?\$[?V7OC5??M$_L_?L@^"_"GC/4!*'UW2M,VO;B4
M$2"V0DQV@8$JP@6,%25/!(KS#PG^QQ\,]5_:Y\6_"BZ\5>+QI>E>%;"]M63Q
M-,)C+*[!MS]67C@=J]3_ .'=7P/_ .AN\=_^%?/0!Z>_P-^$C_'%/VE'\!V!
M\=Q>%&\-1^)RA^U+I+7*W368.<>69U63&,Y YKJZ\%_X=U? _P#Z&[QW_P"%
M?/1_P[J^!_\ T-WCO_PKYZ />J*\%_X=U? __H;O'?\ X5\]'_#NKX'_ /0W
M>.__  KYZ />J*\%_P"'=7P/_P"AN\=_^%?/1_P[J^!__0W>._\ PKYZ />J
M*\%_X=U? _\ Z&[QW_X5\]'_  [J^!__ $-WCO\ \*^>@#WJBO!?^'=7P/\
M^AN\=_\ A7ST?\.ZO@?_ -#=X[_\*^>@#WJBO!?^'=7P/_Z&[QW_ .%?/1_P
M[J^!_P#T-WCO_P *^>@#WJBO!?\ AW5\#_\ H;O'?_A7ST?\.ZO@?_T-WCO_
M ,*^>@#WJBO!?^'=7P/_ .AN\=_^%?/1_P .ZO@?_P!#=X[_ /"OGH ]ZHKP
M7_AW5\#_ /H;O'?_ (5\]'_#NKX'_P#0W>.__"OGH ]ZHKP7_AW5\#_^AN\=
M_P#A7ST?\.ZO@?\ ]#=X[_\ "OGH ]ZHKP7_ (=U? __ *&[QW_X5\]'_#NK
MX'_]#=X[_P#"OGH ]ZHKP7_AW5\#_P#H;O'?_A7ST?\ #NKX'_\ 0W>._P#P
MKYZ />J*\%_X=U? _P#Z&[QW_P"%?/1_P[J^!_\ T-WCO_PKYZ />JQ[+_D=
M[W_KRB_F:\=_X=U? _\ Z&[QW_X5\]>6>$_V./AGJO[7/BWX477BKQ>-+TKP
MK87MJR>)IA,9978-N?JR\<#M0!]FT5X+_P .ZO@?_P!#=X[_ /"OGH_X=U?
M_P#Z&[QW_P"%?/0![U17@O\ P[J^!_\ T-WCO_PKYZ/^'=7P/_Z&[QW_ .%?
M/0![U17@O_#NKX'_ /0W>.__  KYZ/\ AW5\#_\ H;O'?_A7ST >]45X+_P[
MJ^!__0W>._\ PKYZ/^'=7P/_ .AN\=_^%?/0![U17@O_  [J^!__ $-WCO\
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MNKX'_P#0W>.__"OGH_X=U? __H;O'?\ X5\] 'O5%>"_\.ZO@?\ ]#=X[_\
M"OGH_P"'=7P/_P"AN\=_^%?/0![U17@O_#NKX'_]#=X[_P#"OGH_X=U? _\
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M&<HF0.K8ZGO0!]FT5X+_ ,.ZO@?_ -#=X[_\*^>C_AW5\#_^AN\=_P#A7ST
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M/8BM>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M](%JI5<9.[RQ@8SS7PSXF_9B^.?QN_X-=/AM\'/AU\,K_6?%FC?#OP?K%SX
MN;=HI]:BTR^L[VYTUHW&[S)(K>0+&5)9PJXRU '!?!3]L/X._P#!0#]O?]A_
M0/@]^S!XB^!-W\.M U;6X[WX@>'DT-=5TO\ L<VIT+0#G_B:P,T@E9DVHL$7
MF8R64?L?7Y;?&W]LGX;?\%>OC[^S%\)?V+?A9X_DU?X:_'+1OB!\2M?\2^ +
M_1H? VG:;#/]ITRYGNHD5KJY,JVXA@:1&PQ+$*"/U)H **** "BBB@ HHHH
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M-&@6WM]3\2K=2#^TM0N!\]Q#%#)"(K;A1+&9">2K?H[\*O\ DE_AO_L 6?\
MZ(2OFK_@NMX>U_Q9_P $A_CYX<\+:'>:GJ%YX#FCM+#3[9YIIW\V+Y41 68^
MP%?2WPPBEM_AIX=@GB9'30K171UP5(A3(([&@#=HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]$KGP^+PV+Y_8S4N23B[=)+=/S1,9PG?E=[:?,****Z"@HHHH **QOB)\1?
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M]JK]J+POX'US5-+&HV&F:W<NLLUH9'B$P"J?E+Q2+GU0^E;O@W]N7]D/Q_\
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M+XD^"OA!XZ\:P:=XD^(M[>6G@O2Y()6?5)K2V:ZN$1D4JA2!&<[RH(&!D\4
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M3++1OC9\.-.\26NG3M-8P:BC,L,C+M+#!')'%>>_\.R?V"/^C7/"_P#X#O\
M_%UQUI9@JC]E&+CYMI_A%_F?29=2X0EA$\?6KQJZW4*=.4=]+.56+VWTW/3O
M^%V?!G_HKGAC_P ']O\ _%T?\+L^#/\ T5SPQ_X/[?\ ^+KS'_AV3^P1_P!&
MN>%__ =__BZ/^'9/[!'_ $:YX7_\!W_^+K+FS?\ DA_X%+_Y$[O8>'W_ $$8
MK_P32_\ EY\<?\%7_P#@K9#<PZA^S)^REXK62.16M_%?C+3;@%64C#6EI(IY
M!Z/,I]54]37YCU^EW_!47_@CUI7A;0[C]H#]C_PDT5G8P%_$G@NS+R%(U'-U
M:@DL0!R\0[#<O=:_-&OR;B?^U?[2?UW_ +=M\-O[OZ];[G]^>"'^HBX*I_ZL
MO3_E[SV57VEM?:6O_P!NV;CR_#U/TX_X)0?\%;(;:'3_ -F3]JWQ6L<<:K;^
M%/&6I7 "JH&%M+N1CP!T29CZ*QZ&OT5_X79\&?\ HKGAC_P?V_\ \77YP?\
M!+K_ ((]:5XIT.W_ &@/VP/"32V=] '\-^"[PO&7C8<75T 0P!'*1'L=S=EK
M[1_X=D_L$?\ 1KGA?_P'?_XNOON'WQ LMA[:,7VYFU*W2]D_EUMN?RAXN4_"
M2?&M?^SZE6+_ .7GL84YTO:7][DYJD+?WK)QYKVZGIW_  NSX,_]%<\,?^#^
MW_\ BZ/^%V?!G_HKGAC_ ,']O_\ %UYC_P .R?V"/^C7/"__ (#O_P#%T?\
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M#]M'QA=Z!J%KIVO_ !5\/WFC7=[8R0K>0'PW8C?&7 W@'*G&<$$'D4 >N_\
M!,?]L/6/V]_V&? 7[5'B?P7#X=UKQ%:WEOX@T2VE+Q6FHV5]<6%VL98D^69[
M61D!)(5E!+'D^\U^;7_!+/\ :6T7]@C_ ()(_!R[^.'PN\:O)XO^.VM>#[:S
MTG1%,^GW6K>,-62UNKM+B2+RK3)3=(-S8ECVH^X5^DM 'XR?L-?MP_'W]AC_
M ((9?LU>(?V;OA;H/C+Q+\1?VE]7\"0:!X@EEBCN/[0U[Q"8PDT;K]G?[1!
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M_2'_ (6]\)O^BH>'?_!W!_\ %T?\+>^$W_14/#O_ (.X/_BZ\[_X=Y?L4?\
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MA)<> O!'[-7@V#Q/+XP73G:TN_'C63Q:#IMM-<(3-;6J%Y;AUW$A_+?:X!H
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M/_5O!/P,\ Q>,]6T7Q9H7B.]^'T]R(8_%UAIVH0W5QI3,WRGS4C)"G.YHU4
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M2LY""/! W$ _/WP&_;=T_P#X(]VWQV_8Z^/7P5^(=_XUN_BYXG\5_ NU\-^
MM1U6V^(-EJ\[7EE!;7-K$\27"32-#,LK1A,#!8Y \T_:C\57'C[]L+PCI_\
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M30IM3\/26KM"-Y#FWB,DJ[F,;>8KG<K5]E?\%_/V4OAU\2_BG^SK^UA^T/\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622885344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,223,756,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,512,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents Incorporated by Reference: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement to be filed for its 2022 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622875392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Grandview Heights, Ohio<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622921808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 181,364<span></span>
</td>
<td class="nump">$ 162,467<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">174,819<span></span>
</td>
<td class="nump">155,689<span></span>
</td>
<td class="nump">146,054<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,778<span></span>
</td>
<td class="nump">6,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">4,557<span></span>
</td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">5,741<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings/(loss)</a></td>
<td class="num">(596)<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="num">(4,098)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">(Gain)/Loss on sale of equity interest in naviHealth</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings/(loss) before income taxes</a></td>
<td class="num">(769)<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="num">(3,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="nump">163<span></span>
</td>
<td class="num">(289)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">(932)<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="num">(3,693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings/(loss) attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (933)<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings/(loss) per common share attributable to Cardinal Health, Inc.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="num">$ (3.35)<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="num">$ (3.35)<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659626622768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">$ (932)<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net unrealized gain/(loss) on derivative instruments, net of tax</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income/(loss)</a></td>
<td class="num">(1,012)<span></span>
</td>
<td class="nump">682<span></span>
</td>
<td class="num">(3,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (1,013)<span></span>
</td>
<td class="nump">$ 681<span></span>
</td>
<td class="num">$ (3,721)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622686400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 4,717<span></span>
</td>
<td class="nump">$ 3,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">10,561<span></span>
</td>
<td class="nump">9,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">15,636<span></span>
</td>
<td class="nump">14,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,021<span></span>
</td>
<td class="nump">2,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">32,935<span></span>
</td>
<td class="nump">31,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">10,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">43,878<span></span>
</td>
<td class="nump">44,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">27,128<span></span>
</td>
<td class="nump">23,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">580<span></span>
</td>
<td class="nump">871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,842<span></span>
</td>
<td class="nump">2,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">30,550<span></span>
</td>
<td class="nump">27,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">4,735<span></span>
</td>
<td class="nump">5,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">9,299<span></span>
</td>
<td class="nump">9,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212; 327 million shares at June 30, 2022 and 2021</a></td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings/(accumulated deficit)</a></td>
<td class="num">$ (280)<span></span>
</td>
<td class="nump">$ 1,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common shares in treasury</a></td>
<td class="nump">54,000,000<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 54 million shares and 36 million shares at June 30, 2022 and 2021, respectively</a></td>
<td class="num">$ (3,128)<span></span>
</td>
<td class="num">$ (2,186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity/(deficit)</a></td>
<td class="num">(709)<span></span>
</td>
<td class="nump">1,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity/(deficit)</a></td>
<td class="num">(706)<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity/(deficit)</a></td>
<td class="nump">$ 43,878<span></span>
</td>
<td class="nump">$ 44,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, issued</a></td>
<td class="nump">327,000,000<span></span>
</td>
<td class="nump">327,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625048048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Retained Earnings/(Accumulated Deficit)</div></th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2019</a></td>
<td class="nump">6,330<span></span>
</td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">(3,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</a></td>
<td class="num">(3,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">$ 2,789<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">1,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2021</a></td>
<td class="num">$ (2,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">(932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Share repurchase program activity</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOtherShares', window );">Stockholders' Equity, Other Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="num">$ (706)<span></span>
</td>
<td class="nump">$ 2,813<span></span>
</td>
<td class="num">$ (280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (114)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Jun. 30, 2022</a></td>
<td class="num">$ (3,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOtherShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of increase (decrease) in shares of stock classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOtherShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623034448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">$ (932)<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherInvestments', window );">Impairments and loss on sale of other investments</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">(Gain)/Loss on sale of equity interest in naviHealth</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Provision for/(benefit from) deferred income taxes</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">(Increase)/decrease in trade receivables</a></td>
<td class="num">(1,526)<span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(1,071)<span></span>
</td>
<td class="num">(1,584)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="nump">3,428<span></span>
</td>
<td class="nump">2,325<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">6,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">3,122<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures, net of cash sold</a></td>
<td class="nump">923<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of other investments</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from sale of investments</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from net investment hedge terminations</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="nump">567<span></span>
</td>
<td class="num">(378)<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities', window );">Proceeds from interest rate swap terminations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(885)<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="num">(1,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net tax proceeds/(withholding) from share-based compensation</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(559)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
<td class="num">(569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury shares</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,463)<span></span>
</td>
<td class="num">(1,317)<span></span>
</td>
<td class="num">(2,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates changes on cash and equivalents</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashReclassifiedtoAssetsHeldforSale', window );">Cash reclassified from/(to) assets held for sale</a></td>
<td class="nump">109<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and equivalents</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">3,407<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">$ 2,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and equivalents at end of period</a></td>
<td class="nump">4,717<span></span>
</td>
<td class="nump">3,407<span></span>
</td>
<td class="nump">2,771<span></span>
</td>
<td class="nump">$ 4,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Net cash payments/(refunds) for income taxes</a></td>
<td class="num">$ (766)<span></span>
</td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashReclassifiedtoAssetsHeldforSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CashReclassifiedtoAssetsHeldforSale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashReclassifiedtoAssetsHeldforSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) included in earnings for investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622882176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">1. Basis of Presentation and Summary of Significant Accounting Policies </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#8220;we,&#8221; &#8220;our,&#8221; "us," and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries, unless the context otherwise requires.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on June&#160;30. References to fiscal 2022, 2021 and 2020 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2022, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively. Certain prior year amounts have been reclassified to conform to the current year presentation. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, vendor reserves, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts may differ from these estimated amounts.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $273 million and $243 million at June&#160;30, 2022 and 2021, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $12 million) and $63 million (current portion $7 million) at June&#160;30, 2022 and 2021, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $8 million and $12 million at June&#160;30, 2022 and 2021, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS Health") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS Health</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 19 percent, 19 percent and 21 percent of revenue for fiscal 2022, 2021 and 2020, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (52 percent and 50 percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $416 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$565 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain personal protective equipment as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand decreased compared to the peak of COVID-19, during fiscal 2021 we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The reserve balance was $42&#160;million at June 30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $147 million and $185 million at June&#160;30, 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize project costs relating to computer software developed or obtained for internal use when the activities related to the project reach the application stage. Costs that are associated with the preliminary stage activities, training, maintenance, and all other post-implementation stage activities are expensed as they are incurred.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;3 to 39 years; machinery and equipment&#8212;3 to 20 years; capitalized software held for internal use&#8212;3 to 7 years; and furniture and fixtures&#8212;3 to 7 years. We recorded depreciation and amortization expense of $412 million, $377 million and $405 million for fiscal 2022, 2021 and 2020, respectively.</span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,724</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized software held for internal use</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">358</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,522)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was 4 percent at June&#160;30, 2022. The amount of capitalized interest was immaterial for all periods presented.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 10 to 12 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2022, 2021 and 2020 and with the exception of our Medical Unit in fiscal 2022, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. As discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements," during fiscal 2022, we recognized goodwill impairment charges related to our Medical Unit of $2.1&#160;billion, respectively, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings. There were tax benefits related to these goodwill impairment charges. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we signed a definitive agreement with Hellman &amp; Friedman to sell the Cordis business. Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $923 million net of cash transferred, and we retained certain working capital accounts and certain liabilities. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information. Cardinal Health retained product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2022, 2021, and 2020 was not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms from less than 1 year up to approximately 20 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding leases.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically update our reserve estimates to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues. Vendor reserves were $105 million and $77 million at June&#160;30, 2022 and 2021 respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of $1.17&#160;billion and $5.63 billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively, which were retained at Corporate. In February 2022, we and two other national distributors announced that each company had determined that a sufficient number of political subdivisions had agreed to participate in the previously disclosed settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2022. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $1.96, $1.94 and $1.92 in fiscal 2022, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2022 and 2021, the accrual for estimated sales returns and allowances was $617 million and $689 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.4 billion, $2.6 billion and $2.3 billion, for fiscal 2022, 2021 and 2020, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2022, 2021 and 2020. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $748 million, $634 million and $620 million, for fiscal 2022, 2021 and 2020, respectively. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_103" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amortization and Other Acquisition-Related Costs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding amortization of acquisition-related intangible assets. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2022 and 2021 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_127" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting standards adopted in fiscal 2022 that had a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the adoption impacts of recently issued accounting standards by the FASB on our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2021 Form 10-K. There were no accounting standards issued in fiscal 2022 that will have a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627724560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">2. Divestitures and Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $923 million, net of cash transferred, and we retained certain working capital accounts and certain liabilities. Cardinal Health retained product liability associated with lawsuits and claims related to IVC filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Cordis business operated within our Medical segment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. We determined that the sale of the Cordis business did not meet the criteria to be classified as discontinued operations. In connection with the divestiture, we recognized a $60&#160;million pre-tax loss in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss) in fiscal 2021.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">naviHealth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $579&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not complete any acquisitions during fiscal 2020. While we completed small acquisitions during fiscal 2022 and 2021, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $22 million and $3 million for fiscal 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659707773520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">3. Restructuring and Employee Severance </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:57.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of accelerated depreciation, lease costs associated with vacant facilities, professional, project management and other service fees to support divestitures, vendor transition fees, project consulting fees, and certain other divestiture-related costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022 and 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures, which includes facility exit costs related to decreasing our overall office space, and the divestiture of the Cordis business. In fiscal 2020, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(92)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630542112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">4. Goodwill and Other Intangible Assets </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.801%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,657&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,357</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(64)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,673</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,182</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,855</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Medical segment accumulated goodwill impairment loss was $3.5 billion and $1.4 billion, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, the Medical Unit experienced adverse financial results related to inflationary impacts and the adverse impact of global supply chain constraints and lower volumes from PPE. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit at June&#160;30, 2022. This quantitative testing resulted in the carrying amount of the Medical Unit exceeding the fair value, resulting in a pre-tax impairment charge of $303 million and cumulative pre-tax impairment charges of $2.1&#160;billion recognized during fiscal 2022, due to the impairment charges recognized during the third and second quarters of fiscal 2022 as described further below. This impairment charge was driven by an increase in the discount rate primarily due to an increase in the risk-free interest rate. Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach and the market-based approach. For this testing performed at June&#160;30, 2022, we used a discount rate of 10 percent and a terminal growth rate of 2 percent. The goodwill balance of the Medical Unit, after recognizing the impairment, was $1.9 billion at June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third and second quarters of fiscal 2022, we performed interim goodwill impairment testing for the Medical Unit at March 31, 2022 and December 31, 2021, which resulted in pre-tax impairment charges of $1.3&#160;billion and $474&#160;million, which were recognized during the second and third quarters of fiscal 2022, respectively, and are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(using a terminal growth rate of 2 percent), and the market-based approach. For the income-based approach, we also used discount rates of 9 percent and 9.5 percent for the interim testing during the second and third quarters of fiscal 2022, respectively. The increase in the discount rate was primarily due to an increase in the risk-free interest rate. Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the divestiture of the Cordis business, during fiscal 2021 we allocated and reclassified $388 million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,272</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,165</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,107</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">552</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">192</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,038</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">574</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">464</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,862</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,763</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,873</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,774</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,928&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Total amortization of intangible assets was $311 million, $428 million and $512 million for fiscal 2022, 2021 and 2020, respectively. The estimated annual amortization for intangible assets for fiscal 2023 through 2027 is as follows: $283 million, $260 million, $235 million, $208 million and $175 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630182784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">5. Leases </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:27.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost primarily includes payments for property taxes, maintenance and insurance. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe">Operating lease right-of-use assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711">Current portion of operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f">Long-term operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">490</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f">Finance lease right-of-use assets</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c">Current portion of finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5 years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheets. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheets. </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">123</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:50.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622591488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">6. Long-Term Obligations and Other Short-Term Borrowings </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:57.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">556</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">779</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,193</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">441</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">560</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,315</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,735</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)      Maturities are presented on a calendar year basis. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of existing long-term obligations and other short-term borrowings for fiscal 2023 through 2027 and thereafter are as follows: $580 million, $1.2 billion, $532 million, $131 million, $1.2 billion and $1.7 billion.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The 7.0% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $27.1 billion and $23.7 billion at June&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we redeemed all outstanding $572 million principal amount of 2.616% Notes due 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with this redemption, we recorded a $10&#160;million loss on early extinguishment of debt. We also repaid the full principal of the $282&#160;million Floating Rate Notes due 2022 as they became due. The early redemption and repayment were funded with available cash.</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principal amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. We also early repurchased $40 million of the Floating Rate Notes due 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $2 million of the 2.616% Notes due 2022. In connection with the early debt repurchases, we recorded a $1&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss on early extinguishment of debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we redeemed $500 million aggregate principal amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $7 million loss on early extinguishment of debt. We also early repurchased&#160;$247&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$11&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$20&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $104&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$6&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$5&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$35&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$9 million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $450&#160;million 2.4% Notes due 2019 as they became due. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redemptions and repurchases were paid for with available cash and other short-term borrowings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp; Poor's Ratings Services, Moody&#8217;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at 101% of the principal amount plus accrued and unpaid interest.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Financing Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$2.0 billion&#160;commercial paper program backed by a $2.0 billion&#160;revolving credit facility. We also have a&#160;$1.0 billion&#160;committed receivables sales facility.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, we amended our receivables sales facility to temporarily increase the maximum permitted delinquency ratio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">than 3.75-to-1. As of June&#160;30, 2022, we were in compliance with this financial covenant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $1 million at both June&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we had a daily maximum amount outstanding under our commercial paper and committed receivables programs of $1.2 billion and an average daily amount outstanding of $19 million.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no amounts outstanding as of June&#160;30, 2022 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $31 million at both June&#160;30, 2022 and 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no amounts outstanding under the commercial paper program as of June&#160;30, 2022 and 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $74 million and $67 million balance of other obligations at June&#160;30, 2022 and 2021, respectively, consisted of finance leases and short-term borrowings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630621040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text"><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">7. Commitments, Contingent Liabilities and Litigation </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commitments</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture with CVS Health Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations and Cash Requirements section of MD&amp;A. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contingencies</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New York Opioid Stewardship Act</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $41&#160;million for calendar years 2017 and 2018 during the fiscal year ended June 30, 2021 based on the probable estimated payment amount. In the second quarter of fiscal year 2022, we paid the State of New York approximately $20&#160;million, our portion of the assessment for calendar year 2017. As a result, as of June&#160;30, 2022, we had an accrual of $20&#160;million, which reflects our best estimate of the portion of the assessment that we may owe for sales during calendar year 2018.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, temporary interruptions in product sales, restrictions on importation, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss); however, losses and recoveries of lost profits from disputes that occur in the ordinary course of business are included within segment profit. For example, in the second quarter of fiscal year 2022, our Pharmaceutical segment profit was positively impacted by a $16&#160;million judgment for lost profits related to an ordinary course intellectual property rights claim.</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opioid Lawsuits and Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">States &amp; Political Subdivisions</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">National Settlement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in fiscal year 2017, state attorneys general, counties and municipalities began filing lawsuits related to the distribution of prescription opioid pain medications against pharmaceutical wholesalers, including us, and other participants in the pharmaceutical supply chain. These lawsuits sought equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. The lawsuits filed by states and political subdivisions were filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and were transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By fiscal year 2022, Cardinal Health was a defendant in approximately 2,775 lawsuits brought by these plaintiffs. In July 2021, we and two other national distributors (collectively, the "Distributors") announced a proposed settlement with a group of state attorneys general intended to resolve the vast majority of these lawsuits (the "National Settlement") as well as a proposed settlement agreement (the "Settlement Agreement") containing, among other things, a sign-on process to allow states and political subdivisions to participate in the National Settlement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Distributors each determined that a sufficient number of states and political subdivisions had agreed to participate in the National Settlement to proceed with the Settlement Agreement. The Settlement Agreement became effective on April 2, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Distributors, parties to the Settlement Agreement include 46 states, the District of Columbia and 5 U.S. territories. As of August 9, 2022, over 99 percent of political subdivisions (by population as calculated under the Settlement Agreement) that had brought opioid-related suits against us as calculated under the Settlement Agreement had chosen to join the Settlement Agreement or have had their claims addressed by state legislation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this Settlement Agreement, we will pay up to approximately $6.0&#160;billion, the majority of which is expected to be paid over 18 years. The exact payment amount will depend on several factors, including the extent to which states take action to foreclose opioid lawsuits by political subdivisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by passing laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which additional political subdivisions in participating states file additional opioid lawsuits against us. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement also includes injunctive relief terms related to distributors&#8217; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating controlled substances monitoring programs; (3) due diligence for new and </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the Distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which distributors will fund for ten years.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The participating states and the distributors are cooperating to obtain consent judgments embodying the terms of the Settlement Agreement in each participating state and the participating states and subdivisions are dismissing their lawsuits. As a result, as of August 9, 2022, approximately 2,300 lawsuits against us have been dismissed. We expect additional lawsuits to be dismissed over the coming months.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the effective date of the Settlement Agreement, Distributors had entered into separate settlement agreements with each of the states of Florida, New York, Ohio and Rhode Island. When the Settlement Agreement became effective, each of these states and their participating subdivisions became a part of the National Settlement; however, the New York, Ohio and Rhode Island agreements required us to make certain payments separately from those required by the Settlement Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended June&#160;30, 2022, we made our first annual payment under the Settlement Agreement. We also made certain payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. In total, during fiscal year ended June&#160;30, 2022, we paid $417&#160;million in connection with these matters. In July 2022, we made our second annual payment of $374&#160;million under the Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Settlements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Virginia subdivisions and Native American tribes were not a part of the National Settlement and we had separate negotiations with these groups. A bench trial before a federal judge in West Virginia in a case brought by Cabell County and City of Huntington against the Distributors concluded in July 2021. In July 2022, a judgment in favor of the Distributors was entered. In July 2022, the Distributors reached an agreement to settle the opioid-related claims of the majority of the remaining West Virginia subdivisions. Under this agreement, we have agreed to pay eligible West Virginia subdivisions up to approximately $124&#160;million over an eleven-year period. This agreement is subject to certain contingencies related to subdivision participation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Distributors reached an agreement with the State of Oklahoma to resolve the opioid-related claims of the state and its political subdivisions. Under this agreement, Cardinal Health agreed to pay approximately $95&#160;million to the State and its participating subdivisions. This amount is consistent with the amount that would have been allocated to Oklahoma under the Settlement Agreement. The terms of this agreement are consistent with the terms of the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Distributors reached an agreement with the Washington Attorney General, under which Cardinal Health will pay up to approximately $160&#160;million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with the amount that would have been allocated to Washington under the Settlement Agreement plus certain attorneys' fees and costs. The terms of this agreement in principle are substantially consistent with the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. If this agreement and the Washington agreement are finalized, Oklahoma and Washington would become subject to the Settlement Agreement and 48 of 49 eligible states would then be subject to the Settlement Agreement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021 we announced that the Distributors had reached an agreement with the Cherokee Nation in connection with ongoing negotiations toward a broader agreement with Native American tribes. In January 2022, the Distributors entered into a term sheet with the Native American tribes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement and separate state settlements have not resolved all opioid lawsuits and claims brought by states and political subdivisions. As of August 9, 2022, we are still defendants in approximately 475 lawsuits brought by counties, municipalities and other political subdivisions; however, we expect this number to decline as additional cases are dismissed as a result of the Settlement Agreement.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In total, we have recorded total pre-tax charges of $1.17&#160;billion and $5.63&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $6.36&#160;billion accrued at June&#160;30, 2022, of which $532&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and none of these agreements is an admission of liability or wrongdoing.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice Investigations</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with these investigations. We are unable to predict the outcome of any of these investigations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Plaintiffs</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately 440 lawsuits as of August 9, 2022. Of these, 151 are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A trial in a case involving 21 plaintiffs began in state court in Georgia in July 2022. A mistrial was declared shortly thereafter due to rising COVID-19 cases and a new trial date has not been set. We are vigorously defending ourselves in all of these matters; however, trials are inherently unpredictable and it is possible that an unfavorable outcome in these matters, individually or in the aggregate, could have a negative impact on our financial results.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in ongoing legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#8220;National Union&#8221;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cordis IVC Filter Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Lawsuits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August 9, 2022, we are named as a defendant in 470 product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately 5,967 plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase IVC filter products. Another 18 lawsuits involving similar claims by approximately 20 plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately 1,300 claims. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with plaintiffs. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had a total of $512&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, related to the IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $1.05&#160;billion, net of estimated </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Mexico Attorney General Action</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Attorney General for the State of New Mexico filed an action against certain IVC filter manufacturers, including us, alleging claims under New Mexico's Unfair Practices Act, Medicaid Fraud Act and Fraud Against Taxpayers Act. The allegations made are similar to those made in the product liability lawsuits, described above. We intend to vigorously defend ourselves against these claims.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Securities Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In September 2021, the court denied our motion to dismiss. We are vigorously defending ourselves against these claims.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Solutions DOJ Investigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the United States Attorney&#8217;s Office for the District of Massachusetts (the "USAO") commenced an investigation of Cardinal Health regarding possible violations of the U.S. healthcare fraud and abuse laws. In January 2022, without admitting liability, we settled this matter with the DOJ for approximately $13 million, which was recorded as expense within litigation charges/(recoveries) net in our consolidated statements of earnings/(loss) during the fiscal year ended June 30, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Civil Litigation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic Pharmaceutical Pricing Antitrust Litigation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. The court granted our motion to dismiss, and the indirect purchasers filed an amended complaint. We intend to vigorously defend ourselves. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Active Pharmaceutical Ingredient Impurity Litigation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#8220;Sartan MDL&#8221;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation Proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $18 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$112 million and $16 million during fiscal 2022, 2021, and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627751392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">8. Income Taxes </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,000)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,056)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">231</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(769)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Goodwill Impairment Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we recognized cumulative pre-tax charges of $2.1&#160;billion for goodwill impairments related to the Medical Unit. The net tax benefit related to these charges was $150&#160;million.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Self-Insurance Pre-Tax Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we filed for a refund of $974&#160;million and in April 2022, we received a payment for $966&#160;million, which was net of certain adjustments. See Note 7 of the "Notes to Consolidated Financial Statements" for additional detail. We also increased our non-current deferred tax liability by approximately $700&#160;million during fiscal 2021 related to this matter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Effects of Opioid Litigation Charges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the $1.17&#160;billion and $5.63&#160;billion pre-tax charges for the opioid litigation recorded during fiscal 2021 and 2020, the net tax benefits were approximately $228&#160;million and $488 million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million and $469&#160;million, respectively.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the U.S. Tax Cuts and Jobs Act ("Tax Act"); however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.482%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Divestitures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4.9)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill Impairment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(49.5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(129.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense, fiscal 2021 is pretax income with tax benefit, and fiscal 2020 is pretax loss with tax benefit.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit rate was (21.2)% and (89.7)% in fiscal 2022 and fiscal 2021 compared to an income tax benefit rate of 2.1% in fiscal 2020. Fluctuations in the effective tax rates are primarily due to the impact of goodwill impairment in fiscal 2022, impact of opioid litigation in fiscal 2021 and 2020, as well as the </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $21 million during fiscal 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, foreign earnings of approximately $833 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our consolidated financial statements in fiscal 2022. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">675</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">778</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,584</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(468)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,164)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(288)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(683)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(733)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,110)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,994)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,932)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 we had gross federal, state and international loss and credit carryforwards of $275 million, $3.5 billion and $2.2 billion, respectively, the tax effect of which is an aggregate deferred tax asset of $778 million. Substantially all of these carryforwards are available for at least three years. Approximately $449 million of the valuation allowance at June&#160;30, 2022 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related</span><span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $943 million, $932 million and $998 million of unrecognized tax benefits at June&#160;30, 2022, 2021 and 2020, respectively. The June&#160;30, 2022, 2021 and 2020 balances include $858 million, $849 million and $753 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">943</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between zero and a net decrease of up to $75 million, exclusive of penalties and interest.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2022, 2021 and 2020, we had $48 million, $49 million and $146 million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2022 and 2021. During fiscal 2020, we recognized $16 million of expense for interest and penalties in income tax expense, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Tax Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly based on available information. This information may support either an increase or a decrease in the required valuation allowance. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described above. We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $75 million and $72 million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $1 million and $12 million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627735152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div>(2)The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">9. Fair Value Measurements </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets and (Liabilities) Measured on a Nonrecurring Basis</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities held for sale of $1.1&#160;billion and $96 million, respectively, at June&#160;30, 2021 were primarily related to the divestiture of the Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the divestiture of Cordis business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659707198432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">10. Financial Instruments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into </span></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Currency Exchange Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:69.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2022, 2021 and 2020 there was no gain or loss recorded to interest expense as changes in the market value of our </span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we entered into pay-floating interest rate swaps with total notional amounts of $600 million. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $550&#160;million. In connection with the unwind of these contracts, we received cash proceeds of $18&#160;million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $200&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $112 million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June 30, 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the debt repayment as described in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_115" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 6</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, two pay-floating interest rate swaps with notional amounts of $200 million matured in the second quarter of fiscal 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2027</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 2029</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.100%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into </span></div></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $200&#160;million to hedge probable, but not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2022 and 2021, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, Euro, Chinese renminbi, Thai baht, Philippine peso, Japanese yen, Australian dollar and British pound.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we entered into a &#165;24&#160;billion ($200&#160;million) cross-currency swap maturing in September 2025 and a &#165;24&#160;billion ($200&#160;million) cross-currency swap maturing in June 2027.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we terminated the &#165;64 billion ($600 million) cross-currency swap entered into in August 2019 and received a net settlement of $71&#160;million in cash recorded in proceeds from net investment hedge terminations in our consolidated statements of cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $86 million gain and a $7 million loss during fiscal 2022 and 2021, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $21 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$19 million during fiscal 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Economic (Non-Designated) Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currencies managed through foreign currency contracts are the Canadian dollar, Euro, Chinese renminbi, Indian rupee and Thai baht.</span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">265</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2022</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2022 and 2021 approximate fair value due to their short-term maturities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,049</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,751&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,315</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:31.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">633</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627731632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">11. Shareholders' Equity/(Deficit) </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, authorized capital shares consisted of the following: 750 million Class A common shares, without par value; 5 million Class B common shares, without par value; and 500 thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#8220;common shares&#8221;. Holders of </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to one vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchased $1.6 billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, as described below. We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022, we repurchased 19.5 million common shares having an aggregate cost of $1.0 billion. We repurchased 9.8&#160;million, 6.1&#160;million and 3.6&#160;million common shares under multiple accelerated share repurchase ("ASR") programs with average paid per common share of $51.10, $49.39 and $56.02, respectively. These repurchases began on August 18, 2021 and concluded on April 18, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we repurchased 3.7 million common shares having an aggregate cost of $200 million. The average price paid per common share was $54.40. These repurchases were made under an ASR program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, we repurchased 7.3 million common shares having an aggregate cost of $350 million. The average price paid per common share was $48.00. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.050%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $4&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $24&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(102)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659629702928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(932)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,693)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(933)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020 were 5 million, 3 million and 6 million, respectively. During fiscal 2022 and 2020, there were 1 million and 2 million potentially dilutive employee stock options, restricted share units and performance share units, respectively, not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630708256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">13. Segment Information </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are principally managed on a products and services basis and are comprised of two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><div style="display:inline-block;vertical-align:top;width:48.214%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">164,580</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,462</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">176,855</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157,756&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148,707&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,523</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not allocate the following items to our segments: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">last-in first-out, or ("LIFO"), inventory charges/(credits);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $85&#160;million during fiscal 2020;</span></div></div><div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.215%"><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a pre-tax charge of $41&#160;million during fiscal 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">restructuring and employee severance;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">amortization and other acquisition-related costs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">impairments and (gain)/loss on disposal of assets; in connection with goodwill impairment testing for the Medical Unit as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized goodwill impairment charges of $2.1&#160;billion during fiscal 2022; in connection with the divestiture of the Cordis business, we recognized a $60&#160;million pre-tax write-down of the net assets held for sale</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized pre-tax charges of $1.17&#160;billion and $5.63 billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">other (income)/expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">interest expense, net;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">loss on early extinguishment of debt;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized a $579&#160;million pre-tax gain ($493&#160;million after tax) during fiscal 2020;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt">provision for/(benefit from) income taxes </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $50 million, $27 million and $69 million for fiscal 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,770</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,986</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">283</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">692</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">140</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">168</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26,409</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,624&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,398&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,632</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,837</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43,878</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,976</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">385</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630703488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">14. Share-Based Compensation </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2022, 24 million shares remain available for future grants under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan ("2021 LTIP"). Under the 2021 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only 10 million shares could be issued under awards other than stock options while 24 million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were no stock options granted to employees during fiscal 2022, 2021 or 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides total share-based compensation expense by type of award:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total tax benefit related to share-based compensation was $12 million, $12 million and $16 million for fiscal 2022, 2021 and 2020, respectively.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share units granted under the Plans generally vest in equal annual installments over three years. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.92&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.37&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.05&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.60&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46.03</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Share Units</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units generally vest over a three-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from zero to 240 percent of the target award amount for fiscal 2020 and 2021 grants and zero to 234 percent for the fiscal 2022 grant. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:49.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.89&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54.32</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630706864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Cardinal Health, Inc. and Subsidiaries</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Schedule&#160;II - Valuation and Qualifying Accounts</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.594%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to Costs<br/>and Expenses (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Other Accounts&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions&#160;(3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of Period</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">154</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">273</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">689</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,359</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">617</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">944</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,514</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,561)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">898</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,702&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,488)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance notes receivable</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales returns and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,407&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,366)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Fiscal 2022, 2021 and 2020 include $87 million, $70 million and $49 million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Recoveries of amounts provided for or written off in prior years was $1 million in each fiscal year 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Write-off of uncollectible accounts or actual sales returns.</span></div>The sum of the components may not equal the total due to rounding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659626459216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively. Certain prior year amounts have been reclassified to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, vendor reserves, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts may differ from these estimated amounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables are presented net of an allowance for doubtful accounts of $273 million and $243 million at June&#160;30, 2022 and 2021, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $12 million) and $63 million (current portion $7 million) at June&#160;30, 2022 and 2021, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $8 million and $12 million at June&#160;30, 2022 and 2021, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div>Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#8217; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Major Customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation ("CVS Health") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS Health</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>We have entered into agreements with group purchasing organizations (&#8220;GPOs&#8221;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 19 percent, 19 percent and 21 percent of revenue for fiscal 2022, 2021 and 2020, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our inventories (52 percent and 50 percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#8220;distribution facilities&#8221;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $416 million and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$565 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain personal protective equipment as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand decreased compared to the peak of COVID-19, during fiscal 2021 we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The reserve balance was $42&#160;million at June 30, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $147 million and $185 million at June&#160;30, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Discounts</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize project costs relating to computer software developed or obtained for internal use when the activities related to the project reach the application stage. Costs that are associated with the preliminary stage activities, training, maintenance, and all other post-implementation stage activities are expensed as they are incurred.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#8212;3 to 39 years; machinery and equipment&#8212;3 to 20 years; capitalized software held for internal use&#8212;3 to 7 years; and furniture and fixtures&#8212;3 to 7 years. We recorded depreciation and amortization expense of $412 million, $377 million and $405 million for fiscal 2022, 2021 and 2020, respectively.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,724</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized software held for internal use</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">358</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,522)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was 4 percent at June&#160;30, 2022. The amount of capitalized interest was immaterial for all periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#8220;Medical Unit&#8221;); and Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 10 to 12 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed annual impairment testing in fiscal 2022, 2021 and 2020 and with the exception of our Medical Unit in fiscal 2022, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. As discussed further in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the "Notes to Consolidated Financial Statements," during fiscal 2022, we recognized goodwill impairment charges related to our Medical Unit of $2.1&#160;billion, respectively, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings. There were tax benefits related to these goodwill impairment charges. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated </span></div>methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AssetsHeldforSalePolicyPolicyTextBlock', window );">Assets Held for Sale, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assets Held for Sale</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify assets and liabilities (the &#8220;disposal group&#8221;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, we signed a definitive agreement with Hellman &amp; Friedman to sell the Cordis business. Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In August 2021, we sold the Cordis business to Hellman &amp; Friedman for proceeds of $923 million net of cash transferred, and we retained certain working capital accounts and certain liabilities. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information. Cardinal Health retained product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock', window );">Vendor Reserves</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vendor Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically update our reserve estimates to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, </span></div>the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues. Vendor reserves were $105 million and $77 million at June&#160;30, 2022 and 2021 respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock', window );">Distribution Service Agreement and Other Vendor Fees</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Distribution Services Agreement and Other Vendor Fees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#8217; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#8217;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Loss Contingencies and Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the opioid litigation as described further in the </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recorded pre-tax charges of $1.17&#160;billion and $5.63 billion</span><span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during fiscal 2021 and 2020, respectively, which were retained at Corporate. In February 2022, we and two other national distributors announced that each company had determined that a sufficient number of political subdivisions had agreed to participate in the previously disclosed settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding loss contingencies and product liability lawsuits.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock', window );">Other Accrued Liabilities, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Accrued Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text">Noncontrolling InterestsNoncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding share-based compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DividendsPolicyPolicyTextBlock', window );">Dividends, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid cash dividends per common share of $1.96, $1.94 and $1.92 in fiscal 2022, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.</span></div>Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SalesreturnsPolicyTextBlock', window );">Sales Returns and Allowances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales Returns and Allowances</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#8220;merchantable product&#8221;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2022 and 2021, the accrual for estimated sales returns and allowances was $617 million and $689 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.4 billion, $2.6 billion and $2.3 billion, for fiscal 2022, 2021 and 2020, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2022, 2021 and 2020. </span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Returns</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect </span></div>or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ShippingandHandlingCostsPolicyTextBlock', window );">Shipping and Handling</a></td>
<td class="text">Shipping and HandlingShipping and handling costs are primarily included in SG&amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $748 million, $634 million and $620 million, for fiscal 2022, 2021 and 2020, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restructuring and Employee Severance</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_103" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our restructuring activities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock', window );">Amortization and Other Acquisition-Related Costs</a></td>
<td class="text">Amortization and Other Acquisition-Related Costs<span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 4</a></span> for additional information regarding amortization of acquisition-related intangible assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of Foreign Currencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Translation of Foreign Currencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#8217; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.</span></div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2022 and 2021 are presented in </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 11</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives', window );">Interest Rate, Currency and Commodity Risk</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#8217; equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#8217;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_127" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding fair value measurements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Adopted Financial Accounting Standards</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no accounting standards adopted in fiscal 2022 that had a material impact on our consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the adoption impacts of recently issued accounting standards by the FASB on our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2021 Form 10-K. There were no accounting standards issued in fiscal 2022 that will have a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.</span></div>From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2022, 2021, and 2020 was not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms from less than 1 year up to approximately 20 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i06b8b3ff48e94029843042d968c5bda7_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Notes to Consolidated Financial Statements&#8221; for additional information regarding leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AssetsHeldforSalePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Held for Sale, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AssetsHeldforSalePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CostofSalesVendorReservesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CostofSalesVendorReservesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DividendsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DividendsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accrued Liabilities, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SalesreturnsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>sales returns [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SalesreturnsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShippingandHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ShippingandHandlingCosts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShippingandHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EEEE<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999725-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627695776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:35.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVS Health</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OptumRx</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Components of Property and Equipment</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net at June&#160;30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land, building and improvements</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,724</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,114</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capitalized software held for internal use</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">358</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,883</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,522)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,228)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627726032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize restructuring and employee severance costs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:57.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related costs </span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility exit and other costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total restructuring and employee severance</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-<br/>Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility Exit<br/>and Other Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(92)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659631010128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.801%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,657&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,357</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cordis goodwill reclassified to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,989</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill acquired, net of purchase price adjustments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(64)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,673</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,182</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,855</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.</span></div>(2)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Medical segment accumulated goodwill impairment loss was $3.5 billion and $1.4 billion, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,272</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,165</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,107</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">552</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">192</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,038</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">574</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">464</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,862</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,763</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,873</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,774</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,928&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize other intangible assets by class at June&#160;30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted- Average Remaining Amortization Period (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,272</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,165</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,107</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">552</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">360</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">192</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,038</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">574</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">464</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,862</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,763</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,873</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,099</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,774</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:42.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross<br/>Intangible</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net<br/>Intangible</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Indefinite-life intangibles:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks and patents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total indefinite-life intangibles</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Definite-life intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks, trade names and patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology and other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total definite-life intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total other intangible assets</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,928&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622926736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of lease cost:  </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:27.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.740%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock', window );">Leases Supplemental Balance Sheet Information</a></td>
<td class="text">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe">Operating lease right-of-use assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711">Current portion of operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f">Long-term operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">490</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f">Finance lease right-of-use assets</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c">Current portion of finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a">Long-term finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5 years</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.1 years</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2 years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasePaymentsTableTextBlock', window );">Leases Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">123</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows paid for finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New finance leases</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended lease standard adoption impact as of July 1, 2019 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Lease Payments for Operating Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:50.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Lease Payments for Finance Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:50.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">117</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">562</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Lease Payments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659750321312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes long-term obligations and other short-term borrowings at June 30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:57.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.026%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions) (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.616% Notes due 2022</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating Rate Notes due 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2% Notes due 2023</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">556</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.079% Notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">779</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% Notes due 2024</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% Notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.41% Notes due 2027</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,193</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,216&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6% Notes due 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% Notes due 2044</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9% Notes due 2045</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">441</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.368% Notes due 2047</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">560</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0%&#160;Debentures due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Obligations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,315</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term borrowings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;&#160;Long-term obligations, less current portion</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,735</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>(1)      Maturities are presented on a calendar year basis.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624733280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings/(loss) before income taxes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,000)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,056)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">231</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(loss) before income taxes</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(769)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,772)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit), Current and Deferred</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of provision for/(benefit from) income taxes:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provision for/(benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.482%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision at Federal statutory rate</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nondeductible/nontaxable items </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Divestitures</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4.9)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Withholding Taxes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Valuation Allowances</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">US Taxes on International Income</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of Resolutions with IRS and other related matters </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opioid litigation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill Impairment</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(49.5)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss Carryback Claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(129.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(89.7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense, fiscal 2021 is pretax income with tax benefit, and fiscal 2020 is pretax loss with tax benefit.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.</span></div>(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the deferred income tax assets and liabilities at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable basis difference</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">675</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">778</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets related to uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,584</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Valuation allowance for deferred income tax assets</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(468)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,293</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory basis differences</span></td><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,164)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(288)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(375)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(683)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(733)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Self-Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,110)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,225)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,994)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,932)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax asset (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,030)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent deferred income tax liability transferred to held for sale</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net deferred income tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,932)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in other assets in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Included in deferred income taxes and other liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">932</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlements with tax authorities </span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expiration of the statute of limitations </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of fiscal year</span></div></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">943</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659620108480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other investments (1)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div>(2)The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622524416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:69.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.834%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (1) </span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fixed-rate debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward interest rate swaps (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commodity contracts (3)</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Included in SG&amp;A expenses in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"><tr><td style="width:1.0%"/><td style="width:46.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.359%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.363%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts (1)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.591%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Estimated fair value</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,049</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,751&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,315</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock', window );">Schedule of Fair Value Gain/(Loss) Derivative Instrument</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:31.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair&#160;Value<br/>Gain/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(43)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">633</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">265</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 2022</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2027</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">May 2029</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.100%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-floating interest rate swaps</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mar 2028</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Outstanding Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the outstanding cash flow hedges at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jul 2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jun 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturity&#160;Date</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jul 2021</span></div></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jun 2022</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659708034512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.875%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.050%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized<br/>Gain/(Loss) on<br/>Derivatives,<br/>net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(104)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $4&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to earnings</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $24&#160;million</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(102)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627721760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(932)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,693)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net earnings/(loss) attributable to Cardinal Health, Inc.</span></div></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(933)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,696)</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares&#8211;basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock options, restricted share units, and performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average common shares&#8211;diluted</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3.35)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12.61)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624765632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue for each reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Revenue by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">164,580</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,462</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.004%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">164,580</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nuclear and Precision Health Solutions</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165,491</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical distribution and products (3)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,462</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,485&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cardinal Health at-Home Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,425</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical segment revenue</span></div></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,887</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,444&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (4)</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by geographic area:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.183%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.269%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">176,855</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157,756&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148,707&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,523</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment revenue</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,378</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,483&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,939&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate (1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">181,364</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,467&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,922&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,770</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,684&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment profit</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,986</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(2,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating earnings/(loss)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,098)</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">216</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">283</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">692</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">913&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:47.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">140</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">168</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total additions to property and equipment</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents total assets for each reportable segment and Corporate at June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pharmaceutical</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">26,409</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,624&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,398&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,632</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,837</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43,878</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Property and Equipment, Net by Geographic Area</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present property and equipment, net by geographic area:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:46.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,976</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,958&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,880&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">385</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,361</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659620105760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text">The following table provides total share-based compensation expense by type of award:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted share unit expense</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Performance share unit expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock option expense</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total share-based compensation expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:51.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.92&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.37&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.05&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.60&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">46.03</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock', window );">Additional Restricted Shares and Restricted Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to restricted share unit activity:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:53.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:49.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance<br/>Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair<br/>Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.24&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.72&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.89&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.36&#160;</span></td><td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canceled and forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.2</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54.32</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock', window );">Additional Data Related to Performance Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional data related to performance share unit activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"/><td style="width:58.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;padding:0 1pt"/><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total fair value of shares vested during the year</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalPerformanceShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Performance Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalPerformanceShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Restricted Shares And Restricted Share Units Data [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624686160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 898<span></span>
</td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Finance notes and related accrued interest, net, total</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Finance notes and related accrued interest, net, current</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReceivableFinancingAgreementTerm', window );">Receivable financing agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReceivableFinancingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivable Financing Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReceivableFinancingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623984496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details) - Pharmaceutical<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent&#160;of&#160;Gross Trade&#160;Receivables</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">CVS Health | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">OptumRx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GrossTradeReceivablesMajorCustomerPercentage', window );">Percent&#160;of&#160;Gross Trade&#160;Receivables</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">OptumRx [Member] | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of Revenue</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GrossTradeReceivablesMajorCustomerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Trade Receivables, Major Customer Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GrossTradeReceivablesMajorCustomerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSCaremarkCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_OptumRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_OptumRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659626489488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details) - organization<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations', window );">Largest group purchasing organizations</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember', window );">Group Purchasing Organizations | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue, major customer, percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ConcentrationRiskLargestGroupPurchasingOrganizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Largest Group Purchasing Organizations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ConcentrationRiskLargestGroupPurchasingOrganizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_GroupPurchasingOrganizationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622565840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">Portion of inventories held at LIFO, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">Inventories valued at LIFO amount higher than average cost value</a></td>
<td class="nump">$ 565<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveExcessAndObsoleteMember', window );">Inventory Reserve Excess and Obsolete [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_InventoryReserveTableLineItems', window );"><strong>Inventory Reserve Table [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserves for excess and obsolete inventory</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveWriteDownToNetRealizableValueMember', window );">Inventory Reserve Write-down to Net Realizable Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_InventoryReserveTableLineItems', window );"><strong>Inventory Reserve Table [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserves for excess and obsolete inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_InventoryReserveTableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory Reserve Table [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_InventoryReserveTableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveExcessAndObsoleteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveExcessAndObsoleteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveWriteDownToNetRealizableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=cah_InventoryReserveWriteDownToNetRealizableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623991472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 412<span></span>
</td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Interest rate on long-term projects (approximates weighted-average on long-term obligations)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625587712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 5,883<span></span>
</td>
<td class="nump">$ 5,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(3,522)<span></span>
</td>
<td class="num">(3,228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">2,114<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, at cost</a></td>
<td class="nump">$ 1,562<span></span>
</td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618961440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,084<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember', window );">Medical Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillAndIntangibleAssetsLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodwillAndIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodwillAndIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cah_MedicalUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625666560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VendorReserves', window );">Vendor reserves</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VendorReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VendorReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622572288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>Distribution, selling, general and administrative expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">$ 4,557<span></span>
</td>
<td class="nump">$ 4,533<span></span>
</td>
<td class="nump">$ 4,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodsandservicessoldLineItems', window );"><strong>Distribution, selling, general and administrative expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">$ 634<span></span>
</td>
<td class="nump">$ 620<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodsandservicessoldLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for goods and services sold [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodsandservicessoldLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627587184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share (in usd per share)</a></td>
<td class="nump">$ 1.96<span></span>
</td>
<td class="nump">$ 1.94<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623953728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances', window );">Accrual for estimated sales returns and allowances</a></td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">$ 689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns', window );">Revenue Recognition, Sales Returns, Reserve for Sales Returns</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_RevenueRecognitionReserveforSalesReturnsandAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Reserve for Sales Returns and Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_RevenueRecognitionReserveforSalesReturnsandAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627542368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="num">$ (109)<span></span>
</td>
<td class="num">$ (1,129)<span></span>
</td>
<td class="num">$ (5,741)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627587056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures, net of cash sold</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625597328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures and Acquisitions (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures, net of cash sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NaviHealthAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures, net of cash sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures, net of cash sold</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_WriteDownOfAssetsHeldForSale', window );">Write-down of assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_WriteDownOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-down of assets held for sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_WriteDownOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NaviHealthAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NaviHealthAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630667616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622534304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624916784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 8,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">64<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">5,855<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">8,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">64<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">2,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,182<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">2,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">$ 2,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">$ 829<span></span>
</td>
<td class="nump">829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Disposal Group, Including Discontinued Operation, Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625500384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">4,862<span></span>
</td>
<td class="nump">4,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,099<span></span>
</td>
<td class="nump">2,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,763<span></span>
</td>
<td class="nump">2,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 4,873<span></span>
</td>
<td class="nump">4,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">1,774<span></span>
</td>
<td class="nump">2,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">Trademarks and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,272<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,165<span></span>
</td>
<td class="nump">1,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="nump">1,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 552<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,038<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624931440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 5,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,855<span></span>
</td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 8,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization of intangible assets - 2023</a></td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization of intangible assets - 2024</a></td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization of intangible assets - 2025</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization of intangible assets - 2026</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization of intangible assets - 2027</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember', window );">Medical Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TerminalGrowthRateFairValueInput', window );">Terminal Growth Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">$ 2,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="nump">$ 829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">829<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TerminalGrowthRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminal Growth Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TerminalGrowthRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cah_MedicalUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622652048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630351184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Schedule of Lease Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630723696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">457<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other accrued liabilities<span></span>
</td>
<td class="text">Other accrued liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Deferred income taxes and other liabilities<span></span>
</td>
<td class="text">Deferred income taxes and other liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Current portion of long-term obligations and other short-term borrowings<span></span>
</td>
<td class="text">Current portion of long-term obligations and other short-term borrowings<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term obligations, less current portion<span></span>
</td>
<td class="text">Long-term obligations, less current portion<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624835344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Impactofadoptionofnewaccountingstandard', window );">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Impactofadoptionofnewaccountingstandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>impact of adoption of new accounting standard</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Impactofadoptionofnewaccountingstandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625537840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Schedule of Future Lease Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearOne', window );">2023</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiability', window );">Total Lease Liability</a></td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember', window );">Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OperatingLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember', window );">Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinanceLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinanceLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinanceLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OperatingLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OperatingLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted Lease Liability Payments Due for both operating and financing leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623085552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 27,128<span></span>
</td>
<td class="nump">$ 23,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total</a></td>
<td class="nump">5,315<span></span>
</td>
<td class="nump">6,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">580<span></span>
</td>
<td class="nump">871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">4,735<span></span>
</td>
<td class="nump">5,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member', window );">3.079% Notes due fiscal 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member', window );">3.5% Notes due fiscal 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member', window );">3.75% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member', window );">4.5% Notes due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0%&#160;Debentures due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624433040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 27,128<span></span>
</td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other Borrowings</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts Payable</a></td>
<td class="nump">23,700<span></span>
</td>
<td class="nump">27,100<span></span>
</td>
<td class="nump">23,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Maturities of existing long-term obligations and other short-term borrowings - 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Maturities of existing long-term obligations and other short-term borrowings-2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Maturities of existing long-term obligations and other short-term borrowings-2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Maturities of existing long-term obligations and other short-term borrowings-2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Maturities of existing long-term obligations and other short-term borrowings-Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Line of Credit Facility, Maximum Amount Outstanding During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember', window );">Floating rate notes, 2.616% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember', window );">3.2% notes, 2.616% Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotes2616NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A32Notes2616NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624178832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="nump">$ 27,128<span></span>
</td>
<td class="nump">$ 23,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OfferAsPercentageOfPrincipalAmount', window );">Offer as percentage of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due fiscal 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due fiscal 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember', window );">2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member', window );">2.4% Notes due 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OfferAsPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OfferAsPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A24NotesDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625490800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other obligations</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount', window );">Average amount outstanding</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities | Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average amount borrowed under the credit facility during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAverageOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618752112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 09, 2022 </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($) </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>lawsuit </div>
<div>states </div>
<div>numberOfUSTerritories</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Loss Contingency Accrual, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SettlingUSTerritories', window );">Settling U.S Territories | numberOfUSTerritories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IncomefromSettlementsofClassActionLawsuits', window );">Income from Settlements of Class Action Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,819<span></span>
</td>
<td class="nump">155,689<span></span>
</td>
<td class="nump">146,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,557<span></span>
</td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="num">(1,129)<span></span>
</td>
<td class="num">(5,741)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_JudgmentForLostProfits', window );">Judgment for lost profits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SettlingStates', window );">Loss Contingency, Number of State | states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyNumberOfEligibleStates', window );">Loss Contingency, Number of Eligible States | states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss Contingency, Claims Settled, Number | lawsuit</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number | lawsuit</a></td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss Contingency, Claims Settled, Number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember', window );">New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct', window );">Estimated Liability for New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AggregateAnnualAssessment', window );">Aggregate Annual Assessment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_DOJInvestigationMember', window );">DOJ Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember', window );">Alameda County [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">5,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WA', window );">WASHINGTON | Opioid Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WV', window );">WEST VIRGINIA | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OK', window );">OKLAHOMA | Opioid Lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember', window );">Other Jurisdictions [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed | lawsuit</a></td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Estimated Litigation Liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember', window );">Private Parties [Member] | GEORGIA | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember', window );">Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AggregateAnnualAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Annual Assessment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AggregateAnnualAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Liability for New York Opioid Stewardship Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IncomefromSettlementsofClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income from Settlements of Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IncomefromSettlementsofClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_JudgmentForLostProfits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Judgment for lost profits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_JudgmentForLostProfits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyLawsuitsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Lawsuits, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyLawsuitsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyNumberOfEligibleStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyNumberOfEligibleStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SettlingStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settling States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SettlingStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SettlingUSTerritories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settling U.S Territories</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SettlingUSTerritories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_DOJInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_DOJInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_AlamedaCountyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PlaintiffTypeAxis=cah_PrivatePartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_GA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_GA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630337072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (4,056)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S. operations</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings/(loss) before income taxes</a></td>
<td class="num">$ (769)<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
<td class="num">$ (3,772)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625515056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="num">$ (989)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">156<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="nump">882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="num">(822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618906272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal benefit</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations', window );">Tax effect of foreign operations</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible/nontaxable items (2)</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Impact of Divestitures</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes', window );">Withholding Taxes (2)</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation Allowances</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome', window );">US Taxes on International Income (2)(3)</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="num">(6.70%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters', window );">Impact of Resolutions with IRS and other related matters (2)</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(13.60%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation', window );">Opioid litigation</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">17.70%<span></span>
</td>
<td class="num">(23.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill Impairment</a></td>
<td class="num">(49.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims', window );">Loss Carryback Claims</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(129.90%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other (2)</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(21.20%)<span></span>
</td>
<td class="num">(89.70%)<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Loss Carryback Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Withholding Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveIncomeTaxReconciliationOpioidLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Opioid Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveIncomeTaxReconciliationOpioidLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Reconciliation, US Taxes on International Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659619502080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.20%)<span></span>
</td>
<td class="num">(89.70%)<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions', window );">Effective Tax Rate Impact From Certain Foreign Jurisdictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed Earnings of Foreign Subsidiaries</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Provision at Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30)<span></span>
</td>
<td class="num">$ (539)<span></span>
</td>
<td class="nump">$ 822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Deferred tax assets on tax credit carryforwards</a></td>
<td class="num">(778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(778)<span></span>
</td>
<td class="num">(805)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Valuation allowance on operating loss carryforwards</a></td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">943<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">9,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,299<span></span>
</td>
<td class="nump">9,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember', window );">Medical Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember', window );">Net Operating Loss Carryback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Proceeds from Income Tax Refunds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income Taxes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_CareFusionMember', window );">CareFusion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">$ 6,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(228)<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GoodwillImpairmentAxis=cah_MedicalUnitGoodwillImpairmentMember', window );">Medical Unit Goodwill Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate Impact From Certain Foreign Jurisdictions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cah_MedicalUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cah_MedicalUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NetOperatingLossCarrybackAxis=cah_NetOperatingLossCarrybackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_CareFusionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_CareFusionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GoodwillImpairmentAxis=cah_MedicalUnitGoodwillImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GoodwillImpairmentAxis=cah_MedicalUnitGoodwillImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625402368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable basis difference</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Loss and tax credit carryforwards</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions', window );">Deferred tax assets related to uncertain tax positions</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="num">(468)<span></span>
</td>
<td class="num">(515)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory basis differences</a></td>
<td class="num">(1,164)<span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property-related</a></td>
<td class="num">(288)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Other</a></td>
<td class="num">(683)<span></span>
</td>
<td class="num">(733)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals', window );">Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals</a></td>
<td class="num">(975)<span></span>
</td>
<td class="num">(975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred Tax Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(3,110)<span></span>
</td>
<td class="num">(3,225)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,994)<span></span>
</td>
<td class="num">$ (1,932)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DeferredTaxAssetsRelatedtouncertaintaxpositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets related to uncertain tax positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DeferredTaxAssetsRelatedtouncertaintaxpositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630809376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred Income Taxes and Other Assets, Noncurrent</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">1,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent', window );">Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liability</a></td>
<td class="num">$ (1,994)<span></span>
</td>
<td class="num">$ (1,932)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618935728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="num">$ (989)<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">156<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="nump">882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="num">(822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="num">(961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">163<span></span>
</td>
<td class="num">(289)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of fiscal year</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of the current year</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements with tax authorities</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of fiscal year</a></td>
<td class="nump">$ 943<span></span>
</td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623097504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 2,425<span></span>
</td>
<td class="nump">$ 1,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">1,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625479888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624938048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Prepaid Expenses and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Foreign Currency Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swap | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swap | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total liabilities</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Cross Currency Interest Rate Contract [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Cross Currency Interest Rate Contract [Member] | Prepaid Expenses and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total assets</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624135200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>JPY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from net investment hedge terminations</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 64,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest Income (Expense), Nonoperating, Net</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount', window );">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount', window );">Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedging [Member] | Currency Swap [Member] | September 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedging [Member] | Currency Swap [Member] | June 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 24,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124267147&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaturityDateAxis=cah_September2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaturityDateAxis=cah_September2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaturityDateAxis=cah_June2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaturityDateAxis=cah_June2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624422672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details) - Interest Rate Swap - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge', window );">Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, matured notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124267147&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624160672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details) - Fair Value Hedging - Interest Expense, Net - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="num">$ (44)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fixed-Rate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(loss) on derivative</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">$ (106)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cah_FixedRateDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630253792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630278976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624133888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details) - Cash Flow Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | Cost of Products Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Foreign Currency Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Forward Contracts [Member] | Interest Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Commodity Contracts | SG&amp;A Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630961184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contracts | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627735152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Currency Contracts | Other Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630711024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings', window );">Carrying Amount of Long-Term and other Short-Term Borrowings</a></td>
<td class="nump">$ 5,315<span></span>
</td>
<td class="nump">$ 6,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Carrying amount</a></td>
<td class="nump">5,315<span></span>
</td>
<td class="nump">6,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 5,049<span></span>
</td>
<td class="nump">$ 6,751<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Amount of Long-Term and other Short-Term Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingAmountofLongTermandotherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623271360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Foreign Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">633<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair&#160;Value Gain/(Loss)</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624386688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method | $</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings decrease | $</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="num">$ (1,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CommonStockVotingRightsVotes', window );">Common Stock, Voting Rights, Votes</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method | $</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">19,500,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.40<span></span>
</td>
<td class="nump">$ 48.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares | $200 million share repurchase program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 56.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares | $300 million share repurchase program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 49.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares | $500 million share repurchase program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="nump">9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CommonStockVotingRightsVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CommonStockVotingRightsVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A200MillionShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A200MillionShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A300MillionShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A300MillionShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A500MillionShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ShareRepurchaseProgramAggregatePurchasePriceAxis=cah_A500MillionShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625453776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 1,792<span></span>
</td>
<td class="nump">$ 6,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(706)<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other Comprehensive Income (Loss), Tax</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income, before reclassifications</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income, before reclassifications</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income, before reclassifications</a></td>
<td class="num">(72)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624943248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="num">$ (932)<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
<td class="num">$ (3,693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">$ (933)<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="num">$ (3,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Employee stock options, restricted share units, and performance share units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="num">$ (3.35)<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="num">$ (3.35)<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="num">$ (12.61)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659627521472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss', window );">shares that would be antidilutive as a result of net loss</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares that would be antidilutive as a result of net loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Sharesthatwouldbeantidilutiveasaresultofnetloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624214448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project costs on investment and other spending</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember', window );">Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_WriteDownOfAssetsHeldForSale', window );">Write-down of assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain', window );">Sterile Surgical Gown Recall [Member] [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember', window );">New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct', window );">Estimated Liability for New York Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GainonDivestitureAfterTax', window );">Gain on Divestiture After Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 5,630<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Liability for New York Opioid Stewardship Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GainonDivestitureAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on Divestiture After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GainonDivestitureAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_WriteDownOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-down of assets held for sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_WriteDownOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624392720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 181,364<span></span>
</td>
<td class="nump">$ 162,467<span></span>
</td>
<td class="nump">$ 152,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">4,727<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">176,855<span></span>
</td>
<td class="nump">157,756<span></span>
</td>
<td class="nump">148,707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">181,378<span></span>
</td>
<td class="nump">162,483<span></span>
</td>
<td class="nump">152,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">165,491<span></span>
</td>
<td class="nump">145,796<span></span>
</td>
<td class="nump">137,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Pharmaceutical Distribution and Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">164,580<span></span>
</td>
<td class="nump">144,988<span></span>
</td>
<td class="nump">136,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Nuclear Precision Health Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">15,887<span></span>
</td>
<td class="nump">16,687<span></span>
</td>
<td class="nump">15,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Medical distribution and products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">13,462<span></span>
</td>
<td class="nump">14,485<span></span>
</td>
<td class="nump">13,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Cardinal Health At Home Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659623101632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings/(loss)</a></td>
<td class="num">$ (596)<span></span>
</td>
<td class="nump">$ 472<span></span>
</td>
<td class="num">$ (4,098)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings/(loss)</a></td>
<td class="nump">1,986<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings/(loss)</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">1,684<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings/(loss)</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings/(loss)</a></td>
<td class="num">$ (2,582)<span></span>
</td>
<td class="num">$ (1,789)<span></span>
</td>
<td class="num">$ (6,514)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618611264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 783<span></span>
</td>
<td class="nump">$ 913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total additions to property and equipment</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624289744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 43,878<span></span>
</td>
<td class="nump">$ 44,453<span></span>
</td>
<td class="nump">$ 40,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember', window );">Medical | Cordis Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">26,409<span></span>
</td>
<td class="nump">23,624<span></span>
</td>
<td class="nump">22,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,632<span></span>
</td>
<td class="nump">15,408<span></span>
</td>
<td class="nump">14,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,837<span></span>
</td>
<td class="nump">$ 5,421<span></span>
</td>
<td class="nump">$ 3,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CordisDivestitureAxis=cah_CordisDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CordisDivestitureAxis=cah_CordisDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624937920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information Property and Equipment, net by Geographic Area) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 2,361<span></span>
</td>
<td class="nump">$ 2,360<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,958<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 385<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
<td class="nump">$ 486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659618953584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total expense on employee retirement savings plans</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">234.00%<span></span>
</td>
<td class="nump">240.00%<span></span>
</td>
<td class="nump">240.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2021LTIPMember', window );">2021 LTIP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2021LTIPMember', window );">2021 LTIP [Member] | Awards Other than Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cah_A2021LTIPMember', window );">2021 LTIP [Member] | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cah_A2021LTIPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cah_A2021LTIPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cah_AwardsOtherThanStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659631003760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659622644784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details) - Restricted Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 49.05<span></span>
</td>
<td class="nump">$ 45.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">51.83<span></span>
</td>
<td class="nump">53.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">49.60<span></span>
</td>
<td class="nump">49.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">50.58<span></span>
</td>
<td class="nump">48.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 46.03<span></span>
</td>
<td class="nump">$ 49.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659624997936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659630595664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 54.89<span></span>
</td>
<td class="nump">$ 54.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">51.91<span></span>
</td>
<td class="nump">55.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">52.36<span></span>
</td>
<td class="nump">42.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share)</a></td>
<td class="nump">52.66<span></span>
</td>
<td class="nump">53.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 54.32<span></span>
</td>
<td class="nump">$ 54.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659625487664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details) - Performance Share Units<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>vestingPeriods</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which performance share unit cost is expected to be recognized (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested during the year</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VestingPeriodinyearsforShares', window );">Vesting Period in years for Shares | vestingPeriods</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VestingPeriodinyearsforShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Period in years for Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VestingPeriodinyearsforShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140659620046976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuations and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 898<span></span>
</td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,514<span></span>
</td>
<td class="nump">2,702<span></span>
</td>
<td class="nump">2,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">2,561<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember', window );">Pricing Disputes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember', window );">Prior Year Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember', window );">SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Sales Returns and Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">2,359<span></span>
</td>
<td class="nump">2,568<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="nump">$ 2,431<span></span>
</td>
<td class="nump">$ 2,374<span></span>
</td>
<td class="nump">$ 2,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PricingDisputesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=cah_PriorYearRecoveriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLossesOnFinanceReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>cah-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cah="http://www.cardinal.com/20220630"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cah-20220630.xsd" xlink:type="simple"/>
    <context id="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iffab656ed24e4a6ca73f74c927197d64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2afea71cb9b47288a9896a84bf285d6_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id718ed1e33ce417a8b54b992f9f06368_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9e1921e87f164ec2a076a8022000e553_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iefd42525ba6945e0a2388b3cfd583b55_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8ab48f8f0ca84770b2cdd725d449c559_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0a74100c06424e0c80abaeaaf61e0fae_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i62cf4cc6eb9443bc92ba424345a43970_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idba5b8a7abac4a44b7b7aea83c67e7c3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i16f1640dafb24aadbf40453cd1ad0423_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5dee667c44cf4729bf5c5fff72aa3e3a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2a2a315588dc47fa848589f8d339e4f4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia1647e6a3df7432b93b26a7bd668dfc9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib28ba902d1c94df4a3c67814f8c372a5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iea5f56de7fee4d1dac477ee0cf61168f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i68d3316767394706be72a492bdcd2efd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id0fb00ebcf504ae6b0af6dc851474deb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibba299e1050549689ffb0f8eacbea9c0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i934ea3588a144dd5b265a98b3005fb6d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie319b7f528d244d180aab748fdbce12d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0e1f19c62f9f42bcb0e306e9ba872206_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i73da689c634e4d5ba2674bf686bd3f86_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i63aae49541134c39aa2c99f778658cc5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf660360901949d98a491a3d5fbb5d7d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id528f552d5104bcaa9fa12a73626119f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic85d2f2f06c94ebe83e8327bd00e68ce_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1711b8d7bfa14e438a604b5eb731fd63_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i242004258f7948c09176905c6439d71e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iebb7741eed65481097e07facd023b229_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia9621b37a8dc4e7ea9c3508d6c8eb651_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSCaremarkCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie54dcff3023345b3b8dbceb05e183894_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2597c971f6604c2a9a6b84309d0885b9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77687ae7a5664be792bcbd38bb67e2b2_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8188d649f96f4d47aa2ede0789bc920c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4737f6e39b0e4dc09e8ec181488988cc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:OptumRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifb74843eaf0a48e78b9e853f892a30ba_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d51d1a743744443b9f40a909974d9c4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i38cd3d843f544dd0ac41d8cae2504a85_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:GroupPurchasingOrganizationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5ca12a2ea9cd462c9141a9d8057be00c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveWriteDownToNetRealizableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id4140159ea4a43739df00326c541235c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveExcessAndObsoleteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i99a45ec948a346c4a693ae4491ab887b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cah:InventoryReserveExcessAndObsoleteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf515cb8fd624891a66b5f7e1ea44ba1_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifd7a6fadd3f148f883ebb6412075c8ac_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0a58c6e8721a4d5c9f8d148d848b3c73_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib42f20105ab0411cab507a7959ade5cb_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61d5020105b54ebdbda79ad2cdd2c486_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2f4bb9b89da04d04968694a6fec77b68_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5978dceb66ad409fb3003c8699c5492a_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i887ae0d04a84497d824efb8ead276201_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7c38ba87cbb64d34ac1bacba542abf6a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i033b0d1b48434099a70157ef43c38a49_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9bf7f9f717bf419d972451fe5f3da912_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib5bf3f5eefca4129a06653b17bf04363_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iee55f0b9ac1749cd8fad660d4398d09f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i937b0ef4a4ca4ea3bea8db2f1a6b54c7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19e847a45be14fb698f7a64309bc2a65_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0d6189c62c3b4fc08a6ec02502390bf5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5bb96066e3a547e9b5b6924d06661609_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8f9c6746ba5745d2bb4039a6f7b03117_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f8bd16b589e44678ce911885626954d_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idce5118955de4439a550969fa0cc542c_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id7e703a9570f493582c8bc1a69a64a7d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2a84380ffecb45f7abba964081bd5ef7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i16a1465dba6b406da9f48c90f84ff2fb_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i546d299bf20c4b749073124f61b96f80_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1114e2457f3f4ea59b1038c632c920f6_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5735c211d1fd471db52d24b85e925378_D20210802-20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="i95da9ef4bd164992be47943c8af11f5a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia4cc2b4bbaa0449790c4c94fb3395ed8_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i28546e72017346d28b45df1b4a2b2885_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NaviHealthAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id264d3093a7a4580ad949f73349b6a5c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9cf2368a61474f8f89d5d38fec24f64f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ied971d2805b0409083a7c40b38503d50_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0092967ac5424faf8778330ec9444ee4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i75c1fef25e9e4f83a31d3467e3e59555_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icbd545e35312405cb520c9f72a124131_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i002c719a8c5b420b8af67195661dda98_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if25aa8308d1943b59cbe926e3c5d3649_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2f92afd839604684abe9404d6d95434d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib9fc6bbba81b4a1ca1be4f2ccbed4b27_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48d77a4c2a834917a3f42f75ef217b73_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:CordisDivestitureAxis">cah:CordisDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2570c791ecea44d9bc344bd115d28c3c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1abfa91513984b189f3f0624a3d7175e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i59345f7aaab84656a49d8caf50ebe1b9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifbeba755f36e4c298fc6035248db673b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cah:MedicalUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i111b02e3c4c4435d83e0af77b9189c58_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9bb8d1c3bce41a4917f5b1276888172_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6e89ba2935f840fa91b39e91552d9dc6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i80fae599ff554c3fa75995b90567c93a_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib41241d46b104c50b08e484eb87e196f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie7c528a8d9694aee94274e9b419173e7_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0d56789271704cc391e10e73a9dc6d56_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7778605f8f09452483e387ca04e5f798_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iced246337ea748e18ce3b7196e968243_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie3ed9de2f40646068fda63624fe9021c_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6aaeb4ce0c834fc793b1f0b25fa82f9b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i101a75214a2841688c2ee6c7e7f23e10_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i37112b83786b4ac1ba34031420b8575a_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i3d8be49bdf674067abb0a9b7f7453d19_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2c254b1595ff47c8bf6dd60488bbc357_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ice004f9102ba4d5fa58a7477de8fe13e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id882b2f82db24e5c857e6ba1a0e384af_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64e77764f4c64f7abd7d4a5227eb6f41_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3fbf71c602bb40a5b964360fc429bff3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i885fe3ac6e1a4babbc66a8db94f82e38_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i59e90c5526e84b74be02b2b7a029bb5d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i55f78f224039402a88005fb30536dad1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5b7d966b6b934db1a5c6c380f6d08006_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f4a7953acf34ee99b0152b4348d298c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i19940e136f3f4037ac958751189f0e42_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieb2dda3fb1b24c6c9dd6058e3deb85a2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9db02e14f91846b1b3f5268f07efaf25_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i83d82da09b63414d9e4d23de0552e992_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5be0282727a4d219c233e858971eab3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ief95ead6d3304e5283a841e043450002_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2ebb9851a4a6454d878d280244504203_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icf9550d3a90c4fe7abe3b7f766ed70ad_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia0809664ee714c24958018126d48a37c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie1588ed89bc745b2a267d8c2daef772e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ida1ad8e9f740460c9717fa142af909bf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibb9f3742e0b84411bd2e5b40340f02e2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3a4a7026d7514fa682d445bca65f8fce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i621b77904b4340b2bcbbba0f4babdffd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i15dc38ffa0654e75a949152dac07365f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia6a04d5f0835442bae0648463d282df4_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic80b7f23b79f4c74a63a2aea8a160669_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if2c4addddd22425095e8747d5010555f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i880c502ad6a54517904d884280fcde32_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A32Notes2616NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3827a1282fa341608b2ab469d733c58a_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2624de343f9148a89e5e879c4c82b456_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25174483a8524ab68a643c722a044868_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotes2616NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7fa51c2037854bb89d8846afa4ed5e99_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i07524980d6a64ab0900fdee89c51519e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i33da3620cedb405488c45ea93f45f9f7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia07846c1c0304317b72bad3a3eea1a34_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5ce95bfc57ac401db96d15c30dac19f1_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia624d146ecb046bebe9077aabecd86e5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icbdef24d9ef64b91aa1ffa7ea2f55a2f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6dc70dd563e3469b9d8e95f7e3db1e7d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3a684eeb749345e9b75d857b1e1719eb_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A24NotesDue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i29917c8b4aab4eb2a08720812cda9e5f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3c2bf417d2ce4569b7095141c8585f43_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib802e2c8dcb949298f691230fa6a001e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i41cb6234b1c242c1b3d5212ab191fccc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia602868425d84c939a48b46f4b7f99a3_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62274a161fe54af9b457ca7496c6d48e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i58cef62c3cd5423a91e3afefd7967e2a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67e0a63d6182434b947a044598b6b9be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e905accc4fc429dbe8fb2baa9d577ac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i22cd37e98bb24d1eac47e3997f243e60_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:NewYorkOpioidStewardshipActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4b3c6bcb9476438a921794e67914851b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5df3ad6b3a5c472db6a4ef8acf2ccee2_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i57e04e176378443dbece7c929cced18b_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i22b99fd673554c27875a602f3ebd6229_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="iaf6d168e90384511a71c377dfd7de3ce_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i17df012ad7434bfbb9d2eb2b368409f0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7356694aafaa470bb4b7829c91e1f795_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6fbfe1e2d6514850b46a3e54db3b64c8_I20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-09</instant>
        </period>
    </context>
    <context id="i20857812252441139f2a9488cc8b4bba_I20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-09</instant>
        </period>
    </context>
    <context id="if6e7b27e6d834a1c8986340dacdd8d75_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i6832ede5864441bc8fc50fdb23a84d6d_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i49994de05a53424c945a894b6a702b21_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i3536e19ef529496ab3333df7b2c14579_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i34d64ff0f91940089c6a221af627861f_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i0d398a83243b4879a927f24535bca4ad_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ib7b1ad13d2d3426a96e738a22b1d3ab6_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:DOJInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3a49e2802adb47ebb172f2416918baa4_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:GoodwillImpairmentAxis">cah:MedicalUnitGoodwillImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1ba6181b3f81427f9ba8073d79075732_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib692a8c8095746b7ac437f383074870f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idd9b4528179f4b06825682ef3bc16324_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:NetOperatingLossCarrybackAxis">cah:NetOperatingLossCarrybackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib70a49e43657407780e301606b63b480_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie478c499b6e14ab2bbc046275533973f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaf55d738e4c2417989763623ac863aba_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4049be5d431a45859642596069133d4c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf7f919960364e29acc09ea1ecf5403b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9d73f184d2b949538033de20922de133_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3cf2679b91854d43ae797e4fa386a35a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i155edd13bdcd4fe6a997c9048e92a4cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4f315442d4d144f597f8e7072738b52c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0c79bf8fa09b4d96b7509598247edd5d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6f334187da934dae8f50e09f680684be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e2109c867604d538c15c36e5773bfcd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2daf1b96e99540f9a365925bbd666b52_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i702e037993f84f039a387fa5716c2c5f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9b3e38adae184a0f962abd0822c6e227_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8252480092a4420d9a47a8420945e070_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6e0d0c9e1e2f467d97bbc64581905f40_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iff344aae68f94110aca38462cc1fbfeb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i37f8e752754a4c0a8560dab2d9697e94_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i06ff51c1469749a9be8eb3406df0e62c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic059bb286acc4a4f9c4085b5a0410159_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibccd2d0c1e544d42a1d4b65d126614e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie9d72cfa1fc7448e8a4d03ab71fc0b20_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i14a755a6106242698132be9ad227180a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8588473d4f2c40a7ac9bf6e97f477a07_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icddad5bf093244d1b4387d8a979d72cb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic69376b6c620458997976028c1214422_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3cfc47e3aa3a4886af27a182bd671ec1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id10d0b211539491aaf593b13a51c07c6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec28629ea39c43e4840b61f68f95c92c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie6d851e08ef540a6aceb7daa376a4bc2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i945df5b6d2454f3bb10a110ca1cfb83c_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8568be76a18940d69f23584500123552_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3961f5fc579946a7adb7919493a245f9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0e787599e79e498b900200587d8ebe7d_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iaa6abd62fa79443881013d61bc42a3cd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iec5a8f432dfb4a669e5b7ba55a35b302_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i773662d7d9b448b8b333e4a1b94246ba_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icf50b11230f141ef80acceb9da69ce09_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i235c4dd623e14a40ae30c1c514b56b33_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cah:FixedRateDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie20a6b75339f4305bd27c3566e131b42_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2a7bc307cde846ad8020785fb428b704_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6655370d79f845c5b210b9cbc38baa6a_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i008e5300d1fe41a1815096bec1786b2e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaec740da2e31443ca3a03df609402dba_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if84712198fd34c77a01fe1cc4008c915_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6d06eff618844ea9b294766cd40c0cbb_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d390067fa94438188ada7ef9dd06ef3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i46e636c0a4764fbda3673d5e4c24027e_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3689b6ecce894dcf9310fad3bfb4484c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iad1d6e92138f4a2bbfefa3aa6fa73311_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7e36bc811b8e4e04b871a13fd2292653_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i012e1ceb9763423189450a46d2c76f14_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9f4b437cafd548ff9b69d8d997ae280d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibfff6e07744441528f22c7027f392bc3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib9ef85b7c88a4539972e810d6676bcd2_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i50482f61b49343aea4800caf3921c613_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i25a7c5d5859848dd88abbc1a8fbb11c9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i421ac4ebd1c940d5be641a14b6a8565a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7bee56b9093547aab3e10f4b7c9d0c93_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i17d114542faa4edc9d89c757065598f7_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a935fc8248a4a1890e47ba459c9f8bb_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i269c8552647a4321a761031c80f05289_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6cddbe3b6c7a4e719277441f86f08a81_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5b8544764a8141e69a14460e4f902fb7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if46bf92b1ae9412db7eb482248d3e631_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i66d0afbc7f24472f9a3373a8620e9bb0_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5ba25e5360ae47298c3f879441851557_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie01d7cee22094964ba6e1b1c964e79d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:MaturityDateAxis">cah:September2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i49b160e1a7e845e9b7fce15173ef887a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:MaturityDateAxis">cah:June2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibba1dd6808f54a86a81fd6308d260b0f_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i94d8c3f959e54f26b4608732cff6a528_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie2f1b851c9794bb5a1866c1ef80be14e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if2791b320bdf418283ef26f40f8960d2_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id83a99daa0324eaf9c0d86f62c609f16_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb30ce6147144d6cb2de94c1c28b34d8_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i458d92552dd24194973d1eecdc2b3c4e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if4a6cbd72cc74687b9d7255c26b5ee6f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i84a04898d27345438f4a7a3a130a15be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9f63f23b1554e848a59e032b744632e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1cd2559051274accba49716a53ea4d55_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib5cfbdd2a57c495092c1346adb91387e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie251c72e85d34942ab0769ac0f335908_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i170f7cf26f08409dac798c226dec905e_D20190701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A500MillionShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A300MillionShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:ShareRepurchaseProgramAggregatePurchasePriceAxis">cah:A200MillionShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic12e802652d64575be3f052d531ee71a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6cd6dc10bbdf4a9887f38ce5a9b7eebb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i017776f20a154be38946329695a6e3bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i27066680d4f44a88bd6f0bde058453f4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f0080970b8347daab96c670e8f07328_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i671a35d442834525849f31bba3176fbe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id6ae84c9f59a4cb4885c9e03cdef73cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if032321307a24934b26372b254b11bbe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id52a151c12bb455583b0ce7e29399157_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i14af28fc8088402b8cf9586da815c628_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if1375be2585e496ba632f589f37aecdd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41b64a0ab009497cb6651f141753bb14_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i55ab01785f1e4a10a2f627369a131981_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1fe4938f791c47a7a2e7be341d8ae001_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i26fa0488c0b0421a9bd978c6e75ec078_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib18eb292c9cd45549a3cce1a8564d34a_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibf54a140331447bc971da869fab4170b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic3a872d654474220917795caa5437ced_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id9d75341c0824694ace8cacae3c3cff4_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9c1190aafabb474bb7daeda0ceb4428e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22c84b6027bc4bfc9c7fef1cc6232649_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4e5a57d0101144d68ed8cbf6f33a252b_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6012e2f082d64586a52d2f99291c081f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic772b6d04449407f823eef4bab315a1c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if8120134644a4b72b67cf151f13a9267_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6cfa5d379fec4924976b8c213fb2a55e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8a97b6e528884b40b6ab715fd4b1afbf_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4f0d63f2484f4781b52456c257c21f31_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:SterileSurgicalGownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iedce1d5b11c3477faba70a05739a2a83_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if72f2f625f914e10845cc7ec67500cb9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4ad6131da723466fbfb29da932695b7c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i61201f0b4adc4f448c19177911dff7b9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4e0b4a7378184981b9c5ac2d3f486cba_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifddfe552f3a644c3aabf1bd148586afd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ief926b64f91a4cdb97a0f010db30b234_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8396dd140b7c4e5088714d90bba871dd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia9470b5d20374655a7021f0f36d0030f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia84a995d73354904960f0fc24a118169_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i10081408aa87434ab81112bdd4bddd79_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibaf9ed3e3c2146e69762157a21265754_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4540961b5e6b4808a8026bb9516ae3e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1b498db236d3482f9f42a2a0a3f882f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0593a5c8012d425ebb9b526021b07458_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7f6f204ca12940be95285479dd9fd419_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i73fc8886bd8f4f4e8e6f8813d56985a8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cah:AwardsOtherThanStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i93a070ccd43d454bb5c9cb38b3cf6771_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cah:A2021LTIPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i38081f76db524efdac004049a6ebca1e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ba87bba31c44ccc98e13df2983e423b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i25d09281a7c14a70bbb09c9ca514ae47_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia467dc323b074fc7af8717e8d527a287_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61b77b415b584f6ab312fd1c96fca6e3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i43325093a8ee44ed8f85cdbf2059ce09_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ad9e1e9c9c24a5a93fb7c80fa81eeeb_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6e641c3a7b314110b555c0df32c0642c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i056274b9166742cdaee278d9b684a643_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i34c301733ef2486eb8a91bd315f448fa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia953d01035744830b89e0d49aa3ef798_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0b79de0e173c49a293e4e8121d68cf5d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20a5929938d842bca82c533a67d3e5ad_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia768abc477b149ba8b237395ef925335_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic14268b63f5e4696bfec9d26f5249db2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idd7cd7c5e10e435f9a63d042307ff0a5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLossesOnFinanceReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iad140489fe934c8caf9ef36be5139d4f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ica1d90385829420fac7b1024979b31c3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie6d67fb03b394de5bfd91a7161298584_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i79b7882d67e14e36b7002a6ff0299b96_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i71d69bac84194be3ae102ae751b16751_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PricingDisputesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i82b6099badb34def8ff80369a0b76e44_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i964db25469894c16b81360ef4522965e_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if96021e36fcd47b580794c907494e1f0_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">cah:PriorYearRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="organization">
        <measure>cah:organization</measure>
    </unit>
    <unit id="segment">
        <measure>cah:segment</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cah:lawsuit</measure>
    </unit>
    <unit id="states">
        <measure>cah:states</measure>
    </unit>
    <unit id="numberofusterritories">
        <measure>cah:numberOfUSTerritories</measure>
    </unit>
    <unit id="plaintiff">
        <measure>cah:plaintiff</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="vestingperiods">
        <measure>cah:vestingPeriods</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN18xLTEtMS0xLTE0NzE1Nw_d4690fca-b7c9-453a-a0ea-e2c5060d7a38">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN18zLTEtMS0xLTE0NzE1Nw_cd3bb201-7982-474d-9dce-194f8a6a9540">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN180LTEtMS0xLTE0NzE1Nw_4164348a-46e0-4f0e-bacb-9809a10eadc9">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN180L2ZyYWc6NGY2NTQ5YjA5MGE1NGNmNWIxZWFkZTY0NjMzMjk5ZGEvdGFibGU6YjFhNGE4MmZmZWU0NGJhZGExZDllNmJlZGU1ZWI5YjcvdGFibGVyYW5nZTpiMWE0YTgyZmZlZTQ0YmFkYTFkOWU2YmVkZTVlYjliN181LTEtMS0xLTE0NzE1Nw_5df41b2f-2e44-42a3-a413-9cd844e81068">0000721371</dei:EntityCentralIndexKey>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891">http://fasb.org/us-gaap/2022#DeferredTaxAndOtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f">http://fasb.org/us-gaap/2022#DeferredTaxAndOtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI2_272b9202-9a3e-4e8f-bd2c-ac3fd1fd4c37">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6YTRiZGFiOGI3NzJlNGMwNDg3NzY0MzFlMmViZGEwODAvdGFibGVyYW5nZTphNGJkYWI4Yjc3MmU0YzA0ODc3NjQzMWUyZWJkYTA4MF8wLTAtMS0xLTE0NzE1Nw_9ca55329-54f2-4d9c-9e10-47e9f4713a96">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV82NTk3MDY5NzY4ODk3_a43079dd-b4a7-42c2-ac3c-b0a60d7221af">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV82NTk3MDY5NzY4ODk3_6a898ad8-5ce8-4563-b71d-fa5e1618406f">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MTNhNTU3OWI0YzA5NGJiYjliYjhlNGM0YjE5N2FlYWQvdGFibGVyYW5nZToxM2E1NTc5YjRjMDk0YmJiOWJiOGU0YzRiMTk3YWVhZF8wLTAtMS0xLTE0NzE1Nw_29cd4997-439b-458d-add3-395fa60a4440">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI3_0db52025-d624-4dc4-9b78-16b18f3062be">1-11373</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIx_ece9da10-2ac4-4f03-8750-576d99497f87">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8wLTAtMS0xLTE0NzE1Nw_abebeb72-6df4-4966-9d72-f968ee54d6cb">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8wLTYtMS0xLTE0NzE1Nw_e93cd6b8-110c-49fd-96f8-722a47b77d7b">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTAtMS0xLTE0NzE1Nw_90b3a3fd-17a8-4e07-a775-e770f63c438f">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTItMS0xLTE0NzE1Nw_49c7ff7f-2d85-4fbc-9000-f83bc811ebe8">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTQtMS0xLTE0NzE1Nw_e936c0ad-5b54-43f5-90f5-ec1a75f8b168">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF8zLTYtMS0xLTE0NzE1Nw_a0075288-72f0-4a3f-88bc-f697e3882c78">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF82LTQtMS0xLTE0NzE1Nw_4a29d2b9-68e1-46eb-a728-b7b551c0b81b">(614)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6NzY2NDU4MGE0OWRkNDk3N2E1NDMwMTk4NTJmMzY3NDQvdGFibGVyYW5nZTo3NjY0NTgwYTQ5ZGQ0OTc3YTU0MzAxOTg1MmYzNjc0NF82LTYtMS0xLTE0NzE1Nw_4ff9bc9d-636d-4b67-a05d-878442a4a744">757-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTAtMS0xLTE0NzE1Nw_54a4340c-9e93-4919-a15d-ada4b31f6e8e">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTEtMS0xLTE0NzE1Nw_5f28e529-945a-4509-be82-774c878f7a89">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6MDI4ZmNjYzFkNzg0NDBmZGE5OWYzNzZkODAxMTQ5YjIvdGFibGVyYW5nZTowMjhmY2NjMWQ3ODQ0MGZkYTk5ZjM3NmQ4MDExNDliMl8zLTItMS0xLTE0NzE1Nw_2175ebb8-e837-486f-ba09-250a83ce9105">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIy_54d13830-6ecb-4eba-9fdc-1a60a64babdc">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI4_5dc0efaa-2754-429d-98d5-19f17b03787d">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjIz_e41d3066-b218-4924-b28f-36e43a639f3e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI5_c7505e80-b571-466a-a01c-cc1e678dff6c">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8wLTAtMS0xLTE0NzE1Nw_2ce96618-6599-4611-b078-112359a0e9bf">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8xLTQtMS0xLTE0NzE1Nw_1ed72823-4667-4f2a-9832-2d1db32c66e8">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV8yLTQtMS0xLTE0NzE1Nw_43f81462-d49e-4ea7-829f-9738a2873860">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGFibGU6OWJiMTc2NjcxMDU2NGI0ZDhiMjhlNWM4MzU5Njc5ZmUvdGFibGVyYW5nZTo5YmIxNzY2NzEwNTY0YjRkOGIyOGU1YzgzNTk2NzlmZV81LTAtMS0xLTE0NzE1Nw_35a1daae-fb9f-4789-9220-ac25ce248629">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjI0_da26b027-194c-4d93-9412-8fce01fd4ca3">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="iffab656ed24e4a6ca73f74c927197d64_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8xODQw_15eb473c-2d29-44ff-9482-43c002acbde0"
      unitRef="usd">14223756327</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie2afea71cb9b47288a9896a84bf285d6_I20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8xOTUw_c599c842-b233-4013-a1ca-350451bb8e1b"
      unitRef="shares">272512364</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xL2ZyYWc6ZDRhMzlhNGFmOGUxNDRhOGEyYTRhZDY0ZjBhYmJmNDUvdGV4dHJlZ2lvbjpkNGEzOWE0YWY4ZTE0NGE4YTJhNGFkNjRmMGFiYmY0NV8yMjMw_6e59be51-eb0c-4a24-9b0d-434658ece060">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Documents Incorporated by Reference: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s Definitive Proxy Statement to be filed for its 2022 Annual Meeting of Shareholders are incorporated by reference into the sections of this Form 10-K addressing the requirements of Part&#160;III of Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183MC9mcmFnOmQ4ZjczYzI1NDg4NDQ1MzQ5M2EzNjcyNTAyMDg0MWQwL3RhYmxlOmE4ZTU4MTIwOGZlZDQxOGY4NGFlZGI3ZWUwMTMwMGNlL3RhYmxlcmFuZ2U6YThlNTgxMjA4ZmVkNDE4Zjg0YWVkYjdlZTAxMzAwY2VfMC0wLTEtMS0xODIwOTMvdGV4dHJlZ2lvbjoyMWY2MDg2ZjE2ZGY0NTBmYmU5MTYwODA4M2NkNWM2Y18xOTI0MTQ1MzQ4NjEyMg_43294bb2-a126-4a48-8ff0-7a5d66224bdd">Ernst&#160;&amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183MC9mcmFnOmQ4ZjczYzI1NDg4NDQ1MzQ5M2EzNjcyNTAyMDg0MWQwL3RhYmxlOmE4ZTU4MTIwOGZlZDQxOGY4NGFlZGI3ZWUwMTMwMGNlL3RhYmxlcmFuZ2U6YThlNTgxMjA4ZmVkNDE4Zjg0YWVkYjdlZTAxMzAwY2VfMi0wLTEtMS0xODIwOTg_ba7b968a-e66a-4787-a9a1-9991e4be6755">Grandview Heights, Ohio</dei:AuditorLocation>
    <dei:AuditorName
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183My9mcmFnOjNiMjAxMWViNDdkMzQ2MTJiNTU4YzQwNWI3MWFlN2FiL3RhYmxlOmM2MDIyYzU1MTI3MjRlODQ4YzRmZTU1ODQ0MGMwMjIyL3RhYmxlcmFuZ2U6YzYwMjJjNTUxMjcyNGU4NDhjNGZlNTU4NDQwYzAyMjJfMC0wLTEtMS0xODIxMDAvdGV4dHJlZ2lvbjo0NTBjZWIwNTU0Y2Q0ZDU0OTZhZDZlOTRkYTU5ZDE1OV8xOTI0MTQ1MzQ4NjEyMg_43294bb2-a126-4a48-8ff0-7a5d66224bdd">Ernst&#160;&amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183My9mcmFnOjNiMjAxMWViNDdkMzQ2MTJiNTU4YzQwNWI3MWFlN2FiL3RhYmxlOmM2MDIyYzU1MTI3MjRlODQ4YzRmZTU1ODQ0MGMwMjIyL3RhYmxlcmFuZ2U6YzYwMjJjNTUxMjcyNGU4NDhjNGZlNTU4NDQwYzAyMjJfMi0wLTEtMS0xODIxMDI_3834d1df-18c2-42eb-a96a-03135a9cbfa4">Grandview Heights, Ohio</dei:AuditorLocation>
    <us-gaap:Revenues
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS0xLTEtMS0xNDcxNTc_7d77d764-03d0-42a4-989e-b3ad70862e02"
      unitRef="usd">181364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS0zLTEtMS0xNDcxNTc_0dbce59c-8b03-44ea-8614-9f085f16e681"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMS01LTEtMS0xNDcxNTc_c4e13b54-b27a-420f-a0a6-96e1333d1ba3"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi0xLTEtMS0xNDcxNTc_aa07eb33-1b03-4118-b28c-e046ac90a49b"
      unitRef="usd">174819000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi0zLTEtMS0xNDcxNTc_c9a3e5bb-400c-4dae-bb7f-0c14606a39ee"
      unitRef="usd">155689000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMi01LTEtMS0xNDcxNTc_f3d0da6b-4f69-4350-9d7e-b1900b18f918"
      unitRef="usd">146054000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy0xLTEtMS0xNDcxNTc_9fccc018-d3ba-457b-a954-851085e69d15"
      unitRef="usd">6545000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy0zLTEtMS0xNDcxNTc_8500a479-0c5b-4303-a2e2-01f7b81928a1"
      unitRef="usd">6778000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMy01LTEtMS0xNDcxNTc_b65ce289-50c2-4039-95d4-32712d2b76b8"
      unitRef="usd">6868000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi0xLTEtMS0xNDcxNTc_31a7a468-78df-4d34-8c6d-ef2f32df8bcb"
      unitRef="usd">4557000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi0zLTEtMS0xNDcxNTc_48d7de63-aa1d-48d6-a6ff-9ab4368072b2"
      unitRef="usd">4533000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNi01LTEtMS0xNDcxNTc_2afadcc1-19b1-4ef3-8a89-b56f93171b47"
      unitRef="usd">4572000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy0xLTEtMS0xNDcxNTc_a9520297-e45d-4f9d-b2e3-e6b2321c87b5"
      unitRef="usd">101000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy0zLTEtMS0xNDcxNTc_f056c967-5079-4e42-a451-9156b6770b75"
      unitRef="usd">114000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfNy01LTEtMS0xNDcxNTc_57bf3611-34e4-4412-9c15-490e8c9de103"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC0xLTEtMS0xNDcxNTc_16af9825-7961-4acd-8fc6-340c1462cb80"
      unitRef="usd">324000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC0zLTEtMS0xNDcxNTc_9a63349a-fbf4-4ee7-be9f-1e634560039b"
      unitRef="usd">451000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOC01LTEtMS0xNDcxNTc_16f9b5cb-5eb1-4941-aa52-4493bbafa5bd"
      unitRef="usd">524000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS0xLTEtMS0xNDcxNTc_f5c97154-8bf8-41b3-bb7c-37c474231a08"
      unitRef="usd">-2050000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS0zLTEtMS0xNDcxNTc_116959ff-410d-471e-8667-4cd7578db940"
      unitRef="usd">-79000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfOS01LTEtMS0xNDcxNTc_1c37e577-6e9a-4b25-8270-ee2fb1650d6f"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtMS0xLTEtMTQ3MTU3_add129ed-0a9d-475a-8484-b344c33d5c33"
      unitRef="usd">-109000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtMy0xLTEtMTQ3MTU3_bedb54b3-6b6c-4c38-a64a-a58d0a9fff49"
      unitRef="usd">-1129000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTAtNS0xLTEtMTQ3MTU3_5edf7519-8db1-49c5-a0f6-4ed41757c3af"
      unitRef="usd">-5741000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtMS0xLTEtMTQ3MTU3_9b5cfcba-5c99-42a4-a1ba-89ee9830034a"
      unitRef="usd">-596000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtMy0xLTEtMTQ3MTU3_7b1bb45b-a685-4ca7-b188-d3bdf9127dda"
      unitRef="usd">472000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTEtNS0xLTEtMTQ3MTU3_4291b38f-adc0-4431-997a-1d10f7491abc"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtMS0xLTEtMTQ3MTU3_3422b8c4-a677-4060-9cd2-c67f309dd244"
      unitRef="usd">-16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtMy0xLTEtMTQ3MTU3_c50afd7b-053e-42fb-a75e-6bdd2f77815e"
      unitRef="usd">47000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTMtNS0xLTEtMTQ3MTU3_c87f4979-b330-448b-9d2c-594353cfa188"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtMS0xLTEtMTQ3MTU3_3af37cf0-6343-49d2-9951-bdf13737611b"
      unitRef="usd">149000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtMy0xLTEtMTQ3MTU3_897b34de-13a6-46ce-954b-73a4f8f064f8"
      unitRef="usd">180000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTQtNS0xLTEtMTQ3MTU3_dc37b06c-7e50-4fb1-abc9-0b5c1ac6a0fd"
      unitRef="usd">238000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtMS0xLTEtMTQ3MTU3_4e6a7cfd-2edd-4e38-900f-b37abb6cb7ed"
      unitRef="usd">-10000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtMy0xLTEtMTQ3MTU3_4ac328fe-50c1-4f64-9b95-980ff4f23f12"
      unitRef="usd">-14000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTUtNS0xLTEtMTQ3MTU3_a6a58160-6ee6-4f9a-94e8-1e310ecc1ed5"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtMS0xLTEtMTQ3MTU3_cb64ed2d-1166-423a-81e9-0193fa112d83"
      unitRef="usd">2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtMy0xLTEtMTQ3MTU3_ca16772d-1ac9-494e-8262-2837fe60e466"
      unitRef="usd">-2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTYtNS0xLTEtMTQ3MTU3_011004d3-3feb-478b-924a-2034a631936e"
      unitRef="usd">579000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctMS0xLTEtMTQ3MTU3_48529eed-2b6d-48c9-a23e-dd147104a439"
      unitRef="usd">-769000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctMy0xLTEtMTQ3MTU3_3f46c244-f597-455f-91be-70ca0059f0eb"
      unitRef="usd">323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTctNS0xLTEtMTQ3MTU3_5cba1a8c-86e3-4d3a-b777-205b15e939a4"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktMS0xLTEtMTQ3MTU3_4ae5814d-add5-4d61-8865-ad7265a5eeaa"
      unitRef="usd">163000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktMy0xLTEtMTQ3MTU3_43744f9e-9265-4e31-be76-361a8ba14b5f"
      unitRef="usd">-289000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMTktNS0xLTEtMTQ3MTU3_fe76ea33-6153-43c1-9131-06ba09f73b69"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtMS0xLTEtMTQ3MTU3_e0fc800e-34fc-4739-a916-fb87cb4e0068"
      unitRef="usd">-932000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtMy0xLTEtMTQ3MTU3_799b4c27-de33-4eb0-80dc-a44a12be005d"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjAtNS0xLTEtMTQ3MTU3_c9580fa1-4794-41a9-8f3b-28f360c9d2ef"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItMS0xLTEtMTQ3MTU3_619b1082-6ab9-4ebd-9d88-c63f1e5af791"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjItNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtMS0xLTEtMTQ3MTU3_e63b649d-e9d2-4528-9156-0f8cb2f926e8"
      unitRef="usd">-933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtMy0xLTEtMTQ3MTU3_fc19b1ca-f65e-42c6-9857-a0e28dd3cd06"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjMtNS0xLTEtMTQ3MTU3_e6e10c9c-366e-43ce-abd7-b22dc7c346ec"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtMS0xLTEtMTQ3MTU3_5f4d9ba7-cf39-403c-b1bf-4d04e707f5d0"
      unitRef="usdPerShare">-3.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtMy0xLTEtMTQ3MTU3_5485c54f-a912-4dec-a3c6-12c7a1a362fe"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjYtNS0xLTEtMTQ3MTU3_3a2b97fc-d46b-4776-8522-4868256b3635"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctMS0xLTEtMTQ3MTU3_87a50ccb-b4a0-4507-b7e4-2410e24a727b"
      unitRef="usdPerShare">-3.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctMy0xLTEtMTQ3MTU3_ea2f14c9-9803-47cd-98d2-076b028ca501"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMjctNS0xLTEtMTQ3MTU3_e656079e-537f-4fb3-9bc6-e5e8840fffac"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtMS0xLTEtMTQ3MTU3_f142d1eb-cd50-437d-9fbd-234b0fb3f535"
      unitRef="shares">279000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtMy0xLTEtMTQ3MTU3_fd9ffde4-f4c8-4ed0-a365-8f5c83f9640d"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzAtNS0xLTEtMTQ3MTU3_2fd165a7-c860-4986-b513-4063755da460"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtMS0xLTEtMTQ3MTU3_7c63e060-dcac-4a45-82b3-d52d0b13ead3"
      unitRef="shares">279000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtMy0xLTEtMTQ3MTU3_8d1179ff-57da-423d-983b-8935f1d8c033"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN183OS9mcmFnOmM0NDUwNGM2ZWI0ODRjMjFiMTlmMWNhZjM5MjNlYjVmL3RhYmxlOmYwMDNkYzY3NzRhNDQ3NWRiNjQ5MjdmN2UxY2I4MGEyL3RhYmxlcmFuZ2U6ZjAwM2RjNjc3NGE0NDc1ZGI2NDkyN2Y3ZTFjYjgwYTJfMzEtNS0xLTEtMTQ3MTU3_ebf0b7a2-43cd-4df2-9336-12f34fd82cb2"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS0xLTEtMS0xNDcxNTc_e0fc800e-34fc-4739-a916-fb87cb4e0068"
      unitRef="usd">-932000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS0zLTEtMS0xNDcxNTc_799b4c27-de33-4eb0-80dc-a44a12be005d"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMS01LTEtMS0xNDcxNTc_c9580fa1-4794-41a9-8f3b-28f360c9d2ef"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC0xLTEtMS0xNDcxNTc_5c5b8f83-a3e8-4d8f-abc4-c7a16500a8af"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC0zLTEtMS0xNDcxNTc_87eef964-82a0-48cc-ad03-e64692bc4046"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNC01LTEtMS0xNDcxNTc_040bdb76-8aaa-4365-a949-d43bb48aaad9"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi0xLTEtMS0xNDcxNTc_4e91368b-adef-4cb4-8257-1f6a858c6fee"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi0zLTEtMS0xNDcxNTc_35d4de34-0798-45af-8eb5-73a786ce08ae"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNi01LTEtMS0xNDcxNTc_880d9ba9-48eb-4e14-a7b4-118a07bd18cd"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy0xLTEtMS0xNDcxNTc_e43c7d53-0e5a-48fe-87ea-60a385617bfe"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy0zLTEtMS0xNDcxNTc_0b29494d-5099-4c1f-9499-eca81a36b87c"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfNy01LTEtMS0xNDcxNTc_044a0ac0-a6d7-473c-b706-6654990d8509"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS0xLTEtMS0xNDcxNTc_8e6bd341-57c1-47a8-8d77-13312e2dc41b"
      unitRef="usd">-1012000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS0zLTEtMS0xNDcxNTc_8b99e982-0d3e-404c-b276-d7b89d72898c"
      unitRef="usd">682000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfOS01LTEtMS0xNDcxNTc_0cf38a80-19d4-4742-b4d6-45eba4694f18"
      unitRef="usd">-3718000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtMS0xLTEtMTQ3MTU3_619b1082-6ab9-4ebd-9d88-c63f1e5af791"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTEtNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItMS0xLTEtMTQ3MTU3_8261652e-a0aa-4361-ae75-9b34378cefe5"
      unitRef="usd">-1013000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItMy0xLTEtMTQ3MTU3_fbc8a22c-9b87-42a2-85c3-9f0d6e8aacbd"
      unitRef="usd">681000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184Mi9mcmFnOmI5YmM4ZjVmZDcyYzRhNzU4NzYxMmZmNmU3YWMwY2IzL3RhYmxlOjdlNWJiMjVjMTU1YjQwODdiZjIxOWI5Y2U0OWRkYjZmL3RhYmxlcmFuZ2U6N2U1YmIyNWMxNTViNDA4N2JmMjE5YjljZTQ5ZGRiNmZfMTItNS0xLTEtMTQ3MTU3_092f4ada-2372-44e4-98af-cd7d405512c2"
      unitRef="usd">-3721000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNC0xLTEtMS0xNDcxNTc_2bc228ed-6742-4ecf-b98d-a0a1f8126481"
      unitRef="usd">4717000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNC0zLTEtMS0xNDcxNTc_72c52634-9c14-4284-b269-6ff28e1008f4"
      unitRef="usd">3407000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNS0xLTEtMS0xNDcxNTc_2e8f303b-4f50-4133-be21-10c306a56c42"
      unitRef="usd">10561000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNS0zLTEtMS0xNDcxNTc_b0d06dff-4973-4751-a0c8-7ba9fc26874f"
      unitRef="usd">9103000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNi0xLTEtMS0xNDcxNTc_898bd23e-b64e-4e26-b158-770f1c32a97f"
      unitRef="usd">15636000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNi0zLTEtMS0xNDcxNTc_9f69061e-18cc-4883-bfee-f6173c0c30c1"
      unitRef="usd">14594000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNy0xLTEtMS0xNDcxNTc_ee1cd574-c35c-4954-bdec-208c9e065b35"
      unitRef="usd">2021000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNy0zLTEtMS0xNDcxNTc_5dd6c8a0-87dc-44cd-9d27-483a64709cdf"
      unitRef="usd">2843000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOC0xLTEtMS0xNDcxNTc_44d85f4c-2c55-42db-aa88-efc8c0690da2"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOC0zLTEtMS0xNDcxNTc_3f999de9-d743-4729-be8b-8acb3d898099"
      unitRef="usd">1101000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOS0xLTEtMS0xNDcxNTc_c713f519-c8ee-4f09-9770-fddb2aeecedd"
      unitRef="usd">32935000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfOS0zLTEtMS0xNDcxNTc_f8a10b93-8b69-4015-9a13-7001c013c5ba"
      unitRef="usd">31048000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTEtMS0xLTEtMTQ3MTU3_9f9c5d51-8f0a-476d-af16-47a42abc2a95"
      unitRef="usd">2361000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTEtMy0xLTEtMTQ3MTU3_4e52a283-b0c1-4128-beca-f3ad3b23e315"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTItMS0xLTEtMTQ3MTU3_e209759b-db24-4240-b611-d3d60796c1f5"
      unitRef="usd">7629000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTItMy0xLTEtMTQ3MTU3_1ca889ad-c61d-4517-bf0b-67ce010c2966"
      unitRef="usd">10094000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTMtMS0xLTEtMTQ3MTU3_437148fb-3e45-4d5f-b356-e1a2e6fbfb40"
      unitRef="usd">953000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTMtMy0xLTEtMTQ3MTU3_1293b20d-39bd-44ea-91bb-9b2ef4184f71"
      unitRef="usd">951000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTQtMS0xLTEtMTQ3MTU3_baa7bca4-0c41-4d36-a55e-a509218ffbd4"
      unitRef="usd">43878000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTQtMy0xLTEtMTQ3MTU3_b8ab21d4-536d-479a-b00f-b754c2813a77"
      unitRef="usd">44453000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTgtMS0xLTEtMTQ3MTU3_477f3466-2c2f-4606-85e3-3b340b78479a"
      unitRef="usd">27128000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTgtMy0xLTEtMTQ3MTU3_5862d2ce-b5a3-4853-9944-05d8251c3fcf"
      unitRef="usd">23700000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTktMS0xLTEtMTQ3MTU3_9de00f91-e393-4fe3-a525-6f7cbe36c1d4"
      unitRef="usd">580000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMTktMy0xLTEtMTQ3MTU3_59c8dd51-bce7-4b72-9943-3f70449bab18"
      unitRef="usd">871000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjAtMS0xLTEtMTQ3MTU3_b6d69b89-ddb5-4bf2-96bb-a66cd33e13b4"
      unitRef="usd">2842000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjAtMy0xLTEtMTQ3MTU3_f41fcbdc-5139-4c28-9372-e25781e8f757"
      unitRef="usd">2957000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjEtMS0xLTEtMTQ3MTU3_6ad505d7-0fec-4827-b18c-16f7db1b231e"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjEtMy0xLTEtMTQ3MTU3_a4b96005-cae7-435f-a4a8-f26754b0ca40"
      unitRef="usd">96000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjItMS0xLTEtMTQ3MTU3_e9f4dc4b-853c-4069-a3c2-fe1672fc5385"
      unitRef="usd">30550000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjItMy0xLTEtMTQ3MTU3_304cb38b-a3aa-45ba-bebe-58802be7bd26"
      unitRef="usd">27624000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjQtMS0xLTEtMTQ3MTU3_582b3df6-7c68-4054-af6d-52770a24406e"
      unitRef="usd">4735000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjQtMy0xLTEtMTQ3MTU3_2d447e03-a187-4fe8-b6b0-ae7133499c32"
      unitRef="usd">5365000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjUtMS0xLTEtMTQ3MTU3_c913829c-736f-4257-9967-97574a71b788"
      unitRef="usd">9299000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMjUtMy0xLTEtMTQ3MTU3_75e51536-d1dd-4043-a82e-067c65dbbbde"
      unitRef="usd">9670000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMTU_9d91da76-9f53-490b-aac2-2e096d4fa4ff"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMTU_cfa97fa3-766e-4b75-a11b-e2e436cdf6cc"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMzM_43905e17-d0e3-4b30-a36b-b02af0576d97"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YTc3MGFlOWZmNDM4NDMwNGIzYzNiZDI3NWM4ZWQ1Y2RfMzM_fcd382f6-c2e4-43a1-86db-c9e8896cb084"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMS0xLTEtMTQ3MTU3_87b8bba8-ecfe-41a6-a77b-627d5bb93c10"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzEtMy0xLTEtMTQ3MTU3_d6f3775a-d74a-4fd3-b448-8bc5ccff8ef8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMTU_6169d099-0cda-4000-9af2-fbd4e042e116"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMTU_b2fdcdf3-53b9-47d7-b4f7-094be46a7851"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMzQ_509d2dbc-ab46-4991-80ce-b3d627833835"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246ZGZjY2JhYjI0M2JlNGEzNWE0ZTk3MTE3ZTYxNDk2MDZfMzQ_ac8fde34-cdd9-4c46-8940-f9797f5bf630"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMS0xLTEtMTQ3MTU3_792bbbd2-a3df-4652-b6ec-b4a133cd7fdd"
      unitRef="usd">2813000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzMtMy0xLTEtMTQ3MTU3_5c753ef3-e390-456e-95c4-945c15eb5089"
      unitRef="usd">2806000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzQtMS0xLTEtMTQ3MTU3_1c3921cd-ae06-41fa-80ba-3b1c6a0b4057"
      unitRef="usd">-280000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzQtMy0xLTEtMTQ3MTU3_15d56397-3696-450e-9d1b-d245137ed405"
      unitRef="usd">1205000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246MmNjOTc2NGI4MzVmNDI4MGJmZjBlMWQ0ZmExNDU0NzhfNDA_c96d9c1a-a1fa-4963-b10a-d428c933e5f1"
      unitRef="shares">54000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246MmNjOTc2NGI4MzVmNDI4MGJmZjBlMWQ0ZmExNDU0NzhfNTQ_531a90ef-386b-457f-8f40-34bf68ec1c4f"
      unitRef="shares">36000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMS0xLTEtMTQ3MTU3_b98860e0-b233-4f48-802d-3664bf9e6377"
      unitRef="usd">3128000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzUtMy0xLTEtMTQ3MTU3_cb52a598-d1bb-435e-b395-a4fc3a658f02"
      unitRef="usd">2186000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzYtMS0xLTEtMTQ3MTU3_b13ea251-2c89-4cff-91ee-5b2da79f7a95"
      unitRef="usd">-114000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzYtMy0xLTEtMTQ3MTU3_1c437c77-d14b-46af-96de-b5cb6f7e4713"
      unitRef="usd">-34000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzctMS0xLTEtMTQ3MTU3_37b06dd4-203f-4a54-81b6-3b116d1b1abd"
      unitRef="usd">-709000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzctMy0xLTEtMTQ3MTU3_25d91214-ee81-4969-a348-91278d0a8325"
      unitRef="usd">1791000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzgtMS0xLTEtMTQ3MTU3_ca2351e8-3334-4da4-9205-d539d2a695ba"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzgtMy0xLTEtMTQ3MTU3_08ed420e-e189-47b7-a62d-07d716982679"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzktMS0xLTEtMTQ3MTU3_cde8dbaa-663f-40af-81eb-58edb6dfd06a"
      unitRef="usd">-706000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfMzktMy0xLTEtMTQ3MTU3_fda30820-b2f7-4ef1-9def-7d2e97095189"
      unitRef="usd">1794000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNDAtMS0xLTEtMTQ3MTU3_bd8e7004-695b-400b-9ba9-cda19157967e"
      unitRef="usd">43878000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184NS9mcmFnOmJkNjM4ZTkzMzA3ZTRhMjM5YzYwYWMzNWE0MmNiYzAxL3RhYmxlOjdlNmQ4YTE1MzVhZTRhNTFhMGFkZmY4M2Y3MzA2Y2M1L3RhYmxlcmFuZ2U6N2U2ZDhhMTUzNWFlNGE1MWEwYWRmZjgzZjczMDZjYzVfNDAtMy0xLTEtMTQ3MTU3_7e6a01cf-3629-46db-8d57-055f7b707066"
      unitRef="usd">44453000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xLTEtMS0xNDcxNTc_36ea8e35-5cc4-44d0-99c8-424f1cb7d4a6"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23335ea000334e66b2d0f7cf4a90b7d9_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0zLTEtMS0xNDcxNTc_6533ebcf-6e3e-4ab6-aa68-ade25744f083"
      unitRef="usd">2763000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e1921e87f164ec2a076a8022000e553_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi01LTEtMS0xNDcxNTc_00a092a4-da91-495c-9f13-d88bad194ea6"
      unitRef="usd">5434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="iefd42525ba6945e0a2388b3cfd583b55_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi03LTEtMS0xNDcxNTc_59bd3ec2-0343-408c-ac0c-6b2e6e1fd87a"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iefd42525ba6945e0a2388b3cfd583b55_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi05LTEtMS0xNDcxNTc_43613039-0b35-44aa-9bd2-7e92de56e126"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ab48f8f0ca84770b2cdd725d449c559_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xMS0xLTEtMTQ3MTU3_05ef0103-ccf9-4a7e-88d9-4acc786f2252"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a74100c06424e0c80abaeaaf61e0fae_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xMy0xLTEtMTQ3MTU3_e84d29f6-7049-4849-a4bc-33bb441c7f20"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMi0xNS0xLTEtMTQ3MTU3_c850a1fe-4b68-4713-bc3b-eed9fca18314"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy01LTEtMS0xNDcxNTc_aefd346f-afb9-4e1d-b907-d3bb1678176a"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy0xMy0xLTEtMTQ3MTU3_6c6240cf-c246-4ec4-b2f7-784fd7e232f5"
      unitRef="usd">3000000</us-gaap:ProfitLoss>
    <cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMy0xNS0xLTEtMTQ3MTU3_b6593f8d-8140-4bb4-8b20-7ddf425b7b6a"
      unitRef="usd">-3693000000</cah:NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idba5b8a7abac4a44b7b7aea83c67e7c3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNC0xMS0xLTEtMTQ3MTU3_6d0cf0bb-d78b-4eb4-ba2f-b308268a234b"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNC0xNS0xLTEtMTQ3MTU3_1fefe622-15e4-4617-9f0c-edadfbf7d573"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0xLTEtMS0xNDcxNTc_dd0fdd68-0def-4f55-8af7-22663e10ca8c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0zLTEtMS0xNDcxNTc_cf652744-904c-46ee-94c8-7d5abfb0e69a"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi03LTEtMS0xNDcxNTc_2a01ff37-a2a3-4945-b554-6e34eec8a5cd"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi05LTEtMS0xNDcxNTc_71bd8766-e10b-4bf9-950a-78886e7dcaf5"
      unitRef="usd">74000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNi0xNS0xLTEtMTQ3MTU3_304683d0-a82c-48b0-a892-ffe2bf0d47fc"
      unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy03LTEtMS0xNDcxNTc_03f8edc8-8e07-408f-aada-2f78b65b1711"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy05LTEtMS0xNDcxNTc_3690b45c-124a-4a15-bf9a-80d428ba7cb6"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfNy0xNS0xLTEtMTQ3MTU3_0b845fd1-6e51-4063-a2ba-7b21b1450b76"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOC01LTEtMS0xNDcxNTc_9ad21aca-484b-48bc-a5e0-93ad7e4e1b69"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOC0xNS0xLTEtMTQ3MTU3_2f5b51a6-1a14-4f18-a542-79328a5e08b9"
      unitRef="usd">570000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="ia6e1b83675774216a252bf240c605c2c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0zLTEtMS0xNDcxNTc_b21f2f0e-3621-491d-8e1a-40e5bc7cb7b6"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS01LTEtMS0xNDcxNTc_a941a2af-d4ef-4fce-b8fe-245fba4e6492"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS03LTEtMS0xNDcxNTc_9eae2d2f-1c44-44a0-8c0c-465352115dd1"
      unitRef="shares">0</us-gaap:StockholdersEquityOtherShares>
    <us-gaap:StockholdersEquityOther
      contextRef="i5dbf6d1288e14183b0940bda09702479_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0xMy0xLTEtMTQ3MTU3_f40b4d49-9332-494f-91f1-e3d488fd5826"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfOS0xNS0xLTEtMTQ3MTU3_64bbd09d-885d-4c58-8066-4c4bf0a84c8e"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i16f1640dafb24aadbf40453cd1ad0423_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMS0xLTEtMTQ3MTU3_ced7f68a-35d3-4624-b68a-9667821b4ef3"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16f1640dafb24aadbf40453cd1ad0423_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMy0xLTEtMTQ3MTU3_831febbb-a985-4cb6-8431-a13a760badf1"
      unitRef="usd">2789000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dee667c44cf4729bf5c5fff72aa3e3a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtNS0xLTEtMTQ3MTU3_789a3863-531f-41e7-8608-857affb27b95"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtNy0xLTEtMTQ3MTU3_4bb210bf-1b31-4ab5-95b6-2e2fc8a08aa3"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iae51f08d7bb145c7a2d3c07bc6ceed53_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtOS0xLTEtMTQ3MTU3_c557980d-0cdd-4231-8243-b0a44155b48e"
      unitRef="usd">2066000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a2a315588dc47fa848589f8d339e4f4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTEtMS0xLTE0NzE1Nw_4d67a4c1-74a2-4c04-9efa-dcfe99b793f5"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1647e6a3df7432b93b26a7bd668dfc9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTMtMS0xLTE0NzE1Nw_19b8653c-cad9-459a-8539-a9f235de3de1"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTEtMTUtMS0xLTE0NzE1Nw_7d22df94-7d74-428e-b258-fb27a3221456"
      unitRef="usd">1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItNS0xLTEtMTQ3MTU3_2622447e-6387-406c-be21-f3e7fef06dbd"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItMTMtMS0xLTE0NzE1Nw_7fc02ad4-7546-4de6-8e7d-307a0fc5b7c0"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTItMTUtMS0xLTE0NzE1Nw_c84a3a58-5352-4c92-bca3-5853df2c4386"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTMtMTEtMS0xLTE0NzE1Nw_5ddd1226-24b9-46f4-b11c-4cf83fa661e4"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTMtMTUtMS0xLTE0NzE1Nw_1323860c-84ec-4631-96c5-c04efb239c05"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMS0xLTEtMTQ3MTU3_e33b098e-2fc4-45cc-98f6-bea87c8a78b9"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMy0xLTEtMTQ3MTU3_37139832-db57-4359-b1e3-ac04c9558124"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtNy0xLTEtMTQ3MTU3_67c83bba-7517-4c9a-9241-6e9f9cb94d8b"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtOS0xLTEtMTQ3MTU3_a08e1c5a-0aaa-4c60-89d4-529a8afcd02d"
      unitRef="usd">80000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTUtMTUtMS0xLTE0NzE1Nw_46a79ad3-cc27-4626-a7cb-0cb34b208129"
      unitRef="usd">97000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtNy0xLTEtMTQ3MTU3_ab4d9c12-dd56-4958-aed5-abd1064ad574"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtOS0xLTEtMTQ3MTU3_b8a5af82-d960-4a44-a700-0c3ba9212aa5"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTYtMTUtMS0xLTE0NzE1Nw_952d83a6-ab4c-41c2-ac54-d6553947b9a1"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTctNS0xLTEtMTQ3MTU3_4cef6163-5b71-4745-af1e-58711e24e983"
      unitRef="usd">576000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTctMTUtMS0xLTE0NzE1Nw_789f10e8-e73d-4b39-bd81-0dc5db3ce0b5"
      unitRef="usd">576000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="i0f1008b914514c70b23c4267d763bf48_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMy0xLTEtMTQ3MTU3_f0a15ea5-dc7a-4cee-8603-84f6f76df0b6"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iba708674bf7f4791aa5dd1f1b58db3df_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtNS0xLTEtMTQ3MTU3_6d8cd613-ebab-41eb-b33d-60723bad99a1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtNy0xLTEtMTQ3MTU3_a8b2c881-a4d2-4a8e-b8ea-3b5731f1cb83"
      unitRef="shares">0</us-gaap:StockholdersEquityOtherShares>
    <us-gaap:StockholdersEquityOther
      contextRef="i42b2aa46abc04031a181f84c8bd6d52a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMTMtMS0xLTE0NzE1Nw_ec9a692b-7433-4786-a6f5-96659a3bb3d9"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMTgtMTUtMS0xLTE0NzE1Nw_ca4640bf-577d-4c84-8dcc-4156f4f57957"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib28ba902d1c94df4a3c67814f8c372a5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMS0xLTEtMTQ3MTU3_f7204bf6-58c7-4284-b296-a4c573ceccdf"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib28ba902d1c94df4a3c67814f8c372a5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMy0xLTEtMTQ3MTU3_c0838320-f039-4d5e-9f63-b7e21f25800f"
      unitRef="usd">2806000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea5f56de7fee4d1dac477ee0cf61168f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtNS0xLTEtMTQ3MTU3_01995e32-8fb3-48e7-b704-0c3ca2444d0a"
      unitRef="usd">1205000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtNy0xLTEtMTQ3MTU3_b0254f6e-c3d8-4f7b-9e08-24cc7ff22546"
      unitRef="shares">36000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1e118ee0aa0b4187b787f4fb3b80a8b7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtOS0xLTEtMTQ3MTU3_ac883d02-b951-445a-a6d9-1566af3f5676"
      unitRef="usd">2186000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68d3316767394706be72a492bdcd2efd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTEtMS0xLTE0NzE1Nw_26bfbb52-7295-4529-9454-c3810d98fdb1"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0fb00ebcf504ae6b0af6dc851474deb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTMtMS0xLTE0NzE1Nw_f0f0cab8-9dfb-4b6f-90b9-b78a961be7d2"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjAtMTUtMS0xLTE0NzE1Nw_d7f8a56c-aacd-4149-be5f-8c617d1a0a2b"
      unitRef="usd">1794000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtNS0xLTEtMTQ3MTU3_e36fd618-6f5f-4ef0-8682-c62321d35dc5"
      unitRef="usd">-933000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtMTMtMS0xLTE0NzE1Nw_4edc3dcc-af9f-474c-a03d-aa4a6ca56225"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjEtMTUtMS0xLTE0NzE1Nw_fed57d88-6164-4b32-abf9-9322eb219af3"
      unitRef="usd">-932000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjItMTEtMS0xLTE0NzE1Nw_d5b4530c-e36a-411a-a87e-46faf3c77dab"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjItMTUtMS0xLTE0NzE1Nw_4e0941bf-bc16-42a9-86e6-dad191ddd7ef"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMS0xLTEtMTQ3MTU3_0c1955bd-d55e-4155-950a-57dc903db912"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMy0xLTEtMTQ3MTU3_a2db2ebc-51ba-402a-9ccf-f78608c54582"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtNy0xLTEtMTQ3MTU3_2799633e-9d99-493e-af4a-f9b99694b07a"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtOS0xLTEtMTQ3MTU3_8ebd8eb5-d1fc-485c-b8bb-be532a70f5e3"
      unitRef="usd">58000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjQtMTUtMS0xLTE0NzE1Nw_8d6c2297-5a92-432b-a8d9-ea9e726e33da"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtNy0xLTEtMTQ3MTU3_4e87cb41-bbe7-4ec8-95d4-09cd5eebd5f0"
      unitRef="shares">20000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtOS0xLTEtMTQ3MTU3_8265796d-0a8d-4cc5-aaa5-4cc43edaecfb"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjUtMTUtMS0xLTE0NzE1Nw_8cf6c17b-6239-458f-bc43-dd501b7bf99c"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:Dividends
      contextRef="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjYtNS0xLTEtMTQ3MTU3_bd2ace5c-7d10-4669-a712-fde23f3490d9"
      unitRef="usd">552000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjYtMTUtMS0xLTE0NzE1Nw_f59ccd6a-ff57-4ba2-a45e-4c411c53f531"
      unitRef="usd">552000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="ib9d6f06bb01b4b3ba63fab570f2ac8d3_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMy0xLTEtMTQ3MTU3_b8bea1fd-ccb3-4898-8f7a-1147410b824d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="i287b65792cd34c8bbafcb4e9b2181c66_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctNS0xLTEtMTQ3MTU3_2ff556ec-4ad4-47a5-8e1a-7ab254ff0b3b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOtherShares
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctNy0xLTEtMTQ3MTU3_e2e9337d-f877-40aa-9d6d-1870e3e25a4a"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="icc82615690174aec8f199acd5c3dc6e6_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMTMtMS0xLTE0NzE1Nw_035d794d-fd86-48d7-bc41-b6bb57eac082"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjctMTUtMS0xLTE0NzE1Nw_9603a00a-cd2e-4970-b7cf-2883a3c042bc"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibba299e1050549689ffb0f8eacbea9c0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMS0xLTEtMTQ3MTU3_0d7e4379-bd1a-4472-b2c9-b7e003c0167e"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibba299e1050549689ffb0f8eacbea9c0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMy0xLTEtMTQ3MTU3_8fc4b451-ed2f-4158-8033-bd19bbf7e133"
      unitRef="usd">2813000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i934ea3588a144dd5b265a98b3005fb6d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktNS0xLTEtMTQ3MTU3_6420b0a7-6cc0-4ec0-8d87-b23279a286de"
      unitRef="usd">-280000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ie319b7f528d244d180aab748fdbce12d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktNy0xLTEtMTQ3MTU3_cfe3bbc5-b146-4515-bfd3-eef668a54de8"
      unitRef="shares">54000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ie319b7f528d244d180aab748fdbce12d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktOS0xLTEtMTQ3MTU3_4df98f83-7f58-43f5-adf8-b2f44ce6749b"
      unitRef="usd">3128000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e1f19c62f9f42bcb0e306e9ba872206_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTEtMS0xLTE0NzE1Nw_b3625bfc-dc71-4d26-b308-99b4c7f3d4f9"
      unitRef="usd">-114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73da689c634e4d5ba2674bf686bd3f86_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTMtMS0xLTE0NzE1Nw_fedae516-20ac-4bcf-865b-06be04de97bf"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN184OC9mcmFnOmZjMGU2ZTcyNTZmNDRkYzA5ZTgyMTBmYjdkYWI0MTY2L3RhYmxlOmM4NTczOGRmZTgyMDQ3ZDM5MWE0NGNhMzhmNGY3YWM1L3RhYmxlcmFuZ2U6Yzg1NzM4ZGZlODIwNDdkMzkxYTQ0Y2EzOGY0ZjdhYzVfMjktMTUtMS0xLTE0NzE1Nw_c5be14a0-e536-4f33-b2aa-964f70711e81"
      unitRef="usd">-706000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi0xLTEtMS0xNDcxNTc_e0fc800e-34fc-4739-a916-fb87cb4e0068"
      unitRef="usd">-932000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi0zLTEtMS0xNDcxNTc_799b4c27-de33-4eb0-80dc-a44a12be005d"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMi01LTEtMS0xNDcxNTc_c9580fa1-4794-41a9-8f3b-28f360c9d2ef"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC0xLTEtMS0xNDcxNTc_0acf3eaf-b0cc-4894-9dd9-375440a11338"
      unitRef="usd">692000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC0zLTEtMS0xNDcxNTc_7a12a4e4-6c04-4b6a-bb45-ab701757e81b"
      unitRef="usd">783000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNC01LTEtMS0xNDcxNTc_f4bc4321-2383-450b-bc7e-0847488a185d"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS0xLTEtMS0xNDcxNTc_731db939-0361-42ba-b347-cc3917213c2c"
      unitRef="usd">-24000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS0zLTEtMS0xNDcxNTc_9831e684-32fa-4234-b65e-90a1ee0779ea"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNS01LTEtMS0xNDcxNTc_f8cec5bd-60c0-4566-9137-428f55abeb98"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi0xLTEtMS0xNDcxNTc_3bcd1196-dae6-46f0-a8b5-39e6b9a9f6cf"
      unitRef="usd">2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi0zLTEtMS0xNDcxNTc_f0c5d1f2-b28f-41be-8f23-6328d500d8f2"
      unitRef="usd">-2000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNi01LTEtMS0xNDcxNTc_cd646cc0-be3b-4087-aeba-214c49b6a057"
      unitRef="usd">579000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy0xLTEtMS0xNDcxNTc_aed193af-089f-4471-a665-d921bf1cffb5"
      unitRef="usd">-2050000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy0zLTEtMS0xNDcxNTc_36067d7c-87cb-4d70-86a5-b9fd69e9987a"
      unitRef="usd">-79000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNy01LTEtMS0xNDcxNTc_f91c0752-bc7a-47a6-85d1-f22e40b46ee7"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC0xLTEtMS0xNDcxNTc_1bd9ac55-93d7-45c0-bb3e-906e7a04dd75"
      unitRef="usd">-10000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC0zLTEtMS0xNDcxNTc_a876e174-c2e7-48c4-a5ef-bfcb6461382d"
      unitRef="usd">-14000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOC01LTEtMS0xNDcxNTc_db7daea8-6179-4a80-85fe-d6f9c0d7150d"
      unitRef="usd">-16000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS0xLTEtMS0xNDcxNTc_9ae7ce34-99b0-4e67-a29a-a44417f21565"
      unitRef="usd">81000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS0zLTEtMS0xNDcxNTc_8706fe6f-205f-401a-9d6c-b5e99553cbb1"
      unitRef="usd">89000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfOS01LTEtMS0xNDcxNTc_8de4841e-a03a-4303-841b-7e35a7df4cce"
      unitRef="usd">90000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtMS0xLTEtMTQ3MTU3_511c9ae9-8b0b-46d2-8a18-6f0e1296a598"
      unitRef="usd">7000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtMy0xLTEtMTQ3MTU3_35000819-e8a4-42cf-8366-c4d5d5e8f9cd"
      unitRef="usd">496000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTAtNS0xLTEtMTQ3MTU3_bc2072e5-6785-43e0-8f8d-a7460eb2a8cc"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtMS0xLTEtMTQ3MTU3_7265d74a-ef7d-4056-a11d-2c5e97bdd4b2"
      unitRef="usd">68000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtMy0xLTEtMTQ3MTU3_b20bdcf7-79dd-4895-8556-9afcf4a9b805"
      unitRef="usd">65000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTEtNS0xLTEtMTQ3MTU3_bdddb1d7-e26c-4288-a377-4b6c20b53d05"
      unitRef="usd">106000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtMS0xLTEtMTQ3MTU3_5d6e978c-c0b4-4185-a396-2420b9ce2cc2"
      unitRef="usd">1526000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtMy0xLTEtMTQ3MTU3_7abe3638-ad7e-43bd-8447-1f78396b5c5a"
      unitRef="usd">904000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTQtNS0xLTEtMTQ3MTU3_e3ded83c-8c67-4d0b-abdb-d39fe5a13e43"
      unitRef="usd">-82000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtMS0xLTEtMTQ3MTU3_a80e0351-bab5-4465-9c12-752564474d33"
      unitRef="usd">1071000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtMy0xLTEtMTQ3MTU3_579a7c16-a4e5-45be-bf1e-af92deb81a17"
      unitRef="usd">1584000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTUtNS0xLTEtMTQ3MTU3_2fc6559d-e0b2-4d83-9d16-8fd85c6196d8"
      unitRef="usd">409000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtMS0xLTEtMTQ3MTU3_cb0fe0df-be35-4170-866a-46a348378f04"
      unitRef="usd">3428000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtMy0xLTEtMTQ3MTU3_3efe4718-6e01-4a70-bcea-f09d35d21609"
      unitRef="usd">2325000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTYtNS0xLTEtMTQ3MTU3_f15fd74a-cbe9-47b4-8979-8497938b0c78"
      unitRef="usd">-162000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctMS0xLTEtMTQ3MTU3_1ea07090-3f81-469a-b8ba-08ad04e6d0de"
      unitRef="usd">-293000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctMy0xLTEtMTQ3MTU3_5ae7fcb3-7874-4420-9296-e63856a7e2d2"
      unitRef="usd">-452000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTctNS0xLTEtMTQ3MTU3_cd2eba58-3287-437e-a149-4528daec99bf"
      unitRef="usd">-6550000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtMS0xLTEtMTQ3MTU3_ccdd7c73-53b4-4bce-887f-f348cee8e6a6"
      unitRef="usd">3122000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtMy0xLTEtMTQ3MTU3_32b00452-67ac-4a10-a7d9-33c244db7045"
      unitRef="usd">2429000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMTgtNS0xLTEtMTQ3MTU3_6cee9cb3-5d55-4e7f-99ec-ab9b279e7553"
      unitRef="usd">1960000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMS0xLTEtMTgxNTEz_85d5c1d7-8a26-4ec1-b3e9-5face4a8adae"
      unitRef="usd">923000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMy0xLTEtMTgxNTEz_a706ef18-e634-409a-a4e9-95a88ac30d8e"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtNS0xLTEtMTgxNTEz_39890a5f-eb86-4c25-8584-85188c7c286c"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMS0xLTEtMTQ3MTU3_395b367c-6266-43d1-84e5-7d81295c5d30"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtMy0xLTEtMTQ3MTU3_115016af-af6c-4d78-b9f5-bab8ad5a78f1"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjAtNS0xLTEtMTQ3MTU3_cdf6f311-8907-4b3e-b1a2-4889ca99427d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtMS0xLTEtMTQ3MTU3_cf96e40e-93d1-42d6-b5da-b32e444d66f4"
      unitRef="usd">387000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtMy0xLTEtMTQ3MTU3_d822904a-4c19-4c81-8feb-e03e066cb2b7"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjEtNS0xLTEtMTQ3MTU3_b0ff0723-134b-40aa-8106-50c6b7d4220b"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMS0xLTEtMTgyMTY0_b8b9f88f-0336-4181-be5b-73b01a628a48"
      unitRef="usd">31000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMy0xLTEtMTgyMTgx_b058c26a-5fd7-402d-b58b-feae1f6e9999"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtNS0xLTEtMTgyMTg5_137c0291-f52f-4cc8-89a9-008f24ba837e"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItMS0xLTEtMTQ3MTU3_4eba6bb6-be66-4ef4-ae34-f250f03c6a44"
      unitRef="usd">78000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItMy0xLTEtMTQ3MTU3_26f21477-9ebc-4a76-986e-2bf94159d13d"
      unitRef="usd">22000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjItNS0xLTEtMTQ3MTU3_efe56be4-12c3-40eb-9561-741c8032d081"
      unitRef="usd">20000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMS0xLTEtMTQ3MTU3_66ac4ef0-947c-4ed5-a7e4-191650dce6a1"
      unitRef="usd">29000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtMy0xLTEtMTQ3MTU3_88a8e4d2-d761-4f68-9bfd-649193f7456e"
      unitRef="usd">47000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjMtNS0xLTEtMTQ3MTU3_c5c335fe-b455-422f-b510-643770f7329e"
      unitRef="usd">886000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtMS0xLTEtMTQ3MTU3_ae7413a1-4b0e-4706-80a8-326f07a291ac"
      unitRef="usd">71000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtMy0xLTEtMTQ3MTU3_a6cb7a0d-73e0-4ca4-b116-11fd1633ffb1"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjQtNS0xLTEtMTQ3MTU3_c3cf894f-b594-4ade-85e5-30bb607c1de3"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctMS0xLTEtMTQ3MTU3_51ea9b6a-8ea3-4449-9b14-09363de7be15"
      unitRef="usd">567000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctMy0xLTEtMTQ3MTU3_3474e45e-c66b-46b3-808f-0703d64fb3c6"
      unitRef="usd">-378000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMjctNS0xLTEtMTQ3MTU3_b1e2a3db-39a2-42e4-ae85-f696d491c2e4"
      unitRef="usd">493000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtMS0xLTEtMTQ3MTU3_de670033-4c67-422b-b936-61c26d3e8eb6"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtMy0xLTEtMTQ3MTU3_b1d97b18-b29b-4c93-b28b-d1aac5107075"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzAtNS0xLTEtMTQ3MTU3_31f01a1d-6253-4110-8566-9715beafe21b"
      unitRef="usd">-2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItMS0xLTEtMTQ3MTU3_7a3eb3d7-810a-4a47-8fe4-c3905b7d0e3f"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItMy0xLTEtMTQ3MTU3_cf63cb4c-8fef-485f-9978-e19313ccb991"
      unitRef="usd">-18000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForProceedsFromHedgeFinancingActivities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzItNS0xLTEtMTQ3MTU3_74deece4-6263-4dcf-a701-936deff2cf0f"
      unitRef="usd">-112000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtMS0xLTEtMTQ3MTU3_f40aa384-c391-4bd9-975f-2ee1f11648b8"
      unitRef="usd">885000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtMy0xLTEtMTQ3MTU3_9f92425d-409e-4bb7-a54a-e6cbfe34d44f"
      unitRef="usd">570000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzQtNS0xLTEtMTQ3MTU3_d1cae486-2383-4d3a-bfa7-1fe9299c0d69"
      unitRef="usd">1399000000</us-gaap:RepaymentsOfLongTermDebt>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtMS0xLTEtMTQ3MTU3_92e24264-8ef6-4939-bf00-1f708db8b2f8"
      unitRef="usd">-19000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtMy0xLTEtMTQ3MTU3_7aff6ea2-8a09-438f-b783-c8c285a69162"
      unitRef="usd">8000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzUtNS0xLTEtMTQ3MTU3_72135c22-0a88-4cc3-a304-fa3ac32a5885"
      unitRef="usd">8000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctMS0xLTEtMTQ3MTU3_2c8dfb9c-0ecf-474e-8db2-211b5e7dc307"
      unitRef="usd">559000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctMy0xLTEtMTQ3MTU3_79be0d61-68f9-498a-b31f-8d06930c428c"
      unitRef="usd">573000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzctNS0xLTEtMTQ3MTU3_9654f752-476e-450e-80bc-4b4b08f7ba83"
      unitRef="usd">569000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtMS0xLTEtMTQ3MTU3_5fe92b43-451e-4c8d-b4ed-c3729fa9d72a"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtMy0xLTEtMTQ3MTU3_33649cd9-3bc1-438e-81ea-a4412533623d"
      unitRef="usd">200000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzgtNS0xLTEtMTQ3MTU3_b827bacd-8750-43bd-a895-2eb69f7d2edf"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktMS0xLTEtMTQ3MTU3_7d807045-66cf-4412-ac8a-3559ddacd528"
      unitRef="usd">-2463000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktMy0xLTEtMTQ3MTU3_ce3cdefe-e9ef-41b4-8fc4-5428615cedbd"
      unitRef="usd">-1317000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfMzktNS0xLTEtMTQ3MTU3_567e3071-1143-4a8e-b387-3a3143533abe"
      unitRef="usd">-2200000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtMS0xLTEtMTQ3MTU3_01fce8f9-ec22-4729-8d86-6ecd01138c35"
      unitRef="usd">-25000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtMy0xLTEtMTQ3MTU3_75a499c4-5604-4ee5-95be-8fc44458d3ea"
      unitRef="usd">11000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDAtNS0xLTEtMTQ3MTU3_79344c85-fc8c-4e03-bd10-fb7ef6808d5f"
      unitRef="usd">-13000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtMS0xLTEtMTQ3MTU3_dd211d78-ce30-464b-9cb1-586c4d29a887"
      unitRef="usd">109000000</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtMy0xLTEtMTQ3MTU3_ed0008e2-2235-4650-8540-d9b9c702a75e"
      unitRef="usd">-109000000</cah:CashReclassifiedtoAssetsHeldforSale>
    <cah:CashReclassifiedtoAssetsHeldforSale
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDEtNS0xLTEtMTQ3MTU3_3dc2879d-c7db-4b18-8179-e47d796b70c5"
      unitRef="usd">0</cah:CashReclassifiedtoAssetsHeldforSale>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItMS0xLTEtMTQ3MTU3_22312b29-ee34-40ed-b091-f26ad32c001a"
      unitRef="usd">1310000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItMy0xLTEtMTQ3MTU3_8bd97b8a-61d2-4ba6-b29a-708f99e0bc8f"
      unitRef="usd">636000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDItNS0xLTEtMTQ3MTU3_d590e962-6564-49de-8b42-c2e77466ed6e"
      unitRef="usd">240000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtMS0xLTEtMTQ3MTU3_7cc49403-05b3-43c4-a246-cde41af44c54"
      unitRef="usd">3407000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtMy0xLTEtMTQ3MTU3_3af94fe9-bfa0-4d1f-90ba-6442d0a69d48"
      unitRef="usd">2771000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDMtNS0xLTEtMTQ3MTU3_d053073f-4c18-4fd6-8c03-279cf4eb2c48"
      unitRef="usd">2531000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtMS0xLTEtMTQ3MTU3_4103bc0f-e93d-4082-8dca-d1d68046fbf6"
      unitRef="usd">4717000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtMy0xLTEtMTQ3MTU3_63d86d53-f926-47c5-9e31-b140c916e67e"
      unitRef="usd">3407000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDQtNS0xLTEtMTQ3MTU3_62e87a40-5698-496d-b48f-6e0bd9567270"
      unitRef="usd">2771000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtMS0xLTEtMTQ3MTU3_9df41cda-09d1-465b-bfbc-0431f6246636"
      unitRef="usd">153000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtMy0xLTEtMTQ3MTU3_e9170332-b861-4990-b9cc-b83b05d14dcf"
      unitRef="usd">182000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDYtNS0xLTEtMTQ3MTU3_91e38fc6-284b-4847-9b39-13f2268b7de8"
      unitRef="usd">226000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctMS0xLTEtMTQ3MTU3_05dca837-2057-4a5b-bdd5-5cf7c62e0d8b"
      unitRef="usd">-766000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctMy0xLTEtMTQ3MTU3_95c6c4d2-c071-43d5-9533-b957999f0b4c"
      unitRef="usd">273000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185MS9mcmFnOmM2ODc2YmMzNTZkYzRlMmFiYTdlYzE5MjhhN2Q4ZTQ0L3RhYmxlOjE1NjI0OTk2Yzk3NzQ2MzY4YmQ1MGQzZjE0YWMwNTgxL3RhYmxlcmFuZ2U6MTU2MjQ5OTZjOTc3NDYzNjhiZDUwZDNmMTRhYzA1ODFfNDctNS0xLTEtMTQ3MTU3_74f49850-9c7b-4fff-90a1-2609304449c3"
      unitRef="usd">368000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg5MDE_538981e8-776f-44b2-bea5-2b282203d3b7">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal Health, Inc. is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. References to &#x201c;we,&#x201d; &#x201c;our,&#x201d; "us," and similar pronouns in these consolidated financial statements are to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries, unless the context otherwise requires.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year ends on June&#160;30. References to fiscal 2022, 2021 and 2020 in these consolidated financial statements are to the fiscal years ended June&#160;30, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively. Certain prior year amounts have been reclassified to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, vendor reserves, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts may differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables are presented net of an allowance for doubtful accounts of $273 million and $243 million at June&#160;30, 2022 and 2021, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $12 million) and $63 million (current portion $7 million) at June&#160;30, 2022 and 2021, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $8 million and $12 million at June&#160;30, 2022 and 2021, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation ("CVS Health") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 19 percent, 19 percent and 21 percent of revenue for fiscal 2022, 2021 and 2020, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our inventories (52 percent and 50 percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $416 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$565 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain personal protective equipment as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand decreased compared to the peak of COVID-19, during fiscal 2021 we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The reserve balance was $42&#160;million at June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $147 million and $185 million at June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize project costs relating to computer software developed or obtained for internal use when the activities related to the project reach the application stage. Costs that are associated with the preliminary stage activities, training, maintenance, and all other post-implementation stage activities are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;3 to 39 years; machinery and equipment&#x2014;3 to 20 years; capitalized software held for internal use&#x2014;3 to 7 years; and furniture and fixtures&#x2014;3 to 7 years. We recorded depreciation and amortization expense of $412 million, $377 million and $405 million for fiscal 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Capitalized software held for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;125&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was 4 percent at June&#160;30, 2022. The amount of capitalized interest was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 10 to 12 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed annual impairment testing in fiscal 2022, 2021 and 2020 and with the exception of our Medical Unit in fiscal 2022, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. As discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the "Notes to Consolidated Financial Statements," during fiscal 2022, we recognized goodwill impairment charges related to our Medical Unit of $2.1&#160;billion, respectively, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings. There were tax benefits related to these goodwill impairment charges. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 12, 2021, we signed a definitive agreement with Hellman &amp;amp; Friedman to sell the Cordis business. Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In August 2021, we sold the Cordis business to Hellman &amp;amp; Friedman for proceeds of $923 million net of cash transferred, and we retained certain working capital accounts and certain liabilities. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information. Cardinal Health retained product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2022, 2021, and 2020 was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases have remaining lease terms from less than 1 year up to approximately 20 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically update our reserve estimates to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues. Vendor reserves were $105 million and $77 million at June&#160;30, 2022 and 2021 respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recorded pre-tax charges of $1.17&#160;billion and $5.63 billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021 and 2020, respectively, which were retained at Corporate. In February 2022, we and two other national distributors announced that each company had determined that a sufficient number of political subdivisions had agreed to participate in the previously disclosed settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid cash dividends per common share of $1.96, $1.94 and $1.92 in fiscal 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2022 and 2021, the accrual for estimated sales returns and allowances was $617 million and $689 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.4 billion, $2.6 billion and $2.3 billion, for fiscal 2022, 2021 and 2020, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2022, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $748 million, $634 million and $620 million, for fiscal 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_103" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Amortization and Other Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding amortization of acquisition-related intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2022 and 2021 are presented in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_127" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no accounting standards adopted in fiscal 2022 that had a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the adoption impacts of recently issued accounting standards by the FASB on our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2021 Form 10-K. There were no accounting standards issued in fiscal 2022 that will have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDE_7bf5c8c7-d880-400f-a80a-f0496f2a656c">Basis of PresentationOur consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of the acquisition or up to the date of disposal, respectively. Certain prior year amounts have been reclassified to conform to the current year presentation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4Mjc_5cb22037-ed71-49e3-97eb-237995fd2f20">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, vendor reserves, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts may differ from these estimated amounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTA_344b3ce2-56b5-4834-9369-d71517c5dc3d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider liquid investments purchased with an initial maturity of three months or less to be cash equivalents. The carrying value of cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDg_05f69d97-752a-4778-868d-e8294ba37214">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables are presented net of an allowance for doubtful accounts of $273 million and $243 million at June&#160;30, 2022 and 2021, respectively. An account is considered past due on the first day after its due date. In accordance with contract terms, we generally have the ability to charge customers service fees or higher prices if an account is considered past due. We regularly monitor past due accounts and establish appropriate reserves to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cover potential losses, and consider historical experience, pricing discrepancies, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop our allowance for credit losses. We review these factors quarterly to determine if any adjustments are needed to the allowance. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide financing to various customers. Such financing arrangements range from 1 year&#160;to 5 years at interest rates that are generally subject to fluctuation. Interest income on these arrangements is recognized as it is earned. The financings may be collateralized, guaranteed by third parties or unsecured. Finance notes, net and related accrued interest were $63 million (current portion $12 million) and $63 million (current portion $7 million) at June&#160;30, 2022 and 2021, respectively, and are included in other assets (current portion is included in prepaid expenses and other) in the consolidated balance sheets. Finance notes receivable allowance for doubtful accounts were $8 million and $12 million at June&#160;30, 2022 and 2021, respectively. We estimate an allowance for these financing receivables based on historical collection rates and the creditworthiness of the customer. We write off any amounts deemed uncollectible against the established allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63aae49541134c39aa2c99f778658cc5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjU0OA_100e5a6b-faae-44df-9f8d-7904ec1758b9"
      unitRef="usd">273000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjU1NQ_095b0882-9a8c-48a0-99b7-5a8a966ceba2"
      unitRef="usd">243000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzM4Nw_d29372e4-cc59-4b7b-b261-713088b1cbee">P1Y</cah:ReceivableFinancingAgreementTerm>
    <cah:ReceivableFinancingAgreementTerm
      contextRef="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzM5Mw_cc8eeab5-f355-495d-b018-6b2311b55146">P5Y</cah:ReceivableFinancingAgreementTerm>
    <us-gaap:NotesReceivableNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY1OQ_84415bb3-f1d0-4d56-84db-928760db494f"
      unitRef="usd">63000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY3OQ_c7fc187c-0015-4cda-aa25-642a07bc6e74"
      unitRef="usd">12000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesReceivableNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzY4Nw_3744e6b5-7e14-4e02-a808-3c7f2d6dae9c"
      unitRef="usd">63000000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzcwNw_d333db62-0e56-4f6a-8229-76787d83e498"
      unitRef="usd">7000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzkzMA_f2de80a3-a842-4fb5-8742-920e3dcd4d49"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzkzNw_321e1f92-fe5c-4d45-a061-a4d01ff70bc0"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MDc_5cd4f9da-3cde-42e2-b573-db718d055b17">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.&lt;/span&gt;&lt;/div&gt;Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers&#x2019; financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3MzU_04b64d3f-457e-47d0-9a28-f17c89145a9e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation ("CVS Health") and OptumRx, are our only customers that individually account for at least 10 percent of revenue and gross trade receivables. These customers are primarily serviced through our Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we extended our pharmaceutical distribution agreements with CVS Health through June 2027. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We have entered into agreements with group purchasing organizations (&#x201c;GPOs&#x201d;) which act as purchasing agents that negotiate vendor contracts on behalf of their members. Vizient, Inc. and Premier, Inc. are our two largest GPO member relationships in terms of revenue. Sales to members of these two GPOs collectively accounted for 19 percent, 19 percent and 21 percent of revenue for fiscal 2022, 2021 and 2020, respectively. Our trade receivable balances are with individual members of the GPO, and therefore no significant concentration of credit risk exists with these types of arrangements</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTE_1b9369ee-f56f-4b7f-a66c-0a49b6871231">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes historical percent of revenue and gross trade receivables from CVS Health and OptumRx:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percent&#160;of&#160;Gross Trade&#160;Receivables at June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OptumRx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic85d2f2f06c94ebe83e8327bd00e68ce_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi0xLTEtMS0xNDcxNTc_c72b471b-5cd2-444c-ab27-0e6725bd8409"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1711b8d7bfa14e438a604b5eb731fd63_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi0zLTEtMS0xNDcxNTc_1ddc5b9c-7ae4-4e5e-8e25-6858252b58b2"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i242004258f7948c09176905c6439d71e_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi01LTEtMS0xNDcxNTc_1f659a2e-2f18-4031-beca-ee91d4ee4c4b"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="iebb7741eed65481097e07facd023b229_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi03LTEtMS0xNDcxNTc_d55d4898-3fb4-4ea8-8622-c480c7a531a7"
      unitRef="number">0.24</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="ia9621b37a8dc4e7ea9c3508d6c8eb651_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMi05LTEtMS0xNDcxNTc_64d82a85-b849-40b3-b50d-0140272b4cc1"
      unitRef="number">0.24</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie54dcff3023345b3b8dbceb05e183894_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy0xLTEtMS0xNDcxNTc_e1d607dd-1068-4e26-95ef-8f4003916f84"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2597c971f6604c2a9a6b84309d0885b9_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy0zLTEtMS0xNDcxNTc_3637dc91-8da1-46e0-94bd-c74d94738af7"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i77687ae7a5664be792bcbd38bb67e2b2_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy01LTEtMS0xNDcxNTc_1662cfee-9e4f-4860-a951-e5fc780cb3c3"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="i8188d649f96f4d47aa2ede0789bc920c_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy03LTEtMS0xNDcxNTc_13eac0b3-6b88-4e39-9d01-a2a32a51910c"
      unitRef="number">0.04</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:GrossTradeReceivablesMajorCustomerPercentage
      contextRef="i4737f6e39b0e4dc09e8ec181488988cc_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjk4ZDVmZDIwOWJhYjQzNzA5YTdjNjVmNjYxN2VmODY1L3RhYmxlcmFuZ2U6OThkNWZkMjA5YmFiNDM3MDlhN2M2NWY2NjE3ZWY4NjVfMy05LTEtMS0xNDcxNTc_1ab92b13-5101-44dd-89c5-6a2dd1d037d4"
      unitRef="number">0.03</cah:GrossTradeReceivablesMajorCustomerPercentage>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjExOA_03cefdb2-8b0f-45ec-bdab-7929370996a2"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <cah:ConcentrationRiskLargestGroupPurchasingOrganizations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjIwMQ_03cefdb2-8b0f-45ec-bdab-7929370996a2"
      unitRef="organization">2</cah:ConcentrationRiskLargestGroupPurchasingOrganizations>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifb74843eaf0a48e78b9e853f892a30ba_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjIzNg_9ec76502-7d27-4747-8e5f-538343a68929"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5d51d1a743744443b9f40a909974d9c4_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjI0MA_669cff5c-2882-44f9-b28b-055b1d299a89"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i38cd3d843f544dd0ac41d8cae2504a85_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjI0Nw_1f148b68-232d-41c5-84ab-54f692fe5fbd"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NDQ_9878b297-0fd8-4ae8-8f42-1ba3a94469f6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of our inventories (52 percent and 50 percent at June&#160;30, 2022 and 2021, respectively) are valued at the lower of cost, using the last-in, first-out ("LIFO") method, or market. These inventories are included within the core pharmaceutical distribution facilities of our Pharmaceutical segment (&#x201c;distribution facilities&#x201d;) and are primarily merchandise inventories. The LIFO method presumes that the most recent inventory purchases are the first items sold, so LIFO helps us better match current costs and revenue. We believe that the average cost method of inventory valuation provides a reasonable approximation of the current cost of replacing inventory within the distribution facilities. As such, the LIFO reserve is the difference between (a) inventory at the lower of LIFO cost or market and (b) inventory at replacement cost determined using the average cost method of inventory valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and 2021, respectively, inventories valued at LIFO cost were $416 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$565 million higher than the average cost value. We do not record inventories in excess of replacement cost. As such, we did not write-up the value of our inventory from average cost to LIFO cost at June&#160;30, 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our remaining inventory, including inventory in our Medical segment, that is not valued at the lower of LIFO cost or market is stated at the lower of cost, using the first-in, first-out method, or net realizable value. Net realizable value is defined as the estimated selling prices and estimated sales demand in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Due to the unprecedented demand for certain personal protective equipment as a result of the COVID-19 pandemic ("COVID-19") in fiscal 2021 and 2020, our Medical segment manufactured and sourced inventory at higher costs than in periods prior to COVID-19. Personal protective equipment ("PPE") refers to protective clothing, medical and non-medical &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;grade gloves, face shields, face masks and other equipment designed to protect the wearer from injury or the spread of infection or illness. As selling prices and customer demand decreased compared to the peak of COVID-19, during fiscal 2021 we recorded a reserve of $197&#160;million, primarily related to certain categories of gloves, to reduce the carrying value of certain PPE to its net realizable value. The reserve balance was $42&#160;million at June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reserve for inventory obsolescence using estimates based on historical experience, historical and projected sales trends, specific&#160;categories of inventory, age and expiration dates of on-hand inventory and manufacturer return policies. Inventories presented in the consolidated balance sheets are net of reserves for excess and obsolete inventory which were $147 million and $185 million at June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjUxMg_b77491be-a59f-4f4e-930e-91c793ecdccb"
      unitRef="number">0.52</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjUxOQ_6c9ed684-fe23-409f-9545-c164ba3ee9c3"
      unitRef="number">0.50</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNzQyNA_89ee0d2e-420a-4edd-9da2-d0417ccd6f23"
      unitRef="usd">416000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNzQzMQ_f2eee512-86ca-498d-b59c-4ee47ac4914f"
      unitRef="usd">565000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryWriteDown
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfODYwNg_bb4e4428-0af6-449c-b5fe-2a4846071669"
      unitRef="usd">197000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryValuationReserves
      contextRef="i5ca12a2ea9cd462c9141a9d8057be00c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjU5NzA2OTgxOTgxMw_d24dad87-94ef-4c57-840b-3b6f92d34d3d"
      unitRef="usd">42000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="id4140159ea4a43739df00326c541235c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfOTA5NQ_c74c7509-0416-4f8b-8e4c-2fbb67739c0a"
      unitRef="usd">147000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i99a45ec948a346c4a693ae4491ab887b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfOTEwMg_b302b596-dcdf-430d-830f-6900516dc589"
      unitRef="usd">185000000</us-gaap:InventoryValuationReserves>
    <cah:CashDiscountsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NTI_ad0da08e-133a-453e-856d-1450dd67d1db">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturer cash discounts are recorded as a component of inventory cost and recognized as a reduction of cost of products sold as inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:CashDiscountsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NDY_60e14338-180f-44b4-9a2d-a86ebae47396">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are carried at cost less accumulated depreciation. Property and equipment held for sale are recorded at the lower of cost less accumulated depreciation before the decision to dispose of the asset was made or fair value less cost to sell. When certain events or changes in operating conditions occur, an impairment assessment may be performed on the recoverability of the carrying amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize project costs relating to computer software developed or obtained for internal use when the activities related to the project reach the application stage. Costs that are associated with the preliminary stage activities, training, maintenance, and all other post-implementation stage activities are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including finance lease assets which are depreciated over the terms of their respective leases. We generally use the following range of useful lives for our property and equipment categories: buildings and improvements&#x2014;3 to 39 years; machinery and equipment&#x2014;3 to 20 years; capitalized software held for internal use&#x2014;3 to 7 years; and furniture and fixtures&#x2014;3 to 7 years. We recorded depreciation and amortization expense of $412 million, $377 million and $405 million for fiscal 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Capitalized software held for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;125&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repairs and maintenance expenditures are expensed as incurred. Interest on long-term projects is capitalized using a rate that approximates the weighted-average interest rate on long-term obligations, which was 4 percent at June&#160;30, 2022. The amount of capitalized interest was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaf515cb8fd624891a66b5f7e1ea44ba1_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwNjQ_e949613b-3c18-4a73-a337-dce52166b2bd">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifd7a6fadd3f148f883ebb6412075c8ac_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwNzA_a283d2c4-266c-4155-b4ce-bb9baaa438cc">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0a58c6e8721a4d5c9f8d148d848b3c73_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAwOTg_95498f0e-c786-495a-bb03-4a1965950974">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib42f20105ab0411cab507a7959ade5cb_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxMDQ_b9b906f8-6ab7-4188-a041-4e57f6766865">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i61d5020105b54ebdbda79ad2cdd2c486_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NjAwNQ_fe5bed20-cee1-439f-a2cb-ffc1a922bc1a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2f4bb9b89da04d04968694a6fec77b68_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NjAxMA_f86fda25-0500-4e1e-aa75-a20c1debc467">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5978dceb66ad409fb3003c8699c5492a_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxMzU_537fd904-7f57-47e2-b5ce-9f21d6041f6c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i887ae0d04a84497d824efb8ead276201_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxNDE_114d177a-fd1e-4d30-9da8-5caff8b5b1ab">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAxOTg_09dc214f-d559-4694-8f2d-6b90ed2761c9"
      unitRef="usd">412000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAyMDI_789bf71e-0695-4989-8c6f-b08deee6aa88"
      unitRef="usd">377000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTAyMDk_1ac340d5-e2c0-4991-850d-0e5b15f50163"
      unitRef="usd">405000000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4ODg_aeaa5bab-0f3d-4995-ba93-2b7d8784af20">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Land, building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Capitalized software held for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;125&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,883&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7c38ba87cbb64d34ac1bacba542abf6a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMS0xLTEtMS0xNDcxNTc_5ebfb90e-1a0a-4362-bc96-af96bf609fdf"
      unitRef="usd">1724000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i033b0d1b48434099a70157ef43c38a49_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMS0zLTEtMS0xNDcxNTc_683ac023-cda7-4758-a5ff-4393bf75f0e5"
      unitRef="usd">1717000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9bf7f9f717bf419d972451fe5f3da912_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMi0xLTEtMS0xNDcxNTc_5487e56e-1140-4d2b-a7aa-c541fa01385b"
      unitRef="usd">2114000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib5bf3f5eefca4129a06653b17bf04363_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMi0zLTEtMS0xNDcxNTc_9d34616e-6861-4274-b628-fcaaa45f8b12"
      unitRef="usd">2018000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iee55f0b9ac1749cd8fad660d4398d09f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0xLTEtMS0xNzcyMjU_7396164e-cd20-4882-acaa-c7e201f2c0bb"
      unitRef="usd">1562000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i937b0ef4a4ca4ea3bea8db2f1a6b54c7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0zLTEtMS0xNzcyMzI_ceed25a4-17e6-4955-9076-319d4b568ece"
      unitRef="usd">1075000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i19e847a45be14fb698f7a64309bc2a65_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0xLTEtMS0xNDcxNTc_ed446cd6-9514-4d74-812a-7e1fde487d3b"
      unitRef="usd">125000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0d6189c62c3b4fc08a6ec02502390bf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfMy0zLTEtMS0xNDcxNTc_bc7c5682-c353-4212-980c-6719b523a407"
      unitRef="usd">136000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5bb96066e3a547e9b5b6924d06661609_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0xLTEtMS0xODEwMzM_471ad126-21b3-4fc0-8bbc-9c59f5bfea10"
      unitRef="usd">358000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8f9c6746ba5745d2bb4039a6f7b03117_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0zLTEtMS0xODEwNDA_054ba74e-8949-48f9-ae5a-50d92260f656"
      unitRef="usd">642000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNC0xLTEtMS0xNDcxNTc_c60907fc-1b67-4899-830e-b6d056fe9993"
      unitRef="usd">5883000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNC0zLTEtMS0xNDcxNTc_24cfb292-cc12-4d73-ab0f-24bb7f277645"
      unitRef="usd">5588000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0xLTEtMS0xNDcxNTc_32706df2-6c6b-49e9-9152-e6b9960ca112"
      unitRef="usd">3522000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNS0zLTEtMS0xNDcxNTc_d9c0255e-2bbe-419b-afec-ea3adf408a4c"
      unitRef="usd">3228000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNi0xLTEtMS0xNDcxNTc_9f9c5d51-8f0a-476d-af16-47a42abc2a95"
      unitRef="usd">2361000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RhYmxlOjI4YWRlMTMyMjk4ODQ5MzY5NmZiYjJkNTI2YzVhOTc4L3RhYmxlcmFuZ2U6MjhhZGUxMzIyOTg4NDkzNjk2ZmJiMmQ1MjZjNWE5NzhfNi0zLTEtMS0xNDcxNTc_4e52a283-b0c1-4128-beca-f3ad3b23e315"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTA1NTI_9f80eda2-d172-42e1-b477-b7ca1671c08d"
      unitRef="number">0.04</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDk_2ba23c5f-e4c3-47dd-b1ea-54a041841fd3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually or when indicators of impairment exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased goodwill is tested for impairment at least annually. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We have elected to bypass the qualitative assessment for our annual goodwill impairment test in the current year. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. These operating segments are comprised of divisions (components), for which discrete financial information is available. Components are aggregated into reporting units for purposes of goodwill impairment testing to the extent that they share similar economic characteristics. Our reporting units are: Pharmaceutical operating segment (excluding our Nuclear and Precision Health Solutions division); Nuclear and Precision Health Solutions division; Medical operating segment (excluding our Cardinal Health at-Home Solutions division) (&#x201c;Medical Unit&#x201d;); and Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value can be determined using market, income or cost-based approaches. Our determination of estimated fair value of the reporting units is based on a combination of the income-based and market-based approaches. Under the income-based approach, we use a discounted cash flow model in which cash flows anticipated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over several future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate risk-adjusted rate of return.&#160;We use our internal forecasts to estimate future cash flows, which we believe are consistent with those of a market participant, and include an estimate of long-term growth rates based on our most recent views of the long-term outlook for each reporting unit. Actual results may differ materially from those used in our forecasts. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in our internally-developed forecasts. Discount rates used in our reporting unit valuations ranged from 10 to 12 percent. Under the market-based guideline public company method, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units. To further confirm fair value, we compare the aggregate fair value of our reporting units to our total market capitalization.&#160;Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including forecasted operating results. The use of alternate estimates and assumptions or changes in the industry or peer groups could materially affect the determination of fair value for each reporting unit and potentially result in goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed annual impairment testing in fiscal 2022, 2021 and 2020 and with the exception of our Medical Unit in fiscal 2022, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. As discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the "Notes to Consolidated Financial Statements," during fiscal 2022, we recognized goodwill impairment charges related to our Medical Unit of $2.1&#160;billion, respectively, which are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings. There were tax benefits related to these goodwill impairment charges. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment test for indefinite-lived intangibles other than goodwill involves first assessing qualitative factors to determine if it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. If so, then a quantitative test is performed to compare the estimated fair value of the indefinite-lived intangible asset to the respective asset's carrying amount. Our qualitative evaluation requires the use of estimates and significant judgments and considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, primarily customer relationships; trademarks, trade names and patents; and developed technology, are amortized using a combination of straight-line and accelerated &lt;/span&gt;&lt;/div&gt;methods based on the expected cash flows from the asset over their estimated useful lives. We review intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of the future forecasted undiscounted cash flows expected to be generated by the asset group. Actual results may differ materially from those used in our forecasts.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTE4MTE_5e64b6dc-eba0-4a58-b5d9-13dcb65de422"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTE4MTE_765cef87-0218-4706-871c-886e2c395149"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <cah:DiscountRatefairvalueinputs
      contextRef="if7b94df96dcb405c8d89f9db2d27c10d_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTM1NTU_f2804057-730d-432d-a92e-8ff8c9a327ec"
      unitRef="number">0.10</cah:DiscountRatefairvalueinputs>
    <cah:DiscountRatefairvalueinputs
      contextRef="iedffdcab04ad4db0a736714c13d028c5_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTM1NjE_d91a8988-0044-461b-a56f-a2f8aa06897a"
      unitRef="number">0.12</cah:DiscountRatefairvalueinputs>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTQ1NjU_c008bc39-a9dc-428e-b3fd-4f29bee02e4c"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTQ1NjU_c79764f4-745e-4e2b-a494-0f74596fcff6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNjU5NzA2OTgxOTgyOA_45ba1b67-4027-473a-b19d-a383f27d9d7a"
      unitRef="usd">2100000000</us-gaap:GoodwillImpairmentLoss>
    <cah:AssetsHeldforSalePolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTQ_ddf22f2f-6622-47c6-8f79-ae3d115ce6c8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify assets and liabilities (the &#x201c;disposal group&#x201d;) as held for sale when management commits to a plan to sell the disposal group in its present condition and at a price that is reasonable in relation to its current fair value. We also consider whether an active program to locate a buyer has been initiated and if it is probable that the sale will occur within one year without significant changes to the plan to sell. Upon classification of the disposal group as held for sale, we test the assets for impairment and cease related depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 12, 2021, we signed a definitive agreement with Hellman &amp;amp; Friedman to sell the Cordis business. Upon signing the agreement, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. In August 2021, we sold the Cordis business to Hellman &amp;amp; Friedman for proceeds of $923 million net of cash transferred, and we retained certain working capital accounts and certain liabilities. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information. Cardinal Health retained product liability associated with lawsuits and claims related to inferior vena cava ("IVC") filters in the U.S. and Canada, as well as authority for these matters discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements.&#x201d;&lt;/span&gt;&lt;/div&gt;</cah:AssetsHeldforSalePolicyPolicyTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="idce5118955de4439a550969fa0cc542c_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTY5NDY_aeec2005-8505-460c-8c2c-9d52998ddb06"
      unitRef="usd">923000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTE_5fd2d286-cd6a-4caa-84a4-972b6ef9fdb6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in non-marketable equity securities are accounted for under the fair value, equity or net asset value method of&#160;accounting and are included in other assets in the consolidated balance sheets. For equity securities without a readily determinable fair value, we use the fair value measurement alternative and measure the securities at cost less impairment, if any, including adjustments for observable price changes in orderly transactions for an identical or similar investment of the same issuer. For investments in which we can exercise significant influence but do not control, we use the equity method of accounting. Our share of the earnings and losses are recorded in other (income)/expense, net in the consolidated statements of earnings/(loss). We monitor our investments for impairment&#160;by considering factors such as the operating performance of the investment and current economic and market conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4ODcwMA_f7893a6a-17ff-4923-9665-1959d4906a8d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating leases are primarily for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at its inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our consolidated balance sheets at lease commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements contain lease components and non-lease components. For all asset classes, we have elected to account for both of these components as a single lease component. We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the consolidated financial statements at or for the fiscal years ended June&#160;30, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in fiscal 2022, 2021, and 2020 was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases have remaining lease terms from less than 1 year up to approximately 20 years. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_112" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Notes to Consolidated Financial Statements&#x201d; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NTc0MA_f84b2d23-e8ba-4fd3-b6f7-4d5882ca6b82">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfNTQ5NzU1ODE4NTc2Ng_52c04bf0-667d-458e-bd96-a99a511a2647">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <cah:CostofSalesVendorReservesPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODU_803ee605-bee0-4933-91c1-4e64281a1b44">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Vendor Reserves&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, our vendors may dispute deductions taken against payments otherwise due to them or assert other disputes. These disputes are researched and resolved based upon the findings of the research performed. At any given time, there are outstanding items in various stages of research and resolution. In determining appropriate reserves for areas of exposure with our vendors, we assess historical experience and current outstanding claims. We have established various levels of reserves based on the type of claim and status of review. Though the claim types are relatively consistent, we periodically update our reserve estimates to reflect actual historical experience. The ultimate outcome of certain claims may be different than our original estimate and may require an adjustment. Adjustments to vendor reserves are included in cost of products sold. In addition, &lt;/span&gt;&lt;/div&gt;the reserve balance will fluctuate due to variations of outstanding claims from period-to-period, timing of settlements and specific vendor issues. Vendor reserves were $105 million and $77 million at June&#160;30, 2022 and 2021 respectively, excluding third-party returns. See Third-Party Returns section within this Note for a description of third-party returns.</cah:CostofSalesVendorReservesPolicyPolicyTextBlock>
    <cah:VendorReserves
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTk0MjE_84c2e177-54df-45e8-b280-4dd95a2a7dcf"
      unitRef="usd">105000000</cah:VendorReserves>
    <cah:VendorReserves
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzI5ODUzNDkyMjI3Nw_3af308c2-539b-413b-acb5-4d83be0ad30a"
      unitRef="usd">77000000</cah:VendorReserves>
    <cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTM_3f772ffd-2a56-4249-8477-b7a4feca0a24">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Distribution Services Agreement and Other Vendor Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment recognizes fees received from distribution services agreements and other fees received from vendors related to the purchase or distribution of the vendors&#x2019; inventory when those fees have been earned and we are entitled to payment. Since the benefit provided to a vendor is related to the purchase and distribution of the vendor&#x2019;s inventory, we recognize the fees as a reduction in the carrying value of the inventory that generated the fees, and as such, a reduction of cost of products sold in our consolidated statements of earnings/(loss) when the inventory is sold.&lt;/span&gt;&lt;/div&gt;</cah:DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NjM_cb26c444-a8a1-4238-a346-2615b88599f4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Loss Contingencies and Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the opioid litigation as described further in the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recorded pre-tax charges of $1.17&#160;billion and $5.63 billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021 and 2020, respectively, which were retained at Corporate. In February 2022, we and two other national distributors announced that each company had determined that a sufficient number of political subdivisions had agreed to participate in the previously disclosed settlement agreement (the "Settlement Agreement") to settle the vast majority of the opioid lawsuits filed by states and local governmental entities. This Settlement Agreement became effective on April 2, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop and periodically update reserve estimates for the IVC claims, including those received to date and expected to be received in the future and related costs. To project future IVC claim costs, we use a methodology based largely on recent experience, including claim filing rates, estimated indemnity severity by claim type, historical sales data, implant and injury to report lag patterns and estimated defense costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of ultimate loss may differ materially from these estimates. We recognize these estimated loss contingencies, income from favorable resolution of litigation and certain defense costs in litigation (recoveries)/charges in our consolidated statements of earnings/(loss). See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding loss contingencies and product liability lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We self-insure for employee healthcare, general liability, certain product liability matters, auto liability, property and workers' compensation. Self-insurance accruals include an estimate for expected settlements or pending claims, defense costs, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;administrative fees, claim adjustment costs and an estimate for claims incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies and other liabilities is highly subjective and requires judgments about future&#160;events. We regularly review contingencies and our self-insurance accruals to determine whether our accruals and related disclosures are adequate. Any adjustments for changes in reserves are recorded in the period in which the change in estimate occurs.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LitigationSettlementExpense
      contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTIwOTQ2Mjc5NTUyNjQ_a222c96c-009b-42fc-abc1-1161d3c2568a"
      unitRef="usd">1170000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMTIwOTQ2Mjc5NTUyNzI_add96698-bb05-402d-a363-7d8b0449b70a"
      unitRef="usd">5630000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODc_a6732632-f4e7-4c78-a5c8-53cd1acfe58b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.&lt;/span&gt;&lt;/div&gt;From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June&#160;30, 2022.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NTc_f1b57541-c283-4dc8-bd57-0ff1576d3119">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. We assess the realizability of deferred tax assets on a quarterly basis and provide a valuation allowance for deferred tax assets when it is more likely than not that at least a portion of the deferred tax assets will not be realized. The realizability of deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction and also considers all available positive and negative evidence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes for non-U.S. liabilities are not provided on the unremitted earnings of subsidiaries outside of the United States&#160;when it is expected that these earnings are indefinitely reinvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation processes. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_121" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NDY_b1b1035e-a6af-42c7-b63f-302fd668ad16">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities represent various current obligations, including certain accrued operating expenses and taxes payable.&lt;/span&gt;&lt;/div&gt;</cah:OtherAccruedLiabilitiesPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTk_18b7c422-1390-4d39-aab6-9fe99c48e73c">Noncontrolling InterestsNoncontrolling interests represent the portion of net earnings, comprehensive income and net assets that is not attributable to Cardinal Health, Inc.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MDQ_4f47d46b-22c6-4440-abde-48907b1c6491">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation provided to employees is recognized in the consolidated statements of earnings/(loss) based on the grant date fair value of the awards. The fair value of restricted share units and performance share units is determined by the grant date market price of our common shares. The fair value of stock options is determined on the grant date using a lattice valuation model. The compensation expense associated with nonvested performance share units is dependent on our periodic assessment of the probability of the targets being achieved and our estimate, which may vary over time, of the number of shares that ultimately will be issued. The compensation expense recognized for share-based awards is net of estimated forfeitures and is recognized ratably over the service period of the awards. All income tax effects of share-based awards are recognized in the consolidated statements of earnings/(loss) as awards vest or are settled. We classify share-based compensation expense in distribution, selling, general and administrative ("SG&amp;amp;A") expenses to correspond with the same line item as the majority of the cash compensation paid to employees. If awards are modified in connection with a restructuring activity, the incremental share-based compensation expense is classified in restructuring and employee severance. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding share-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cah:DividendsPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4NTI_2ae458b4-9d88-460f-932a-528d6f1a109e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We paid cash dividends per common share of $1.96, $1.94 and $1.92 in fiscal 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</cah:DividendsPolicyPolicyTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MTQ_58e74017-b754-4127-8d18-da1d4426887c"
      unitRef="usdPerShare">1.96</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MTg_3d659ab0-ce79-4558-b97c-b7334dbeb6bb"
      unitRef="usdPerShare">1.94</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMjc3MjU_b506d121-ea2a-4375-8d25-51f77657cafe"
      unitRef="usdPerShare">1.92</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3NjU_3aeb56c8-2f30-4bcb-89c0-a0ff7c524415">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue in an amount that reflects the consideration to which we expect to be entitled in exchange for the transfer of goods or services to customers.&lt;/span&gt;&lt;/div&gt;Revenue in both segments is primarily related to the distribution of pharmaceutical and medical products, which include both manufactured and sourced products, and we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Service revenues are recognized over the period that services are provided to the customer. Revenues derived from services are not material for either segment for all periods presented.We are generally the principal in a transaction, therefore our revenue is primarily recorded on a gross basis. When we are a principal in a transaction, we have determined that we control the ability to direct the use of the product or service prior to transfer to a customer, are primarily responsible for fulfilling the promise to provide the product or service to our customer, have discretion in establishing prices, and ultimately control the transfer of the product or services provided to the customer.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <cah:SalesreturnsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MTQ_bd9fe41f-4658-4935-85ff-19b753066ca2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Sales Returns and Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive, reduced by estimates for return allowances, discounts, rebates and other variable consideration. Sales returns are recorded based on estimates using historical data. Our customer return policies generally require that the product be physically returned, subject to restocking fees. We only allow customers to return products for credit in a condition suitable to be added back to inventory and resold at full value (&#x201c;merchantable product&#x201d;) or returned to vendors for credit. Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At June&#160;30, 2022 and 2021, the accrual for estimated sales returns and allowances was $617 million and $689 million, respectively, which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were $2.4 billion, $2.6 billion and $2.3 billion, for fiscal 2022, 2021 and 2020, respectively, and the net impact on net earnings/(loss) in the consolidated statements of earnings/(loss) was immaterial in fiscal 2022, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Third-Party Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not accept non-merchantable pharmaceutical product returns from our customers, so many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction). We, in turn, pass the value received to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect &lt;/span&gt;&lt;/div&gt;or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</cah:SalesreturnsPolicyTextBlock>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAxMDU_fdaa4f1f-6c15-46e7-be20-d2364accd657"
      unitRef="usd">617000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <cah:RevenueRecognitionReserveforSalesReturnsandAllowances
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAxMTI_f5696bba-884a-4027-b0ae-f05c13eb618f"
      unitRef="usd">689000000</cah:RevenueRecognitionReserveforSalesReturnsandAllowances>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNjY_a18b7577-ea2d-4cad-b6d1-00eac2035958"
      unitRef="usd">2400000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNzA_d176d1c3-77d0-41d6-a16c-15fa2fffa7db"
      unitRef="usd">2600000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzAyNzc_f5c11f63-f234-4cd8-bc2e-8b42733fb6da"
      unitRef="usd">2300000000</us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns>
    <cah:ShippingandHandlingCostsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTU_1dac3697-bf52-411d-98f7-3ef5c6a7f922">Shipping and HandlingShipping and handling costs are primarily included in SG&amp;amp;A expenses in our consolidated statements of earnings/(loss) and include all delivery expenses as well as all costs to prepare the product for shipment to the end customer. Shipping and handling costs were $748 million, $634 million and $620 million, for fiscal 2022, 2021 and 2020, respectively.</cah:ShippingandHandlingCostsPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i16a1465dba6b406da9f48c90f84ff2fb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3NjM_452e8e5f-c0f9-4d22-b5b8-bfdd8783a039"
      unitRef="usd">748000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i546d299bf20c4b749073124f61b96f80_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3Njc_ae778e78-282f-4de6-a54b-e001550f9ad9"
      unitRef="usd">634000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1114e2457f3f4ea59b1038c632c920f6_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzE3NzQ_1f4f73c8-1818-4197-a5a0-aacd90981106"
      unitRef="usd">620000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTE_b8831882-a046-4e13-a575-4e75b6ec9464">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restructuring and Employee Severance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring activities are programs that are not part of the ongoing operations of our underlying business, such as divestitures, closing and consolidating facilities, changing the way we manufacture or distribute our products, moving manufacturing of a product to another location, changes in production or business process outsourcing or insourcing, employee severance (including rationalizing headcount or other significant changes in personnel) and realigning operations (including realignment of the management structure in response to changing market conditions). Also included within restructuring and employee severance are employee severance costs that are not incurred in connection with a restructuring activity. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_103" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 3&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our restructuring activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3ODg_07b17ad5-4864-44c1-a29b-ddd744a3f746">Amortization and Other Acquisition-Related Costs&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify certain costs incurred in connection with acquisitions as amortization and other acquisition-related costs in our consolidated statements of earnings/(loss). These costs consist of amortization of acquisition-related intangible assets, transaction costs, integration costs and changes in the fair value of contingent consideration obligations. Transaction costs are incurred during the initial evaluation of a potential acquisition and primarily relate to costs to analyze, negotiate and consummate the transaction as well as due diligence activities. Integration costs relate to activities required to combine the operations of an acquired enterprise into our operations and, in the case of the Cordis and Patient Recovery businesses, to stand-up the systems and processes needed to support an expanded geographic footprint. We record changes in the fair value of contingent consideration obligations relating to acquisitions as income or expense in amortization and other acquisition-related costs. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt; for additional information regarding amortization of acquisition-related intangible assets.</cah:AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4OTI_b584b9e1-a519-4339-b54f-b004c76dc99c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial statements of our subsidiaries outside the United States&#160;are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of these foreign subsidiaries into U.S.&#160;dollars are accumulated in shareholders&#x2019; equity through accumulated and other comprehensive loss ("AOCI") utilizing period-end exchange rates. Revenues and expenses of these foreign subsidiaries are translated using average exchange rates during the year.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The foreign currency translation gains/(losses) included in AOCI at June&#160;30, 2022 and 2021 are presented in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_130" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 11&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Foreign currency transaction gains and losses for the period are included in the consolidated statements of earnings/(loss) in the respective financial statement line item.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg4MzQ_d5a88531-4bbc-4b7b-ba63-760d7932b03f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate, Currency and Commodity Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders&#x2019; equity through AOCI, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract&#x2019;s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments received from the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_127" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 10&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3Njc_cb967f29-c1c1-434c-8d5a-59413d477190">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received upon selling an asset or the price paid to transfer a liability on the measurement date. It focuses on the exit price in the principal or most advantageous market for the asset or liability in an orderly transaction between willing market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 -&#160;&#160;&#160;&#160;Observable prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 -&#160;&#160;&#160;&#160;Observable inputs other than quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 -&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_124" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 9&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN185Ny9mcmFnOjgxOWFiNWNhYTM0MzQwNGM4MWRjZTNjNWUyMGQwOWM5L3RleHRyZWdpb246ODE5YWI1Y2FhMzQzNDA0YzgxZGNlM2M1ZTIwZDA5YzlfMzg3OTc_683ff95e-5a10-462e-8d0f-af8b8ec9ba3b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no accounting standards adopted in fiscal 2022 that had a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the adoption impacts of recently issued accounting standards by the FASB on our consolidated financial statements as well as material updates to previous assessments, if any, from our fiscal 2021 Form 10-K. There were no accounting standards issued in fiscal 2022 that will have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4NTg_8260b209-7b81-420e-9e98-0b3e6753734a">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;2. Divestitures and Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cordis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, we sold the Cordis business to Hellman &amp;amp; Friedman for proceeds of $923 million, net of cash transferred, and we retained certain working capital accounts and certain liabilities. Cardinal Health retained product liability associated with lawsuits and claims related to IVC filters in the U.S. and Canada, as well as authority for these matters discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Cordis business operated within our Medical segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we met the criteria for the related assets and liabilities of the Cordis business to be classified as held for sale. We determined that the sale of the Cordis business did not meet the criteria to be classified as discontinued operations. In connection with the divestiture, we recognized a $60&#160;million pre-tax loss in impairments and (gain)/loss on disposal of assets in our consolidated statement of earnings/(loss) in fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;naviHealth&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we sold our majority ownership interest in naviHealth, which operated within our Medical segment in exchange for cash proceeds of $737 million (after adjusting for certain fees and expenses) and a noncontrolling equity interest in a partnership that owned naviHealth. We also had certain call rights to reacquire naviHealth. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020 we sold the remainder of our noncontrolling equity interest in a partnership that owned naviHealth. We recognized a pre-tax gain of $579&#160;million from this disposal in gain on sale of equity interest in naviHealth in our consolidated statements of earnings/(loss) during fiscal year 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not complete any acquisitions during fiscal 2020. While we completed small acquisitions during fiscal 2022 and 2021, the pro forma results of operations and the results of operations for acquired businesses since the acquisition dates have not been separately disclosed because the effects were not significant compared to the consolidated financial statements, individually or in the aggregate. The cash paid for these acquisitions, net of cash acquired was $22 million and $3 million for fiscal 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5735c211d1fd471db52d24b85e925378_D20210802-20210802"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzQwOQ_d9f1c18c-5768-4925-a09f-f8b38d49e3b8"
      unitRef="usd">923000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <cah:WriteDownOfAssetsHeldForSale
      contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzY1OTcwNjk3NzQ5OTk_7bad20bc-0a3e-49e9-8cfc-17a58b49a584"
      unitRef="usd">60000000</cah:WriteDownOfAssetsHeldForSale>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ia4cc2b4bbaa0449790c4c94fb3395ed8_D20180801-20180831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzIwODk_be02e403-a9f4-458c-a862-5a07f4f37194"
      unitRef="usd">737000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="i28546e72017346d28b45df1b4a2b2885_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzI5NjU_5cb2d145-1828-4c3a-bd9a-4f94c483fcbe"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4MTQ_395b367c-6266-43d1-84e5-7d81295c5d30"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDAvZnJhZzplNzY1YmRkZTE2NmI0MTFjOTdhODY2MTBhMWMzNGZiMi90ZXh0cmVnaW9uOmU3NjViZGRlMTY2YjQxMWM5N2E4NjYxMGExYzM0ZmIyXzM4MjE_e47fac4b-fb0c-421f-93ea-34b4fe3f1f37"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExODc_0f6a2d23-872b-44cf-8019-2e5259f9db62">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;3. Restructuring and Employee Severance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility exit and other costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods. Facility exit and other costs primarily consist of accelerated depreciation, lease costs associated with vacant facilities, professional, project management and other service fees to support divestitures, vendor transition fees, project consulting fees, and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2022 and 2021, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures, which includes facility exit costs related to decreasing our overall office space, and the divestiture of the Cordis business. In fiscal 2020, restructuring costs were primarily related to the implementation of certain enterprise-wide cost-savings measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-&lt;br/&gt;Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility Exit&lt;br/&gt;and Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExNzU_e0b91c3e-1342-47b9-b6b7-cef978e4b409">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility exit and other costs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtMS0xLTEtMTQ3MTU3_4b5c1a70-4cca-433a-8439-183f1701a383"
      unitRef="usd">35000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtMy0xLTEtMTQ3MTU3_f6e43588-cc35-4e0f-a5d2-e16f2c04f699"
      unitRef="usd">53000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzEtNS0xLTEtMTQ3MTU3_cb071aa3-1b7b-4a6c-a65c-37f3b4da6cb8"
      unitRef="usd">66000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItMS0xLTEtMTQ3MTU3_73928f81-6c75-47d4-bc8e-a8c97aececd7"
      unitRef="usd">66000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItMy0xLTEtMTQ3MTU3_3ecfc601-7381-4670-b780-cac12184693a"
      unitRef="usd">61000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzItNS0xLTEtMTQ3MTU3_f9661e65-5a64-4fc7-98ce-2bad796770bd"
      unitRef="usd">56000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtMS0xLTEtMTQ3MTU3_325c4f34-56ad-46f2-845f-c129a3c82284"
      unitRef="usd">101000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtMy0xLTEtMTQ3MTU3_111d1f84-89b7-4dd5-8b0f-73c6a09f6258"
      unitRef="usd">114000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTpiYzNmOWYwZWQxMmI0MjNlYTExYThlNmRhMDlhYTQ4Yi90YWJsZXJhbmdlOmJjM2Y5ZjBlZDEyYjQyM2VhMTFhOGU2ZGEwOWFhNDhiXzMtNS0xLTEtMTQ3MTU3_9a5908ca-e532-4381-b4df-e4d30b490847"
      unitRef="usd">122000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90ZXh0cmVnaW9uOjZiYmZhYWRjOGViMzRlNjA5ZDI3NjY3ZjgzNjQ3YjY0XzExNjM_4cd41e73-612f-4385-a974-a90eb0571f4d">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee-&lt;br/&gt;Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility Exit&lt;br/&gt;and Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="id264d3093a7a4580ad949f73349b6a5c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtMS0xLTEtMTQ3MTU3_809f4a73-8a00-431d-bdc3-6e394e13811e"
      unitRef="usd">68000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9cf2368a61474f8f89d5d38fec24f64f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtMy0xLTEtMTQ3MTU3_2042746a-1dee-4f52-a75d-b5370ce46a03"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzEtNS0xLTEtMTQ3MTU3_0e876cfc-ca5f-4007-94c6-f82aee6bb021"
      unitRef="usd">96000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItMS0xLTEtMTQ3MTU3_b305d0d3-bf2b-455a-8676-807d482f9134"
      unitRef="usd">49000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ied971d2805b0409083a7c40b38503d50_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItMy0xLTEtMTQ3MTU3_42de5b92-5962-4589-84f7-e861aa5f9010"
      unitRef="usd">26000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzItNS0xLTEtMTQ3MTU3_29e8c7c9-fe3c-4c80-8007-dee599231ef1"
      unitRef="usd">75000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b70f3dd25fe4016b59be89fe7f5c11c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtMS0xLTEtMTQ3MTU3_a843d81f-9c70-4723-9dd3-560a0846b4bc"
      unitRef="usd">64000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ied971d2805b0409083a7c40b38503d50_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtMy0xLTEtMTQ3MTU3_211bdfec-b65d-4e51-a244-b23cb4ab4e1f"
      unitRef="usd">28000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzMtNS0xLTEtMTQ3MTU3_7ea732c0-0f37-4d6e-8262-8aae4be9ae00"
      unitRef="usd">92000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i0092967ac5424faf8778330ec9444ee4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtMS0xLTEtMTQ3MTU3_1989b474-3660-494a-9b47-03625fdd031b"
      unitRef="usd">53000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i75c1fef25e9e4f83a31d3467e3e59555_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtMy0xLTEtMTQ3MTU3_c9dbc1a5-c3b9-4bb5-b312-d9b6e7321cc2"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzQtNS0xLTEtMTQ3MTU3_97bc1d3f-dea2-4dd7-9404-66aa5cfe147c"
      unitRef="usd">79000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtMS0xLTEtMTQ3MTU3_9c552f79-352f-4148-96a7-23589d609465"
      unitRef="usd">49000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtMy0xLTEtMTQ3MTU3_c22d8ab5-c0f4-4677-9d3e-8dd33ad906e9"
      unitRef="usd">10000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzUtNS0xLTEtMTQ3MTU3_677d97e6-333a-4f58-94ec-59a2879b8a9e"
      unitRef="usd">59000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie36954d6d5194aa0a0ca460268c054b2_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtMS0xLTEtMTQ3MTU3_8bdf7b8a-f04e-4fcd-8552-692e14f96821"
      unitRef="usd">46000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7714a40ff5584b62b9bf328b04a5c727_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtMy0xLTEtMTQ3MTU3_f0fe8514-86bd-461e-94ee-c69aeac1a9f8"
      unitRef="usd">26000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzYtNS0xLTEtMTQ3MTU3_ad861415-47d0-4cd1-9df1-501e4008dcd6"
      unitRef="usd">72000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="icbd545e35312405cb520c9f72a124131_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctMS0xLTEtMTQ3MTU3_207287bc-8d16-47cc-b852-5119a312c41d"
      unitRef="usd">56000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i002c719a8c5b420b8af67195661dda98_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctMy0xLTEtMTQ3MTU3_16a194b7-b92b-4726-8ce7-e10f2269300e"
      unitRef="usd">10000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDMvZnJhZzo2YmJmYWFkYzhlYjM0ZTYwOWQyNzY2N2Y4MzY0N2I2NC90YWJsZTowYTliNTdiMDE1Yzg0MjhiOGUzMDI5ZTUwODk5NWI4Mi90YWJsZXJhbmdlOjBhOWI1N2IwMTVjODQyOGI4ZTMwMjllNTA4OTk1YjgyXzctNS0xLTEtMTQ3MTU3_73bde5cd-c386-483c-9fb6-627ec807b50f"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzEwMjE_bb3c53da-d79d-4f43-973a-f1c0e4f60625">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;4. Goodwill and Other Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.801%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis goodwill reclassified to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Medical segment accumulated goodwill impairment loss was $3.5 billion and $1.4 billion, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, the Medical Unit experienced adverse financial results related to inflationary impacts and the adverse impact of global supply chain constraints and lower volumes from PPE. Due to the risks and uncertainties related to these impacts and an increase in the risk-free interest rate used in the discount rate, we elected to bypass the qualitative assessment and perform quantitative goodwill impairment testing for the Medical Unit at June&#160;30, 2022. This quantitative testing resulted in the carrying amount of the Medical Unit exceeding the fair value, resulting in a pre-tax impairment charge of $303 million and cumulative pre-tax impairment charges of $2.1&#160;billion recognized during fiscal 2022, due to the impairment charges recognized during the third and second quarters of fiscal 2022 as described further below. This impairment charge was driven by an increase in the discount rate primarily due to an increase in the risk-free interest rate. Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach and the market-based approach. For this testing performed at June&#160;30, 2022, we used a discount rate of 10 percent and a terminal growth rate of 2 percent. The goodwill balance of the Medical Unit, after recognizing the impairment, was $1.9 billion at June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third and second quarters of fiscal 2022, we performed interim goodwill impairment testing for the Medical Unit at March 31, 2022 and December 31, 2021, which resulted in pre-tax impairment charges of $1.3&#160;billion and $474&#160;million, which were recognized during the second and third quarters of fiscal 2022, respectively, and are included in impairments and (gain)/loss on disposal of assets in our consolidated statements of earnings/(loss). Our determination of the estimated fair value of the Medical Unit is based on a combination of the income-based approach &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(using a terminal growth rate of 2 percent), and the market-based approach. For the income-based approach, we also used discount rates of 9 percent and 9.5 percent for the interim testing during the second and third quarters of fiscal 2022, respectively. The increase in the discount rate was primarily due to an increase in the risk-free interest rate. Our fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the divestiture of the Cordis business, during fiscal 2021 we allocated and reclassified $388 million of goodwill from the Medical Unit (within our Medical Segment) to the Cordis disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;574&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;464&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,763&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,774&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;Total amortization of intangible assets was $311 million, $428 million and $512 million for fiscal 2022, 2021 and 2020, respectively. The estimated annual amortization for intangible assets for fiscal 2023 through 2027 is as follows: $283 million, $260 million, $235 million, $208 million and $175 million.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk5MQ_4b737215-e43f-40d9-b3d8-431eba12eb98">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.801%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cordis goodwill reclassified to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,182&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2.5pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Pharmaceutical segment accumulated goodwill impairment loss was $829 million.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;At June&#160;30, 2022 and 2021, the Medical segment accumulated goodwill impairment loss was $3.5 billion and $1.4 billion, respectively.</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="if25aa8308d1943b59cbe926e3c5d3649_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtMS0xLTEtMTQ3MTU3_f9fcc405-021b-476c-90cc-c50ae158fec2"
      unitRef="usd">2657000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2f92afd839604684abe9404d6d95434d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtMy0xLTEtMTQ3MTU3_fe922605-7c95-4723-b020-aba003009201"
      unitRef="usd">5700000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEtNS0xLTEtMTQ3MTU3_02fed061-3a1c-4989-95d6-7f9dcab71479"
      unitRef="usd">8357000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItMS0xLTEtMTQ3MTU3_6f510d56-0d8d-4733-8c1e-e23990dd2635"
      unitRef="usd">2000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItMy0xLTEtMTQ3MTU3_f9388e91-fe7f-480e-b26d-b0afeb176e4f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzItNS0xLTEtMTQ3MTU3_833b942f-aa76-4e90-85df-5b7cb1eb59fc"
      unitRef="usd">2000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0733fcbf7c9547fcacb30abc3e2a7004_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtMS0xLTEtMTQ3MTU3_4e50cc08-3844-4687-8b46-5cf8ca203885"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3b92b1280b58448f8ab58abac4478e6f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtMy0xLTEtMTQ3MTU3_a04cbc9c-fa93-466d-af87-112c80bfae86"
      unitRef="usd">18000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzMtNS0xLTEtMTQ3MTU3_1f65ea76-8a57-41f5-acb5-7eb084a06171"
      unitRef="usd">18000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="ib9fc6bbba81b4a1ca1be4f2ccbed4b27_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtMS0xLTEtMTQ3MTU3_152e13fe-7095-4ce5-a555-440da2cd44d5"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtMy0xLTEtMTQ3MTU3_2792ad04-717c-4bfb-a0f0-83186c7d52c6"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzUtNS0xLTEtMTQ3MTU3_10489cf9-796d-4dde-a476-302c536ceffb"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:Goodwill
      contextRef="i2570c791ecea44d9bc344bd115d28c3c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctMS0xLTEtMTQ3MTU3_01152ede-aa30-4a7f-be28-20e071f97df5"
      unitRef="usd">2659000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctMy0xLTEtMTQ3MTU3_b7cf6251-a262-4c4b-bada-7229c909f4ae"
      unitRef="usd">5330000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzctNS0xLTEtMTQ3MTU3_f5e6a82e-f2dc-4d70-b41d-c4603d695735"
      unitRef="usd">7989000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtMS0xLTEtMTQ3MTU3_e1175a5d-6517-4b43-87d1-00ba7e0e0bff"
      unitRef="usd">14000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtMy0xLTEtMTQ3MTU3_dede11a7-2e7f-4c7a-a88b-ea9ad9619379"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzgtNS0xLTEtMTQ3MTU3_939ab85a-c58c-42c3-ab25-e3fede70cffe"
      unitRef="usd">14000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktMS0xLTEtMTQ3MTU3_e1ceb4b5-0aa0-4075-b3fe-9610b659a1a4"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktMy0xLTEtMTQ3MTU3_d6ab9224-0453-4809-8292-0bf2341b248f"
      unitRef="usd">-64000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzktNS0xLTEtMTQ3MTU3_fe03d9d0-5b54-431c-beab-7eef733fb87a"
      unitRef="usd">-64000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTEtMS0xLTE0NzE1Nw_c068a20b-4193-4c28-bd44-0da8c3ae9882"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7ae2ba9ac41e4bd7b7fc5575b840e63f_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTMtMS0xLTE0NzE1Nw_bec1018c-e7d5-48b9-a41f-720d008be733"
      unitRef="usd">2084000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzEwLTUtMS0xLTE0NzE1Nw_381a36da-90e8-4261-a3a2-4a33e261a75c"
      unitRef="usd">2084000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i1abfa91513984b189f3f0624a3d7175e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTEtMS0xLTE0NzE1Nw_e324b4f9-9371-4e59-ba2c-d1e220a83a8f"
      unitRef="usd">2673000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i59345f7aaab84656a49d8caf50ebe1b9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTMtMS0xLTE0NzE1Nw_eae2ff1b-3440-46dc-880b-8fcec7b4ad87"
      unitRef="usd">3182000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTphMmVkNjY4NzJhOWU0NzM3OGEzNDI1OGZlYWU3ZWRlZC90YWJsZXJhbmdlOmEyZWQ2Njg3MmE5ZTQ3Mzc4YTM0MjU4ZmVhZTdlZGVkXzExLTUtMS0xLTE0NzE1Nw_2e09aba2-2330-4fef-8761-4b8cdec16143"
      unitRef="usd">5855000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2570c791ecea44d9bc344bd115d28c3c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzIwOQ_69e97f42-534e-4aa3-81ce-febc27235533"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i1abfa91513984b189f3f0624a3d7175e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzIwOQ_ca50729c-4589-401d-b2af-b5978449df57"
      unitRef="usd">829000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i59345f7aaab84656a49d8caf50ebe1b9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzI5Mg_6c5f8100-1ed0-4a0e-8917-d524e3604741"
      unitRef="usd">3500000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i34e7302efd8e45e3b03cb4e73cbd3b7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIzMjY_a5a04856-ca85-4182-8379-04a4dbd6d840"
      unitRef="usd">1400000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3NzQzODE_9d541597-a71a-41de-9e16-87df6fad5b00"
      unitRef="usd">303000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA0OTU_45ba1b67-4027-473a-b19d-a383f27d9d7a"
      unitRef="usd">2100000000</us-gaap:GoodwillImpairmentLoss>
    <cah:DiscountRatefairvalueinputs
      contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MzE_ef74a9bf-19b2-49f3-ae0e-fe7fb2826cc0"
      unitRef="number">0.10</cah:DiscountRatefairvalueinputs>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_38e93912-92ee-4fa7-86a6-7feb120e3a92"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_41c41006-7af3-4ddf-9077-1fe5667a490c"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDY_d7eb36c4-122c-4b76-9b55-ec60127a3422"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <us-gaap:Goodwill
      contextRef="ifbeba755f36e4c298fc6035248db673b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3Nzg0ODk_ab717f91-f422-492f-8755-fefcb703b291"
      unitRef="usd">1900000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIxMDI_296b1589-54da-4219-8428-736e6e91ae7e"
      unitRef="usd">1300000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIxMTY_f27c6e1d-c46e-48e0-bc19-f9f659211a00"
      unitRef="usd">474000000</us-gaap:GoodwillImpairmentLoss>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_38e93912-92ee-4fa7-86a6-7feb120e3a92"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_41c41006-7af3-4ddf-9077-1fe5667a490c"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <cah:TerminalGrowthRateFairValueInput
      contextRef="i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1NDE_d7eb36c4-122c-4b76-9b55-ec60127a3422"
      unitRef="number">0.02</cah:TerminalGrowthRateFairValueInput>
    <cah:DiscountRatefairvalueinputs
      contextRef="i2e49f44ecf5d42f8b01e4269ceaa1f47_D20211001-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MTc_de36e96f-440e-4875-b9b6-05db3a4d6bdc"
      unitRef="number">0.09</cah:DiscountRatefairvalueinputs>
    <cah:DiscountRatefairvalueinputs
      contextRef="i971d0e29983e40d1a82c65e3792117f9_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzY1OTcwNjk3ODA1MTI_5ebb4422-ae67-47fa-a329-978ac1bc9ba0"
      unitRef="number">0.095</cah:DiscountRatefairvalueinputs>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzU0OTc1NTgxNDIzNDc_2792ad04-717c-4bfb-a0f0-83186c7d52c6"
      unitRef="usd">388000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzEwMDc_b7484b52-d6f6-48ec-b098-f3ea7fe47d88">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;574&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;464&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,763&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,774&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk4OQ_dafabb82-c0bd-4e9f-880e-631c8d30d85f">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize other intangible assets by class at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,038&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;574&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;464&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,763&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3,099&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,774&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Intangible&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks and patents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i111b02e3c4c4435d83e0af77b9189c58_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzMtMS0xLTEtMTQ3MTU3_36d15f6f-2cb9-4ecc-a7f9-1174c763556a"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i111b02e3c4c4435d83e0af77b9189c58_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzMtNS0xLTEtMTQ3MTU3_731829a4-64e0-4a30-b127-b3bd36c57127"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzQtMS0xLTEtMTQ3MTU3_103dabb9-926e-476e-8b6e-1bbcf6c9ef69"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzQtNS0xLTEtMTQ3MTU3_eaa0f40a-b475-44ad-b54b-aa92d181225c"
      unitRef="usd">11000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtMS0xLTEtMTQ3MTU3_6d618b92-115c-4720-9e57-046de288366e"
      unitRef="usd">3272000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtMy0xLTEtMTQ3MTU3_dcc4e400-fd54-48be-b978-c12f8c34c030"
      unitRef="usd">2165000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8996bc20f24448569a53dc1bb2b2c3e2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtNS0xLTEtMTQ3MTU3_2eab534b-8b2d-4d49-ba06-0b22d80dfe19"
      unitRef="usd">1107000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if9bb8d1c3bce41a4917f5b1276888172_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzYtNy0xLTEtMTQ3MTU3_4a0d166f-9b43-4fc0-902d-269f3570bb73">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctMS0xLTEtMTQ3MTU3_a6551cbf-8f1e-43bc-8edd-802e61338521"
      unitRef="usd">552000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctMy0xLTEtMTQ3MTU3_4ecb0d2c-c253-4d2f-b059-fe0146cd41ae"
      unitRef="usd">360000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6e89ba2935f840fa91b39e91552d9dc6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctNS0xLTEtMTQ3MTU3_bf094705-b6de-49f4-b311-5dd4e779b9a9"
      unitRef="usd">192000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i80fae599ff554c3fa75995b90567c93a_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzctNy0xLTEtMTQ3MTU3_a689c396-fd7d-4289-9b29-f7531423bbb7">P8Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtMS0xLTEtMTQ3MTU3_3c5bbb33-74b0-4507-8454-913ea7b0c2d9"
      unitRef="usd">1038000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtMy0xLTEtMTQ3MTU3_73ed8443-498a-42d9-86c4-98a5c0b9c16f"
      unitRef="usd">574000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib41241d46b104c50b08e484eb87e196f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtNS0xLTEtMTQ3MTU3_3892642d-abc4-4e3b-82b7-c7062b48ed44"
      unitRef="usd">464000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie7c528a8d9694aee94274e9b419173e7_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzgtNy0xLTEtMTQ3MTU3_543ca5bb-0e54-4e3e-b50a-8cc8bf690a12">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktMS0xLTEtMTQ3MTU3_e4f6c73b-c1bd-47b5-a4d2-aae0f774695c"
      unitRef="usd">4862000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktMy0xLTEtMTQ3MTU3_ddfb4bd4-c59d-406a-b837-57d9e6c53828"
      unitRef="usd">3099000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktNS0xLTEtMTQ3MTU3_1837dc20-0914-4a85-8e53-a816a922ba49"
      unitRef="usd">1763000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzktNy0xLTEtMTQ3MTU3_b07b667f-e069-4e87-a4fd-05f53b3eade6">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTEtMS0xLTE0NzE1Nw_7f29cde0-f101-4d0d-a014-1570aeab3cf5"
      unitRef="usd">4873000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTMtMS0xLTE0NzE1Nw_0f6f955d-7702-41c0-8dec-fdd10bf74790"
      unitRef="usd">3099000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTpkMmFhMDhjMzBhNmI0NTBhYWQyYTlkNmU4NjFhZjA3NS90YWJsZXJhbmdlOmQyYWEwOGMzMGE2YjQ1MGFhZDJhOWQ2ZTg2MWFmMDc1XzEwLTUtMS0xLTE0NzE1Nw_5902ae49-bded-4f10-bc91-3c4c0e99d684"
      unitRef="usd">1774000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0d56789271704cc391e10e73a9dc6d56_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzMtMS0xLTEtMTQ3MTU3_b8299432-7d7b-4068-9eaa-3b58711ed228"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i0d56789271704cc391e10e73a9dc6d56_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzMtNS0xLTEtMTQ3MTU3_43fa2953-6d63-4402-b55e-7cb3a344f228"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzQtMS0xLTEtMTQ3MTU3_d63ef1f1-a79f-4d33-8c1c-a4a2ce17b29d"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzQtNS0xLTEtMTQ3MTU3_5705415c-b6d0-4f76-927c-450364609325"
      unitRef="usd">12000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtMS0xLTEtMTQ3MTU3_b3a1dea6-7a53-4589-9c82-80544d196e2d"
      unitRef="usd">3330000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtMy0xLTEtMTQ3MTU3_8dec28e7-4cca-4ad4-be9b-95f03f05afeb"
      unitRef="usd">1989000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic54b2a2f6ff0462f8cbfe00f5cdba452_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzYtNS0xLTEtMTQ3MTU3_47b620c6-3a4c-42d1-b9f6-026f628b3e00"
      unitRef="usd">1341000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7778605f8f09452483e387ca04e5f798_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctMS0xLTEtMTQ3MTU3_be699c56-7c05-41ff-8c01-0ec7b21c048c"
      unitRef="usd">551000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7778605f8f09452483e387ca04e5f798_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctMy0xLTEtMTQ3MTU3_df304fac-12cc-4237-a26b-0df5e12b88b6"
      unitRef="usd">328000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7778605f8f09452483e387ca04e5f798_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzctNS0xLTEtMTQ3MTU3_33dcd87f-dfd6-4872-9c90-50b9d112227f"
      unitRef="usd">223000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iced246337ea748e18ce3b7196e968243_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtMS0xLTEtMTQ3MTU3_881d0dd5-060b-4344-ace6-ca379cab1b24"
      unitRef="usd">1035000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iced246337ea748e18ce3b7196e968243_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtMy0xLTEtMTQ3MTU3_fad6b989-6699-4e6b-99e3-e41fe4a894fa"
      unitRef="usd">506000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iced246337ea748e18ce3b7196e968243_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzgtNS0xLTEtMTQ3MTU3_2837ef56-b1af-4ec1-becc-594c9b68562e"
      unitRef="usd">529000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktMS0xLTEtMTQ3MTU3_54296a86-0441-44ae-be58-48218b9fabc8"
      unitRef="usd">4916000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktMy0xLTEtMTQ3MTU3_0209f32d-3746-4b97-a1d7-b88a07902742"
      unitRef="usd">2823000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzktNS0xLTEtMTQ3MTU3_8ec54155-0349-49d4-a382-fe0ae9cf3190"
      unitRef="usd">2093000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTEtMS0xLTE0NzE1Nw_cdd8b582-86fa-42aa-8eab-d04a7e174bc5"
      unitRef="usd">4928000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTMtMS0xLTE0NzE1Nw_ab6f5f30-be8f-4166-8ff6-bdf6017240a1"
      unitRef="usd">2823000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90YWJsZTozMWYyNGE3OTE3ZmU0YzJhYThiMTQyODEwYWRlMDk3Ni90YWJsZXJhbmdlOjMxZjI0YTc5MTdmZTRjMmFhOGIxNDI4MTBhZGUwOTc2XzEwLTUtMS0xLTE0NzE1Nw_89cfc6e3-0f3d-4df8-92bd-a07cd1fa5765"
      unitRef="usd">2105000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgxNg_0e0358e3-63b2-413d-9cc1-40a515b6755a"
      unitRef="usd">311000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgyMA_5afbabdc-1863-423c-b1d7-43f1e4bd1ec6"
      unitRef="usd">428000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4XzgyNw_df3a3dbe-7e02-48a3-bfaf-054e1adb8d9d"
      unitRef="usd">512000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk2Ng_2e0fdb8e-995a-4212-a935-eee7123abd5d"
      unitRef="usd">283000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3MA_7c3dd462-ce86-40fe-8ab3-71b93921cac7"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3NA_1e74d544-4081-4b5b-aa83-f3e9662885b4"
      unitRef="usd">235000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk3OA_37c45e38-2499-4394-bf1f-fc34729b5f9c"
      unitRef="usd">208000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMDYvZnJhZzo5MjZiNzI5MWUxNTU0YWI3OGY2N2JhOGNiMDIyMjcyOC90ZXh0cmVnaW9uOjkyNmI3MjkxZTE1NTRhYjc4ZjY3YmE4Y2IwMjIyNzI4Xzk4NQ_2a92a00c-9e71-4c52-9954-2fcaf61547ec"
      unitRef="usd">175000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <cah:LeasesTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2NzY_dda544f5-c9e9-4397-a597-32c542d32fee">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;5. Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of lease cost:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease cost primarily includes payments for property taxes, maintenance and insurance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our consolidated balance sheets. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;123&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</cah:LeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzc_18f83345-c049-4e49-b23c-4039734417e2">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of lease cost:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMS0xLTEtMTQ3MTU3_586bfbcc-e14a-40e8-8e44-8f7bf8763855"
      unitRef="usd">117000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMi0xLTEtMTQ3MTU3_c70b74e1-1487-42ed-8a0c-c693f6244026"
      unitRef="usd">119000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzItMy0xLTEtMTgxNDcw_a55e8531-575b-4204-91ff-b10fed8b679d"
      unitRef="usd">134000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMS0xLTEtMTQ3MTU3_b5c15bf9-4498-495c-ae21-dfaaf78b6871"
      unitRef="usd">23000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMi0xLTEtMTQ3MTU3_25283d5d-4c95-42fb-b9cf-ed166a058bfa"
      unitRef="usd">16000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzQtMy0xLTEtMTgxNDc4_30a22a2c-df72-41f5-bf54-f4ee888a0c77"
      unitRef="usd">13000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:VariableLeaseCost
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMS0xLTEtMTQ3MTU3_d2fce808-47b9-4d27-99f4-4d926291eb4e"
      unitRef="usd">13000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMi0xLTEtMTQ3MTU3_00586cbe-51ee-49cf-8806-28e54a660d90"
      unitRef="usd">24000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzgtMy0xLTEtMTgxNDg2_f2fd5fc4-b13b-4a2b-b5e3-fd42d07a3d81"
      unitRef="usd">17000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTEtMS0xLTE0NzE1Nw_bd9905a6-4964-4a75-9bde-414fdd1edd7e"
      unitRef="usd">153000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTItMS0xLTE0NzE1Nw_660326c8-db68-45ab-8af5-3b3a104ba181"
      unitRef="usd">159000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTozYmRhZTFlZjY2YWQ0Yzk2YTgyNjMwYzNlNGM5MzE3YS90YWJsZXJhbmdlOjNiZGFlMWVmNjZhZDRjOTZhODI2MzBjM2U0YzkzMTdhXzEwLTMtMS0xLTE5NzU3Mg_35298ffc-43e6-4e54-9c72-944a774888fa"
      unitRef="usd">164000000</us-gaap:LeaseCost>
    <cah:LeasesSupplementalBalanceSheetInformationTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzg_77250d45-73bf-4401-8827-2e3eeeef48c9">The following table summarizes supplemental balance sheet and other information related to leases at June&#160;30:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_2adae48b-283f-4968-b44a-dec91ec92d1a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMC0xLTEtMTk4MzM1_7be72b61-5019-4d8f-80de-d318cc1465fe"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_08d01f9d-df24-45c9-87f3-cb38eba585e9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMC0xLTEtMTk4Mzk3_c9389ddf-18ae-4a7b-8727-b1af945c3711"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_6bc159e2-6142-4d5c-bc8d-1ba9968d0891"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMC0xLTEtMTk4NDA0_f23d917b-193f-4c86-bb15-4be783fb161f"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_237ab08b-9ba2-4c1e-a7dc-934dbd729b36"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMC0xLTEtMTk4NDA3_b50d4177-f61f-4060-b09e-73a1abdf210f"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_243db512-5eaa-4e21-9ef5-0973e3e540a9"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTAtMS0xLTE5ODQwOQ_6801453e-54ca-459c-969e-c2a001a4836c"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_04b582b1-ab49-46f6-90ba-90e570362801"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTAtMS0xLTE5ODQxMg_5ba10362-6c12-43f8-af68-ee4bfb3d7d0a"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;6.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cah:LeasesSupplementalBalanceSheetInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMS0xLTEtMTQ3MTU3_4f9ffd17-0d91-4f64-a637-34cc9dd1f706"
      unitRef="usd">457000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzItMi0xLTEtMTQ3MTU3_1cee382d-2e08-4d15-9278-713394035407"
      unitRef="usd">460000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMS0xLTEtMTQ3MTU3_a1305f09-b38a-4d25-9a8e-569567f857fd"
      unitRef="usd">102000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzQtMi0xLTEtMTQ3MTU3_5b2d71f0-aed3-4391-8fdd-dace2ee516e3"
      unitRef="usd">105000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMS0xLTEtMTQ3MTU3_18a24a65-9744-4e86-9389-44c447118571"
      unitRef="usd">388000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzUtMi0xLTEtMTQ3MTU3_8dcdd0b8-580d-4a64-a533-0d207aec91d2"
      unitRef="usd">374000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzYtMS0xLTEtMTQ3MTU3_b7a5cb1e-bc77-4921-8c1e-08c5fbd8f6f3"
      unitRef="usd">490000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzYtMi0xLTEtMTQ3MTU3_0e3d6b8e-f55c-4011-a5fd-e7aa77a23608"
      unitRef="usd">479000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMS0xLTEtMTQ3MTU3_a4c5b199-65c9-4027-b3b2-95ec89bd3c33"
      unitRef="usd">68000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzktMi0xLTEtMTQ3MTU3_a1fbf283-7b7b-4282-b11e-24aae79877ea"
      unitRef="usd">63000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTEtMS0xLTE0NzE1Nw_82f0943a-5108-408d-8411-4576761438f3"
      unitRef="usd">23000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzExLTItMS0xLTE0NzE1Nw_5302449f-338a-41cf-b45c-52baea355fab"
      unitRef="usd">19000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTEtMS0xLTE0NzE1Nw_59f3e017-1a80-41c7-8798-d6dafb39b2e7"
      unitRef="usd">49000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEyLTItMS0xLTE0NzE1Nw_92497bb8-1342-45d5-8fe0-b2676f63c877"
      unitRef="usd">45000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEzLTEtMS0xLTE0NzE1Nw_fa3c5015-76bb-4025-83a1-c0236f4536b9"
      unitRef="usd">72000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzEzLTItMS0xLTE0NzE1Nw_95e09638-bca7-40b8-bac2-d9b3a0a25ba9"
      unitRef="usd">64000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE2LTEtMS0xLTE0NzE1Nw_72363d27-b820-47e6-8af3-313fcd405703">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE2LTItMS0xLTE0NzE1Nw_7f76a777-f34d-4be0-99c2-81ac80f8906b">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE3LTEtMS0xLTE0NzE1Nw_721d8eaa-0eae-4a2b-b773-871e4d3959b6">P4Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzE3LTItMS0xLTE0NzE1Nw_43f846b7-f871-4968-a11c-0b915632c947">P4Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIwLTEtMS0xLTE0NzE1Nw_c1d03c19-8be6-4f6a-89d5-cd44152995a3"
      unitRef="number">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIwLTItMS0xLTE0NzE1Nw_0084f280-f282-4f46-9b30-3aaf1db5f0da"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIxLTEtMS0xLTE0NzE1Nw_93d1219a-c633-49c4-a0f3-0c9699c4a8e2"
      unitRef="number">0.018</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTo3YWIzZDA5MzA1OWY0OGJjODEyYTc2NDczNDIzY2ZkYy90YWJsZXJhbmdlOjdhYjNkMDkzMDU5ZjQ4YmM4MTJhNzY0NzM0MjNjZmRjXzIxLTItMS0xLTE0NzE1Nw_13d5f0ee-c748-4226-9f13-a57a705ad03c"
      unitRef="number">0.015</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <cah:LeasePaymentsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2Nzk_99cad79a-97b6-437d-ba55-df1f39e48f8b">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;123&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;New finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Includes the effect of $22&#160;million from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance.&lt;/span&gt;&lt;/div&gt;</cah:LeasePaymentsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMS0xLTEtMTQ3MTU3_c6a9eb73-b380-44f7-b783-0d5a6a0bc53f"
      unitRef="usd">123000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMi0xLTEtMTQ3MTU3_93c4f0fa-b3c5-4558-862c-92447313d3ac"
      unitRef="usd">115000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzMtMy0xLTEtMTgyNzc1_1811eb55-37a2-4205-8631-0fd97b4df2d8"
      unitRef="usd">125000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMS0xLTEtMTQ3MTU3_0ea84457-8e39-426f-9e4e-5e0d31c1c81c"
      unitRef="usd">21000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMi0xLTEtMTQ3MTU3_99a1bf7e-1311-455d-9404-7dd93ee91967"
      unitRef="usd">15000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzUtMy0xLTEtMTgyNzgz_8802fe04-5722-4d08-8fa8-27261b24e146"
      unitRef="usd">7000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMS0xLTEtMTQ3MTU3_9a7ff814-decc-4cea-b177-34deda45e953"
      unitRef="usd">101000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMi0xLTEtMTQ3MTU3_f0dde28a-3b14-4436-9cfa-62d904e06de7"
      unitRef="usd">138000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzctMy0xLTEtMTgyNzkx_b666057a-4725-4cc6-85e9-d87b866adca9"
      unitRef="usd">150000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMS0xLTEtMTQ3MTU3_0153c507-204d-44c8-a737-74a15bcc1ae4"
      unitRef="usd">28000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMi0xLTEtMTQ3MTU3_0d75b192-4c33-4eb1-a20a-471e48c7c11c"
      unitRef="usd">45000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzgtMy0xLTEtMTgyNzkx_26c7c15d-2d00-4382-9352-cb0c3d9afde7"
      unitRef="usd">40000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="ie3ed9de2f40646068fda63624fe9021c_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMS0xLTEtMTgyODAz_249aa1d4-166d-4f94-9835-94177d08acc9"
      unitRef="usd">0</cah:Impactofadoptionofnewaccountingstandard>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="i6aaeb4ce0c834fc793b1f0b25fa82f9b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMi0xLTEtMTgyODAz_73553e23-3f02-4db3-bcbc-260d22e52766"
      unitRef="usd">0</cah:Impactofadoptionofnewaccountingstandard>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="i101a75214a2841688c2ee6c7e7f23e10_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTowNWViMWI5OWEwNjM0ZjMyOWZiNzBhYjk5ZDZjZWJlNy90YWJsZXJhbmdlOjA1ZWIxYjk5YTA2MzRmMzI5ZmI3MGFiOTlkNmNlYmU3XzktMy0xLTEtMTgyODAz_9609bbc3-924d-465c-b13d-5bb9093de4da"
      unitRef="usd">400000000</cah:Impactofadoptionofnewaccountingstandard>
    <cah:ReclassificationofdeferredrentinaccordancewithASC842
      contextRef="i37112b83786b4ac1ba34031420b8575a_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzU0OTc1NTgxNDczMzc_729ff462-8963-4d78-a9e4-fdf016035fcb"
      unitRef="usd">22000000</cah:ReclassificationofdeferredrentinaccordancewithASC842>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2ODA_90ccb4b1-0dcb-49a2-81de-b10cd9d5a18a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90ZXh0cmVnaW9uOjgxZGQxNzVjMGRmMjQ2ZDViMjQ4OTE4YzgyNjM2YzVlXzM2ODA_c1746bb7-f000-410b-b8fa-73f88da4487b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future lease payments under non-cancellable leases as of June&#160;30, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItMS0xLTEtMTQ3MTU3_a143006b-fdfd-40c1-8fba-68245cdc7f49"
      unitRef="usd">114000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItMy0xLTEtMTQ3MTU3_9ccff6e6-abb9-4183-a39a-e9131d41c662"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <cah:LesseeLeaseLiabilityPaymentsDueYearOne
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzItNS0xLTEtMTQ3MTU3_2846f22e-2014-4fc0-8f07-7644979f9a14"
      unitRef="usd">138000000</cah:LesseeLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtMS0xLTEtMTQ3MTU3_94186ecc-127f-41bf-8c9c-9d462385365b"
      unitRef="usd">98000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtMy0xLTEtMTQ3MTU3_bc0413ff-7443-4e37-8f24-f0b94903d9c3"
      unitRef="usd">19000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <cah:LesseeLeaseLiabilityPaymentsDueYearTwo
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzMtNS0xLTEtMTQ3MTU3_b25fc4c7-0069-4ab7-b60b-44641136f382"
      unitRef="usd">117000000</cah:LesseeLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtMS0xLTEtMTQ3MTU3_700df52a-af63-4d27-a53a-4aff81af735a"
      unitRef="usd">88000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtMy0xLTEtMTQ3MTU3_6b93bad7-2c2c-49d8-8895-ac1aca247972"
      unitRef="usd">14000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <cah:LesseeLeaseLiabilityPaymentsDueYearThree
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzQtNS0xLTEtMTQ3MTU3_f4115a19-cd85-4a92-9bac-1fc2edeb336b"
      unitRef="usd">102000000</cah:LesseeLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtMS0xLTEtMTQ3MTU3_51d9f738-2ec5-497a-906e-78f2aad28a01"
      unitRef="usd">71000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtMy0xLTEtMTQ3MTU3_8094bf41-6faa-4810-a7e7-27777c3fbbb5"
      unitRef="usd">7000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFour
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzUtNS0xLTEtMTQ3MTU3_773b7eb1-eab4-41ea-9030-fdb7c0a2d292"
      unitRef="usd">78000000</cah:LesseeLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtMS0xLTEtMTQ3MTU3_a43178c2-8be4-4ba6-811d-14e88b60f005"
      unitRef="usd">54000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtMy0xLTEtMTQ3MTU3_645d0997-6da3-4906-9ad8-c42691e92ce6"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFive
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzYtNS0xLTEtMTQ3MTU3_596cd0c1-3a42-4ff6-a443-39dd4f4c42bc"
      unitRef="usd">59000000</cah:LesseeLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctMS0xLTEtMTQ3MTU3_dc8b0edb-334c-469e-a9ff-068672979dfc"
      unitRef="usd">114000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctMy0xLTEtMTQ3MTU3_95af9db9-6a03-4c65-8f5c-dd071dc2a071"
      unitRef="usd">6000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzctNS0xLTEtMTQ3MTU3_6f044e2b-d14b-4cc7-8578-a2c0ce4e9abd"
      unitRef="usd">120000000</cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtMS0xLTEtMTQ3MTU3_0261401d-9c94-43e4-b9d3-92647785c320"
      unitRef="usd">539000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtMy0xLTEtMTQ3MTU3_2bdf8c30-331d-42fe-a396-e277a8a9f967"
      unitRef="usd">75000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <cah:TotalLeaseLiabilityPaymentsDue
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzgtNS0xLTEtMTQ3MTU3_a0a69caa-0eef-4bc5-b7fd-9c57692a571e"
      unitRef="usd">614000000</cah:TotalLeaseLiabilityPaymentsDue>
    <cah:OperatingLeaseImputedInterest
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTEtMS0xLTE0NzE1Nw_df5dea03-f7a5-46d3-ba1a-e50476c58039"
      unitRef="usd">49000000</cah:OperatingLeaseImputedInterest>
    <cah:FinanceLeaseImputedInterest
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTMtMS0xLTE0NzE1Nw_774208f6-3e29-4885-b493-21666f50c74a"
      unitRef="usd">3000000</cah:FinanceLeaseImputedInterest>
    <cah:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzEwLTUtMS0xLTE0NzE1Nw_087cdf27-832d-44f2-ac45-8eae813288af"
      unitRef="usd">52000000</cah:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3d8be49bdf674067abb0a9b7f7453d19_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTEtMS0xLTE0NzE1Nw_03ef4059-e170-4319-b9f8-1f524720dcae"
      unitRef="usd">490000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i2c254b1595ff47c8bf6dd60488bbc357_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTMtMS0xLTE0NzE1Nw_08225a69-36fc-4649-8ef5-70cdb703307b"
      unitRef="usd">72000000</us-gaap:FinanceLeaseLiability>
    <cah:TotalLeaseLiability
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTIvZnJhZzo4MWRkMTc1YzBkZjI0NmQ1YjI0ODkxOGM4MjYzNmM1ZS90YWJsZTpkMTZiZDg0ODYyZGQ0ZjZiYjg0NjQxMzcyNTUyZDA5OC90YWJsZXJhbmdlOmQxNmJkODQ4NjJkZDRmNmJiODQ2NDEzNzI1NTJkMDk4XzExLTUtMS0xLTE0NzE1Nw_838b7a2e-7401-466a-bde9-c40a627d3dd4"
      unitRef="usd">562000000</cah:TotalLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU1NTc_3d93ebea-c5a2-46dd-bc34-bac5d6a6ea47">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;6. Long-Term Obligations and Other Short-Term Borrowings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)      Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of existing long-term obligations and other short-term borrowings for fiscal 2023 through 2027 and thereafter are as follows: $580 million, $1.2 billion, $532 million, $131 million, $1.2 billion and $1.7 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. The 7.0% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $27.1 billion and $23.7 billion at June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, we redeemed all outstanding $572 million principal amount of 2.616% Notes due 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with this redemption, we recorded a $10&#160;million loss on early extinguishment of debt. We also repaid the full principal of the $282&#160;million Floating Rate Notes due 2022 as they became due. The early redemption and repayment were funded with available cash.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we redeemed all outstanding 3.2% Notes due June 2022 for $238&#160;million and $262&#160;million aggregate principal amount of 2.616% Notes due June 2022 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with these redemptions, we recorded a $13&#160;million loss on early extinguishment of debt. We also early repurchased $40 million of the Floating Rate Notes due 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $2 million of the 2.616% Notes due 2022. In connection with the early debt repurchases, we recorded a $1&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;loss on early extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we redeemed $500 million aggregate principal amount of 4.625% Notes due December 2020 at a redemption price equal to 100% of the principal amount and accrued but unpaid interest, plus the make-whole premium applicable to the notes. In connection with the redemption, we recorded a $7 million loss on early extinguishment of debt. We also early repurchased&#160;$247&#160;million&#160;of the&#160;2.616%&#160;Notes due 2022,&#160;$11&#160;million&#160;of the&#160;3.2% Notes due 2022,&#160;$20&#160;million&#160;of the&#160;Floating Rate Notes due 2022, $104&#160;million&#160;of the&#160;3.41% Notes due 2027,&#160;$6&#160;million&#160;of the&#160;4.6% Notes due 2043,&#160;$5&#160;million&#160;of the&#160;4.9% Notes due 2045, and&#160;$35&#160;million&#160;of the&#160;4.368% Notes due 2047. In connection with the early debt repurchases, we recognized a&#160;$9 million&#160;loss on early extinguishment of debt. We also repaid the full principal of the $450&#160;million 2.4% Notes due 2019 as they became due. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The redemptions and repurchases were paid for with available cash and other short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we undergo a change of control, as defined in the notes, and if the notes receive specified ratings below investment grade by each of Standard &amp;amp; Poor's Ratings Services, Moody&#x2019;s Investors Services and Fitch Ratings, any holder of the notes, excluding the debentures, can require with respect to the notes owned by such holder, or we can offer, to repurchase the notes at 101% of the principal amount plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Other Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;$2.0 billion&#160;commercial paper program backed by a $2.0 billion&#160;revolving credit facility. We also have a&#160;$1.0 billion&#160;committed receivables sales facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#x201c;CHF&#x201d;) through September 30, 2022. CHF was organized for&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, we amended our receivables sales facility to temporarily increase the maximum permitted delinquency ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revolving credit and committed receivables sales facilities require us to maintain a consolidated net leverage ratio of no more &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;than 3.75-to-1. As of June&#160;30, 2022, we were in compliance with this financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and 2021, we had no amounts outstanding under the revolving credit facility; however, availability was reduced by outstanding letters of credit of $1 million at both June&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, we had a daily maximum amount outstanding under our commercial paper and committed receivables programs of $1.2 billion and an average daily amount outstanding of $19 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no amounts outstanding as of June&#160;30, 2022 under the committed receivables sales facility program; however, availability was reduced by outstanding standby letters of credit of $31 million at both June&#160;30, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no amounts outstanding under the commercial paper program as of June&#160;30, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The $74 million and $67 million balance of other obligations at June&#160;30, 2022 and 2021, respectively, consisted of finance leases and short-term borrowings.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU1NjA_82cf2899-792e-46ff-b013-d99a34156f25">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes long-term obligations and other short-term borrowings at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)      Maturities are presented on a calendar year basis.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="ice004f9102ba4d5fa58a7477de8fe13e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzMtMS0xLTEtMTQ3MTU3_081eff37-44b3-43fd-9167-70305f506499"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="id882b2f82db24e5c857e6ba1a0e384af_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzMtMy0xLTEtMTQ3MTU3_984624fd-7a9e-4e61-9fbe-699d52ad16f6"
      unitRef="usd">572000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i64e77764f4c64f7abd7d4a5227eb6f41_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzUtMS0xLTEtMTQ3MTU3_757a0b4d-e911-41af-babf-cf2515fbe55c"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i3fbf71c602bb40a5b964360fc429bff3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzUtMy0xLTEtMTQ3MTU3_f4a491c4-c940-44c2-92bc-87cb6aa1eaca"
      unitRef="usd">281000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i885fe3ac6e1a4babbc66a8db94f82e38_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzYtMS0xLTEtMTQ3MTU3_b2a2a8c4-0d06-47a9-90cb-38e81561e781"
      unitRef="usd">556000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i59e90c5526e84b74be02b2b7a029bb5d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzYtMy0xLTEtMTQ3MTU3_fe0dc609-05dc-461c-a351-f38b9f77f4a7"
      unitRef="usd">564000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i55f78f224039402a88005fb30536dad1_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzctMS0xLTEtMTQ3MTU3_211a78cb-762a-4e45-b9d9-f61cbec55cd0"
      unitRef="usd">779000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i5b7d966b6b934db1a5c6c380f6d08006_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzctMy0xLTEtMTQ3MTU3_4361cad0-3bb9-4630-b318-c3e8b2406993"
      unitRef="usd">794000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i3f4a7953acf34ee99b0152b4348d298c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzgtMS0xLTEtMTQ3MTU3_2a62c87d-aeeb-4573-8f62-917800f489b1"
      unitRef="usd">407000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i19940e136f3f4037ac958751189f0e42_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzgtMy0xLTEtMTQ3MTU3_506805e7-f1a5-47b1-8934-16f74b008476"
      unitRef="usd">410000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ieb2dda3fb1b24c6c9dd6058e3deb85a2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzktMS0xLTEtMTQ3MTU3_26ca8b6e-38b0-4ca0-a59d-015ae2c8be72"
      unitRef="usd">518000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i9db02e14f91846b1b3f5268f07efaf25_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzktMy0xLTEtMTQ3MTU3_4b93d848-ceb8-4cf6-b749-741bc85721db"
      unitRef="usd">524000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i83d82da09b63414d9e4d23de0552e992_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEwLTEtMS0xLTE0NzE1Nw_c478e8b9-b6c6-4014-9cdb-0288dc73217a"
      unitRef="usd">1193000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="if5be0282727a4d219c233e858971eab3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEwLTMtMS0xLTE0NzE1Nw_9b514a5f-2d91-4463-819c-6d68b4a46df8"
      unitRef="usd">1216000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ief95ead6d3304e5283a841e043450002_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzExLTEtMS0xLTE0NzE1Nw_7c5409ef-673a-4870-97d6-ecb46a1745a0"
      unitRef="usd">321000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i2ebb9851a4a6454d878d280244504203_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzExLTMtMS0xLTE0NzE1Nw_5baa982d-99b1-406d-8d7d-e9c2699dce34"
      unitRef="usd">341000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="icf9550d3a90c4fe7abe3b7f766ed70ad_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEyLTEtMS0xLTE0NzE1Nw_e5878acb-bdae-4bb7-b175-4c3a7687abda"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ia0809664ee714c24958018126d48a37c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEyLTMtMS0xLTE0NzE1Nw_b13e4c08-593b-4e27-975d-b6c9360213d6"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ie1588ed89bc745b2a267d8c2daef772e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEzLTEtMS0xLTE0NzE1Nw_b399e870-85e4-4432-9eba-60051ec8109b"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ida1ad8e9f740460c9717fa142af909bf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzEzLTMtMS0xLTE0NzE1Nw_163a04c0-1a28-4a8a-b606-aee3700b1a70"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="ibb9f3742e0b84411bd2e5b40340f02e2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE0LTEtMS0xLTE0NzE1Nw_eb3ffe1d-569d-40a1-92c2-6e32c37a43f7"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i3a4a7026d7514fa682d445bca65f8fce_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE0LTMtMS0xLTE0NzE1Nw_dd8546ef-4122-4413-82a7-cec34103e95f"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i621b77904b4340b2bcbbba0f4babdffd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE1LTEtMS0xLTE0NzE1Nw_31061e4f-37cc-4a81-8c37-e963a1be15aa"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i15dc38ffa0654e75a949152dac07365f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE1LTMtMS0xLTE0NzE1Nw_0be284f6-7c32-4fcd-8793-a0af293123e9"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:OtherBorrowings
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE2LTEtMS0xLTE0NzE1Nw_2ef69ecd-1e22-4749-853c-6f0995a53399"
      unitRef="usd">74000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE2LTMtMS0xLTE0NzE1Nw_c4583914-c847-4991-bc0b-a39520981409"
      unitRef="usd">67000000</us-gaap:OtherBorrowings>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE3LTEtMS0xLTE0NzE1Nw_cffe9551-f239-4765-a8bd-f4820e450c09"
      unitRef="usd">5315000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE3LTMtMS0xLTE0NzE1Nw_5e4ae259-7808-4ccd-83fc-c50cca48e82a"
      unitRef="usd">6236000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE4LTEtMS0xLTE0NzE1Nw_9de00f91-e393-4fe3-a525-6f7cbe36c1d4"
      unitRef="usd">580000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE4LTMtMS0xLTE0NzE1Nw_59c8dd51-bce7-4b72-9943-3f70449bab18"
      unitRef="usd">871000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE5LTEtMS0xLTE0NzE1Nw_582b3df6-7c68-4054-af6d-52770a24406e"
      unitRef="usd">4735000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90YWJsZTpiZGIzNzkyYTc0M2U0NmZkOTk5ZjI1MzljNTk5N2I0Zi90YWJsZXJhbmdlOmJkYjM3OTJhNzQzZTQ2ZmQ5OTlmMjUzOWM1OTk3YjRmXzE5LTMtMS0xLTE0NzE1Nw_5aebd993-8c1d-466b-a928-52d808468721"
      unitRef="usd">5365000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMwMg_ffd26063-36c7-4367-abf7-349118cc34aa"
      unitRef="usd">580000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMwNg_00b6d8f7-773a-44c3-8b1c-9a2f9ddbb206"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxMA_d4e9b8c8-8250-47aa-9aad-405a6f33b377"
      unitRef="usd">532000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxNA_db481658-0189-4b06-9143-2ad8514265b0"
      unitRef="usd">131000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMxOA_b765e458-1fb4-41e7-970c-be41314b5e9b"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzMyNQ_e529e34e-ec63-40a4-8c4c-40a72c4cf7e6"
      unitRef="usd">1700000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzk3Mw_54d2c61b-217a-48cc-95b1-08480115ffd7"
      unitRef="usd">27100000000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzk4MA_0c2fe1eb-2b12-40df-9089-6e83a4750aef"
      unitRef="usd">23700000000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <cah:NotesPayableRepurchased
      contextRef="ia6a04d5f0835442bae0648463d282df4_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDg5Mjg_d114659d-76ac-4245-a280-229a63739906"
      unitRef="usd">572000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDg5NzQ_439d80de-8e68-40db-a87f-5c2102cd19e2"
      unitRef="usd">10000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i40f828ff486f4d32b49ccc76ede09797_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNTA2MzE_91c1026a-9870-458a-8f4d-8cb1c10473f2"
      unitRef="usd">282000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="ic80b7f23b79f4c74a63a2aea8a160669_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDU3Mzk_989a5a0a-1194-4c19-b935-705540fd226f"
      unitRef="usd">238000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="if2c4addddd22425095e8747d5010555f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDU3NDc_9a22ebb2-69f6-48da-b31c-d46c25340531"
      unitRef="usd">262000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i880c502ad6a54517904d884280fcde32_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYwMDY_e1f76b63-b384-4768-8306-f4a935882512"
      unitRef="usd">13000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i3827a1282fa341608b2ab469d733c58a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYyOTk_77728f38-1b96-4400-9bbc-c5b22b8b800f"
      unitRef="usd">40000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i2624de343f9148a89e5e879c4c82b456_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYzMDU_836cbab4-5736-4607-98a5-1ae13fa5d72c"
      unitRef="usd">2000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i25174483a8524ab68a643c722a044868_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM4NDgyOTA3MDYyMTE_e7d17a0d-f198-404a-94ec-0aa5cba676cf"
      unitRef="usd">1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE2MTg_2355840b-9246-4704-acf5-e0162f1fa73e"
      unitRef="usd">500000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iff1e98e7a7c64c91921a9e341e2ba72a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE4Nzc_580da2e6-8d01-4e2f-9b7a-9b22b9f3540d"
      unitRef="usd">7000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i7fa51c2037854bb89d8846afa4ed5e99_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE5NDQ_345578a4-d9da-494d-90f9-c06a64c88516"
      unitRef="usd">247000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i07524980d6a64ab0900fdee89c51519e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzE5Nzc_3992d599-10af-4f2a-bb10-67462c93e6b5"
      unitRef="usd">11000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i33da3620cedb405488c45ea93f45f9f7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwMDg_ac2537a2-047a-49da-8600-259c3694c284"
      unitRef="usd">20000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="ia07846c1c0304317b72bad3a3eea1a34_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwNDg_c461067a-1390-44af-b704-d020d2911f0e"
      unitRef="usd">104000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="i5ce95bfc57ac401db96d15c30dac19f1_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIwODA_d4ce0d38-89d7-4d3a-b072-7efb1ade7f50"
      unitRef="usd">6000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="ia624d146ecb046bebe9077aabecd86e5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIxMTE_18ccc180-6729-4890-a21a-ab634e16b87a"
      unitRef="usd">5000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="icbdef24d9ef64b91aa1ffa7ea2f55a2f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIxNDY_e1ce0a11-2680-420c-85b7-171771a0ab13"
      unitRef="usd">35000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6dc70dd563e3469b9d8e95f7e3db1e7d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIyNDI_9816ff0f-4c42-432b-bdd2-ae40deb4c9cc"
      unitRef="usd">9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cah:NotesPayableRepurchased
      contextRef="i3a684eeb749345e9b75d857b1e1719eb_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzIzMjQ_7d795ab3-39d7-447a-9c49-416520092fff"
      unitRef="usd">450000000</cah:NotesPayableRepurchased>
    <cah:OfferAsPercentageOfPrincipalAmount
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM1MTM_be785158-d63e-4a5d-8b9d-8a8209fdfdd3"
      unitRef="number">1.01</cah:OfferAsPercentageOfPrincipalAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i29917c8b4aab4eb2a08720812cda9e5f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3MDE_a55554d1-484e-4f9a-9de2-87a4cc3045d1"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3c2bf417d2ce4569b7095141c8585f43_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3NDE_cfbcde25-25f9-4dbe-9409-01707b373f3e"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib802e2c8dcb949298f691230fa6a001e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzM3ODY_eac47226-3ebd-4573-9bfd-60a87c1b2a69"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i41cb6234b1c242c1b3d5212ab191fccc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ2Nzk_2aa18ae0-4c4f-4b06-b2fa-ffbfdc76727c"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ2Nzk_2e363821-c375-487f-b9bb-66a5005adc9f"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:LineOfCredit
      contextRef="i96faf7a83e724cc9b7b3fd247b3d1afc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ4MDk_2ce247e9-49ea-470a-b257-9cdd9ac86b66"
      unitRef="usd">1000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i41cb6234b1c242c1b3d5212ab191fccc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ4MDk_9f2a6ac8-05e4-4117-9805-5604a9de4bf6"
      unitRef="usd">1000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
      contextRef="ia602868425d84c939a48b46f4b7f99a3_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ5MjY_b2e988dc-e877-4fab-8a07-8220128f90a4"
      unitRef="usd">1200000000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
    <us-gaap:LineOfCreditFacilityAverageOutstandingAmount
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0OTc1NTgxNDk1MjE_f13a8a89-ffd6-4210-a617-adb43df8d6d0"
      unitRef="usd">19000000</us-gaap:LineOfCreditFacilityAverageOutstandingAmount>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i62274a161fe54af9b457ca7496c6d48e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzQ5OTc_138272b1-b84a-4862-9fe1-e2932bffbbf7"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:LineOfCredit
      contextRef="i58cef62c3cd5423a91e3afefd7967e2a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUxNjM_8e58788b-3b1c-4001-a0d0-16fa5abb2cfb"
      unitRef="usd">31000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i67e0a63d6182434b947a044598b6b9be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUxNjM_ee17e444-c223-4e9d-a709-739295697d73"
      unitRef="usd">31000000</us-gaap:LineOfCredit>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i6e905accc4fc429dbe8fb2baa9d577ac_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUyMDk_3cdb2df2-b6a3-4979-96d5-37fdbe2c83bb"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i29917c8b4aab4eb2a08720812cda9e5f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzUyMDk_bc9c05c2-7641-4e28-a4f1-96c223852c95"
      unitRef="usd">0</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0Mjk_2ef69ecd-1e22-4749-853c-6f0995a53399"
      unitRef="usd">74000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTUvZnJhZzpkZTAwZjQwN2U5ZTU0MTg5OWM0NjU2ZTc2MmIxMmU2Mi90ZXh0cmVnaW9uOmRlMDBmNDA3ZTllNTQxODk5YzQ2NTZlNzYyYjEyZTYyXzU0MzY_c4583914-c847-4991-bc0b-a39520981409"
      unitRef="usd">67000000</us-gaap:OtherBorrowings>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE5MjQxNDUzNTQwNTM5_8db7e30c-d18b-4640-b98d-d590b989d373">&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;7. Commitments, Contingent Liabilities and Litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Generic Sourcing Venture with CVS Health Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of 10 years. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. In August 2021, we amended our agreement to extend the term through June 2029. We are required to make quarterly payments to CVS Health for the term of the arrangement. These payments are included as purchase obligations and other payments in the Contractual Obligations and Cash Requirements section of MD&amp;amp;A. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New York Opioid Stewardship Act&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the State of New York passed a budget which included the Opioid Stewardship Act (the "OSA"). The OSA created an aggregate $100&#160;million annual assessment on all manufacturers and distributors licensed to sell or distribute opioids in New York. Under the OSA, each licensed manufacturer and distributor would be required to pay a portion of the assessment based on its share of the total morphine milligram equivalents sold or distributed in New York during the applicable calendar year, beginning in 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The constitutionality of portions of the OSA has been challenged in court. In December 2018, the OSA was ruled unconstitutional by the U.S. District Court for the Southern District of New York. Subsequently, New York passed a new statute that modified the assessment going forward and limited the OSA to two years (2017 and 2018). The U.S. Court of Appeals for the Second Circuit reversed the district court's decision on procedural grounds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue contingencies if it is probable that a liability has been incurred and the amount can be estimated. Because of the Second Circuit ruling, we recorded an aggregate accrual of $41&#160;million for calendar years 2017 and 2018 during the fiscal year ended June 30, 2021 based on the probable estimated payment amount. In the second quarter of fiscal year 2022, we paid the State of New York approximately $20&#160;million, our portion of the assessment for calendar year 2017. As a result, as of June&#160;30, 2022, we had an accrual of $20&#160;million, which reflects our best estimate of the portion of the assessment that we may owe for sales during calendar year 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We become involved from time to time in disputes, litigation and regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we determine that products we source, manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions have led to product recalls, costs to repair or replace affected &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;products, temporary interruptions in product sales, restrictions on importation, product liability claims and lawsuits and can lead to action by regulators. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could directly or indirectly lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have been named from time to time in qui tam actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a qui tam action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our consolidated statements of earnings/(loss); however, losses and recoveries of lost profits from disputes that occur in the ordinary course of business are included within segment profit. For example, in the second quarter of fiscal year 2022, our Pharmaceutical segment profit was positively impacted by a $16&#160;million judgment for lost profits related to an ordinary course intellectual property rights claim.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Opioid Lawsuits and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;States &amp;amp; Political Subdivisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;National Settlement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in fiscal year 2017, state attorneys general, counties and municipalities began filing lawsuits related to the distribution of prescription opioid pain medications against pharmaceutical wholesalers, including us, and other participants in the pharmaceutical supply chain. These lawsuits sought equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. The lawsuits filed by states and political subdivisions were filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and were transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#x201c;MDL&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;By fiscal year 2022, Cardinal Health was a defendant in approximately 2,775 lawsuits brought by these plaintiffs. In July 2021, we and two other national distributors (collectively, the "Distributors") announced a proposed settlement with a group of state attorneys general intended to resolve the vast majority of these lawsuits (the "National Settlement") as well as a proposed settlement agreement (the "Settlement Agreement") containing, among other things, a sign-on process to allow states and political subdivisions to participate in the National Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2022, the Distributors each determined that a sufficient number of states and political subdivisions had agreed to participate in the National Settlement to proceed with the Settlement Agreement. The Settlement Agreement became effective on April 2, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the Distributors, parties to the Settlement Agreement include 46 states, the District of Columbia and 5 U.S. territories. As of August 9, 2022, over 99 percent of political subdivisions (by population as calculated under the Settlement Agreement) that had brought opioid-related suits against us as calculated under the Settlement Agreement had chosen to join the Settlement Agreement or have had their claims addressed by state legislation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under this Settlement Agreement, we will pay up to approximately $6.0&#160;billion, the majority of which is expected to be paid over 18 years. The exact payment amount will depend on several factors, including the extent to which states take action to foreclose opioid lawsuits by political subdivisions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, by passing laws barring or limiting opioid lawsuits by political subdivisions), and the extent to which additional political subdivisions in participating states file additional opioid lawsuits against us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Settlement Agreement also includes injunctive relief terms related to distributors&#x2019; controlled substance anti-diversion programs, including with respect to: (1) governance; (2) independence and training of the personnel operating controlled substances monitoring programs; (3) due diligence for new and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;existing customers; (4) ordering limits for certain products; and (5) suspicious order monitoring. A monitor will oversee compliance with these provisions for a period of five years. In addition, the Distributors will engage a third-party vendor to act as a clearinghouse for data aggregation and reporting, which distributors will fund for ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The participating states and the distributors are cooperating to obtain consent judgments embodying the terms of the Settlement Agreement in each participating state and the participating states and subdivisions are dismissing their lawsuits. As a result, as of August 9, 2022, approximately 2,300 lawsuits against us have been dismissed. We expect additional lawsuits to be dismissed over the coming months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the effective date of the Settlement Agreement, Distributors had entered into separate settlement agreements with each of the states of Florida, New York, Ohio and Rhode Island. When the Settlement Agreement became effective, each of these states and their participating subdivisions became a part of the National Settlement; however, the New York, Ohio and Rhode Island agreements required us to make certain payments separately from those required by the Settlement Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year ended June&#160;30, 2022, we made our first annual payment under the Settlement Agreement. We also made certain payments under the separate New York, Ohio and Rhode Island settlements, as well as certain payments under the Cherokee Nation settlement. In total, during fiscal year ended June&#160;30, 2022, we paid $417&#160;million in connection with these matters. In July 2022, we made our second annual payment of $374&#160;million under the Settlement Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;West Virginia subdivisions and Native American tribes were not a part of the National Settlement and we had separate negotiations with these groups. A bench trial before a federal judge in West Virginia in a case brought by Cabell County and City of Huntington against the Distributors concluded in July 2021. In July 2022, a judgment in favor of the Distributors was entered. In July 2022, the Distributors reached an agreement to settle the opioid-related claims of the majority of the remaining West Virginia subdivisions. Under this agreement, we have agreed to pay eligible West Virginia subdivisions up to approximately $124&#160;million over an eleven-year period. This agreement is subject to certain contingencies related to subdivision participation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Distributors reached an agreement with the State of Oklahoma to resolve the opioid-related claims of the state and its political subdivisions. Under this agreement, Cardinal Health agreed to pay approximately $95&#160;million to the State and its participating subdivisions. This amount is consistent with the amount that would have been allocated to Oklahoma under the Settlement Agreement. The terms of this agreement are consistent with the terms of the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Distributors reached an agreement with the Washington Attorney General, under which Cardinal Health will pay up to approximately $160&#160;million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with the amount that would have been allocated to Washington under the Settlement Agreement plus certain attorneys' fees and costs. The terms of this agreement in principle are substantially consistent with the Settlement Agreement. This agreement is subject to certain contingencies, including the rate of subdivision participation. If this agreement and the Washington agreement are finalized, Oklahoma and Washington would become subject to the Settlement Agreement and 48 of 49 eligible states would then be subject to the Settlement Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021 we announced that the Distributors had reached an agreement with the Cherokee Nation in connection with ongoing negotiations toward a broader agreement with Native American tribes. In January 2022, the Distributors entered into a term sheet with the Native American tribes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Settlement Agreement and separate state settlements have not resolved all opioid lawsuits and claims brought by states and political subdivisions. As of August 9, 2022, we are still defendants in approximately 475 lawsuits brought by counties, municipalities and other political subdivisions; however, we expect this number to decline as additional cases are dismissed as a result of the Settlement Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In total, we have recorded total pre-tax charges of $1.17&#160;billion and $5.63&#160;billion in litigation charges/(recoveries), net in the years ended June&#160;30, 2021 and 2020, respectively. In total, we have $6.36&#160;billion accrued at June&#160;30, 2022, of which $532&#160;million is included in other accrued liabilities and the remainder is included in deferred income taxes and other liabilities in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual, whether as a result of settlement discussions, a judicial decision or verdict or otherwise, but we are not able to estimate a range of reasonably possible additional losses for these matters. We continue to strongly dispute the allegations made in these lawsuits and none of these agreements is an admission of liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Justice Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have received federal grand jury subpoenas issued in connection with investigations being conducted by the U.S. Attorney's Office for the Eastern District of New York and the Fraud Section of the U.S. Department of Justice ("DOJ"). We have also received civil requests for information from other DOJ offices. We believe that these investigations concern operation of our anti-diversion program, our anti-diversion policies and procedures, and distribution of certain controlled substances. We are cooperating &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with these investigations. We are unable to predict the outcome of any of these investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Private Plaintiffs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Settlement Agreement does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals alleging personal injury. Private parties had brought approximately 440 lawsuits as of August 9, 2022. Of these, 151 are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A trial in a case involving 21 plaintiffs began in state court in Georgia in July 2022. A mistrial was declared shortly thereafter due to rising COVID-19 cases and a new trial date has not been set. We are vigorously defending ourselves in all of these matters; however, trials are inherently unpredictable and it is possible that an unfavorable outcome in these matters, individually or in the aggregate, could have a negative impact on our financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in ongoing legal proceedings with two insurers related to the availability of insurance coverage for the lawsuits described above. In October 2020, we filed a complaint for declaratory judgment against National Union Fire Insurance Company of Pittsburgh, PA (&#x201c;National Union&#x201d;) seeking a declaration that National Union is obligated to reimburse us for defense costs incurred in connection with the lawsuits described above. In January, 2021, Swiss Re International SE commenced an arbitration in London seeking a determination that it does not have an obligation to reimburse us for defense and indemnity expenses incurred in connection with the lawsuits described above. We have not recorded a receivable for any recoveries related to these insurance litigation matters as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cordis IVC Filter Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Liability Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of August 9, 2022, we are named as a defendant in 470 product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately 5,967 plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase IVC filter products. Another 18 lawsuits involving similar claims by approximately 20 plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. In July 2021, we entered into an agreement to settle approximately 1,300 claims. We continue to vigorously defend ourselves in these lawsuits and are engaged in ongoing resolution discussions with plaintiffs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, we had a total of $512&#160;million net of estimated insurance recoveries, accrued for losses and legal defense costs, related to the IVC filter lawsuits in the consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately $1.05&#160;billion, net of estimated &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance recoveries. The sale of the Cordis disposal group does not include product liability related to the IVC filters in the U.S. and Canada, which we retained. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Mexico Attorney General Action&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Attorney General for the State of New Mexico filed an action against certain IVC filter manufacturers, including us, alleging claims under New Mexico's Unfair Practices Act, Medicaid Fraud Act and Fraud Against Taxpayers Act. The allegations made are similar to those made in the product liability lawsuits, described above. We intend to vigorously defend ourselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, the Louisiana Sheriffs' Pension &amp;amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. In June 2020, the court appointed 1199 SEIU Health Care Employees Pension Fund as lead plaintiff and a consolidated amended complaint was filed in September 2020. The amended complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the acquisition integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. The complaint also alleges that one of the individual defendants violated Section 20A of the Exchange Act because he sold shares of Cardinal Health stock during the time period. In September 2021, the court denied our motion to dismiss. We are vigorously defending ourselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Specialty Solutions DOJ Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the United States Attorney&#x2019;s Office for the District of Massachusetts (the "USAO") commenced an investigation of Cardinal Health regarding possible violations of the U.S. healthcare fraud and abuse laws. In January 2022, without admitting liability, we settled this matter with the DOJ for approximately $13 million, which was recorded as expense within litigation charges/(recoveries) net in our consolidated statements of earnings/(loss) during the fiscal year ended June 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Civil Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Generic Pharmaceutical Pricing Antitrust Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, pharmaceutical distributors including us were added as defendants in a civil class action lawsuit filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The indirect purchaser case is part of a multidistrict litigation consisting of multiple individual class action matters consolidated in the Eastern District of Pennsylvania. The indirect purchaser plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and improperly engaged in customer allocation. The court granted our motion to dismiss, and the indirect purchasers filed an amended complaint. We intend to vigorously defend ourselves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Active Pharmaceutical Ingredient Impurity Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many participants in the pharmaceutical supply chain, including active pharmaceutical ingredient ("API") manufacturers, finished dose manufacturers, repackagers, distributors, and retailers have been named as defendants in lawsuits arising out of recalls of certain medications due to alleged impurities in the active pharmaceutical ingredients or finished product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, a Multidistrict Litigation was created in the U.S. District Court for the District of New Jersey (the &#x201c;Sartan MDL&#x201d;) alleging API impurities in certain generic blood pressure medications. We have been named as a defendant in the Sartan MDL. We are vigorously defending ourselves in this matter. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation Proceeds&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received and recognized income resulting from settlements of lawsuits in which we were a class member or plaintiff of $18 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$112 million and $16 million during fiscal 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cah:AggregateAnnualAssessment
      contextRef="i22cd37e98bb24d1eac47e3997f243e60_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzgzNQ_02b04daa-5c3b-46bf-af73-f94c73204a0b"
      unitRef="usd">100000000</cah:AggregateAnnualAssessment>
    <cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct
      contextRef="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExMzI_c4562e87-a92b-42ba-a4cd-a5b353783df7"
      unitRef="usd">41000000</cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExMDc_76acc6c4-9e78-48e6-a330-10577ed16f60"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i22cd37e98bb24d1eac47e3997f243e60_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjExNzU_76f429d8-8caa-4e1b-9302-a49c698aabb8"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <cah:JudgmentForLostProfits
      contextRef="i215e95e961c74dfcb286ad1e464fd268_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjE2MDU_5a6ee2d1-bfbd-4b01-9236-09fafbf43203"
      unitRef="usd">16000000</cah:JudgmentForLostProfits>
    <cah:LossContingencyLawsuitsNumber
      contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4NjY_08ff9261-269f-420e-8b8d-79353f074de9"
      unitRef="lawsuit">2775</cah:LossContingencyLawsuitsNumber>
    <cah:SettlingStates
      contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjMwMTM_8acfb336-9e07-47d4-9433-770b17812b6f"
      unitRef="states">46</cah:SettlingStates>
    <cah:SettlingUSTerritories
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjMwMTc_80f369fe-1c96-46b1-b4b1-03984053b507"
      unitRef="numberofusterritories">5</cah:SettlingUSTerritories>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEwMjIy_5470db0b-563b-4eb6-8f55-8c9fff263782"
      unitRef="usd">6000000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i5df3ad6b3a5c472db6a4ef8acf2ccee2_D20220809-20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMzY_bcc82f15-68d2-4308-9e22-7efe6d01ce09"
      unitRef="lawsuit">2300</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i57e04e176378443dbece7c929cced18b_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MDQ2OTQ_03ed7322-9ce0-4981-944e-3f892252de02"
      unitRef="usd">417000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i22b99fd673554c27875a602f3ebd6229_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEyMDk0NjI3OTU2NzI5_81e46ea9-c14a-4d2a-ad00-9a3416f15efc"
      unitRef="usd">374000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="iaf6d168e90384511a71c377dfd7de3ce_I20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMTc_b1f3f8f7-5fc9-4a48-ab5c-bc898988ed3f"
      unitRef="usd">124000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i17df012ad7434bfbb9d2eb2b368409f0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4NzM_ba6fda75-84ed-4a91-b9b0-bc2fdb48edc4"
      unitRef="usd">95000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i7356694aafaa470bb4b7829c91e1f795_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNjgwOTg_f8b7b3d2-f9ac-435b-affa-263efa112320"
      unitRef="usd">160000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <cah:LossContingencyNumberOfEligibleStates
      contextRef="i4b3c6bcb9476438a921794e67914851b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4OTA_1eba0df1-2ad9-40e8-aa5f-d1987bf40e25"
      unitRef="states">49</cah:LossContingencyNumberOfEligibleStates>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i6fbfe1e2d6514850b46a3e54db3b64c8_I20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MjExMzE_b6aa1655-1d52-4013-8b98-65b743b7a58e"
      unitRef="lawsuit">475</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationSettlementExpense
      contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzExNTQ1_a222c96c-009b-42fc-abc1-1161d3c2568a"
      unitRef="usd">1170000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTA3ODI_ed620e9e-5d00-4817-a3e0-4854b7e46584"
      unitRef="usd">5630000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationReserve
      contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzExNjUy_dcd7b07f-ec9d-4d7f-8311-0d92ac4f1db2"
      unitRef="usd">6360000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserveCurrent
      contextRef="ie8e807ff00cf4eee81e7adf2221f3b22_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTA3NzA_d860c02f-a936-42ce-b115-01ec622fee5f"
      unitRef="usd">532000000</us-gaap:LitigationReserveCurrent>
    <cah:LossContingencyLawsuitsNumber
      contextRef="i20857812252441139f2a9488cc8b4bba_I20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzEzNzk1_bcaee0b6-7c3b-4433-99e8-8b701e0c0931"
      unitRef="lawsuit">151</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="if6e7b27e6d834a1c8986340dacdd8d75_D20220701-20220731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzU0OTc1NTgxNzM4NzY_eefcf79a-bc8b-431e-8861-cd0a18475b48"
      unitRef="plaintiff">21</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i6832ede5864441bc8fc50fdb23a84d6d_D20220809-20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1NTky_ad900197-bb61-4166-a3ad-65b6ec47d0a0"
      unitRef="lawsuit">470</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i49994de05a53424c945a894b6a702b21_D20220809-20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1NzE1_8423e72a-5a29-43a1-8d0a-78d590678e31"
      unitRef="plaintiff">5967</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i3536e19ef529496ab3333df7b2c14579_D20220809-20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1ODY2_f330cd76-fd04-4dc4-9825-2f611e236c17"
      unitRef="lawsuit">18</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i34d64ff0f91940089c6a221af627861f_D20220809-20220809"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE1OTIw_c8de768f-2ae4-4754-a34a-91f8be8faa1a"
      unitRef="plaintiff">20</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i0d398a83243b4879a927f24535bca4ad_D20210701-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzY1OTcwNjk4MTc4OTM_dfffea85-eac3-4665-a56a-8cd0fe7bae77"
      unitRef="lawsuit">1300</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE2MzQ4_7487ca0e-74d0-4904-a132-50f59917d9f0"
      unitRef="usd">512000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE2ODMy_8fd75594-226d-4cb3-b306-afe0d76aee87"
      unitRef="usd">1050000000.00</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ib7b1ad13d2d3426a96e738a22b1d3ab6_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzE5MzA5_69850f97-70d3-4ad4-83ba-f04483679797"
      unitRef="usd">13000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzQ4_d21fbb46-25b3-4d7c-b2e6-876a5ebb41a6"
      unitRef="usd">18000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzUy_59d68807-0855-48b8-994a-0e99ee446053"
      unitRef="usd">112000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <cah:IncomefromSettlementsofClassActionLawsuits
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMTgvZnJhZzo3MWQ5NmRkMDQxNjE0NTJmYmYyN2IwYzc4MzhkNjg2NS90ZXh0cmVnaW9uOjcxZDk2ZGQwNDE2MTQ1MmZiZjI3YjBjNzgzOGQ2ODY1XzIxMzU5_ef3bd930-cc79-4852-bb3c-07e9eb9d2fff"
      unitRef="usd">16000000</cah:IncomefromSettlementsofClassActionLawsuits>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkwOTM_83bba078-6171-410e-8065-82dd076a03f6">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;8. Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings/(Loss) before Income Taxes and Provision for/(Benefit From) Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Effects of Goodwill Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, we recognized cumulative pre-tax charges of $2.1&#160;billion for goodwill impairments related to the Medical Unit. The net tax benefit related to these charges was $150&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Effects of Self-Insurance Pre-Tax Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, our wholly-owned insurance subsidiary recorded a self-insurance pre-tax loss in its fiscal 2020 statutory financial statements primarily related to opioid litigation. This self-insurance pre-tax loss, which did not impact our pre-tax consolidated results, was deducted on our fiscal 2020 consolidated federal income tax return and contributed to a significant net operating loss for tax purposes. The net operating loss was carried back and applied to adjust our taxable income for fiscal 2015, 2016, 2017, and 2018 as permitted under the Coronavirus Aid, Relief and Economic Security ("CARES") Act enacted by the United States Congress in March 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accordingly, our provision for income taxes during fiscal 2021 included a $424 million benefit from the net operating loss carryback primarily to reflect the difference between the federal statutory income tax rate during the fiscal years from 2015 to 2018 (35 percent for fiscal 2015, 2016, and 2017 and 28 percent for fiscal 2018) and the current federal statutory income tax rate of 21 percent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2021, we filed for a refund of $974&#160;million and in April 2022, we received a payment for $966&#160;million, which was net of certain adjustments. See Note 7 of the "Notes to Consolidated Financial Statements" for additional detail. We also increased our non-current deferred tax liability by approximately $700&#160;million during fiscal 2021 related to this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of tax law; however, it is possible that the tax authorities could challenge these tax benefits. The actual amount of the tax benefit may differ materially from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Effects of Opioid Litigation Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the $1.17&#160;billion and $5.63&#160;billion pre-tax charges for the opioid litigation recorded during fiscal 2021 and 2020, the net tax benefits were approximately $228&#160;million and $488 million, respectively. Our tax benefits are estimates, which reflect our current assessment of the estimated future deductibility of the amount that may be paid under the accrual taken in connection with the opioid litigation and are net of unrecognized tax benefits of $219&#160;million and $469&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the U.S. Tax Cuts and Jobs Act ("Tax Act"); however, these estimates require significant judgment since the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible Congress or the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit may differ materially from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nondeductible/nontaxable items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Withholding Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Valuation Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;US Taxes on International Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Resolutions with IRS and other related matters &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Opioid litigation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(49.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss Carryback Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(129.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(89.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense, fiscal 2021 is pretax income with tax benefit, and fiscal 2020 is pretax loss with tax benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit rate was (21.2)% and (89.7)% in fiscal 2022 and fiscal 2021 compared to an income tax benefit rate of 2.1% in fiscal 2020. Fluctuations in the effective tax rates are primarily due to the impact of goodwill impairment in fiscal 2022, impact of opioid litigation in fiscal 2021 and 2020, as well as the &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impact of the carryback claim filed in accordance with the CARES Act provision in fiscal year 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate has benefits from negotiated lower than statutory tax rates in select foreign jurisdictions which individually are not material to our effective tax rate but in aggregate have a favorable tax impact of approximately $21 million during fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, foreign earnings of approximately $833 million are considered indefinitely reinvested for working capital and other offshore investment needs. The computation of tax required if those earnings are repatriated is not practicable. For amounts not considered indefinitely reinvested, we have recorded an immaterial amount of income tax expense in our consolidated financial statements in fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities and operating loss and tax credit carryforwards for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receivable basis difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Self-Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability transferred to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 we had gross federal, state and international loss and credit carryforwards of $275 million, $3.5 billion and $2.2 billion, respectively, the tax effect of which is an aggregate deferred tax asset of $778 million. Substantially all of these carryforwards are available for at least three years. Approximately $449 million of the valuation allowance at June&#160;30, 2022 applies to certain federal, state and international loss carryforwards that, in our opinion, are more likely than not to expire unutilized. However, to the extent that tax benefits related&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to these carryforwards are realized in the future, the reduction in the valuation allowance would reduce income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had $943 million, $932 million and $998 million of unrecognized tax benefits at June&#160;30, 2022, 2021 and 2020, respectively. The June&#160;30, 2022, 2021 and 2020 balances include $858 million, $849 million and $753 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate. The remaining unrecognized tax benefits relate to tax positions for which ultimate deductibility is highly certain but for which there is uncertainty as to the timing of such deductibility. Recognition of these tax benefits would not affect our effective tax rate. We include the full amount of unrecognized tax benefits in deferred income taxes and other liabilities in the consolidated balance sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;943&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between zero and a net decrease of up to $75 million, exclusive of penalties and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. At June&#160;30, 2022, 2021 and 2020, we had $48 million, $49 million and $146 million, respectively, accrued for the payment of interest and penalties. These balances are gross amounts before any tax &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;benefits and are included in deferred income taxes and other liabilities in the consolidated balance sheets. As a result of our IRS audit settlements and carryback claim, an immaterial amount of interest was recorded in fiscal 2022 and 2021. During fiscal 2020, we recognized $16 million of expense for interest and penalties in income tax expense, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state and local jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2015 through the current fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expiring or unusable loss and credit carryforwards and the required valuation allowances are adjusted quarterly based on available information. This information may support either an increase or a decrease in the required valuation allowance. After applying the valuation allowances, we do not anticipate any limitations on our use of any of the other net deferred income tax assets described above. We operate in a complex multinational tax environment and are subject to tax treaty arrangements and transfer pricing guidelines for intercompany transactions that are subject to interpretation. Uncertainty in a tax position may arise as tax laws are subject to interpretation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was $75 million and $72 million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was $1 million and $12 million at June&#160;30, 2022 and 2021, respectively, and is included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTc_b67820b5-e2a6-4bd6-a3ae-1dbce64f09ab">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes earnings/(loss) before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Earnings/(loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtMS0xLTEtMTQ3MTU3_42647347-6dc6-4909-875b-db0e91355c32"
      unitRef="usd">-1000000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtMy0xLTEtMTQ3MTU3_1495839f-24cc-4dda-ad32-178a17c7f3c2"
      unitRef="usd">-47000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzEtNS0xLTEtMTQ3MTU3_d79d40d2-5812-4a0e-9805-122f98bd3073"
      unitRef="usd">-4056000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItMS0xLTEtMTQ3MTU3_98e11cbc-8943-4fc3-9a93-b6bf414b98f6"
      unitRef="usd">231000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItMy0xLTEtMTQ3MTU3_e340e62b-1eaa-4dd9-9517-e8c3e44644d9"
      unitRef="usd">370000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzItNS0xLTEtMTQ3MTU3_92ab3eaf-2480-487a-a48c-6b11b018c002"
      unitRef="usd">284000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtMS0xLTEtMTQ3MTU3_28362f86-2296-4a45-a084-18ba08b3024b"
      unitRef="usd">-769000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtMy0xLTEtMTQ3MTU3_4323cb1a-f89a-45de-9b46-7cebfd174e09"
      unitRef="usd">323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpjZjgyOWJjZjBkMTg0YTM1ODFlYTllYzllMDdkYjQ0MC90YWJsZXJhbmdlOmNmODI5YmNmMGQxODRhMzU4MWVhOWVjOWUwN2RiNDQwXzMtNS0xLTEtMTQ3MTU3_64f6b524-dfb9-4118-9ff0-de755f273270"
      unitRef="usd">-3772000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTI_feccb40d-f107-4931-851b-0369e9fb95a7">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of provision for/(benefit from) income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provision for/(benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItMS0xLTEtMTQ3MTU3_e375b5bb-e68e-4525-a90d-fe5e47d70d41"
      unitRef="usd">34000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItMy0xLTEtMTQ3MTU3_b0c5a442-4132-4ecf-9e6f-0debe24695b1"
      unitRef="usd">-989000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzItNS0xLTEtMTQ3MTU3_faa4b849-8aa8-4452-8076-5fc1177f948c"
      unitRef="usd">659000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtMS0xLTEtMTQ3MTU3_871b6d2f-ab25-4aea-8541-0e4845503428"
      unitRef="usd">29000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtMy0xLTEtMTQ3MTU3_8d55b8e1-1a51-48a6-9420-69d6d6098af0"
      unitRef="usd">92000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzMtNS0xLTEtMTQ3MTU3_a262f609-42d8-46ce-aeac-bf8c396105b5"
      unitRef="usd">154000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtMS0xLTEtMTQ3MTU3_1884a07a-f6d1-4ccc-a88e-ddafa30a1a78"
      unitRef="usd">93000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtMy0xLTEtMTQ3MTU3_a93ab989-a49b-4993-90e6-cbc6691bc71e"
      unitRef="usd">112000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzQtNS0xLTEtMTQ3MTU3_9f2c9825-8634-4db9-b4f2-dd45dbb840b2"
      unitRef="usd">69000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtMS0xLTEtMTQ3MTU3_a8dede5f-b1fb-4ed6-92f7-4197e22fa3fb"
      unitRef="usd">156000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtMy0xLTEtMTQ3MTU3_ebb1accf-6268-4709-a863-3a0aa753d6b3"
      unitRef="usd">-785000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzUtNS0xLTEtMTQ3MTU3_a2c75a8a-2f62-48b5-9824-9245c8eee984"
      unitRef="usd">882000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtMS0xLTEtMTQ3MTU3_bc92ed19-a262-4bd1-85eb-932d04a79afb"
      unitRef="usd">30000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtMy0xLTEtMTQ3MTU3_84f83cb5-5c4c-4102-a4b9-dc86d0e0a5fd"
      unitRef="usd">539000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzgtNS0xLTEtMTQ3MTU3_7d3ca6d6-ed01-47a3-a1bf-e109cc076345"
      unitRef="usd">-822000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktMS0xLTEtMTQ3MTU3_88781fc1-2a74-4a6a-b851-cc72c4bb9661"
      unitRef="usd">-22000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktMy0xLTEtMTQ3MTU3_a7eef617-fdee-4802-9bb3-4ac6f857790d"
      unitRef="usd">-28000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzktNS0xLTEtMTQ3MTU3_81acaa7b-6d1c-4c24-9a8d-5488dd327334"
      unitRef="usd">-127000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTEtMS0xLTE0NzE1Nw_cfd5b629-38e2-49ee-b74d-4a2540f0d6d3"
      unitRef="usd">-1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTMtMS0xLTE0NzE1Nw_053d4cf6-ee7f-4812-8267-591c2be56f66"
      unitRef="usd">-15000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEwLTUtMS0xLTE0NzE1Nw_44290378-2034-4718-9233-3f3256845c92"
      unitRef="usd">-12000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTEtMS0xLTE0NzE1Nw_51caa9db-06f1-4721-86d8-2e2973731559"
      unitRef="usd">7000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTMtMS0xLTE0NzE1Nw_96a65b81-6a1e-4640-9696-e9458eb62140"
      unitRef="usd">496000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzExLTUtMS0xLTE0NzE1Nw_1808985d-c3eb-49c8-b04e-cc9b630dce18"
      unitRef="usd">-961000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTEtMS0xLTE0NzE1Nw_ac52959c-08f4-41f3-946b-373494aa95c4"
      unitRef="usd">163000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTMtMS0xLTE0NzE1Nw_d54f6180-db24-40e0-af0d-a54f52f1a433"
      unitRef="usd">-289000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTpkM2JmZmIwMzBlNjU0N2I3OTUzZTQ5OTMxMmM5Yjk4MC90YWJsZXJhbmdlOmQzYmZmYjAzMGU2NTQ3Yjc5NTNlNDk5MzEyYzliOTgwXzEyLTUtMS0xLTE0NzE1Nw_4d55aff2-a0d7-489e-a223-d2debc5c501d"
      unitRef="usd">-79000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODM5MDc_45ba1b67-4027-473a-b19d-a383f27d9d7a"
      unitRef="usd">2100000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3a49e2802adb47ebb172f2416918baa4_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTAwNzM_4f65ed65-cf6a-47b9-8262-66c236345cc1"
      unitRef="usd">-150000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1ba6181b3f81427f9ba8073d79075732_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTEzMTk_f20bd410-4dae-49a3-a65b-a5902a8595c6"
      unitRef="usd">-424000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReceivable
      contextRef="ib692a8c8095746b7ac437f383074870f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzE0MDk_2c4bc038-f3b7-4df3-8849-fd0ad0acbf9a"
      unitRef="usd">974000000</us-gaap:IncomeTaxReceivable>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="idd9b4528179f4b06825682ef3bc16324_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU0OTc1NTgxNTE0OTg_8acece84-79b8-4e91-a90d-51024b0e8ae6"
      unitRef="usd">966000000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="ib692a8c8095746b7ac437f383074870f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzE3MjU2_8a2c43cc-738f-4112-8bbb-3184354cf8d3"
      unitRef="usd">700000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:LitigationSettlementExpense
      contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzIxMDU_8f096e93-c07f-4276-8d6d-827a00a32852"
      unitRef="usd">1170000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyOTA_ed620e9e-5d00-4817-a3e0-4854b7e46584"
      unitRef="usd">5630000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzIyMTI_c607fa27-67af-426d-92cb-c2df5e50b0ea"
      unitRef="usd">-228000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyNTk_52b2933d-2ef2-4618-9b90-1cf21b51eec9"
      unitRef="usd">-488000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ib70a49e43657407780e301606b63b480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzI0ODQ_0ad9bf2a-edc7-4ea4-b5d8-9947c42cbb22"
      unitRef="usd">219000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ie478c499b6e14ab2bbc046275533973f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzY1OTcwNjk3ODIyNzA_287e80bb-1a1e-4009-ae85-777139c92311"
      unitRef="usd">469000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxMTA_f98025b9-e823-4f14-bffd-ae755972a66f">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Provision at Federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nondeductible/nontaxable items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Withholding Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Valuation Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;US Taxes on International Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impact of Resolutions with IRS and other related matters &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Opioid litigation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(49.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss Carryback Claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(129.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(89.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The table represents the following: fiscal 2022 is pretax loss with tax expense, fiscal 2021 is pretax income with tax benefit, and fiscal 2020 is pretax loss with tax benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Certain prior year amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;(3)&#160;&#160;&#160;&#160;Includes the tax impact of Global Intangible Low-Taxed Income ("GILTI") tax, the Foreign-Derived Intangible Income deduction and other foreign income that is taxable under the U.S. tax code.</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtMS0xLTEtMTQ3MTU3_2e58dde4-6f04-4346-b8df-ee9e5a01c347"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtMy0xLTEtMTQ3MTU3_2a6aaf4c-e580-4bbd-9137-9bd4adc1ba4f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEtNS0xLTEtMTQ3MTU3_4072cb93-6c74-4394-b51a-b052739a2e02"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItMS0xLTEtMTQ3MTU3_576c85e0-79f5-4dab-ba22-699e17c5b106"
      unitRef="number">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItMy0xLTEtMTQ3MTU3_68cfdf0d-9f0e-4c6d-8cfd-fd55b6deb812"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzItNS0xLTEtMTQ3MTU3_24524e56-7be3-49b3-9030-c85956179788"
      unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtMS0xLTEtMTQ3MTU3_1fca69fc-8de1-40fc-b049-93cc5b967169"
      unitRef="number">0.035</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtMy0xLTEtMTQ3MTU3_7873a204-2c19-4297-ba9a-d2b1270141be"
      unitRef="number">0.007</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzMtNS0xLTEtMTQ3MTU3_2c357cae-64b4-431f-be14-f04cb007cda9"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtMS0xLTEtMTQ3MTU3_1cf1cfbe-55cb-4562-9751-0a80aa19e8ce"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtMy0xLTEtMTQ3MTU3_7b55695c-8ad7-42ea-ad30-654e10a0c060"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzQtNS0xLTEtMTQ3MTU3_e68a397b-55b3-44bf-8b1d-2383ea41b88d"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtMS0xLTEtMTQ3MTU3_48d35ad7-98f2-421b-80b5-cdb3925ab34e"
      unitRef="number">-0.049</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtMy0xLTEtMTQ3MTU3_7bdcfba1-c088-4646-992a-bc3394150915"
      unitRef="number">0.070</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzUtNS0xLTEtMTQ3MTU3_5149a009-1cdc-462f-a62e-97a9fcae0685"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtMS0xLTEtMTQ3MTU3_a8957c46-7374-4e70-92f0-b7fdbdd9f6bd"
      unitRef="number">-0.011</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtMy0xLTEtMTQ3MTU3_0a9e4f7a-8eaa-4388-8fa4-b64ae436ae03"
      unitRef="number">0.090</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzYtNS0xLTEtMTQ3MTU3_f01f216c-d5af-4bf8-896d-8f54a1e544b6"
      unitRef="number">-0.003</cah:EffectiveIncomeTaxRateReconciliationWithholdingTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctMS0xLTEtMTQ3MTU3_d3456d71-af3f-49b1-aae3-0c126e91f992"
      unitRef="number">0.035</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctMy0xLTEtMTQ3MTU3_e0707784-57b1-42a9-af31-ddfd2aa41592"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzctNS0xLTEtMTQ3MTU3_b4352b6c-6477-4e57-ac2e-863e649aec46"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtMS0xLTEtMTQ3MTU3_ceaab9ec-3d2d-443d-befd-8e92c1bfbb2b"
      unitRef="number">0.032</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtMy0xLTEtMTQ3MTU3_fad78a35-f410-4be2-902e-b9beb9028d2b"
      unitRef="number">-0.067</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzgtNS0xLTEtMTQ3MTU3_d3f9de96-dc1a-403d-923d-c4fe35129e45"
      unitRef="number">0.002</cah:EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTEtMS0xLTE0NzE1Nw_3665fd66-5d9f-4d50-b442-8f7fccbe1624"
      unitRef="number">-0.006</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTMtMS0xLTE0NzE1Nw_5662556d-71ab-4164-aa78-abc5b86d241c"
      unitRef="number">-0.136</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEwLTUtMS0xLTE0NzE1Nw_3c575f86-463f-4e98-9a69-388fc82083b1"
      unitRef="number">-0.004</cah:EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTEtMS0xLTE0NzE1Nw_ab46617b-76f8-46f9-a24c-2ec622ce0865"
      unitRef="number">-0.005</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTMtMS0xLTE0NzE1Nw_934783d1-8c4c-42d3-a553-40ab40339f39"
      unitRef="number">0.177</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <cah:EffectiveIncomeTaxReconciliationOpioidLitigation
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzEzLTUtMS0xLTE0NzE1Nw_9d4c391e-cd15-4f57-836e-ba5c0e013160"
      unitRef="number">-0.232</cah:EffectiveIncomeTaxReconciliationOpioidLitigation>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTEtMS0xLTE5NzcyNg_e6f2efbe-71cc-40f7-ae60-5c6490a4f430"
      unitRef="number">-0.495</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTMtMS0xLTE5NzcyOA_b841b6c8-3c22-4e78-b1db-63df062f7cba"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTUtMS0xLTE5NzczMA_06128b6e-cce1-41a0-b342-239d7ce38b73"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTEtMS0xLTE0NzE1Nw_b375d062-149e-4144-b95d-df3ca4d1cd85"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTMtMS0xLTE0NzE1Nw_5a7db7a8-9a31-4c0f-b577-214ce54a1478"
      unitRef="number">-1.299</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE0LTUtMS0xLTE0NzE1Nw_87ba0b85-13da-4a56-9088-7c5b18b7041a"
      unitRef="number">0</cah:EffectiveIncomeTaxRateReconciliationLossCarrybackClaims>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTEtMS0xLTE0NzE1Nw_4f26ac32-2e8a-4aa9-a371-e8996cff27e5"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTMtMS0xLTE0NzE1Nw_b3c0a88c-bc64-4cd7-9b32-bfdfd248f809"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE1LTUtMS0xLTE0NzE1Nw_6e00bddc-7eec-4580-8c6e-408347e6367d"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTEtMS0xLTE0NzE1Nw_1783fb13-5d98-48a5-9eae-f0b97ec09d6d"
      unitRef="number">-0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTMtMS0xLTE0NzE1Nw_b504a7df-d4b1-40a7-9857-674e0922f848"
      unitRef="number">-0.897</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo3ZDMyNGRlYjkwMjg0MmU4OGIyMWU4OGYzOWUwOWNmMi90YWJsZXJhbmdlOjdkMzI0ZGViOTAyODQyZTg4YjIxZTg4ZjM5ZTA5Y2YyXzE2LTUtMS0xLTE0NzE1Nw_1b7b93b0-8c7d-493c-ae21-59760c3c6bc2"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM3NDU_8d20b820-b23c-4b7d-9905-7568cdbac31d"
      unitRef="number">-0.212</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM3NTI_b504a7df-d4b1-40a7-9857-674e0922f848"
      unitRef="number">-0.897</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzM4MjQ_1b7b93b0-8c7d-493c-ae21-59760c3c6bc2"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzQzMTM_0af09547-bdbe-41a9-a1cf-2a5fcd651799"
      unitRef="usd">21000000</cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzQzNzg_bace3bd9-ee8d-4c3c-a6ce-5fde1dfbc5f0"
      unitRef="usd">833000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTk_981e26fa-d061-47a3-b89c-20bf48717da4">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the deferred income tax assets and liabilities at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receivable basis difference&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax assets related to uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Inventory basis differences&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Self-Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzItMS0xLTEtMTQ3MTU3_1382bb0a-dafb-4df4-9548-c956bf4dba5f"
      unitRef="usd">41000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzItMy0xLTEtMTQ3MTU3_736c7fe7-d90c-4a84-bc01-be50c6d59078"
      unitRef="usd">40000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzMtMS0xLTEtMTQ3MTU3_73771a53-9c17-4d2e-9c0e-84b13ac0b58e"
      unitRef="usd">675000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzMtMy0xLTEtMTQ3MTU3_ac0e167d-17e9-4aa2-b8b3-49d4cdfcfd40"
      unitRef="usd">874000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzQtMS0xLTEtMTQ3MTU3_f15b70c7-bcce-42e3-802c-90d5e450e47c"
      unitRef="usd">34000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzQtMy0xLTEtMTQ3MTU3_6f5f035e-be21-4fad-96ad-af52bcdb4dfe"
      unitRef="usd">38000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzUtMS0xLTEtMTQ3MTU3_f6f63e4c-9db8-493d-83e2-f7b044164072"
      unitRef="usd">778000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzUtMy0xLTEtMTQ3MTU3_95e83830-2584-4e12-8ba5-e767af919b92"
      unitRef="usd">805000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzYtMS0xLTEtMTQ3MTU3_b6959f19-a613-4c14-a653-70f81e08ca2c"
      unitRef="usd">33000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <cah:DeferredTaxAssetsRelatedtouncertaintaxpositions
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzYtMy0xLTEtMTQ3MTU3_1a2f612f-e59c-4f06-b738-4196afe346a2"
      unitRef="usd">35000000</cah:DeferredTaxAssetsRelatedtouncertaintaxpositions>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzctMS0xLTEtMTQ3MTU3_3549d35b-66f1-4d44-bbc5-4da68aa79b3e"
      unitRef="usd">23000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzctMy0xLTEtMTQ3MTU3_d4b56a55-a5d5-4c69-b58f-0c5d24215a0f"
      unitRef="usd">16000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzgtMS0xLTEtMTQ3MTU3_cb3260f6-666c-49e1-ad4e-19b28d14b753"
      unitRef="usd">1584000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzgtMy0xLTEtMTQ3MTU3_8a6cdf33-6c4f-4fdf-83f9-5b0a9fea0a10"
      unitRef="usd">1808000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzktMS0xLTEtMTQ3MTU3_ea27a41b-035c-4f6a-a30e-f2d325f79dea"
      unitRef="usd">468000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzktMy0xLTEtMTQ3MTU3_9072d248-2816-47bc-a0d1-0fb6f9df7bc2"
      unitRef="usd">515000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEwLTEtMS0xLTE0NzE1Nw_fa914b96-b62c-4027-aa5c-e3f1da287103"
      unitRef="usd">1116000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEwLTMtMS0xLTE0NzE1Nw_7ac30a29-1acb-48cf-b3d4-4e93d18e3b2a"
      unitRef="usd">1293000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEzLTEtMS0xLTE0NzE1Nw_392fd549-59e4-443b-b6fd-5ec0eac7dae3"
      unitRef="usd">1164000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzEzLTMtMS0xLTE0NzE1Nw_db62f17f-98ce-455f-9850-fdd8a331fd03"
      unitRef="usd">1119000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE0LTEtMS0xLTE0NzE1Nw_7fee9e79-9fae-48a7-9ca9-6dc0c7ab8090"
      unitRef="usd">288000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE0LTMtMS0xLTE0NzE1Nw_e389f4ac-135a-47df-aba7-8a5387916cc8"
      unitRef="usd">375000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE1LTEtMS0xLTE0NzE1Nw_83749c12-aa4e-4711-b333-30a5d008ce5d"
      unitRef="usd">683000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE1LTMtMS0xLTE0NzE1Nw_40ac1732-7a89-4244-945a-ac2cf95a1ba2"
      unitRef="usd">733000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE2LTEtMS0xLTE0NzE1Nw_8c53d0c0-2943-49fe-98e6-471b549df7b3"
      unitRef="usd">975000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE2LTMtMS0xLTE0NzE1Nw_146e75e1-324f-4b5d-b2e5-46ee2a3f2539"
      unitRef="usd">975000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE3LTEtMS0xLTE0NzE1Nw_6e8c3efe-c04a-4c86-a635-677bf332fe5f"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE3LTMtMS0xLTE0NzE1Nw_72866a11-9160-4d91-a28f-909661eea7b9"
      unitRef="usd">23000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE4LTEtMS0xLTE0NzE1Nw_903df654-06ad-4ff8-8f43-481b04269bfa"
      unitRef="usd">3110000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE4LTMtMS0xLTE0NzE1Nw_9bd7e5a7-685f-4e7d-8bfa-bdb90cad68f0"
      unitRef="usd">3225000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE5LTEtMS0xLTE0NzE1Nw_68adc421-c1be-4905-8674-5621271bfeca"
      unitRef="usd">1994000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2YmYyYTNjNWMwMjQ0YTkyYjg0ODdkYWU3ZmNjYWYyYi90YWJsZXJhbmdlOjZiZjJhM2M1YzAyNDRhOTJiODQ4N2RhZTdmY2NhZjJiXzE5LTMtMS0xLTE0NzE1Nw_1262f747-99a2-433b-b000-885e65dc5dea"
      unitRef="usd">1932000000</us-gaap:DeferredTaxLiabilities>
    <cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxNTQ_6f041e0f-1892-467c-bc82-82fd89a778a8">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction and for uncertain tax positions, are in the following captions in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax liability transferred to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net deferred income tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzEtMS0xLTEtMTQ3MTU3_53c52ae0-a054-4a78-b0ad-135fba1ca759"
      unitRef="usd">36000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzEtMy0xLTEtMTQ3MTU3_6388f132-e319-4c80-ac34-64dd9b23f117"
      unitRef="usd">52000000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzItMS0xLTEtMTQ3MTU3_122538e9-fa5d-4e70-a9ab-71702e4a46a9"
      unitRef="usd">2030000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzItMy0xLTEtMTQ3MTU3_9ecc0c5c-b6ad-4f79-8f5f-2ec6c27d179a"
      unitRef="usd">1981000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzMtMS0xLTEtMTQ3MTU3_39ee76ef-8d2e-4313-a78a-b42b2c7e1b80"
      unitRef="usd">0</cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent>
    <cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzMtMy0xLTEtMTQ3MTU3_db32f8a5-73c6-4f26-9e59-fb7c40a397c9"
      unitRef="usd">3000000</cah:DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzQtMS0xLTEtMTQ3MTU3_f2479498-0e59-4857-b12a-2e1e4db0aa1a"
      unitRef="usd">1994000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTo2NzkyMDI4ZTU1NWE0YmNlODljOGExODI2Y2VlYTMzOC90YWJsZXJhbmdlOjY3OTIwMjhlNTU1YTRiY2U4OWM4YTE4MjZjZWVhMzM4XzQtMy0xLTEtMTQ3MTU3_68099b2b-2e34-42df-b3da-5a9f58c29bf7"
      unitRef="usd">1932000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="iaf55d738e4c2417989763623ac863aba_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MDM_ba088f93-cff1-484a-b1f1-0d4b966f5785"
      unitRef="usd">275000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i4049be5d431a45859642596069133d4c_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MDc_6d72d6c0-a233-46cc-be5e-848a51b7655a"
      unitRef="usd">3500000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="idf7f919960364e29acc09ea1ecf5403b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1MTQ_4e6b8229-1668-4320-81e7-77863a32c17a"
      unitRef="usd">2200000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU1OTQ_fe1f6918-3409-4fa0-9af7-b212388b4c54"
      unitRef="usd">778000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzU2OTM_a0544b23-bf66-42a9-b783-1d45d5c318a6"
      unitRef="usd">449000000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwNzY_29fecf06-0832-4f3f-ba65-7a088d776307"
      unitRef="usd">943000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwODA_29c10ccb-c67a-4f44-8380-1297aad14a98"
      unitRef="usd">932000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYwODc_076b192b-6bfa-499b-94e7-0644822c7894"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxODY_8c0f044c-4fb7-4c02-9e51-5aa28eff38e2"
      unitRef="usd">858000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxOTA_56ea1d18-fa5f-48f9-804b-590e2167d457"
      unitRef="usd">849000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzYxOTc_982b335e-20a6-41fc-b7eb-6794f96c3e01"
      unitRef="usd">753000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzkxMDY_6851a3a8-3964-4f57-b0dc-18a03c970fc9">The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;932&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Settlements with tax authorities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of fiscal year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;943&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtMS0xLTEtMTQ3MTU3_4ca68944-453d-4758-a507-069a26da0fd3"
      unitRef="usd">932000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtMy0xLTEtMTQ3MTU3_32d28539-6fb2-4fe5-8841-0bfdf74a9dad"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzEtNS0xLTEtMTQ3MTU3_7c22e367-9b90-4538-8fba-59526d51c069"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItMS0xLTEtMTQ3MTU3_7f1f1a76-4e2c-42eb-a60b-05b4f30a616d"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItMy0xLTEtMTQ3MTU3_73387f20-7480-45ff-aef2-1311a4f80811"
      unitRef="usd">121000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzItNS0xLTEtMTQ3MTU3_c89fb16c-fa93-46a8-857a-1242fa62ca3a"
      unitRef="usd">500000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtMS0xLTEtMTQ3MTU3_5e7a4d90-d36e-4072-84ea-0c45aea2e9fe"
      unitRef="usd">39000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtMy0xLTEtMTQ3MTU3_00ac3ff8-3125-4980-a2e0-681e25221549"
      unitRef="usd">223000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzMtNS0xLTEtMTQ3MTU3_8821f164-6dea-4aae-aa09-771bd2b0f0e5"
      unitRef="usd">78000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtMS0xLTEtMTQ3MTU3_a173556a-ba1b-47f0-aa46-4e21bb162e0c"
      unitRef="usd">19000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtMy0xLTEtMTQ3MTU3_6b210485-b0e1-4af1-af23-77fdde1264e5"
      unitRef="usd">138000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzQtNS0xLTEtMTQ3MTU3_474f1977-65de-4d85-a575-1ba92cbf11c5"
      unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtMS0xLTEtMTQ3MTU3_86fbd332-b540-40e2-977f-76e24f133c96"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtMy0xLTEtMTQ3MTU3_5bdd1fd3-d4a7-4e28-9d06-1b1c2cbbbc68"
      unitRef="usd">271000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzUtNS0xLTEtMTQ3MTU3_1cfd2554-5ece-46c9-9f75-708466553969"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtMS0xLTEtMTQ3MTU3_190c4f75-b957-40de-b019-2ece6dd02349"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtMy0xLTEtMTQ3MTU3_39081b2e-27f5-4ad9-a5c1-e06f25e13407"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzYtNS0xLTEtMTQ3MTU3_a19dd9f9-baef-4819-be53-b3d7c7768e9c"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctMS0xLTEtMTQ3MTU3_29fecf06-0832-4f3f-ba65-7a088d776307"
      unitRef="usd">943000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctMy0xLTEtMTQ3MTU3_29c10ccb-c67a-4f44-8380-1297aad14a98"
      unitRef="usd">932000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90YWJsZTphZDhkZmQxYjk2OTQ0ZDY4OWIwYzhlOTNhZTlmM2QwMi90YWJsZXJhbmdlOmFkOGRmZDFiOTY5NDRkNjg5YjBjOGU5M2FlOWYzZDAyXzctNS0xLTEtMTQ3MTU3_076b192b-6bfa-499b-94e7-0644822c7894"
      unitRef="usd">998000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="id7e703a9570f493582c8bc1a69a64a7d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzczMDg_166f774a-7da4-4e8d-b1f9-203e8505254f"
      unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i2a84380ffecb45f7abba964081bd5ef7_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzczMTQ_aca0d641-7591-4695-83e9-f729a169b75b"
      unitRef="usd">75000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc0OTY_2e49b456-0f3b-498c-8f68-36dbcb9baae4"
      unitRef="usd">48000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc1MDA_2c08bc30-c56e-48d0-85a3-400d8d4f7b7f"
      unitRef="usd">49000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc1MDc_4bed1c6a-99c5-4cf1-9fd4-9309885d123e"
      unitRef="usd">146000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzc5MDM_667b25a3-f504-4ba7-af7d-0cc9a114133e"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <cah:IndemnificationReceivable
      contextRef="i9d73f184d2b949538033de20922de133_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg2MTI_c7c9cfbd-f499-455f-bcb9-dd1907841849"
      unitRef="usd">75000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="i3cf2679b91854d43ae797e4fa386a35a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg2MTk_788dd3d5-fefd-4ac5-9954-32587d5ce48b"
      unitRef="usd">72000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="i155edd13bdcd4fe6a997c9048e92a4cb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg5ODM_e0a9ab51-fdb8-4de6-95a1-240570f46671"
      unitRef="usd">1000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="i4f315442d4d144f597f8e7072738b52c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjEvZnJhZzo4MmVhNWFhNTE5YWU0YTlkOWY5ODIwNTRjMWRlMzFmZC90ZXh0cmVnaW9uOjgyZWE1YWE1MTlhZTRhOWQ5Zjk4MjA1NGMxZGUzMWZkXzg5OTA_e269efc0-ed3c-4867-aa39-329bfa924dbf"
      unitRef="usd">12000000</cah:IndemnificationReceivable>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2NjI_539253e5-72b2-405a-98ad-70a5243fa003">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;9. Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Assets and (Liabilities) Measured on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities held for sale of $1.1&#160;billion and $96 million, respectively, at June&#160;30, 2021 were primarily related to the divestiture of the Cordis business. These estimated fair values utilized Level 3 unobservable inputs based on expected sales proceeds following a competitive bidding process. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding the divestiture of Cordis business.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2Nzg_157716a3-d1ea-4dd4-8005-2eab27c425a4">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;9. Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;(2)The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzE2OTI_8f9c51e9-763f-4707-8fba-ca91486f75d9">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;The other investments balance includes investments in mutual funds, which offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high-quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;(2)The fair value of interest rate swaps, foreign currency contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the consolidated balance sheets.</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtMS0xLTEtMTQ3MTU3_671a4774-93c4-45e9-bd8e-22891e3d41ed"
      unitRef="usd">2425000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6f334187da934dae8f50e09f680684be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtMy0xLTEtMTQ3MTU3_4988a149-bd95-45c3-846f-35037b150772"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtNS0xLTEtMTQ3MTU3_908ee27f-faa5-46e1-ac73-9276018e5958"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzMtNy0xLTEtMTQ3MTU3_0049dd9b-6196-4c22-a1e1-de0cc5302eb8"
      unitRef="usd">2425000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtMS0xLTEtMTQ3MTU3_4de6e142-9edb-459c-82e0-78c335be78df"
      unitRef="usd">97000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6f334187da934dae8f50e09f680684be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtMy0xLTEtMTQ3MTU3_14e83da4-5b23-41a8-987a-8a9b25555cdf"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtNS0xLTEtMTQ3MTU3_9767b630-7b84-4471-b6da-191402490392"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzUtNy0xLTEtMTQ3MTU3_bc13f6b1-18b1-4df2-ad8a-bb04e4ab595b"
      unitRef="usd">97000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i0c79bf8fa09b4d96b7509598247edd5d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtMS0xLTEtMTQ3MTU3_703a166c-864a-4d65-b30d-5c46d9bded31"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i6f334187da934dae8f50e09f680684be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtMy0xLTEtMTQ3MTU3_ed78e079-151a-409f-9ffb-bbd21b5710e2"
      unitRef="usd">15000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="icbdbf096e98a4c7cb6dd490fecdd9b0d_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtNS0xLTEtMTQ3MTU3_860c8da3-bebe-4502-b45c-7c8912fa6a65"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i3e2109c867604d538c15c36e5773bfcd_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZToxZGZhOTk4ZDk4ZDI0Y2E0OGE3NDIxMWQwZDhiZGRkNy90YWJsZXJhbmdlOjFkZmE5OThkOThkMjRjYTQ4YTc0MjExZDBkOGJkZGQ3XzYtNy0xLTEtMTQ3MTU3_5bed8762-9090-4de9-8c2d-b80fcac24acd"
      unitRef="usd">15000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtMS0xLTEtMTQ3MTU3_52e09c25-eea0-4902-bd8a-8f1a1c93cb07"
      unitRef="usd">1883000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtMy0xLTEtMTQ3MTU3_ae00def7-75e4-4cbe-8ce4-db2a110864d0"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtNS0xLTEtMTQ3MTU3_47e1930a-43be-455f-a9c0-60b403fd2a76"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzMtNy0xLTEtMTQ3MTU3_ba92d581-0051-44f5-8911-615d2d41ded3"
      unitRef="usd">1883000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtMS0xLTEtMTQ3MTU3_9b8df0eb-26b7-42e6-a2cd-26c2f66046b7"
      unitRef="usd">126000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtMy0xLTEtMTQ3MTU3_038a1482-9f70-4260-b9fe-9bc438f85c37"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtNS0xLTEtMTQ3MTU3_edf876d0-3305-4fc2-9ccb-9e6dd2ac730d"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzUtNy0xLTEtMTQ3MTU3_4c22c6a3-8cd7-4dd6-91ea-400d6e3bd4bf"
      unitRef="usd">126000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i2daf1b96e99540f9a365925bbd666b52_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtMS0xLTEtMTQ3MTU3_18a64580-cc13-4c98-9816-cd743734dc8b"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i702e037993f84f039a387fa5716c2c5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtMy0xLTEtMTQ3MTU3_eab1e37e-a542-45b1-ace4-ced19538c5f8"
      unitRef="usd">42000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i9b3e38adae184a0f962abd0822c6e227_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtNS0xLTEtMTQ3MTU3_04567cb1-94ab-4f6a-a328-ce9695fdac26"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i6924e456b7eb4eb4ae5c2760621cedaf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90YWJsZTo3MjA3ZmVmNDY2YTE0NTE0YjdkZGI3M2NmNDg2MDU1MC90YWJsZXJhbmdlOjcyMDdmZWY0NjZhMTQ1MTRiN2RkYjczY2Y0ODYwNTUwXzYtNy0xLTEtMTQ3MTU3_88b44442-47b3-4bd0-8a5c-6e430c7ca8a4"
      unitRef="usd">42000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i8252480092a4420d9a47a8420945e070_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzY1OTcwNjk3Nzg1NTY_328deaab-97fa-45a4-b2a6-bd9e22ea6411"
      unitRef="usd">1100000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i8252480092a4420d9a47a8420945e070_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjQvZnJhZzozOWFiMjFlNTI4MTU0NWQ2YTZlYjFjZWNhODFiMzc0Yy90ZXh0cmVnaW9uOjM5YWIyMWU1MjgxNTQ1ZDZhNmViMWNlY2E4MWIzNzRjXzY1OTcwNjk3Nzg1NjY_ad6adcec-8925-483a-ab3c-f1370dba64a6"
      unitRef="usd">96000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzMw_6e5b814f-77f2-40f9-98e7-85f33f549967">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;10. Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk but are not designated as hedging instruments. These derivative instruments are adjusted to current fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into &lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Currency Exchange Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce earnings and cash flow volatility associated with foreign exchange rate changes to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the consolidated statements of earnings/(loss). During fiscal 2022, 2021 and 2020 there was no gain or loss recorded to interest expense as changes in the market value of our &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;derivative instruments offset changes in the market value of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, we entered into pay-floating interest rate swaps with total notional amounts of $600 million. These swaps have been designated as fair value hedges of our fixed rate debt and are included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During fiscal 2021, we unwound certain interest rate swap contracts with the notional amount of $550&#160;million. In connection with the unwind of these contracts, we received cash proceeds of $18&#160;million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the debt agreement, which matures in March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we entered into a pay-floating interest rate swap with total notional amounts of $200&#160;million. This swap has been designated as fair value hedges of our fixed rate debt and is included in deferred income taxes and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we unwound certain interest rate swap contracts. In connection with the unwind of these contracts, we received cash proceeds of $112 million. The related gain will be recognized in interest expense, net in our consolidated statements of earnings/(loss) over the remaining term of the related debt agreements, which ranged from 48 months to 63 months at June 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the debt repayment as described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_115" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 6&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, two pay-floating interest rate swaps with notional amounts of $200 million matured in the second quarter of fiscal 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;May 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive loss and reclassified into &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we entered into forward interest rate swaps with a total notional amount of $200&#160;million to hedge probable, but not firmly committed, future transactions associated with our debt. During fiscal 2021, we terminated these swaps and reclassified an immaterial deferred gain from accumulated other comprehensive loss into interest expense, net in our consolidated statements of earnings/(loss) because the forecasted transactions were probable of not occurring. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All gains and losses currently included within accumulated other comprehensive loss associated with our cash flow hedges that are expected to be reclassified into net earnings within the next 12 months are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency contracts to protect the value of anticipated foreign currency revenues and expenses. At June&#160;30, 2022 and 2021, we held contracts to hedge probable, but not firmly committed, revenue and expenses. The principal currencies hedged are the Canadian dollar, Mexican peso, Euro, Chinese renminbi, Thai baht, Philippine peso, Japanese yen, Australian dollar and British pound.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into commodity contracts to manage the price risk associated with forecasted purchases of certain commodities used in our Medical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jul 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, we entered into a &#xa5;24&#160;billion ($200&#160;million) cross-currency swap maturing in September 2025 and a &#xa5;24&#160;billion ($200&#160;million) cross-currency swap maturing in June 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, we terminated the &#xa5;64 billion ($600 million) cross-currency swap entered into in August 2019 and received a net settlement of $71&#160;million in cash recorded in proceeds from net investment hedge terminations in our consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax gain and loss from net investment hedges recorded in the foreign currency translation component of accumulated other comprehensive loss was a $86 million gain and a $7 million loss during fiscal 2022 and 2021, respectively. Gains recognized in interest expense, net in the consolidated statements of earnings/(loss) for the portion of the net investment hedges excluded from the assessment of hedge effectiveness were $21 million and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$19 million during fiscal 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Economic (Non-Designated) Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The principal currencies managed through foreign currency contracts are the Canadian dollar, Euro, Chinese renminbi, Indian rupee and Thai baht.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;265&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and equivalents, trade receivables, net, accounts payable, and other accrued liabilities at June&#160;30, 2022 and 2021 approximate fair value due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,049&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;633&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzgw_9fa35ae3-3db3-4f61-9f7c-6b3d9306d12e">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of our assets and liabilities related to derivatives designated as hedging instruments and the respective line items in which they were recorded in the consolidated balance sheets at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in other accrued liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6e0d0c9e1e2f467d97bbc64581905f40_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzItMS0xLTEtMTQ3MTU3_726df017-f0cb-4457-a79a-1576bac18571"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iff344aae68f94110aca38462cc1fbfeb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzItMy0xLTEtMTQ3MTU3_75ff64c3-a0b4-4fe7-a407-890940ccdadd"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i37f8e752754a4c0a8560dab2d9697e94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzMtMS0xLTEtMTQ3MTU3_f63ea49a-69ae-4110-a996-8bb01dd66749"
      unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i06ff51c1469749a9be8eb3406df0e62c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzMtMy0xLTEtMTQ3MTU3_f2bc452f-6e71-4a5a-9448-6c3ff5011fb7"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic059bb286acc4a4f9c4085b5a0410159_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzQtMS0xLTEtMTQ3MTU3_c501324e-7a81-4009-a965-2b89e27e6bfd"
      unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibccd2d0c1e544d42a1d4b65d126614e6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzQtMy0xLTEtMTQ3MTU3_f79c02b5-342d-44b9-be3f-e2094a8dc032"
      unitRef="usd">34000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie9d72cfa1fc7448e8a4d03ab71fc0b20_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzUtMS0xLTEtMTQ3MTU3_45da23ad-ca2e-4b51-a501-12a5277d8f55"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i14a755a6106242698132be9ad227180a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzUtMy0xLTEtMTQ3MTU3_29c9ab9a-95ac-482d-a7fe-b2843745f762"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzktMS0xLTEtMTQ3MTU3_e6abaad1-1f45-4442-8530-0c1b175dcded"
      unitRef="usd">61000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzktMy0xLTEtMTQ3MTU3_014565c8-208d-4779-a40d-c5508629a56a"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8588473d4f2c40a7ac9bf6e97f477a07_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzEzLTEtMS0xLTE0NzE1Nw_155ef93b-6ba5-4c3d-b309-3b2b24bc38b3"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icddad5bf093244d1b4387d8a979d72cb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzEzLTMtMS0xLTE0NzE1Nw_84cf0007-f90b-4a2e-b622-ccdff28a2879"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic69376b6c620458997976028c1214422_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE1LTEtMS0xLTE0NzE1Nw_3c06836e-0c9e-485e-b437-c1bcdf9e71ed"
      unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3cfc47e3aa3a4886af27a182bd671ec1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE1LTMtMS0xLTE0NzE1Nw_f6505c22-f387-4b8a-b055-6efa5cbf8881"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE3LTEtMS0xLTE0NzE1Nw_3e6b4342-9588-4ca8-87d6-37a0a4ff182e"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToxY2QyYTU3ZTE5MzA0YzA3YTg5YzA5NTQzMzkwMmI2ZS90YWJsZXJhbmdlOjFjZDJhNTdlMTkzMDRjMDdhODljMDk1NDMzOTAyYjZlXzE3LTMtMS0xLTE0NzE1Nw_90d75b25-0ce0-4e5f-bfc7-44162cde0f7b"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_915df962-7812-45d2-95f7-b2dbfd333656"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_e0a05a6d-85f9-4110-a24c-854295fca80c"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzM4MjY_edbcff67-8073-4b13-865d-81e831c5e3ad"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="id10d0b211539491aaf593b13a51c07c6_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4MTI_de9d6be0-37d0-45b4-9968-8dd0fc74061f"
      unitRef="usd">600000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount
      contextRef="iec28629ea39c43e4840b61f68f95c92c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NDQ_c2b56258-7240-475a-985c-94da7c8ab3fa"
      unitRef="usd">550000000</cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount>
    <us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
      contextRef="ie6d851e08ef540a6aceb7daa376a4bc2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NTg_7856d43e-f130-460a-9470-d5dd689bf702"
      unitRef="usd">18000000</us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="iec28629ea39c43e4840b61f68f95c92c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTE4NzE_a0ee9269-bcc4-43c0-a757-73f71e7f1225"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
      contextRef="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzQ3OTI_04a2b4ca-4893-4986-a09f-da184057b59a"
      unitRef="usd">112000000</us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge>
    <cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount
      contextRef="ifab5fae79e7a49b8868aa3b645dd05c5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzUxMjI_1eedac9d-ec2a-403c-8d2a-780e7995f036"
      unitRef="usd">200000000</cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i945df5b6d2454f3bb10a110ca1cfb83c_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzU0_1ba9dddb-b2a8-40b9-8e56-67dc796f624a">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding interest rate swaps designated as fair value hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;May 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mar 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8568be76a18940d69f23584500123552_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo2OWMyNDBlNjhmN2M0ZTYyOGI2ZDNiMDc2NmE2ZGJiZS90YWJsZXJhbmdlOjY5YzI0MGU2OGY3YzRlNjI4YjZkM2IwNzY2YTZkYmJlXzItMS0xLTEtMTQ3MTU3_e58dc1a7-452c-4c4c-808c-4cf196c23486"
      unitRef="usd">800000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0YjY5ODZlNTFhYTk0YTFlOTkwY2M2OGJkZWIwMGE2Mi90YWJsZXJhbmdlOjRiNjk4NmU1MWFhOTRhMWU5OTBjYzY4YmRlYjAwYTYyXzItMS0xLTEtMTQ3MTU3_1c29ebc3-4020-4d21-ad88-4ebbc3e554f6"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQw_cf6d955e-958d-4cf7-bfde-c223e4d6ab13">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for interest rate swaps designated as fair value hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fixed-rate debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0e787599e79e498b900200587d8ebe7d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtMS0xLTEtMTQ3MTU3_5a53839b-0e0c-4515-894d-552799aca10b"
      unitRef="usd">-44000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iaa6abd62fa79443881013d61bc42a3cd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtMy0xLTEtMTQ3MTU3_445913c5-048c-4fc4-b65c-00b8d5588291"
      unitRef="usd">-8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iec5a8f432dfb4a669e5b7ba55a35b302_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzEtNS0xLTEtMTQ3MTU3_42566fd3-2b51-4d5f-a88d-1d610c63912b"
      unitRef="usd">106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i773662d7d9b448b8b333e4a1b94246ba_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItMS0xLTEtMTQ3MTU3_4bd9f0b9-61da-432d-8d5b-fc08f3cf3b63"
      unitRef="usd">44000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icf50b11230f141ef80acceb9da69ce09_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItMy0xLTEtMTQ3MTU3_c55eee73-5727-48a8-a669-886c66db6ac5"
      unitRef="usd">8000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i235c4dd623e14a40ae30c1c514b56b33_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpiOWNmNDYzNjFmYWQ0YTg2YjRjNTkyMGQ1NDY3ZTIwMC90YWJsZXJhbmdlOmI5Y2Y0NjM2MWZhZDRhODZiNGM1OTIwZDU0NjdlMjAwXzItNS0xLTEtMTQ3MTU3_1c842ad3-3332-48fc-8e10-a339e77c0e17"
      unitRef="usd">-106000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount
      contextRef="ie20a6b75339f4305bd27c3566e131b42_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzY0MzE_0b67c904-98b2-4795-a82e-052bfbcb97e5"
      unitRef="usd">200000000</cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i2a7bc307cde846ad8020785fb428b704_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzY0MzE_eecd2c6c-0366-40c2-bf77-2f4e015a9d93"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i6655370d79f845c5b210b9cbc38baa6a_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzU2_6d1bd0d9-ff1b-4f73-a742-5dcdcf56834c">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding cash flow hedges at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jul 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jun 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jun 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo3Y2UwNWEzMzlmZWM0OWEyOTRiZWZmZGM1NjhiNDdlZi90YWJsZXJhbmdlOjdjZTA1YTMzOWZlYzQ5YTI5NGJlZmZkYzU2OGI0N2VmXzMtMS0xLTEtMTQ3MTU3_77c959fe-daf1-4902-86a9-fc66d51b62db"
      unitRef="usd">327000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iaec740da2e31443ca3a03df609402dba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTphN2E4N2JmZDM4ZmQ0MGQyODZlYTlhMzIyZTJiZGU4Ni90YWJsZXJhbmdlOmE3YTg3YmZkMzhmZDQwZDI4NmVhOWEzMjJlMmJkZTg2XzMtMS0xLTEtMTQ3MTU3_6c840f1b-cb14-488c-851d-44001e0f602a"
      unitRef="usd">436000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQx_957fd3d1-2178-40fa-a2f0-b24c0547e340">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) included in OCI for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if84712198fd34c77a01fe1cc4008c915_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtMS0xLTEtMTQ3MTU3_da782b5b-d535-4dbe-8fbb-9fb208da6dfe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6d06eff618844ea9b294766cd40c0cbb_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtMy0xLTEtMTQ3MTU3_1dfcd06d-ebba-49a1-874e-c2d571946e17"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9d390067fa94438188ada7ef9dd06ef3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzEtNS0xLTEtMTQ3MTU3_6dd1eff2-5c91-40b5-b055-224dcfcb4756"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i46e636c0a4764fbda3673d5e4c24027e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItMS0xLTEtMTQ3MTU3_3acb9f70-bdc8-4b27-bc2a-9b388d6e8c8e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3689b6ecce894dcf9310fad3bfb4484c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItMy0xLTEtMTQ3MTU3_c6714ef5-63a7-4387-9ad5-4b8e2bc493db"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iad1d6e92138f4a2bbfefa3aa6fa73311_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzItNS0xLTEtMTQ3MTU3_0f69f275-f36f-4d52-81f4-96681641e05b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7e36bc811b8e4e04b871a13fd2292653_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtMS0xLTEtMTQ3MTU3_2403a700-a85c-435c-a5cf-a56d7c296bcc"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i012e1ceb9763423189450a46d2c76f14_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtMy0xLTEtMTQ3MTU3_5d19700d-aa0f-4349-9173-9dfa45ef2bed"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9f4b437cafd548ff9b69d8d997ae280d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpmZmY4MDcyZjBhNDA0MmRmYWI1NjIzMTk3M2VjNzczNy90YWJsZXJhbmdlOmZmZjgwNzJmMGE0MDQyZGZhYjU2MjMxOTczZWM3NzM3XzMtNS0xLTEtMTQ3MTU3_487f3723-3fd5-4210-bc41-3e3ec6ac8847"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ5_9ef47731-d1b0-4ec0-9e7a-5da564e76786">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the pre-tax gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forward interest rate swaps (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commodity contracts (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Included in cost of products sold in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Included in SG&amp;amp;A expenses in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4) &#160;&#160;&#160;&#160;Included in interest expense, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtMS0xLTEtMTQ3MTU3_6064ba09-1982-4af6-9303-c4bf1a0bfb22"
      unitRef="usd">5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ibfff6e07744441528f22c7027f392bc3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtMy0xLTEtMTQ3MTU3_0d243abd-f1aa-40a4-8813-c7523dbab5cf"
      unitRef="usd">-12000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib9ef85b7c88a4539972e810d6676bcd2_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzEtNS0xLTEtMTQ3MTU3_a52a5641-0a89-401a-934e-ee21b88f15ff"
      unitRef="usd">7000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i50482f61b49343aea4800caf3921c613_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItMS0xLTEtMTQ3MTU3_84838c81-74c7-43bc-9ccc-f224e671201a"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i25a7c5d5859848dd88abbc1a8fbb11c9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItMy0xLTEtMTQ3MTU3_fc89a775-fe24-4345-99af-8d4d970bd71a"
      unitRef="usd">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i421ac4ebd1c940d5be641a14b6a8565a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzItNS0xLTEtMTQ3MTU3_7122c460-6950-4c22-b9ad-24c7ecd1745b"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i7bee56b9093547aab3e10f4b7c9d0c93_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtMS0xLTEtMTQ3MTU3_ff136f6d-2b34-4fba-9543-c4dc1d0306ac"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i17d114542faa4edc9d89c757065598f7_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtMy0xLTEtMTQ3MTU3_8ee7eef5-ca0c-4ec0-8440-a81f827b60e7"
      unitRef="usd">4000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i2a935fc8248a4a1890e47ba459c9f8bb_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzMtNS0xLTEtMTQ3MTU3_c9e7e37c-403d-4ab6-a20a-58fb992de5cb"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i269c8552647a4321a761031c80f05289_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtMS0xLTEtMTQ3MTU3_25d9a734-1429-4264-9844-7a900959e9e5"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i6cddbe3b6c7a4e719277441f86f08a81_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtMy0xLTEtMTQ3MTU3_68061dcc-c600-449d-b7d5-fa23c68bbc30"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5b8544764a8141e69a14460e4f902fb7_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzQtNS0xLTEtMTQ3MTU3_ae000b0d-cda1-47bf-8cae-0da63710c340"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if46bf92b1ae9412db7eb482248d3e631_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtMS0xLTEtMTQ3MTU3_a0914d12-0b25-4b66-9ad8-4128d5058e0d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i66d0afbc7f24472f9a3373a8620e9bb0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtMy0xLTEtMTQ3MTU3_7c261f1e-e205-4740-9513-cd7357a02095"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i5ba25e5360ae47298c3f879441851557_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTowMzYwZTFlZDhhNjc0MmQ2OWQzZDFiMDZkNzQyZWZlOS90YWJsZXJhbmdlOjAzNjBlMWVkOGE2NzQyZDY5ZDNkMWIwNmQ3NDJlZmU5XzUtNS0xLTEtMTQ3MTU3_48979008-8e83-4be2-9859-7707bead9b9e"
      unitRef="usd">-5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ie01d7cee22094964ba6e1b1c964e79d9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1Mjk_6db8f9ae-6838-45e8-bd0c-e77c4f08bee3"
      unitRef="jpy">24000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ie01d7cee22094964ba6e1b1c964e79d9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1MTE_0328b7f7-20c2-4a97-bfa1-613c19e987ba"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i49b160e1a7e845e9b7fce15173ef887a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1NDc_c9b8a1b9-031e-4e8b-9c26-a2f0374b9e18"
      unitRef="jpy">24000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i49b160e1a7e845e9b7fce15173ef887a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI1NjU_73836b12-8bbc-4077-962a-a110306ac044"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzg0NjM_ff948a95-d35b-4ab5-9f8d-6cc9ca04ecf2"
      unitRef="jpy">64000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ia7a07ee2791c4e74bd6139f1ced0abd5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzg0Njc_6ed0db1b-e288-4714-8f3d-217a188b7648"
      unitRef="usd">600000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzU0OTc1NTgxNTI4NzY_27e65111-c4ab-4a76-8593-ca34e8bcfde7"
      unitRef="usd">71000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzkyNzM_2b0895c4-024e-48c1-9374-ef0cb8e53147"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzkyODc_77ce379e-eace-454c-ac91-5171a033436d"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="id5d870ca05584e8cb134c5e001aa56a5_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzk1Mjg_ca9bfab3-6993-43c3-88b1-4f1e25eac03c"
      unitRef="usd">21000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i37b910d812ed4d168b5f9938c80e545a_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzk1MzU_0aa20dc2-fa42-4518-a35f-b04116e57f94"
      unitRef="usd">19000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="ibba1dd6808f54a86a81fd6308d260b0f_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ1_43da7a0a-5fca-47b5-93df-ffc1416b3164">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the outstanding economic (non-designated) derivative instruments at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;265&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Jul 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i94d8c3f959e54f26b4608732cff6a528_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo1NWQ0MjU4OWQzZWI0ZWFkOTQ1OGFkNjZhNjZkYTY1Yi90YWJsZXJhbmdlOjU1ZDQyNTg5ZDNlYjRlYWQ5NDU4YWQ2NmE2NmRhNjViXzItMS0xLTEtMTQ3MTU3_2a58f0b9-8eb1-41d0-8e09-fcc48992ebee"
      unitRef="usd">265000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie2f1b851c9794bb5a1866c1ef80be14e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZToyZmJmNjE0ZmM5NzE0MDQ3ODMxZWM1NTg5YmM2N2JmNS90YWJsZXJhbmdlOjJmYmY2MTRmYzk3MTQwNDc4MzFlYzU1ODliYzY3YmY1XzItMS0xLTEtMTQ3MTU3_a199d81f-43c4-4b6d-96ba-60ecebfddea1"
      unitRef="usd">254000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzEx_fab98b43-2e5a-4d49-b4b6-d831a52762ce">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gain/(loss) recognized in earnings for economic (non-designated) derivative instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.382%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Included in other income, net in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="if2791b320bdf418283ef26f40f8960d2_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtMS0xLTEtMTQ3MTU3_2fcfeb38-7f3a-469d-b1ea-20af9a5743b7"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="id83a99daa0324eaf9c0d86f62c609f16_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtMy0xLTEtMTQ3MTU3_ac1653d5-78e9-40b2-8f31-67ece829a797"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="idb30ce6147144d6cb2de94c1c28b34d8_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo0NmIzODljZDg1YjM0MmFiOGEzZDRjOTNlMmU5NjI0Mi90YWJsZXJhbmdlOjQ2YjM4OWNkODViMzQyYWI4YTNkNGM5M2UyZTk2MjQyXzEtNS0xLTEtMTQ3MTU3_ef83cbe7-919e-4130-bd5f-882ad889a890"
      unitRef="usd">-11000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzIz_186b6a8d-f925-4f6e-bf4e-236d8efd693f">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,049&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,315&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i458d92552dd24194973d1eecdc2b3c4e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzEtMS0xLTEtMTQ3MTU3_42ac0e1e-a619-4ffc-a69a-984da44008b6"
      unitRef="usd">5049000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if4a6cbd72cc74687b9d7255c26b5ee6f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzEtMy0xLTEtMTQ3MTU3_da94ba0e-4767-439d-a795-f9d99f93e37a"
      unitRef="usd">6751000000</us-gaap:DebtInstrumentFairValue>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzItMS0xLTEtMTQ3MTU3_d75e4c41-0552-4456-ba4b-a70f00b1685b"
      unitRef="usd">5315000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTo5NGM0ODE3MDJkZjM0NDY5OTQxNWNkMzI2OTQ0NWRkOC90YWJsZXJhbmdlOjk0YzQ4MTcwMmRmMzQ0Njk5NDE1Y2QzMjY5NDQ1ZGQ4XzItMy0xLTEtMTQ3MTU3_e7a3be46-dd91-49f7-b1b6-70b84f3ab3d9"
      unitRef="usd">6236000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90ZXh0cmVnaW9uOjQ0NzlkYjA1MTFkOTQ3NzA5NGQ5OWQyMzdlNTk5ZTExXzExNzQ4_b0ed23c1-904a-4761-9787-90a95d2a415e">&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the fair value gain/(loss) of our derivative instruments based upon the estimated amount that we would receive (or pay), considering counter-party credit risk, to terminate the contracts at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair&#160;Value&lt;br/&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-floating interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;633&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8568be76a18940d69f23584500123552_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItMS0xLTEtMTQ3MTU3_8812fc12-0916-474d-9262-286d7172d365"
      unitRef="usd">800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8568be76a18940d69f23584500123552_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItMy0xLTEtMTQ3MTU3_336f0bc0-cf68-4542-a24f-010caeaa4127"
      unitRef="usd">-43000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItNS0xLTEtMTQ3MTU3_5bd08e5f-ee12-468c-8d77-1bd543668ee3"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3961f5fc579946a7adb7919493a245f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzItNy0xLTEtMTQ3MTU3_14cfc763-8896-404a-92e8-c50696aeedf1"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtMS0xLTEtMTQ3MTU3_ca5e02ac-7932-470e-b94a-d1a0ab4aadeb"
      unitRef="usd">592000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i008e5300d1fe41a1815096bec1786b2e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtMy0xLTEtMTQ3MTU3_54e06528-0e09-4a59-b0f0-740a9eab0b96"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaec740da2e31443ca3a03df609402dba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtNS0xLTEtMTQ3MTU3_ee85194d-af50-4752-9a6b-ed8ae9282e74"
      unitRef="usd">690000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iaec740da2e31443ca3a03df609402dba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzMtNy0xLTEtMTQ3MTU3_48fadfaf-2c4b-4b02-b489-ac2f6fc82c46"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i84a04898d27345438f4a7a3a130a15be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtMS0xLTEtMTQ3MTU3_5e9d12b9-65c2-4bf6-a1ae-bfa79e31f86e"
      unitRef="usd">633000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i84a04898d27345438f4a7a3a130a15be_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtMy0xLTEtMTQ3MTU3_9a853164-9ed5-42e4-ad4c-541beb6ef4ac"
      unitRef="usd">54000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if9f63f23b1554e848a59e032b744632e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtNS0xLTEtMTQ3MTU3_6b8b817b-8a3e-478e-87df-56b66d4db9f1"
      unitRef="usd">833000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if9f63f23b1554e848a59e032b744632e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMjcvZnJhZzo0NDc5ZGIwNTExZDk0NzcwOTRkOTlkMjM3ZTU5OWUxMS90YWJsZTpkODVjNTk1YTBkYTY0MTIwOWNkMGFiNWE5ZTkxNjNjYy90YWJsZXJhbmdlOmQ4NWM1OTVhMGRhNjQxMjA5Y2QwYWI1YTllOTE2M2NjXzUtNy0xLTEtMTQ3MTU3_f0c93a49-0050-45a2-813a-7b552109a7c6"
      unitRef="usd">40000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzIwNzM_f7cb6269-f69a-4336-a8fe-6ddcb1e0bf9b">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;11. Shareholders' Equity/(Deficit) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and 2021, authorized capital shares consisted of the following: 750 million Class A common shares, without par value; 5 million Class B common shares, without par value; and 500 thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as &#x201c;common shares&#x201d;. Holders of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to one vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We repurchased $1.6 billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 and 2020, as described below. We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022, we repurchased 19.5 million common shares having an aggregate cost of $1.0 billion. We repurchased 9.8&#160;million, 6.1&#160;million and 3.6&#160;million common shares under multiple accelerated share repurchase ("ASR") programs with average paid per common share of $51.10, $49.39 and $56.02, respectively. These repurchases began on August 18, 2021 and concluded on April 18, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, we repurchased 3.7 million common shares having an aggregate cost of $200 million. The average price paid per common share was $54.40. These repurchases were made under an ASR program, which began on February&#160;9, 2021 and was completed on March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, we repurchased 7.3 million common shares having an aggregate cost of $350 million. The average price paid per common share was $48.00. These repurchases were made under an ASR program, which began on August&#160;20, 2019 and was completed on December&#160;4, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain/(Loss) on&lt;br/&gt;Derivatives,&lt;br/&gt;net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $24&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1cd2559051274accba49716a53ea4d55_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzc3_bdff0f35-5629-48db-bb9c-9a7b857f9e9d"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib5cfbdd2a57c495092c1346adb91387e_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzEyMg_483f8a2d-a73f-43c4-a245-beb225e2131f"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3MQ_d97a7314-b992-4855-80d4-1a25547b8847"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <cah:CommonStockVotingRightsVotes
      contextRef="ie251c72e85d34942ab0769ac0f335908_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzU3Ng_6cc4eea6-6a29-4dd9-8faa-cdf4a206df84"
      unitRef="number">1</cah:CommonStockVotingRightsVotes>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i170f7cf26f08409dac798c226dec905e_D20190701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzkwNw_e01ede48-6d32-498f-b98f-7f1657f40703"
      unitRef="usd">1600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3Njg3NTc_3db649d6-2078-4c0b-8451-c47669245808"
      unitRef="shares">19500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if26c8c6a752a485d9a9ad8e193f74b88_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzEyNzg_fc084c8c-2a45-429b-bc37-a9c43c21d6ac"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwMjI_00bde260-b837-44e8-a664-32568cdb5c3f"
      unitRef="shares">9800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwMjg_20b10832-8dcf-465b-8cf0-5b4ebd858649"
      unitRef="shares">6100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUwNDc_14547a7f-b112-42c9-a8ec-ae57150ebd46"
      unitRef="shares">3600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i86c0d842590a4f56acdb8aa07050be7c_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzNjc_f5bca8cd-9633-4969-9577-ac0a9609315d"
      unitRef="usdPerShare">51.10</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="idd3720a8d31341b1b031ed1d46db5d2b_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzNzY_5f870085-e2b8-43aa-934c-b7b22ecdebf9"
      unitRef="usdPerShare">49.39</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i11f2709da6ea48e2832167bdc0fbef25_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzY1OTcwNjk3NzUzODg_f7e67541-7209-485a-af5b-967e448b3302"
      unitRef="usdPerShare">56.02</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE0OTA_9eef6293-7639-4c26-a3e1-d888cfa00a97"
      unitRef="shares">3700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE1MzU_12cf96c2-6ad2-4518-a333-c6368ffc0208"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i95ec725fee08414a9fdc8f28efe53ea5_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE1ODM_e09bf3dc-447e-4a6c-ae6f-84f16631c565"
      unitRef="usdPerShare">54.40</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3MTQ_72321de9-10c3-475d-92d5-934aae44cc51"
      unitRef="shares">7300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE3NTk_315b6e24-091d-4e46-9302-6667a6e28fad"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i493ec3d1150f4707a31e7a49a1ee7d19_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzE4MDc_e0cd0e0c-73cf-42d4-951d-621d05687929"
      unitRef="usdPerShare">48.00</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90ZXh0cmVnaW9uOmRiYTNiNzE0NTZlYzQ1MGNhNjE4MmYxN2FhNmNjYzQyXzIwODQ_011b3fe2-9aed-42ab-adb2-c558896aef8a">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain/(Loss) on&lt;br/&gt;Derivatives,&lt;br/&gt;net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax expense of $24&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic12e802652d64575be3f052d531ee71a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtMS0xLTEtMTQ3MTU3_1e8532ad-4900-44cc-abad-9e8db545ebf8"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cd6dc10bbdf4a9887f38ce5a9b7eebb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtMy0xLTEtMTQ3MTU3_1be00ec5-88a9-402b-be38-1bbdbc2f3ab2"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a2a315588dc47fa848589f8d339e4f4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzEtNS0xLTEtMTQ3MTU3_1556a40c-27a2-44ba-b88b-c76ca0218921"
      unitRef="usd">-104000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItMS0xLTEtMTQ3MTU3_76088ad7-aaf9-4801-b32a-661f0d9bde71"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItMy0xLTEtMTQ3MTU3_350b050a-bcf1-4d86-93bd-931909d0d769"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzItNS0xLTEtMTQ3MTU3_a24311d6-37a8-4417-a157-4de771d3242d"
      unitRef="usd">68000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtMS0xLTEtMTQ3MTU3_bdd47eec-9103-40bc-8b27-44cbb89dd25c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtMy0xLTEtMTQ3MTU3_b6200625-3e7d-4379-955a-6a5819b72dbe"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzMtNS0xLTEtMTQ3MTU3_f0f2f706-0fa3-403d-bad1-57ce6e45c5b1"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246YzdkYTZhYmY0MDhjNDg5MWE4MTg2ZGE4YWMzY2RkODdfNjU5NzA2OTc2Njc4MQ_a842777d-9a44-4ae8-915f-4abac5bbe07f"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia5a897bf373445b99a28ab9d25fa130e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMS0xLTEtMTQ3MTU3_112d2a3a-374d-4050-9870-415c1cfd91e5"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9978a0b999a1423f8c9049e91643556c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtMy0xLTEtMTQ3MTU3_13e80da0-7495-49ba-bb4e-9cbd8d2b02a0"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib17f2b48296d4532bdcecaebcff476be_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzQtNS0xLTEtMTQ3MTU3_b1748ffe-7819-48cb-80aa-77461f35f181"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i017776f20a154be38946329695a6e3bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtMS0xLTEtMTQ3MTU3_1bb250e3-9292-4257-ad6f-a4dae0826891"
      unitRef="usd">-46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27066680d4f44a88bd6f0bde058453f4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtMy0xLTEtMTQ3MTU3_972d864e-0188-4fdb-9680-7e0ea7644ab1"
      unitRef="usd">12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68d3316767394706be72a492bdcd2efd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzUtNS0xLTEtMTQ3MTU3_6f1a89fa-bc9e-4bd2-b408-0b7aaa3e3042"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtMS0xLTEtMTQ3MTU3_e633172b-caa8-4c14-8ee2-9552d5bd5d09"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtMy0xLTEtMTQ3MTU3_ded37b79-c4fd-40c3-ba0b-0aeebcecbda0"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzYtNS0xLTEtMTQ3MTU3_dfc98fc1-fcdd-4884-8247-24e844fb5ea9"
      unitRef="usd">-72000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctMS0xLTEtMTQ3MTU3_c22eb153-2282-4502-893e-a218a1b03ae5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctMy0xLTEtMTQ3MTU3_27ef4869-b320-4cf0-a1a9-80576da39c8c"
      unitRef="usd">8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzctNS0xLTEtMTQ3MTU3_15d47745-2130-4a8d-b170-4ae90486918f"
      unitRef="usd">8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMC0xLTEtMTQ3MTU3L3RleHRyZWdpb246N2NjMmNiOTI1NDc3NDFhNTg1ZDI3Y2Y0OGMyNDg1MmRfNjU5NzA2OTc2Njc4NQ_9338f577-0f61-46d9-ba33-1f96c45b5045"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3f0080970b8347daab96c670e8f07328_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMS0xLTEtMTQ3MTU3_6a1b8780-d169-4b3b-b5ac-a7f51fee3a3e"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia282db0ab3eb4ffaa05e2df2e01abffb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtMy0xLTEtMTQ3MTU3_a8227995-b8b8-4238-a8e8-d6f9608d560e"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icfa32e4446574aeba0b6ace9bb13432d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzgtNS0xLTEtMTQ3MTU3_94f47a64-1e3f-40e0-b383-c0459fcfab26"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i671a35d442834525849f31bba3176fbe_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktMS0xLTEtMTQ3MTU3_b7ec08b6-e73f-421b-89b2-e718081f401d"
      unitRef="usd">-102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6ae84c9f59a4cb4885c9e03cdef73cb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktMy0xLTEtMTQ3MTU3_028ddd9b-9e9c-4bb7-a3c3-90b7f43b7459"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if032321307a24934b26372b254b11bbe_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzAvZnJhZzpkYmEzYjcxNDU2ZWM0NTBjYTYxODJmMTdhYTZjY2M0Mi90YWJsZToxZjlkYjQ0MTA1OTY0MGZiYmE2ZmU3NTNlM2FiNWI0Yy90YWJsZXJhbmdlOjFmOWRiNDQxMDU5NjQwZmJiYTZmZTc1M2UzYWI1YjRjXzktNS0xLTEtMTQ3MTU3_6d659973-1440-42e4-b94d-99bca938e97f"
      unitRef="usd">-114000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzY0NA_c6f1de78-faa0-4f5e-ab0a-92d4bc960d21">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 and 2020 were 5 million, 3 million and 6 million, respectively. During fiscal 2022 and 2020, there were 1 million and 2 million potentially dilutive employee stock options, restricted share units and performance share units, respectively, not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal years.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzY0Ng_7220cf7d-34ea-4b7c-adb1-c99d3f38c3ed">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net earnings/(loss) attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(3.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtMS0xLTEtMTQ3MTU3_0a3506a5-aef1-49b6-9f90-a783bf639c7f"
      unitRef="usd">-932000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtMy0xLTEtMTQ3MTU3_4a9252bc-c4c4-42c7-afc2-c735ce009590"
      unitRef="usd">612000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEtNS0xLTEtMTQ3MTU3_14545488-f088-4d0d-8099-f92f413604c5"
      unitRef="usd">-3693000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItMS0xLTEtMTQ3MTU3_1a60259d-5bbd-45bd-9271-1af40f8bb836"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItMy0xLTEtMTQ3MTU3_3fd355bd-1ced-48e1-8e54-68f0f76aa3fa"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzItNS0xLTEtMTQ3MTU3_77ad291c-db57-47ad-b8d9-f205c461dd3b"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtMS0xLTEtMTQ3MTU3_88f83389-eac7-4223-a120-31a04745346b"
      unitRef="usd">-933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtMy0xLTEtMTQ3MTU3_fc19b1ca-f65e-42c6-9857-a0e28dd3cd06"
      unitRef="usd">611000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzUtNS0xLTEtMTQ3MTU3_e6e10c9c-366e-43ce-abd7-b22dc7c346ec"
      unitRef="usd">-3696000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtMS0xLTEtMTQ3MTU3_e065f466-e66b-44ae-a2b4-90fe0adecaf8"
      unitRef="shares">279000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtMy0xLTEtMTQ3MTU3_fd9ffde4-f4c8-4ed0-a365-8f5c83f9640d"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzYtNS0xLTEtMTQ3MTU3_2fd165a7-c860-4986-b513-4063755da460"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtMS0xLTEtMTQ3MTU3_473cb17e-85da-4c9f-9991-f5e8e5cfc352"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtMy0xLTEtMTQ3MTU3_0d359041-80f2-4a26-b267-77831aa58a41"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzgtNS0xLTEtMTQ3MTU3_cda98c6b-c9b8-43fe-8e90-e9e93763cebc"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktMS0xLTEtMTQ3MTU3_3b7f7501-f867-4a40-affd-8101f196e1f3"
      unitRef="shares">279000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktMy0xLTEtMTQ3MTU3_8d1179ff-57da-423d-983b-8935f1d8c033"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzktNS0xLTEtMTQ3MTU3_ebf0b7a2-43cd-4df2-9336-12f34fd82cb2"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTEtMS0xLTE0NzE1Nw_4878608f-107f-49d2-b7fc-486bdb1b3ff9"
      unitRef="usdPerShare">-3.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTMtMS0xLTE0NzE1Nw_641e4783-5e07-426b-96b5-f2fbcf718b27"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzEwLTUtMS0xLTE0NzE1Nw_64275d2e-016b-4553-bba2-f77a5b9e33de"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTEtMS0xLTE0NzE1Nw_ed6a9511-f032-4829-9de4-12d88d050887"
      unitRef="usdPerShare">-3.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTMtMS0xLTE0NzE1Nw_ea2f14c9-9803-47cd-98d2-076b028ca501"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90YWJsZToyZDVmOTljODYzYjQ0ZGU5OGMxODcyZjI0NGRmMmIyYS90YWJsZXJhbmdlOjJkNWY5OWM4NjNiNDRkZTk4YzE4NzJmMjQ0ZGYyYjJhXzE1LTUtMS0xLTE0NzE1Nw_f8c3d038-327b-4e56-9e5f-5dc56fbdd29e"
      unitRef="usdPerShare">-12.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzI5MQ_58714914-2bb5-47be-9aed-fa49e165e0ad"
      unitRef="shares">5000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzI5NQ_a26678fd-dca7-43e9-94ba-13462d84dae4"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzE2NDkyNjc0NDIzNDg_f1a57583-b226-4621-a177-664453e6b115"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzU0OTc1NTgxMzk2MDE_1701c182-cb34-4381-9176-c281e6023f71"
      unitRef="shares">1000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzMvZnJhZzpiNjhmMGMzYjRmZGU0ZDY4ODJkODZmMzU4NzMzODA4OS90ZXh0cmVnaW9uOmI2OGYwYzNiNGZkZTRkNjg4MmQ4NmYzNTg3MzM4MDg5XzU0OTc1NTgxMzk2MTY_efc2b0da-d879-4e65-98ef-f745c05f7bdf"
      unitRef="shares">2000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzQ_e784333a-c5c6-4659-80c5-c5c6c0052faa">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;13. Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are principally managed on a products and services basis and are comprised of two operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates pharmacies, including pharmacies in community health centers, nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;165,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.214%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;164,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;165,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;176,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;157,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;148,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,523&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general, and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial and customer care shared services, human resources, information technology, legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not allocate the following items to our segments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;last-in first-out, or ("LIFO"), inventory charges/(credits);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;surgical gown recall costs/(income); in connection with a voluntary recall for certain surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns, we recognized a pre-tax charge of $85&#160;million during fiscal 2020;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.571%;min-width:2.571%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.215%"&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;state opioid assessment related to prior fiscal years; in connection with the New York Opioid Stewardship Act as discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized a pre-tax charge of $41&#160;million during fiscal 2021;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;restructuring and employee severance;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;amortization and other acquisition-related costs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;impairments and (gain)/loss on disposal of assets; in connection with goodwill impairment testing for the Medical Unit as discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_106" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 4&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized goodwill impairment charges of $2.1&#160;billion during fiscal 2022; in connection with the divestiture of the Cordis business, we recognized a $60&#160;million pre-tax write-down of the net assets held for sale&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;litigation (recoveries)/charges, net; in connection with the opioid litigation as discussed further in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_118" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized pre-tax charges of $1.17&#160;billion and $5.63 billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during fiscal 2021 and 2020, respectively;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;other (income)/expense, net;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;interest expense, net;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;loss on early extinguishment of debt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;(gain)/loss on sale of equity interest in naviHealth; in connection with the sale of our remaining equity interest in a partnership that owned naviHealth as discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i06b8b3ff48e94029843042d968c5bda7_100" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we recognized a $579&#160;million pre-tax gain ($493&#160;million after tax) during fiscal 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.13pt"&gt;provision for/(benefit from) income taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was $50 million, $27 million and $69 million for fiscal 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,986&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;283&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,837&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;43,878&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzEwMg_5e64b6dc-eba0-4a58-b5d9-13dcb65de422"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzEwMg_765cef87-0218-4706-871c-886e2c395149"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzNDA_3164e035-9965-427a-82b7-80906bf920a5">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;165,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtMS0xLTEtMTQ3MTU3_802d0497-81e8-429a-bde9-18af3c649845"
      unitRef="usd">165491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtMy0xLTEtMTQ3MTU3_2af607b4-d231-438e-80ab-616003345e5b"
      unitRef="usd">145796000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzEtNS0xLTEtMTQ3MTU3_c9aa5c6d-bfc1-41c4-bb43-05533397f080"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItMS0xLTEtMTQ3MTU3_40cbfe6c-2db2-4813-99a5-bc556dd54934"
      unitRef="usd">15887000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItMy0xLTEtMTQ3MTU3_7193016e-1541-481b-8847-d80f4b69d1a0"
      unitRef="usd">16687000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzItNS0xLTEtMTQ3MTU3_a3d69dee-48a1-4d8a-821d-b8e7c8a12a40"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtMS0xLTEtMTQ3MTU3_a3578fb7-eb42-4844-87e0-35b8e2790670"
      unitRef="usd">181378000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtMy0xLTEtMTQ3MTU3_f7cbf0fb-26b9-4edb-9443-ec606957d2ec"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzMtNS0xLTEtMTQ3MTU3_d08b0776-060e-471a-9b79-bcf117002a2e"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtMS0xLTEtMTQ3MTU3_e60a7f95-4204-472e-be0f-11eb9f63c48d"
      unitRef="usd">-14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtMy0xLTEtMTQ3MTU3_05276cc6-fe8d-4b30-9202-565728fe6f28"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzQtNS0xLTEtMTQ3MTU3_1a589bf2-dcb0-4183-9e9c-76844fdd0fee"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtMS0xLTEtMTQ3MTU3_f21fcc0b-1d4e-411c-8ab3-e2a2f7378835"
      unitRef="usd">181364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtMy0xLTEtMTQ3MTU3_5b3906b0-f6ad-482b-85a7-9f8dd9da3375"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo4NWRlMDllODEwMmI0YzM3OWViZmE4YjJkNWJmMWI1NS90YWJsZXJhbmdlOjg1ZGUwOWU4MTAyYjRjMzc5ZWJmYThiMmQ1YmYxYjU1XzUtNS0xLTEtMTQ3MTU3_0b16bbc0-7481-40f3-a231-34dd0069a388"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMjk_f4817a91-c140-48c6-a8d4-46c765b3ac3c">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;164,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;165,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMDg_2177b1e3-8af4-4550-a244-9c65176266f6">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;164,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;165,491&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;13,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15,887&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i14af28fc8088402b8cf9586da815c628_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtMS0xLTEtMTQ3MTU3_596f32f7-7375-4884-b333-9243fa2945b4"
      unitRef="usd">164580000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1375be2585e496ba632f589f37aecdd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtMy0xLTEtMTQ3MTU3_2e75dcdf-112d-4870-8845-51974dc1eec8"
      unitRef="usd">144988000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41b64a0ab009497cb6651f141753bb14_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzEtNS0xLTEtMTQ3MTU3_0540a852-daf3-4db8-adc5-9d9248caa142"
      unitRef="usd">136693000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55ab01785f1e4a10a2f627369a131981_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItMS0xLTEtMTQ3MTU3_942d2826-d1eb-499a-83da-e859846fa5da"
      unitRef="usd">911000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1fe4938f791c47a7a2e7be341d8ae001_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItMy0xLTEtMTQ3MTU3_f1a04dbb-3f38-4cca-af12-32eb5687aba3"
      unitRef="usd">808000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26fa0488c0b0421a9bd978c6e75ec078_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzItNS0xLTEtMTQ3MTU3_a4ac78de-7f70-4c7c-9e36-e7b2af2e5946"
      unitRef="usd">802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtMS0xLTEtMTQ3MTU3_802d0497-81e8-429a-bde9-18af3c649845"
      unitRef="usd">165491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtMy0xLTEtMTQ3MTU3_2af607b4-d231-438e-80ab-616003345e5b"
      unitRef="usd">145796000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzMtNS0xLTEtMTQ3MTU3_c9aa5c6d-bfc1-41c4-bb43-05533397f080"
      unitRef="usd">137495000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib18eb292c9cd45549a3cce1a8564d34a_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtMS0xLTEtMTQ3MTU3_d1581670-6627-4eb1-9455-134a4027b3a3"
      unitRef="usd">13462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf54a140331447bc971da869fab4170b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtMy0xLTEtMTQ3MTU3_7c39c619-24e3-4f3a-bc34-a6e9fb4de5b2"
      unitRef="usd">14485000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3a872d654474220917795caa5437ced_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzQtNS0xLTEtMTQ3MTU3_4887eb46-e71c-4b27-bffe-499fb6b53bd5"
      unitRef="usd">13429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9d75341c0824694ace8cacae3c3cff4_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtMS0xLTEtMTQ3MTU3_acb60276-615d-4d16-8d3f-459154139908"
      unitRef="usd">2425000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c1190aafabb474bb7daeda0ceb4428e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtMy0xLTEtMTQ3MTU3_02ec3b41-6b21-4a03-99c7-6a5897da68bd"
      unitRef="usd">2202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22c84b6027bc4bfc9c7fef1cc6232649_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzUtNS0xLTEtMTQ3MTU3_ca201509-309b-4c3c-934c-2750aeefd319"
      unitRef="usd">2015000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtMS0xLTEtMTQ3MTU3_40cbfe6c-2db2-4813-99a5-bc556dd54934"
      unitRef="usd">15887000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtMy0xLTEtMTQ3MTU3_7193016e-1541-481b-8847-d80f4b69d1a0"
      unitRef="usd">16687000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzYtNS0xLTEtMTQ3MTU3_a3d69dee-48a1-4d8a-821d-b8e7c8a12a40"
      unitRef="usd">15444000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctMS0xLTEtMTQ3MTU3_a3578fb7-eb42-4844-87e0-35b8e2790670"
      unitRef="usd">181378000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctMy0xLTEtMTQ3MTU3_f7cbf0fb-26b9-4edb-9443-ec606957d2ec"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzctNS0xLTEtMTQ3MTU3_d08b0776-060e-471a-9b79-bcf117002a2e"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtMS0xLTEtMTQ3MTU3_e60a7f95-4204-472e-be0f-11eb9f63c48d"
      unitRef="usd">-14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtMy0xLTEtMTQ3MTU3_05276cc6-fe8d-4b30-9202-565728fe6f28"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzgtNS0xLTEtMTQ3MTU3_1a589bf2-dcb0-4183-9e9c-76844fdd0fee"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktMS0xLTEtMTQ3MTU3_f21fcc0b-1d4e-411c-8ab3-e2a2f7378835"
      unitRef="usd">181364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktMy0xLTEtMTQ3MTU3_5b3906b0-f6ad-482b-85a7-9f8dd9da3375"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpkYzk3OWI5NThhZTA0YTM5OTFmZmE4NGFjNjVkMWE1Ni90YWJsZXJhbmdlOmRjOTc5Yjk1OGFlMDRhMzk5MWZmYTg0YWM2NWQxYTU2XzktNS0xLTEtMTQ3MTU3_0b16bbc0-7481-40f3-a231-34dd0069a388"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzA_029f5c7f-1f82-4e0e-8dd9-0901a015aa1d">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;176,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;157,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;148,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,523&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,378&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;181,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="i4e5a57d0101144d68ed8cbf6f33a252b_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtMS0xLTEtMTQ3MTU3_91a8c0eb-2d7f-49e3-ba81-016af9276183"
      unitRef="usd">176855000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6012e2f082d64586a52d2f99291c081f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtMy0xLTEtMTQ3MTU3_a4d46fad-5a4f-42ae-845c-606bc780f07e"
      unitRef="usd">157756000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic772b6d04449407f823eef4bab315a1c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzEtNS0xLTEtMTQ3MTU3_2eaa89d6-2d9c-474c-bb71-102ec808a414"
      unitRef="usd">148707000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8120134644a4b72b67cf151f13a9267_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItMS0xLTEtMTQ3MTU3_19eba950-e209-42a7-a8b7-3c60a47a4dc6"
      unitRef="usd">4523000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6cfa5d379fec4924976b8c213fb2a55e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItMy0xLTEtMTQ3MTU3_1e3a814b-4a8f-4dca-99e5-74b510558b14"
      unitRef="usd">4727000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a97b6e528884b40b6ab715fd4b1afbf_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzItNS0xLTEtMTQ3MTU3_dad34951-a7d8-4083-bd90-289ce0565e6d"
      unitRef="usd">4232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtMS0xLTEtMTQ3MTU3_4c9bef9e-0ff9-4bc8-8223-eb2892d6ec77"
      unitRef="usd">181378000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtMy0xLTEtMTQ3MTU3_b50d0e28-de9b-4ce4-b2e2-843386d08900"
      unitRef="usd">162483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzMtNS0xLTEtMTQ3MTU3_8492704f-5491-47dc-a02e-770a42434670"
      unitRef="usd">152939000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtMS0xLTEtMTQ3MTU3_a7ef9957-f737-4816-8839-c2545c2e63b9"
      unitRef="usd">-14000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtMy0xLTEtMTQ3MTU3_616a73a0-3464-44e2-9a95-84b5a979a155"
      unitRef="usd">-16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzQtNS0xLTEtMTQ3MTU3_f9cf3ef4-82af-40fc-acfe-cbae18bd2b47"
      unitRef="usd">-17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtMS0xLTEtMTQ3MTU3_e3a97ac1-f755-436d-a4e9-437b5b85191d"
      unitRef="usd">181364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtMy0xLTEtMTQ3MTU3_fa1c2bbc-9ac5-4b31-8f83-310579128152"
      unitRef="usd">162467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTpmNjM1NzdiMmFhY2M0NGJkOTM2NmJmOWQ4MTMzZDI1My90YWJsZXJhbmdlOmY2MzU3N2IyYWFjYzQ0YmQ5MzY2YmY5ZDgxMzNkMjUzXzUtNS0xLTEtMTQ3MTU3_755935bb-6f43-4cda-8301-9cbd26bb85dc"
      unitRef="usd">152922000000</us-gaap:Revenues>
    <us-gaap:InventoryRecallExpense
      contextRef="i4f0d63f2484f4781b52456c257c21f31_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ4ODI_8010f5e6-b16c-4273-b5d1-5f14430745b4"
      unitRef="usd">85000000</us-gaap:InventoryRecallExpense>
    <cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct
      contextRef="i74de4b53d2854db7933eaa6980a1212e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MDY_c4562e87-a92b-42ba-a4cd-a5b353783df7"
      unitRef="usd">41000000</cah:EstimatedLiabilityForNewYorkOpioidStewardshipAct>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f8bd16b589e44678ce911885626954d_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5Mzk_45ba1b67-4027-473a-b19d-a383f27d9d7a"
      unitRef="usd">2100000000</us-gaap:GoodwillImpairmentLoss>
    <cah:WriteDownOfAssetsHeldForSale
      contextRef="i95da9ef4bd164992be47943c8af11f5a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5NjA_7bad20bc-0a3e-49e9-8cfc-17a58b49a584"
      unitRef="usd">60000000</cah:WriteDownOfAssetsHeldForSale>
    <us-gaap:LitigationSettlementExpense
      contextRef="i963e7d82f258426e9485c47abe09bb74_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzQ1ODM_a222c96c-009b-42fc-abc1-1161d3c2568a"
      unitRef="usd">1170000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i41e2cb809dde4a6ab4edd818b71cb79e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU0OTc1NTgxNDY4MzQ_add96698-bb05-402d-a363-7d8b0449b70a"
      unitRef="usd">5630000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MDk_31a942fc-450e-4c5e-bb74-131c99b443e0"
      unitRef="usd">579000000</us-gaap:GainOnSaleOfInvestments>
    <cah:GainonDivestitureAfterTax
      contextRef="i6fc5cef3017040e2ab71e0b54779234f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzY1OTcwNjk3NzQ5MjM_0a0ecbe9-bd17-4ff2-8183-11c024ca84d9"
      unitRef="usd">493000000</cah:GainonDivestitureAfterTax>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3MjQ_09d2547a-ba54-47ad-991c-f5e45ed0b455"
      unitRef="usd">50000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3Mjg_e7f300f0-f5f9-435c-b5a2-ec35a1696a1a"
      unitRef="usd">27000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzU3MzU_f3c05a71-4d20-40ac-9a29-b51a4c959783"
      unitRef="usd">69000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzNDI_4ac12fe3-5b7e-415e-ad26-a86cc56fd264">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.074%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,770&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,986&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtMS0xLTEtMTQ3MTU3_3d740c4b-f275-4967-8544-bab7f12b8042"
      unitRef="usd">1770000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtMy0xLTEtMTQ3MTU3_8e33472c-c048-4666-a705-1b2a55bcc258"
      unitRef="usd">1684000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzEtNS0xLTEtMTQ3MTU3_02357bf8-1ff8-4514-98d9-76a76a297b25"
      unitRef="usd">1753000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItMS0xLTEtMTQ3MTU3_f1bb65d1-ced6-472a-9c1b-8cfa573df6aa"
      unitRef="usd">216000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItMy0xLTEtMTQ3MTU3_b60d226b-267a-4407-b0fa-0156e9a53d37"
      unitRef="usd">577000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzItNS0xLTEtMTQ3MTU3_f9c2e494-9028-4bcc-bb29-6af061ce46d7"
      unitRef="usd">663000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtMS0xLTEtMTQ3MTU3_68544d04-c691-4d92-8631-f8b2dd3eeedf"
      unitRef="usd">1986000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21f9b15d513646bf93b62f76bdff4227_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtMy0xLTEtMTQ3MTU3_a83dc327-4220-4e9f-8a06-4e8efef8b84e"
      unitRef="usd">2261000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9ecd3e4a4bdd4e51a5c78b4aa3205fff_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzMtNS0xLTEtMTQ3MTU3_847b1f0c-8771-4fb4-b0fa-41f6b6f9654a"
      unitRef="usd">2416000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtMS0xLTEtMTQ3MTU3_17be8ffa-b904-4729-a0c8-a4d0794a3e24"
      unitRef="usd">-2582000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtMy0xLTEtMTQ3MTU3_01dadb19-2c9b-4cd6-9441-faf6b7386591"
      unitRef="usd">-1789000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzQtNS0xLTEtMTQ3MTU3_9e82aa57-2304-4c8d-a2ac-1ab2e8350da4"
      unitRef="usd">-6514000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtMS0xLTEtMTQ3MTU3_33349ef3-6b63-41f3-907a-bd783f74705f"
      unitRef="usd">-596000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtMy0xLTEtMTQ3MTU3_a07d0d59-d8f7-4848-b226-cb891e9cd684"
      unitRef="usd">472000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo5MDY4ZmEwZmNiNWU0YTg3YTg3NzYzMWNjZTQ3Njc3Zi90YWJsZXJhbmdlOjkwNjhmYTBmY2I1ZTRhODdhODc3NjMxY2NlNDc2NzdmXzUtNS0xLTEtMTQ3MTU3_d1550003-c8e1-4ad8-b1ac-004e4c8d9d2f"
      unitRef="usd">-4098000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMjA_c6b7cc63-4984-4052-ba02-5d3f626cccf3">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;283&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total additions to property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtMS0xLTEtMTQ3MTU3_f4999d69-0581-46c9-a14e-85f19884aff8"
      unitRef="usd">193000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtMy0xLTEtMTQ3MTU3_e5fede83-38db-4c44-98d4-4c2891723cce"
      unitRef="usd">151000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzEtNS0xLTEtMTQ3MTU3_4111bdac-6bd1-4d34-b413-27df27bd9a57"
      unitRef="usd">135000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItMS0xLTEtMTQ3MTU3_a8ff5339-9dce-4346-ac26-d05e2c107e29"
      unitRef="usd">216000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItMy0xLTEtMTQ3MTU3_29aef5c9-6bbd-47d9-b305-0092ddeae768"
      unitRef="usd">226000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzItNS0xLTEtMTQ3MTU3_cca26091-db40-4db1-a0d7-0483b3051ebd"
      unitRef="usd">243000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtMS0xLTEtMTQ3MTU3_107e492e-8da5-4d45-80af-490a2f748716"
      unitRef="usd">283000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtMy0xLTEtMTQ3MTU3_262408cc-831f-4a7c-9976-48d64b6ad979"
      unitRef="usd">406000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzMtNS0xLTEtMTQ3MTU3_00e2555e-1770-4e27-9097-4f7b3a613a39"
      unitRef="usd">535000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtMS0xLTEtMTQ3MTU3_296ffaa9-bb38-4fc7-9fdf-b7bab24f03f5"
      unitRef="usd">692000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtMy0xLTEtMTQ3MTU3_273e7863-cf7c-4472-97b2-33dfa42703a8"
      unitRef="usd">783000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo0NDFkMWI4MzZhMDQ0YjNjYjlmZDFiMGQ3MjNlOGE3MS90YWJsZXJhbmdlOjQ0MWQxYjgzNmEwNDRiM2NiOWZkMWIwZDcyM2U4YTcxXzQtNS0xLTEtMTQ3MTU3_97bc9ed8-62a1-4904-864c-b5393e48d223"
      unitRef="usd">913000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i468bb70dfe6343eea9940ca51720261e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtMS0xLTEtMTQ3MTU3_0b40e75b-e0f1-4df8-85bd-c111123b5c32"
      unitRef="usd">79000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id793fa6fa5fb47aabf81d5fcf5cac3c3_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtMy0xLTEtMTQ3MTU3_b30afddb-74eb-4436-8df8-fdf5a0a8e53e"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3a4759e0ffee4c26bf7e7e1b823c4f57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzEtNS0xLTEtMTQ3MTU3_121ecb22-9e67-4287-b1a0-48978f3ca2d5"
      unitRef="usd">47000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id52a151c12bb455583b0ce7e29399157_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItMS0xLTEtMTQ3MTU3_732ffab1-940c-4e58-8e5a-8e668cf3b536"
      unitRef="usd">140000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7d2346d60d904943b88cd99eb59f0a01_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItMy0xLTEtMTQ3MTU3_1672bb2a-51b6-405c-ae19-ce99648581ef"
      unitRef="usd">97000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5046c71e08ea47108712ecb1fdc9e59b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzItNS0xLTEtMTQ3MTU3_a337a1a6-06e2-4c60-8fec-b5d1f197f3a5"
      unitRef="usd">86000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3fac0bccf59f4f45851558ae705471a0_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtMS0xLTEtMTQ3MTU3_23c2d8be-001a-4032-a123-0b220b172687"
      unitRef="usd">168000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic76cc9961380424d8b4eb6d40c7d6152_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtMy0xLTEtMTQ3MTU3_61f34419-6579-48e9-b589-63be9a8f2bac"
      unitRef="usd">248000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8104e5d9c43f4b9c9c6e6a39d4b2725e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzMtNS0xLTEtMTQ3MTU3_95833bbe-8ea2-4e37-b05f-9b80b6dabb60"
      unitRef="usd">242000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtMS0xLTEtMTQ3MTU3_f12a77d0-0ead-42ef-9210-460f247c4aab"
      unitRef="usd">387000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtMy0xLTEtMTQ3MTU3_af940f12-1cf5-493a-b5bf-7b7eab0997ba"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTozN2M3Yjg1NjU3MTg0NWExYmFhYThiZWFkM2Y3OGVjYS90YWJsZXJhbmdlOjM3YzdiODU2NTcxODQ1YTFiYWFhOGJlYWQzZjc4ZWNhXzQtNS0xLTEtMTQ3MTU3_d46cf2fc-fccd-4902-af9e-2477b6cfedc9"
      unitRef="usd">375000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYzMzM_3f7f88ad-8328-47e0-8a58-ec707e9a1f31">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents total assets for each reportable segment and Corporate at June 30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;26,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medical (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;11,632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,837&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;43,878&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;44,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="iedce1d5b11c3477faba70a05739a2a83_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtMS0xLTEtMTQ3MTU3_bf6fb6e8-e754-43df-be98-9e84eaeab145"
      unitRef="usd">26409000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if72f2f625f914e10845cc7ec67500cb9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtMy0xLTEtMTQ3MTU3_24a640aa-6e9a-4483-b8c0-98fe3a674193"
      unitRef="usd">23624000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4ad6131da723466fbfb29da932695b7c_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzEtNS0xLTEtMTQ3MTU3_9a3d8ba8-64ac-4887-80b1-53b4d031fe0f"
      unitRef="usd">22398000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i61201f0b4adc4f448c19177911dff7b9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItMS0xLTEtMTQ3MTU3_976c8bb0-c679-4730-b068-bc1eefdd5ec8"
      unitRef="usd">11632000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4e0b4a7378184981b9c5ac2d3f486cba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItMy0xLTEtMTQ3MTU3_9d0e15f9-ade3-43e2-96a6-375ca094a7d1"
      unitRef="usd">15408000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifddfe552f3a644c3aabf1bd148586afd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzItNS0xLTEtMTQ3MTU3_1b727132-9254-439e-9969-50e9faf72eb5"
      unitRef="usd">14691000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ief926b64f91a4cdb97a0f010db30b234_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtMS0xLTEtMTQ3MTU3_6eaaba25-c295-4473-b6da-39d29d44e221"
      unitRef="usd">5837000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8396dd140b7c4e5088714d90bba871dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtMy0xLTEtMTQ3MTU3_e186f8d3-3e6b-4eb4-acd6-a04251bf60c4"
      unitRef="usd">5421000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9470b5d20374655a7021f0f36d0030f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzMtNS0xLTEtMTQ3MTU3_f3a873d8-8d89-486b-97ba-e51339a8edaa"
      unitRef="usd">3677000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtMS0xLTEtMTQ3MTU3_58685e24-236f-4d3b-b20e-839be72caf88"
      unitRef="usd">43878000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtMy0xLTEtMTQ3MTU3_d8420e24-ab7e-497a-8825-03299fb68d83"
      unitRef="usd">44453000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTplMWQ1ZDc1ZjVkZWU0ZTVhOWYwYzYwYTJlZDg1Njk1ZS90YWJsZXJhbmdlOmUxZDVkNzVmNWRlZTRlNWE5ZjBjNjBhMmVkODU2OTVlXzQtNS0xLTEtMTQ3MTU3_00a7a8b8-368b-44ea-966b-88358094112d"
      unitRef="usd">40766000000</us-gaap:Assets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i48d77a4c2a834917a3f42f75ef217b73_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYxMTQ_08b01a59-7cf1-4856-91e8-b15176d779a6"
      unitRef="usd">1100000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90ZXh0cmVnaW9uOjQ2NGIyMDIyMGVjMzRlMjliYjZiNWY5Y2ViOGY2ZjkxXzYyOTc_a0ce00a3-b9e0-40d6-8e20-f212ecf42f3a">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present property and equipment, net by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia84a995d73354904960f0fc24a118169_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtMS0xLTEtMTQ3MTU3_12b4e6a6-8edb-48da-aa93-883a2bd34da5"
      unitRef="usd">1976000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i10081408aa87434ab81112bdd4bddd79_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtMy0xLTEtMTQ3MTU3_69c283d4-3c43-4535-a0ca-25a96841c09b"
      unitRef="usd">1958000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibaf9ed3e3c2146e69762157a21265754_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzEtNS0xLTEtMTQ3MTU3_2538bb70-b1eb-438a-9340-614075a6e701"
      unitRef="usd">1880000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4540961b5e6b4808a8026bb9516ae3e9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItMS0xLTEtMTQ3MTU3_d900a4fc-d0e0-4070-aa11-04cf17dd5fad"
      unitRef="usd">385000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1b498db236d3482f9f42a2a0a3f882f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItMy0xLTEtMTQ3MTU3_66ffd8c3-9bb1-418e-b369-c7497f5d31b1"
      unitRef="usd">402000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0593a5c8012d425ebb9b526021b07458_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzItNS0xLTEtMTQ3MTU3_8a50b2da-658d-4d69-a8a7-f431981ab2e2"
      unitRef="usd">486000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtMS0xLTEtMTQ3MTU3_3145d0a2-08f9-47d8-a069-128a27f263d9"
      unitRef="usd">2361000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtMy0xLTEtMTQ3MTU3_ba19bdcc-6a6c-4da7-bdbc-b4e7ca9f9c2a"
      unitRef="usd">2360000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzYvZnJhZzo0NjRiMjAyMjBlYzM0ZTI5YmI2YjVmOWNlYjhmNmY5MS90YWJsZTo2MDQ1ZWYxYTYwZWM0MDdmYjk3M2NjOTM1NmRiMjg0Ny90YWJsZXJhbmdlOjYwNDVlZjFhNjBlYzQwN2ZiOTczY2M5MzU2ZGIyODQ3XzMtNS0xLTEtMTQ3MTU3_83315ab1-7bd7-4b48-88d4-87ee9c84a487"
      unitRef="usd">2366000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNTA_9c16f1cf-4e33-4fe6-b3b2-dbad08f1307c">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#ee2724;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;14. Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain stock incentive plans (collectively, the &#x201c;Plans&#x201d;) for the benefit of certain of our officers, directors and employees. At June&#160;30, 2022, 24 million shares remain available for future grants under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan ("2021 LTIP"). Under the 2021 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only 10 million shares could be issued under awards other than stock options while 24 million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were no stock options granted to employees during fiscal 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Performance share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total tax benefit related to share-based compensation was $12 million, $12 million and $16 million for fiscal 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over three years. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance share units generally vest over a three-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from zero to 240 percent of the target award amount for fiscal 2020 and 2021 grants and zero to 234 percent for the fiscal 2022 grant. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7f6f204ca12940be95285479dd9fd419_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzE0Nw_65bfcdc9-7121-454b-830d-c34174ad9fb3"
      unitRef="shares">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i73fc8886bd8f4f4e8e6f8813d56985a8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQ3NA_7a467323-e251-41c7-b209-9154c7a5dc56"
      unitRef="shares">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i93a070ccd43d454bb5c9cb38b3cf6771_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzU0NA_dac23c1b-f0b0-4a4c-9146-658701fd1deb"
      unitRef="shares">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_799065df-b3df-423f-9f02-a128ba91c504"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_a46e897c-51e7-404d-a88c-d53438d20737"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEyMDk0NjI3OTE0MTk1_f11e1cfb-d270-45d9-8f9e-f380471d8f8b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwMjg_d9556d7e-58a5-4931-a1b4-b73482178c62">The following table provides total share-based compensation expense by type of award:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Performance share unit expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Employee stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtMS0xLTEtMTQ3MTU3_174b6071-ec7b-4a93-ac38-ce3808ad392b"
      unitRef="usd">69000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtMy0xLTEtMTQ3MTU3_aca71e04-f67d-4dda-b193-cb14d75badff"
      unitRef="usd">73000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzEtNS0xLTEtMTQ3MTU3_80a5d375-b1d8-418d-86ef-2ad71118598b"
      unitRef="usd">70000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMS0xLTEtMTgxNTM2_f59f082e-bfac-4770-ad10-d40584d36243"
      unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMy0xLTEtMTgxNTM2_430ad74b-b3c3-4ccf-8286-9bfd288b2991"
      unitRef="usd">16000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItNS0xLTEtMTgxNTM2_14322383-2105-4999-8c48-16547a7b1230"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic59c0e507a954a359a8f7d58af7b67a4_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMS0xLTEtMTQ3MTU3_a5d9faad-4738-4bad-8dfd-1abd2d9a70f2"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f6765e680ef4b428373d3c79130715c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItMy0xLTEtMTQ3MTU3_a7e6f1af-608a-4b2e-b6b3-dc1797d4033b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i44c4d91acbb2404c90f9a81116da83e9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzItNS0xLTEtMTQ3MTU3_56275f11-da54-473f-8a10-f344fd4b8d07"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtMS0xLTEtMTQ3MTU3_df386620-b6f8-4113-bb41-636d09c817be"
      unitRef="usd">81000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtMy0xLTEtMTQ3MTU3_8135c3c1-7d46-41d4-85e7-89a2f13c514c"
      unitRef="usd">89000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTo4YzAzYWIzZDBlYjA0NTkyODcyNDM3Zjc2YjI0MGQ1YS90YWJsZXJhbmdlOjhjMDNhYjNkMGViMDQ1OTI4NzI0MzdmNzZiMjQwZDVhXzQtNS0xLTEtMTQ3MTU3_a9746c13-32f5-4a7a-8304-d73b9bd6dd5d"
      unitRef="usd">90000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg4Mg_97d1d3ee-c8a4-4acf-a0bc-9fcf8ba2f1d2"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg4Ng_f8c52f48-af9b-441c-809d-93274766cd70"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzg5Mw_1b52f609-4fa5-4149-9a18-b84d55f0cdad"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzEwNTU_4cb90cd3-a26d-4a7a-a5cb-b65f7df3edbf">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNzE_51b52274-0e31-4a09-8a92-12135da4e144">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;46.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzEtMS0xLTEtMTQ3MTU3_17a59c09-d5fd-440f-b915-985d248cf8bb"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzEtMy0xLTEtMTQ3MTU3_7bc585e5-01dc-4a2d-a68d-e2264b706ee4"
      unitRef="usdPerShare">45.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzItMS0xLTEtMTQ3MTU3_29f918da-403f-417e-beda-eba1cef76681"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzItMy0xLTEtMTQ3MTU3_846d1029-91f4-4c36-9c34-a960a7a6c6f0"
      unitRef="usdPerShare">53.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzMtMS0xLTEtMTQ3MTU3_a2c11046-abea-4d8b-96b5-ada7c4845342"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzMtMy0xLTEtMTQ3MTU3_d1d9d9d5-1bcb-4edb-b9ea-07c4b6cb6061"
      unitRef="usdPerShare">49.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzQtMS0xLTEtMTQ3MTU3_4547c4f2-0add-4afd-9dae-69778e5d4d77"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzQtMy0xLTEtMTQ3MTU3_4e6c7bb0-1fc1-4b97-90df-b3b338230b24"
      unitRef="usdPerShare">48.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzUtMS0xLTEtMTQ3MTU3_66e28f46-69ed-44f4-9cbb-56ddb7af2208"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzUtMy0xLTEtMTQ3MTU3_c118f47e-13f0-4e63-a8ad-1b930eb15f94"
      unitRef="usdPerShare">49.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzYtMS0xLTEtMTQ3MTU3_b95a4cbe-2e06-4b04-b088-a347c782612b"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzYtMy0xLTEtMTQ3MTU3_fb9282ec-3a5d-437c-8491-f3db336b41c4"
      unitRef="usdPerShare">51.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzctMS0xLTEtMTQ3MTU3_5c25bb20-c461-444d-a607-c2978a3b3092"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzctMy0xLTEtMTQ3MTU3_a9ecef00-8c95-4e11-8738-044bb8a1d168"
      unitRef="usdPerShare">49.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzgtMS0xLTEtMTQ3MTU3_8c91c47a-8061-4d33-a3d5-9964c144f97d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzgtMy0xLTEtMTQ3MTU3_fd10d617-711b-44e6-acb2-4e6bdea7429d"
      unitRef="usdPerShare">50.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzktMS0xLTEtMTQ3MTU3_b791839b-a404-440b-a45a-7e948b8c3f9f"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplY2QxYjc5MjdmYzQ0OGQwYmVmYzQzMjNjNzQ1YzAwOC90YWJsZXJhbmdlOmVjZDFiNzkyN2ZjNDQ4ZDBiZWZjNDMyM2M3NDVjMDA4XzktMy0xLTEtMTQ3MTU3_15b6bd81-629e-4323-ab47-b8f87db5ccd1"
      unitRef="usdPerShare">46.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwODk_bd6b3337-6154-4d23-bbcc-ecf3b6005f5e">&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to restricted share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ia467dc323b074fc7af8717e8d527a287_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtMS0xLTEtMTQ3MTU3_65038797-0b64-4011-bdcd-7ccff006e023"
      unitRef="usd">73000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i25d09281a7c14a70bbb09c9ca514ae47_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtMy0xLTEtMTQ3MTU3_e0cc533f-3555-46bd-a339-dba061f22c42"
      unitRef="usd">73000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i7ba87bba31c44ccc98e13df2983e423b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzEtNS0xLTEtMTQ3MTU3_615cee8e-cd6d-421a-b76a-ba86ee1aba8c"
      unitRef="usd">77000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItMS0xLTEtMTQ3MTU3_c04a6d94-eeee-4a68-8a41-61c0f4f7c51d">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItMy0xLTEtMTQ3MTU3_befda654-20d8-4997-afdd-3aeedc99e6b7">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzItNS0xLTEtMTQ3MTU3_017b3b08-2f1e-409a-b562-dac1fac71658">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i966da7010e3642cdbc15af92fdca5e07_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtMS0xLTEtMTQ3MTU3_ad84d0d3-0413-43ce-ac08-e4c3b70e44bd"
      unitRef="usd">74000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ic36c5a600a204ee992771ac5129808e4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtMy0xLTEtMTQ3MTU3_13160a97-4161-4f64-98f0-97924b365b0d"
      unitRef="usd">70000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i4dcb65e769d24d64bd502ba85e2457cb_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTowNzEwMTNmMjQ0NTk0MzZjYTA5YTM0MjU1NTA5YTIwOS90YWJsZXJhbmdlOjA3MTAxM2YyNDQ1OTQzNmNhMDlhMzQyNTU1MDlhMjA5XzMtNS0xLTEtMTQ3MTU3_679d67ca-677a-4498-bb61-693d1cd558d4"
      unitRef="usd">57000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwMjE_cfaa8186-fff6-49af-9b19-370c1e818bcf"
      xsi:nil="true"/>
    <cah:VestingPeriodinyearsforShares
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzMwNDk_03b2d9b3-3fa9-434a-826e-dc06997c357c"
      unitRef="vestingperiods">3</cah:VestingPeriodinyearsforShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzMyMTI_22cc094e-303f-4943-a0e2-c4cd44697a87"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i61b77b415b584f6ab312fd1c96fca6e3_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDg0MDY_06a0cb84-0c1e-4af3-9295-002a4b1a6511"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i43325093a8ee44ed8f85cdbf2059ce09_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDg0MDY_b4798d46-7a77-4efd-9c6d-98bebd52f5e5"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i14df6215389e42dfbbacb4bc5bd9aa9d_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDgwNzk_22cc094e-303f-4943-a0e2-c4cd44697a87"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1ad9e1e9c9c24a5a93fb7c80fa81eeeb_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDgyNzY_f58a9927-1bf7-4fb5-ba71-bdb898ee1079"
      unitRef="number">2.34</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNDg_32f73e9f-9ddc-4908-aa64-05e54ff7b51f">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;br/&gt;Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Nonvested at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Canceled and forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;54.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzEtMS0xLTEtMTQ3MTU3_5d07ce3c-ae5b-4039-b116-a03c9268c690"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzEtMy0xLTEtMTQ3MTU3_780c2a17-48fa-4b8a-9095-4e5335850da3"
      unitRef="usdPerShare">54.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzItMS0xLTEtMTQ3MTU3_95c703a0-e40d-4413-8b54-7b48e8645f50"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzItMy0xLTEtMTQ3MTU3_033ea652-577d-4a74-a8aa-759a8ea11bd7"
      unitRef="usdPerShare">55.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzMtMS0xLTEtMTQ3MTU3_ec0ad549-de4a-475b-847f-111713b587d6"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzMtMy0xLTEtMTQ3MTU3_fbbade5a-cfed-4397-a240-e0b304c926c8"
      unitRef="usdPerShare">42.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzQtMS0xLTEtMTQ3MTU3_214522f1-94b1-4cb8-945b-bee5fd042a9d"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzQtMy0xLTEtMTQ3MTU3_2bcba604-86fc-4c80-a8bc-00edf1ba19e3"
      unitRef="usdPerShare">53.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzUtMS0xLTEtMTQ3MTU3_caa5022c-387e-4333-957c-a238b0302ec3"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzUtMy0xLTEtMTQ3MTU3_1801cf14-be7f-4e24-8108-f58dfd85eec4"
      unitRef="usdPerShare">54.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzYtMS0xLTEtMTQ3MTU3_18927200-5ab6-486d-8730-5035e07a501f"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzYtMy0xLTEtMTQ3MTU3_975f691e-6b09-4100-bd76-32af4f5d0597"
      unitRef="usdPerShare">51.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzctMS0xLTEtMTQ3MTU3_33316acc-d76f-4da6-99d8-3ccfc793e92d"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzctMy0xLTEtMTQ3MTU3_44a4a8c0-3923-4e89-9c55-6abee7181b18"
      unitRef="usdPerShare">52.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzgtMS0xLTEtMTQ3MTU3_bdf39b7a-a3e1-47ab-82be-9e9d63c91be9"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzgtMy0xLTEtMTQ3MTU3_ad968f50-8bce-4d74-8d6b-683ace7582b0"
      unitRef="usdPerShare">52.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i056274b9166742cdaee278d9b684a643_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzktMS0xLTEtMTQ3MTU3_4203e866-3e86-41c9-8125-8ce2eda5be0a"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i056274b9166742cdaee278d9b684a643_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTplNTJjNmJkNWEwYzY0YzBmYTczYzg5ZWEzYjVmNGQ1MS90YWJsZXJhbmdlOmU1MmM2YmQ1YTBjNjRjMGZhNzNjODllYTNiNWY0ZDUxXzktMy0xLTEtMTQ3MTU3_d26ca77b-dd0c-48e7-8aa9-7a0355e35ec8"
      unitRef="usdPerShare">54.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cah:AdditionalPerformanceShareUnitsDataTableTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0XzQwNTc_37214633-7d40-44b5-82df-a67211ddf0cb">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional data related to performance share unit activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average period over which performance share unit cost is expected to be recognized (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cah:AdditionalPerformanceShareUnitsDataTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i056274b9166742cdaee278d9b684a643_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtMS0xLTEtMTQ3MTU3_c545b16d-b096-43cc-bed0-5edaee3a8fa2"
      unitRef="usd">17000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6e641c3a7b314110b555c0df32c0642c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtMy0xLTEtMTQ3MTU3_a8da6a90-a279-473f-9081-b7a47b69b9a2"
      unitRef="usd">26000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id0bdced14fdd46b6bfb7ccda7b355a44_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzEtNS0xLTEtMTQ3MTU3_273664f5-5a89-4c38-8f93-d87cb89169f6"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItMS0xLTEtMTQ3MTU3_fae84110-3fae-4895-99e5-3202996b0e4e">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItMy0xLTEtMTQ3MTU3_e45d09d3-d93a-4412-ad10-219b0ee9a412">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzItNS0xLTEtMTQ3MTU3_6d479277-be16-4eb0-835a-7e75740e9836">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtMS0xLTEtMTQ3MTU3_f07931ee-5e63-4623-9d80-095b843d7cc9"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i82d87cbec65c4ba6a5d4582177b3dc44_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtMy0xLTEtMTQ3MTU3_93fb41f9-ba83-41bd-9a71-2da496602944"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i38081f76db524efdac004049a6ebca1e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90YWJsZTphNTBkZWUzNWEzYWM0MTFkYmU1OWIzNDMyODNhNmU0MS90YWJsZXJhbmdlOmE1MGRlZTM1YTNhYzQxMWRiZTU5YjM0MzI4M2E2ZTQxXzMtNS0xLTEtMTQ3MTU3_463d7366-8547-47fe-974f-fd187d2cfc8d"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzODI_a8d8d4aa-2b46-4801-a4aa-90c50d22178b"
      unitRef="usd">60000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzODg_ea87b048-126b-4ff4-b00e-d692aaa8e2e9"
      unitRef="usd">55000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xMzkvZnJhZzpjMzY4M2Q1NDdhZjQ0NjE3ODYzM2MwMWNjOTBhZGIyNC90ZXh0cmVnaW9uOmMzNjgzZDU0N2FmNDQ2MTc4NjMzYzAxY2M5MGFkYjI0Xzc2OTY1ODE0MDIzOTY_fb0e5cf8-b351-45c6-9376-18fe6cc24ae2"
      unitRef="usd">66000000</us-gaap:DefinedContributionPlanCostRecognized>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzYzNg_f29a323b-7bff-450c-9707-3bc695238357">&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%"&gt;Cardinal Health, Inc. and Subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:13pt;font-weight:700;line-height:120%"&gt;Schedule&#160;II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to Costs&lt;br/&gt;and Expenses (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Other Accounts&#160;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&#160;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;273&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;617&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;944&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,514&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(2,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;898&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cccccc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales returns and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cccccc;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Fiscal 2022, 2021 and 2020 include $87 million, $70 million and $49 million, respectively, for reserves related to service charges and customer pricing disputes, excluded from provision for bad debts on the consolidated statements of cash flows and classified as a reduction in revenue in the consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Recoveries of amounts provided for or written off in prior years was $1 million in each fiscal year 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Write-off of uncollectible accounts or actual sales returns.&lt;/span&gt;&lt;/div&gt;The sum of the components may not equal the total due to rounding.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItMS0xLTEtMTQ3MTU3_095b0882-9a8c-48a0-99b7-5a8a966ceba2"
      unitRef="usd">243000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItMy0xLTEtMTQ3MTU3_6f2c07f9-9df1-4719-a65d-c07501117769"
      unitRef="usd">154000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItNS0xLTEtMTQ3MTU3_9791b89d-9ecc-49e6-8fcb-649865a5e09b"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifea6c79d6dfc4237bc1fe7d2b21fdb8b_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItNy0xLTEtMTQ3MTU3_b2cbd840-c533-4144-b78b-30f755b639a9"
      unitRef="usd">125000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63aae49541134c39aa2c99f778658cc5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzItOS0xLTEtMTQ3MTU3_100e5a6b-faae-44df-9f8d-7904ec1758b9"
      unitRef="usd">273000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtMS0xLTEtMTQ3MTU3_767817c6-dc92-496b-a6b5-25adc90ecac1"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtMy0xLTEtMTQ3MTU3_009c1d5e-4721-460a-a85e-6dd2b5178f58"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtNS0xLTEtMTQ3MTU3_b68ea4e4-5d32-42ff-ad80-b34a1f509e6c"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id06cffbc2aab473ba8c23237f76acafb_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtNy0xLTEtMTQ3MTU3_59067f45-5240-4225-a4bc-ee30cba621b5"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0efd4fbb53d04dafa0b1d7718e8ec1ef_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzMtOS0xLTEtMTQ3MTU3_120243f6-03da-43c2-8554-dbe3d2c5d702"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i34c301733ef2486eb8a91bd315f448fa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtMS0xLTEtMTQ3MTU3_1ee231df-cd6e-475d-9580-66a1c1c565f7"
      unitRef="usd">689000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtMy0xLTEtMTQ3MTU3_1e57442b-c774-4bac-b447-676dc8a16850"
      unitRef="usd">2359000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtNS0xLTEtMTQ3MTU3_242f77e3-f518-4d71-a690-56bf09068354"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ibb140a4b6cb9475b9aa85ee67ea8ce99_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtNy0xLTEtMTQ3MTU3_a54b8ba7-b36c-4701-af58-13720c1bc170"
      unitRef="usd">2431000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia953d01035744830b89e0d49aa3ef798_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzQtOS0xLTEtMTQ3MTU3_30d2605d-04bd-4154-a8b3-e0d3274040c7"
      unitRef="usd">617000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtMS0xLTEtMTQ3MTU3_ac4a1201-e3ac-4e13-8d61-2af63b585124"
      unitRef="usd">944000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtMy0xLTEtMTQ3MTU3_4112809d-a394-49af-bb9e-82fc47435808"
      unitRef="usd">2514000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtNS0xLTEtMTQ3MTU3_a528193f-579a-4615-902e-5f124d91aef3"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtNy0xLTEtMTQ3MTU3_e0b05856-5ba3-4fc8-ab07-217e9504c139"
      unitRef="usd">2561000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzYtOS0xLTEtMTQ3MTU3_64b2fa3c-bab3-42f7-bfb3-2f4f71860ebd"
      unitRef="usd">898000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0b79de0e173c49a293e4e8121d68cf5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktMS0xLTEtMTQ3MTU3_6e4dd675-79a0-4b5c-a56d-6ad188ad6778"
      unitRef="usd">207000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktMy0xLTEtMTQ3MTU3_44f9a675-5243-4557-b2ee-faeecf4d02da"
      unitRef="usd">129000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktNS0xLTEtMTQ3MTU3_9c6c073d-8fab-4cc0-9ee8-f8ebec03200d"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iafa6746a4eae4e08a87dcbc946bca69e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktNy0xLTEtMTQ3MTU3_10d2a5c8-04a5-4bdf-b969-b1041a04b4c6"
      unitRef="usd">94000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf660360901949d98a491a3d5fbb5d7d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzktOS0xLTEtMTQ3MTU3_095b0882-9a8c-48a0-99b7-5a8a966ceba2"
      unitRef="usd">243000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i20a5929938d842bca82c533a67d3e5ad_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTEtMS0xLTE0NzE1Nw_61606fec-2a6e-4f2c-bb5c-3f547bc3a991"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTMtMS0xLTE0NzE1Nw_7d7b3030-b605-4b31-9140-dec22a2e0a02"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTUtMS0xLTE0NzE1Nw_f6286dd8-c1ad-414c-a222-532d83961a96"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0174760a9e524b238ba45a012e1b4873_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTctMS0xLTE0NzE1Nw_67c19b77-6793-4a78-8ef6-4512c49cd418"
      unitRef="usd">20000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id528f552d5104bcaa9fa12a73626119f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEwLTktMS0xLTE0NzE1Nw_767817c6-dc92-496b-a6b5-25adc90ecac1"
      unitRef="usd">12000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia768abc477b149ba8b237395ef925335_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTEtMS0xLTE0NzE1Nw_fc8401ab-10f9-4d51-bf54-ec30c8c00a08"
      unitRef="usd">495000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTMtMS0xLTE0NzE1Nw_b2be865b-d662-439e-9976-8ae081a3a484"
      unitRef="usd">2568000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTUtMS0xLTE0NzE1Nw_a0d25d5e-60a3-49a9-89cf-34316964a75a"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i51f85cd8665241dfb07330260c2c0a3f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTctMS0xLTE0NzE1Nw_08ead8e3-2e74-48eb-abcc-dd91df0bc66a"
      unitRef="usd">2374000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i34c301733ef2486eb8a91bd315f448fa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzExLTktMS0xLTE0NzE1Nw_1ee231df-cd6e-475d-9580-66a1c1c565f7"
      unitRef="usd">689000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTEtMS0xLTE0NzE1Nw_6b66b394-4967-4430-810c-90931814b5c6"
      unitRef="usd">729000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTMtMS0xLTE0NzE1Nw_9e6e998b-f1f1-4c14-a487-af4a43075c96"
      unitRef="usd">2702000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTUtMS0xLTE0NzE1Nw_09c42e9a-7bab-4dcf-9887-6a9770750853"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6de92a2515fa4d87b6236f90c70bd728_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTctMS0xLTE0NzE1Nw_a8451c2d-ff00-401d-801e-c081359e2bd6"
      unitRef="usd">2488000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id718ed1e33ce417a8b54b992f9f06368_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzEzLTktMS0xLTE0NzE1Nw_c116ddf8-06ec-45b5-9237-390aef83333a"
      unitRef="usd">944000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic14268b63f5e4696bfec9d26f5249db2_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTEtMS0xLTE0NzE1Nw_c13d5aec-2698-4e30-b03a-cebcb9d003c2"
      unitRef="usd">194000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTMtMS0xLTE0NzE1Nw_fb7cc82f-115d-48ec-83db-c3d3bf41f5a4"
      unitRef="usd">139000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTUtMS0xLTE0NzE1Nw_878a21e3-9d0e-412a-91fc-eb586787160d"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if9ce8eebcccf41fe83b2c06b3c7e0df5_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTctMS0xLTE0NzE1Nw_821e7bcc-602c-4106-aab9-addec033b6dd"
      unitRef="usd">127000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0b79de0e173c49a293e4e8121d68cf5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE2LTktMS0xLTE0NzE1Nw_f9d9b7df-1e93-4a31-ab0c-6f3e25b3289d"
      unitRef="usd">207000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idd7cd7c5e10e435f9a63d042307ff0a5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTEtMS0xLTE0NzE1Nw_3f8b2e1e-25ee-4e1f-b3d4-6cad12c4dca9"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTMtMS0xLTE0NzE1Nw_69b678ab-3b52-42be-a279-e76763f37631"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTUtMS0xLTE0NzE1Nw_2cae6325-63d7-40c0-98fe-d936c346f080"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ie580b49712624d48bbe1484a4e10c16b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTctMS0xLTE0NzE1Nw_19967e39-3132-4706-b380-5a6b27149dfe"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i20a5929938d842bca82c533a67d3e5ad_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE3LTktMS0xLTE0NzE1Nw_388d0858-da65-475f-ac7e-a96f1c00e37e"
      unitRef="usd">27000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iad140489fe934c8caf9ef36be5139d4f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTEtMS0xLTE0NzE1Nw_5bd85225-3eee-4522-ae0b-986738d6b854"
      unitRef="usd">479000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTMtMS0xLTE0NzE1Nw_fba3ea5a-89e7-4afc-9245-19f0d11b971b"
      unitRef="usd">2253000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTUtMS0xLTE0NzE1Nw_1e858453-7739-4f61-9fe8-18774a392e9a"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ica1d90385829420fac7b1024979b31c3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTctMS0xLTE0NzE1Nw_ce4fe697-a731-4e2e-a9b9-422fc52cf2d4"
      unitRef="usd">2237000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia768abc477b149ba8b237395ef925335_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzE4LTktMS0xLTE0NzE1Nw_8c714c05-1457-4ff8-a27b-ae62e5c4a92c"
      unitRef="usd">495000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i62cf4cc6eb9443bc92ba424345a43970_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTEtMS0xLTE0NzE1Nw_e73b049d-9386-42ab-8aa3-d9c7db7bbdd9"
      unitRef="usd">687000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTMtMS0xLTE0NzE1Nw_1def2278-8403-46f3-8f2e-b022a5abacf7"
      unitRef="usd">2407000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTUtMS0xLTE0NzE1Nw_4ec7b145-db28-4af3-a7c9-e87c07cff5ff"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTctMS0xLTE0NzE1Nw_04df4150-a1b0-4e2d-ae54-75241660e162"
      unitRef="usd">2366000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90YWJsZTowMTVjYThkMzZiZTc0MDQ4OTA4YjQ4YmM2NWQ0ZGRkYi90YWJsZXJhbmdlOjAxNWNhOGQzNmJlNzQwNDg5MDhiNDhiYzY1ZDRkZGRiXzIwLTktMS0xLTE0NzE1Nw_d5420105-7466-4988-b784-fa57ceef5b00"
      unitRef="usd">729000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie6d67fb03b394de5bfd91a7161298584_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEyNA_2ccb743a-b1f8-4856-ae4b-65ed04649084"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i79b7882d67e14e36b7002a6ff0299b96_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEyOA_f9469bce-d836-4c62-aa33-a89da48c0416"
      unitRef="usd">70000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i71d69bac84194be3ae102ae751b16751_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzEzNQ_f3687535-2a39-481d-bf59-b84d8825fb2e"
      unitRef="usd">49000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i82b6099badb34def8ff80369a0b76e44_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_7067e515-2cf1-416f-9a19-be4aa03aa159"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="i964db25469894c16b81360ef4522965e_D20210701-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_8f7646d1-3966-4398-80bb-056e5d1d01b5"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries
      contextRef="if96021e36fcd47b580794c907494e1f0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNDgvZnJhZzphMmJmMTYyYzdlZGM0ZWIxYjZmM2M4NGQ1ZGRhNjk0My90ZXh0cmVnaW9uOmEyYmYxNjJjN2VkYzRlYjFiNmYzYzg0ZDVkZGE2OTQzXzQ2OA_b4d0b4ae-db5c-4828-827e-0a3cb54fea68"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <dei:AuditorFirmId
      contextRef="i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2YjhiM2ZmNDhlOTQwMjk4NDMwNDJkOTY4YzViZGE3L3NlYzowNmI4YjNmZjQ4ZTk0MDI5ODQzMDQyZDk2OGM1YmRhN18xNTcvZnJhZzo1NDhiOGI3MzhmMjI0YzRlYjEyYTBhYmY4YjcxYzc1Mi90YWJsZTo2MjkxNTRkZGU2Yzk0YjNjYjhjYzIxNzhlYmNjNmYzZS90YWJsZXJhbmdlOjYyOTE1NGRkZTZjOTRiM2NiOGNjMjE3OGViY2M2ZjNlXzMtMC0xLTEtMTk4NTM1L3RleHRyZWdpb246MWI0MDMxODI2ZDNhNDM4ZDljZTdmYmYyZGY5ZDU3YmFfMTkyNDE0NTM0ODY1MjY_f43d67cb-082e-4916-afb7-8ce529d089e9">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>123
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MUCER 5SE MALXPM:MS'E&[6@_0P*<@OY4[PCB7[8_<?W!>:XUMC.D13@*BG
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M!OA^S9C<GZ@?*.OHQ_\ 4$L#!!0    ( !J""U7(^Z11/0(  ,0%   8
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MX[&5WB ,C8*\Q4"^;TP4##3JJ-G)CNODE98#)*!8-T)/%DV-%>N</S,&Q+?
MMYRC_6AB%YWK&:00C&<TK!C!=+4ASVW%@MM+ZKK@0F7_)+5D TY<K9@ \?9C
MD\E,OQT*EE=:8@X]"Y<#KC4RGYKM%@$%H1&&& &%M*,[>7N"R.OE>%>LDTS4
M*DA3/%F">CYU<MVU@'6:R367,%NA'R=2,@42J&0*9>I9XZ-NZ)I4;=3([,08
MIH,G;7G27IZ?(%_+.I,G@LTYS,F,R5-G#AIOR7I8462&FBL,!O*H1<M&A:/
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M3!>2NFC&;K7C5NWXI-HO0F-6!^G4[GA.X+B_LG'0$=C'C#J0U$$3#=T")ZW
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MTO)RRQD47P& W]="Z*>;XIM9\XUT^1]02P,$%     @ &H(+5=]@4-*-"@
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MGJQ0/0Z*%FF:/^X(^UBMT&:9E;:38!M?8WL%>NRIUD5(_6EI:00H73@6:C6
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MY*K45BX=@ R95F3D3W6W!Z&"L9%44*Q)J//T&;X&M;X&V;<W]![8+CY]@+0
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MV]/LG5NZEGXEH+HF^]N_/+VX>/ALYV;\V_DSN]+T;;ATU/O9$<_MRTU9Y2T
MJFGO/.T%34O;35#5!$E9\+8L:0MK6FF5>2(#1XP;L!,V:<;I'<;@)3VTR?\D
MA'6W)\VNIH%H6VC@KFVJ"OO5SSUM8M[R)O1UY3Q6S9-W[E.7-?1'NRL)G-;]
MU9<M4/QKWQ(\'FB\=02ZJPNBTCHC+N&(2XP1HH^"=3 #.6?0Z)>'_\!: 5LR
MM\?D](I./9N:94:@^ZWL;75[Z%1A49^'HJP754^D!3!R.6P\%)VB+T$T0,,K
M/CF[.(.M'2YBA+7/%T*%_/1&YEKG1*!SYX@"*Z*<&J">9K^ML3^>9"5#,^\]
M,1/O<4H6O&L,3E'Z;>/Q^Y+1J8LI=!ONL?QEVVSX43R#800/-(4O&8LT2[^U
M?;*'9-Z\&F_$2]=V.$O;MJ3WF)3VE]FZ195[3U@BH&A@ A+*DLVQZ%NBM$[>
MWB8;>IK][GGV[WU7DGY!N+C?%@,S-- V;P4SV.:V8 ZP*[NU;3L8'P%.KV_I
MT&0K5[N6>2G==]LN8O7WNL1?[SN&X8$R@Q^NK]\J,SB6_9,YA1@)[ /D9^LG
M.A-P,% XFUG/)VZ3?W29LW7/LC_[8J6+ REYTA&W"8/+F?/)7BK^"9:F[;Z$
M-'CDA=(OD%,W'9C%]_<! SCO?9PNP3$>)0):5 W)!5!YQ3!T#61&0P\PAR).
MQR*%=J#9\5Y!_A1-/^^6?16.ZHPFN"$((&9N\JJ/ E6U!GIBU33%KJ3#B<LZ
M.-%4O2KGE0/4I,N7M,JRQ5IF&8U7T%QQ (+4\]$G\(D)0E8]D*,F-,.")ZO*
M?%Y6V$:6 JY:GI0U+9&!)WC;GD36L; *>KO9$-/)/P&CUXN.[H6MVN2WA"#:
MPC8<3Q]W/W ..FZY7V??$Z'0RGD7/LB^DJAL"1RZ43!Z?">;M.U;DG78%:'[
MFN[2*<_!Z;H>G$XX0.M<MA%]D_ @$J2APYLM,*&+$PJ=DP[0,H%@ _B$CI_+
M\BUAZ9.>VB5A6IZ%8%DX>FI>J?R_'FSW*]ON:^/,O[5Y 9I)WI+3#39!"ZMI
M+\$,Z\\1#I[ZZN+)(S(2JLIHYJN+R^1"-Q1")G[.QUSONK91H839!A PV]QW
M60&4U"KF6ER@[<V7'9.XY]LXA*<DX_<X$XN;'"?9M3@,.Y>P)>:H?+:4[,!+
M24%:.=7?2-4RC2];.L>;N2:KRX&OLAI8"J;N!)X5L-:M2)EK:5:BBY).6UQ;
M0"C00Z1&NU+2[O..TS20&':2A-O?8'YB)353'LZ6"=! N^O20R>$3N ^;5T+
MM<S-&&K0&;@'>&LMFF8J-1R-09KK@K2(FY(4,#G1AH^,7BO*+@-3KE>,D'E>
M?VS[;;<(8IQL==_4.?,&'&12$HES\M]$28YHN^.5%(ZVO]EFI 6.B$UGD:4I
M_FY@<<M)7M*.-K0W?_4Y<60@E4?#'I.0ETTA$BG^[.W@@L9KYPH1F+SG-B$/
MOZ.SBX.G;RH?*1QQ\H)TP 4T%B)77M**!+07V1!VRQ6?.RX#-5S%!>T$07-#
M&E!#4BK0W"G9,HMU\A"Q!V*V*E7X5^%KYR+C:8PK5?UR59H(,.R1,W'6IG1/
MBM>?+-U($:UZL$[1#M[8F\I<&U-%!_.7$(6+AK0T6#<Y76#"I^EKT[L"Y,**
MP?<(@00.S8^W2*+0SI&&1SN2S6GWUF6+\])VI1PR4OH=$23&>\UC.9&=,V9/
M0F,B]%@LL)14V'?T(_OJ<>1"#XRR082X\-7YA=T\%J9UY]-/DH?OQ]!4F1VI
MDR(W65CZ_6E*/WB8-1\2/CB\M5?6SB,<3^H?9+.*00:_C!]A+>'VGV7J@KZG
M0Z8>$79_GOXA"MQ]8:+'.!!X*H[F+%]IJH2'V?F#7XZI&K,R$IA1[ B):U;O
M30&WL_1_=KA?-C6,<U%6&8R7PL/>E?XC@("_DE5[%NT%*9.^9*4KHAX"BRTF
MYJG*3'=.-1#L.X0/N!ZDU8PVF]9] JX7=17?M3V?4U.3:,3VHQ/NRX>JQ"$3
MB_7. 42E$3G*))<H-0H8"U BL62KV'/"Q%TPMNV<&BO'M-V^"E*;"FTD>^<9
MQ]&BD\&&&S&Q'&<A8I_U)Q530+XH FI852/QSBOA!\(E/5\M(:T4E7?@ &+1
M<VK;RS.0L0HF)T:#L#32(XAC\F"M*S?SOO7,/Q,5.DA:*%_0Y#TKT0O6\0%!
M,FU9%P1?BW,%8/6HL3KP17 3T4"TI.@AS@.S&7!#&Z$A56"S'ROP[7#D"CK@
MK0^J;D0FG]Q9%O7ZDHFZ@.AI5FV^7=-:8?CB=<@;"$37LNFJZI$!YH(EPD<)
M"D)8)TS$\R?/$I.+\%B4T2\03EK0FG!FA0!!QDU/A^B+#_B/"8DK%G7(:)CK
M40&X8-P+,;N]>G],\SCZ0I7]B#</A!V.(NW9+W1,^/F\D,43(LI:@B9\"/;,
MQH[T,E:'@-(!;CZ[^)^9*[T,I/;RC_?J62/&UVX;/7@/CN*-(Y&MOVZ[?O/N
MTXS/+!#3U' 8AI%8/2'J+DDOZLU9P,HT T8ZH(.>?/X0I+((P).%V8MVN6IA
M6^ZQ%%9$_."DLYE# JDMH0.)6E\$@@!L;P?>47J&;7,V+*[[%8VDDFX']M.)
MFPWO#;VJH/&N+>>]6-*KUJGFQ'PF09U-S0*51GZBVE.#[> =$Z[-CFW2FWPJ
M$K\,':(O)G,G>_--]C:.]4['2B[]P$.*W3@@W: *B"; 'D;V8<8_DQDOKK)_
MS2X>A_\N[3\%(SO'Y7,\=8[+^/>(_GU0.<.N;Y$"S1Y6:=G]ULQSH*YI5SEI
MJ,I#@HOI[:_>7$S9CO@1?%<=E-CDU7S%XS)EUF[5=&R"J4_##$KV[L[=.J^6
MR@?))-^XS9SU]S_*OY=L-P6W\]O6;4K7VA4]#*2YB$0BTB+8=  1? !\76Z%
MK\-Z3;::+(2\$G-0YU0@B.(Q)M89E";H8W:JX*JB59Q_;?0S2WX77>Y\BK3P
MTF&G]5CWFQ+RIJ+*0>1-B\=^M K /S.!TSH8C:06#%S#=TI\]ZGT1AF*E-NM
M$Z]T8LK@8(OK"V;'==#%5>*4R<T'5Q<#+%U%?G1/C?B8U\U.FP+O8)ETS&FW
M 7SC:2=Z;Y*_(IYW4M8S<7B<-'U'O/6G-Z]_):ZZ<=VZ(1.*=D14.V-U*;P#
MXR.(#1@-[3@(-&179%K#%U*Z('BGF6(X4@?>#J?,3*'(>HD;0SLJRB',PORP
M2%TBZT6DB^I1!/B;!G:M8[Q'MZ5YY30B$OQ$[ !%Z(JPY1L9>NVJ+?N$YZZ#
M!XFD)?0AM<:P#Z9[ZD'[ -E>E8Y=10H&L:,VAQH)<!18PM:4(U4M?H064[=(
M\.8IO:4>&!Z5S]ZVRMD\B@,G6WD \:?9M6?U1-PZO&@5]E#UY,VE!J. A1TT
MEP?Y<3++F#QY$ '+B(Z1]& ^>DM %D67GP].F2*A[ONCCQ9S7Y,[I?YXRB+D
M8MA>DI 9F+97CZ_"!77MT3;7^W"JNY7(H6C8YH$3I"T&\R((^FFA9N@8%\G&
M[+ '!8_"MND) D1K%]V_*?NY%=D] *9KDI7M,2#:)&!(^##)'=*%!U0TT-'#
M+*JX_JS18#WG,]70/$-[@'U-T0>]P:&0SS,[X7%#;I<P.7A\Z.A4),QQ='0?
M?IFXBCD+MV1JR[VI^.KS]XXV60)4%K]/;K(T+0A5=0BX-!Q!1M"]@?&6!A%G
MXM(/!QJ1?Z!-]#5A(KS0S;9RH.-9"/B)5$,HDWVB0N2O^A#([>LM^%LASGB%
MB%VB%ADD,<G*/G&03J/S"!1LQ;H41H.PI[&5E[_^\>;5":0\#>5@;Y*:KM>.
MV)L4!7LJTB>(@?:V[N%\[<6\1W(#\5Y7#+F GB/! Y\F@;ML"J^1383H%893
MZ)IW+.G!T=NWWQ.@+6PH5GF2QQ95 X:XFH4L!D!5-_6)_;UB/615-1R((N#A
M)"M=5=A?F]Q_]*E9'F8FMDT:A_@8=$[&Z,Z1G-'04EG_V2/IA'U:F>2I"3-;
MJM%&MXB_@&R$ ^S383"@=;L+MP!IN4(22]KHM-ZZ_"/[EA1W1%=]B]'2+=PY
MY4W8H\#[$:TY_SHX,V>)0(X!Q$!E"[JP$J9&+QKVZ $"IE^(D)V(6NG;M&%X
M%O;_].G5X#P#9J[+'='N5Y>'/8T:!I"7<"(BS35S$O+.+UBD"6,)H=Y)?V(:
M$TDN:U+/G^+%$:9 5G,-6H&L@?(Y0DW"5,&=F:U\VI:JEQ8, 1AZ?;(6WA+.
M"7LJPG$"HZ:?=$XT26FHG,;XW.>]OQKLV#?S538QJ3/&.I>J%FP.B9@\OWPR
M\@ _O?IR%S!'5U\198I_\^=TM>(%#??R-B5:SRZ]S;:IU0R)4(K$8P4MC4'D
M0IC!&% 5*J0T00GD6$44=W*1N$_;$#%HT/G[</@'EQ,&VPKAER+8>"(6!F1@
M]9M>#E+AP,1+Y>X'1B)-5#@[Z&R$@ F)>?<LI,BQE<3J'5WD%%8$Q22_)>2E
M<*@>)VT#K@BC+H2290)3+\"FZ,2M23>T4PV-N./P3.+<Q-)R=14&+UQ#4+8S
M#H^'K ">VWL5(QP44N>?G$YQ77)PT\*QIA<;GPEA>T3I<TZCH_VW$ZOR1FQG
MB:R!AGIH^;Y9=CN@6$..DOS3S+$N-8G9N0PAU!.Z=EBWN,^(F,4<2K@DLV*=
ME9C;0MR)I-33T97M(-5GY1 5\%T2@B,4--@PRQ^0<31K"6E^'?.0,.<,F@(K
M;S/Q:CIVD<=D*9%86^3JE= U-B%W:SR4^<P133+MZ-;,1';7DQJ2$I0^*S%M
M1F.JPB,M%>G')TC1##K\C6M'6A<A$Y[$JKQQ?D"$/E5"S?4/7Y_=-_<,;YK"
MY9(Y@DM$7"^1\\@H0B4QYHE=[0;.-8FCT@ #&$$*[-*;/K21^7]#VF!9%1SD
M9,Z^@:DGC@5V45\\>P1:>?2UA&:?T0XN$*1J1V.F#U\\M(<C?1>1>@/+2(DU
M??^)O<Y:(XF3DD,X$E[YA-_]Q.,J697Y#-B*YMFUG;K2 EE G;B,<<%9]M6C
M)R.9<?DPRHPO\Q]->4%5 EHJI@H'KUQ^8J\T5AR$U3=(.3* _''BI/R)WIN%
M[=S;S>RK['SVY.)2?IX_(4$VN9'9Q>S\_)+^?WC^E&3???>/!KUZ?$'_/WQR
ME;V>W+/L_.(J.W_T&%%&Q.=$SG&8N%DA>)0]NGJ:/2;EZ;>F$SUZ$B$FL*YF
M3Y\^HO^OGCY%E&%:HNQM_8-'LZN+BV/\O+AX>GQ K@G:OR(T/'I\KC\?9N\0
MSFZ3^(QP,B&GHI15CEE4Y$PA,X' J)IZ)3%+9<&<DI">%V%3.8>*E?FFV5.B
MPH-[N>+$S.I!UL1PFF9>E2OQQ\Y,2R+H+@]Z (6 15I),E>$+>8I8($;0-0B
MAJ5AF,1,4H7O-/LAS;[[E3G^FYA]=RW<\FW(3!LDZXW3]'SPO,).1EA<V!ZK
MC&3@ZX8[/@\=AX-AT+!?C: V69E(];J6L U=9JD)I^XBY_0<*&[Q27;*GDX!
M"K?4]. 6_K%93K/_X.!WSHS>TH  G7C\1,<0(3W(!Y(<E0U4I*K\"(<XVZ58
M<O#J):H0',6:\ E2ZFMY7U/!H=<@ZW^HE_"NMRPPD7S/:9R<]7>[S36#_*\$
M^$0=XKWG6/EPPIJO"D68;;) RDQ1TC'M).U)E2@3S#1%W=D<$<,1I\#T:0RJ
M5&+KW!M.SM7BW3@X>C!1DCQD.1+W @XZ>E,Q4:K]6_KH)(VJQ7"[1'T<X$\5
MM40SV-NQ'P[ H)XQ <-R=%.-!0.7<-)P/,+,CB$ Q"U21,:8-AY599K-_[(E
M%DP*FU4'?!'E#I5LB7RP@CC#V[6#R9?#/$VPESB=][&H:BQ8QG ]D6H08HJ*
MOSJ' G,T)[S/-R ?)AD929-0Y/%OQI$%X$(=3A;2V)]$## B"Z(*2=M'#,E+
ME"^J!<<SIE8!2+(=.Y>D#*21<AS8F[RL !U4]J!:L,J^(@&[RCL+/(ZVF&?9
M]BV,+'&5W$%12I <.HY\A]3^-6=H:-5+2 M!*BIQ.#K^]/K"FSMW.#^]N8?(
M/:QE#\CT5\K%;OS2+RHN+9# I)J+&J=]'TI]#+/'S[[TC6?!<_A96$:5.L3S
M3WY$\N$$&"'F9(.CCL "3:+SWG^TT^QU)'U-X-F+5H@O>Q82(L6I>2(N)58J
M2!6TM"9[.Y[Q>_,J5F&"HXKYWCP9B+D-@V!3LQH%V"9@^;TNU$8:OJ./</@!
M>F<>_"_P-,(?LR2-FUA-X7! ]/"$&V!61%_E-MIAWMUP:M"R9Y55=9=9MJUZ
M<&]%1Z4K5S'KZD+6A+]+PNJ:[*F_PX1@6R^"),>E##4L.HQJ=_4P0;KT'T\D
MX9?>;+7*1EQJS+>P8(FJJ.8]R$0.F8JZDKCHH/'%,*!PH-K3L014:LFKER6W
M^ =GLP);K'A+Q0+721'D83IZ(>J9J[;9(;=KZ+4$T&G8$VG0P91.E-2^JYKF
MH_CYX)$8\VXMD;"2J*1$PG30ZM:J); 6JSW!_ %7 96V3>,D8Z(W%%#WO /!
MQX'=$5G7U^I-ZA!P@KY4!WTA$=1[7*X.L-@&5K<GT9F3 /AJ"%FZC)%^D.28
ML2^@T*3JAZ"(\Q#O3P_4X,RM>M( V/^Q[<E$6(0R4 M>[1*.DK( I >*8J,\
M<+Q<^-]4&B1U:[2S<4J9"XZ='6]73.T4L65Y'YR&(2G% J0L078RKWP3/"-Q
M[*32SEP[ ZTD78J1J546D"G92?D7X8Q *&*!'/LY-2PFH >RL=72-!/X(&V@
M@3>CDZA23;K^)@&"$:V1$M%@3&:/^.X!5',B#MO->G2#O:8.7*W7"O'*P:#C
M 4/=&4?SA"G$8(24M\8TEEC_%7"1B(&ZYW0@E+ZIJ9/XS)3D\6R0L7JZ1=O6
MR4D.XL!T;@1&6FPV].F*Z)"$4]S:.@*",ZS@"^RK(F492:7<G@!,,'6 +XE9
M8[4L'(OBV"5!,:%)I2FC+ 79#IG4W>\JL0TYOZ*-H38Q2?M)E8N]@9!V)$DU
MIKXAF<E)?E($9*@*[L6BAQ0TA19 Q=4J T-3HV?7GOEOSY:NG0N"E%-"+TTV
M'/W"B=2(M*:QHM=!!WX?*A5G1_MQQ(N9!1(URC*EV4JUU, WOH="+A,[/<_F
MYBD<YFU$FR&M?TA1R9DFR,L_/N,Z0L35+)H.^A:_AO+X05PLJ<5D/+=PI7LS
MU'G;NOP3"?;:+<MN[.+WTS:JKODT>^^<H/RIH5S5T_LCWFK?#^?QRE$>F\CB
M0S0?SDG%C#;Z>KP&!MA2C&LP@S;UE6#3_YKPJ?S/'2C*10[!:&6CG_6JO%EF
MOF'S%2QQX$(0=X%/6((&?4P2W*6!?QZV?0<"7_^W"2"A_Q\P]O]1@9#6\Z5.
M2_$>P/FP<*/7%\X*[\TW0<LZZ&E@(T(TRXK@1<)#R[G]0]8]R^9$31G7JS .
MD& !\4I_P#(*= )\[-9.N-'_'[E,>SQ3;V>:^Q!R+P8YM\]$;X(^($$XTMOK
M?&,M-G+(*XVR1"6T<XMUW53-ZE9,F>!+#0[ID5DW#*)IM3CMA70=$<TKL01$
M6FW%89>894'!$A19A(R0.QV'2^LI#_B'![[AD5,67E[8?=/QX"&)J3,X29TT
M%CL.ZK)! O*8)V%@^&->35#7T.<E0F&A14?AN$UY#T>SV@DG12CXP\0 3+2K
MOIXRDWW<"JGLEE!C9P6-MANL-OVO65_J[/_1XDC( N=HN/2#N+5-!"U9-3VG
M+R?2*<A.!BWFZ?I11@)[\S=YG:\LAW&S48TY)PL_KRU-P+)1DU%9A'<ABA%S
M X3*.XR _*>07)CDQG+ACIQ%2R(R3W):]V[F2RAY3HA#K!^)CN7<%Z-JF QS
MLJ=N41Z=>ZG8D?+]3ETJ0<[1FW,&)M"MH 1BE"DME/K0P>4:7/R-Q,5!CKH>
M"\L82'!&1N66UF=]/!8#5\\(E^.=8<6,15^,IN^'98A6.9IN!^[.V!X)L#K[
M.6])$SM7=9EGT?RW/%.^S/S?2B^$51 M5D0EV=_RS?99]AJ),9L1;;Q$*J4/
MIJRNG3%E&<$V)L^Z<;*T!7)CZ6Q8R6@L")RF<DMX'$YGG1=BRY0Q0B<+?#AC
MZ,!P!];,OF )T4AWA*\O8F&Q)F0Q V$#FPY_BSB;UE)RV1Z0;>DV:"['>35B
MC0[;!(1RQKC\1"&]^*<JI&,?:X!\HH_'*.&ERG>^-X<.[4BY&2C=2)KD]%"2
M+,2^\YL\>W#TYH^71\<DD6#&!O/T]]/WI^KPK?,BGV%/=TYLK;SOUMQU*"DU
M)MCY]6@WF;WTY!_&U:DAZTW2(23]O:PE$S46X$(V=;?[SIJT-J</WJ94!],W
M-1]:9(OH3C&!?M0BYLX"]'L5D3?M!,3&Z;B@H8 .%>Q^[O P],N$O)NH[&V(
M+Y&,%3ZES@E3+/6>L-P$2VFF7=II1EH]I)&YM.L#!RSGR(#4%!*(G#1YK2VD
M>T3:6DJBL:I!<PBC#?ZIV O&J(:#7*7W/6K-7S?I(SXZT7<28G"?7+M V<NP
MR=62L,+%&(15+2[0-ED#%.I63.VWE7-S79D&2M7:%2XIE:J#),- $0\D3'!\
MIKD7DL$Q12#3]O39 PQ_S"+9FIM8 4.Z$XEX8@^HR&WV.JC1R56UZBV)3BVU
M[LR\$4,A[(,D4(]ZE\3X2)*6>)K]Q)EAC*LXO*2+C6J4..->*UN===*;':JY
M0<<CVN?*&J"$9!BI%QDV)DE+T*3GH*:]=:SKT&:H/XJ09&9DHONRN$Q&H/7=
MN%NO?G;8AYWX= ,-J\SS6K1C Q%E20(D-V+K<O/ <5ZATI#A,WA(I!0%I>43
MO7,D+2&U<X."(@2J"XVUFS$_+Z'[7!,?0FX,*9%2)2C\(_0.\5)N$I^BO=%
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MIW0HL3R5@8$7F[U'?2[6"4^\;>QV7"JF*>_:<#I.H%Q/7[/&5FE))I>A(2#
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M/$#WEPT=./T#$R!VP^"]^&]02P,$%     @ &H(+527<J<%V!0  (PT  !@
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MZ .\61Q$_+VQ4W$Z/Q:+^6)Q .]T2/@TX9T^@G?3!'P)0:Q<M=96MMK@Q$-
M#XS2%W]=KT/TT,W?^XAHMSG;OPWWTJM0RXRN)FB60/Z.)LLGOYP\G[\^D,39
MD,39(?3]2;S1(3,NH)+[PCT,N)B*@TK875TYKW00[ZVX;@IHE&MS<BPV)((S
M2L22>I-U'VATXAU:KY)6/)%5_5J\]9H4OV*PB-J[C$@%X7)Q]')Q"J4;@WV/
MA45-\#&3H12HA0TY>4_J.$6(#3U%3!Y2(B//3VD(:%O H]91&K1]YAH;VY1Z
M(Z/E6AND1F$J5A*A6IB^(VEBN85$5*K)XF#](&0(+M,R8G&C86KD)C2Z!S=2
M5P'N)AD@X_=?5B+7)I(/ KLR+Y^GGZ;)>B6M5!)Y!*1A#/^732R=YWV8$U@'
M0JO'Y XR,0T"< 'TAXLD+L14_+F':<QK/T0(8]=X<4M*9\@P4(&!&E'LQC-)
M.5#Q>2A?!;8YR@Q1D->R#V1(2G*3M.F...0*/5+T-3$O(>A<)W=1$A3"L$$:
MFHJOA!F*O:K$>"QE&P O/H:JM!+6103[<[3[]F/B,)&T;?#><L."GK)ZL6"[
MTR&5D\'45NC'K< R5UC]#Z.)H^?S7II0!_T:Y;U RZ7JZJJ6VC.]+3]/"ZCH
MV2PMPQQQU YI<58=BUUQ$ 7:1JM$<(CXQR!L1]);E"G,GC+*,W8856PJK+S3
MG6C'O7CR8MN+O$$EO[6R<AL++96Z!A(80YX,N46!6ZFS\K](B!WI/BNE+2B5
M,W7H3A]?G%X,9#V5.3844GU#B$EY[-)U8T[=Q*%[W#4"(5-^DZBRY=IY!Q#X
M$.81LAC'+D4M?>RS2O+A)-4HJ:0Q:8(3I=Q. *1BA.<C.\D4]QF>=IYV'$'J
MK7Q@LN<[P\T37W<4$D*>3,[_%^B.W'J)L9(2I><7+P=*<^\J .FPE1:L6E,[
M--">4$:J.:C L$^":F=P/& YT3/=/2VXJ[LNS5Q5&W0X2HKY.392/\\@H'PM
M->(&U[T;XJFX5(<]%TDP[1CC D&'(EU8P6? _2RELFW^9-T6<M\J:[.3@QK&
M#B2*AXR2WR@:P:QAK,D[2OFNB< ^H=KX;A[2_ %UC$29;$(+0'F.P<.CW[=N
M0:/J.3K,MI1)WQXA:;Z-RY/CJ+(X@\RH4,<H).:65@VH0IO[_K211>&I@%E[
M5+0]*K4:'3!C8G>/VX&"#<;H$3CNE<?L'9UNA0BL_:4 O36E:[=YF.Z[]LQ&
M%]>*?)&NYT&D$[N]PPY?AU\ U^W%=VO>_GRXE;[0*)ZA'*[SZ<7YI.WO_B6Z
M.EV#UR[B4IT>2_R*(<\&6,\=3M7NA3<8?A<M_P502P,$%     @ &H(+55C]
M 6M?!   !0L  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULQ59M;^,V
M#/XKA'<86J!-'.>E+TL"M-T=[@8<4+2W[<.P#XI-U[J3)4^2DW:_?J24N&Z7
M]HI]V1?9DLB'#RF*XGQC[#=7(7JXKY5VBZ3ROCD?#EU>82W<P#2H::<TMA:>
MIO9NZ!J+H@A*M1IF:3H;UD+J9#D/:]=V.3>M5U+CM077UK6P#Y>HS&:1C)+=
MPHV\JSPO#)?S1MSA+?I?FVM+LV&'4L@:M9-&@\5RD5R,SB\G+!\$?I.X<;U_
M8$]6QGSCR:=BD:1,"!7FGA$$?=9XA4HQ$-'X:XN9="99L?^_0_\0?"=?5L+A
ME5&_R\)7B^0T@0)+T2I_8S8?<>O/E/%RHUP881-EQR<)Y*WSIMXJ$X-:ZO@5
M]]LX]!1.TQ<4LJU"%GA'0X'ES\*+Y=R:#5B6)C3^":X&;2(G-1_*K;>T*TG/
M+V_0>=OFOK52WX'0!;RO&V4>$.$6UVB%SG$^]&2)Y8?Y%O4RHF8OH(XR^&RT
MKQR\UP463P&&1+'CF>UX7F:O(O[2Z@&,TR/(TBQ[!6_<^3T.>.,W^7U5"7N'
M#OZX6-$R9<J?^WR.B)/]B'Q[SETC<EPD=#T<VC4FRQ]_&,W2GU[A.^GX3EY#
M_\_G]"KJ?L[C ;S%&GRI$$JCZ%JSD!<K11&,EUO^C71CGV/@#L-U&+EQWIW#
M@=24W$K1/76'X8AY&/&0=J:/+2KAL8A*\ [&4QJF8QIF,_@@<JFD?P"\ESZ8
M,[Y"NQ4F@=D(IC/X8KQ0;^/V#D;IB,?1A$?B] *3QDKV63W0G*J5\V!*\&CI
MNHI0>E:HL91!TJPE70CPIK/H8%,9J,0:20XU2+TVJM4^(NY@L#B"HFV4S.D?
M&O%@*?);^\S?HD<=C1G=.D*5.F^M)5M%])+RFL@%D0:M-(4;?"=H>_T2>4XE
MU0;W"Z2LR65P\@@44G7<47+.\ 8);:2O8"URH3V4T9Y$=\2Q*-%Q<1<JS+Y2
MH:;2INDMH*K?I\.)*>E$2HX6A<ZU36.LAX(*NO.2CI$!UZ@+8_M^LOPC-#M!
MM9IC$3?80([6T].U-=0#?'K& _A$<-+EE#PA/5F74_3H62Y%]S=HL1>^'111
M)S,@Z>2#BS$[**@[%K2&EO0<'M,S$(-Y[,2:D!W4%-_HZ::2><4'K-J"(E(^
M.<7(H&>RP)R>:\?L3&O!<'Y3[IBRY)B&ZQ]CP=QZ$0A93$M7QA;2P:HE"#JP
M9Z%(_X<(#/;5GL?2X^);SQ'IV552K+;)]Z_T?$L]>%ZENF+P>(O><_QCA;D4
M*A01X8&>+MP]72D7JU,:,A[.9G!1%"%7'4S.()O!R12NQ0.'QO4N@"B^4BL0
M5P]FDT,XR$YI.,L.7S(TXL+(>&=/38Q2F)Y]U\1DQB9X.'G91,;5=Q;*9"S!
M^YZY8:\UJ9$>66[ '!TK5;C8I72K78]W$5N;1_'8('ZF-UJ2%PI+4DT')],$
M;&RZXL2;)C0Z*^.I;0J_%?6I:%F ]DMC_&["!KK.=_D/4$L#!!0    ( !J"
M"U43GRW!-P@  ',7   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;,58
M:V_C-A;]*X1K% F@V'K8CITF 9))VYU%IPUFIELL%ON!EFB;.Y*H(:EXTE_?
M<TE)MA,[XV8^+&!8KWLO[^/<!WFY5OJ360EAV9<B+\U5;V5M=3$<FG0E"FX&
MJA(EOBR4+KC%HUX.3:4%SQQ3D0_C,)P,"R[+WO6E>W>OKR]5;7-9BGO-3%T4
M7#_>BERMKWI1KWWQ7BY7EEX,KR\KOA0?A/V]NM=X&G92,EF(TDA5,BT65[V;
MZ.)V1/2.X%]2K,W6/2-+YDI]HH>WV54O)(5$+E)+$C@N#^*-R',2!#4^-S)[
MW9+$N'W?2O_)V0Y;YMR(-RK_0V9V==6;]E@F%KS.[7NU_H=H[!F3O%3EQOVS
MM:<=)SV6UL:JHF&&!H4L_95_:?RPQ3 -#S#$#4/L]/8+.2WON.77EUJMF29J
M2*,;9ZKCAG*RI*!\L!I?)?CL]<]*96N9YXR7&?O-KH1F;TO+RZ6<YX+=&".L
MN1Q:K$3TP[21>NNEQ@>D1C%[ITJ[,NS',A/9KH A5.STC%L];^,7)?ZS+@<L
M"0,6AW'\@KRDLSMQ\I)C['YF,;N3)LV5J;5@_[F9&ZN!GO_N\X-?9;1_%<JH
M"U/Q5%SUD#)&Z ?1N_[^NV@2_O""#:/.AM%+TE\=NQ>E[M=Y-&#'K+8A^K@2
M;*%RY+PLE\QRHO&)+_\4AH&=I2LPXUZ6_I%K_4C$O%!U:9E:L&4K;?[(C%BB
M%EBW.G$HR_,+=H+; A1(<'/*[E<<B9J*VLJ4Y^PD.F7O1.;OXU/VD7C8+<]Y
MF0K&+0.H1 NJD/59'$S&Y[B.@_.0GJ=!@N>-X>GG6FJ1!:P43K^JUC#""%9I
M21*S_R%A24O#8O;]=],XBG_ '<H'BD.)=-9:E.DC YQ*DW-?EK:8R#;E/-LR
M1U/ZO5$ZDV;C#BW2G!LC%U)D\ 3CWODKD6=P.DHNA[=;$2?)='K:_!^P/7*6
MSV!WDH3L/)A-9Z^S.AIM-!]]B]TGD]&I_^OTD$7%I788Z*CB()P287,]8%[L
M0WN>X)H$T31V(9Z.QPXA-T^)21MR2N!@^013'0S3M"YJV(((+/>HB.)AV)H;
MUI_&LQ:B P?#KRS8(O;OKY0,QFSN5W(R^]%@U+X( !I3"=<#\\<!NZLUY=H"
M=0YKD1J[J_]>2LO$ETIHB=!A:9X]"(V@+V0)'TM.*#1H?097KQR *,N%#R_Z
MN],Q;:)+HEL)_KW+[US-R=*ZJO)'J@?(YA29#)S(%A>H(,#%@\KK K5BH57!
M[N]_) ,$K4B"M32?/'$-5;4E9BEV% -9M[(GY26T33''T/NRDW.VT()>6 'S
M+-,0P&HCLI8&>9BZ\D1? K86S T8?I7Y8X54='2?:YY+R\G=+CV-Z:H7?$K#
M%)% SX9F7V0M-'!!0DH_B\U3C ]0<E$C=H2V GRD-D;L*;5[8I\*/%/QIE(.
MG=@#SVL1--+H"\1Q5 %Q9OF7;<412;T4)+:?A$F+?F=\@V72[B"C<9SQ(.K0
MC(*GEB4Z1\:R/<#--EC8(^PY,Q':E=294\G@.R[PG$;4W>);TA$]3'DFU7(.
M 8M:NSHUIVFV<?ESPRD;,PT;2^I<>Y"V@R*JH]07D0*-(<=C<\!^JS7TPRL,
MA[ZR-M&DV!<._YO@[8TT3*"Y%B68PIFJ8OY$$G11A3CS1+RJM.+IJDMKJ/Y)
MV"=?!U3\R<>F V$#>R)Z EV71B[)^!//0($H),ZT31[.&E-SML2X9%<=8=S2
M#=SPL9D=FJ:PQ_2 \07$=0AIL;&):. K:S28;2KKL\2[^_NH<B9O/.)B*HM7
M58%W'.V8)=%6,[D3J2CF,*QYB__U2H)JNQ!\)?VB0;+;3$;GHS:36W&HS.)
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M8/7ZXZA7Q\-F863IFOR%-/AD<-,5OM&XL@0X3Z4TFX6]H/WJF_\'4$L#!!0
M   ( !J""U57$SOK/0H  !<>   9    >&PO=V]R:W-H965T<R]S:&5E=#$S
M+GAM;-596W/;N!7^*QBM-TUF9%FD*,F.+S-.4C?;2;J9..T^=/H D:"$FB04
M +2L_OI^YX#4S;+J>+8/^V"9)'#NWSDXA[Q8&'OG9DIY\5 6E;OLS+R?OSTY
M<>E,E=+US%Q56,F-+:7'K9V>N+E5,F.BLCB)^_W122EUU;FZX&=?[-6%J7VA
M*_7%"E>7I;3+=ZHPB\M.U&D??-73F:<')U<7<SE5M\K_??[%XNYDQ273I:J<
M-I6P*K_L7$=OWR6TGS?\0ZN%V[@69,G$F#NZ^26[[/1)(56HU!,'B7_WZKTJ
M"F($-;XW/#LKD42X>=UROV';8<M$.O7>%+_IS,\N.Z<=D:E<UH7_:A8?56//
MD/BEIG#\*Q9A[S#IB+1VWI0-,30H=17^RX?&#QL$I_TG".*&(&:]@R#6\H/T
M\NK"FH6PM!O<Z()-96HHIRL*RJVW6-6@\U>?3#4]_J9L*7Z=%'HJR55.R"H3
MO_J9LN)V9JP/&]X9"^:ZFKJ+$P_1Q. D;<2\"V+B)\1$L?AL*C]SXL]5IK)M
M!B=@NU(\;A5_%Q_D^->ZZHE!OROB?AP?X#=8.6+ _ 9/\/N@)EY\T"XMC*NM
M$O^\GCAO 9I_[;,V\$KV\Z)$>NOF,E67'62*4_9>=:Y>_12-^N<'-$U6FB:'
MN/]^(3LL9M03+Y(DOLV4R$U1\*WP<E*H)N?U?Y03!3'U1&-VF!IFZI@I;YBL
MF4HO$'&%B+\5KW6%5"@*(GPC7D=O& /T$XFX-XI&/XN_&0]16:W"TI%X]=-I
M',7GN!J.8W%3&,B%=E^E5[N;VZWQ:20&O7B'V4 ,AR,Q'"58ZX_/=E83,1Z?
MB?$9K0X?K27]L4BB/M;&NXM#,8Q.Q3 FPB3:61R+J!N=#? ;1R.1]'8,3 9B
M -,'282U'<8)&"8Q_R6]'6V3H4B(AND&H].=U3&L[//?N-?_62!!5.61&BNU
M1B*"OO07X+ )DG$B1F/QS7A9B&%W$ W%J!L/1N*3<NXM"INU8";F"#759I._
M$!;#T[XX'4<!J;O475% VB-A1R+IC@=#@D)W,!HR@#Y+6*:]AG$2R<]96WD%
MX3@X1"H+5672BJ62? AHU]LD@?KJ03M&U,OLP.DJ<A0?>(LQYF?6U--9"#X1
M$ZV2.>A80>F:%(,SC\@)33YTQ5'4B\5D=3<<Q)MK@VC_3I:!!^/VP6;R<VF\
M+@I20E0,$:L:%XFZ<@H>)E=MV N/O)<VTQ4,^JADX6==\4N5]EB.E=6=4-]K
M611+@5RV='(2R5PN2^*YT'XFL$K/3&W7SB7JO"80;LBEA[BKX4X22%'3.&0F
MN*@0_QX7I%T(/\, 6*RF6E:I$N^-!7IX2;R68C&#[Y?'9E&!"H*=SC0ZFC==
MK.AT]H3I,P1M6DM8[Y7*>D@VU#/(@5>=VD:+I8HY^3<Z%^$- .AT=4?VYW65
MM7#8U&^7&$&"A9E" T?5=VXU\ 5.9<#LL@>- "7EO- .;M>9F-?6U5"-MA%W
M0JAKU-ODS^YT+0Y(F,ISQ;T5HKD5A893H25 M<H4"NC*9WC61;32HL[XL+ R
M4P0#4IMW'\7C7K2-TGBPANG&N1 Z =Y")T$7#G#S5K&>^ ##R8.K)(L1+=5X
MB5!$<*N]\V! &X_HG&ARA1Q8I7H.0EF:NF*P[C]IH(]DIN7<-Y2(#X.=_!'U
M </&J8^8DNHR36T-=28U(9,CHYM0=<6\J!V3EO).'1,*N525NBZ%G,\+G7*X
M&[]SA"C2(C55U73!G%I^IMV&DHTC4D2.'($ZL*HG*&>HH/B/PH?PJ@=*PUJ[
M&><I#*$\ZXG?4)$*9RBK2&.2GM=PZ-K$QN:C^'3MU8.GL&1+EV*B4EDJ>AX2
M.2BRX6&N*&I5.N J3A-8$LK(O=0%NR65;K8'!]%A'.QT  PV5I!*-K!XNC(G
M@'.TMD].IU9-R;9GX6?-^@\"(BH#:RW=8Q@-7@BC-L:H22FJ)K@=)6M(-I8?
M1@_'8I=D;\H^95RC!6FVH<H>*W_0R$< [&\#\&C8[S\30N@$XZU^[X-*53E!
MCT!L_S P.E2*QK\?A.)D_"Q 4&<4[>Y\/ C0OOB'4$F,^\ECSH_[?>P<[>[;
MT_93?_=XVZ,NOQO28;!G[YZN_Z7Y,*TPWG',SOYOIT<R7#L\[B7;JD=G3QX:
M&U6J/2]:_<.)P8*IHN\Y,_Y7\PZ'Y>0$.G3LE-HU<*ZFW-O!C]Z:HDN:92K7
M%3>GZY0(H='Y5FN=*O0L@IH7G6M%_;+G(6%"K]! ?H\$9 ].N5V:P+,272?$
MW=*IA>93O)+E_%Q\,<;^R1$4F?Y6V7M4  C];$RVY#EW?.X0;^)H['H':W6C
M/;@VQ*3H4B#+86,;CL8"];!JW_ P6_7877B/7MQ]KS4\S(YM6K*MJB!"&SVA
MYA'R@HBNH%@HYF#07^*!-QMAVR!'E8OZT=.5C M56\K"K+!5RGK-]'J#KA64
M,./:6HH?N9B<(V26:4X%J+ "!)EU3W.A;Z:[N0IQ"EMRA*K;H@8M;QK:V4*#
M#-R63=.K*%_B7G_5SZ:F+)5--?2?2["$/09A!MYD>A?<M$-AU;TI[EDP8*Z]
MR&5*[?9RG5@S><^"HAU!VE.;'@ 7.FXGZ7?- =;?JKEO#Y7HK$GW2BUH8$(K
M_QP^*R/:L79G0!(W-3=;7?'ITWOQFH 9]\_??[SAJ^C\S8IPK4S;\/<$]HD%
M\LO8J0PUB!*9L.#X4*HQNSG.QDF])#]M*DJA<PHNP7-2XEYG:HT-%Y+5<*.S
M)F+X:IL=SZ4EZQI06I2":YC#FB+S(5YG/ DQ^/=/A9K>3--YQX,<;_S+]?67
M+IN%-AW#'\JBI=,$XQZH@3AR:6Y->6#&YN6M46L)G9$K9*S;M0:R>JW 3#D]
MK<+X-B'8<"$B/ 9'=@'%ZL[6<Y\NCW'@(PE;G1;L*>F<\F$T7!=2"@6. /!T
MR!*7+SE :2%UF#(U* )^C0V-PF>Y7(]IJ.;<TI-%!W!&@4&AQZAN-;]; ,NV
M6I3R09=H3I!4#6 SA;!_KU65+KG&&I0"YK^34.3/9\!<<_$.U:YV8=P&D*3F
M5TB;<*B41S#O43!P2K!D<D$% F-)610]>D5X[,UQ!$BQ@[:F7/8)'UR:,QGM
MUAH^/-WEH9HA;*FY5[A&G;M^>E8&NYG,2(50-=W6#,0G6].I/5%LSE&X%V12
MMPUZB @E)G;6::A=FUP+!7]:-JYA1O/^NO,"6"<HH$_H_.1$3W9(D4D"0!OS
MMF5^9%-;P;9*[M/Q;NI8>#.Q^_H,49--3(/T/5*9;M4?<84^X'?Y./(;L?B1
MRON"\/ %GNT/T^#Y<3ILX[8]>X^^?6Y8LZ?^[FB<;(_AHW6K/Y%%>$>6-\?Q
MULNRY[T^ZG+^:L=OA/,FN:@@<P?)9\C>SG#?UYZ3C8]UL'?*GR11_,@UX;O=
MZNGJJ^=U^-BWWAX^F7Z6=JIA1:%RD/91,CKA96I[X\V</_TA/MZ4?#E3Z!DM
M;<!Z;E"]FQL2L/H6?/5?4$L#!!0    ( !J""U6BSW1I A\  ))>   9
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M#WFR\Z>>&2E'58\O@?@VB]((FYZH'6"FLNS$OTB2G14:K36_"(EU"21?O,B
M-'*?<CC XP?,"33;OO*@E/%$E??JQ_M86]Q'_[%N+W<IZ+XZ]8<!!W@H,Z0V
MOF1X&3A?0VF$Q7\V?M/W/LOHDJD$OC/. A0%]-DE'HDNNG25#X5#^10ATKZ!
MQ5;= /])810VA*HU+I0\/3G-%J%>00)3<^%+S=",3UO-/F. A:_#R"[-GX>V
M!,HC$"XV?ESCT?D+NV670$-D?"TVBP6 9@R'.AFB\WJ@DWL]TRQ@'B06WL,R
M! M5Y<2.WQZ4E<R>K$ZRF3QB--"4'.C"M%)*(2QFK5'^_MQACV<QLIZ2'E2,
M[O.@WQ_L J?UJZ7G3E^?4C/(Y!UV %%K$Y244_W9UVH//"RDF9NF(*()H+>=
M/WNY'XE)]A>K )KU#I^5\M%6BO&"Z&XU;?]-]F!^[-,B'.)E]N#LF)E($8L(
M$0%&Q%/$NAAF:.K:D@.V-6E>?$21([X5HX(' CF8X_%Q5O1$\@&'$G6P%,W)
M[">L5T;T25F^<7[,^,?*0"(,XP X%%]>R@@/GAR#!K?%_@FNY(L))3!OX9,J
M02.59KN3B?> HVV"7$@/$%=?-H7&A=@VKV>C7/>."Y-Y;+T"QL<(DB9]J*FO
M:S!:T]+44?'J>84A0>BZ88*'DP+VF5@P'L+\6'50P2YV9ES"&"JD@[E+#,)>
MZ0[Z,AJ&073>#-O,C/I">$Y$2GD>DCQVLVB*VV Q5(YC27ROIU+7OH>:2,Q!
M2D<*2RI!]J94\Z&V>J@Z[:D93WW;%(0^/CW=I]=):MG/QUS<']9;XM0XQ+?5
M-L?'AWPLY(W4;J1)\B3[ +&*]8D!)A1)07J_,QE)&GV59:Y58@QI^0$/.<8^
MC.A4TF4;_!R>Q_CT8P5]*<S0-S+3"(#L_V7= &.\@<>K"U]D.KC/4^0S2^=S
M=B)_93O=]'2G_5A&G@DD[T%L2:9)GKA[!2E#8M]2[V)'7+0SH3,M,!6RXE.!
M='KQ55]@V(\07VF'P-TM&]K'L#&%E5S3LFQ=%SK @B._&^EHBIO.1D;96<+P
M=I20^[@T2)";I8'('6-?(J9H/MJP1\D0VF3"]JY9:)KX')8(QOGJ?/XL)M#4
M%M6^[2^QW+$C(HD3)WSUN;X)8]DO\OC9>9SA/D:_E\AI^(V-'=BNW\MV!;]I
M)K8*\Y$94.V+#;M"#=C DJU/#[#9XE[Q]HD"T?:X?:'A5+,@ Q\D3J49A/;4
M4#Q-'2PLT1JF"AD(&G()@L;$2UHA9[=F$HM?F@7W_I)(4NO!EQZ;_D/KY!V=
ME#>;.]Z0A7=-RY9)!#_=)S.D1IEB9,8Z<&3L6R&!WN)-A]AYMJ7E"?U72;>L
MBJ6FE,?11BBY+G=0.#]KT8RR>WC'1^& &<4 XDW28/0V PA<24G^#A':&S',
MSP:!%1>#-=J*M9:'HE *6^C_4S(8121M'$&3#];#$CI2,^VK_:&Y^+-9/P33
MH7/L_<?*K)N-F>9,[MR6 3-(T_1>5']H&Z89JO%V3)C\XDGD<8C!QU,?]%R!
M\1I\E:($#OP9<<'_JMUETB$PX WF7O*P#9%+]YFF7\=(;+3UBNUVJ;@7N?UO
MA&@:4+9^O^\6J'?FRU0YKN$/X];>#%WXO)R>0J"[4:8I:-Y)4-X9EL^?GNX7
M *PDF?)^<4C%>Z]H_VOE):'MGOS(MNH'AQY3FE_#2WB()LUP=PN61&38[G);
M6=\Q(1$A6_GTO,/.2OX_Q6Q7,7SPD>[H2&O8^E65_[3%;-!$OI2\$/K@IXUR
M!QG/]\^?D];S%X,7\-A81^L(LQ>?-9QHSY7==J'E_&RN"?*0V1:9V5$JXHF[
M%6L*Z/:@KZ;6;O$1'ND:[1PGBC"4P,G8^R&1>A53WYD>3J,=HX=2]&1C)/K0
MX(>3-'6"J]2[).!7M8Q S:MP(><P=M)!=?13"72Z-T-]*/UZXW6IT\2=KZ"X
MW1+*^8$"RJ%26%KKW$M1$DS=Q%!7=,8GWJ5/0WI])(,Q!,'$C:/P7 \ A6C\
M;B<SQ <!*L7^>3T6(G4P\RD+_0C$[?,3A :+>&0&L<*3DZ>/XS?CK@;_XJ.T
MNX$%TB[4 K3M?E]'O7;AGYW.0CI-ZDG[B/[JZ<GCIP-)TG0$+G33X"8F=K]Z
M\OALB&Y"N5?1LFY3&*2:'+\;("DU;/(J1:9511&C!,Z-]CX=S"]_5'5<F$IR
M8Z);;NA VM.<\N]H0^K&'?C_ENXCC9>"'@]R$MIH[NM'(E5?W'7$+UOUC#Z7
MP%%TP%F<9:(U23*';4^]<]IA*4%3*5W)PQF9-H-L%U+\\5VM-R4[B&% @U61
MJ%-:UIKA& 0FY)D^SI<TH<6FX339I=T\OGJ<QMY_A",XVLT'NPWW4-V&IA[=
M5C9RFM"*6(1*7%H2Y<ZR0W#(&B4I&_*+Z5?)_X5&IM!RQRPOYRP:R?V^HE7O
M0IC_$RQL"9F>-,7\,=@;=FT5,49>M23DS[Z]3?I\I5N^V.<)Q[W!<-T^4\YD
M]9 FDOI;0*E?N^P]ZYHVEN)?&]<=.N$5M?Y'Z0Z_&LX^#@7^O0M^</3J_4\\
M?QB6*IFBN-X<IK^ZIP];K0:&P;@D6#=[P2K&M8WXPMDI%WS;?:@=*+FB1'OK
M%[.]O\$JY;%[PQ\ L[YM9]HAE +%G1)%/ :;9KF3Y,F8^/AT7P=M\:9-@]2A
M!]#4265_.L@'W_WZ(38S'(8B18-EBGIJT3%"BMMI*_5L? :5:;B8<=+-6OL0
M5Y)'U5*@+ _,S>#@W;:D3W6WD+;-[DMR!D%J(85T2X4V.QN:"XD6"NW)I#I+
MR4?J1-((0949UAWJV&F5=X)ASM/\^QX\= (U4>[.LOF3N6R*;P'6&(H=@*')
MG<P59Z7]_OYF".FLCVHXZBU1I%7""1N?DF=^-WW#MU6E[2@7/K,V9,ST5!=9
M <20C*Z-;NQ'[/3H!%MO\/'OMFE7FG.+62PI5XE$LV'-R-E'4$4A7F.QE1 /
M\RR-Z(5:V;:4.LCE^]_?O'HX?Q%@6!V.?.I@4EE@1S*E2]OE;1<E_+I<-=@:
M1ULM8%,*@&P]!.!5U%E5@XA[@Y_FW3G)9V !WS,=O(IV=]0CB!#T*OJ%>$AE
MD+MPBD(]2CA<.?,G+=3&,2314$#[,5GXUO3Z<)2''E;B#M>W@G>2'BK/FGA8
MCX#,!SN[AR_4B-RPV.OT:/:DD]%<&\A7<%-+?4ZF%##*6F'P 5$5"FEV7!!
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M-9,$A*.LWCZ>,@71RD)C=F-\H"XZZ</W?/AK/';*H!1E5C68]>XZ[8OV+D=
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M[\H\!\P7XKV,<:J$*!L18?,9DSD9S\5#$162!9=D2RP)YV(>BF \JEDR'XH
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M/[RF2$'*"U?UCR@IC>1N2<147!ABL65$-(S%KP\6$A;=DZJGD<T@;"<$&+H
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MD"JWXNJ;@VT==VJTK'.$VV2/QVR "NLZV^+ F,IU5BCV2[!)ECJD4(>2FH/
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M\\<.!91C!:>-QJ/+I4#(53#3@1V&;>P ?&RYCOM3+^_&#:T,7'HE%,0%^MJ
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MRQE>A)L]&T_9PF/2LQ"A/NKBP]^BH':1?1(9Z'HAJ-.=N1GK-Q.E$H-=>I<
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MVQ,DKO:_42P*4Z"G,%GLO^WD])!GOCQ5"O+&('P!3>56Y4G9][$S$!N"X]&
M(E@B;;HS3S_-.&_]JF5 _E2TI47D%[6FF;[WY=D@"71]=N09-Y[6TJ70,;W9
M.\":/1FS*9L_&?9<<YU/)@Q2^17\,QVRKA_,708_?-P(O:*?=QJG+?<;R/+3
M\A>DU^Z'D]5R]_-3Z/17"/$3L81'AQ>/9R>@8/I)IWMC548_HP3(8-6&7JX%
M9#F-"^#[I0(7]V]P@_)WM2__!U!+ P04    "  :@@M5TI-+9TP&  "&$
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;+56VV[;.!#]E8&Z*!+
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MKO)"/ WADHS^Z,A#XQT_ZW.B,EGJ?RC./,X(L/1:R#5J-A0A9%/^3$S8SU8
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MG*4Z-MPDF'[7O&QC>^((I:3KDA]H4EG$/_5_HA82,9CV,4Y^3-S0,)@[3!^
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MNZ>0)XV\E#.$R*D;F/LDHG\*#,1Y[^-T!L?X*!#QLFI\W^))JPB&KIDAL/!
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M;!C%YPRH#S;B&-EPU-U\U_;$.%1UA1';CX[% 9WR$D_]"5ECDP.PBL>"G<Z
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MG1*HH_/;40P+35+RC *65;8;+:2N.3P#7Y.4QY@-<'5,<D"M-S[I[DIT8XT
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M8(CO+G1)L??[ 0LL'#(MKZFII@&MVEI6,X07)8!*6V][2:'YMLB7'RGY##\
M#F[SMC E6V)N,NVPOP<  3D1T\E,M0+^9C=5JGI-/-93;D1(]A_/:0C)%2GU
MB1Z&H0L*] PI$#$:(!;O5%^W;EMV2(G!\8QQ?]/%GSQB2!>R8VF/=;/]49>3
M\*^WWNS6)D\0QV-G,&[M[X&BJ:1(&LO<<:IFL 80>Z9Q;HB5F):K^$@'1(*R
MT?95#4UI5M)>&(]@2"?UL4)S]%Z"F 0:9Z*G=VCCL+S]-4D;QM1R (5W#W-4
ML:LRUH.0EYPIQ#\VY"\V\8MTK9";G(P>&;/DP1UT)(EY*WQTXA8(C1>CC1S!
M[B[?#I+\*86$%-HM:KS!/ZQ#6>W9RMEFE=D.D7 H' HH;" >%4 * W-;8J/;
MFI7ABI2/2KR!5'G?60L[XBUD2JR1*#3?S#2W$]2@>]XQR%I12L'VH MQC"A)
MQ:.A)>Q#B54K#IT*N(R,Q%UD704<,31+LV,GF7L'J;!)U_JI^U=BX\'Y=.M
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M964/H'=PK< !2 Y74]&<=A&QM]A8:]X'*%P).@ 8+@7$DLRF/A[^P$YLZB]
M1Y8R!T0N#:_:M$TQZ'*%$!FR$R&+006H<D,H0J=YT9XIP1K%&%6\ 5L0U!C)
MQ!D<W#L2<:)Z%N5K42, NC4GO,O15%2MDB]"\NU(VW-[4YQDIX1#'IVOCYD2
MY*!1CXVH\W2K-B:UP5M)E&HO(U<[\.]A?+=#%@G+1FM:.W,6I;K^_ 9PQ3>I
MR<FX12UJ05E4<DB24O.$NT@)P!Z'HJ%U/,[(X<O:5N86"[ST&XAM@WKL (JQ
MFL.QE.19P !E9EK,&_*6'I!P:',^59$]B( P0''M "8#-/:VY^H^W*EN#PZ/
M@:J.YC5J/2I6U.%]EP6Y!.5Z*&?.OFFG8-394%*NRC1+7.OT"$(.)6_-]\$T
ML9DT:4L,A?%WO/P?[$)O>UX1OD>UIQ<D6[[+N_R;K\ 26KLK,'[H7JT:=!]T
M"8=O,8<?&_9\<3D_>@%OQL>_^6J7K]U/5!R!37)7\.KIR>N71TR$^J%K=C@D
M\A@PN^A/S*!S+3X OV.6AG[ ";#;%8'WS7\#4$L#!!0    ( !J""U7K]B.;
MP@,  )D(   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;'U6;8_B-A#^
M*Z/TKMJ5T.8% H@"TD+OI5571<OV^J'J!Y-,B'N.G;,=V+U?W[$#;/8$?,#Q
MR\PSS[S8PW2O]%=3(EIXKH0TLZ"TMIZ$H<E*K)BY4S5*.BF4KIBEI=Z&IM;(
M<J]4B3")HF%8,2Z#^=3OK?1\JAHKN,25!M-4%=,O"Q1J/POBX+CQR+>E=1OA
M?%JS+:[1_E6O-*W"$TK.*Y2&*PD:BUEP'T\6J9/W E\X[DUG#LZ3C5)?W>*W
M?!9$CA *S*Q#8/39X1*%<$!$X]L!,SB9=(K=^1']H_>=?-DP@TLE_N:Y+6?!
M.( <"]8(^ZCVG_'@CR>8*6'\"/M6=D3"66.LJ@[*Q*#BLOVRYT,<.@KCZ()"
M<E!(/._6D&?Y*[-L/M5J#]I)$YJ;>%>]-I'CTB5E;36=<M*S\P4SW( J8*71
MH+2LC97,8=VFR9VM^5;R@F=,6KC/,M5(R^465DKPC*.!FR>V$6ANIZ$E2@XX
MS [F%ZWYY(+Y.($')6UIX(/,,7\+$)(O)X>2HT.+Y"KB[XV\@W[4@R1*DBMX
M_5. ^AZO?P'OG+__W&^,U510_Y[SN,4;G,=SEVQB:I;A+*A=R/4.@_G//\7#
MZ)<K; <GMH-KZ/,U7=J\$>BR]H@[E WZ9'[2RAAXTBQ'VL^0[WS&8(4Z<UG?
M(FQ>X(']IS0L?=6A-N><NV[^J40HE*";[N)EG8W#=>??R5K)"5E3'0FH6\..
MI^[PW'J>UO/4'9Z%5A4LOZSA,S)A2R_[9VV;ZO%Y<G2BZW-GZY+KS +5"E*M
M^%)Q0^R&[K)C,4GA/23#TS X#@<:$+OMV$G%;MO]^O#^2D[34T[3JT%=JJI6
MDKPYW%-ZD+5]\2'X\*WA-3V1]ERJKJ*>K\-S^:O;AX&R0H?9&RYUEPL>N?1
M4C-Y#>\$;KBDMTL(>EK,;2>\?Y!>#S8-%[FSYU!X1: [K+R)=Q#W1A1D_XU'
M5)]926[H'PQ"THLIYDDOBL>P9#6W3%"]Y6!48?=,(Y0H<G), Y<6M:3Z:PP2
M:#I,:(Q&*7QLM.2VT6T9%OS9S0W$E/:X/X0E,;>Z:3L)>4,DMW1NH)^.83A(
MX$E95]47 D+!R)2QD/;&XSZ-Z7CL'M*F:@2S1#1'BG+&7Q]?5BEM^?=VXZ;?
M2Y/DUGV39'S[M@1^"/L["D-_&!^^$9RKO[#3+NB>;WU3-.#?N;9SG'9/??>^
M;3>OXFW3?F!ZRZ4!@06I1G<C*CK=-L)V857MF\]&67I4_+2D_PZHG0"=%TK9
MX\(9./T;F?\/4$L#!!0    ( !J""U5[AG72- ,  %$(   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;)U6VV[;1A#]E0%K!#;0F!=)M.5* B371EHT
M@&$[R4/0AQ4Y$K=9<M7=I67WZSNSI"C%D!4A+R/N9<Z<V;EIM-;FFRT0'3R7
MJK+CH'!N=16&-BNP%/9<K["BDX4VI7"T-,O0K@R*W"N5*DRB* U+(:M@,O)[
M=V8RTK53LL([ [8N2V%>9JCT>AS$P6;C7BX+QQOA9+022WQ ]VEU9V@5=BBY
M++&R4E=@<#$.IO'5;,#W_87/$M=VYQO8D[G6WWCQ1SX.(B:$"C/'"()^GO :
ME6(@HO%OBQET)EEQ]WN#?NM])U_FPN*U5E]D[HIQ<!E C@M1*W>OUQ^P]<<3
MS+2R7L*ZO1L%D-76Z;)5)@:EK)I?\=R^PS$*2:N0>-Z-(<_R=^'$9&3T&@S?
M)C3^\*YZ;2(G*P[*@S-T*DG/3>[1.E-GKC:R6H*H<K@I5TJ_(,(#/J$1589P
M^BCF"NW9*'1DDA7#K(6?-?#)&_!Q A]UY0H+-U6.^?< (7'M""<;PK/D(.*?
M=74.O>A72*(D.8#7ZQZ@Y_%Z1SW =2',$BU\G<YIFU+F[WT^-XC]_8A<1E=V
M)3(<!U0G%LT3!I-WO\1I]-L!OOV.;_\0^N2AJ1[0"S@F=OOH'S2PG_YC@;#0
MBDJ833F?#FTAR_^0JO,U$]PPL5T69=HZ>P6GLJ)$5HIJTI[Y*+*(642= ^\-
M*N$P;Y3@!'H#$H,>B32%6Y%))=T+X+-TWIQV!9KV,EU(8QBD\*B=4,=Q.X$X
MBEG&?9;$Z4"H!EVH!H=#11TTKQ5RK*;<?9CR?>N8T_"7%'/V0]);3JW5F?0G
M:^F*GX[M049'QW8;6MOT369NMLS5#G/QBODQ[_TZ"[JP;T-[PZ%M(C@3R@=)
M.*#JQTWU1YP,ER02%L,4IGDNN=5;Z \A2>%B '?BA28()<4V243^#[759O<T
M[9_!:7))8IB<O64HYL1CO.'W)N((!L,?FNBG;(+%Q=LF$L[NU*=AD^+[TB_<
M:?,E4I_B868IZ^O*-1V_V^WFY;09$]OKS;#]2&U.DA<*%Z0:G5]0WIAF@#4+
MIU=^:,RUHQ'D/PN:^6CX ITOM':;!1OH_D5,_@=02P,$%     @ &H(+51ZA
MDRKL!   -A$  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL[5AM;]LV
M$/XK!S<H$D"-)<J2Y30QX*3KR[!V09.M&(9]8*2SQ54259**F_[Z'2E9=CK;
M\+JO 0R1E.\>WMMS$G6^E.JSSA$-?"V+2E\,<F/JL^%0ISF67)_*&BOZ9RY5
MR0TMU6*H:X4\<TIE,62^'P]++JK!]-S=NU;3<]F80E1XK4 W9<G5PR46<GDQ
M" :K&Q_%(C?VQG!Z7O,%WJ#YK;Y6M!KV*)DHL=)"5J!P?C&8!6>7L95W K\+
M7.J-.5A/[J3\;!?OLHN!;PW" E-C$3@-]WB%16&!R(PO'>:@W](J;LY7Z*^=
M[^3+'==X)8M/(C/YQ2 90(9SWA3FHUR^Q<Z?R.*ELM#N"LM6-@H'D#;:R+)3
M)@M*4;4C_]K%84,A\7<HL$Z!.;O;C9R5K[CATW,EEZ"L-*'9B7/5:9-QHK))
MN3&*_A6D9Z9OI,R6HBB 5QG\:G)4\*XRO%J(NP)AIC4:#<>WG%;ZY'QH:$NK
M.$P[^,L6GNV #QB\EY7)-?Q499@]!AB2K;W!;&7P)=N+^'-3G4+H>\!\QO;@
MA7T 0H<7'A* ?[O^2NBTD+I1"'_.[K115$9_;8M#N\MH^RZ66F>ZYBE>#(@[
M&M4]#J;/GP6Q_W*/#Z/>A]$^].D-435KR&@YA]Z?NP?XB+54QN8.;G!!5#+;
M+-^/?9LCS&5!Y!75 EJPEL'B&VJ@BH$TIZ#17%3MDBOU8(5Y*9O*6*,6&T;I
MUA(7;ZLA#2_.X)BF)4D04_4)7.><&)=B8T3*"S@.3N ]9NV<G<"MU8%+7O J
M1> &J"AP510^' 'SXFA,8^2-?;M.O)#6ZU2G7QJA,/.@0F=?W2AR0B/42EC$
M[&]BGK52 X/GSQ(6L)<THSY +*^(ETIAE3X E4.E"][VEPTEZYMT9%HI!XG]
M74F5";T.A\*TX%J+N<",(@&\+;H<BXR"3KV34[17$,=ADIQTUQV^!\[S"?D=
MACZ,O4DR^3&O@]':\M'_\?LX'IVTE]X.4=9<*%<#O13S_,0*=N,.]UB;VG%(
M8^@%"7,I3J+(5<CL>V%KC0V*Y\KRNYKJRS!-F[(A7R@#BRTF$ODU++F&HX1-
M5B5ZNH>T44_:Z&#2OA:5,/CB%WI ;6E"VTB[%WM[N]G"9+VF<I<WL=Z\*T:B
MK"O2C62<M?%]S-DWRD9JMA'.#U1FG]QC$;,7,+M'18]Y:DKV7<&:,"NI.XEO
M;1E=HQ(R@^,_D"M">T>/BWD;E4+,<<,N?0:WBF>$0N\M+L<U[6:K[PB"@"ZK
MHG++#\-9UR[$;D0KV)=[J_-J]^Y7[JE,L5+84D#GHM94D&S,J#R#.(+ "_PQ
M!/Z&I9XE3890\1(?FQU%#,+8AV#"(*&-[^E-J;;] -.\DH5</&SP*O#\,(%H
M/()1/())Y]MNST9>$A.\YT\FI#N.PUYG5[Z/K$Y',:MU9/5H/QL5UV(.2?L/
MIH\]3A\[)'7K!DW3'TF;;96!:Y6!%XZ" W,60,@28"P\)&,11'X,$3LD7Y,@
MIBI*")B:X20\(%L3,N2HT[%CX$>PIT'%?8.*#VY0&_G\#TUJ+_Y3DWIJ4D]-
MZJE)?=>DAAMG60K$PIW8-:3V*-$>:_N[_4>!67L67HNW7Q3><[40E88"YZ3J
MGX[II4FUI_1V863M3L9WTE#4W31'BJ6R O3_7$JS6M@-^D\ETW\ 4$L#!!0
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MP,0MG5 <44SH(% ;<(W)4&L=(OH19&];Q \J'8<SFL0TQN*W7$,'1&MM7-8
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MW:$^L>T?]MQ\ 1/)T-IQX7RX[W7ZR :+0I7(W:7"4 P/E4RO=*5UJOJNI+"
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MXJ&YG1,,.5EW@/8IYVKUH"?(_HE@]!]02P,$%     @ &H(+5?N1249, P
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M#F=$MM\UV@<M:OLM82$T2E5[N^8LY](,P/]+(73_8!88OBY=_0502P,$%
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M^ Q-5]"8@78*ASPGEJ<I6:DC6VXS>&9PX0:I*CS6Y,ZZAE7.=>WL *(Q#</
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MD#&@W^="Z.V-"5#_.3+Y"U!+ P04    "  :@@M5<%HR7+4$   <'0  &0
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M03$L29:H>[[[!.6 ^H8OXHG,CVA7QGH.BC*I>%J"=0]2RHHS>2R%. #@P3,
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M"=#OEUPOCO+&-%!MB,[^!U!+ P04    "  :@@M5_:T-9,@#   5$P  &0
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ME=(B*YQ-!AGE^3]Y+(2H.(3=9QRBPB$Z=&@_X] J'%J.:)Z9HW5+-!D/I=B
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M-BFJUESN=2$X#_HOM+ VN>O$< 0SU!W4Z@ZLZDX+3%*]*NHLN\N4BFND\TR
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M5 /CU;)\M2-97JX*/S,I65INK@F."2\,U/DE8_)MIVB@^3AB^A]02P,$%
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M;*(P!GI]SKG:#(R#NGT=_@)02P,$%     @ &H(+54:3AR>7 @  X 8  !D
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M*(R#7L\Y5X>)"3 \:O$_4$L#!!0    ( !J""U78[G;XW@(  !,(   9
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;*U6;6_:,!#^*U963:W4-2&\M.L@
M$C2KMDF=$*C;AVD?3'($JXZ=V0YT_WYG)V3  JJF?B%^N>?QW>/S'<.-5$]Z
M!6#(<\Z%'GDK8XI;W]?)"G*JKV0! G>64N74X%1EOBX4T-2!<NZ'03#P<\J$
M%PW=VE1%0UD:S@1,%=%EGE/U>P)<;D9>Q]LNS%BV,G;!CX8%S6 .YK&8*ISY
M#4O*<A":24$4+$?>N',;]ZV],_C&8*-WQL1&LI#RR4X^IR,OL X!A\18!HJ?
M-=P!YY8(W?A5<WK-D1:X.]ZRW[O8,98%U7 G^7>6FM7(N_%("DM:<C.3FT]0
MQ^,<3"37[I=L:MO (TFIC<QK,'J0,U%]Z7.MPPZ@,S@""&M > CH'0%T:T#W
MI8!>#>@Y9:I0G XQ-30:*KDAREHCFQTX,1T:PV?"7OO<*-QEB#/1A&JFB5R2
MJ0(-PM#J-D1*YE4BV+TYRP1;LH0*0\9)(DMAF,C(5'*6,-#D_"M5BMH+O"1S
MRG%E!J940CNB,<?<HB(!?4'.8S"4<1R](X_SF)R?79 SP@1Y8)SCR7KH&XS*
M^N8G=023*H+P2 2=D#Q(85::?!0II/L$/LK1:!)N-9F$)QF_E.**=(-+$@9A
MV.+0W<OAG19X_')X<"*:;G/#7<?7/<+7=F$_Q@MM%+ZYGVUZ5WR]=CY;AVYU
M01,8>87-&;4&+WK[IC,(/K1I]9ID\2N1[>G8:W3LG6*W.JJ2<H*EEH V#&L.
MI$2[=%<[Z4Z;=&_3MCJC[\ZP)7D=#3K70W^]*UF+S<W[?9OXI*__J42_4:)_
M4HD9K$&4@(\\D5@8;,4X>/>7.'"G.K7VMMI$Z?\3<-@+@@-56HP&AT9QBU%W
MQZ@*U]\IESFHS+4=3=PSJ:I$L]ITMK$KZ ?K$^QX58/Z2U.URP>J,H8)P6&)
ME,'5-;JDJA9438PL7%%>2(,EW@U7V+5!60/<7TIIMA-[0/,_(/H#4$L#!!0
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MA,&C0++,<RQ>QT#Y9NCX3K,P(ZM,F04W'A1X!7-03\6CT#.W94E)#DP2SI"
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M0'__Q+G:'A0#U%O/9O\ 4$L#!!0    ( !J""U6WI^@>\@4  !\G   9
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MT<I O%\0PA]OJ@;:,W'3_P%02P,$%     @ &H(+5>P'-KZ%!@  H#4  !D
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M;<&L$LR^"5:54*@_+F>WD,;VF;^8I\D1I7DTI^4?"GV+;*Y($.=+\9&E_-N
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MY7Y9[B*B@E-0< J,7VN/WP2BF$K)YBRB)K!\KN,%0L ,\Y\J#8M&$1<SFD:
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MA\[0W?0:O7WS#KU!)$:?"*7*0 Q<J4#IT&Z8 [C*  05 /Y*XW/4]!HH\(+
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MZV-\F"?JH(C%<B5JJH^_*;9^;77;G:B7LZX?II5C]S/LBL,</]I%."Q0D(N
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M+2X3\9D=?B-M06&5;\T27O\%A^;>.'3 NN2"I6VP)$AIUGSB;VU'] )@<"0
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M+:L"^?V*2?*'-]533.U3:[/_ 5!+ P04    "  :@@M5M0IXA*@)  "$8P
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MS;Z&XY#^H XQF/5J9CTKLYL-<+60(9*QM1H1M00*J>:%*O<VBB56?Z_]\.J
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M-GJ&CB]3PE2_L&YB P^RTEA5-&#*H."R_F=WC0\;@/YH#R!L .$N8+ '$#6
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M"Y5O/HR<$;G.E<K7]8^WG"VYK +*WZ_R7#V\J JXS^6WNCEG_P%02P,$%
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MV(WFUO;B9U:G&36BB%^IBE9&_2-@BUO0A;5-1F%?]1L%Q,,2V"\Z/]F^85L
M1Q'&%K7++ S[:MQH)1X62[U>#U(?G<QS:[,[PO.YM4 XS:*PP^RWSG?F</V)
MB">:2\1@K?V"BYD.(,KS:GFC^+8X\CURI0^0Q>5&G_%!& /]?LVY>KDQI\CZ
MOP:K_P%02P,$%     @ &H(+53Z+6+;* @  P <  !D   !X;"]W;W)K<VAE
M971S+W-H965T-S N>&ULK95K3]LP%(;_RE&&)I" W-H,6!NIM)H #88H;!^F
M?7"3D];"L3O;:<N_GYV$J)=PD<:7UH[/>_P^)R=V;RGDHYHA:ECEC*N^,]-Z
M?N:Z*IEA3M2QF",W*YF0.=%F*J>NFDLD:2G*F1MX7N3FA'(G[I7/;F7<$X5F
ME..M!%7D.9%/Y\C$LN_XSO.#.SJ=:?O C7MS,L4QZH?YK30SM\F2TARYHH*#
MQ*SO#/RS863CRX"?%)=J;0R69"+$HYU<IGW'LX:08:)M!F+^%CA$QFPB8^-O
MG=-IMK3"]?%S]F\ENV&9$(5#P7[15,_ZSHD#*6:D8/I.+"^PYNG:?(E@JOR%
M91WK.9 42HN\%AL'.>75/UG5=5@3^)T7!$$M"-XK"&M!6()6SDJL$=$D[DFQ
M!&FC338[*&M3J@T-Y?8MCK4TJ]3H='S)$Y$CW),5*M@?FR9)"X8@,AAAAE)B
M:M=@H!1J!82G\)V2"6544R,89!HEW*#6E$]A\E3&7A62JI26K^D ]D>H"67J
M ([@83R"_;T#V /*X9HR9B)4S]6&P[IQD]KS>>4Y>,'S5<&/(?0.(?""H$4^
M?+_<WY2[IGI-"8.FA$&9+WRSA#"B*F%"%1+A]V"BM#1=^J<-L,K8:<]HO]PS
M-2<)]AWS:2J4"W3BSY_\R/O:AOM!R3;@PP8^?"U[W'3)1B/9/OFA9Z8WJL8Y
MA!O!D\($<MU6CFJ/;KF'/7<6<1CUW,4ZY&Y(-VA"-JQW&NN=_[)N7^A:L[_%
M4&T6K1D,O-#;HM@-\D]/_':.;L/1_5B.>TFXJC5:P 6R%,Q] &/"\"W*[@[
M-N)NQ%'8#A@U@-&K@.9\L2=S99A6D-I L1KJJ<UHM-,O1_[I:6?+;&M4N-U8
M[MKY:N^V:R*GE"M@F!F==_S%))#5?5%-M)B71^Y$:'. E\.9N6)1V@"SG@FA
MGR?V%&\N[?@?4$L#!!0    ( !J""U5AKW@P!04  "(5   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<Q+GAM;*V876_;-A2&_PKA%4,"-+5(V;*=.082NT4S
MM$#@K-M%L0M&.K:)2J1'TG&R7S]25F2;I%0'RTVBC_<<\^''X2N.MT+^4"L
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M0JZ[G89$9.!-R("J:<'M715NMU5FLV*R+O%V?2GCKS:Z/(O(6<%T^3+,%K!
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M!E^A3U*"ODJ3$'UA](E%3#&0SRDA,A."'F"9"L&2-;JADLGWZ.(6%&61/OJ
M*KQ+ZTF7M;0/Z.OC+;IX^QZ]12Q!=RR*]%3+J:^T4L/77Q:J;G)5Y("J?]+D
M"O6"2T0"0EK2%\>G8SO=U^-;#C(I!YED>+T#>/GH7;?IR!/[[8EF#5_++5W"
MS-.+5(+8@3=_]P8/@X]MJCH"LS3V2HT]%_I\0>4&P<^4[6ADYK5-;(XPR!!,
M?]G-29\,IOZN+J(9A,?C7AEDD>N7Y/I.<GK%[ZD(T9(G2NC.T<HNAQC6'_R2
M6S.D3]J9#4IF R>S?]4&A"[V'4@5'QJW0>.QD]$+9LT03(;MU(8EM:&S:FL+
MO;5TAUV6;D=@EM!1*71T?G6,7J^.9LBAZAB7S,9.9E]@!U&N$[>1<F:?.@4=
M@5E")Z70R>]VR$F7&CL"LS3BH/+:X.P>64 ,W4VR)>IPE\2UEP%\_DHH,.K/
M#E[2<X78W"H/Q4[[.JY3%AC.5MD2<[!7XLK^<.^L;HF=]GEJ'7>%9HNM[!1W
MX*>XZ9:-.G&%V-PJ0\5N1ZWUS+97OQMW^LD3T1&:+;:R:.SV:$??Q)WZ<U=H
MML[*H;';HH_JG$W_;=2;*\2F5EDT=GOT<6MA_/KK0TO,H?<'7/DJ=EK:D5US
M\OK(N4+L35%EAR0XJV42IYN>O#GJ",T66UDKZ<!:2=,W&V72$G.H3$AM@^HV
MUUK3[+42ZW:?^B<VJJ2R:N*V:M=VO%.7[@K-UEFY-'&[]#%-D[QNTLX0FUIE
MTL1MTL>MAN:FML'-%6)SJSR5.+WLN)998#BYN4)L;I4/DM%Y+=-IHR?7;T=H
MMMC*64D'SEI@#%P3X0K)N?FU+ZCF\_4=%6N62!3!2N<$5R.=+/(OPOF)XMOL
MH^H35XK'V>$&: C"!.C[*\[5\XGY3EM^EY__#U!+ P04    "  :@@M5"@@)
MV+4"  #%"0  &0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6S-5EU/VS 4
M_2M7&9I 8N2C;=JQ-!(4H3'!A$"PAVD/;G+;6#AQ9SLM^_>SG31*U5! ZJ2]
M)+9SS_$YU[ZQHQ473S)#5/"<LT*.G4RIQ:GKRB3#G,@3OL!"?YEQD1.ENV+N
MRH5 DEI0SMS \T(W)[1PXLB.W8HXXJ5BM,!; ;+,<R+^G"/CJ['C.^N!.SK/
ME!EPXVA!YGB/ZF%Q*W3/;5A2FF,A*2] X&SLG/FGDY&)MP&/%%>RU0;C9,KY
MD^E<I6/',X*08:(, ]&O)4Z0,4.D9?RN.9UF2@-LM]?LE]:[]C(E$B><_:"I
MRL;.R($49Z1DZHZOOF+M9V#X$LZD?<*JCO4<2$JI>%Z#M8*<%M6;/-=Y: '\
M_@N H 8$;P7T:D#/&JV465L71)$X$GP%PD1K-M.PN;%H[8869A7OE=!?J<:I
M^))0 8^$E0@W2&0I4"^1DG!X@8I0)H_@$SS<7\#AP1$< "W@AC*F\R\C5^GI
M#8F;U%.=5U,%+TSUK2Q.H.<=0^ %00=\\G:XOPEWM>G&>= X#RQ?[U7GQW F
M)6K3I$CAFI(I9511E.N,I*#WVQTFI1"TF-NH[[P0S< YD53"SVL] 5PIS.6O
MKN14:OK=:DRQGLH%27#LZ&J4*);HQ!\_^*'WI2M5>R+;2%RO25QO%WM<)RM#
MEH+^C8 D#+L,5RP#RV)^)LO8B]QEV\5VA.][?A.TH:[?J.OO5-=>/X&,*+U\
MB@-YH^C^JZ*KB+ 5\3GLECQH) ]V2F[OQ/;&ZM*WD^F]NVA/9!NFP\9T^%^5
M7[C/Q.V);"-QPR9QP[V4WTZ6]QH>;FUZ7:E>][8?-49&_[)2=Y*_U]]HJ^RW
MBMIM';+F@G-#Q)P6$AC.-,@[&6JTJ"X-54?QA3UWIUSI4]PV,WW/0F$"]/<9
MYVK=,4=Y<W.+_P)02P,$%     @ &H(+54(#L/ Z!   D!<  !D   !X;"]W
M;W)K<VAE971S+W-H965T-S0N>&ULO5C;;MLX$/V5@;98I$ WNO@69VT#J;-!
M4S38(-YV'XI]H*6Q390BO21EIT _?JE+=+%E)=[(?4ETF3F>.3P<'W.T%?*;
M6B%J> P95V-KI?7ZTK:5O\*0J'.Q1F[>+(0,B3:W<FFKM402)$DALSW'Z=LA
MH=R:C))G]W(R$I%FE..]!!6%(9'?WR,3V['E6D\/'NARI>,']F2T)DN<H?Z\
MOI?FSLY1 AHB5U1PD+@86U?NY=3SXH0DX@O%K2I=0]S*7(AO\<UM,+:<N")D
MZ.L8@IA_&YPB8S&2J>/?#-3*/S-.+%\_H=\DS9MFYD3A5+"_::!78^O"@@ 7
M)&+Z06P_8-90+\;S!5/)7]AFL8X%?J2T"+-D4T%(>?J?/&9$E!+<[H$$+TOP
M7IK0R1(Z2:-I94E;UT23R4B*+<@XVJ#%%PDW2;;IAO)X&6=:FK?4Y.G)#>6$
M^Y0PN.5*R\BLD%9P-C-R"2*&(!:@5P@WA$KX0EB4/+E2"DT4X0%\HF1.&=44
M%3P@(QH#T *N4=(-B5=(F6M%ESQY0Q1\P&!)^;+\<6_A[!HUH<Q<_0:?9]=P
M]N8MO '*X8XR9E9;C6QMFHU+MOVLL?=I8]Z!QCY&_!PZSCOP',^K29^^/-VM
MIMN&XIQG+^?92_ Z!_!*A+PKL_GUDPF$6XVA^J>NR12U6X\:[_%+M28^CBVS
MB17*#5J37W]Q^\[O=2VW!%8AH),3T&E"G_PEM!$92913UVB:W4NRX]FSF?0-
M[YMR^?LAW7X>4BFJFQ?5?4%1K-!P764I1+_^8]/*:D+J"^OEA?4:"WMNS\ /
MF!*U@ALSAO/7/\!,-C.W.$PC*9'[WV$JN)9F5"KS\E[BFM  _G@TWP$*T_W[
MI]G=LJ[KQOJ.%5Y+8!4J^SF5_9/LO'Z;!+0$5B%@D!,P>-7.&^R)=[ C[_V(
M7KV\+_*2+GZZO!,EPY7ORP@KWTMU/3>6=^SBM@1687*8,SD\B;J';1+0$EB%
M -<I'(SS^B&>890UW-E1>4W(@2GNEMR5^UJAEQ:M4/HMUVBXTO!@<F&V)>M"
MX:GY^GJ'X1QE[>(V%W7LZK:%5J6P,$[N:9R3VZIU:@NM2D)AGMS7N:<LO:Q=
M9U?>^R'N 7D7]LEM]D^GD/?+!GAS84>O;DMH51H+L^?V3B/Q5DU:6VA5$@J;
MYC::H!>.\?[^C-Z;X_LQS@&A%Q;*;?90_U?H4RF4*OQ*5?=/[B6?Y4?-^,:"
MCU[[EM"J]!9VT+TXS09HU<>UA58EH7!R;J-/>G[&#_=T[?5VM;\?<^ GLE?X
M*Z_97_TT[1_W [6YZJ./1EI"JW)<^$3//<WQ4*M.KRVT*@FE([)&$_7L!LC2
MRP= WG!G ]3$='9=O%TZ+HW/JN^(-))5P'!ADISS@<F6Z?%O>J/%.CE!G0NM
M19A<KI $*., \WXAA'ZZB0]E\T/XR7]02P,$%     @ &H(+54!)+YDL!P
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ME2;9QR6C,R9, ?W]/$W5]L T4+QT.OD/4$L#!!0    ( !J""U72&F0[4@,
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M_.)9V ]>M^%Q*98X$FN@BRMT<:$>/X(N <76U*X2Y/L'O$<N#&3Z1QO V"5
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MPWT)^+6SO?T2\Y$JS#A-.,Q1/C@:H#-J^W%CVS%R51SWKZ4Q,BN:2Z I*#L
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M'^6J-8N>-+N*.AG_+L0I&03') JBJ,6A^>OA80L\?CT\Z(AF4&? P/$-#V6
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MNUP 13*- <[/A-#;&_. HO4^_!]02P,$%     @ &H(+5<WX)89W @  1P8
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M(T'+N"#:?7BX3Z"QLPL[CO>:"T&'PG1#2R$Z1\.T"N>T#"=>$4XSAFLE[=C
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MX!-YI,N.6$ZLFO@>\:@L=1P_'--/!&IG0/M#I>SKQ'V@_BWI_P-02P,$%
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M&P89Y>6;/%4^K !:[2T OP+X;P4$%2 HA);,"EGG1).X*\42I(TVV6RC\*9
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M.^D8O"SOX[*CQ;RXTL9"FPNR:*;F%P:E#3#?IT+HEXZ])>N?HO@/4$L#!!0
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M#.3W,TK%TX4:H#IL-/X74$L#!!0    ( !J""U4;/_<)4P0  $40   9
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MZ8*X73$$_4!;QS972?1(VDZ _?B1DBQ9ML+% _/%UH7G(?GR^HK]-1<_Y!Q
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M8[J?&= X3#R2S5:H"7,^S= &/V'Q*5LR.3)+EH@D..6$IH#A]<RXA3<!]%6
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M=&4N ,\+4D9=W_,B-\.$.<F@N#86R8"O%24,Q@+)=99A\7(#E&^'3L=YO?!
MEBME+KC)(,=+F(!ZS,="S]Q:94XR8))PA@0LALYUYRKM&WP!^$5@*W?&R&0R
MY?S)3$;SH>.9@(#"3!D%K$\;N 5*C9 .XU^EZ=2/-,3=\:OZMR)WG<L42[CE
M]#>9J]70B1TTAP5>4_7 MS^@RB<T>C-.97%$VPKK.6BVEHIG%5E'D!%6GO%S
MY<,.H=-]A^!7!/]80E 1@F,)W8K0+9PI4RE\2+'"R4#P+1(&K=7,H#"S8.OT
M"3.O?:*$ODLT3R436.J7J-"(E25DWL58Z*H2Z@5A-D=?_ZU);B#GB.DJG+Z@
M[\"7 N<K,D/7NM+.T&D*"A,JS] %>IRDZ/3D#)T@PM ]H50+RH&K=*CF@>ZL
M"NNF#,M_)ZR?:W:) N\<^9[OM]!OCZ=W6NCI\72O27>UO[7)?FVR7^@%[^C=
M<;:\N-/U/4?74H*2Z,^=AJ"1@DS^;7.GU.NVZYE/P97,\0R&CNYU"6(#3O+Y
M4R?ROK1Y95,LM236\#&H?0P.J2>-PH1&8;:96(J%A9CY_&T2/XAT.6QVS6D%
M>4U0V@J*:E CF6Z=3/=@,H^,*%T0$X45M';(0?I':\"F6&I)K&%;6-L66NZE
MT*:/-L522V(-'Z/:Q\AF+Y5BT4X'=/J]:*^7VD!AO-=++: X]MI[J5<GTSN8
MS(@I$*Q8O3!M"_\@_:,U8%,LM236L"VN;8LM]U)LTT>;8JDEL8:/_=K'OLU>
MZK]938(XW&NEMYBNY^]U4@LFWE^4W)VMH=G'WV.Q)$PB"@O-\BY[FB[*O7$Y
M43PO=HM3KO3>LQBN].\$" /0]Q><J]>)V8#6/RC)?U!+ P04    "  :@@M5
M:ZGUS9T$  #-&@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6S%6=MN
MXS80_96!NB@28#>Z^))+;0-)U$N*S:ZQ2=J'11]H:6P+D425I.T$Z,>7E!1=
M;(6.%P3R8DO4S"'/X0PU%$<;RA[Y$E' 4Q*G?&PMA<@N;)L'2TP(/Z$9IO+)
MG+*$"'G+%C;/&)(P=TIBVW.<H9V0*+4FH[QMRB8CNA)QE.*4 5\E"6'/5QC3
MS=ARK9>&;]%B*52#/1EE9(%W*!ZR*9-W=H421@FF/*(I,)R/K4OWPO<<Y9!;
M_!7AAC>N05&94?JH;F["L>6H$6&,@5 01/ZM\1KC6"')<?Q;@EI5G\JQ>?V"
M_EM.7I*9$8[7-/X["L5R;)U9$.*<K&+QC6[^P)+00.$%-.;Y+VQ*6\>"8,4%
M34IG.8(D2HM_\E0*T7!PAZ\X>*6#M^W0?\6A5SKTWNK0+QWZN3(%E5P'GP@R
M&3&Z ::L)9JZR,7,O27]*%7S?B>8?!I)/S&Y6Q*&GZZD<B%<TT2&$R?YA!Q]
M(8P1-2G'<.2C(%',C^$3/-SY</3A&+ARY!"E<+^D*T[2D'^$#^K^-HICB<!'
MMI #5-W803F8JV(PWBN#<3VXI:E8<O@U#3%L ]B2647/>Z%WY6D1_URE)]!S
M/H+G>%['@*[?[NYVN/MO=W<T;'K59/5RO)YVLF:[DW4IIRI=H,Q' ;-G:-I-
MR7/>?+DA+(3OGR4DW A,^#]=\U/TW^_N7ZU!%SPC 8XMN<AP9&NT)C__Y Z=
M7[JT-0GF&P)KZ=ZO=._KT"?WY EFF.(\$G*MBXF0N@I:I$ I<]"8CBYABPX&
M>0=J+5[+8!_9ZZ9<^TW\#I-A9=*B-JBH#?34J" QX),:/((,)4RRF#XC2J(B
M8D5(<;*.T@6'+";=:3W8&=?0V6*W:S(8;+'K0'F%W;!B-]2RFR++7XUI@$52
MP$,:"0[_P2UYBI)5TD5&"WEH#I@$\PV!M:0\K:0\?>>UY]2D[B;!?$-@+=W/
M*MW/]JP];"'+OZP1R0LJ4_:(<""J.9 *'W?I6>">-=+).^GUM]*RRVC+QM?;
MM%B=5ZS.M:SN! T>X6LF7BL4M.Z'!H-),-\06$LVUZG+->>=T[ <@"'IC:+Y
MIM#:XC=J95<;M;]+B=6[_TA6N47]VYEX)<JPD3#;;\/])K[6I$W JPEX6@*J
MC(7/]S=3^'Z+R0Q9=P1H00Z. )-HOBFTMH!U >Z^=P7N&BW!C:+YIM#:XM=5
MN*LOP[^L5,@"G;]L/LE:[DK)+$:0[T98J.SLE+2_DTE>WW%V<E+;^\%:&4)K
M:U67]:Z^KM_-=%GTYA'(X:M82AG%DJ2P]SVL[^;@<#2)YIM":TM<[RW<X7NO
M!4:W(D;1?%-H;?'KW8BK+;I_?"TXW5D+7*=C+3"Z?S"%UM:JWD&X^BU$YUJP
M/_.UH <'GTDTWQ1:6]!Z\^*>OW?F&]W_&$7S3:&U/^C6.R!/6^3_<.:7L/NJ
M 'WOAVIE"JW0RFY\YT^0+?+S$@X!7:6B^"9>M59G,I?Y2<16^Y5[X1<G*S5,
M<=!S2]@B2CG$.)>0SLFI?,>RXNRDN!$TRT\39E0(FN272R0A,F4@G\\I%2\W
MJH/J!&OR/U!+ P04    "  :@@M5:7J\@(\#  "S$0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Y-BYX;6S%6%UOHS@4_2L6.UJUTDSY2DG339":,*/M:JJ)
MFNG,PVH?'+A)4,%F;:=I__W8AE)("=-J/.I+@LT]AWN/?<#V>$?9+=\ "'2?
M9X1/K(T0Q;EM\W@#.>8GM  B[ZPHR[&03;:V><$ )QJ49[;G.(&=XY18X5CW
MS5DXIEN1I03F#/%MGF/V,(6,[B:6:SUV7*?KC5 ==C@N\!H6(&Z*.9,MNV9)
MTAP(3RE!#%83Z\(]CUQ? 73$MQ1VO'&-5"E+2F]5XS*96([*"#*(A:+ \N\.
M9I!EBDGF\7]%:M7/5,#F]2/[)UV\+&:).<QH]CU-Q&9BG5DH@17>9N*:[OZ&
MJJ!3Q1?3C.M?M*MB'0O%6RYH7H%E!GE*RG]\7PG1 +C! 8!7 ;Q]P.  P*\
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MIJF*RWPQ,7+C[L.OTN#MV@W7^ $$R@K@\Z64YC"Q&U2?5+-_ 5!+ P04
M"  :@@M5%'HBQ1P$  !K$@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6S56-MNXS80_96!NB@2((DNOB6I;<")6G2+!C"2IOM0](&6QA:Q$NF2E!WW
MZTO2LFPYLI(-!!3[8I/4G*.9P]&,Q.&:BZ\R053PDJ5,CIQ$J>6MZ\HHP8S(
M*[Y$IJ_,N<B(TE.Q<.52((DM*$O=P//Z;D8H<\9#NS85XR'/54H93@7(/,N(
MV-QARM<CQW=V"X]TD2BSX(Z'2[+ )U3/RZG0,[=DB6F&3%+.0.!\Y$S\V]#O
M&("U^)/B6AZ,P80RX_RKF7R.1XYG/,(4(V4HB/Y;X3VFJ6'2?OQ3D#KE/0WP
M<+QC_\4&KX.9$8GW//U"8Y6,G&L'8IR3/%6/?/TK%@'U#%_$4VE_85W8>@Y$
MN50\*\#:@XRR[3]Y*80X /C]$X"@  3'@.X)0*< =-X+Z!: KE5F&XK5(22*
MC(>"KT$8:\UF!E9,B];A4V;V_4D)?95JG!H_)43@Y9U6+H9[GNETDL1NR-DD
MCJD9D10,,SQB2I2V4EP/I1(T,C.+AV=&%4S,%E*U.8>S$!6AJ3R'2WA^"N'L
MTSE\ LK@@::III1#5VG?C0=N5/AYM_4S..&G'\ #9RJ1\#.+,:X2N#KH,O)@
M%_E=T,CX6\ZNH.-=0. %08U#]^^'^S7P\/UPKR&:3KF/'<O7/<%7NR6U.C?R
MF#)S*Y<DPI&CZXA$L4)G_.,/?M_[J4ZC-LG"EL@J^G5+_;J6O=/X',Q>/P<3
M(0A;H"YU"F8;.+2;DHU=GJR)B.&OWS4E?%:8R;_K=.^VJ7N;9&%+9!7=>Z7N
MO<:\_8,K76"B0\4C+M4%,-WS^!QT6M/,UAW=X^9(5:Y]N- =IRQ&C+.5MM(3
ML7\&I'T&"-N-<E.@B-DGJ0$*-II=8,07C/Z+\07HR"X5>:G;MZW_/>N_Z:*K
M\: S=%>'N_&V25AC,BA-*LKU2^7ZC<I]L2T-XTNR0J%;-"Q14!Z;,KM!(B1P
MO0[KA$;)F\H8R8%*P)<E1H6N,SQ0",YVM.=U&C5[&FR1=7G\46#X 6!%Y4&I
M\N =^3DG5,"*I#F:G+3"22BR+LX%90M0"=J;ULDS>+WYW:,4JC'QCE+HM4GO
M1 I=E\%=-P:W+5PF#A-!D3_-.]U,V#F]TXW ;ZU8+9%51+LI1;MIC'&*PKYN
MLPC?:K6-1-]:\MLD"ULBJPCH>_MW3N]_;K:% RU)WRI;V!9;5?R#%W[_.^^X
M10"'E<X?'-7+&IN@?U0PZVQNZBNF'^SE"[Z;MON&JPU]]\/(\"/(JM3[3QJ_
M^9NFE=Y;W*.23,?-M\[F.)=>F_2.4LD]^ K/4"SL:8;4FYPSM?TL+5?+$Y.)
M/2<X6K\S)RGVZWY/LSV&>2!B09F$%.>:TKL::'_$]F1C.U%\:;_U9UPIGMEA
M@B1&80ST]3GG:C<Q-RC/E\;_ 5!+ P04    "  :@@M5,A-2F[0#  "!#0
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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MB!.*B2SD#[DVTYG5")"% F8+84S:A )DH8#90GA6HQ--9*& V4(8LQ--9*&
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MJK<%Z&U5;PO0VZG>#J"W4[T=0&^G>CN WJYZ6 +0VZG>#J"W4[T=0&^G>CN
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ML^J= 7H7U;L ]"ZJ=P'H753O M"[J-X%H'=1O0M [Z)Z%X#>1?4N +V+ZET
M>A?5NP#T+M5A'8#>IJN/ZP#\-EUU8*?[3L''Z7/?C[>BKW45\)U>3Y?/]K?O
MORZ_+M:WX4IT>Y\Q/OT%4$L#!!0    ( !J""U5_X$/,6P(  $TY   3
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MK"5%UI(B:TF156XHM,K-_[3U^S@>_G'\\DS[JAU>\L7R+\J;GU!+ 0(4 Q0
M   ( !J""U4'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ &H(+5;S.0D?N    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( !J""U7BJD.PFP8  $X<   8
M  " @502  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  :
M@@M5:B2A=<H#  !1#0  &               @($E&0  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ &H(+5<&V@[:8!@  +QT  !@
M         ("!)1T  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( !J""U7?8%#2C0H  &UG   8              " @?,C  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  :@@M5+0$ 5>,)  "R.
M&               @(&V+@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ &H(+5?PZI0:W*@  KH4  !@              ("!SS@  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !J""U4EW*G!=@4
M ",-   8              " @;QC  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    "  :@@M56/T!:U\$   %"P  &0              @(%H
M:0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !J""U43
MGRW!-P@  ',7   9              " @?YM  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ &H(+54H#T4%Q!0   0X  !D
M     ("!;'8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !J""U50E7_@-1   &,[   9              "
M@8R^  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ &H(+
M5=*32V=,!@  AA   !D              ("!^,X  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    "  :@@M5#>NV@^\#  "3"@  &0
M        @(%[U0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( !J""U53@9C[J P  %(E   9              " @:'9  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ &H(+57PM41#W!@  210
M !D              ("!@.8  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    "  :@@M5=XZ(6E4$   J"@  &0              @(&N[0
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !J""U59V%2+
MT#$  /6H   9              " @3KR  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ &H(+5>OV(YO" P  F0@  !D
M ("!020! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  :
M@@M5>X9UTC0#  !1"   &0              @($Z* $ >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( !J""U4>H9,J[ 0  #81   9
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M970S,"YX;6Q02P$"% ,4    "  :@@M5'+>#L8$'  !0(   &0
M    @($N1@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M !J""U7[D4E&3 ,  .P'   9              " @>9- 0!X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ &H(+53AJM0QA P  +0@  !D
M             ("!:5$! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    "  :@@M5,=+Q*<T&  !I&@  &0              @($!50$ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !J""U46SDZ>)@4
M "@1   9              " @05< 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ &H(+57!:,ERU!   '!T  !D              ("!
M8F$! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  :@@M5
M_:T-9,@#   5$P  &0              @(%.9@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( !J""U7%Z#?>& ,  ,(*   9
M      " @4UJ 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ &H(+539!GRN? P  2 T  !D              ("!G&T! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  :@@M5@[_ A;@$  "@'P
M&0              @(%R<0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( !J""U7LSWH\K08  *4Z   9              " @6%V 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ &H(+5:7M"_ZN
M!   *"$  !D              ("!17T! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    "  :@@M59U&U-D("  !$!0  &0
M@($J@@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( !J"
M"U7M+:?1" ,  ,H*   9              " @:.$ 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ &H(+54:3AR>7 @  X 8  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( !J""U483H*EX0(  '<(   9
M  " @;>8 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M&H(+56R"2KCA P  Q!   !D              ("!SYL! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    "  :@@M501@:7]$%  "&)@  &0
M            @('GGP$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( !J""U6WI^@>\@4  !\G   9              " @>^E 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ &H(+5>P'-KZ%!@
MH#4  !D              ("!&*P! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    "  :@@M5D[F]'5P#  "C#@  &0              @('4
ML@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !J""U7=
M(DX@X0(  ,X(   9              " @6>V 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ &H(+5:R*$<>N!   =14  !D
M     ("!?[D! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !J""U5ZHGQSQ 8  /0]   9              "
M@=C6 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ &H(+
M53-D7^M@!   ;!@  !D              ("!T]T! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    "  :@@M5)Z9P3"$-  "OG@  &0
M        @(%JX@$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( !J""U59Q30E#0,  'T)   9              " @<+O 0!X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ &H(+58Y@C+6O P  W0T
M !D              ("!!O,! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    "  :@@M5?BB,[\@$  "+$@  &0              @('L]@$
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( !J""U5\\-H"
M" T   B*   9              " @>O[ 0!X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ &H(+5>L.%9,Z!   01   !D
M ("!*@D" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    "  :
M@@M5/HM8MLH"  # !P  &0              @(&;#0( >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( !J""U5AKW@P!04  "(5   9
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M970W-2YX;6Q02P$"% ,4    "  :@@M5TAID.U(#   F#P  &0
M    @('M* ( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M !J""U68I8&Y, ,  )<+   9              " @78L @!X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ &H(+5>0'#L:( P  ;A(  !D
M             ("!W2\" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    "  :@@M5V%3CX)0#  "D#P  &0              @(&<,P( >&PO
M=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( !J""U7,&!9+1P0
M (87   9              " @6<W @!X;"]W;W)K<VAE971S+W-H965T.# N
M>&UL4$L! A0#%     @ &H(+5<WX)89W @  1P8  !D              ("!
MY3L" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    "  :@@M5
MHTT?4/H"  "B"   &0              @(&3/@( >&PO=V]R:W-H965T<R]S
M:&5E=#@R+GAM;%!+ 0(4 Q0    ( !J""U5?LY$S] (  " )   9
M      " @<1! @!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%
M  @ &H(+56TF K5. P  6 T  !D              ("![T0" 'AL+W=O<FMS
M:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    "  :@@M5[MU3@DT&  #O,0
M&0              @(%T2 ( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+
M 0(4 Q0    ( !J""U5R6PC[U 4  '@D   9              " @?A. @!X
M;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ &H(+51L_]PE3
M!   11   !D              ("! U4" 'AL+W=O<FMS:&5E=',O<VAE970X
M-RYX;6Q02P$"% ,4    "  :@@M517UA)_4"   ["   &0
M@(&-60( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( !J"
M"U4XF2&ZU@0  -4;   9              " @;E< @!X;"]W;W)K<VAE971S
M+W-H965T.#DN>&UL4$L! A0#%     @ &H(+54[VV^G$!0  %BD  !D
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M=#DT+GAM;%!+ 0(4 Q0    ( !J""U5KJ?7-G00  ,T:   9
M  " @5IW @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @
M&H(+56EZO("/ P  LQ$  !D              ("!+GP" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-BYX;6Q02P$"% ,4    "  :@@M5]%TP-; #  !>#0  &0
M            @('T?P( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4
M Q0    ( !J""U44>B+%' 0  &L2   9              " @=N# @!X;"]W
M;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ &H(+53(34INT P
M@0T  !D              ("!+H@" 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX
M;6Q02P$"% ,4    "  :@@M5?<FA>OL#  #(#@  &@              @($9
MC ( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    "  :@@M5
M8LM]674&  #M-0  &@              @(%,D ( >&PO=V]R:W-H965T<R]S
M:&5E=#$P,2YX;6Q02P$"% ,4    "  :@@M53(QZ&D0#  #&$P  #0
M        @ 'YE@( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !J""U67BKL<
MP    !,"   +              "  6B: @!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( !J""U5A<YIRQ08  +A"   /              "  5&; @!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    "  :@@M58\012MT"  !<.P  &@
M    @ %#H@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M"  :@@M5?^!#S%L"  !-.0  $P              @ %8I0( 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     ;0!M /0=  #DIP(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>412</ContextCount>
  <ElementCount>481</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>137</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050007 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210181002 - Disclosure - Divestitures and Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresandAcquisitions</Role>
      <ShortName>Divestitures and Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210211003 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210251004 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210301005 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210371006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210431007 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210451008 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210551010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210601011 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210731012 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210771013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210811014 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210891015 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>211001016 - Disclosure - Schedule II - Valuations and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>230223003 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeverance</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>230263004 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230313005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230383006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230463007 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230563008 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230613009 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230743010 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230783011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230823012 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230903013 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240174014 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240204015 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails</Role>
      <ShortName>Divestitures and Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/DivestituresandAcquisitions</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240234016 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240244017 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240284019 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240294020 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240324021 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LeasesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240334022 - Disclosure - Leases Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails</Role>
      <ShortName>Leases Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240344023 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240354024 - Disclosure - Leases Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240364025 - Disclosure - Leases Schedule of Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails</Role>
      <ShortName>Leases Schedule of Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240424029 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240444030 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240474031 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails</Role>
      <ShortName>Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240484032 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240494033 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240504034 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240524036 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240534037 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails</Role>
      <ShortName>Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240574038 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240594040 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240624041 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240634042 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240644043 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240654044 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240664045 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240684047 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240694048 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails</Role>
      <ShortName>Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240704049 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240714050 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails</Role>
      <ShortName>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240724051 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails</Role>
      <ShortName>Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240754052 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240764053 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240804055 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240834056 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240844057 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240854058 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240864059 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240874060 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240884061 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails</Role>
      <ShortName>Segment Information Property and Equipment, net by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240914062 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240924063 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240964067 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240974068 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240984069 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240994070 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails</Role>
      <ShortName>Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="cah-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>241014071 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuations and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts</ParentRole>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cah-20220630.htm">cah-20220630.htm</File>
    <File>a22q4_10kx063022xex10146.htm</File>
    <File>a22q4_10kx063022xexhibit311.htm</File>
    <File>a22q4_10kx063022xexhibit312.htm</File>
    <File>a22q4_10kx063022xexhibit321.htm</File>
    <File>a22q4_10kx063022xexhibit991.htm</File>
    <File>a22q4_10kx63022xexhibit211.htm</File>
    <File>a22q4_10kx63022xexhibit231.htm</File>
    <File>cah-20220630.xsd</File>
    <File>cah-20220630_cal.xml</File>
    <File>cah-20220630_def.xml</File>
    <File>cah-20220630_lab.xml</File>
    <File>cah-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cah-20220630_g1.jpg</File>
    <File>cah-20220630_g2.jpg</File>
    <File>cah-20220630_g3.jpg</File>
    <File>cah-20220630_g4.jpg</File>
    <File>cah-20220630_g5.jpg</File>
    <File>cah-20220630_g6.jpg</File>
    <File>cah-20220630_g7.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1375">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>128
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cah-20220630.htm": {
   "axisCustom": 11,
   "axisStandard": 35,
   "contextCount": 412,
   "dts": {
    "calculationLink": {
     "local": [
      "cah-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cah-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cah-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 841,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 16
   },
   "keyCustom": 72,
   "keyStandard": 409,
   "memberCustom": 63,
   "memberStandard": 70,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.cardinal.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211003 - Disclosure - Restructuring and Employee Severance",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeverance",
     "shortName": "Restructuring and Employee Severance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalPerformanceShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i056274b9166742cdaee278d9b684a643_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994070 - Disclosure - Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Performance Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ia6cada5cb1ff42e38f3bc27b469d95a6_D20210701-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cah:VestingPeriodinyearsforShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vestingperiods",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014071 - Disclosure - Schedule II - Valuations and Qualifying Accounts (Details)",
     "role": "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuations and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210251004 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301005 - Disclosure - Leases",
     "role": "http://www.cardinal.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210371006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210431007 - Disclosure - Commitments, Contingent Liabilities and Litigation",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation",
     "shortName": "Commitments, Contingent Liabilities and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210451008 - Disclosure - Income Taxes",
     "role": "http://www.cardinal.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210551010 - Disclosure - Fair Value Measurements",
     "role": "http://www.cardinal.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210601011 - Disclosure - Financial Instruments",
     "role": "http://www.cardinal.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731012 - Disclosure - Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771013 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.cardinal.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210811014 - Disclosure - Segment Information",
     "role": "http://www.cardinal.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210891015 - Disclosure - Share-Based Compensation",
     "role": "http://www.cardinal.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211001016 - Disclosure - Schedule II - Valuations and Qualifying Accounts",
     "role": "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts",
     "shortName": "Schedule II - Valuations and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223003 - Disclosure - Restructuring and Employee Severance (Tables)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables",
     "shortName": "Restructuring and Employee Severance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230263004 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230313005 - Disclosure - Leases (Tables)",
     "role": "http://www.cardinal.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230383006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230463007 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.cardinal.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - Consolidated Statements of Earnings",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230563008 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230613009 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743010 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783011 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230823012 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cardinal.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230903013 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Receivables) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NotesReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "iebb7741eed65481097e07facd023b229_I20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cah:GrossTradeReceivablesMajorCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "iebb7741eed65481097e07facd023b229_I20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "cah:GrossTradeReceivablesMajorCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cah:ConcentrationRiskLargestGroupPurchasingOrganizations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "organization",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Components of Property and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Goodwill and Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:VendorReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134010 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Shipping and Handling) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i16a1465dba6b406da9f48c90f84ff2fb_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Dividends) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:DividendsPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:SalesreturnsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154012 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Sales Returns and Allowances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:SalesreturnsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:RevenueRecognitionReserveforSalesReturnsandAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164013 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Loss Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174014 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details)",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Assets Held for Sale) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204015 - Disclosure - Divestitures and Acquisitions (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
     "shortName": "Divestitures and Acquisitions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ia4cc2b4bbaa0449790c4c94fb3395ed8_D20180801-20180831",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234016 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails",
     "shortName": "Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244017 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails",
     "shortName": "Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274018 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284019 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294020 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "cah:TerminalGrowthRateFairValueInput",
       "cah:TerminalGrowthRateFairValueInput",
       "span",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i710b408f414f44fd940fd38d5f1ed302_D20220401-20220630",
      "decimals": "3",
      "lang": "en-US",
      "name": "cah:TerminalGrowthRateFairValueInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i37112b83786b4ac1ba34031420b8575a_D20190701-20190701",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:ReclassificationofdeferredrentinaccordancewithASC842",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324021 - Disclosure - Leases (Details)",
     "role": "http://www.cardinal.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id7e703a9570f493582c8bc1a69a64a7d_I20220630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334022 - Disclosure - Leases Schedule of Lease Costs (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails",
     "shortName": "Leases Schedule of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344023 - Disclosure - Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354024 - Disclosure - Leases Supplemental Cash Flow Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:LesseeLeaseLiabilityPaymentsDueYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364025 - Disclosure - Leases Schedule of Future Lease Payments (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
     "shortName": "Leases Schedule of Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "cah:LeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:LesseeLeaseLiabilityPaymentsDueYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i394a93549b704f59890a8a7cf53f81b4_D20190701-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i864ea7c23dc947fbba05d966f01221d3_D20190701-20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394026 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ice004f9102ba4d5fa58a7477de8fe13e_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404027 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414028 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cah:OfferAsPercentageOfPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424029 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Other Financing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityAverageOutstandingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444030 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
     "shortName": "Commitments, Contingent Liabilities and Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474031 - Disclosure - Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails",
     "shortName": "Income Taxes (Schedule of Income before Income Tax, Domestic and Foreign) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484032 - Disclosure - Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
     "shortName": "Income Taxes (Schedule of Components of Income Tax Expense (Benefit), Current and Deferred) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494033 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504034 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cah:EffectiveTaxRateImpactFromCertainForeignJurisdictions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514035 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfOtherInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524036 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities After Netting by Tax Jurisdiction) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534037 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
     "shortName": "Income Taxes (Schedule of Unrecognized Tax Benefits Roll Forward) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i3e2109c867604d538c15c36e5773bfcd_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574038 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i3e2109c867604d538c15c36e5773bfcd_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594040 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i8252480092a4420d9a47a8420945e070_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624041 - Disclosure - Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
     "shortName": "Financial Instruments (Schedule of the Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634042 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ie6d851e08ef540a6aceb7daa376a4bc2_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644043 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i0e787599e79e498b900200587d8ebe7d_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654044 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i0e787599e79e498b900200587d8ebe7d_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "cah:DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount",
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i2a7bc307cde846ad8020785fb428b704_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664045 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "if84712198fd34c77a01fe1cc4008c915_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674046 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "if84712198fd34c77a01fe1cc4008c915_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684047 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i5179f99e117a47fc945575ebde30b1c6_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i94d8c3f959e54f26b4608732cff6a528_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694048 - Disclosure - Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
     "shortName": "Financial Instruments (Schedule of Outstanding Instruments, Economic Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i94d8c3f959e54f26b4608732cff6a528_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "if2791b320bdf418283ef26f40f8960d2_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704049 - Disclosure - Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Gain/(Loss) Recognized in Earnings for Derivatives Not Designated as Hedging Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "if2791b320bdf418283ef26f40f8960d2_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714050 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
     "shortName": "Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i8568be76a18940d69f23584500123552_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724051 - Disclosure - Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
     "shortName": "Financial Instruments (Schedule of Fair Value Gain Loss Derivative Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i8568be76a18940d69f23584500123552_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754052 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ie251c72e85d34942ab0769ac0f335908_D20210701-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cah:CommonStockVotingRightsVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id718ed1e33ce417a8b54b992f9f06368_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764053 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794054 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804055 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834056 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210181002 - Disclosure - Divestitures and Acquisitions",
     "role": "http://www.cardinal.com/role/DivestituresandAcquisitions",
     "shortName": "Divestitures and Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844057 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
     "shortName": "Segment Information (Revenue by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "if8120134644a4b72b67cf151f13a9267_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854058 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails",
     "shortName": "Segment Information (Segment Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i5774e90097cf4d519cceb9c49d19ea41_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864059 - Disclosure - Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
     "shortName": "Segment Information (Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i468bb70dfe6343eea9940ca51720261e_D20210701-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874060 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
     "shortName": "Segment Information (Assets by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ibc2e8742efab40caa87b3f3acd2b0fdc_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i925a03f1cd7147388a76d1e7a5ee1d5a_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884061 - Disclosure - Segment Information Property and Equipment, net by Geographic Area) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
     "shortName": "Segment Information Property and Equipment, net by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ia84a995d73354904960f0fc24a118169_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914062 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924063 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails",
     "shortName": "Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ecf01b3a62c43d0b2c44a81436e6681_D20210701-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i25d09281a7c14a70bbb09c9ca514ae47_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964067 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i7ba87bba31c44ccc98e13df2983e423b_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ia467dc323b074fc7af8717e8d527a287_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974068 - Disclosure - Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
     "shortName": "Share-Based Compensation (Additional Data Related to Restricted Share Unit Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cah:AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "ia467dc323b074fc7af8717e8d527a287_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "i6e641c3a7b314110b555c0df32c0642c_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984069 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cah-20220630.htm",
      "contextRef": "id0bdced14fdd46b6bfb7ccda7b355a44_I20200630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 137,
   "tag": {
    "cah_A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "label": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]",
        "terseLabel": "2.616% Notes, 3.2% Notes, 3.41% Notes, 4.6% Notes, 4.9% Notes and 4.368% Notes [Member]"
       }
      }
     },
     "localname": "A2.616Notes3.2Notes3.41Notes4.6Notes4.9Notesand4.368NotesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.616% Notes due 2022",
        "label": "2.616% Notes due 2022 [Member]",
        "terseLabel": "2.616% Notes due fiscal 2022"
       }
      }
     },
     "localname": "A2.616Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A200MillionShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$200 million share repurchase program",
        "label": "$200 million share repurchase program [Member]",
        "terseLabel": "$200 million share repurchase program [Member]"
       }
      }
     },
     "localname": "A200MillionShareRepurchaseProgramMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2021LTIPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 LTIP",
        "label": "2021 LTIP [Member]",
        "terseLabel": "2021 LTIP [Member]"
       }
      }
     },
     "localname": "A2021LTIPMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A24NotesDue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.4% Notes due 2019",
        "label": "2.4% Notes due 2019 [Member]",
        "terseLabel": "2.4% Notes due 2019"
       }
      }
     },
     "localname": "A24NotesDue2019Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.079Notesdue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.079% Notes due 2024",
        "label": "3.079% Notes due 2024 [Member]",
        "terseLabel": "3.079% Notes due fiscal 2024"
       }
      }
     },
     "localname": "A3.079Notesdue2024Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% Notes due 2022",
        "label": "3.2% Notes due 2022 [Member]",
        "terseLabel": "3.2% Notes due 2022"
       }
      }
     },
     "localname": "A3.2Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% Notes due 2023",
        "label": "3.2% Notes due 2023 [Member]",
        "terseLabel": "3.2% Notes due 2023"
       }
      }
     },
     "localname": "A3.2Notesdue2023Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.41Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.41% Notes due 2027",
        "label": "3.41% Notes due 2027 [Member]",
        "terseLabel": "3.41% Notes due fiscal 2027"
       }
      }
     },
     "localname": "A3.41Notesdue2027Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.5Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.5% Notes due 2025",
        "label": "3.5% Notes due 2025 [Member]",
        "terseLabel": "3.5% Notes due fiscal 2025"
       }
      }
     },
     "localname": "A3.5Notesdue2025Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.75Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.75% Notes due 2026",
        "label": "3.75% Notes due 2026 [Member]",
        "terseLabel": "3.75% Notes due 2025"
       }
      }
     },
     "localname": "A3.75Notesdue2026Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A300MillionShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$300 million share repurchase program",
        "label": "$300 million share repurchase program [Member]",
        "terseLabel": "$300 million share repurchase program [Member]"
       }
      }
     },
     "localname": "A300MillionShareRepurchaseProgramMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A32Notes2616NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.2% notes, 2.616% Notes",
        "label": "3.2% notes, 2.616% Notes [Member]",
        "terseLabel": "3.2% notes, 2.616% Notes"
       }
      }
     },
     "localname": "A32Notes2616NotesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.368Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.368% Notes due 2047",
        "label": "4.368% Notes due 2047 [Member]",
        "terseLabel": "4.368% Notes due fiscal 2047"
       }
      }
     },
     "localname": "A4.368Notesdue2047Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.5Notesdue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.5% Notes due 2044",
        "label": "4.5% Notes due 2044 [Member]",
        "terseLabel": "4.5% Notes due 2044"
       }
      }
     },
     "localname": "A4.5Notesdue2044Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.625Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% Notes due 2021",
        "label": "4.625% Notes due 2021 [Member]",
        "terseLabel": "4.625% Notes due 2020"
       }
      }
     },
     "localname": "A4.625Notesdue2021Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.6Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.6% Notes due 2043",
        "label": "4.6% Notes due 2043 [Member]",
        "terseLabel": "4.6% Notes due 2043"
       }
      }
     },
     "localname": "A4.6Notesdue2043Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.9Notesdue2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.9% Notes due 2045",
        "label": "4.9% Notes due 2045 [Member]",
        "terseLabel": "4.9% Notes due 2045"
       }
      }
     },
     "localname": "A4.9Notesdue2045Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A500MillionShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$500 million share repurchase program",
        "label": "$500 million share repurchase program [Member]",
        "terseLabel": "$500 million share repurchase program [Member]"
       }
      }
     },
     "localname": "A500MillionShareRepurchaseProgramMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A7.0Debenturesduefiscal2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.0% Debentures due fiscal 2027",
        "label": "7.0% Debentures due fiscal 2027 [Member]",
        "terseLabel": "7.0%\u00a0Debentures due 2026"
       }
      }
     },
     "localname": "A7.0Debenturesduefiscal2027Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ASC842Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC 842",
        "label": "ASC 842 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "ASC842Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AdditionalPerformanceShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Performance Share Units Data [Table Text Block]",
        "label": "Additional Performance Share Units Data [Table Text Block]",
        "terseLabel": "Additional Data Related to Performance Share Units Activity"
       }
      }
     },
     "localname": "AdditionalPerformanceShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "label": "Additional Restricted Shares And Restricted Share Units Data [Table Text Block]",
        "terseLabel": "Additional Restricted Shares and Restricted Share Units Activity"
       }
      }
     },
     "localname": "AdditionalRestrictedSharesAndRestrictedShareUnitsDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AggregateAnnualAssessment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Annual Assessment",
        "label": "Aggregate Annual Assessment",
        "terseLabel": "Aggregate Annual Assessment"
       }
      }
     },
     "localname": "AggregateAnnualAssessment",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_AlamedaCountyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alameda County [Member]",
        "label": "Alameda County [Member]",
        "terseLabel": "Alameda County [Member]"
       }
      }
     },
     "localname": "AlamedaCountyMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the costs incurred during and relating to an acquisition. These costs specifically include transaction and integration costs; changes in fair value of contingent consideration obligations and amortization of acquisition-related intangible assets, and are recorded within amortization and other acquisition-related costs.",
        "label": "Amortization and Other Acquisition Related Costs Policy [Policy Text Block]",
        "terseLabel": "Amortization and Other Acquisition-Related Costs"
       }
      }
     },
     "localname": "AmortizationandOtherAcquisitionRelatedCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_Amortizationandotheracquisitionrelatedcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Amortization and other acquisition-related costs",
        "terseLabel": "Amortization and other acquisition-related costs"
       }
      }
     },
     "localname": "Amortizationandotheracquisitionrelatedcosts",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_AssetsHeldforSalePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Held for Sale, Policy [Policy Text Block]",
        "label": "Assets Held for Sale, Policy [Policy Text Block]",
        "terseLabel": "Assets Held for Sale, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "AssetsHeldforSalePolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.cardinal.com/20220630",
     "xbrltype": "stringItemType"
    },
    "cah_AwardsOtherThanStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards Other than Stock Options [Member]",
        "label": "Awards Other than Stock Options [Member]",
        "terseLabel": "Awards Other than Stock Options"
       }
      }
     },
     "localname": "AwardsOtherThanStockOptionsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CVSCaremarkCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVS Caremark Corporation [Member]",
        "label": "CVS Caremark Corporation [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSCaremarkCorporationMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CardinalHealthAtHomeSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardinal Health At Home Solutions [Member]",
        "label": "Cardinal Health At Home Solutions [Member]",
        "terseLabel": "Cardinal Health At Home Solutions [Member]"
       }
      }
     },
     "localname": "CardinalHealthAtHomeSolutionsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CareFusionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CareFusion [Member]",
        "label": "CareFusion [Member]",
        "terseLabel": "CareFusion [Member]"
       }
      }
     },
     "localname": "CareFusionMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CarryingAmountofLongTermandotherShortTermBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "label": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "terseLabel": "Carrying Amount of Long-Term and other Short-Term Borrowings"
       }
      }
     },
     "localname": "CarryingAmountofLongTermandotherShortTermBorrowings",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Discounts [Policy Text Block]",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_CashReclassifiedtoAssetsHeldforSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CashReclassifiedtoAssetsHeldforSale",
        "label": "CashReclassifiedtoAssetsHeldforSale",
        "terseLabel": "Cash reclassified from/(to) assets held for sale"
       }
      }
     },
     "localname": "CashReclassifiedtoAssetsHeldforSale",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Action Lawsuits [Member]",
        "label": "Class Action Lawsuits [Member]",
        "terseLabel": "Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommittedReceivablesSalesFacilityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.",
        "label": "Committed Receivables Sales Facility Program [Member]",
        "terseLabel": "Committed Receivables Sales Facility Program"
       }
      }
     },
     "localname": "CommittedReceivablesSalesFacilityProgramMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommonStockVotingRightsVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Votes",
        "label": "Common Stock, Voting Rights, Votes",
        "terseLabel": "Common Stock, Voting Rights, Votes"
       }
      }
     },
     "localname": "CommonStockVotingRightsVotes",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cah_ConcentrationRiskLargestGroupPurchasingOrganizations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Largest Group Purchasing Organizations",
        "label": "Concentration Risk, Largest Group Purchasing Organizations",
        "terseLabel": "Largest group purchasing organizations"
       }
      }
     },
     "localname": "ConcentrationRiskLargestGroupPurchasingOrganizations",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_CordisDivestitureAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture",
        "label": "Cordis Divestiture [Axis]",
        "terseLabel": "Cordis Divestiture [Axis]"
       }
      }
     },
     "localname": "CordisDivestitureAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_CordisDivestitureDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture [Domain]",
        "label": "Cordis Divestiture [Domain]",
        "terseLabel": "Cordis Divestiture [Domain]"
       }
      }
     },
     "localname": "CordisDivestitureDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CordisDivestitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cordis Divestiture",
        "label": "Cordis Divestiture [Member]",
        "terseLabel": "Cordis Divestiture"
       }
      }
     },
     "localname": "CordisDivestitureMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CostofSalesVendorReservesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for allowances received from a vendor. The disclosure differentiates between those allowances that are recorded as a reduction in the price of the vendors' products or services (that is, the entity's inventory) and which ultimately will be recorded as a reduction in the entity's cost of sales and those that are not.",
        "label": "Cost of Sales, Vendor Reserves, Policy [Policy Text Block]",
        "terseLabel": "Vendor Reserves"
       }
      }
     },
     "localname": "CostofSalesVendorReservesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DOJInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DOJ Investigation",
        "label": "DOJ Investigation [Member]",
        "terseLabel": "DOJ Investigation"
       }
      }
     },
     "localname": "DOJInvestigationMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent",
        "negatedTerseLabel": "Deferred Income Taxes and Other Tax Liabilities, Transferred to Held for Sale, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DeferredTaxAssetsRelatedtouncertaintaxpositions": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets related to uncertain tax positions",
        "label": "Deferred Tax Assets, Related to uncertain tax positions",
        "terseLabel": "Deferred tax assets related to uncertain tax positions"
       }
      }
     },
     "localname": "DeferredTaxAssetsRelatedtouncertaintaxpositions",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount",
        "label": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount",
        "terseLabel": "Derivates, Hedge Discontinuances, Hedging Instrument Terminated, Amount"
       }
      }
     },
     "localname": "DerivatesHedgeDiscontinuancesHedgingInstrumentTerminatedAmount",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "label": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "terseLabel": "Derivatives, matured notional amounts"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DiscountRatefairvalueinputs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, fair value inputs",
        "label": "Discount Rate, fair value inputs",
        "terseLabel": "Discount Rate, fair value inputs"
       }
      }
     },
     "localname": "DiscountRatefairvalueinputs",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for fees received from distribution service agreements and other fees received from vendors related to the purchase or distribution of the vendor's inventory. Such fees are recognized as a reduction of inventory when those fees have been earned and the entity is entitled to payment.",
        "label": "Distribution Service Agreement And Other Vendor Fees [Policy Text Block]",
        "terseLabel": "Distribution Service Agreement and Other Vendor Fees"
       }
      }
     },
     "localname": "DistributionServiceAgreementAndOtherVendorFeesPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_DividendsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends, Policy [Policy Text Block]",
        "label": "Dividends, Policy [Policy Text Block]",
        "terseLabel": "Dividends, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DividendsPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationLossCarrybackClaims": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Loss Carryback Claims",
        "label": "Effective Income Tax Rate Reconciliation, Loss Carryback Claims",
        "terseLabel": "Loss Carryback Claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLossCarrybackClaims",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations",
        "label": "Effective Income Tax Rate Reconciliation, Tax Effect of Foreign Operations",
        "terseLabel": "Tax effect of foreign operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxRateReconciliationWithholdingTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Withholding Taxes",
        "label": "Effective Income Tax Rate Reconciliation, Withholding Taxes",
        "terseLabel": "Withholding Taxes (2)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWithholdingTaxes",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveIncomeTaxReconciliationOpioidLitigation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Opioid Litigation",
        "label": "Effective Income Tax Reconciliation, Opioid Litigation",
        "terseLabel": "Opioid litigation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationOpioidLitigation",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveTaxRateImpactFromCertainForeignJurisdictions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "label": "Effective Tax Rate Impact From Certain Foreign Jurisdictions",
        "terseLabel": "Effective Tax Rate Impact From Certain Foreign Jurisdictions"
       }
      }
     },
     "localname": "EffectiveTaxRateImpactFromCertainForeignJurisdictions",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters",
        "label": "Effective Tax Rate Reconciliation, Impact of Resolutions with IRS and other related matters",
        "terseLabel": "Impact of Resolutions with IRS and other related matters (2)"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate Reconciliation, US Taxes on International Income",
        "label": "Effective Tax Rate Reconciliation, US Taxes on International Income",
        "terseLabel": "US Taxes on International Income (2)(3)"
       }
      }
     },
     "localname": "EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Liability for New York Opioid Stewardship Act",
        "label": "Estimated Liability for New York Opioid Stewardship Act",
        "terseLabel": "Estimated Liability for New York Opioid Stewardship Act"
       }
      }
     },
     "localname": "EstimatedLiabilityForNewYorkOpioidStewardshipAct",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FacilityExitAndOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.",
        "label": "Facility Exit and Other Costs",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityExitAndOtherCosts",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Imputed Interest",
        "label": "Finance Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Member]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FixedRateDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Rate Debt [Member]",
        "label": "Fixed Rate Debt [Member]",
        "terseLabel": "Fixed-Rate Debt"
       }
      }
     },
     "localname": "FixedRateDebtMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotes2616NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating rate notes, 2.616% Notes",
        "label": "Floating rate notes, 2.616% Notes [Member]",
        "terseLabel": "Floating rate notes, 2.616% Notes"
       }
      }
     },
     "localname": "FloatingRateNotes2616NotesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes due 2022",
        "label": "Floating Rate Notes due 2022 [Member]",
        "terseLabel": "Floating Rate Notes due fiscal 2022"
       }
      }
     },
     "localname": "FloatingRateNotesdue2022Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GainonDivestitureAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on Divestiture After Tax",
        "label": "Gain on Divestiture After Tax",
        "terseLabel": "Gain on Divestiture After Tax"
       }
      }
     },
     "localname": "GainonDivestitureAfterTax",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_GoodsandservicessoldLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for goods and services sold [Table]",
        "label": "goods and services sold [Line Items]",
        "terseLabel": "Distribution, selling, general and administrative expenses [Line Items]"
       }
      }
     },
     "localname": "GoodsandservicessoldLineItems",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodsandservicessoldTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "goods and services sold [Table]",
        "label": "goods and services sold [Table]",
        "terseLabel": "Distribution, selling, general and administrative expenses [Table]"
       }
      }
     },
     "localname": "GoodsandservicessoldTable",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Line Items]",
        "label": "Goodwill and Intangible Assets [Line Items]",
        "terseLabel": "Goodwill and Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsLineItems",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillAndIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Table]",
        "label": "Goodwill and Intangible Assets [Table]",
        "terseLabel": "Goodwill and Intangible Assets [Table]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsTable",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillImpairmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment",
        "label": "Goodwill Impairment [Axis]",
        "terseLabel": "Goodwill Impairment [Axis]"
       }
      }
     },
     "localname": "GoodwillImpairmentAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GoodwillImpairmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment",
        "label": "Goodwill Impairment [Domain]",
        "terseLabel": "Goodwill Impairment [Domain]"
       }
      }
     },
     "localname": "GoodwillImpairmentDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gown Recall [Axis]",
        "label": "Gown Recall [Axis]",
        "terseLabel": "Gown Recall [Axis]"
       }
      }
     },
     "localname": "GownRecallAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gown Recall [Axis]",
        "label": "Gown Recall [Domain]",
        "terseLabel": "Gown Recall [Domain]"
       }
      }
     },
     "localname": "GownRecallDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GrossTradeReceivablesMajorCustomerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Trade Receivables, Major Customer Percentage",
        "label": "Gross Trade Receivables, Major Customer Percentage",
        "terseLabel": "Percent\u00a0of\u00a0Gross Trade\u00a0Receivables"
       }
      }
     },
     "localname": "GrossTradeReceivablesMajorCustomerPercentage",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_GroupPurchasingOrganizationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Purchasing Organizations [Member]",
        "label": "Group Purchasing Organizations [Member]",
        "terseLabel": "Group Purchasing Organizations"
       }
      }
     },
     "localname": "GroupPurchasingOrganizationsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IPRDTrademarksandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "IPR&amp;D,TrademarksandOther [Member]",
        "terseLabel": "Trademarks and patents"
       }
      }
     },
     "localname": "IPRDTrademarksandOtherMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Impactofadoptionofnewaccountingstandard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "impact of adoption of new accounting standard",
        "label": "impact of adoption of new accounting standard",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "Impactofadoptionofnewaccountingstandard",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IncomefromSettlementsofClassActionLawsuits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income from Settlements of Class Action Lawsuits",
        "label": "Income from Settlements of Class Action Lawsuits",
        "terseLabel": "Income from Settlements of Class Action Lawsuits"
       }
      }
     },
     "localname": "IncomefromSettlementsofClassActionLawsuits",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IndemnificationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.",
        "label": "Indemnification Receivable",
        "terseLabel": "Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority"
       }
      }
     },
     "localname": "IndemnificationReceivable",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_InventoryReserveExcessAndObsoleteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Reserve Excess and Obsolete",
        "label": "Inventory Reserve Excess and Obsolete [Member]",
        "terseLabel": "Inventory Reserve Excess and Obsolete [Member]"
       }
      }
     },
     "localname": "InventoryReserveExcessAndObsoleteMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_InventoryReserveTableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Reserve Table [Line Items]",
        "label": "Inventory Reserve Table [Line Items]",
        "terseLabel": "Inventory Reserve Table [Line Items]"
       }
      }
     },
     "localname": "InventoryReserveTableLineItems",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_InventoryReserveTableTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Reserve Table",
        "label": "Inventory Reserve Table [Table]",
        "terseLabel": "Inventory Reserve Table [Table]"
       }
      }
     },
     "localname": "InventoryReserveTableTable",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_InventoryReserveWriteDownToNetRealizableValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Reserve - Write-down to Net Realizable Value",
        "label": "Inventory Reserve - Write-down to Net Realizable Value [Member]",
        "terseLabel": "Inventory Reserve Write-down to Net Realizable Value [Member]"
       }
      }
     },
     "localname": "InventoryReserveWriteDownToNetRealizableValueMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_JudgmentForLostProfits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judgment for lost profits",
        "label": "Judgment for lost profits",
        "terseLabel": "Judgment for lost profits"
       }
      }
     },
     "localname": "JudgmentForLostProfits",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_June2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2027",
        "label": "June 2027 [Member]",
        "terseLabel": "June 2027 [Member]"
       }
      }
     },
     "localname": "June2027Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LawsuitTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Axis]",
        "terseLabel": "Lawsuit Type [Axis]"
       }
      }
     },
     "localname": "LawsuitTypeAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LawsuitTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Domain]",
        "terseLabel": "Lawsuit Type [Domain]"
       }
      }
     },
     "localname": "LawsuitTypeDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Lease Payments [Table]",
        "label": "Lease Payments [Table Text Block]",
        "terseLabel": "Leases Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeasePaymentsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesSupplementalBalanceSheetInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]",
        "label": "LeasesSupplementalBalanceSheetInformation [Table Text Block]",
        "terseLabel": "Leases Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LeasesSupplementalBalanceSheetInformationTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due After Year Five",
        "label": "Lessee Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Five",
        "label": "Lessee Lease Liability Payments Due Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Four",
        "label": "Lessee Lease Liability Payments Due Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year One",
        "label": "Lessee Lease Liability Payments Due Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Three",
        "label": "Lessee Lease Liability Payments Due Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Two",
        "label": "Lessee Lease Liability Payments Due Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LitigationTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Type [Axis]",
        "label": "Litigation Type [Axis]",
        "terseLabel": "Litigation Type [Axis]"
       }
      }
     },
     "localname": "LitigationTypeAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LitigationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Litigation Type [Axis]",
        "label": "Litigation Type [Domain]",
        "terseLabel": "Litigation Type [Domain]"
       }
      }
     },
     "localname": "LitigationTypeDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LossContingencyLawsuitsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Lawsuits, Number",
        "label": "Loss Contingency, Lawsuits, Number",
        "terseLabel": "Loss Contingency, Lawsuits, Number"
       }
      }
     },
     "localname": "LossContingencyLawsuitsNumber",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_LossContingencyNumberOfEligibleStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible States",
        "label": "Loss Contingency, Number of Eligible States",
        "terseLabel": "Loss Contingency, Number of Eligible States"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleStates",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_MaturityDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity Date",
        "label": "Maturity Date [Axis]",
        "terseLabel": "Maturity Date [Axis]"
       }
      }
     },
     "localname": "MaturityDateAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_MaturityDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity Date",
        "label": "Maturity Date [Domain]",
        "terseLabel": "Maturity Date [Domain]"
       }
      }
     },
     "localname": "MaturityDateDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical Member [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMemberMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalUnitGoodwillImpairmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Unit Goodwill Impairment",
        "label": "Medical Unit Goodwill Impairment [Member]",
        "terseLabel": "Medical Unit Goodwill Impairment [Member]"
       }
      }
     },
     "localname": "MedicalUnitGoodwillImpairmentMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Unit",
        "label": "Medical Unit [Member]",
        "terseLabel": "Medical Unit"
       }
      }
     },
     "localname": "MedicalUnitMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicaldistributionandproductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical distribution and products [Member]",
        "label": "Medical distribution and products [Member]",
        "terseLabel": "Medical distribution and products [Member]"
       }
      }
     },
     "localname": "MedicaldistributionandproductsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth",
        "label": "naviHealth [Axis]",
        "terseLabel": "naviHealth [Axis]"
       }
      }
     },
     "localname": "NaviHealthAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_NaviHealthDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth [Domain]",
        "label": "naviHealth [Domain]",
        "terseLabel": "naviHealth [Domain]"
       }
      }
     },
     "localname": "NaviHealthDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "naviHealth [Member]",
        "label": "naviHealth [Member]",
        "terseLabel": "naviHealth [Member]"
       }
      }
     },
     "localname": "NaviHealthMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "label": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net Earnings Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NetOperatingLossCarrybackAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback",
        "label": "Net Operating Loss Carryback [Axis]",
        "terseLabel": "Net Operating Loss Carryback [Axis]"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_NetOperatingLossCarrybackDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback [Domain]",
        "label": "Net Operating Loss Carryback [Domain]",
        "terseLabel": "Net Operating Loss Carryback [Domain]"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NetOperatingLossCarrybackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryback",
        "label": "Net Operating Loss Carryback [Member]",
        "terseLabel": "Net Operating Loss Carryback"
       }
      }
     },
     "localname": "NetOperatingLossCarrybackMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Netproceedstaxwithholdingsfromsharebasedcompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.",
        "label": "Net proceeds/(tax withholdings) from share-based compensation",
        "terseLabel": "Net tax proceeds/(withholding) from share-based compensation"
       }
      }
     },
     "localname": "Netproceedstaxwithholdingsfromsharebasedcompensation",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NewYorkOpioidStewardshipActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Stewardship Act",
        "label": "New York Opioid Stewardship Act [Member]",
        "terseLabel": "New York Opioid Stewardship Act"
       }
      }
     },
     "localname": "NewYorkOpioidStewardshipActMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NotesPayableRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Amount of Notes Payable Repurchased during the year",
        "label": "Notes Payable Repurchased",
        "terseLabel": "Notes Payable Repurchased"
       }
      }
     },
     "localname": "NotesPayableRepurchased",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NuclearPrecisionHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nuclear Precision Health Services [Member]",
        "label": "Nuclear Precision Health Services [Member]",
        "terseLabel": "Nuclear Precision Health Services [Member]"
       }
      }
     },
     "localname": "NuclearPrecisionHealthServicesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OfferAsPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount that the company is required to offer to purchase certain notes, under certain circumstances.",
        "label": "Offer As Percentage Of Principal Amount",
        "terseLabel": "Offer as percentage of principal amount"
       }
      }
     },
     "localname": "OfferAsPercentageOfPrincipalAmount",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_OperatingLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Imputed Interest",
        "label": "Operating Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "OperatingLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Lawsuits [Member]",
        "label": "Opioid Lawsuits [Member]",
        "terseLabel": "Opioid Lawsuits"
       }
      }
     },
     "localname": "OpioidLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Litigation",
        "label": "Opioid Litigation [Axis]",
        "terseLabel": "Opioid Litigation [Axis]"
       }
      }
     },
     "localname": "OpioidLitigationAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_OpioidLitigationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Litigation [Domain]",
        "label": "Opioid Litigation [Domain]",
        "terseLabel": "Opioid Litigation [Domain]"
       }
      }
     },
     "localname": "OpioidLitigationDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OptumRxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumRx [Member]",
        "label": "OptumRx [Member]",
        "terseLabel": "OptumRx [Member]"
       }
      }
     },
     "localname": "OptumRxMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OtherAccruedLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "label": "Other Accrued Liabilities, Policy [Policy Text Block]",
        "terseLabel": "Other Accrued Liabilities, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_OtherJurisdictionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Jurisdictions [Member]",
        "label": "Other Jurisdictions [Member]",
        "terseLabel": "Other Jurisdictions [Member]"
       }
      }
     },
     "localname": "OtherJurisdictionsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PatientRecoveryBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Recovery Business [Member]",
        "label": "Patient Recovery Business [Member]",
        "terseLabel": "Patient Recovery Business [Member]"
       }
      }
     },
     "localname": "PatientRecoveryBusinessMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalDistributionandSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Distribution and Specialty [Member]",
        "label": "Pharmaceutical Distribution and Specialty [Member]",
        "terseLabel": "Pharmaceutical Distribution and Specialty [Member]"
       }
      }
     },
     "localname": "PharmaceuticalDistributionandSpecialtyMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical [Member]",
        "label": "Pharmaceutical Member",
        "terseLabel": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PlaintiffTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Axis]",
        "terseLabel": "Plaintiff Type [Axis]"
       }
      }
     },
     "localname": "PlaintiffTypeAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PlaintiffTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Domain]",
        "terseLabel": "Plaintiff Type [Domain]"
       }
      }
     },
     "localname": "PlaintiffTypeDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PricingDisputesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to pricing disputes, excluded from provision for bad debts in the consolidated statements of cash flows and recorded as a reduction in gross margin in the consolidated statements of earnings.",
        "label": "Pricing Disputes [Member]",
        "terseLabel": "Pricing Disputes [Member]"
       }
      }
     },
     "localname": "PricingDisputesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PriorYearRecoveriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Year Recoveries [Member]",
        "label": "Prior Year Recoveries [Member]",
        "terseLabel": "Prior Year Recoveries"
       }
      }
     },
     "localname": "PriorYearRecoveriesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PrivatePartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Parties [Member]",
        "label": "Private Parties [Member]",
        "terseLabel": "Private Parties [Member]"
       }
      }
     },
     "localname": "PrivatePartiesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of available-for-sale securities and other investments.",
        "label": "Proceeds from sale of available-for-sale securities and other investments",
        "terseLabel": "Proceeds from sale of investments"
       }
      }
     },
     "localname": "Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ProductLiabilityLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Lawsuits [Member]",
        "label": "Product Liability Lawsuits [Member]",
        "terseLabel": "Product Liability Lawsuits"
       }
      }
     },
     "localname": "ProductLiabilityLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ProjectCostsOnInvestmentAndOtherSpending": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.",
        "label": "Project Costs On Investment And Other Spending",
        "terseLabel": "Project costs on investment and other spending"
       }
      }
     },
     "localname": "ProjectCostsOnInvestmentAndOtherSpending",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Purchaseofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from purchases of available-for-sale securities and other investments.",
        "label": "Purchase of available-for-sale securities and other investments",
        "negatedLabel": "Purchase of other investments"
       }
      }
     },
     "localname": "Purchaseofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ReceivableFinancingAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivable Financing Agreement Term",
        "label": "Receivable Financing Agreement Term",
        "terseLabel": "Receivable financing agreement term"
       }
      }
     },
     "localname": "ReceivableFinancingAgreementTerm",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_ReclassificationofdeferredrentinaccordancewithASC842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of deferred rent in accordance with ASC 842",
        "label": "Reclassification of deferred rent in accordance with ASC 842",
        "terseLabel": "Reclassification of deferred rent in accordance with ASC 842"
       }
      }
     },
     "localname": "ReclassificationofdeferredrentinaccordancewithASC842",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_RevenueRecognitionReserveforSalesReturnsandAllowances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "label": "Revenue Recognition, Reserve for Sales Returns and Allowances",
        "terseLabel": "Accrual for estimated sales returns and allowances"
       }
      }
     },
     "localname": "RevenueRecognitionReserveforSalesReturnsandAllowances",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_SalesreturnsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "sales returns [Policy Text Block]",
        "label": "sales returns [Policy Text Block]",
        "terseLabel": "Sales Returns and Allowances"
       }
      }
     },
     "localname": "SalesreturnsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "label": "Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAfterNettingByTaxJurisdictionTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarizes the fair value and notional amounts of derivative instruments held as of the balance sheet date.",
        "label": "Schedule Of Fair Value Gain Loss Derivative Instrument [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Gain/(Loss) Derivative Instrument"
       }
      }
     },
     "localname": "ScheduleOfFairValueGainLossDerivativeInstrumentTableTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_September2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2025",
        "label": "September 2025 [Member]",
        "terseLabel": "September 2025 [Member]"
       }
      }
     },
     "localname": "September2025Member",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SettlingStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling States",
        "label": "Settling States",
        "terseLabel": "Loss Contingency, Number of State"
       }
      }
     },
     "localname": "SettlingStates",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_SettlingUSTerritories": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling U.S Territories",
        "label": "Settling U.S Territories",
        "terseLabel": "Settling U.S Territories"
       }
      }
     },
     "localname": "SettlingUSTerritories",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_ShareRepurchaseProgramAggregatePurchasePriceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share repurchase program aggregate purchase price",
        "label": "Share repurchase program aggregate purchase price [Axis]",
        "terseLabel": "Share repurchase program aggregate purchase price [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAggregatePurchasePriceAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_ShareRepurchaseProgramAggregatePurchasePriceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program Aggregate Purchase Price",
        "label": "Share Repurchase Program Aggregate Purchase Price [Domain]",
        "terseLabel": "Share Repurchase Program Aggregate Purchase Price [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAggregatePurchasePriceDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Sharesthatwouldbeantidilutiveasaresultofnetloss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shares that would be antidilutive as a result of net loss",
        "label": "shares that would be antidilutive as a result of net loss",
        "terseLabel": "shares that would be antidilutive as a result of net loss"
       }
      }
     },
     "localname": "Sharesthatwouldbeantidilutiveasaresultofnetloss",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_ShippingandHandlingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ShippingandHandlingCosts [Policy Text Block]",
        "label": "ShippingandHandlingCosts [Policy Text Block]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingandHandlingCostsPolicyTextBlock",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_ShortTermCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other short-term credit facilities and an unsecured line of credit",
        "label": "Short Term Credit Facilities Member",
        "terseLabel": "Short Term Credit Facilities"
       }
      }
     },
     "localname": "ShortTermCreditFacilitiesMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall",
        "label": "Sterile Surgical Gown Recall [Axis]",
        "terseLabel": "Sterile Surgical Gown Recall [Axis]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_SterileSurgicalGownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Domain]",
        "label": "Sterile Surgical Gown Recall [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallMemberDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Member] [Domain]",
        "label": "Sterile Surgical Gown Recall [Member] [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Member] [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallMemberDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxMatterAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Matter [Axis]",
        "label": "Tax Matter [Axis]",
        "terseLabel": "Tax Matter [Axis]"
       }
      }
     },
     "localname": "TaxMatterAxis",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Tax Matter [Axis]",
        "label": "Tax Matter [Domain]",
        "terseLabel": "Tax Matter [Domain]"
       }
      }
     },
     "localname": "TaxMatterDomain",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TerminalGrowthRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminal Growth Rate, Fair Value Input",
        "label": "Terminal Growth Rate, Fair Value Input",
        "terseLabel": "Terminal Growth Rate, Fair Value Input"
       }
      }
     },
     "localname": "TerminalGrowthRateFairValueInput",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total Lease Liability"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total undiscounted Lease Liability Payments Due for both operating and financing leases",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalOpioidLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Opioid Litigation",
        "label": "Total Opioid Litigation [Member]",
        "terseLabel": "Total Opioid Litigation [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TrademarksAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Trademarks And Patents Member",
        "terseLabel": "Trademarks, trade names and patents"
       }
      }
     },
     "localname": "TrademarksAndPatentsMember",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_VendorReserves": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of reserves, relating to vendor disputes or deductions, that are netted against vendor liabilities in the ordinary course of business.",
        "label": "Vendor Reserves",
        "terseLabel": "Vendor reserves"
       }
      }
     },
     "localname": "VendorReserves",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeVendorReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_VestingPeriodinyearsforShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Period in years for Shares",
        "label": "Vesting Period in years for Shares",
        "terseLabel": "Vesting Period in years for Shares"
       }
      }
     },
     "localname": "VestingPeriodinyearsforShares",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_WriteDownOfAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-down of assets held for sale",
        "label": "Write-down of assets held for sale",
        "terseLabel": "Write-down of assets held for sale"
       }
      }
     },
     "localname": "WriteDownOfAssetsHeldForSale",
     "nsuri": "http://www.cardinal.com/20220630",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r127",
      "r192",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r212",
      "r216",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r334",
      "r336",
      "r337",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r127",
      "r192",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r212",
      "r216",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r334",
      "r336",
      "r337",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r225",
      "r404",
      "r407",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r313",
      "r315",
      "r316",
      "r317",
      "r342",
      "r379",
      "r419",
      "r421",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r743",
      "r747",
      "r778",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r313",
      "r315",
      "r316",
      "r317",
      "r342",
      "r379",
      "r419",
      "r421",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r743",
      "r747",
      "r778",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r225",
      "r404",
      "r407",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r219",
      "r315",
      "r316",
      "r404",
      "r405",
      "r689",
      "r742",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r219",
      "r315",
      "r316",
      "r404",
      "r405",
      "r689",
      "r742",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r287",
      "r313",
      "r315",
      "r316",
      "r317",
      "r342",
      "r379",
      "r408",
      "r419",
      "r421",
      "r452",
      "r453",
      "r454",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r743",
      "r747",
      "r778",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r287",
      "r313",
      "r315",
      "r316",
      "r317",
      "r342",
      "r379",
      "r408",
      "r419",
      "r421",
      "r452",
      "r453",
      "r454",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r743",
      "r747",
      "r778",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r220",
      "r221",
      "r404",
      "r406",
      "r745",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r790",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r220",
      "r221",
      "r404",
      "r406",
      "r745",
      "r763",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r134",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_GA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEORGIA",
        "terseLabel": "GEORGIA"
       }
      }
     },
     "localname": "GA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OKLAHOMA",
        "terseLabel": "OKLAHOMA"
       }
      }
     },
     "localname": "OK",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WASHINGTON",
        "terseLabel": "WASHINGTON"
       }
      }
     },
     "localname": "WA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEST VIRGINIA",
        "terseLabel": "WEST VIRGINIA"
       }
      }
     },
     "localname": "WV",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r44",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r705",
      "r731"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable",
        "terseLabel": "Accounts Payable"
       }
      }
     },
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r18",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r58",
      "r64",
      "r72",
      "r73",
      "r74",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments and Other"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r59",
      "r64",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gain/(Loss) on Derivatives, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r61",
      "r63",
      "r64",
      "r725",
      "r755",
      "r759"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r64",
      "r72",
      "r73",
      "r74",
      "r137",
      "r138",
      "r139",
      "r543",
      "r672",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r140",
      "r141",
      "r142",
      "r143",
      "r152",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r463",
      "r464",
      "r465",
      "r503",
      "r504",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r637",
      "r638",
      "r645",
      "r646",
      "r647",
      "r648",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r691",
      "r692",
      "r693",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForLossesOnFinanceReceivablesMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of investment in contractual right to receive money on demand or on fixed or determinable date recognized as asset in creditor's statement of financial position.",
        "label": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]",
        "verboseLabel": "SEC Schedule, 12-09, Allowance, Loss on Finance Receivable [Member]"
       }
      }
     },
     "localname": "AllowanceForLossesOnFinanceReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r108",
      "r266",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r60",
      "r64",
      "r72",
      "r73",
      "r74",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r22",
      "r122",
      "r200",
      "r207",
      "r214",
      "r237",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r536",
      "r544",
      "r618",
      "r673",
      "r675",
      "r697",
      "r723"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r13",
      "r42",
      "r122",
      "r237",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r536",
      "r544",
      "r618",
      "r673",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r285"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r560",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r418",
      "r420",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "verboseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r418",
      "r420",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r525",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r11",
      "r16",
      "r110"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r102",
      "r110",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and equivalents at end of period",
        "periodStartLabel": "Cash and equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r102",
      "r627"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "terseLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r119",
      "r122",
      "r155",
      "r156",
      "r157",
      "r159",
      "r161",
      "r171",
      "r172",
      "r173",
      "r237",
      "r324",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r377",
      "r378",
      "r382",
      "r386",
      "r393",
      "r618",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r318",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingent Liabilities and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r321",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityContractMember": {
     "auth_ref": [
      "r409",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.",
        "label": "Commodity Contract [Member]",
        "terseLabel": "Commodity Contracts"
       }
      }
     },
     "localname": "CommodityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends per common share (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r137",
      "r138",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]",
        "terseLabel": "Common shares, without par value:"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Authorized\u2014755 million shares, Issued\u2014 327 million shares at June 30, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r70",
      "r82",
      "r711",
      "r736"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r69",
      "r81",
      "r534",
      "r548",
      "r710",
      "r735"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r225",
      "r615",
      "r616",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r225",
      "r615",
      "r616",
      "r761",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r225",
      "r615",
      "r616",
      "r761",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r176",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r181",
      "r182",
      "r225",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue, major customer, percentage",
        "verboseLabel": "Percent of Revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r183",
      "r615",
      "r617",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r225",
      "r615",
      "r616",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r88",
      "r689"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r409",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r499",
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "verboseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r499"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r499",
      "r509",
      "r511"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r499",
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r180",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r704",
      "r732"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "totalLabel": "Total",
        "verboseLabel": "Carrying amount"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r356",
      "r363",
      "r364",
      "r366",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r121",
      "r127",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r367",
      "r368",
      "r369",
      "r370",
      "r643",
      "r698",
      "r700",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r354",
      "r367",
      "r368",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48",
      "r121",
      "r127",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r367",
      "r368",
      "r369",
      "r370",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r121",
      "r127",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r394",
      "r397",
      "r398",
      "r399",
      "r640",
      "r641",
      "r643",
      "r644",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Estimated range of decrease in unrecognized tax benefits within the next 12 months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r500",
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Federal",
        "terseLabel": "Federal",
        "verboseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r500",
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S.",
        "verboseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge": {
     "auth_ref": [
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective interest rate fair value hedge that is amortized upon discontinuation of the interest rate fair value hedge.",
        "label": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge",
        "terseLabel": "Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge"
       }
      }
     },
     "localname": "DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r123",
      "r500",
      "r509",
      "r510",
      "r511"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Provision for/(benefit from) deferred income taxes",
        "totalLabel": "Total deferred",
        "verboseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r26",
      "r27",
      "r489",
      "r699",
      "r721"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent",
        "terseLabel": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r123",
      "r500",
      "r509"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local",
        "verboseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes and other liabilities"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r495",
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "negatedLabel": "Deferred tax assets on tax credit carryforwards",
        "terseLabel": "Loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Receivable basis difference"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r472",
      "r492"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesAfterNettingbyTaxJurisdictionDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedLabel": "Inventory basis differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from reserves and accruals.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals",
        "negatedTerseLabel": "Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Deferred Tax Liabilities, Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r497",
      "r498"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property-related"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total expense on employee retirement savings plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r108",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r108",
      "r195"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Total depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r551",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional Amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r54",
      "r55",
      "r56",
      "r564",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r54",
      "r55",
      "r56",
      "r564",
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair\u00a0Value Gain/(Loss)"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain/(loss) on derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r55",
      "r561",
      "r565",
      "r571",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r558",
      "r561",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r569",
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Gain/(loss) reclassified from AOCI into earnings for derivative instruments designated as cash flow hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r570",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain/(loss) recognized in earnings for economic (non-designated) derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r551",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative Liability, Notional Amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r550",
      "r553",
      "r554",
      "r558",
      "r559",
      "r567",
      "r571",
      "r583",
      "r584",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.",
        "label": "Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]",
        "terseLabel": "Interest Rate, Currency and Commodity Risk"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingHedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed technology and other"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r424",
      "r425",
      "r458",
      "r459",
      "r461",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedTerseLabel": "Disposal Group, Including Discontinued Operation, Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r400",
      "r716"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r83",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r153",
      "r155",
      "r159",
      "r160",
      "r161",
      "r166",
      "r167",
      "r601",
      "r602",
      "r712",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings/(loss) per common share attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r83",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r155",
      "r159",
      "r160",
      "r161",
      "r166",
      "r167",
      "r601",
      "r602",
      "r712",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per common share attributable to Cardinal Health, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share Attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r627"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rates changes on cash and equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r125",
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Provision at Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in Valuation Allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "terseLabel": "Impact of Divestitures"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Nondeductible/nontaxable items (2)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "verboseLabel": "Goodwill Impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
        "terseLabel": "Other (2)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r474",
      "r513"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "netLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "netLabel": "Weighted-average period over which performance share unit cost is expected to be recognized (in years)",
        "terseLabel": "Weighted-average period over which stock option compensation cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to share-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee- Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r72",
      "r73",
      "r74",
      "r137",
      "r138",
      "r139",
      "r141",
      "r149",
      "r151",
      "r170",
      "r241",
      "r393",
      "r400",
      "r463",
      "r464",
      "r465",
      "r505",
      "r506",
      "r600",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r634",
      "r672",
      "r750",
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r604",
      "r605",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r608",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r354",
      "r367",
      "r368",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r605",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r604",
      "r605",
      "r606",
      "r607",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r354",
      "r409",
      "r410",
      "r415",
      "r416",
      "r605",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r354",
      "r367",
      "r368",
      "r409",
      "r410",
      "r415",
      "r416",
      "r605",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r354",
      "r367",
      "r368",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r605",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r354",
      "r367",
      "r368",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r610",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsReconciliationofLiabilitiesMeasuredatFairValueonaRecurringBasisUsingUnobservableInputsLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r560",
      "r567",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r650",
      "r665"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments for Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r653",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r649"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r652",
      "r657",
      "r666"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r663",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r662",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r20",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization of intangible assets - 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization of intangible assets - 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization of intangible assets - 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization of intangible assets - 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization of intangible assets - 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r267",
      "r269",
      "r273",
      "r277",
      "r690",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r273",
      "r694"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r267",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r273",
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r55",
      "r409",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Currency Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "(Gain)/Loss on sale of equity interest in naviHealth"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherInvestments": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) included in earnings for investments classified as other.",
        "label": "Gain (Loss) on Sale of Other Investments",
        "negatedTerseLabel": "Impairments and loss on sale of other investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Impairments and (gain)/loss on disposal of assets, net"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r310"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation (recoveries)/charges, net",
        "terseLabel": "Gain (Loss) Related to Litigation Settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r85",
      "r86",
      "r108",
      "r706",
      "r738"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on Sale of Investments",
        "terseLabel": "Gain on Sale of Investments"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r108",
      "r371",
      "r372"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r19",
      "r251",
      "r253",
      "r260",
      "r264",
      "r675",
      "r696"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r254",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r261",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r253",
      "r260",
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r108",
      "r252",
      "r257",
      "r263",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r87",
      "r122",
      "r200",
      "r206",
      "r210",
      "r213",
      "r216",
      "r237",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r618"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r558",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r124",
      "r512"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r78",
      "r200",
      "r206",
      "r210",
      "r213",
      "r216",
      "r695",
      "r707",
      "r714",
      "r740"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings/(loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r124",
      "r512"
     ],
     "calculation": {
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofIncomebeforeIncomeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r284",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r479",
      "r486",
      "r488",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r475",
      "r487",
      "r494",
      "r507",
      "r514",
      "r518",
      "r519",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r150",
      "r151",
      "r198",
      "r473",
      "r508",
      "r516",
      "r741"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax Expense (Benefit)",
        "totalLabel": "Provision for/(benefit from) income taxes",
        "verboseLabel": "Provision for/(benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitCurrentandDeferredDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r71",
      "r470",
      "r471",
      "r487",
      "r488",
      "r493",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r31",
      "r720"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income Taxes Receivable",
        "terseLabel": "Income Taxes Receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Net cash payments/(refunds) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other accrued liabilities and operating items, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "(Increase)/decrease in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r268",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r268",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r265",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r76",
      "r194",
      "r639",
      "r642",
      "r713"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest Income (Expense), Nonoperating, Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r103",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash payments for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofFairValueGainLossDerivativeInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforInterestRateContractsDesignatedasFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsCashFlowHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsFairValueHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryofEstimatedFairValueofLongtermObligationsandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "Inventories valued at LIFO amount higher than average cost value"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r12",
      "r40",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r38",
      "r115",
      "r169",
      "r246",
      "r248",
      "r250",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r40",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Reserves for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r236",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, building and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r664",
      "r666"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r36",
      "r122",
      "r237",
      "r618",
      "r675",
      "r702",
      "r728"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity/(deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity/(Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r47",
      "r122",
      "r237",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r537",
      "r544",
      "r545",
      "r618",
      "r673",
      "r674",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r285"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities related to assets held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails",
      "http://www.cardinal.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r25",
      "r700",
      "r722"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Long-term Line of Credit",
        "verboseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average amount borrowed under the credit facility during the period.",
        "label": "Line of Credit Facility, Average Outstanding Amount",
        "terseLabel": "Average amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityAverageOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r45",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r45",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount borrowed under the credit facility at any time during the period.",
        "label": "Line of Credit Facility, Maximum Amount Outstanding During Period",
        "terseLabel": "Line of Credit Facility, Maximum Amount Outstanding During Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity",
        "verboseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r45",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r49",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r49",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Estimated Litigation Liability, Current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Property and Equipment, Net by Geographic Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term obligations and other short-term borrowings",
        "verboseLabel": "Less: current portion of long-term obligations and other short-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings - 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r127",
      "r323",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Maturities of existing long-term obligations and other short-term borrowings-2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "verboseLabel": "Interest rate on long-term projects (approximates weighted-average on long-term obligations)"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesLossContingenciesDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Loss Contingency Accrual, Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [
      "r312",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Loss Contingency, Claims Settled, Number"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r313",
      "r315",
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r312",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of lawsuits filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r312",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r312",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Loss Contingency, Pending Claims, Number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r179",
      "r181",
      "r182",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Major Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r122",
      "r237",
      "r324",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r618",
      "r701",
      "r727"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r102",
      "r105",
      "r109"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r10",
      "r65",
      "r68",
      "r74",
      "r79",
      "r109",
      "r122",
      "r140",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r158",
      "r200",
      "r206",
      "r210",
      "r213",
      "r216",
      "r237",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r602",
      "r618",
      "r708",
      "r733"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc.",
        "verboseLabel": "Net Income (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r65",
      "r68",
      "r74",
      "r150",
      "r151",
      "r540",
      "r547"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net earnings attributable to noncontrolling interest",
        "negatedTerseLabel": "Less: Net earnings attributable to noncontrolling interests",
        "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International",
        "verboseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r400",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofOutstandingInstrumentsEconomicHedgesDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r227",
      "r228",
      "r703"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Finance notes and related accrued interest, net, current"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r25",
      "r700",
      "r724"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r227",
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Finance notes and related accrued interest, net, total"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r200",
      "r206",
      "r210",
      "r213",
      "r216"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating earnings/(loss)",
        "totalLabel": "Operating earnings/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r658",
      "r666"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r654",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r649"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r663",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r662",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Valuation allowance on operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r41",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r560",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Other Borrowings",
        "terseLabel": "Other obligations",
        "verboseLabel": "Other Borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsSummaryofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r64",
      "r72",
      "r73",
      "r75",
      "r628",
      "r630",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income, before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net unrealized gain/(loss) on derivative instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r59",
      "r61",
      "r563",
      "r568",
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossIncludedinAOCIforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r72",
      "r73",
      "r75",
      "r80",
      "r393",
      "r628",
      "r633",
      "r634",
      "r709",
      "r734"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income/(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income/(loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r66",
      "r69",
      "r534",
      "r535",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income, net of tax",
        "verboseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r62",
      "r72",
      "r80",
      "r473",
      "r515",
      "r517",
      "r628",
      "r631",
      "r634",
      "r709",
      "r734"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossRecognizedinEarningsforDerivativesNotDesignatedasHedgingInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-Term Borrowings",
        "terseLabel": "Other Short-term Borrowings"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for Legal Settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromHedgeFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for (Proceeds from) Hedge, Financing Activities",
        "negatedTerseLabel": "Proceeds from interest rate swap terminations"
       }
      }
     },
     "localname": "PaymentsForProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury shares",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r100",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common shares"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment",
        "terseLabel": "Total additions to property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "Portion of inventories held at LIFO, percentage"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]",
        "terseLabel": "Preferred shares, without par value:"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Authorized\u2014500 thousand shares, Issued\u2014none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleoftheFairValueofAssetsandLiabilitiesRelatedtoDerivativesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestitures, net of cash sold"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAssetsHeldforSaleDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r94",
      "r106"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from net investment hedge terminations"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "auth_ref": [
      "r105",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.",
        "label": "Proceeds from Income Tax Refunds",
        "terseLabel": "Proceeds from Income Tax Refunds"
       }
      }
     },
     "localname": "ProceedsFromIncomeTaxRefunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Net change in short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r10",
      "r65",
      "r68",
      "r74",
      "r101",
      "r122",
      "r140",
      "r150",
      "r151",
      "r200",
      "r206",
      "r210",
      "r213",
      "r216",
      "r237",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r534",
      "r539",
      "r541",
      "r547",
      "r548",
      "r602",
      "r618",
      "r714"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings/(loss)",
        "totalLabel": "Net earnings/(loss)",
        "verboseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cardinal.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r17",
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r283",
      "r675",
      "r715",
      "r730"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r283",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Components of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Useful life of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r84",
      "r244"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]",
        "terseLabel": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r675",
      "r729",
      "r762"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r229",
      "r231",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r64",
      "r72",
      "r73",
      "r75",
      "r628",
      "r632",
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r207",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r206",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r206",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Segment Profit by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r208",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r205",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Revenue by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Reduction of long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of Notes Payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeGoodwillandOtherIntangibleAssetsDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Restricted Share Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r289",
      "r291",
      "r294",
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeverance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r108",
      "r288",
      "r297",
      "r301"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "totalLabel": "Total restructuring and employee severance",
        "verboseLabel": "Restructuring and employee severance"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r290",
      "r291",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r291",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r400",
      "r675",
      "r726",
      "r754",
      "r759"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Retained earnings decrease",
        "terseLabel": "Retained earnings/(accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r137",
      "r138",
      "r139",
      "r141",
      "r149",
      "r151",
      "r241",
      "r463",
      "r464",
      "r465",
      "r505",
      "r506",
      "r600",
      "r750",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings/(Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of estimated sales returns.",
        "label": "Revenue Recognition, Sales Returns, Reserve for Sales Returns",
        "terseLabel": "Revenue Recognition, Sales Returns, Reserve for Sales Returns"
       }
      }
     },
     "localname": "RevenueRecognitionSalesReturnsReserveForSalesReturns",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeSalesReturnsandAllowancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r77",
      "r122",
      "r191",
      "r192",
      "r205",
      "r211",
      "r212",
      "r219",
      "r220",
      "r225",
      "r237",
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r331",
      "r333",
      "r335",
      "r337",
      "r338",
      "r618",
      "r714"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsOtherFinancingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r661",
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r661",
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.",
        "label": "Sales Returns and Allowances [Member]",
        "terseLabel": "Sales Returns and Allowances [Member]"
       }
      }
     },
     "localname": "SalesReturnsAndAllowancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r181",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeMajorCustomersDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r64",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Reclassified from AOCI into Earnings for Derivative Instruments Designated as Cash Flow Hedges"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Total Share-based Compensation Expense by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit), Current and Deferred"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsandOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Included in AOCI for Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r561",
      "r571",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Interest Rate Contracts Designated as Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities Related to Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r550",
      "r553",
      "r554",
      "r558",
      "r559",
      "r567",
      "r571",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r267",
      "r272",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r267",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r276",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r276",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Performance Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r570",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Gain/(Loss) Recognized in Earnings for Economic (Non-designated) Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails",
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativePropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r301",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r295",
      "r296",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r291",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Revenue and Gross Trade Receivables Percentage by Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r77",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationPropertyandEquipmentnetbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r200",
      "r203",
      "r209",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r200",
      "r203",
      "r209",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r422",
      "r423",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Restricted Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Range of Assumptions Used to Estimate Fair Value of Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r119",
      "r171",
      "r172",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r386",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r486",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r187",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r225",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r293",
      "r303",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r189",
      "r190",
      "r200",
      "r204",
      "r210",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r224",
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Distribution, selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsScheduleofGainLossReclassifiedfromAOCIintoEarningsforDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Employee-related costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceActivityRelatedtoRestructuringandEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share",
        "verboseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested during the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoRestrictedShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAdditionalDataRelatedtoStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoRestrictedShareUnitsUnderthePlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofRemainingStockOptionPlanDataDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofTotalShareBasedCompensationExpensebyTypeofAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r428",
      "r449",
      "r450",
      "r451",
      "r452",
      "r455",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Target performance goal (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationAdditionalDataRelatedtoPerformanceShareUnitActivityDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleofAllTransactionsRelatedtoPerformanceShareUnitsUnderthePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeShippingandHandlingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesComponentsofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r187",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r225",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r286",
      "r293",
      "r303",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Operating and Reportable Segment"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenueandGrossTradeReceivablesPercentagebyMajorCustomersDetails",
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDepreciationandAmortizationandAdditionstoPropertyandEquipmentbyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r119",
      "r122",
      "r155",
      "r156",
      "r157",
      "r159",
      "r161",
      "r171",
      "r172",
      "r173",
      "r237",
      "r324",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r377",
      "r378",
      "r382",
      "r386",
      "r393",
      "r618",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r51",
      "r72",
      "r73",
      "r74",
      "r137",
      "r138",
      "r139",
      "r141",
      "r149",
      "r151",
      "r170",
      "r241",
      "r393",
      "r400",
      "r463",
      "r464",
      "r465",
      "r505",
      "r506",
      "r600",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r634",
      "r672",
      "r750",
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r170",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleofFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r393",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r400",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r34",
      "r35",
      "r122",
      "r230",
      "r237",
      "r618",
      "r675"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Cardinal Health, Inc. shareholders' equity/(deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity/(deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r73",
      "r122",
      "r137",
      "r138",
      "r139",
      "r141",
      "r149",
      "r237",
      "r241",
      "r400",
      "r463",
      "r464",
      "r465",
      "r505",
      "r506",
      "r532",
      "r533",
      "r546",
      "r600",
      "r618",
      "r628",
      "r629",
      "r634",
      "r672",
      "r751",
      "r752"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity/(deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesintheAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r378",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r400",
      "r403",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOtherShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of increase (decrease) in shares of stock classified as other.",
        "label": "Stockholders' Equity, Other Shares",
        "terseLabel": "Stockholders' Equity, Other Shares"
       }
      }
     },
     "localname": "StockholdersEquityOtherShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenuebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r635",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r635",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r635",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesandLitigationDetails",
      "http://www.cardinal.com/role/DivestituresandAcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury shares acquired, average price per share (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r50",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r50",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period (in shares)",
        "terseLabel": "Common shares in treasury"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r30",
      "r393",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Treasury shares acquired (in shares)",
        "terseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r50",
      "r401",
      "r402"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common shares in treasury, at cost: 54 million shares and 36 million shares at June 30, 2022 and 2021, respectively",
        "negatedPeriodEndLabel": "Treasury, balance at end of period",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r393",
      "r400",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Share repurchase program activity",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r140",
      "r141",
      "r142",
      "r143",
      "r152",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r463",
      "r464",
      "r465",
      "r503",
      "r504",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r637",
      "r638",
      "r645",
      "r646",
      "r647",
      "r648",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r691",
      "r692",
      "r693",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r290",
      "r291",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringandEmployeeSeveranceLiabilitiesAssociatedwithRestructuringandEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r468",
      "r520",
      "r718",
      "r760"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r469",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of fiscal year",
        "periodStartLabel": "Balance at beginning of fiscal year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements with tax authorities",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefits, interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions of the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years",
        "verboseLabel": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of the statute of limitations",
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r174",
      "r175",
      "r177",
      "r178",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r128",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeReceivablesDetails",
      "http://www.cardinal.com/role/ScheduleIIValuationsandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r659",
      "r666"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Employee stock options, restricted share units, and performance share units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r154",
      "r161"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average common shares\u2013diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r153",
      "r161"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares\u2013basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributabletoCardinalHealthIncReconciliationofCommonSharesUsedtoComputeBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cardinal.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EEEE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999725-113959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124267147&loc=d3e75592-113984"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r780": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r781": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r782": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r783": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r784": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r785": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r786": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r787": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r788": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r789": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r790": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r791": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r792": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r793": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r794": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r795": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r796": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r797": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r798": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r799": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r800": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r801": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r802": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r803": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r804": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r805": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r806": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r807": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r808": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r809": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r810": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r811": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r812": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>129
<FILENAME>0000721371-22-000058-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-22-000058-xbrl.zip
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MKJ=H=R5MVSJAL:D=OZ\PC]0'CUG891=\Q&H'%=(6%09#2$(%R3)(0M89,1[
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M,V!P=#Z0"<S?7P!FL!WZ,4MC^#,#.F(T"),I1>=ALR</Q#WN^ZS'[T6&[7B
M(P\?^X('8 B"]HQC0(<@=B*@0K;%1/42*_ M '6_6DB4CC>F9B;7HFE;(92=
MQ<I/QF,RS0W%6;K\\9IPP#T/Q&+'%UV5Z_A)/+_J^+'\IX @S&7DUVIM9?C*
M38$7(PS^C,@30:^X@(/K^AP8GVUWWZ]N;$DSP "#9I );3('LS89+6W,O$"H
MGI?.Z;-)@U =S3J*, ("*NW)TTJ=,$G"_M'>) OOQ*&?)H^S/-F(Z=^]:-*Q
M.['3B03_LL.[H)Z/N#_DHWBV^D6'JA;4^=0X4EF%(B? :,Y2&M@5"0DD^CT
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M&#Z!1"GMZR2I#.%@*<?>X76LK<-[.DB'+YO T>\54C1<[]Q3)0.@06\WK.O
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MYDK,-G2K$C.UD&4A3 $XE>XPD()"C'6B-@Y5 '@6YUPK@'BC)O# QC\./W*
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MMT2(1Z0QD 3?-?!07X,#S,9X$CTMWF0^G*WXBF7.G.GQ2,N>:^0:B1);GZM
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M%)6J@.K7HIJFXL@82Y!]+-N2J@W;JCT#ORC!>O6>8+V\_>0_!CADQ_: &/
M8HL':)CT+PG)^.A4\#8B6%NT4WN)NDR)"DRV"\Y!+.H%P;=\0"WF Q'@QKZF
M:CZV:O(7)>J[=VME%CTV%)6&Y0<J?'J)T)7ENI9,9>Z;=<G0E=6K8Y6EY>3H
M>-H+N]:O'2ZZ2+Y=S/.WE\NJ9_CNW5.<?OV;[SR[A.7\9+%^MBXHNW(FYJ?"
M]5>6?\]/).NUW_-GD]J?MXDLOEE?D'RP6NS:S?]^=PWS_0]_?_[2NV<_7M<.
MG#];KFBQNJYZU L:[(%)!^;UJ=Z\]_HRZ_FA[L#$@UX*]>X[Y\_/O^2[=V[4
M!^];:\0Q1*D.!"@62KXE*.B2Q50CG)H'Z[P=P.TZ+11<G=XL50C_YD1G[WS:
M'3B934Y__LE:^DY?/%*5.%G(]V>5>U=^>7#]_./G;YT_[Y__X-T41TTHV<+(
MD)RZ;\P8*:NVNAQJ/'/?:6AWTW71^^*[N3PD5=+?W= S<5Z_^=EW-%9!1R[8
MT AJ3AR=CPU-2:8G(O):K\VY7MLAZK7Y=+VV&]-KCT#H R G RVH&!I2,EE:
M4"=B&?I]LWA^W\P [YO%3[]OYDONV]O6X)XL'G1!?7TOZN2Y_H:W#UV[2%K-
M%W_1</SN\_W%ZS*;'RF+^L!I/U5]WCG%=^]>_<>T[#/"CNT+R;MVZVW</\]N
MO7,'/H,F#^H.V(W= >>]#Z(AL/$>E#.QJZ:IP5 [8CA5['= +<8EW($SB9<G
M/;HX?5KURUX>3R=ELKHM1ZQ?42='/<3H.TG. Y;7$4G/%*Y>79L?'<]G^G1Y
M]>5$W=+Y8?KZT7SV8#4OST[/]??O/O@5K^_:ZROY+&BZ_=H0-"@6G96<FHT@
M/4^1E%1TC30:6@:_,]#<EQ5-9E)_I,5L,GNR' D^TBJXX#1:BPA!##DUH>Q+
MJR%[#F%G\'FX6#N>5V-2GDP,N>5FBO+PE'ID6)4YA@J )83=L6M72SDY.IGV
MO7/KQ=M^W$(.^]F>R\U9F1_)2"#K6_>L,<5$T+#4E&R(28A:M&(:R<Y UK-I
M^L,7\^E4S=U-O05*\E8C02DZ)0>E1&$$\%S0,2E>'@*!QV0N#Z6MF1;UQAI3
M.5\+0FK,9$+%&)NQSMGJMQ!DC=Y!;R4$? ?54+EI].-R%@M6';A!,%S)J$P[
M2+A[J%Z6&=H^MI4IL$:WZD\*$  G3NI9LB\Q22H[J+%;807;!YJB6,X^II 2
M.!M)^3DW!Z9$$XHKNP?TA8:UVP<4T$OQU=I@&B23R/?\%"!9D53M#EKE"PZV
MM@^IC3V?82HU=D"D;A<,!%^JI6K K=,:.X'D)66<WH?F"YAMJ"(QI@*@'+_7
M>[900FLM.2(OGG8&FLO,.&T0'Y)@F\DU,5L()9&KOIC$)1:1&G9'=2XMX[1!
M<!PY]4XAY%R+AH64(8>,+5?O4:#!SH"SY8S3)O5)'5&22+ZV!-XQ>G:1$M<8
M<VT%=P:RR\\X;1 E+DZRTGEIQ,KDB7)BWSR5ZMBT6BX/I6W= 7"L'A@B<3%@
MO"6;;<M0LDIJ#8ZV4 ZQ(P*[_9(-MJDYANPP5J7!CFN10L*E*06+++N'[=9S
M$]L!VC1K3&94YF:A%S(Y7\#%5%/T&@-MHZ9IS '0]@'%("6YT$1,!@N$ZHMR
M<UF:!"\4=@_02\Q-;,D84S(Y)N"6U/JB)0JUVF8YY,K*$G</TLM=VMD2JBXS
MH7'5%H3:@'K>/UMHN?CD*%Q>E=>8#>Z%E)^IF6PA5DEJ1:':2AHZ)S6HI45K
M8VX[ \VE9IPVAX\5:[/B0608K 9>*:ME;.PY&\J<=@:?R\LX;0Z<V'-+-J:8
M/$(RL??+(L >0E2-ENO.@+/MC-/F(*NFL3$]N@L&2"(;:E%IHX8$":KPSD"V
MA8S3YE J);MH0T1CDZ*DK-XB4JFA^%JBQ"UL*]L1N+:_]:TT\KU%*<30L65U
M;)&*(+/UX%W=/6RWGV_9"M",-39UBFPL@Q(6BKX1AV2:HY)/R_1V"^C+R[=L
M9].JBR672"DHR\FA(B'5++WUE4;L.>\>H)>9;]D*I*YO[0P)7:F^+V<PM<*@
MQMC9;$O<04=[R?F6[5A>)H<HU@03>L]G;$IZ6Q8J+(3%7-Z^PC$;W O9\(@>
MA'S(F2Q K8%=#(29O3&A<:P[ \VEYELVAX]XBYQ:<+DZ!<AF0\0)<JM<Q+K=
MP>?R\BV; \>(U4"PQ+X]&!P7-N)-5&]%.750=@:<;>=;-@=9\I74 96H=@_4
MW)%;K^[$'+GZEG<'LBWD6S:'4O1$ AC :@Q>/!*Y@MA2RC'D4L+P4?HW34_6
M/96N3J?S%[V!UO+JK-Z7I2R>R[)/.WM/P\X/NS%?7%M(G:QNS9=C<5*J/]'X
M:-!8!*R8"="2K\H@.-0T@KSS".#:7#:S)>[+GABKQE8FE%R5D6-E5UTJUHPA
MX[5<K*[<I]F3,UCZT]N3V>3HY&@7XR>IK=5";( J5#:4?$P6BO75N%S"2 &C
ME[L*F.FM(+KQ4X"@4B/#MJ;>6R9+L=)VVW]U4RC+N[.SSI'WI<CD.?%4QN+/
MJH9;+017@S7 A0@;6=>USD5K<01%"".$;X.K=3E4UUPSL2 (2_;ZGTM<C9&8
MBXS 7+Y)*"D"?1AAQ_+^9/GLAU<_R*P<'M'BV;L(/B %Z+X\E]F)W)&/$?U/
MLM>WZ:FRFY/E2L.[Q5EX4>CPRK5_/[A&"^G7<&V^.)Z?7MV7?N.?_.3?R^OY
M5?WNX$U=Q>LHZX>3Y60FR^6#4^S>N@WW#FEQ1$5.5I-"TQUQ8Z^[X,U.^H7_
M01?'8WUX?H)/[N%HD[7<]ZJI,=7@VV>*O56R</*VU>A'5$NY5\N]6FZO?-6!
MJ@FXD%M"R,6@31$UCHO@L28K(]H#OU>DO2)MK_. ,*<$5J3& -D:3&)2HZ)1
MM6?G<+AAVO;$=P""<R$Q'V%TEGVBOEM;4E^7]L'D&DL6CL$.-^;;R\+&-R$$
MJ*4UKV; 0^BU[7VUE4T0FWU&V >07R:5=X]7)T?W7^X]ZBY$C.]2TX"I8+)]
M00B*(Z3(&;S!:G(.C/L8;Z\Y@]><K01U*<6<J/?:C[%/:\5>3U)]9HY)'+M]
M4+?7G*%KSG:BN&RSTG3 AK%!A43DI&H@E[$W(S9EG%'<AN5U ))R(6$;))]:
M%(]L1$F[P?4*:[:0,^9<RCC#MIT&_XOBM-?K$_/%$YI-?EN;U-^M4O1?]/8!
MG[U6T7J-+7BA9@BRI,PJ6'UF$CKRAFD? 7Z9@/^TF)\<WSM9E$-2B7QR]RVL
M/K;*/ P7/<KH+-1@JZ4$/@'T9OW8^NQD@YB@8H%]=+:7ZO%%3CZ7ZJM:ZQ;Z
M%A9#!6S-A<3U+?4Y[".GO52/+ZH)I9><N;X.42&Z@A8L8<TF)!8SY*CF'*Y[
M)ZQ'_++J Z,GLKPY4V%=S1>OWDC6ZY?."M-^74Q6<GW^8O9PKC)]7VBJ<L93
MZ=5L8]E@4L&"L0&%@-3/>JS-&.]B"6"=#SN)VX\OBP855V?U+B_G4UF-!2M$
M@B %(9.'6( B>A+HFQ<XYS2"YBM#QVIS:W+4@@V%<ZO105:$8N30DECI\UMH
M&Y.]_TK$_Y<V+7RZ."SF>DM7K^Y-]2XKQGV+V/$Z\/^ ._WA9*)GG3W1X\X?
MWCPZ7LR?KU,%.[D1O=5$L5&MOMD^#3![88YJF$T*)5,9@1!M >J_)-@[O+F#
M0BY1LF)*4$/I+?U5FC0"Z<,^TQCZR S,$MVF<CB9B;JMMP[<1=%A<$T#"A/Z
M7BYK"W$PB1(&I"KJW48@.I<&\-[JO+LEVM9@UK+# 80K5Y4;JGV*K2N0Q]09
MY[-$Y\&\K5[00O2X\X?7Y;E,Y^M/7)LO+\9][>YF4M> &3EC)0/5]'X\$37T
M:5)2XCBFKEEC$*3=M4@!4ZY%.$:J8+#UGD&^J#!A"8!N#&MD ^-!-TX6L\GJ
M9"VC-R8O^Z.=#,-RKW0RM6?G 3#5[$ :9U%WEJ+ZN!%(SF7AN[<Y[U;)%9][
M=Z72P_;J@8IE*DP!''&+-(+LZN<(S"UZ$[#WG-W%YF<NID>6]VRJY5Y.H5X"
M2;4Z)&G@%4H"'$&.=12(;2[3BGW8";9D$S>P6#$Y"+9):+X26K=C.G9)R8>+
M:;P4N/D61%HAL [)Q!@\=^0,^.AW3+DN'ZH-[BF2$)IA5(^5 $O-C6J,IH+'
M7 V.H"7,)4=;0]$Q](F-^BL"U3$AST*YLFN6(@<H(YAX,BK@-CBJ!B5#(@@L
M%AI'S"U1[)N1N#B*(V@B.,#@\6(X8HVV]^1TQ3.T8C)%*<8%XSP:;B.8QS5L
MI#:G4X$9HY(,\1IR)4$E(!$=5'TIVF@&O&/^+R%U;:ZW:G%2>J'9S9E^](E"
M-1:MRDU5*D'4Z#A!J(X9C$>*3?V9MW;7'-<6L-K,3H:S+__@)H:S]\Y/\<G[
M%US+7*T2E(P"$%,N@M;F'**+&& ,+3[?-&X_GB]6&D[_HC_V35W3;:E]ITI_
M<1<37;5(4, PA*H JMJ&8#!B(U-* #>&2I5U_XGYHDZ6UR?/9;DZ=7EO6E.\
M_]9.PI@D&4_8IPP!^I!=R5PT=% [#)0&W+[_,A=%+\3].<K@LVE-"D-0ZL],
M&,%DRS5(2^.Z]1>5TK^8D#EZZ:LZS84,+@I"#D5#,1:-O3B-89_1Z2[,R7Q2
M;TU6DR>GO51?VZZ'\Q5-WW][%_?6@!57.!NLZH8H$H/4FFWF9 LG'$.KN<$A
MN9W])#:2A1@J4]0X(%;"!KF@:1E:<VT,I6?=$"JOK\KQ[RX>R.+YI+R?O#J<
M'!^?UKG^DV:U3[[81581(%:'R,V9 FI/50&]=="BU>B\93,"^SI$++=B8:VU
M( Y":KZ!4$"VQN<2O>O-*UH<@84=()9;VK.7?"C.VFI;A60K!U<=< Z"+OAT
M7EJ7C3LX?S T+(<7M.4#XSY1)=\^] M@Q*#>41KT# H@.A9("+YD:M:V0,--
MG&T?O8O9^P6E. 8-X,CT@C%4MU<0&GN/0>I:KVQ6=>HVLC_P=HC(W*'GDW\*
M35>';R!Y\]H%&\2\5H]/,8BGAWJ[ 4UR6:F*)#UG\IVS9(W$:[,,Y-CE46S-
MWSIP6_%DU?7R.H.>^@)J-E01L"7O 3G2V2[F0>+U)FU\NAIPLE"RT9>MW\P_
M>9>;_'AT/)V_$GD@SV71!YY<J%$TFTNRE.9\S!0M)&BY9:RA^MRD]$@ V@Y!
M=(-*W^#\ZMITOKP0ZG@Q '$RS=?J0A,P?3$&63(V22T4:\L(HK0A*M/V0S:I
MJ.3>91/8@$&E&Y0*&/8Y&%_#&,+OX:G@]F$U!AW&1'U]#1JUG%+VWO3^$  B
M,%S:/T0UO9! (*GA;-*<!M2B/L^3MU6)91(O 4,80:'0<!3N8JI<_;J\(-9@
M$31:(U,(HG$Q%Q/@M(OQP+/,0U2F[:><4[) 8%H+(0-'Q\C-:SQG0*.!Y-(N
M GNY/F\KL!:N 8+XT-</3"@<G"D:Z#G2Y];;X2Z2#U%-+Z8XUKB2+%(N@<$9
MSM2B/@\QVEH)\PY!=)D^;W, *1TARM[DJC[/:Y176-!%\47C\7BVPVW0@?BP
M^D-O+@)W#1VUFCU& S$#*3!@.CU1DN*A[@0R9X60I^<8"3 F>=\*MU04B-0*
M%?:&N'AQE(P90X'0@'1G^Z&S9W1L73:L[+ W5B-]0$P%(&6);;?PO&"-VSZ<
MC*U$9J;<EVIL(<L:;KNBCJUJ$#?@G0,;7@ =DQ6XD'@><DV)^B2O[ %M(M_
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M""(;&QR#AUP=YC)J+0EO 1)&HB,6U5II9!C[Z /C$Q4,.:W'GC4C,()EU$$
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M21]1H$68U;UD\E4E*KA,3R+2E%I6_=YVIC!'2CQ8K@$?> &Z48@G&71@VKS
MZTM@"90+M:F%FY386]BO!O]\\<^M1XB_P3+^%U=Q*Q9QR=902H'WHFK%&>B-
MAMSJMIKU-M7[=97V2;TW,/2ZC-7[;;5/^H9^]/X[]?)$TY($>V>.X=11['UQ
MQL1^$<VF:&6U:7P#(82"R'OA!!1-7?75V]J!%^S&QJ3(M5.0S=@+.3C/5;!F
M ZG^"#S?',P*+O1MQX??_!V8> W"[3= F .7(:IX6=<B/P>YA?44Z5\QX(OX
MNLP5_R!LUCK,S=/4?JEIUU2QM^OX#\<*;)^X#,_"]5[?-:S^I1EZDPX(J2L=
M3"-4>D:]US6TNMP;R)U^L]7I=@PN9M.W\-YE7_HJ++D G(XH*Q:;DX+'\@G?
MX1'HN"C_#(E85B0$D]*Q3\478. ,@9B2@0EM.+3_4"[BQPC^(QGPJ3UD7YVX
M5*?,WRXK?#R&O>=)QS H6/"2%^@CR1LY"*@08N[X(^+/+V5*O$5ISAX6JSD!
M1=XVI&,EL>0^I7 Z0?\'+ @?8M^')W$^8C $W/+83-ATB>=+O28?P2 S;W^J
MOH SY!!@Z*'SB1^\0A'S\R^JRD:KV6[7^XK<K:L]185_=0=UV$T5]KC5&[1H
MIJ9?,!E3E&OQVMG[QAR*XIDC=U'V@-@9F[X/THI:('Y<QT8GD363Z -U9](E
M^HZ(SC)MSXE/. K7G$2.QTCJJ^BAD(1SX@L=!A:O9;VMWTG'>*:==TI+:43>
M"Y,!UDP0L&8GDIE/.I*UU#O9GQ!-[#)NLI"IKT^(:G_I':VIT6ZSWM<ZF$K8
M)G72E/6ZKLNTW>D:@T$[VUWRFBV: Y3?2Z*A+CM# 8]YR,*<^8\M6 F5B*Z#
M,'<)2F04;>@\MC-_*P$'U3,^\,9P!\ [W%"M Z$WAN7/:JAEPV"@D.*>#:4A
MK-(?A1\W0.FF;&;,5<T@*EGE!J8'*K#(G/FQC^5WX=>>_4+^_,(OHI)]E#/+
MH[0#75;Z=24T&I*60F,-W.687':<O=AI-+N]=;(7Y6Y#;BX'H[52]F)#ZZP'
MT?;DJ'*CK2F;QSW;UAXTM]']KMGHR=O&/=M3OOS.T:QCH%?W#.3-T'%G&3%[
M]B4FB73QI5*'[Q& ^NI.5ZY_Z(]7YU^5ZX^7S3_/8:X(:/WM2KWZ^56#S[0_
MQU_GP_?:]_'E(\O,_WDQO;[[WOS^X\O]S<?+&;Q;_OYS^//Z[AX^L\9__I$-
M:*W37KL-!G);Z_5 P9/E>K^)H+*RTM)ZI$E[_<'1^T_9]\3V :Y7)?$7*W#-
M#"??@=;"9*_]=/&0]WVHFU(^FUG*Y\Z2N@MURM=9>F9UTH?#QK=<(^<:=:26
M\Q^%VEV:X]Y_CPVNE; ]_6_@P9L][W#;:^Q(&WG,J%R5J=%1NDH+/4V=NCI0
M2+W7;2EUQ9"-?DO1VVT$ 'IY>XU2UH\77>1<I*W[E*S)<CWM>\FED3OAQGYD
M^WH6.DTJ^?,B^3/+JIQO#>!LVDK=4'O8>I9TZEVE-ZCW.JTN4;KP9WLC[7V>
MES]R]\7,P)QDNQ8"EX,GW)%8>[QD)A;&PE@$#)133,GR'2GPN"L3EL][.F:T
MW7%<]BYKAB_'<A^8S4RRZ13]I"Y],#VF[-K$UG'!H (CG#I^V?.);1#7\"2$
M"#.-O"3HUC$YR7).2KL.-30S(J+;H*=-]YA:DHY6CIR*1!7A@\921?0Y$]^G
M"/R&9P?'B'TXQL0F0Y;!$17)$\\#E0Y_%1XM'0PH"P#: NL(GS0Q+H@ H"CC
M7<>2'-BK!#G%[N\ "#3*!Y34IIJH8KXE;I_ L/6;1XO.&.T<RYKTM7&+_= [
M2AM+GD]PX?$J15)^WX(+)D&T ],=\^CJ!-Y-\$M YRQ#W6 S)H%A^F)>#09E
MG'$';]:F78E>-L,%6[R!+_6!>XJ;Z+BG,2E]L,@PW2!T8#Y2H^Z[09GK.7=T
M\\H9?LB61F2#$%H?].&^53O=7KT'IU$GNJ+I5%&[;:47.^9>7]N%%2MK2ALQ
M]4;4LD)]03K.*[+)C1'F9XU\I]ZJ=_3&[(3=]"*[Q;T[8//@1;DLS;\,HK3[
M3:53EWNJ7E>-7JO>4V6EWAWHM"D/#%4GK6>5^UVSD)1.WJ@2:O:R]E6Z)Q9"
M\MZ!6"3#(4A7%+\H=:G/(0]0:#XXPN3!6EP0&BQ]FZ6>###-&1[Q4'\^ISI%
MR"C1O5MFW;KA3TS=0[D[<$":3/&JDMX(X?:!I<W!LX%M<M$6>,916M8-!J3?
MUMK44%2JDK9..JU!1]5[2D?N=8RV^M<EOD966O(1"'_='!/+^\]1AKS[S/3A
M#Y9#TLV.W]K!N&XX?ET\#3<KJ*>4C?&:Q-XCS&/ZEZS1OMIIZ77%4'IU51T,
M0.QUE;K:TIM-A>A]@S:/WLMJ35%:M8[6KK64"-TV/,[WSZ;>%)$!..!9J"6X
MB]AH>A(>I"8MP(/4)/B1.0886AJS W\+K%F*(91,ALCE!_ZR.9:@"AE0TI'U
M?@_.2NEV2:_;:Y.NVA\H7<UH,Y90FIUG68(#GK B^UOVHIMX 16/9/+(W=?I
M7[K6Z^E=5:GWE5:KKC;E5IW(.JFWM*:JR?U^ER)BIM)1:IJLU%IM=04&6:5]
M[O:[Q'MQ1T%J_'<&8U.7VCJ]@Q?]UP*R>5W'#YKAU?2O-M5Z?:K)==K'+F-$
MP<[*30-$I-K6NG +-MNPF10X9(('BD;^#KO3/HOCP 1>=,!2\H3Q8H_.^.U2
M_77W)[,_H_-,)*CF2.QSD<;Z0*7/KO,XDUC7!^:X2U:CH1\8W5_("=*I;0<P
MP2M*F=8#@S/1.'(L@[H>@F!*YMR6N>&6H<O/89/QN"_/BZHC/H PE>1F_7\E
MPA'1PQ*)5(D8?/LS<7U^8UQ>7N(O\$EAQL+C<Y)CWNY(')+8+$5I8 KJQ.&^
M[[<NQ5*.!RHR3X5++/&<N)N;\2.D[SE6X.<_LL*MGB7'DG_BJ$RD--O];K\U
M&*A=VE.;2J^KMIJJ8O3:75WK&Z3S5^<H?&;DQLZ0(:WW74KN03D%SGI+K"F9
M>4>_I*<+<Q6[T]78[BR]L"=6\<QCNTTHAJ4TFLVU\%![W4:ON5P7X2VE-^6%
MHBB%.U5=69PH\PZ7;&B;N9[C3WE_UIR(W%UJ(HMR=Y/"55:6FL0'$S4\+A)C
MV;7__^5%L-+.SNWL7'NIJ_6.,3H([C-4R$"J%[:#>Z^A-M?JX+ZZB)B[E)Z"
MY1+KQET!H2'!U6,:4LAR:WB[L]2M'6\T;)?636QTQJK#=\%E3M<I*^C!A]WU
M>K\_-6R[T5$V<A?DK&]KN4X[:]&VX,[/EJ>?R3 #_&R3^[7)A(_!X.7[D!5\
MY9,SJ"[:"K]ED6_\%DR(%&,BTLA%$_H?SVN@<A.#5K[K& '3]O_]"YG7;/./
M+5O,"2)\P9FN865N8I.SJ'XOI[WB1%8[;27GB"MF+C\SMX[>7T6Y/O_RI'/0
M@ .PTT5JT"F8!C//9#;ZARB'!W0\@^>4X7>^4"^PN!E_,Z%\,MY*4J%B_ (R
M/E!&JV+\0V5\%>3ZQ2,<DTT2C*P[P. 8W,1? 3]C"=3'T]//"=Z_HL0+7%HQ
M>-D9'"E V3J'O^R;E: IOZ#I';W_'3/$39]YX)FD@5]8X<^H<5@.DRD2Z6-L
M^8JG8GPQO?M*RI1=RL#Q*]U*CSA4]M:4H_=AN6?%K"5G5CS,5K-BUH-E5NWH
M/=ZJT@>B^XY;,6SI&18.M-6K&/9@&;9[]/ZSZTQP@RN3N_SL"L>IMBMV/51V
M;<M'[S_1(4P(F%:G# .XXMJR<RV>JMHI,->NDZ!:,?121Z]B>(QYHS!=-FX=
M_R]/$GU3+_X.3']6,7G9F1Q.6JW\5/L^W^UQ<@=,7][.I.+5LO,JG*56N:GV
M?;Y;X]5.&S.QPX!S5+WBL=#1;3"96.QGXLY8?X^*GTO.SWC>FE9@?JX4[*UE
M&6E@7)V;+F7^Z)IT\4CU@(6%;P8#4Z?X.^3ZL[#T3/J(>%(H&VC%]R7G>W;X
MW:V[K\N?@E+)G^V18 ?SX$9FWZP,@P,0*'":/;G FD3%KB\[8(26C0LSSUS'
M\^+:?>D2AGQ,GOX6"YZR41:S*C4K^5$:^8'DU2NR)5+)CQ<><.OH_2UL*O&K
M'/:#8%@XS]Z3$?5-X(&N"GRQ]DAB?S1UK]@E^RH8[S0415FG,K^E-.1M-*U3
M&NIVAI5;:A&A1K:K&[V@J>HF:M'E@DKZ[6WX#K!=EMOZ_UL/5'@3>Y")Z+(R
M)3P'O+$>EA/65K\<S*FCK +EE"GGU[GC=G\]]!I=35[G>E#41KN[^0:L&O8T
MS7_T!>UBY69G$]=#G^CW0]<!Q:H>LKDJ#UK:.W%68O>3>#/\\PVV%AJP_VU+
ML*1Q* 3I/HL^\>RZEP!A66NHK2JD2['LYD3_\_AB2NX)/3W3]E,KWY7*P"8?
M>98\1$Z<OTXQ+B6NE^^4N,\B7NUQ>=E8DJ<>]@MB70,86B-O@5*3CJ:T=B0=
M.8&+?P4>_CFW^".V>L^$*1$7NP'9(&8\C@F9L5<U!-QLL&=X=YD?CFOZL[HS
MQ:X%^&O=L1D#,71)+^A[IF$2UT3(X<"VL+\,PD8*M-<0/M*3'&R2,#4]VI!N
M FPSPXYC!L<A4=M@"-V_!3:56DW1\R!]I(-(.VB%.,4<OAO^;.*?<H_-#O[1
M92"8 N@R\1Y/XHV6\#4"\Y@]N<2(-5B'-^$M=*Q9 WLT4! D)+$L"3\W!R8U
ML"\4QR;&VOSTD6%;B*@C4PC!/#<=I4#PU$NRWY/H R7CM<LY'C-MW0H89#8[
M2BH=)375&[AA'TPZ/0HA5?%(MX+3(AT?79W_#QE/WIT>G=2D*64MQ.)V36.Q
MX;R#$K( 7'M KX8T<)UQFFWCI^!G(O4#_@"V)IO $*AM,F'C!,F&4%Z<WQ.]
M(^K4!-_&5DZN@0%_WJP,>T!)0VK#"BQKQAIN3W#@1,NGB0O;:TY ;$C'"(NK
M--\A';%_RN].&M+="*83KPU?B2L!_L&7BD?LD/P6=T.,)%I8L8955 ] I)F4
M9RE%[58P2]CDYQ1.Y?;B+)R)Y 8P238?H SBX8&((_#9%)^8 WL/Q])-PG9X
M0D:9KC1V/%\R6'(%;!3K%^,RE3UW1 [S"X09W@HTW(P7886$VQ42<X0!+X6T
M-R?0EI55Q5$5M@2BM.PN[$.DX84;G1^R9GB&<8 N9E.#;PGU$G>NPE8>_RR#
M<D#'G+#Q:JW[3IU=Y9QT3<8>?>I/*;6?&D9<];% ;28&-J*S89N]PGODN?<T
M8WF%(B[-.*EMT.%D$'<;33'\.":6&+1[4_)<R%<!Z/TE:O07SP8K&>:4F(0.
M(PE]09:.YZXE.1[CZ&0%;6(?['@YQG5CQZS+A-;TA0Z97CK$E4SAG_5/CG./
M/\=)I@66/'E=/&(]\#BI5B2UQ1SH]I.0:CVD"K8CEMB1Q+6<P&ZGCZBO<E*K
MH<[)]%?X)X7UCUE3'"1-IK^"FN_[B!Z?4!TF2&AP*L$$KX$ HW 2?> H\"Y\
M#HJP,V%O;2"7S)Z<UF2"I(O\%$HAQA:) O<:4T)P,I1-@,T+)^0ZP9#U,4DI
M9=.1J8]@VC/D5A,GRE1OW+*I@VU/O0 ^!P5;7(I\-VKA]29^BU@WH'W /.<_
MP=Z8MC'_6[Q8YW_7IY8)FS'_ZZEI6?._\V =UL*@>M8OIUF_A$/\D;$*-+5,
M.UB8@F7>@[$2_39I!L)V,#IAM,%L/4Y<R4,#TL..M:PQ)S]^-Q1CKC0,3*;H
MU9)/@'B#@\+S9V/BGMN@&8&ZYX*$\R)E3A ;'C/8C[@DU(1 FM]SF@Q@8! )
M< 9FJ,ZR30+I'+#Q_("U)^6S@4<-<S#@5$R16>$28RJO/W(\U%#9KJ%=%I\W
M[RPZGL#9&5RI8RJ8!Q(""$DG4>M4&"!O8IQ//-TU^_PN$?N>).MP\^>L0+[E
MDDAGDWJ]AAP:K+'T7[BFA,85B<0,3IM[#_ \N8<[!;7OJ!$%F@!1WP=#--J(
M;%HQ#8IMB2/SG3$6<+$%6X-JJ46FW )!K=HG]WBO2DX?!&S4FS:8\/>$C8JE
M)V5$^4S>TP<"K(2;D;BW"KR*?,TP7P&I(?R7"TQES<3'7O+SWVO26>"Z2"?S
MGW;Q8=:Q&$[7$#:C(SC2%5]&!B+1-@Y<RL@2S#$7S#&':T=3VO= )92.I]-I
M0Q>^JA%S535 "3RI)2P[P7^7]@/<<:P(U!*J%E/>E'<)!>U+U-PX_ R,/?C<
MPD+PD&MU,L'G:\@\GH/*G">,/YCQ#"0+MDOB',$B0,@2K,VWZ]CH=4=!9%K,
M0APSO;N&_# (7-OT1ORWOE/C5NG%&9=#. T0E@Y(,Y S\!_V$4WM MAFC:'S
M<(*=1V$'9T[ U%8/KEBX\U!G).Q$:]+?T>DQQYTX*[']3"EXG E9%*L@L32I
M)32$Y#?<2#D+DDJ$:.C,NYV"@-P(3S\3[%KH)I+X;"Z<U<=^4!GMG4702NTV
M%%G=1N.8YZ8T)H]UD6_0T#KR/]]AR%!$F/@O,GM2+S?XT^O5_GF4.]<JPZ7*
M<*DR7+83#56J#)<JPZ58&2ZMW6>XE":?I=OH*FOU*E/4I?O3K)K/TNUM/I\%
MANTMER;SZO-90D?6!G-9-K#F[=Y:IPSS>4Z2;RN99[<9.,6V(U80X^U\A;Y,
MQD<A,J+V$BG$ADL;#Q,NUQGP:?Y^8K[=0MAL.^TI.F<E[[)A8%%]B9F99.A#
MDFY&IB.%@2V>5N".N6-;[G5Z-<R*(M+0<OK,9X;!ER$/@7%/G\Y"!9AHHXNP
MU82G*GK"VS03257HDP(NA7V!>1L2<SPP!R!ZQ4:.-S%]8GFUU+ S#R/.-6DR
M(NZ8Z"R1C8S[@45\QYU)7N .*?S-B1H^TV'E2(>21?JX'H?GODU&( Y "&"&
MQ2">)ZPW=LQ3F,.8-J1O-$P""]]* T;;_"'8&O:":)$\[<[SZW0PX$EHB:6Q
M^ BU1RSOQD/,G1GZ4.&%%"<"K]=G[)6Z8]L8:PGG5 LG@:N:D!G_6^R")UX[
M)G8PP(B+BR$;UHDZ/AV=I^,X[-PCL=>G&-\)7X,C""G*9L%_9+[=OD"C9T^)
MB$4ZXRB,\>#N31T@@2%S3+Z5/J>VC0UPQ7<MW^NXI3M^M\UO>6OQ].IO^;:L
M$ ]/=W8M@.SN]1KMWEHE W*WT9&7\V"M-&ROT50V[V\KV6QQV/9&KT59>W7W
M(L;8YCA6"#),<?)=LQ]@-D;?)2RU!V49R\8R];G;H<9SC.'JFLU]PJ,P#[B;
M(UIGV94@@1.W7)BX'8RI&]\KXE+Z:ILHS5EF#8O2PW4<SI"%HL0]X<5WL._,
MSR!]4>#[$J^/+AIV@^2N(IS8.\EA^C*\R YT"W-'XMN9WQ;$,)W<&;"<!8(Y
MCQBH?Q?/7SPQ2UQ*J34E5 2"^9V6A7_S^Y@'MD<PKTGJ^<0UC^D/H)#,;51B
M4!XHR]P8/@Q>PN_"^Y#H]_ 2+X<:O&<//=S.QCS612DLP_U<K4*+.(0[]07V
MD+R\/50-N[UA"W>I%B>7DJ4T"UX-[ZK$%02RU@-3(C3#DO?L?"0JO'>%U55C
M%E]TJ49&WBP2IV'V(;,>'<O(O$9K\!Z;&*0F7038%J0FG7HF2:5<(E@YR.9+
M&],VS3!O*IHJ7F)Y<XVGXB]<ULFU$GC"(7A=8H6#,UA^D=*][4Q9P@NW[.";
M[.5IHS16#))V9\I23QBJZ?MU51,[L7>9%VC6*7!$2G8067I-<JL6C&Y4<82E
M_"]FM^>\0J2H,LMUH?#0K_\*3TJWT28 :YGH1&QD7<D'CU<23WD/%>FMM=,Y
MM*VD<RC=[:1S;*0B?84"ZRI%8=,I"OL#Q=M,BL)F*,'%B>TCSMG:-4+5FBD;
MO=VG;)07E.0%UE"5Q5%E<1Q.%D=8L;[#Q(UBAO?/DA7Q(E:_7LKZ,I)P#_'\
M+)R"9<+Y6KG$<RF"]WO!Q'F@=D!+5R8KYLU"!<G:\2GQI#=R5VZH4M^T+%Z8
M(\F*-*$N<B 6S&%U#@VK_] [8,(@6#>-P6X35FQBA7O X&$\@K 3<,%-0=EG
MC\P%%&)7C(ALYP8N>,X!\UUPWY"%-4P,RL'V8!2L-QS$WINY8!";!TR(/L)7
MT>V#[[*I#_]-XZ$7 ]M[H"D&&X'3BS D1&83S/J"N#963_UR_,GQO),#E#3M
M3D-K;AY'KMOH=M93+Y_^3%,W'VDNVUPWH@CO7[?KOA  _-BTI3$7F@G.7,N2
MY\K.'M:<4TH#5\,*"WJ9/VMO:\]VUR#4Q^&O/?O<SQAJ4VKU*YNS.OO?JJ;;
MV#0,B^YAR>R^=:+[ED;WK96Z;]/"+G?5V9JM6$!R2YI2T3?FS?;6_F[>(5F8
M11]KO?;V#AT_77$#GG(D/,=Z\Z+I((DW6X@?./%F+UKM*.D2W$,CX%7&6&5-
M13C2;'ETW;AJK'(=[ZHMX'Z_N;).(AS>Q=-)LAGY-LPC&6*ZB$L1]835*H!:
M@F!F8YIO;BBK;4.F*"\6#\B;C]PN=PPK"M-L(MNJO)Q[9:Z\+#-19)_-L=)=
M7D\K\,FL.\;AF&4Y(M!G0&<3TS$1T]NCGC?F.$L6"RUA(AGS0R>QR-<2BAD;
M4RCZSQ:* F"K)*(QF_@*H4J6F32RSZ;5/9S367>,0]<0OU#/=X.P+(<!@XXG
MEC.C6-(+D^0-XE^/BMBLE,1*25PD"UD]G..I-,7L0SX=(^;HS[A4GI<S$/WO
MP.3Y]?50:60F]"M2$EN*6A*Q6& 5I,QDD>,GUN3#.9Y*0\P^Y,OQA)BN:!4
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MD+T$@V<VG?(,@D=8+QL1#L\9PZO@"?5$8L8DHV"D6%[6$45K70=+2^";#*A
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MD*HJI*H*R:\*V4=@+QW3O!6&/<,Y,'5/^LSQY2H/V6OTD-V-(A<20W["#(C
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M=5G(++5 - <RG 8FD) ]-#$BR:T%EL#]IB7+464#;LT;58FK9;#"(96."U_
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M(!8P97']51UK7U_'VKQ4XC*&:)8OJ]_"7:,UE"5>GQ%B1M%15QK=1=Y&+4"
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M'TR=IAZO24!%I@%3YN-[(_0FN'0"6S&"$X(1\=?WMC.U,QR/7NR^B\Q^Z7*
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M. 8W@[%6OLW#&!._5:"9$MP1F$;FH6<B9L4D\,EY!*Q2 CH_N'Y*N74X/'%
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M_9ABGARRZ'N3CKV,8%TB6(JA8O<X2=B.[^D.J<#L!7NV,:W-BV:<*QBDE'<
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MX;-:+*RUBD@=RM70,L]?JJ3=NM'.X#AU[3^'<(%A8]!Z!R:6!53\R?E[JH@
M]F1;\-@Z]EKP9P(GN4]]-Z)\[0=//*)8+A!OC,3K*>)UW-$H2EV_H$8IX4A
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M^.'.?2%_%$:U$HE>1[%YE6&3A[Y3H24SGM1M=R4"G@H)+^5(=Q%=ROE)#$'
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MSYDFP%:\H1[@UQGBK_B&_BR!,P-!@%=I+.L%U"3A3\T.\HI4B6- J;]LZD7
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M(L.BS\KPT%E&)9%9QCK(:\5*D;0*\T/7'FEG</Z9,VNU:RK;TU8&Y\6^;J
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M<.E6HNX9-V0%PIEK=)W!)9;TI6D[GRFQ1_9S*+B""ZVQB!2X;5?&<8SUR!7
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MB]>]6AG78WB.S'H.$&%H1-^3,"#62&]A/Q<^YL8.+"PE,QQY>QKEYI][:B*
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MWA/I,X,#A ]\]>]W(,[\D([*N1N&:>+\XD9?1>)\\N*OU==UZ ! Q=(G-"!
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MW[-#)DNBTTN"'G%-,_.AO@NK"7@FW(ZH>Y__@N[OVBW.JVZ]Q%/\AV'01W9
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M=J!7TJ)5*;$T^^/ B/ 4^7_%",RRIT;(#4<J-5 L"8-*&I5 ]4.LU1K.?4L
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MYS $"*%Q$<4:D$0'QPS)9)M\E')/-O>%'(03SR#>,,6&VQ/38'*H+JDO*L)
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M3SD6+G5O7^]H-*WX$KX^G0R;LK+HZ9#@<QC.-78FRSWMH7!Q5W0J@A<W\FR
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M:H\PDOQM'2$@B6HD XN]S+*BHC"8!,\],M"W;C\\4RZ!KYE%L?*"TXKRRRS
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M0IQ,$2Y9(J62Z4OC*K6.QG<(@W&>X<8Y(TK$2X'?1*DZ,'QM1@W:I('9?,3
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M6TNQ !(#^"!P[\[2)&; SCY: ;&ROW$ BOKWW#MNKWTE-Q:L2V[&AMA).IG
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M%\B&G00_46N8-TRXC$[."=)7L[4_XSID0S"/JT T"I0 AA48I\.43A@E [+
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M!^.4&I<8,R.X'YWLCBE\ [W_* C(K5Q;#9 =; "G9PQ?SJPH,\RZU%6:& I
M).(%W_E=C2R<;KSA>5/"7</@I$J9.>XG=-R#DPD6<D>#X"7/MT=UA"FKKL;>
M&L&(1QTGK!=7BY :#B$#B"Q&(C79C<JOTK+HR!QJAOB0 BP<UM-D8Q+?' 0G
M)H^ &0,B@;H4OM FI]5)(Z^[H-N(G1)GAH<ECFP4E&:0!1(O'#:@-'(W!L 8
M1H/@L&"-M1,X7#3D4:*VL7;5R/75?1H6*,)<6BB)%-A.C%DTPVPS)W9#[*^1
M5DX/6M; 2'/-_9HYO\E9(&EU:U-4,JWTZWPQ@:O3RB:?:U )&,GUL,C!GXN
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MWO->H.9&#*_/4^<C^ZCO84#:Y(#=/0%ER2_.]Y*/1$9C>-,)XV&=7F7=FSD
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M"QA&% MU@3P2^0V:',Z-FE]N8C5-)+QVL%1(/HG4EDBF0"/*YB!S<5IAH^\
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M'#MT)I2"JGA2LI:<X?,)ZLKW>,3,1%MK8)@_C],L]?%SWI)$6=9:DLJ2Y5&
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M]N=(BM66;OC$ZZYC7,=@B3L"'6W15V*JP\0\??4'!J+9=/W9FTRXP_6P=/G
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MO;2N=K[1]=9'H3 M/VA'](RRM9^ G;V[G>TCWQ\J;!E\*@.?.:7+L)>!0&(
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M:F!YGW]@_*9;NFU]0_<;?URU?8/ W49"^U4*WFQ@[Z<J\MH-ED8KB!VRBKI
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MO)-<$J9I ,QHIFMVNOLB=/=Q+9).=]>HNPT3)#@5;+0:2:(, I:&P01)$04
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M@'(ZC07 A&B1:[13US:',#IU7:.Z-FV)$((C0:%(I<]5I32R3*E<TAJL#">
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M^)2$1S3WP>8\&>2H=JAT0 C4&*MO%GTA)JM)GVD?6 #53R*3?&P])T%[&ZG
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M9_5]L'6$Q-M1/G"QU'?><VW[<A^?3_W6P ^)_Z'1A,#^MN?U!B/]=LWIA8&
M9;S.:!J'Q1BS2<;7N'@74]H*8P65-$]S)YGAI2IH5CB1Z#)1IJ3<WV9)?9O=
M(K>M#B/L-#OQ[X6"7=?_8@WY:L>C[]CQ]SO<8^^/=))PI3,!ZHK1A%$.5F?F
M0(5Q5"B+[:.Q.N4.!YH))D66,Z'*A+E<<)%(+DOM\LSQ5#$\T%34!YIL#G35
M!UJ*LF".D9+EEC"+34V88"1Q\ =1..U<\>+E\#:.W%:8S#HP975MO'*9*$;)
M8KW&T(TN^T? ^*N\Q3;UX>WZ0@9I<T.R^RK:RB^3K-<UO_T_\GE,I'<R1F[[
M__I)H3@PK&/<"I90P5F6,&I$ 9: ,K(\ I'YXN4>W((]]G_^(1^A@."6MU7M
M%'B!<_$*$B()8K:I)Z%WC0/^SPG\(80-0#!,O38[<^]<H 6N1Z#H?)U)M6BO
M/O2/H[XQMJ$B/6IC,[<93.>_[B#60*U7)BU4SH5EK"BYMB)-.<\+6HB<W61)
MWT^L765UB>],MH%<R_>^OJ+[!_"^@^/+_5='+%<R@-8D%/O+99*H5(#5G?',
MT=((@_87W5XLH0EZMPH=K+<Z?IW!93=.U:^5F_YP1A"BPO3#L>P/?_S'  X,
ME6GTVHXJ#&FX.G4J^G1TE\2KAK"#E!P/@;2K.K?&*TX3^:6G[-"ZH.TWU#OQ
M,:]K2'V[]Z>U&X&Y$H%)TR@P^;,0F#&R=7NQ&>->(??*F#[NQ&Q@<_UL';0Y
MYY.I0C^?.CN1#+Q;H,UB!"[SBH1/T6E9I\XDZF;5X17SWTNR[QZ>:A?-W:OF
M&,3%+?+O=ERO&OF\(;3=9Y+-0F)9U;$%8=I=O\5UP;N;Y[:8:N;__K^73!)#
MAU=D6=W7<^%SLC": 7S<+5<(:5N8]:7MW.,Z>B8&35(8+.O*%"\??PP!C ',
M%UYNT+\44E*[SB!@B9,>B/E^V -X;(C.(/@%@ZH-G>!^7)S8H,(^%;FL'7OO
M+,\][N8=;Z$O$.8/;^Z!J0#SM^-P1:*7Z:1_7OT<O)+H;8-O^Y^]SA4.&8.]
M0 (A&:"-S4RL/AG"$H\O0YBOR6IN2F?F(M@5#(PS)]ZGZ9U=6@/MC*\()L^6
M*ES_]\Y)Q>W)&>Q?H#JXSL)R/]L8_XWU@YVGXL$F[2-259C@</4CMR2)F*%3
MO\;7C %I#.1Y97^J?_AY+G[M'_IY]@V(Z# ?T<87AH_C-(78YGF&,XTX%/'%
M<1';?A%S%7 Q_@XJ7Y9?^7&RG5[YV0W#,LH?8]@T*V\U[ VH'#="[BQ^]:[5
MPAVBZ3R"L0P[_L9"(W;ZF\WHN493LY:6E#U\(LO1&_[G*71$_V;0_QK#N/<.
M;O]>FI#_.R>$OA4E^%K0QR6$Y?M?9$M6O*3L='5EIMU_3\;M=AY;HL96?B+2
M 5/\) <7\K)Z\8_95\-[X_1+K$*ZM6"^9]GK-Q?>L)3M)"SGKM*;LNV27OWQ
M?<5LGFP++E8^+(5AQ=6/WD%Z+U9O6Y:Z+)^KWNX4:,?/5X@/&>O%'XE'&_-U
MF<5Z)2AD9X=NN1&WN/_N-=2R*O9YUEL@_Z5I>5G!J+"9THEPC+I,EDRG*M="
M\50;7LRGY169U"G-J%.E84:F/$\+ESI'9<%+*LR+AV80LOMIA-_<2%B^G3=G
M+89<@T[26@AUGH?RL$Y6:)-2$,PLGTD8$OU:$QIL5S<=!)/$)SN,+>:\754]
M.5,Y.5<"B#60F*=8&Z>S@?)9,S662MK6<*R]@W.V7\B=0Q-3!3<Y)D+Z]/4W
M2RS4V8*EX,_4 6F@-=F7U:K-O;7V$E33LZ:8*>0J=E()0+HMR=*MVJ/ 2CW;
M.X9="<:4NNR<AL\16%6BX#(+K'N?/DY%.69<A9KA?]J!@=G\*0<VU)!O*LEA
M#4?&.$H==:0H*"6LU 7AKL1>&YE)TUS;0O-G4AD>SK'WS[JQ.![EVKE=0'SI
M ; 7O+Z66NC0&/2EZ@]"UM</'1=T$^?PO%B75V XN.FO[I.Q?''WF1R".AQB
M%*.SLY@4)7MP._G:X<H.!B&S9V94'VZ9-.@/R'O!@QU<+1,< 7@R"L(^1DDD
MR"6OX/:'C4,(W^ ]8[%0MW6SM1EJM5^Q*PU#@EMH:B;/<!1@1Y2[LJ>FE_"=
M$UBMLKYX':;EQ91/_ZV=P_"D\I-I!'78$O0]>]'J[P442$/KRX?][Z/I9,8!
M6M\#4:QV]VR[]_X<UA?/K5/PNF0OYT_&QTZ]O[B1JPNWDG>1PIZV-\RU>-[K
MYVO<'_9VY5B?]-*8#.5W!7<?S[(7G:_>R7L\MH&"_5T.O#X JN[]+WEV_G/O
MW;AOS=D<+;\&U1+K7V)V93PK?[(QP:\9T[_US(:CT..^O[S\871O]RNX,A[W
MW.OB!5J31D .FB$ A _JO9H>P^YWECX:F*N&NV+-OK8M5.Q7=XVD&VWS-.4B
MQYI1E@F9YXDHA).)UCFC^LZ1]-_B1-[!K?\&%:V)!U':=[\T2:Y_:U"S!Z0,
M'>9[;PZ/I+6:)DE.> [_L"+1A&NJB3 Y%8(;HS"'1-#%'C"]LQ!&1\S;@/,#
M6IW/\P6-;(S0(#Z_$.D9RRI0[PL%%KV+T?@3\D1,BD4G>E!?@_P)7^J0_";
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MGRHC6(=OVQ*S P>HD\""?.ZU]H 532)>=^9A/*"8NGX5AFW1G;'WSMDP(+,
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M,[T0<Z4%,W!7&:<$RU@"EEN:ID;K/"MT5JAY4;$W&L:FR+XB:@>5;U#+JL6
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MU!Q!1D@\D@B&VC_^Z5D2-D@")"1 PBM5P:##6K-FNJ^^NJ>GF]=+_11+#2P
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M*@V*HB.G-XD2'U :LLU*ED5Q)5H(^K;ROR=7&RX#^#A/W71+/&<(=X.H1,'
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ML)")!QF(Y-XE)Z3,I2H96U3)V^?,6ZG9]7<E[1<C/._+UN$!!2\-]XPX#Y:
MRHI8ZAW^2%)3H3CRP'K6%SWKTCM6)I>H@(X-B&R(R\J0E,!G+Z*.U%U/"W],
M4KWL9[*6FU37*:-SZ,48KY8VBT29)LP96FRO)D9;0Z**#O7">IY*D8=QV[LB
MO+H^<KEBO+I6[SG4>XQ:6PY6>V\($^4$FHR2F)PH\1R]YJQ$,*6!-[R$0Y<O
M*"7\?O(Q6PW\U6J.L=@N:BO2_&*Y.5<-Q;-!\>4$II6=")(R2;3ROF1!(!0+
MQTB@I?\22*&\7=O0*UO<X@$P_,@]@U8+]A;;$VA%8&^YN6@->S/#WC@#E8E:
M)0SQP6F$/>2B*+N<1.N%HXY+7S:3%]WUYY&[^BPH@>3:8&]O"CQ/9L@2WN#E
MI*]/IFR?JC]2) Y'Y Y3HYM*^Z-OYSNK\.(/%\EUIVI\49_Q6+1U&:F;OI!3
M'DL4WKG3DYC8MFH6U^&NXW%7HO]V(/E_7@E^]>8NBCU;:PQZ(>%-<9YZ*;R.
M9]VB"K5]G<:^\@ENA4;O0<224FTX):"3*@U#!1%,Y!"!ECTEM*_K=+2S5*."
MH!<F_'?RR8G"/PN!K(7_>85_C%SJK)73Y:2-@%A*/%%B+9)+PUPP-!M+E2_"
M+Z<0_I=#3"8KP8WS1G/U-%I"O7]*HW?=5:RU_I&U7DPT>2R:DII,4U5'F7OB
MM1;$:)8@"BNM+_TSUMD"3=[RBOY3FKQ:])]6],<,7DE< >71X*&P#[IQ.<8"
MH=XRJ00/%LI^WCJ?WN#51V%6Q[)/&7*(S5[ Y^DWD)^F.L:PS#&&54XDF7'/
MLGUVXE-W(=N68B9?;'.H#G^B-OP[=</UW!+":V,T37N@\PD\++!(16"6&)]4
MZ6/FB+%1DA !F.362B?6-L3ZJE?SFG/;X*D5\%\O$FQFW"F<"#8/VRRLP>89
MP&:,^5)J('-#22['S"&#(M8+2H1SF44O,XUN;8.O+ZI@V-(J_61%^%<=RWI9
MI]^6B%S=X?77:#<_VDTZ[FI%9)Q91X(2 OW\ ,31+ @-5EG\RYG$US;8^G=>
M,V<UJ-6R0\T24:L::AX;:L:(%1,1R5-*)&@P!#A'8I69($YJIZETQ<<K4#/W
M&8%E5_FIB=5/?>=;::.:CZ($S?:9&V#OX@;'Z'VCXY/B3 W738UF.[3.8HKX
M2Z/3/TK=84'!5U=_A= ]P[>O'2QXU7#MB(J94[=;?3%T3E*C[[Z42^([@R]>
M^T)U[;-N 8$JZ0N5,C:\:U6TK'>4\';KC9LT;6QLI]U2^[Y_4=TA_=^SYND)
M*O6K1COACS!>Z*3UK6F/1Z&HYOSZ\'I'^-G!!WRGS"W.R_#))G[U%0ZLUQN[
MTS1/]E4H8O.?JY_XXVKM8[-WVG(7KYOM:LE\JQ..WYRX+^2\&?M'K\6ZU.Q?
M;TZ:[>$+?/#"B,SW.Z=KTUY\_*MO!I<&L\Z9O&='2*>0*?/"*1Y 1.KQ'^08
M#(1*2AEVL%FAMZ:,C.Z*!G?TNH+K?[N+LGR]W:(<NWCIG\O 5A27]_\^HN'D
M/VWWR9[M?#[\LO_;AR_;E__YO/7;GR=;GS_P_<W_-/%?V-E]A^,[O-C^O,5Q
MG*V_+[?X]N7Q 7(T%S7R-ZN](B!T)-Y)26)F6=@$)AN_UDAHODYQ#ONHCFLW
MUOC$=0]1.@:H]UK<Y F?SWK]9KY8*!A.B3>[1ZF1.ZU6I5N-"@=[C=[9"8X7
MKU)^/3UMI2('>,/@>D>-C)]%E1KL!!;UZJ96I5+]SA 77M]4IO%9*-FE\K8I
MJ,;PU>@,TE%Q*EKNM)=>7_WR9D1GJB^]N3G)Y0ZC6E1N.'A[J$UH$];I@!X-
MW>OAG8=OKU=OC9C"H2+2=2[-K6_3=7;K>W==EIEU)<5C7%8 /,YEY527O2>&
M<;6B"&GI[IVII_KD/0->C=C*8%C(T#O=2EU?(X%+W?*IM8T?T#+BS5K%=DZ3
MNGS'$Q?VGKI+X]<5H[:B#S29M19S_=(>B,X7XERQ'>1?BO$\=<U8DFC&3P*_
MGB=Q=ZI#,@LZ%K(L-_B.ZJ%^<PJ_,K#>-U'JW).:,'<8:ZER8V8^/[ET1R3G
M/AG^(.=N^J9(5W[?2SDL>;[]"7V[3WC]3^_.T:^C^Y^W+G8^[3>W+W\^VOM\
M+/<W]S_O?_J]M3T6BWO+]C^]_U(^L[?[EF]=HJ]X^5[NG[P76[_]VMS9;1UO
MG^#SG'P4Z">.U\D/RMGDM2!>E%H\D#7QVI0&CM(I1WV0(J]ML+K(Y6H#U8(.
M>B\=4,U]EEO%9+GCDLGL(!KM5:F,8&G0M+2J,150T2N@FKE[6PU4#P6JT;K_
M5@3(-#L$JB )2&F(0>-"+ ?0@HDH7-DR8$NR95 #Q@L%#&'!62'!>DTA2VLL
M=<;ID-%0&N:A  :S5X!!:\!X*L"XN *,PXOMR\ .F&$L>2F)T*4+&:<2 4,P
M0G.TVD/,/)K";)8),%Y:_/$EU20>;"S>YN'F^;/#ECT;=OF<PNN9&__N-G%U
M3EVK1M '(>C'<=^0)F< I"8F"8L(JC*Q"1*1B4;! @N&(>7B;%5=P[I.ZPKX
M4[6.+U3'Q]PJZYC/.A$FJLXF,A(+%(B.T8J4++-*(TM:IF*MM:X]EBM2Z]I"
M=>V&1W)X>6 ,Y3FA<DG-T2.)U!"3G2%<<\4\A\1 K6WH)5*UEWZF8[O3)A6;
MG] *N='Q?8??J-(&TY=PY-J'Z=K&Z+6DOH=MC#[V>><E.C.]"O[==CJ_=Y_R
M1=B=Y?/C1IKD[@P5[WW[W5#M?NUT;X;)7ERYU">R2F'<R[-.9Z0+4!*P H&0
M'/&ED;R F*(#F:P4R !I[>:]' A8/C>OAH GA(!1)S#3&!,WC@B/. "(X\2&
M[(CBT5)(%%>[.(%B_.1?K8K/KHH+]P)K57Q"5;SA(QY_.?!**2JU(Z"Y1&L<
M%#%H@DG!6*.4BZ&4+F=RO+[)RGN)J^(D+&"K9]E/YZZFB_"B^RD\$20=3M@&
M8K)TD=&X4J7@+01#G!:::'!,^A"82["VP;_SL@ O2O]7TS^H]7\A^C_J'="H
MI6>6(QLI=4%2:2/,:6$H+($).K"R#3Q_/[]:#U^(<U#KX4+T<-0UX*KHFHR$
M1TH)",,)+BTGP=,@HG6Y\M)A;L_@Z?+9[CMJ-3PE??.TU8,WEZX=\AY>@I3/
MOU:5R_$,>OSV)+5+68K!?E*O[]K1=6/#Q<[IH"C$R2FN8,/U2B&*W\]:%PWV
MJE'TM;%X9B77^30G=4\[O69U1+<Z4=_\)[TIQ^$(7S?C)]D]/M7P$"_[\;FX
MX&C5C >$CJ86QJ4R'7.[<$FD:&/B&:@"197)T2FA..1DD;*%J5VX4JWC?27*
MG7PEVYW<3N<N5,652L64H>S?J-[^.C>_I$@N4[=3&X^9C,?Q-2?N\&)G\^WE
M 0?K'(M F%+HQ&4+Q!HAB06F=:0&U\(6S\EPQM^LJB?W .OQ%+'GU020^7U
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M>)KCBK@9]6[&(ZS![E'J)I?[J5OO:2R#L_&V+$6-B0_"Q E=BB.23)JB)T)
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MFW.RLM0ZYL(BF5&2H&&))(/A-(&DH2"7?"687%4^\U#@>N20RE3CF2?>LIK
MM#0TJ0:FIP2F\?,U"5SBTA)M:"DU4F(W(@<2$)*" Y,,=TBI7G$Q]SG>IP*(
MEQ[:^2/U>J\;X:S;3>U^X[33K52UDQNM3ON0]%/WI-'YID$-UXZ-3A4-ZAWA
M9P<?\%_]DCHN])BTZP]<DEV<\+M1[I?!6M9X-AN>P02B96.B-*-CF(05!'(2
MQ$DNB<HZ^"148!&0:)DZ&:8.&RTE'ZH1XW$18YP!V6!BE"64E#0!KSFQ%@01
M65, ZYUG9FW#Z+FS<I<GJN0[_7[G!$<P2K]FX69+P(\FF_G!LES_^<<D8O2J
MT4(B-<JC'LAFYY_19>H5/WE>I^\5O_"Y608+L6*<LO:<%V@WY 2F*0WW(E99
M#PH]9RJ!N*PBD5QKZC@ 52B0\$J+%Q+26XC5>,*0WWSC'66YWZ4AF"Q%W[DA
M6#%7H38$BS4$XPZ$2SY:*X@)+!)0RA-GN4%#$ TUH(SFK-K;4>.&8$4!N?(_
M?NJ7!$K\-S;_V;AZLNVS$U2?L/%_\,6KYSAQW<-F^VJXXB:R?3[K]9OYXFDU
MEE]I;-'+9ONLTI2! J2H??3>,&D29.F\"C$8C\PLRZQ97-OX@?W8J/[;<OVS
M;K/?3+V&ZZ;&:3?UT)-(L8'7<HVB5^WHNHV+A#^\ZS5[Z]4L7;_G1N/KVE>S
M^)RSQNA4TW;MJ3NYD;XT<23MPX<%GPLT-7*S8%#5W+S1/T)Y/SRJJFM77R[?
M32[C]ZHY=N4KK5;GO/>Z\5_/S+V_3<2?Z=1=G.#:]W;RO[O-=FB>NM;[]C;>
M?O<\M?Y)6SB6HQ>.Q/M_']%P\I^V^V3/=D[^;&UM_HSC>ROV=UNM[=T/7W8V
MC^7>Y0>^O;O?VK[<N]C[_.YB?W?OXN_+K?.MPX.<(U>X $2HH D(I8GS61,!
MEC$3@H!RJF!2X+:!$M["7UXMOT3L(13LGG>F$P3['0K"]N$!I5Y%@RNOJQ*@
M$-"P>A:(=4B0(D(S+LK:!EL?K\73\*LE"$?=],(+5<\A"E^VWAY$2-:;8(CA
MDA+0SJ$4N'+&63J5A?!"EY/-8H(HK!8F_-HYZ]:2<)LD;*,D>#!,24,H,Y:
MIXI8!H)P%XUDP)7T%$%!C ?I5TT2FO],B0G?H7GXLO/VP&LE$Z DL.R! *X)
ML9H&XM&5%@R\3*6JTEWFH>*52RX,;POCK>7A'GFXV/YPD"2W24 B*2!Y!.H
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M</G@+%K@E*,09:9&2 #N7:(*#"@1N>$QP\%FI06:,G(WH0WNZ$81!:2P9]V
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MTHE5QAIK:^%Y\1&['90=%^XP\!Y_,1HTQ*QQN1IU;@18 #?MAO->;F=\0C5
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M >[__.T7L,>NCDX.LU-A=>'2Q!!+A28\YPG14EAB,YG #]*F11J-8[!BG#U
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M94\9N)GW<%NX;AL3[;9 F&LYW9UPN5Y'!F$DR0TKU^U/%BR ;,C)#!9M]"*
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MH_<,NJJB8WF#Y6AYPM&;<YB^\T'/AG9(9CR,U<%;G/[8W!E4QIWQ^V#<+;N
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M'[^&G/4-+7;FA>HZI!E<JQ3T92PO8##UR^O>)]7OJAN'VTS-C!G@0:G^VK*
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MV$$LVUN24CLK#O.!U^ ,!I18\'U/-8(ENE%TL+!D=^(J:A[/8#P.W3?HV&M
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M(I6*N82U:'0G-/K1&ZJ&:J00'>UA'^&9"NO=.L^GCHU4P<V?J/GJYENXR]M
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M&Q%_6PXKDXW=Z8:=W1FISYTA[.UOB<&M;1*W )<W.[_P&3R[VQ_#?!Y?NF&
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M IHK,A<,BE$'Q'UVF$D?D4@!YB,Y+Q+>V-*,W;S\,^K"',. QVZA^@+@/:R
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MXGQ#R/F=ISM6:E'_SSR]6-W0]F=PS$S9"?#+\+,JT_E'8(Y=L*G!@GCC?7<
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MII4ATGN]L<5FI-1]3&%[Z8Z;WSN=<-YLC1?:S,>2VT=-U_JATGFOCDH?3@D
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M"B@7R B\K)7E94JO+M;C4AA6QI+/JO!Q$C*M4M]G$^G,!Z[U_:6']^UVVGX
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M9] K+\F;H[&8=5 @$Y?V7A5?#*_/7@CH]_5+-AOY=#R\Z3SO6<2SZCX H0S
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M5C)@Q!@6B"</XNR]0R;*$&BN2X!#+<0O7(B7Y1RI*?-RA76JF)+/L&H9TCX
M90Y!(D-B3D.!@XS,!>[2JE'F.JU7G=9KQ2S[.D?%TR+9C+1>1%O)A<;(>\(0
M]R9G7B82 :YQIA@/7KME;R_5N2)^,+Q8EH/AA\L5\72X,)5>RSH2F8K("DX1
M%R[71HL< 0TE)F?[$$EO;'%:0T(-"<_IKJ@IQ%-#Q93G H/!JCP A.'6(9ZD
M1991#5!AI!$I6$^7'J%2X\4/AA?+\HS4%.+1<&&20FCM./P#[$$Y,"T W9&V
MPB,9.<->>:LM7S,*48>-U$ETUNO*>F"?+CO16/Z:Z_EF&&C#"GY0]HF^)OJZ
M6JYRW)0?-=LAMONO4;[H:94RS4IY+)[I:5\],40X]W[_.#8Z4R%7SK9LVT?X
MS+<&(?:N?9ES80SZ VA1 B71>]4X/V[ZXT8G)=#WC=0:^'Z9QZBX-,04N]V8
MI_WT++9[98:CUA4KV&Q &WKQVC.K]^7[H6W%D=3^1:,7_:!;W ,O*YYGV_F/
M\V;_N $KX;C1@E41&[8-R@SX2:L!J^0KM,G;LV8?%L)E^?+\_3&,"OHOO# _
MN#!6<F<[IQ$:[/ICKRJ:UTA 7!K?,G/)K^X7#;XV)CVXKQ^[IS#DH3'HP2@W
M_COH].&/J@UGW::'IXV4[BC=UGCFIUF?O(Q%?T,NK;MR8TWDN I,*!TP48D8
MCKVS6'JL,!7:8>_3C;FT[LR--?$>#X^V1&K/+>?&*(V#LP)^"$D=R:7RBJV-
M.69O901]]L#<=T#O'J!IJ6GF#!E9JKNV'QN]<WL&V)$Z76AWNP'BUHUM?W&U
M>_2JD--V[(\)6N,XAJ,X*6[.]N!GI\2*,WA%OG+TVOC]+/HLB D IAL!#'K'
M@%*=\UY^5Z\)G#9+:[ZWV^Q]+;"GT_H6PZL*_O*WH)C06>P6'HX,C/G*LH&E
MK(,"\T"9R[[U&O;LK-L!B<\=A7O*A\=>;@@81@ )_1&Z[#F8X6]%XK4BY4F#
MPFO/!H I%AH[R#WK=ZYZNV@?;X:O,#+4QL>\Q/+\ZM[ G<!#\]M/;0]>G^>B
MGSL+R].VCV*)?$66I(8'4F\!K7VSZP>GO7X>)'@:S%/5UG*"; ,LBU[6+[UF
MH1W@VS,+-D3N0+N71PZ&M-!'KRJU9 LK<O27]UT0TG']44[#2,U4*-ZWW\>?
M-GY#H2\JS9)70#9B;+]81Z76ZQU'>.7F//+=N([GMV+US)1[Y=VN^_/6U).6
MB1J$WI5$A5XE42F&[:<QP_WOC9UH<V!#-8F[G78W*\A"<'[-<SGG,,C;AF%)
M/<5SZ:.QGHXOC>/8"H7$]FRKD)7_6<"%HJF@7&-L*( BQ<%8KJR&WPP7$5!U
M7A=*V;:]]!98<0<:\CM8XV?;0RS*829#9;4'F%0LQ/G.X)@U];0<_G6,_>E_
MVO:S&>R=[(B#S]L7.Y\_D9V3H^^[^Q_(X=O#X]W3_S1W/D.;Z#N^\WG[<O?R
MX\E?EP=D;]^?[YY\9;N71V1W_^ +HSI$:QTR*EG$A>7(42N1"R92&JWDA&QL
MD4UR@]?$E6G@BI7S'(MC3"P?886LJR]N:2ODY."+#=(&'SW2A@K$-;/(.N91
M A:9:8[D%GB1F0X]&J8(?#6FZUL7H)_ZC3\&[5@E,\.O&GFF&^= AK)5  @)
MV :WM HE!.HV*R: 4. \S4*;ERJ[\5NG"S2CX3+CB+V1W90O.RUNO=+RH);[
ML$@NX<.25#!8FITKIE$QC!%Q&O&'#'M99W=\C&"&I4X+2$2A\TO[#5J4"8-K
M%ORRO# WY<\8&W=PW90>!\MOR]OX#[L:#6D<=S,(_+\FEDX[!L:.CL"WJ=&<
M84Z# 28M7+#J"\%X8VL7#,<&_<?/]A'LASGU8Z$$LQ61>P+/;+9+^,@HUXU'
MMAN&I'EBI4ZNTKL,WKMR$M]"D$JHNGM(J=H8WG4M??5$#$7T"1,P$27UG 7L
MX#_<:L*9C%)J\N5M = *$W15>.,Z-K]OMH% PA1LMWO][J @R%=1H?OPJE]S
MRNIGQU@_Q%B\^]:+P]^WSW?W<WF+KWCWTI_O[7^$=[2^[ISLL,/]3V+O\Z?O
M.W].8NP'N+;U]>#D#=G9?P_7?P#\?"-V?_\ UW^XV+D,@-M?Q2$\]Z_+=]]W
M+W?.O\@H'(QG0DHEBG)<&S(Z*J1%8BP)L"/E5%9K*FU,7H"M:2G'@6H8=J$Q
MPPE+H9G; /SS]BRO'C ,-I;$/6.DBO+%98O-Q;()WFR,EDIC;*TLQ9IX4ICX
M'(>:9MR>3*/.-<<Z5QB2;7L4L[HI)")_-+0<2]M[3 MV!EU034>=C#.=(8NI
M[-E2;5Y4-Y5/A9N.@08='1>H!(9S1J.Q1HTWI?)K3K@D2J-^Y(F(W_UQMG/'
MC'W0@:>=D%V&A3NO^&:S 8,0.HUVIU^\]897%FZ KBU@,]L7H' 'K?*RLT$7
MQB,[ SX?-UNEB7]J3SK=_"+H1!Z)&YZ:#?40>[ *BF&SO<)#DM\Q=A58];$!
M=++3*)*4YEYW;GI@_QC8RM53RZDHO"Y  7)W =G+"W)_[WSUD*3<TGP;\OHM
M7U2.?7_<7S&<U&B[;7AX+[.IPB><3?L$'_OC!JR.9B<4$Y&?6"ROZH'9*1.[
M9[8+0^G!@&WVRUYD!M]JW3ZZFXTWWG<*39=I' SBL?U6$"X@4<W><>YU.SMX
M84#S$H8;F[X_\YU'@V:(67PJGT0;&-_=DU$XMHN5,"%2H&U+!_MHNKK%)(QY
MRHY@K<6\TESLPWO&5VG1BSQQS=3T%JX=ET?;AC77CM=[D=L,W7?0!:"3(U]9
M'KY6]N<TL^2> FN!(1MQAFK,JI=VLQ,_NZ9R&0%X,/2D=!V5WBA[U(VE1VES
M%1PAVT-@^)B!X6/NZTZ!,KF)ZXC2$W*19[!Y>@:&R[1GMD2][)K,"%PX 8N%
M.8[@<]R?16S,UYJ74 ELQ7;(R!F9Q<]U<A^S=!?+=*A1+!A4WTL4=_TQIRE(
M+BB&L6V?,MBL>'E^S3>PJ+*94WY2W'S5\F'K0%ZO-1M>O=T>,=YBY8X)Z#2+
MG:Z",K4<JCD0/&_4='K%@U\7&@[&\ZH(QM^NLY9J]>"K6ZSK=5J#_LVWW+KN
MRLS4&T]=W<.H35J6Z%BTN >CFX0MOZH#/)8_SF,)X\LL%K'H.9]E(^2=F#*C
M=-PCOGYVNF^-)T3RYN""!XSK#,MT)$Y//N*_%48W/.R?T;8 ]6X9^_O:+_.-
M_?_=Y>IYO#%XW\R.RNQ HXWWG>YI@V#TOPNOA.FDWA-5L,9^'G>O[CZ*R'6C
M_8IL@C7PVK;.[45OX^?K6 PX63599:XQ-V;?X>NXY;:U*=M$^:;4RR_;)/"F
M(?<M('1+:\DFP?/5+%KXZ&?D)#$Q$5(YEH6^^GZ)1S^K(,Y'@H3LL2SXX95?
MX\\^L*K366GD9XW0G ,Q?P6/Q1YU(PB,B=[4\I]=MNU.A]5U!U?4D;!$C8E,
M<Z."3ERS8+ S2?N8PL9#*^#Q1<CB,QHI,\)#\H)*@VZQ@5_1]VPNC)NKU^\J
MF']I&4]XDJY,C-(2Z8#A>@Z/+;Q,W[(YVKJZ!J:HMR*&Z&]#;]2[H3?J!1BC
M( %A *;C<),@&V.]6,Q"Y>XHIK5MJ\V'RB77K+PG$]$II1/0]GH=WRRFO# ,
MB]'*<SF,,+IRYY76WBSKMANA77',UY1]?D,;MO&MDTVW(F)P\FTS7S*R-;-;
M)6^D58NX\,_DI=WQ ^A[]H/U^_!9QA#X_VA4QKV>DYZH,=LT+_K.H#=V[K[P
M"E4-@:$M;6W;NV$HAE?"H\ZZ@..^=+"-!1<U>_WQD1QY2.W,((I7A9NT645&
M%A,&??/-LW*3<O(A79CX]J"TW(=A0*LA>B-G[[\+9^\+$+Q)[^B5+Z0,*\O=
MS*&UPVBN:@2:CR(OWA9NW[-!%]K1*X-Z2V?@V'L?679F!<$USH]CNP&#U&MF
M7GW=Z77E]Y]&G&K49O5M8D$_[C;DG_X8YJ45]]+58:RQ7:;M]HB:[:417_MW
MY6T:'='ZL;<KC\Z_F&29L)$A%O+QJB1)SO_FD73 SQB6@= X__;CZN! $1 Z
M"NRHC,?!:8Y#N<P"-Q4OFCG2;*@?9UE7HM2[>U]HY X>BXK-+06)CJ<%()6!
MJ'#)11DIT\UQ%:'8X[@K<G,8<--@^/4"@8G5)[D>F%@-%ZK9E(;<Q]"69I/K
M^2K8+E08EVYJ=C]#^ZXJOO>K#7QG8Y_5,?NTIWV76;]V%0M=SG8\9!VX0(?F
M\!^L8M^74X=YV@T57/[?"F886WZ-SZJKCU>9<F(L'_*,NC+EY,S_VUX@L"EL
MO^01TYZB&4GB%^G[*E4VF;WVU[^RR>Q^+9*B(N* O8DDTL2E"D8YYW-R-6*P
M2+P,H:>+I*@8&3OCIE*!,FN0S>9^9E&5M>+[ ?UP<;#_";Y[)W8NW^"#RS?L
M8/]('&2S:!_>>?GU?.=TFQ[^.9FUXOW)X=L_CG?W0VMG_RNT[>/)SMMPO/>V
M!?_]2J!_EWO[;RX.3@Y;?UUN3R?$4U0&L' 52M@[Q+E0R"IC$1%*PF(F6BAR
M<S:;9SA0.6.[NZ[S5-=Y>I1^+8"&*3'.K8U2)\,)P=9;IKFDWI/D4G2+)^RY
M#0UKU%L,]29S]2B1DN2>(8L=1SQ%0#V.%=(&YX/7/L#ZW-BZZ=#9"E9P6B-C
MXH9PFGP2&8VV(3*-S"RR<:-U<5OZL!E]7ZGT8 _F7DPE'96@2G#+/;9:2!RL
MR^=LC(J&+Y=[U6BS -K,J .>)(N6 ZF2QD:4M0.RQDBDG<,D!"D5-QM;5*PK
MO9H--8]*K^8U[]<9)1[,2;!,21!/.( "+#_CHHZ.<9P9?P1J4G.2YT2)24Z2
MJ/-<T(1D5 1Q*RPRG&LD/8-IQ 1XI-K8>G")A24*ZTMW<\WD) \KHK"R8/-@
M2N*Q,,Y1+:W/:8B2\1QKX83%G& B3$U)G@UL/DQ3$@^ PBB/2%E-<AT7 Y1$
M"D2=-I&J*%V.=:1F72G)ZGE\7@1*/)B2.+"M:<">1,%YX-22P)T4@5 I"8^R
MIB3/B1)3E$09CZD3B'$:$.?.(!=90C'GR;$Z>,SHQA;CM9_DR63M_8T9^NY-
M35;=#GHP-8DF*.J3)<DK8-116QXPLT[!!]C1)>]4U:"S .C,J,_,1;"465B>
MED;$G2#( EM!A%I!53Z2(<3&EEI79E([2U:3F1!NE1!6 OF@G$JC@1^[:&R@
M5!&-;<U,GA,D)ID)-=Y89RPRPGK$-= 3JU)$8(!RIKA(2@(SF?:HKJRS9$4S
MOM<-?KX&WU7Z8SH@;>9"59M*K 2AG<WC]CM]>% 9T'[/&BAW#,0JQ4\L*9IL
MSHZO@F)^,'LW5%C,$O%!$:Z8UE;)0**R(D82A*W9^[,IYJ_3[#U*ZZP-0-<3
M%ZBHAZ0%PPA[XH@2P8<8-K;D=&C%FM#W>T'PTY1BNZ4QBX:?K1^P+BDP;8V
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MUXK;+TJ^EC5C"[Y]#M^ 8BGX]E$[6TBWNH.R:IG?'=3H .6MRLR>PMN*>K<
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MQK/@"U%7$.C"EH09B/WCWZQN<9,$(R$!$O3R,@9=NJNK,I_*S,I\LA\?V*H
M;>%.UY.9+Y*GLNMS2 XNM8+;S_M6JYCT<HGR1(!A6$88!R >U\VS\NK#E$X7
M>IL@-*/A09AE.RA"BGG5_*#LCUUV^AF)V>75O+8VAN,H^I3"!-8(O>ZUDWO"
M7HO4ZG7:N1M1'@OVWC1JS3V9>V# ^T$Q#=<=J2WLL[YY6LS[V-=[\9\(1FRY
MS$-%R3':LC-!B1K#+D6T^,RU1A_%5KA[]^DA97C7D9OF$NM3T)<\V-;5$'/+
MM:&%EU<R/]GOMF-#$Y8A9*>XMUZKQ^]@.'? 0NQWUVL?SGKP\W<0AXPS< T
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MMY4HS'C-L#6W888)C23WJU:2<<H(>%\"6RX#]4HFPBN_:[5@:]3O$H$80*V
MK,5@F#%ND"&*(1.2Y2(FZF)8VQ3/5/%5P<<JP,=,QUR).\Z4MRD(KE,R3IJ@
M@S'*1JIQJ(ZY5A-(QCP\KE5BBC($)JU '+8"Y#PGB$46O;1>:Z[6-O7"3KF>
M%$.6J.3ICBCWKQI,;W?>W[3RJ J?'BY\$@<F)JX4(R@0AQ&/'B,3E44B@'G.
MHY)*R]%6<2): 2MF*"P=!Q/>:0R>FA R)N]8D&^H4.I.4Y>BO<_[7"]5=*BX
M;NWR)JJGC-E@94_-1Q1/<;+X7LI$;##QN)JL'Q1/B2>@U5JUP<JJ>*HJGGK-
M!415\=0S%T\M83R_]A-YNE2S9<I4K4JH'A,!%$299$PD1%FNDC=<""6B"Y%A
M1[R<^>!B(HG#E9/^Y9:I^1$LS=MNSN_;VV!QEKY-2?H U_BSV\M/T(BOA0"J
M>UZ_W#O?W_W8VM\Z.FH<>_#A/U-P;2[WMSXVZUO[)^#27.Q_VV_M_#7*W_[^
MLG'\6ZO^[>^3G4\?:/&YK3VQO]4XJ7^#,;3!5=K*7.Y?Q<2J*8DE=Q8;1(RF
MB-LDD6&8(<]=(A:[Y"B=% Q<R3.,JEI@>3:G5X[!\X=174I)1JP4A_\1076B
MU"M,56*&.L^F.(:Y)XQ:H?&RH/'HT0P.E#/K @+LM8ACRY'6!-!8"<J"LT[X
MM+9)Z H4#E2(6"'B8L^EG8E)"Z>\UI8+9HRB41,<I%32^4!G3ABL<'!)<'#L
M9,D*FJ/T!&&K#> @L6"5\HABI,1IG8A(@(/C/866U#I\IB*JI0PTT/N#AZN<
M_CR_CXVYIDD2QT&RF8V6:XR]S<8=>-AD]N3 "LV6 LTF5%%IKIGVFB#%?2YT
M<!X9P!T$!CV/4A'8MNRD3.@5\;&K HLE]2"IL,J+(+0P(((A@-WDG"<VT^(0
MXDWE0:X^UHQZD,EK8U6NNHB4Y^0^@8RQ">G @U'8!96Q9AX'LE+WY72/."76
M\^@":#;'0;@H<]]4[J350@I;N4>KJN1C[A&8#-1SB9$T B/N*47.V( HV!?1
M!Z+X:RFM>@T>$'N<!S1A!I8*L.8OCW(Q"ND,-DQP9:UCD>#$G?(F8&^6R0-Z
MU?P2SP5D$RJH4B),)@G(Y1A8*\E99 3/IX_!DX 9EM:O/+_$9"A[R:#ZJ\"?
MN0TFH@(A7'":K.4Q .IHXY506 IPF)*:N<ZI,IB6!6=&O2(=HXJ9:L);[,MD
M<,UY+MPD25/E)(YJ;9,O*)Y<:?J2:3JU8&* 9TRYMMP2;7#DREDNC#=)E]RC
M2^(:59;&0A!@S&7R!A" *5!^S +BUDED*;9(Z.2,H2$*[^ZW-%X.!][ T=%]
M'/^UGWAU=C09SZ3Q6@@JP6WBC!*K),&,>(T3%E2;)?*<*MR: ;<^3^"8$,%8
M!<X1X=0@#DN.#)@N2%F#L1$FFB@FQ7-7Q#>J@LG+:3%)'X*+S$D/"!,5,33G
M(8*Q+!/6=EC/6OE&JX@PH[Z1U%B2X#WR$F/$N0G(J2! _"CS$JQC#VL[ 6$J
M37\5FBZ<%CS3^N9J=1*EL81S\(=Y,I@FIY;(-ZHT?29-'\^JBR!Q#H-L!TL0
M>, ):6\CPL%*I@CVN1?H4FGZ6V?DFT!0/N]YTLH2T\S?&(Q+EPQUQ$;#"0U.
M1<<UI5P'%B6;S-%118%6%@&_CGM3%AO" Z$(.YJ)AJ7,E,,:@3CH(+#0$8?7
M<MY4$6^M%K[-[[/)@&UR7B4*!AU-QC*FF-62XFB<PY7/MK(X-NJS*4\E222B
M2#'@F.(8&9'KQ()B0EE89B/6-A?<:ZM"DI5&DEDRAX6S5$3!)+81H,1HSY)6
MAG.B!1%B&J>PRAQ>;DR9P.9GE,%8(QTU ]LH4F2T,$@IK%RTP3@3)S$!K J;
MWX-<;<-[HNS]O2-Z(O-8^5*S$T!DWZ'\H>?5XH+.[2?R<PGBXS^OB )KS4ZM
M%_^)G;-,R58PO(%R%W-<\+'U!_"?DJ6MFZ[)W(;$;QL_8F9;R4FC4TV:[_8'
M>4I.>]UPEEUMF+,P]Q2.LDB.3>P(49W+K(V_MNUW5+*.L0VAR'_\VH:Y+U^@
MY0L3.ZA-=_'QKPZY[KC>H"5C'0QZR(U8,(.5F/I#?L17(S!L*H'YZ]/_M>W3
M7]_7XO?3V.G'?J5OY?3QGVO3S-_UH?]P_M9KG3A8B,+=EMUB5A?*O$E_%)HJ
M9@&LDMIVYQ]XOCSP6LGF.L-R+P=_Z+=8<G86:Y)&T]Q[S?Y)#4RVKF\6ZW3>
M'!S5/, +6'3#Q;R>@--NOYG7H]"2JROUSUR_&9JVUXS]C=INMV8]6'BGK6;_
M".[8[*_7SF.MX)$KN4=]#U8<7=^_3!09'-E!S?;B".MHR36:!>;N2/JS*-UR
MK,)VIU:W/7]4RY')FSDIU AFQ1;J)GZ]U\0_/KT8,?$C)H#@,5+P%;G))% R
M$D>\R>2X)IB#[5F#H/]J6M=L-0<7C6Z^N6V];X/U-Q+-[)RU4>@6I)/YDM=F
MNUE1L_WQ/,5?\<ZN)XW=P^^-W6T"SW(@@]/)V(BD9AIQ$35R 7L4E?(\8>UB
M9&N;]+XT55>R==9^^C\S>'I+)@:KZKTM3 QV/QQ@1K5328%K[3,EFU'()4N0
M),P3$XU6+I=P8GR/' Q96W^>A)4U6(&S7F:"SN9+/(5-U0&TPAJ+FNV$QP )
M-P[N&HE548/,&ABZCT00Q6+26MD*2)Y5@N">!]XX;8DS"#,2$8_:(>-ISGA-
MF"D.CCS1BP:2)1.#MPXDC>.O!XII)AVA*"?Q((Z50D92BRPA96D5YGPA0/+'
M62=F#%&OP; "LPI\[<*&S";OS'AHE<4*-E1EB(<]E+L P&T2\3%@ZX*H\/")
M%>$0-X[K!RD9KJT1*##A<L*_0";I@*3WQEO,HT]T;5..8V#M4?"W9*O^]N O
MK[H_D##=P1&'(M5@0BO"D4XL($J4)1K,*LEAYY,3(*_V(-K=\;8 \=Z?'0)F
MU?(I2&$W]:*/L&;9@,J^9C\.!JTB7I&]SUGDZ%&-9!X2J#][73#O0S^?IQ0A
MB#(D <C]/A^A@$<>^Y5,3;&E\L;EW@%540I""/* *( J2B(M#$/>LFQF^11R
M(:&ZCWIA*&-%L#FW1.GEU@O#8-CI<*'*;BLCL9-A"&:X-5T%4;IGO8?"9-==
M5U8PX/'[I#C/W?#.I"GJ%V$@>*B3&-"@BXK?!K6S?M'\)D<5BRN"AIYV<]C1
M']D.3&Q1=&2+2<L?BJ#1PU]/8?C=L%X&MG*#G'ZA[SGN6(1[;X*9$^-C@Q[,
M0:L,H>>X5K<SQ 1[<[19Z^9F3L7;U]V<BAL 3@R:K>+"?=# 6K=7A,L&%EZ&
M:6XU_^<LKWN^]G"T9?^.B_RPHR&O'%LKGNW[( ^AF(MYYK@#\W<$"]:ZJ,6K
MX]CU6CF?_5+ >[UB)/_8UAG,[F#0:[JSLG?/H!S+</;AP\5RY%4H+WY;+ZZ"
MO1NUE1/B/V\U5KH6F_OUNW_GN9] GLYA1>U,VU$002L,]I(0&@#..\*X%Q%C
M8JV05BRTA7$C#F[BY3/T\:LVKTF;U\E%X[)^0!W61GB.,.41<>T),DQQ%!/V
M3D?!2-&C;SQ5Z,H>NA'>V22'*6<(#IK0&'@@4CN1C,D\B#@*7M)1+:R+;"4Y
MBY6<G2U_H)2/3)F(HO4@.8)[9+TA2!!%+&8,+-(PB8/W6G *R EED" U\VP6
M3G8A2WG)UP'N^J?ESM&ZV*A]*G;7#(&''0#919X0%IWJBNV\3!BZVB\GHS"8
M!>6N7B!U_IS-NWW_RIXOC;'K7:\3,[3",%\66;>'4S5,D2KGJ]'M=,&$L=G>
M'\LLKR3^6N))_?CPP%OCDG4,20 JQ)EG"%Q&@G@BD0I0 \S\VB8=-^ZO11Y$
M>\8D\=UF&R2N$<]K7[IMVYG/WJ@M/D-]RCN_Z,Y02?Y<DG_Y]0!;2W'P%"2#
M4\!ZHI%E(B&'.2$R"I4,7]LDYG[)GQ[GQZSX%TC-^  "V6TW?>TG$!.T=>WR
M_+S"61JWDB3&W(:;ZC%X%V#&POZ5@P=7'[QVA&&;[?;/"@^L]"7@\]GW[)>>
M1[GJ_?5R7\X>ANU<P*)W;,<7'O:M#Q7K7[HBSK;@ ^#%'L6\X<(^W<^>[#'(
M1+Y!+V87L71JBE2.T"W<RW;^=-Y^>Q$\W=YP=\];>;D#YU21["(7-XZVV,,W
M:N]]]J'@Q=;%>OYV/][7HS9[FC;D52L?]"HV, P:7/FMMT,"L D<#6,"\'*O
M>W9X=,M!S;UV"W,9AEA8/]?^7/%D>2BW[]_LW_;GP9'NIM2'&[N+X5.WH\V+
M4=@=Y4!+$^0>YS#$+-17OGN^4A['51BY'-[=R&2^S,3)*1;O"091S#EHS]W0
M5RDE/S4+_/[YE]NV7CGJ4P 7WSP%91G>IPD26<KQS3H\(/7YKGFTO\-70A-T
M,^0NP;WUVH>S7G>]]OL1*%0_/VP'ANZ:Z[7M3O&QWMEIC,5<[![9)LCQT6 T
MV>R>E+,QY!BJJ^ YD6^8"?6NT#*8^6'ZY;#DY]:WAD"#;[YB'=B\9X/[O_(@
M1)4M.9^_A[+:H/11/909W2!LNI:\,UZ6/\UEP8Q_R0;"B]Y/?[C]3*A0?,+;
M3RX"UG1$*1_5KO9'\WIUB4GJ].PS_KO->QQ<[+^B;0&</C#W^522\J>:^_]]
M$:>CY Z[96Q^!.N^1C#Z[YDEX4Z)V(2ZD=L_CWHWWSZ,R('5<8)L AEX9UOG
M]J*_]LM=+ :<' Y99<MT:LP>BM3F?[K>+YO36Z//#NSP*!NX?)Q9D9WR#:D7
MW\-=X U#'MM4_H'1D@V"U2*0?;PN*G*2F!BIB[K5B6KX_@))*X84'4\$"8UN
M/L<!@_ICZ1C 9?^ZCLY-T7U\VHF8HCOYHRYU+PC<4KTQ\9^OYH;?6W.#8PB:
M<A,L3IQ'HHWDEB;/=. $//7K$O%A@=%(SSQG20A28YT$MUIFPML@&=:!2NQP
MFAAEO!M=^<N#MW76BCMI8NWF+MSKM_R$;RYT\N%[X_(S.> LY.0?BT3R-K/J
M"&182"@E3SB1CA')UVH1MJK3;#STSN(,]OH+AA1V"^^NU>J>%PYVUH;LK[9A
MO'"5PIWJG@VR]YHUJ!:O0RH@BRC<"JG<YWT/RKQ!AM_]:(/+G?G$?1.S,AL>
MTQN*3.<<S+B/"C+=SC3;+1E?O(-$V ;'<O%S 'O^XDV)8K#Z);VYY6":N7X@
M(GZ\L4XNXAZ/02P-@U3>]^X\\:M8RW)8(0?9"F/B79D:!)]:V_RIV;F*V_?O
MYQ(;,Z*FZH^ZQ M]E4=;*Q-I%_7@]UJA9FIE>2437"]* @87M2W8^&=1J5?/
MXW=_>ZA%DV>L9#_TR>+TV'[H"YB;96#QF9OOT/"0>7LR2;C@B4K')=:*49^2
MM(+JV4L2WN?SG-%RA!4_.A_R[I#&M\^X?OR5%UP[W[;Q_K?"_R,[GSZ>-([W
MC^#?D[W=/;+7'.7=^4KV83R-W</,M=/:._[2VOOV632VOG+X+VVT/\"_,,;C
MOYL3NP-3*W3"SB =<ZX)"1A^PP8E[[DVAD878<^F<IQYYW7Q$3YY%_;GIA@S
M\]_CE1@&?YRU+FJ3[>Q[.9HJ7[_R]2M?O_+U%_K,.=A=^?JORM>?O-"5K__$
M$USY^I6OO\!)>^.^_MS<WY$FXK0@WBC#G1.6:"D]B4EC%PF/A:\_$^7W*_;U
M+_;;?[0;QQ_P?KLN&I<?X%Z?V<Y6_?O^MWJN]A9[[3IM4/C,&,?N'^V]]AZM
M[WYI[UV>@/_^&9['\_KE1WB&KV1GJ]7<N]QC\!DRT=>WQ)B@2<K%)3SW'PC(
M2&>1Q-%'ET*(EH"5(A;5B;;RN=^ SST9/,#GKDTV=T<R6T;H:1]()GD4-\5]
MR21%.><-W/0!:F[J,-[W<QT&3/2M1).;%**==)U8]&?L%74]'1_?=\+-R\-L
MZ7]URWK/W?S$;SM3Y</W@V2=T8XS1*.PB =ND ,,0D$S8@55L*SQE62JW"2J
M](M,E5R5<54+>K?"]*IZHZ@KF36)994R5XS98/I1.?A<;O"2%7JQ(1>QP81Y
MBF"6>(+XT*H-5DX7T*L"(-,_\9)%U<<"ZC/DN:_.LT\9R'M;SXZKB,M4$9?:
M3V3A[4E6,NI295@\24?)3/?H&,4N)$XTU2PF*A/'21N) UU,1\D?>D977#=O
MH'4DAGM=[FRUCO>W#LG><1W7VQ^;.Y\^7.YO?3G>V6VTZNVOHG&\C>MC:1J?
MX;GJ?.=;XV1GZ^]F_?+SQ=XW&/=NXZ3QJ2[J].L%C)W6CS]?@,,T(4TC^10=
MTT@E!LZ3S&VR2;2PL#89*Q1G3KV5UI&O)6ST)K>"*@#_)"WS@F;6F& M9I1'
MP 2/@Y9)4B^Q241.P6HS2\N\V3:%"OQG __1?IO6$RE8$$CI:!#'CF9:88*D
MBCYJ:JPRF47OZ7OC5<A;(6^%O"/(ZQCV49+,]LV#](Z&:+@GGFK'>- +;E9:
M(>\3(N]85]*8-/,N*F2(B8@3AI$+(B&MJ0U:&ZL-7MLDXYQ\JP>]L_0LE2O5
M#G"ZGJ4E"U1) K6X3H"WSS9?AFSNHVWV:G\79&(PXAM.A%N0L7)\<_G([9K@
MVQ;9(3>4\YDO*S.V_0/0!Z^O9UJX$(<]$HHZ\F)YUZ\(W/JU4WN17U^_Q1D'
M[_7.8+VOJ,,RX]>P9+P4'8;7[_(,UNSI::_['6!]$&LI3WK)X!;.K@C'X:7^
M4;<W0)E(?]C!)E]X1&R>ZPC\]^$$%K+1?]\)'V ]\^A#%IGRU<RZX :W^1:J
MH^SMRP.BI9-6!Y0,%8@G&9%+/"+*9- Q!6E8>J5'V?%*2&[+.*A>YG-L=6$_
M*(2[Z^!1["@1XRWIA^VL5]RE7S#%VU[)@5AR_EW1=8[K^)MC;>!JPZ@GJ.1@
M&\(\[LSX^2LYBL%.=TQ=G2>OP+EB=9X\;V'(O5[$:@CXVN:'";O((SVFU0K"
M+/8D=$6"+'.?='*A UA:@H9 .3'<*!9(C#YXZI@?YI=/=<!YVYB]-G-?-SO[
M,(@"%FT=[VQ]8'48R_YQ':ZQ)V",WQO?&B?URVT*O^/&-[C&[Z-!E!.\=_F9
MUW?]>;W]I5V_A,\=GXC&U@>R1V&LQWOP^V>R_^DSGWAVR:GU.)*(K"0&K.7D
MX3=CD=$\6 X H9U<VQ3KF(\SO*_DR>72Q,?GC'^O%K0N-KZ](M Z=^E.XE9Z
M%Q3U7G&IE3/PNQ">2B=BE&GZTIT*6I\>6D=/!H,UW%D<$5=2(<Y,0%89@9()
MQB3#(E-V;5.N*W%?3\BE@[@?F;ZO)&OP][NAC7L]'_JH)Y^(RRMK_H'I9S%+
MQ =%N&):6R7!_E,6$(H$\</F[MX>O;N:[[*6L)O^U>T<[L9<NQ.*X-1?.3:5
M7_CM.C)58=?BL&M"-6)0(G+/"<)@V"/.A43.<@< AA/&CD@M7#8+&5D5[J'9
MH&F1!N"\A8NO &7FMH0 7'0$6&',1TZ4U4YP9PQ-)@&T2/TC2ZA"F65 F5$+
M"78)YB*7* 1#$#=)(4><1 H[S1.SC@63+23*QIN0OKBV3U$PNRJG2@LZ+&KV
M;YU .=LOFUO%9O&5?'KT/V?=_-:PB=8IS%'L7_??[(.B%GVLF_",M@=7ZY_!
MV_#*U>G_Z=F@7U9;7C7@M/]8^&P^+AI>L]DI%1;&NUX[/VKZW$WJM!?[):]X
M[5_QG]BJT=JMSE7/<L*;\>?F=/?: [O*!YJ4352=Y@*T'#@< V6Y-3'FF4)?
MPF]**_C3&A&HY43,6)A\ZPARR=1PY'"WF06V/.&]N.K(=DM5;]<M#]7V'CK]
M4A7/3H=]V6YTM'1ORL9ZY[%VWCUKA6$N1JS]!)IW:B]^7B^2;)KYVC"T(BL#
MH/74]@87-=^+H3FH]9K]D_7BB!@0H6CP=I6<<]5D;26/AHW9D.5![,P<?_"F
MF8XR;E8F.O$T)\./8PY\<+!R0SSRLB\PV)6:6;'!IN0YG/+,?0K2E&4\L'W:
MP^KE?O:*Q?"-L!@^W+&@Z +W3$R&KVX2LQU>^I&%-5[,Y:?"K,I&^2PI/*]Q
MSAZFSZP$;QY:@AD$[[6G&_UI+U!J=6W1K+MH'@X.2JV7G8C^.=CS5>K1:ST?
MG_OL20NI7532$FTX#M(DRH3F F,"OP@Z>QN+5\EJ>9KKJXX;NR=D;_>WW*D"
MUW>WSW/=5?W3QV;CVP<!]__>.&X<[UV,1'C;GWGC6YWL[/Y]5/^4.U5\AK&\
M%WOT\_G>MVVX7@N>]0.MT\;QQ',DK0E-GE"$#9&(*QZ0H9(BJF501-' I%C;
MU!BOR"E2E5Q4@><R@^<LQ;&/1\\?UL1>![AO=X9]/46OSPBHHT=FC,F$G<?(
M)ZD1%YPB2WE"F&!OH[6<4+6VR=G"BEXK2%L>4_F50]K<60+,2))$\D(9PZ55
M-CAE<DHZ QT1R<Q.=5[9@W/!UUC-OG !ZR@2BA&,0BZU1SHHA8@+@C,I=8PL
M1S''[<'*+JM K *Q1X%898TM"LY&K3'"??)*,J2U ?<VIR@8&C7R DLC;8PA
MD;7-5Y/>/3:P5/QO94*-T_??F91\.<W3+U76Y=SQ-9SW:H9Q("ER GXB$=A(
M%SU16CHZ0VE?94\M (#JX_$U;T7$U'JD# -[2N&(G $4"L1BZ[BU(>8\;4-7
M-;XV&6&>U%0;N>4T>=D5-,P/#965LBB0&+52!(]8"JH1SLVCN14&.9PP4AQ;
M$ZW#SLBUS?'&4A5$O&6(F-N1L=&#A 5+(R.<,V^9Q2PDB0W'-#A;16.>&1C&
M&12C%N!9!F23P& ]"(J,E0[%H&TT5-.H^-JF-'-'8RH5?2LJ6NWBBU+6T5V<
MZV1#L@E1SQWB#E/DN#;(>IID\AI>E@N(-2Q057\03KA*TX?!QH>UN_KDW4^^
M]:X^O_>Z_3ZZCN+D-+%'!7 >,2U+A?_S)U!QBP%#=*"*<<&93MPJV 0(PY8(
M5P5XGA?UOXX'>$0T@5!GD!2> NHGB2RQF=+4*@.[=M(28$&R\0/_%?'>'@=-
MR]S H(*>EX&>RO1<% B-FI[&:L&(Y,C$(!"GD2,;N$>"$Q>=C+!T?FUS0FOR
M"H,J#%IB]S>9)%FBS!$A>-1<6V$B9M0ISB4;!K&K"-7S(<]8A$HZ[311#FG+
M,I&:CDBKD)"03LK @S/Y@%U/,'\J"*@@X$4@H#)#%@4&HV9(PMXPRPW".(>K
MA:5($V:1<D+ &AFK?#['6G#NX-.3"%4ALB<*D3W,SI3_SEC0[)S9TEJ=EC?F
M7GZ24L!R-><XS4FA\SAO:"PEKF,.L1O-&>8T&*F]<,&J W!_UIZ6BNBZV<R@
MZT^.NBV0\?Z'_SEK#B[ >(E;S;YO=3,WTM)0#UV^'\+5Z<E>^\/EWK'_WMCZ
M2O>_U7%C][=C@*#O.UM_M.N[X6AO=_]XC]:+7F-WJ(?:7YI[NXUFX_(#?&<?
MQO"9U#\U ((^\'I[[WN#?CQJM &R+G.O,8##R_I!4MY)*@U*F0^;,R:1U2DB
M&8)W)&*7C"LW$Q"@&-YGDK@DB11<4LN3A_\;@S&%)::!DQ1T\-,S%<D9J(EB
MI(KRV:F)V%0]J@C9J/UU9'MQ*"O_KU9*RR\_;<74],W!S[65ZU'U_L%N4>LU
M>S8XZN:^.H W]K0Y@-OV\Q3T2RZD?B9/NF)DNF)M>E>[U^PHOSMB>1 ?J! &
M"T(5^,_>P<ZFB+2"1<N#$),#(-N-CZ.*_'NWW>YV"G4NUJG__GKT*\)?^.P:
M[MF!"RGAQ 2X$M0@KH-#SAF/P(IP6JADH@EKFTJ,6Q-7=".UWUNVWZ^]STV2
M8 &&$K)>.V_"])\-:J=V2-7UZXR2X81/+@1JA?+<"&RH)XQ+"]X.85K=$QJK
M)&,1DO'AHGYXP#5+VM+,U\T20+_GN<A.(!<=I2)2PDA:VQQGOAV1C-^FD(R,
M.;-)Q^,(ER=(QY^]F&*O%\,< L+>GH"P^N>#8!2(!N$H<] "> B!- X<$0N0
MS@% -%<@(!/*F&I9 OIYU>%5]$^W8+TXO5J)^R5EHY8I B<B3B%#$R6N!C^R
MP=PJ6[:U+FK7-QIT:R["QE6S_=K__?\T",RO=[Y:O$9^W:C]5[GKY^WNX0Z:
M8YO_" V?R[8D6-'?T9 C;T,H\A^_ML$^&+82*U\8I>7KGJY->_'QKPZ9_+C>
MH$0,(P.W;?Y2>G]LMMTU\X1V1D5GL4F6@\UM,867&#6""!.=_A$%Y7(80>.B
M$N$A!ZU2.HJ7<Z].VP*Y:79 RBYJ\%3-$#LAT[#Z5M$8T%T49M!O7=LK;**M
M9@^DK=LKQ1(NE)DBP4P\S80NMR_7:L'E^H->TYV5]++P99#A..B75)6M)IB9
MH5BEC=JGV(F]_-7UXFY'-T)YCTJ,/,V]$ O YF)O!&(C%<0K&K4(C!M.K<,*
MG  /]@(#BTU/]*XF8FW!.WVS"_]=Z/N7O A]^#W>)9B&A?09:<^[O="/G6N0
MQ6\.9+^RQN&!])[':"62-EMH(1BDD[7(A\0M3'I(FJ]M@L\_#K* J[%V6A 5
M@R24O6,GRLTDP+PM-W!UE)II<%10K';BR)4SO_%IKWO:[</"UX8\P[?TY^I^
MF>,X?W.C]C4SU]4\ )4%)?#-GC]K]P>VXS/J/VJ(Q8ALP14;0=>RFOG\Q8W:
M3@=4;;)^G,<\^+-!OG4H.ET\Z!%MK)R']RWW*CT]Z_FC@OSV_\P0$B8*@^^?
MJ$Q8<VR"]<IH3ZD$#0=W+=YM&C_%$?6?]J(@XOW8[7VY'M-.NH4+TQE;YLWA
MP,EYX_P@8A)#Y!K)D&N<C$Y@=L$/E6#75HG#2K"U3;(QSA%?<T-[?,B//&*.
M#WN(V\/#7CP$O<D*V.N>'1X-E?M&@+*2'_9L&_:]LX(&.37SFM1N4XU.*>*[
MS3;H7R.>U[YTV[8SGY2OUQ9_PC[EK<NVVB4^ %S8;!+T/>SFV2;(EN5&#70P
M9:;.,&P=?#6;_<*\O47>?MT:?"*O?&GZWL6OV[J=E^HHMHI&\8->0>Q^4=JW
MM;/\?@;?P])^@*OT3KL%1L+W ;;'&GRO +1MC8G@>F;OOCTELWF4 '5>>VF5
M  L8;!YCC0TZ$L.2XN#+_,#<06(4\':'JW#;L?1@S?6JN,-]2+='=G;]>>/X
MA#6.#UECUQ^PX"0W0<*<*XVXQPYI+@CR7$EI*!<:@Z-!S,8#<8B[2G-D_RFV
M^LX-Y,$G^H,,C[-LD//*R]@&>4=>BK/3*W'Y'897C^ +3RDX;V^+_'#1N#P\
M2!YL%5@4!"N2,[2,0\XSA:SQG'E*@LP96F1C0D!BN$<6</UX#-'2XZ Y!?<(
MO&@!MPM.6PM"(+"+RE<8\JP8<OD5GF7[ &,7(I48.0W"P'G4R$K)$:-":E@A
MX5E:VS0;^IXC\R&.K,\H#"$P1;'5@1'&B2,.,S#A2. 2;AFHJX3A^87A\(!B
M1[ &$UH'GQ"7 C84GS 2CD<7M-"PW:QMRHW[2HBN-I790]:$)*JR)R4C;!B1
MPB"(5"YXG%Q,5%3R\-SRT-CR!X0+KJP";XID+B[J#;(Z>F2C4$1@D(E<4,8F
M^%5WY>&ND5%0\]?:9ZU!\Q1,>^M];,5>T6YFS*OZ:>W]7U_6?K[QKH9^ 7S^
M$"QTVPQ%J.7V#7YHJ_R9&[G!!Q>[/]$')?!*]MZ7(\]&R\TPWFP0[X[$73:.
M_4$2SEO8=Y"1C($G+PTR0H&5XK$U$AM&1%C;%&2#C-LIZX]:]CEWHFK9YU[V
MR[T#D;3"6 L4J0-/AEF+#.,>.>4HC3Y$EV#CX6:#C?>8+W:;QZS\G'M.M?+S
MKOS.%K@E*DHE.$&@A#G)0MA,->! _U7D7#O&, 6%EQMXG*!H'7:*_NG5R641
M!.K?C2(Y<&$[.03__NSP#-Q8HHNP=1F6 F'PK;-0]B!\?]IKMJ[>IZ\@Y$/F
M#/D8$;VB(L4(?B/AUJ3@=:(ZIICSCTKMP%?:,9[_7%ED"_#<\<[N^P,38Y+4
M,*0D Q7Q5"++(D%!:[#.+8:=464K3#UWE&=>$7G"*,\;E!52O_QZ0*A/1GJ*
MI U@L0L"[CP#2\KG%L@I>5@//9D]]TI6RECZM86=.[#>8V>?V_ZC]MTYQ:;:
M=Q\C'#M;]8.(C4LL>,2YBHA;F3TYF9#FB4C)B!>YU8;@&Q,*)";MKL41<=N&
M.'3I %# 6[ORU:ZZZU[OP1^CZYW9WD7I&YI;.W&6)! M\ 8'Y6Y<MW"/X4DS
M*3^XL7HYQ&-[,IYS3^:&1<\" =\[<86593FKCQM+8E2!F+OGSKC:DY\FNV_W
M\X&BX"R$:!#!GF5>K-RU)HCLM5@+AJOW@JQMJHWQJL,GWI/G%9%J3UZHK#1V
M3PX8$4Y&RG.'HX!X[F9OP*M!4DH%OB?-K$U@OSV01_[T>_*<8E/MR8\0#E[?
M\K G^X#A!U(LA]QIX,@($!,)\(*%U,K0'/G0&Q-,M@7LR:5?7.ZTM,CI(F;R
MEKP5?<R)D.5G>?G1C?&$W[OU<L/71W?LX38I..RCI]U^LVC9VHNMHA)VF)$[
M+-2]]:WA!H]OOF)=O]LZ&]S_E2E-@V?O&JX%>U37<+I!F%AXNVBX+*>+;T9>
MC':ZYM;S=J&>OU_Q+:$9ZPKZS,9CR6!F>_ <<+'_BK8U.'HHC>NQU7VC YG,
MV/._+Y% 5MRY]O$F@:GV$2R,&L'HOT<@Y[DDH2C5?EI!F#S_FDUXX@G%RX]S
MB";5(M_^>=2[F<[#B!SLZR?()E"*=[9U;B_Z:[_<O37<=SA\1>'&4P/S#VJC
M'_C:\X(W/ KLQ?@QZ$WYAM1TX3 K\(8A]W_UL9>E^9!M(>@]SI\0.4E,C/ G
MW.I8,GQ_@6R30]+2)]+17!??SQFE'P&R.SY?]J\!N'!%4O?TS:]_.!'3][^>
M[5+/ ">WKC>F2/-5;?%[J[:FJ\):**;3J2KFWWM_UCYK%3D/.X,CL--_!UN[
M%X]BIP\6<"WW^+X[B4_,]."/8CAKQ9UT:V3%P.Z,:[L#+D',@]O-HO*6^1]@
M+ >8P*RGF"G1(SCVU#ID@Z/("Y&[/=F8M)V>SV%YXI:[MTD+:L/M]:P-PX6+
M](M4?? V.X?P^[! PME6+E J"O1NB7:W$&U_1[1;(#VY)#"_VNT /A;N9KY.
M=V!;[WZT\S](KK(RE@ #?]Y,M[?.<EDB-[AYG('Q\"T99XL?K-C0ZG&^[/,/
MEM(-+.Y_^Q&N['(S:)?#"M'G4I@<:2FB2?E3:YL_@;(. Y/]L9[!LSUQZ5XO
MR3-?=W\K;)C?A]SAQ1^[/;AHJYB)XN_W(8-.8=T5\%5LE3-,Q7QQC"6;M:\=
M< I;F1&BF)M/MMGYY:=L)/Q<&T[7#<M=?[UXH1.+@XV!_?[Z)VVRQS!F 99"
M=WNK+%ZY8PG.P^R_&KBSMOG;T)08EAO7AI7&^.EZPE;]<)>1H?.G&0X]/:%1
M8RH%#9(+)5QD"<,?@N7C*U(2WDP\Z^S#,\)O/V:^VRYR!6'>_NSV\G#>#TI>
MBL(/ZC:ZG:)1*)B8\)'MC#2QOT1\GH]TD$H^S^[W_>/6R=[Q9US??4]V,I_G
MI_TF7 =&^Y4U=ANM.LV\GMMXC,_S^&-[Y]N79F/K\_?ZUE?1./Y\OM_^ QRM
M_?;^KB=U^O6RX/4\_G+\[\L/X[T-2-2"40O.E<$8Y6-U9!W\::(.3G 170(G
M?D+ORC&[9&$J4[4!KV!O26!/^B"#)]BYS'=BM%:):1^%-4[%Z%P%>RL">V--
MPUW$.'J!M+8&<4P=@BU-(P(K[3Q-S#JZMDDJV%MMV)OL&;QRV)O\T+/ 'K74
M,I)CK,%SE:SF6FB3=&#,1)YX!7NK 7MCK1Q@3:7EV".J+ 5KSUGDM';(*^DM
MID0;2@#V\'@7F>7#O9G=],E=%9< I2;;*3L30OO-XGAHO>9BZA9EO 7+6#/!
M> O^OD=UX'O]'5:%U4:YQ!3C7#AC+-76F4!%RJVNXLQ5- ^=V_U6+,V7T95I
MQ,%.VK7?*PR;"<.VQSU6)3$8;4$A:U.N9X15<^#!(BE)PL&X$!5@&+^O8K[J
ME[SBVFR,TA:#%AM+.&5)>X.YB89(SF![\Y4V+[,VCSIB3&"'!08[Q">">- Y
M==\%^$$,-@$')<W:)AUWQ"IM7@9MGKL%I2,J4<<U-3)PP:@+/GH;01H25])5
M>_,R:_.8?V$I9X0$B9BR&OP+ KLT$0KT.BI% J.<AK5-.4YUM2)-*I^O,?O*
MGS*6W1?[MWR4DBHYVEXG,XK.TRQ\:>%P^5R54;#[V.NVI\A +',S<A%9LQMN
M\/%V$6)J?H\!7<9>M\+-F7"S/N[3N!"XBM$C0S!#'#N/M*.9+= [ITV ]?<9
MK#0E]-<%M=9;HMASI?L+<FSN";\N%@0J99]-V4=='B=S[)P*Q*(*B#.5&=B$
M1=(*38Q3-+@(+D^EYDNIYLO@\51JOGQJ/N8+)9QH4E@BG&S>TUE S@:"A/)1
M1BZ\<&22FJ^(*[1 >'GL2<ZM(R:\(7YTR/28ZM3A)5#^_#NYH<3I8@M4IUN9
MW5RW,;'4HSP/^N6G5I$+;&^=H697:Z3 >;T&^KZQ7KM)#:[%[Z=PI1\3NHZF
MQ81HJ*6"@%?"@U:PHS&9#/8*NZ"H7FC09LSQ>&WL)\^+5)\']=_O(M6_V)=6
M_*\O%_O?PJFC7.Y=AA/X[M%>&\:P=73<V#H4]6\?>'WWD,+<\+UO]<L]^N5D
M9RNDQC'<[_(]W=GUM''L>?WS@=6<*@66C;&<(VZC!J]&)/@-%%DX%[%*:YOC
M)\QW"(U_4((^1<AT!G!8*OMB^4((#RGGE;DP,8OC3YOMBDH_9]7/L:P-0@.U
MS"*F.#@,6&!DM,*($^&)3\&0*!9XXCG;MOH<1RA3CFB>$Y8W"Q?/>IQ:P<43
MP,58;BN+&@>+D>)&(&YRDI?C$1GO@@[486HQ.![W[< 57+QBN%B&Z$4%%R\)
M%V-Q"EA1KE.*2&F2\ZF\0QI;BY3B,O.9)*(ST>8X.=Z*!"J>#Z8>>Z0[2ZKL
MTI[WWE-52N8YYYVOYF"Y3+)9\N\Q 0=:)HHM$3S7I1@N&2"N$59&YGR1?S]+
M9+C*OW\!K/TZP9-SC@H<&3+4Y'9/0B$;9$*6!QNQIE*;R;FKRY=^_Q08-\^!
MT6O"BEE*=1264H*]SU.FI-(.Q"DW',1"@WDV+-69P@RK$.)E$&+4>3.*!BW!
M6\-$:\13R(UZ-/AR$4>K)*QQ/C6:4)CXN..;"B96 B;F+^F3N7B/2"45,QPP
MPT5%+3?9?PLTIE"9%*L!&&/NFTS$:I-R KV)B+M D>-8(^R4M99%ACE=VV15
M1=_+;^N3*OKRR6U5SS<CF+&$L<9&8:<95\%:9Z27"D>=L&)TFN;G]Z!:53WP
M7%"V-^X=10E;E*(.>9NK!SSA2,=,_BDRTY +(F"3.Q7. 655&="2JK2EF@:'
MK6/1\92LQ2+2D&C$Q+J4?MBNO%+II5#I47<FQ,"44P9Y<&40SZV<G,4.81NC
M\]&[D,^B2*722Z?2\[L</EE&(^=<"L5M)@EWTOIHG".,,QHJE5X%E1YS.$+R
M1B=/4/(!5%IKV*4I5XCRJ#E/3D0+N[2:ASJI*K.KRNR>-&JZ  >B*K-;<NCR
MXPZ&IS0Z(ABB8&TB+C!%VK"(+"7:$H>9S8ET59G=ZNG^,[L:5=W-\BCYJ,M!
M54Q<2Y-9@3#B/F%DB35(8Z%DL,QX[=<VQRD(9HZ'5IK]"CV.2K.71K,GL!<&
MKA07B!(&FFUU0([D/'@;#<XJ3W1:&LU>0%';XI+!JI*V'T''HUI\525M2P$5
MAS\L:6O0QG&]W6CN[&Z3QI9GC:V/1XW=0[*_M<WVZ!Z&9[YH;!V2>OO+6$E;
MX_.!84PGH13"21+$90#CPC*&2 *WD0LG,!</9-0_14W;"B4OK.IY7Y5]_@2*
M.I:^ 'ZW5AJC0,!DYXXYY(3UR*HD2(J16187<^:W-*E.LXQG034J;PHM7N8H
ML4*+)T"+4=_>:DJ5,0(Y[33BE&ED==0H2-B)L0Y"XCAQ(Z[0XG6BQ5+$#"JT
M6 JT&(L7&)ZXLI(C$EE"'$>,'-,,>3#738*%=U2N;>KQRK;E0XLY2\N&37?I
MV-AF'K@J(@9+<!PZ6?/OJ4*CC\QUG7_>7F\WG 7,S>O80:0BEHG .07O5%"A
MN4F,.&<943*Y6*36S[)Q5*GU+[!_G$Q@95718^TDBBKO'Y0XI(VC\"?16)/$
M,0FY6\[BNH0M#J>?ITYGOO$^L@59!<H5*/\0E(.T47-ODC"6>\>U%MY$S'R(
M23'O*E!>$5 >#0%@JD,(QB$3C4?<.84L\PP9[%3BS"FP[1?:N;'"Y J3*TQ>
M!"8GS"C+9_?*4FX8!_>;*>JHX(Z O5P9RBN"R>,UJ$$*8Q1#A',,AG+DR!D>
MD#'.6\-T-)GRDY#%%:&^'"@7D9A?"H&Z/LHM'ZIQU@85\N7?6<Z:G3-;,B7=
MRK]HV]YALW/U .PNWAV?]0?-=#'4X\W_=+U?-N\>&^<K%4**I=..I<1A=CFF
M1O-<Z1N,U%ZX8-4!86SMZEMW!KB Q(>[:OAAF&O^9^S]=61[<1<N_EL+5//%
M]:E^I4_-QO%1N_ZI#CKUI;W_Z2O>W]KC._D>6_OM^N57WKBL7^YLO><[?QF\
M_^\C[-M_=^PW<[;3WH9K[IWO73::C4_[)_N[7TX:QX>\WO[,&VUX=?>0P7UX
M?>M0_/MR#S?>'WB92(A*HWSTA'@2$5F'+3(T<.>-Q(&2M5H$T#F%21STSN+:
M Q(B'Y*0$:2/D2K*9T9ZPGX$]31#/:$;M:NE_N6G?Q7Y.;#DM6+-:^^GR=2I
MW17FIQ7+O_Q1#&>MN).^%8\1PWO0;'L8X88N]G92,?#^;K$WO&61/3Q0,(,^
MJ8 8CQ:,:N61#8X@;TQ@N>4]BV%ZD7T0U!9CG!#\HV/C0F1WCV(MP6[?/0>A
MK96RV8L@:+[9BOW: -[.V6<@M87MTDTU9_L@BK83:J'9.@.9N:ZDJ9V"K/<+
M69\J*^W=.'#?J^##5_*N-1)=]S%;*3!WY<VNML=REX,Y;-G3?GQW]<NOH=D_
M;=F+=\U.,1G%EWZ]>[]\@Y$=KKA?^?:OY\TP.'IGS(8T)!?5# \=AC<NWR4;
M1;W-R)Y=OB?)AN+ZWK?Q!KGWO8<N2_ &YN)1EWWXEHRKIQ@L$RLUV.D6[ >G
M4*M1,U<."_R+;J_0^G=@9,9>_A1X,\U.;9BMUU^OQ>\^@I5X2^_+8KLQHW6V
MN2A5>FD\N$G'8P\\T+TY!LO][)/3BAXDJ'S]SX[O//MK+Y5MQ,'U9C[,+W\R
M"J37&\UZ,]&J!50$W!.V^K/73<U!=J"6*/3T.+]C&'J"Z_W=WMEM'>]L[5WF
M$!1\3\#UO^]L^8O]XVW<^/2E76]O7^S]-1IZ^N.D\6U/['RK\\8Q^"M;7\!?
M.8%G^0#W^:-=+ZZU=[%W_,?1OR\_C)_18LL$EE8@&W/_<.,D,LE@9)5F+DEF
M? X]&;:X\X!EB_<_23Q_M1!N,MZ_<H2;FP1AX5V\*EQ[/*Z-'G-R:ZB@SB//
M/4><>H5L\A1YQ82/&!MA\-JFK(A@*W![.^ V4\V8 15B BP"A7D21AMLM54^
M"98T<3RC&S%7Z(8?:;ZM1A'G:F#@>+TW%_"/UBCAS(4=<$ :&X.2H8D3)C'W
M8FV3K4O#5L"Z>P)VVV%D?6GT\[:'/18D[]PY?*\UAZ?OKY+B=BF\S[NH!6MS
M4WZR8FD1JX!?VQ.Z?5B)J3 !"><"X@)^&*H((C9QG+1SFLFU3;(<1'D5]^4B
MK8^%^U:5^CZY^HZZ8"P%)K+2$A\ST64D2$?!D=0))R6M9<E6ZOLJU7<!SD.E
MOL^KOF/>@U(V4$,\"DXHQ.$OY'0 [X%BX;DD(3 'WL-RJ.\/G(.KM X89WQ8
MXU?YD]4D+%L3R?MXP\P3DX9-]I\F'.!.EXHUF7GI548+J\/>)3OLO;/S5[OZ
M3+OZA Z:6B?-F#8H6@^[.J4,64(Q8L1BKKA@7+I\WKL*$<'J2*0Z$EGE\]X*
MVN:"MM%X0_+$..(M2E+$?.0KD=&Y0S".N>:5^8!E/O(=CSA41[X5OKU2?%N.
M(]\1I*M.?1<'@V-QFR@CP=YXQ*0$&&0^E\\%A1REP2L/!E[TY:GO*K1)7P -
M^'B1ZZID7%_5W2%;%M[E8JLVZ'!13=$O^JR07XN*JWE.@:>>JJ4*4D_V6>]%
MNW+*GOJ0^,%"R9VS07]@.WDZ?\MK5D'=3% WJ>$IEB)Q*1&LED.P=+D5D>/(
MX!2QA86R2:]M4F7&@.Y*7YY;HV>T-!\!9L],IGK_>!9$IKI"D#2CASD1DA;N
M9%:0]*20-.:$!I-2B!PE[C7B,6!DF11()^$U2T9R' "2S-QYQQ4TO#5H6/BA
M>@4-3PD-8XX938%(817R6F+$C9;("<(0AY520@3+)<[0,!YZ7U)H>#T%KY.=
MB0\I15\T1BJX+')WI7[T9[WFH!G[[Z:H>WY\'[KJ&F\BX?M#^[35O8B9EZ3K
M3VK=TT')G) SF'I-G^E32N:$O#/ ZYE7Y33VBOA9INF^]>:KS -?Q+;Y/$[^
M5LEV,[9WO@]9YMI%/X*E;TN\"AOKA!Y(/!/2$A61ADT49=):9(PA*(FHH_#)
M,T$7UI:XRCE=6DU_'M]Y&DVO-'HVC1XC*0Y,&,P)TCA1Q"T%4YE*A932C%@K
MM.4$3.5*EU^M+C^/LUOMVL^FXV/NL _6:"\=\B;W(F,)]N]H,(HF&J8D\]'Y
M9=RUGR/!>!5:!4UU.#DD@7R4<[*0#)3J>/+' ;_[4+#"N)DP;D(''.944@+6
M)VFP7KCE&-F4 M($DT2,C"2QE3Z@?$VI<*\?E%;'R:I :7&@-.I<Z4"(,BDA
MH7*XA+* C&:Y-Q<3B03M<6:^I^:^=NP5.%3@\,)'E!4X+ @<QK-'7<).69H3
M1P/B(5%D&).(T,1X"IIZ1Q=R2%DED#Y+.]?,QC]:\YD)N6\[:[/R\2_Z_'F9
M2@?FK?^<^=F7 ?H?4?]YU:MFL2XKO;>"8+1'SMV<%%S!_304<><%U)>0CQN7
M'TCC_(!KI276"<&J),1-H B<5H^XEBXXDELDF;5-ML'$0MM\KVZRVJN$O7DK
MIE82]F:O"+T']>;TB6D%=D\#=O51L).<1*XT0R+B7/TN'3+2"91H<CXIHAU5
M8-UNX/& W)+FX%6(5R'>D]:(W@-Y<WKZE:'WU-CW=1S[J!*!1H1)+I82@B'G
MP-%/2EGA3&0LQ*))H5P )=]+YQXO'R]51?A534(U"<M,_79O3^15B?9MC73<
M7'"\[Q%'(%--Z5*=@JQ@*&RX[)6--)N-1"8$PV*0U@A"4,*,(JZI0287<Q(:
MM Y88*W5W,&PQZ'.,YZ,_G!("S@<73UD6)EH484'C\6#L7A1M#01[@$%-&:(
M*Y]3)0)%6$F'J?968%+$B_1BCT,K4%AI4%CJ@$H%#X^%A[&02M(>##NF$:/*
M(1Z%1":*A$3P0B87 C4+"*D\(S14;F0U"=4DW)V$7PHW^9K\O%3CQED;=@9_
MA^&];7N'S<Z5@K*)E><+W8P(_M%N1/-NM'L4:Z?=0>P,X(JMBQLR@SA3]?E#
MQ>>UP9$=U,YCCBW ;=#U+>##M=3,.TTM.[DS9K7O-MNQ7VO$\]J7+MQSOFE8
MKRT^IW[*6V<SOIB^O'.7T_3"E2#O896N%NFO:TZ+#]]]ZRS$\+'7;?_>;9^>
M#6P>W$X:M2'>MV&#&KQN(L_]?Q]AW_Z[8[^9LYWV-EQS[WSO$NR$3_M@)WPY
M:1P?\GK[,V^TX=7=0P;WX?6M0_'ORVU1_WP@M"+<$(ZH<P)<!Q>1L3& ='$3
MB129H&YM<SR.4 /A:\$OZS.*R,+S\BL1>5(1:7P^L%1*I5- P5N%.(O@9W)G
M$6%<TJ!YL)%/ZK!S)2(%I+QP@G8E)4\H)1]H8^ODHG'L<6-K^[*Q=7B0B!5*
M:);9?"4",2'($J60E)P+%J4C1*QMCA/[WJ *R,1I]'FY6A<;M2U8L,[A[2WZ
M>I]:ATT][U0OL%VQ*RGS]NA=F>2?#8SS[EDKN&AOB9SMYS?/6H-NZL1!Z]6S
M2S]>EK[BG5U/X#6X]PFM;WTX(##_GFB*O&,<X$<39(B2R%--HL24)44F]>=[
M0?BI!./)!6-W[R F3QT.%H$981"/4B"C8T))<>&Q2,J%-(E]XUHPGMC;N MB
MZ[5.=U!K=LH=!W[)N)7/.Z]VG6L"-W@W"\(CST-K+GI[UH_Y\LU>+9;D<(7H
MP5LC?H^%!ZB5 IAOGT<$8EC>/OM$^84AZ%Y$V^N/MMA:B)>Y^9^N]\OFR)6+
MG[>N=^7W-CN%W^):L#B_MNUW=-X,@Z-W;$,H\A^_MN&6Y0NT?&$DC#3HGJY-
M>_'QK_Y:7IKK#4K$?PS[IA5JB*73.06=ZV@XID9SACD-1FHO7+#J@.06P,,;
MWYFT!>Q(=RV=O^)A)@3Y$D^[,/[.X18L'ZSG62_NPFU^RX_VXMBQ-\2.+FX<
M?VG6C]]?U(]_@^O4\?[NMM@#7-@[_KN]\PVN#=@"6"#JH]AQ_)DV/FU?P'TN
MZI_^/JY??FG5CUO-O>/]9HZ6[M&_FX M=/_XY/N_+^'*EY\/HH)E8<PB+WPV
M2H1!&GM1_.DQ%C196VX$S<Y9#.\S!,.G?.Y#Q34.X#0GI['.7\+$>@E6\%HM
M@G:<POP/>F=Q[0$5D#,$6F*DBO+9W7SVHRR!PLTG;*,VE!) C'*WR?AS5P-7
M(&*T<]8#?(Z]8OB 9 "1IV G^N9I >D R/80P#2; /!&-YSY(6##_?YI^MBO
MY:8$Y4OYRQF,>\U^_DIZP&(HIVZQMN1VX^-8,Y)A$>E.^82=P^&:W;408.Y\
MMA+.N[W0CYTE.BYY;B7_<%X_/!!1<B>#1]%9C+@5&CD1#/BJP3LI0N24/E0M
M_,QK6Z)TWL^KQ?WQXBH XYBT0C#;&G&%)=**>*2UC-0S(P@W:YM@9D^@*1FU
M ;M76E4;KCF8:^='37]4($&V>_JP8ME Z@+*]*[7Z?KC[VI_@E'6MCZ>%69"
M@2+U&/+O&[4<S$YPKVZO-*1"',0>6"?YAOGB$RYX91L6[P-V=<#\ RNQ'%2)
M905DQW]LZ\P.8O^.W9EO<GK6.^WVX0V +T# KB\?$.P[>(8,=P70]>$3_?SZ
M[:\#]#G UU [;PZ.2CO0#L!FN+(*FQW8#YKA#)[3G<&WX1*U/)7_%'&4C27>
M.B;O@5_B/Q$V^24>]_U;WHC<#>4'?(=^Z1[D?:T'2PVKF1?\,'8*0_/TSM?6
M:]DU@6$-+D;>*;[4_2>GQ1]%Y'/@"R3QJ' Q?.&&=/+)5*>?#=B;?77HT'P%
M*(4;_S7($IKU /;7JQ$"&G;S%T"08O]F$P9/9F0$()-G67M  'NEU-ZZ_? "
M0\6Z]RFN!O;K4-6SOI2? (%='RI;H0;7K^9GR Y7W@XNAK>L^9B?'[[1.?,M
M\(%N?SZ/K&=#LWOO^(NH%7RX5>C)KS=//_S&Q6W-OCTC1]W^:7, ,Y8AZ#RV
M6OF_[0)>BBTK![WLZ9VO%ZXHO)M_[YX-<A^S_N1KKM>Z^?N39[6\S 7\^FOY
M@/'4^A.X2?\>4>K_4&*NUF)C6AMS%F/YZ15NB.K7<GQ+/&$J;X/K;1T<\<ZO
M=;)<Q*R 9_#(5PK7LJX+4MKM75S/UNT-J=]MA8DJM@[WZ=A@UVL?SGH@Z>NU
M]_VF+5>D6&.8V).8IWX;S. 0FJ7T=&^&FD7TOK'>#&4PILBWG]7"-[HV*T/G
ML-@SIG[(VDFG>][)PMTI!#MO,+U"!&\;[#>@<79Z"J:]/[(P&=>R7=CTW1S3
MR'[ 74FW;7?6*N^9QQ+AO]<J[6&]B\%=#^Q*JQ_0CTFK4'RG7(A)F'=[JH8S
M<_-\&?Y*K>W_/QAX.]YSB\%1KWMV>%38(Z/K90?HO^";M;^N)R%OUWWX;61K
M?N+8@S^*X:P5=])H%.*6G_G;Q?#-MQR/:&R]/V!$\HB90,9(@3A5%FGJ%-+8
M8.F2H=B*Z>,+RV.C%+9O%^S/\\+:+8S<4X#*PLCME897L7='"^@V;@F7RM0%
M6S9OV^]^M&7DXKT1 M)2P>'9A]<=IJR5F6DP!RU[VH_OKG[Y=23\5WSIU[NS
MFV\P&A#,]RO?'@8&"<8;N$RW'J8D#>\\?'NC>&LDD:Y\3X@-:>Y_&V^0>]][
MZ+*$;G#]N,L^?$O&V5,,EJC'#>B%!CO=97^0H[9\95N3LH7+887HNV6X[=T9
M& B]_*FUS9]@OQJ>J?3'\D5G>^)2<Y>FH.IV,M@4#S1%;YEE?/;)V>%YMW_#
MSX[O//OKZ2$U^8'OQA2>K@/Y$C%KS$NA-O.S+T,AR(Q\W^/-U[G4SBD<4I2P
MK<9HC>'86T$4Z(PD<>84SV$D;F7R'A[G*PRK0'CC&_@%6ZW6SM:'\WI[&\/W
MV,XW&$_[ XPA5WK\T:Y_VR:-L2J00[+_Z>OYSK>OO+[[_F+O^ OX&%[LP^?W
MP.&LMS_#&/>^[QU_)?^^_#!.\:TQ#9@;\"Y(U.!L&(M<B 81;1/SDAO-Q=HF
MD6*=F_%<FHKF>Y[2M)D)BU895N<E+%I)6)V]Z'8$5H,R+%F9K$B.*VM=TB2(
MY)/PUC//9DZ+KF#U26!UE*2<VB2Q<AP%RDA.3HQ(8^N0!-S"C'$1A0-8Y6)=
MF?%TUPK>*GA[$_#&+%?"1)Q2C-Q3Z9***A*G*?,\"35S/G\%;T\!;^/-KXRU
MPLN 7/( ;\1SY!QG" O!&#,J88US0ID"JW&\1FA)X>U5Q./6-H>GDJ^RH>[<
M;FH0U!)!/*$@KT((S1SV #G4,&-("3B5F_K"@+,]H4<N]BY%Z1$-+C,;$8:,
ML0(Y+X0,07##. ".6-=:K:J76K7S7$XC18$-SV60.!C,#6=.:Q^,B4Z8A"TF
ME0^V')@QZH,I8A@F,B(B.,F8X9#67*&@<>).FD!L-E+DNIR &97NO@K=%9A+
MKTC$.H*K0;!6A$;O2 K>1&%<Y6 LA>Z..1B6!5#0&$%M+>ANT#D'AH"_H:/R
M\!*U'!?[/>=S]WFKFNLN7$-WNX-;>9&]D:3J-].3;FYW12C%H\'8*)]X$,1X
M'YWQ'/8N X V.W%*!5^+AZ_ZN+MBF5 Z.86BX]E=X1QI%3%B @",*H.ERO"E
MR3I3X]R+*^*O+&G8N>J/^32F%"7)."( A9CD.0^5.4F3DBZDQ"E5E1NT'%@T
MZ@8EY5W"R2$J7:9#" X9SAF*7F)I!'BWT6<WB*YSO3)M,2M,6 I,,-$'%KGE
M+@0>!;'"*^VXM8QB 49UY5XM!2:,N5<!:X>5D@A+##Z6(A89IPQR/A$"5BNU
M-#._"KINV-R]Q*KSFYG4[[K"H?83N3]K>I6C.H]H4C%Z;IRLQ\[[)$SBB0LM
MB!#:1H5%%F8\A5]T#]WT#0!5&#,#QGP>]X&BQ%8EDRN8, >,H1&YB!,B!%S8
M))GG.N04F/F[=551UQ=GA1_13Z^D]\9(PC3FE >P":*3@6.O@H1M90I?H=+/
M!>OGJ%^ !<VK)%&*.B#N&$8&%@,)*135*<I$=?8+*OU\??JI"09S/1C/6>+.
M>.-EE):9P!U55,0I[/9*/Q>KGV,V.CA3VKA$4? .(TXT0R8:CY34G*<0<(K9
M1A\_NGP1_7RJYG6K>S(RV<HM3T;N.1%YMLE:ILS9Q=9;+6!NE@'BYSXY6CCE
M?A6963SJ?QWWFA(ER8-OBTC@$5 _TYA9QU"DEB;%E-9,#$^.Y+CKM)(G1XO#
M_A=N)?:H*/.;Q/S%5DN\$LR?.QJ_\!X:%>8_">:/>N+"L<SL@U&2-N2VK0YI
M814R28=@@F5,B>$)G9P[4['"W@I[*^Q=?"7;HCO35-C[%-@[%F7!CDCG/$:*
M:X(X3@S97+++> BP2L8RK8<GH72\9<2*8N^$QH /\L<-[XDR8KTC>B*C7/E2
MLQ-B9_ .Y0\]K\(6%'.W3DR?]]8C4X3ST]\<Y%Z1VV5VW&9_T+]B3XZM9KO9
MN>[RT<Q<1V@D:_86[>35*[EAR)#'.8;,$UG04@_IHG_0BN.I6W.,2=-PD@3/
M<M3M%SRC[WJQ97.CD1N"O*NV&=><?,4@\,U7K"N8/.__RH/#?R'F/Z,V**6/
M(?YC=(.PQ=/3P67YTUR6,/Z2K'>%V#TGI>6$N,=SLI47M]=\1 4?Q;'VHWF]
MNL0D=7KV&1]EN'U@[A_;+66ZN?_?%^G'6MSZXZUV=Q_!.*P1C/Y[9DFXXPQ-
M:A5\Z^=1[^;;AQ&Y7K0GR":0@7>V=6XO^FN_W,5BP,GAD!78-]-C]@/[RP^^
MMC*4KI1O2$T7#L$";QCR6";4!T9+-@A6BT#V<7,X<I*8&#&';UF\P_<7F+@W
M//!\(DAH= <EH?Y'0*A.;C]0<G07=MD4E)G33L04E)J/NM2L;L%,YN$3]H ;
M4TFP<8?MNDK;NG"-?]RR:Z3%%R=:6X:==I$GSAQ.,63>+<DHXSDW9LY6<?PF
MPO!4Q.M?(EPQ=YD8]J\=!A5R7]NKQD*[W=_!*\G"D;V)M\R]#N,_2%P390U!
MGG",N/8261TXRE7$4L!:>.9?"?=Z_XI\?6KN=9!Q>WC8BX>%WWGUK=P9J-DI
MV@\,SKL3.Q@]1-S^M JP=3/DVPJPF\?WIF5]Z_" $J4<B0QIFT#"A<#(4LZ1
M\5(0):F424XAZT.>_54RP;C<4&;QMA(1&US*)R"JQW@ZW_IU#]94K/H5J_Y]
M#NSJ/'O%JK]X5OW)B:Q+JMRCK/JUK>N66\.N]']=-Z^[:=ST$_FY]A.=.;=W
M)8^HYTT)G?G9E^$(>NZ43\)MHCKY[-=R3)WVR0@M UC,PLMA^D^5\CGY"/KT
M9._RA.U\VQ:-W:.C_=WW>&^W+G9V/[;S$73CT\?CQO'?)_5O'TBC.7($W?YR
MO+/KQ=[Q"=GY]+%5W_IR5+\\$?5O^^V]W4/X;)TVOGW^OK?[E4ZDX!=&)D:3
M0HHI 3ZGYL@QQI"AG"5+#1<N<QM*OBXT7M64SUE5\H7KA%XEK,Z;^;.2L#IW
M9D\BH)8N4J%%Y$:Z'/]+0IO$E(T^A"JK<CE@=8R"/RH1?,@%QS1G5:K_G[TO
M;6HK6;;]*PKN\-P1%%WSX#Y!A+L]7)]W$.UN;!_XXJ@1A(7$E80QQ/OQ+VM+
M8)"$$4C EJASKVG0L*>J7+4R*W,ESO*/ @EB% ^>Q.AS9@_GZT9/:C 5>"OP
M]BS@C1,GN<7686RX4=Y)*4@BG"C!G",E<;$>\#:9N"@XMEI0%&QBB >GD0U>
M(!. -VIO+>$T2_#+=6GFEG5Z+'A;]79ZS5&O^.SD_]D#4\BMF"]262Y]_7F$
M,FM;M#Z_%J8 C")*BT0BMP1;FB153!I+&#%S5306++H#%DU1YS><!JJI1(%$
MA[@Q%FD6+(I:&,US]ZI@US8-6?8&<C5JHK02F# W>2$)7#*FDS+$<V65!=+O
M(N,D:!OQ7-+\!1/NA@D3LI/$8F E#K'$-.+>6V03H8C1Z(34RCK+UC8UGMOU
M*K993]ND@/N8:^VQPYP2:UPP2GL);GGT6.DY'(MBFW>RS4EU?6Z]TB$BE10&
MVU0>F<@D O"D-M$H#)?9-A=5\/0DKL$]?);[9,5?*_PQCUWU-&T[\2;9_>F)
MX3,(82VGN&UI:?T<T&V*^/ZS:&E=TX#SPPEM+S46E3[0SP2+GK0/=$TQH9A]
MZ8^\VF;_M/V1R^;,0ALGYS*7Z^F8Q[UN./&#?N,%NY\@?]UC/7.[2H[HZ*BA
MWOC A>#&,N\CL5I('ABWQ56J 4Y-T>@/1&@B%4924H5X= 09&#]$8,PXILJQ
M'*0E;)W+R5C0DGA*)3Y<3V[CDN"6<&#!A'/EO%$D6"U-LHX3A5UQ:>J!&1-M
ME3TS7A*#*(\,\<0L<IYQ9&4TX)P&\&ARX@E?YWIN:E-LMYZVZYG5B@8IP'(Y
MK.>&*&6$!]++F?(Q%+^D%K8[X9=PK55T/._T$(]RLP?P4%+,*1O)22>8"V*X
MWM-%M?UZRKV?9?$\QD6-[ #]3_<HSID15O<V)G-['<$$)1AXUUA3+@VW/FIO
MO8W,,Y\2+UY'#5!HBL:]]4Z"<R&1)"(@'HA$.K"$N#!$<,*,P7IMDP((31*(
M)7$Z2N>C>A(7XPGP$FO!R7! 79Q3P<9@L8=5D5,=B]-1#\B8:%9&HV?@%R+I
M*$'<8H:,\0K)W"0)QE!J%S)DT/ES5HKIUM-T*?6:5PN'\]PE#\.?8B+>2\JH
MY*;X'+4PW<F]$ OC(K!!#!N'.% S9!CWB"J!;8PI,&*RZ<*':F2Z<_8S6^5T
MLXM]DL7EF=WUV=4*V.9W8P2U1!!/*' 2(81F#OB(BM0 $R;#3=[BQCPQL.U.
MNC$<>Y>B!"0+CB*N2>8D5B#GA9 A" XPEUL'K&L]V;5E2?R8>Z#:(W:#>8 T
MLZ6&HKDYE@J4<1DD#@9SPYG3V@=CHA,F83M7/4V!H@5"T<2>##$,$QE1CI]D
M*')9ZT"AH'$"SFP"L3G?1*[+*5!4(*% PD_*;G'6OB41ZVBY(E@K KZX(REX
M$X5QQ>VJ!21,UOBP '8?(Z"!!4@(VB)-24!.1^7A)6HYKM@)YY-]1&L*"8]1
M U2O)M(_(W'#G\.&TC?Y8L\FU79^>0&E>#08&^43#X(8[Z,SGL/::0#Y2L/D
M.N"<G[*9Q(32R2D4'<]>&.=(JX@1$X!T5!DL%1XU3%:3M<9+XH;5-+._5/L\
M4*B;)..( !1BDDN7#'.2)B5=2(E3JHH;5@\LFM \4-XEG!RBTAG$8W#(<,Y0
M]!)+(\"[CG[4R%<OC293P81:8(*)/K#(+7<A\"B(%5YIQZUE% MX+L4/JP4F
M3/AA 6N'E9((2PS.F"(6&:<,<CX1 JR56AI'#6;9W#EWI11H00EYEZU;7_#G
M5/+SXBZUB<EZ[+Q/PB2>N-"""*%M5%CD68YG<)CZ<+/P6Q%Z60CX[$\Z1U%B
MJY(1B%/, 7QH1"[B+(D+OFV2S',=<J[^!.[,WF>@I.@_(B[=Q3Z]DMX;(PG3
MF%,>@"Q$)P/'7@4)Z\T,3D2QSP7;YT1:FZ!YE"1*40?$'</(P& @(86B.D69
M<I]!,JD,4.QSZ>U3$PP\/AC/6>+.>.-EE):9D,LRJ(@S$/IBGXNUSPGR3G)Z
MJ4L4!>\PXD0S9*+Q2$G->0H!IYC)^^2>ZI/8YYS;(Z/F>W3"8UC>[9/I+'>X
M97+#5LFC/:PZ2><OMN'2 IY-'2!^[BVE>_4O+2&;QT7]KY->4Z(D>?!M$0D\
M NH3C[1U#$5J:5),:<W$:$M)3KI.2[FEM#CL?YSP\GS7>\]V**N%^8MME[(B
MF#]WF%Z&:  F!!')@L^MG*1,)@-.-W9!C9KPE:V[)\?\<4]<.&:P!)*?I,W=
MHJA#6EB%3-(AF& 94V*T=2?G3J$LV%NPMV#OXM42#;>&"6Z<PCP)HPVVVBJ?
M!$N:N-+*JA[8.]G*RA'IG,=(<4T0QXDAF^52&0\!1LE8IO5HBY0NJKSWR;&W
M"M;\.K"N'2]JYJZ4^1W9WGZK<W%Y#"SE6N$?T==A[/"D/VBEL^%+K4Z(G<%+
ME#_TN 9+JQ@H^>4)7" X]=@CPOGN_[R0;LPZCG#0;RT?^XUN2K$70\.=-;HG
MO:GMMF$LALVY;"\V>A$^G[\PZ#9LO_'?_Z'!6_^M?_FUX^L"_,?33KJV<;U
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MV)Q#,G&&N \6:0:#9+P+5#I@W,$O3$>W+MA;='2?K9!CK33_)J(<U2#^/7H
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MX#[GWE=<3<:]YHJ^%Y0M*%M0=A$!CP7HZ)6 Q]. \43 (Q A8%8QY'4DB-L
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MPWC! !95[5)!7G]5[8(7#X$7X^X8-3:"QVR M+B N H&.88%PMC0$**-2FK
M"SJWBE2QVWK:[<)EMHO=/H#=3C@;WELJL2$H.([!V7 $61P4PAR(&A@PB2Z
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M*4NL1%A&BKB7&.D4<Y)+((D8E9@%YT/7261DU?<*BUC!XXH5%+AY(+B9(EE
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M1CF;A0@G\PP*^!;P+>#[U."[<$&# KX/!KX3X9C I4\T>92\#UG6@"+ XXB
M;<,JZE,,W@#C5G.GT]<%?*?(&HSNK'ER!*;B+Z;^Z,\%>)?79_=?$8[H6^VA
M8,=V>M7OQT'_;:][]'?<SY-ZI_M'MU/=N!W$L /G_KW=]5^7=(;O_?L ^Z-/
M'?O9G&P??J#-=^_/X#QG6S";M\[_:F\=MEN[AWNMYN==L4L_M;;?[=*]PZ_?
M_WT.1S[?^L*22EJ#-Z@9U8BKB)&V0J,(W$Y%8TEB9*T1 0>.LRQ%[R2N71.J
MN"XLP:ZO0S^D*Q:'KP3?!K"TBI4=Q$;JMMO=4YC1C:%RQG$O]C/P-0;#0%HU
M,^!3O4:T_J#1B\?=WDAC8SA5JJC:989 PPX:_SSIQ ;#+R_M<ERX8_0\LH&-
MA1*'5>'+).,A-[1^ +$)N2'NJ6'Q!,H82W6Q=$-0460\BHS'"DM9%!F/(N.Q
ML@691<;C/AXR.%&1!.$(\;"LJF2=5=ABH9BQU&KVY?UL6U%#5V$M,\(C.X #
M?Q^\[)P<H="M5IG\O17QB(_;6Y\_D+W7GNP=?OJZ]_DC?.?3P?;GW=/=<_BW
M\\_VWNOL+7\E>^,>\=''[WNO/WUMGG\Z:G[^J[VW\U<;O&FQ=_C[8?/P]X.M
MHT]?L[>\O?.I/56VPR69G(S@82C!$3AY";EH-#)1\VBC=80+ #NYSG&1[BBU
M[:6V_5&#C4G11).D(AG"(\&:"^]5]%()C+TS%93.L,%3H/0!H'1"JII;R;&U
M2$9C$>>:(:<]1D:GR*Q4G!@&4,K6)>7+4L]>(*U VF(AC=L@"2/!JESV"N0C
M.6J"-8Q*(YSR%:3-L&U2(&WQD#:9OFI9T,YJ)+GUB&NMD,:.(,$<#YB1%''*
M?;C7F5E4_OE32W0LBSL^4N)HO" WQ].6N31W;C=4$HI)P@X Q_,$R[$GABAE
M" DIJ1%W*F[H$P#-%/4-HZ37SF$$U-8@KAA&#DN-G"<QIA!$]'IMDY!UR9:]
ML5.IX:\;(XD9)!13FFAN-''&"^MI8(EKZ9TM3M83 L6XDV4"C@3<861#9(BS
M2)&15B*FA+?8P#@& D AUCF>FY$4@ZVGP<)ZD*(0-(%7S;EG6=*4N$"RWHJT
M*107XND,=E+ASRFJ" ,SI56 V41DC#1(X&B238I&)[*NUKHTI$8&N^J[>45H
MX^=[6,E0Z21/AECN@S/*XH0)#HYA1QDOSL-30<P480T9806P5"!/C<@] AG*
MM;6(F4!-X#Q2"IQ K&NVM)54I3B_GE1$,R,#, _LE.=18*T5X<%@YRS\%D+Q
M'9X0)\9]ATBT3#HPQ*)TB$?'D?5!(HLY%<0EB3W/.,'IW$RDV&L][=4:KK 3
M@6*FN!3"*C#/A!.3 6.&4W$=GLY>)UP'\.^T8D$C'726O@&CS=5Q* K"F+$Z
M!FO7-MFZ5(O2!W\,S^%YJF14]E*$,(H0Q@,Y;(8*BUDB/@ !4TQKJV0@45D1
M<S*B+0[;4P'[%.$+H:46D7*4Z]81#\PA1W%$P*9=5-3;I/7:)F?K6BVM&&)=
M*@!+^76MXF[/'.<7T,R, .\CD3$?.5%6.\&=,329!. N=7&XGQ#GQQWNH#G
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M[&\T7DVI,Z;KC1O7UGX>B/[8\JJ23!1S;PD%J''1"*H%5R8$DP(G,Z<G_,"
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M"^SK;O/-, L4T?L %#)CC!/>>,> H?HDE2)EOM5SOL%G7GT)UE/FB4,).XS
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MU0N9CDM/&5A>"3297ZIVSA*!@B9U\4XNT$1%F8A-2&)M 4UR8$,ZAH(GRJC
M,6/N9C0I5KT25CUOT6!Q41[;11E9KY!4B40("E;P3 @2TI9@E!CG*7"G U9K
MFXO: W[*O9![BR[=V[>Y4C(P.@3*GW]I*@!Y;,:_,U/1R%A)R(R>YV*>;9TV
MS.=-KUSL@ZG#&C&W'WFO*K>R1CSR&O%A2O>AQ+24% .O2WDWG3#D'"=(,AFP
M\9HH%]<V]=+J4R]Z@7B,B/G\%SMSWM/*8OR\25&KA_%S^P$R1$,M%40DRX-6
M3E(FD\%>81<4U66/L288/^[%:\*$9YX@\-@E8'S6/Q51(6TL381Y0;@'C)_,
MKR]86["V8.V3; N;7 8CN'$*\R2,-CBWD_))L*2)XR7F4@^LG8BY6*.X],"B
M&4T"<:MLUL7D*"CFC LR!!'6-LW<V:FUP-KK4M,3HM)+H]^2!3F&NAL#^_U2
M&;<WU)G.XC4W1E9.;;_QGT_I)U_L>?\=>]]:/DZW[AW[_??A3;WM=8]NW4$I
M.H87FC#[?&O_BU&!!!8C\MIR,&F?D,7.(Y-\TBY3J$"GYG1>"!&LWVF*+)QF
MERGRL%.DN?\E:2]HXAK99!SBG'BDL0G(,*JXDM('A7\Z12JEQ[O,DH43A#)+
M'G26B*W3+\3!))'8()ZRMA3A!AE+-'*:!R$2]B%W^IZ2ZWDY2RIM[ G=M#QW
M\B"O9\72XPL-^$D9M86NK'0F%?XK6@[5C&I\S#*I2R?P-E62XH>\W0^!\DIK
MO[$/-M*S[?99I0?;R.*M_WL"EV([G?R?K.0-[U8*;8TN,*S&SP3D[B5KL""E
MQ>K')[@'8(I#F45RS<+A>?J7X:1W"C2S'SO/SJS?G#9W/G[AWL'R'!BR5(8A
MY\^U.\A)D51(+ :7UC8'![T8&V?1]OKC<FP;C1LFF/6^=Q(;WO8/&F FK1!'
M'6B_ 8[FV5,)N>?/']NS2E[LY!A@XMMPQ"KU8YB40V7N,3QX+,G"Z7/OQ_W^
MG7,U*U08SKB,7JW!V;,7(VR>O_DB\HH!# *![1.86+!T:&LH(I0P$2R/A-^A
M-TM]X'2: &+_Y @N%PX"L[X-CAA@4W^X_/6O>F(W:'*/(?#+&5>8W*[F9L6_
M'T]H::3[R :E]Y6F^XG G-Y0A"^)&AX5&Y04-;P)-;SU1OSNX_$@:]>/;,<>
MY?8B*Z:3=POE7%GUN.E/XW/U1PSH%5R1W8__<+U?-ROE[,9KP-3&6]OJ5:]]
MLFU@&GEN5$_M62G.-;N=3)ER[X=A8ZO&J*<5GJ=J9#XQD279NIC>)LCE5IG.
M,@+$$1Z%T9&PD*C1+'+*W*R-,^_MM^0.FX.S]^!G]4XJ-VL[=Z79.;"=D7;\
MY8@/&[PL?61BN.]QW-ZE'[[O'GJQ=1B.=L\_X.UW'TYWCS[EW\^W#IN'S?,/
M!-CFZ?8?8_L>1Y\.]UZ_;37/OYXUZ=XAL%.^]_KWUM[G_/O6&9R3-5]_.MQZ
M_8K?H.%F<RF104$D\($X3L@9(I#1(E"N<Z34+2[7M.@-U0Y#B][06,#VSSC4
MYE\(-M(G@,8+ZC!B#A5IR)PA4X:*+2Q]5XU'1\WQS!SEO- B"H1)\.#@TX"L
MU %%2B5W"LL8^=HF%QMF<NN@ILBYZG)&[X8QWY74+5H$]UNX9.3#(=WU!D*%
M ]X)S:;4'E.3#-'!(HY90IRHB%R$/Z.SQ,>D<NQX;7-N)"M2)G4P_IL9SIP(
M\(A4YSH %+ZS<(28R$3F,A!,<\_9Q!&'F8*,9QQ9([%55GJ9\-JF8!NJ3H)'
MJQ[^^E31_9442)E^PR]6EM(,A[)0FGL!UM84.17J"<%<(NLB\)J@'3+2"62#
M59YK+AC/N7\38#6QI5)4#^I@^"O-9J[;?F$S"P>'<3832##P?P(1YQWB,3CD
M#, $!FAPTCN))?@[W&RPN57@:J"QL"QLYH^L--T>]7%/W5Z*K><5KUE==O/V
M8C0+P;D7ADVI_^>" UHEBC!,<L1M"L@$&Y$T2NDH @]*S4=P2KBF$)R%FO\)
M8%AA-PM'AG%VPZ/TRCF,2/($<6<4,C@DY)AC3%.&'<U[4WI#\16(U=QE7ZRV
MU.?&/*:;FZ>6/*:?4",J C94$_#U";<*.S 'XXVW OZ,7%5[]4_*B$H>TSRH
M]W&2#TD9J4Y< @&*.8\I<62\<TC($)RRB5*LGU\>4PD)S0\+)85G)0!CG"9Y
M0@ O5$2$)8R -#%DM0V(.,-P=$0DPZL@$!8E"%2R=&K";!;>*[MDZ=02L'8G
M&8XSPG+O(J(12_#K,$<.:XTLX\HK327)W;9+ELY*&/_-)&9.!"A9.JN#$..4
M)CE@MS1ZQ*P 'X@ICS0W!"46'&/2<>*!T@BRH>?V@VH0^5D62E.R=%:&TI0L
MG3D RT]2&N&I<(YBY+DDB'.>RRBP0IX:I2US#-SU:92F9.G4TO!7FLV4+)T'
M!H>)'D8F^I@P1MH;@7@D!.G<&PUS[IRV)!"IJP"-7%3+^!*@*5DZSS=>,R5)
M9Z7;LST6M.U/\AY -'#%LL0PSKPG,(8L"P(9([DGG">CPL+:LY6 3AW0814H
M4,GC>4B0F(CF!(*#) HI0K(V;93(>D?S5I4+T2I.#8"$P!M"UP@BYLSCN;L@
M>CWS?*:+.MV8YT,7D.<S_Z.K%;[>L;795/9EN53!,\H<5CQY99-61$4=!%66
MZN&&_Y.2KI('- ]J?IVR2Z8,T<PX9#GF6<\H_R8L4M%P[;1GR:1I>4!+TA;M
M =#R,8)AMUWOG#I,MQZW;E),\W:RO,_M+R&HWTR:[X?L)95K)3!_G"D3X8 2
M:X(D-1%QF!7(.JZ0TS K@A/>AUS/)S?PJN/^XIL##5L.7Y<]?R -<F\/7KZ"
MZ\_C8MM7E,8K:O>J$\9>JO1AP93LL]<<WW[]]8L+TC'&%)(D-PT/-#>$]1[!
M># G,19)Q-DUQWFM-<>/>]VLJ=]OV,OIT@@P$6X5'&_8D4S]8H3&AYK!RZ0S
MSN";LVELWTEGG&UP<3\M\<?7&2=T0U"Z/!>KF2BBZ..BZ*LE??[3"-#*")U/
M)T(_K7);_7N_KE3^ +EPHZ6[-O>\4_5KO-:,T7?[@_5&)PYRXYO< N>H6L33
MC^V&]:LK>^<RBCJQQN=-Z:NK?=5 ![XP:)S%W!C2=_<[<*EA'2A$7H"_/YSX
M\<I&&Y9$^/GNH88'"A[/U*#O,EQ011?ZE9%<??\/,)%F=[ ;X>(N)O&*!(N[
MN672Z=9.\V@K?SZ?ZWSO<'?GE=C=V<);AQ])L_K]_>GV1-/?5VQKY]7W+;I[
MUJP:_GXX;QXU#[9>MP^VSC^<-7<^DNKWPU=BJOB]%)AI913"3H+/A E!+OB
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M$O$ QD.P!W1MXWVEZT/C<UV @>C+3C9&(Y6W*EYJ?VC\NBWOZS(C\@O%Z'O
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M/&;[!T1; W%/@$B[0&1C@,A&@<C* W&<+-1 G V(C@9B%8'854<M0E5Y[J.
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M!3!FIFEB8 OL*_6R^FB_UJ-Q]NAGZ>;&L=]6;V-.V6%QO6Z=2:,N4B/H-)[
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M)7<Z\?:+^;;+_5!0^"(K1)7FJ[2@3BNN5 [3K%HKJ]=**MYA0$L_KXD%+4S
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M+B@;>[^'@OD.L^N7U"VYF7HXD\M)4QL_M5S,&%]$378 Q2U[-:$!X,7[82R
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M:%T(%#,(KK:4%T$7J1U1.[4^J-N+)@^7>.LBWSIHR;:8':D_J0B*5D@@Y]B
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MIQS-['S\7)EK@7B8Y_-B4%,\H(3Z(4\;+$/F(=(V*YIT)6OKPG,G66GO?;'
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MU@'9?RBH+;]60WJ]B3U _]L:\;^I[E+"D+55ET>@)H-7L RQ-HA&F;CTJ.M
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M(3!11!:6"=M:BVR+\=D*T5Z8,D#H_5&\=]N)WY*[350:Z>**4-Q"<#& XFC
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M$#!',%%J+G-AI5/=Z#,8)];GHNY-NO:-^NL&*7D>/9?:@D]UE&'D 4*69>&
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MPP"Y8* -8YR9E'CJ\J(^^Z 35W%;038F7/OA[7_6^9[++5:&S*(QH;(769]
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M:$0*V^P$.Q7YQ".F/3];2'_>7G2-3TTZ3?Z!JU5>K"U55\H#G@I8PWPM8LY
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M%<>BR4;169XD+2]X#9X'1=X;T]RAM"IWX<MY\B%GXLRT%6;#B0E/ KMUR[M
MZU%P_,SCIB] ;JB8+NH>(-6I7N]-N8")+I4UO:6N-%V.@\O9@/6QWL5T+K9+
MA\"+*/R) N:7T7<?84ZEY\U@[ICIG#("7(G5/RP14&L&Q20MHK/,B4$;^4M4
MRS951Q<U'R#+$2*0[_+G^:)BJYV[-\X_IKQN7XI>UJ *N7V!"PDF%N^1NR""
M;AQF>@3B3$[Q-D(>87+- T";!'H'2"/E*'? >9GTY$!%/:7V 5(>(<"\"UHV
MS(3@&)C &2C.':#5&83.+CFI%*K6(_(F4_PSJ<CQ]=Y'N./Q7&SNF:8D'[4
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M3PG N>A-HK6+2A*L?(I 6V*&Y*R@WYEH;6N?IQNR;]GQ&4%W+WI\L>)X"&A
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MX77@*O-B<T'TS 5^,N#G;[DE3\-R^:'\L9JG_WIWG;!%[7PJY [079!KPM9
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MKZ:VEH0&C](:3_= ZU[_'KYEVZU<3QJO&;=""9 \&%"1,(ZI<"B!)9ZRZS
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MIL4KSB"BYD#^2HJR\"!R\W?SYX1Z@2%= W0:=O$-$O!R]PP1L7_8MQ_U%YV
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M_R)]KC?)@]]KO*;!G]VE33Z.[%VS'*O%L=UOEW]<_U.)M_[/__K_4$L#!!0
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MH6QXJ$,;S-M>?)ME3QI?Q8!7)Q=6P5R6$[BVL(MMQA$%![_#TF!)DKF5W\.
M3+SCY6&06W(HZHG'EZ_ _4\S]PK]^=>LIJF+PN!^UFDH-))Y@Y4 53V ]K29
MZ#R]4AZ1XI(VC%HLJ"K;I_SUHE3IJPMJ*"4ZX(N!=N$6,.S0N? _Z(6';!?(
MH;,^YSZZ(.K1C]P9_>T)JL3EFFZ9XYMU'KR1*]41NGRP\DTZI+\QY0H"52ED
M(:TG40RDL=9.DY[;Q$-)+%XMV[^(=ZBN-U"^OZ2T-,MLVYC&JLMHKHPYKN>V
M+(UW_0& %[L6D)RM#8OI@VVLK]P8DO8ICL( 4>1,UBG0.C5[^'G>JG:UH]3+
M^L;)X*T=98TR/-1SX65!"?MM&#_21Z2K,^V3'TNI?O#GY%@/BPR6Q.A3W(^,
M7;O_;'*I\66B =XXF"&Y*_V2]FSP>(;-9>T'W'NXB^FCYUB#X"FD3--\G=)5
ME)D367Y[8^#I@T.N;C5W4WNV,/^RYY=^XR%OOR5->P7)\6_!-EA$@7T 23).
MC=[L8T#+$9P_;C/'FUE!>]A* Q]>G=^'U)]JS-MH77?["\/S&YZ+7/,Z=?AQ
M4_]LP:@$,0N6/,D,;_N*0/<3W#>QB5N(58&RFB<E*>GQ8VE/'T1@VE=PXT:?
MM@]?;0F0FRIX&\%HN&_A=WF3U6J=@Q0:@7SL<6+D-%D!'N.AZCXFI)C[E05F
MN$>T.7EM#MMJXS'PY>CC\ABUC>W;6DNG,5>ONRU22$I RV-@A8BGZG/3KH?#
M?_T:X_8\V)"\\[_5T+=H]!E< I+*RA"&YPJ]1Q(:+#1L;E\Q24W MA5]5SI/
MS0U7-K=^8@>?VHV$_U#X7F&Q1X5\Y9.0*:VYR13R0_J%0A@Z(1&6_$C$E?_X
ML^-![A\LM<0A(.SB^V<3+V6LM<H>:G4W2QEN5OG%\I7C:R8-*X44/X=[<#(_
MHU1:;S0TT%!!N\?&Q@^=SPQ0ZO0]87W,P4 =):S^E]OL-X[B/!@T+=R,L!5-
MS?1&76;)E%,24?7I9\Y%6CUUL-'YX:F U1Z^ :.[,L^O%-6HG@^3$#*\O2<C
MZ%=R,@J^@:,G 2^6%Z,93I^L8+&MH)Y^'%8'!)))V_W!3Y"!N6/1YX!S;G<>
M#EO$:[X\)%$M['X_>JSHDOO-H+? :?R8$VL40E:#0 >4CYPO0 K(.8E9S/%B
M>N>\?@S5=)F:Z=1)MSV9L-W^V0&8;2[_UL'_EB!6&^VT5+=T$5GV@\%R?)PE
MH@*DP#Z$1]#V@(=2P/E%(@L+AQF#&%V,6\\ZIK0KA29MGWJWC\VFAGVSNM@O
MZGO;IC?WY+9(ERLK6T@OD6X21(5I= (9M*-%^X@RE^-^Z:(]!ANEJ@*5;*K.
M:% ^UA82N\[?L>,O/AT;PS?;5%UT$[<91W^/B\9LP0IR!* O3S@AD#&#)GPJ
M4$5_X/$+*E)!0JZNO;*FW-MC0Q6YU:R^P>;@#@35(A":V46_.UG+A'K!H Z2
M-#S"O):T(YN'$L4EA%S$CB6&.;Y7*$R9Y7MMZ+8MY-0O>;:%-0K  J U[5,"
MZS43L\!$LH<^9(QN=9*'<.UXF=J]"'_F=V!XRWQS2'>[WY6DT!WO%6?M"YCM
M'1W** K3C-DSC:Q[)]R8+6L,<D!F>!PJ1LZ!D"IR3F0^FMQL[AM<&8!59W9\
M2-&(NS86MH"66PT4<I=O_'XF0#7.*!J]5#=#NX;,-H(N2 /I-8LLS!!.,+<6
M1_^TG$1[P6H *]NQ4M"=)T3;IH\<S<<178?(#IES*WR^D2CGJTGL5T/O+VJP
MG[UK)V>,W(I0@,7F$2_N@?H<61X*,2G&B&.*G*.(#GU-.M]S,B+\K*&DHO&Y
MG+S7\042\S-=6Y]Y\<N5R222AO4VB,!1KW[/_SF+!&$C0$>4$VBO#^T<:4?*
M=^_"%V;%:KM2;P<PID:7_1Q(,HE[,43X)=>4I_U*+7$G+OC&KN#%J1/'CE0]
MOVVJHGP?I'+D>V&Q5X@U6M OL(&NO[ 5\6^T%K((#[BFP/B6V.A-MZ/H[MC=
M:9SIH33[0<U/0/5"V&W[;]T?JIYJ( B<Z-[)SQ2'-R9QR3Q4(' +7Q>^,(+<
MS@')66*!A7L'8-G/'D]J?(M_K'RH._[C3][<IM:9TZ[^Y=\FU7W\E4\\$17L
M,^W!@R?3;Y-!%S*DO=9!'IUF/4/*6LS%B+5FG&2C*:,22?IB <%/? *OWQJJ
M/C7J&%7ZOGIXC_Q3]_+BU%'YS>TSWN 4[HG63GYP%=[8"!'8EAQS;@7--WU\
M=<JV>3&HLUZSS=O?Z:GU(P]'G5 ?ST#77-!B?WO::8]6L[)L-0.J"\H<S5%(
MP7.? O3'-#X>ZHS^6 +"J:H2THVBG(Z/--H"#">1 %B%-K0#7+C 0QU.P]3N
MK;,YF;E7(D6M:W-8S\X.X*#1,6%&%V=+)!L#?\((\E AM%@,Z%GY*6L**06I
ME?#6MJ!STUOY#P\^;L@TKGV9X^^7L]DB>W$V?O9&I+?P4HZ1>NIX@B+;&)[
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ML/'$&U#*%A7)B/(/J=B[,;-1(5YQ^@3!O WF/]0/>D>*27N,9LO?0]U QFQ
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M( 9XKB*H?N&]\[M!8!74U:9QW'Y\)E*<V,M]]$)@_X;3=FJ_-\0I^_-KM]'
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MX$AU_6G?6X2P5)79G9_2GA<=W'A \D8Z1\IS_ 0%F;M]<*]!$%_C-#C[<1#
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M&^BJ)?]"2H+6[^Z;V(RB)D+1/_M5>81+IDV/(U949/!0F@_0A_[53T&V8[4
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M7>["K\^VPMD,6C].'9]S6/'*D=JJYD@-JF&;A7E^%G;XM55%F8-*>6!$S'V
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MZ[?O/^9^,I=75G^QUJ#??];UX@/X^?[OXQ_J)8OHM6'=!L+K>O%M"%V_0%9
M<.MN(;E#CL(7@^4U]D2)*!Q.?5Q%%M4T/,50]+PZ(*:D94359JZK]C?-_N<4
MB_ZG-/M_%/L?>DT $OQ\B/'X90$,P.4\2=P._*O]G]$JVXB0.;N3!R@%6)@2
M^EIE(,=9R6L.+:-&]!L3NNZJ9S(_3YU8VW_5ZJE51W OQ7>$=&N>L0)+I9X%
MH1U+"THICTJ8XP*R9-2DJS$0@>;(+,%BRK>\>(#0]#Q8ZY#$<3 IK,!+,WA
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MY^.UGZY4*/G"4RD?0M'!6BD2(T/A)TPO1NIL\M%9AR3U\#"I6KEK"=HG[#X
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M#(F*#_HV;-P<).G6.:"?I)N9XY:WQ!J)2CJV02-0KL26@29BZY3IN>Q0D*S
MP2#1P>9F(*.FPH:,UF1&J?V #U1(BU"3<Y0J/)!N&4#RJG<+"5^L,% S>+8I
M[:SHUJW#1H5_KCV)Q"!R0 B>E)Z0GG7@J#:RE<)0U)D%YFS?Z4X/52)2 EKV
M>5'FQZ]+'EA8=5GX:CA99G4LJ^]NI,M!LRPU2\(:'E776 7942-T)\.WYJ"D
MQIY^?!?CLO%@9(GPO4.4V^Z*"GQ0.N+N*C"9!S0HMSM,-E,+.$H%L.A7!OLD
MTZJ1,FGF%J3XXX])MO:OKI81(CKCFG8M]G7^",X_9^(B:GMJ]#$I%\)I[BL,
MY06R9DZ(O&C3]EMHA*PRTF'1JA+HRHS;2$"%N>.U9W-K0TE9T0>9X0W*NZVE
M"BY7QZ3F'#[A=>@;WRO3U2Y+@*"!Y" ?$B4>K,7$DBA9,S6J\-LFO583*(Z]
M<^ZM4E'1#Y9/>%W\-S?_BL7 1YHAW\QZSZ1> )HM]1X(9OG/XA%Z(7@-":(*
MD&S;>@!O (FSA4&R2:"%C/N$>PS42$,KA\GIV]G<W9U\*=.JL29^G"SBDN<E
M%[Y<4W;9QI&T5IT(<!!F=CL)O(B>]*56TAL9H;"X-F) "'('9P^ U*FB9P6T
M($F_IN-9-<7C.IG'#%1&I*?[@_2<Y=V.:Y"39:7YDM#?*SG*TJQ'B"3WX<\3
MW]O0$]:L,6ZF [E2U+[2PQ\CV2(=H=89NB9?.O86?&ZG]D[KL9;^Y=3,HX*>
MOP_]SN,!YT%*"X9A7PGMF.GI3R8 W'J$\_. 6O7*)V&]Y#]G7#WJ*+G@)ING
M'2\L!3]GW1C:[NOF_^'W-QO/5UO5#]S6XSN]HDY$I$9H9_0*LJ@NI$#4G0(%
M$J6J2?E.BRACGKJMNNF^JTEJB7_:Z^7?'^V-=ED6?S[O8W<[4"!(:W![BK$V
M'T87",4RG!TB><!F?"#B(\;P&XP27I6!Z[I)B@FQE^]X6QZ6>YQ![^LNN/"V
MXF<*+>+.D<V6C@/Q/AN=3H5I$"']M38P!2.#(+^9L0(:-A*6#*MT8WR+*@L+
MK)N1\5=7:VRL&CIK;CNX+S_L8X_(.?C:ZUCE]!YC]B'$%]#KQ0S#!^_EV*[?
M*8$[I@] U];GAF,0"*CLEX:;&$F@3N:6VAO+=V96&YZWE]MS>,.&+XW =BV&
MX7E3CB*1@J4[_/=%&+=$7",5TF=OQ^(O0EZSY6KZ^-!'<TT1GV_%!GLKYG5>
M74@\'?C*;?)SC]G6(]N@#_M14SG;^9>/P")L]B60? *D%&(9)Z5E\.$C).\#
M&*KT0D>1_Q(WHQ!*:F,Q9_I#6<$2CJ[8W#"??*L'=9T5CY\D.[]]H_>4.<.P
M(OUM"<61)=0@C&,4.$'K:IC&&H_AK8P<9'^VJC4VO!PVA:+?'5TVT#JTN3G5
M);9[WUFMOW19T8@_>D"W&*C9Y :.NOUL04HH1JC%&15]Q5Q;X@:\&Y3ZG+S3
M65UFB+JSP=L\T^)R;9ADWCOGYQJMMYA+G3Q@G7/I(O.B.5CN(R/B6'I7@:Q1
M?]*[/QZWM^7ZWGCIX%WB\.QS[AOMV(F+9D>T2Y*I@-J[MFJ*"AS_X]&&Q.W_
M94TZ&TVBU*(8-J_WL +-3B(62<!KQ$:$N^ZCIG>/1*4.4TI4H2W1NH,8WZ7)
M=)8AM[3RBE'E>"'K!71KMG=R+WZ^SZP]WZ"VM;$A:4MXVA&%V*/G[YGNB4H?
M(3VLA$Q+89'?["T@^9R%'CPH"W\:@!['1=9-;?F!823/>_;#&-]/+3S <'<K
MDIY6D]1VKUSOPZ[?(2&T@1(82@R6<8XX7KPN%0%_BFDT"F\9,>(>QDKC5)Z&
MFM9WU6G7AHEW;?:F5]#"MX[]M)G<]?D0WT%,<8[N5RRT$\U1TF0AJ"?:%E(^
MQD33-5]<_A-;0[/.P)M2EL1=K8-+L&41^+?UO5K!76)*)R^%GL]LC]N2^ 6D
M9&(8'OUCH;#8V\K+!5*PZ%L:2B)L]%BU:8.Z%#/OX:ZI\Q-"8J-*_0+5/?MW
M7)(P%79ONS^Y<E)X4L'Y70'#(0C20RTT(WZM"14Q=2G%Y'ZD=T?K3NATN%I#
M8BUVL[_)2'J083__;PWQ[([XKPV7\/0)#XOF5^D=,PQGTOCM+B1AGW9W@$7M
MJ&@):.@TE/1XCAY>/J]T\VR-7Z9L^=W0Y&_G55.W;_5.U(P_H9UZ<FT+_\^;
MNBLZK&$D1U9@*+FHJBRZX@M"WYHZBOF=>!TM=5G:BY;L1E8)?)AIHGQLTKO!
MQ>#*8\->U0T5,@$28DM:,A8-#)"CT,-RA#+8&W 8QBF'F%:]%B:ZXY9X^\W8
MUR5J.S^"?I9J=]'Z?:6'=+?UWE\>QS=X"U!B)\CQPJ0!; 96GD190LRH71QE
MH1#F3#.-PYLQ49VNQ$0G&A8Z6F:$TR(-;HG]9@?N6:V;29=-?7(CQ3CURXZZ
M;$=WFS]+E!F.8C'+&OJ-) ;&*%*3GV'$K^L'G6)(Q]1*VIUF*CUHPN-*QP[<
MV8;+W;?%_[!XS$$1=9]NJ;L59V^?%!XZX]P_4Z7#44BGZ-"9;%0_.X"C])'C
MX$M5#1W.H../%),%?YNXK%1M/OWF(=V,0(B@O43F>(AA.!''<;!8.$.S"UOK
MV];L(/=#?1/C2IU!;L5G:/'#1-=COW+/IK2 KN ](ID[SF3YG \,N"OQ47BH
MUOD+#XC'4)@%D/:).&:[0PP+5H5RGX?=4%WQXP$R 7BS*R'??M?GWHFIL!PZ
M-!.:\4UVT+ ;/&6ASCG(<.@"-_C-R+>JAN7WNS&0@4+>&*O).P]]DSL4CMLC
MJI%IHG8V(PKE"HS]+[KISO][&Q(95B!9!^./AA &?!?CU[P>U^U-D%M9&/_I
MZNM#L\K^PO';6G)/+WOE1/@//#K75YC\;1]I].%V\M0BAA'0L,!FZR!LEG$F
M&:1^YR@H'V=&P(.@5!TNFR/[%"IVM@D91Y>)ND6^>>>=!@]W#W9EJVC$#^Y<
MC'$E68*420=(VY2.T!N!3U 4VS(LCE7&2$DMFL1;?3+:QS&8\'@M.)>M7_0I
MYQ1- ]\B_FIW?C/Q<84R+'X:Z6+!K8(U0;*UA3I2CI $0<F8N!$G3=0S**\T
MO^C]?'[W.:N)F"0K_4I,V,%LG\A;^7[+>UY6' E/\>/_&@3M_-Z-25S/O\YS
MKL]RV:@9PD=GC"3>]!GZCH5\!V$+_/'L@#K'MNSC":"AJ3ES2=W-^]%W-6MO
M*E$$F>X8R6\=3<6M$\EG2/47N,KL;U/;_P'NL822]IR_U33!FG9Z5=\X?,7;
MS>Y"\4*6KKRWZM>&(P]7_WC!XJ)(ARQN*VQ(& +%0$HE B?N#YF;,9?:706?
MJN]@&!25N489)<DG5YVWM:Q=D*-%V&1:'_MZ9X>3@$P?8C,<H1U9\O.D9"S#
M\0VB^!,4X^Q,DC)*:O6UL(V2:V@[* #U6696..V3V_B]86C1IX&]TZCZQ'1
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M$NDXZ$.,GK!>F&'O@\19-S]JN^BUB%/Z# _693AO.%I3E_(9PQ'O[:\T_EZ
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M**YU?2WQ;U,ZM5MLP2D%/C;J_V<FPZ[O#SM#FDBBC2YTL<U_I!+Z>Y]US?*
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M^K@(CCPR=D,/"+F<YP%(-E#@HX*,)3 :7#6!EGB N&X!LQ!66V(XP+$S:CR
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M][F_^_Z.[_V^X[@OQSE<,W-MSO/\7>?Y.]=:^(-\.K!FOY6M%2"P0@ XA?X
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M,36#(Y"<QZ4/XO+JA@P-UF_5_J;9/Z98U#^EV?]4[#_U&@96"0J@SA.4 O
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MJ8#3_ZE'=-!GT;M^17@'@4J!++%)[NLA E=*B4YMQ2:/2^L:=N(.PE>(1GQ
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M@A8?^,P'4,*8BRABD"=8+@6M^(($OLLZH75)DP4?Z,WE VBXY16GP&?QRW?
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M)T]@;^VR\\OET.Z?3_+?2-LGJVGM'E%:&2=,RZ*,=+,[>5=I],?R8^J\I]Q
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MO]8)1*!5Y\I/L /+<]*:*_UZ@AI5)SEWV]'>_..AZO(;%V7<3@R[6P0&K_5
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MW:%Z'R=5+3;O&]5>B4_),ZX<&[<+(Z4M NX;H.HV=787MD=Q:A=V S6'HD>
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MEN-D2O$1$XT%SZ;6BG/+4[/KUZIXN/;>E%TZU(B\O@N#"H0T4WR9S8\$JIS
M1<9MT*X7+3P1N'BI&6R[^]+P'KK)L"7B4I%2;D$J>8*[Q$/W[Q$&$C/T&">]
M"UN+1+$L&M-:&'<P0T6(AFU6YCL,.V]UBX-QFF;&%O@+1:(/5%N*E2./]B'G
M,&1Z^IM?TR=;WL7F+K1VN'[MKW<=/O'R2&".Z<_5FZH"QVZEZ&ZY57Q_\=Q/
MDI4T>9=@&*!TXCPYY\*-AT-FW"+GN,-JEGWH/9"KJNQ^A!"21)1'T($4PD[2
M<G\5E@NTZ2_,QVHUS;VZI?E]ZFT@]W2.Z;A,S..$K?YG!Z[?,%6W\%A\@P*"
M<1G,<TN+H*+6VBZL)A)W)6]]56M/4\*G$WG!A\?7*=.2@VMUQONPWA(<=!,)
MV[-[_@L#(0S-!09#>KP-H<E^\4LR*@6Q]ZTZM4LQ4L^./0\(]VTEG'KK(]IX
MU\GB($6GY.1[S[CZ <'C OOP:FQ!#.$]1#=X4 5/*#:@*X,;4!CG)YD62UJ\
M*RMED7=[%0X#]"KYCP\OE!I@SARX4OC 7J!*YXI*X>ORACIMO2T_$QAZ/X;0
MC@!L<. 17"J25*:@#T6M"[V(@2,(04M!@K;W_>[]*&;A7OE'1#2XXI_DP7@:
M6S(/SC%(;V<OJGU_&@K9'9CR'I.%X,>3GB&;<:E=1V-D::CD4&ITWYC%<W^%
M P#UT^-]:1C_U1$7_L,FSLDSID-BQU:CTUC/2N.0XGA2QRZL;IO:SE"$0G&I
M2P%#",5<Q]]W+#D3R],MB)0'[UZLS5N/+%%5;HQ22A;Q#O!;.WQ,YX%,]UBP
M!Y>F(7R@<(8*J2]>&S81PV]HL(3]4N4"(@$$.>_9-EJM?<JKM5#*62FIQFSN
M<'.+:WJJ9_R!9+ZEPUK'BP>O?$26$E6Y?D.AW,/P@A[O@+F^./=BHG]!F54T
M.H#YLH@:%].P>G_/)B%(,X]H?$NQ4&T.6_])_8[2K^5^;TY^SX<FVU,%1K90
MS%S0PR7'61V04"F1@CZFL#]B@$O%5O1 4)ZD%O%N\@#N4K2:VWG ^>NYYEG#
MEZ7:'S>?15;/#&>I#GJVO<?\S$J#,=58U1"M/E\$;'%?6NB=8!& 9 NL,& (
M8C3I9%LX%6C^,4">3_>C?U:O;]0>.-"0K51 SE8LD<5]2B4[&#?^<$. NG-T
M6?![*7H.*8<AE;N,KC6\8HJ -Y:L%39-P6A@T\%B*41RNBPXTO!Q\16SY 4#
M^XR+'U[^"!?-4-O#ZBF-,]R@=XS_.1-,MP:?E_Y\%[J=GX_;^Z=50T/CAI]R
MB6-M@;WH5;&/%C"8ML7[FN5-NBOD+!K]N02Y"TNTZ]*/.4S36_N[= 8Y<$]E
M  =:=FB18VVZ6V[[ZP4(-Z=*Y!@'TE*]>.9K)"U?#2MR?)[9PIK ,'J8>@Q3
M?!-BE6!(#%:Q)\*)+6N,)57T0:8YF%IFX4G6 YJ(JPTK=/VNC+IL7\_-)SR,
MT +!S+B6L]:A2. *'I*B'T"H(O-\00]^CCD#GJ:TS^&3.:WP"I$*&OM(_@YU
MEBVB%7.SN6+9_%^KD[ZFWT%Q<-6R'_Q\!O\!Q;B'<9%-7 0<45_TR(OW_S$
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MYT>@WFXZTS_7>.KL0-+TS65BX" :T=+1/FO6 S!V.._.]1-<7FG\3$>DOHF
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MVI:J3V13N,@H3K0HVFM7GN'&S%3E:\5)O9]ECFAY;;ZSX8T8H!WO7Z'0?+.
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MR6,A2BXM0_*UU=!($>A_=YR^-.(:ET:KK3GC4[E0IC_K\UKW1(*D^\VE; U
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M,[[:G'_;6@EJS67GRP61%;HEXMIWOBMX5*5</Z)DI]%Z;>N;]\LW?E<3R)$
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MC8V;E/S6JV76+CUR1XZ[O7W\C'>R<KI)R;YDKO0%4X]S+4D/.^11H"J!*?F
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M.8$\$]X^]X=3/T(69HH#DI"/Q26GF^Q3H^%'R(@HU/9&)+@/OR+$T LI[U!
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M?Y)8_E?Y)\CWT)KA"=;#'TXHT%COGHV6'^/ND<@DUKN-L[\I]FP@K6F2A29
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MPJU:T^H_?E1#@:Z:N_"9LF5KC;.")#?D_=<+"0"5 /H()^,VW"!]-M !*^9
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M_Q/^U\Y_E?\YA9,]_7\ 4$L#!!0    ( !J""U46<!_K9C0   Y#   3
M8V%H+3(P,C(P-C,P7V<V+FIP9^U["3A4?]_WL64WV9)URA(E1*$D4PE)&K0H
M_DR%9*\D4XTY(7N(DC_*2(E(D[W0C%V29"E;S");3&;0.)KM/=WO=MW/_;SO
M=3_W<[_O\[[7]9SQF\LY<\[Y?=?/]_/]S1G!L( *K#]B[V@/" D+ 6?A%R#X
M <@=\ T[[P?X ? F)!@#; %AH=_;[W?AWYNHR.]W,5%1$=%U8NO6_66(2TK
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ME0ZG&]DQR+3M%LD#7NC+N!YKF;M.ZTU+U%/[2R0J]]Y"O!( 9S'0;I O628
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MHS<$O@[B6C.%N7"=CTD-G*>&:'A!-^DOGZR+OKKK76./V98\3.J3NI W<4>
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MC/_!JC-UA9Q@(\,ZEAU5Y#7OYJ1<GI98%ZEV^SPMULR^HF-(YEIFZ0'#N[)
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M,(]JJ0WB3*U=9&WZ)0K[)Q4ZFG$MWP(N(W,2>?,<GUSH)&QB=UZ>M0B+P\Z
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M7'H>'Q*W7P=FBL=;,<Q#Q%$,^S0OI6@(!S-1,7.H_!S+DL;.>OY]0J6".='
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M^Z"J<ZQ.MCM4M>Y1%+TWL3ZXGA!KW@WN=2*<D>^:&G^ R5?8OW=0V//#Q_V
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M_PJ=%_GWQ? O?[8.[PX82![)[JCO3?K+K[H<K<-8M:VN_5]&.^W@WG0A^/S
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MH[ON^>Y=0@N[_@G/9/_G^+\S0,'(?P%02P,$%     @ &H(+57[FO?X&/@$
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M\%(?4DZV].Q;>73J06&I4*->?(BP@P#=C@VTW00E.*ON,V%CWUV]/KJ.&1O
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M9#$\U7XB!0FG^8<O3[1D>W1.=Y&1/&KFT=:?W@K=A1AQH-@$JX6ETX]QAT3
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M!JQ\![_T<1)KSI.)#$ERDP,7Q:VY\Q!L/>@3+"$^[^B:6\*%JPKOKJSK'4"
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M0>3_8.\]H)KLVC7A6! !$:1+BTJ3&AN"E$1%1$1 +" U(BA-B A(T) HO4=
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M/[+[XZL^;.L- !Y%^6_6)R\^'-S^A9')S"58W4_M8XDN3^'?5T3:T[#T.2"
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M!%OK]U,.J.#+L/^E]8^*F[9*CRA$\?DBV1Z1FE^ZD)5Q\+9]=!<KZQGCI.7
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M6P[H,@G.YG>C*CC=BR5Q0,_8AU'G4,]QU"BD\NQ-%=9\&%(^IU:] 5R2NSA
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M3I+,]+79DX,&QDI-XT4QQ<L*2T>0,X(A39W1'\X=61*<SN3A/B"=:<3*(?C
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MKG8YBR,U/TJU[2"X+HA,7U!<Q^>S SGZ)=US2LX=P[7-W!C?K$?6%V_#)8U
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MM TLB4]ORC*"W+$34*;O25P:)Q Y!*;\E;H76$JS%'S;56X_[7"XU<!M8\3
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MN23[;?7GTQ+T=,GKGQ32%!,VFO\9_5MJYXZW;\>WH_@-]MP:=Z((<?2Z9MV
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M&6S_=_=I.UX_?&*/OX'2">1BU#/VK[NH')I6X!;N11[L:"QC=3::K8ZU\?9
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M6:[,4!L8PUD*!;>93WC[3U(9W<#B50>#=L!P?:(,.62/HM515P*H__3V+&3
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MZ2+>)DSE!N$%46R@71FE:V%YC^]-O[PLAZL?P\?4XTVFSWTZ\J3NP=Z'V][
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MMJ+ZM6^]S9_[]5Y@R[9YS0^C9E+I/I<G9 <A,6X/9T3,<IE)K%N=NLH1-3O
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M4ZA>X 89<]INVOWY)Z;"?W=+4LFUTHV64$PMSBX2RQ0(8IJR2JHA=POEB/[
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M('>(>FPX07%[#EE_^D7*@0J'4=27 Q!F+7?+);:_O'MVG0=;"55JYPZO1VA
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M[$UAV%'Z3<]7ZYD\8-Z=:4P:G^_'NC<$]L7Q8/-%1@4\&/4B&I0_ ?%T#DF
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M54#^1NG!=;%MIG$U.*I[$H4CLI#&A78MV@J1J&[""A%*QX'](\$8;V^V/MZ
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M4K9_T<$-;E?NK/MC88X [I.8=?D-9B"SH!E>5\'Q4Z4'E#4A%3Q^8);82-?
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M;'[$W'#2N<0'!_&Y[B14MU88_"#0K+/>BI/9V%W*M* 0(U\ U7KBDNR+U4E
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MHB3&DV'ZBIC766*0E3O^,?-4*EC63@J_;G;I\9>:B/KVINRR[@\[/8(HA$2
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M;#L#J1]?ADET3K9YOS^08T<3B.P8)4M4:FG2U3D[$71_1;2439QM/U:2UVF
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MG@9DYL##E7->#Q.%+>/;.+O6"N#Y"^HQ)]^CL:LTA\'J[D3[0OH5MZ,GT=I
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MI$;;>X[MRAI4_79I22=5P=K%<? )O!:2W#,USPI$B#S-NEWUSH97045!D+O
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M$_Q#=MBE1#G;C)W4SO?99Q&W<58?<I3,<62YM4 ].Q&WV FQ/Z=YM9!<WX*
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M5_X&O%')@I3?]AM1EK<'<3[&#PDUB_.W(&L# T4PGBYD*W>"0<QN"*P *?9
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MGBIN= FM)X+9AI^9LK#E0>2!? 42Z"+-G'M/\!AWC;0!L[G7!/JY&S=3"7L
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MW_WE>NLP\_&5D*)2VX6W*U;>B8.3X78/O%9[W\X5IX\^:-U4A#6+5 @D,Q'
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M$T4^>@>&$F6,$!D&D(4Q0@&/,*9.\=(G9YH;Y^P$!492H$4=:)6<AM>.:[R
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MN8GF1IJMK, (>P5:<=M,K-K\*BQ31LX"?-ZD]P7;R 0W&6+VYKHOY"8RT2]
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MA8@RG0A%,GUX00C$F=H/9RQ0-ES&B.1.-0PN%VEN=&G$A53+"_9U GM* ?H
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M1X)"A),(YIASR&F2A$0BA&3DEL%P;)JYL;Z6TK$^GPNHM@[42Z$:W6_JC-(
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M/W149U^Y0H\'GS8OZ*AB!SE QZ\:>%:VIG4;IMUVY,K45CB,: "#.) 0H3R
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MF^*K6DA[AG)?H_,?@%&1'_E+L ?Z*9#-8K1QAU9'&QXPM_\\C(K]1-^)$=;
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M5Y#W"A"IA -ORDH*<VCK&)CBOG)V[#GN>HS,F7U+\<+#4KB'LPQ&TU=@B[L
MTX:X# ;H(-AE^$@#0XL[[[1Z;G:Y>!^DFN&N7!EI%BR(B20T@A+E$J*("=U+
MAD,24,R$C/,X%8N5N-&E1NWH\ORD5J]CWKZ.^U./&$+6B6E<,/HH?ET]="T:
M'..)SR.>8)))24-(,Z3M]PQ!$M,<XBAD689BE#*GVK:>\)XR"K*3V&14[&36
MX+=2 R.V=^3M/B]^\1SY<W(IE.[AVM;H^ K3/C_AM.'9U@ <A&7;WSG45E94
MJ:<P-8(^2#.FV98&$29$<TX6ZD[-NDXL13*#62#B(,E$&(5.5<I.SC0WJC'R
MZ;?!2#C('W :55MSU0-6(].(&TP#;,PS$'@S)4_-,['%>$;=0\/PW T#\J2-
M/U,+]UDTS;)-5RQE6SZ,:>/R'?E6KXNF7K HX[%,8A@A*2#"G,(<$PD)XGG,
M,AYA^WZI]M/.C2JZ<P(3NKPGN_F4FM>C%1]LY'=(%+9?BGY*&0_@D?EE%M@Z
MI&2/@O%T"=I^L';+"G:&K"]'V'ZPZ3*&G15\E#_L?O? EBOEZN:+J.Y>"=K\
MF33KRB1H*'NS,SYUHDU7"NE:^Y2VT9="DIR$:0IU+AY$02KTL5(,1<9S1O,X
MD=C)1!PJR-P^"SO938++)M=_J=LFJ?GO0$F77>6#-LNES;VO;\NJ:2^@9565
MWW2'4/A%_9,POCS']BQ#5]7.1)UBK4;^PI@V5EH'H)6X IT:#QO7Z0C1M9>B
MYJL5RU QIFW%<B%8!ZU8+AUO<"*AXG$3'+ LV,,7\;UYL=2^)1(F*$NC $8Z
MN09EVK^7LACB.(P8CN(HP*YI@T<GFAL]=M:&$M3557H22CO.\@'0-%9O%VJD
MI02_=__5X@(CK]\,O5Y(_.7C'9]FZNR[7F6/Y-KU7^^^Q;Y&/R?F2)RO110@
MU 6-,R1DF+$(1H)@B'3&'149A1G+6)I0QK&=)75ZBKF1@!+R'[MRFDI.H 6U
MW\&=0/'\3OAR;$9^_X_ ,J#,V E\['>SE^,TT<[5Y3%RVISV(]"S$3UQXV2;
MSG[!]S>89ZYT)S>3YU1_7M_?M[M5LGQ!ECH!ZO.M$,W;E2RK._,\F/H,NZ\W
MBN(@PPC#6.C6G5D4PYSF$>19%!&*:(R9-?L-E&%N]-BJ ?;U )TBP&@"]E2Q
M)X:A*W2>62? ?>SMH*T&_S][[]KD-HZ>#?\55J62QUO5F %!D 2RG]J'F77B
MM?W8WJ12\T&%8S>SLM0KJCW3^?4/0%(26P<*($$V\]9;E>ST:$C@OB\0%VX
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M9>,5PF3,E;TQ50G2]A2+F'4M%T!A1A*B&$Z54QK\SE[F1@5M"3W=:[K1[&:
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MTW<F8ZN+XK89ZO)#_;:EUD7WS;HJT:Y6PNRR/AC&>[]5W\N%P#S10N8 :J8
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MV;Q3SUSSQV'"GK8TR>2\J,!N(EY^H-_ZO?<IMK$WQEIH#ID2@>(X8QD@.,D
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M5=S=;Y4$T>T/,U)W*MI+'[7%CVKYHU?_I=BF_).G[=!SS!R-B_%'8FSKH](
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M3I&1.K)B1U;N\)!Z7+"'AW:JB_<@$/M=R?N!U755[]C2=%?X?JH]N]KW?'5
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M7^?1Q@Z^,Q_X^GLAHE<?URL@]\#]*3I &K7 ZVLWON2WYVN,_B_YHD9>+UH
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M[ 0!\F)%GC"M^U&V5,7BJQ*/FV+[%"/^K=@NU<*F,3)/*:!1DAOK'@E "46
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M=)$W_;!Z7?^- '['36'(WB:[5!P!HO;]XQC-][VJ;!<U;:+N(8,)USE@,.<
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M>+EM?:<;A9'INCT .U4B.P>CG3+17ILZ!;?W* W(OCT$W.!)N'L)\T*YN(<
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MSGETJ9>Y,<%>T*B6-#J(ZI'4YR*FUPW*($B-3 4C@^21^B@$6!-9<7U \\N
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M; X)>=[@&RLU[P(8W=+TK)#I2MCK?L!XJ7M6BKQ(XK.[P[U5^#?3A+QY1T6
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MC*&X;CC,94@A3D,12)*1%%GMRCK&F-K7O183M.1T=.1WX7G>F>4!I8'Y<E"
M[)U8'H :R875!S G]]49*#J<5Z?N',UU=4;TMN/JW*7]]E1_6S.]@5\I59JS
MAH=%GFF"K>CT>B'_R<SNOLI.76KBU?^=15%(8I)FII9H"+&BVB[&5$&6I$02
MP9"B3@5%'<>?&EONQ#?-Q5\J4'EM=RJ C0[@C^IOS^!6/:W 6_TJ_.GHMG*=
M-#LS=\"I&)B2!Y\%9V.U)Y:>#%'7T4<U,GM"LV] ]GU,/YJ\+:IPGN?O*_V>
M5.6;K\6_UGE1N[Q^4ZO[I9RIF$0XI Q&*><02Y9 FE$*:<)C'JHDC+*XA^/
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M9(A 'BK3E"!%>@/"TT0XM6D>1,JI+>A;5MRI%7A41;8L'DSU?7"W9'/PAI6
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MH?1!DJ;-/?THY"/+BZK._Z?%XWI5?E8_U#QL#&\LDI I%L)("@%QA+5U(,(
MRA@A$2>2<"E=&*1CK*D12"7;__Y?81+\G]"-*KH M6,*3S -3!1&RDU7CUK0
M*U")"D*/844.F'ABBJZ11B4*"Y7W><+FEIZ6AKA7<CU7-]D_E4GV5O+ZARK8
MG=KXQ:HD\?+6;&!,B["J0]@LP;&,>1Q#DND]AMY>$,CT?@,B&<H@X9PJ[)2X
MTDN*J5&+WNGI%T!O[K8]G\TF4/^M%A[\;FH\F!KSRX='TR'X+2MS49V1O\_G
M:^,;^-!4IS=%'NJ['*V97I-I:>8,/45#VS^-_&9>-AJ 1@6P<\4W<_5'I<<P
M3?$N0M*7V=1+AG'MJ4M@.C"T+GI8CVH7T2\!2:M:@W*M-/RXL118* 4GB,((
MH<B4MN!0;]<$3!/%$QX0FBHKYNP:9&K$6(FY*1:J)0597IIT#B.Q0UF&4Y">
M]]?[ &I@>CK R$C9IWC%*90<:E9X0&LDM_I1U#S5I3B#0E<YBE.WCE>%XHSP
M+XI/G+NV1R:E%J]ZAGY:O*GN$P4A8@A#*6@ ,9$4IH+%,(FPX*F,PB"RVG.>
M>/[4.&\KHGDEXQX+^1B&YYGN0F2&ML&& ,4A__$R<,;*>GP!DJ<\Q].:=V4W
M'KEKO)S&TR*_R&3LN,R=N-[?_-]/BZJS_%T[?XQ%:9#0E,,D(U)O=XFVUR@2
M$"L>1H)C1.RVNZ>'F!I]:2G!"S'MU^@)#,]SU^7(#$Q?!Z#T8+ 3Z-B3V.4H
MC<1C]J^0$Y5UZ]_!9B=N'(W0N@5O<]J9*_LY^HRWJ;S)ONHIWLS]]4)^S^_J
MEO&+U;40IE93OKC;-(O?N8@H35)JN$_*-#-'C@PR:C:Q*C;I12F32>I6T>H2
M<5Q>]G'J757:&/=16Y_*M?=]_?# BN?*M;13#NRT QOUW%Q]%TVGG<=OK"D:
MF+4[YJ9[0L ?@[C_?,#JR0MXD2BC.@-]@+;O$_3RS)ZY VIESGN_UA%]\NVS
M.1OXM-C&(%^+5?ZCRK*:2:F0R%!LVHA$$'-!(0])"D,4ZN];$(:8IXXM>BV'
M=K))1^K?*TS@0A,(*4W\XW(;.L^V@CNWEK6="SO>' ;A@5G2@%M%A7QM@?NF
M.K+*%W]M92A<GX>Y3W]:1\3\-:^U'7CLSK:.@!QI>^OZA'Y4UI!D63D0-7]^
M7K)%N0MZ_;P-IHQ"K!0A :0I,0TIA>DU'H=0(,98@F3 J%-(JNW 4]M:;^2^
MJMW65Z 2O#)(/N8+MA!5M?^M'A<$M%I/C1VO#0'XP*PV"-;.].8*G"=RLQYV
M5&IS!6.?V)SO=_<":N[4)H902I8K]O0S7]W?+^?2!&88=<IMUP31:JPP4SAD
M3*02HBSC$$L60LX#!-,@0BH,,(JQ=1)7'P&F1G/&H-#"@XTBO[YIZ?%78!0!
ME2:P4@6T=;%WI_6:JO.NR*$G8 1C;H>[F86V"J\+OKVG<^A)&,D/>GNOP&*S
M=<D7V7SY\]<WR_7*_.6O@)7E4N2FZDTU1V"EKZZ+IC?Y6_H7U709W?6R!>I)
M%2(OS8=+7YL7H*R:,RR;Y@SFT_;(\LI\-\\RX+!%E3]F$"JS9WT)4 ^/\^6S
M4G\QZ6+Z$@7V7A*PW%:\!C_OU:)^6_3C"U5?IN:-7*5:K>;;P'+VXK5B50<C
M/;18_C"])-B3*G\!M_>Y'E9SM![[7A7ZSOFS5DO,U]*,L*C^H<JRDHFKA<KR
MU966(A<U//H&D_SVP)[!/?MA\MS8//^W&6YATNL>EX5!LU2/S/17G3][2GZ[
MY'7L<$OW>NQH3NM+E&Z[M"]Z3K^-R8<L4Z*NPV7>\%OV9/K O@S2_+)<Z,W1
M6E^F38</3V9H-4NJ;D,1A3Q-4H@CF4$F])=<92G/0H*B!&.7C4I?02;W16_+
M^.MBJ9GSJ;*:S5HNP1ODV'ZN]P39;5?&@'W@[_A6!5#K4)7:,EJ EVJ8[4U+
M$=!HLFT6YV\K<RFHGK8VO<48=:MS*5C[6Y^+G^>^%?HZ9[G^W&;9K;ZW*:4D
MA(Q23&(8Q"J#.,4AI)@E4$22(AH*0>VC(8X\?VJTMQ41&!E[U*(ZAN'Y+<B%
MR S,3(. 8K\UN!"<URC3M8^8QTI='6AT&)['[AK-KNP0N6TV=EUV85ID7:GP
M-\7*=:'DC:D,MBX*;9%6QX*_+Y:\5$7E4JIRKEZR;)4G8%P^02I5 .,D,GV^
M.(5I2#-(J:F]P%+%>- KC?)RV:9&HNVDPEH[L%$/+*OR=;6"55)4>07:.M99
MB'LF3Y.AX^@1]SG[=E;H*\WIP/0__G3V3RSU![SO1%0/DKU.XJH_2$\FNGH<
MPNU#(54^>]_8!]>+Q9K-OU4NI5D6I23"00J54 SB2&'(0D(@E2I+PX3*+$EL
MV/[4 %.C[(V,H!82U%+:\>U)$+M)TP<T S.?(RK6M'5.]2/<4RKQR]WRQZ_Z
MUIIV]%]V;'/R@:-0QCEU-NO^['476GEOGS<5JY_?S5E95NT?J!0HBA,)22)B
MB.- FVR(1GIA2TX(BU.5QKWLMF.C36U9;R4$E8B]FFMTP^MH&%T*VL +WA&O
M_G9*%PZ^+8^C8[V.+=&E]DGKH/,F]^_]9W7'YA^J8Z7J#28*11(S"B7'D<E5
M9) EB,,0ZSVTE"2+F-4)P)%G3XX.C'B@EL^)"X[A=O[K?@$:0Z]S!R"<ONHG
M5.[U0=]_UFC?\A-*M#_CIRYQ6XZE-A*W5;'^IDR-S,=[TZ.P>L%PQH(((PJ#
M4!"H_Q)#FF("!<E$H*C*5&:51-PYRM26:%L^IR7:C67W8O6&T,#+U@4<ZV5K
MI7S7-UD_H/4]UO_:+>/N9X^RH*W4VRQMNXO=3Y:VD<A5@_5/54DDTTBFJF(\
MHXR*0&8$QB3*M(DN!>1I3*"D*)8D#I* 6T?3=8XTM<7^697E?X*\%G);U=G^
M7*4;UO/'3M[ &GC=[Q(2*D%!(RGXY!DQ^S,I;\B-=#K5&T&GLRDK5#I.J;KO
M'^V\RDJ-]LF5W0U]2JNL5OI7=[]_OU5%D6O@36)2JGB0T$!!1)7I()&:>GR:
M,Y%2DL94)BJSRJTX.<+4:'(C)/C]E^^@):=+*9%C0)XGR(OA&9@8AT+&I<S*
MA0B-5FC%$2G'DBL=*'0673EVWXAE5SK$?EEXI>O"'O9@EJGBNFPBUMB=,IFY
M^4+DC]K4K *B9WJ3AT402TUK3$',]-]HAC-H^N,$ 4ZRA(?61N'9X:9&>97$
M@)7@<2NSB;A^W$C=A(T[&#[G$;>P%[WB.+316$%X78*=N.#&% ;80'CM'T('
M ](KE".1Z-?.E[%N9=/.0\A+4*A_K?.BKH6[K&;$-+?1 MT;,U2H8L7R!5C4
M"7OKA::/[0]%7FBMRA73/.:KJ8T][%UFZOF'C&>K6BOTPF"UO^LU(Z\^;Y-6
MF>)*,&$J(6AS%ZL@JKLL9BG-1,3BE,96C6$'DF]JGX\!0G8^]TU,]OTJ.)XX
MCC_! W_77FEN7RDFZV &)A67]?EUTJH'@G:8^*S#8?I]4KX6IOS+ZOGKW%3K
M6<@/VK!X-$;/KM25PJE($*$P%&$(<:!B2$V731&(4!"28F$7M64_Y-2(W[0;
M6"Y,1].Z"%8M?Y4LN17>C;XM8+=C9+]@#DRR&V&O0"7N2P ';1A@#Y,G)K08
M<%1RLP=@GZ\<[NQ+04K;S9H"OYLT[+J+P*>R7"MI\D@3Q!,.PS1+M8$J*61)
M:#RSA*!0ZOL8<J.>4T--C7*VDC9IXU=ZVV?D=*69D]#:THL/P :GE0U6E917
MFPXDG[H1ZT$BY\#P1AXG!QJ9-,XI?$@69^]P]VN: UVEJE.@;<S:5_9<M1A_
MK^VH3"_(_U*L^)C_4#,ETP!CA6%(40RQ-$7R*=>4$5"1A))F@1UEN X\-0*Y
M-74AF)'0WA?G!/1YQ^90\ U,)[78S9'N+G9U(SG0HH-*=F"$!T;Z@2"V=WP.
M!?5(+E"?D#MY+OO@UN'#='K<:-[,/DJV_9J][N_92\]\,=Z:,B;O6F5,KHM"
MORU5^-3;Y]TEC0S7ID2.L4I7SY\6Y:JH7MCR9J4)\/:>+6[JLCY?EE4]<"6_
M+>?SC\O"W#0+4Y7(*-.[6A&:8,@DU1\+S/1G P6IBI3^L5L?X%'%G]HGYYL6
ML,B%B8"IM 2_+_*58RG9D5\ DL4B2I,0II'0&PRL4L@)2F"6R% %E$L5(+>J
M[--]!<:IX_Y5%=FR>##'2_]CW@*[O=!T9W9@@ZC2"E9J@;;JH*6[*9;6OJ[1
M'U0 7($: M#" %0@F-/-!6A@J&KPU$!<'>DG:< !#3H^>TF^RK3Z:D(YKO#C
M=J]\E8DY:'OY.E+T,Y_>&607JZ*2\5M>_OE6+<3] RO^W-2'25A$HE3!,*95
M838,F90,HBSE,<5Q%"'B8O"<&W!J)LH+>8$1&&PE=BS!8XVYW=?%)Y(#?P\N
M ]&9H&V1\42I9X<;E01ME=^G+>O[^A%-9>JOQ6IMSBO?+4MS,*!_IHH?JLJ,
M$IB1(!$8ZMT5UW9U3"$EA, L2HA"A"9".O',F?&F1C,OQ+6J5M4+93MF\8C=
MP,3B#ILSF5B"X8E+SHTV*I58JK[/)+:W]>CP37X)WBNN:6I=5)USZZ;6&D72
M]/1#H4BIC"(8A;%IFB8$I"%+8,@DH4&89LB^X^W9T:9&(EK>__C?_RM,@O^S
M$WO3H3EQ:&=]%N7SGGROV U,(@8VL(?8KELZZ=,0_"R"#IW!?2(YDG?^#**>
MFH7; M/5-?SL,\9K'VZKSHL^XM8W];/:]+-7[_4CYTL3<K8+->*(L2#$"10R
MB#3-A@@RI*TU(606TT!%BCOU%3HQSM0(]O-R<0=O5?$ ;K:E^NOR_[5OZOO]
MLEC5%[Q=%L7RIRFV[F;!G4+<SG+S@./ 9&LD!#L1!^KW> 8'3\;:J5%&-=+.
MJ+IOG)V[O.<IW*98P=MUF2]467Y7=Y4+J][;94IQ*?1FCB$),6(2<L$0Y%3Q
M.!0TDBAU.C3K&FUJG+&1K==^KAO7@& 1TH3") @%Q'H+#1F) DAXI$)&4L$"
M['@6Y0O9<8Z.=NGTAH/K*G952&@CMD^P+8]\? $X] F-Y5OI?CAB X"OLXS.
ML<8]>K!1^^"DP.HF]UI.7XNEZ49@.K5]U[ON7*ARTT8@PZED@D'%3*Q;E$E(
M61! %@4R0IAHTK J\=(YRM08N!&T;C]=2^KHN>\&M9L9O$$U,"/T0LFINM-9
M%"ZH[G3ZV:-5=SJK7KNZT_F+^Y[G/3PL%U5]QK<;EQAAE%)M<TFA304L90R9
MU%LWF4J*E4K"B#F%+!T.,;4%7TO8U Y]ZWHX=P"@[7'<); ,?@#71N2\1ZO'
MD=LI[;T=LAT,,/*QVBD%#P_23E[I7B7U0U7;\?N]FL_?U=G\LZS*H(L05((R
MB*E2^O.M]&Y*_U^(4,)I9ET3_?#Q4UO+M82@$A$T,MH72ST"7_=JOAR4@5>R
M$QY.-5-/J]VK;.J1QXU6.?6T*NWBJ1U7N1]-O=,7YN7[W 3HY,8;N_GZ4H&)
M"1#ERM0]1X1#%O ,)F&61D0226.KNN<=8TQMR=9B@I:<]B<GIV \?^+D 9S!
M/\+[N/0X6CH%D/V!D@>@1CI&<GB1G$Z.SB#0<5YTZL[13HG.B-X^&SIW:;\-
MQN^+0HGEW<(T_[UE3V_K5L'E>R4*D^Y1?E/E>FY<<A^UW%^+?%E\5?I/<^W7
M99E7)R:SB&215&D*D?% 8($$3(4)^PDIYRG.3%3A;*'N3(MFNTV)#[&L5D!:
MKX"V<,,M@&]U5TESR&3:V56MW3?2-J6?](^?%2L<3YF\S*+=OFBTF1F'Q-OJ
M5*UA-PI=@8U*8*M2W:V[4@K46E6W;/7RM__RB;*G'9L7D4;=X_D$<7]7Z/79
M/7K*-HW J\[?;*Z6&?O!\KDY+-',8GY2FF(R>AQ5LH5<FN/LO(HVKQS2LR1.
M]"934[2)H]*,'4A(:1!"DE#".4:9RJRZ<WB096KF[D:=>K$;\0TUMP1V:-!Z
MX2R=MY)'Q'YX?_41V+?:0*T.K'ZZ4ZCR;5<JO<[T./3:'6^:1K+E;TT]2E;>
M:^2S^?+G;M;*GM/FJ1*E)Z2[>OY>.,)X_8']0/&BE["G1WI*;JJ;R&;Z2\:4
MC* B202Q:2])XQ#!F,A8$4QQ$EJ5-.X>9FJ?J2,Y.+W:^9X U?:0Y%*H!O?1
M.*-T>7K2$ UO3PSRNJE(G6UHSUS=CP+J2A0O&T,<*TGQ13VM;G^J^0_UVW*Q
MNB]GA,L@PCR%2:#_P (32!DQX1)A3$0D>*2<3DW["C(U&M$O6N1&&+VGP(Y2
MQ@!V8-*I5;@">]UAKG:%;:Y,N6ZNP%>6RZNZI,W-PH,WU!>(GDBKMQBCTMJE
M8.T3W\7/ZTF-R\6="54W$<&_L55CA7U3C\V(K5KDGQ;FE;O5LZQF42!9@D(*
M$Q/"BQE3,(TC I-$13R+@CCE;L382XRIT>).<K.=44]Y6:WCN4D86)E\@.5>
MPD"]GRFKA('J KY-&##K(G;DV'YS:<FP@\_0T/RZ3=LP*ER!1HGGADDK<3UR
MZ45P^6+2?D*,RZ,7 77 HI<]K7>X75/G^29[WQ2RO&5/&_;6 ESS4INT8C6+
M:"!)@"BD>D.L#<HL@32*,41(*<V;(HF$XZ[3=NBI<>5&6J"G8_F@JF.M^4[L
M_W0.V+.= ML]ZA# #KYO;1<<WR)L3IM:@H,_-J+[#?USQ,M?2*#MP&.'"CH"
M<B2$T/4)_?CKA-'Y12NZUH,N5ML4A9OL8[Y@FC_9?',>]>%II19EKC?IGW/3
M/I8JE(21*;@=FYQ0J2 W!">S0&^<,Y02'+@0G$?9IL: 71N]G7Y78*NA6=1;
M';?GQ^"/G9K@PV+]H&KGB:-'S^=+8$>QKS2U W/PJ\VJ,V4/@+\G3O<IV:BD
M/P"D^U^%(8;HV59L\_16L;IC2>M2IJE(TA0R14QTE\*0BB2!0F222L583*VJ
ML3B..S6ZWZWQEMR.W;LL$;?CWP%P')A;CT(X?!T!1Z!\-<6R''7<9E=N4!PT
ML7*\O1\QF399=;G-^7SYL^I8N2L^M<G7Y 1'1"8I3!)J0O)9 EE ,.2(QU01
M&6>A52R3RZ!3HZ3O']Z![^)>R?5<&RHA@D%Z!;:*@)TF369]K4O/@I=6LV+'
M7+ZQ'IBVAH+9F<A<<//$8E9#CDIA+B#L\Y?3O>XI^^^6BW(YSV4U1-6FKUD6
M)&9(12*!H>FZC5D@(,U2"54L6*8X2B-L94)U#3(U<GHA9]T0LT?"_DE(NYG&
M%U##!ZJX8^24KG\.A NR]4\^>K1D_7/*M7/USU[;LV;2FI?J7VMM"'WXH?]H
M\K@X#WFBA(!9*"C$RJ3&)*&"F(<AYRE-*7:KE71LE*DM^)V0H)+2L6[/42#M
M[(F+X1G:@-A#9H#4_4X(?%7J.3K&N!5ZNM0\J,S3>7'/]6ZB7;\I_3P3RK%Y
M3;&*$IKJ[WN2H=!\WU/(!(Z@"N(T(Y@FD73JE7MTE*FM]T8^L"TQ[KC@CR)I
MN> OQ6?@!7\ S1 KO@L#7RO^Z!CCKO@N-0]6?.?%[H4[WC=I%746UX>%?,]6
M:J8"&M(X8I (K+_N(<E@*H6$-$)"Q#(EC%B=D9T<86HK?2/D)OU1BPF,G/8E
M/(X#V;W8O< S\$)W1L:IF$>G]KWJ>1Q_XF@E/3H5:E?UZ+ZPWZ?[;]K:_[PL
MRYN%H8F;[%,KJ2L4(6,LPS!240PQ(1%,L4 P%B+#,1,)9DX?\(ZQIK:XWQA9
M__JKD1;H3>@F!T_5K;ORA99!BZ[_ A;L1_YWQ>:K>[<O?1?P=M][3W .3 9&
M2O#&R/E7@^3W!LE/%EF*SE]_"T0\V0!=(XUJ"5BHO&\/V-SBGH;]MT(_\K9@
M4GU30N4_3(9+^1O[[V7Q;EVNE@_*9'V;+!AVIV8)%1F+,&J,A903S2RAII>,
ML215BC%BW9C:9>"IT4PC6=W98IG5_ZT4 I5&]0]:>MEG]#K-1S?A#(GRT.RS
MPQ*T!#>!TEITL)$=[(0?"&'[!.FAD!XI&]HCXD[9SGU@ZTAM=GK<:'G,?91L
M)RWWNK]'Q3A6R'S!YK5==+WZNW[R]^5\7>6(-#X-0>(T0\J<_E"D/P$H@!RQ
M$*I,RCAC :;"OGK<^?&FQOP;D4$M,[A> 2,UV(K=IX":!>SGF=XSF$,?%KT2
MC@Y%Z?SB.5:!NLMQ=2M<9X]25Q$[BZ>,5]#.7J47Q>T<;NOIKF_"-FZR:Z%?
MIO7<U'NKVOR8Z/Q"W9MPRA_J4Y7#8G8*5;KZ+A(O19S36 8P34T".<DRR",>
M0X:#-$YC27E&G1S[E\DS-6K?J&.VN>_N36ODTC@*M#[@+9M7S>#U;UJJ-BV6
M7B@+*M<#?P;;A(DJCD8_YW:Y8G/'4X4+)]SR_&&\:1SZ:+(U@^?FJ59GX^&H
M*VJ 02(V/>'KZQ3D0FG&/2_Q ]W!R8JGQ_:C\>NR5*MRA@5AVH8.(8T1@9B+
M$#)$$YBPC&2:CTU!C]G*D(8=&]>/=2+5[<.'6Y(5ZP%6R>9&?AN8))4B(0G$
MR)Q&9T)"GHH,1B0282HB*:537[\>,(WP[;D8)CNJ=U=^8,:^[M;8F6M?*NB)
M,IN'CLI\+Q79)["]W_;CH0^L6)CB#E]5\?V>%6J;E$PE4X0J!%4:91"'G$&*
M:0PCQH34:RX.D%/C\U,#36T1;N0T/BY026J3G>R&K=TZ]8'8P"NW'UC."_H<
M$IZ6^,EA1EWTYY3=IX&SU[N[ "LK2%M%Q5K)5G+WU^4\%\_UG[O]A8IX*+,D
MA%%DRA9FG.IO,Q:0*D)4DF8<*>O6YBX#3XTXZOU%(WR[NL$5J"4'?S3_M=E@
M7#8GYQV%0R$],.%,"61[+^)08(_D3O0+NI-GL0]R'2Y&I\>-YFOLHV3;Z=CK
M_G[FHO[(9,OBP?C!JH_-QJ.>,:0"F0HH18;T1T!OU:AI)Q3$J>2A0B%VRZ@^
M,<[4.+\E9F/^_+[(73=OIS"ULQ(](#4P9Q^ Y//XP1(&3Q;BJ5%&-1#/J+IO
M'YZ[O!\1?&JBZ+ZQE?K^DSTV[RQ)HC2(6 89#XRC1O^1IGH3F5 12D4B*F+B
MUOK[^$ NK_<X/;\W<@(C*#"2NK' "4 %"B0.9 @SA$RP51Q#'F8!C"2*0Y0*
M$HK(A5@OAW,,7AT(3#M&O1RB@0GU$)T!"+4;!4]\>F*04>FT6]%]-CUS]:5G
MNM^4J4(A3)G(Q5V5R%T=2[Q;EJNRZ1(@<$!H8DPKJ;?;1(608BEAK"**"(Y2
M&KDE8MJ//366:)_TO1"^J5I0G_M5\O?K*> R+Z['K%[1'O%(]5*@+S@YM8;,
M^RGI^9%?Z434&I+3IY_VCQBVU8&I??LQ_Z$9#O&(*\IA$!#C4(P5I(0&D*LT
MI"G'F(=.!1M=!9@:S>GWD@S3VF +N1UY#0GDP S6JY6!T6'\7@;[Z(W<PV [
M_"1[%^R#T[=GP<%S^NZ"-\$AICWBN^5"#[K6XS8"+!?E6]-0J@DBN65/JOSP
MM"K8LHH2+)ZKJAVF4**^4\.E1[K;&)@S1=-0)HA!2<VY"H]32+E$,$UPQAG#
M&1/()31D0%FG%F^R.1+[]<V\"NSBE6*MNMZVN3ACS+/MIG02LS?XSK8=CU?U
MXMNI"G:Z;F:TN;Y2MRYFNU,/;/3SN2<>?!*\;:R'DW3DW?G@D!]N\8<?LJ>?
M0-V9#UA3+PRI3"D:(1BJP$3&)1RF+&50B)3'(54RH&Z1W.VG3\T(;H3K6^KQ
M)7*6>_6^> R]&[>&PGVO?4QE7[OI%\\>=[]\3*V#'?'1BRYUZ/UMN90_\_F\
M=A*1)!,H1"ED5 B(:4"AWM!F,&0\S91 ,</([7CDQ$C3.Q_9B'>I)^XEH"D/
M>1K2#.) :D %99#C*-8<& 9,!(0$:4]O:&\XQ_9\#@.LJSNS-UPCNBZMD;K
M1WD4!^_^R)>CO)+O\:BJI_V,QR_W$[6\"\J*.2-)2DT@"@LUPR8)9"S2YI'@
M#(4R",+ D6%/CC4]CCT2CGN]6A4Y7Z^JS*;5$NREAEZ9+=3IEN6.X-N1AA=
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M\W[YP/+%3%']+0_TEYX2Q2".N8)I0!4,$A:P4/^2)4XG3!UC38T47H@*C*S
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M-&/^\O[AD<[7YC%]_;T\OIP)BF+*( 9%JO27!<D,D$Q;E:(@A.4JS@7"^Z3
MK_9VI:L<5F_:TW3!KV-L'Q[DK$*,7]QKO5[^L=":F2("8A\1MU(1+16\B9:N
M&XG.2V9GN@ZR N-\:8SHT0LC_$N#LI'?(%PGHY2AWN:OT5&'J%8BG/'K"U\@
MT]AY^E$-9U]P3LUJ[W&FUASE4"2XZO$VRV*5Q'D, 98H!3!).&!Y#D&A,AR+
MA.02YK/'LMZ[=BW66TMG?2SY7;C@5(OA:.%8J9MN(R;OY\ME&2RHHDH&_T3N
M\1Z,@F2<Y(D$B&3Z<\L%!3B1"4 R*2CD,DL)JA^,MTO++/P)/Q9['49Z**3^
M-/Q3/0Z6NU!37. QO,U16MD<,-AWB?UGZ%'3LG"3[T%S*O?_(SUF6I9CO!XR
M;0*X[T[>9G'\C_EBH4>][+W6)V8\+_(T3Q(@$D0 U'XBP$H0@&.28$6E0"*Q
MW9*TG'-J^Y#_4XL=/51R5U^::'W<F'FL-V;<SRIMEZ!_PW$ 8 ?F_>?&U'X[
M<0!L1]I#M,(XS+ZA(T@=FX6V(XVV0^BH6G-;T/56S\KE[>4>_EQKKWN6$E,[
MAFK.Y@4R11@*@&G. 2HT?],4)8S$+H?)?1-.C;]+H;PKR?3":V?<AP1M8&Y^
MUUDEYB8JY0U8S=P2F5 US?NF&[>RN:7R9_7-;>_SW$*3FK66]W_*I5S319F+
M^Z!GW)1Y43_V484SF4&1$$X!P:DI=8XQH#*+@42$2$P5(C)U"E.QFG9J_/*F
MT7[F)MI4.MQ$]Y46Y48V?:+'OD"Q:_,_NT6QW&P(#O70.P5[7/]LX/I4Z*B6
M.J!G[X12*+?<;M)Q?6HG(,X<8K>[W;U9<[KPNLS^UV\=_UUYQW?J[6)>$F,9
MUZ,-(4D8RP0$L<JU(<0P!32A,> 82HZ4P"BV,H2L9YP:4QFAHX;4^ZTPLYNZ
MESRJ1+=WN>RP[W=B@R,Z,"$](YCVWFMP4$?R74. Z^3!.@'5X;_:C3.:]^JD
M5M-W=;LQ1"^=SZ8A]IWZ:U/9L;-"$9SPC("$Q I %&< 9YD$2$F5"9REF1+^
M?71.9IL:4Y_U?BGE!2L%M,25)W9- YU3K.ULQF (#LS,UX!W9=><%E &Z9AS
M.M<S=LMI4;N[4T[;37YD<LOUAVE7ME\O3TW,T<M:?M>&I;8PJV2X>N^7Y!RE
M7&: Y2(!D,0YP"I+RYKM*$4D2U*GBAK6,T^-9!J"UT>F3T2//G3M\URY"':,
M,PBT [//[=WK]]'MMMH2*#O);U?1)[HN,SB"%RQU1B@0%=G/.RHM.<-Q2E'N
M [A[J^7 _W>WGF_$G)?GNOOLV41!I10'/"$I@*E$@!:T %+*+,$I1HG M@YJ
MVR13(Z&*>)X(ZG'NUPIIO]\9 JBA#9IA,;)W)T-@-9('Z869D\O8!T:'E]AZ
MZVB.89_P35^P]UHW"A1R/KO=B;E&]MU\_?!>S C)1$8ETQ:9J5K$E028%@SP
M(E,RC1%BF56ZZ]G(4R.[6KC(2!>]?V/W[I[CU4UJ5Z$PM'%D"8#UB]BJ[ 4[
M9R/YW^Y7/_[0]U0FCO[+T;(Y'VF4E[%5@?T;V'Z!=[R J;+[M%GIZZI3Z2$!
M]DY5E\WIXM-J4Y;A??MK:ZP@;=!^F&^V,T6%DDBD@$'C1:$B!C3+%$ 9T7]G
M5$JWSE=AQ)K:"U]K=:&#;ZW:373,[UZIZ*!>M-<O^G;4,'J[U)_.JC:E8VY\
MH%6W<]O&7\N!:>LYEM$GD"(@ZN'"+4((-7901D @+X1NA!S=LX&DONU.?98F
MTIAOM6FWO-_7(%!QEL8B YBK,J;#U')**!!<T@3!0I#$*::C=::I4;41U+R[
M3T1U3&[OA]>.0(. -C G>N+EWL>P#XM070Q;YQFWAV&?NF<=#'MO<'?/WM0^
M^M<U75;L\UD^KM;;69HEO$@(!RG%"$!50$!2T]!+,")BBI2 5L4FNR:9&C'L
MY8R.@D:5I/;^6RN@_:Y<")@&I@(/A)P<O#X(O'R]UD%'<_OZU&IZ@+W7>CJ#
MJ[6<WR]?KW;+[?IWO1\8,PB3A&6 Q+%V[5C! 45)!@J<%91GG*78:ANZ:Y*I
MO>2UC(Y.U27T+%VD*S$9VN&IQ(N^TE_1[6[[?;4V.9;ACZ^Z8 CE@5R:8EQ_
MHD/),^^@ZUKW#_D'O0*+3]]72WDL6< %RPN0")YI\UZ9GG<$ 2I2J!"G*4%6
M4367!I_:.UW*%Y4"]N7\]@/7_Z&^!HZ!7V<'))P^S&TJ>WV0SP8;[4/<ID;S
M ]QZS96Q;]69L@FUF%&<LC3.8Y!@ 0&$G *6I@602BBI4,I%JM_-U98N[+Z[
M%^9P>D4/,PUX2G<(U9)T;>I\;/YX8<HN.99RN(0FIE!2) 1(.:8 QBH')*,8
M)#(5&2HX(;'31L:U:(ZQA6%6+%H-AZF=;7,E4@-SX?&1VQ>V_] )CG]$X+GZ
MH>, &S,\3_3?N8JM,7\7+O4H6Y#;Y7<7"F(BTQ@0++290X6V<&)<@#A)"2:Y
M0CFR3O6PG'-J9/ _\X%2["V7H)LK!@)V8.YX;DP=RA:$QW:LL@4V& <J6^ &
M4E?9 LN1QBM;X*;:D[(%CK?Z5NF;/S[JS\+M4OR=+H6^\KY^R%5:,$25!(I+
M 6!1<(#3(@8Q5WFA"I9EQ&G[J76FJ3'V7M RM74OJB.;],-K9\,% 6U@-O;$
MRZ.^5P\6P>IQM<TS<OVL'G7/ZUWUW>!'$1_ESUO.S4Z8'E%SSU+_E9?'XYM/
MJ\6<_Z[^_"I_;5]I!?YSEF20",,7&64,0,D%8#D5@"+]@P03I?UK%^9P%6!J
MA/)9FEZVC6B4HS8F7F4IZ%HX9G@XKXD=W0R)], LI$5OXOI4^)NH$CSZ5O_7
M:!"5*@0D*%_T O&6\_2CTIDO.*<LYSV.'_G]FS3I<5+<_M#^\WV]Z?AFOMCI
MGY5FV>9NM]V8E]@PK_B/W69;UA%DIJH"W\YRBE.L8@)2$G, L>9"@C($LE0_
MQ@7/L<JL.L$&DF=JU/A6*<G+6#UA=##I;AO)=^OY=BXW_^+&B=<NE1U%CK@
M S/F7I.H5J61VU\I$C4TN8EJ'6^BHU+1M[U: 5DT$,"!2/5::4;EV$#0G5)N
MJ&'=]QG_7*W$3^T#'VO3U_%[69RD+&$I,*UU >0P!X3&YFB!JT1AC&-HO;'8
M-LG4N'(O9[,3@WO3GU9(^S<*0P U,*<-C)']QE\(K$;:Z;N 69A]O3X,.C;R
M6F\=;>>N3_CF5EWOM7ZVYQNIY'HMQ5?ZJZHIJ/^R_UE=K.NSW,CU#UDV\>!\
MO:.+3?E?*?8Q[7-3J$AFL<I(:KH?F,0^Q !&<0%0C/3$B9(H<ZKA$DJPJ3%L
M+6&T.(KH9H(&6S$[6_0YUF%@ M^+7X6\U:5.S=\/OZ@5NXGVJE4E"&OE;J+]
M(GZP6$1GXS0TXH&LU&!BC6JNA@;SU&X-/OX5C87U!&7H4C-_>U\(IU"J2(7F
M9&%J^\.$ YQC!7("BXS+))&)>Y?A]OFF1KJEN.4[7 KLT6NX UO+4Y9PB U]
MUO(4K">%%88X<K$#)F2'XH[9QF]7W*_ZQ=[%%K<%W(V\4V=.>.V<OYEO^&*U
MV:VK+LJ'G:XXH2E2V@",61Z;L!REO6<N 292FH1QHC*K;B)AQ9H:,>VU K3>
M'UL>]L?XZN%A'Q:QB59'#4-L6;JOYQ4[EX.NTI0V,+6Y:-Y\_4FO.EN-MG7I
MC?"0.YCN0CW_1J8WD%;[F?ZCNV]KZD=Q03>;N9KS\F%<*5&;I2;[?+ZDG.NA
M3'KZS_GV^^V7UQBFLR+.)3;U$F.]Q !*F !<B!@4.9=%422,%59FHJ\ 4Z/G
M4QW*0Z2]DUB6^9LOHZ,BD=$DTJI$6A?[K4"OI>K?2AUZ 09FW@EC;[]%._0:
MC+1].\A:..WS7@-DQQZPU["C[0]?HW1S[_BJ<3QK]!Z.Z#9?5WNS2'Z4VV-N
MP-?5:[KY_FF]^C$74KSZ_=?&=+@Y)!'<:I?F1[DW<K!!41%+P:$$4,7Z#T@(
MH'$*M7>1I9(B3I*".Y7S'4#(J7W"&CJ:ZK3KO9:FK?UIUI"YP/R8:Y5-^'6I
ML^G)>LPSH@>%'=V001X(.Z?DN9=YX _ER0H?%(RTAD\3G\ROC9[1I\;:OC"Z
M:OY^&1W3I8[Z#N+##+D@H8H>#R'BN/61!P3YK)3RD'/Y?8#VYZ6WR[.V:4=G
MZQB[JC\MO,@*!7+!"P#CF *<Y1G(!,0%DS+F"7'YM+A-/[6/QN&XWNP"5^5U
MS[H#NM&_XW+8$?MP((\50F+P/4,V.@H??1LDBM@/N$#4ZCCYJ*3I!\PI'7J.
M<GV1UY,^&P[5/KG@<9KD!.!<LQXL"@FH,)E8(E:9%)F$U+5S[/5238T63VJ#
MGO>:>8X2K_YK;D>RHZ_DP-S['(MX58'7JT$?H+ZKOTS/5M[U:AB[JKM>/[@?
M^6M[6EO0V]^?]".^U9^;M_^UFS^:B4]SLPI5B#0C&4")-FVA1!G *-%_2[(,
MISR6F#,7?K>=>&H4OI>[M+P.0KNQKS7H=@0[!)0#<^A>Y)NH%/HIF.,DPKFB
M%H@$K:<=E>=<P3BE,N?[_=CJ@]3D*)^VACO4Q?Y$?Y<;"&]V\M\E7;_3#^LL
M2:E$:5$ C+EAK30'!',,($MS7&14.^Q._=M<!9@:>^G'L7#C*F?([3AK2" '
MYJY*])O&;N=YJ?_M*F(R^D3GXB8R*D1&AW#<Y8M>( YSGGY4+O,%YY33O,?Q
MX[9JI_-@^!W/K%))8JA2$&<BUL0E%2 "$I#GA!<$D:+(K<IH]\PS-::JSQV.
MGI3%.8(3KG8\%0"M@>G(!RAGPNF!(1"OM,TR*GWTJ'K*$GV7^U8\HFOY2A..
M,$TEM;M7[@_<KM=ZY<MY7OT^7E)ST>U/NA9WCV73M3_UA=O-^^4GN9ZOQ)]K
M4Y!1PH)S20A0,68 "H@ 0Q@!*01GN(AAFKN%\(>7<6HD5(HH1?1BOH^C=2R,
M.<0ZVA'7,Z_.P*17B@Y*V:.F?E%#07,VW;RN5C(JM33F6ZGG351I:@*0*EW-
M3[JZ&7O4A!IL*8)5DPHOX<AUJ :#^+R"U7!3>7XL^'<I=@MYI]XNM]HV_;>Y
MD)_E#[G<R5>__T'_8[5^O=ML]5=JO7GUNVH%H>W9+_*^.F\W?:=GK,A9SB@"
M5!4I@$5>  )5#)A$18X2SBESBHP*(-/4/@9[E:I&1J4JAF)*9:*#-C?F9P>%
MHKU&T;=2)]?*? %6UO)S,>YZ#?UY&'2IW#\ X< -1?@!)!J7X,-!>$;H 8>^
MKH;".ZGOH8O*I?A*?]7YOZ_D4JKY=B;3+,X9I$!F65ZU?,<9YX 0GL)8P2PM
ME$^%A.YIIT;#M;1^-0]Z$$Y9G@I%A?[V%5"[2*9E;89RD&C7B# I11ZSV5+>
M:V=/?'T6H$D%])D,_YQXYP02BE(.6 $Y@"A/ 5:Q-D)@FBDD(!&9G/V0:[9Z
MOF>Z.?UP*!\J1]2"[^-N356)6O;H12V]HP]JN19V=D)X? <V!<( ZUV#PPZG
MP!4V>B9]EOH9=D"T5<>PO-N_>^6[^<;T["E]LG?Z9YN9$JF*8ZP 1I@ F.<"
M,)1QD,HTS[.<%DI8;9=USC*UC^NA.V,E:;TC$I6RNG>P/ >UFV2"034TI_B@
MY-7%LA6%J]I8GH\Z>A_+5L4N-;)LO]C/WGY;9RWI$?=;-7-^.!@2,,;$9(4)
MBC& "N: IL34"%<R(7&>,.BT3]XYV]0(X.U)0M>C7#\I)!'1[78]9[NM<7NJ
M=*"UF"_U2_!W21?;[S?F^_HW-P.E>SGL[))@( ],'7LY#6=4N],W42GK(,=V
M5J@$,CZZYQK5YK!2^]34L+O)U\%?SW]04SGZPWQ956B8%2I5VHS0IH5 2I-+
M'&M+0WM!<9$RFN4XCXECO<.S.:9&+D<1HV]&R*B4TG%/]!*6MK[+50@-[JBX
M@>/ADK2J'\S_.)]A9&>C5<5SSZ+]TJ!UK]IJ4,\2*8HL03E0@L0 9E@"(C((
M,*18QD4F4WA]U?WV^2='#I6<_F?MKOCC&"+,4@5H(KDFX"S7T,<28)IH(A:(
M285<6J@.B?\([57/*HD]J1_VO_X'3I/D_XBQ%\F.V0>$?F#6]^MO,'@UL#[D
MABW[U3K[%.I[]4%C6<BK=QC/"'GMM;U>E7UGY)+__DBWN[6L"\/GE"(BD#8Q
M8VK.CT@&*!8)R'&B$"]2 JE;,'S[7%/[N!A1HX:L-U$EK6/=?1N4[1@K$'8#
MLY,_;.XA[?V A(I>[YAIW$#U?I7/8M(M;KG61:WRS!NEI6^W[^A\_:]TL3,5
M.6:YB)&F"@EH+K3C*O3?2))G0.G_P9SR-+;KE^P\\]1(Y=UJ;>*ZM*&T+#<)
MG.OPVR+NZMX&Q'$\I[<N7?&B(?;+FXAN(R-Z5,I^8RH2#>$06P(6W$WNF_>9
MG&=+.-I=:ML!_*CJ:9'<.W5(T?FT7JGYUG#D.ZW=(4)GI1ESLUK,11DR40;%
M*:)B_3\(%#79S%AB0(N" FT.<2J4$C#/7#CL>I&F1FXGE8BU/W+,=ZN4VM<$
M,T_2,7C.' DT=/.+>PRPPG:<.>ZZ#4RF8RV9,]&&0SD0 P<0:%1J#@?@*6<'
M'-F/S%_MY@M1-83>__7]@RD=6;5+K5MDL$Q)E,02J#A) 40, T9E"E*(,IYC
MB'/EU.?=:M:I4?)>TJKH5T-<-W*U0]R./X/C.#!%/H'P\(^FR ,T*'$"*1##
MV<TY*HDYP7#*4VXW^U'1ZW+#^\MVQ?_SS=Q4F5R*PVEP67N2SL5,IJ:KI]+N
M;B8+T]F3 X*D *G"BLD"J31SB@ZQF71J1%26@!5[:<]C1,SIP&XCRE^4/W$\
M)+!:"#N""@WOP/Q4B1N5\IK=_EKBFV:X2%6 5\L=CJ%<4 I$4%93CLI/+B"<
MTI/3O>Y1JN^Y6M_NQ%ROXNUV*S=5N?YW"WH_HQ(F.4(%P(AI/D(D 0QQ 7(H
MXS2+$Q3#PC9,M7V:J3'0^]?O/D>UJ%%#UL@(:Q^HVH%K-[V$0VM@0O$#RBE6
MM1\'KV#5CF%'BU;M5ZT9KFIQM7L;GD^:0A[TVNZV<TX7;^:;*OQ2#ZQ-V"^/
MTE0&W/ZNC?8,*YGE3 ":0:K)(*8FE0:"1'!MJ2092FEJVW['9>*IT<-3V:.F
M\*7E?Q"_W]J_;D&Z661(F ?FE<D@;-]*9RBD1VJA$Q!QI\8Y/K!U-,QQ&FZT
M1CD^2C8;Y'C=/W)I(%.3<?O[_5++5CZOF[(N_]?O='FQ,L5)W$KYRS=T*P\'
M.3-$)!900/VU41S A$E ,&8@-CV"98%C$8]34"BT9E/[G#7+$%WC5T\&X*%K
M&#WG S'PAS= Y:,*G:@!3]VB8ZL!ZJJ+=!:L6%X2&:@:I_03*)PTU/H_=[FE
MX'K]<Q1I&FHY@Y5V&DQ SZ+N=7'2=ZOUI_6*2RG*0[R_2W$OZW+RS89),QI+
MGF5I N(LY:;$: Y8@0H@:,JS(E,42^Q1]L)1#"N2';_^Q5[TZM!\KC_$>O1M
MM#:DM_E)'R/]@P>M3;G.CG7@'=?)[JLY!.PC.96UY)%:K:,73X!_&97RWT0'
M#1H]Y@(6A??#+E1M>,?9QRT1[P?-6:5XSV'<=\[^88)C-2T;9JUCLSDB)",L
M!1*:PSM>($ 3J !C6<(+@6F"K*K<71Y^:F[#7L+*0'.+=&\!L'\_ZSI8!B:8
M 1"QWW^Z#IF1=IF>(!1F ZE=[XYMH@LWC;89U"YP<\NGXZIKRW@>[, JCO9V
M*1JAM/^0U'1_$W?+SY+OUFM-ER95O2I$=VP=DQ09I3C)028)!#!GFNJ84"#F
M*40R$5F.G/I1!I5N:DS9##&OX]#-EFI#KVBO6*1=[8-J9>D&1Z,O[#);;J0\
MU^(-O1G2J/-YW1K60:_#M!H:!/[@E4!#R/9,-4$#PMI>'33D)'Y?B$-P[CX<
MMSX#PZGVT5.*02JP]M\+I0!110R0@JGBL>(R=RH,VC+/U%C[&-V^E].-B=O@
MM./4 " -S([G^ P0W-H#0R"6:IME5+[I4?64.?HN]VW86)=$+(/-JO3QV]WV
M^VH]_V]IPE.AP!E) 2.9 )#1 A"A,!!()9"2@D'HE./=/=W4&.$@;5V<XB:B
M!UE=6S1VPFRY$Q<,O*$WW@ZXU9&G=>V)VW[T//HNVH 2K-MBYV0C]UBT4?R\
MLZ+57;Y)WWQMVIJ]7_ZU7$N^NE^:0;_27W5AU<W[S6?]^]526S&_/ZTV9=?9
M62R5$))#D*BBT!P#$T AA:!0>98HS+0G[Y@ [B'%U*CG[68[?RC3Y\K3(N.1
MB%HO<X2Z:V@6;>FOB-6Z13_GV^_Z@NUW&2V-\Y&DT<-JN?WNG$WNLY1V/#;X
M @U,;V\:"]'4H"P"O=<ATD[@48MHKT;(=/,K4 R6>NXCP\AIZ%? =)Z2?LU@
M?J3Z46ZK.M4F>?*V42[UZ^JCAL 4BU@M%B:!J3Y+G.4QSS"+8Y/=:"K!00AP
M;!*+<)+$(BG2K( >YZ_.@DST!-8TXOP74_HADOOJJ:=5:)=/]#F<TCIRJ/O*
M<9BGBNBEXKE,M.<-!:!Y+K4C3C,HB$P+F+M\"H=9LA$_@V:5Z@K[=:[Y[<E2
M/=4CVBLR]$JA%!/!% .$4>,8201(RA)0$)PC$2LAV:&UQW1>KQ%6R_6=&GJA
M[$R205^4@<V1\.^(LRWB#5\@.\1]_E%M$&]X3NT/_X'\4YCGVW*WZ78ICI7"
MYG+S9K[ABY79I#Z>'L6<$":4 C'EL2EUGP&2H0PD/!>)4BG.$JOD0;_II_;M
M:DA_<ZQZMWURA%0=*6WG]^4YO'M:L\/BV!'A<) /S((-P4M4GX@>'66/O@UR
M)N>'6\#D9X?)1T^#=@?F4D*TQRA^K/?G:B5^SA>+]P^/=+Z6XI;SW<-N80RH
MZD=&#L/ ,XP$47F.019KFH,)3@"!) >9()SJ52*.=62L9YX:US4$C>YK):+Y
M0>1HT=4!^<I%L".V0: =F-/V,M]$>ZEOHB;21\&C#T%;3#N#%8C([.<=E<.<
MX3BE+_<!KBXY4VWMO]]L=E+,4$Z4%$D!$B$A@ @K[;<F##"5)%3$N4RX4SOF
MEGFFQDJOFR7G;Z)Y*:1W[9@GB"88,YK$*8@UM@!J  '+<@4$%I0KA=,XD;/'
M,CWCRY:NMZ/A>CKG<.B^HOJ?W+1PBIB\GR^-VV_.*2H)_&OZMT$N4 JIR"'0
MS@0R6RX9P PBH!!/)85%G,1Q#?G;I>6F2S# ]S.. K?4]NV 0-M["E="-X)+
M<*Q^]*5F@??=+'!-L:-+.(2O;_1DEN<J:71)U8XJ1A<O]_W&:5E-A6SC,7^>
M;_[SPZ%O$Z6\$ AK2YPQIC]S5 "&4P%DD>49Y[&VQJG;9ZYMJNE]Z1J21D;4
M*UIB=2!L2PTA<!N<'?P@\R"(/C2"<43K1"/31)_"YTS1>X=[PM:M!BCY\/7]
MISH.DTI)"\2)\=.U$<P0-HTXJ3;>\@3&*8(BLXIENS#VU.C 2!<9\3S*Y9S"
MUOW*7PG&P.]X2!SL,[.NP&.DM*P#+F%2LEH4[LC'.KUCM&2L%E&;F5AMEWB:
M*W3S_=UB]=-DI&H':5^ FB**%$F!2#(.(!0YH(0K(!'3,-%<JC1QLE0NS3(U
M5BHKC1HIHUI,1[/D(I*6%LFU^ QMC)Q",T!H?2<&H4R0BW.,:WUTJ7EF>'1>
M[/?&5VGG\H,)%-N?]?U^O5NO-:_/A'ZU!47:_I"IU"X*)(!@F((L9C1G,D<B
M<8KPZ9IL:N]_+6M4"GMS. ?]?1/5 KOQ02?.=K00"KV!V<$?.&>2L$$D$%=T
M3C4J9=@H?<H<5O=X$HAC9J"^X./*Q*,V$@6/+GO,*=2N3P(2FIG>1%D*6"(E
MR"@LE% \+7*GQN!!I9L<1?EF_9JKFFKNTX"]-V'"/@26=/A<2SLT?S['JKI3
M[Q#HA^+JH+*-2^Y#P'KV-1AD$M_/!Z\^1HO5YN@GD8)D+#%'P @S $5JBK*E
MVOHDL: 9RB5)G/;&+\XR/3JOA(S>_IIOR[>YJDSY>N4<S'\955M>O1*KP?FQ
MAJD6< #GLQ."8"1U:8Z1R:9#S7/2Z+K8.UNH;!"R7IFV(>+5[[\V4KQ?OE_^
MD)OMT_)_7!&9904'.3&M/N),,T)""I"RG&("65Y -=NNMG1AQPCV4SO1Q$&
MX9Y_$T'/S0[,8RU[Q'[_\6)G:MW.ER_U_VL-(MI?(_#:5;%CE&&P'IAF#,Q5
MMZ$CS-&+O_8P'X0?I!2C.V+A<A-L)QX[*<$1D O9"*XCN)_BE0[VOLKC2;4J
M3O(LSS("\K2 AL$(8"+6-@UE!2<R20N[?(.>>:9FU92B;J(ON\?'15E'F"ZB
MXP;R^Z5:K1\<\@GZ4.X_  R$W<#T4TH9'8K".E3H<H++_IPP$&PCG1F>XU76
MU;V(:J!>(18 =9PQ=MT]VGFCA0K-LT>;RWUK<U1U/ZK\L:_TES1>:ND.53ZK
M22"K-\^3+%9881,N7&0 DJP\G=3_Y%S$.44JQ4[AP@YS3XUK]Z+O,RQ+X1N>
M9"7_3734P+7.AOVRV)F& X$],#D'Q-FCDH8S8L'J9]C//'+5#&=(SFMEN _A
M1VUELNN2+C[+'W*YDU_D^L><R_>?O]2;-$F&N!2" :%B!&#&R[14S6D\AS2E
MA/(B<Z&SGOFF1F'OI(:2+MQXJ0]3.RX*B-3 _+.7-*I%C6I9HQ=:VI<#;(A9
M0A.(:/IF&Y5<+%4_)13;V]Q]S.99[CY *X8$FO8E)E++Q)-+0,T.&4:,2I@B
MCC.KS,[+PT^.(IH!!I9[6RW ]7N+U\$Q]%9X$PF/J-$+B-@[A-<A,Y(?^ 2A
M,'Y>N]X=[MV%FT;SZMH%;CIS'5?Y&3HF0_28^_[[H_SY>D'G#YMW\X44'W=5
MSUY$TR(C$A1$%0#"3 "*T@(P*(LDSV4>,Z>4=(LYI\9FE50F0VY!?VYVIAB?
M,M*Z64 V8-M908$A''J;3$O;J)[Q6_M<\F=421R5(NN?E$*',X8<$ ID$-G,
M.*I1Y #!J6'D<JNOAV6V],W'Y=-J,>>_C[N=VD@JI$87P+1( )10 E*D0@,N
M&2\PHY@ZT4WK3%,CF:.@CF>![5C:^E0!$!K<F]K+>!-54D;?ZO\.4GVG%Y-@
M;E3;/",[4#WJGKM.?3=XUYMX7,OO<KF9_Y#51L]'N;U37^FO6:RRF'&6@IPG
M"D"1)( 1G $37""%I%"9363[\(*.N:863_#5S!'QIL#1O-K7/*V*^)JNQ=SL
M._Q=TL7V^XW9__R;<QI_ZR+844H@: <FE2=2/JUX>%.6<]4&GY;XYJS\X2<:
M=K_8 JYP6?^M,XV=^=^G\H7L_]Y;W%AGL][.CL7R7FNOZO;7?#-CF*$TEQ @
M;6X 2 H*,,DHR$2B_Y[QC#*K*(#+PT_-[CA*:,[\VQUP&^2ZV>%Z/(;V5)Y"
M$7TS\@6P*KH5[WJU]9V-UUK_Z_A*MPPZREO<K=#^Q>VYZMHNA'7;FL_R<;7>
MEB5*#W$JKW[7OVR$]BA.I3!;K[F4 ,8* \(% 07F*B,D2:%PREKQE&-J;W^S
M0UTM:W30I!GZ<V-BZ_97^(:Z7+N(=M;'"$LS,!$-OBI7M CTPC1X,T W*9ZI
M[9\75.T-_OR&<Z-9(>>SM\OM,?7P,-N7+=WN-C-9P#A1F )-F89,16QZ^17Z
MGSA))<H28;<=W#?1U(BRDG6?']MX&RMQ[?BO%]UN@@N)V< ,Y@N7-3'98G&!
M>3:2_^U^]>,//41%.OHO1Z[I'7@4,K%5;\\6UM=[=O6K(PC?K=:?Y6:[WG'3
M7'IY/V,J99(2!&0J"DT':0$H3B5064*3E!"J$')K6]$VE=7#/6IWBD.,JHDJ
M6Y51953\Q\YK$[<58#N3YRK01NKAMT?+!/D^$3)@[[X>&$)U[6N;9MQ^?3W*
MGG7JZ[O><\MV;4Z+2M+AO_=M(C[KU\^<(*TIW]91"TJ*K, 9!VG"A7; ( >L
MP P4))4)ET56)$Y=^2SGG9H=48H=[>4^M$Z)C.317G3'.!'7I;#<Q T/\- ;
MNF&P==^_=4,JU%ZNY:SC[NNZ07&VQ^MX>\""2GMZ?+.3'[43]?6G7/R0_R@[
M7<ZDD$6:9 5 K,@!E H#ADS\;TX*+ 1D!+F5/'$48&HDII_%+$!MI2[([3AJ
M2" ')JOV&DS;5<1,!M1<W$3_+NDZNEL&;//I"]F019JZIG_^PDT6X%@5<[(9
MQX_0M+-7CWVG/JZV<J.G,GN!,\45XT6> 4&9B::1 A#$,8A%@J VQA243D97
MVT13(ZBCG&8+M90TJD5UXZU69.WX*01> _.0#U3.I-.'0R!R:9UF5!+I4_:4
M+'JO]R.%MTI)DS O#PE3QI#Z+(T6FH_*?>/;;9W,4^X2Z37\_>3B68R*%,$4
M 495#"#G&< )EJ85'Y8PDQRZ59<,(-/4J*:L5K Q9\9T&]621YN]Z-%:B^Q&
M.2'6S8Z=1EZ-H;><]]HT4CXKU^^I1C?-A3IH=7K33?1)KGG0,)^ < ?BRQ 2
MC4JM 2$\9>&00WL2]L/C8O5;RB_RAYY#XU%OUW"J$&8Q!K#(S!Y[D0#*\A3@
MG!54_U\RG#J1\.5YID:L>S&!?G^K]G0>5=;:,+4DR.N1&IKT:@FC@X@#[&_U
MP!"*C%IF&9=@NE4](XV>R]U31\M0W[O'^6HNCK%3^\0_E&!.N  Y,5WW1)X
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M=<JRO%*>J3']09UH4ZIP$_V<;[^O=MOHD:ZC'T:;?W$U':];,%OK<K1E&-P
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MU=JU#V2.79A@5(NK7<%3HZKC2D]?<;.1V\V^E4PADR0U3F"<2P$@$1E@.".
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M>$TIX2_;%?_/CSMS,'NGRD28S2>Z-A$X4G-)637^V.GH>/;'4JRPH@QPFL0
MQC@&F*H8Q)AG&4H3&B.GFBC7"#,UFJB+\5:]R6^BG_/M]]5N&SW2=?3#J/(O
M/A6+/=?)CEW&0G]@(JJ!+_6XB2I-C)__I5X)K4T935BE'E==+YJ=VP:P@$(@
M&[3"LJ<HSU"+^3K0+E=MOG),3Z(UI:+U=&;NHQN=LQ2FB"*0Y;%FT(PH0&)9
M )D(+$RF69(Z;59>G&5RU%@6*#>OI!'SBLV)RYA:LMVU2 U-8QX@N1-3%PBA
M&.?B'.-229>:9QS1>;'?RU\.]GZSV4GQI@QD^237\Y6HN.=RXO$L5C&)$<D
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M8)XE@+ , R6%HI1G&<F=<O(NS#&U=_/C:GOH'5_U$=EWE'^_W&S7._?2/Y>
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M]/[Z(R79EMN63$J46L !@T[2(ZFJ'DH/B\5BU8SJQ@X#?:0:LCV5>M-ZLL.
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M$8X)C<+ #SVCW=(V 7,CD5K'\HQ/K:;UT>2+0'8SA0MX1J:&'LA8'4ON,G_
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MU5VOPC1"7==VF6]6T?4J#%VU7*_?;)\?\TGPC)%55?6^;HM F>_[G"4*W32
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MP/@HIBE/$ R86CYC%L8P07$ $RX(H32,(D&L=NHO29D;M1R5!,]:2\MM^HM
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M5R^E,4F%@"P.8N4X$ ^FC''HLS2-D#YSDX96W[ZQZ+F1PNN6K:#2N]?BP&(
M#-EB%%A'II&>B-K3B#4XKOC%7/"TQ&,-R!DCV3^A1[/=1KHEJ3LTW+!_[K*B
M;IA>%L?1!3>*^\TJ8R_5SV,,T,<\#IBGECFASR&.N,XRQPP2DF 1Q2B)F%'&
MI MEYD9G37L:+4P:)L%]]:'2*(N^M4.'K9ORIAZ,D4GP^CB DW$ E2G@M_I/
MZU/Q3H;(H@?QA$,U4?WEQF'WC=1A!7T66L?2GZLAD1N==U)U<RQTJX!=6?R>
M'\MSY=IJ_8_M!NCVCT<\?@;?'I6/5]];/ N6R8R1U>I%/VBUXP)L<[(N"#N\
M,-EZ*Q[RZ@4J;_MOP![U1KZ6#:3>*2A;2FIEV9Z<M_JO1::(N#Y<0E>UBUFU
MB'I]\J2A(LSK]_'L-$I5,D<7R<D%TRQ?U2=36I#7;_FF#LF</[4TX6='S9\=
MO7Q=7:*'BIBNG;0C,$[Z3KMZ9L_MB;+DU@VO2CG5:0="8BZ# $$>"@9QF"8P
M29B$<1S2 #$4>,@JX^.2D-G-YD<2^JJKXI"<%^ OSUQGL_7K)'D16L-MC(&
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M/JJ__>D/^]^H'Y04XD]_^#]02P,$%     @ &H(+5?$3\N29+ $ 20P. !0
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M'I^^4*A] >U4I%&E%+"I!E1<90A!UEM\9IBQ#H5LX65>7W,[,'2<T3R0C5V
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MPK$S3&=DOSMO.S9)QEA7:EZ,V_HBJ,8\UB3(7A)G0O$N'Y9CN+7@.,V#AD3
M7JSL P5OILOCMWEB?-2E& $IDR%3(C)PT9*;*Y,2W*?"S&%7VC>6&Z=9T) (
MV(.-O9KQ5XOY:C&;YNJY;EZ6;OS91?DM+.?3^=%J#[/^Y$<V:A&X"^$'FOW3
M%1R%<#*I?OXQ7BYWB:>D4#!%2H"A+N3>,P_.DJ/(+3=!6(N>/9:,*6$5-V(_
M7^?L5.%LO;KXR=7Q>H*4?97$Q<=^Q*\X/\75Q*2 *I-A*ZI&+#H+B$D6R+I>
MGY S7.)C;['VV=+%VN,X#2UE?*$S#N+JB";C@NY7B]7Z??E]L<BK%_/\"9=?
MIPE7GQ:S/(E%.L2$0+J.@4+2HS$F"T&C-!P+A3*/U;WL@X^'J1G'R1@2,8TX
MOS>&*/B-BT8H^GVY6*T^+!=ENIZ4((/TA'B;Z_,DZRW93*G FJ)Y*4$%\]@5
MYSZPN;;\.*[(D#C9E[?[*Y?%.LR:P.+]"=8V6O.CW[Z=X'R%JTN&U&*/$&.F
M\$K5/GS10]2&$)Y$TM(+J<QC,<H^('F0F'&:' X)F39\[\ Z?<+9K%:5XIPV
M-",U^2(?3^>;-G[U;<+Y]B;6!_+PN0+#&*NY.P$!2P3TH6BCA!/\L6AG'S1M
M1]FX?DXC&"P&ETD'2/N(M('3M#Y=TMY>?0G+(_+E GJM+1+EW)"ZQ4)?>2]I
M2\ZA2]IE]5@OYOT\Y+MTC.O[#(.B@_D]JM^S23T<U^=S_[610YCGQ?I+?3+U
MGZ?3LW;#2YS5P#61E[>:^**X4HF!U:G6(GB$* 0=!B&\C,KQY&XE9._/&V^_
MY+A^4%O,#,GM#E3/[V$Z?T<^WOOYIS##U?OR8K7"=0T*-E^\/3X)TV7U#2Z.
MB8_1,2<YH,0 *CD*,7-2H)%S&8)"'5L'9KO2.*Y/-8S*&E1.N^/0G^%PCD<5
M^9^;P_'CV9'ZO'A')^SHK!LNKM>SC9LZD2@C2N[!NZ) U3)<+\D]Q11*J(TI
MN&L>Y6U#V#B]JI\'>.TDT@_:+CEV%@?5;4XR1;=&!@_2< I]=#'@/>W$A,Q<
M1F_0M4Y,WD/&N$@:-"S<D]<]9!2JW?]C,5_<W,I%T%$DFF!=@L0X.9"L%' 8
M(N@<HLI6><8?>Y6U%W(>I6B<ENB#@JB=! [50DT0M6EU0,'(Q08XT6@C1XI6
M$QGMDFL,DBW(F-&9;+4<X*+G!@GC]$8?$C.'\+@3!WU5M24Y??/?OE704]SQ
MI;+G?7F-<3U1RB5,.0 ZPKJ2AK8FN87"*)*U& R3K1-03Q(U3A?U03/A3>70
MCP]T,[!X7][.O])AV=QV3T2@XZ$1P41'.\):QV IAG"B-@$5/.G\6,WWX;'>
M#7+&:<(^-*9:\+X#-77EU;TAUKU:S.F G-(9.7?[%O/52RR+)9[]WN?P#5=T
MB)9AL2F\6'Y_2VQ=D65/]"^)M-G&MI\I[HG@UCL3#+A2FXZB4)7%#K@R,@M+
M_,B/]>[<O_QAD.V,U"Y^6!/;A_ [B!$NMWCN;KS$.=;+T]H6.[M4'W<8 <H)
M <[9 ,8+V@[WQ/O6=XX/D#)2/_KA\7<8T[LH93B[:=_$QIXQ8741H#&2FXI(
M_)#H*#9F(A7:E1"/]:S=!S!7JX_4LGY(C.S)V@Y4RA^XOE*P+];KY32>KD.<
MX>?%0SHS&A%9'1&&Y$ H(AMBD098T%8;8X6WK2."G8D<J37^D! ;5E#]A PW
M]CE)1*K=]&4TF1Q5'P($8B&(4%QM%<T\?^R]Q\%@&ZG)_K,!:2<&=Z"N+BJD
M/^!RTSOE95A-TR5;@E$R..U ;KJR.1'(.&L)UJ4@C?%6\L=ZZ.Z#ED<)&JE3
M_Y#H:2> #N+*>S<S"2FC5:H^L! :E$F!'+N0B$<Q"HXEB4>?BS9#T;@E5@T%
MO0V$=N)ZA]!Y/9V=DAV<<(E<R\@AQCJ$6YD,/C/:1FT*F;03RCXVR+H%>,Y)
M&;>VZOG@LP_G.P#0/W!Z](7H?D$A7C@ZGX#TOMSI"':^O=?359HM5J=+W.0S
MKAYWNUB,4!F,*A1NU-;%3C,'D5LM-!?2^-9X:T/Y2!-,AK2-(XCT!P+RF9J7
M.0N#,H#00H"RC-1\K6#CRDHOG,*46M]C[T3@N$9W# 3M">+=Q=DO5L_9>;<;
M8]&92RD04G+UR9MB$+PUX*-F&"AN4H\.]FJ(UH=('-?*]XO7)B+]T1X^U][#
M2_R"\]7TZ_E]R,VM'/0&^KY/'_0Y])/;:?0R^G+->DE:5WDQS_>L?57QJ /Y
MIPG!ZCKKO+9-B-XSR-(D%9&E;%L_GMB1Q(97!89%)W)44.IC396JAD](_I'3
M*6KII=6M2Q9WO2H82KL-B8M';A!VX7@'-G53-G</6^I>_D#BW>?P[:R%%/U\
MB6&%K_'LOU<M+5A@VF\F=\4Z M*2T\U\@L1]B*(V.#2M@YC#J1[7\CXG-I]9
MPIUC^LUB22['_*SQ8OK^>1GFJSI0BN0^SYOO9F<HR/]Q>E9O<\&C2=2!6^$-
M%%XD":'.!*AY"FZ8%5$I95/K_/0P.QGY]><SXW&'X_!,X.C\B+P*JR]O9HL_
M_XKY""_JT%X46OPCIEE8K:9E>M:'JG*%]EYSOLX81P$ CT!;+> 5TR0=IU1D
M7LKFM8 MZ1_Y&6N_QV%0('1^""X/MJ=MD)D58()DH()""($5R$HR)Y-R10_R
M=.,)ND9^1]LO:/<27 =WX_=LYV(K]-WLM*8_/M2WQB3A;>I'8O .,P;@HC[L
M,R76?D\:;#!<)I>LP-:U%XVW,"[$G]-%'U/V'4!_]^(HLB]:.,.@U-E]2G@$
M[XL&.M-91I%R;-X";)@JML%JCYX3OL/*KP-'X9'S.1&;UB#>@V8V@V(Y@<M6
M C+&@M;)6]6^&]V#Y(S[.+@3G;F33)KIOP%O"5Z&69@G_/0%<7UH7]2;G]7\
M!N 14MOG^]\0'?,T#;,/B[-V*Y?(RDQ%S4,!%Y@"BD8H"+%"03',83&>V-,Z
M[[T-78<JHO/.'A>[]-IE%[V J&K;O>+K+CGM5VAT&&3VV/HAP$T*NLGPMT'"
M;1US +L[L%IGU)^/F+DJD>$QHXH2@C6D<[W@$)R4(*2,NCBE>6Y='WDO(>-"
MYQ#)W@N20]C< 59JJJ<::_K/;_]Y.OT:9O42]\7Z55@NOY/G]N]A=HH3(;W.
M0C/ P&0-J2FNP*2AEOW9*'(A1K7V=;8AK <L'02 V[Y-<VET +&/Y.C15B@L
MJ#F:<W:1"^BLQ%2 !3I^B@X<.*D,;8+.9 S)*M'Z\>.]A(R;!&X/H<.YW0%D
MZJ/W.?W*=]K")%ME!>H,?A,S%N4@LLA <N4\:H>^>4+K^OKC9J/: V1OWG:
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MR3N95BM;*Z#?Q]GYD(S+9 5QQ$B9 YTTQ<C8:T7\DI(LOLV,"1>1M[X$VXG
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M0W '^KJLP!T,BT,)KHO>'W=V1VPEOV/]_<,LS-<OYKD^2SNIOS*QEGO-!+G
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MRX<O87D<$IZNR>^9G=\M9LY#"IA!1E2@E"?2@T)(NFC!?4A9;C/WY;[/'AD
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M@#47P$]=/_!V3B$O(7DZ^MC+>RCIIW+@*38]0P<IIKD6@I2>CJ7VPV#@DQ%
M>J]@0F9#V>H&K(NR@:NC^+Z\>_OF_05[OT^,]!EM"H A<E#,D!-J4P;'8Q8%
MI6>E=4N4!XGIMGA@%RS<F0G<A/4=&-A+PNLNSEOM3K+VV=>^Y<GP4@,9)">!
MW-R4<LHFRBB;/]6YCXXNVM:V1L[!#.\)-/]83M<46?\YGY"]5U:09T'.A"?8
MUU;W.A6HI\&KA+K(UCF(NU1TT:!V,,#LQ^R1H\1+ZL^A_OFJ1WUQBN6D"UB1
M*!21Q(\03(%8&&?!<A?]-@4&#Z_015/95G!HR,P.-,B'TT@\^?MZ.INNB3.7
M&SN;H^I"<L(YR)NW0T9X\(X5,)I'[Y%SU?R=U6/TC./ M)3W;>>E%?,[!M+U
ME&^)O&@5(<1Z,UY[=WO!+629L$12G-FT;D3Y-%7C>L7M$+ EM/841V?&Z[=O
M"5>UA_?[N*)5UA?3SZ*)23KI" A*@M(L@D<9P07KB]6,!6WWL&0/+-<G=/:5
M\"/FK06[.T/0I0_W>?$'KC]BF$W_J^KS.OKD8GOHK666M+H('D&A4>!R4+6\
M75CK,QW ;7+D>RP];L#UC,AJ+8;.4/;YYM2";*1G(3 @KY.!BN0F.,DL%"-<
MX-S;;+=I2_?X*N-@9P OJ3%#._"1+G=S.6#I8J;21&:T418'DE=;S["VEB'-
MJIE)(1 QRK5.%#Y,36>.]I[R?BA\/XSY/_7UR8?EX@27Z^_T+W_[S]/IR::?
M\;CW*(^1U,^%RM:,&_YF1>22=% 9R&32&1&10T MR2DS26<F(\^MHZSGF,UQ
MP>$/LRJ):VP^,S#!&')$,8$6%"$I+ 4\#PF83DDKJ6/BK1\_;$M;M_<NNR#E
MX2D;#073@8E^<#?7JB$].2N9T1XD!D=62"<(2@:PD0Q09F@QM;Z5V8*L7L9J
MM,3#[:1&8^'TC+=KP9;VKKC,)1@K#84]WD HFQ84@1=O0A:A=:W[%F2-G/UH
M#85MH;:G7#J VLM3XF@=R3G/%U^^/3Y9+KYNII9<O(IT*4GK'8)A,9)14!*B
M81YL$<F3_^T8%XW!MA5AG<)M7S@LAI9-!X#[6R"NSG'Y_3K#SK>B+??,4>C&
MM?2@7/#@2@R@$\I8@K;)MRX9?(2<D?-M X.KE1Q&[6AUL9DWI\OY='VZQ,W4
M]6_UJXOC8>KIP-H[2=1&^-&3OJ\-YF2VB?Y":<Y:8^IA:L8M@1@:4HVD,"JB
M:N.!CV%^=.8L<,LM?;Z!K#'006!U0)<ELG7RW-I2AS9M YXG6G)<+MC+;*(!
MW/7]&3MRPY8-T1=OB&C?K$@-VCI2C.1+@L]"07%*R)K-MG:KIX';X&'L]AM[
M"NNVN/?@W-B-FZ;SZ?'I\27AT@51NSMZ6QOD.@FDR(@-HJCHLF92;!5G/=6S
MZ?JB(PM]'Y$M6O!O;,&';]<(]T$F49_$FQ1JU6?!:K(RA"R%T4XXLUV9[9/-
MNK[M*/A!)@DU$?S>_.L@+GG0Y%U=-'$KE3,6P49#3HST!&6?-=3K#>6RR@Y;
MMSUYFJI>Y@>-D>';3S0]@^WO*RRGLW?3@A-M,L^"?&11^:2B*A"<5:"LS3&+
MJ.E(/1?:KLCJ-..R)Q*V!=J>8NDB-GZ-M'::;F0TL2J(F)0%;1@C[M3&_SR1
MC@Y1&RYY0MXZ&KZ^?J<IE3;HV9O1'2BD=XOY$7W:\6N,ZW_@].C+&O,+0F$X
MPK=S^@M<K3^&-:$_<6Z3$N"DEJ *LQ"2D) M!N.MB-F%QOC9DK1NGR,=<J$Z
MA%@:*J6.JE5>+8Y/%O.:%E^4?@I6MJ5J])J5O=@W?-E*L9@"KT_8BT8@!:PA
M\(RDCGE )AP:T]I<=5"V@K4+A*BA5Z@#GVPMGI;HP IO./D?"5WKV[8?OFQE
M%Z3L7;:RBV!ZR%J>C0\KV940#$1.?HUB$L$9J8 LALPV>&'55G%$TQSV^"4G
M.\GRWASV+HSM 0WG>9E2"O<.<PV]R1_1V=-)B0F$X*EPD\G=W4JG_E@Y[)V$
M]4 .>Q?.=97*=)'<S-I'J.@Z^50H#;$$!38K9WF2P<<6*F#W5.;@.>R=1/9@
M*G,7_HTM^!O)=VV]],(%*.@2645>GZ++ LP4HU,T0;DF@M_Y\F+P'/;>@M^;
M?QU$\5O5OR%S HT$U+7=E)2.5"+IQ6"M(=_)<-N\1VZK.M7Q+[[W<1J&$D[/
M>+M64)*2S99C .-$JMTP! 177'V=PR+IT\)M\_?=/T6=ZBY0V*-.=1>Y= "U
M[6HA@V$<->GKR,3F? 9PHCXK-,$8+U%9W;IU\T]2I[H3'/:J4]U%-AT [EVX
MVDU]Y7Y?Y:WQP6 2%$30P51.U[&UQ#.MLI B2IE]:]7V-%6=7K$T@EICJ72
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M3><C\AAY\[&*/T/%YTY(V*/B<Q>Q](RTWY>+U6K"!'.\$(^,8A3+<.X@E%@
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M!?((*<M.L3VJ.=U"&)UBJGZZ1;SIU902K4D05[*A$]()B#S4W6:E85QZCL=
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M/L;*>LF3F@#"'\[M[A#1P3XY:(%W[D%+PNQT'14J:PD_2@?>,+)R$(47#'G
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MK03C$+.+P$WVQ:GD!G:6G3#WX/C]X28 83(3E\;!8VVZA5/"VIJQR%D Q4N
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M/4_O==S%A/C%5!XNCX)]TR=#R$)$HCLY1;9-/>!BR1D,^;\Z6!62'C0@:?P
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M:;)[A5!/0&!Z6MV;@YHB'\F\;)V).8[?'<#FD4Z:-AO:+&BKI^2),\5 4"Z
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M6-XI<NJG6[P.I%E!7@IGG#Q>6I4JJ8"33(,E%NF2F?+-6^T]2]2RMTU-1#\
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M"UQE'F5TW$$2Y'^J: PI7Q] (CD:9!XR*9MKK"&$#0/92PESSR>3_H!VG39
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M]%(+GS@SO/54ZE=(ZL2S.5[Y3SOR&FJBB_V*&X;J+BA\,\\?Z!]L8:LV$JC
M-!1IR?PR0_Y@L0R""(9%YC.SK?O:]R*LOU"L*<P::J4GL+U;+''V>;[E]*12
ME.8<O"]D\(,,X)1)D*(2V5EK9&S=(/<*2?VYW&WM6 M-] 2M.XD]X<=)HY0Q
M=#:\,C6@#20KE""D2":ZQ'WSB4$O4]2?S]446"WTT('C=5ODL+GO=W$EM7)9
M" <>,=[D'4/R"%DHA]DS;>Q8Y7@O4S9M)]!X*!M!+UU8L5N^'EW\.[GC0C.F
M/'@MZ?IW)4.4*H.(427+>=%^K.FD^] W;8O0^-AKKJ.N$+CQ#';QQ6/*/-I
M7N=Z=I?V$"@<!ZN#K%,$N99C-0R]3-FTL]1.8/':Z:4KO.UD2,4DZ@Q47@R"
M(AF1]%PD$XZF2DQX/GJSQ0$(&VV:VO@(:Z&)+J"UBY$<2TYU8D*))H-*08,+
M)"X=<A)"6?2E];UY#)1&&Y8V'I1:2+X#[[^65<S3['*V5LG'766PO_R5+J\S
M"?#-U_5:B-]NYN[2'_RQ^.6O\)5$6O_Z)[RZ7LX?%LU>%)T+$SR#M*R.>A;D
M'122,2NR#NHEQR&W1N+8/.WW\#O:?M3Q,-T5&#HX'#OXOZC3%;R2&G1D)&.5
M%'A),5>,47JMI$NI-:9WD#)M#J(OO.RW)GJ0\@[&X+=U8I?"I^75F$@D4[#$
ML,+5)UQ=7U9C\(Z4M'F?NDDNURSSW6AT#":9NNLDR,S(O_'DWSA=4S<&E4O*
M<M'Z\;D-Y=,F0<X1YV-"HU_3O)WKWXC;Y1:>A96"^U(H=+0D]FPE^$BF0)<Z
MWC8CDZ)UJ5P+NJ=-V/PXAZ$%+/H]"C_C$)ZU=3:3A(%ENAH5<P4B9DN_U!>5
M(C5G)W)I!M$];8KI'(_">+#H8O+B(*[OUV&O_FMV]87^?E72IJ2W=OJB4]$9
MN@\UK]N)&#F,OG"D2U%'I0)#65H7.S9E8-K<V(]S/)H"I>=S\@GS]7KDTF/^
M/X1O*_Q8WGS[=CE+M6ZQ)H:NK^B//LR^SFX0M;H(3A7&HX?,2">J% 71%0\\
M9M*$9X9CZP*$$=B8-J=WCF?F9*#I9Q['KL>%3/(,M8@W*G1UIH@!KXJ%%*S"
M]5+%TCJ5<\S+T&A)PG.$\2#E'?DR],O\H1EO/-3C;]=A&>97B(<,Z'CPCYL,
MV]A%S-W@C/\XE,UW8;:L6Y#P[W1A7R]OKN<#.-[^<YHPOP>)C0:(W'W2_<B(
M^P&QUOEJ2 78'"+96.GIL(@$(J>2Z:N@1>M*AI?H.=;X;I/J^_FW:_+>[C[L
M#Y+K3_2/_OM"2\Z-HQB^H/:@I!/@G(^ UDB%F+S@K>NZ!Q$X[1-^,]P\-;+C
M*:F#)Y=M4KMG)DJK4ZA#;GUM %6N]G"Y3,PX(:,MP?+6?O"+!$W[>#X^PHY6
M0C-$-;[(MUX?Z[ZQ9O?<YJ>-=]MM(_<4=UY,"3U'"L'#S834NA91)>"I8+0Y
M,I=/<0A;W7FW@\H^EKM/V6S\>S1&>2/Y_'%.'OCU<DF>]$]A-;O1POWA*%S'
MJ#VYMI;<725RW4X1D QOE('DYD3SHHRF#'1\9P[!W5.+-IV2S\H"WOWAHFP;
M)7XKGL4\/);/X5,+1R%C/)O;5$ G"5!X2CD*"SYF#2IK!H'% D84[Z*)):K6
MB=B3!"A[GE[Z"[\NZJ/$T\-\84VP/F&&:'P&9=&!-_4,&QZP2"[:5QHU([YC
M(ST$;SO=SI,JMZ>@YZ?O#XS-NR7^\[J6(*[G8:"*22>+Y,\["PI+@BB$!PKA
MI"[%%"Y:=XGM058G2#PM8';!MI'V>@+D-H8V0U62+*X(I@!S(I:*1_"*CKOB
M2G*2&OUQZZEJ>Y#5"2!;06&/IY]C]-(IU%9W)W8SB]!94QS3L8[ K(,QHJBE
MUP:P-BP5Q:(JK=?%[$-7)V!K!88]P':49GI%V\,[8<.6)B]&^.)!Z#I]RM#-
MX&M.K+C(.&?&!M%ZR-*>I'7RY'A*S!VIGYY@]]/WNR__<X9+(NK+]P_X)UZN
MKP91A%6926 .27*,6/.A",A)NEC73KKF15'[4=8)Z'IQ\UKIL"=D;GWEN.-O
M<[1-L=)(%D$F<EM4X@)<%JS.R1?HDHNI>2WK( ([N9 ;(F0?^]A$73UA\2:;
MN988WQA\:4R.=4UJ\'440HP>8N8<@O):F9S1B]%RS<_)Z01G[4&P"VY':J13
M<(D-*T:0SXHE$@8,L<(#!R=<!,:93%P&^H/1WE:>D]/)93L)N [12*?@DG>N
MJI76HP)75 "E:B*>)T:<J8Q2H<^N=>'B"^1,V^$T+;@.T4A/X#K"_?UPU\7.
M@F$"$T)PN9ZL3,XP\0U)I.BCD9ZYT6*,%@QT N ^0I&3(Z*#XW##\Y8DU%T.
M2K-BG*Z>"=8*9J<CN&0$J. <DM<B-6O],OTJ49UXC*<'S&),[74 Q[=A]87$
M5?_SRS^O9W^&RT=WVCV#%^0/NZA"!A9XG5[I$+Q+DFZWD&R(VHF@&\-R;^*F
MA6=C4#P=*CJ*ACJ WL^X)&ZN9G]NCO6#,_WFZHZ_7_'J(M)YS<(G*$X28Z@+
M>$8!FXWD"C'O%8;652![$S=MN#,N],;14 ?0>S__$U=77W<=)".M]4K7 ="\
M#A(,?K,D6''N N:@16M3]S)%TWJ-XX*LH2XZ0-:#(_*2P)Q+WF22E8A>@_(Y
MU67C"-E90=\SR=K6/MY^E'7R>C.YHS>"'CM Y_X&G17'8PP&!"^U1C@:\,73
ML2;3+GDBVF+[^<HMK]S1O+TQD''PO3M$36=5ROVX3WA1MMB!<"^*9P7+_UC1
M5_^8+^(*EW_6!XN'[VB-R[U/0>IX)>$G%_0IRL:5"#EPY0!5S5$F#."**1"E
M$$G+Q*T_X[+Q76T>S]3P6+<W#W<QIB@XUY!T7<PLZQ+*(JL!B1@]T\[F..X#
MZC'D=_(.=2SF7GD1/9F".W!)]JPZ0.Y<T,C!A%IVJC,#)Y2$[!6/W$25_&@5
M;<?7%IWJ9?1TP#FLNFB(%GO"YE[Y/NY=01,EQ1<VUNF "6*B2)5G$5-@,7,Y
MFF7]8:J+!B'DJ.JB(>KJ"8M;:EF\T2S0*:48-V90 5.=5..!4<@K3 FQ_4*2
M'Z2Z:! (!E07#=%(I^"ZK64IJ1B=?(:P'JB4M:,361._23+Z/ZDE^S_512<!
MUR$:Z11<M[4L*!27RDHP3--AJ<M[@C7UG5<*F:/(.HQV9YYW=5%K<!VBD9[
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M8^AV-[?/0=01B(7^2[;?.X@L>/(WBW9DJY,3S8?\OT10+X Z5N]/K\EF2N@
M4>_G]+-P=?4I7.'O_PK?;KU%NO"3B @HN08EK8+(A8<DN-!.615TZ[+5[93T
MTC_<&$,-Q'XP>/[$95RTBNZ6% &_O:;/GJ?O#YEZ<BKJ.!!AC !IM0'%>(#
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M76IKU_#J$6="<-0Q,_"VU/'BVD,H/ -+VL4<F$K-QROL3]VT@>!(Z!I).1W
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M#W!^BONPSVD[K6^]@Z3>%8*VM%!GI$,EC0/C-/FEJJX)2=[4Y<O:)TL<-;=
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M:H@RNL#7084X').Q+$7(H1:+6^TA2!,@\H0\.&8<MM[G]$-,E#KB,CR!ICK
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M9IQN5&O=ZGA9KX(,VI;6(^0>/="T"&K&]N\,ZU8\Z !0=^ZPC;=+Y3E+6 ?
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MUQ)14<"A<Z")^M)%:1-O#>L#CCNMI7$L+!^+GUVLOKI[E1IOV>'9NPQ8UOI
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M[0T<5])CBA/16G!:5E,K! @RU@Q!T,XKPZW;Y:EYX.>GTQH-&/88^_>@7F\
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M'Q_;/;?*\?_^L/CR_VQ_\1(,VW^XQL'U]Z8K?&G+_CTIV($JV*FM0V..6ID
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ME&1Y#8PRQT%QRP&+K7T (H8HN([>G(PX_N!SX;N4R,,@]R,(Y7=&?(C>ZX#
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M;ED!I)%]+=A*NGGNXUE.1!@$@D<G(@SA2 =PVI]PCW1"NQ "MXY#9CF#8C:
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M,3 Q-#8N:'1M4$L! A0#%     @ &H(+51H8'4K\!P  /2<  !\
M     ( !-Q$  &$R,G$T7S$P:W@P-C,P,C)X97AH:6)I=#,Q,2YH=&U02P$"
M% ,4    "  :@@M5NHT^A ((  "T)P  'P              @ %P&0  83(R
M<31?,3!K># V,S R,GAE>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( !J""U60
M0$4,[ 0  &P7   ?              "  :\A  !A,C)Q-%\Q,&MX,#8S,#(R
M>&5X:&EB:70S,C$N:'1M4$L! A0#%     @ &H(+50*\FIOR&P  +;   !\
M             ( !V"8  &$R,G$T7S$P:W@P-C,P,C)X97AH:6)I=#DY,2YH
M=&U02P$"% ,4    "  :@@M5.]/)$V -  !=+@$ '@              @ $'
M0P  83(R<31?,3!K>#8S,#(R>&5X:&EB:70R,3$N:'1M4$L! A0#%     @
M&H(+5?Z+],8S!P  =%4  !X              ( !HU   &$R,G$T7S$P:W@V
M,S R,GAE>&AI8FET,C,Q+FAT;5!+ 0(4 Q0    ( !J""U4;UV+D)WL$ 'HE
M,@ 0              "  1)8  !C86@M,C R,C V,S N:'1M4$L! A0#%
M  @ &H(+59 R L]%(   ?WX! !               ( !9],$ &-A:"TR,#(R
M,#8S,"YX<V102P$"% ,4    "  :@@M5-))1L4HD  !-9P$ %
M    @ ':\P0 8V%H+3(P,C(P-C,P7V-A;"YX;6Q02P$"% ,4    "  :@@M5
M(8)4\RG?  !P/0H %               @ %6& 4 8V%H+3(P,C(P-C,P7V1E
M9BYX;6Q02P$"% ,4    "  :@@M5HZ@Y3Q9,  !<7   $P
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M,C R,C V,S!?9S4N:G!G4$L! A0#%     @ &H(+519P'^MF-   #D,  !,
M             ( !;4\' &-A:"TR,#(R,#8S,%]G-BYJ<&=02P$"% ,4
M"  :@@M5?N:]_@8^ 0 #OP$ $P              @ $$A < 8V%H+3(P,C(P
M-C,P7V<W+FIP9U!+ 0(4 Q0    ( !J""U4B(-):K9,! (AE$  4
M      "  3O"" !C86@M,C R,C V,S!?;&%B+GAM;%!+ 0(4 Q0    ( !J"
M"U7Q$_+DF2P! $D,#@ 4              "  1I6"@!C86@M,C R,C V,S!?
=<')E+GAM;%!+!08     %  4 &$%  #E@@L    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
